Citrus Sinensis ID: 005289
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 704 | 2.2.26 [Sep-21-2011] | |||||||
| Q9ZVM9 | 572 | Probable serine/threonine | no | no | 0.526 | 0.648 | 0.666 | 1e-157 | |
| F4I114 | 714 | Probable serine/threonine | no | no | 0.779 | 0.768 | 0.507 | 1e-156 | |
| Q5JK68 | 513 | Cyclin-dependent kinase C | no | no | 0.494 | 0.678 | 0.487 | 6e-96 | |
| Q9LFT8 | 505 | Cyclin-dependent kinase C | no | no | 0.494 | 0.689 | 0.490 | 2e-94 | |
| Q6I5Y0 | 519 | Cyclin-dependent kinase C | no | no | 0.497 | 0.674 | 0.477 | 4e-93 | |
| Q8W4P1 | 513 | Cyclin-dependent kinase C | no | no | 0.461 | 0.633 | 0.507 | 1e-92 | |
| E1BB52 | 1512 | Cyclin-dependent kinase 1 | no | no | 0.522 | 0.243 | 0.416 | 5e-78 | |
| Q14004 | 1512 | Cyclin-dependent kinase 1 | yes | no | 0.480 | 0.223 | 0.436 | 6e-78 | |
| Q69ZA1 | 1511 | Cyclin-dependent kinase 1 | yes | no | 0.480 | 0.223 | 0.436 | 8e-78 | |
| B5DE93 | 1239 | Cyclin-dependent kinase 1 | yes | no | 0.407 | 0.231 | 0.466 | 7e-77 |
| >sp|Q9ZVM9|Y1461_ARATH Probable serine/threonine-protein kinase At1g54610 OS=Arabidopsis thaliana GN=At1g54610 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 556 bits (1433), Expect = e-157, Method: Compositional matrix adjust.
Identities = 248/372 (66%), Positives = 309/372 (83%), Gaps = 1/372 (0%)
Query: 92 RLGNLHKYIEGEQVAAGWPAWLSAVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARD 151
RL N K+ GEQVAAGWP+WLS GEA+ GWVP +AD FEK++KIGQGTYS+V++A+D
Sbjct: 78 RLSNPSKHWRGEQVAAGWPSWLSDACGEALNGWVPRKADTFEKIDKIGQGTYSNVYKAKD 137
Query: 152 LDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFE 211
+ TGKIVALKKVRFDN EPESV+FMAREIL+LRRLDHPN++KLEGL+TSR+SCS+YLVF+
Sbjct: 138 MLTGKIVALKKVRFDNLEPESVKFMAREILVLRRLDHPNVVKLEGLVTSRMSCSLYLVFQ 197
Query: 212 YMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLK 271
YM+HD+ GL S P +KFSE+++KC M QL+ GLEHCHSRGVLHRDIKGSNLL+++ GVLK
Sbjct: 198 YMDHDLAGLASSPVVKFSESEVKCLMRQLISGLEHCHSRGVLHRDIKGSNLLIDDGGVLK 257
Query: 272 LADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 331
+ADFGLA + H++P+TSRVVTLWYR PELLLGATDYG +DLWS GC+ AELL G+P
Sbjct: 258 IADFGLATIFDPNHKRPMTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCILAELLAGRP 317
Query: 332 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 391
I+ GRTEVEQLHKI+KLCGSP +DYWKK K H ++KP++PY S+RETFKD P +++
Sbjct: 318 IMPGRTEVEQLHKIYKLCGSPSEDYWKKGKFTHGAIYKPREPYKRSIRETFKDFPPSSLP 377
Query: 392 LIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHR-EDARRKKV 450
LI+ LLS+EP R TASAAL SE+F+++PYAC+ + LP YPPSKEIDAK R E+ RR++
Sbjct: 378 LIDALLSIEPEDRQTASAALKSEFFTSEPYACEPADLPKYPPSKEIDAKRRDEETRRQRA 437
Query: 451 GGRVRGAETRKT 462
+ +G RK
Sbjct: 438 ASKAQGDGARKN 449
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|F4I114|Y1960_ARATH Probable serine/threonine-protein kinase At1g09600 OS=Arabidopsis thaliana GN=At1g09600 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 552 bits (1423), Expect = e-156, Method: Compositional matrix adjust.
Identities = 306/603 (50%), Positives = 402/603 (66%), Gaps = 54/603 (8%)
Query: 102 GEQVAAGWPAWLSAVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALK 161
G QV AGWP+WL++VAGEAI GW+P +AD+FEKLEKIGQGTYSSV++ARDL+T ++VALK
Sbjct: 133 GAQVMAGWPSWLASVAGEAINGWIPRKADSFEKLEKIGQGTYSSVYKARDLETNQLVALK 192
Query: 162 KVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL 221
KVRF N +P+SVRFMAREI+ILRRLDHPN++KLEGLITSR+S S+YL+FEYMEHD+ GL
Sbjct: 193 KVRFANMDPDSVRFMAREIIILRRLDHPNVMKLEGLITSRVSGSMYLIFEYMEHDLAGLA 252
Query: 222 SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281
S P I FSEAQIKCYM QLLHGLEHCHSRGVLHRDIKGSNLL+++ LK+ DFGLANF
Sbjct: 253 STPGINFSEAQIKCYMKQLLHGLEHCHSRGVLHRDIKGSNLLLDHNNNLKIGDFGLANFY 312
Query: 282 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ 341
+QPLTSRVVTLWYRPPELLLG+TDYG +VDLWS GC+ AEL GKPI+ GRTEVEQ
Sbjct: 313 QGHQKQPLTSRVVTLWYRPPELLLGSTDYGVTVDLWSTGCILAELFTGKPIMPGRTEVEQ 372
Query: 342 LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEP 401
LHKIFKLCGSP ++YWK SKLPHAT+FKPQQPY + ETFK LP++A+ L+E LL+VEP
Sbjct: 373 LHKIFKLCGSPSEEYWKISKLPHATIFKPQQPYKRCVAETFKSLPSSALALVEVLLAVEP 432
Query: 402 YKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRK 461
R T ++AL SE+F+T P A D SSLP Y P KEID K +E+ ++K + ++++
Sbjct: 433 DARGTTASALESEFFTTSPLASDPSSLPKYQPRKEIDVKAQEEEAKRKKDTSSKQNDSKQ 492
Query: 462 TTRKSHGMSKLAPVEDVAVRTQFAKKINGHSLHILKDDELSGREVQKPLVDNREEASHVK 521
+R+S K P D N SL + R+ Q V N ++ + +
Sbjct: 493 VSRES----KAVPAPDS----------NAESL-----TSIQKRQGQHNQVSNSDKFNPGE 533
Query: 522 NASHGDIPFSGPLQVSTSSGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNN 581
+A+ I PL+ T AK + S R+ + ++ P L T+ +
Sbjct: 534 DAASFRIE---PLKSGT------AKDGHTRYGVSSVNRNGENVMMGSSRSPRKELRTQRS 584
Query: 582 YDSRKHENGDIINGSRTDSRGHDSLEA---VKIAMLN-QWSQLERPDSFDASDGYH---- 633
+ R G+ SR +S+ A A+ N +W + DS++ ++G
Sbjct: 585 FVQR---------GTAQLSRFSNSVAARDGSHFAIANPRWFE----DSYNNNNGRQNGGA 631
Query: 634 -SQELSLALYQREEMATKRNNLGFQ-DQGEKVEFSGPLLSQSHRIDELLERHERQIRQAV 691
SQ L + + +E + ++ ++ E++ SGPL+S +DE+L+ HERQI+ AV
Sbjct: 632 WSQRL---VVKHKEFTKHKESITVNGEKKERMHCSGPLVSAGGNLDEMLKEHERQIQLAV 688
Query: 692 RKS 694
RK+
Sbjct: 689 RKA 691
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q5JK68|CDKC2_ORYSJ Cyclin-dependent kinase C-2 OS=Oryza sativa subsp. japonica GN=CDKC-2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 352 bits (903), Expect = 6e-96, Method: Compositional matrix adjust.
Identities = 181/371 (48%), Positives = 243/371 (65%), Gaps = 23/371 (6%)
Query: 124 WVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILI 182
W D FEKLE+IG+GTY V+ A++ +T +IVALKK+R DN E E A REI I
Sbjct: 17 WGSRSVDCFEKLEQIGEGTYGQVYMAKETETNEIVALKKIRMDN-EREGFPITAIREIKI 75
Query: 183 LRRLDHPNIIKLEGLITS---------------RLSCSIYLVFEYMEHDITGLLSCPDIK 227
L++L H N+I+L+ ++TS + SIY+VFEYM+HD+TGL P ++
Sbjct: 76 LKKLHHQNVIQLKEIVTSPGPERDEQGKPIEGNKYKGSIYMVFEYMDHDLTGLADRPGMR 135
Query: 228 FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287
F+ QIKCYM QLL GL +CH VLHRDIKGSNLL++NEG LKLADFGLA ++ H
Sbjct: 136 FTVPQIKCYMRQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSSDHNG 195
Query: 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 347
LT+RV+TLWYRPPELLLG+T YGP+VD+WSVGC+FAELL GKPIL G+ E EQL KIF+
Sbjct: 196 NLTNRVITLWYRPPELLLGSTRYGPAVDMWSVGCIFAELLNGKPILTGKNEPEQLSKIFE 255
Query: 348 LCGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 406
LCG+P + W +K+P FKPQ+P ++E+FK A++L+E +L+++P +R +
Sbjct: 256 LCGTPDELIWPGVTKMPWYNNFKPQRPMKRRVKESFKHFDQHALDLLEKMLTLDPSQRIS 315
Query: 407 ASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKS 466
A AL +EYF T P CD SLP Y S E K + +R+ A R+ +
Sbjct: 316 AKDALDAEYFWTDPLPCDPKSLPKYEASHEFQTKKKRQQQRQ-----AEEAAKRQKLQHP 370
Query: 467 HGMSKLAPVED 477
S+L P+++
Sbjct: 371 PPHSRLPPIQN 381
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q9LFT8|CDKC1_ARATH Cyclin-dependent kinase C-1 OS=Arabidopsis thaliana GN=CDKC-1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 347 bits (889), Expect = 2e-94, Method: Compositional matrix adjust.
Identities = 181/369 (49%), Positives = 237/369 (64%), Gaps = 21/369 (5%)
Query: 124 WVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILI 182
W D FEKLE+IG+GTY V+ A+++ TG+IVALKK+R DN E E A REI I
Sbjct: 18 WGSRSVDCFEKLEQIGEGTYGQVYMAKEIKTGEIVALKKIRMDN-EREGFPITAIREIKI 76
Query: 183 LRRLDHPNIIKLEGLITS--------------RLSCSIYLVFEYMEHDITGLLSCPDIKF 228
L++L H N+I+L+ ++TS + IY+VFEYM+HD+TGL P ++F
Sbjct: 77 LKKLHHENVIQLKEIVTSPGRDRDDQGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRF 136
Query: 229 SEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288
+ QIKCYM QLL GL +CH VLHRDIKGSNLL++NEG LKLADFGLA + H
Sbjct: 137 TVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSYSHDHTGN 196
Query: 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 348
LT+RV+TLWYRPPELLLGAT YGP++D+WSVGC+FAELL KPIL G+ E EQL+KIF+L
Sbjct: 197 LTNRVITLWYRPPELLLGATKYGPAIDMWSVGCIFAELLHAKPILPGKNEQEQLNKIFEL 256
Query: 349 CGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 407
CGSP + W SK+P FKP +P +RE F+ A+ L+E +L ++P +R +A
Sbjct: 257 CGSPDEKLWPGVSKMPWFNNFKPARPLKRRVREFFRHFDRHALELLEKMLVLDPAQRISA 316
Query: 408 SAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSH 467
AL +EYF T P CD SLP Y S E K + +R+ A+ +K
Sbjct: 317 KDALDAEYFWTDPLPCDPKSLPTYESSHEFQTKKKRQQQRQN----EEAAKRQKLQHPPL 372
Query: 468 GMSKLAPVE 476
S+L P++
Sbjct: 373 QHSRLPPLQ 381
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q6I5Y0|CDKC1_ORYSJ Cyclin-dependent kinase C-1 OS=Oryza sativa subsp. japonica GN=CDKC-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 343 bits (879), Expect = 4e-93, Method: Compositional matrix adjust.
Identities = 178/373 (47%), Positives = 236/373 (63%), Gaps = 23/373 (6%)
Query: 124 WVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILI 182
W D FEKLE+IG+GTY V+ AR+ +T +IVALKK+R DN E E A REI I
Sbjct: 17 WGSRSVDCFEKLEQIGEGTYGQVYMARETETQEIVALKKIRMDN-EREGFPITAIREIKI 75
Query: 183 LRRLDHPNIIKLEGLITS---------------RLSCSIYLVFEYMEHDITGLLSCPDIK 227
L++L H N+I+L+ ++TS + SIY+VFEYM+HD+TGL P ++
Sbjct: 76 LKKLHHQNVIQLKEIVTSPGPERDEQGKPIHGNKYKGSIYMVFEYMDHDLTGLADRPGMR 135
Query: 228 FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287
F+ QIKCYM QLL GL +CH VLHRDIKGSNLL++NEG LKLADFGLA + H
Sbjct: 136 FTVPQIKCYMKQLLTGLHYCHINQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSNDHNG 195
Query: 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 347
LT+RV+TLWYRPPELLLG+T YGP+VD+WSVGC+FAELL GKPIL G+ E EQL KIF
Sbjct: 196 NLTNRVITLWYRPPELLLGSTKYGPAVDMWSVGCIFAELLNGKPILPGKNEPEQLSKIFD 255
Query: 348 LCGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 406
+CG+P + W +K+P FKP + ++E FK A++L+E +L+++P +R +
Sbjct: 256 VCGTPDESNWPGVTKMPWYNNFKPPRQLKRRVKEYFKHFDRLALDLLEKMLTLDPAQRIS 315
Query: 407 ASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKS 466
A AL +EYF + P CD SLP Y S E K + R+ A R+ T+
Sbjct: 316 AQDALDAEYFWSDPLPCDPKSLPKYESSHEFQTKKKRQQMRQ-----ADEAAKRQKTQHP 370
Query: 467 HGMSKLAPVEDVA 479
+L P++
Sbjct: 371 QPHGRLPPIQQTG 383
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q8W4P1|CDKC2_ARATH Cyclin-dependent kinase C-2 OS=Arabidopsis thaliana GN=CDKC-2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 341 bits (875), Expect = 1e-92, Method: Compositional matrix adjust.
Identities = 177/349 (50%), Positives = 228/349 (65%), Gaps = 24/349 (6%)
Query: 124 WVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILI 182
W D FEKLE+IG+GTY V+ A+++ TG+IVALKK+R DN E E A REI I
Sbjct: 18 WGSRSVDCFEKLEQIGEGTYGQVYMAKEIKTGEIVALKKIRMDN-EREGFPITAIREIKI 76
Query: 183 LRRLDHPNIIKLEGLITS--------------RLSCSIYLVFEYMEHDITGLLSCPDIKF 228
L++L H N+I L+ ++TS + IY+VFEYM+HD+TGL P ++F
Sbjct: 77 LKKLHHENVIHLKEIVTSPGRDRDDQGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRF 136
Query: 229 SEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288
+ QIKCYM QLL GL +CH VLHRDIKGSNLL++NEG LKLADFGLA + H
Sbjct: 137 TVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSYSHDHTGN 196
Query: 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 348
LT+RV+TLWYRPPELLLGAT YGP++D+WSVGC+FAELL GKPIL G+TE EQL+KI++L
Sbjct: 197 LTNRVITLWYRPPELLLGATKYGPAIDMWSVGCIFAELLNGKPILPGKTENEQLNKIYEL 256
Query: 349 CGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 407
CGSP + W SK+P K +P +RE ++ A+ L+E +L ++P +R A
Sbjct: 257 CGSPDESNWPGVSKMPWYNQMKSSRPLKRRVREIYRHFDRHALELLEKMLVLDPSQRICA 316
Query: 408 SAALASEYFSTKPYACDLSSLPIYPPSKEIDAK-------HREDARRKK 449
AL +EYF T P CD SLP Y S E K H E+A +K+
Sbjct: 317 KDALDAEYFWTDPLPCDPKSLPTYESSHEFQTKKKRQQMRHNEEAAKKQ 365
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|E1BB52|CDK13_BOVIN Cyclin-dependent kinase 13 OS=Bos taurus GN=CDK13 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 292 bits (748), Expect = 5e-78, Method: Compositional matrix adjust.
Identities = 161/387 (41%), Positives = 227/387 (58%), Gaps = 19/387 (4%)
Query: 124 WVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILI 182
W D F+ + IG+GTY V++ARD DTG++VALKKVR DN E E A REI I
Sbjct: 698 WGKRCVDKFDIIGIIGEGTYGQVYKARDKDTGEMVALKKVRLDN-EKEGFPITAIREIKI 756
Query: 183 LRRLDHPNIIKLEGLITSRLSC--------SIYLVFEYMEHDITGLLSCPDIKFSEAQIK 234
LR+L H +II ++ ++T + + YLVFEYM+HD+ GLL + F+E IK
Sbjct: 757 LRQLTHQSIINMKEIVTDKEDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFNENHIK 816
Query: 235 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 294
+M QL+ GL++CH + LHRDIK SN+L+NN G +KLADFGLA ++ +P T++V+
Sbjct: 817 SFMRQLMEGLDYCHKKNFLHRDIKCSNILLNNRGQIKLADFGLARLYSSEESRPYTNKVI 876
Query: 295 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 354
TLWYRPPELLLG Y P++D+WS GC+ EL KPI Q E+ QL I ++CGSP
Sbjct: 877 TLWYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRICGSPCP 936
Query: 355 DYWKKS-KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413
W KLP+ KP++ Y LRE F +P A++L + +L+++P KR TA AL
Sbjct: 937 AVWPDVIKLPYFNTMKPKKQYRRKLREEFVFIPAAALDLFDYMLALDPSKRCTAEQALQC 996
Query: 414 EYF-STKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRK--SHGM- 469
E+ +P LP++ E+ +K R RR+K G T K RK S GM
Sbjct: 997 EFLRDVEPSKMPPPDLPLWQDCHELWSKKR---RRQKQMGMTDDVSTVKAPRKDLSLGMD 1053
Query: 470 -SKLAPVEDVAVRTQFAKKINGHSLHI 495
S+ + + V +Q + N ++ +
Sbjct: 1054 DSRTSTPQSVLPSSQLKPQGNSNAAPV 1080
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, probably by phosphorylating SRSF1/SF2. Required during hematopoiesis. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q14004|CDK13_HUMAN Cyclin-dependent kinase 13 OS=Homo sapiens GN=CDK13 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 292 bits (748), Expect = 6e-78, Method: Compositional matrix adjust.
Identities = 154/353 (43%), Positives = 212/353 (60%), Gaps = 15/353 (4%)
Query: 124 WVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILI 182
W D F+ + IG+GTY V++ARD DTG++VALKKVR DN E E A REI I
Sbjct: 697 WGKRCVDKFDIIGIIGEGTYGQVYKARDKDTGEMVALKKVRLDN-EKEGFPITAIREIKI 755
Query: 183 LRRLDHPNIIKLEGLITSRLSC--------SIYLVFEYMEHDITGLLSCPDIKFSEAQIK 234
LR+L H +II ++ ++T + + YLVFEYM+HD+ GLL + F+E IK
Sbjct: 756 LRQLTHQSIINMKEIVTDKEDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFNENHIK 815
Query: 235 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 294
+M QL+ GL++CH + LHRDIK SN+L+NN G +KLADFGLA ++ +P T++V+
Sbjct: 816 SFMRQLMEGLDYCHKKNFLHRDIKCSNILLNNRGQIKLADFGLARLYSSEESRPYTNKVI 875
Query: 295 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 354
TLWYRPPELLLG Y P++D+WS GC+ EL KPI Q E+ QL I ++CGSP
Sbjct: 876 TLWYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRICGSPCP 935
Query: 355 DYWKKS-KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413
W KLP+ KP++ Y LRE F +P A++L + +L+++P KR TA AL
Sbjct: 936 AVWPDVIKLPYFNTMKPKKQYRRKLREEFVFIPAAALDLFDYMLALDPSKRCTAEQALQC 995
Query: 414 EYF-STKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRK 465
E+ +P LP++ E+ +K R RR+K G T K RK
Sbjct: 996 EFLRDVEPSKMPPPDLPLWQDCHELWSKKR---RRQKQMGMTDDVSTIKAPRK 1045
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, probably by phosphorylating SRSF1/SF2. Required during hematopoiesis. In case of infection by HIV-1 virus, interacts with HIV-1 Tat protein acetylated at 'Lys-50' and 'Lys-51', thereby increasing HIV-1 mRNA splicing and promoting the production of the doubly spliced HIV-1 protein Nef. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q69ZA1|CDK13_MOUSE Cyclin-dependent kinase 13 OS=Mus musculus GN=Cdk13 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 292 bits (747), Expect = 8e-78, Method: Compositional matrix adjust.
Identities = 154/353 (43%), Positives = 212/353 (60%), Gaps = 15/353 (4%)
Query: 124 WVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILI 182
W D F+ + IG+GTY V++ARD DTG++VALKKVR DN E E A REI I
Sbjct: 697 WGKRCVDKFDIIGIIGEGTYGQVYKARDKDTGEMVALKKVRLDN-EKEGFPITAIREIKI 755
Query: 183 LRRLDHPNIIKLEGLITSRLSC--------SIYLVFEYMEHDITGLLSCPDIKFSEAQIK 234
LR+L H +II ++ ++T + + YLVFEYM+HD+ GLL + F+E IK
Sbjct: 756 LRQLTHQSIINMKEIVTDKEDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFNENHIK 815
Query: 235 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 294
+M QL+ GL++CH + LHRDIK SN+L+NN G +KLADFGLA ++ +P T++V+
Sbjct: 816 SFMRQLMEGLDYCHKKNFLHRDIKCSNILLNNRGQIKLADFGLARLYSSEESRPYTNKVI 875
Query: 295 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 354
TLWYRPPELLLG Y P++D+WS GC+ EL KPI Q E+ QL I ++CGSP
Sbjct: 876 TLWYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRICGSPCP 935
Query: 355 DYWKKS-KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413
W KLP+ KP++ Y LRE F +P A++L + +L+++P KR TA AL
Sbjct: 936 AVWPDVIKLPYFNTMKPKKQYRRKLREEFVFIPAAALDLFDYMLALDPSKRCTAEQALQC 995
Query: 414 EYF-STKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRK 465
E+ +P LP++ E+ +K R RR+K G T K RK
Sbjct: 996 EFLRDVEPSKMPPPDLPLWQDCHELWSKKR---RRQKQMGMTDDLSTIKAPRK 1045
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, probably by phosphorylating SRSF1/SF2. Required during hematopoiesis. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|B5DE93|CDK12_XENTR Cyclin-dependent kinase 12 OS=Xenopus tropicalis GN=cdk12 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 288 bits (738), Expect = 7e-77, Method: Compositional matrix adjust.
Identities = 139/298 (46%), Positives = 194/298 (65%), Gaps = 11/298 (3%)
Query: 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLD 187
D F+ + IG+GTY V++A+D DTG++VALKKVR DN E E A REI ILR+L
Sbjct: 707 VDKFDIIGIIGEGTYGQVYKAKDKDTGELVALKKVRLDN-EKEGFPITAIREIKILRQLI 765
Query: 188 HPNIIKLEGLITSRLSC--------SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQ 239
H +++ ++ ++T + + YLVFEYM+HD+ GLL ++FSE IK +M Q
Sbjct: 766 HKSVVNMKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVQFSEDHIKSFMKQ 825
Query: 240 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYR 299
L+ GLE+CH + LHRDIK SN+L+NN G +KLADFGLA ++ +P T++V+TLWYR
Sbjct: 826 LMEGLEYCHKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYSSEESRPYTNKVITLWYR 885
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359
PPELLLG Y P++D+WS GC+ EL KPI Q E+ QL I +LCGSP W
Sbjct: 886 PPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPD 945
Query: 360 S-KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
KLP+ KP++ Y LRE F +PT A++L++ +L+++P KR TA L S++
Sbjct: 946 VIKLPYFNTMKPKKQYRRRLREEFSFVPTPALDLLDHMLTLDPSKRCTAEQTLQSDFL 1003
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit rpb1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating srsf1/sf2. Xenopus tropicalis (taxid: 8364) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 704 | ||||||
| 255547313 | 661 | ATP binding protein, putative [Ricinus c | 0.937 | 0.998 | 0.761 | 0.0 | |
| 356516828 | 677 | PREDICTED: probable serine/threonine-pro | 0.960 | 0.998 | 0.737 | 0.0 | |
| 224119046 | 685 | predicted protein [Populus trichocarpa] | 0.965 | 0.992 | 0.761 | 0.0 | |
| 356508521 | 674 | PREDICTED: probable serine/threonine-pro | 0.955 | 0.998 | 0.734 | 0.0 | |
| 359491675 | 663 | PREDICTED: probable serine/threonine-pro | 0.933 | 0.990 | 0.744 | 0.0 | |
| 297733936 | 686 | unnamed protein product [Vitis vinifera] | 0.965 | 0.991 | 0.751 | 0.0 | |
| 449439293 | 697 | PREDICTED: probable serine/threonine-pro | 0.981 | 0.991 | 0.723 | 0.0 | |
| 356565121 | 671 | PREDICTED: probable serine/threonine-pro | 0.943 | 0.989 | 0.704 | 0.0 | |
| 356511986 | 670 | PREDICTED: probable serine/threonine-pro | 0.941 | 0.989 | 0.696 | 0.0 | |
| 79346260 | 709 | protein kinase domain-containing protein | 0.985 | 0.978 | 0.680 | 0.0 |
| >gi|255547313|ref|XP_002514714.1| ATP binding protein, putative [Ricinus communis] gi|223546318|gb|EEF47820.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1067 bits (2759), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 537/705 (76%), Positives = 589/705 (83%), Gaps = 45/705 (6%)
Query: 1 MGCVTSKQAVSVTPALDVSGGFRGGDVAEAGGAGDNSGRIRVGNGSGSRNGRGSSNRKKG 60
MGCV+SKQAVSVTPA D SGGF NSGRIR G
Sbjct: 1 MGCVSSKQAVSVTPAFDHSGGF-------------NSGRIRAG----------------- 30
Query: 61 SKGEFGVAVSCGGSELGESGRASSNSESLSFRLGNLHKYIEGEQVAAGWPAWLSAVAGEA 120
ELGESGRASSN ES+SFRL NL KYIEGE VAAGWPAWLSAVAGEA
Sbjct: 31 --------------ELGESGRASSNGESVSFRLRNLQKYIEGEHVAAGWPAWLSAVAGEA 76
Query: 121 IQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREI 180
IQGWVPL+ADAFEKLEKIGQGTYSSVFRAR+++TG+IVALKKVRFDNFEPESVRFMAREI
Sbjct: 77 IQGWVPLKADAFEKLEKIGQGTYSSVFRAREIETGRIVALKKVRFDNFEPESVRFMAREI 136
Query: 181 LILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQL 240
LILRRLDHPN++KL+GLITSRLSCSIYLVFEYMEHDITGLLSCPD++FSE+QIKCYM QL
Sbjct: 137 LILRRLDHPNVMKLDGLITSRLSCSIYLVFEYMEHDITGLLSCPDVRFSESQIKCYMRQL 196
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP 300
L GLEHCHS+GV+HRDIKGSNLLVNNEG+LK+ DFGLANF +TGHRQPLTSRVVTLWYRP
Sbjct: 197 LFGLEHCHSKGVMHRDIKGSNLLVNNEGMLKVGDFGLANFCHTGHRQPLTSRVVTLWYRP 256
Query: 301 PELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360
PELLLG+T+YG SVDLWSVGCVFAELL+GKP+LQGRTEVEQLHKIFKLCGSPPD+YWKKS
Sbjct: 257 PELLLGSTEYGASVDLWSVGCVFAELLLGKPVLQGRTEVEQLHKIFKLCGSPPDEYWKKS 316
Query: 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420
+LPHATLFKPQQPYDSSLRE FKDLPTTAVNLIETLLSVEPYKR TAS+ALASEYF TKP
Sbjct: 317 RLPHATLFKPQQPYDSSLREIFKDLPTTAVNLIETLLSVEPYKRGTASSALASEYFMTKP 376
Query: 421 YACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVEDVAV 480
YACD SSLP YPPSKEIDAK+RE+ARRKK GR RGAETRK RK G++KLAP ED
Sbjct: 377 YACDPSSLPKYPPSKEIDAKNREEARRKKTSGRSRGAETRKPARKPGGINKLAPAEDATA 436
Query: 481 RTQFAKKINGHSLHILKD-DELSGREVQKPLVDNREEASHVKNASHGDIPFSGPLQVSTS 539
R Q ++ ++ + K D SG E +K +D EE HVKNAS GDIPFSGPLQVS+S
Sbjct: 437 RIQGSQNSITTNVCLPKGVDAKSGGEARKASLDKLEEIFHVKNASQGDIPFSGPLQVSSS 496
Query: 540 SGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSRKHENGDIINGSRTD 599
SGFAWA+RRKDDAS+RSH+RSTSR + N LE S AL ++N+DSR+ ENGD I G RT+
Sbjct: 497 SGFAWARRRKDDASVRSHSRSTSRSLINNGLENSTALQEKSNFDSRRRENGDAIYGIRTN 556
Query: 600 SRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMATKRNNLGFQDQ 659
SRGHDS E K A+ QWSQLERPDSFDAS+GYHSQELSLALYQREEM +RNNLGFQDQ
Sbjct: 557 SRGHDSNEISKRALQKQWSQLERPDSFDASEGYHSQELSLALYQREEMEARRNNLGFQDQ 616
Query: 660 GEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQRGKKFRK 704
G+KV+FSGPLLSQSHR+DELLERHERQIRQAVRKSWFQRGKK K
Sbjct: 617 GDKVDFSGPLLSQSHRVDELLERHERQIRQAVRKSWFQRGKKHGK 661
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356516828|ref|XP_003527095.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1061 bits (2744), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 520/705 (73%), Positives = 584/705 (82%), Gaps = 29/705 (4%)
Query: 1 MGCVTSKQAVSVTPALDVSGGFRGGDVAEAGGAGDNSGRIRVGNGSGSRNGRGSSNRKKG 60
MGCV+SKQAVSVTPA+D SG FR + AGG + ++
Sbjct: 1 MGCVSSKQAVSVTPAIDHSGAFR----SNAGGLAE------------------PEKKRSK 38
Query: 61 SKGEFGVAVSCGGSELGESGRASSNSESLSFRLGNLHKYIEGEQVAAGWPAWLSAVAGEA 120
+ E G A SE+GESGR SSN +SLSFRLGNLHKY++GE VAAGWPAWLSAVAGEA
Sbjct: 39 KRTESGGA---SQSEVGESGRTSSNCDSLSFRLGNLHKYVQGEHVAAGWPAWLSAVAGEA 95
Query: 121 IQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREI 180
I GWVPLRADAFEKLEKIGQGTYSSVFRAR+L+TGKIVALKKVRFDNFEPESVRFMAREI
Sbjct: 96 IHGWVPLRADAFEKLEKIGQGTYSSVFRARELETGKIVALKKVRFDNFEPESVRFMAREI 155
Query: 181 LILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQL 240
LILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS PDIKF+E QIKCYM QL
Sbjct: 156 LILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSSPDIKFTEPQIKCYMKQL 215
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP 300
L GLEHCH RGV+HRDIKGSNLLVNNEGVLK+ADFGLANF N GHRQPLTSRVVTLWYRP
Sbjct: 216 LVGLEHCHLRGVMHRDIKGSNLLVNNEGVLKVADFGLANFVNPGHRQPLTSRVVTLWYRP 275
Query: 301 PELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360
PELLLG+TDYGP+VDLWSVGCVFAELL+GKPILQGRTEVEQLHKIFKLCGSPPD+YWKKS
Sbjct: 276 PELLLGSTDYGPAVDLWSVGCVFAELLVGKPILQGRTEVEQLHKIFKLCGSPPDEYWKKS 335
Query: 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420
+LPHATLFKPQQPYDS LR++FKDLP T+V+L++TLLS+EPYKR TA++AL+SEYF TKP
Sbjct: 336 RLPHATLFKPQQPYDSCLRQSFKDLPVTSVHLLQTLLSIEPYKRGTATSALSSEYFKTKP 395
Query: 421 YACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVEDVAV 480
YACD SSLP+YPPSKEIDAKHRE++ RKK+ GRVRG ETRK +RK G +KLAP ED+A
Sbjct: 396 YACDPSSLPVYPPSKEIDAKHREES-RKKISGRVRGTETRKPSRKPLGFNKLAPAEDLAS 454
Query: 481 RTQFAKKINGHSLHILKDDELS-GREVQKPLVDNREEASHVKNASHGDIPFSGPLQVSTS 539
+TQ + K+N S +L+++ G + QKP E+ASHVKNAS GDIP SGPLQVSTS
Sbjct: 455 QTQTSHKVNARSFRVLEEERTKIGDKAQKPSSGKPEDASHVKNASQGDIPLSGPLQVSTS 514
Query: 540 SGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSRKHENGDIINGSRTD 599
SGFAWAK RKDD S RSH R+ SRG N LEP L++RNN D+R EN + G T+
Sbjct: 515 SGFAWAKSRKDDTSFRSHCRTISRGHTFNPLEP-CTLNSRNNLDTRNQENKEFSGGC-TN 572
Query: 600 SRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMATKRNNLGFQDQ 659
SRGHD LE K++M NQWS+ +RPDSFDASD YHSQELS+ALY RE+ A+KR+NL FQDQ
Sbjct: 573 SRGHDLLEISKLSMQNQWSKFDRPDSFDASDEYHSQELSIALYHREDSASKRSNLSFQDQ 632
Query: 660 GEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQRGKKFRK 704
GEKVEFSGPLLSQ H +DELLERHER IR+ VR+SWFQRGKK K
Sbjct: 633 GEKVEFSGPLLSQMHTVDELLERHERHIRRTVRRSWFQRGKKLGK 677
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224119046|ref|XP_002317972.1| predicted protein [Populus trichocarpa] gi|222858645|gb|EEE96192.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1059 bits (2738), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 540/709 (76%), Positives = 596/709 (84%), Gaps = 29/709 (4%)
Query: 1 MGCVTSKQAVSVTPALDVSGGFRGGDVAEAGGAGDNSGRIRVG---NGSGSRNGRGSSNR 57
MGCV++KQAVSVTPALD SG F N+GRIRVG + S +NG +R
Sbjct: 1 MGCVSAKQAVSVTPALDHSGAF-------------NTGRIRVGVDQHPSFKKNG----DR 43
Query: 58 KKGSKGEFGVAVSCGGSELGESGRA-SSNSESLSFRLGNLHKYIEGEQVAAGWPAWLSAV 116
+ + + VSCGGSELGESGRA SSN ESLSFRL NLHKYIEGEQVAAGWPAWLSAV
Sbjct: 44 RHHHE----MVVSCGGSELGESGRAPSSNGESLSFRLRNLHKYIEGEQVAAGWPAWLSAV 99
Query: 117 AGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFM 176
AGEAI GWVPL AD FEKL+KIGQGTYSSVFRAR+ +TG+IVALKKVRFDNFEPESVRFM
Sbjct: 100 AGEAIHGWVPLNADGFEKLDKIGQGTYSSVFRARETETGRIVALKKVRFDNFEPESVRFM 159
Query: 177 AREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCY 236
AREILILRRLDHPNI+KL+GLITSRLSCS+YLVFEYMEHDITGLLSCPD++FSE+QIKCY
Sbjct: 160 AREILILRRLDHPNIMKLDGLITSRLSCSLYLVFEYMEHDITGLLSCPDVRFSESQIKCY 219
Query: 237 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 296
M QLL GL+HCHS+GV+HRDIKGSNLLVNNEG+LK+ DFGLANF +GHRQPLTSRVVTL
Sbjct: 220 MRQLLSGLDHCHSKGVMHRDIKGSNLLVNNEGILKVGDFGLANFCTSGHRQPLTSRVVTL 279
Query: 297 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 356
WYRPPELLLG+TDYG SVDLWSVGCVFAELL+GKPILQGRTEVEQLHKIFKLCGSPPD+Y
Sbjct: 280 WYRPPELLLGSTDYGASVDLWSVGCVFAELLLGKPILQGRTEVEQLHKIFKLCGSPPDEY 339
Query: 357 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
WKKSKLPHATLFKPQQPYDS LRETFKDLPTTAVNLIETLLSVEPY R TA +ALASEYF
Sbjct: 340 WKKSKLPHATLFKPQQPYDSCLRETFKDLPTTAVNLIETLLSVEPYNRGTAFSALASEYF 399
Query: 417 STKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVE 476
STKPYACD SSLP YPPSKEIDAK E+A RKK+ GR RG ETRK TRK +G+SKLAP E
Sbjct: 400 STKPYACDPSSLPKYPPSKEIDAKKHEEAGRKKISGRGRGTETRKCTRKPYGISKLAPAE 459
Query: 477 DVAVRTQFAKKINGHSLHILK-DDELSGREVQKPLVDNREEASHVKNASHGDIPFSGPLQ 535
D+A R Q +IN ++ I K D SG E +KP +D EE H+KNAS GDIPFSGPLQ
Sbjct: 460 DLAARIQCG-QINTSNMRIPKVRDGKSGGEARKPSLDKLEEIFHIKNASQGDIPFSGPLQ 518
Query: 536 VSTSSGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSRKHENGDIING 595
VS+SSGFAWAKRR DASIRSH+RS SRG N LEPS+ +NN DS++H NGD+I G
Sbjct: 519 VSSSSGFAWAKRRNGDASIRSHSRSISRGHSNNGLEPSS--EEKNNSDSKQHNNGDLIYG 576
Query: 596 SRTDSRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMATKRNNLG 655
RT+SRGH+S E K A+ QWSQ ERPDSFDAS+ YHSQELSLALYQRE M +KR+NL
Sbjct: 577 VRTNSRGHNSYEISKFALQKQWSQFERPDSFDASEEYHSQELSLALYQREGMESKRSNLV 636
Query: 656 FQDQGEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQRGKKFRK 704
FQDQ +KV+FSGPLLSQSHR+DELLERHER IRQAVRKSWF RGKK K
Sbjct: 637 FQDQMDKVDFSGPLLSQSHRVDELLERHERHIRQAVRKSWFHRGKKHGK 685
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356508521|ref|XP_003523004.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1049 bits (2713), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 518/705 (73%), Positives = 580/705 (82%), Gaps = 32/705 (4%)
Query: 1 MGCVTSKQAVSVTPALDVSGGFRGGDVAEAGGAGDNSGRIRVGNGSGSRNGRGSSNRKKG 60
MGCV+SKQAVSVTPA+D G FR + AGG + + R +G G
Sbjct: 1 MGCVSSKQAVSVTPAIDHYGAFR----SNAGGPCEPEKK-RTESGGGPSQ---------- 45
Query: 61 SKGEFGVAVSCGGSELGESGRASSNSESLSFRLGNLHKYIEGEQVAAGWPAWLSAVAGEA 120
SE+GESGR SSN ESLSFRLGNL KY++GE VAAGWPAWLSAVAGEA
Sbjct: 46 -------------SEVGESGRTSSNCESLSFRLGNLQKYVQGEHVAAGWPAWLSAVAGEA 92
Query: 121 IQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREI 180
IQGWVPLRADAFEKLEKIGQGTYSSVFRAR+L+T KIVALKKVRFDNFEPESVRFMAREI
Sbjct: 93 IQGWVPLRADAFEKLEKIGQGTYSSVFRARELETRKIVALKKVRFDNFEPESVRFMAREI 152
Query: 181 LILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQL 240
LILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS PDIKF+E QIKCYM QL
Sbjct: 153 LILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSSPDIKFTEPQIKCYMKQL 212
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP 300
L GLEHCH RGV+HRDIKGSNLLVNNEGVLK+ADFGLAN+ N+GHRQPLTSRVVTLWYRP
Sbjct: 213 LAGLEHCHLRGVMHRDIKGSNLLVNNEGVLKVADFGLANYVNSGHRQPLTSRVVTLWYRP 272
Query: 301 PELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360
PELLLG+TDY PSVDLWSVGCVFAELL+GKPILQGRTEVEQLHKIFKLCGSPPD+YWKKS
Sbjct: 273 PELLLGSTDYDPSVDLWSVGCVFAELLVGKPILQGRTEVEQLHKIFKLCGSPPDEYWKKS 332
Query: 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420
KLPHATLFKP+QPYDS LR++FKDLPTT+V+L++TLLSVEPYKR TA++AL+SEYF TKP
Sbjct: 333 KLPHATLFKPEQPYDSCLRQSFKDLPTTSVHLLQTLLSVEPYKRGTATSALSSEYFKTKP 392
Query: 421 YACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVEDVAV 480
YACD SSLP+YPPSKEIDAKHR D RKK+ GRVRG TRK +RK G +KLAP E +A
Sbjct: 393 YACDPSSLPVYPPSKEIDAKHR-DESRKKISGRVRGTATRKPSRKPLGFNKLAPAEGLAS 451
Query: 481 RTQFAKKINGHSLHILKDDELS-GREVQKPLVDNREEASHVKNASHGDIPFSGPLQVSTS 539
+TQ ++K+NG S HIL+++++ G + QK E+A H+KNAS GDIP SGPLQVSTS
Sbjct: 452 QTQTSQKVNGRSFHILEEEKIKIGDKAQKSSSGKPEDAFHMKNASQGDIPLSGPLQVSTS 511
Query: 540 SGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSRKHENGDIINGSRTD 599
SGFAWAK RKDD S RSH R+ SRG + NALEPS L+TRNN D+ EN + G +
Sbjct: 512 SGFAWAKSRKDDTSFRSHCRTISRGHIFNALEPS-TLNTRNNLDTTNQENKEFC-GRYPN 569
Query: 600 SRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMATKRNNLGFQDQ 659
SRGHD LE K++M NQWS+ +RPDSFDASD YHSQELS ALY RE+ +KR+NL FQDQ
Sbjct: 570 SRGHDLLEISKLSMQNQWSKFDRPDSFDASDEYHSQELSTALYHREDSVSKRSNLTFQDQ 629
Query: 660 GEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQRGKKFRK 704
GEKVEFSGPLLSQ H +DELLERHER IR+ VR+SWFQRGKK K
Sbjct: 630 GEKVEFSGPLLSQMHTVDELLERHERHIRRTVRRSWFQRGKKLGK 674
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491675|ref|XP_003634302.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1041 bits (2691), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 524/704 (74%), Positives = 587/704 (83%), Gaps = 47/704 (6%)
Query: 1 MGCVTSKQAVSVTPALDVSGGFRGGDVAEAGGAGDNSGRIRVGNGSGSRNGRGSSNRKKG 60
MGCV+SKQAVSVTPA DVS FR DN+G R SR GR
Sbjct: 1 MGCVSSKQAVSVTPAFDVSVAFR-----------DNAGSGR------SRGGR-------- 35
Query: 61 SKGEFGVAVSCGGSELGESGRASSNS--ESLSFRLGNLHKYIEGEQVAAGWPAWLSAVAG 118
LGESGR SSN +SLSFRLGNLHKY+EGEQVAAGWPAWLSAVAG
Sbjct: 36 ---------------LGESGRVSSNGGGDSLSFRLGNLHKYVEGEQVAAGWPAWLSAVAG 80
Query: 119 EAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAR 178
EAIQGWVPLRAD+++ LEKIGQGTYS+VFRAR+L+TG++VALKKVRFDNFEPESVRFMAR
Sbjct: 81 EAIQGWVPLRADSYQTLEKIGQGTYSTVFRARELETGRVVALKKVRFDNFEPESVRFMAR 140
Query: 179 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMN 238
EI ILRRLDHPNI+KL+GLITSRLSCSIYLVFEYMEHD++GL+SCPDIKFSE+Q+KCY
Sbjct: 141 EITILRRLDHPNIVKLDGLITSRLSCSIYLVFEYMEHDLSGLMSCPDIKFSESQVKCYTK 200
Query: 239 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 298
QLL GLEHCHSRGV+HRDIKG+NLLVNNEG+LK+ADFGLANF ++ +RQPLTSRVVTLWY
Sbjct: 201 QLLSGLEHCHSRGVMHRDIKGANLLVNNEGILKIADFGLANFCSSVYRQPLTSRVVTLWY 260
Query: 299 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 358
RPPELLLG+TDYG SVDLWSVGCVFAELL+G+PIL+GRTEVEQLHKIFKLCGSPPD+YWK
Sbjct: 261 RPPELLLGSTDYGASVDLWSVGCVFAELLVGRPILKGRTEVEQLHKIFKLCGSPPDEYWK 320
Query: 359 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418
KSKLPHATLFKPQQPY+S LRE+FKDLPT +V+LIETLLSVEPYKR TAS+ALASEYF T
Sbjct: 321 KSKLPHATLFKPQQPYESCLRESFKDLPTISVDLIETLLSVEPYKRGTASSALASEYFKT 380
Query: 419 KPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVEDV 478
KPYACD SSLP Y P+KEIDAK+RE++RRKKVGGRVRG+E K TRK +G++KL P E+
Sbjct: 381 KPYACDPSSLPKYSPNKEIDAKNREESRRKKVGGRVRGSE--KPTRKPNGINKLVPAENF 438
Query: 479 AVRTQFAKKINGHSLHILKD-DELSGREVQKPLVDNREEASHVKNASHGDIPFSGPLQVS 537
+TQ K+NG+ HI K+ D G E KP +D EASH+KNAS GDIPFSGPLQVS
Sbjct: 439 TAQTQGPHKLNGNGFHIFKEGDGKLGGEPPKPSIDVLTEASHMKNASQGDIPFSGPLQVS 498
Query: 538 TSSGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSRKHENGDIINGSR 597
TSSGFAWAKRRKDDAS RSH+RS+SRG NALEP+AALH RNN S + EN D+ NG R
Sbjct: 499 TSSGFAWAKRRKDDASTRSHSRSSSRGLGCNALEPNAALHARNN--SNRLENSDVSNGGR 556
Query: 598 TDSRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMATKRNNLGFQ 657
TDSRG+DS E K ML QW Q ERPDSFDASD YHSQELSL +Y+REEMA KRN+L +Q
Sbjct: 557 TDSRGYDSSEIAKRVMLKQWGQFERPDSFDASDMYHSQELSLPMYRREEMAAKRNHLSYQ 616
Query: 658 DQGEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQRGKK 701
DQGEKVEFSGPLLSQSHR+DELLERHER IRQAVR+SWFQRGKK
Sbjct: 617 DQGEKVEFSGPLLSQSHRVDELLERHERHIRQAVRRSWFQRGKK 660
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297733936|emb|CBI15183.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1035 bits (2676), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 529/704 (75%), Positives = 594/704 (84%), Gaps = 24/704 (3%)
Query: 1 MGCVTSKQAVSVTPALDVSGGFRGGDVAEAGGAGDNSGRIRVGNGSGSRNGRGSSNRKKG 60
MGCV+SKQAVSVTPA DVS FR DN+G R SR GR + +
Sbjct: 1 MGCVSSKQAVSVTPAFDVSVAFR-----------DNAGSGR------SRGGRVVAAEFEK 43
Query: 61 SKGEFGVAVSCGGSELGESGRASSNS--ESLSFRLGNLHKYIEGEQVAAGWPAWLSAVAG 118
K G GSELGESGR SSN +SLSFRLGNLHKY+EGEQVAAGWPAWLSAVAG
Sbjct: 44 KKKSGGGESGLSGSELGESGRVSSNGGGDSLSFRLGNLHKYVEGEQVAAGWPAWLSAVAG 103
Query: 119 EAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAR 178
EAIQGWVPLRAD+++ LEKIGQGTYS+VFRAR+L+TG++VALKKVRFDNFEPESVRFMAR
Sbjct: 104 EAIQGWVPLRADSYQTLEKIGQGTYSTVFRARELETGRVVALKKVRFDNFEPESVRFMAR 163
Query: 179 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMN 238
EI ILRRLDHPNI+KL+GLITSRLSCSIYLVFEYMEHD++GL+SCPDIKFSE+Q+KCY
Sbjct: 164 EITILRRLDHPNIVKLDGLITSRLSCSIYLVFEYMEHDLSGLMSCPDIKFSESQVKCYTK 223
Query: 239 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 298
QLL GLEHCHSRGV+HRDIKG+NLLVNNEG+LK+ADFGLANF ++ +RQPLTSRVVTLWY
Sbjct: 224 QLLSGLEHCHSRGVMHRDIKGANLLVNNEGILKIADFGLANFCSSVYRQPLTSRVVTLWY 283
Query: 299 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 358
RPPELLLG+TDYG SVDLWSVGCVFAELL+G+PIL+GRTEVEQLHKIFKLCGSPPD+YWK
Sbjct: 284 RPPELLLGSTDYGASVDLWSVGCVFAELLVGRPILKGRTEVEQLHKIFKLCGSPPDEYWK 343
Query: 359 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418
KSKLPHATLFKPQQPY+S LRE+FKDLPT +V+LIETLLSVEPYKR TAS+ALASEYF T
Sbjct: 344 KSKLPHATLFKPQQPYESCLRESFKDLPTISVDLIETLLSVEPYKRGTASSALASEYFKT 403
Query: 419 KPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVEDV 478
KPYACD SSLP Y P+KEIDAK+RE++RRKKVGGRVRG+E K TRK +G++KL P E+
Sbjct: 404 KPYACDPSSLPKYSPNKEIDAKNREESRRKKVGGRVRGSE--KPTRKPNGINKLVPAENF 461
Query: 479 AVRTQFAKKINGHSLHILKD-DELSGREVQKPLVDNREEASHVKNASHGDIPFSGPLQVS 537
+TQ K+NG+ HI K+ D G E KP +D EASH+KNAS GDIPFSGPLQVS
Sbjct: 462 TAQTQGPHKLNGNGFHIFKEGDGKLGGEPPKPSIDVLTEASHMKNASQGDIPFSGPLQVS 521
Query: 538 TSSGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSRKHENGDIINGSR 597
TSSGFAWAKRRKDDAS RSH+RS+SRG NALEP+AALH RNN S + EN D+ NG R
Sbjct: 522 TSSGFAWAKRRKDDASTRSHSRSSSRGLGCNALEPNAALHARNN--SNRLENSDVSNGGR 579
Query: 598 TDSRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMATKRNNLGFQ 657
TDSRG+DS E K ML QW Q ERPDSFDASD YHSQELSL +Y+REEMA KRN+L +Q
Sbjct: 580 TDSRGYDSSEIAKRVMLKQWGQFERPDSFDASDMYHSQELSLPMYRREEMAAKRNHLSYQ 639
Query: 658 DQGEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQRGKK 701
DQGEKVEFSGPLLSQSHR+DELLERHER IRQAVR+SWFQRGKK
Sbjct: 640 DQGEKVEFSGPLLSQSHRVDELLERHERHIRQAVRRSWFQRGKK 683
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449439293|ref|XP_004137420.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Cucumis sativus] gi|449486990|ref|XP_004157463.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1017 bits (2630), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 510/705 (72%), Positives = 581/705 (82%), Gaps = 14/705 (1%)
Query: 1 MGCVTSKQAVSVTPALDVSGGFRGGDVAEAGGAGDNSGRIRVG-NGSGSRNGRGSSNRKK 59
MGCV +KQAVSVTPA D SG FR + G NSGR R+G G + + + KK
Sbjct: 1 MGCVNTKQAVSVTPAFDHSGVFRDNESTAVG----NSGRSRLGLVGEIEKVSKPKAKVKK 56
Query: 60 GSKGEF-GVAVSCGGSELGESGRASSN---SESLSFRLGNLHKYIEGEQVAAGWPAWLSA 115
S EF GV GSE GESGRASS +E+LSFRLGNL+KYIEGEQVAAGWPAWLSA
Sbjct: 57 KSSSEFNGV-----GSEFGESGRASSKGGGNETLSFRLGNLNKYIEGEQVAAGWPAWLSA 111
Query: 116 VAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRF 175
VAGEAIQGWVPLR+DA+EKLEKIGQGTYSSVFRAR+L+TG+IVALKKVRFDNFEPESVRF
Sbjct: 112 VAGEAIQGWVPLRSDAYEKLEKIGQGTYSSVFRARELETGRIVALKKVRFDNFEPESVRF 171
Query: 176 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 235
MAREI+ILR LDHPNIIKLEGLITSRLSCSIYLVFEYM+HDITGLLSCPDI FSE+QIKC
Sbjct: 172 MAREIMILRGLDHPNIIKLEGLITSRLSCSIYLVFEYMDHDITGLLSCPDITFSESQIKC 231
Query: 236 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 295
YM QLL GLEHCHSRGV+HRDIKGSNLLVNNEGVLK+ADFGLANF NTGHRQPLTSRVVT
Sbjct: 232 YMKQLLSGLEHCHSRGVMHRDIKGSNLLVNNEGVLKVADFGLANFCNTGHRQPLTSRVVT 291
Query: 296 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 355
LWYRPPELLLG+TDY SVDLWSVGCVFAELL+GKPILQGRTEVEQLHKIFKLCGSPPD+
Sbjct: 292 LWYRPPELLLGSTDYNASVDLWSVGCVFAELLVGKPILQGRTEVEQLHKIFKLCGSPPDE 351
Query: 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415
YWKKSKLPHATLFKPQ PY++ LR+TFKD P+T VNL+ETLLSVEPYKR AS+AL SEY
Sbjct: 352 YWKKSKLPHATLFKPQHPYNNCLRQTFKDHPSTTVNLLETLLSVEPYKRGVASSALISEY 411
Query: 416 FSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPV 475
FSTKPYACD SS+PIYPP+KEIDAK RE+ RRKK GR RG + R+ TRK G+SKLAP
Sbjct: 412 FSTKPYACDPSSMPIYPPNKEIDAKQREETRRKKGSGRSRGLDNRRLTRKHLGISKLAPA 471
Query: 476 EDVAVRTQFAKKINGHSLHILKDDELSGREVQKPLVDNREEASHVKNASHGDIPFSGPLQ 535
ED++V + KI+ ++ ++ ++ + G E +K +D EE HVKN+S GDIPFSGPLQ
Sbjct: 472 EDLSVSARDLHKISINAQNLKEEKVIKGVEAEKMSMDKLEETIHVKNSSQGDIPFSGPLQ 531
Query: 536 VSTSSGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSRKHENGDIING 595
VSTSSGFAWA+RR+DDASIR ++RS SRG +IN LE S LH+ +N DS+ HE D+ +
Sbjct: 532 VSTSSGFAWARRRRDDASIRCYSRSISRGHLINGLEDSTTLHSISNLDSKIHEKSDMSSI 591
Query: 596 SRTDSRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMATKRNNLG 655
SR+ S+GH+S E K+ M N W + ERPDSFD SD YHSQE + ALY R+E KR L
Sbjct: 592 SRSSSKGHESNERSKVVMRNPWGKFERPDSFDTSDEYHSQEFAAALYLRDEKEAKRKQLS 651
Query: 656 FQDQGEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQRGK 700
+QDQ +KVE+SGPLLSQS R+DELL+RHER IRQ VR+SWFQRGK
Sbjct: 652 YQDQVDKVEYSGPLLSQSSRVDELLDRHERHIRQTVRRSWFQRGK 696
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356565121|ref|XP_003550793.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1001 bits (2587), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 497/705 (70%), Positives = 572/705 (81%), Gaps = 41/705 (5%)
Query: 1 MGCVTSKQAVSVTPALDVSGGFRGGDVAEAGGAGDNSGRIRVGNGSGSRNGRGSSNRKKG 60
MGCV KQAVSVTPA++ S +N NRKK
Sbjct: 1 MGCVVVKQAVSVTPAIEHSV-------------------------ESEKN-----NRKKK 30
Query: 61 SKGEFGVAVSCGGSELGESGRASSN--SESLSFRLGNLHKYIEGEQVAAGWPAWLSAVAG 118
++ +V SELGESGRASSN SESLSFRLGNL KY+EGEQ AAGWPAWLSAVA
Sbjct: 31 TE-----SVGASRSELGESGRASSNGGSESLSFRLGNLSKYVEGEQAAAGWPAWLSAVAC 85
Query: 119 EAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAR 178
EAI GWVPLRADAFEKL+KIGQGTYSSVFRA++++TGKIVALKKVRFDNFEPESVRFMAR
Sbjct: 86 EAIHGWVPLRADAFEKLDKIGQGTYSSVFRAKEVETGKIVALKKVRFDNFEPESVRFMAR 145
Query: 179 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMN 238
EI+ILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL+ P+IKFSE+QIKCYM
Sbjct: 146 EIMILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLARPEIKFSESQIKCYMK 205
Query: 239 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 298
QLL GLEHCHSRGV+HRDIKGSNLLVNNEG+LK+ADFGLANFSN+G++QPLTSRVVTLWY
Sbjct: 206 QLLSGLEHCHSRGVMHRDIKGSNLLVNNEGILKVADFGLANFSNSGNKQPLTSRVVTLWY 265
Query: 299 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 358
RPPELLLG+T YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP++YWK
Sbjct: 266 RPPELLLGSTAYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPEEYWK 325
Query: 359 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418
K++LPHATLFKPQQPYDSSLRETFKD + VNL++TLLSVEP KR TAS+AL+ EYF
Sbjct: 326 KTRLPHATLFKPQQPYDSSLRETFKDFHASTVNLLQTLLSVEPSKRGTASSALSLEYFKI 385
Query: 419 KPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVEDV 478
KPYAC+ SSLPIYPPSKEIDAKH E++RRKK+GGR E+RK +RK +SKLAP ED+
Sbjct: 386 KPYACEPSSLPIYPPSKEIDAKHEEESRRKKIGGRACKPESRKPSRKPLALSKLAPAEDL 445
Query: 479 AVRTQFAKKINGHSLHILK-DDELSGREVQKPLVDNREEA-SHVKNASHGDIPFSGPLQV 536
+TQ + K+N S HI+K +D + E K E+A S++KNAS DIPF GPLQV
Sbjct: 446 TSQTQTSHKMNDRSAHIIKQEDTNTCEEAPKQSSGKPEDASSYMKNASQVDIPFPGPLQV 505
Query: 537 STSSGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSRKHENGDIINGS 596
S SSGFAWAKRR+DD S+RSH+RS SRG + N+LE ++ L++R+N +SR HEN + G+
Sbjct: 506 SKSSGFAWAKRRRDDTSVRSHSRSISRGFIFNSLE-TSTLNSRDNSESRNHENKEFF-GA 563
Query: 597 RTDSRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMATKRNNLGF 656
RT+SRG+ LE K+AM NQWS+ +RPDSFD D YHSQELSLA+Y R++ +KR+NL +
Sbjct: 564 RTNSRGNHLLEISKLAMQNQWSKFDRPDSFDTCDEYHSQELSLAIYNRQDSLSKRSNLSY 623
Query: 657 QDQGEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQRGKK 701
QDQ EKVEFSGPLLSQ H +DELLERHER IR VR+SWFQRGKK
Sbjct: 624 QDQEEKVEFSGPLLSQMHTVDELLERHERHIRHTVRRSWFQRGKK 668
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356511986|ref|XP_003524702.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 991 bits (2563), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 491/705 (69%), Positives = 568/705 (80%), Gaps = 42/705 (5%)
Query: 1 MGCVTSKQAVSVTPALDVSGGFRGGDVAEAGGAGDNSGRIRVGNGSGSRNGRGSSNRKKG 60
MGCV +KQAVSVTPA++ S NRKK
Sbjct: 1 MGCVVAKQAVSVTPAIEHSV-------------------------------ESEKNRKKK 29
Query: 61 SKGEFGVAVSCGGSELGESGRASSN--SESLSFRLGNLHKYIEGEQVAAGWPAWLSAVAG 118
++ +V SELGESGRASSN SESLSFRLGNL KY+EGEQ AAGWPAWLSAVA
Sbjct: 30 TE-----SVGASRSELGESGRASSNGGSESLSFRLGNLSKYVEGEQAAAGWPAWLSAVAC 84
Query: 119 EAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAR 178
EAI GWVPLRADAFEKL+KIGQGTYSSVFRA+++ TGKIVALKKVRFDNFEPESVRFMAR
Sbjct: 85 EAIHGWVPLRADAFEKLDKIGQGTYSSVFRAKEIQTGKIVALKKVRFDNFEPESVRFMAR 144
Query: 179 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMN 238
EI+ILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL+ P+IKFSE+QIKCYM
Sbjct: 145 EIMILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLARPEIKFSESQIKCYMK 204
Query: 239 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 298
QLL G+EHCHSRGV+HRDIKGSNLLVNNEG+LK+ADFGLANFSN+G++QPLTSRVVTLWY
Sbjct: 205 QLLSGIEHCHSRGVMHRDIKGSNLLVNNEGILKVADFGLANFSNSGNKQPLTSRVVTLWY 264
Query: 299 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 358
RPPELLLG+T YG SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP++YWK
Sbjct: 265 RPPELLLGSTAYGASVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPEEYWK 324
Query: 359 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418
K++LPHATLFKPQQPYDS LRETFKD ++VNL++TLLSVEP KR TAS+AL+ EYF T
Sbjct: 325 KTRLPHATLFKPQQPYDSCLRETFKDFHASSVNLLQTLLSVEPSKRGTASSALSLEYFKT 384
Query: 419 KPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVEDV 478
KPYACD SSLPIYPPSKEIDAK+ E++RRKK+GGR AE+RK +R +SKLAP ED+
Sbjct: 385 KPYACDPSSLPIYPPSKEIDAKNEEESRRKKIGGRACRAESRKPSRNPLALSKLAPAEDL 444
Query: 479 AVRTQFAKKINGHSLHILKDDEL-SGREVQKPLVDNREEA-SHVKNASHGDIPFSGPLQV 536
+ +TQ ++K++ S+HI+K++ + E K E+A S++KNAS DIPF GPLQV
Sbjct: 445 SSQTQTSQKMDDRSVHIIKEENTNTCEEAPKQSSGKPEDASSYMKNASQVDIPFPGPLQV 504
Query: 537 STSSGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSRKHENGDIINGS 596
S SSGFAWAKRR+DD S+RSH+RS SRG + N+ E S L++RNN +SR HEN G+
Sbjct: 505 SKSSGFAWAKRRRDDTSVRSHSRSISRGYIFNSSETS-TLNSRNNSESRNHENKKFF-GA 562
Query: 597 RTDSRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMATKRNNLGF 656
+SRGHD LE K+AM NQWS+ +R DSFD D YHSQELS+ALY R++ +KR+NL +
Sbjct: 563 HANSRGHDLLEISKLAMQNQWSKFDRLDSFDTCDEYHSQELSVALYNRQDSLSKRSNLSY 622
Query: 657 QDQGEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQRGKK 701
QDQ EKVEFSGPLLSQ H +DELLERHE IR+ VR+SWFQRGKK
Sbjct: 623 QDQAEKVEFSGPLLSQMHTVDELLERHESHIRRTVRRSWFQRGKK 667
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|79346260|ref|NP_173302.2| protein kinase domain-containing protein [Arabidopsis thaliana] gi|332191623|gb|AEE29744.1| protein kinase domain-containing protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 949 bits (2453), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 485/713 (68%), Positives = 559/713 (78%), Gaps = 19/713 (2%)
Query: 1 MGCVTSKQAVSVTPALDVSGGFRGGDVAEAGGAGDNSGRIRVGNGSGSRNGR----GSSN 56
MGCV SKQ VSVTPA+D SG FR + SGRI V + + S +
Sbjct: 1 MGCVNSKQTVSVTPAIDHSGVFRDNVCS-------GSGRIVVEDLPPVTETKLLSWWSKS 53
Query: 57 RKKGSKGEFGVAVSCGGSELGESGRASSN--SESLSFRLGNLHKYIEGEQVAAGWPAWLS 114
KK S + G + EL ESGRASSN SES+SFRLGNL KY+E EQVAAGWPAWLS
Sbjct: 54 GKKSSSKKSGSELGSDFGELSESGRASSNCRSESVSFRLGNLSKYLEAEQVAAGWPAWLS 113
Query: 115 AVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVR 174
VAGEAI GWVP R+DAFEKLEKIGQGTYSSVFRAR+ +TG+IVALKKVRFDNFEPESVR
Sbjct: 114 NVAGEAIHGWVPFRSDAFEKLEKIGQGTYSSVFRARETETGRIVALKKVRFDNFEPESVR 173
Query: 175 FMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIK 234
FMAREILILR+L+HPNIIKLEG++TS+LSCSI+LVFEYMEHD+TGLLS PDI F+ QIK
Sbjct: 174 FMAREILILRKLNHPNIIKLEGIVTSKLSCSIHLVFEYMEHDLTGLLSSPDIDFTTPQIK 233
Query: 235 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN-TGHRQPLTSRV 293
CYM QLL GL+HCH+RGV+HRDIKGSNLLVNNEG+LK+ADFGLANF N +G++QPLTSRV
Sbjct: 234 CYMKQLLSGLDHCHARGVMHRDIKGSNLLVNNEGILKVADFGLANFCNASGNKQPLTSRV 293
Query: 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 353
VTLWYRPPELLLGAT+YG SVDLWSVGCVFAELLIGKP+LQGRTEVEQLHKIFKLCGSPP
Sbjct: 294 VTLWYRPPELLLGATEYGASVDLWSVGCVFAELLIGKPVLQGRTEVEQLHKIFKLCGSPP 353
Query: 354 DDYWKKSKLPHATLFKPQQPYDSSLRET--FKDLPTTAVNLIETLLSVEPYKRATASAAL 411
+DYWKKSKLPHA LFKPQQ YD LRET K L +NLIETLLS++P+KR TAS AL
Sbjct: 354 EDYWKKSKLPHAMLFKPQQHYDGCLRETLKLKGLSDADINLIETLLSIQPHKRGTASTAL 413
Query: 412 ASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGR-VRGAETRKTTRKSHGMS 470
S+YF++KP+ACD SSLP+Y PSKEIDAKHRED RKK+ G RG E+RK TRK +
Sbjct: 414 VSQYFTSKPFACDPSSLPVYSPSKEIDAKHREDTTRKKISGNGRRGTESRKPTRKPPAFA 473
Query: 471 KLAPVEDVAVRTQFAKKINGHSLH-ILKDDELSGREVQKPLVDNREEASHVKNASHGDIP 529
KLAP EDV +Q +K NGHS+H + D ++QKP ++EASHVKNAS GD+P
Sbjct: 474 KLAPAEDVRHHSQKFQKRNGHSVHNSIDSDSTLFEKMQKPSNHEKDEASHVKNASQGDVP 533
Query: 530 FSGPLQVSTSSGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDS-RKHE 588
FSGPLQVS SSGFAWAKRRKDD +RSH RS SRG + N L PS A + DS +
Sbjct: 534 FSGPLQVSVSSGFAWAKRRKDDICVRSHNRSLSRGHIPNLLGPSPAFSENTDVDSKNNEK 593
Query: 589 NGDIINGSRTDSRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMA 648
+ +G RTDS+ ++ E +K++ML +W QLERPDSF SD YHSQELSL LYQREE A
Sbjct: 594 EKEEKHGERTDSQDREAYEMLKLSMLKKWRQLERPDSFGGSDEYHSQELSLELYQREEKA 653
Query: 649 TKRNNLGFQDQGEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQRGKK 701
K +LG++D EK+EFSGPLLS+S+ +DELLERHERQIRQ VRKSWFQ+GKK
Sbjct: 654 AKLGHLGYEDNDEKIEFSGPLLSKSYGVDELLERHERQIRQLVRKSWFQKGKK 706
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 704 | ||||||
| TAIR|locus:2034944 | 709 | IBS1 "IMPAIRED IN BABA-INDUCED | 0.890 | 0.884 | 0.711 | 1.8e-249 | |
| TAIR|locus:2019115 | 699 | AT1G74330 [Arabidopsis thalian | 0.867 | 0.874 | 0.702 | 2e-239 | |
| TAIR|locus:2175743 | 644 | cdc2cAt "CDC2C" [Arabidopsis t | 0.521 | 0.569 | 0.705 | 6.8e-160 | |
| TAIR|locus:2012290 | 714 | AT1G09600 [Arabidopsis thalian | 0.609 | 0.600 | 0.600 | 6.7e-147 | |
| TAIR|locus:2037042 | 694 | AT1G53050 [Arabidopsis thalian | 0.636 | 0.645 | 0.617 | 2.5e-145 | |
| TAIR|locus:2199491 | 573 | AT1G54610 [Arabidopsis thalian | 0.556 | 0.684 | 0.625 | 3e-142 | |
| TAIR|locus:2012643 | 614 | AT1G33770 [Arabidopsis thalian | 0.517 | 0.592 | 0.656 | 1.7e-141 | |
| TAIR|locus:2158715 | 644 | AT5G44290 [Arabidopsis thalian | 0.680 | 0.743 | 0.534 | 2.4e-140 | |
| TAIR|locus:504955609 | 629 | AT3G01085 [Arabidopsis thalian | 0.661 | 0.740 | 0.542 | 1.5e-138 | |
| TAIR|locus:2020708 | 740 | AT1G03740 [Arabidopsis thalian | 0.617 | 0.587 | 0.575 | 1.2e-136 |
| TAIR|locus:2034944 IBS1 "IMPAIRED IN BABA-INDUCED STERILITY 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2337 (827.7 bits), Expect = 1.8e-249, Sum P(2) = 1.8e-249
Identities = 452/635 (71%), Positives = 519/635 (81%)
Query: 75 ELGESGRASSN--SESLSFRLGNLHKYIEGEQVAAGWPAWLSAVAGEAIQGWVPLRADAF 132
EL ESGRASSN SES+SFRLGNL KY+E EQVAAGWPAWLS VAGEAI GWVP R+DAF
Sbjct: 72 ELSESGRASSNCRSESVSFRLGNLSKYLEAEQVAAGWPAWLSNVAGEAIHGWVPFRSDAF 131
Query: 133 EKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192
EKLEKIGQGTYSSVFRAR+ +TG+IVALKKVRFDNFEPESVRFMAREILILR+L+HPNII
Sbjct: 132 EKLEKIGQGTYSSVFRARETETGRIVALKKVRFDNFEPESVRFMAREILILRKLNHPNII 191
Query: 193 KLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 252
KLEG++TS+LSCSI+LVFEYMEHD+TGLLS PDI F+ QIKCYM QLL GL+HCH+RGV
Sbjct: 192 KLEGIVTSKLSCSIHLVFEYMEHDLTGLLSSPDIDFTTPQIKCYMKQLLSGLDHCHARGV 251
Query: 253 LHRDIKGSNLLVNNEGVLKLADFGLANFSN-TGHRQPLTSRVVTLWYRPPELLLGATDYG 311
+HRDIKGSNLLVNNEG+LK+ADFGLANF N +G++QPLTSRVVTLWYRPPELLLGAT+YG
Sbjct: 252 MHRDIKGSNLLVNNEGILKVADFGLANFCNASGNKQPLTSRVVTLWYRPPELLLGATEYG 311
Query: 312 PSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 371
SVDLWSVGCVFAELLIGKP+LQGRTEVEQLHKIFKLCGSPP+DYWKKSKLPHA LFKPQ
Sbjct: 312 ASVDLWSVGCVFAELLIGKPVLQGRTEVEQLHKIFKLCGSPPEDYWKKSKLPHAMLFKPQ 371
Query: 372 QPYDSSLRETFK--DLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLP 429
Q YD LRET K L +NLIETLLS++P+KR TAS AL S+YF++KP+ACD SSLP
Sbjct: 372 QHYDGCLRETLKLKGLSDADINLIETLLSIQPHKRGTASTALVSQYFTSKPFACDPSSLP 431
Query: 430 IYPPSKEIDAKHREDAXXXXXXXXXXXA-ETRKTTRKSHGMSKLAPVEDVAVRTQFAKKI 488
+Y PSKEIDAKHRED E+RK TRK +KLAP EDV +Q +K
Sbjct: 432 VYSPSKEIDAKHREDTTRKKISGNGRRGTESRKPTRKPPAFAKLAPAEDVRHHSQKFQKR 491
Query: 489 NGHSLH-ILKDDELSGREVQKPLVDNREEASHVKNASHGDIPFSGPLQVSTSSGFAWAKR 547
NGHS+H + D ++QKP ++EASHVKNAS GD+PFSGPLQVS SSGFAWAKR
Sbjct: 492 NGHSVHNSIDSDSTLFEKMQKPSNHEKDEASHVKNASQGDVPFSGPLQVSVSSGFAWAKR 551
Query: 548 RKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSRKHENG-DIINGSRTDSRGHDSL 606
RKDD +RSH RS SRG + N L PS A + DS+ +E + +G RTDS+ ++
Sbjct: 552 RKDDICVRSHNRSLSRGHIPNLLGPSPAFSENTDVDSKNNEKEKEEKHGERTDSQDREAY 611
Query: 607 EAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMATKRNNLGFQDQGEKVEFS 666
E +K++ML +W QLERPDSF SD YHSQELSL LYQREE A K +LG++D EK+EFS
Sbjct: 612 EMLKLSMLKKWRQLERPDSFGGSDEYHSQELSLELYQREEKAAKLGHLGYEDNDEKIEFS 671
Query: 667 GPLLSQSHRIDELLERHERQIRQAVRKSWFQRGKK 701
GPLLS+S+ +DELLERHERQIRQ VRKSWFQ+GKK
Sbjct: 672 GPLLSKSYGVDELLERHERQIRQLVRKSWFQKGKK 706
|
|
| TAIR|locus:2019115 AT1G74330 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2244 (795.0 bits), Expect = 2.0e-239, Sum P(2) = 2.0e-239
Identities = 447/636 (70%), Positives = 520/636 (81%)
Query: 73 GSELG-ESGRASSNSESLSFRLGNLHKYIEGEQVAAGWPAWLSAVAGEAIQGWVPLRADA 131
GSELG ESGRAS +SLSFRLGN+ +Y+E EQVAAGWPAWLS VAGEAI GWVPLR+DA
Sbjct: 64 GSELGSESGRAS---DSLSFRLGNVSRYLEAEQVAAGWPAWLSNVAGEAIHGWVPLRSDA 120
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
FEKLEKIGQGTYS+VFRA + +TG+IVALKKVRFDNFEPESV+FMAREILILRRL+HPNI
Sbjct: 121 FEKLEKIGQGTYSNVFRAVETETGRIVALKKVRFDNFEPESVKFMAREILILRRLNHPNI 180
Query: 192 IKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG 251
IKLEGLITS+LSC+I LVFEYMEHD+TGLLS PDIKF+ QIKCYM QLL GL+HCHSRG
Sbjct: 181 IKLEGLITSKLSCNIQLVFEYMEHDLTGLLSSPDIKFTTPQIKCYMKQLLSGLDHCHSRG 240
Query: 252 VLHRDIKGSNLLVNNEGVLKLADFGLANFSNT-GHRQ-PLTSRVVTLWYRPPELLLGATD 309
V+HRDIKGSNLL++NEG+LK+ADFGLANFSN+ GH++ PLTSRVVTLWYRPPELLLGATD
Sbjct: 241 VMHRDIKGSNLLLSNEGILKVADFGLANFSNSSGHKKKPLTSRVVTLWYRPPELLLGATD 300
Query: 310 YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369
YG SVDLWSVGCVFAELL+GKPIL+GRTEVEQLHKIFKLCGSPP+DYWKKSKLPHA LFK
Sbjct: 301 YGASVDLWSVGCVFAELLLGKPILRGRTEVEQLHKIFKLCGSPPEDYWKKSKLPHAMLFK 360
Query: 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLP 429
PQQ YDS LRET KDL T +NLIETLLS++P+KR TAS+AL S+YF+TKP+ACD SSLP
Sbjct: 361 PQQTYDSCLRETLKDLSETEINLIETLLSIDPHKRGTASSALVSQYFTTKPFACDPSSLP 420
Query: 430 IYPPSKEIDAKHREDAXXXXXXXXXXXA-ETRKTTRKSHGMSKLAPVEDVAVRTQ-FAKK 487
IYPPSKEID KHR++A + RK +RK+H ++LAP DV +T+ F K+
Sbjct: 421 IYPPSKEIDTKHRDEAARKKISGNGRRGIDPRKPSRKAHSFNRLAP--DVRHQTETFQKR 478
Query: 488 INGHSLH--ILKDDELSGREVQKPLVDNREEASHVKNASHGDIPFSGPLQVSTSSGFAWA 545
I GH +H I D L G+ +Q PL ++EASHVK+AS GD+PFSGPLQVS S+ FAWA
Sbjct: 479 I-GHLVHSSIESDARLCGK-LQNPLDHKKDEASHVKHASQGDVPFSGPLQVSKSNSFAWA 536
Query: 546 KRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSR--KHENGDIINGSRTDSRGH 603
KR KDD +R H RS SRG + + S A + +++ +S+ K E D +TDSRG
Sbjct: 537 KREKDDVCVRVHNRSLSRGYIPSLSGHSPAFNGKSDVESKINKDEKED-----KTDSRGE 591
Query: 604 DSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMATKR-NNLGFQDQGEK 662
+S E VK +ML QW QLERPDSF ASD YHSQELSL LYQR+EMA K NNLG G+K
Sbjct: 592 ESYEMVKRSMLKQWRQLERPDSFGASDEYHSQELSLGLYQRDEMAKKMGNNLG---DGDK 648
Query: 663 VEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQR 698
+EFSGPLLSQS+ +DELLERHER IR+ +RK WFQ+
Sbjct: 649 IEFSGPLLSQSYGVDELLERHERNIRKLIRKPWFQK 684
|
|
| TAIR|locus:2175743 cdc2cAt "CDC2C" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1406 (500.0 bits), Expect = 6.8e-160, Sum P(2) = 6.8e-160
Identities = 259/367 (70%), Positives = 310/367 (84%)
Query: 78 ESGRASSNSESLSFRLGNLHKYIEGEQVAAGWPAWLSAVAGEAIQGWVPLRADAFEKLEK 137
+S R + + LG+ H+ IE EQ AAGWPAWL + A EA+ GWVPL+A+AF+KLEK
Sbjct: 51 KSRRLGGSDLRIGVSLGSSHRNIEAEQAAAGWPAWLCSAAAEAVHGWVPLKAEAFQKLEK 110
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGL 197
IGQGTYSSVFRAR+++TGK+VALKKV+FDN +PES+RFMAREILILR+L+HPNI+KLEG+
Sbjct: 111 IGQGTYSSVFRAREVETGKMVALKKVKFDNLQPESIRFMAREILILRKLNHPNIMKLEGI 170
Query: 198 ITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDI 257
+TSR S SIYLVFEYMEHD+ GL S PDI+F+E QIKCYM QLL GLEHCH RGV+HRDI
Sbjct: 171 VTSRASSSIYLVFEYMEHDLAGLSSNPDIRFTEPQIKCYMKQLLWGLEHCHMRGVIHRDI 230
Query: 258 KGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 317
K SN+LVNN+GVLKL DFGLAN ++ LTSRVVTLWYR PELL+G+T YG SVDLW
Sbjct: 231 KASNILVNNKGVLKLGDFGLANVVTPSNKNQLTSRVVTLWYRAPELLMGSTSYGVSVDLW 290
Query: 318 SVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSS 377
SVGCVFAE+L+GKPIL+GRTE+EQLHKI+KLCGSP D +WK++KLPHAT FKPQ Y+++
Sbjct: 291 SVGCVFAEILMGKPILKGRTEIEQLHKIYKLCGSPQDSFWKRTKLPHATSFKPQHTYEAT 350
Query: 378 LRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEI 437
LRE KDL T V L+ETLLS+EP KR TAS+AL SEYF T+PYACD SSLP YPP+KE+
Sbjct: 351 LRERCKDLSATGVYLLETLLSMEPDKRGTASSALNSEYFLTRPYACDPSSLPKYPPNKEM 410
Query: 438 DAKHRED 444
DAK+R+D
Sbjct: 411 DAKYRDD 417
|
|
| TAIR|locus:2012290 AT1G09600 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1360 (483.8 bits), Expect = 6.7e-147, Sum P(2) = 6.7e-147
Identities = 260/433 (60%), Positives = 325/433 (75%)
Query: 73 GSELGESGRASSNSESLSFRLGNLHKYIEGEQVAAGWPAWLSAVAGEAIQGWVPLRADAF 132
G E+G + + ++ R+ ++ G QV AGWP+WL++VAGEAI GW+P +AD+F
Sbjct: 105 GIEVGANNIGTLQQPKMT-RICSVSNGERGAQVMAGWPSWLASVAGEAINGWIPRKADSF 163
Query: 133 EKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192
EKLEKIGQGTYSSV++ARDL+T ++VALKKVRF N +P+SVRFMAREI+ILRRLDHPN++
Sbjct: 164 EKLEKIGQGTYSSVYKARDLETNQLVALKKVRFANMDPDSVRFMAREIIILRRLDHPNVM 223
Query: 193 KLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 252
KLEGLITSR+S S+YL+FEYMEHD+ GL S P I FSEAQIKCYM QLLHGLEHCHSRGV
Sbjct: 224 KLEGLITSRVSGSMYLIFEYMEHDLAGLASTPGINFSEAQIKCYMKQLLHGLEHCHSRGV 283
Query: 253 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGP 312
LHRDIKGSNLL+++ LK+ DFGLANF +QPLTSRVVTLWYRPPELLLG+TDYG
Sbjct: 284 LHRDIKGSNLLLDHNNNLKIGDFGLANFYQGHQKQPLTSRVVTLWYRPPELLLGSTDYGV 343
Query: 313 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQ 372
+VDLWS GC+ AEL GKPI+ GRTEVEQLHKIFKLCGSP ++YWK SKLPHAT+FKPQQ
Sbjct: 344 TVDLWSTGCILAELFTGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKISKLPHATIFKPQQ 403
Query: 373 PYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYP 432
PY + ETFK LP++A+ L+E LL+VEP R T ++AL SE+F+T P A D SSLP Y
Sbjct: 404 PYKRCVAETFKSLPSSALALVEVLLAVEPDARGTTASALESEFFTTSPLASDPSSLPKYQ 463
Query: 433 PSKEIDAKHREDAXXXXXXXXXXXAETRKTTRKSHGMSKLAPVEDVAVRTQFAKKINGHS 492
P KEID K +E+ ++++ +R+S + AP + T K+ H+
Sbjct: 464 PRKEIDVKAQEEEAKRKKDTSSKQNDSKQVSRESKAVP--APDSNAESLTSIQKRQGQHN 521
Query: 493 LHILKDDELSGRE 505
+ D+ + E
Sbjct: 522 -QVSNSDKFNPGE 533
|
|
| TAIR|locus:2037042 AT1G53050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1420 (504.9 bits), Expect = 2.5e-145, P = 2.5e-145
Identities = 290/470 (61%), Positives = 344/470 (73%)
Query: 98 KYIEGEQVAAGWPAWLSAVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKI 157
K EGE VAAGWP WL++VAGEAI+GWVP RAD+FEKL+KIGQGTYS+V+RARDLD KI
Sbjct: 100 KATEGEYVAAGWPPWLASVAGEAIRGWVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKI 159
Query: 158 VALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDI 217
VALKKVRFDN EPESVRFMAREI ILRRLDHPNIIKLEGL+TSR+SCS+YLVFEYMEHD+
Sbjct: 160 VALKKVRFDNLEPESVRFMAREIQILRRLDHPNIIKLEGLVTSRMSCSLYLVFEYMEHDL 219
Query: 218 TGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL 277
GL S P IKFSE+Q+KCY+ QLLHGL+HCHSRGVLHRDIKGSNLL++N GVLK+ADFGL
Sbjct: 220 AGLASHPAIKFSESQVKCYLQQLLHGLDHCHSRGVLHRDIKGSNLLIDNSGVLKIADFGL 279
Query: 278 ANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT 337
A+F + QPLTSRVVTLWYRPPELLLGAT YG +VDLWS GC+ AEL GKPI+ GRT
Sbjct: 280 ASFFDPRQTQPLTSRVVTLWYRPPELLLGATRYGAAVDLWSAGCILAELYAGKPIMPGRT 339
Query: 338 EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 397
EVEQLHKIFKLCGSP +DYW KS+LPHAT+FKP QPY + ETFK+ P A+ L+ETLL
Sbjct: 340 EVEQLHKIFKLCGSPTEDYWVKSRLPHATIFKPTQPYKRLVGETFKEFPQPALALLETLL 399
Query: 398 SVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHR-EDAXXXXXXXXXXX 456
SV P R TA+AAL SE+FST+P CD SSLP YPPSKE+DA+ R E++
Sbjct: 400 SVNPDDRGTATAALKSEFFSTRPLPCDPSSLPKYPPSKELDARMRDEESRRQVGGNRDQR 459
Query: 457 AETRKTTRKSHGM-SKLAPVEDVAV----RTQFAKKINGHSLHILKDDELSGREVQKP-- 509
+ R+ T++S + + A E VA ++Q + + ++ SG + P
Sbjct: 460 HQERRGTKESRAIPAPDANAELVASMQKRQSQSTNRSRSEKFNPHPEEVASGFPIDPPRP 519
Query: 510 ----LVDNREEASHV---KNASHGDIPFSGPLQVSTSSGFAWAKRRKDDA 552
NRE ++ K ASH SGPL S S A +R D+
Sbjct: 520 SSQAFEPNRESQGNIIPHKRASH-----SGPL--SRRSASAKGRRNYQDS 562
|
|
| TAIR|locus:2199491 AT1G54610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1373 (488.4 bits), Expect = 3.0e-142, Sum P(2) = 3.0e-142
Identities = 245/392 (62%), Positives = 308/392 (78%)
Query: 92 RLGNLHKYIEGEQVAAGWPAWLSAVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARD 151
RL N K+ GEQVAAGWP+WLS GEA+ GWVP +AD FEK++KIGQGTYS+V++A+D
Sbjct: 78 RLSNPSKHWRGEQVAAGWPSWLSDACGEALNGWVPRKADTFEKIDKIGQGTYSNVYKAKD 137
Query: 152 LDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFE 211
+ TGKIVALKKVRFDN EPESV+FMAREIL+LRRLDHPN++KLEGL+TSR+SCS+YLVF+
Sbjct: 138 MLTGKIVALKKVRFDNLEPESVKFMAREILVLRRLDHPNVVKLEGLVTSRMSCSLYLVFQ 197
Query: 212 YMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLK 271
YM+HD+ GL S P +KFSE+++KC M QL+ GLEHCHSRGVLHRDIKGSNLL+++ GVLK
Sbjct: 198 YMDHDLAGLASSPVVKFSESEVKCLMRQLISGLEHCHSRGVLHRDIKGSNLLIDDGGVLK 257
Query: 272 LADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 331
+ADFGLA + H++P+TSRVVTLWYR PELLLGATDYG +DLWS GC+ AELL G+P
Sbjct: 258 IADFGLATIFDPNHKRPMTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCILAELLAGRP 317
Query: 332 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 391
I+ GRTEVEQLHKI+KLCGSP +DYWKK K H ++KP++PY S+RETFKD P +++
Sbjct: 318 IMPGRTEVEQLHKIYKLCGSPSEDYWKKGKFTHGAIYKPREPYKRSIRETFKDFPPSSLP 377
Query: 392 LIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDAXXXXXX 451
LI+ LLS+EP R TASAAL SE+F+++PYAC+ + LP YPPSKEIDAK R++
Sbjct: 378 LIDALLSIEPEDRQTASAALKSEFFTSEPYACEPADLPKYPPSKEIDAKRRDEETRRQRA 437
Query: 452 XXXXXAETRKTTRKSHGMSKLAPVEDVAVRTQ 483
+ + R ++ P + Q
Sbjct: 438 ASKAQGDGARKNRHRDRSNRALPAPEANAELQ 469
|
|
| TAIR|locus:2012643 AT1G33770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1310 (466.2 bits), Expect = 1.7e-141, Sum P(2) = 1.7e-141
Identities = 239/364 (65%), Positives = 301/364 (82%)
Query: 81 RASSNSESLSFRLGNLHKYIEGEQVAAGWPAWLSAVAGEAIQGWVPLRADAFEKLEKIGQ 140
R S N + + N+ + E E +AAGWP WL++VAGEAI+GWVP RAD+FEKL+KIGQ
Sbjct: 90 RVSDNGKGGGLIISNVPRSAEAELIAAGWPYWLTSVAGEAIKGWVPRRADSFEKLDKIGQ 149
Query: 141 GTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITS 200
GTYS V++ARDL+TGKIVA+KKVRF N +PESVRFMAREI ILR+LDHPN++KL+ L+TS
Sbjct: 150 GTYSIVYKARDLETGKIVAMKKVRFANMDPESVRFMAREINILRKLDHPNVMKLQCLVTS 209
Query: 201 RLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGS 260
+LS S++LVFEYMEHD++GL P +KF+E QIKC+M QLL GLEHCHSRG+LHRDIKGS
Sbjct: 210 KLSGSLHLVFEYMEHDLSGLALRPGVKFTEPQIKCFMKQLLCGLEHCHSRGILHRDIKGS 269
Query: 261 NLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVG 320
NLLVNN+GVLK+ DFGLA+F QPLTSRVVTLWYR PELLLG+T+YGP++DLWSVG
Sbjct: 270 NLLVNNDGVLKIGDFGLASFYKPDQDQPLTSRVVTLWYRAPELLLGSTEYGPAIDLWSVG 329
Query: 321 CVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRE 380
C+ AEL + KPI+ GRTEVEQ+HKIFKLCGSP +++W +K P AT +KPQ PY L E
Sbjct: 330 CILAELFVCKPIMPGRTEVEQMHKIFKLCGSPSEEFWNTTKFPQATSYKPQHPYKRVLLE 389
Query: 381 TFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAK 440
TFK+L +++++L++ LLSVEP KR +AS+ L SE+F+T+P C +SSLP YPPSKE+DAK
Sbjct: 390 TFKNLSSSSLDLLDKLLSVEPEKRCSASSTLLSEFFTTEPLPCHISSLPKYPPSKELDAK 449
Query: 441 HRED 444
R++
Sbjct: 450 VRDE 453
|
|
| TAIR|locus:2158715 AT5G44290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1300 (462.7 bits), Expect = 2.4e-140, Sum P(2) = 2.4e-140
Identities = 265/496 (53%), Positives = 338/496 (68%)
Query: 104 QVAAGWPAWLSAVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKV 163
++AAGWPAWL +VAGEA+ W P RA FEKLEKIGQGTYSSV++ARDL KIVALK+V
Sbjct: 109 ELAAGWPAWLVSVAGEALVNWTPRRASTFEKLEKIGQGTYSSVYKARDLTNNKIVALKRV 168
Query: 164 RFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC 223
RFD + ESV+FMAREI+++RRLDHPN++KLEGLIT+ +S S+YLVFEYM+HD+ GL S
Sbjct: 169 RFDLSDLESVKFMAREIIVMRRLDHPNVLKLEGLITASVSSSLYLVFEYMDHDLVGLASI 228
Query: 224 PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283
P IKFSE Q+KCYM QLL GL HCHSRGVLHRDIKGSNLL+++ GVLK+ADFGLA F +
Sbjct: 229 PGIKFSEPQVKCYMQQLLSGLHHCHSRGVLHRDIKGSNLLIDSNGVLKIADFGLATFFDP 288
Query: 284 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLH 343
+ PLTSRVVTLWYRPPELLLGA YG VDLWS GC+ EL GKPIL G+TEVEQLH
Sbjct: 289 QNCVPLTSRVVTLWYRPPELLLGACHYGVGVDLWSTGCILGELYSGKPILAGKTEVEQLH 348
Query: 344 KIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK 403
KIFKLCGSP +DYW+K KLP + F+P PY + E FKDLPT ++L+E LLS++P +
Sbjct: 349 KIFKLCGSPTEDYWRKLKLPPSAAFRPALPYGRRVAEMFKDLPTNVLSLLEALLSIDPDR 408
Query: 404 RATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDAXXXXXXXXXXXAETRKTT 463
R +A+ AL SEYF T+P+ACD SSLP YPPSKEIDAK R+DA + +T
Sbjct: 409 RGSAARALESEYFRTEPFACDPSSLPKYPPSKEIDAKIRDDAKRQRPTQEKHERQDSQT- 467
Query: 464 RKSHGMSKLAPVE------DVAVRTQFAKK-INGHSLHILKD----DELSGREVQK-PLV 511
R+SH + PV+ AV + + + G+S ++D + SGR P++
Sbjct: 468 RRSHERKLIPPVKANNPSLSTAVENPYLRSCVPGNSQRQMQDMTCNNPTSGRVSHSGPMM 527
Query: 512 DNRE--EASHVKNASHGDIPFSGPLQVSTSSGFAWAKRRKDDASIRSHTRSTSRGQVI-N 568
NR ++VK+ + IP G+ + ++ D R R+ +R + N
Sbjct: 528 KNRNLSRLTYVKDNAAPRIPSYRANSAGQGGGYVGSDQQMMDQQ-RKELRTFNRADTMDN 586
Query: 569 ALEPSAALHTRNNYDS 584
+ + + + YDS
Sbjct: 587 SKRQTKIPNDPSWYDS 602
|
|
| TAIR|locus:504955609 AT3G01085 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1329 (472.9 bits), Expect = 1.5e-138, Sum P(2) = 1.5e-138
Identities = 266/490 (54%), Positives = 349/490 (71%)
Query: 84 SNSESLSFRLGNLHKYIEGEQVAAGWPAWLSAVAGEAIQGWVPLRADAFEKLEKIGQGTY 143
S + +S R G H +E EQVAAGWP+WLS+ A EA+ GWVPLRA+ FEK EKIGQGTY
Sbjct: 67 SRTTGVSLRSGLPHSNVEAEQVAAGWPSWLSSAAPEAVHGWVPLRAEDFEKREKIGQGTY 126
Query: 144 SSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203
S+VFRA ++ TG+++ALKK+R NFE E++RF+AREI+ILRRLDHPNI+KLEG+I SR S
Sbjct: 127 SNVFRACEVSTGRVMALKKIRIQNFETENIRFIAREIMILRRLDHPNIMKLEGIIASRNS 186
Query: 204 CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLL 263
S+Y VF+YMEHD+ GL S PDIKF+EAQIKCYM QLL G+EHCH RG++HRDIK +N+L
Sbjct: 187 NSMYFVFDYMEHDLEGLCSSPDIKFTEAQIKCYMKQLLWGVEHCHLRGIMHRDIKAANIL 246
Query: 264 VNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVF 323
VNN+GVLKLADFGLAN ++ LTSRVVTLWYR PELL+G+T Y SVDLWSVGCVF
Sbjct: 247 VNNKGVLKLADFGLANIVTPRNKNQLTSRVVTLWYRAPELLMGSTSYSVSVDLWSVGCVF 306
Query: 324 AELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL-PHATLFKPQQPYDSSLRETF 382
AE+L G+P+L+GRTE+EQLHKI+KL GSP +++W+K+KL P +F+PQ Y+ LRE F
Sbjct: 307 AEILTGRPLLKGRTEIEQLHKIYKLSGSPDEEFWEKNKLHPQTKMFRPQHQYEGCLRERF 366
Query: 383 KDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHR 442
+ P TA+NL+E LLS++P KR TAS+AL SEYF+T+PYACD S+LP YPP+KE+DAK+R
Sbjct: 367 DEFPKTAINLLENLLSIDPEKRGTASSALMSEYFNTQPYACDPSTLPKYPPNKEMDAKYR 426
Query: 443 EDAXXXXXXXXXXXAETRKTTRKSHGMSKLAPVEDVAVRTQFAKKINGHSLHILKDDELS 502
E+ T+K G S+ A V++ +L+ L + +
Sbjct: 427 EELQRRRRVSIKK--RDNLATKKL-GKSRRATVKEPT------------NLNRLPTHQET 471
Query: 503 GREVQKPLV-DNREEASHVKNASHGDIPFSGPLQVST-SSGFAWA--KRRKDD--ASIRS 556
+E + +V E S S + P++ Q + +SGFAWA K+RK++ AS +
Sbjct: 472 KKEAETEIVVQTPSETSQATTRS--EFPYNSLSQTTAPASGFAWAGTKKRKENDVASTLT 529
Query: 557 HTRSTSRGQV 566
+ + S V
Sbjct: 530 YIQPGSASHV 539
|
|
| TAIR|locus:2020708 AT1G03740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1269 (451.8 bits), Expect = 1.2e-136, Sum P(2) = 1.2e-136
Identities = 254/441 (57%), Positives = 313/441 (70%)
Query: 98 KYIEGEQVAAGWPAWLSAVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKI 157
K E +QVAAGWP+WL +VAGE++ W P RA+ FEKLEKIGQGTYSSV+RARDL KI
Sbjct: 179 KDAERKQVAAGWPSWLVSVAGESLVDWAPRRANTFEKLEKIGQGTYSSVYRARDLLHNKI 238
Query: 158 VALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDI 217
VALKKVRFD + ESV+FMAREI+++RRLDHPN++KLEGLIT+ +S S+YLVFEYM+HD+
Sbjct: 239 VALKKVRFDLNDMESVKFMAREIIVMRRLDHPNVLKLEGLITAPVSSSLYLVFEYMDHDL 298
Query: 218 TGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL 277
GL S P +KF+E Q+KCYM QLL GLEHCHSRGVLHRDIKGSNLL++++GVLK+ADFGL
Sbjct: 299 LGLSSLPGVKFTEPQVKCYMRQLLSGLEHCHSRGVLHRDIKGSNLLIDSKGVLKIADFGL 358
Query: 278 ANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT 337
A F + LTS VVTLWYRPPELLLGA+ YG VDLWS GC+ EL GKPIL G+T
Sbjct: 359 ATFFDPAKSVSLTSHVVTLWYRPPELLLGASHYGVGVDLWSTGCILGELYAGKPILPGKT 418
Query: 338 EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 397
EVEQLHKIFKLCGSP ++YW+K KLP + FK PY + E FKD P + ++L+ETLL
Sbjct: 419 EVEQLHKIFKLCGSPTENYWRKQKLPSSAGFKTAIPYRRKVSEMFKDFPASVLSLLETLL 478
Query: 398 SVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDAXXXXXXXXXXXA 457
S++P R++A AL SEYF TKP+ACD S+LP YPPSKEIDAK R++A
Sbjct: 479 SIDPDHRSSADRALESEYFKTKPFACDPSNLPKYPPSKEIDAKMRDEAKRQQPMRAEKQE 538
Query: 458 ETRKTTRKSHGMSKLAPVE-DVAVRTQFAKKINGHSLHILKDDELSGREVQKPL--VDNR 514
TR SH + PV+ + ++ K+ L D S +E + P V +
Sbjct: 539 RQDSMTRISHERKFVPPVKANNSLSMTMEKQYK--DLRSRNDSFKSFKEERTPHGPVPDY 596
Query: 515 EEASHVKNASHG-DIPFSGPL 534
+ H +N G I SGPL
Sbjct: 597 QNMQHNRNNQTGVRISHSGPL 617
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 704 | |||
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-159 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-122 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-116 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-111 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-108 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-108 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-108 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-95 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-95 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-91 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-88 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-88 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-88 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-84 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-84 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-82 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-81 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-78 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-78 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-77 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-76 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-75 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-75 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-75 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-74 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-73 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-70 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-68 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-67 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-65 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-64 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-63 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-63 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-61 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-61 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 9e-61 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-60 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-59 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 8e-59 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-59 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-58 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-58 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-57 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-56 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-55 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-54 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-53 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-52 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-51 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-51 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-50 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-50 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-48 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-48 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-47 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-47 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-47 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-47 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-47 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-44 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-43 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-42 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-40 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-40 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-39 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-39 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-38 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-38 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-37 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-36 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-36 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-36 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-36 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-35 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-34 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-34 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-34 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-34 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-33 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-33 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-33 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-31 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-30 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-29 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-29 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-29 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-28 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-28 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-28 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-27 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-27 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-27 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-26 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-26 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-26 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-26 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-26 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-25 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-25 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-25 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-25 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-25 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-25 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-25 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-25 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-25 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-24 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-24 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-24 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-24 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 7e-24 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-23 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-23 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-23 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-23 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-23 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-23 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-23 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-23 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-23 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-22 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-22 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-22 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-22 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-21 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-21 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-21 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-21 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-21 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 9e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-20 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-20 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-19 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-19 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-19 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-19 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-19 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-19 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-19 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-19 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-19 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-18 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-18 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-18 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-18 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-18 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-18 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-18 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-18 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-18 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-17 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-17 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-17 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-17 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-17 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-17 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-17 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-17 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-17 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-17 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-16 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-16 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-16 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-16 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-16 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-16 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 9e-16 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 9e-16 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-15 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-15 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-15 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-15 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-15 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-15 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-15 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 8e-15 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-15 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-14 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-14 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-14 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-14 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-13 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-13 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-13 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-13 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-13 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-13 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-13 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-13 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-13 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-13 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-13 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-13 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-13 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-13 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 7e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-13 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-12 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-11 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-11 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-10 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-10 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-10 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-10 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-10 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 5e-10 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-09 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-09 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-09 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-09 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-09 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-08 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-08 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-08 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-07 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-07 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-07 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-07 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-06 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-06 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-06 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-06 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-06 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 6e-05 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.001 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.002 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.002 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 0.003 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 0.004 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 460 bits (1185), Expect = e-159
Identities = 164/287 (57%), Positives = 218/287 (75%), Gaps = 2/287 (0%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+EK+ +IG+GTY V++AR+ TG++VALKK+R +N + REI +L++L HPNI
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 192 IKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG 251
++L+ ++TS+ SIY+VFEYM+HD+TGLL P++KF+E+QIKCYM QLL GL++ HS G
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG 120
Query: 252 VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYG 311
+LHRDIKGSN+L+NN+GVLKLADFGLA + T+RV+TLWYRPPELLLGAT YG
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYG 180
Query: 312 PSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHATLFKP 370
P VD+WSVGC+ AEL +GKPI QG TE+EQL KIF+LCGSP D+ W SKLP KP
Sbjct: 181 PEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKP 240
Query: 371 QQPYDSSLRETFKDLPT-TAVNLIETLLSVEPYKRATASAALASEYF 416
++PY LRE FK L +A++L++ LL+++P KR +A AL EYF
Sbjct: 241 KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 366 bits (941), Expect = e-122
Identities = 131/291 (45%), Positives = 178/291 (61%), Gaps = 15/291 (5%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE----PESVRFMAREILILRRLD 187
+EKLEK+G+GTY V++ARD TG+IVALKK+R DN E ++R EI +L+ L
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR----EISLLKELK 56
Query: 188 HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
HPNI+KL +I + +YLVFEY + D+ L S IK M QLL GL +C
Sbjct: 57 HPNIVKLLDVIHTERK--LYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYC 114
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYRPPELLLG 306
HS +LHRD+K N+L+N +GVLKLADFGLA F T VVTLWYR PE+LLG
Sbjct: 115 HSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT--YTHEVVTLWYRAPEILLG 172
Query: 307 ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHA 365
+ Y +VD+WSVGC+FAE++ GKP+ G +E++QL KIF++ G+P ++ W +KLP
Sbjct: 173 SKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232
Query: 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
P+ P L + L ++L+ +L P KR +A AL YF
Sbjct: 233 KPTFPKFPPK-DLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 350 bits (901), Expect = e-116
Identities = 135/302 (44%), Positives = 191/302 (63%), Gaps = 9/302 (2%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE--PESVRFMA-REILILRRLDH 188
+EK +K+G+GTY+ V++ARD +TG+IVA+KK++ + + + F A REI +L+ L H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
PNII L + + +I LVFE+ME D+ ++ I + A IK YM L GLE+ H
Sbjct: 62 PNIIGLLDVFGHK--SNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH 119
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
S +LHRD+K +NLL+ ++GVLKLADFGLA + +R +T +VVT WYR PELL GA
Sbjct: 120 SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR-KMTHQVVTRWYRAPELLFGAR 178
Query: 309 DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHATL 367
YG VD+WSVGC+FAELL+ P L G ++++QL KIF+ G+P ++ W + LP
Sbjct: 179 HYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVE 238
Query: 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSS 427
FKP P L++ F A++L++ LL++ P KR TA AL YFS P S
Sbjct: 239 FKPFPPTP--LKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTPPSQ 296
Query: 428 LP 429
LP
Sbjct: 297 LP 298
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 338 bits (868), Expect = e-111
Identities = 147/308 (47%), Positives = 200/308 (64%), Gaps = 14/308 (4%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDHPN 190
FEKL +IG+GTY V+RARD +G+IVALKKVR DN E + + + REI +L L HPN
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDN-ERDGIPISSLREITLLLNLRHPN 67
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEHDITGLL---SCPDIKFSEAQIKCYMNQLLHGLEHC 247
I++L+ ++ + SI+LV EY E D+ LL P FSE+Q+KC M QLL GL++
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP---FSESQVKCLMLQLLRGLQYL 124
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-RQPLTSRVVTLWYRPPELLLG 306
H ++HRD+K SNLL+ ++G LK+ADFGLA G +P+T +VVTLWYR PELLLG
Sbjct: 125 HENFIIHRDLKVSNLLLTDKGCLKIADFGLA--RTYGLPAKPMTPKVVTLWYRAPELLLG 182
Query: 307 ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHA 365
T Y ++D+W+VGC+ AELL KP+L G++E+EQL I +L G+P + W S LP
Sbjct: 183 CTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV 242
Query: 366 TLFK-PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACD 424
F P+QPY ++L+ F L + L+ LL +P KRATA AL S YF KP C+
Sbjct: 243 GKFTLPKQPY-NNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCE 301
Query: 425 LSSLPIYP 432
+P +P
Sbjct: 302 PEMMPTFP 309
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 330 bits (848), Expect = e-108
Identities = 147/302 (48%), Positives = 197/302 (65%), Gaps = 11/302 (3%)
Query: 124 WVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILI 182
W D F+ + +IG+GTY V++ARD DTG++VALKKVR DN E E A REI I
Sbjct: 1 WGKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDN-EKEGFPITAIREIKI 59
Query: 183 LRRLDHPNIIKLEGLITSRLSC--------SIYLVFEYMEHDITGLLSCPDIKFSEAQIK 234
LR+L+H NI+ L+ ++T + + YLVFEYM+HD+ GLL + FSE IK
Sbjct: 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK 119
Query: 235 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 294
+M QLL GL +CH + LHRDIK SN+L+NN+G +KLADFGLA N+ +P T++V+
Sbjct: 120 SFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 295 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 354
TLWYRPPELLLG YGP++D+WS GC+ EL KPI Q E+ QL I +LCGSP
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239
Query: 355 DYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413
W KLP+ KP++ Y LRE F +PT A++L++ +L+++P KR TA AL S
Sbjct: 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299
Query: 414 EY 415
+
Sbjct: 300 PW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 329 bits (847), Expect = e-108
Identities = 133/300 (44%), Positives = 185/300 (61%), Gaps = 24/300 (8%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN----FEPESVRFMAREILILRR 185
D +EKL +I +GTY V+RARD TG+IVALKK++ + F S+R EI IL +
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR----EINILLK 60
Query: 186 LDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
L HPNI+ ++ ++ IY+V EY+EHD+ L+ F ++++KC M QLL G+
Sbjct: 61 LQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVA 120
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ------PLTSRVVTLWYR 299
H H +LHRD+K SNLL+NN G+LK+ DFGLA R+ P T VVTLWYR
Sbjct: 121 HLHDNWILHRDLKTSNLLLNNRGILKICDFGLA-------REYGSPLKPYTQLVVTLWYR 173
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359
PELLLGA +Y ++D+WSVGC+FAELL KP+ G++E++QL+KIFKL G+P + W
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPG 233
Query: 360 -SKLPHATLFKPQQPYDSSLRETFK--DLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
S+LP A + + LR+ F L +L+ LL+ +P KR +A AL YF
Sbjct: 234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 329 bits (846), Expect = e-108
Identities = 135/303 (44%), Positives = 191/303 (63%), Gaps = 19/303 (6%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDHPN 190
+E L K+G+GT+ V++AR + TG++VALKK+ N E + A REI IL++L HPN
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHN-EKDGFPITALREIKILKKLKHPN 68
Query: 191 IIKLEGLI------TSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGL 244
++ L + + R S+Y+V YM+HD++GLL P +K +E+QIKCYM QLL G+
Sbjct: 69 VVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGI 128
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA----------NFSNTGHRQPLTSRVV 294
+ H +LHRDIK +N+L++N+G+LK+ADFGLA G + T+ VV
Sbjct: 129 NYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVV 188
Query: 295 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 354
T WYRPPELLLG Y +VD+W +GCVFAE+ +PILQG+++++QLH IFKLCG+P +
Sbjct: 189 TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTE 248
Query: 355 DYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413
+ W LP Y +L E F L ++L+ LLS++PYKR TAS AL
Sbjct: 249 ETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308
Query: 414 EYF 416
YF
Sbjct: 309 PYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 296 bits (759), Expect = 2e-95
Identities = 134/287 (46%), Positives = 181/287 (63%), Gaps = 6/287 (2%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDHPN 190
++KL KIG+GTY V++ARD TG+IVA+KK++ FE E + A REI +L+ L+HPN
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLR-FESEGIPKTALREIKLLKELNHPN 59
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
IIKL + + +YLVFE+M+ D+ L+ E+ IK Y+ QLL GL CHS
Sbjct: 60 IIKLLDVFRHK--GDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH 117
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDY 310
G+LHRD+K NLL+N EGVLKLADFGLA + R P T VVT WYR PELLLG Y
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-PYTHYVVTRWYRAPELLLGDKGY 176
Query: 311 GPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHATLFK 369
VD+WSVGC+FAELL +P+ G++E++QL KIF+ G+P + W K + L F
Sbjct: 177 STPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236
Query: 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
+ L + F + A++L+ +L +P+KR TA ALA YF
Sbjct: 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 296 bits (759), Expect = 5e-95
Identities = 138/305 (45%), Positives = 181/305 (59%), Gaps = 24/305 (7%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDH 188
+EKL KIGQGT+ VF+AR T +IVALKKV +N E E A REI IL+ L H
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMEN-EKEGFPITALREIKILQLLKH 70
Query: 189 PNIIKL------EGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLH 242
N++ L + +R S YLVFE+ EHD+ GLLS ++KF+ ++IK M LL+
Sbjct: 71 ENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLN 130
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA---NFSNTGHRQPLTSRVVTLWYR 299
GL + H +LHRD+K +N+L+ +G+LKLADFGLA + S T+RVVTLWYR
Sbjct: 131 GLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYR 190
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359
PPELLLG DYGP +D+W GC+ AE+ PI+QG TE QL I +LCGS + W
Sbjct: 191 PPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPG 250
Query: 360 -SKLPHATLFK----PQQPYD---SSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411
KL LFK PQ L+ KD A++LI+ LL ++P KR A AL
Sbjct: 251 VDKLE---LFKKMELPQGQKRKVKERLKPYVKDP--HALDLIDKLLVLDPAKRIDADTAL 305
Query: 412 ASEYF 416
++F
Sbjct: 306 NHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 284 bits (729), Expect = 7e-91
Identities = 128/292 (43%), Positives = 182/292 (62%), Gaps = 16/292 (5%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDHPN 190
++K+EKIG+GTY V++ARD TG+IVALKK+R + E E V A REI +L+ L+HPN
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLET-EDEGVPSTAIREISLLKELNHPN 59
Query: 191 IIKLEGLITS--RLSCSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHC 247
I++L ++ S +L YLVFE+++ D+ + S P IK Y+ QLL G+ +C
Sbjct: 60 IVRLLDVVHSENKL----YLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYC 115
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
HS VLHRD+K NLL++ EG LKLADFGLA R T VVTLWYR PE+LLG+
Sbjct: 116 HSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGS 174
Query: 308 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHAT 366
Y VD+WS+GC+FAE++ +P+ G +E++QL +IF+ G+P +D W + LP
Sbjct: 175 RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD-- 232
Query: 367 LFKPQQP--YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
+KP P L + +L ++L+ +L +P KR +A AAL YF
Sbjct: 233 -YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 279 bits (715), Expect = 1e-88
Identities = 115/292 (39%), Positives = 167/292 (57%), Gaps = 15/292 (5%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKV----RFDNFEPESVRFMAREILILRRLD 187
++ L +IG+G + VF+A+D +TG+ VALKKV + REI L+
Sbjct: 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQ----ALREIKALQACQ 57
Query: 188 HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
HP ++KL L LV EYM D++ +L + EAQ+K YM LL G+ +
Sbjct: 58 HPYVVKL--LDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
H+ G++HRD+K +NLL++ +GVLK+ADFGLA + + + +V T WYR PELL GA
Sbjct: 116 HANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175
Query: 308 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHAT 366
Y P VDLW+VGC+FAELL G P+ G ++EQL +F+ G+P ++ W + LP
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235
Query: 367 --LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
F +P L E F D A++L++ LL +P KR +A+ AL YF
Sbjct: 236 KITFPESKP--IPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 277 bits (711), Expect = 1e-88
Identities = 107/286 (37%), Positives = 158/286 (55%), Gaps = 33/286 (11%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+E LEK+G+G++ V+ ARD TGK+VA+K ++ + + R + REI IL++L HPNI
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERIL-REIKILKKLKHPNI 59
Query: 192 IKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
++L + +YLV EY E D+ LL + SE + + Y+ Q+L LE+ HS+
Sbjct: 60 VRLYDVFEDEDK--LYLVMEYCEGGDLFDLL-KKRGRLSEDEARFYLRQILSALEYLHSK 116
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDY 310
G++HRD+K N+L++ +G +KLADFGLA + G + LT+ V T Y PE+LLG Y
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK--LTTFVGTPEYMAPEVLLG-KGY 173
Query: 311 GPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 370
G +VD+WS+G + ELL GKP G +QL ++FK G P +
Sbjct: 174 GKAVDIWSLGVILYELLTGKPPFPGD---DQLLELFKKIGKPKPPFPPP----------- 219
Query: 371 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
D+ A +LI LL +P KR TA AL +F
Sbjct: 220 -----------EWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 277 bits (710), Expect = 5e-88
Identities = 122/298 (40%), Positives = 180/298 (60%), Gaps = 24/298 (8%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE---PESVRFMAREILILRRLD- 187
+E+L +IG+G Y +V++ARDL+TG+ VALKKVR E P S REI +L++L+
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLS---TLREIALLKQLES 57
Query: 188 --HPNIIKL----EGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQL 240
HPNI++L G T R + LVFE+++ D+ LS CP IK M QL
Sbjct: 58 FEHPNIVRLLDVCHGPRTDR-ELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQL 116
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVVTLWYR 299
L G++ HS ++HRD+K N+LV ++G +K+ADFGLA +S LTS VVTLWYR
Sbjct: 117 LRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE---MALTSVVVTLWYR 173
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW-K 358
PE+LL ++ Y VD+WSVGC+FAEL +P+ +G +E +QL KIF + G P ++ W +
Sbjct: 174 APEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR 232
Query: 359 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
LP ++ F P S + ++ ++L++ +L+ P+KR +A AL YF
Sbjct: 233 NVSLPRSS-FPSYTP--RSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 269 bits (690), Expect = 2e-84
Identities = 124/318 (38%), Positives = 184/318 (57%), Gaps = 31/318 (9%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVR---FDNFEPES--------VRFMA-REILILRR 185
+G+GTY V +A D TGKIVA+KKV+ N + + F RE+ I+
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 186 LDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
+ H NI+ L + I LV + M D+ ++ I+ +E+Q+KC + Q+L+GL
Sbjct: 77 IKHENIMGLVDVYVEG--DFINLVMDIMASDLKKVVD-RKIRLTESQVKCILLQILNGLN 133
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------------NFSNTGHRQPLTSR 292
H +HRD+ +N+ +N++G+ K+ADFGLA R+ +TS+
Sbjct: 134 VLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSK 193
Query: 293 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 352
VVTLWYR PELL+GA Y +VD+WSVGC+FAELL GKP+ G E++QL +IF+L G+P
Sbjct: 194 VVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTP 253
Query: 353 PDDYW-KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411
+D W + KLP T F P++P D L+ F + A++L+++LL + P +R +A AL
Sbjct: 254 NEDNWPQAKKLPLYTEFTPRKPKD--LKTIFPNASDDAIDLLQSLLKLNPLERISAKEAL 311
Query: 412 ASEYFSTKPYACDLSSLP 429
EYF + P CD S LP
Sbjct: 312 KHEYFKSDPLPCDPSQLP 329
|
Length = 335 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 266 bits (682), Expect = 3e-84
Identities = 109/287 (37%), Positives = 151/287 (52%), Gaps = 29/287 (10%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+E L K+G G++ +V++A+ TGKIVA+K ++ + + + + REI ILRRL HPNI
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 192 IKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
++L +YLV EY E D+ LS SE + K Q+L GLE+ HS
Sbjct: 61 VRLIDAFED--KDHLYLVMEYCEGGDLFDYLS-RGGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDY 310
G++HRD+K N+L++ GV+K+ADFGLA LT+ V T WY PE+LLG Y
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLK-SSSSLTTFVGTPWYMAPEVLLGGNGY 176
Query: 311 GPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK-LCGSPPDDYWKKSKLPHATLFK 369
GP VD+WS+G + ELL GKP G ++QL I + L D K
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKW---------- 226
Query: 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
SS E KD LI+ L+ +P KR TA L +F
Sbjct: 227 ------SSGSEEAKD-------LIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 262 bits (673), Expect = 6e-82
Identities = 115/319 (36%), Positives = 171/319 (53%), Gaps = 23/319 (7%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR--FDNFEPESVRFMAREILILRRLDHP 189
+E L+ IG G Y V A D TG+ VA+KK+ FD+ + + REI +LR L H
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDD--LIDAKRILREIKLLRHLRHE 59
Query: 190 NIIKLEGLITSRLSCS---IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEH 246
NII L ++ +Y+V E ME D+ ++ P ++ I+ ++ Q+L GL++
Sbjct: 60 NIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSP-QPLTDDHIQYFLYQILRGLKY 118
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP--LTSRVVTLWYRPPELL 304
HS V+HRD+K SN+LVN+ LK+ DFGLA + + LT VVT WYR PELL
Sbjct: 119 LHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELL 178
Query: 305 LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364
L ++ Y ++D+WSVGC+FAELL KP+ GR ++QL+ I ++ G+P ++ K
Sbjct: 179 LSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK 238
Query: 365 ATLFKPQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422
A + P L + F A++L+E +L +P KR TA ALA Y +
Sbjct: 239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLA----- 293
Query: 423 CDLSSLPIYPPSKEIDAKH 441
++ P E AK
Sbjct: 294 ------QLHDPEDEPVAKP 306
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 258 bits (661), Expect = 6e-81
Identities = 125/290 (43%), Positives = 175/290 (60%), Gaps = 12/290 (4%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDHPN 190
F+K+EKIG+GTY V++AR+ TG++VALKK+R D E E V A REI +L+ L+HPN
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPN 60
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
I+KL +I + +YLVFE++ D+ + + P IK Y+ QLL GL CHS
Sbjct: 61 IVKLLDVIHTE--NKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD 309
VLHRD+K NLL+N EG +KLADFGLA R T VVTLWYR PE+LLG
Sbjct: 119 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKY 177
Query: 310 YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHATLF 368
Y +VD+WS+GC+FAE++ + + G +E++QL +IF+ G+P + W + LP +
Sbjct: 178 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD---Y 234
Query: 369 KPQQPY--DSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
KP P + L +L+ +L +P KR +A AALA +F
Sbjct: 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 252 bits (646), Expect = 1e-78
Identities = 128/293 (43%), Positives = 186/293 (63%), Gaps = 17/293 (5%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDHPN 190
+ K+EKIG+GTY V++ R+ TG+IVA+KK+R ++ E E V A REI +L+ L HPN
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES-EEEGVPSTAIREISLLKELQHPN 60
Query: 191 IIKLEGLIT--SRLSCSIYLVFEYMEHDITGLL-SCPDIKFSEAQ-IKCYMNQLLHGLEH 246
I+ L+ ++ SRL YL+FE++ D+ L S P ++ +A+ +K Y+ Q+L G+
Sbjct: 61 IVCLQDVLMQESRL----YLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILF 116
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG 306
CHSR VLHRD+K NLL++N+GV+KLADFGLA R T VVTLWYR PE+LLG
Sbjct: 117 CHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV-YTHEVVTLWYRAPEVLLG 175
Query: 307 ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHA 365
+ Y VD+WS+G +FAE+ KP+ G +E++QL +IF++ G+P +D W + LP
Sbjct: 176 SPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD- 234
Query: 366 TLFKPQQP--YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
+K P SLR K+L ++L+E +L +P KR +A AL YF
Sbjct: 235 --YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 252 bits (645), Expect = 2e-78
Identities = 127/290 (43%), Positives = 176/290 (60%), Gaps = 12/290 (4%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDHPN 190
+EKLEKIG+GTY +VF+A++ +T +IVALK+VR D+ + E V A REI +L+ L H N
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKN 60
Query: 191 IIKLEGLITS--RLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
I++L ++ S +L+ LVFEY + D+ + +K +M QLL GL CH
Sbjct: 61 IVRLYDVLHSDKKLT----LVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH 116
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
S VLHRD+K NLL+N G LKLADFGLA R ++ VVTLWYRPP++L GA
Sbjct: 117 SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC-YSAEVVTLWYRPPDVLFGAK 175
Query: 309 DYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHAT 366
Y S+D+WS GC+FAEL G+P+ G +QL +IF+L G+P ++ W SKLP
Sbjct: 176 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235
Query: 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
+ P P +SL L +T +L++ LL P +R +A AL YF
Sbjct: 236 PY-PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 248 bits (636), Expect = 4e-77
Identities = 108/292 (36%), Positives = 164/292 (56%), Gaps = 9/292 (3%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDH 188
+ +E L +G+G Y V + R+ TG+IVA+KK + ++ + E V+ A RE+ +LR+L H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFK-ESEDDEDVKKTALREVKVLRQLRH 59
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
NI+ L R +YLVFEY+E + LL ++ Y+ QLL + +CH
Sbjct: 60 ENIVNL--KEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCH 117
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
S ++HRDIK N+LV+ GVLKL DFG A PLT V T WYR PELL+G T
Sbjct: 118 SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT 177
Query: 309 DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS-PP---DDYWKKSKLPH 364
+YG VD+W++GC+ AELL G+P+ G ++++QL+ I K G PP + + +
Sbjct: 178 NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237
Query: 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
+P QP +S R + + A++ ++ L ++P +R T L YF
Sbjct: 238 VAFPEPSQP-ESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 247 bits (631), Expect = 2e-76
Identities = 127/292 (43%), Positives = 181/292 (61%), Gaps = 11/292 (3%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDH 188
D +EK+EKIG+GTY V++ARD T + +ALKK+R + E E V A REI +L+ + H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQH 60
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHC 247
NI++L+ ++ S +YLVFEY++ D+ + S PD + IK Y+ Q+L G+ +C
Sbjct: 61 GNIVRLQDVVHSEKR--LYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC 118
Query: 248 HSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG 306
HS VLHRD+K NLL++ LKLADFGLA R T VVTLWYR PE+LLG
Sbjct: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT-FTHEVVTLWYRAPEILLG 177
Query: 307 ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLP-H 364
+ Y VD+WSVGC+FAE++ KP+ G +E+++L KIF++ G+P ++ W + LP +
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY 237
Query: 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
+ F P D L L V+L+ +L ++P KR TA AAL EYF
Sbjct: 238 KSAFPKWPPKD--LATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYF 287
|
Length = 294 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 245 bits (626), Expect = 1e-75
Identities = 130/302 (43%), Positives = 179/302 (59%), Gaps = 23/302 (7%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDH 188
DA+EKLEKIG+GTY V++ARD +TGK+VALKK R + + E + A REI +L+ L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLE-MDEEGIPPTALREISLLQMLSE 59
Query: 189 -PNIIKL---EGLITSRLSCSIYLVFEYMEHDITGLLSC----PDIKFSEAQIKCYMNQL 240
I++L E + S+YLVFEY++ D+ + P IK +M QL
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLA-NFSNTGHRQPL---TSRVVT 295
L G+ HCH GV+HRD+K NLLV+ + G+LK+AD GL FS P+ T +VT
Sbjct: 120 LKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS-----IPVKSYTHEIVT 174
Query: 296 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 355
LWYR PE+LLG+T Y VD+WSVGC+FAE+ +P+ G +E++QL IFKL G+P +
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ 234
Query: 356 YWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 414
W SKL F +P D L DL ++L++ +L +P KR +A AAL
Sbjct: 235 VWPGVSKLRDWHEFPQWKPQD--LSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHP 292
Query: 415 YF 416
YF
Sbjct: 293 YF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 243 bits (622), Expect = 4e-75
Identities = 114/299 (38%), Positives = 174/299 (58%), Gaps = 20/299 (6%)
Query: 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRL 186
+ + ++KL+K+G+G+Y++V++ R TG++VALK++R + E F A RE +L+ L
Sbjct: 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLE--HEEGAPFTAIREASLLKDL 60
Query: 187 DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLE 245
H NI+ L +I ++ + + LVFEY++ D+ + C S ++ ++ QLL GL
Sbjct: 61 KHANIVTLHDIIHTKKTLT--LVFEYLDTDLKQYMDDCGGG-LSMHNVRLFLFQLLRGLA 117
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF----SNTGHRQPLTSRVVTLWYRPP 301
+CH R VLHRD+K NLL++ G LKLADFGLA S T ++ VVTLWYRPP
Sbjct: 118 YCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT-----YSNEVVTLWYRPP 172
Query: 302 ELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV-EQLHKIFKLCGSPPDDYWKK- 359
++LLG+T+Y S+D+W VGC+F E+ G+P+ G T+V +QLHKIF++ G+P ++ W
Sbjct: 173 DVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGV 232
Query: 360 SKLPHATLFKPQQPYDSSLRETFK--DLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
S P + L D L L EP KR +A+ A+ YF
Sbjct: 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 242 bits (620), Expect = 7e-75
Identities = 116/290 (40%), Positives = 177/290 (61%), Gaps = 12/290 (4%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKV--RFDNFEPESVRFMAREILILRRL-DH 188
++ ++++G GT+ SV+ AR+ +TG++VA+KK+ +F ++E E + RE+ LR+L +H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNL--REVKSLRKLNEH 57
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIK-FSEAQIKCYMNQLLHGLEHC 247
PNI+KL+ + R + +Y VFEYME ++ L+ K FSE+ I+ + Q+L GL H
Sbjct: 58 PNIVKLKEVF--RENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
H G HRD+K NLLV+ V+K+ADFGLA R P T V T WYR PE+LL +
Sbjct: 116 HKHGFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTRWYRAPEILLRS 173
Query: 308 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS-KLPHAT 366
T Y VD+W++GC+ AEL +P+ G +E++QL+KI + G+P W + KL
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233
Query: 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
F+ Q +SL + + A++LI+ +L +P KR TAS AL YF
Sbjct: 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 240 bits (613), Expect = 6e-74
Identities = 115/301 (38%), Positives = 169/301 (56%), Gaps = 34/301 (11%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE--PESVRFMAREILILRRLDHP 189
F++LEK+G+GTY++V++ R+ TG+IVALK++ D E P + REI +++ L H
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTA---IREISLMKELKHE 58
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIK-----FSEAQIKCYMNQLLHGL 244
NI++L +I + + LVFEYM+ D+ + D +K + QLL G+
Sbjct: 59 NIVRLHDVIHTE--NKLMLVFEYMDKDLKKYM---DTHGVRGALDPNTVKSFTYQLLKGI 113
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA--------NFSNTGHRQPLTSRVVTL 296
CH VLHRD+K NLL+N G LKLADFGLA FSN VVTL
Sbjct: 114 AFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSN---------EVVTL 164
Query: 297 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 356
WYR P++LLG+ Y S+D+WSVGC+ AE++ G+P+ G +QL KIF++ G+P +
Sbjct: 165 WYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTEST 224
Query: 357 WKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415
W S+LP P+ P L++ F ++L+ LL + P R +A AL +
Sbjct: 225 WPGISQLPEYKPTFPRYPP-QDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283
Query: 416 F 416
F
Sbjct: 284 F 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 241 bits (617), Expect = 1e-73
Identities = 121/325 (37%), Positives = 170/325 (52%), Gaps = 36/325 (11%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF--EPESVR-FMAREILILRRL-D 187
+E L+K+G+G Y V++A D T ++VALKK+ FD F ++ R F REI+ L+ L D
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKI-FDAFRNATDAQRTF--REIMFLQELGD 65
Query: 188 HPNIIKLEGLITSRLSCSIYLVFEYMEHDIT-----GLLSCPDIKFSEAQIKCYMNQLLH 242
HPNI+KL +I + IYLVFEYME D+ +L + + M QLL
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILE-------DVHKRYIMYQLLK 118
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA----NFSNTGHRQPLTSRVVTLWY 298
L++ HS V+HRD+K SN+L+N++ +KLADFGLA LT V T WY
Sbjct: 119 ALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWY 178
Query: 299 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 358
R PE+LLG+T Y VD+WSVGC+ E+L+GKP+ G + + QL KI ++ G P + +
Sbjct: 179 RAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238
Query: 359 --KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
KS L L E A++L++ LL P KR TA AL Y
Sbjct: 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYV 298
Query: 417 STKPYACDLSSLPIYPPSKEIDAKH 441
+ + PS E +
Sbjct: 299 A-----------QFHNPSDEPVLPY 312
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 232 bits (593), Expect = 2e-70
Identities = 113/320 (35%), Positives = 167/320 (52%), Gaps = 40/320 (12%)
Query: 132 FEKLEKIGQGTYSSVFRARDLD--TGKIVALKKVRFDNFEPESVRFMA-REILILRRLDH 188
+E IG+GTY V++A+ + GK A+KK + D + + A REI +LR L H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKF---------SEAQIKCYMNQ 239
N++ L + S+YL+F+Y EHD+ + IKF + +K + Q
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQI-----IKFHRQAKRVSIPPSMVKSLLWQ 116
Query: 240 LLHGLEHCHSRGVLHRDIKGSNLLVNNE----GVLKLADFGLANFSNTGHRQPLTSR--V 293
+L+G+ + HS VLHRD+K +N+LV E GV+K+ D GLA N + V
Sbjct: 117 ILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176
Query: 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE---------VEQLHK 344
VT+WYR PELLLGA Y ++D+W++GC+FAELL +PI +GR +QL +
Sbjct: 177 VTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236
Query: 345 IFKLCGSPPDDYWKK-SKLPH----ATLFKPQQPYDSSLR---ETFKDLPTTAVNLIETL 396
IF++ G+P + W K+P FK + +SL E K + +L+ L
Sbjct: 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKL 296
Query: 397 LSVEPYKRATASAALASEYF 416
L +P KR TA AL YF
Sbjct: 297 LEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 225 bits (575), Expect = 3e-68
Identities = 103/296 (34%), Positives = 159/296 (53%), Gaps = 19/296 (6%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ +EKL KIG+G+Y VF+ R+ +TG+IVA+KK +P + REI +L++L HP
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
N++ L + R ++LVFEY +H + L E IK + Q L + CH
Sbjct: 61 NLVNL--IEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK 118
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD 309
+HRD+K N+L+ +G +KL DFG A T V T WYR PELL+G T
Sbjct: 119 HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD-YTDYVATRWYRAPELLVGDTQ 177
Query: 310 YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS---------PPDDYWKKS 360
YGP VD+W++GCVFAELL G+P+ G+++V+QL+ I K G + ++K
Sbjct: 178 YGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237
Query: 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
+P +P L F ++ + A++ ++ L ++P +R + L YF
Sbjct: 238 SIPEPETREP-------LESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 222 bits (569), Expect = 2e-67
Identities = 106/285 (37%), Positives = 158/285 (55%), Gaps = 9/285 (3%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALK--KVRFDNFEPESVRFMAREILILRRL-DHPNI 191
L KIG+GT+S V +A+ TGK A+K K F + E + REI LRRL HPNI
Sbjct: 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNL--REIQALRRLSPHPNI 60
Query: 192 IKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG 251
++L ++ R + + LVFE M+ ++ L+ E ++K YM QLL L+H H G
Sbjct: 61 LRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG 120
Query: 252 VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYG 311
+ HRDIK N+L+ ++ +LKLADFG + + P T + T WYR PE LL YG
Sbjct: 121 IFHRDIKPENILIKDD-ILKLADFGSCRGIYS--KPPYTEYISTRWYRAPECLLTDGYYG 177
Query: 312 PSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 371
P +D+W+VGCVF E+L P+ G E++Q+ KI + G+P + KK + +
Sbjct: 178 PKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFP 237
Query: 372 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
+ LR+ + ++L++ LL+ +P +R TA AL YF
Sbjct: 238 SKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 216 bits (551), Expect = 6e-65
Identities = 116/297 (39%), Positives = 177/297 (59%), Gaps = 19/297 (6%)
Query: 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD 187
+ + + KL+K+G+GTY++VF+ R T +VALK++R ++ E + RE+ +L+ L
Sbjct: 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKNLK 61
Query: 188 HPNIIKLEGLI-TSRLSCSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLE 245
H NI+ L +I T R + LVFEY++ D+ L +C ++ S +K +M QLL GL
Sbjct: 62 HANIVTLHDIIHTER---CLTLVFEYLDSDLKQYLDNCGNL-MSMHNVKIFMFQLLRGLS 117
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
+CH R +LHRD+K NLL+N +G LKLADFGLA + + + ++ VVTLWYRPP++LL
Sbjct: 118 YCHKRKILHRDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLL 176
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365
G+T+Y +D+W VGC+ E+ G+P+ G T E+LH IF+L G+P ++ W P
Sbjct: 177 GSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETW-----PGI 231
Query: 366 TLFKPQQPYD------SSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
T + + Y L L T ++L+ +LL E R +A AAL YF
Sbjct: 232 TSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 217 bits (555), Expect = 1e-64
Identities = 112/306 (36%), Positives = 170/306 (55%), Gaps = 22/306 (7%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVR--FDNFEPESVRFMAREILILRRLDHPNIIKLE 195
IG+G Y V A++ +T + VA+KK+ FDN ++ R + REI +LR LDH N+I ++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDN-RIDAKRTL-REIKLLRHLDHENVIAIK 70
Query: 196 GLI--TSRLSCS-IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 252
++ R + + +Y+V+E M+ D+ ++ S+ + ++ QLL GL++ HS V
Sbjct: 71 DIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQT-LSDDHCQYFLYQLLRGLKYIHSANV 129
Query: 253 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGP 312
LHRD+K SNLL+N LK+ DFGLA ++ +T VVT WYR PELLL ++Y
Sbjct: 130 LHRDLKPSNLLLNANCDLKICDFGLARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTT 188
Query: 313 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQ 372
++D+WSVGC+FAELL KP+ G+ V QL I +L GSP ++ + A +
Sbjct: 189 AIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSL 248
Query: 373 PYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPI 430
PY S F A++L+E +L +P KR T ALA Y + +
Sbjct: 249 PYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLA-----------SL 297
Query: 431 YPPSKE 436
+ PS E
Sbjct: 298 HDPSDE 303
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 211 bits (539), Expect = 3e-63
Identities = 116/293 (39%), Positives = 166/293 (56%), Gaps = 14/293 (4%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL---DH 188
+E + +IG G Y +V++ARD +G VALK VR E RE+ +L+RL DH
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 189 PNIIKLEGLI-TSRL--SCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGL 244
PNI++L + TSR + LVFE+++ D+ L P IK M Q L GL
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELL 304
+ H+ ++HRD+K N+LV + G +KLADFGLA + + LT VVTLWYR PE+L
Sbjct: 122 DFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS--CQMALTPVVVTLWYRAPEVL 179
Query: 305 LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS-KLP 363
L +T Y VD+WSVGC+FAE+ KP+ G +E +QL KIF L G PP+D W + LP
Sbjct: 180 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP 238
Query: 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
F P+ P ++ ++ + L+ +L+ P+KR +A AL +F
Sbjct: 239 RGA-FSPRGP--RPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 212 bits (542), Expect = 7e-63
Identities = 101/300 (33%), Positives = 155/300 (51%), Gaps = 16/300 (5%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKV--RFDNFEPESVRFMAREILILRRLD 187
++ +E IG G Y V A D +GK VA+KK+ FD P + RE+ ILR
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV--PTLAKRTLRELKILRHFK 62
Query: 188 HPNIIKLEGLITSR--LSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
H NII + ++ +Y+V + ME D+ ++ D +E I+ ++ QLL GL+
Sbjct: 63 HDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHS-DQPLTEEHIRYFLYQLLRGLK 121
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF---SNTGHRQPLTSRVVTLWYRPPE 302
+ HS V+HRD+K SNLLVN + L++ DFG+A S T H+ +T V T WYR PE
Sbjct: 122 YIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPE 181
Query: 303 LLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362
LLL +Y ++D+WSVGC+FAE+L + + G+ V QL I + GSP ++ +
Sbjct: 182 LLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241
Query: 363 PHA----TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418
+QP + F A++L+ +L +P +R T AL + +
Sbjct: 242 DRVRKYIQNLPRKQPVP--WSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQ 299
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 208 bits (530), Expect = 1e-61
Identities = 112/292 (38%), Positives = 172/292 (58%), Gaps = 9/292 (3%)
Query: 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD 187
+ + + KL+K+G+GTY++V++ R T +VALK++R ++ E + RE+ +L+ L
Sbjct: 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLK 62
Query: 188 HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEH 246
H NI+ L +I + S + LVFEY++ D+ L C + + +K ++ QLL GL +
Sbjct: 63 HANIVTLHDIIHTEKSLT--LVFEYLDKDLKQYLDDCGNS-INMHNVKLFLFQLLRGLNY 119
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG 306
CH R VLHRD+K NLL+N G LKLADFGLA + + + ++ VVTLWYRPP++LLG
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVVTLWYRPPDILLG 178
Query: 307 ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK--SKLPH 364
+TDY +D+W VGC+F E+ G+P+ G T EQLH IF++ G+P ++ W S
Sbjct: 179 STDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238
Query: 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
+ P+ D + L + L+ LL E KR +A A+ YF
Sbjct: 239 KSYNYPKYRADCLHNHAPR-LDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 207 bits (529), Expect = 2e-61
Identities = 116/312 (37%), Positives = 181/312 (58%), Gaps = 25/312 (8%)
Query: 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD 187
+ + + KLEK+G+GTY++VF+ R T +VALK++R ++ E + RE+ +L+ L
Sbjct: 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKDLK 62
Query: 188 HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEH 246
H NI+ L ++ + S+ LVFEY++ D+ + C +I S +K ++ Q+L GL +
Sbjct: 63 HANIVTLHDIVHT--DKSLTLVFEYLDKDLKQYMDDCGNI-MSMHNVKIFLYQILRGLAY 119
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG 306
CH R VLHRD+K NLL+N G LKLADFGLA + + + ++ VVTLWYRPP++LLG
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLG 178
Query: 307 ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW--------- 357
+++Y +D+W VGC+F E+ G+P+ G T ++LH IF+L G+P ++ W
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238
Query: 358 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417
K P +KPQ + + R L T + L+ L E KR +A A+ YF
Sbjct: 239 KNYNFPK---YKPQPLINHAPR-----LDTEGIELLTKFLQYESKKRISAEEAMKHAYF- 289
Query: 418 TKPYACDLSSLP 429
+ + SLP
Sbjct: 290 -RSLGTRIHSLP 300
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 206 bits (524), Expect = 9e-61
Identities = 119/301 (39%), Positives = 180/301 (59%), Gaps = 16/301 (5%)
Query: 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRL 186
+AD++EKLEK+G+G+Y++V++ + GK+VALK +R E E F A RE +L+ L
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQ--EEEGTPFTAIREASLLKGL 60
Query: 187 DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEH 246
H NI+ L +I ++ + + LVFEY+ D+ + +K ++ QLL GL +
Sbjct: 61 KHANIVLLHDIIHTKETLT--LVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSY 118
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG 306
H R +LHRD+K NLL+++ G LKLADFGLA + + ++ VVTLWYRPP++LLG
Sbjct: 119 IHQRYILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVLLG 177
Query: 307 ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE-QLHKIFKLCGSPPDDYWKK-SKLPH 364
+T+Y +D+W VGC+F E++ G G +++ QL +IF + G+P +D W LPH
Sbjct: 178 STEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237
Query: 365 ATLFKPQQ--PYDS-SLRETFKDLPTT--AVNLIETLLSVEPYKRATASAALASEYFSTK 419
FKP++ Y +LR+ + L A +L LL P R +A AAL+ EYFS
Sbjct: 238 ---FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294
Query: 420 P 420
P
Sbjct: 295 P 295
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 200 bits (510), Expect = 8e-60
Identities = 76/191 (39%), Positives = 114/191 (59%), Gaps = 6/191 (3%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGL 197
+G+G + +V+ ARD TGK VA+K ++ ++ + REI IL++L+HPNI+KL G+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELL-REIEILKKLNHPNIVKLYGV 59
Query: 198 ITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 256
+YLV EY E + LL + K SE +I + Q+L GLE+ HS G++HRD
Sbjct: 60 FEDENH--LYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 257 IKGSNLLVNN-EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVD 315
+K N+L+++ G +KLADFGL+ T + L + V T Y PE+LLG Y D
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLL-TSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 316 LWSVGCVFAEL 326
+WS+G + EL
Sbjct: 177 IWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 203 bits (518), Expect = 2e-59
Identities = 108/312 (34%), Positives = 167/312 (53%), Gaps = 19/312 (6%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
D ++ L +G G Y V A D TG+ VA+KK+ + RE+ +L+ +DH
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE 74
Query: 190 NIIKLEGLITSRLSCS----IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
N+I L + T S +YLV M D+ ++ C K S+ I+ + Q+L GL+
Sbjct: 75 NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQ--KLSDDHIQFLVYQILRGLK 132
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
+ HS G++HRD+K SN+ VN + LK+ DFGLA ++ +T V T WYR PE++L
Sbjct: 133 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIML 188
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365
Y +VD+WSVGC+ AELL GK + G ++QL +I L G+P ++ +K A
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESA 248
Query: 366 TLFKPQQPYDSSLRETFKDLPTT----AVNLIETLLSVEPYKRATASAALASEYFSTKPY 421
+ P ++ FK++ + A++L+E +L ++P KR TA+ ALA Y Y
Sbjct: 249 RNYIQSLPQMP--KKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL--AEY 304
Query: 422 ACDLSSLPIYPP 433
D P+ PP
Sbjct: 305 H-DPEDEPVAPP 315
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 200 bits (509), Expect = 8e-59
Identities = 117/295 (39%), Positives = 171/295 (57%), Gaps = 14/295 (4%)
Query: 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLD 187
A ++ LEK+G+G+Y++V++ G++VALK + E V F A RE +L+ L
Sbjct: 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKT--EEGVPFTAIREASLLKGLK 61
Query: 188 HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
H NI+ L +I ++ + + VFEYM D+ + ++ +M QLL GL +
Sbjct: 62 HANIVLLHDIIHTKETLT--FVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYI 119
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
H + +LHRD+K NLL++ G LKLADFGLA + + Q +S VVTLWYRPP++LLGA
Sbjct: 120 HGQHILHRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVVTLWYRPPDVLLGA 178
Query: 308 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEV-EQLHKIFKLCGSPPDDYWKK-SKLPH- 364
TDY ++D+W GC+F E+L G+P G ++V EQL KI+ + G P +D W SKLP+
Sbjct: 179 TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNY 238
Query: 365 -ATLFKPQQPYDSSLRETFKDL--PTTAVNLIETLLSVEPYKRATASAALASEYF 416
F P +P LR +K L P A +L +L + P R +A AL YF
Sbjct: 239 KPEWFLPCKP--QQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 201 bits (514), Expect = 8e-59
Identities = 109/310 (35%), Positives = 156/310 (50%), Gaps = 42/310 (13%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPE--SVRFMAREILILRRLDHP 189
++ L IG+G Y V A TG VA+KK+ FE + R + REI ILRR H
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI--SPFEHQTFCQRTL-REIKILRRFKHE 63
Query: 190 NIIKLEGLITSRLSCS---IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEH 246
NII + +I S +Y+V E ME D+ L+ + S I+ ++ Q+L GL++
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHL--SNDHIQYFLYQILRGLKY 121
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQPLTSRVVTLWYRPPELL 304
HS VLHRD+K SNLL+N LK+ DFGLA H LT V T WYR PE++
Sbjct: 122 IHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIM 181
Query: 305 LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD--------- 355
L + Y ++D+WSVGC+ AE+L +P+ G+ + QL+ I + G+P +
Sbjct: 182 LNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLR 241
Query: 356 ---YWK----KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 408
Y K K K+P LF P A++L++ +L+ P+KR T
Sbjct: 242 ARNYIKSLPFKPKVPWNKLF----PNADPK----------ALDLLDKMLTFNPHKRITVE 287
Query: 409 AALASEYFST 418
ALA Y
Sbjct: 288 EALAHPYLEQ 297
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 198 bits (504), Expect = 4e-58
Identities = 101/289 (34%), Positives = 169/289 (58%), Gaps = 9/289 (3%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDHPN 190
+E L +G+G+Y V + + +TG+IVA+KK ++ + + V+ +A REI +L++L H N
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKF-LESEDDKMVKKIAMREIRMLKQLRHEN 61
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
++ L + R +YLVFE+++H + L E++++ Y+ Q+L G+E CHS
Sbjct: 62 LVNL--IEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH 119
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDY 310
++HRDIK N+LV+ GV+KL DFG A + T V T WYR PELL+G T Y
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTDYVATRWYRAPELLVGDTKY 178
Query: 311 GPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY---WKKSKLPHATL 367
G +VD+W+VGC+ E+L G+P+ G ++++QL+ I K G+ + ++K+ L A +
Sbjct: 179 GRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL-FAGM 237
Query: 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
P+ L + F L ++L + L ++P R ++S L E+F
Sbjct: 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 199 bits (507), Expect = 8e-58
Identities = 115/315 (36%), Positives = 171/315 (54%), Gaps = 36/315 (11%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+ L +G G+ VF A D D K VA+KK+ +P+SV+ REI I+RRLDH NI
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLT--DPQSVKHALREIKIIRRLDHDNI 64
Query: 192 IKLEGLI---TSRLSC---------SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQ 239
+K+ ++ S L+ S+Y+V EYME D+ +L + SE + +M Q
Sbjct: 65 VKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPL--SEEHARLFMYQ 122
Query: 240 LLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLA-----NFSNTGHRQPLTSRV 293
LL GL++ HS VLHRD+K +N+ +N E VLK+ DFGLA ++S+ G+ L+ +
Sbjct: 123 LLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY---LSEGL 179
Query: 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 353
VT WYR P LLL +Y ++D+W+ GC+FAE+L GKP+ G E+EQ+ I + S P
Sbjct: 180 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE---SVP 236
Query: 354 -----DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 408
D + +P +P LR+ + A++ +E +L+ P R TA
Sbjct: 237 VVREEDRNELLNVIPSFVRNDGGEPR-RPLRDLLPGVNPEALDFLEQILTFNPMDRLTAE 295
Query: 409 AALASEYFSTKPYAC 423
AL Y S Y+C
Sbjct: 296 EALMHPYMS--CYSC 308
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 195 bits (496), Expect = 5e-57
Identities = 119/295 (40%), Positives = 171/295 (57%), Gaps = 17/295 (5%)
Query: 132 FEKLEKIGQGTYSSVFRARDL-DTGKIVALKKVRFDNFEPESVRFMAREILILRRLD--- 187
+E + +IG+G Y VF+ARDL + G+ VALK+VR E RE+ +LR L+
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62
Query: 188 HPNIIKLEGLIT-SRL--SCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHG 243
HPN+++L + T SR + LVFE+++ D+T L P+ IK M QLL G
Sbjct: 63 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 122
Query: 244 LEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPEL 303
L+ HS V+HRD+K N+LV + G +KLADFGLA + + LTS VVTLWYR PE+
Sbjct: 123 LDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALTSVVVTLWYRAPEV 180
Query: 304 LLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP-PDDYWKKSKL 362
LL ++ Y VDLWSVGC+FAE+ KP+ +G ++V+QL KI + G P +D+ + L
Sbjct: 181 LLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 239
Query: 363 PHATLF-KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
P K QP + + D+ +L+ L+ P KR +A +AL+ YF
Sbjct: 240 PRQAFHSKSAQP----IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 193 bits (492), Expect = 6e-56
Identities = 110/301 (36%), Positives = 159/301 (52%), Gaps = 29/301 (9%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+ L+ +G G + V ARD TG+ VA+KK+ P + RE+ +L+ L H NI
Sbjct: 12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENI 71
Query: 192 IKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQ-IKCYMNQLLHGLEHCHSR 250
I L + S L IY V E + D+ LL+ + E Q I+ ++ Q+L GL++ HS
Sbjct: 72 ISLSDIFISPLE-DIYFVTELLGTDLHRLLTSRPL---EKQFIQYFLYQILRGLKYVHSA 127
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDY 310
GV+HRD+K SN+L+N LK+ DFGLA + + +T V T +YR PE++L Y
Sbjct: 128 GVVHRDLKPSNILINENCDLKICDFGLARIQD--PQ--MTGYVSTRYYRAPEIMLTWQKY 183
Query: 311 GPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK----------S 360
VD+WS GC+FAE+L GKP+ G+ V Q I L G+PPDD
Sbjct: 184 DVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ 243
Query: 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420
LP + P E FK+ +A++L+E +L +P KR +A+ ALA Y P
Sbjct: 244 SLPK----REPVP----FSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL--AP 293
Query: 421 Y 421
Y
Sbjct: 294 Y 294
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 2e-55
Identities = 74/203 (36%), Positives = 117/203 (57%), Gaps = 6/203 (2%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+ + E +G+G++ SV+ A D DTG+++A+K V E + + REI IL L HPNI
Sbjct: 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNI 61
Query: 192 IKLEGLITSRLSCSIYLVFEYM-EHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
++ G ++ + EY+ ++ LL K E I+ Y Q+L GL + HS
Sbjct: 62 VRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHS 119
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
G++HRDIKG+N+LV+++GV+KLADFG A + + S T ++ PE++ G
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG-E 178
Query: 309 DYGPSVDLWSVGCVFAELLIGKP 331
+YG + D+WS+GC E+ GKP
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 1e-54
Identities = 117/337 (34%), Positives = 181/337 (53%), Gaps = 25/337 (7%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE--PESVRFMAREILILRRLDHP 189
++ E IG+G+Y V A D TG+ VA+KK+ D FE ++ R + REI +LR L HP
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIN-DVFEHVSDATRIL-REIKLLRLLRHP 59
Query: 190 NIIKLEGLI---TSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEH 246
+I++++ ++ + R IY+VFE ME D+ ++ D + + ++ QLL L++
Sbjct: 60 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHHQFFLYQLLRALKY 118
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHRQPLTSRVVTLWYRPPELL 304
H+ V HRD+K N+L N + LK+ DFGLA F++T T V T WYR PEL
Sbjct: 119 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 178
Query: 305 LGA--TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362
G+ + Y P++D+WS+GC+FAE+L GKP+ G+ V QL I L G+P + + +
Sbjct: 179 -GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237
Query: 363 PHATLF----KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418
A + + +QP + F + A+ L+E LL+ +P R TA ALA YF
Sbjct: 238 EKARRYLSSMRKKQP--VPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFK- 294
Query: 419 KPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVR 455
L+ + P ++ I E RR+ VR
Sbjct: 295 -----GLAKVEREPSAQPITKLEFEFERRRLTKEDVR 326
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 187 bits (476), Expect = 1e-53
Identities = 102/305 (33%), Positives = 164/305 (53%), Gaps = 29/305 (9%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDT--GKIVALKKVR--FDNFEPESVRFMAREILILRRL- 186
+E ++++GQG Y V AR+ +T + VA+KK+ F + RE+ +LR
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK--KILAKRALRELKLLRHFR 59
Query: 187 DHPNIIKLEGL--ITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGL 244
H NI L + + +YL E ME D+ ++ ++A + ++ Q+L GL
Sbjct: 60 GHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIR-SGQPLTDAHFQSFIYQILCGL 118
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN------FSNTGHRQPLTSRVVTLWY 298
++ HS VLHRD+K NLLVN + LK+ DFGLA N G +T V T WY
Sbjct: 119 KYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF---MTEYVATRWY 175
Query: 299 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 358
R PE++L Y ++D+WSVGC+ AELL KP+ +G+ V+QL++I ++ G+P ++
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235
Query: 359 KSKLPHA-----TL-FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
+ P A +L P++P++S F + A++L+E LL+ +P KR + AL
Sbjct: 236 RIGSPKAQNYIRSLPNIPKKPFESI----FPNANPLALDLLEKLLAFDPTKRISVEEALE 291
Query: 413 SEYFS 417
Y +
Sbjct: 292 HPYLA 296
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 8e-52
Identities = 106/295 (35%), Positives = 166/295 (56%), Gaps = 14/295 (4%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDH 188
D + L+++G G Y +V A D TG VA+KK+ + F+ E A RE+ +L+ + H
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKL-YRPFQSELFAKRAYRELRLLKHMKH 73
Query: 189 PNIIKLEGLITSRLSCS----IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGL 244
N+I L + T LS YLV +M D+ L+ K SE +I+ + Q+L GL
Sbjct: 74 ENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHE--KLSEDRIQFLVYQMLKGL 131
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELL 304
++ H+ G++HRD+K NL VN + LK+ DFGLA +++ +T VVT WYR PE++
Sbjct: 132 KYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS----EMTGYVVTRWYRAPEVI 187
Query: 305 LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364
L Y +VD+WSVGC+ AE+L GKP+ +G ++QL +I K+ G+P ++ +K +
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSED 247
Query: 365 ATLFKPQQP--YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417
A + + P R + AVN++E +L ++ R TA+ ALA YF
Sbjct: 248 AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFE 302
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 181 bits (461), Expect = 2e-51
Identities = 108/300 (36%), Positives = 168/300 (56%), Gaps = 20/300 (6%)
Query: 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILIL 183
+P R + L+++G G Y SV A D TG+ VA+KK+ F+ E A RE+ +L
Sbjct: 13 LPER---YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLS-RPFQSEIFAKRAYRELTLL 68
Query: 184 RRLDHPNIIKLEGLITSRLSC----SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQ 239
+ + H N+I L + TS +S YLV YM+ D+ ++ P SE +++ + Q
Sbjct: 69 KHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHP---LSEDKVQYLVYQ 125
Query: 240 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYR 299
+L GL++ HS G++HRD+K NL VN + LK+ DFGLA ++ +T VVT WYR
Sbjct: 126 MLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA----EMTGYVVTRWYR 181
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359
PE++L Y +VD+WSVGC+ AE+L GK + +G+ ++QL +I K+ G P ++ +K
Sbjct: 182 APEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241
Query: 360 SKLPHATLF---KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
+ A + P+ P F AV+L+E +L ++ KR TA+ AL YF
Sbjct: 242 LEDKAAKSYIKSLPKYP-RKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYF 300
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 181 bits (462), Expect = 3e-51
Identities = 102/286 (35%), Positives = 153/286 (53%), Gaps = 11/286 (3%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVR--FDNFEPESVRFMAREILILRRLDHPNIIK-L 194
IG G + V+ D GK VALKK+ F N S + + RE+ +L H N++ L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLV--SCKRVFRELKMLCFFKHDNVLSAL 65
Query: 195 EGLITSRLSC--SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 252
+ L + IY+V E M+ D+ ++ P S +K ++ Q+L GL++ HS G+
Sbjct: 66 DILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLHSAGI 124
Query: 253 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGP 312
LHRDIK NLLVN+ VLK+ DFGLA + +T VVT +YR PE+L+G+ Y
Sbjct: 125 LHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTS 184
Query: 313 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS---KLPHATLFK 369
+VD+WSVGC+FAELL + + Q ++ ++QL I L G+P + + + H
Sbjct: 185 AVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGP 244
Query: 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415
+ P L AV+L+ +L +P KR +A+ ALA Y
Sbjct: 245 HKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 179 bits (455), Expect = 2e-50
Identities = 109/318 (34%), Positives = 166/318 (52%), Gaps = 15/318 (4%)
Query: 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILR 184
VP R ++ L +G G Y SV A D + VA+KK+ R RE+ +L+
Sbjct: 13 VPER---YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLK 69
Query: 185 RLDHPNIIKLEGLITSRLSCS----IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQL 240
+ H N+I L + T S +YLV M D+ ++ C K S+ ++ + QL
Sbjct: 70 HMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQ--KLSDEHVQFLIYQL 127
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP 300
L GL++ HS G++HRD+K SN+ VN + L++ DFGLA ++ +T V T WYR
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD----DEMTGYVATRWYRA 183
Query: 301 PELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360
PE++L Y +VD+WSVGC+ AELL GK + G ++QL +I ++ G+P + KK
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI 243
Query: 361 KLPHATLFKPQQPY--DSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418
HA + P+ L++ F+ A++L+E +L ++ KR +AS ALA YFS
Sbjct: 244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303
Query: 419 KPYACDLSSLPIYPPSKE 436
D Y S E
Sbjct: 304 YHDPEDEPEAEPYDESPE 321
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 3e-50
Identities = 75/202 (37%), Positives = 115/202 (56%), Gaps = 10/202 (4%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
FE LEKIG+G + V++AR TGK VA+K ++ + E + EI IL++ HPNI
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLE--SKEKKEKIINEIQILKKCKHPNI 59
Query: 192 IKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
+K G + +++V E+ + LL + +E+QI +LL GLE+ HS
Sbjct: 60 VKYYGSYLKKDE--LWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVVTLWYRPPELLLGATD 309
G++HRDIK +N+L+ ++G +KL DFGL+ S+T R + V T ++ PE++ G
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGTPYWMAPEVING-KP 173
Query: 310 YGPSVDLWSVGCVFAELLIGKP 331
Y D+WS+G EL GKP
Sbjct: 174 YDYKADIWSLGITAIELAEGKP 195
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 4e-48
Identities = 102/299 (34%), Positives = 155/299 (51%), Gaps = 15/299 (5%)
Query: 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILR 184
VP R ++ L +G G Y SV A D TG VA+KK+ + RE+ +L+
Sbjct: 15 VPER---YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 71
Query: 185 RLDHPNIIKLEGLITSRLSCS----IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQL 240
+ H N+I L + T S +YLV M D+ ++ C K ++ ++ + Q+
Sbjct: 72 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQI 129
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP 300
L GL++ HS ++HRD+K SNL VN + LK+ DFGLA ++ +T V T WYR
Sbjct: 130 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD----DEMTGYVATRWYRA 185
Query: 301 PELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360
PE++L Y +VD+WSVGC+ AELL G+ + G ++QL I +L G+P + KK
Sbjct: 186 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 245
Query: 361 KLPHATLFKPQQPY--DSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417
A + + F AV+L+E +L ++ KR TA+ ALA YF+
Sbjct: 246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 304
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 4e-48
Identities = 111/315 (35%), Positives = 171/315 (54%), Gaps = 40/315 (12%)
Query: 137 KIGQGTYSSVFRARDLD--TGKIVALKKVRFDNFEPESVRFMA-REILILRRLDHPNIIK 193
K+G+GTY V++A+ D + ALK++ E + A REI +LR L HPN+I
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQI-----EGTGISMSACREIALLRELKHPNVIS 62
Query: 194 LEGLITSRLSCSIYLVFEYMEHDITGLL--------SCPDIKFSEAQIKCYMNQLLHGLE 245
L+ + S ++L+F+Y EHD+ ++ + ++ +K + Q+L G+
Sbjct: 63 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGV----LKLADFGLANFSNTGHR--QPLTSRVVTLWYR 299
+ H+ VLHRD+K +N+LV EG +K+AD G A N+ + L VVT WYR
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE---------VEQLHKIFKLCG 350
PELLLGA Y ++D+W++GC+FAELL +PI R E +QL +IF + G
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 242
Query: 351 SPPDDYWKK-SKLP-HATL---FKPQQPYDSSL---RETFKDLP-TTAVNLIETLLSVEP 401
P D W+ K+P H+TL F+ + SL E K P + A +L++ LL+++P
Sbjct: 243 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDP 302
Query: 402 YKRATASAALASEYF 416
KR T+ A+ YF
Sbjct: 303 IKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 2e-47
Identities = 76/217 (35%), Positives = 124/217 (57%), Gaps = 18/217 (8%)
Query: 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLE 195
+ IG+G + V++ +L+TG VA+K++ + + E+++ + +EI +L+ L HPNI+K
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 196 GLITSRLSCSIYLVFEYMEHDITGLLSCPDI-----KFSEAQIKCYMNQLLHGLEHCHSR 250
G I + S S+Y++ EY E+ G L I F E+ + Y+ Q+L GL + H +
Sbjct: 66 GSIET--SDSLYIILEYAEN---GSLR--QIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ 118
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDY 310
GV+HRDIK +N+L +GV+KLADFG+A N + + V T ++ PE++ +
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV-VGTPYWMAPEVIEMS--- 174
Query: 311 GPSV--DLWSVGCVFAELLIGKPILQGRTEVEQLHKI 345
G S D+WS+GC ELL G P + L +I
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI 211
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 172 bits (435), Expect = 2e-47
Identities = 93/335 (27%), Positives = 146/335 (43%), Gaps = 40/335 (11%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFD-NFEPESVRFMAREILILRRLDHP- 189
+ L K+G+G++ V+ ARD K+VALK + + + V REI IL L+HP
Sbjct: 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 190 NIIKLEGLITSRLSCSIYLVFEYME-HDITGLLSCPDI--KFSEAQIKCYMNQLLHGLEH 246
NI+KL S +YLV EY++ + LL SE++ + Q+L LE+
Sbjct: 59 NIVKLYDFFQDEGS--LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116
Query: 247 CHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANF-----SNTGHRQPLTSRVVTLWYRP 300
HS+G++HRDIK N+L++ + V+KL DFGLA S + ++ V T Y
Sbjct: 117 LHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 301 PELLLGATD--YGPSVDLWSVGCVFAELLIGKPILQGRTE---VEQLHKIFKLCGSPPDD 355
PE+LLG + S D+WS+G ELL G P +G Q KI +P
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236
Query: 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415
P + A +L++ LL+ +P R ++S+ L+ +
Sbjct: 237 SPLSPSNPE-------------------LISKAASDLLKKLLAKDPKNRLSSSSDLSHDL 277
Query: 416 FSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKV 450
+ S + P + +
Sbjct: 278 LAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALI 312
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 6e-47
Identities = 91/295 (30%), Positives = 135/295 (45%), Gaps = 48/295 (16%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+E +++IG+G++ V+ R GK+ LK++ N + E+ IL++L+HPNI
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 192 IKL-EGLITSRLSCSIYLVFEYMEHDITGLLS-------CPDIKFSEAQIKCYMNQLLHG 243
IK E + +V EY + G LS F E QI + QL
Sbjct: 62 IKYYESFEEK---GKLCIVMEYAD---GGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA 115
Query: 244 LEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVV-TLWYRPP 301
L++ HSR +LHRDIK N+ + + G++KL DFG++ S+T L VV T +Y P
Sbjct: 116 LKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST---VDLAKTVVGTPYYLSP 172
Query: 302 ELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361
EL Y D+WS+GCV EL K +G +E KI K G P
Sbjct: 173 ELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK--GQYP-------P 222
Query: 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
+P Y S LR NL+ +LL +P +R + + L S +
Sbjct: 223 IP--------SQYSSELR-----------NLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 168 bits (426), Expect = 8e-47
Identities = 113/315 (35%), Positives = 171/315 (54%), Gaps = 40/315 (12%)
Query: 137 KIGQGTYSSVFRARDLDTG--KIVALKKVRFDNFEPESVRFMA-REILILRRLDHPNIIK 193
K+G+GTY V++A+ D K ALK++ E + A REI +LR L HPN+I
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQI-----EGTGISMSACREIALLRELKHPNVIA 62
Query: 194 LEGLITSRLSCSIYLVFEYMEHDITGLL--------SCPDIKFSEAQIKCYMNQLLHGLE 245
L+ + S ++L+F+Y EHD+ ++ + ++ + +K + Q+L G+
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGV----LKLADFGLANFSNTGHR--QPLTSRVVTLWYR 299
+ H+ VLHRD+K +N+LV EG +K+AD G A N+ + L VVT WYR
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE---------VEQLHKIFKLCG 350
PELLLGA Y ++D+W++GC+FAELL +PI R E +QL +IF + G
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242
Query: 351 SPPDDYWKK-SKLP-HATL---FKPQQPYDSSL---RETFKDLPTTAVN-LIETLLSVEP 401
P D W+ K+P + TL F+ +SSL E K P + V L++ LL+++P
Sbjct: 243 FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDP 302
Query: 402 YKRATASAALASEYF 416
KR T+ AL YF
Sbjct: 303 TKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 167 bits (423), Expect = 9e-47
Identities = 106/291 (36%), Positives = 154/291 (52%), Gaps = 8/291 (2%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDH 188
+ FE L +G+G Y V + R +T +IVA+KK + D+ E E V+ RE+ +LR L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFK-DSEENEEVKETTLRELKMLRTLKQ 59
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
NI++L+ R +YLVFEY+E ++ LL +++ Y+ QL+ + CH
Sbjct: 60 ENIVELKEAFRRR--GKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCH 117
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
++HRDIK NLL+++ VLKL DFG A + G T V T WYR PELLLGA
Sbjct: 118 KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177
Query: 309 DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK--KSKLPHAT 366
YG +VD+WSVGC+ EL G+P+ G +E++QL I K+ G P + K S
Sbjct: 178 -YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236
Query: 367 LFKPQQPYDSSLRETFKD-LPTTAVNLIETLLSVEPYKRATASAALASEYF 416
L P + SL + L ++L++ LL + P R L F
Sbjct: 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 4e-44
Identities = 91/304 (29%), Positives = 140/304 (46%), Gaps = 47/304 (15%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
++ LEKIG+G V++A D TGK VA+KK+R E + EILI++ HPNI
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI---INEILIMKDCKHPNI 77
Query: 192 IKLEGLITSRLSC-----SIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
+ +++V EYM+ +T +++ ++ +E QI ++L GLE
Sbjct: 78 VDY-------YDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLE 130
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
+ HS+ V+HRDIK N+L++ +G +KLADFG A S V T ++ PE++
Sbjct: 131 YLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK-SKRNSVVGTPYWMAPEVIK 189
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365
DYGP VD+WS+G + E+ G+P + L I G PP L +
Sbjct: 190 R-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIPP--------LKNP 239
Query: 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDL 425
+ P+ FKD + L +P KR +A L + AC
Sbjct: 240 EKWSPE----------FKD-------FLNKCLVKDPEKRPSAEELLQHPFLKK---ACPK 279
Query: 426 SSLP 429
Sbjct: 280 EEFA 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 7e-43
Identities = 106/296 (35%), Positives = 160/296 (54%), Gaps = 32/296 (10%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGL 197
IG G++ V+ A +DT + VA+KKV D P+ + RE+LI++ L+H NII L+
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQD---PQ---YKNRELLIMKNLNHINIIFLKDY 127
Query: 198 ITS----RLSCSIYL----------VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHG 243
+ + +I+L V +YM+H + P +K Y QL
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLF-----LVKLYSYQLCRA 182
Query: 244 LEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPE 302
L + HS+ + HRD+K NLL++ N LKL DFG A G R S + + +YR PE
Sbjct: 183 LAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS--VSYICSRFYRAPE 240
Query: 303 LLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362
L+LGAT+Y +DLWS+GC+ AE+++G PI G++ V+QL +I ++ G+P +D K+
Sbjct: 241 LMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNP 300
Query: 363 PHATL-FKPQQPYDSSLRETF-KDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
+A + F +P D L++ F K P A+N I L EP KR ALA +F
Sbjct: 301 NYADIKFPDVKPKD--LKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFF 354
|
Length = 440 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 1e-42
Identities = 94/312 (30%), Positives = 158/312 (50%), Gaps = 44/312 (14%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR--FDNFEPESVRFMAREILILRRLDHP 189
++ L+ IG G V A D TG+ VA+KK+ F N + RE+++++ ++H
Sbjct: 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQN--VTHAKRAYRELVLMKLVNHK 75
Query: 190 NIIKLEGLITSRLSCS----IYLVFEYMEHDITGLLSCPDIK--FSEAQIKCYMNQLLHG 243
NII L + T + S +YLV E M+ ++ C I+ ++ + Q+L G
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDVYLVMELMDANL-----CQVIQMDLDHERMSYLLYQMLCG 130
Query: 244 LEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPEL 303
++H HS G++HRD+K SN++V ++ LK+ DFGLA + T +T VVT +YR PE+
Sbjct: 131 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEV 188
Query: 304 LLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK---- 359
+LG Y +VD+WSVGC+ E++ G + G ++Q +KI + G+P D++ +
Sbjct: 189 ILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPT 247
Query: 360 ----------------SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK 403
+L LF P + L+ + A +L+ +L ++P K
Sbjct: 248 VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLK------ASQARDLLSKMLVIDPEK 301
Query: 404 RATASAALASEY 415
R + AL Y
Sbjct: 302 RISVDDALQHPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 85/299 (28%), Positives = 136/299 (45%), Gaps = 57/299 (19%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKV--RFDNFEPESVRFMAREILILRRLD-H 188
F+ + IG+G++S+V A++ +T K A+K + R E + V+++ E +L RL+ H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKE-KKVKYVKIEKEVLTRLNGH 61
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
P IIKL T + ++Y V EY + ++ + E + Y ++L LE+
Sbjct: 62 PGIIKLYY--TFQDEENLYFVLEYAPNGELLQYI-RKYGSLDEKCTRFYAAEILLALEYL 118
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-------------------RQP 288
HS+G++HRD+K N+L++ + +K+ DFG A + R+
Sbjct: 119 HSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178
Query: 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 348
S V T Y PELL G S DLW++GC+ ++L GKP +G E KI KL
Sbjct: 179 FASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL 237
Query: 349 CGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 407
S P ++ D A +LIE LL ++P R
Sbjct: 238 EYSFPPNF-------------------------PPD----AKDLIEKLLVLDPQDRLGV 267
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 4e-40
Identities = 90/284 (31%), Positives = 144/284 (50%), Gaps = 38/284 (13%)
Query: 133 EKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192
++ KIG GT+ V+ A +LDTG+++A+K++R + +P++++ +A E+ +L L HPN++
Sbjct: 3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 193 KLEGLITSRLSCSIYLVFEY-MEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG 251
K G+ R +Y+ EY + LL I E I+ Y QLL GL + HS G
Sbjct: 63 KYYGVEVHRE--KVYIFMEYCSGGTLEELLEHGRIL-DEHVIRVYTLQLLEGLAYLHSHG 119
Query: 252 VLHRDIKGSNLLVNNEGVLKLADFG----LANFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
++HRDIK +N+ +++ GV+KL DFG L N + T + + S T Y PE++ G
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE-VQSLAGTPAYMAPEVITGG 178
Query: 308 TD--YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI-FKLCGSPPDDYWKKSKLPH 364
+G + D+WS+GCV E+ GK +E++ +I F +
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPW---SELDNEFQIMFHVGAGH------------ 223
Query: 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 408
KP P L KD ++ L +P KR TAS
Sbjct: 224 ----KPPIPDSLQLSPEGKD-------FLDRCLESDPKKRPTAS 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 2e-39
Identities = 86/273 (31%), Positives = 128/273 (46%), Gaps = 44/273 (16%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVR-FDNFEPESVRFMAREILILRRLDHPNIIKLE- 195
+G+G++ V R DTGK+ A+K ++ + + V E IL R++HP I+KL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 196 GLITSRLSCSIYLVFEYMEHDITGLLS---CPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 252
T +YLV EY G L + +FSE + + Y +++ LE+ HS G+
Sbjct: 61 AFQTEE---KLYLVLEYAP---GGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGI 114
Query: 253 LHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVVTLWYRPPELLLGATDYG 311
++RD+K N+L++ +G +KL DFGLA S+ G R + T Y PE+LLG YG
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR--TNTFCGTPEYLAPEVLLGK-GYG 171
Query: 312 PSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 371
+VD WS+G + E+L GKP E KI K + P
Sbjct: 172 KAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK----------DPLRFP-------- 213
Query: 372 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 404
+ L A +LI LL +P KR
Sbjct: 214 -----------EFLSPEARDLISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 5e-39
Identities = 67/204 (32%), Positives = 107/204 (52%), Gaps = 14/204 (6%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
E+++ +GQG+ V++ R TGKI ALKK+ D + E + + RE+ LR + P +
Sbjct: 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDG-DEEFRKQLLRELKTLRSCESPYV 61
Query: 192 IKLEGLITSRLSCSIYLVFEYME----HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
+K G I +V EYM+ D+ K E + Q+L GL++
Sbjct: 62 VKCYGAFYK--EGEISIVLEYMDGGSLADLLK----KVGKIPEPVLAYIARQILKGLDYL 115
Query: 248 HS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG 306
H+ R ++HRDIK SNLL+N++G +K+ADFG++ + V T+ Y PE + G
Sbjct: 116 HTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT-LDQCNTFVGTVTYMSPERIQG 174
Query: 307 ATDYGPSVDLWSVGCVFAELLIGK 330
+ Y + D+WS+G E +GK
Sbjct: 175 ES-YSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 1e-38
Identities = 87/283 (30%), Positives = 136/283 (48%), Gaps = 36/283 (12%)
Query: 134 KLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN---FEPESVRFMAREILILRRLDHPN 190
K E +G G++ SV+ +LD G A+K+V + E+V+ + +EI +L +L HPN
Sbjct: 4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPN 63
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
I++ G T R ++Y+ E + + LL F E I+ Y Q+L GLE+ H
Sbjct: 64 IVQYLG--TEREEDNLYIFLELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHD 120
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD 309
R +HRDIKG+N+LV+ GV+KLADFG+A S + ++ PE++
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE--FSFAKSFKGSPYWMAPEVIAQQGG 178
Query: 310 YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369
YG + D+WS+GC E+ GKP +++E + +FK+ G +
Sbjct: 179 YGLAADIWSLGCTVLEMATGKPPW---SQLEGVAAVFKI-GRSKE--------------L 220
Query: 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
P P L A + I L +P R TA+ L
Sbjct: 221 PPIP---------DHLSDEAKDFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 6e-38
Identities = 73/223 (32%), Positives = 113/223 (50%), Gaps = 11/223 (4%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+E LE IG+G++ +V + R GKI+ K++ + N + + + E+ ILR L HPNI
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 192 IKLEGLITSRLSCSIYLVFEYMEH-DITGLLS-CPDIK--FSEAQIKCYMNQLLHGLEHC 247
++ I R + ++Y+V EY E D+ L+ C + E I + QLL L C
Sbjct: 62 VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYEC 121
Query: 248 HSRG-----VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPE 302
H+R VLHRD+K +N+ ++ +KL DFGLA + V T +Y PE
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS-SFAKTYVGTPYYMSPE 180
Query: 303 LLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 345
L + Y D+WS+GC+ EL P R +++ KI
Sbjct: 181 QLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 142 bits (358), Expect = 4e-37
Identities = 100/332 (30%), Positives = 169/332 (50%), Gaps = 33/332 (9%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+++L+ IG G V A D G VA+KK+ + RE+++L+ ++H NI
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82
Query: 192 IKLEGLITSRLSCS----IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
I L + T + S +YLV E M+ ++ ++ ++ ++ + Q+L G++H
Sbjct: 83 ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIH---MELDHERMSYLLYQMLCGIKHL 139
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
HS G++HRD+K SN++V ++ LK+ DFGLA + T +T VVT +YR PE++LG
Sbjct: 140 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM--MTPYVVTRYYRAPEVILG- 196
Query: 308 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK--SKLPHA 365
Y +VD+WSVGC+ EL+ G I QG ++Q +K+ + G+P ++ + + +
Sbjct: 197 MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNY 256
Query: 366 TLFKPQQPYDSSLRETFKD--LP----------TTAVNLIETLLSVEPYKRATASAALAS 413
+PQ P S E F D P + A +L+ +L ++P KR + AL
Sbjct: 257 VENRPQYP-GISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315
Query: 414 EYFST--KPYACDLSSLPIYPPSKEIDAKHRE 443
Y + P + PP + DA+ E
Sbjct: 316 PYITVWYDPAEAEA------PPPQIYDAQLEE 341
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 79/282 (28%), Positives = 125/282 (44%), Gaps = 52/282 (18%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVR---FMAREILILRRLDHPNIIKL 194
I +G Y VF A+ TG I A+K ++ + ++ R+IL + P ++KL
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILS--QAQSPYVVKL 58
Query: 195 -EGLITSRLSCSIYLVFEYMEH-DITGLLS---CPDIKFSEAQIKCYMNQLLHGLEHCHS 249
+ ++YLV EY+ D+ LL E + Y+ +++ LE+ HS
Sbjct: 59 YYSFQGKK---NLYLVMEYLPGGDLASLLENVGS----LDEDVARIYIAEIVLALEYLHS 111
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLANF------SNTGHRQPLTSRVV-TLWYRPPE 302
G++HRD+K N+L+++ G LKL DFGL+ N + R+V T Y PE
Sbjct: 112 NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 303 LLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362
++LG + +VD WS+GC+ E L+G P G T E I P+D
Sbjct: 172 VILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED------- 223
Query: 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 404
++ A++LI LL +P KR
Sbjct: 224 --------------------VEVSDEAIDLISKLLVPDPEKR 245
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 4e-36
Identities = 90/326 (27%), Positives = 166/326 (50%), Gaps = 23/326 (7%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
++ L+ IG G V A D + VA+KK+ + RE+++++ ++H NI
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 192 IKLEGLITSRLSCS----IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
I L + T + S +Y+V E M+ ++ ++ ++ ++ + Q+L G++H
Sbjct: 86 IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHL 142
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
HS G++HRD+K SN++V ++ LK+ DFGLA + T +T VVT +YR PE++LG
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVILG- 199
Query: 308 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367
Y +VD+WSVGC+ E++ G + G ++Q +K+ + G+P ++ KK + T
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 259
Query: 368 FKPQQPYDS-SLRETFKDL------------PTTAVNLIETLLSVEPYKRATASAALASE 414
+ + Y S + F D+ + A +L+ +L ++ KR + AL
Sbjct: 260 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319
Query: 415 YFSTKPYACDLSSLPIYPPSKEIDAK 440
Y + + + P P K++D +
Sbjct: 320 YINVWYDPSEAEAPPPKIPDKQLDER 345
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 7e-36
Identities = 68/212 (32%), Positives = 109/212 (51%), Gaps = 22/212 (10%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
F LE IG+G++ V++A D T ++VA+K + + E E + + +EI L + P I
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSPYI 61
Query: 192 IKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI----KFSEAQIKCYMNQLLHGLEHC 247
K G + ++++ EY G SC D+ K E I + ++L GLE+
Sbjct: 62 TKYYG--SFLKGSKLWIIMEYC-----GGGSCLDLLKPGKLDETYIAFILREVLLGLEYL 114
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR----VVTLWYRPPEL 303
H G +HRDIK +N+L++ EG +KLADFG++ G S+ V T ++ PE+
Sbjct: 115 HEEGKIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAPEV 169
Query: 304 LLGATDYGPSVDLWSVGCVFAELLIGKPILQG 335
+ + Y D+WS+G EL G+P L
Sbjct: 170 IKQ-SGYDEKADIWSLGITAIELAKGEPPLSD 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 8e-36
Identities = 94/326 (28%), Positives = 169/326 (51%), Gaps = 23/326 (7%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
++ L+ IG G V A D + VA+KK+ + RE+++++ ++H NI
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 192 IKLEGLITSRLSCS----IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
I L + T + S +YLV E M+ ++ ++ ++ ++ + Q+L G++H
Sbjct: 79 ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHL 135
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
HS G++HRD+K SN++V ++ LK+ DFGLA + T +T VVT +YR PE++LG
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVILG- 192
Query: 308 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-------- 359
Y +VD+WSVGC+ E++ K + GR ++Q +K+ + G+P ++ KK
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252
Query: 360 --SKLPHATLFKPQQPYDSSL---RETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 414
++ +A L P+ DS E K + A +L+ +L ++P KR + AL
Sbjct: 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP 312
Query: 415 YFSTKPYACDLSSLPIYPPSKEIDAK 440
Y + ++ + P K++D +
Sbjct: 313 YINVWYDPAEVEAPPPQIYDKQLDER 338
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 4e-35
Identities = 73/230 (31%), Positives = 124/230 (53%), Gaps = 12/230 (5%)
Query: 134 KLEKIGQGTYSSVFRARDLDTGKIVALKKV--------RFDNFEPESVRFMAREILILRR 185
K E IG+GTY V+ A ++ TG+++A+K+V R D+ + + V+ + EI L+
Sbjct: 5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKD 64
Query: 186 LDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
LDH NI++ G T+ SI+L EY+ G +F E ++ + Q+L GL
Sbjct: 65 LDHLNIVQYLGFETTEEYLSIFL--EYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLA 122
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT--GHRQPLTSRVVTLWYRPPEL 303
+ HS+G+LHRD+K NLLV+ +G+ K++DFG++ S+ + Q ++ + W P +
Sbjct: 123 YLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182
Query: 304 LLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 353
+ Y VD+WS+GCV E+ G+ + + K+ +PP
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPP 232
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 1e-34
Identities = 67/204 (32%), Positives = 113/204 (55%), Gaps = 11/204 (5%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ F+ LEK+G+G+Y SV++A +TG++VA+K V + E ++ + +EI IL++ D P
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCDSP 58
Query: 190 NIIKLEGLITSRLSCSIYLVFEYME-HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
I+K G + +++V EY ++ ++ + +E +I + Q L GLE+ H
Sbjct: 59 YIVKYYGSY--FKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH 116
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-TLWYRPPELLLGA 307
S +HRDIK N+L+N EG KLADFG++ + V+ T ++ PE++
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFWMAPEVIQE- 173
Query: 308 TDYGPSVDLWSVGCVFAELLIGKP 331
Y D+WS+G E+ GKP
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGKP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 66/209 (31%), Positives = 111/209 (53%), Gaps = 16/209 (7%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ +E +++IG GTY V++ARD+ TG++VA+K ++ + + + +EI +L+ HP
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHP 60
Query: 190 NIIKLEGLITSRLSCSIYLVFEYME----HDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
NI+ G + +++V EY DI + P SE QI + L GL
Sbjct: 61 NIVAYFG--SYLRRDKLWIVMEYCGGGSLQDIYQVTRGP---LSELQIAYVCRETLKGLA 115
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLWYRPPELL 304
+ H G +HRDIKG+N+L+ +G +KLADFG+ A + T ++ S + T ++ PE+
Sbjct: 116 YLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR--KSFIGTPYWMAPEVA 173
Query: 305 L--GATDYGPSVDLWSVGCVFAELLIGKP 331
Y D+W++G EL +P
Sbjct: 174 AVERKGGYDGKCDIWALGITAIELAELQP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 6e-34
Identities = 81/294 (27%), Positives = 128/294 (43%), Gaps = 34/294 (11%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
D +E +E IG G + V+ A L + VA+K++ + SV + +E+ + + +HP
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC-QTSVDELRKEVQAMSQCNHP 59
Query: 190 NIIKLEGLITSRLSCSIYLVFEYME----HDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
N++K ++LV Y+ DI S P EA I + ++L GLE
Sbjct: 60 NVVKYYTSFVVGDE--LWLVMPYLSGGSLLDIMKS-SYPRGGLDEAIIATVLKEVLKGLE 116
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVV--TLWYRPPE 302
+ HS G +HRDIK N+L+ +G +K+ADFG+ A+ ++ G R + T + PE
Sbjct: 117 YLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176
Query: 303 LLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362
++ Y D+WS G EL G ++ L L PP L
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLT--LQNDPPS-------L 227
Query: 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
+K Y S R+ +I L +P KR TA L ++F
Sbjct: 228 ETGADYK---KYSKSFRK-----------MISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 7e-34
Identities = 75/226 (33%), Positives = 116/226 (51%), Gaps = 19/226 (8%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPES---VRFMAREILILRRLDHPNIIKL 194
+GQG + V+ D+DTG+ +A+K+V FD PE+ V + EI +L+ L H I++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 195 EGLITSRLSCSIYLVFEYME----HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
G + + SI++ EYM D +E + Y Q+L G+E+ HS
Sbjct: 70 YGCLRDDETLSIFM--EYMPGGSVKDQLKAYGA----LTETVTRKYTRQILEGVEYLHSN 123
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV--TLWYRPPELLLGAT 308
++HRDIKG+N+L ++ G +KL DFG + T + V T ++ PE++ G
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183
Query: 309 DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 354
YG D+WSVGC E+L KP E E + IFK+ P +
Sbjct: 184 -YGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTN 225
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 78/233 (33%), Positives = 125/233 (53%), Gaps = 13/233 (5%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRF----DNFEPESVRFMAREILILRRLD 187
+ K +++G G +SS ++ARD+ TG ++A+K+V + + + E V + +EI ++ RL+
Sbjct: 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN 61
Query: 188 HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
HP+II++ G ++++ E+M L F EA I Y QLL GL +
Sbjct: 62 HPHIIRMLGATCEDSHFNLFV--EWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYL 119
Query: 248 HSRGVLHRDIKGSNLLVNNEG-VLKLADFGLA---NFSNTGHRQPLTSRVVTLWYRPPEL 303
H ++HRD+KG+NLL+++ G L++ADFG A TG + + T+ + PE+
Sbjct: 120 HENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 304 LLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS--PPD 354
L G YG S D+WSVGCV E+ KP L IFK+ + P
Sbjct: 180 LRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPS 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 78/265 (29%), Positives = 136/265 (51%), Gaps = 28/265 (10%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPES-------VRFMAREILILRRLDHPN 190
IG G++ SV+ + +G+++A+K+V + S + +AREI +L+ L H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
I++ G +I+L EY+ + LL+ F E ++ ++ Q+L GL + H+
Sbjct: 68 IVQYLGSSLDADHLNIFL--EYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLHN 124
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGL-----ANFSNTGHRQPLTSRVVTLWYRPPELL 304
RG++HRDIKG+N+LV+N+G +K++DFG+ AN +T S ++++ PE +
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE-V 183
Query: 305 LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG----SPPDDYWKKS 360
+ T Y D+WS+GC+ E+L GK + QL IFK+ P + ++
Sbjct: 184 VKQTSYTRKADIWSLGCLVVEMLTGK---HPFPDCTQLQAIFKIGENASPEIPSNISSEA 240
Query: 361 KLPHATLFKPQQPYDSSLRETFKDL 385
F+ D + R T +L
Sbjct: 241 IDFLEKTFEI----DHNKRPTAAEL 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 4e-33
Identities = 88/293 (30%), Positives = 136/293 (46%), Gaps = 52/293 (17%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR-FDNFEPESVRFMAREILILRRLDH 188
F+ +KIG+G +S V++A L G++VALKKV+ F+ + ++ + +EI +L++LDH
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61
Query: 189 PNIIK-LEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIK--------FSEAQIKCYMN 238
PN+IK L I + + +V E + D++ + IK E I Y
Sbjct: 62 PNVIKYLASFIENN---ELNIVLELADAGDLSRM-----IKHFKKQKRLIPERTIWKYFV 113
Query: 239 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQPLTSRVVTL 296
QL LEH HS+ ++HRDIK +N+ + GV+KL D GL F S T S V T
Sbjct: 114 QLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH---SLVGTP 170
Query: 297 WYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDD 355
+Y PE + Y D+WS+GC+ E+ + P + + L K + C PP
Sbjct: 171 YYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPP-- 227
Query: 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 408
P Y LR+ L+ ++ +P KR S
Sbjct: 228 -------------LPADHYSEELRD-----------LVSRCINPDPEKRPDIS 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 74/234 (31%), Positives = 110/234 (47%), Gaps = 25/234 (10%)
Query: 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-D 187
FE +E IG+GTY V++AR TG++VA+K + E E ++ E ILR+ +
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIK---EEYNILRKYSN 61
Query: 188 HPNIIKLEGLITSRLSCS----IYLVFEYMEHD-----ITGLLSCPDIKFSEAQIKCYMN 238
HPNI G + ++LV E + GL + E I +
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK-RLKEEWIAYILR 120
Query: 239 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLW 297
+ L GL + H V+HRDIKG N+L+ +KL DFG+ A +T R+ + + T +
Sbjct: 121 ETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRR--NTFIGTPY 178
Query: 298 YRPPELLLGATDYGPSV------DLWSVGCVFAELLIGKPILQGRTEVEQLHKI 345
+ PE++ A D P D+WS+G EL GKP L + L KI
Sbjct: 179 WMAPEVI--ACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKI 230
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 6e-30
Identities = 78/275 (28%), Positives = 123/275 (44%), Gaps = 34/275 (12%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKK-VRFDNFEPESVRFMAREILILRRLDHPN 190
FE L IG+G + V + DT K+ A+K + E SVR + E IL+ L+HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
++ L + YLV + + D+ LS +KFSE Q+K ++ +++ LE+ HS
Sbjct: 62 LVNLWYSFQDEENM--YLVVDLLLGGDLRYHLS-QKVKFSEEQVKFWICEIVLALEYLHS 118
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD 309
+G++HRDIK N+L++ +G + + DF +A TS T Y PE+L
Sbjct: 119 KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD--TLTTSTSGTPGYMAPEVLCRQ-G 175
Query: 310 YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369
Y +VD WS+G E L GK +G + D + + L+
Sbjct: 176 YSVAVDWWSLGVTAYECLRGKRPYRGHS-------------RTIRDQIRAKQETADVLYP 222
Query: 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 404
+ A++ I LL +P KR
Sbjct: 223 ATWSTE-------------AIDAINKLLERDPQKR 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 93/300 (31%), Positives = 130/300 (43%), Gaps = 70/300 (23%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGL 197
+G+GTY V+ ARDL T +A+K++ + V+ + EI + L H NI++ G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLG- 72
Query: 198 ITSRLSCSIYLVFE-YMEHDITGLLSC-------PDIKFSEAQIKCYMNQLLHGLEHCHS 249
S S F+ +ME G LS P +K +E I Y Q+L GL++ H
Sbjct: 73 -----SDSENGFFKIFMEQVPGGSLSALLRSKWGP-LKDNEQTIIFYTKQILEGLKYLHD 126
Query: 250 RGVLHRDIKGSNLLVNN-EGVLKLADFGLANFSNTGHR----QPLTSRVV-TLWYRPPEL 303
++HRDIKG N+LVN GV+K++DFG T R P T TL Y PE+
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFG------TSKRLAGINPCTETFTGTLQYMAPEV 180
Query: 304 L-LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362
+ G YG D+WS+GC E+ GKP F G
Sbjct: 181 IDKGPRGYGAPADIWSLGCTIVEMATGKP-------------PFIELGE----------- 216
Query: 363 PHATLFK-------PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415
P A +FK P+ P + L A N I +P KRA+A L +
Sbjct: 217 PQAAMFKVGMFKIHPEIP---------ESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 47/155 (30%), Positives = 77/155 (49%), Gaps = 14/155 (9%)
Query: 132 FEKLEKIGQGTYSSVFRAR----DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD 187
E +K+G+G + V++ T VA+K ++ E E F+ E I+++L
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFL-EEASIMKKLS 59
Query: 188 HPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-LLSC---PDIKFSEAQIKCYMNQLLHG 243
HPNI++L G+ T +Y+V EYM G LL K + + Q+ G
Sbjct: 60 HPNIVRLLGVCTQGEP--LYIVTEYMPG---GDLLDFLRKHGEKLTLKDLLQMALQIAKG 114
Query: 244 LEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
+E+ S+ +HRD+ N LV V+K++DFGL+
Sbjct: 115 MEYLESKNFVHRDLAARNCLVTENLVVKISDFGLS 149
|
Length = 258 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 89/310 (28%), Positives = 144/310 (46%), Gaps = 43/310 (13%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+ + EKIGQG +V+ A D+ TG+ VA+K++ +P+ + EIL++R HPNI
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKK-ELIINEILVMRENKHPNI 78
Query: 192 IKLEGLITSRLSC-SIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
+ + S L +++V EY+ +T +++ + E QI + L LE HS
Sbjct: 79 VNY---LDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHS 133
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD 309
V+HRDIK N+L+ +G +KL DFG T + ++ V T ++ PE++
Sbjct: 134 NQVIHRDIKSDNILLGMDGSVKLTDFGFCA-QITPEQSKRSTMVGTPYWMAPEVVT-RKA 191
Query: 310 YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369
YGP VD+WS+G + E++ G+P + L+ I AT
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------------------ATNGT 232
Query: 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS-TKPYACDLSSL 428
P+ L F+D + L ++ KR +A L + KP LSSL
Sbjct: 233 PELQNPEKLSAIFRD-------FLNRCLEMDVEKRGSAKELLQHPFLKIAKP----LSSL 281
Query: 429 -PIYPPSKEI 437
P+ +KE
Sbjct: 282 TPLIAAAKEA 291
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 3e-28
Identities = 84/269 (31%), Positives = 119/269 (44%), Gaps = 49/269 (18%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR-FDNFEPESVRFMAREILILRRLDH 188
D FE ++ IG+G + V+ RD DTG++ A+K +R D + + + E IL D
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 189 PNIIKLEGLITSRLSCS------IYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLL 241
P I+KL S +YLV EYM D+ LL D+ F E + Y+ +L+
Sbjct: 61 PWIVKLY--------YSFQDEEHLYLVMEYMPGGDLMNLLIRKDV-FPEETARFYIAELV 111
Query: 242 HGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA----------NFSNTGHRQPLTS 291
L+ H G +HRDIK N+L++ +G +KLADFGL + N H
Sbjct: 112 LALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171
Query: 292 RVVTLW------------------YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL 333
V+ Y PE+L G T YG D WS+G + E+L G P
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPF 230
Query: 334 QGRTEVEQLHKI--FKLC-GSPPDDYWKK 359
T E +KI +K PPD
Sbjct: 231 YSDTLQETYNKIINWKESLRFPPDPPVSP 259
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 78/292 (26%), Positives = 128/292 (43%), Gaps = 50/292 (17%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
F+ L+K+G+G+Y SV++ + L + ALK+V + + EI IL ++HPNI
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61
Query: 192 IKL-EGLITSRLSCSIYLVFEYME-HDITGLLSCPDIK---FSEAQIKCYMNQLLHGLEH 246
I E + + +V EY D++ +S K E +I QLL GL+
Sbjct: 62 ISYKEAFL---DGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQA 118
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-----NFSNTGHRQPLTSRVVTLWYRPP 301
H + +LHRD+K +N+L+ ++K+ D G++ N + T P Y P
Sbjct: 119 LHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPH--------YMAP 170
Query: 302 ELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361
E+ G Y D+WS+GC+ E+ P + R+ ++ L +K+ K
Sbjct: 171 EVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARS-MQDLR--YKVQRG------KYPP 220
Query: 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413
+P Y L+ N I ++L V+P R LAS
Sbjct: 221 IPPI--------YSQDLQ-----------NFIRSMLQVKPKLRPNCDKILAS 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 7e-28
Identities = 76/237 (32%), Positives = 113/237 (47%), Gaps = 33/237 (13%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN-FEPESVRFMAREILILRRLDHPN 190
F+ L ++GQG Y VF A+ DTG+IVALK+++ F+ VR + E IL
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
++KL L + +YL EY+ D LL+ + SE + YM ++ ++ H
Sbjct: 63 LVKL--LYAFQDDEYLYLAMEYVPGGDFRTLLNNLGV-LSEDHARFYMAEMFEAVDALHE 119
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
G +HRD+K N L++ G +KL DFGL+ + S V + Y PE+L G
Sbjct: 120 LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYAN-----SVVGSPDYMAPEVLRG-K 173
Query: 309 DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD------YWKK 359
Y +VD WS+GC+ E L G P GS P++ YWK+
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFP---------------PFSGSTPNETWENLKYWKE 215
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 70/206 (33%), Positives = 109/206 (52%), Gaps = 12/206 (5%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP-ESVRFMAREILILRRLDHPN 190
F L +IG G++ +V+ ARD+ T ++VA+KK+ + + E + + +E+ L++L HPN
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
I+ +G + +LV EY + +L E +I + L GL + HS
Sbjct: 77 TIEYKGCYLREHTA--WLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH 134
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD- 309
+HRDIK N+L+ G +KLADFG A+ + P S V T ++ PE++L A D
Sbjct: 135 ERIHRDIKAGNILLTEPGTVKLADFGSASLVS-----PANSFVGTPYWMAPEVIL-AMDE 188
Query: 310 --YGPSVDLWSVGCVFAELLIGKPIL 333
Y VD+WS+G EL KP L
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 84/291 (28%), Positives = 129/291 (44%), Gaps = 43/291 (14%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH--- 188
+++LE IG+G Y +V+R + + TG++VALK + D + + V + RE+ +L +L
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD-VSDIQREVALLSQLRQSQP 61
Query: 189 PNIIKLEG--LITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEH 246
PNI K G L RL +++ EY E L +E I + ++L L++
Sbjct: 62 PNITKYYGSYLKGPRL----WIIMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKY 116
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQPLTSRVVTLWYRPPELL 304
H GV+HRDIK +N+LV N G +KL DFG+A N+ R T ++ PE++
Sbjct: 117 IHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVG---TPYWMAPEVI 173
Query: 305 LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364
Y D+WS+G E+ G P + L KSK P
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPPYSD----VDAFRAMMLIP--------KSKPPR 221
Query: 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415
Y LRE + L EP +R +A L S++
Sbjct: 222 L----EDNGYSKLLRE-----------FVAACLDEEPKERLSAEELLKSKW 257
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 6e-27
Identities = 74/226 (32%), Positives = 116/226 (51%), Gaps = 17/226 (7%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPES---VRFMAREILILRRLDHPNIIKL 194
+GQG + V+ D+DTG+ +A K+V+FD PE+ V + EI +L+ L H I++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 195 EGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 254
G + R ++ + EYM +E+ + Y Q+L G+ + HS ++H
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVH 129
Query: 255 RDIKGSNLLVNNEGVLKLADFGLAN------FSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
RDIKG+N+L ++ G +KL DFG + S TG R S T ++ PE++ G
Sbjct: 130 RDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIR----SVTGTPYWMSPEVISG-E 184
Query: 309 DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 354
YG D+WS+GC E+L KP E E + IFK+ P +
Sbjct: 185 GYGRKADVWSLGCTVVEMLTEKPPW---AEYEAMAAIFKIATQPTN 227
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 60/233 (25%), Positives = 98/233 (42%), Gaps = 37/233 (15%)
Query: 133 EKLEKIGQGTYSSVFRAR----DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH 188
+K+G+G + V++ VA+K ++ D E + F+ RE I+R+LDH
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFL-REARIMRKLDH 60
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITG-----LLSCPDIKFSEAQIKCYMNQLLHG 243
PNI+KL G+ T + +V EYM G L + S + + + Q+ G
Sbjct: 61 PNIVKLLGVCTEEEP--LMIVMEYMPG---GDLLDYLRKNRPKELSLSDLLSFALQIARG 115
Query: 244 LEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL-WYRPPE 302
+E+ S+ +HRD+ N LV V+K++DFGL+ + + + W PE
Sbjct: 116 MEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM-APE 174
Query: 303 LLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 355
L + D+WS G + L +IF L P
Sbjct: 175 SLKEGK-FTSKSDVWSFGVL-------------------LWEIFTLGEEPYPG 207
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 62/229 (27%), Positives = 101/229 (44%), Gaps = 30/229 (13%)
Query: 133 EKLEKIGQGTYSSVFRAR----DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH 188
+K+G+G + V++ + VA+K ++ D E + F+ RE I+R+LDH
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFL-REARIMRKLDH 60
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
PN++KL G+ T +Y+V EYME D+ L K S + + + Q+ G+E+
Sbjct: 61 PNVVKLLGVCTEEEP--LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL 118
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL-WYRPPELLLG 306
S+ +HRD+ N LV V+K++DFGL+ + + W PE L
Sbjct: 119 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWM-APESLKE 177
Query: 307 ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 355
+ D+WS G + L +IF L P
Sbjct: 178 GK-FTSKSDVWSFGVL-------------------LWEIFTLGEQPYPG 206
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 74/225 (32%), Positives = 116/225 (51%), Gaps = 19/225 (8%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPES---VRFMAREILILRRLDHPNIIKL 194
+GQG + V+ D DTG+ +A+K+V+FD PE+ V + EI +L+ L H I++
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 195 EGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 253
G + + ++ + E+M I L +E + Y Q+L G+ + HS ++
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLHSNMIV 128
Query: 254 HRDIKGSNLLVNNEGVLKLADFGLAN------FSNTGHRQPLTSRVVTLWYRPPELLLGA 307
HRDIKG+N+L ++ G +KL DFG + S TG + S T ++ PE++ G
Sbjct: 129 HRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTG----MKSVTGTPYWMSPEVISG- 183
Query: 308 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 352
YG D+WSVGC E+L KP E E + IFK+ P
Sbjct: 184 EGYGRKADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQP 225
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-26
Identities = 86/304 (28%), Positives = 143/304 (47%), Gaps = 50/304 (16%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+ KIG+G+ V A D TG+ VA+KK+ + + F E++I+R HPNI
Sbjct: 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLF--NEVVIMRDYQHPNI 78
Query: 192 IKLEG--LITSRLSCSIYLVFEYMEHDITGLLSCPDI----KFSEAQIKCYMNQLLHGLE 245
+++ L+ L ++V E++E G L+ DI + +E QI +L L
Sbjct: 79 VEMYSSYLVGDEL----WVVMEFLE---GGALT--DIVTHTRMNEEQIATVCLAVLKALS 129
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLWYRPPELL 304
H++GV+HRDIK ++L+ ++G +KL+DFG A S R+ S V T ++ PE +
Sbjct: 130 FLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR--KSLVGTPYWMAPE-V 186
Query: 305 LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364
+ YG VD+WS+G + E++ G+P ++ + +I PP K K H
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN--LPP-----KLKNLH 239
Query: 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACD 424
LR ++ +L +P +RATA+ L + + A
Sbjct: 240 KV--------SPRLRS-----------FLDRMLVRDPAQRATAAELLNHPFLAK---AGP 277
Query: 425 LSSL 428
SS+
Sbjct: 278 PSSI 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 4e-26
Identities = 71/217 (32%), Positives = 114/217 (52%), Gaps = 10/217 (4%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP-ESVRFMAREILILRRLDHPN 190
F L +IG G++ +V+ ARD+ T ++VA+KK+ + + E + + +E+ L+R+ HPN
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
I+ +G + +LV EY + LL E +I + L GL + HS
Sbjct: 87 SIEYKGCYLREHTA--WLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 144
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD- 309
++HRDIK N+L+ G +KLADFG A+ ++ P S V T ++ PE++L +
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASIAS-----PANSFVGTPYWMAPEVILAMDEG 199
Query: 310 -YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 345
Y VD+WS+G EL KP L + L+ I
Sbjct: 200 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 236
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 71/241 (29%), Positives = 103/241 (42%), Gaps = 36/241 (14%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
D E L ++G G V + TGKI+A+K +R + E + + RE+ IL + + P
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQIL-RELDILHKCNSP 59
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITGL---LSCPDIKFSEAQIKCYMNQLLHGLEH 246
I+ G + + I + EYM D L L + E + +L GL +
Sbjct: 60 YIVGFYGAFYN--NGDISICMEYM--DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTY 115
Query: 247 CHS-RGVLHRDIKGSNLLVNNEGVLKLADFG--------LANFSNTGHRQPLTSRVVTLW 297
H ++HRD+K SN+LVN+ G +KL DFG LA + G T
Sbjct: 116 LHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK-TFVG----------TSS 164
Query: 298 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGK----PILQGRTEV-EQLHKIFKLCGSP 352
Y PE + G DY D+WS+G EL G+ P + E L I P
Sbjct: 165 YMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN--EPP 221
Query: 353 P 353
P
Sbjct: 222 P 222
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 2e-25
Identities = 80/274 (29%), Positives = 132/274 (48%), Gaps = 22/274 (8%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP-ESVRFMAREILILRRLDHPN 190
F L +IG G++ +V+ ARD+ ++VA+KK+ + + E + + +E+ L++L HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
I+ G + +LV EY + LL E +I + L GL + HS
Sbjct: 77 TIQYRGCYLREHTA--WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD- 309
++HRD+K N+L++ G++KL DFG A+ P V T ++ PE++L +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANXFVGTPYWMAPEVILAMDEG 189
Query: 310 -YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP--PDDYWKKSKLPHAT 366
Y VD+WS+G EL KP L + L+ I + SP +W +
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NESPALQSGHWSEY------ 242
Query: 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVE 400
F+ DS L++ +D PT+ V L + E
Sbjct: 243 -FR--NFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 68/203 (33%), Positives = 114/203 (56%), Gaps = 13/203 (6%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+ + EKIGQG +VF A D+ TG+ VA+K++ +P+ + EIL+++ L +PNI
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-QPKK-ELIINEILVMKELKNPNI 78
Query: 192 IKLEGLITSRLSCSIYLVFEYMEH-DITGLLS--CPDIKFSEAQIKCYMNQLLHGLEHCH 248
+ L + + +++V EY+ +T +++ C D EAQI + L LE H
Sbjct: 79 VNF--LDSFLVGDELFVVMEYLAGGSLTDVVTETCMD----EAQIAAVCRECLQALEFLH 132
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
+ V+HRDIK N+L+ +G +KL DFG T + ++ V T ++ PE++
Sbjct: 133 ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCA-QITPEQSKRSTMVGTPYWMAPEVVTRKA 191
Query: 309 DYGPSVDLWSVGCVFAELLIGKP 331
YGP VD+WS+G + E++ G+P
Sbjct: 192 -YGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 55/209 (26%), Positives = 98/209 (46%), Gaps = 27/209 (12%)
Query: 136 EKIGQGTYSSVFRA--RDLDTGKI-VALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192
+K+G+G + V++ + D VA+K ++ ++ E + +E ++++L HPN++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLK-EDASEEERKDFLKEARVMKKLGHPNVV 59
Query: 193 KLEGLITSRLSCSIYLVFEYMEH-DITGLL--------SCPDIKFSEAQIKCYMNQLLHG 243
+L G+ T +YLV EYME D+ L S S + + Q+ G
Sbjct: 60 RLLGVCTEEEP--LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 244 LEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA------NFSNTGHRQPLTSRVVTLW 297
+E+ S+ +HRD+ N LV + V+K++DFGL+ ++ L R W
Sbjct: 118 MEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----W 173
Query: 298 YRPPELLLGATDYGPSVDLWSVGCVFAEL 326
PE L + D+WS G + E+
Sbjct: 174 M-APESLKDGI-FTSKSDVWSFGVLLWEI 200
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 70/217 (32%), Positives = 112/217 (51%), Gaps = 10/217 (4%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP-ESVRFMAREILILRRLDHPN 190
F L +IG G++ +V+ A + T ++VA+KK+ + + E + + +E+ L++L HPN
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
I+ +G + +LV EY + LL E +I + L GL + HS
Sbjct: 83 TIEYKGCYLKEHTA--WLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 140
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD- 309
++HRDIK N+L+ G +KLADFG A+ S+ P S V T ++ PE++L +
Sbjct: 141 NMIHRDIKAGNILLTEPGQVKLADFGSASKSS-----PANSFVGTPYWMAPEVILAMDEG 195
Query: 310 -YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 345
Y VD+WS+G EL KP L + L+ I
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 232
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 73/285 (25%), Positives = 114/285 (40%), Gaps = 38/285 (13%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+ + +G+G + R + +V K+V + R EI+IL L HPNI
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61
Query: 192 IKLEGLITSRLSCSIYLVFEYME----HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
I + I + EY +D ++ F E + Y+ Q++ + +
Sbjct: 62 IAYYNHFMDDNTLLIEM--EYANGGTLYDK--IVRQKGQLFEEEMVLWYLFQIVSAVSYI 117
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
H G+LHRDIK N+ + G++KL DFG++ + + T V T +Y PEL G
Sbjct: 118 HKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV-VGTPYYMSPELCQGV 176
Query: 308 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367
Y D+W++GCV ELL K + + KI + +P
Sbjct: 177 -KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVS------------ 223
Query: 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
Y S L L+ +LL +P KR TA L
Sbjct: 224 -----VYSSELIS-----------LVHSLLQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 28/213 (13%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDH 188
D FE ++ +G G++ V R +GK ALK + + + V + E IL+ + H
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITG------LLSCPDIKFSEAQIKCYMNQLLH 242
P ++ L G + + ++YLV EY + G L +F E + Y Q++
Sbjct: 61 PFLVNLYG--SFQDDSNLYLVMEY----VPGGELFSHLRKSG--RFPEPVARFYAAQVVL 112
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW----Y 298
LE+ HS +++RD+K NLL++++G +K+ DFG A + R TL Y
Sbjct: 113 ALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKR--------VKGRTYTLCGTPEY 164
Query: 299 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 331
PE++L YG +VD W++G + E+L G P
Sbjct: 165 LAPEIILS-KGYGKAVDWWALGILIYEMLAGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 79/231 (34%), Positives = 112/231 (48%), Gaps = 16/231 (6%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR-FDNFEPESVRFMAREILILRRLDHPN 190
F +KIG+G +S V+RA L G VALKKV+ FD + ++ +EI +L++L+HPN
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFS-------EAQIKCYMNQLLHG 243
+IK +I L E G LS F E + Y QL
Sbjct: 64 VIKYYASFIEDNELNIVL-----ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA 118
Query: 244 LEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPEL 303
LEH HSR V+HRDIK +N+ + GV+KL D GL F ++ S V T +Y PE
Sbjct: 119 LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYYMSPE- 176
Query: 304 LLGATDYGPSVDLWSVGCVFAEL-LIGKPILQGRTEVEQLHKIFKLCGSPP 353
+ Y D+WS+GC+ E+ + P + + L K + C PP
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP 227
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 5e-25
Identities = 65/221 (29%), Positives = 113/221 (51%), Gaps = 10/221 (4%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+E ++KIG+G++ ++ A+ + +K++ + +E+++L ++ HPNI
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 192 IKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCP-DIKFSEAQIKCYMNQLLHGLEHCHS 249
+ + + + +++V EY + D+ ++ + FSE QI + Q+ GL+H H
Sbjct: 62 VTF--FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 250 RGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
R +LHRDIK N+ ++ G V KL DFG+A N T V T +Y PE+
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC-VGTPYYLSPEICQNRP 178
Query: 309 DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 349
Y D+WS+GCV EL K +G + QL + K+C
Sbjct: 179 -YNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQL--VLKIC 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 84/286 (29%), Positives = 128/286 (44%), Gaps = 51/286 (17%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF----EPESVRFMAREILILRRLDHPN 190
L+ I +G + SV+ A+ TG A+K ++ + + +V+ R I++++ + P
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVK-AERAIMMIQG-ESPY 58
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIK----FSEAQIKCYMNQLLHGLEH 246
+ KL S+ +YLV EY+ L IK E K Y+ +++ G+E
Sbjct: 59 VAKLYYSFQSK--DYLYLVMEYLNGGDCASL----IKTLGGLPEDWAKQYIAEVVLGVED 112
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR--VVTLWYRPPELL 304
H RG++HRDIK NLL++ G LKL DFGL+ R L ++ V T Y PE +
Sbjct: 113 LHQRGIIHRDIKPENLLIDQTGHLKLTDFGLS-------RNGLENKKFVGTPDYLAPETI 165
Query: 305 LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364
LG D D WS+GCV E L G P T PD + +
Sbjct: 166 LGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAET---------------PDAVFD--NILS 207
Query: 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 410
+ P+ E + AV+LI LL ++P KR A+
Sbjct: 208 RRINWPE--------EVKEFCSPEAVDLINRLLCMDPAKRLGANGY 245
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 77/232 (33%), Positives = 118/232 (50%), Gaps = 18/232 (7%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR-FDNFEPESVRFMAREILILRRLDHPN 190
F+ +KIG+G +S V+RA L K VALKKV+ F+ + ++ + +EI +L++L+HPN
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 191 IIK-LEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFS-------EAQIKCYMNQLLH 242
+IK L+ I + +V E + G LS F E + Y QL
Sbjct: 64 VIKYLDSFIEDN---ELNIVLELAD---AGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPE 302
+EH HSR V+HRDIK +N+ + GV+KL D GL F ++ S V T +Y PE
Sbjct: 118 AVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYYMSPE 176
Query: 303 LLLGATDYGPSVDLWSVGCVFAEL-LIGKPILQGRTEVEQLHKIFKLCGSPP 353
+ Y D+WS+GC+ E+ + P + + L + + C PP
Sbjct: 177 -RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP 227
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 57/201 (28%), Positives = 102/201 (50%), Gaps = 6/201 (2%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+ K++KIG+G++ + + GK +K++ P+ +E+ +L + HPNI
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 192 IKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPD-IKFSEAQIKCYMNQLLHGLEHCHS 249
++ + + ++Y+V +Y E D+ ++ + F E QI + Q+ L+H H
Sbjct: 62 VQYQESFEE--NGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD 309
R +LHRDIK N+ + +G +KL DFG+A N+ T + T +Y PE+
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTC-IGTPYYLSPEICENRP- 177
Query: 310 YGPSVDLWSVGCVFAELLIGK 330
Y D+W++GCV E+ K
Sbjct: 178 YNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 6e-24
Identities = 77/236 (32%), Positives = 119/236 (50%), Gaps = 18/236 (7%)
Query: 110 PAWLSAVAGEAIQGWVPLRADAFEKLEK---IGQGTYSSVFRARDLDTGKIVALKKVRFD 166
+ S+ + + G P A + +LE+ IG G +V++ TG++ ALK V +
Sbjct: 51 SSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALK-VIYG 109
Query: 167 NFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI 226
N E R + REI ILR ++HPN++K + + I ++ E+M+ G L I
Sbjct: 110 NHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH--NGEIQVLLEFMDG---GSLEGTHI 164
Query: 227 KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286
E + Q+L G+ + H R ++HRDIK SNLL+N+ +K+ADFG++
Sbjct: 165 A-DEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT-M 222
Query: 287 QPLTSRVVTLWYRPPE-----LLLGATDYGPSVDLWSVGCVFAELLIGK-PILQGR 336
P S V T+ Y PE L GA D G + D+WS+G E +G+ P GR
Sbjct: 223 DPCNSSVGTIAYMSPERINTDLNHGAYD-GYAGDIWSLGVSILEFYLGRFPFGVGR 277
|
Length = 353 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 88/310 (28%), Positives = 146/310 (47%), Gaps = 45/310 (14%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+ + EKIGQG +V+ A D+ TG+ VA++++ +P+ + EIL++R +PNI
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKK-ELIINEILVMRENKNPNI 79
Query: 192 IKLEGLITSRLSCSIYLVFEYMEH-DITGLLS--CPDIKFSEAQIKCYMNQLLHGLEHCH 248
+ L + + +++V EY+ +T +++ C D E QI + L LE H
Sbjct: 80 VNY--LDSYLVGDELWVVMEYLAGGSLTDVVTETCMD----EGQIAAVCRECLQALEFLH 133
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
S V+HRDIK N+L+ +G +KL DFG T + ++ V T ++ PE++
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA-QITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 309 DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368
YGP VD+WS+G + E++ G+P + L+ I AT
Sbjct: 193 -YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-------------------ATNG 232
Query: 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS-TKPYACDLSS 427
P+ L F+D + L ++ KR +A L ++ KP LSS
Sbjct: 233 TPELQNPEKLSAIFRD-------FLNRCLDMDVEKRGSAKELLQHQFLKIAKP----LSS 281
Query: 428 L-PIYPPSKE 436
L P+ +KE
Sbjct: 282 LTPLIAAAKE 291
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 7e-24
Identities = 86/301 (28%), Positives = 126/301 (41%), Gaps = 73/301 (24%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR-FDNFEPESVRFMAREILILRRLDH 188
D FE ++ IG+G + V + DTG I A+KK+R + E E V + E IL D+
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 189 PNIIKLEGLITSRLSCS------IYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLL 241
P ++KL S +YL+ EY+ D+ LL D F+E + + Y+ + +
Sbjct: 61 PWVVKL--------YYSFQDENYLYLIMEYLPGGDMMTLLMKKDT-FTEEETRFYIAETI 111
Query: 242 HGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR--------------- 286
++ H G +HRDIK NLL++ +G +KL+DFGL HR
Sbjct: 112 LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNF 171
Query: 287 -----QPLTS-RVVTLW----------------YRPPELLLGATDYGPSVDLWSVGCVFA 324
+P++S R W Y PE+ L T Y D WS+G +
Sbjct: 172 LDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-QTGYNKECDWWSLGVIMY 230
Query: 325 ELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKD 384
E+L+G P E KI WK+ TL P + L KD
Sbjct: 231 EMLVGYPPFCSDNPQETYRKIIN---------WKE------TLQFPD---EVPLSPEAKD 272
Query: 385 L 385
L
Sbjct: 273 L 273
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 80/264 (30%), Positives = 121/264 (45%), Gaps = 29/264 (10%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPES---VRFMAREILILRRLDHPNIIKL 194
+G+G + V+ D DTG+ +A+K+V FD E+ V + EI +L+ L H I++
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 195 EGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 253
G + + + EYM I L +E + Y Q+L G+ + HS ++
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHSNMIV 128
Query: 254 HRDIKGSNLLVNNEGVLKLADFGLAN------FSNTGHRQPLTSRVVTLWYRPPELLLGA 307
HRDIKG+N+L ++ G +KL DFG + S TG + S T ++ PE++ G
Sbjct: 129 HRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTG----IKSVTGTPYWMSPEVISG- 183
Query: 308 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367
YG D+WSV C E+L KP E E + IFK+ P K LP
Sbjct: 184 EGYGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQP-----TKPMLPDGVS 235
Query: 368 -----FKPQQPYDSSLRETFKDLP 386
F Q + R T + L
Sbjct: 236 DACRDFLKQIFVEEKRRPTAEFLL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 61/201 (30%), Positives = 95/201 (47%), Gaps = 9/201 (4%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ +L ++G+G SV + R +TG I ALK + D P+ + + RE+ I + P
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSP 59
Query: 190 NIIKLEGLITSRLSCSIYLVFEYME----HDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
I+K G S SI + EY E I + + E + +L GL
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
+ HSR ++HRDIK SN+L+ +G +KL DFG++ T T +Y PE +
Sbjct: 120 YLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTG---TSFYMAPERIQ 176
Query: 306 GATDYGPSVDLWSVGCVFAEL 326
G Y + D+WS+G E+
Sbjct: 177 GKP-YSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 66/203 (32%), Positives = 112/203 (55%), Gaps = 13/203 (6%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+ + EKIGQG +V+ A D+ TG+ VA+K++ +P+ + EIL++R +PNI
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ-QPKK-ELIINEILVMRENKNPNI 78
Query: 192 IKLEGLITSRLSCSIYLVFEYMEH-DITGLLS--CPDIKFSEAQIKCYMNQLLHGLEHCH 248
+ L + + +++V EY+ +T +++ C D E QI + L L+ H
Sbjct: 79 VNY--LDSYLVGDELWVVMEYLAGGSLTDVVTETCMD----EGQIAAVCRECLQALDFLH 132
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
S V+HRDIK N+L+ +G +KL DFG T + ++ V T ++ PE++
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA-QITPEQSKRSTMVGTPYWMAPEVVTRKA 191
Query: 309 DYGPSVDLWSVGCVFAELLIGKP 331
YGP VD+WS+G + E++ G+P
Sbjct: 192 -YGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 62/201 (30%), Positives = 99/201 (49%), Gaps = 18/201 (8%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVR----FDNFEPESVRFMAREILILRRLDHPNIIK 193
+G G + V + + ALK V+ + + E + E IL +HP I+K
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIF---SEKEILEECNHPFIVK 57
Query: 194 LEGLITSRLSCSIYLVFEYME-HDITGLLSCPDI-KFSEAQIKCYMNQLLHGLEHCHSRG 251
L T + IY++ EY ++ +L D F E + Y+ ++ E+ H+RG
Sbjct: 58 LYR--TFKDKKYIYMLMEYCLGGELWTILR--DRGLFDEYTARFYIACVVLAFEYLHNRG 113
Query: 252 VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-TLWYRPPELLLGATDY 310
+++RD+K NLL+++ G +KL DFG A +G + T T Y PE++L Y
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---TWTFCGTPEYVAPEIILN-KGY 169
Query: 311 GPSVDLWSVGCVFAELLIGKP 331
SVD WS+G + ELL G+P
Sbjct: 170 DFSVDYWSLGILLYELLTGRP 190
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 58/204 (28%), Positives = 100/204 (49%), Gaps = 15/204 (7%)
Query: 134 KLEKIGQGTYSSVFRAR----DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
++++G+G + V R +TG+ VA+K + E + REI ILR LDH
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSG-EEQHRSDFEREIEILRTLDHE 66
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
NI+K +G+ S+ L+ EY+ + L + + ++ + +Q+ G+++
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-----RQPLTSRVVTLWYRPPEL 303
S+ +HRD+ N+LV +E ++K++DFGLA ++P S + WY PE
Sbjct: 127 SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI--FWY-APEC 183
Query: 304 LLGATDYGPSVDLWSVGCVFAELL 327
L + S D+WS G EL
Sbjct: 184 LRTSKFSSAS-DVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 72/231 (31%), Positives = 121/231 (52%), Gaps = 21/231 (9%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP-ESVRFMAREILILRRLDHPN 190
FE +++IG GTY V++AR+++TG++ A+K ++ EP E + +EI++++ H N
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKL---EPGEDFAVVQQEIIMMKDCKHSN 67
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI-----KFSEAQIKCYMNQLLHGLE 245
I+ G R +++ E+ G S DI SE+QI + L GL
Sbjct: 68 IVAYFGSYLRR--DKLWICMEF-----CGGGSLQDIYHVTGPLSESQIAYVSRETLQGLY 120
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLWYRPPEL- 303
+ HS+G +HRDIKG+N+L+ + G +KLADFG+ A + T ++ S + T ++ PE+
Sbjct: 121 YLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR--KSFIGTPYWMAPEVA 178
Query: 304 -LLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 353
+ Y D+W+VG EL +P + + L + K PP
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 4e-23
Identities = 73/243 (30%), Positives = 122/243 (50%), Gaps = 31/243 (12%)
Query: 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREIL----ILR 184
D +E +E IG+GTY V++ + G + A+K + + + + EI IL+
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL-------DPISDVDEEIEAEYNILQ 73
Query: 185 RL-DHPNIIKLEGLITSRLSCS---IYLVFEY-----MEHDITGLLSCPDIKFSEAQIKC 235
L +HPN++K G+ ++LV E + + GLL C + EA I
Sbjct: 74 SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ-RLDEAMISY 132
Query: 236 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVV 294
+ L GL+H H+ ++HRD+KG+N+L+ EG +KL DFG+ A ++T R+ + V
Sbjct: 133 ILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR--NTSVG 190
Query: 295 TLWYRPPELLLGATDYGPS----VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 350
T ++ PE++ Y S D+WS+G EL G P L ++ + +FK+
Sbjct: 191 TPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL---FDMHPVKTLFKIPR 247
Query: 351 SPP 353
+PP
Sbjct: 248 NPP 250
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 5e-23
Identities = 68/206 (33%), Positives = 117/206 (56%), Gaps = 18/206 (8%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
F KLE+IG+G++ VF+ D T ++VA+K + + E E + + +EI +L + D P +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYV 64
Query: 192 IKLEGLITSRLSCS-IYLVFEYMEHDITGLLSCPDI----KFSEAQIKCYMNQLLHGLEH 246
K G S L + ++++ EY+ G S D+ F E QI + ++L GL++
Sbjct: 65 TKYYG---SYLKGTKLWIIMEYL-----GGGSALDLLRAGPFDEFQIATMLKEILKGLDY 116
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYRPPELLL 305
HS +HRDIK +N+L++ +G +KLADFG+A ++T ++ + V T ++ PE++
Sbjct: 117 LHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIQ 174
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKP 331
+ Y D+WS+G EL G+P
Sbjct: 175 QSA-YDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 8e-23
Identities = 75/257 (29%), Positives = 130/257 (50%), Gaps = 11/257 (4%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ F KLEKIG+G++ VF+ D T K+VA+K + + E E + + +EI +L + D P
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSP 62
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
+ K G + ++++ EY+ L P E QI + ++L GL++ HS
Sbjct: 63 YVTKYYG--SYLKDTKLWIIMEYLGGGSALDLLEPG-PLDETQIATILREILKGLDYLHS 119
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
+HRDIK +N+L++ G +KLADFG+A ++T ++ + V T ++ PE ++ +
Sbjct: 120 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPE-VIKQS 176
Query: 309 DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368
Y D+WS+G EL G+P +E+ + +F + + P P
Sbjct: 177 AYDSKADIWSLGITAIELAKGEP---PHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFV 233
Query: 369 KPQQPYDSSLRETFKDL 385
+ + S R T K+L
Sbjct: 234 EACLNKEPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 1e-22
Identities = 82/291 (28%), Positives = 134/291 (46%), Gaps = 41/291 (14%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+E ++++G GTY V++AR+L TG++ A+K ++ + + S+ + +EI +++ H NI
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL--IQQEIFMVKECKHCNI 68
Query: 192 IKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI-----KFSEAQIKCYMNQLLHGLEH 246
+ G SR +++ EY G S DI SE QI + L GL +
Sbjct: 69 VAYFGSYLSREK--LWICMEY-----CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAY 121
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG 306
HS+G +HRDIKG+N+L+ + G +KLADFG+A T S + T ++ PE+
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGDVKLADFGVAA-KITATIAKRKSFIGTPYWMAPEVAAV 180
Query: 307 ATD--YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364
+ Y D+W+VG EL +P + + L + K PP K K
Sbjct: 181 EKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPK---LKDKTKW 237
Query: 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415
++ F N ++ L+ P KR TA L +
Sbjct: 238 SSTFH---------------------NFVKISLTKNPKKRPTAERLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 3e-22
Identities = 81/314 (25%), Positives = 130/314 (41%), Gaps = 39/314 (12%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN-FEPESVRFMAREILILRRLDH 188
F+ +G+G + V R+ TG I A+K ++ E+V F E IL +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
P I +L+ ++YLV EY D+ LL+ + +F E + Y+ +L+ +
Sbjct: 61 PWIPQLQYAFQD--KDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSV 118
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFG-LANFSNTGHRQPLTSRVVTLWYRPPELLL- 305
H G +HRDIK N+L++ G +KLADFG A + V T Y PE+L
Sbjct: 119 HQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS-KLPVGTPDYIAPEVLTT 177
Query: 306 ----GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361
G YG D WS+G + E++ G+ T + + I
Sbjct: 178 MNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNI---------------- 221
Query: 362 LPHATLFK-PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420
+ K P+ P SS ++LI++LL +R +FS
Sbjct: 222 MNFQRFLKFPEDPKVSS----------DFLDLIQSLLC-GQKERLGYEGLCCHPFFSKID 270
Query: 421 YACDLSSLPIYPPS 434
+ +SLP + P+
Sbjct: 271 WNNIRNSLPPFVPT 284
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 4e-22
Identities = 72/243 (29%), Positives = 123/243 (50%), Gaps = 25/243 (10%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR-FDNFEPESVRFMAREILILR 184
P +D +E +E IG+GTY VF+ + G A+K + + + E + E IL+
Sbjct: 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEE----IEAEYNILK 69
Query: 185 RL-DHPNIIKLEGLITSRLSCS---IYLVFEY-----MEHDITGLLSCPDIKFSEAQIKC 235
L DHPN++K G+ + + ++LV E + + G L + + E I
Sbjct: 70 ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGE-RMEEPIIAY 128
Query: 236 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVV 294
+++ L GL+H H +HRD+KG+N+L+ EG +KL DFG+ A ++T R+ + V
Sbjct: 129 ILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR--NTSVG 186
Query: 295 TLWYRPPELLLGA----TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 350
T ++ PE++ + Y D+WS+G EL G P L ++ + +FK+
Sbjct: 187 TPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL---ADLHPMRALFKIPR 243
Query: 351 SPP 353
+PP
Sbjct: 244 NPP 246
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 7e-22
Identities = 65/228 (28%), Positives = 99/228 (43%), Gaps = 26/228 (11%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
FE L KIG+G++ VF+ ++ A+K++ E +L +LD I
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 192 IK-LEGLITSRLSCSIYLVFEYME----HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEH 246
I+ E + + +V EY E H + L E Q+ + Q+L GL H
Sbjct: 62 IRYYESFLDKGK---LNIVMEYAENGDLHKL--LKMQRGRPLPEDQVWRFFIQILLGLAH 116
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------NFSNTGHRQPLTSRVVTLWYR 299
HS+ +LHRDIK NL ++ +K+ D G+A NF+NT V T +Y
Sbjct: 117 LHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--------IVGTPYYL 168
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 347
PE L Y D+W++G V E GK + + KI +
Sbjct: 169 SPE-LCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 7e-22
Identities = 63/227 (27%), Positives = 109/227 (48%), Gaps = 28/227 (12%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRF-----MAREILILR 184
D E+++ +G GT+ V RD + ALK + PE +R + E +L+
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAI----PEVIRLKQEQHVHNEKRVLK 56
Query: 185 RLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD--ITGLLSCPDIKFSEAQIKCYMNQLLH 242
+ HP II+L T +Y++ EY+ + L + +FS + Y ++++
Sbjct: 57 EVSHPFIIRLFW--TEHDQRFLYMLMEYVPGGELFSYLRNSG--RFSNSTGLFYASEIVC 112
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW----Y 298
LE+ HS+ +++RD+K N+L++ EG +KL DFG A + L R TL Y
Sbjct: 113 ALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFA--------KKLRDRTWTLCGTPEY 164
Query: 299 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 345
PE ++ + + +VD W++G + E+L+G P KI
Sbjct: 165 LAPE-VIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI 210
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-21
Identities = 75/254 (29%), Positives = 121/254 (47%), Gaps = 9/254 (3%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
F KLE+IG+G++ V++ D T ++VA+K + + E E + + +EI +L + D P I
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYI 64
Query: 192 IKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG 251
+ G + ++++ EY+ L P E I + ++L GL++ HS
Sbjct: 65 TRYYG--SYLKGTKLWIIMEYLGGGSALDLLKPG-PLEETYIATILREILKGLDYLHSER 121
Query: 252 VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYG 311
+HRDIK +N+L++ +G +KLADFG+A + T W P + A D+
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDF- 180
Query: 312 PSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 371
D+WS+G EL G+P + L I K SPP + SK P +
Sbjct: 181 -KADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPK--NSPPTLEGQYSK-PFKEFVEAC 236
Query: 372 QPYDSSLRETFKDL 385
D R T K+L
Sbjct: 237 LNKDPRFRPTAKEL 250
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 3e-21
Identities = 79/316 (25%), Positives = 126/316 (39%), Gaps = 62/316 (19%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKV-RFDNFEPESVRFMAREILILRRLDH 188
F+K++ +G+G VF R TGK+ ALK + + + + V+ + E IL LDH
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 189 PNIIKLEGLITSRLSCSIYLVFEY-MEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEH 246
P + L + + LV +Y ++ LL P SE + Y ++L LE+
Sbjct: 61 PFLPTLYASFQT--ETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEY 118
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA---------------NFSNTGHRQPLTS 291
H G+++RD+K N+L++ G + L+DF L+ S + S
Sbjct: 119 LHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 292 RVV-------------TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE 338
T Y PE++ G +G +VD W++G + E+L G +G
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237
Query: 339 VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLS 398
E I + P P SS +A +LI LL
Sbjct: 238 DETFSNIL-----------------KKEVTFPGSPPVSS----------SARDLIRKLLV 270
Query: 399 VEPYKRATASAALASE 414
+P KR S A+E
Sbjct: 271 KDPSKR-LGSKRGAAE 285
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 5e-21
Identities = 67/241 (27%), Positives = 111/241 (46%), Gaps = 35/241 (14%)
Query: 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH 188
D +E + ++G G + V++A+ +TG A K ++ ++ E E FM EI IL H
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMV-EIDILSECKH 61
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CP-----------DIKFSEAQIKCY 236
PNI+ L Y + + E+ + L+ C + +E QI+
Sbjct: 62 PNIVGL------------YEAY-FYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYV 108
Query: 237 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 296
Q+L L HS V+HRD+K N+L+ +G +KLADFG++ N Q + + T
Sbjct: 109 CRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSA-KNKSTLQKRDTFIGTP 167
Query: 297 WYRPPELLLGATD----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 352
++ PE++ T Y D+WS+G EL +P E+ + + K+ S
Sbjct: 168 YWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEP---PHHELNPMRVLLKILKSE 224
Query: 353 P 353
P
Sbjct: 225 P 225
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 7e-21
Identities = 58/206 (28%), Positives = 103/206 (50%), Gaps = 17/206 (8%)
Query: 132 FEKLEKIGQGTYSSV----FRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD 187
+K+ +G+G + V + + TG++VA+K ++ + ++ +EI IL+ L
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLY 64
Query: 188 HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEH 246
H NI+K +G + + + L+ EY+ + L P K + AQ+ + Q+ G+ +
Sbjct: 65 HENIVKYKGCCSEQGGKGLQLIMEYVP--LGSLRDYLPKHKLNLAQLLLFAQQICEGMAY 122
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-----RQPLTSRVVTLWYRPP 301
HS+ +HRD+ N+L++N+ ++K+ DFGLA GH R+ S V WY
Sbjct: 123 LHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV--FWYAVE 180
Query: 302 ELLLGATDYGPSVDLWSVGCVFAELL 327
L + + D+WS G ELL
Sbjct: 181 --CLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 8e-21
Identities = 80/284 (28%), Positives = 139/284 (48%), Gaps = 41/284 (14%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
E KIG+G+ V AR+ +G+ VA+K + + + F E++I+R H N+
Sbjct: 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLF--NEVVIMRDYQHQNV 80
Query: 192 IKL--EGLITSRLSCSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
+++ L+ L +++ E+++ +T ++S + +E QI +L L + H
Sbjct: 81 VEMYKSYLVGEEL----WVLMEFLQGGALTDIVS--QTRLNEEQIATVCESVLQALCYLH 134
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
S+GV+HRDIK ++L+ +G +KL+DFG A S ++ S V T ++ PE ++
Sbjct: 135 SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR--KSLVGTPYWMAPE-VISR 191
Query: 308 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367
T YG VD+WS+G + E++ G+P + V+ + +L SPP P
Sbjct: 192 TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK---RLRDSPP---------PKLKN 239
Query: 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411
P LR+ +E +L+ EP +RATA L
Sbjct: 240 AHKISPV---LRD-----------FLERMLTREPQERATAQELL 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 9e-21
Identities = 75/231 (32%), Positives = 119/231 (51%), Gaps = 37/231 (16%)
Query: 135 LEKIGQGTYSSVFRARDL---DTGKIVALK-------KVRFDNFEPESVRF-MAREILIL 183
L+ +GQG++ VF R + D G++ A+K KVR + VR M R+IL
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVR------DRVRTKMERDILA- 53
Query: 184 RRLDHPNIIKL------EGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 236
++HP I+KL EG +YL+ +++ D+ LS ++ F+E +K Y
Sbjct: 54 -EVNHPFIVKLHYAFQTEG--------KLYLILDFLRGGDLFTRLS-KEVMFTEEDVKFY 103
Query: 237 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 296
+ +L L+H HS G+++RD+K N+L++ EG +KL DFGL+ S H + S T+
Sbjct: 104 LAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKES-IDHEKKAYSFCGTV 162
Query: 297 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 347
Y PE ++ + S D WS G + E+L G QG+ E + I K
Sbjct: 163 EYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK 212
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 2e-20
Identities = 66/227 (29%), Positives = 112/227 (49%), Gaps = 22/227 (9%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESV----RFMAREILILRRLD 187
+ K E +G+G Y +V+ + G+++A+K+V D + + E+ +L+ L
Sbjct: 2 WTKGEVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60
Query: 188 HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFS---EAQIKCYMNQLLHGL 244
H NI++ G + SI+ ME G +S +F E Y Q+L G+
Sbjct: 61 HVNIVQYLGTCLDDNTISIF-----MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGV 115
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-----FSNTGHRQPLTSRVVTLWYR 299
+ H+ V+HRDIKG+N+++ G++KL DFG A + H L S T ++
Sbjct: 116 AYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 346
PE ++ + YG D+WS+GC E+ GKP L +++L +F
Sbjct: 176 APE-VINESGYGRKSDIWSIGCTVFEMATGKPPL---ASMDRLAAMF 218
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-20
Identities = 62/197 (31%), Positives = 111/197 (56%), Gaps = 11/197 (5%)
Query: 137 KIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEG 196
KIG+G+ V A +GK+VA+KK+ + + F E++I+R H N++++
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLF--NEVVIMRDYQHENVVEMYN 84
Query: 197 LITSRLSCSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 255
+ + +++V E++E +T +++ + +E QI +L L H++GV+HR
Sbjct: 85 --SYLVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIAAVCLAVLKALSVLHAQGVIHR 140
Query: 256 DIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSV 314
DIK ++L+ ++G +KL+DFG A S R+ S V T ++ PE L+ YGP V
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KSLVGTPYWMAPE-LISRLPYGPEV 197
Query: 315 DLWSVGCVFAELLIGKP 331
D+WS+G + E++ G+P
Sbjct: 198 DIWSLGIMVIEMVDGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 7e-20
Identities = 68/247 (27%), Positives = 115/247 (46%), Gaps = 33/247 (13%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ +E + ++G G + V++A++ +TG + A K + + E E +M EI IL +HP
Sbjct: 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMV-EIEILATCNHP 69
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP-----------DIKFSEAQIKCYMN 238
I+KL G I + F CP D +E QI+
Sbjct: 70 YIVKLLGAFYWDGKLWIMIEF------------CPGGAVDAIMLELDRGLTEPQIQVICR 117
Query: 239 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 298
Q+L L++ HS ++HRD+K N+L+ +G +KLADFG++ N Q S + T ++
Sbjct: 118 QMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSA-KNVKTLQRRDSFIGTPYW 176
Query: 299 RPPELLLGAT----DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 354
PE+++ T Y D+WS+G E+ +P E+ + + K+ S P
Sbjct: 177 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP---PHHELNPMRVLLKIAKSEPP 233
Query: 355 DYWKKSK 361
+ SK
Sbjct: 234 TLSQPSK 240
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 60/234 (25%), Positives = 108/234 (46%), Gaps = 32/234 (13%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKV---RFDNFEPESVRFMAREILILRRLDHPNIIKL 194
+G+G + V + TGK+ A KK+ R + E + ++IL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKIL------------- 47
Query: 195 EGLITSRLSCSIYLVFEYMEH--DITGLLSCPDIK----------FSEAQIKCYMNQLLH 242
++SR S+ FE + + L++ D+K F EA+ Y Q++
Sbjct: 48 -EKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIIC 106
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPE 302
GLEH H R +++RD+K N+L+++ G ++++D GLA + + R T Y PE
Sbjct: 107 GLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPE 164
Query: 303 LLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 356
+L G Y SVD +++GC E++ G+ + R E + ++ + +Y
Sbjct: 165 VLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEY 217
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 2e-19
Identities = 74/289 (25%), Positives = 125/289 (43%), Gaps = 46/289 (15%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+EK+ +G+G + V R K+V +K++ + + E +L+ L HPNI
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61
Query: 192 IK-LEGLITSRLSCSIYLVFEYMEHDITGLLS------CPDIKFSEAQIKCYMNQLLHGL 244
I+ E + + ++ +V EY G L+ C + E I + Q+L L
Sbjct: 62 IEYYENFLEDK---ALMIVMEYAP---GGTLAEYIQKRCNSL-LDEDTILHFFVQILLAL 114
Query: 245 EHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPEL 303
H H++ +LHRD+K N+L++ ++ V+K+ DFG++ + + V T Y PEL
Sbjct: 115 HHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYTVVGTPCYISPEL 172
Query: 304 LLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363
G Y D+W++GCV EL K + + KI +P D
Sbjct: 173 CEGKP-YNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDR------- 224
Query: 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
Y LR+ LI ++L+++P KR S +A
Sbjct: 225 ----------YSPDLRQ-----------LILSMLNLDPSKRPQLSQIMA 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 64/218 (29%), Positives = 110/218 (50%), Gaps = 22/218 (10%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREI---LILRRL-----DHP 189
+G+G++ VF A T + A+K ++ D V M ++ ++ +R+ +HP
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKD------VVLMDDDVECTMVEKRVLSLAWEHP 56
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHD--ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
+ L T + +++ V EY+ + + SC KF + Y +++ GL+
Sbjct: 57 FLTHL--YCTFQTKENLFFVMEYLNGGDLMFHIQSCH--KFDLPRATFYAAEIICGLQFL 112
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
HS+G+++RD+K N+L++ +G +K+ADFG+ + G + T T Y PE+LLG
Sbjct: 113 HSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTF-CGTPDYIAPEILLG- 170
Query: 308 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 345
Y SVD WS G + E+LIG+ G E E I
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 3e-19
Identities = 83/300 (27%), Positives = 127/300 (42%), Gaps = 54/300 (18%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR-FDNFEPESVRFMAREILILRRLDH 188
D FE L+ IG+G + V + DTG I A+K +R D E E V + E IL D
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
++K+ + + ++YL+ E++ D+ LL D SE + Y+ + + ++
Sbjct: 61 AWVVKM--FYSFQDKRNLYLIMEFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAI 117
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN----------FSNTGH------------ 285
H G +HRDIK NLL++ +G +KL+DFGL + N H
Sbjct: 118 HQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 286 ------------RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL 333
RQ S V T Y PE+ + T Y D WS+G + E+LIG P
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 334 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 393
T E K+ WK++ +F P+ P ++ T + N I
Sbjct: 237 CSETPQETYRKVMN---------WKET-----LVFPPEVPISEKAKDLILRFCTDSENRI 282
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 3e-19
Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 21/216 (9%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKV-RFDNFEPESVRFMAREILILRR 185
++A+ F+ ++ IG+G + V R + ++ A+K + +F+ + F E I+
Sbjct: 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAH 99
Query: 186 LDHPNIIKLEGLITSRLSCS------IYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMN 238
+ I+ +L + +Y+V EYM D+ L+S DI E + Y
Sbjct: 100 ANSEWIV--------QLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDI--PEKWARFYTA 149
Query: 239 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 298
+++ L+ HS G +HRD+K N+L++ G LKLADFG + + V T Y
Sbjct: 150 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDY 209
Query: 299 RPPELLL---GATDYGPSVDLWSVGCVFAELLIGKP 331
PE+L G YG D WSVG E+L+G
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 245
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 3e-19
Identities = 60/223 (26%), Positives = 104/223 (46%), Gaps = 32/223 (14%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNF----EPESVRFMAREILILRRLDHPNIIK 193
+G+G++ V A T ++ A+K ++ D + E + +L L HP
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECT-MTEKRVLALAG-KHP---- 56
Query: 194 LEGLITSRLSC-----SIYLVFEY------MEHDITGLLSCPDIKFSEAQIKCYMNQLLH 242
+T SC ++ V EY M H + +F E + + Y +++
Sbjct: 57 ---FLTQLHSCFQTKDRLFFVMEYVNGGDLMFH----IQRSG--RFDEPRARFYAAEIVL 107
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPE 302
GL+ H RG+++RD+K N+L+++EG +K+ADFG+ ++ T Y PE
Sbjct: 108 GLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCK-EGILGGVTTSTFCGTPDYIAPE 166
Query: 303 LLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 345
+L YGP+VD W++G + E+L G+ +G E E I
Sbjct: 167 ILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI 208
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 6e-19
Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 31/204 (15%)
Query: 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLE 195
EKIG+G + V++ L VA+K R +F+ +E IL++ DHPNI+KL
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFL-QEAEILKQYDHPNIVKLI 58
Query: 196 GLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLH-------GLEHCH 248
G+ + IY+V E + LL+ ++ + ++ + +LL G+E+
Sbjct: 59 GVCVQKQP--IYIVMELVPGG--SLLTF--LRKKKNRLT--VKKLLQMSLDAAAGMEYLE 110
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-------FSNTGHRQPLTSRVVTLWYRPP 301
S+ +HRD+ N LV VLK++DFG++ + G +Q + W P
Sbjct: 111 SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ-----IPIKWTAPE 165
Query: 302 ELLLGATDYGPSVDLWSVGCVFAE 325
L G Y D+WS G + E
Sbjct: 166 ALNYGR--YTSESDVWSYGILLWE 187
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 7e-19
Identities = 80/295 (27%), Positives = 130/295 (44%), Gaps = 18/295 (6%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPES-VRFMAREILILRRLDHPNIIKLEG 196
IG+G++ V + R DT +I ALK +R + S V E +L +++ P I+ L+
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 197 LITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 256
S +YLV ++ + +F ++ + Y +LL LE+ H V++RD
Sbjct: 61 SFQSPEK--LYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRD 118
Query: 257 IKGSNLLVNNEGVLKLADFGLA--NFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSV 314
+K N+L++ +G + L DFGL N + T Y PELLLG Y +V
Sbjct: 119 LKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCG---TPEYLAPELLLG-HGYTKAV 174
Query: 315 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK--PQQ 372
D W++G + E+L G P E KI + PD + + +K L P +
Sbjct: 175 DWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTR 234
Query: 373 PYDSSLRETFKDLPTTAVNLIETLLS---VEPYKRATASAA----LASEYFSTKP 420
+ + K+ P + + LL P+K A +SA E+ KP
Sbjct: 235 RLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAIDTSNFDEEFTREKP 289
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 7e-19
Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 22/205 (10%)
Query: 135 LEKIGQGTYSSVFRAR-----DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
++++G+G + SV R D +TG++VA+KK++ E +R REI IL+ L H
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQD-NTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHD 65
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
NI+K +G+ S ++ LV EY+ + + L + ++ Y +Q+ G+E+
Sbjct: 66 NIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG 125
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-----RQPLTSRVVTLWYRPPEL 303
S+ +HRD+ N+LV +E +K+ DFGL R+P S + WY P L
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPI--FWYAPESL 183
Query: 304 LLGATDYGPSV--DLWSVGCVFAEL 326
T+ SV D+WS G V EL
Sbjct: 184 ----TESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 7e-19
Identities = 64/232 (27%), Positives = 111/232 (47%), Gaps = 16/232 (6%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPES---VRFMAREILILRRLDH 188
+ L +G+G++ + +++ + A+K++R P+S V +E ++L ++ H
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRL----PKSSSAVEDSRKEAVLLAKMKH 57
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIK-FSEAQIKCYMNQLLHGLEH 246
PNI+ + + +Y+V EY + D+ + K F E I + Q+ G++H
Sbjct: 58 PNIVAFKESFEA--DGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQH 115
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVVTLWYRPPELLL 305
H + VLHRDIK N+ + G +KL DFG A ++ G + V T +Y PPE+
Sbjct: 116 IHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA--CTYVGTPYYVPPEIWE 173
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP-PDDY 356
Y D+WS+GC+ EL K Q + + K+ + P P Y
Sbjct: 174 NMP-YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHY 224
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 7e-19
Identities = 77/290 (26%), Positives = 138/290 (47%), Gaps = 38/290 (13%)
Query: 137 KIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEG 196
KIG+G+ V A + TGK VA+KK+ + + F E++I+R H N++ +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLF--NEVVIMRDYHHENVVDMYN 86
Query: 197 LITSRLSCSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 255
+ + +++V E++E +T +++ + +E QI +L L + H++GV+HR
Sbjct: 87 --SYLVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIATVCLSVLRALSYLHNQGVIHR 142
Query: 256 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-TLWYRPPELLLGATDYGPSV 314
DIK ++L+ ++G +KL+DFG + P +V T ++ PE ++ YG V
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFC--AQVSKEVPKRKSLVGTPYWMAPE-VISRLPYGTEV 199
Query: 315 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY 374
D+WS+G + E++ G+P ++ + +I D+ + K H
Sbjct: 200 DIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI-------RDNLPPRVKDSHKV-------- 244
Query: 375 DSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS-TKPYAC 423
SS+ F DL +L EP +RATA L + P +C
Sbjct: 245 -SSVLRGFLDL----------MLVREPSQRATAQELLQHPFLKLAGPPSC 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 62/224 (27%), Positives = 99/224 (44%), Gaps = 31/224 (13%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR----FDNFEPESVRFMAREILILRRLD 187
F L +G+G + V A TG++ A+K ++ E ES+ R
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 188 HPNIIKLEGLITSRLSC-----SIYLVFEY------MEHDITGLLSCPDIKFSEAQIKCY 236
HP ++ L +C + V EY M H T + FSE + Y
Sbjct: 61 HPFLVNL-------FACFQTEDHVCFVMEYAAGGDLMMHIHTDV-------FSEPRAVFY 106
Query: 237 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 296
++ GL++ H +++RD+K NLL++ EG +K+ADFGL G ++ T
Sbjct: 107 AACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFCGTP 165
Query: 297 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE 340
+ PE+L T Y +VD W +G + E+L+G+ G E E
Sbjct: 166 EFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE 208
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 1e-18
Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 15/206 (7%)
Query: 132 FEKLEKIGQGTYSSV----FRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD 187
+++ +G+G + V + +TG+ VA+K ++ ++ + + +EI ILR L
Sbjct: 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG-NHIADLKKEIEILRNLY 64
Query: 188 HPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEH 246
H NI+K +G+ T I L+ E++ + L K + Q Y Q+ G+++
Sbjct: 65 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDY 124
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-----RQPLTSRVVTLWYRPP 301
SR +HRD+ N+LV +E +K+ DFGL T + L S V WY P
Sbjct: 125 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPV--FWY-AP 181
Query: 302 ELLLGATDYGPSVDLWSVGCVFAELL 327
E L+ + Y S D+WS G ELL
Sbjct: 182 ECLIQSKFYIAS-DVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 66/237 (27%), Positives = 118/237 (49%), Gaps = 13/237 (5%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ +E + ++G G + V++A++ +TG ++A KV E E +M EI IL DHP
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETG-VLAAAKVIDTKSEEELEDYMV-EIDILASCDHP 62
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
NI+KL L +++++ E+ + ++ + +E QI+ Q L L + H
Sbjct: 63 NIVKL--LDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH 120
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
++HRD+K N+L +G +KLADFG++ NT Q S + T ++ PE+++ T
Sbjct: 121 ENKIIHRDLKAGNILFTLDGDIKLADFGVSA-KNTRTIQRRDSFIGTPYWMAPEVVMCET 179
Query: 309 D----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361
Y D+WS+G E+ +P E+ + + K+ S P + S+
Sbjct: 180 SKDRPYDYKADVWSLGITLIEMAQIEP---PHHELNPMRVLLKIAKSEPPTLAQPSR 233
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-18
Identities = 82/290 (28%), Positives = 127/290 (43%), Gaps = 58/290 (20%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR-FDNFEPESVRFMAREILILRRLDHPN 190
FE L+ IG+G + V + DTG + A+K +R D E E V + E IL D
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
++K+ +L+ +YL+ E++ D+ LL D +E + + Y+ + + ++ H
Sbjct: 63 VVKMFYSFQDKLN--LYLIMEFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIHQ 119
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN----------FSNTGH-------------- 285
G +HRDIK NLL++++G +KL+DFGL + N H
Sbjct: 120 LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSK 179
Query: 286 ----------RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 335
RQ S V T Y PE+ + T Y D WS+G + E+LIG P
Sbjct: 180 RKAETWKRNRRQLAFSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238
Query: 336 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDL 385
T E K+ WK++ +F P+ P + E KDL
Sbjct: 239 ETPQETYKKVMN---------WKET-----LIFPPEVP----ISEKAKDL 270
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 3e-18
Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 15/200 (7%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVR-------FMAREILILRRLDH-P 189
IG+GT+ V++ R DT +I A+K + + E V R IL+ LD P
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLS----KKEIVAKKEVAHTIGERNILVRTLLDESP 56
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
I+ L+ + + +YLV +YM + +FSE + K Y+ +L+ LEH H
Sbjct: 57 FIVGLK--FSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHK 114
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD 309
+++RD+K N+L++ G + L DFGL+ +N + + T Y PE+LL
Sbjct: 115 YDIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPEVLLDEKG 173
Query: 310 YGPSVDLWSVGCVFAELLIG 329
Y VD WS+G + E+ G
Sbjct: 174 YTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 3e-18
Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 14/201 (6%)
Query: 136 EKIGQGTYSSVFRARDLDTGK---IVALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192
E IG G + V R R GK VA+K ++ E + F++ E I+ + DHPNII
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLS-EASIMGQFDHPNII 68
Query: 193 KLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG 251
LEG++T S + ++ E+ME+ + L D +F+ Q+ + + G+++
Sbjct: 69 HLEGVVTK--SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN 126
Query: 252 VLHRDIKGSNLLVNNEGVLKLADFGLANF-----SNTGHRQPLTSRVVTLWYRPPELLLG 306
+HRD+ N+LVN+ V K++DFGL+ F S+ + L ++ W P +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY- 185
Query: 307 ATDYGPSVDLWSVGCVFAELL 327
+ + D+WS G V E++
Sbjct: 186 -RKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 3e-18
Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 38/214 (17%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
E +G G +V++A L T +I+A+K + D E + + E+ IL + D P II
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLD-ITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 195 EG--LITSRLS-CSIYL------VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
G + +R+S C+ ++ V+ + + G ++ +K GL
Sbjct: 65 YGAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVAVVK---------------GLT 109
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS----RVVTLWYRPP 301
+ S +LHRD+K SN+LVN G +KL DFG++ Q + S V T Y P
Sbjct: 110 YLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVS-------TQLVNSIAKTYVGTNAYMAP 162
Query: 302 ELLLGATDYGPSVDLWSVGCVFAELLIGK-PILQ 334
E + G YG D+WS+G F EL +G+ P Q
Sbjct: 163 ERISG-EQYGIHSDVWSLGISFMELALGRFPYPQ 195
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 84.8 bits (209), Expect = 3e-18
Identities = 67/219 (30%), Positives = 106/219 (48%), Gaps = 21/219 (9%)
Query: 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH 188
A FE +E +G GTY V++ R + TG++ A+K + E E ++ +EI +L++ H
Sbjct: 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK---QEINMLKKYSH 61
Query: 189 -PNIIKLEGLITSR----LSCSIYLVFEYM-EHDITGLL-SCPDIKFSEAQIKCYMNQLL 241
NI G + + ++LV E+ +T L+ + E I ++L
Sbjct: 62 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 121
Query: 242 HGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLWYRP 300
GL H H V+HRDIKG N+L+ +KL DFG+ A T R+ + + T ++
Sbjct: 122 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR--NTFIGTPYWMA 179
Query: 301 PELLLGATDYGPSV------DLWSVGCVFAELLIGKPIL 333
PE++ A D P DLWS+G E+ G P L
Sbjct: 180 PEVI--ACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 5e-18
Identities = 69/239 (28%), Positives = 114/239 (47%), Gaps = 24/239 (10%)
Query: 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH 188
A FE +E +G GTY V++ R + TG++ A+K + E E ++ EI +L++ H
Sbjct: 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKL---EINMLKKYSH 71
Query: 189 -PNIIKLEGLITSRLSC----SIYLVFEYM-EHDITGLL-SCPDIKFSEAQIKCYMNQLL 241
NI G + ++LV E+ +T L+ + E I ++L
Sbjct: 72 HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREIL 131
Query: 242 HGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLWYRP 300
GL H H+ V+HRDIKG N+L+ +KL DFG+ A T R+ + + T ++
Sbjct: 132 RGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR--NTFIGTPYWMA 189
Query: 301 PELLLGATDYGPSV------DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 353
PE++ A D P D+WS+G E+ G P L ++ + +F + +PP
Sbjct: 190 PEVI--ACDENPDATYDYRSDIWSLGITAIEMAEGAPPL---CDMHPMRALFLIPRNPP 243
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 7e-18
Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 13/207 (6%)
Query: 132 FEKLEKIGQGTYSSVFRARDL---DTGKIVA---LKKVRFDNFEPESVRFMAREILILRR 185
FE L +G G Y VF R + D GK+ A LKK + ++
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 186 LDHPNIIKLEGLITSRLSCSIYLVFEYMEHD--ITGLLSCPDIKFSEAQIKCYMNQLLHG 243
P ++ L + ++L+ +Y+ T L F+E++++ Y+ +++
Sbjct: 62 RRCPFLVTLHYAFQT--DTKLHLILDYVNGGELFTHL--YQREHFTESEVRVYIAEIVLA 117
Query: 244 LEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPEL 303
L+H H G+++RDIK N+L+++EG + L DFGL+ + S T+ Y PE+
Sbjct: 118 LDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEV 177
Query: 304 LLGATD-YGPSVDLWSVGCVFAELLIG 329
+ G + + +VD WS+G + ELL G
Sbjct: 178 IRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 7e-18
Identities = 72/235 (30%), Positives = 118/235 (50%), Gaps = 20/235 (8%)
Query: 132 FEKLEKIGQGTYSSVFRARDL---DTGKIVALKKVRFDNF-----EPESVRFMAREILIL 183
FE L+ +G G Y VF R + DTGK+ A+K ++ E R R +L
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTR-TERNVLEH 60
Query: 184 RRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLH 242
R P ++ L + ++L+ +Y+ ++ L D FSE +++ Y +++
Sbjct: 61 VR-QSPFLVTLHYAFQTE--AKLHLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIIL 116
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPE 302
LEH H G+++RDIK N+L+++EG + L DFGL+ + ++ S T+ Y PE
Sbjct: 117 ALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPE 176
Query: 303 LLLGATDYGPSVDLWSVGCVFAELLIGKP--ILQGR--TEVEQLHKIFKLCGSPP 353
++ G +G +VD WS+G + ELL G L+G T+ E +I K PP
Sbjct: 177 IIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC--DPP 229
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 68/220 (30%), Positives = 109/220 (49%), Gaps = 38/220 (17%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALK---KVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
IG+G + V+ R DTGK+ A+K K R + E++ R +L L
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL----------- 50
Query: 195 EGLITSRLSCSIYLVFEYMEHD------ITGLLSCPDIK--------FSEAQIKCYMNQL 240
S C + Y H I L++ D+ FSE +++ Y ++
Sbjct: 51 ----VSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEI 106
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYR 299
+ GLEH H+R V++RD+K +N+L++ G ++++D GLA +FS ++P S V T Y
Sbjct: 107 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK---KKPHAS-VGTHGYM 162
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIG-KPILQGRTE 338
PE+L T Y S D +S+GC+ +LL G P Q +T+
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 58/222 (26%), Positives = 107/222 (48%), Gaps = 34/222 (15%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTG-KIVALKKVRFDNFE--------PESVRFMAREILI 182
+ LE +G G + V++ R + G ++ALK++ N +S+ + E+ I
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 183 LR-RLDHPNIIK-----LEGLITSRLSCSIYLVFEYM------EHDITGLLSCPDIKFSE 230
++ +L HPNI++ LE RL Y+V + + EH + L +F+E
Sbjct: 62 IKEQLRHPNIVRYYKTFLEN---DRL----YIVMDLIEGAPLGEHFNS--LKEKKQRFTE 112
Query: 231 AQIKCYMNQLLHGLEHCH-SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289
+I Q++ L + H + ++HRD+ +N+++ + + + DFGLA L
Sbjct: 113 ERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKL 170
Query: 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 331
TS V T+ Y PE++ YG D+W+ GC+ ++ +P
Sbjct: 171 TSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQP 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 68/220 (30%), Positives = 109/220 (49%), Gaps = 38/220 (17%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALK---KVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
IG+G + V+ R DTGK+ A+K K R + E++ R +L L
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL----------- 50
Query: 195 EGLITSRLSCSIYLVFEYMEHD------ITGLLSCPDIK--------FSEAQIKCYMNQL 240
S C + Y H I L++ D+ FSEA+++ Y ++
Sbjct: 51 ----VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEI 106
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYR 299
+ GLEH H+R V++RD+K +N+L++ G ++++D GLA +FS ++P S V T Y
Sbjct: 107 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK---KKPHAS-VGTHGYM 162
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIG-KPILQGRTE 338
PE+L Y S D +S+GC+ +LL G P Q +T+
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 1e-17
Identities = 74/258 (28%), Positives = 108/258 (41%), Gaps = 48/258 (18%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR-FDNFEPESVRFMAREILILRRLDHPN 190
F K++ IG G + V R +DT + A+K +R D + E IL D+
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
++KL + + ++Y V +Y+ D+ LL I F E + Y+ +L +E H
Sbjct: 63 VVKL--YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGI-FEEDLARFYIAELTCAIESVHK 119
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLANF-----------SNTGHRQ----------- 287
G +HRDIK N+L++ +G +KL DFGL HRQ
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179
Query: 288 -------PLTSR-------------VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 327
PL R V T Y PE+LL T Y D WSVG + E+L
Sbjct: 180 IDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVILYEML 238
Query: 328 IGKPILQGRTEVEQLHKI 345
+G+P T E K+
Sbjct: 239 VGQPPFLADTPAETQLKV 256
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 2e-17
Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 35/220 (15%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
D E L+++G+G Y SV++ TG +A+K++R + + + E+ IL + P
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSP 59
Query: 190 NIIKLEGLITSRLSCSIYLVFEYME----HDITGLLSCPDIKFSEAQIKCYMNQLLHGL- 244
I+ G + ++Y+ EYM+ + + E ++ ++ GL
Sbjct: 60 YIVDFYGAFF--IEGAVYMCMEYMDAGSLDKLYAGGVATEGI-PEDVLRRITYAVVKGLK 116
Query: 245 ----EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-----ANFSNTGHRQPLTSRVVT 295
EH ++HRD+K +N+LVN G +KL DFG+ A+ + T +
Sbjct: 117 FLKEEH----NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN--------IGC 164
Query: 296 LWYRPPELL--LGATD---YGPSVDLWSVGCVFAELLIGK 330
Y PE + G Y D+WS+G E+ +G+
Sbjct: 165 QSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 3e-17
Identities = 71/236 (30%), Positives = 112/236 (47%), Gaps = 11/236 (4%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKV-RFDNFEPESVRFMAREILILRR 185
++A+ +E ++ IG+G + V R T K+ A+K + +F+ + F E I+
Sbjct: 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99
Query: 186 LDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGL 244
+ P +++L + +Y+V EYM D+ L+S D+ E + Y +++ L
Sbjct: 100 ANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV--PEKWARFYTAEVVLAL 155
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELL 304
+ HS G +HRD+K N+L++ G LKLADFG N + V T Y PE+L
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 215
Query: 305 L---GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF--KLCGSPPDD 355
G YG D WSVG E+L+G + V KI K + PDD
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD 271
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 23/204 (11%)
Query: 136 EKIGQGTYSSVFRARDLDTGK---IVALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192
+ IG G + V R R GK VA+K ++ + + + + F+ E I+ + DHPNII
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFL-TEASIMGQFDHPNII 68
Query: 193 KLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG 251
+LEG++T I + EYME+ + L D KF+ Q+ + + G+++
Sbjct: 69 RLEGVVTKSRPVMI--ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN 126
Query: 252 VLHRDIKGSNLLVNNEGVLKLADFGL--------ANFSNTGHRQPLTSRVVTLWYRPPEL 303
+HRD+ N+LVN+ V K++DFGL A ++ G + P+ W P +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPI------RWTAPEAI 180
Query: 304 LLGATDYGPSVDLWSVGCVFAELL 327
+ + D+WS G V E++
Sbjct: 181 AYRK--FTSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 4e-17
Identities = 70/227 (30%), Positives = 113/227 (49%), Gaps = 27/227 (11%)
Query: 135 LEKIGQGTYSSVFRARDL---DTGKIVA---LKKVRFDNFEPESVRFMAREILILRRLDH 188
L+ +G+G Y VF+ R + DTGKI A LKK + ++ A E IL + H
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKA-ERNILEAVKH 59
Query: 189 PNIIKLEGLITSRLSCSIYLVFEY-------MEHDITGLLSCPDIKFSEAQIKCYMNQLL 241
P I+ L + + +YL+ EY M + G+ F E Y++++
Sbjct: 60 PFIVDL--IYAFQTGGKLYLILEYLSGGELFMHLEREGI-------FMEDTACFYLSEIS 110
Query: 242 HGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-TLWYRP 300
LEH H +G+++RD+K N+L++ +G +KL DFGL S H +T T+ Y
Sbjct: 111 LALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESI--HEGTVTHTFCGTIEYMA 168
Query: 301 PELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 347
PE+L+ + +G +VD WS+G + ++L G P + + KI K
Sbjct: 169 PEILM-RSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK 214
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 5e-17
Identities = 64/217 (29%), Positives = 108/217 (49%), Gaps = 20/217 (9%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDN-FEPESVR--FMAREILILRRLDHPNIIKL 194
+G+G++ V A T + A+K ++ D E + V + R +L L +HP + L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALA-WEHPFLTHL 61
Query: 195 EGLITSRLSCSIYLVFEY------MEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
T + ++ V EY M H + S +F EA+ + Y +++ GL+ H
Sbjct: 62 --FCTFQTKEHLFFVMEYLNGGDLMFH----IQSS--GRFDEARARFYAAEIICGLQFLH 113
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
+G+++RD+K N+L++ +G +K+ADFG+ + G + ++ T Y PE+L G
Sbjct: 114 KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA-STFCGTPDYIAPEILKGQK 172
Query: 309 DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 345
Y SVD WS G + E+LIG+ G E E I
Sbjct: 173 -YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 6e-17
Identities = 73/262 (27%), Positives = 118/262 (45%), Gaps = 27/262 (10%)
Query: 177 AREILILRRLDHPNIIKLEGLIT-SRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC 235
A E ILR ++HP+II+L+G T ++ +C L+ + D+ L+ + I
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTC---LILPRYKTDLYCYLAAKR-NIAICDILA 186
Query: 236 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 295
+L +++ H ++HRDIK N+ +N+ G + L DFG A F + T
Sbjct: 187 IERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGT 246
Query: 296 LWYRPPELLLGATD-YGPSVDLWSVGCVFAEL------LIGKPILQGRTEVE-QLHKIFK 347
+ PELL A D YGP+VD+WS G V E+ L K L G + + Q+ I +
Sbjct: 247 IATNAPELL--ARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIR 304
Query: 348 LCGSPPDDYWKKSKLPHATLFK---------PQQPYDSSLRETFKDLPTTAVNLIETLLS 398
G+ P+++ A L + ++P L +LP LI +L+
Sbjct: 305 RSGTHPNEFPID---AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLA 361
Query: 399 VEPYKRATASAALASEYFSTKP 420
+ + R +A A L F P
Sbjct: 362 FDAHHRPSAEALLDFAAFQDIP 383
|
Length = 391 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 8e-17
Identities = 65/209 (31%), Positives = 107/209 (51%), Gaps = 11/209 (5%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKV-RFDNFEPESVRFMAREILILRR 185
++A+ ++ ++ IG+G + V R + K+ A+K + +F+ + F E I+
Sbjct: 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99
Query: 186 LDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGL 244
+ P +++L + +Y+V EYM D+ L+S D+ E K Y +++ L
Sbjct: 100 ANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDV--PEKWAKFYTAEVVLAL 155
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYRPPEL 303
+ HS G++HRD+K N+L++ G LKLADFG TG + T+ V T Y PE+
Sbjct: 156 DAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA-VGTPDYISPEV 214
Query: 304 LL---GATDYGPSVDLWSVGCVFAELLIG 329
L G YG D WSVG E+L+G
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 29/200 (14%)
Query: 145 SVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204
V A+ T +VA+KK+ D+ E ++ + +EI+ R+L HPNI+ TS +
Sbjct: 15 IVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV---TSFIVD 71
Query: 205 S-IYLVFEYMEHDITGLLSCPD-IK------FSEAQIKCYMNQLLHGLEHCHSRGVLHRD 256
S +Y+V M + SC D +K E I + +L+ L++ HS+G +HR
Sbjct: 72 SELYVVSPLMAYG-----SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRS 126
Query: 257 IKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQ-----PLTSRVVTLWYRPPELL----LG 306
+K S++L++ +G + L+ + + G RQ S V L + PE+L G
Sbjct: 127 VKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQG 186
Query: 307 ATDYGPSVDLWSVGCVFAEL 326
Y D++SVG EL
Sbjct: 187 ---YNEKSDIYSVGITACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-16
Identities = 76/264 (28%), Positives = 116/264 (43%), Gaps = 52/264 (19%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRF-DNFEPESVRFMAREILILRRLDHPN 190
F K++ +G G + V AR +DT + A+K +R D V + E IL D+
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
+++L + + ++Y V +Y+ D+ LL I F E + Y+ +L +E H
Sbjct: 63 VVRL--YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGI-FPEDLARFYIAELTCAVESVHK 119
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLA-----------------------NFSN---- 282
G +HRDIK N+L++ +G +KL DFGL +FSN
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGD 179
Query: 283 -----TGHR-QPLTSR-------------VVTLWYRPPELLLGATDYGPSVDLWSVGCVF 323
G R +PL R V T Y PE+LL T Y D WSVG +
Sbjct: 180 PANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVIL 238
Query: 324 AELLIGKPILQGRTEVEQLHKIFK 347
E+L+G+P +T +E K+
Sbjct: 239 YEMLVGQPPFLAQTPLETQMKVIN 262
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 3e-16
Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 25/208 (12%)
Query: 134 KLEK-IGQGTYSSVFRARDLDTGK---IVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
K+EK IG G + V R GK VA+K ++ E + F++ E I+ + DHP
Sbjct: 7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLS-EASIMGQFDHP 65
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
NII LEG++T S + +V EYME+ + L D +F+ Q+ + + G+++
Sbjct: 66 NIIHLEGVVTK--SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS 123
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGL---------ANFSNTGHRQPLTSRVVTLWYR 299
G +HRD+ N+LVN+ V K++DFGL A ++ G + P+ W
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR------WTA 177
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELL 327
P + + + D+WS G V E++
Sbjct: 178 PEA--IAYRKFTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 54/205 (26%), Positives = 101/205 (49%), Gaps = 9/205 (4%)
Query: 132 FEKLEKIGQGTYSSVFRARDL---DTGKIVALKKVRFDNF--EPESVRFMAREILILRRL 186
FE L+ +G G Y VF R + D+GK+ A+K ++ + ++ E +L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 187 DH-PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
P ++ L + ++L+ +Y+ +F E +++ Y +++ LE
Sbjct: 62 RQSPFLVTLH--YAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALE 119
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
H H G+++RDIK N+L+++ G + L DFGL+ + + S T+ Y P+++
Sbjct: 120 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVR 179
Query: 306 GA-TDYGPSVDLWSVGCVFAELLIG 329
G + +VD WS+G + ELL G
Sbjct: 180 GGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 5e-16
Identities = 52/149 (34%), Positives = 72/149 (48%), Gaps = 6/149 (4%)
Query: 179 EILILRRLDHPNIIKLEGL-ITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 237
E +LRRL HP ++ L + + L+C LV D+ L AQ+
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTC---LVLPKYRSDLYTYLGARLRPLGLAQVTAVA 266
Query: 238 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-TL 296
QLL +++ H G++HRDIK N+LVN + L DFG A F+ P + T+
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTV 326
Query: 297 WYRPPELLLGATDYGPSVDLWSVGCVFAE 325
PE+L G Y PSVD+WS G V E
Sbjct: 327 DTNAPEVLAG-DPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 6e-16
Identities = 72/230 (31%), Positives = 113/230 (49%), Gaps = 30/230 (13%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF----EPESVRFMAREILILRRLD 187
FE ++ I G Y +V+ R +T + A+KK+ N + + V F+ R+IL +
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQV-FVERDILTFA--E 59
Query: 188 HPNIIKLEGLI-TSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQI-KCYMNQLLHGL 244
+P ++ + T R C +V EY+E D LL +I + + Y + + L
Sbjct: 60 NPFVVSMFCSFETKRHLC---MVMEYVEGGDCATLLK--NIGALPVDMARMYFAETVLAL 114
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN---FSNT-----GH-----RQPLTS 291
E+ H+ G++HRD+K NLL+ + G +KL DFGL+ S T GH R+ L
Sbjct: 115 EYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDK 174
Query: 292 RVV-TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE 340
+V T Y PE++L YG VD W++G + E L+G G T E
Sbjct: 175 QVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 223
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 6e-16
Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 136 EKIGQGTYSSVFRARD---LDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192
+++G+G++ +V+ +D + ++ LK++ P +E +L +LDHP I+
Sbjct: 6 QRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 193 KLEGLITSRLSCSIYLVFEYME----HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
K R + I + EY E L SE Q+ + QLL G+ + H
Sbjct: 66 KFHASFLERDAFCI--ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
R +LHRD+K N+ + N +LK+ DFG++ G T+ T +Y PE L
Sbjct: 124 QRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLL-MGSCDLATTFTGTPYYMSPE-ALKHQ 180
Query: 309 DYGPSVDLWSVGCVFAEL 326
Y D+WS+GC+ E+
Sbjct: 181 GYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 7e-16
Identities = 47/182 (25%), Positives = 86/182 (47%), Gaps = 22/182 (12%)
Query: 179 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYM 237
E ++ +L HPN+++L G+ T + I++V EYM + + L K +
Sbjct: 49 EAKVMMKLSHPNLVQLYGVCTKQRP--IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMC 106
Query: 238 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-------SNTGHRQPLT 290
+ + +E+ S G +HRD+ N LV + V+K++DFGLA + S+ G + P+
Sbjct: 107 SDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVK 166
Query: 291 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTE---VEQLHKIF 346
+ PPE+ + + D+WS G + E+ GK + + VE + +
Sbjct: 167 -------WAPPEVFD-YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY 218
Query: 347 KL 348
+L
Sbjct: 219 RL 220
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 9e-16
Identities = 82/332 (24%), Positives = 138/332 (41%), Gaps = 43/332 (12%)
Query: 137 KIGQG--TYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
+IG+G +SV+ AR TG +V ++ +N E ++ + E+++ HPNI+
Sbjct: 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64
Query: 195 EGLITSRLSCSIYLVFEYMEH-DITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRG 251
+ T+ ++++ +M + LL P+ SEA I + L GL + H G
Sbjct: 65 WTVFTT--GSWLWVISPFMAYGSANSLLKTYFPE-GMSEALIGNILFGALRGLNYLHQNG 121
Query: 252 VLHRDIKGSNLLVNNEGVLKLADFGLANFS---NTGHRQ------PLTSRVVTLWYRPPE 302
+HR+IK S++L++ +G++ L+ GL++ G + P S V W P
Sbjct: 122 YIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPEL 179
Query: 303 LLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362
L Y D++SVG EL G+ Q + L + K PP +
Sbjct: 180 LRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLK---GPPYSPLDITTF 236
Query: 363 PH--ATLFKPQQPYDSSLRETF-------------------KDLPTTAVNLIETLLSVEP 401
P + + Q DS + E+ K NL+E L +P
Sbjct: 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDP 296
Query: 402 YKRATASAALASEYFSTKPYACDLSSLPIYPP 433
KR +AS+ L+ +F S L + PP
Sbjct: 297 EKRPSASSLLSHAFFKQVKEQTQGSILSLLPP 328
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 9e-16
Identities = 62/266 (23%), Positives = 106/266 (39%), Gaps = 56/266 (21%)
Query: 179 EILILRRLDHPNIIKL-EGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYM 237
E ++L+ ++HP++I++ + L++ ++C +V + D+ L+ Q
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITC---MVLPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 238 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS-NTGHRQPLTSRVVTL 296
Q+L GL + H++ ++HRD+K N+ +N+ + + D G A F L V T
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVET- 222
Query: 297 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 356
PE+L Y D+WS G V E+L P IF+ S P++Y
Sbjct: 223 --NAPEVLARDK-YNSKADIWSAGIVLFEML-AYP-----------STIFEDPPSTPEEY 267
Query: 357 WKKSKLPHATLFK------------PQQPYDSSLRETF-------------------KDL 385
K H+ L K P+ P S L F +L
Sbjct: 268 VKSC---HSHLLKIISTLKVHPEEFPRDP-GSRLVRGFIEYASLERQPYTRYPCFQRVNL 323
Query: 386 PTTAVNLIETLLSVEPYKRATASAAL 411
P L+ +L+ + R +A L
Sbjct: 324 PIDGEFLVHKMLTFDAAMRPSAEEIL 349
|
Length = 357 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 67/234 (28%), Positives = 106/234 (45%), Gaps = 32/234 (13%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+++IG G + V+ L+ K VA+K +R E E ++ +L HP
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFI---EEAQVMMKLSHP 59
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
+++L G+ T R I LVFE+MEH ++ L KFS+ + + G+ +
Sbjct: 60 KLVQLYGVCTER--SPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE 117
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-------SNTGHRQPLTSRVVTLWYRPP 301
S V+HRD+ N LV V+K++DFG+ F S+TG + P+ W P
Sbjct: 118 SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK------WSSPE 171
Query: 302 ELLLGATDYGPSVDLWSVGC----VFAELLIGKPILQGRTE---VEQLHKIFKL 348
Y D+WS G VF+E GK + R+ VE ++ F+L
Sbjct: 172 VFSFS--KYSSKSDVWSFGVLMWEVFSE---GKTPYENRSNSEVVETINAGFRL 220
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 32/222 (14%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDHPN 190
F +G+G + V + TGK+ A KK+ + MA E IL +++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEHD----ITGLLSCPDIKF----------SEAQIKCY 236
++ L + Y D + L++ D+KF E + Y
Sbjct: 62 VVSL--------------AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFY 107
Query: 237 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 296
++ GLE H +++RD+K N+L+++ G ++++D GLA G + + RV T+
Sbjct: 108 AAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG--ETIRGRVGTV 165
Query: 297 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE 338
Y PE ++ Y S D W +GC+ E++ GK + R E
Sbjct: 166 GYMAPE-VVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 55/197 (27%), Positives = 93/197 (47%), Gaps = 16/197 (8%)
Query: 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLE 195
E+IG+G + VF R VA+K R + P+ +E IL++ HPNI++L
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIVRLI 59
Query: 196 GLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 254
G+ T + IY+V E ++ D L + ++ + G+E+ S+ +H
Sbjct: 60 GVCTQKQP--IYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIH 117
Query: 255 RDIKGSNLLVNNEGVLKLADFGLAN------FSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
RD+ N LV + VLK++DFG++ +++TG + ++ W P L G
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK----QIPVKWTAPEALNYGR- 172
Query: 309 DYGPSVDLWSVGCVFAE 325
Y D+WS G + E
Sbjct: 173 -YSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-15
Identities = 64/204 (31%), Positives = 96/204 (47%), Gaps = 16/204 (7%)
Query: 153 DTGKIVALKKVRFDNFEPESVRF-MAREILILRRLDHPNIIKL--EGLITSRLSCSIYLV 209
TG VA+K +R D E E R RE + RL HPNI+ L G L ++ V
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL---LFAV 57
Query: 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV 269
FEY+ + D + M Q+L L H++G++HRD+K N++V+ GV
Sbjct: 58 FEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGV 117
Query: 270 ---LKLADFGLANFSNTGH-----RQPLTSRVV-TLWYRPPELLLGATDYGPSVDLWSVG 320
K+ DFG+ T+ V+ T Y PE L G P+ DL++ G
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEP-VTPNSDLYAWG 176
Query: 321 CVFAELLIGKPILQGRTEVEQLHK 344
+F E L G+ ++QG + E L++
Sbjct: 177 LIFLECLTGQRVVQGASVAEILYQ 200
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 3e-15
Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN-FEPESVRFMAREILILRRLDHPN 190
FE E +G G++ V A+ TG+ A+K ++ + + V+ +A+E IL L HP
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 191 IIK-LEGLITSRLSCSIYLVFEYM--EHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
I+ + +Y + E++ T L +F K Y +L+ E+
Sbjct: 80 IVNMMCSFQDEN---RVYFLLEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYL 134
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW----YRPPEL 303
HS+ +++RD+K NLL++N+G +K+ DFG A + + R TL Y PE
Sbjct: 135 HSKDIIYRDLKPENLLLDNKGHVKVTDFGFA--------KKVPDRTFTLCGTPEYLAPE- 185
Query: 304 LLGATDYGPSVDLWSVGCVFAELLIGKP 331
++ + +G +VD W++G + E + G P
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYP 213
|
Length = 329 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 78/282 (27%), Positives = 115/282 (40%), Gaps = 56/282 (19%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKK-VRFDNFEPESVRFMAREILILRRLDH 188
+ E L +IG GT V++ R TG ++A+K+ R N E M ++ +L+ D
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDV-VLKSHDC 73
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYME---------------HDITGLLSCPDIKFSEAQI 233
P I+K G + +++ E M DI G K + A +
Sbjct: 74 PYIVKCYGYFIT--DSDVFICMELMSTCLDKLLKRIQGPIPEDILG-------KMTVAIV 124
Query: 234 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF---SNTGHRQPLT 290
K LH L+ H GV+HRD+K SN+L++ G +KL DFG++ S R
Sbjct: 125 KA-----LHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGC 177
Query: 291 SRVVTLWYRPPELLLGAT---DYGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIF 346
+ Y PE + Y D+WS+G EL G+ P +TE E L KI
Sbjct: 178 AA-----YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKIL 232
Query: 347 KLCGSPPDDYWKKSKLPHATLFKP--QQPYDSSLRETFKDLP 386
+ PP LP F P D L + + P
Sbjct: 233 QE--EPP-------SLPPNEGFSPDFCSFVDLCLTKDHRKRP 265
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 5e-15
Identities = 70/244 (28%), Positives = 109/244 (44%), Gaps = 32/244 (13%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN-FEPESVRFMAREILILRRLDHPN 190
F L +G+G++ V A T ++ A+K ++ D + + V E +L D P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61
Query: 191 IIKLEGLITSRLSC-----SIYLVFEY------MEH-DITGLLSCPDIKFSEAQIKCYMN 238
+T SC +Y V EY M H G KF E Q Y
Sbjct: 62 ------FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVG-------KFKEPQAVFYAA 108
Query: 239 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV--TL 296
++ GL H RG+++RD+K N+++++EG +K+ADFG+ +T+R T
Sbjct: 109 EISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV---DGVTTRTFCGTP 165
Query: 297 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 356
Y PE ++ YG SVD W+ G + E+L G+P G E E I + S P
Sbjct: 166 DYIAPE-IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSL 224
Query: 357 WKKS 360
K++
Sbjct: 225 SKEA 228
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 5e-15
Identities = 59/225 (26%), Positives = 108/225 (48%), Gaps = 22/225 (9%)
Query: 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLE 195
E IG+G + +V + TG+ VA+K ++ D + + E ++ +L H N+++L
Sbjct: 12 EIIGEGEFGAVLQGEY--TGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLL 65
Query: 196 GLITSRLSCSIYLVFEYMEHD--ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 253
G+I L +Y+V E M + L + S Q+ + + G+E+ S+ ++
Sbjct: 66 GVI---LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLV 122
Query: 254 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 313
HRD+ N+LV+ +GV K++DFGLA G S++ W P L +
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLA---RVGSMGVDNSKLPVKWTAPEALKHK--KFSSK 177
Query: 314 VDLWSVGCVFAELL-IGK---PILQGRTEVEQLHKIFKLCGSPPD 354
D+WS G + E+ G+ P + + E + K +++ PP+
Sbjct: 178 SDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRM--EPPE 220
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 7e-15
Identities = 59/197 (29%), Positives = 95/197 (48%), Gaps = 11/197 (5%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLE- 195
+G+GT+ V R+ TG+ A+K +R + + V E +L+ HP + L+
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 196 GLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 255
T C V EY + F+E + + Y +++ LE+ HSR V++R
Sbjct: 63 AFQTHDRLC---FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 119
Query: 256 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV--TLWYRPPELLLGATDYGPS 313
DIK NL+++ +G +K+ DFGL G T + T Y PE +L DYG +
Sbjct: 120 DIKLENLMLDKDGHIKITDFGLC---KEGISDGATMKTFCGTPEYLAPE-VLEDNDYGRA 175
Query: 314 VDLWSVGCVFAELLIGK 330
VD W +G V E++ G+
Sbjct: 176 VDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 7e-15
Identities = 64/258 (24%), Positives = 111/258 (43%), Gaps = 38/258 (14%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
D E +E++G+G Y V + R + TG I+A+K++R E R + + +R +D P
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCP 60
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS---CPDIKFSEAQIKCYMNQLLHGLEH 246
+ G + +++ E M+ + + E + ++ LE+
Sbjct: 61 YTVTFYGALFRE--GDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEY 118
Query: 247 CHSR-GVLHRDIKGSNLLVNNEGVLKLADFG--------LANFSNTGHRQPLTSRVVTLW 297
HS+ V+HRD+K SN+L+N G +KL DFG +A + G +
Sbjct: 119 LHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKP---------- 168
Query: 298 YRPPELLLGATD---YGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSPP 353
Y PE + + Y D+WS+G EL G+ P +T +QL ++ + P
Sbjct: 169 YMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE--EPSP 226
Query: 354 DDYWKKSKLPHATLFKPQ 371
+LP F P+
Sbjct: 227 -------QLPAEK-FSPE 236
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 7e-15
Identities = 44/159 (27%), Positives = 78/159 (49%), Gaps = 8/159 (5%)
Query: 124 WVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILIL 183
W R D K K+G G Y V+ VA+K ++ D E E F+ +E ++
Sbjct: 1 WEMERTDITMK-HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FL-KEAAVM 56
Query: 184 RRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYM-NQLL 241
+ + HPN+++L G+ T Y++ E+M + ++ L + + A + YM Q+
Sbjct: 57 KEIKHPNLVQLLGVCT--REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 114
Query: 242 HGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 280
+E+ + +HRD+ N LV ++K+ADFGL+
Sbjct: 115 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 153
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 7e-15
Identities = 66/236 (27%), Positives = 110/236 (46%), Gaps = 24/236 (10%)
Query: 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLE 195
E +G+G + VF+ L VA+K + D + ++F++ E IL++ DHPNI+KL
Sbjct: 1 ELLGKGNFGEVFKG-TLKDKTPVAVKTCKEDLPQELKIKFLS-EARILKQYDHPNIVKLI 58
Query: 196 GLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 254
G+ T R IY+V E + D L + Q+ + G+ + S+ +H
Sbjct: 59 GVCTQRQP--IYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIH 116
Query: 255 RDIKGSNLLVNNEGVLKLADFGLAN------FSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
RD+ N LV VLK++DFG++ +S++G +Q + W P L G
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ-----IPIKWTAPEALNYGR- 170
Query: 309 DYGPSVDLWSVGCVFAEL----LIGKPILQGRTEVEQLHKIFKLCGSP--PDDYWK 358
Y D+WS G + E + P + + EQ+ K +++ PDD +K
Sbjct: 171 -YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYK 225
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 8e-15
Identities = 66/264 (25%), Positives = 110/264 (41%), Gaps = 52/264 (19%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR-FDNFEPESVRFMAREILILRRLDH 188
+ F ++ IG+G + V + DTGKI A+K + + F+ + + + E +L D
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
P ++ L + + + +YL+ E++ D+ +L D FSE + YM + + +E
Sbjct: 61 PWVVSL--YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDT-FSEDVTRFYMAECVLAIEAV 117
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-----FSNTGHRQPLTSRVVT------- 295
H G +HRDIK N+L++ G +KL+DFGL+ + +++ L +
Sbjct: 118 HKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRN 177
Query: 296 ------------------LW----------------YRPPELLLGATDYGPSVDLWSVGC 321
W Y PE+ L YG D WS+G
Sbjct: 178 SVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGA 236
Query: 322 VFAELLIGKPILQGRTEVEQLHKI 345
+ E LIG P E KI
Sbjct: 237 IMFECLIGWPPFCSENSHETYRKI 260
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 8e-15
Identities = 56/222 (25%), Positives = 94/222 (42%), Gaps = 42/222 (18%)
Query: 135 LEKIGQGTYSSVFRAR-----DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
LE++G+G + V++ + + VA+K ++ +N EP+ + +E ++ L HP
Sbjct: 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLK-ENAEPKVQQEFRQEAELMSDLQHP 68
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH-----------------------DITGLLSCPDI 226
NI+ L G+ T ++FEY+ H + L C D
Sbjct: 69 NIVCLLGVCTKEQPTC--MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126
Query: 227 KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTG 284
QI G+E+ S +HRD+ N LV +K++DFGL+ +S
Sbjct: 127 LHIAIQIAA-------GMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADY 179
Query: 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 326
+R S + W P +L G + D+WS G V E+
Sbjct: 180 YRVQSKSLLPVRWMPPEAILYGK--FTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-14
Identities = 56/197 (28%), Positives = 99/197 (50%), Gaps = 10/197 (5%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRL-DHPNIIKLE 195
IG+G+Y+ V R T +I A+K V+ + + E + ++ E + + +HP ++ L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 196 GLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 255
+ ++ V EY+ K E + Y ++ L + H RG+++R
Sbjct: 63 SCFQTE--SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 256 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV--TLWYRPPELLLGATDYGPS 313
D+K N+L+++EG +KL D+G+ G R T+ T Y PE+L G DYG S
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMC---KEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFS 176
Query: 314 VDLWSVGCVFAELLIGK 330
VD W++G + E++ G+
Sbjct: 177 VDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 66/229 (28%), Positives = 102/229 (44%), Gaps = 32/229 (13%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN-FEPESVRFMAREILILRRLDHPN 190
F L +G+G++ V A T ++ A+K ++ D + + V E +L P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61
Query: 191 IIKLEGLITSRLSC-----SIYLVFEY------MEH-DITGLLSCPDIKFSEAQIKCYMN 238
+T SC +Y V EY M H G KF E Y
Sbjct: 62 ------FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-------KFKEPHAVFYAA 108
Query: 239 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV--TL 296
++ GL HS+G+++RD+K N++++ EG +K+ADFG+ + G T+R T
Sbjct: 109 EIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG---GKTTRTFCGTP 165
Query: 297 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 345
Y PE++ YG SVD W+ G + E+L G+P G E E I
Sbjct: 166 DYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.5 bits (190), Expect = 1e-14
Identities = 66/244 (27%), Positives = 107/244 (43%), Gaps = 31/244 (12%)
Query: 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD 187
R + +E ++KIG G + VF + T + K + + + + E+ ++R L
Sbjct: 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELK 70
Query: 188 HPNIIKLEGLITSRLSCSIYLVFEYMEH-DIT-GLLSCPDI--KFSEAQIKCYMNQLLHG 243
H NI++ ++ + +Y++ E+ + D++ + C + K E I QLLH
Sbjct: 71 HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHA 130
Query: 244 LEHCHS-------RGVLHRDIKGSNLL-----------------VNNEGVLKLADFGLAN 279
L +CH+ VLHRD+K N+ +N + K+ DFGL+
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190
Query: 280 FSNTGHRQPLTSRVVTLWYRPPELLLGAT-DYGPSVDLWSVGCVFAELLIGKPILQGRTE 338
N G S V T +Y PELLL T Y D+W++GC+ EL GK
Sbjct: 191 --NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN 248
Query: 339 VEQL 342
QL
Sbjct: 249 FSQL 252
|
Length = 1021 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 16/217 (7%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPE---SVRFMAREILILRRLDHPNIIKL 194
+G+G++ V AR ++G++ A+K ++ D + + IL L R +HP + +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQL 61
Query: 195 EGLI--TSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 252
RL + V E++ +F EA+ + Y ++ L H +G+
Sbjct: 62 YCCFQTPDRL----FFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGI 117
Query: 253 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV--TLWYRPPELLLGATDY 310
++RD+K N+L+++EG KLADFG+ G T+ T Y PE +L Y
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMC---KEGIFNGKTTSTFCGTPDYIAPE-ILQEMLY 173
Query: 311 GPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 347
GPSVD W++G + E+L G + E + I
Sbjct: 174 GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 32/224 (14%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRAR-----DLDTGKIVALKKVRFDNFEPESVRFMAREIL 181
++ D ++G+G + VF + ++VA+K ++ + ++ + RE
Sbjct: 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLK-ETASNDARKDFEREAE 60
Query: 182 ILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSC--PDIKFSEAQ----IK 234
+L H NI+K G+ T +VFEYMEH D+ L PD F ++ +
Sbjct: 61 LLTNFQHENIVKFYGVCTE--GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGE 118
Query: 235 CYMNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGH 285
++QLL G+ + S+ +HRD+ N LV + V+K+ DFG++ ++ +
Sbjct: 119 LTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY 178
Query: 286 RQPLTSRVVTLWYRPPELLLGATDYGP---SVDLWSVGCVFAEL 326
R ++ + + PPE ++ Y D+WS G V E+
Sbjct: 179 RVG-GHTMLPIRWMPPESIM----YRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 64/259 (24%), Positives = 113/259 (43%), Gaps = 51/259 (19%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
++ + ++K+G G + V+ K VA+K ++ PES E I+++L H
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTMSPES---FLEEAQIMKKLRHD 61
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH--------DITG-LLSCPDIKFSEAQIKCYMNQL 240
+++L +++ IY+V EYM D G L P++ AQ+
Sbjct: 62 KLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAA----- 113
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-------SNTGHRQPLTSRV 293
G+ + +HRD++ +N+LV + V K+ADFGLA + G + P+
Sbjct: 114 --GMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIK--- 168
Query: 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL----IGKPILQGRTEVEQLHKIFKL- 348
W P L G + D+WS G + EL+ + P + R +EQ+ + +++
Sbjct: 169 ---WTAPEAALYGR--FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMP 223
Query: 349 C--GSPPDDY------WKK 359
C P + WKK
Sbjct: 224 CPQDCPISLHELMLQCWKK 242
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 4e-14
Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 17/200 (8%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLE- 195
+G+GT+ V R+ TGK A+K ++ + + V E +L+ HP + L+
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62
Query: 196 GLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 254
T C V EY ++ LS + FSE + + Y +++ L + HS V++
Sbjct: 63 SFQTHDRLC---FVMEYANGGELFFHLSRERV-FSEDRARFYGAEIVSALGYLHSCDVVY 118
Query: 255 RDIKGSNLLVNNEGVLKLADFGLA----NFSNTGHRQPLTSRVVTLWYRPPELLLGATDY 310
RD+K NL+++ +G +K+ DFGL + T + + T Y PE +L DY
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGLCKEGISDGAT-----MKTFCGTPEYLAPE-VLEDNDY 172
Query: 311 GPSVDLWSVGCVFAELLIGK 330
G +VD W +G V E++ G+
Sbjct: 173 GRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 4/208 (1%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDHPN 190
F + +G+G + V + TGK+ A K++ + MA E IL +++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
++ L ++ + + L + + + F E + Y ++L GLE H
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDY 310
++RD+K N+L+++ G ++++D GLA G + + RV T+ Y PE +L Y
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--ESIRGRVGTVGYMAPE-VLNNQRY 178
Query: 311 GPSVDLWSVGCVFAELLIGKPILQGRTE 338
S D W +GC+ E++ G+ +GR E
Sbjct: 179 TLSPDYWGLGCLIYEMIEGQSPFRGRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 6e-14
Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 24/203 (11%)
Query: 138 IGQGTYSSVFRARDLDTGK---IVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
IG G + VFR G+ VA+K ++ E + F++ E I+ + H NII+L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLS-EASIMGQFSHHNIIRL 71
Query: 195 EGLITSRLSCSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 253
EG++T I + EYME+ + L D +FS Q+ + + G+++ +
Sbjct: 72 EGVVTKFKPAMI--ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYV 129
Query: 254 HRDIKGSNLLVNNEGVLKLADFGL---------ANFSNTGHRQPLTSRVVTLWYRPPELL 304
HRD+ N+LVN+ K++DFGL ++ +G + P+ W P
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIR------WTAPEA-- 181
Query: 305 LGATDYGPSVDLWSVGCVFAELL 327
+ + + D+WS G V E++
Sbjct: 182 IAYRKFTSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 7e-14
Identities = 64/245 (26%), Positives = 114/245 (46%), Gaps = 38/245 (15%)
Query: 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH 188
A+ + L +IG+G + +V + +G I+A+K++R E E R + +++R D
Sbjct: 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDC 62
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYME----------HDITGLLSCPDI--KFSEAQIKC- 235
P I+K G + C I + E M+ +++ + +I K + A +K
Sbjct: 63 PYIVKFYGALFREGDCWICM--ELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKAL 120
Query: 236 -YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 294
Y+ + L ++HRD+K SN+L++ G +KL DFG++ G ++
Sbjct: 121 NYLKEELK---------IIHRDVKPSNILLDRNGNIKLCDFGIS-----GQLVDSIAKTR 166
Query: 295 TLWYRP---PELLLGATDYGPSV--DLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKL 348
RP PE + + G V D+WS+G E+ GK P + + +QL ++ K
Sbjct: 167 DAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK- 225
Query: 349 CGSPP 353
G PP
Sbjct: 226 -GDPP 229
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 69/217 (31%), Positives = 96/217 (44%), Gaps = 33/217 (15%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
D FEKL ++G G V + +G I+A K + + +P + RE+ +L + P
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE-IKPAIRNQIIRELKVLHECNSP 59
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS--------CPDI---KFSEAQIK--CY 236
I+ G S SI MEH G L P+ K S A ++ Y
Sbjct: 60 YIVGFYGAFYSDGEISIC-----MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTY 114
Query: 237 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 296
L H ++HRD+K SN+LVN+ G +KL DFG+ S S V T
Sbjct: 115 -------LREKHK--IMHRDVKPSNILVNSRGEIKLCDFGV---SGQLIDSMANSFVGTR 162
Query: 297 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK-PI 332
Y PE L G T Y D+WS+G E+ IG+ PI
Sbjct: 163 SYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 62/243 (25%), Positives = 110/243 (45%), Gaps = 32/243 (13%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDHPN 190
F + +G+G + V + TGK+ A KK+ + MA E IL +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEK----- 56
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEHD----ITGLLSCPDIKF----------SEAQIKCY 236
+ SR S L + Y D + L++ D+KF E + Y
Sbjct: 57 -------VNSRFVVS--LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFY 107
Query: 237 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 296
++ GLE H +++RD+K N+L+++ G ++++D GLA G Q + RV T+
Sbjct: 108 AAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--QTIKGRVGTV 165
Query: 297 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 356
Y PE++ Y S D W++GC+ E++ G+ Q R + + ++ +L ++Y
Sbjct: 166 GYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEY 224
Query: 357 WKK 359
+K
Sbjct: 225 SEK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 24/213 (11%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL 186
LR + E + +G G SV + + + TG ++A KKV + + + RE+ I+
Sbjct: 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMA-KKVVHIGAKSSVRKQILRELQIMHEC 60
Query: 187 DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKC---YMNQLLHG 243
P I+ G + +I + E+M+ G L K ++ ++ G
Sbjct: 61 RSPYIVSFYGAFLNE--NNICMCMEFMD---CGSLDRIYKKGGPIPVEILGKIAVAVVEG 115
Query: 244 LEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLA-----NFSNTGHRQPLTSRVVTLW 297
L + ++ ++HRDIK SN+LVN+ G +KL DFG++ + ++T V T
Sbjct: 116 LTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT--------FVGTST 167
Query: 298 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 330
Y PE + G Y D+WS+G EL +GK
Sbjct: 168 YMSPERIQGG-KYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 67/216 (31%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL 186
L+ D FEK+ ++G G VF+ +G I+A K + + +P + RE+ +L
Sbjct: 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHEC 60
Query: 187 DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS--------CPDIKFSEAQIKCYMN 238
+ P I+ G S SI MEH G L P+ + I
Sbjct: 61 NSPYIVGFYGAFYSDGEISIC-----MEHMDGGSLDQVLKKAGRIPEQILGKVSIA---- 111
Query: 239 QLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 297
++ GL + + ++HRD+K SN+LVN+ G +KL DFG+ S S V T
Sbjct: 112 -VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV---SGQLIDSMANSFVGTRS 167
Query: 298 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGK-PI 332
Y PE L G T Y D+WS+G E+ IG+ PI
Sbjct: 168 YMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 58/218 (26%), Positives = 94/218 (43%), Gaps = 34/218 (15%)
Query: 138 IGQGTYSSVFRARDL-----DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192
IGQG + VF+AR + +VA+K ++ + F RE ++ DHPNI+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-REAALMAEFDHPNIV 71
Query: 193 KLEGL-ITSRLSCSIYLVFEYME--------------------HDITGLLSC--PDIKFS 229
KL G+ + C L+FEYM H + C + S
Sbjct: 72 KLLGVCAVGKPMC---LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 230 EAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQP 288
+ C Q+ G+ + R +HRD+ N LV V+K+ADFGL+ N + + +
Sbjct: 129 CTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188
Query: 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 326
+ + + + PPE + Y D+W+ G V E+
Sbjct: 189 SENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 51/217 (23%), Positives = 91/217 (41%), Gaps = 10/217 (4%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
F K+G G + V+ + + VA+K ++ D+ + +E+ L+RL H ++
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVR-VAIKILKSDDLL--KQQDFQKEVQALKRLRHKHL 64
Query: 192 IKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMN-QLLHGLEHCHS 249
I L + + +Y++ E ME + L P+ + M Q+ G+ +
Sbjct: 65 ISLFAVCSV--GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD 309
+ +HRD+ N+LV + V K+ADFGLA ++ W P G
Sbjct: 123 QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGT-- 180
Query: 310 YGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKI 345
+ D+WS G + E+ G+ G E +I
Sbjct: 181 FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 45/155 (29%), Positives = 74/155 (47%), Gaps = 24/155 (15%)
Query: 136 EKIGQGTYSSVFRA--RDLDTGKI-VALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192
IG+G + V++ + KI VA+K + +F+ E I+R+ DHP+I+
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQ-EAYIMRQFDHPHIV 70
Query: 193 KLEGLITSRLSCSIYLVFE---------YMEHDITGLLSCPDIKFSEAQIKCYMNQLLHG 243
KL G+IT +++V E Y++ + L I + Y QL
Sbjct: 71 KLIGVITEN---PVWIVMELAPLGELRSYLQVNKYSLDLASLILY------SY--QLSTA 119
Query: 244 LEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
L + S+ +HRDI N+LV++ +KL DFGL+
Sbjct: 120 LAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLS 154
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 16/217 (7%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
K+G G + V+ T K VA+K ++ PE+ +E I+++L H +++L
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEA---FLQEAQIMKKLRHDKLVQL 66
Query: 195 EGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMN-QLLHGLEHCHSRGV 252
+ + IY+V EYM + L + K M Q+ G+ + SR
Sbjct: 67 YAVCSEEEP--IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNY 124
Query: 253 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGP 312
+HRD+ N+LV V K+ADFGLA + + PE A +YG
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPE----AANYGR 180
Query: 313 ---SVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKI 345
D+WS G + E++ G+ G T E L ++
Sbjct: 181 FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV 217
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 2e-13
Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 11/159 (6%)
Query: 175 FMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEA--- 231
+ EIL L RL+H NI+K+E ++ R + Y++ + + D+ + + +
Sbjct: 209 QLENEILALGRLNHENILKIEEIL--RSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLL 266
Query: 232 -QIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPL 289
Q + M QLL +E+ H + ++HRDIK N+ +N +G + L DFG A F R+
Sbjct: 267 KQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEK--EREAF 324
Query: 290 T-SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 327
V T+ PE+L G Y D+WS G + ++L
Sbjct: 325 DYGWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 69/288 (23%), Positives = 114/288 (39%), Gaps = 43/288 (14%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
+ +G+G+Y V R GK +KK+ N + +E +L +L HPNI+
Sbjct: 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV-- 62
Query: 195 EGLITSRLS-----CSIYLVFEYMEH-DITGLLSCPDIKF-SEAQIKCYMNQLLHGLEHC 247
R S +Y+V + E D+ L K E Q+ + Q+ L++
Sbjct: 63 ----AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYL 118
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
H + +LHRD+K N+ + ++K+ D G+A ++ + T +Y PE L
Sbjct: 119 HEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN-QCDMASTLIGTPYYMSPE-LFSN 176
Query: 308 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367
Y D+W++GC E+ K + +++I + KL
Sbjct: 177 KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII------------EGKL----- 219
Query: 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415
P P KD LI T+LS P KR + + L Y
Sbjct: 220 --PPMP---------KDYSPELGELIATMLSKRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 18/216 (8%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDN-FEPESVR--FMAREILILRRLDHPNIIKL 194
+G+G++ V A T ++ A+K ++ D + + V + IL L HP
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHP----- 56
Query: 195 EGLITSRLSC-----SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
+T+ C ++ V EY+ KF E + + Y ++ L H
Sbjct: 57 --FLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHR 114
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD 309
GV++RD+K N+L++ EG KLADFG+ + T+ T Y PE +L +
Sbjct: 115 HGVIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIAPE-ILQELE 172
Query: 310 YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 345
YGPSVD W++G + E++ G+P + E + I
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 60/229 (26%), Positives = 107/229 (46%), Gaps = 41/229 (17%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ + ++K+G G + V+ K VA+K ++ + PE+ F+A E ++++L HP
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTK-VAIKSLKQGSMSPEA--FLA-EANLMKQLQHP 61
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLL-------H 242
+++L ++T IY++ EYME+ S D + IK +N+L+
Sbjct: 62 RLVRLYAVVTQE---PIYIITEYMENG-----SLVDFLKTPEGIKLTINKLIDMAAQIAE 113
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-------SNTGHRQPLTSRVVT 295
G+ + +HRD++ +N+LV+ K+ADFGLA + G + P+
Sbjct: 114 GMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIK----- 168
Query: 296 LWYRPPELLLGATDYGP---SVDLWSVGCVFAELLI-GKPILQGRTEVE 340
W P A +YG D+WS G + E++ G+ G T E
Sbjct: 169 -WTAPE-----AINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE 211
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 77/257 (29%), Positives = 116/257 (45%), Gaps = 32/257 (12%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL 186
L+ D FE++ ++G G V + + +G I+A K + + +P + RE+ +L
Sbjct: 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHEC 60
Query: 187 DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS--------CPDIKFSEAQIKCYMN 238
+ P I+ G S SI MEH G L P+ + I
Sbjct: 61 NSPYIVGFYGAFYSDGEISIC-----MEHMDGGSLDQVLKEAKRIPEEILGKVSIA---- 111
Query: 239 QLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 297
+L GL + + ++HRD+K SN+LVN+ G +KL DFG+ S S V T
Sbjct: 112 -VLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGV---SGQLIDSMANSFVGTRS 167
Query: 298 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSPPDDY 356
Y PE L G T Y D+WS+G EL IG+ PI + ++L IF G P D
Sbjct: 168 YMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPP--PDAKELEAIF---GRPVVD- 220
Query: 357 WKKSKLPHATLFKPQQP 373
+ PH+ +P+ P
Sbjct: 221 -GEEGEPHSISPRPRPP 236
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-13
Identities = 70/262 (26%), Positives = 110/262 (41%), Gaps = 52/262 (19%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRF-DNFEPESVRFMAREILILRRLDHPN 190
F K++ +G G + V A +DT + A+K +R D V + E IL D+
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
++KL + + +Y V +Y+ D+ LL ++ F E + Y+ +L +E H
Sbjct: 63 VVKLYYSFQDKDN--LYFVMDYIPGGDMMSLLIRMEV-FPEVLARFYIAELTLAIESVHK 119
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLA------------------------------N 279
G +HRDIK N+L++ +G +KL DFGL +
Sbjct: 120 MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179
Query: 280 FSN---------------TGHRQPLTSRVV-TLWYRPPELLLGATDYGPSVDLWSVGCVF 323
SN H++ L +V T Y PE+LL Y D WSVG +
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWWSVGVIL 238
Query: 324 AELLIGKPILQGRTEVEQLHKI 345
E+L+G+P T E K+
Sbjct: 239 FEMLVGQPPFLAPTPTETQLKV 260
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-13
Identities = 62/222 (27%), Positives = 99/222 (44%), Gaps = 8/222 (3%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKV-RFDNFEPESVRFMAREILILRRLDH 188
D FE ++ IG+G + V + T +I A+K + +++ + E +L D
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 189 PNIIKLEGLITSRLSCSIYLVFEY-MEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
I L +YLV +Y + D+ LLS + + E + Y+ +++ +
Sbjct: 61 QWITTLHYAFQD--ENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
H +HRDIK N+L++ G ++LADFG N + V T Y PE+L
Sbjct: 119 HQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAM 178
Query: 308 TD----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 345
D YGP D WS+G E+L G+ + VE KI
Sbjct: 179 EDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-13
Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 6/211 (2%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNF--EPESVRFMAREILILRRLDHPNIIKLE 195
IG+G++ V AR K A+K ++ + E M+ ++L+ + HP ++ L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 196 GLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 255
+ + + +Y V +Y+ + F E + + Y ++ L + HS +++R
Sbjct: 63 --FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 256 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVD 315
D+K N+L++++G + L DFGL N H ++ T Y PE +L Y +VD
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPE-VLHKQPYDRTVD 178
Query: 316 LWSVGCVFAELLIGKPILQGRTEVEQLHKIF 346
W +G V E+L G P R E I
Sbjct: 179 WWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 6e-13
Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 12/213 (5%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALK-----KVRFDNFEPESVRFMAREILILRRLDHPNII 192
IG+G++ V A+ GK A+K + E MA ++L+ + HP ++
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKK---EQKHIMAERNVLLKNVKHPFLV 59
Query: 193 KLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 252
L + + + +Y V +Y+ + F E + + Y ++ L + HS +
Sbjct: 60 GLH--YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNI 117
Query: 253 LHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGP 312
++RD+K N+L++++G + L DFGL H + ++ T Y PE+L Y
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVLR-KQPYDR 175
Query: 313 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 345
+VD W +G V E+L G P R E I
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 6e-13
Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRL-DHPNIIKLE 195
IG+G+Y+ V T +I A+K ++ + + E + ++ E + +HP ++ L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 196 GLI--TSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 253
SRL + V E++ K E + Y ++ L H RG++
Sbjct: 63 SCFQTESRL----FFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGII 118
Query: 254 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV--TLWYRPPELLLGATDYG 311
+RD+K N+L++ EG +KL D+G+ G R T+ T Y PE+L G DYG
Sbjct: 119 YRDLKLDNVLLDAEGHIKLTDYGMC---KEGIRPGDTTSTFCGTPNYIAPEILRG-EDYG 174
Query: 312 PSVDLWSVGCVFAELLIGK 330
SVD W++G + E++ G+
Sbjct: 175 FSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 7e-13
Identities = 52/187 (27%), Positives = 87/187 (46%), Gaps = 39/187 (20%)
Query: 158 VALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDI 217
VA+K + E F+ E ++ +L HP +++L G+ T + +Y+V E+ME+
Sbjct: 31 VAIKAINEGAMSEED--FI-EEAKVMMKLSHPKLVQLYGVCTQQKP--LYIVTEFMENGC 85
Query: 218 --------TGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV 269
G LS D+ S Q C G+E+ +HRD+ N LV++ GV
Sbjct: 86 LLNYLRQRQGKLS-KDMLLSMCQDVC------EGMEYLERNSFIHRDLAARNCLVSSTGV 138
Query: 270 LKLADFGLANF-------SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGC- 321
+K++DFG+ + S++G + P+ + PPE+ + Y D+WS G
Sbjct: 139 VKVSDFGMTRYVLDDEYTSSSGAKFPVK-------WSPPEVFN-FSKYSSKSDVWSFGVL 190
Query: 322 ---VFAE 325
VF E
Sbjct: 191 MWEVFTE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 7e-13
Identities = 52/194 (26%), Positives = 96/194 (49%), Gaps = 5/194 (2%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEG 196
+G+GT+ V R+ +GK A+K ++ + + V E +L+ HP + L+
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK- 61
Query: 197 LITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 256
+ + + V EY+ + FSE + + Y +++ L++ HS +++RD
Sbjct: 62 -YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 257 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 316
+K NL+++ +G +K+ DFGL T + + T Y PE +L DYG +VD
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGIT-DAATMKTFCGTPEYLAPE-VLEDNDYGRAVDW 178
Query: 317 WSVGCVFAELLIGK 330
W +G V E++ G+
Sbjct: 179 WGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 7e-13
Identities = 59/228 (25%), Positives = 98/228 (42%), Gaps = 38/228 (16%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
L K+G G + V+ +T VA+K ++ +P+ F+ E I+++L HP +I+L
Sbjct: 11 LRKLGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMDPKD--FL-AEAQIMKKLRHPKLIQL 66
Query: 195 EGLITSRLSCSIYLV---------FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
+ T L IY+V EY++ L P + AQ+ M L
Sbjct: 67 YAVCT--LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL----- 119
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-------SNTGHRQPLTSRVVTLWY 298
++ +HRD+ N+LV + K+ADFGLA + G + P+ W
Sbjct: 120 --EAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIK------WT 171
Query: 299 RPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKI 345
P L + D+WS G + E++ G+ G T E L ++
Sbjct: 172 APEAALYNR--FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV 217
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 7e-13
Identities = 63/222 (28%), Positives = 102/222 (45%), Gaps = 8/222 (3%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKV-RFDNFEPESVRFMAREILILRRLDH 188
D FE L+ IG+G + V + +TG++ A+K + +++ + E +L D
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 189 PNIIKLEGLITSRLSCSIYLVFEY-MEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
I L + +YLV +Y + D+ LLS + + E + Y+ +++ ++
Sbjct: 61 RWITNLHYAFQDENN--LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSV 118
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
H G +HRDIK N+L++ G ++LADFG V T Y PE+L
Sbjct: 119 HQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAM 178
Query: 308 TD----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 345
D YGP D WS+G E+L G+ + VE KI
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 7e-13
Identities = 51/196 (26%), Positives = 94/196 (47%), Gaps = 14/196 (7%)
Query: 133 EKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192
+ IG+G + V G+ VA+K ++ D+ ++ F+A E ++ L HPN++
Sbjct: 9 KLGATIGKGEFGDVMLG--DYRGQKVAVKCLKDDSTAAQA--FLA-EASVMTTLRHPNLV 63
Query: 193 KLEGLITSRLSCSIYLVFEYMEHD--ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
+L G++ +Y+V EYM + L S + AQ + + G+E+ +
Sbjct: 64 QLLGVVLQ--GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK 121
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDY 310
+HRD+ N+LV+ + V K++DFGLA ++ G + ++ W P L +
Sbjct: 122 NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD---SGKLPVKWTAPEALREK--KF 176
Query: 311 GPSVDLWSVGCVFAEL 326
D+WS G + E+
Sbjct: 177 STKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 7e-13
Identities = 57/186 (30%), Positives = 92/186 (49%), Gaps = 19/186 (10%)
Query: 157 IVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH- 215
+VA+K +R D + F+ +EI I+ RL +PNII+L G+ S + ++ EYME+
Sbjct: 46 LVAVKMLRADVTKTARNDFL-KEIKIMSRLKNPNIIRLLGVCVS--DDPLCMITEYMENG 102
Query: 216 DITGLLSCPDI--KFSEAQ-IKC-------YMN-QLLHGLEHCHSRGVLHRDIKGSNLLV 264
D+ LS +I F+ A I YM Q+ G+++ S +HRD+ N LV
Sbjct: 103 DLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162
Query: 265 NNEGVLKLADFGLANFSNTGHRQPLTSRVV--TLWYRPPELLLGATDYGPSVDLWSVGCV 322
N +K+ADFG++ +G + R V W +LLG + + D+W+ G
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG--KFTTASDVWAFGVT 220
Query: 323 FAELLI 328
E+
Sbjct: 221 LWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 8e-13
Identities = 54/204 (26%), Positives = 98/204 (48%), Gaps = 24/204 (11%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAR-EILILRRLDHPNIIKLEG 196
+G+G + V + +TGK+ A KK+ + +S MA E IL +++ P I+ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 197 LITSRLSCSIYLVFEYMEHDITGLLSCPDIKF----------SEAQIKCYMNQLLHGLEH 246
S+ + + L++ D+K+ ++ Y Q+ G+ H
Sbjct: 61 AFESKTHLCL----------VMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILH 110
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG 306
HS +++RD+K N+L++++G +L+D GLA G + +T R T Y PE+L
Sbjct: 111 LHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTITQRAGTNGYMAPEILKE 168
Query: 307 ATDYGPSVDLWSVGCVFAELLIGK 330
Y VD +++GC E++ G+
Sbjct: 169 EP-YSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-12
Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 10/222 (4%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKV-RFDNFEPESVRFMAREILILRRLDHPN 190
FE L+ IG+G + V + + K+ A+K + +++ + E +L D+
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 191 IIKLEGLITSRLSCSIYLVFEY-MEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
I L ++YLV +Y + D+ LLS + + E + Y+ +++ ++ H
Sbjct: 63 ITTLHYAFQD--ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFG-LANFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
+HRDIK N+L++ G ++LADFG G Q + V T Y PE+L
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA-VGTPDYISPEILQAME 179
Query: 309 D----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 346
D YGP D WS+G E+L G+ + VE KI
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 38/110 (34%), Positives = 63/110 (57%), Gaps = 2/110 (1%)
Query: 236 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 295
Y +++ GL+ HS+G+++RD+K N++++ +G +K+ADFG+ + G + ++ T
Sbjct: 101 YAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA-STFCGT 159
Query: 296 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 345
Y PE+L G Y SVD WS G + E+LIG+ G E E I
Sbjct: 160 PDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 56/215 (26%), Positives = 100/215 (46%), Gaps = 14/215 (6%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALK----KVRFDNFEPESVRFMAREILILRRLDHPNIIK 193
IG+G++ V A+ GK A+K K+ + E + + MA ++L+ + HP ++
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHI--MAERNVLLKNVKHPFLVG 60
Query: 194 LEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 253
L + + + +Y V +++ + F E + + Y ++ L + HS ++
Sbjct: 61 LH--YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIV 118
Query: 254 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 313
+RD+K N+L++++G + L DFGL T+ T Y PE++ Y +
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIR-KQPYDNT 176
Query: 314 VDLWSVGCVFAELLIGKPILQGRTEVEQ----LHK 344
VD W +G V E+L G P R E LHK
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK 211
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 55/197 (27%), Positives = 97/197 (49%), Gaps = 10/197 (5%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFD-NFEPESVRFMAREILILRRLD-HPNIIKLE 195
IG+G+Y+ V R +I A+K V+ + + E + ++ E + + +P ++ L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 196 GLI--TSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 253
TSRL +LV EY+ K E + Y ++ L H RG++
Sbjct: 63 SCFQTTSRL----FLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGII 118
Query: 254 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 313
+RD+K N+L++ +G +KL D+G+ G ++ T Y PE+L G +YG S
Sbjct: 119 YRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEILRG-EEYGFS 176
Query: 314 VDLWSVGCVFAELLIGK 330
VD W++G + E++ G+
Sbjct: 177 VDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 7e-12
Identities = 58/221 (26%), Positives = 103/221 (46%), Gaps = 12/221 (5%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNF--EPESVRFMAREILILRRLDHPNIIKLE 195
IG+G++ V A+ G A+K ++ + E MA ++L+ L HP ++ L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 196 GLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 255
+ + + +Y V +Y+ + F E + + Y ++ + + HS +++R
Sbjct: 63 --YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 256 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVD 315
D+K N+L++++G + L DFGL + ++ T Y PE +L Y +VD
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFCGTPEYLAPE-VLRKEPYDRTVD 178
Query: 316 LWSVGCVFAELLIGKPILQGRTEVEQ-----LHKIFKLCGS 351
W +G V E+L G P R +V Q LHK +L G
Sbjct: 179 WWCLGAVLYEMLYGLPPFYSR-DVSQMYDNILHKPLQLPGG 218
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 7e-12
Identities = 57/233 (24%), Positives = 105/233 (45%), Gaps = 33/233 (14%)
Query: 137 KIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEG 196
K+GQG + V+ T + VA+K ++ PE+ +E ++++L H +++L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYA 68
Query: 197 LITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSE----AQIKCYMNQLLHGLEHCHSRGV 252
+++ IY+V EYM LL + + Q+ Q+ G+ +
Sbjct: 69 VVSEE---PIYIVTEYM--SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 123
Query: 253 LHRDIKGSNLLVNNEGVLKLADFGLANF-------SNTGHRQPLTSRVVTLWYRPPELLL 305
+HRD++ +N+LV V K+ADFGLA + G + P+ W P L
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK------WTAPEAALY 177
Query: 306 GATDYGPSVDLWSVGCVFAELL----IGKPILQGRTEVEQLHKIFKLCGSPPD 354
G + D+WS G + EL + P + R ++Q+ + +++ PP+
Sbjct: 178 GR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-PCPPE 227
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 45/167 (26%), Positives = 82/167 (49%), Gaps = 31/167 (18%)
Query: 179 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMN 238
E ++ +L H +++L G+ T + IY+V EYM + C E + +
Sbjct: 49 EAKVMMKLSHEKLVQLYGVCTKQRP--IYIVTEYMSN------GCLLNYLREHGKRFQPS 100
Query: 239 QLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-------SNTG 284
QLL G+ + S+ +HRD+ N LV+++G +K++DFGL+ + S+ G
Sbjct: 101 QLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG 160
Query: 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGK 330
+ P+ + PPE+LL + + D+W+ G + E+ +GK
Sbjct: 161 SKFPVR-------WSPPEVLL-YSKFSSKSDVWAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 58/225 (25%), Positives = 106/225 (47%), Gaps = 28/225 (12%)
Query: 137 KIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEG 196
K+GQG + V+ T K VA+K ++ PE+ +E I+++L H ++ L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEA---FLQEAQIMKKLRHDKLVPLYA 68
Query: 197 LITSRLSCSIYLVFEYM-EHDITGLLSCPDIKFSE-AQIKCYMNQLLHGLEHCHSRGVLH 254
+++ IY+V E+M + + L D K+ + Q+ Q+ G+ + +H
Sbjct: 69 VVSEE---PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIH 125
Query: 255 RDIKGSNLLVNNEGVLKLADFGLANF-------SNTGHRQPLTSRVVTLWYRPPELLLGA 307
RD++ +N+LV + V K+ADFGLA + G + P+ W P L G
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIK------WTAPEAALYGR 179
Query: 308 TDYGPSVDLWSVGCVFAELL----IGKPILQGRTEVEQLHKIFKL 348
+ D+WS G + EL+ + P + R +EQ+ + +++
Sbjct: 180 --FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM 222
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 14/222 (6%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN-FEPESVRFMAREILILRRLDHPN 190
F L +G+G++ V A T ++ A+K ++ D + + V E +L P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 191 IIKLEGLITSRLSC-----SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
+T SC +Y V EY+ +F E Y ++ GL
Sbjct: 62 ------FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLF 115
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
HS+G+++RD+K N+++++EG +K+ADFG+ N + T Y PE ++
Sbjct: 116 FLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENMWDGVTTKTFCGTPDYIAPE-II 173
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 347
YG SVD W+ G + E+L G+ +G E E I +
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 50/210 (23%), Positives = 92/210 (43%), Gaps = 18/210 (8%)
Query: 134 KLEKI-GQGTYSSVFRAR---DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
KL KI G+G + SV + D + VA+K ++ D + E ++ DHP
Sbjct: 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHP 61
Query: 190 NIIKLEGL-ITSRLSCSI---YLVFEYMEH-DITGLLSCPDI-----KFSEAQIKCYMNQ 239
N++KL G+ + I ++ +M+H D+ L + K + +M
Sbjct: 62 NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVD 121
Query: 240 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHRQPLTSRVVTLW 297
+ G+E+ +R +HRD+ N ++ + + +ADFGL+ +S +RQ +++ W
Sbjct: 122 IALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 181
Query: 298 YRPPELLLGATDYGPSVDLWSVGCVFAELL 327
L Y D+W+ G E+
Sbjct: 182 IAIES--LADRVYTSKSDVWAFGVTMWEIA 209
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 58/224 (25%), Positives = 103/224 (45%), Gaps = 33/224 (14%)
Query: 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKI--VALKKVRFDNFEPESV-RFMAREIL---- 181
+D+ ++ ++ + Y R L TG V L + ++F P ++ RF +I+
Sbjct: 15 SDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQ 74
Query: 182 ---------ILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQ 232
IL ++HP + L G + + +YLV E++ + +F
Sbjct: 75 VDHVFSERKILNYINHPFCVNLYG--SFKDESYLYLVLEFVIGGEFFTFLRRNKRFPN-D 131
Query: 233 IKC-YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 291
+ C Y Q++ E+ S +++RD+K NLL++ +G +K+ DFG A +T
Sbjct: 132 VGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-------- 183
Query: 292 RVVTLWYRP----PELLLGATDYGPSVDLWSVGCVFAELLIGKP 331
R TL P PE+LL +G + D W++G E+L+G P
Sbjct: 184 RTYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCP 226
|
Length = 340 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 55/198 (27%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLE- 195
+G+GT+ V ++ TG+ A+K ++ + + V E +L+ HP + L+
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 196 GLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVLH 254
T C V EY + FSE + + Y +++ L++ HS + V++
Sbjct: 63 SFQTHDRLC---FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 119
Query: 255 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV--TLWYRPPELLLGATDYGP 312
RD+K NL+++ +G +K+ DFGL G + T + T Y PE +L DYG
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLC---KEGIKDGATMKTFCGTPEYLAPE-VLEDNDYGR 175
Query: 313 SVDLWSVGCVFAELLIGK 330
+VD W +G V E++ G+
Sbjct: 176 AVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 36/222 (16%)
Query: 136 EKIGQGTYSSV----------FRARDLDTGKI------VALKKVRFDNFEPESVRFMARE 179
EK+G+G + V F +D VA+K +R D + F+ +E
Sbjct: 11 EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFL-KE 69
Query: 180 ILILRRLDHPNIIKLEGL-ITSRLSCSIYLVFEYME----------HDITGLLSCPDIKF 228
I I+ RL PNII+L + ITS C ++ EYME H+ D+
Sbjct: 70 IKIMSRLKDPNIIRLLAVCITSDPLC---MITEYMENGDLNQFLSRHEPQEAAEKADVVT 126
Query: 229 SEAQIKCYM-NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287
+M Q+ G+++ S +HRD+ N LV +K+ADFG++ +G
Sbjct: 127 ISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYY 186
Query: 288 PLTSRVV--TLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 327
+ R V W +LLG + + D+W+ G E+L
Sbjct: 187 RIQGRAVLPIRWMSWESILLG--KFTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 7e-11
Identities = 52/205 (25%), Positives = 95/205 (46%), Gaps = 17/205 (8%)
Query: 138 IGQGTYSSVFRAR---DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
+G+G + SV A+ + + + VA+K ++ D F + RE ++ DHPN+IKL
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 195 EGL-ITSRLSCSI---YLVFEYMEH-DITGLLSCPDI-----KFSEAQIKCYMNQLLHGL 244
G+ + SR + ++ +M+H D+ L I + +M + G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHRQPLTSRVVTLWYRPPE 302
E+ S+ +HRD+ N ++N + +ADFGL+ +S +RQ S++ W
Sbjct: 127 EYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALES 186
Query: 303 LLLGATDYGPSVDLWSVGCVFAELL 327
L Y D+W+ G E++
Sbjct: 187 --LADNVYTTHSDVWAFGVTMWEIM 209
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 41/150 (27%), Positives = 75/150 (50%), Gaps = 15/150 (10%)
Query: 136 EKIGQGTYSSVFRAR-DLDTGKI--VALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192
+K+G G++ V R GK+ VA+K ++ D F+ +E I+ LDH N+I
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFL-KEAAIMHSLDHENLI 59
Query: 193 KLEGLITSRLSCSIYLVFEYMEHDITGLLSC-----PDIKFSEAQIKCYMNQLLHGLEHC 247
+L G++ L+ + +V E + LL F + + Y Q+ +G+ +
Sbjct: 60 RLYGVV---LTHPLMMVTELAP--LGSLLDRLRKDALGH-FLISTLCDYAVQIANGMRYL 113
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGL 277
S+ +HRD+ N+L+ ++ +K+ DFGL
Sbjct: 114 ESKRFIHRDLAARNILLASDDKVKIGDFGL 143
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 56/213 (26%), Positives = 85/213 (39%), Gaps = 45/213 (21%)
Query: 158 VALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-D 216
VA+K +R D + F+ +E+ IL RL PNI +L G+ T + + EYME+ D
Sbjct: 49 VAVKVLRPDASDNAREDFL-KEVKILSRLSDPNIARLLGVCTVDPPLCM--IMEYMENGD 105
Query: 217 ITGLLS---------CPDIKFSEAQIKCYM-NQLLHGLEHCHSRGVLHRDIKGSNLLVNN 266
+ L + K YM Q+ G+ + S +HRD+ N LV
Sbjct: 106 LNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGK 165
Query: 267 EGVLKLADFGL------ANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVG 320
+K+ADFG+ +++ R PL R W +LLG + D+W+ G
Sbjct: 166 NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIR----WMAWESVLLGK--FTTKSDVWAFG 219
Query: 321 CVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 353
L +I LC P
Sbjct: 220 VT-------------------LWEILTLCREQP 233
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 50/192 (26%), Positives = 84/192 (43%), Gaps = 30/192 (15%)
Query: 226 IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTG 284
+ F E ++ Q++ L+ HSR ++HRD+K +N+ + G++KL DFG + +S++
Sbjct: 164 LPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223
Query: 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHK 344
+S T +Y PE L Y D+WS+G + ELL LH+
Sbjct: 224 SLDVASSFCGTPYYLAPE-LWERKRYSKKADMWSLGVILYELL-------------TLHR 269
Query: 345 IFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 404
FK P + ++ L+ P+ + K L++ LLS P R
Sbjct: 270 PFK---GP-----SQREIMQQVLYGKYDPFPCPVSSGMK-------ALLDPLLSKNPALR 314
Query: 405 ATASAALASEYF 416
T L +E+
Sbjct: 315 PTTQQLLHTEFL 326
|
Length = 478 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 49/204 (24%), Positives = 85/204 (41%), Gaps = 38/204 (18%)
Query: 136 EKIGQGTYSSV----FRARDLDTGKI--VALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+++G G + SV + + GK VA+K ++ + RE ++ +LDHP
Sbjct: 1 KELGHGNFGSVVKGVYLMKS---GKEVEVAVKTLK-QEHIAAGKKEFLREASVMAQLDHP 56
Query: 190 NIIKLEGLITSRLSCSIYLVFEYME----HDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
I++L G+ + LV E L +I + +K +Q+ G+
Sbjct: 57 CIVRLIGVC---KGEPLMLVMELAPLGPLLKY--LKKRREIP--VSDLKELAHQVAMGMA 109
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA---NFSN------TGHRQPLTSRVVTL 296
+ S+ +HRD+ N+L+ N K++DFG++ + T R PL
Sbjct: 110 YLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLK------ 163
Query: 297 WYRPPELLLGATDYGPSVDLWSVG 320
WY P + G D+WS G
Sbjct: 164 WYAPECINYGKFSS--KSDVWSYG 185
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 36/111 (32%), Positives = 61/111 (54%), Gaps = 2/111 (1%)
Query: 228 FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287
F E + Y Q++ GLEH H R +++RD+K N+L++N+G ++++D GLA G +
Sbjct: 94 FPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK 153
Query: 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE 338
T + PELL G +Y SVD +++G E++ + + R E
Sbjct: 154 T-KGYAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGE 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 50/208 (24%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 131 AFEKLEKIGQGTYSSVFRAR---DLDTGKI-VALKKVRFDNFEPESVRFMAREILILRRL 186
EK++ +G G + +V++ + + KI VA+K +R + P++ + + E ++ +
Sbjct: 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR-EETSPKANKEILDEAYVMASV 66
Query: 187 DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCY--MN---QLL 241
DHP++++L G+ LS + L+ + M LL ++ + I +N Q+
Sbjct: 67 DHPHVVRLLGIC---LSSQVQLITQLMPLG--CLLDY--VRNHKDNIGSQYLLNWCVQIA 119
Query: 242 HGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS--RVVTLWYR 299
G+ + + ++HRD+ N+LV +K+ DFGLA + ++ +V W
Sbjct: 120 KGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMA 179
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELL 327
+L Y D+WS G EL+
Sbjct: 180 LESILHR--IYTHKSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 63/239 (26%), Positives = 109/239 (45%), Gaps = 37/239 (15%)
Query: 138 IGQGTYSSVFRARDLDTGK-------IVALKKVRFDNFEPESVRFMAREILILRRL-DHP 189
+G+G + V A L K VA+K ++ D+ + + + E+ +++ + H
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHK 81
Query: 190 NIIKLEGLITSRLSCSIYLVFEY-----------------MEH--DITGLLSCPDIKFSE 230
NII L G T +Y++ EY ME+ DI + PD + +
Sbjct: 82 NIINLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARV---PDEQMTF 136
Query: 231 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPL 289
+ Q+ G+E+ S+ +HRD+ N+LV V+K+ADFGLA + +N + +
Sbjct: 137 KDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196
Query: 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFK 347
T+ + + + PE L Y D+WS G + E+ +G G VE+L K+ K
Sbjct: 197 TNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG-IPVEELFKLLK 253
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 62/232 (26%), Positives = 100/232 (43%), Gaps = 32/232 (13%)
Query: 138 IGQGTYSSVFRARDLD-----TGKI-VALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+G G + V+ D +G I VA+K +R + E F+ E ++ +HPNI
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLK-EAHLMSNFNHPNI 61
Query: 192 IKLEGLITSRLSCSIYLVFEYMEH-DITGLL--------SCPDIKFSE-AQIKCYMNQLL 241
+KL G+ L+ Y++ E ME D+ L P + E I + +
Sbjct: 62 VKLLGVCL--LNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 242 HGLEHCHSRGVLHRDIKGSNLLVNNEG-----VLKLADFGLAN--FSNTGHRQPLTSRVV 294
LE H +HRD+ N LV+ +G V+K+ DFGLA + + +R+ +
Sbjct: 120 VYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 295 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKI 345
W P LL G + D+WS G + E+L +G+ E L +
Sbjct: 177 VRWMAPESLLDGK--FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV 226
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 52/177 (29%), Positives = 75/177 (42%), Gaps = 14/177 (7%)
Query: 178 REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIK--FSEAQIKC 235
REI IL+ + H II L + R ++ +V + D L + D Q
Sbjct: 135 REIDILKTISHRAIINL--IHAYRWKSTVCMVMPKYKCD---LFTYVDRSGPLPLEQAIT 189
Query: 236 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT-SRVV 294
+LL L + H RG++HRD+K N+ ++ L DFG A + P
Sbjct: 190 IQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSG 249
Query: 295 TLWYRPPELLLGATD-YGPSVDLWSVGCVFAELLIGKPIL---QGRTEVEQLHKIFK 347
TL PELL A D Y D+WS G V E+ + L Q ++ QL I +
Sbjct: 250 TLETNSPELL--ALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR 304
|
Length = 392 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 43/172 (25%), Positives = 82/172 (47%), Gaps = 7/172 (4%)
Query: 158 VALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD- 216
VA+ +R + + F+A E L L + DH NI++LEG+IT ++ +V EYM +
Sbjct: 36 VAIHTLRAGCSDKQRRGFLA-EALTLGQFDHSNIVRLEGVITR--GNTMMIVTEYMSNGA 92
Query: 217 ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFG 276
+ L + + Q+ + L G+++ G +H+ + +LVN++ V K++ F
Sbjct: 93 LDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR 152
Query: 277 -LANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 327
L + ++ + LW P + + + D+WS G V E++
Sbjct: 153 RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH--HFSSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 5e-10
Identities = 80/337 (23%), Positives = 130/337 (38%), Gaps = 55/337 (16%)
Query: 133 EKLEKIGQG--TYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPN 190
E L IG+G +V AR TG+ V ++++ + E V F+ E+ + + +HPN
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPN 60
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIK--FSEAQIKCYMNQLLHGLEHCH 248
I+ + +++V +M + L C SE I + +L L++ H
Sbjct: 61 IVPYRATFIA--DNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH 118
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQ--------PLTSRVVTLWYR 299
G +HR +K S++L++ +G + L+ GL +N S H Q P S V W
Sbjct: 119 HMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLS 176
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGK------PILQGRTEVEQLHKIFKLCGS-- 351
P L Y D++SVG EL G P Q E KL G+
Sbjct: 177 PEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE--------KLNGTVP 228
Query: 352 --------PPDDYWKK----------SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 393
P ++ K + + +P +SS + + +
Sbjct: 229 CLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNG-ESSSHPYNRTFSPHFHHFV 287
Query: 394 ETLLSVEPYKRATASAALASEYF-STKPYACDLSSLP 429
E L P R +AS L +F K A + +LP
Sbjct: 288 EQCLQRNPDARPSASTLLNHSFFKQIKRRASE--ALP 322
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 47/159 (29%), Positives = 81/159 (50%), Gaps = 25/159 (15%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR----FDNFEPESVRFMAREILILRRLD 187
F ++ I +G + V+ R + K+ A+K V+ + V+ R+ L L +
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQ-AERDALALSK-- 62
Query: 188 HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIK--------FSEAQIKCYMNQ 239
P I+ L + S + ++YLV EY+ I G D+K F E Y+++
Sbjct: 63 SPFIVHLYYSLQS--ANNVYLVMEYL---IGG-----DVKSLLHIYGYFDEEMAVKYISE 112
Query: 240 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
+ L++ H G++HRD+K N+L++NEG +KL DFGL+
Sbjct: 113 VALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 53/227 (23%), Positives = 108/227 (47%), Gaps = 32/227 (14%)
Query: 125 VPLRADAFEKLEKIGQGTYSSVFRAR----DLDTGKIVALKKVRFDNFEPESVRFMAREI 180
+PL A F +E++G+ + +++ +D ++VA+K ++ D P+ +E
Sbjct: 2 LPLSAVRF--MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLK-DINNPQQWGEFQQEA 58
Query: 181 LILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME----HDITGLLSCP--DIKFS---EA 231
++ L HPNI+ L G++T + ++FEY+ H+ ++ P D+ S +
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQ--PVCMLFEYLNQGDLHEFL-IMRSPHSDVGCSSDEDG 115
Query: 232 QIKCYMN---------QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--F 280
+K ++ Q+ G+E+ S +H+D+ N+L+ + +K++D GL+ +
Sbjct: 116 TVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIY 175
Query: 281 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 327
S +R S + W P ++ G + D+WS G V E+
Sbjct: 176 SADYYRVQPKSLLPIRWMPPEAIMYG--KFSSDSDIWSFGVVLWEIF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 50/209 (23%), Positives = 95/209 (45%), Gaps = 22/209 (10%)
Query: 137 KIGQGTYSSVFRARDL----DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192
++G+G + VF A + KI+ K D + F RE +L L H +I+
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFH-REAELLTNLQHEHIV 70
Query: 193 KLEGLITSRLSCSIYLVFEYMEH-DITGLLSC------------PDIKFSEAQIKCYMNQ 239
K G+ + +VFEYM+H D+ L + +++Q+ Q
Sbjct: 71 KFYGVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 240 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWY 298
+ G+ + S+ +HRD+ N LV ++K+ DFG++ + +T + + ++ + +
Sbjct: 129 IAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188
Query: 299 RPPELLLGATDYGPSVDLWSVGCVFAELL 327
PPE ++ + D+WS+G V E+
Sbjct: 189 MPPESIM-YRKFTTESDVWSLGVVLWEIF 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 58/223 (26%), Positives = 104/223 (46%), Gaps = 33/223 (14%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRA---RDLDTGKIVALKKVRFDNFEPES-VRFMAREILI 182
L+ ++++ +G G + +V++ + +T KI K+ + P++ V FM E LI
Sbjct: 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFM-DEALI 62
Query: 183 LRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMN---Q 239
+ +DHP++++L G+ LS +I LV + M H LL + +N Q
Sbjct: 63 MASMDHPHLVRLLGVC---LSPTIQLVTQLMPHGC--LLDYVHEHKDNIGSQLLLNWCVQ 117
Query: 240 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA--------NFSNTGHRQPLTS 291
+ G+ + R ++HRD+ N+LV + +K+ DFGLA ++ G + P+
Sbjct: 118 IAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKW 177
Query: 292 RVVT-LWYRPPELLLGATDYGPSVDLWSVGCVFAELLI--GKP 331
+ + YR + D+WS G EL+ GKP
Sbjct: 178 MALECIHYR---------KFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 64/244 (26%), Positives = 100/244 (40%), Gaps = 52/244 (21%)
Query: 135 LEKIGQGTYSSVFRA--RDLDTGK---IVALKKVRFDNFEPESVRFMAREILILRRL-DH 188
+ +G+G + V +A LD VA+K ++ D E + ++ E+ +++ + H
Sbjct: 17 GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVS-EMEMMKMIGKH 75
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHD-----------ITGLLSCPDIKFSEAQIKCY- 236
NII L G+ T +Y+V EY H S D + E +
Sbjct: 76 KNIINLLGVCTQ--EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133
Query: 237 ----MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHRQPLT 290
Q+ G+E S+ +HRD+ N+LV + V+K+ADFGLA +R+
Sbjct: 134 LVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN 193
Query: 291 SRVVTLWYRPPELLLGATD--YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 348
R+ W P L D Y D+WS G +L L +IF L
Sbjct: 194 GRLPVKWMAPEALF----DRVYTHQSDVWSFG-----------VL--------LWEIFTL 230
Query: 349 CGSP 352
GSP
Sbjct: 231 GGSP 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 72/288 (25%), Positives = 117/288 (40%), Gaps = 61/288 (21%)
Query: 138 IGQGTYSSVFRARDL-------DTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HP 189
+G+G + V RA D VA+K ++ DN + + + E+ +++ + H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLK-DNATDKDLADLISEMELMKLIGKHK 78
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH-------------------DIT----GLLSCPDI 226
NII L G+ T +Y++ EY DIT LS D+
Sbjct: 79 NIINLLGVCTQ--EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 227 KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN--TG 284
+ C Q+ G+E+ SR +HRD+ N+LV + V+K+ADFGLA +
Sbjct: 137 ------VSC-AYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDY 189
Query: 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-------GKPILQGRT 337
+++ R+ W P L Y D+WS G + E+ G P+ +
Sbjct: 190 YKKTSNGRLPVKWMAPEALF--DRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247
Query: 338 EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDL 385
+ + H++ K + Y + HA P Q R TFK L
Sbjct: 248 LLREGHRMDKPSNCTHELYMLMRECWHAV---PTQ------RPTFKQL 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 8/210 (3%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDHPN 190
F +G+G + V + TGK+ A KK+ + MA E IL +++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEH-DIT-GLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
++ L ++ LV M D+ + + + F E + Y +L GLE
Sbjct: 62 VVSLA--YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ 119
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
+++RD+K N+L+++ G ++++D GLA G + RV T+ Y PE++
Sbjct: 120 RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRVGTVGYMAPEVINNEK 177
Query: 309 DYGPSVDLWSVGCVFAELLIGKPILQGRTE 338
Y S D W +GC+ E++ G+ + R E
Sbjct: 178 -YTFSPDWWGLGCLIYEMIQGQSPFRKRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-09
Identities = 59/227 (25%), Positives = 96/227 (42%), Gaps = 36/227 (15%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFD--NFEPESVRFMAREILILRRLDHP 189
++ + IG+G V+ A D + VALKK+R D RF+ RE I L HP
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFL-REAKIAADLIHP 62
Query: 190 NIIKLEGLITSRLSCSIYLVFEYME-HDITGLL----SCPDIKFSEAQIKCYMNQLL--- 241
I+ + + + +Y Y+E + + LL + E K + L
Sbjct: 63 GIVPVYSICSD--GDPVYYTMPYIEGYTLKSLLKSVWQKESLS-KELAEKTSVGAFLSIF 119
Query: 242 ----HGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN--------------- 282
+E+ HS+GVLHRD+K N+L+ G + + D+G A F
Sbjct: 120 HKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 283 -TGHRQPLTSRVV-TLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 327
+ ++V T Y PE LLG S D++++G + ++L
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 17/200 (8%)
Query: 134 KLEK-IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192
KLEK +G G + V+ A K VA+K ++ + SV E +++ L H ++
Sbjct: 9 KLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLV 64
Query: 193 KLEGLITSRLSCSIYLVFEYMEHD--ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
KL ++T IY++ E+M + L S K ++ + Q+ G+ R
Sbjct: 65 KLHAVVTKE---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 121
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDY 310
+HRD++ +N+LV+ V K+ADFGLA + + PE A ++
Sbjct: 122 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE----AINF 177
Query: 311 GP---SVDLWSVGCVFAELL 327
G D+WS G + E++
Sbjct: 178 GSFTIKSDVWSFGILLMEIV 197
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 66/238 (27%), Positives = 109/238 (45%), Gaps = 33/238 (13%)
Query: 128 RADAFEKLEKIGQGTYSSVFRAR--DLDTGK---IVALKKVRFDNFEPESVRFMAREILI 182
R D K E +G+G + VF A +L K +VA+K ++ + RE +
Sbjct: 4 RRDIVLKRE-LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREAEL 60
Query: 183 LRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSC--PDIKF------SEAQI 233
L L H +I+K G+ + +VFEYM+H D+ L PD +A+
Sbjct: 61 LTNLQHEHIVKFYGVCGD--GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 118
Query: 234 KCYMNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTG 284
+ ++Q+LH G+ + S+ +HRD+ N LV ++K+ DFG++ +S
Sbjct: 119 ELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 178
Query: 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GK-PILQ-GRTEV 339
+R + + W PPE ++ + D+WS G + E+ GK P Q TEV
Sbjct: 179 YRVGGHTMLPIRWM-PPESIM-YRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 234
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 65/265 (24%), Positives = 112/265 (42%), Gaps = 40/265 (15%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
L+ IG+G + V G VA+K ++ D + F+A E ++ +L H N+++L
Sbjct: 11 LQTIGKGEFGDVMLGDY--RGNKVAVKCIKND---ATAQAFLA-EASVMTQLRHSNLVQL 64
Query: 195 EGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLH-------GLEHC 247
G+I +Y+V EYM S D S + + LL +E+
Sbjct: 65 LGVIVEEKG-GLYIVTEYMAKG-----SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 118
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
+ +HRD+ N+LV+ + V K++DFGL +++ T ++ W P L
Sbjct: 119 EANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD---TGKLPVKWTAPEALR--E 173
Query: 308 TDYGPSVDLWSVGCVFAELL-IGK------PILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360
+ D+WS G + E+ G+ P+ VE+ +K+ G PP Y
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVY---- 229
Query: 361 KLPHATLFKPQQPYDSSLRETFKDL 385
+ K D++ R +F L
Sbjct: 230 -----DVMKQCWHLDAATRPSFLQL 249
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-09
Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 14/219 (6%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKL-EG 196
+G G +V A+ + G+ A+K V + E+ L D +I+K E
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHED 99
Query: 197 LITS--RLSCSIYLVFEYMEHDITGLLSCPDIK--------FSEAQIKCYMNQLLHGLEH 246
R ++ ++ +++ G L +IK F E + Q+L + H
Sbjct: 100 FAKKDPRNPENVLMIALVLDYANAGDLR-QEIKSRAKTNRTFREHEAGLLFIQVLLAVHH 158
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVVTLWYRPPELLL 305
HS+ ++HRDIK +N+L+ + G++KL DFG + ++ T + T +Y PE+
Sbjct: 159 VHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWR 218
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHK 344
Y D++S+G + ELL K G E +HK
Sbjct: 219 -RKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK 256
|
Length = 496 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 64/228 (28%), Positives = 99/228 (43%), Gaps = 41/228 (17%)
Query: 128 RADAFEKLEKIGQGTYSSVFRAR------DLDTGKIVALKKVRFDNFEPESVRF-MAREI 180
R D K E +G+G + VF A + D +VA+K ++ + ES R RE
Sbjct: 4 RRDIVLKWE-LGEGAFGKVFLAECHNLLPEQDK-MLVAVKALKEAS---ESARQDFQREA 58
Query: 181 LILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSC--PDIKFSE------- 230
+L L H +I++ G+ T + +VFEYM H D+ L PD K
Sbjct: 59 ELLTVLQHQHIVRFYGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAP 116
Query: 231 -----AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA------N 279
Q+ +Q+ G+ + S +HRD+ N LV V+K+ DFG++ +
Sbjct: 117 GQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 176
Query: 280 FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 327
+ G R L R + PPE +L + D+WS G V E+
Sbjct: 177 YYRVGGRTMLPIR-----WMPPESIL-YRKFTTESDIWSFGVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 59/235 (25%), Positives = 105/235 (44%), Gaps = 29/235 (12%)
Query: 138 IGQGTYSSVFRARDLDTGK-------IVALKKVRFDNFEPESVRFMAREILILRRL-DHP 189
+G+G + V A + K VA+K ++ D+ + + + E+ +++ + H
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLK-DDATDKDLSDLVSEMEMMKMIGKHK 78
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSC---PDIKFS-------EAQIKCY-- 236
NII L G T +Y++ EY ++ L P + +S E Q+
Sbjct: 79 NIINLLGACTQ--DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 237 ---MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSR 292
Q+ G+E+ S+ +HRD+ N+LV + V+K+ADFGLA + N + + T+
Sbjct: 137 VSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 293 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 347
+ + + PE L Y D+WS G + E+ VE+L K+ K
Sbjct: 197 RLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 9e-09
Identities = 54/229 (23%), Positives = 104/229 (45%), Gaps = 40/229 (17%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
++ + ++K+G G + V+ ++ K VA+K ++ SV+ E +++ L H
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTM---SVQAFLEEANLMKTLQHD 61
Query: 190 NIIKLEGLITSRLSCSIYLVFEYM---------EHDITGLLSCPD-IKFSEAQIKCYMNQ 239
+++L ++T IY++ EYM + D G + P I FS Q
Sbjct: 62 KLVRLYAVVTKEEP--IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA--------Q 111
Query: 240 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-------SNTGHRQPLTSR 292
+ G+ + + +HRD++ +N+LV+ + K+ADFGLA + G + P+
Sbjct: 112 IAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK-- 169
Query: 293 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVE 340
W P + G+ + D+WS G + E++ GK G + +
Sbjct: 170 ----WTAPEAINFGS--FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD 212
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 47/204 (23%), Positives = 91/204 (44%), Gaps = 18/204 (8%)
Query: 138 IGQGTYSSVFRARDLDTGKI--VALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLE 195
+G+G + SV + I VA+K ++ + E + ++ DHPN+++L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 196 GLITSRLSCSIY----LVFEYMEH-DITGLL------SCPDIKFSEAQIKCYMNQLLHGL 244
G+ + Y ++ +M+H D+ L CP ++ +K +M + G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVK-FMTDIASGM 125
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHRQPLTSRVVTLWYRPPE 302
E+ S+ +HRD+ N ++N + +ADFGL+ ++ +RQ +++ W
Sbjct: 126 EYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIES 185
Query: 303 LLLGATDYGPSVDLWSVGCVFAEL 326
L Y D+WS G E+
Sbjct: 186 --LADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 40/149 (26%), Positives = 72/149 (48%), Gaps = 13/149 (8%)
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKF---SEAQIKCYMNQLLHGLE 245
PN++ L I S S ++LV ++ E G L KF E +K + +++ L+
Sbjct: 45 PNMVCLHKYIVSEDS--VFLVLQHAE---GGKLWSHISKFLNIPEECVKRWAAEMVVALD 99
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
H G++ RD+ +N+L+++ G ++L F +S V Y PE +
Sbjct: 100 ALHREGIVCRDLNPNNILLDDRGHIQLTYFS--RWSEV--EDSCDGEAVENMYCAPE-VG 154
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQ 334
G ++ + D WS+G + ELL GK +++
Sbjct: 155 GISEETEACDWWSLGAILFELLTGKTLVE 183
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 43/221 (19%), Positives = 95/221 (42%), Gaps = 28/221 (12%)
Query: 127 LRADAFEKLEKIGQGTYSSVFR--ARDLDTGKI---VALKKVRFDNFEPESVRFMAREIL 181
L + + ++GQG++ V+ A+ + G+ VA+K V + E + F+ E
Sbjct: 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLN-EAS 61
Query: 182 ILRRLDHPNIIKLEGLITSRLSCSIYLVFEYM--------------EHDITGLLSCPDIK 227
+++ + ++++L G++ S +V E M E + L P ++
Sbjct: 62 VMKEFNCHHVVRLLGVV-STGQ-PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119
Query: 228 FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHR 286
+ ++ G+ + ++ +HRD+ N +V + +K+ DFG+ + T +
Sbjct: 120 ----KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYY 175
Query: 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 327
+ ++ + + PE L + D+WS G V E+
Sbjct: 176 RKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMA 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 60/223 (26%), Positives = 96/223 (43%), Gaps = 40/223 (17%)
Query: 130 DAFEKLEKIGQGTYSSVF----RARDLDTGKI-VALKKVRFDNFEPESVRFMAREILILR 184
D+ L +G G + V+ R RD D ++ VA+K + E + F+ E LI+
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFL-MEALIMS 64
Query: 185 RLDHPNIIKLEGLITSRLSCSIYLVFEYME-HDITGLL----SCPDIKFSEAQIKCYMNQ 239
+ +H NI++L G+ RL +++ E M D+ L P+ S M
Sbjct: 65 KFNHQNIVRLIGVSFERL--PRFILLELMAGGDLKSFLRENRPRPERPSSLT-----MKD 117
Query: 240 LLH-------GLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLA------NFSNT 283
LL G ++ +HRDI N L+ +G V K+ADFG+A ++
Sbjct: 118 LLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRK 177
Query: 284 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 326
G R L + + PPE L + D+WS G + E+
Sbjct: 178 GGRAMLPIK-----WMPPEAFLDGI-FTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 39/148 (26%), Positives = 71/148 (47%), Gaps = 8/148 (5%)
Query: 136 EKIGQGTYSSVFRARDLDTGKI---VALKKV-RFDNFEPESVRFMAREILILRRLDHPNI 191
IG+G + V+ +D+ A+K + R + E V +E +I++ HPN+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLE--EVEQFLKEGIIMKDFSHPNV 58
Query: 192 IKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
+ L G I S +V YM+H D+ + + + + Q+ G+E+ S+
Sbjct: 59 LSLLG-ICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK 117
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLA 278
+HRD+ N +++ +K+ADFGLA
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLA 145
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 59/235 (25%), Positives = 102/235 (43%), Gaps = 29/235 (12%)
Query: 138 IGQGTYSSVFRARDLDTGK-------IVALKKVRFDNFEPESVRFMAREILILRRLDHPN 190
+G+G + V A + K VA+K ++ D E + ++ ++ H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 191 IIKLEGLITSRLSCSIYLVFEYME----------HDITGLLSC------PDIKFSEAQIK 234
II L G T +Y++ EY G+ C P+ + S +
Sbjct: 86 IINLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 235 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRV 293
Q+ G+E+ S+ +HRD+ N+LV + V+K+ADFGLA + + + + T+
Sbjct: 144 SCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 203
Query: 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFK 347
+ + + PE L Y D+WS G + E+ +G G VE+L K+ K
Sbjct: 204 LPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPG-VPVEELFKLLK 256
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 50/204 (24%), Positives = 86/204 (42%), Gaps = 25/204 (12%)
Query: 138 IGQGTYSSVFRARDLDTGKI-----VALKKVRFDNFEPESVRFMAREILILRRL-DHPNI 191
+G G + V A K VA+K ++ E M+ E+ I+ L +H NI
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS-ELKIMSHLGNHENI 101
Query: 192 IKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQ-IKCYMNQLLHGLEHCHS 249
+ L G T + I ++ EY + D+ L F + + + Q+ G+ S
Sbjct: 102 VNLLGACT--IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS 159
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLA-------NFSNTGHRQPLTSRVVTLWYRPPE 302
+ +HRD+ N+L+ + ++K+ DFGLA N+ G +R+ W P
Sbjct: 160 KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKG-----NARLPVKWMAPES 214
Query: 303 LLLGATDYGPSVDLWSVGCVFAEL 326
+ Y D+WS G + E+
Sbjct: 215 IFNCV--YTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 52/214 (24%), Positives = 97/214 (45%), Gaps = 36/214 (16%)
Query: 137 KIGQGTYSSV------FRARDLDTGKIVALKKVRFDNFEPESVR-FMAREILILRRLDHP 189
++G G + V R + +D VA+K ++ +N +SVR M RE I+ +LD+P
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQID----VAIKVLKNEN--EKSVRDEMMREAEIMHQLDNP 55
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
I+++ G+ + ++ LV E + LS + + + + M+Q+ G+++
Sbjct: 56 YIVRMIGVCEAE---ALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE 112
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANF---------SNTGHRQPLTSRVVTLWYR 299
+ +HRD+ N+L+ N+ K++DFGL+ + + + PL WY
Sbjct: 113 GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLK------WYA 166
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLI--GKP 331
P + + D+WS G E KP
Sbjct: 167 PECINF--RKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 53/209 (25%), Positives = 91/209 (43%), Gaps = 25/209 (11%)
Query: 138 IGQGTYSSVFRARDLDTG--KIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKL 194
IG+G + V +AR G A+K+++ + + R A E+ +L +L HPNII L
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 195 EGLITSRLSCSIYLVFEYMEH-DITGLLSCPDI---------------KFSEAQIKCYMN 238
G R +YL EY H ++ L + S Q+ +
Sbjct: 74 LGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 239 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 298
+ G+++ + +HRD+ N+LV V K+ADFGL+ ++ + R+ W
Sbjct: 132 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM-GRLPVRWM 190
Query: 299 RPPELLLGATDYGPSVDLWSVGCVFAELL 327
L + Y + D+WS G + E++
Sbjct: 191 AIES--LNYSVYTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (128), Expect = 2e-07
Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 41/204 (20%)
Query: 141 GTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITS 200
G + V + T K+ K ++ NF + M +++ D+PN IKL +T+
Sbjct: 27 GKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--IEPMVHQLM----KDNPNFIKLYYSVTT 80
Query: 201 RLSCSIYLVFEYMEHDITGLLSCPDI--------KFSEAQIKCYMNQLLHGLEHCHSRGV 252
L + L+ +Y++ D+ K SEA++K + QL+ L H +
Sbjct: 81 -LKGHV-LIMDYIK--------DGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNI 130
Query: 253 LHRDIKGSNLLVN-NEGVLKLADFGLANFSNT-----GHRQPLTSRVVTLWYRPPELLLG 306
+H DIK N+L + + + L D+GL T G TL Y PE + G
Sbjct: 131 IHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDG----------TLDYFSPEKIKG 180
Query: 307 ATDYGPSVDLWSVGCVFAELLIGK 330
+Y S D W+VG + ELL GK
Sbjct: 181 H-NYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 52/193 (26%), Positives = 86/193 (44%), Gaps = 26/193 (13%)
Query: 157 IVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH- 215
+VA+K +R D + F+ +E+ IL RL PNII+L G+ + ++ EYME+
Sbjct: 48 LVAVKILRPDANKNARNDFL-KEVKILSRLKDPNIIRLLGVCVD--EDPLCMITEYMENG 104
Query: 216 DITGLLSCPDIKFSEAQIKCYMNQ-----------LLH-------GLEHCHSRGVLHRDI 257
D+ LS + E + LLH G+++ S +HRD+
Sbjct: 105 DLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDL 164
Query: 258 KGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV--TLWYRPPELLLGATDYGPSVD 315
N LV +K+ADFG++ G + R V W +L+G + + D
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG--KFTTASD 222
Query: 316 LWSVGCVFAELLI 328
+W+ G E+L+
Sbjct: 223 VWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 33/74 (44%), Positives = 43/74 (58%), Gaps = 2/74 (2%)
Query: 233 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG-HRQPLTS 291
IK M Q+L GL H G++HRDIK NLLV +G +K+ DFG A TG + PL
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYG 370
Query: 292 RVVTLWYRPPELLL 305
++ Y PPE L+
Sbjct: 371 -MLDPRYSPPEELV 383
|
Length = 507 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 52/216 (24%), Positives = 97/216 (44%), Gaps = 28/216 (12%)
Query: 135 LEKIGQGTYSSVFRARDLDTG-----KIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+E++G+ + V++ T + VA+K ++ D E E ++ RL HP
Sbjct: 10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK-DKAEGPLREEFKHEAMMRSRLQHP 68
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH-DITGLL----------SCPDIKFSEAQIKC--- 235
NI+ L G++T S ++F Y H D+ L S D K ++ ++
Sbjct: 69 NIVCLLGVVTKEQPLS--MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF 126
Query: 236 --YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHRQPLTS 291
+ Q+ G+E S V+H+D+ N+LV ++ +K++D GL ++ ++ S
Sbjct: 127 VHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186
Query: 292 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 327
+ W P ++ G + D+WS G V E+
Sbjct: 187 LLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-07
Identities = 47/208 (22%), Positives = 96/208 (46%), Gaps = 13/208 (6%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTG---KI-VALKKVRFDNFEPESVRFMAREILI 182
L+ F+K++ +G G + +V++ + G KI VA+K++R + P++ + + E +
Sbjct: 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYV 62
Query: 183 LRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYMNQLL 241
+ +D+P++ +L G+ L+ ++ L+ + M + + + + Q+
Sbjct: 63 MASVDNPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 119
Query: 242 HGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR--QPLTSRVVTLWYR 299
G+ + R ++HRD+ N+LV +K+ DFGLA + +V W
Sbjct: 120 KGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELL 327
+L Y D+WS G EL+
Sbjct: 180 LESIL--HRIYTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 46/221 (20%), Positives = 93/221 (42%), Gaps = 36/221 (16%)
Query: 138 IGQGTYSSV-----FRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192
+G+G + V FR + VA+K ++ +N +R + E +L++++HP++I
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK-ENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 193 KLEGLITSRLSCSIYLVFEYMEH-----------------------DITGLLSCPDIK-F 228
KL G + + L+ EY ++ + L PD +
Sbjct: 67 KLYGACSQ--DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 229 SEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHR 286
+ + + Q+ G+++ ++HRD+ N+LV +K++DFGL+ + +
Sbjct: 125 TMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 327
+ R+ W L Y D+WS G + E++
Sbjct: 185 KRSKGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIV 223
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 52/232 (22%), Positives = 101/232 (43%), Gaps = 25/232 (10%)
Query: 137 KIGQGTYSSVFRA--RDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
++G G + +V + + + K VA+K ++ DN +P + RE ++++LD+P I+++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 195 EGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 254
G+ + S LV E E + +E I ++Q+ G+++ +H
Sbjct: 62 IGICEAE---SWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVH 118
Query: 255 RDIKGSNLLVNNEGVLKLADFGLAN--------FSNTGH-RQPLTSRVVTLWYRPPELLL 305
RD+ N+L+ + K++DFGL+ + H + P+ WY P +
Sbjct: 119 RDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK------WYAPE--CM 170
Query: 306 GATDYGPSVDLWSVGCVFAELLI--GKPILQGR-TEVEQLHKIFKLCGSPPD 354
+ D+WS G + E KP + EV Q+ + + P
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQR 222
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 28/95 (29%), Positives = 48/95 (50%), Gaps = 4/95 (4%)
Query: 235 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHRQPLTSR 292
CY Q+ G+E SR +HRD+ N+L++ V+K+ DFGLA + + + + ++R
Sbjct: 178 CYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR 237
Query: 293 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 327
+ W P + Y D+WS G + E+
Sbjct: 238 LPLKWMAPESIFDKV--YTTQSDVWSFGVLLWEIF 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 47/202 (23%), Positives = 89/202 (44%), Gaps = 16/202 (7%)
Query: 138 IGQGTYSSVFRAR----DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIK 193
+G+G + VF A+ + + G+ + L K + RE+ + R+L H N+++
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 194 LEGLITSRLSCSIYLVFEYME-HDITGLLSCPDIK--------FSEAQIKCYMNQLLHGL 244
L GL R + Y++ EY + D+ L K S Q Q+ G+
Sbjct: 73 LLGLC--REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELL 304
+H + +HRD+ N LV+++ +K++ L+ L + ++ L + PE +
Sbjct: 131 DHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAV 190
Query: 305 LGATDYGPSVDLWSVGCVFAEL 326
D+ D+WS G + E+
Sbjct: 191 Q-EDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 47/209 (22%), Positives = 97/209 (46%), Gaps = 22/209 (10%)
Query: 135 LEKIGQGTYSSVFR--ARDLDTGKI---VALKKVRFDNFEPESVRFMAREILILRRLDHP 189
L ++GQG++ V+ ARD+ G+ VA+K V E + F+ E +++
Sbjct: 11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMKGFTCH 69
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSC--PDIKFSEAQIKCYMNQLLH---- 242
++++L G+++ +V E M H D+ L P+ + + + + +++
Sbjct: 70 HVVRLLGVVSK--GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 127
Query: 243 ---GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHRQPLTSRVVTLW 297
G+ + +++ +HRD+ N +V ++ +K+ DFG+ + +R+ + W
Sbjct: 128 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 298 YRPPELLLGATDYGPSVDLWSVGCVFAEL 326
P L G + S D+WS G V E+
Sbjct: 188 MAPESLKDGV--FTTSSDMWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 46/209 (22%), Positives = 90/209 (43%), Gaps = 15/209 (7%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRA---RDLDTGKIVALKKVRFDNFEPESVRFMAREILIL 183
L+ KL+ +G G + +V + + D+ KI K D ++ + + +L +
Sbjct: 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAM 63
Query: 184 RRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMN---QL 240
LDH I++L G+ S+ LV + LL + +N Q+
Sbjct: 64 GSLDHAYIVRLLGICPG---ASLQLVTQLSPLG--SLLDHVRQHRDSLDPQRLLNWCVQI 118
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT--LWY 298
G+ + ++HR++ N+L+ ++ ++++ADFG+A+ ++ S T W
Sbjct: 119 AKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWM 178
Query: 299 RPPELLLGATDYGPSVDLWSVGCVFAELL 327
+L G Y D+WS G E++
Sbjct: 179 ALESILFGR--YTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 28/95 (29%), Positives = 47/95 (49%), Gaps = 4/95 (4%)
Query: 235 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHRQPLTSR 292
CY Q+ G+E SR +HRD+ N+L++ V+K+ DFGLA + + + + +R
Sbjct: 183 CYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242
Query: 293 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 327
+ W P + Y D+WS G + E+
Sbjct: 243 LPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIF 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 51/220 (23%), Positives = 89/220 (40%), Gaps = 36/220 (16%)
Query: 130 DAFEKLEKIGQGTYSSVFRA--RDLDTGKI--VALKKVRFDNFEPESVRFMAREILILRR 185
D + + +GT+ +F D GK V +K V+ D+ V + +E +L
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVK-DHASEIQVTLLLQESCLLYG 64
Query: 186 LDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-----LLSCPDIK------FSEAQIK 234
L H NI+ + + ++++ YM G L C + S Q+
Sbjct: 65 LSHQNILPI-LHVCIEDGEPPFVLYPYMNW---GNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 235 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGH------R 286
Q+ G+ + H RGV+H+DI N +++ E +K+ D L+ F H
Sbjct: 121 HMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNEN 180
Query: 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 326
+P+ W L+ +Y + D+WS G + EL
Sbjct: 181 RPVK------WMALESLV--NKEYSSASDVWSFGVLLWEL 212
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 52/214 (24%), Positives = 91/214 (42%), Gaps = 25/214 (11%)
Query: 132 FEKLEKIGQGTYSSVFRAR-DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHP 189
FE + IG+G + V RA D K+ A K+ + R A E+ +L +L HP
Sbjct: 6 FEDV--IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHP 63
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDI---------------KFSEAQI 233
NII L G +R +Y+ EY + ++ L + + Q+
Sbjct: 64 NIINLLGACENR--GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 234 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 293
+ + + G+++ + +HRD+ N+LV K+ADFGL+ ++ + R+
Sbjct: 122 LQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTM-GRL 180
Query: 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 327
W L + Y D+WS G + E++
Sbjct: 181 PVRWMAIES--LNYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 23/208 (11%)
Query: 138 IGQGTYSSVFRARDLDTG-KIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLE 195
IG+G + V +AR G ++ A K + + R A E+ +L +L HPNII L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 196 GLITSRLSCSIYLVFEYMEH-DITGLLSCPDI---------------KFSEAQIKCYMNQ 239
G R +YL EY H ++ L + S Q+ +
Sbjct: 63 GACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 240 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYR 299
+ G+++ + +HRD+ N+LV V K+ADFGL+ ++ + R+ W
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM-GRLPVRWMA 179
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELL 327
L + Y + D+WS G + E++
Sbjct: 180 IES--LNYSVYTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 26/71 (36%), Positives = 38/71 (53%), Gaps = 1/71 (1%)
Query: 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 345
R T+ V T YR PE++LG + S D+WS+GC+ EL GK + +E LH +
Sbjct: 299 RHSRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM 357
Query: 346 FKLCGSPPDDY 356
K G P ++
Sbjct: 358 EKTLGRLPSEW 368
|
Length = 467 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 27/94 (28%), Positives = 46/94 (48%), Gaps = 4/94 (4%)
Query: 235 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHRQPLTSR 292
Y Q+ G+E SR +HRD+ N+L++ V+K+ DFGLA + + + + +R
Sbjct: 177 SYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236
Query: 293 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 326
+ W P + Y D+WS G + E+
Sbjct: 237 LPLKWMAPESIFDKV--YTTQSDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 6e-05
Identities = 61/248 (24%), Positives = 89/248 (35%), Gaps = 62/248 (25%)
Query: 184 RRLDHPNIIKLEGLITSRLSCSIYLVFEYME-HDITGLLSCPDIKFSEAQI------KCY 236
R L HPNI++ G + LVFEY E D+ LS +Q+ C
Sbjct: 50 RILQHPNILQCLGQCVE--AIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMAC- 106
Query: 237 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS--RVV 294
++ G+ H H LH D+ N + ++ +K+ D+G+ S T + V
Sbjct: 107 --EIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCV 163
Query: 295 TLWYRPPEL-------LLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 347
L + PEL L+ A PS ++W++G EL F+
Sbjct: 164 PLRWLAPELVGEFHGGLITAEQTKPS-NVWALGVTLWEL-------------------FE 203
Query: 348 LCGSPPDDYWKKSKLPHAT------LFKPQ--QPYDSSLRETFKDLPTTAVNLIETLLSV 399
P + L H LFKPQ PY E + +
Sbjct: 204 NAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQ------------FCWL 251
Query: 400 EPYKRATA 407
P KRATA
Sbjct: 252 SPEKRATA 259
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 43/207 (20%), Positives = 91/207 (43%), Gaps = 11/207 (5%)
Query: 127 LRADAFEKLEKIGQGTYSSVFR---ARDLDTGKIVALKKVRFDNFEPESVRFMAREILIL 183
L+ +K++ +G G + +V++ D + KI KV +N P++ + + E ++
Sbjct: 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVM 63
Query: 184 RRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYMNQLLH 242
+ P + +L G+ L+ ++ LV + M + + + + + + Q+
Sbjct: 64 AGVGSPYVCRLLGIC---LTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAK 120
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS--RVVTLWYRP 300
G+ + ++HRD+ N+LV + +K+ DFGLA + + +V W
Sbjct: 121 GMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMAL 180
Query: 301 PELLLGATDYGPSVDLWSVGCVFAELL 327
+L + D+WS G EL+
Sbjct: 181 ESIL--HRRFTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 48/206 (23%), Positives = 83/206 (40%), Gaps = 19/206 (9%)
Query: 136 EKIGQGTYSSVF--RARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIK 193
++IG G + V A + V +K++R E + F+ +E+ R L+HPN+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFL-QEVQPYRELNHPNVLQ 59
Query: 194 LEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLH----GLEHCH 248
G S LV E+ D+ L ++ K + ++ GL H
Sbjct: 60 CLGQCIE--SIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH 117
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS--RVVTLWYRPPELL-- 304
+H D+ N + + +K+ D+GLA +T V L + PEL+
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVEI 176
Query: 305 ----LGATDYGPSVDLWSVGCVFAEL 326
L D ++WS+G EL
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 34/125 (27%), Positives = 57/125 (45%), Gaps = 22/125 (17%)
Query: 222 SCPDIKFSEAQIKCYMN------QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADF 275
+ D +E+ YM+ Q+ +G+E S+ +HRD+ N+L+ ++K+ DF
Sbjct: 224 TRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDF 283
Query: 276 GLA-------NFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL-- 326
GLA N+ + G S + L + PE + Y D+WS G + E+
Sbjct: 284 GLARDIMRDSNYISKG------STFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFT 336
Query: 327 LIGKP 331
L G P
Sbjct: 337 LGGTP 341
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.002
Identities = 60/253 (23%), Positives = 98/253 (38%), Gaps = 69/253 (27%)
Query: 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN 266
Y V Y+ + L + + I+ M Q+L L+ HS G++HRD+K N++ +
Sbjct: 233 YNVEPYLLGKVQDLPKGLERE--NKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSE 290
Query: 267 E-GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG------------------- 306
G K+ D G A V + Y P E LL
Sbjct: 291 GSGSFKIIDLGAA-----------ADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAP 339
Query: 307 ----ATDYGPSV---------DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 353
AT P + D++S G +F ++ P L+ + + Q ++ K
Sbjct: 340 SAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAF--PNLRSDSNLIQFNRQLKRN---- 393
Query: 354 DDY----WKKSKLPHATLFKPQQPYDSSLRETFK--DLPTTA-VNLIETLLSVEPYKRAT 406
DY W+K P A+ LR F+ DL A L+++++ + +R +
Sbjct: 394 -DYDLVAWRKLVEPRAS---------PDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRIS 443
Query: 407 ASAALASEYFSTK 419
A AALA YF +
Sbjct: 444 AKAALAHPYFDRE 456
|
Length = 566 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 9/97 (9%)
Query: 239 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA----NFSNTGHRQPLTSRVV 294
Q+ G++ S+ +HRD+ N+L+ + V K+ DFGLA N SN + +R+
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG--NARLP 277
Query: 295 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGK 330
W P + Y D+WS G + E+ +GK
Sbjct: 278 VKWMAPESIFDCV--YTVQSDVWSYGILLWEIFSLGK 312
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 56/264 (21%), Positives = 102/264 (38%), Gaps = 54/264 (20%)
Query: 136 EKIGQGTYSSVFRAR---DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192
++IG G + V ++V +K++R E ++F+ E R L H N++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVV-VKELRVSASVQEQMKFLE-EAQPYRSLQHSNLL 58
Query: 193 KLEGLITSRLSCSIYLVFEYME-HDITGLL-SC-------PDIKFSEAQIKCYMNQLLHG 243
+ G T LV E+ D+ G L SC PD + ++ C ++ G
Sbjct: 59 QCLGQCTE--VTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQ-RMAC---EIALG 112
Query: 244 LEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV-VTLWYRPPE 302
L H H +H D+ N L+ + +K+ D+GL++ ++ V L + PE
Sbjct: 113 LLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPE 172
Query: 303 LL------LGATDYGPSVDLWSVGCVFAELL--------------------------IGK 330
L+ L D ++WS+G EL + K
Sbjct: 173 LVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPK 232
Query: 331 PILQGRTEVEQLHKIFKLCGSPPD 354
P L+ ++ +++ + C P+
Sbjct: 233 PRLK-LPLSDRWYEVMQFCWLQPE 255
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 45/225 (20%), Positives = 84/225 (37%), Gaps = 23/225 (10%)
Query: 136 EKIGQGTYSSVFRAR-----DLDTGKIVALKKVRFDNFEPESVRFMA--REILILRRLDH 188
E +GQGT++++++ DLD V + +A ++ +L H
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH 60
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
+++KL G+ + +V EY++ + L S QL L +
Sbjct: 61 KHLVKLYGVC---VRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYL 117
Query: 248 HSRGVLHRDIKGSNLLVNNEGV-------LKLADFGLANFSNTGHRQPLTSRVVTLWYRP 300
+ ++H ++ G N+LV G+ +KL+D G+ R+ R+ W P
Sbjct: 118 EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP--ITVLSREERVERIP--WIAP 173
Query: 301 PELLLGATDYGPSVDLWSVGCVFAELLIGKPI-LQGRTEVEQLHK 344
+ G + D WS G E+ L + E+
Sbjct: 174 ECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF 218
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 704 | |||
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.98 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.92 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.81 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.78 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.77 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.74 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.73 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.72 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.69 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.66 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.65 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.62 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.55 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.54 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.38 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.36 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.35 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.34 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.32 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.32 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.16 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.13 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.12 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.03 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.99 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.99 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.97 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.8 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.75 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.63 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.63 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.56 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.54 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.41 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.38 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.31 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.23 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.22 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.06 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.05 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.03 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.85 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.84 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.79 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.77 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.62 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.6 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.56 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.51 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.51 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.36 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.35 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.31 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.27 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.26 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.23 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.23 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.21 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.03 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.81 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.58 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.51 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.47 | |
| PLN02236 | 344 | choline kinase | 96.46 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.36 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.23 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.03 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.81 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.42 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.38 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.19 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.08 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.96 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.7 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.39 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 93.65 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 92.83 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 90.71 |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-79 Score=655.77 Aligned_cols=362 Identities=70% Similarity=1.172 Sum_probs=349.2
Q ss_pred ccccCCcccccchhhhhcccchhhhhhhhhhhcCccccccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC
Q 005289 90 SFRLGNLHKYIEGEQVAAGWPAWLSAVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE 169 (704)
Q Consensus 90 s~~~g~~~~~~~ge~~~~~~p~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~ 169 (704)
+.+.+...+..++++.+++||.|+..+++++..+|.+...+.|+.+++||+|+||.||+|++..||+.||+|++++++..
T Consensus 77 ~~~~~~~~~~~e~~~~~a~~p~~l~~~~ge~~~~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~ 156 (560)
T KOG0600|consen 77 GSRPSSVPKSTEAEQVAAGWPAWLSSVAGEALHGWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK 156 (560)
T ss_pred ccCCCCCCCcchhhhhhccCccccccccccccccccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC
Confidence 44566777778889999999999999999999999999999999999999999999999999999999999999999988
Q ss_pred hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHh
Q 005289 170 PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249 (704)
Q Consensus 170 ~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~ 249 (704)
++....+.|||.||++|+|||||+|.++..++..+.+|||||||+++|.+++..+...|++.++++||+||+.||+|||.
T Consensus 157 ~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~ 236 (560)
T KOG0600|consen 157 EGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHS 236 (560)
T ss_pred CcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhh
Confidence 88888999999999999999999999999987778999999999999999999999999999999999999999999999
Q ss_pred cCcccccCCCccEEEccCCceEEeccccccccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhC
Q 005289 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG 329 (704)
Q Consensus 250 ~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG 329 (704)
+||+|||||.+|||||++|.+||+|||||+++......+++.++.|+||+|||+|++...|+.++|+||+||||.||+.|
T Consensus 237 ~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~g 316 (560)
T KOG0600|consen 237 RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLG 316 (560)
T ss_pred cCeeeccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcC
Confidence 99999999999999999999999999999999888878899999999999999999999999999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHH
Q 005289 330 KPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 409 (704)
Q Consensus 330 ~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e 409 (704)
+|+|+|.++.+|+++|+++||+|.+++|...++|....+++.++|...+.+.|..++..+.+||..||++||.+|+||.+
T Consensus 317 kPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~ 396 (560)
T KOG0600|consen 317 KPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASS 396 (560)
T ss_pred CCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHhccccCCCCCCCCCCCCCCCCCChhHHhHhHHHHHhhhhC
Q 005289 410 ALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVG 451 (704)
Q Consensus 410 ~L~hpwf~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 451 (704)
+|+|+||++.|.+|++..||.|++.++++++.+.+.++....
T Consensus 397 aL~seyF~t~p~~~~p~~Lp~y~~s~E~~~K~r~e~~r~~~~ 438 (560)
T KOG0600|consen 397 ALQSEYFTTEPLPCDPSSLPKYPPSHELDAKRRREQKRRNKG 438 (560)
T ss_pred HhcCcccccCCCCCCcccCCCCCcchhHHHHHHHHHhhcccc
Confidence 999999999999999999999999999999999988777653
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-62 Score=497.70 Aligned_cols=307 Identities=43% Similarity=0.745 Sum_probs=273.4
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.+.|+.+++|++|+||.||+|+++.|++.||+|+++.+.-....--.-.|||.+|.+++|||||.+-++......+.+||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 56899999999999999999999999999999999865422111122468999999999999999999998877788999
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
|||||++++..++.....+|.+.++++++.|+|.||+|||.+.|+||||||+|+|+++.|.+||+|||+|+.+... ..+
T Consensus 155 VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-~k~ 233 (419)
T KOG0663|consen 155 VMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-LKP 233 (419)
T ss_pred eHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC-ccc
Confidence 9999999998888777789999999999999999999999999999999999999999999999999999988765 356
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC-cc-
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH-AT- 366 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~-~~- 366 (704)
++..+.|.||+|||+|++...|++++|+||+|||+.||++++|+|.|..+.+|+.+|+.++|.|.+..|....... ..
T Consensus 234 ~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~ 313 (419)
T KOG0663|consen 234 YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKK 313 (419)
T ss_pred CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhc
Confidence 8888999999999999999999999999999999999999999999999999999999999999999999855433 32
Q ss_pred cCCCCCCCCchhhhhccCCC--HHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCCCCCCCCCCCCCCChhH
Q 005289 367 LFKPQQPYDSSLRETFKDLP--TTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEI 437 (704)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~s--~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~~~~~~~~p~~~~~~~~ 437 (704)
+..+.++| ..++..|..++ +...+||+.||.+||.+|+||.++|+|+||.+.|.+++|..+|.+|...+.
T Consensus 314 ~~f~~~py-n~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~Pt~P~k~~~ 385 (419)
T KOG0663|consen 314 MTFSEHPY-NNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFPTWPAKSEQ 385 (419)
T ss_pred cccCCCCc-hhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcCCCcccccc
Confidence 23333443 45677776655 999999999999999999999999999999999999999999999986543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-60 Score=468.86 Aligned_cols=299 Identities=44% Similarity=0.759 Sum_probs=265.8
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
++|..+++||+|+||+||+|++..||+.||||+|...+..........|||++|+.++|+||+.|+++|-. ...+.||
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~--~~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH--KSNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC--CCceEEE
Confidence 47999999999999999999999999999999998876655555667899999999999999999999977 5678999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCc
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~ 289 (704)
+|||+-++...+......|++.+++.|+.++++||+|||++.|+||||||.|+||+.+|.+||+|||+|+.+..... ..
T Consensus 80 fEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~-~~ 158 (318)
T KOG0659|consen 80 FEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR-IQ 158 (318)
T ss_pred EEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc-cc
Confidence 99999999888888889999999999999999999999999999999999999999999999999999999876543 34
Q ss_pred ccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccC-CCCcccC
Q 005289 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK-LPHATLF 368 (704)
Q Consensus 290 ~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~-~~~~~~~ 368 (704)
+..+.|.||+|||+++|...|+..+||||+|||+.||+-+.|.|.|.++.+|+..|+..+|+|.++.|.... +|+...+
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~ 238 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI 238 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence 445889999999999999999999999999999999999999999999999999999999999999998754 3332222
Q ss_pred CCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCCCCCCCCCCCCCC
Q 005289 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPP 433 (704)
Q Consensus 369 ~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~~~~~~~~p~~~~ 433 (704)
. +.-...+...|...+.++.|||.+||.+||.+|+||.|+|+|+||++.|.+++++.+|....
T Consensus 239 ~--~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~~lp~p~~ 301 (318)
T KOG0659|consen 239 Q--QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPSKLPIPST 301 (318)
T ss_pred h--cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChhhCcCCcc
Confidence 1 11122344478899999999999999999999999999999999999999998887776433
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-58 Score=461.62 Aligned_cols=284 Identities=35% Similarity=0.630 Sum_probs=251.7
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
+.|+.+.++|+|+||+||+|+++.||+.||||++.-..-++...+...|||++|++|.|+|+|.|+++|.. ...++||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr--krklhLV 79 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR--KRKLHLV 79 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh--cceeEEE
Confidence 57999999999999999999999999999999997555445556667899999999999999999999976 5789999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCc
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~ 289 (704)
||||++..+..+......+++..++.|+.|++.|+.|||++++|||||||+||||+.+|.+||||||+|+.... ....+
T Consensus 80 FE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~Y 158 (396)
T KOG0593|consen 80 FEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDNY 158 (396)
T ss_pred eeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC-Ccchh
Confidence 99999999998877777799999999999999999999999999999999999999999999999999998774 33567
Q ss_pred ccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhh---ccCCCCcc
Q 005289 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK---KSKLPHAT 366 (704)
Q Consensus 290 ~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~---~~~~~~~~ 366 (704)
+.++.|.||+|||++.+...|+.++|||++||++.||++|.|+|+|.++.+++..|.+.+|...+.-.. ...+.. .
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~-G 237 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH-G 237 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee-e
Confidence 899999999999999999999999999999999999999999999999999999999999998765322 111111 1
Q ss_pred cCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccC
Q 005289 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417 (704)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~ 417 (704)
+-.|...-...|...++.++.-+.||++.||..||.+|++.+|+|.|+||.
T Consensus 238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 122333445678889999999999999999999999999999999999994
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-58 Score=488.97 Aligned_cols=288 Identities=39% Similarity=0.677 Sum_probs=259.5
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeEEEeecCCCeE
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~~ 206 (704)
..++|.++++||.|+||.||+|+.+.++..||||.|+.....-+.+-. .||++.|++|+ |||||+|.+++.+... .+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~n-LREvksL~kln~hpniikL~Evi~d~~~-~L 85 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNPHPNIIKLKEVIRDNDR-IL 85 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHH-HHHHHHHHhcCCCCcchhhHHHhhccCc-eE
Confidence 357899999999999999999999999999999999876655443333 47999999998 9999999999988533 89
Q ss_pred EEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC
Q 005289 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~ 286 (704)
|+|||||+.++.+++..++..|++..++.||.||+.||+|+|.+|+.|||||||||||.....|||+|||+|+.....
T Consensus 86 ~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk-- 163 (538)
T KOG0661|consen 86 YFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK-- 163 (538)
T ss_pred eeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC--
Confidence 999999999999999988999999999999999999999999999999999999999998899999999999987654
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhc-cCCCCc
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHA 365 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~-~~~~~~ 365 (704)
.++|.++.|.||+|||+|+....|+.++|||++|||++|+.+-+|+|+|.++.+++.+|..++|.|..+.|.. .++...
T Consensus 164 pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~ 243 (538)
T KOG0661|consen 164 PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASA 243 (538)
T ss_pred CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHH
Confidence 6789999999999999999999999999999999999999999999999999999999999999999998887 334344
Q ss_pred ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
-.|...+.....+...++..+.++.+||.+||.+||.+||||.++|+||||+..
T Consensus 244 mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 244 MNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred hccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 444444445566778888899999999999999999999999999999999853
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-56 Score=468.53 Aligned_cols=265 Identities=31% Similarity=0.466 Sum_probs=225.5
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCCh-----HHHHHHHHHHHHHHhcCCCCceeEeEEEeecC
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP-----ESVRFMAREILILRRLDHPNIIKLEGLITSRL 202 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 202 (704)
..+.|.+.+.||+|+||.|-+|.++.||+.||||++++..... .....+.+|++||++|+|||||+++++|+.
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~-- 247 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV-- 247 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec--
Confidence 3567999999999999999999999999999999998765432 123346799999999999999999999988
Q ss_pred CCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccC---CceEEecccccc
Q 005289 203 SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE---GVLKLADFGLAN 279 (704)
Q Consensus 203 ~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~---g~iKL~DFGla~ 279 (704)
..+.||||||++|+.|....-..+.+.|...+.|++|||.||.|||++||+||||||+||||..+ ..+||+|||+|+
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred CCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 57889999999998777666677789999999999999999999999999999999999999877 679999999999
Q ss_pred ccCCCCCCCcccccccccccCcccccCC--CCCCCccchhhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCCchh
Q 005289 280 FSNTGHRQPLTSRVVTLWYRPPELLLGA--TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE-QLHKIFKLCGSPPDDY 356 (704)
Q Consensus 280 ~~~~~~~~~~~~~~gT~~Y~APEvl~~~--~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e-~l~~I~~~~g~~p~~~ 356 (704)
..... ..+.+.||||.|.|||++.+. ..|..++|||||||+||.+|+|.|||.+..... ..++|.+ |.++..
T Consensus 328 ~~g~~--sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~--G~y~f~- 402 (475)
T KOG0615|consen 328 VSGEG--SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK--GRYAFG- 402 (475)
T ss_pred ccccc--eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc--Cccccc-
Confidence 88744 567889999999999999642 345558999999999999999999998765444 5666654 332210
Q ss_pred hhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCC
Q 005289 357 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (704)
Q Consensus 357 w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~ 421 (704)
...|..+++++++||.+||.+||++|||++|+|+||||+..|.
T Consensus 403 ----------------------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~ 445 (475)
T KOG0615|consen 403 ----------------------PLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPC 445 (475)
T ss_pred ----------------------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence 1234689999999999999999999999999999999997554
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-54 Score=474.52 Aligned_cols=257 Identities=31% Similarity=0.493 Sum_probs=234.6
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.+|...+.||+|||++||.+++..+|..||+|++.+..+ .....+.+.+||+|.+.|+|||||+++++|++ ..++||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED--s~nVYi 95 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFED--SNNVYI 95 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeec--CCceEE
Confidence 469999999999999999999999999999999987654 35667889999999999999999999999999 689999
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
|+|+|..+.+..+....+.|+|.+++.|++||+.||.|||+++|||||||..||||+++.+|||+|||||.....+.. .
T Consensus 96 vLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E-r 174 (592)
T KOG0575|consen 96 VLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE-R 174 (592)
T ss_pred EEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccc-c
Confidence 999999988888877888999999999999999999999999999999999999999999999999999998875533 3
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccC
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~ 368 (704)
..+.||||.|+|||++.. ..++..+||||+|||||.||+|+|||+..+..+++.+|...-...|
T Consensus 175 k~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P--------------- 238 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMP--------------- 238 (592)
T ss_pred cceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccc---------------
Confidence 456899999999999986 6689999999999999999999999999999999999976433332
Q ss_pred CCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 369 ~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
..++.++++||.+||..||.+|||++++|.|+||+..
T Consensus 239 --------------~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g 275 (592)
T KOG0575|consen 239 --------------SHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSG 275 (592)
T ss_pred --------------cccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCC
Confidence 3789999999999999999999999999999999654
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-54 Score=448.03 Aligned_cols=294 Identities=36% Similarity=0.594 Sum_probs=251.9
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEee---cCCCeE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITS---RLSCSI 206 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~---~~~~~~ 206 (704)
..|..++.||.|+||.|+.|.++.+|+.||||++..........+...||+++|+.++|+||+.+++++.. ..-..+
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 35677899999999999999999999999999998544456667888899999999999999999999875 234578
Q ss_pred EEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC-C
Q 005289 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG-H 285 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~-~ 285 (704)
|+|+|+|+-+|...+. .+..+++..+..++.|||.||.|+|+.+|+||||||+|+|++.+..+||||||+|+..... .
T Consensus 102 YiV~elMetDL~~iik-~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~ 180 (359)
T KOG0660|consen 102 YLVFELMETDLHQIIK-SQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFE 180 (359)
T ss_pred EEehhHHhhHHHHHHH-cCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCc
Confidence 9999999877666654 4445999999999999999999999999999999999999999999999999999977532 2
Q ss_pred CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
...++.++.|.||+|||++.....|+.++||||+||||.||++|+|+|.|.+..+|+..|...+|.|+++.+.......+
T Consensus 181 ~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~a 260 (359)
T KOG0660|consen 181 DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKA 260 (359)
T ss_pred ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHH
Confidence 24568889999999999999889999999999999999999999999999999999999999999999888776553222
Q ss_pred ccCC--CCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCCCCC
Q 005289 366 TLFK--PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACD 424 (704)
Q Consensus 366 ~~~~--~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~~~~ 424 (704)
..+. ..+.....+...|+..++.++|||++||.+||.+|+|++|+|+||||.....+.+
T Consensus 261 r~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~d 321 (359)
T KOG0660|consen 261 RPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPED 321 (359)
T ss_pred HHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCcc
Confidence 1111 1112233457788999999999999999999999999999999999997655543
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-53 Score=440.80 Aligned_cols=292 Identities=42% Similarity=0.738 Sum_probs=250.3
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCC-ceeEeEEEeecC----C
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPN-IIKLEGLITSRL----S 203 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hpn-Iv~l~~~~~~~~----~ 203 (704)
...|+.+++||+|+||+||+|+++.+|+.||||+++.+.-.+..-....+|+.+|+.|+|+| ||.|++++.... .
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34688899999999999999999999999999999876543233445679999999999999 999999998742 2
Q ss_pred CeEEEEEecccccccccccCCC---ccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccc
Q 005289 204 CSIYLVFEYMEHDITGLLSCPD---IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 280 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~~~~~~---~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~ 280 (704)
..+||||||++-++...+.... ..++...++.+|.||+.||+|||+++|+||||||+||||+++|.+||+|||+|+.
T Consensus 90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence 3789999999988777665433 4578899999999999999999999999999999999999999999999999997
Q ss_pred cCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhcc
Q 005289 281 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (704)
Q Consensus 281 ~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~ 360 (704)
+.-+. ..++..++|.||+|||++++...|+..+||||+|||++||++++++|.|..+.+++..|++++|.|.++.|+..
T Consensus 170 ~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 170 FSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred hcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence 66333 34678899999999999999989999999999999999999999999999999999999999999999999874
Q ss_pred C-CCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCC
Q 005289 361 K-LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (704)
Q Consensus 361 ~-~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~ 421 (704)
. ++......+.......+....+....++.+|+.+||+++|.+|+||..+|.||||...+.
T Consensus 249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 4 333332222222244566667777889999999999999999999999999999997544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-53 Score=439.82 Aligned_cols=263 Identities=31% Similarity=0.478 Sum_probs=234.1
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
..++|++++.||+|+||+||+++.+.|++.||+|++++.... ....+.+..|..||.+++||+||+|+..|++ ...+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt--~~kL 100 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQT--EEKL 100 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEeccc--CCeE
Confidence 356899999999999999999999999999999999887653 3457778899999999999999999888888 6899
Q ss_pred EEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC
Q 005289 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~ 286 (704)
|||+||+.|+.|...+...+.|+|..++.|+.+|+.||.|||+.|||||||||+|||||.+|+|+|+|||||+..-...
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~- 179 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG- 179 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC-
Confidence 9999999999888888888899999999999999999999999999999999999999999999999999998554332
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcc
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~ 366 (704)
....+.|||+.|||||++.+ ..|+..+|+|||||++|||++|.+||.+.+....+++|...-...
T Consensus 180 ~~t~tfcGT~eYmAPEil~~-~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~-------------- 244 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLG-KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPL-------------- 244 (357)
T ss_pred CccccccCCccccChHHHhc-CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCC--------------
Confidence 34456899999999999987 579999999999999999999999999999999999997621111
Q ss_pred cCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCc----CHHHHHhccccCCCCCC
Q 005289 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA----TASAALASEYFSTKPYA 422 (704)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRp----Ta~e~L~hpwf~~~~~~ 422 (704)
....++.++++||++||..||++|. .+.++-+||||....|.
T Consensus 245 --------------~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~ 290 (357)
T KOG0598|consen 245 --------------PPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWE 290 (357)
T ss_pred --------------CCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHH
Confidence 1124789999999999999999995 78999999999987763
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-52 Score=448.07 Aligned_cols=279 Identities=32% Similarity=0.496 Sum_probs=239.0
Q ss_pred cccccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC
Q 005289 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (704)
Q Consensus 125 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 203 (704)
..+..++|+++..||+|+||.||+|+.+.||.+||+|++++..+ ...+++.+..|..||...++|+||+|+..|++ .
T Consensus 136 ~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD--~ 213 (550)
T KOG0605|consen 136 TRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD--K 213 (550)
T ss_pred ccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC--C
Confidence 34568899999999999999999999999999999999998765 45677888999999999999999999999988 6
Q ss_pred CeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCC
Q 005289 204 CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~ 283 (704)
.++||||||++|+.+..++.....|+|..++.|+.+++.||+.||+.|+|||||||+|+|||..|+|||+|||||..+..
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred CeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence 89999999999988888877888999999999999999999999999999999999999999999999999999853211
Q ss_pred ----------------------CCCC------------------------CcccccccccccCcccccCCCCCCCccchh
Q 005289 284 ----------------------GHRQ------------------------PLTSRVVTLWYRPPELLLGATDYGPSVDLW 317 (704)
Q Consensus 284 ----------------------~~~~------------------------~~~~~~gT~~Y~APEvl~~~~~y~~~~DIW 317 (704)
.... ...+.+|||.|||||+|.+ ..|+..||+|
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~~~cDwW 372 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYGKECDWW 372 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCCccccHH
Confidence 0000 1134589999999999998 5699999999
Q ss_pred hHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhc-cCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHh
Q 005289 318 SVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 396 (704)
Q Consensus 318 SlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~-~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~m 396 (704)
|||||+||||.|.|||.+.+..++..+|+. |+. ++.|.. ..++.+++|||.+|
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~n---------wr~~l~fP~~-----------------~~~s~eA~DLI~rl 426 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVN---------WRETLKFPEE-----------------VDLSDEAKDLITRL 426 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHH---------HhhhccCCCc-----------------CcccHHHHHHHHHH
Confidence 999999999999999999999999999976 322 222211 35679999999999
Q ss_pred hccCCCCCcC---HHHHHhccccCCCCCCCCCCCCCCCCC
Q 005289 397 LSVEPYKRAT---ASAALASEYFSTKPYACDLSSLPIYPP 433 (704)
Q Consensus 397 L~~dP~kRpT---a~e~L~hpwf~~~~~~~~~~~~p~~~~ 433 (704)
|+ ||++|.- ++||-+||||+...|..--...|.+.|
T Consensus 427 l~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~apfvP 465 (550)
T KOG0605|consen 427 LC-DPENRLGSKGAEEIKKHPFFKGVDWDHLREMPAPFVP 465 (550)
T ss_pred hc-CHHHhcCcccHHHHhcCCccccCCcchhhcCCCCCCC
Confidence 99 9999975 899999999999888654433344433
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-51 Score=443.49 Aligned_cols=262 Identities=32% Similarity=0.507 Sum_probs=234.0
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCCeE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~ 206 (704)
..+|.+.+.||+|+|++|++|+++.+++.||||++.+..+- +...+.+.+|-.+|.+| .||.|++|+..|++ ...+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD--~~sL 149 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD--EESL 149 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec--ccce
Confidence 46799999999999999999999999999999999776543 33456678899999999 89999999999988 5789
Q ss_pred EEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC
Q 005289 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~ 286 (704)
|+|+||++++.+..++..-+.|+|..++.|+.||+.||+|||++|||||||||+|||||.++++||+|||.|+.+.+...
T Consensus 150 YFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~ 229 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK 229 (604)
T ss_pred EEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence 99999999977777777778999999999999999999999999999999999999999999999999999987754321
Q ss_pred C----------C--cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCc
Q 005289 287 Q----------P--LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 354 (704)
Q Consensus 287 ~----------~--~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~ 354 (704)
. . ..+.+||..|.+||+|.. ...++.+|||+||||||.|+.|.|||.+.++.-++++|+++...+|
T Consensus 230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp- 307 (604)
T KOG0592|consen 230 SQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP- 307 (604)
T ss_pred cccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC-
Confidence 1 1 255899999999999876 6789999999999999999999999999999999999999766554
Q ss_pred hhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCCC
Q 005289 355 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422 (704)
Q Consensus 355 ~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~~ 422 (704)
+.+++.+.|||+++|..||.+|+|+.+|-+||||....|.
T Consensus 308 ----------------------------~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~ 347 (604)
T KOG0592|consen 308 ----------------------------EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWE 347 (604)
T ss_pred ----------------------------CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChh
Confidence 4688999999999999999999999999999999876654
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-51 Score=426.97 Aligned_cols=280 Identities=39% Similarity=0.650 Sum_probs=239.2
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCC---eEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSC---SIY 207 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~---~~~ 207 (704)
.|...+.+|.|+||+||.|....+++.||||++-.+.- .-.+|++||+.++|||||+|+.+|....+. +..
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 48999999999999999999999999999999865431 224699999999999999999988754444 557
Q ss_pred EEEeccccccccccc---CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccC-CceEEeccccccccCC
Q 005289 208 LVFEYMEHDITGLLS---CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNT 283 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~---~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~-g~iKL~DFGla~~~~~ 283 (704)
||||||+.++...+. ..+..++...++-|+.||++||.|||+.||+||||||.|||||.+ |.+||||||.|+....
T Consensus 99 lVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 99 LVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred HHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 899999998777664 346678999999999999999999999999999999999999977 8999999999998876
Q ss_pred CCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCC
Q 005289 284 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 284 ~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
++ +..++..|..|+|||++++.+.|+.++||||.||++.||+-|+|+|.|++..+|+..|++.+|.|..+....++..
T Consensus 179 ~e--pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~ 256 (364)
T KOG0658|consen 179 GE--PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPN 256 (364)
T ss_pred CC--CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcc
Confidence 64 4477888999999999999999999999999999999999999999999999999999999999998876665543
Q ss_pred CcccCCCCCCCCchhhh-hccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 364 HATLFKPQQPYDSSLRE-TFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 364 ~~~~~~~~~~~~~~l~~-~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
.... ...+.....+.+ .+..+++++.+|+.++|.++|.+|.++.|+|.||||.+.
T Consensus 257 y~~~-~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 257 YTEF-KFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL 312 (364)
T ss_pred cccc-cCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence 2211 111111122222 457899999999999999999999999999999999864
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-51 Score=425.35 Aligned_cols=259 Identities=29% Similarity=0.433 Sum_probs=226.3
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEE
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 207 (704)
..++.+.++.||+|..|+||+|+++.|++.+|+|+|.. ..++...+.+.+|++||++.+|||||++|+.|..... .++
T Consensus 77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~is 154 (364)
T KOG0581|consen 77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EIS 154 (364)
T ss_pred CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEE
Confidence 34578899999999999999999999999999999953 4567778889999999999999999999999998543 699
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHh-cCcccccCCCccEEEccCCceEEeccccccccCCCCC
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~-~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~ 286 (704)
|+||||+++.|+.+....+.++|..+..++.+|++||.|||+ ++||||||||+||||+..|.|||||||.+...-..
T Consensus 155 I~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred eehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 999999999999887777889999999999999999999995 89999999999999999999999999999866542
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHHHcCCCCchhhhccC
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR-----TEVEQLHKIFKLCGSPPDDYWKKSK 361 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~-----~~~e~l~~I~~~~g~~p~~~w~~~~ 361 (704)
...+.+||..|||||.+.+ ..|+.++||||||++|+||++|+.||... ...+.+..| +..+|+..
T Consensus 233 -~a~tfvGT~~YMsPERi~g-~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I---v~~ppP~l----- 302 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISG-ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI---VDEPPPRL----- 302 (364)
T ss_pred -hcccccccccccChhhhcC-CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH---hcCCCCCC-----
Confidence 5578899999999999987 67999999999999999999999999874 344555554 33333211
Q ss_pred CCCcccCCCCCCCCchhhhhcc-CCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCC
Q 005289 362 LPHATLFKPQQPYDSSLRETFK-DLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (704)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~-~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~ 420 (704)
.. .+++++++||..||.+||.+|+|+.|+|+|||+++..
T Consensus 303 --------------------P~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 303 --------------------PEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred --------------------CcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 12 4899999999999999999999999999999998643
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-51 Score=410.67 Aligned_cols=261 Identities=26% Similarity=0.434 Sum_probs=235.2
Q ss_pred ccccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCC
Q 005289 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (704)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 204 (704)
+...++|++++.||.|+||.|.+++++.+|.+||+|++.+... ...+.+...+|..+|+.+.||+|++|++.|.+ ..
T Consensus 40 ~~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d--~~ 117 (355)
T KOG0616|consen 40 PYSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD--NS 117 (355)
T ss_pred CcchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc--CC
Confidence 3567899999999999999999999999999999999987654 34566778899999999999999999988887 68
Q ss_pred eEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
.+||||||++|+.+..++...++|++..++.|+.||+.||+|||+++|++|||||||||||.+|.+||+|||+|+.....
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 99999999999988888888889999999999999999999999999999999999999999999999999999877642
Q ss_pred CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
.-+.||||.|+|||++.. +.|+.++|+|+|||++|||+.|.+||...+...++++|.+.--.+|
T Consensus 198 ----T~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP----------- 261 (355)
T KOG0616|consen 198 ----TWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFP----------- 261 (355)
T ss_pred ----EEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCC-----------
Confidence 456799999999999986 7899999999999999999999999999999999999987432222
Q ss_pred cccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCc-----CHHHHHhccccCCCCCC
Q 005289 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPYA 422 (704)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRp-----Ta~e~L~hpwf~~~~~~ 422 (704)
..++.+++|||+++|+.|-.+|. -..++..||||+...|.
T Consensus 262 ------------------~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~ 306 (355)
T KOG0616|consen 262 ------------------SYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWE 306 (355)
T ss_pred ------------------cccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHH
Confidence 36789999999999999999993 46789999999987775
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-52 Score=411.18 Aligned_cols=260 Identities=32% Similarity=0.479 Sum_probs=232.7
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.+.|++.+.||+|.|+.|+++.+..||+.+|+|+|....+.....+.+.+|+.|.+.|+|||||+|++.+.. ....||
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~--~~~~yl 87 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHYL 87 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcc--cceeEE
Confidence 567999999999999999999999999999999998887777778889999999999999999999998877 578899
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccC---CceEEeccccccccCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE---GVLKLADFGLANFSNTGH 285 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~---g~iKL~DFGla~~~~~~~ 285 (704)
|+|+|+|+.+..-+.....++|..+..+++|||.+|.|||.+||||||+||+|+||-.. ..+||+|||+|.....+
T Consensus 88 vFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g- 166 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG- 166 (355)
T ss_pred EEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc-
Confidence 99999996554433334678999999999999999999999999999999999999654 35999999999888733
Q ss_pred CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
.....++|||.|||||++.. .+|+..+|||+.|||||.||.|.+||.+.+...++++|++.-...+..+|
T Consensus 167 -~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w-------- 236 (355)
T KOG0033|consen 167 -EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEW-------- 236 (355)
T ss_pred -cccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCccc--------
Confidence 56678899999999999986 67999999999999999999999999999999999999886655554444
Q ss_pred ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
+.+++++++||++||..||.+|+|+.|+|+|||+.+
T Consensus 237 -----------------~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 237 -----------------DTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred -----------------CcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 689999999999999999999999999999999985
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-51 Score=382.89 Aligned_cols=286 Identities=41% Similarity=0.720 Sum_probs=253.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
..|...++||+|+||+||++++..+++.||+|.++.+.-++..-....+||.+|+.|.|.|||+++++... ...+-||
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs--dkkltlv 79 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLV 79 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc--CceeEEe
Confidence 35888899999999999999999999999999999877655555567899999999999999999999877 5678999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCc
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~ 289 (704)
+|||..++...+..-++.+..+.++.+|.|++.||.|||+++|.||||||.|+||+.+|.+||+|||+++.+.-.- ..+
T Consensus 80 fe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv-rcy 158 (292)
T KOG0662|consen 80 FEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-RCY 158 (292)
T ss_pred HHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce-Eee
Confidence 9999998888887778889999999999999999999999999999999999999999999999999999877543 234
Q ss_pred ccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccC
Q 005289 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (704)
Q Consensus 290 ~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~ 368 (704)
...+.|.||++|.++++.+-|+...|+||.|||+.||.. |+|+|+|.+..+++.+|+.++|.|.++.|....-......
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~ 238 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP 238 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence 566889999999999999999999999999999999985 8999999999999999999999999999987543333333
Q ss_pred CCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 369 ~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
.|.-+-...+.+..+.+....+||++++|..+|.+|++|+++|+||||..
T Consensus 239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 34444445667777888999999999999999999999999999999975
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-50 Score=418.89 Aligned_cols=262 Identities=29% Similarity=0.482 Sum_probs=232.4
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEE
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 207 (704)
..++|.+.++||.|+|++||+|+++.++..||||.|.+..+.....+.+..||.||+.|+|||||.|++++.. .+++|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~--~~~i~ 85 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED--DDFIY 85 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec--CCeEE
Confidence 3568999999999999999999999999999999999988888889999999999999999999999999988 57999
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccC------CceEEecccccccc
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE------GVLKLADFGLANFS 281 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~------g~iKL~DFGla~~~ 281 (704)
||||||.|+.|..++...+.++|..++.+|.||+.||++||+++||||||||.||||+.. -.+||+|||+|+..
T Consensus 86 lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 999999998888888777799999999999999999999999999999999999999875 45899999999988
Q ss_pred CCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccC
Q 005289 282 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (704)
Q Consensus 282 ~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~ 361 (704)
.+. ....+.||+|.|||||++.. ..|+.++|+||+|+|||+|++|++||...+..+.+..+.+.-...+
T Consensus 166 ~~~--~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~-------- 234 (429)
T KOG0595|consen 166 QPG--SMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVP-------- 234 (429)
T ss_pred Cch--hHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccC--------
Confidence 755 45677899999999999975 6799999999999999999999999999999988876644211110
Q ss_pred CCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCC
Q 005289 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (704)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~ 420 (704)
.....++....+|+..+|..+|..|.+..+-+.|++....|
T Consensus 235 ------------------~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 235 ------------------VLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred ------------------chhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 01124566778999999999999999999999999998655
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-49 Score=428.20 Aligned_cols=259 Identities=32% Similarity=0.477 Sum_probs=223.8
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC---hHHHHHHHHHHHHHHhcC-CCCceeEeEEEeecCC
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE---PESVRFMAREILILRRLD-HPNIIKLEGLITSRLS 203 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~---~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~ 203 (704)
....|.+.+.||+|+||+|++|++..++..||+|++.+.... ....+.+.+|+.+|+.+. ||||+++++++...
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~-- 92 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP-- 92 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC--
Confidence 356899999999999999999999999999999988765222 133556778999999998 99999999999884
Q ss_pred CeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccC-CceEEeccccccccC
Q 005289 204 CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSN 282 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~-g~iKL~DFGla~~~~ 282 (704)
..+|||||||.++.+.......+++.|..++.+++||+.||+|||++||+||||||+||||+.+ +++||+|||++....
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 5699999999985444444447899999999999999999999999999999999999999999 999999999998774
Q ss_pred CCCCCCcccccccccccCcccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccC
Q 005289 283 TGHRQPLTSRVVTLWYRPPELLLGAT-DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (704)
Q Consensus 283 ~~~~~~~~~~~gT~~Y~APEvl~~~~-~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~ 361 (704)
.....+.+.|||+.|+|||++.+.. .-+.++|||||||+||.|++|+.||...+....+.+|.+.....|
T Consensus 173 -~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p-------- 243 (370)
T KOG0583|consen 173 -GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIP-------- 243 (370)
T ss_pred -CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCC--------
Confidence 2235678889999999999998855 346899999999999999999999999888888888765322111
Q ss_pred CCCcccCCCCCCCCchhhhhccCC-CHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 362 LPHATLFKPQQPYDSSLRETFKDL-PTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~-s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
..+ +.++++||.+||..||.+|+|+.+++.||||+.
T Consensus 244 ---------------------~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 244 ---------------------SYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred ---------------------CCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 234 999999999999999999999999999999997
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=410.85 Aligned_cols=283 Identities=40% Similarity=0.718 Sum_probs=236.0
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|+++++||.|+||+||+|++..+++.||+|++...... .....+.+|+.+|+.++||||+++++++.. ...+|+
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 80 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHT--ERCLTL 80 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcC--CCeEEE
Confidence 56899999999999999999999999999999999754322 223456789999999999999999999877 468999
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
||||+.+++...+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-~~ 159 (288)
T cd07871 81 VFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-KT 159 (288)
T ss_pred EEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC-cc
Confidence 99999987766665555568999999999999999999999999999999999999999999999999997654322 22
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc--c
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA--T 366 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~--~ 366 (704)
.....+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.++.+.|........ .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 34457799999999987767789999999999999999999999999999999999999999999998876432211 1
Q ss_pred cCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
...+.. ....+......++.++++||.+||.+||.+|||+.|+|+||||
T Consensus 240 ~~~~~~-~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 240 YLFPQY-RAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred cccCcc-CCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 111111 1112233446788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-49 Score=432.76 Aligned_cols=282 Identities=28% Similarity=0.527 Sum_probs=233.1
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-C-----CCceeEeEEEeecCCC
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-H-----PNIIKLEGLITSRLSC 204 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-H-----pnIv~l~~~~~~~~~~ 204 (704)
+|++++.||+|+||.|.+|++..|++.||||+|+.. .........|+.||..|+ | -|||+++++|.. .+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f--r~ 261 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF--RN 261 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc--cc
Confidence 689999999999999999999999999999999754 344555677999999996 4 389999999998 57
Q ss_pred eEEEEEecccccccccccCCC-ccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCC--ceEEecccccccc
Q 005289 205 SIYLVFEYMEHDITGLLSCPD-IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG--VLKLADFGLANFS 281 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~~~~-~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g--~iKL~DFGla~~~ 281 (704)
++|||+|+++-+|..++.... ..|+...++.++.|||.||.+||+.||||+|||||||||.+-+ .|||+|||.|+..
T Consensus 262 HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 262 HLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred ceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 999999999999888776533 4599999999999999999999999999999999999997654 6999999999877
Q ss_pred CCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccC
Q 005289 282 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (704)
Q Consensus 282 ~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~ 361 (704)
... ..+++.+..|+|||+|++ .+|+.++||||||||++||++|.|+|.|.++.+|+..|++++|.||....+.++
T Consensus 342 ~q~----vytYiQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~ 416 (586)
T KOG0667|consen 342 SQR----VYTYIQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK 416 (586)
T ss_pred CCc----ceeeeeccccccchhhcc-CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 642 337888999999999998 789999999999999999999999999999999999999999999976554432
Q ss_pred CCCcccCC--------------------------------CCCC-CCchhhhhcc-CCCHHHHHHHHHhhccCCCCCcCH
Q 005289 362 LPHATLFK--------------------------------PQQP-YDSSLRETFK-DLPTTAVNLIETLLSVEPYKRATA 407 (704)
Q Consensus 362 ~~~~~~~~--------------------------------~~~~-~~~~l~~~~~-~~s~~~~dLI~~mL~~dP~kRpTa 407 (704)
-.+..+.. -..| ....+...+. .-...+.|||.+||.+||.+|+|+
T Consensus 417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp 496 (586)
T KOG0667|consen 417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP 496 (586)
T ss_pred ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence 21111100 0001 1111222222 233567999999999999999999
Q ss_pred HHHHhccccCCCCCC
Q 005289 408 SAALASEYFSTKPYA 422 (704)
Q Consensus 408 ~e~L~hpwf~~~~~~ 422 (704)
.++|+||||+.....
T Consensus 497 ~qal~Hpfl~~~~~~ 511 (586)
T KOG0667|consen 497 AQALNHPFLTGTSLE 511 (586)
T ss_pred HHHhcCccccccccc
Confidence 999999999976554
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-49 Score=431.98 Aligned_cols=259 Identities=26% Similarity=0.435 Sum_probs=232.7
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecC-CCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFD-NFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~-~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.-|++.+.||.|+-|.|.+|++..||+.+|||+|.+. .........+.+||-||+.|.||||++|+++++. ..++||
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~--~~~lyl 89 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN--KQHLYL 89 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc--CceEEE
Confidence 3588999999999999999999999999999999876 4445556668899999999999999999999987 689999
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
|.||++++.+..+....++|+|.+++.++.||+.||.|||..+|+||||||+|+|||..++|||+|||+|....++ ..
T Consensus 90 vlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g--kl 167 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG--KL 167 (786)
T ss_pred EEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC--cc
Confidence 9999999877777777889999999999999999999999999999999999999999999999999999876554 45
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccC
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~ 368 (704)
+.+.||+|.|.|||++.+..+.+.++||||+|||||.||+|+.||.+++-...+.++.....
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f------------------ 229 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF------------------ 229 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc------------------
Confidence 77889999999999999987788999999999999999999999998888888888866322
Q ss_pred CCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCC
Q 005289 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (704)
Q Consensus 369 ~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~ 421 (704)
++...++.++++||.+||.+||++|+|.++|++|||+..-.-
T Consensus 230 -----------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 230 -----------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred -----------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCC
Confidence 223579999999999999999999999999999999986433
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=412.84 Aligned_cols=264 Identities=31% Similarity=0.468 Sum_probs=228.2
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC------------hHHHHHHHHHHHHHHhcCCCCceeEeE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE------------PESVRFMAREILILRRLDHPNIIKLEG 196 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~------------~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 196 (704)
.+.|++++.||+|.||.|-+|++..+++.||||++.+..+. ....+.+.+||.||++|+|||||+|++
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 56899999999999999999999999999999999764321 112457889999999999999999999
Q ss_pred EEeecCCCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccc
Q 005289 197 LITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFG 276 (704)
Q Consensus 197 ~~~~~~~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFG 276 (704)
+..++....+|||+|||..+...+....+..+++.+++.|++.++.||+|||.+|||||||||+|+||+++|++||+|||
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFG 255 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFG 255 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccc
Confidence 99999999999999999988777766555459999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCC----CCCcccccccccccCcccccC---CCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Q 005289 277 LANFSNTGH----RQPLTSRVVTLWYRPPELLLG---ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 349 (704)
Q Consensus 277 la~~~~~~~----~~~~~~~~gT~~Y~APEvl~~---~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~ 349 (704)
.+..+..+. ...+...+|||.|+|||.+.+ ....+.+.|||||||+||.|+.|+.||.+....+.+.+|+..-
T Consensus 256 Vs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~p 335 (576)
T KOG0585|consen 256 VSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDP 335 (576)
T ss_pred eeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCc
Confidence 998763321 122344689999999999876 2345778999999999999999999999999999999998732
Q ss_pred CCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 350 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 350 g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
-.+| ..+.+.+.++|||.+||.+||++|+|+.++..|||....
T Consensus 336 L~fP---------------------------~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 336 LEFP---------------------------ENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred ccCC---------------------------CcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 2221 123678899999999999999999999999999999864
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=403.12 Aligned_cols=284 Identities=35% Similarity=0.593 Sum_probs=234.3
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
++|++++.||+|+||+||+|++..+++.||||++..........+.+.+|+.+++.++||||+++++++.. ...+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR--RGKLYLV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec--CCEEEEE
Confidence 36999999999999999999999999999999997654444455677889999999999999999999977 5789999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCc
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~ 289 (704)
|||++++++..+......+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||+|||++...........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence 99999988777665556799999999999999999999999999999999999999999999999999987654333334
Q ss_pred ccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC---cc
Q 005289 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH---AT 366 (704)
Q Consensus 290 ~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~---~~ 366 (704)
....+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+....+..+.+.|....... ..
T Consensus 159 ~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 159 TEYVATRWYRSPELLLG-APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred cccccccccCCcHHHcC-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 45678999999999876 458999999999999999999999999999888888888888888776554321100 00
Q ss_pred cCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
.+................++.++.+||++||.+||++|||++++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00000001111122335688999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-48 Score=427.20 Aligned_cols=264 Identities=26% Similarity=0.413 Sum_probs=233.6
Q ss_pred cccccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecC
Q 005289 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRL-DHPNIIKLEGLITSRL 202 (704)
Q Consensus 125 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~ 202 (704)
.++..++|.+++.||+|.||+|+++..+.++++||||+++++.+ ..+.++.+..|..|+... +||+|+.|+..|+.
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT-- 440 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT-- 440 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc--
Confidence 35678899999999999999999999999999999999998765 567788899999999988 59999999999988
Q ss_pred CCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccC
Q 005289 203 SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (704)
Q Consensus 203 ~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~ 282 (704)
..++|+||||+.|+.+.. ......|+|..++.|+..|+.||.|||++||||||||.+|||||.+|++||+|||+++..-
T Consensus 441 ~~~l~fvmey~~Ggdm~~-~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 441 KEHLFFVMEYVAGGDLMH-HIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred CCeEEEEEEecCCCcEEE-EEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC
Confidence 689999999999988443 3455689999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCC
Q 005289 283 TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (704)
Q Consensus 283 ~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~ 362 (704)
-.. ....+.||||.|||||++.+ ..|+.++|+|+|||+|||||.|.+||.|++++++++.|+..--.+|
T Consensus 520 ~~g-~~TsTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP--------- 588 (694)
T KOG0694|consen 520 GQG-DRTSTFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYP--------- 588 (694)
T ss_pred CCC-CccccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC---------
Confidence 222 34577899999999999987 6799999999999999999999999999999999999976321111
Q ss_pred CCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcC-----HHHHHhccccCCCCCC
Q 005289 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPYA 422 (704)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpT-----a~e~L~hpwf~~~~~~ 422 (704)
..++.++.++|++||..||++|.- +.+|.+||||+...|.
T Consensus 589 --------------------~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~ 633 (694)
T KOG0694|consen 589 --------------------RFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWD 633 (694)
T ss_pred --------------------CcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHH
Confidence 368999999999999999999976 4889999999987774
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-48 Score=405.12 Aligned_cols=278 Identities=27% Similarity=0.374 Sum_probs=235.2
Q ss_pred ccccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCC
Q 005289 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (704)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 204 (704)
.+..+.|++++.||.|.-|+||+|+...++..+|+|+|.++.+. .....++..|.+||..++||+|+.||..|+. ..
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet--~~ 150 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET--DK 150 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec--cc
Confidence 35567899999999999999999999999999999999887654 4456667789999999999999999999988 68
Q ss_pred eEEEEEeccccccccccc--CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccC
Q 005289 205 SIYLVFEYMEHDITGLLS--CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~--~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~ 282 (704)
.+|||||||.|+.|..+. +++..|++..++.|+.+|+.||+|||..|||+|||||+||||-++|+|.|+||.|+....
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 999999999998877664 456789999999999999999999999999999999999999999999999999874221
Q ss_pred C---------------------------------C-C---------------------CCCcccccccccccCcccccCC
Q 005289 283 T---------------------------------G-H---------------------RQPLTSRVVTLWYRPPELLLGA 307 (704)
Q Consensus 283 ~---------------------------------~-~---------------------~~~~~~~~gT~~Y~APEvl~~~ 307 (704)
. . . .....+.+||-.|+|||++.+
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G- 309 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG- 309 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec-
Confidence 0 0 0 011244688999999999998
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCH
Q 005289 308 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPT 387 (704)
Q Consensus 308 ~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~ 387 (704)
...+.++|||+|||+|||||.|..||.|.+..+++.+|+..--.+|+ .+.++.
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~---------------------------~~~vs~ 362 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPE---------------------------EPEVSS 362 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCC---------------------------CCcchh
Confidence 45799999999999999999999999999999999998653222211 126778
Q ss_pred HHHHHHHHhhccCCCCCcC----HHHHHhccccCCCCCCCCCCCCCCCCC
Q 005289 388 TAVNLIETLLSVEPYKRAT----ASAALASEYFSTKPYACDLSSLPIYPP 433 (704)
Q Consensus 388 ~~~dLI~~mL~~dP~kRpT----a~e~L~hpwf~~~~~~~~~~~~p~~~~ 433 (704)
.++|||++||.+||.+|+- |.||-+||||+...|+.-....|.+.|
T Consensus 363 ~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP 412 (459)
T KOG0610|consen 363 AAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIP 412 (459)
T ss_pred HHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcCC
Confidence 9999999999999999999 999999999999888754444444433
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=405.49 Aligned_cols=288 Identities=38% Similarity=0.660 Sum_probs=232.5
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|+++++||.|+||+||+|++..+++.||||++...... .....+.+|+.+|+.++||||+++++++.+ ...+|+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 80 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHT--KETLTL 80 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEec--CCeEEE
Confidence 46899999999999999999999999999999999754322 223346689999999999999999999987 468999
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
||||+.++++..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 159 (303)
T cd07869 81 VFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HT 159 (303)
T ss_pred EEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-cc
Confidence 99999988877776666678999999999999999999999999999999999999999999999999987543222 23
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHcCCCCchhhhccCCC-Ccc
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR-TEVEQLHKIFKLCGSPPDDYWKKSKLP-HAT 366 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~-~~~e~l~~I~~~~g~~p~~~w~~~~~~-~~~ 366 (704)
....++|+.|+|||++.+...++.++|||||||+||+|++|.+||.+. +..+.+..+....+.+....|...... ...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK 239 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence 345678999999999877667899999999999999999999999875 445778888888888887777653311 100
Q ss_pred cCCCCCCCCchhhhhcc--CCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCC
Q 005289 367 LFKPQQPYDSSLRETFK--DLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (704)
Q Consensus 367 ~~~~~~~~~~~l~~~~~--~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~ 420 (704)
...........+...+. .++..+.+||.+||++||.+|||+.++|+||||+..+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 00000011122233332 3568899999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-49 Score=396.00 Aligned_cols=293 Identities=38% Similarity=0.673 Sum_probs=238.4
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCC----cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTG----KIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g----~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 204 (704)
...|+++.+||.|+||.||+|....++ +.+|||++..+.-.........|||.+++.|+||||+.|..+|... ..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH-DK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-Cc
Confidence 357999999999999999999655443 3689999976532222223356899999999999999999988764 57
Q ss_pred eEEEEEecccccccccccC----CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccC----CceEEeccc
Q 005289 205 SIYLVFEYMEHDITGLLSC----PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE----GVLKLADFG 276 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~~----~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~----g~iKL~DFG 276 (704)
.++|++||.+++|+..+.. ....++...++.|+.||+.||.|||++-|+||||||.||||..+ |.|||+|||
T Consensus 102 ~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 102 KVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred eEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 8999999999999887642 33569999999999999999999999999999999999999888 899999999
Q ss_pred cccccCCCCCC--CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC---------HHHHHHHH
Q 005289 277 LANFSNTGHRQ--PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT---------EVEQLHKI 345 (704)
Q Consensus 277 la~~~~~~~~~--~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~---------~~e~l~~I 345 (704)
+++.+...-.. .....+.|.||+|||+|++...|+.++|||++|||+.|||+-.|+|.+.. ..+++.+|
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI 261 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI 261 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence 99987654322 23445779999999999999999999999999999999999999998853 36899999
Q ss_pred HHHcCCCCchhhhcc-CCCCc-ccC-CCC-CCCCch-h---hhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccC
Q 005289 346 FKLCGSPPDDYWKKS-KLPHA-TLF-KPQ-QPYDSS-L---RETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417 (704)
Q Consensus 346 ~~~~g~~p~~~w~~~-~~~~~-~~~-~~~-~~~~~~-l---~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~ 417 (704)
++++|.|.+..|... ++|+. +.. ... ..+.+. | ...++.-++.+.+||.+||++||.+|+|++++|+|+||+
T Consensus 262 f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~ 341 (438)
T KOG0666|consen 262 FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFT 341 (438)
T ss_pred HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccc
Confidence 999999999999874 34443 111 111 122221 2 233455567799999999999999999999999999999
Q ss_pred CCCCC
Q 005289 418 TKPYA 422 (704)
Q Consensus 418 ~~~~~ 422 (704)
+.+.+
T Consensus 342 ~d~lp 346 (438)
T KOG0666|consen 342 EDPLP 346 (438)
T ss_pred cCCCC
Confidence 87654
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=399.83 Aligned_cols=302 Identities=47% Similarity=0.799 Sum_probs=251.7
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|++.+.||.|+||.||+|.+..+|+.||+|++............+.+|+.+|++++|+||+++++++.+.....+|+
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 56899999999999999999999999999999999765433322334567999999999999999999997754567899
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
||||+++++...+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 86 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~-~~ 164 (309)
T cd07845 86 VMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA-KP 164 (309)
T ss_pred EEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc-CC
Confidence 99999987666655445679999999999999999999999999999999999999999999999999998765432 22
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCC-Cccc
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP-HATL 367 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~-~~~~ 367 (704)
.....+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++.+....|...... ....
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (309)
T cd07845 165 MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGK 244 (309)
T ss_pred CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccccc
Confidence 233455888999999877667899999999999999999999999999999999999999999988888654321 1111
Q ss_pred CC-CCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCCCCCCCCCCCCC
Q 005289 368 FK-PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYP 432 (704)
Q Consensus 368 ~~-~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~~~~~~~~p~~~ 432 (704)
+. ...++ ..+...+..+++.+.+||.+||.+||++|||+.++|.||||+..+.+|.+..+|.+|
T Consensus 245 ~~~~~~~~-~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~~~~~~~~~ 309 (309)
T cd07845 245 FTLPKQPY-NNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCEPEMMPTFP 309 (309)
T ss_pred ccccCCCC-CchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCCCCcCCCCC
Confidence 11 11222 234445566799999999999999999999999999999999999999988888765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-48 Score=414.70 Aligned_cols=259 Identities=31% Similarity=0.497 Sum_probs=230.8
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
++|.+...||+|.||.||+|+.+.+.+.||+|.+.+..-.....+.+.+|++|++.|+|||||.+++.|+. ..++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt--~~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET--SAHLWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc--cceEEEE
Confidence 57899999999999999999999999999999998877777788999999999999999999999999987 5789999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCc
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~ 289 (704)
+|||.|++.. ++..+..++|+.++.++.|++.||.|||+++|+|||+||.||||+..+++|+||||+|+....+ ....
T Consensus 80 te~a~g~L~~-il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t~vl 157 (808)
T KOG0597|consen 80 TEYAVGDLFT-ILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-TSVL 157 (808)
T ss_pred ehhhhhhHHH-HHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccC-ceee
Confidence 9999995544 4456678999999999999999999999999999999999999999999999999999988764 3556
Q ss_pred ccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCC
Q 005289 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (704)
Q Consensus 290 ~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~ 369 (704)
+...|||.|||||++.+ .+|+..+|+||||||||||++|+|||......+.++.|...--.+
T Consensus 158 tsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~----------------- 219 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKP----------------- 219 (808)
T ss_pred eeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCC-----------------
Confidence 77789999999999886 789999999999999999999999999888877777775421111
Q ss_pred CCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCCC
Q 005289 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422 (704)
Q Consensus 370 ~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~~ 422 (704)
...++..+++||+.+|.+||.+|+|=.++|.|||.+..-..
T Consensus 220 ------------p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~ 260 (808)
T KOG0597|consen 220 ------------PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINI 260 (808)
T ss_pred ------------cccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhh
Confidence 13678999999999999999999999999999999865443
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-48 Score=385.15 Aligned_cols=263 Identities=31% Similarity=0.445 Sum_probs=230.7
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC------ChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCC
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF------EPESVRFMAREILILRRL-DHPNIIKLEGLITSRLS 203 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~------~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 203 (704)
.|.--+.||.|..++|.+|.++.+|+.+|+|+|..... ..+..+...+|+.||+++ .||+|++|.++|+. .
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes--~ 95 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES--D 95 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC--c
Confidence 57778899999999999999999999999999964321 123344556799999999 79999999999987 5
Q ss_pred CeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCC
Q 005289 204 CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~ 283 (704)
..+++|+|+|..+.+.+++.....++|.+.+.||+||+.|+.|||.++||||||||+|||++++-+|||+|||+++...+
T Consensus 96 sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~ 175 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP 175 (411)
T ss_pred chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCC
Confidence 78999999999888888877888899999999999999999999999999999999999999999999999999999887
Q ss_pred CCCCCcccccccccccCccccc-----CCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhh
Q 005289 284 GHRQPLTSRVVTLWYRPPELLL-----GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 358 (704)
Q Consensus 284 ~~~~~~~~~~gT~~Y~APEvl~-----~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~ 358 (704)
+ ..+...||||+|+|||.+. +...|+..+|+|++|||+|.||.|.|||......-.+..|+..-..+..
T Consensus 176 G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~s---- 249 (411)
T KOG0599|consen 176 G--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRS---- 249 (411)
T ss_pred c--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCC----
Confidence 7 4678899999999999985 3456899999999999999999999999998888888888874443332
Q ss_pred ccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCCC
Q 005289 359 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422 (704)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~~ 422 (704)
..|.+++.+.+|||.+||++||.+|+|+.|+|+||||.+....
T Consensus 250 ---------------------peWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~ 292 (411)
T KOG0599|consen 250 ---------------------PEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQ 292 (411)
T ss_pred ---------------------cchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHh
Confidence 3457899999999999999999999999999999999754433
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-49 Score=389.04 Aligned_cols=293 Identities=43% Similarity=0.755 Sum_probs=244.8
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeec------C
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR------L 202 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~------~ 202 (704)
...|+.+.+||+|.||.||+|+...+|+.||+|++..++-....-....+|+.+|..|.|+|++.|+++|... .
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 4579999999999999999999999999999998866443222233457899999999999999999887431 2
Q ss_pred CCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccC
Q 005289 203 SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (704)
Q Consensus 203 ~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~ 282 (704)
...+||||.+|++++.+.+.....+|+..+++.+|++++.||.|+|.+.|+|||+|++|+||+.+|.+||+|||+++.+.
T Consensus 96 r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs 175 (376)
T KOG0669|consen 96 RATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFS 175 (376)
T ss_pred cceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccccee
Confidence 34589999999999999999888999999999999999999999999999999999999999999999999999997664
Q ss_pred CCC---CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhc
Q 005289 283 TGH---RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359 (704)
Q Consensus 283 ~~~---~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~ 359 (704)
... ...++.++.|.||++||.+++...|+++.|||..|||+.||+++.|+|++.++..+++.|..+||+...+.|..
T Consensus 176 ~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~ 255 (376)
T KOG0669|consen 176 TSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPN 255 (376)
T ss_pred cccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCC
Confidence 322 23467788899999999999999999999999999999999999999999999999999999999999999976
Q ss_pred cC-CCCcccC--C--CCCCCCchhhhhcc--CCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCCC
Q 005289 360 SK-LPHATLF--K--PQQPYDSSLRETFK--DLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422 (704)
Q Consensus 360 ~~-~~~~~~~--~--~~~~~~~~l~~~~~--~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~~ 422 (704)
.. ++-.... . +...+ +.+....+ --.+++.|||.+||.+||.+|++++++|+|.||...|.|
T Consensus 256 ~d~lpL~~sie~ePl~~~~~-rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 256 VDNLPLYQSIELEPLPKGQK-RKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred cccchHHHhccCCCCCcchh-hhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 33 3211111 1 11111 11111111 125689999999999999999999999999999987765
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=403.25 Aligned_cols=290 Identities=34% Similarity=0.566 Sum_probs=233.3
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC---CCeEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL---SCSIY 207 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~---~~~~~ 207 (704)
+|++.++||.|+||.||+|++..+++.||||++............+.+|+.+|+.++||||+++++++.... ...+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 599999999999999999999999999999998754333334456788999999999999999999886432 23589
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC--
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-- 285 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~-- 285 (704)
||||||++++...+. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 lv~e~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 159 (338)
T cd07859 81 VVFELMESDLHQVIK-ANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159 (338)
T ss_pred EEEecCCCCHHHHHH-hcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence 999999877665543 34468999999999999999999999999999999999999999999999999997543221
Q ss_pred CCCcccccccccccCcccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC
Q 005289 286 RQPLTSRVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~-~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
.......++|+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+...++..+....|.++...+.......
T Consensus 160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 239 (338)
T cd07859 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEK 239 (338)
T ss_pred cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence 1122445789999999987642 468999999999999999999999999999999999999999988877655432211
Q ss_pred cc-cC-CCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCC
Q 005289 365 AT-LF-KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (704)
Q Consensus 365 ~~-~~-~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~ 421 (704)
.. .. .........+...++.+++.+.+||.+||..||++|||+.++|+||||+....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 240 ARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred HHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 00 00 00011112234556778999999999999999999999999999999986544
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=398.57 Aligned_cols=288 Identities=37% Similarity=0.682 Sum_probs=238.5
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|.++++||+|+||+||+|++..+++.||||++...... .....+.+|+.+|++++||||+++++++.. ...+|+
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 81 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHT--DKSLTL 81 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEee--CCeEEE
Confidence 56899999999999999999999999999999999755422 223446689999999999999999999987 568999
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
||||+++++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ..
T Consensus 82 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 160 (309)
T cd07872 82 VFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT-KT 160 (309)
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc-cc
Confidence 99999988777666555668999999999999999999999999999999999999999999999999997654322 12
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCccc-
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL- 367 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~- 367 (704)
.....+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.++.+.|..........
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 2344679999999998776678999999999999999999999999999999999999999999988887643221100
Q ss_pred CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCC
Q 005289 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (704)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~ 420 (704)
..........+....+.++.++++||.+||.+||.+|||+.|+|+||||+..+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 00000011122334467899999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-49 Score=392.46 Aligned_cols=247 Identities=30% Similarity=0.482 Sum_probs=216.4
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeE-EEeecCCCeEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEG-LITSRLSCSIYL 208 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~-~~~~~~~~~~~L 208 (704)
.+|+|+++||.|.||+||++++..+|..||.|.|..+.++......+..|+.+|++|+|||||++++ .|.. ....++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~-~~evlni 97 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIE-DNEVLNI 97 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhc-cchhhHH
Confidence 4699999999999999999999999999999999998888888888999999999999999999987 3433 3566899
Q ss_pred EEeccccccccccc----CCCccccHHHHHHHHHHhhhhHHHHHh--cC--cccccCCCccEEEccCCceEEeccccccc
Q 005289 209 VFEYMEHDITGLLS----CPDIKFSEAQIKCYMNQLLHGLEHCHS--RG--VLHRDIKGSNLLVNNEGVLKLADFGLANF 280 (704)
Q Consensus 209 V~Ey~~g~ll~~~~----~~~~~l~e~~~~~i~~QIl~aL~yLH~--~g--IvHrDLKp~NILl~~~g~iKL~DFGla~~ 280 (704)
|||||.++.+..++ .....++|..+|.++.|++.||.+||. .. |+||||||.||+|+.+|.+||+||||+++
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 99999987666543 355679999999999999999999999 44 99999999999999999999999999998
Q ss_pred cCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhcc
Q 005289 281 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (704)
Q Consensus 281 ~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~ 360 (704)
+... .....+.+|||+||+||++.. ..|+.++|||||||++|||+.-++||.|++-.+...+|... ..|+
T Consensus 178 l~s~-~tfA~S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg--d~~~------ 247 (375)
T KOG0591|consen 178 LSSK-TTFAHSLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG--DYPP------ 247 (375)
T ss_pred hcch-hHHHHhhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC--CCCC------
Confidence 8754 345678899999999999987 67999999999999999999999999999888888888653 2210
Q ss_pred CCCCcccCCCCCCCCchhhhhc-cCCCHHHHHHHHHhhccCCCCCcCH
Q 005289 361 KLPHATLFKPQQPYDSSLRETF-KDLPTTAVNLIETLLSVEPYKRATA 407 (704)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~-~~~s~~~~dLI~~mL~~dP~kRpTa 407 (704)
.+ ..+|.++..||..|+.+||..||+.
T Consensus 248 --------------------~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 248 --------------------LPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred --------------------CcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 01 2568889999999999999999986
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=410.94 Aligned_cols=263 Identities=34% Similarity=0.507 Sum_probs=228.9
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcC-CCCceeEeEEEeecCCCeE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLD-HPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~~ 206 (704)
.+.|++.+.||.|.||.||+|+++.+|+.+|+|++.+.... ......+.+|+.||++|. |||||.++++|++ ...+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~--~~~~ 111 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED--PDSV 111 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc--CCeE
Confidence 34799999999999999999999999999999999876653 234567889999999998 9999999999998 4689
Q ss_pred EEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccC----CceEEeccccccccC
Q 005289 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE----GVLKLADFGLANFSN 282 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~----g~iKL~DFGla~~~~ 282 (704)
|||||+|.|+.+...+... .++|..+..++.||+.++.|||+.||+||||||+|||+... +.+|++|||++....
T Consensus 112 ~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 9999999986555443332 49999999999999999999999999999999999999644 479999999999887
Q ss_pred CCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCC
Q 005289 283 TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (704)
Q Consensus 283 ~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~ 362 (704)
. .......+||+.|+|||++.. ..|+..+||||+||++|.|++|.+||.+.++.+...+|...-..++.
T Consensus 191 ~--~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~-------- 259 (382)
T KOG0032|consen 191 P--GERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTS-------- 259 (382)
T ss_pred C--CceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCC--------
Confidence 6 356778899999999999975 67999999999999999999999999999999988888664333332
Q ss_pred CCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCCC
Q 005289 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422 (704)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~~ 422 (704)
+.|+.++..+++||+.||..||.+|+|+.++|+|||++.....
T Consensus 260 -----------------~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~ 302 (382)
T KOG0032|consen 260 -----------------EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEA 302 (382)
T ss_pred -----------------CCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCccc
Confidence 3457899999999999999999999999999999999875433
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-46 Score=391.29 Aligned_cols=280 Identities=41% Similarity=0.708 Sum_probs=226.3
Q ss_pred CeeEEEEeeccCceEEEEEEECC-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc---CCCCceeEeEEEee---cCC
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLD-TGKIVALKKVRFDNFEPESVRFMAREILILRRL---DHPNIIKLEGLITS---RLS 203 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIv~l~~~~~~---~~~ 203 (704)
+|++++.||+|+||+||+|++.. +++.||||++............+.+|+.+++.+ +||||+++++++.. ...
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 69999999999999999999864 468899999976543333334456787777766 69999999998853 224
Q ss_pred CeEEEEEecccccccccccC-CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccC
Q 005289 204 CSIYLVFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~~~~-~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~ 282 (704)
..+||||||+.+++...+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 82 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T cd07862 82 TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS 161 (290)
T ss_pred CcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEecc
Confidence 56899999999876665543 23458999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccC-
Q 005289 283 TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK- 361 (704)
Q Consensus 283 ~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~- 361 (704)
.. .......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+.+|+..++.+....|....
T Consensus 162 ~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (290)
T cd07862 162 FQ--MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 238 (290)
T ss_pred CC--cccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhc
Confidence 33 23345578999999999876 568999999999999999999999999999999999999998888766664422
Q ss_pred CCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
++.. .+... ....+....+.++..+++||.+||++||++|||+.++|+||||
T Consensus 239 ~~~~-~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 239 LPRQ-AFHSK--SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred ccch-hccCC--CCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 2111 11111 1123344556789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=417.33 Aligned_cols=284 Identities=34% Similarity=0.571 Sum_probs=228.8
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeec------C
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR------L 202 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~------~ 202 (704)
..+|++++.||+|+||+||+|.+..+++.||||++..+. ....+|+.+|+.++|||||+++++|... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 357999999999999999999999999999999986432 2234799999999999999999887432 1
Q ss_pred CCeEEEEEecccccccccc---cCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCC-ceEEeccccc
Q 005289 203 SCSIYLVFEYMEHDITGLL---SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLA 278 (704)
Q Consensus 203 ~~~~~LV~Ey~~g~ll~~~---~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g-~iKL~DFGla 278 (704)
...+||||||+++++...+ ......+++..++.|+.||+.||.|||++||+||||||+||||+.++ .+||+|||+|
T Consensus 139 ~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 139 NIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred ceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 2357899999998765543 23456799999999999999999999999999999999999998665 7999999999
Q ss_pred cccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhh
Q 005289 279 NFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 358 (704)
Q Consensus 279 ~~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~ 358 (704)
+...... .....++|+.|+|||++.+...|+.++|||||||+||+|++|.+||.+.+..+++.++...+|.++.+.+.
T Consensus 219 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 296 (440)
T PTZ00036 219 KNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK 296 (440)
T ss_pred hhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 8665432 23446789999999998876679999999999999999999999999999999999999999998877665
Q ss_pred ccCCCCcccCCCCCCCCchhhhhc-cCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCC
Q 005289 359 KSKLPHATLFKPQQPYDSSLRETF-KDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (704)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~l~~~~-~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~ 421 (704)
........+..+. .....+...+ ...+.++++||.+||.+||.+|||+.|+|+||||.....
T Consensus 297 ~~~~~~~~~~~~~-~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 297 EMNPNYADIKFPD-VKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred HhchhhhcccCCc-cCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 4321111111111 1112223333 357899999999999999999999999999999986443
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=407.87 Aligned_cols=289 Identities=34% Similarity=0.527 Sum_probs=234.3
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC---CCeEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL---SCSIY 207 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~---~~~~~ 207 (704)
+|+++++||+|+||+||+|.+..+++.||||++..........+.+.+|+.+|+.++||||+++++++.... ...+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 488999999999999999999999999999998754334445567889999999999999999999987632 12689
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCC
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~ 287 (704)
+||||+.+++...+. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++........
T Consensus 81 lv~e~~~~~l~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~ 159 (372)
T cd07853 81 VVTELMQSDLHKIIV-SPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK 159 (372)
T ss_pred EEeeccccCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence 999999987666554 3457999999999999999999999999999999999999999999999999999866544333
Q ss_pred CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCC-Ccc
Q 005289 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP-HAT 366 (704)
Q Consensus 288 ~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~-~~~ 366 (704)
.....++|+.|+|||++.+...|+.++|||||||++|+|++|++||.+.+..+++..|...+|.++.+.+...... ...
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 239 (372)
T cd07853 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAH 239 (372)
T ss_pred cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHH
Confidence 4455678999999999987667899999999999999999999999999999999999999998886554321100 000
Q ss_pred cC--CCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCC
Q 005289 367 LF--KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (704)
Q Consensus 367 ~~--~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~ 420 (704)
+. ....+....+.......++++.+||.+||.+||.+|||+.++|.||||....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 240 ILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 00 0000111111122356789999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-46 Score=409.41 Aligned_cols=284 Identities=26% Similarity=0.390 Sum_probs=223.2
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
+...+|++++.||+|+||.||+|++..+++.||||+... ..+.+|+.+|+.|+|||||+++++|.. ....
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~ 158 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTY--NKFT 158 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEE--CCee
Confidence 445689999999999999999999999999999997542 235789999999999999999999987 5689
Q ss_pred EEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC
Q 005289 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~ 286 (704)
|+|||++.+++...+.. ...+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||++........
T Consensus 159 ~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 159 CLILPRYKTDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred EEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 99999998776655543 34689999999999999999999999999999999999999999999999999975433222
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC-------CHHHHHHHHHHHcCCCCchhhhc
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR-------TEVEQLHKIFKLCGSPPDDYWKK 359 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~-------~~~e~l~~I~~~~g~~p~~~w~~ 359 (704)
......+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||... ....++..|...+|.+|.+++..
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred cccccccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 33345678999999999876 56899999999999999999999776543 24567888888888877554321
Q ss_pred cCCCCcccC------CCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCCC
Q 005289 360 SKLPHATLF------KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422 (704)
Q Consensus 360 ~~~~~~~~~------~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~~ 422 (704)
........+ ....+...........++.++.+||.+||++||.+||||.|+|+||||+..+.+
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~ 385 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP 385 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence 100000000 000011111112223567889999999999999999999999999999875543
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=401.56 Aligned_cols=286 Identities=31% Similarity=0.546 Sum_probs=229.7
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC----CC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL----SC 204 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----~~ 204 (704)
.++|++++.||.|+||+||+|++..+++.||||++............+.+|+.+|+.++||||+++++++.... ..
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 46899999999999999999999999999999999765444455666788999999999999999999986532 13
Q ss_pred eEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
.+|+||||+++++...+. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 100 ~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 176 (359)
T cd07876 100 DVYLVMELMDANLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN 176 (359)
T ss_pred eeEEEEeCCCcCHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccC
Confidence 579999999987766553 24789999999999999999999999999999999999999999999999999754332
Q ss_pred CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
.......+|+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+.+.++.++..++.......
T Consensus 177 --~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (359)
T cd07876 177 --FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253 (359)
T ss_pred --ccCCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence 22345578999999999876 568999999999999999999999999999999999999999888876654321100
Q ss_pred cccC--CC---CCCCCc--------hhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCC
Q 005289 365 ATLF--KP---QQPYDS--------SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (704)
Q Consensus 365 ~~~~--~~---~~~~~~--------~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~ 420 (704)
.... .+ ...+.. .........+..+++||.+||.+||++|||+.|+|+||||+.+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 322 (359)
T cd07876 254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWY 322 (359)
T ss_pred HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhc
Confidence 0000 00 000000 00111223577899999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=385.06 Aligned_cols=281 Identities=39% Similarity=0.692 Sum_probs=226.5
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc---CCCCceeEeEEEeec---CCC
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL---DHPNIIKLEGLITSR---LSC 204 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIv~l~~~~~~~---~~~ 204 (704)
+|++++.||.|+||+||+|++..+++.||+|++............+.+|+.+++.+ +||||+++++++... ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 49999999999999999999999999999999976433222223345677777665 799999999988642 235
Q ss_pred eEEEEEecccccccccccC-CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCC
Q 005289 205 SIYLVFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~~-~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~ 283 (704)
.+++||||+.+++...+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 6899999999876665543 234589999999999999999999999999999999999999999999999999986643
Q ss_pred CCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCC
Q 005289 284 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 284 ~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
. .......+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+....+.+.++....+.+....|......
T Consensus 161 ~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07863 161 Q--MALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL 237 (288)
T ss_pred c--ccCCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccc
Confidence 2 22344567999999999876 56899999999999999999999999999999999999998888877666532111
Q ss_pred CcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
....+.+. ....+....+.++..+.+||.+||++||++|||+.++|.||||
T Consensus 238 ~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 238 PRGAFSPR--GPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccCCC--CCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 11111111 1123345557889999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=391.08 Aligned_cols=309 Identities=24% Similarity=0.397 Sum_probs=250.0
Q ss_pred CCCCCcccccCCcccccchhhhhcccchhhhhhhhhhhcCccccccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEe
Q 005289 84 SNSESLSFRLGNLHKYIEGEQVAAGWPAWLSAVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKV 163 (704)
Q Consensus 84 s~~~s~s~~~g~~~~~~~ge~~~~~~p~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i 163 (704)
-..+...|+.|+||++..||.+..+ +|.+.++||+|.|+|||+|+|....++||+|++
T Consensus 54 eqE~~~dY~kGGYHpV~IGD~F~~g----------------------RY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVv 111 (590)
T KOG1290|consen 54 EQEDPEDYRKGGYHPVRIGDVFNGG----------------------RYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVV 111 (590)
T ss_pred cccChhhhhcCCCceeeccccccCc----------------------eEEEEEeccccccceeEEEeeccCCeEEEEEEE
Confidence 3466789999999999999999864 899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHHHHHHHHHHhcC-----C---CCceeEeEEEee--cCCCeEEEEEecccccccccccCCC-ccccHHH
Q 005289 164 RFDNFEPESVRFMAREILILRRLD-----H---PNIIKLEGLITS--RLSCSIYLVFEYMEHDITGLLSCPD-IKFSEAQ 232 (704)
Q Consensus 164 ~~~~~~~~~~~~~~~Ei~iL~~L~-----H---pnIv~l~~~~~~--~~~~~~~LV~Ey~~g~ll~~~~~~~-~~l~e~~ 232 (704)
+.. ....+....||++|+++. | .+||+|++.|.. .++.++|||+|+++.+||.++.... ..++...
T Consensus 112 KSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~ 188 (590)
T KOG1290|consen 112 KSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSC 188 (590)
T ss_pred ehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHH
Confidence 754 344556678999999982 3 479999999964 5678999999999999999886543 3589999
Q ss_pred HHHHHHHhhhhHHHHHh-cCcccccCCCccEEEc----------------------------------------------
Q 005289 233 IKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVN---------------------------------------------- 265 (704)
Q Consensus 233 ~~~i~~QIl~aL~yLH~-~gIvHrDLKp~NILl~---------------------------------------------- 265 (704)
++.|++|||.||.|||. +||||.||||+||||.
T Consensus 189 VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~ 268 (590)
T KOG1290|consen 189 VKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKS 268 (590)
T ss_pred HHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchh
Confidence 99999999999999996 4999999999999981
Q ss_pred --------------------------------------------------------------------cC----------
Q 005289 266 --------------------------------------------------------------------NE---------- 267 (704)
Q Consensus 266 --------------------------------------------------------------------~~---------- 267 (704)
..
T Consensus 269 ~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~s 348 (590)
T KOG1290|consen 269 KFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTS 348 (590)
T ss_pred hHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccchhhcccccccccccCCccccccCcccccccccc
Confidence 00
Q ss_pred ------------------------------------------CceEEeccccccccCCCCCCCcccccccccccCccccc
Q 005289 268 ------------------------------------------GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305 (704)
Q Consensus 268 ------------------------------------------g~iKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APEvl~ 305 (704)
-.+||+|||.|++... .++.-+.|..|+|||||+
T Consensus 349 l~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~k----hFT~DIQTRQYRapEVll 424 (590)
T KOG1290|consen 349 LPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVHK----HFTEDIQTRQYRAPEVLL 424 (590)
T ss_pred ccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEEeeccchhhhhh----hhchhhhhhhccCcceee
Confidence 0378999999988753 467778899999999999
Q ss_pred CCCCCCCccchhhHHHHHHHHHhCCCCCCCC------CHHHHHHHHHHHcCCCCchhhhccCCCCcccCCC---------
Q 005289 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGR------TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP--------- 370 (704)
Q Consensus 306 ~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~------~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~--------- 370 (704)
+ ..|++.+||||++||+|||+||..+|... .+.+.+..|+++||..|..+....+.....+...
T Consensus 425 G-sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~L 503 (590)
T KOG1290|consen 425 G-SGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRL 503 (590)
T ss_pred c-CCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceeccccc
Confidence 8 56999999999999999999999999653 3678999999999999976544443322111110
Q ss_pred -CCCCCchhhhhccC---CCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCCC
Q 005289 371 -QQPYDSSLRETFKD---LPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422 (704)
Q Consensus 371 -~~~~~~~l~~~~~~---~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~~ 422 (704)
..+....|.+.+.- -..++.|||.-||+++|++||||.++|+|||++..+.+
T Consensus 504 K~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 504 KPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLNPVAGP 559 (590)
T ss_pred CCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCccccCCCCC
Confidence 11222334444422 23457899999999999999999999999999976654
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=407.41 Aligned_cols=256 Identities=29% Similarity=0.522 Sum_probs=224.6
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
..|....+||+|+.|.||.|+...+++.||||.+...... ..+.+.+|+.+|+.++|+|||.+++-|.. ...+|+|
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~--~keLilnEi~Vm~~~~H~NiVnfl~Sylv--~deLWVV 348 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP--KKELLLNEILVMRDLHHPNIVNFLDSYLV--GDELWVV 348 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC--chhhhHHHHHHHHhccchHHHHHHHHhcc--cceeEEE
Confidence 4689999999999999999999999999999999876533 34668899999999999999999988866 3679999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCc
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~ 289 (704)
||||+|+.|.++.. ...++|.+++.+++++|.||+|||.+||||||||.+|||++.+|.+||+|||+|..+..... .-
T Consensus 349 MEym~ggsLTDvVt-~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR 426 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVT-KTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KR 426 (550)
T ss_pred EeecCCCchhhhhh-cccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC-cc
Confidence 99999988776653 34599999999999999999999999999999999999999999999999999988765543 45
Q ss_pred ccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCC
Q 005289 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (704)
Q Consensus 290 ~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~ 369 (704)
.+.+|||+|||||++.. ..|++++||||||+|++||+-|.|||-..+....+..|.. .|.|.-
T Consensus 427 ~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-ng~P~l--------------- 489 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPKL--------------- 489 (550)
T ss_pred ccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-cCCCCc---------------
Confidence 67899999999999976 7899999999999999999999999998888777766654 344431
Q ss_pred CCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 370 ~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
.....++..++|||.+||+.||.+|++|.++|+||||+.
T Consensus 490 ----------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 490 ----------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred ----------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 123579999999999999999999999999999999953
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=400.55 Aligned_cols=287 Identities=29% Similarity=0.512 Sum_probs=231.2
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC----CC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL----SC 204 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----~~ 204 (704)
.++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.... ..
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 46899999999999999999999999999999999765444455566788999999999999999999886421 24
Q ss_pred eEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
.+|+||||+++++...+. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 103 ~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 179 (364)
T cd07875 103 DVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179 (364)
T ss_pred eEEEEEeCCCCCHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCC
Confidence 689999999987766553 24788999999999999999999999999999999999999999999999999765432
Q ss_pred CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
......++|+.|+|||++.+ ..++.++|||||||+||+|++|+.||.+.+..+.+.++...++.+..+++.......
T Consensus 180 --~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (364)
T cd07875 180 --FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256 (364)
T ss_pred --CcccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHH
Confidence 22345578999999999876 568999999999999999999999999999999999999999988877665432110
Q ss_pred cccCCCCCC---------CCc----hhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCC
Q 005289 365 ATLFKPQQP---------YDS----SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (704)
Q Consensus 365 ~~~~~~~~~---------~~~----~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~ 421 (704)
......... +.. .........+..+++||.+||.+||.+|||+.++|+||||..+..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 326 (364)
T cd07875 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD 326 (364)
T ss_pred HHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccC
Confidence 000000000 000 001112234678999999999999999999999999999986433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=410.11 Aligned_cols=283 Identities=23% Similarity=0.322 Sum_probs=221.2
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC------CCceeEeEEEeecC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH------PNIIKLEGLITSRL 202 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~H------pnIv~l~~~~~~~~ 202 (704)
.++|+++++||+|+||+||+|++..+++.||||+++... .....+..|+.+++.+.| .+|++++++|...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~- 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE- 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC-
Confidence 568999999999999999999999999999999996432 223345568888877754 4588999888764
Q ss_pred CCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHh-cCcccccCCCccEEEccCC-------------
Q 005289 203 SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEG------------- 268 (704)
Q Consensus 203 ~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~-~gIvHrDLKp~NILl~~~g------------- 268 (704)
..++|||||++.+.++..+.. ...+++..++.|+.||+.||.|||+ .|||||||||+||||+.++
T Consensus 204 ~~~~~iv~~~~g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 204 TGHMCIVMPKYGPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred CceEEEEEeccCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 467999999998877766543 3579999999999999999999998 5999999999999998765
Q ss_pred ---ceEEeccccccccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 005289 269 ---VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 345 (704)
Q Consensus 269 ---~iKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I 345 (704)
.+||+|||++..... ..+..++|+.|+|||++.+ ..|+.++|||||||+||||++|++||.+.+..+++..|
T Consensus 283 ~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i 357 (467)
T PTZ00284 283 DPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM 357 (467)
T ss_pred CCceEEECCCCccccCcc----ccccccCCccccCcHHhhc-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 499999998864332 2345688999999999986 56999999999999999999999999999999999999
Q ss_pred HHHcCCCCchhhhccCCCCcc-cCCCC----CCCC-chhhhh-----c--cCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 346 FKLCGSPPDDYWKKSKLPHAT-LFKPQ----QPYD-SSLRET-----F--KDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 346 ~~~~g~~p~~~w~~~~~~~~~-~~~~~----~~~~-~~l~~~-----~--~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
...+|.+|..++......... ++... ..+. ..+... + ....+.+.|||.+||.+||.+|||+.|+|+
T Consensus 358 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 999999987765432221100 00000 0000 000000 0 012466889999999999999999999999
Q ss_pred ccccCCCCC
Q 005289 413 SEYFSTKPY 421 (704)
Q Consensus 413 hpwf~~~~~ 421 (704)
||||+....
T Consensus 438 Hp~~~~~~~ 446 (467)
T PTZ00284 438 HPYVLKYYP 446 (467)
T ss_pred CccccccCC
Confidence 999986433
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=387.31 Aligned_cols=286 Identities=38% Similarity=0.692 Sum_probs=236.6
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEE
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 207 (704)
+.++|+++++||.|+||.||+|++..+++.||+|.+...... .....+.+|+.+|+.|+||||+++++++.. ...+|
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~--~~~~~ 80 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHT--EKSLT 80 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEec--CCeEE
Confidence 357899999999999999999999999999999999754322 223446689999999999999999999987 56899
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCC
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~ 287 (704)
|||||+.+++...+......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... .
T Consensus 81 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~ 159 (301)
T cd07873 81 LVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-K 159 (301)
T ss_pred EEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-C
Confidence 999999987777666555678999999999999999999999999999999999999999999999999997544322 2
Q ss_pred CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCccc
Q 005289 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (704)
Q Consensus 288 ~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~ 367 (704)
......+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..+...++.+....|...... ...
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 238 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN-EEF 238 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcc-ccc
Confidence 2233466899999999877667889999999999999999999999999999999999999999888888653211 111
Q ss_pred CCC--CCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 368 FKP--QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 368 ~~~--~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
... .......+......+++.+.+||.+||.+||.+|||+.++|+||||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC 291 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 110 111122233444678999999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=396.50 Aligned_cols=258 Identities=25% Similarity=0.370 Sum_probs=219.7
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
..++|++.+.||.|+||+||+|++..+++.||||++..... .......+.+|+.+|+.++||||+++++++.+ ...+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~ 93 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD--ENRV 93 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc--CCEE
Confidence 35789999999999999999999999999999999976432 22345667899999999999999999999987 5789
Q ss_pred EEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC
Q 005289 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~ 286 (704)
||||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-- 171 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-- 171 (329)
T ss_pred EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--
Confidence 999999998766655555567899999999999999999999999999999999999999999999999999866432
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcc
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~ 366 (704)
....++|+.|+|||++.+ ..++.++|||||||+||+|++|.+||.+.+..+.+.++... .++
T Consensus 172 --~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~--~~~------------- 233 (329)
T PTZ00263 172 --TFTLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG--RLK------------- 233 (329)
T ss_pred --cceecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CcC-------------
Confidence 234578999999999876 56899999999999999999999999988887777766431 110
Q ss_pred cCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcC-----HHHHHhccccCCCCC
Q 005289 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPY 421 (704)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpT-----a~e~L~hpwf~~~~~ 421 (704)
....++..+++||.+||..||.+|++ +.++|.||||....|
T Consensus 234 --------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~ 279 (329)
T PTZ00263 234 --------------FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANW 279 (329)
T ss_pred --------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCH
Confidence 01246788999999999999999997 799999999986443
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=390.39 Aligned_cols=254 Identities=29% Similarity=0.473 Sum_probs=230.7
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.+|++.+.||+|+||.|-+|++...|+.||||.|+++.+. ....-.+.+||+||..|+||||+.++++|+. ...+.|
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN--kdKIvi 130 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN--KDKIVI 130 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC--CceEEE
Confidence 4799999999999999999999999999999999998875 4556678899999999999999999999987 578999
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
||||..++.|..++...+.|+|.+++.+++||..|+.|||.++|+|||||.+|||||.++++||+||||+..+... ..
T Consensus 131 vMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~--kf 208 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK--KF 208 (668)
T ss_pred EEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc--cH
Confidence 9999999988888888889999999999999999999999999999999999999999999999999999988755 46
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccC
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~ 368 (704)
++++||+|.|.+||++.+...-++.+|-|||||+||.|+.|..||.|.+-...+.+|......-
T Consensus 209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE---------------- 272 (668)
T KOG0611|consen 209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE---------------- 272 (668)
T ss_pred HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC----------------
Confidence 7889999999999999987777899999999999999999999999999888888886522111
Q ss_pred CCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccC
Q 005289 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417 (704)
Q Consensus 369 ~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~ 417 (704)
+.-|.++.-||+.||.+||++|.|+.++..|=|.+
T Consensus 273 --------------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 273 --------------PETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred --------------CCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 34577889999999999999999999999997765
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-46 Score=392.27 Aligned_cols=260 Identities=32% Similarity=0.458 Sum_probs=212.3
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 210 (704)
++...+.||+|+||+||++.+..+|..+|||.+...... ..+.+.+|+.+|.+|+|||||++++.........++|.|
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~--~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP--TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccch--hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 588889999999999999999999999999999876322 267789999999999999999999975543223799999
Q ss_pred ecccccccccccCCCc-cccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEcc-CCceEEeccccccccCC--CCC
Q 005289 211 EYMEHDITGLLSCPDI-KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-EGVLKLADFGLANFSNT--GHR 286 (704)
Q Consensus 211 Ey~~g~ll~~~~~~~~-~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~-~g~iKL~DFGla~~~~~--~~~ 286 (704)
||+.++.+..+....+ .|+|..++.|.+||+.||.|||++|||||||||+||||+. ++.+||+|||+++.... ...
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~ 175 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKS 175 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccc
Confidence 9999987776655443 7999999999999999999999999999999999999999 79999999999986653 111
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR-TEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~-~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
.......||+.|||||++........++|||||||++.||+||.+||... ...+.+-.|.... ..
T Consensus 176 ~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~-~~------------- 241 (313)
T KOG0198|consen 176 DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED-SL------------- 241 (313)
T ss_pred cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC-CC-------------
Confidence 22345788999999999985222335999999999999999999999873 3333333332110 00
Q ss_pred ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
......++.++++||.+||..||++||||.++|.|||.+..
T Consensus 242 -------------P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 242 -------------PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred -------------CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 01224689999999999999999999999999999999763
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=389.81 Aligned_cols=256 Identities=26% Similarity=0.376 Sum_probs=218.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
++|++++.||.|+||+||+|.+..+++.||||++..... .......+.+|+.+|+.++||||+++++++.+ ...+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 78 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD--QRFLYM 78 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc--CCeEEE
Confidence 369999999999999999999999999999999975432 22345567889999999999999999998876 578999
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
||||+.++.+..+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---- 154 (291)
T cd05612 79 LMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---- 154 (291)
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC----
Confidence 9999998766655555567999999999999999999999999999999999999999999999999999765432
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccC
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~ 368 (704)
....++|+.|+|||++.+ ..++.++|||||||+||+|++|.+||.+.+..+.+..+... .+
T Consensus 155 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~--~~---------------- 215 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG--KL---------------- 215 (291)
T ss_pred cccccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--Cc----------------
Confidence 234578999999999876 56899999999999999999999999998888877777542 11
Q ss_pred CCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcC-----HHHHHhccccCCCCC
Q 005289 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPY 421 (704)
Q Consensus 369 ~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpT-----a~e~L~hpwf~~~~~ 421 (704)
.....++..+++||++||..||.+|++ ++++|.||||+...|
T Consensus 216 -----------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 262 (291)
T cd05612 216 -----------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW 262 (291)
T ss_pred -----------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence 001246788999999999999999995 999999999986544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-45 Score=380.89 Aligned_cols=283 Identities=40% Similarity=0.733 Sum_probs=231.5
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 210 (704)
+|++++.||.|+||+||+|++..+++.||||++............+.+|+.+|+.++||||+++++++.+ ...+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ--ESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee--CCeEEEEE
Confidence 4899999999999999999999999999999997654333344567789999999999999999999987 57899999
Q ss_pred ecccccccccccC--CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 211 EYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 211 Ey~~g~ll~~~~~--~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
||+.+++...+.. ....+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... ..
T Consensus 79 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~ 157 (285)
T cd07861 79 EFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RV 157 (285)
T ss_pred ecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-cc
Confidence 9999766555432 23568999999999999999999999999999999999999999999999999997654322 22
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccC
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~ 368 (704)
.....+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.+....|...........
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence 23446689999999987666688999999999999999999999999999888888888888888777754332111000
Q ss_pred CCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 369 ~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
.........+......+++++.+||.+||..||.+|||+.++|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 000111122334456789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=392.38 Aligned_cols=257 Identities=28% Similarity=0.522 Sum_probs=233.4
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 210 (704)
-|.+.+.||.|.|..|-+|++..||..||||+|.+..++.-....+..|+..|+.++|||||+||+++.. ...+|||+
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT--QTKlyLiL 96 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT--QTKLYLIL 96 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc--cceEEEEE
Confidence 4889999999999999999999999999999999988887777888999999999999999999999977 46899999
Q ss_pred ecccc-cccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEE-ccCCceEEeccccccccCCCCCCC
Q 005289 211 EYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV-NNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 211 Ey~~g-~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl-~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
|+-++ ++.+++......+.|..+++|+.||+.||.|||+..||||||||+||++ ..-|-+||.|||++..+.++ +.
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG--~k 174 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG--KK 174 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc--ch
Confidence 99988 5666667777789999999999999999999999999999999999876 45689999999999988877 46
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccC
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~ 368 (704)
+++.||++.|-|||+|++..+..+++||||||||||.|+||++||+..++.+.+..|+..-...|
T Consensus 175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvP--------------- 239 (864)
T KOG4717|consen 175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVP--------------- 239 (864)
T ss_pred hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCc---------------
Confidence 78899999999999999977777899999999999999999999999999999999987543332
Q ss_pred CCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCC
Q 005289 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (704)
Q Consensus 369 ~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~ 420 (704)
..++.+++|||..||..||.+|.|.++|..|+|++...
T Consensus 240 --------------shvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D 277 (864)
T KOG4717|consen 240 --------------SHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGD 277 (864)
T ss_pred --------------hhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCC
Confidence 46889999999999999999999999999999998644
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=383.37 Aligned_cols=283 Identities=41% Similarity=0.693 Sum_probs=232.9
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 210 (704)
+|++++.||.|+||.||+|++..+|+.||+|++............+.+|+.+++.++||||+++++++.+ ...+|+|+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS--DKKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc--CCceEEEE
Confidence 4899999999999999999999999999999997654433334556789999999999999999999977 56899999
Q ss_pred ecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCcc
Q 005289 211 EYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 290 (704)
Q Consensus 211 Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~ 290 (704)
||++++++..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ....
T Consensus 79 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~ 157 (284)
T cd07839 79 EYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-RCYS 157 (284)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC-CCcC
Confidence 999988777666555679999999999999999999999999999999999999999999999999997654332 2233
Q ss_pred cccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCC
Q 005289 291 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI-LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (704)
Q Consensus 291 ~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~p-F~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~ 369 (704)
...+++.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..++..++.++...|............
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence 456789999999987766689999999999999999998765 6777778889999999888887777543211111111
Q ss_pred CCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 370 ~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
+..+....+.+..+.+++++.+||.+||..||.+|||+.++|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 11122222344556789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-45 Score=388.03 Aligned_cols=278 Identities=36% Similarity=0.662 Sum_probs=217.6
Q ss_pred EEEeeccCceEEEEEEEC--CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEec
Q 005289 135 LEKIGQGTYSSVFRARDL--DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEY 212 (704)
Q Consensus 135 ~~~LG~G~fg~Vy~a~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey 212 (704)
..+||+|+||+||+|+++ .+++.||+|++...... ..+.+|+.+|++++||||+++++++.......+|+||||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 368999999999999965 46789999998754322 335689999999999999999999976666789999999
Q ss_pred ccccccccccC--------CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEE----ccCCceEEeccccccc
Q 005289 213 MEHDITGLLSC--------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANF 280 (704)
Q Consensus 213 ~~g~ll~~~~~--------~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl----~~~g~iKL~DFGla~~ 280 (704)
+.+++...+.. ....+++..++.++.||+.||.|||++||+||||||+|||+ +..+.+||+|||++..
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 82 AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 99876554321 22358999999999999999999999999999999999999 4567899999999986
Q ss_pred cCCCCC--CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCH---------HHHHHHHHHHc
Q 005289 281 SNTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE---------VEQLHKIFKLC 349 (704)
Q Consensus 281 ~~~~~~--~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~---------~e~l~~I~~~~ 349 (704)
...... ......++|+.|+|||++.+...|+.++|||||||++|+|++|++||.+... .+++..++..+
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence 643221 1234567899999999998766789999999999999999999999976442 46788899999
Q ss_pred CCCCchhhhccCC-CCcccC-C-------CCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 350 GSPPDDYWKKSKL-PHATLF-K-------PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 350 g~~p~~~w~~~~~-~~~~~~-~-------~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
|.+....|..... +..... . ........+.......+..+.+||.+||.+||.+|||++|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 9998887765321 111000 0 00000111112223456789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=394.29 Aligned_cols=253 Identities=25% Similarity=0.394 Sum_probs=213.4
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEeccc
Q 005289 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME 214 (704)
Q Consensus 136 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~ 214 (704)
+.||+|+||+||+|++..+++.||||++..... .......+.+|+.+|+.++||||+++++++.. ...+||||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT--HDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc--CCEEEEEEeCCC
Confidence 369999999999999999999999999976432 23345567789999999999999999999877 578999999999
Q ss_pred ccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCcccccc
Q 005289 215 HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 294 (704)
Q Consensus 215 g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~~~g 294 (704)
++.+.........+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++...... ......+|
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~~g 157 (323)
T cd05571 79 GGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCG 157 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccccceec
Confidence 87776655556679999999999999999999999999999999999999999999999999987543221 22345678
Q ss_pred cccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCC
Q 005289 295 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY 374 (704)
Q Consensus 295 T~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~ 374 (704)
|+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+....+..+.... +
T Consensus 158 t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~--~---------------------- 212 (323)
T cd05571 158 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--I---------------------- 212 (323)
T ss_pred CccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC--C----------------------
Confidence 999999999876 568999999999999999999999999887776666553311 0
Q ss_pred CchhhhhccCCCHHHHHHHHHhhccCCCCCc-----CHHHHHhccccCCCCC
Q 005289 375 DSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 421 (704)
Q Consensus 375 ~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRp-----Ta~e~L~hpwf~~~~~ 421 (704)
.....++.++.+||.+||..||++|| ++.++|+||||....|
T Consensus 213 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~ 259 (323)
T cd05571 213 -----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINW 259 (323)
T ss_pred -----CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 00135789999999999999999999 8999999999986443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=394.05 Aligned_cols=285 Identities=35% Similarity=0.589 Sum_probs=231.8
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC----CC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL----SC 204 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----~~ 204 (704)
.++|++++.||.|+||+||+|.+..+++.||||++............+.+|+.+|+.++||||++++++|.... ..
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 35799999999999999999999999999999999765433344556778999999999999999999885421 24
Q ss_pred eEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
.+|++|+++.+.+...+. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 94 ~~~~~~~~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 171 (343)
T cd07878 94 EVYLVTNLMGADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE 171 (343)
T ss_pred cEEEEeecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCC
Confidence 579999999766554442 346999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
....++|+.|+|||++.+...++.++|||||||+||+|++|++||.+.+..+.+..+....+.++.+.+.......
T Consensus 172 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07878 172 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH 247 (343)
T ss_pred ----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhh
Confidence 3456789999999999876678999999999999999999999999999999999999988888766554322111
Q ss_pred cccCCC--CCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 365 ATLFKP--QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 365 ~~~~~~--~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
...+.. .......+...+...++.+.+||.+||.+||.+|||+.++|.||||...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred HHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 100000 0011122344556778889999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-45 Score=394.88 Aligned_cols=285 Identities=30% Similarity=0.529 Sum_probs=229.9
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC----CC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL----SC 204 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----~~ 204 (704)
.++|++++.||+|+||+||+|.+..+++.||||++............+.+|+.+|+.++||||+++++++.... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 46899999999999999999999999999999999765544555667788999999999999999999886432 24
Q ss_pred eEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
.+|+||||+++++...+. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 96 ~~~lv~e~~~~~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~ 172 (355)
T cd07874 96 DVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_pred eeEEEhhhhcccHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc
Confidence 579999999987766553 24789999999999999999999999999999999999999999999999999765432
Q ss_pred CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
......++|+.|+|||++.+ ..|+.++|||||||+||+|++|+.||.+.+..+.+..+...++.+..++|....-..
T Consensus 173 --~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (355)
T cd07874 173 --FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_pred --cccCCccccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence 22345678999999999876 568999999999999999999999999999999999998888888776655432110
Q ss_pred cccCCCCCC-----C----Cc----hhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 365 ATLFKPQQP-----Y----DS----SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 365 ~~~~~~~~~-----~----~~----~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
......... + .. .........+..+++||.+||..||++|||+.|+|+||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 000000000 0 00 0011123456789999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=398.87 Aligned_cols=263 Identities=31% Similarity=0.473 Sum_probs=217.6
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
++|++++.||+|+||+||+|++..+++.||||++..... .......+.+|+.+|..++||||++++++|.+ ...+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~l 78 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD--ENYLYL 78 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCeEEE
Confidence 369999999999999999999999999999999976432 23445567789999999999999999999987 578999
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCC-
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ- 287 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~- 287 (704)
|||||.++.+..+......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++.........
T Consensus 79 v~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 79 IMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred EECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 9999998766655555567999999999999999999999999999999999999999999999999998754321100
Q ss_pred ------------------------------------CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCC
Q 005289 288 ------------------------------------PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 331 (704)
Q Consensus 288 ------------------------------------~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~ 331 (704)
.....+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhhcCCC
Confidence 0113468999999999876 568999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcC---HH
Q 005289 332 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT---AS 408 (704)
Q Consensus 332 pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpT---a~ 408 (704)
||.+.+..+.+..+........ . + ....+++++++||.+||. +|.+|++ +.
T Consensus 238 Pf~~~~~~~~~~~i~~~~~~~~--------~----------~-------~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~ 291 (364)
T cd05599 238 PFCSDNPQETYRKIINWKETLQ--------F----------P-------DEVPLSPEAKDLIKRLCC-EAERRLGNNGVN 291 (364)
T ss_pred CCCCCCHHHHHHHHHcCCCccC--------C----------C-------CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHH
Confidence 9999888777766653110000 0 0 012578899999999996 9999998 99
Q ss_pred HHHhccccCCCCC
Q 005289 409 AALASEYFSTKPY 421 (704)
Q Consensus 409 e~L~hpwf~~~~~ 421 (704)
++|.||||+...|
T Consensus 292 ~ll~h~~~~~~~~ 304 (364)
T cd05599 292 EIKSHPFFKGVDW 304 (364)
T ss_pred HHhcCCCcCCCCH
Confidence 9999999987544
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-45 Score=397.92 Aligned_cols=263 Identities=28% Similarity=0.412 Sum_probs=217.1
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
++|++++.||+|+||+||+|++..+++.||||++..... .......+.+|+.+|..++||||+++++.+.+ ...+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~--~~~~~l 78 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD--KLNLYL 78 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCeEEE
Confidence 369999999999999999999999999999999976432 23345567889999999999999999999987 578999
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC--
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-- 286 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~-- 286 (704)
|||||+++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.......
T Consensus 79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 79 IMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred EEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 999999876666655566899999999999999999999999999999999999999999999999999875432110
Q ss_pred --------------------------------CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 005289 287 --------------------------------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 334 (704)
Q Consensus 287 --------------------------------~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~ 334 (704)
......+||+.|+|||++.+ ..|+.++|||||||+||||++|++||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 01124578999999999876 568999999999999999999999999
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCC---CcCHHHHH
Q 005289 335 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK---RATASAAL 411 (704)
Q Consensus 335 ~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~k---RpTa~e~L 411 (704)
+.+..+.+.+|........ + . ....+++++++||.+||. +|.+ ||+++++|
T Consensus 238 ~~~~~~~~~~i~~~~~~~~--------------~------p-----~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~ 291 (363)
T cd05628 238 SETPQETYKKVMNWKETLI--------------F------P-----PEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIK 291 (363)
T ss_pred CCCHHHHHHHHHcCcCccc--------------C------C-----CcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHh
Confidence 9888888877754211110 0 0 012478899999999885 5554 58999999
Q ss_pred hccccCCCCC
Q 005289 412 ASEYFSTKPY 421 (704)
Q Consensus 412 ~hpwf~~~~~ 421 (704)
+||||+...|
T Consensus 292 ~hp~f~~~~~ 301 (363)
T cd05628 292 TNPFFEGVDW 301 (363)
T ss_pred CCCCCCCCCH
Confidence 9999997655
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=384.94 Aligned_cols=272 Identities=27% Similarity=0.435 Sum_probs=225.3
Q ss_pred ccccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCe
Q 005289 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (704)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (704)
++..+.|++...||.|..++||+|+...++.+||||++..+..+.+ ...+.+|+..|+.++||||++++..|.. ...
T Consensus 22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv--~~~ 98 (516)
T KOG0582|consen 22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVV--DSE 98 (516)
T ss_pred CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEe--cce
Confidence 3446789999999999999999999999999999999998776544 7889999999999999999999998887 578
Q ss_pred EEEEEecccccccccccC--CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCC
Q 005289 206 IYLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~--~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~ 283 (704)
+|+||.||.++.+..+.. -...|.|..++.|+++++.||.|||.+|.||||||+.||||+.+|.|||+|||.+..+..
T Consensus 99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 999999999876665543 223499999999999999999999999999999999999999999999999998754432
Q ss_pred -CCCC--CcccccccccccCccccc-CCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhc
Q 005289 284 -GHRQ--PLTSRVVTLWYRPPELLL-GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359 (704)
Q Consensus 284 -~~~~--~~~~~~gT~~Y~APEvl~-~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~ 359 (704)
+.+. .+.+.++|++|||||+++ .-..|+.++||||||++..||.+|..||........+.. ++.+.||....
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~--tLqn~pp~~~t-- 254 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLL--TLQNDPPTLLT-- 254 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHH--HhcCCCCCccc--
Confidence 2211 124568999999999954 445799999999999999999999999988777665533 33455542110
Q ss_pred cCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
...-.+..+.++..++.+|..||.+||.+||||+++|+|+||+..
T Consensus 255 ---------------~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 255 ---------------SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred ---------------ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 000133446778899999999999999999999999999999863
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=392.10 Aligned_cols=263 Identities=29% Similarity=0.423 Sum_probs=221.7
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
+|++++.||+|+||.||+|++..+++.||||++...... ......+.+|+.+|..++||||+++++++.. ...+|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~~lv 79 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD--DEYLYLA 79 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc--CCEEEEE
Confidence 699999999999999999999999999999999765322 2345567889999999999999999999987 5789999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCc
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~ 289 (704)
|||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..... ..
T Consensus 80 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~~ 155 (333)
T cd05600 80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YA 155 (333)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc----cc
Confidence 99999877776666666799999999999999999999999999999999999999999999999999976543 23
Q ss_pred ccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCC
Q 005289 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (704)
Q Consensus 290 ~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~ 369 (704)
...++|+.|+|||++.+ ..++.++|||||||+||+|++|.+||.+.+..+.+..+........ .
T Consensus 156 ~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~---------------~ 219 (333)
T cd05600 156 NSVVGSPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ---------------R 219 (333)
T ss_pred CCcccCccccChhHhcC-CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccccc---------------C
Confidence 45678999999999876 4789999999999999999999999999888777776654211100 0
Q ss_pred CCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCC
Q 005289 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (704)
Q Consensus 370 ~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~ 421 (704)
+.. ......++.++.+||.+||..+|.+|||+.++++||||...++
T Consensus 220 ~~~------~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~ 265 (333)
T cd05600 220 PVY------DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDW 265 (333)
T ss_pred CCC------CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence 000 0001357899999999999999999999999999999997554
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=366.80 Aligned_cols=255 Identities=32% Similarity=0.480 Sum_probs=226.6
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCCh-HHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP-ESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 207 (704)
.++|++.+.||+|-||.||+|+.+.++-.||||++.+..+.. .....+.+|++|-..|+||||++++++|.+ ...+|
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd--~~riy 98 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD--SKRIY 98 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec--cceeE
Confidence 678999999999999999999999999999999998766532 234557899999999999999999999998 57899
Q ss_pred EEEecccccccccccC--CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 208 LVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~--~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
|++||...+.+...+. ...+|+|..++.|++|++.||.|||..+||||||||+|+|++..+.+||+|||.+.....+
T Consensus 99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~- 177 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSN- 177 (281)
T ss_pred EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCCC-
Confidence 9999998765554444 6678999999999999999999999999999999999999999999999999999766532
Q ss_pred CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
.-.+.|||..|.+||...+ ..++..+|+|++|++.||++.|.+||...+..+.+++|.+.--..|
T Consensus 178 --kR~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p------------ 242 (281)
T KOG0580|consen 178 --KRKTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP------------ 242 (281)
T ss_pred --CceeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC------------
Confidence 3467799999999999887 6789999999999999999999999999999999999987432222
Q ss_pred ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
..++.++.|||.+||.++|.+|.+..|++.|||+..
T Consensus 243 -----------------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 243 -----------------STISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred -----------------cccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 478999999999999999999999999999999975
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=381.57 Aligned_cols=261 Identities=23% Similarity=0.370 Sum_probs=214.0
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
.|++++.||+|+||+||+|.+..+++.||||++...... ......+.+|+.+|..++|+||+++++++.+ ...+|+|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~--~~~~~lv 78 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET--KDALCLV 78 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc--CCeEEEE
Confidence 388999999999999999999999999999999765432 2233456789999999999999999999877 4689999
Q ss_pred Eeccccccccccc--CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCC
Q 005289 210 FEYMEHDITGLLS--CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (704)
Q Consensus 210 ~Ey~~g~ll~~~~--~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~ 287 (704)
|||+.++.+..+. .....+++..+..++.||+.||.|||++||+||||||+|||+++++.+||+|||++...... .
T Consensus 79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~--~ 156 (285)
T cd05631 79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG--E 156 (285)
T ss_pred EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC--C
Confidence 9999987665332 22346899999999999999999999999999999999999999999999999999765432 2
Q ss_pred CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCccc
Q 005289 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (704)
Q Consensus 288 ~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~ 367 (704)
.....++|+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.........+...+....
T Consensus 157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------- 221 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ-------------- 221 (285)
T ss_pred eecCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccc--------------
Confidence 2345578999999999976 5789999999999999999999999988765444333333221111
Q ss_pred CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcC-----HHHHHhccccCCCCC
Q 005289 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPY 421 (704)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpT-----a~e~L~hpwf~~~~~ 421 (704)
......++.++.+||++||+.||.+||| ++++++||||....+
T Consensus 222 -----------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05631 222 -----------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINF 269 (285)
T ss_pred -----------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence 0112467899999999999999999997 899999999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=398.19 Aligned_cols=262 Identities=30% Similarity=0.421 Sum_probs=215.4
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
.|+++++||+|+||+||+|++..+++.||||++..... .......+.+|+.+|+.++|||||++++.|.+ ...+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~--~~~~~lv 79 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD--KDNLYFV 79 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe--CCEEEEE
Confidence 59999999999999999999999999999999975432 23445667889999999999999999999987 5789999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC----
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH---- 285 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~---- 285 (704)
||||+++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~ 159 (382)
T cd05625 80 MDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (382)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence 9999987665555455678999999999999999999999999999999999999999999999999975321000
Q ss_pred ------------------------------------------CCCcccccccccccCcccccCCCCCCCccchhhHHHHH
Q 005289 286 ------------------------------------------RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVF 323 (704)
Q Consensus 286 ------------------------------------------~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iL 323 (704)
.......+||+.|+|||++.+ ..|+.++|||||||+|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvil 238 (382)
T cd05625 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVIL 238 (382)
T ss_pred cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEechHHH
Confidence 001123478999999999876 5689999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCC
Q 005289 324 AELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK 403 (704)
Q Consensus 324 yeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~k 403 (704)
|||++|++||.+.+..+...++........ ......+++++.+||.+|+ .||.+
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------~p~~~~~s~~~~~li~~l~-~~p~~ 292 (382)
T cd05625 239 YEMLVGQPPFLAQTPLETQMKVINWQTSLH-------------------------IPPQAKLSPEASDLIIKLC-RGPED 292 (382)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHccCCCcC-------------------------CCCcccCCHHHHHHHHHHc-cCHhH
Confidence 999999999999888777666653211110 0011357899999999987 59999
Q ss_pred CcC---HHHHHhccccCCCCC
Q 005289 404 RAT---ASAALASEYFSTKPY 421 (704)
Q Consensus 404 RpT---a~e~L~hpwf~~~~~ 421 (704)
|++ +.++++||||+...+
T Consensus 293 R~~~~~~~ei~~hp~f~~~~~ 313 (382)
T cd05625 293 RLGKNGADEIKAHPFFKTIDF 313 (382)
T ss_pred cCCCCCHHHHhcCCCcCCcCh
Confidence 997 999999999987544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=397.38 Aligned_cols=263 Identities=30% Similarity=0.411 Sum_probs=214.6
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
.|++++.||+|+||+||+|++..+++.||||++..... .......+.+|+.+|+.++||||+++++++.+ ...+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~~~~~lv 79 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYFV 79 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec--CCEEEEE
Confidence 59999999999999999999999999999999976543 33445678899999999999999999999987 5789999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC----
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH---- 285 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~---- 285 (704)
||||+++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++++||+|||++.......
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence 9999987666555555679999999999999999999999999999999999999999999999999975431100
Q ss_pred ------------------------------------------CCCcccccccccccCcccccCCCCCCCccchhhHHHHH
Q 005289 286 ------------------------------------------RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVF 323 (704)
Q Consensus 286 ------------------------------------------~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iL 323 (704)
.......+||+.|+|||++.+ ..|+.++|||||||||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG~il 238 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGVIL 238 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceeehhhHH
Confidence 000123578999999999876 5689999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhcc--CC
Q 005289 324 AELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSV--EP 401 (704)
Q Consensus 324 yeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~--dP 401 (704)
|||++|.+||...+..+...++........ ......+++++++||.+||.. +|
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~dli~~ll~~~~~~ 293 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVINWENTLH-------------------------IPPQVKLSPEAVDLITKLCCSAEER 293 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHccccccC-------------------------CCCCCCCCHHHHHHHHHHccCcccc
Confidence 999999999998887766666543111110 001135789999999997755 44
Q ss_pred CCCcCHHHHHhccccCCCCC
Q 005289 402 YKRATASAALASEYFSTKPY 421 (704)
Q Consensus 402 ~kRpTa~e~L~hpwf~~~~~ 421 (704)
..|+|+.++|.||||+...|
T Consensus 294 ~~R~~~~~~l~hp~f~~~~~ 313 (381)
T cd05626 294 LGRNGADDIKAHPFFSEVDF 313 (381)
T ss_pred cCCCCHHHHhcCcccCCCCh
Confidence 45999999999999986443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-45 Score=393.34 Aligned_cols=259 Identities=25% Similarity=0.362 Sum_probs=219.9
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCC-cEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCC
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTG-KIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g-~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 204 (704)
+..++|++++.||.|+||.||+|.+..++ ..||||++..... .......+.+|+.+|+.++||||+++++++.+ ..
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~ 104 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD--ES 104 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe--CC
Confidence 34668999999999999999999876654 6899999975432 23345567889999999999999999999987 57
Q ss_pred eEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
.+||||||+.++.+..+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 89999999998776666656667999999999999999999999999999999999999999999999999999765432
Q ss_pred CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
....+||+.|+|||++.+ ..++.++|||||||+||+|++|.+||.+.+....+.++......+
T Consensus 185 ----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~------------ 247 (340)
T PTZ00426 185 ----TYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYF------------ 247 (340)
T ss_pred ----cceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC------------
Confidence 234578999999999876 568999999999999999999999999988877777765421111
Q ss_pred cccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCc-----CHHHHHhccccCCCCC
Q 005289 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 421 (704)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRp-----Ta~e~L~hpwf~~~~~ 421 (704)
...++..+.+||++||..||.+|+ |++++++||||....|
T Consensus 248 -----------------p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~ 292 (340)
T PTZ00426 248 -----------------PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW 292 (340)
T ss_pred -----------------CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 135688899999999999999995 8999999999987654
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=393.89 Aligned_cols=263 Identities=33% Similarity=0.482 Sum_probs=220.4
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
++|++++.||+|+||+||+|++..+++.||||++...... ......+.+|+.+|..++||||+++++++.+ ...+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD--EEHLYL 78 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec--CCeEEE
Confidence 3699999999999999999999999999999999765332 2445667889999999999999999999877 578999
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC---
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH--- 285 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~--- 285 (704)
||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 79 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 79 VMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 99999886666555455689999999999999999999999999999999999999999999999999997655432
Q ss_pred -------------------------CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHH
Q 005289 286 -------------------------RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE 340 (704)
Q Consensus 286 -------------------------~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e 340 (704)
.......++|+.|+|||++.+ ..++.++|||||||+||+|++|++||.+.+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcC-CCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 112334578999999999876 578999999999999999999999999988777
Q ss_pred HHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcC-HHHHHhccccCCC
Q 005289 341 QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-ASAALASEYFSTK 419 (704)
Q Consensus 341 ~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpT-a~e~L~hpwf~~~ 419 (704)
.+.++........ . .....+++++.+||.+||. ||.+|++ +.++|+||||+..
T Consensus 238 ~~~~i~~~~~~~~--------~-----------------p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 238 TYNKIINWKESLR--------F-----------------PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred HHHHHhccCCccc--------C-----------------CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 7777654211100 0 0012378999999999997 9999999 9999999999875
Q ss_pred CC
Q 005289 420 PY 421 (704)
Q Consensus 420 ~~ 421 (704)
.|
T Consensus 292 ~~ 293 (350)
T cd05573 292 DW 293 (350)
T ss_pred CH
Confidence 54
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=396.44 Aligned_cols=263 Identities=28% Similarity=0.427 Sum_probs=214.8
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
++|+++++||+|+||+||+|++..+++.||||++..... .......+.+|+++|+.++||||++++++|.+ ...+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~~l 78 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD--AQYLYL 78 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCeeEE
Confidence 369999999999999999999999999999999875432 23445667889999999999999999999987 578999
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCC-
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ- 287 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~- 287 (704)
||||++++.+..+......+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+......
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 79 IMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 9999988766655555567999999999999999999999999999999999999999999999999998633210000
Q ss_pred ---------------------------------------------CcccccccccccCcccccCCCCCCCccchhhHHHH
Q 005289 288 ---------------------------------------------PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCV 322 (704)
Q Consensus 288 ---------------------------------------------~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~i 322 (704)
.....+||+.|+|||++.+ ..|+.++|||||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvi 237 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGAI 237 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEecchh
Confidence 0012478999999999876 568999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCC
Q 005289 323 FAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPY 402 (704)
Q Consensus 323 LyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~ 402 (704)
||||++|.+||.+.+..+.+.+|....... .++ ....++.++.+||.+||. +|.
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~--------~~p-----------------~~~~~s~~~~dli~~lL~-~~~ 291 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINWRETL--------YFP-----------------DDIHLSVEAEDLIRRLIT-NAE 291 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHccCCcc--------CCC-----------------CCCCCCHHHHHHHHHHhc-CHh
Confidence 999999999999988877777765411100 000 012478899999999997 777
Q ss_pred CC---cCHHHHHhccccCCCCC
Q 005289 403 KR---ATASAALASEYFSTKPY 421 (704)
Q Consensus 403 kR---pTa~e~L~hpwf~~~~~ 421 (704)
+| +|+.++|.||||+...|
T Consensus 292 ~r~~r~~~~~~l~hp~~~~~~~ 313 (377)
T cd05629 292 NRLGRGGAHEIKSHPFFRGVDW 313 (377)
T ss_pred hcCCCCCHHHHhcCCCcCCCCH
Confidence 65 59999999999986433
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-45 Score=390.42 Aligned_cols=264 Identities=27% Similarity=0.387 Sum_probs=219.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
++|.+.+.||+|+||+||+|++..+++.||||++..... .......+.+|+.+++.++||||+++++++.+ ...+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~--~~~~~l 78 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD--KDNLYL 78 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCeEEE
Confidence 369999999999999999999999999999999986543 23445667889999999999999999999877 578999
Q ss_pred EEecccccccccccC-CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCC
Q 005289 209 VFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~-~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~ 287 (704)
||||++++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.........
T Consensus 79 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 79 VMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred EECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 999998866555443 3367999999999999999999999999999999999999999999999999999876543322
Q ss_pred CcccccccccccCcccccC-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCC
Q 005289 288 PLTSRVVTLWYRPPELLLG-----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (704)
Q Consensus 288 ~~~~~~gT~~Y~APEvl~~-----~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~ 362 (704)
.....++|+.|+|||++.. ...++.++|||||||+||+|++|..||...+....+.+|....... .+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~--------~~ 230 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFL--------KF 230 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCcc--------CC
Confidence 2334578999999999863 3467899999999999999999999999888877777765421100 00
Q ss_pred CCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCC
Q 005289 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (704)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~ 421 (704)
.....++.++.+||.+||. ||.+|||+.+++.||||....|
T Consensus 231 -----------------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~ 271 (330)
T cd05601 231 -----------------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDW 271 (330)
T ss_pred -----------------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCH
Confidence 0113578999999999998 9999999999999999987544
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=394.68 Aligned_cols=267 Identities=25% Similarity=0.374 Sum_probs=222.1
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCe
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (704)
+..++|++++.||+|+||+||+|++..+++.||||++.+... .......+.+|+.+|+.++||||+++++++.+ ...
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~--~~~ 117 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD--DKY 117 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec--CCE
Confidence 456789999999999999999999999999999999975432 22334557789999999999999999998877 578
Q ss_pred EEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
+|||||||+++.+..+... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999998766655433 368999999999999999999999999999999999999999999999999997665433
Q ss_pred CCCcccccccccccCcccccCC---CCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCC
Q 005289 286 RQPLTSRVVTLWYRPPELLLGA---TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~---~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~ 362 (704)
.......+||+.|+|||++.+. ..++.++|||||||+||+|++|.+||.+.+....+.+|........ +
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~--------~ 268 (370)
T cd05596 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLT--------F 268 (370)
T ss_pred cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCC--------C
Confidence 2233456789999999998653 2478999999999999999999999999888877777754211110 0
Q ss_pred CCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCC--CcCHHHHHhccccCCCCC
Q 005289 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK--RATASAALASEYFSTKPY 421 (704)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~k--RpTa~e~L~hpwf~~~~~ 421 (704)
.....++.++.+||.+||..+|.+ |+|+.++|+||||+...|
T Consensus 269 -----------------~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~ 312 (370)
T cd05596 269 -----------------PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW 312 (370)
T ss_pred -----------------CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence 011357899999999999999998 999999999999997655
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=371.77 Aligned_cols=285 Identities=39% Similarity=0.688 Sum_probs=236.4
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 210 (704)
+|++.+.||.|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.. ...+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH--GSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec--CCeeEEEe
Confidence 4899999999999999999999999999999998765544556678899999999999999999999987 57899999
Q ss_pred ecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCcc
Q 005289 211 EYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 290 (704)
Q Consensus 211 Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~ 290 (704)
||+.+++...+......+++..++.++.||+.+|.|||+.||+|+||||+||+++.++.++|+|||++............
T Consensus 79 e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (286)
T cd07832 79 EYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS 158 (286)
T ss_pred cccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence 99955555555444567999999999999999999999999999999999999999999999999999876544322344
Q ss_pred cccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCC-CcccCC
Q 005289 291 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP-HATLFK 369 (704)
Q Consensus 291 ~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~-~~~~~~ 369 (704)
...++..|+|||++.+...++.++|||||||++|+|++|.++|.+.++.+.+..+...++.+....|...... ......
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07832 159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT 238 (286)
T ss_pred cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhccc
Confidence 5578999999999877667899999999999999999999999999999999999999988877666543221 100000
Q ss_pred CCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccC
Q 005289 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417 (704)
Q Consensus 370 ~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~ 417 (704)
........+...++.++..+.+||.+||..||.+|||+.++|.||||.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 239 FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred CCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 011111224455678889999999999999999999999999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=396.67 Aligned_cols=262 Identities=29% Similarity=0.394 Sum_probs=214.6
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
.|+++++||+|+||+||+|++..+++.||||++..... .......+.+|+.+|+.++||||+++++.|.+ ...+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~lv 79 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYFV 79 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCEEEEE
Confidence 69999999999999999999999999999999965432 22334567789999999999999999999987 5789999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC-----
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG----- 284 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~----- 284 (704)
||||+++.+..+......+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|..+...
T Consensus 80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~ 159 (376)
T cd05598 80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (376)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence 999998776666555667899999999999999999999999999999999999999999999999997532100
Q ss_pred -------------------------------------CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHH
Q 005289 285 -------------------------------------HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 327 (704)
Q Consensus 285 -------------------------------------~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLl 327 (704)
........+||+.|+|||++.+ ..++.++||||||||||+|+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeeeccceeeehh
Confidence 0001123578999999999876 56899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCc--
Q 005289 328 IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-- 405 (704)
Q Consensus 328 tG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRp-- 405 (704)
+|++||.+.+..+.+.++........ ......++.++.+||.+|+ .+|.+|+
T Consensus 239 ~G~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~~li~~l~-~~p~~R~~~ 292 (376)
T cd05598 239 VGQPPFLADTPAETQLKVINWETTLH-------------------------IPSQAKLSREASDLILRLC-CGAEDRLGK 292 (376)
T ss_pred hCCCCCCCCCHHHHHHHHhccCcccc-------------------------CCCCCCCCHHHHHHHHHHh-cCHhhcCCC
Confidence 99999999887776665533110000 0011357899999999987 5999999
Q ss_pred -CHHHHHhccccCCCCC
Q 005289 406 -TASAALASEYFSTKPY 421 (704)
Q Consensus 406 -Ta~e~L~hpwf~~~~~ 421 (704)
|+.++|+||||+...+
T Consensus 293 ~t~~ell~h~~~~~~~~ 309 (376)
T cd05598 293 NGADEIKAHPFFKGIDF 309 (376)
T ss_pred CCHHHHhCCCCcCCCCH
Confidence 9999999999986443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=384.17 Aligned_cols=249 Identities=29% Similarity=0.430 Sum_probs=210.9
Q ss_pred eeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEeccccc
Q 005289 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD 216 (704)
Q Consensus 138 LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~ 216 (704)
||+|+||+||+|++..+++.||||++..... .......+.+|+.+|..++||||+++++++.. ...+||||||+.++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS--PEKLYLVLAFINGG 78 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec--CCeEEEEEcCCCCC
Confidence 7999999999999999999999999975432 23445667789999999999999999999877 57899999999987
Q ss_pred ccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCcccccccc
Q 005289 217 ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 296 (704)
Q Consensus 217 ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~~~gT~ 296 (704)
.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+||+
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~ 157 (312)
T cd05585 79 ELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCGTP 157 (312)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccCCc
Confidence 776655556679999999999999999999999999999999999999999999999999997543222 2234467899
Q ss_pred cccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCc
Q 005289 297 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDS 376 (704)
Q Consensus 297 ~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~ 376 (704)
.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+.... +
T Consensus 158 ~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~--~------------------------ 210 (312)
T cd05585 158 EYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP--L------------------------ 210 (312)
T ss_pred ccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC--C------------------------
Confidence 9999999876 568999999999999999999999999888777766654310 0
Q ss_pred hhhhhccCCCHHHHHHHHHhhccCCCCCc---CHHHHHhccccCCC
Q 005289 377 SLRETFKDLPTTAVNLIETLLSVEPYKRA---TASAALASEYFSTK 419 (704)
Q Consensus 377 ~l~~~~~~~s~~~~dLI~~mL~~dP~kRp---Ta~e~L~hpwf~~~ 419 (704)
.....++.++.+||.+||..||.+|| ++.++|.||||...
T Consensus 211 ---~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 211 ---RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred ---CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 01135788999999999999999997 58999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=386.65 Aligned_cols=253 Identities=25% Similarity=0.409 Sum_probs=212.4
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEeccc
Q 005289 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME 214 (704)
Q Consensus 136 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~ 214 (704)
+.||+|+||+||+|++..+++.||||++..... .......+.+|+.+|+.++||||+++++++.. ...+||||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT--KDRLCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCEEEEEEeCCC
Confidence 368999999999999999999999999976532 23445667889999999999999999999877 578999999999
Q ss_pred ccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCcccccc
Q 005289 215 HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 294 (704)
Q Consensus 215 g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~~~g 294 (704)
++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......++
T Consensus 79 ~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~g 157 (328)
T cd05593 79 GGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKTFCG 157 (328)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cccccccC
Confidence 87776655556679999999999999999999999999999999999999999999999999987543221 22344578
Q ss_pred cccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCC
Q 005289 295 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY 374 (704)
Q Consensus 295 T~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~ 374 (704)
|+.|+|||++.+ ..++.++|||||||+||+|++|++||...+..+.+..+... .+
T Consensus 158 t~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~--~~---------------------- 212 (328)
T cd05593 158 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--DI---------------------- 212 (328)
T ss_pred CcCccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC--Cc----------------------
Confidence 999999999876 56899999999999999999999999988776666554321 00
Q ss_pred CchhhhhccCCCHHHHHHHHHhhccCCCCCc-----CHHHHHhccccCCCCC
Q 005289 375 DSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 421 (704)
Q Consensus 375 ~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRp-----Ta~e~L~hpwf~~~~~ 421 (704)
.....++.++.+||.+||..||.+|+ ++.++|+||||....|
T Consensus 213 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 259 (328)
T cd05593 213 -----KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNW 259 (328)
T ss_pred -----cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 01135788999999999999999997 8999999999986443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=385.50 Aligned_cols=253 Identities=26% Similarity=0.407 Sum_probs=213.2
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEeccc
Q 005289 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME 214 (704)
Q Consensus 136 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~ 214 (704)
+.||+|+||+||++++..+|+.||+|++..... .......+.+|+.+|+.++||||++++++|.. ...+||||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCEEEEEEeCCC
Confidence 368999999999999999999999999976432 23345567789999999999999999999877 568999999999
Q ss_pred ccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCcccccc
Q 005289 215 HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 294 (704)
Q Consensus 215 g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~~~g 294 (704)
++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......++
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~g 157 (323)
T cd05595 79 GGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCG 157 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-CccccccC
Confidence 87776655556679999999999999999999999999999999999999999999999999987543221 22344578
Q ss_pred cccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCC
Q 005289 295 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY 374 (704)
Q Consensus 295 T~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~ 374 (704)
|+.|+|||++.+ ..++.++|||||||+||+|++|+.||...+....+..+......
T Consensus 158 t~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~----------------------- 213 (323)
T cd05595 158 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR----------------------- 213 (323)
T ss_pred CcCcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-----------------------
Confidence 999999999876 56899999999999999999999999988877776665431100
Q ss_pred CchhhhhccCCCHHHHHHHHHhhccCCCCCc-----CHHHHHhccccCCCCC
Q 005289 375 DSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 421 (704)
Q Consensus 375 ~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRp-----Ta~e~L~hpwf~~~~~ 421 (704)
....+++++.+||.+||..||.+|+ ++.++|+||||....|
T Consensus 214 ------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~ 259 (323)
T cd05595 214 ------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 259 (323)
T ss_pred ------CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 1135789999999999999999998 9999999999986443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=391.57 Aligned_cols=267 Identities=25% Similarity=0.372 Sum_probs=219.8
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCe
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (704)
+..++|++++.||+|+||.||+|++..+++.||+|++.+... .......+.+|+.+++.++||||+++++++.+ ...
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--~~~ 117 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD--DKY 117 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCE
Confidence 446789999999999999999999999999999999975322 22334557789999999999999999999987 578
Q ss_pred EEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
+|||||||+++.+..+... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence 9999999998666655433 368999999999999999999999999999999999999999999999999998765433
Q ss_pred CCCcccccccccccCcccccCC---CCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCC
Q 005289 286 RQPLTSRVVTLWYRPPELLLGA---TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~---~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~ 362 (704)
.......+||+.|+|||++.+. ..++.++|||||||+||+|++|.+||.+.+....+.+|......+. +
T Consensus 197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~--------~ 268 (370)
T cd05621 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLN--------F 268 (370)
T ss_pred ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccC--------C
Confidence 2233456789999999998653 2478999999999999999999999999988888877765221110 0
Q ss_pred CCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCC--CcCHHHHHhccccCCCCC
Q 005289 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK--RATASAALASEYFSTKPY 421 (704)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~k--RpTa~e~L~hpwf~~~~~ 421 (704)
.....++..+++||..||..+|.+ |+|+.++|+||||+...|
T Consensus 269 -----------------p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~ 312 (370)
T cd05621 269 -----------------PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW 312 (370)
T ss_pred -----------------CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence 001257889999999999866544 899999999999987544
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=386.58 Aligned_cols=260 Identities=29% Similarity=0.451 Sum_probs=211.2
Q ss_pred CeeEEEEeeccCceEEEEEEEC---CCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCC
Q 005289 131 AFEKLEKIGQGTYSSVFRARDL---DTGKIVALKKVRFDNF--EPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSC 204 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAvK~i~~~~~--~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~ 204 (704)
+|+++++||+|+||+||+|++. .+++.||+|++.+... .....+.+..|+.+|..+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT--EA 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec--CC
Confidence 4899999999999999999864 5789999999975432 123345677899999999 59999999998876 56
Q ss_pred eEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
.+||||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 89999999998766655555567999999999999999999999999999999999999999999999999999865443
Q ss_pred CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHcCCCCchhhhcc
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE----VEQLHKIFKLCGSPPDDYWKKS 360 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~----~e~l~~I~~~~g~~p~~~w~~~ 360 (704)
........+||+.|+|||++.+...++.++|||||||+||+|++|..||..... ......+... .+
T Consensus 159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~--~~-------- 228 (332)
T cd05614 159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC--DP-------- 228 (332)
T ss_pred CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcC--CC--------
Confidence 333334567899999999998755688999999999999999999999975432 2222222210 00
Q ss_pred CCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCc-----CHHHHHhccccCCCCC
Q 005289 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 421 (704)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRp-----Ta~e~L~hpwf~~~~~ 421 (704)
.....++..+.+||.+||..||++|| +++++|+||||+...|
T Consensus 229 -------------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 275 (332)
T cd05614 229 -------------------PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDW 275 (332)
T ss_pred -------------------CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 01135788999999999999999999 8899999999986443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=372.54 Aligned_cols=290 Identities=42% Similarity=0.716 Sum_probs=236.8
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC---hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE---PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~---~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 207 (704)
+|++.+.||.|+||.||+|.+..+++.||||++...... ......+..|+.+++.++|+||+++++++.+ ...+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~ 78 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH--KSNIN 78 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec--CCEEE
Confidence 489999999999999999999999999999999865543 2334456789999999999999999999987 57899
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCC
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~ 287 (704)
+||||+.+.+...+......+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... .
T Consensus 79 lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~ 157 (298)
T cd07841 79 LVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN-R 157 (298)
T ss_pred EEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC-c
Confidence 999999555544443333379999999999999999999999999999999999999999999999999998765432 2
Q ss_pred CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCccc
Q 005289 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (704)
Q Consensus 288 ~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~ 367 (704)
......+++.|+|||++.+...++.++|||||||++|+|++|.++|.+.+..+.+.++...++.+....|........ .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 236 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD-Y 236 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc-c
Confidence 223345688999999987666789999999999999999999999999998888999988888887777754322111 1
Q ss_pred CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCCCCC
Q 005289 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACD 424 (704)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~~~~ 424 (704)
..........+...+..++..+.+||.+||.+||.+|||+.++|.|+||+..+.+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~ 293 (298)
T cd07841 237 VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP 293 (298)
T ss_pred ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence 111111222344556778899999999999999999999999999999998776654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=381.56 Aligned_cols=258 Identities=27% Similarity=0.407 Sum_probs=215.9
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCC-CceeEeEEEeecCCCeEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHP-NIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~Hp-nIv~l~~~~~~~~~~~~~L 208 (704)
+|++++.||+|+||.||+|++..+++.||||++.+... .....+.+..|+.+|..+.|+ +|+++++++.+ ...+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc--CCEEEE
Confidence 48999999999999999999999999999999986532 234456677899999999765 58888888876 468999
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ..
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~ 157 (324)
T cd05587 79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-KT 157 (324)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-Cc
Confidence 99999987666555555678999999999999999999999999999999999999999999999999986432221 22
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccC
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~ 368 (704)
....+||+.|+|||++.+ ..++.++|||||||+||+|++|++||.+.+..+.+..+.......
T Consensus 158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~---------------- 220 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSY---------------- 220 (324)
T ss_pred eeeecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC----------------
Confidence 345578999999999876 568999999999999999999999999988888777775421111
Q ss_pred CCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCH-----HHHHhccccCCCCC
Q 005289 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA-----SAALASEYFSTKPY 421 (704)
Q Consensus 369 ~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa-----~e~L~hpwf~~~~~ 421 (704)
...++.++.+||.+||..||.+|+++ .++++||||....|
T Consensus 221 -------------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~ 265 (324)
T cd05587 221 -------------PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW 265 (324)
T ss_pred -------------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 13578899999999999999999986 89999999986433
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=380.28 Aligned_cols=256 Identities=25% Similarity=0.377 Sum_probs=213.3
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHH---HhcCCCCceeEeEEEeecCCCeEE
Q 005289 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILIL---RRLDHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 132 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL---~~L~HpnIv~l~~~~~~~~~~~~~ 207 (704)
|++++.||+|+||+||+|.+..+++.||||++..... .....+.+.+|+.++ +.++||||+++++++.. ...+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~--~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT--EDHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc--CCEEE
Confidence 7899999999999999999999999999999976432 223345566676655 56689999999999987 57899
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCC
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~ 287 (704)
|||||++++.+..... ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... .
T Consensus 79 lv~E~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~ 156 (324)
T cd05589 79 FVMEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG-D 156 (324)
T ss_pred EEEcCCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-C
Confidence 9999999876665543 3469999999999999999999999999999999999999999999999999987543222 2
Q ss_pred CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCccc
Q 005289 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (704)
Q Consensus 288 ~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~ 367 (704)
.....++|+.|+|||++.+ ..++.++|||||||+||+|++|++||.+.+..+.+..+......
T Consensus 157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~---------------- 219 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVR---------------- 219 (324)
T ss_pred cccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC----------------
Confidence 2345678999999999876 56899999999999999999999999998888877776542111
Q ss_pred CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCc-----CHHHHHhccccCCCCC
Q 005289 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 421 (704)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRp-----Ta~e~L~hpwf~~~~~ 421 (704)
....++..+.+||.+||..||.+|| ++.++++||||+...+
T Consensus 220 -------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~ 265 (324)
T cd05589 220 -------------YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINW 265 (324)
T ss_pred -------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCH
Confidence 0135788999999999999999999 7999999999986443
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=376.37 Aligned_cols=277 Identities=36% Similarity=0.652 Sum_probs=215.4
Q ss_pred EEeeccCceEEEEEEECC--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEecc
Q 005289 136 EKIGQGTYSSVFRARDLD--TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYM 213 (704)
Q Consensus 136 ~~LG~G~fg~Vy~a~~~~--~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~ 213 (704)
.+||+|+||+||+|++.. ++..||+|.+..... ...+.+|+.+|+.++||||+++++++.......+|+||||+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 689999999999999654 668999999875432 23466899999999999999999998765567899999999
Q ss_pred cccccccccC--------CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEE----ccCCceEEecccccccc
Q 005289 214 EHDITGLLSC--------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFS 281 (704)
Q Consensus 214 ~g~ll~~~~~--------~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl----~~~g~iKL~DFGla~~~ 281 (704)
++++...+.. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 9876554421 22358899999999999999999999999999999999999 45678999999999866
Q ss_pred CCCCC--CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCH---------HHHHHHHHHHcC
Q 005289 282 NTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE---------VEQLHKIFKLCG 350 (704)
Q Consensus 282 ~~~~~--~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~---------~e~l~~I~~~~g 350 (704)
..... ......++|+.|+|||++.+...++.++|||||||++|+|++|.+||....+ ..++.+++..+|
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd07867 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242 (317)
T ss_pred CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcC
Confidence 43321 1233457799999999998766789999999999999999999999976442 466788888899
Q ss_pred CCCchhhhccCCCCc----c-cCCCC----CCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 351 SPPDDYWKKSKLPHA----T-LFKPQ----QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 351 ~~p~~~w~~~~~~~~----~-~~~~~----~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
.+....|........ . .+... ......+.......+..+.+||.+||..||.+|||+.|+|+||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 243 FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 888888865331100 0 00000 000001111112456779999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=379.30 Aligned_cols=285 Identities=23% Similarity=0.316 Sum_probs=218.1
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEE
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 207 (704)
..++|+++++||.|+||.||++++..++..||+|++.... .......+.+|+++|++++||||+++++++.. ...+|
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 79 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEIS 79 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEEE
Confidence 3578999999999999999999999999999999997643 34456678899999999999999999999987 56899
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhc-CcccccCCCccEEEccCCceEEeccccccccCCCCC
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~-gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~ 286 (704)
|||||++++.+..+......+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 9999999977776665556789999999999999999999986 6999999999999999999999999998765432
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccC-CCCc
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK-LPHA 365 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~-~~~~ 365 (704)
......+|+.|+|||++.+ ..++.++|||||||+||+|++|+.||...+..+....+...........+.... .+..
T Consensus 158 -~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred -ccccCCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccc
Confidence 2234578999999999876 568999999999999999999999998776655433221111000011110000 0000
Q ss_pred --ccC----CCCCCCCc---h---h------hhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 366 --TLF----KPQQPYDS---S---L------RETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 366 --~~~----~~~~~~~~---~---l------~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
... ....+... . + ......++.++++||.+||.+||++|||+.++|+||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 000 00000000 0 0 00012468899999999999999999999999999999863
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=389.78 Aligned_cols=264 Identities=29% Similarity=0.424 Sum_probs=218.0
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
++|++++.||+|+||+||+|++..+++.||||++..... .......+.+|+.+|..++||||+++++.+.+ ...+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--~~~~~l 78 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD--KRNLYL 78 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEEE
Confidence 369999999999999999999999999999999975432 23445667889999999999999999999887 578999
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC--
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-- 286 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~-- 286 (704)
|||||.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 79 IMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred EEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 999999876666655566799999999999999999999999999999999999999999999999999865432110
Q ss_pred --------------------------------CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 005289 287 --------------------------------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 334 (704)
Q Consensus 287 --------------------------------~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~ 334 (704)
......+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCCCCCC
Confidence 01123578999999999876 568999999999999999999999999
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCc---CHHHHH
Q 005289 335 GRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA---TASAAL 411 (704)
Q Consensus 335 ~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRp---Ta~e~L 411 (704)
+.+..+.+.++........ + . ....++.++++||.+|+ .||.+|+ ++.+++
T Consensus 238 ~~~~~~~~~~i~~~~~~~~--------------~------p-----~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~ 291 (360)
T cd05627 238 SETPQETYRKVMNWKETLV--------------F------P-----PEVPISEKAKDLILRFC-TDSENRIGSNGVEEIK 291 (360)
T ss_pred CCCHHHHHHHHHcCCCcee--------------c------C-----CCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHh
Confidence 9888877777653110000 0 0 01247889999999987 5999998 489999
Q ss_pred hccccCCCCCC
Q 005289 412 ASEYFSTKPYA 422 (704)
Q Consensus 412 ~hpwf~~~~~~ 422 (704)
+||||+...|.
T Consensus 292 ~hp~f~~~~~~ 302 (360)
T cd05627 292 SHPFFEGVDWG 302 (360)
T ss_pred cCCCCCCCCHH
Confidence 99999976654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=373.59 Aligned_cols=287 Identities=45% Similarity=0.776 Sum_probs=236.4
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|++.+.||.|+||.||+|.+..+++.||+|.+............+.+|+.+|++++||||+++++++.......+||
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 35799999999999999999999999999999999765544333345678999999999999999999987754478999
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
||||+.+++...+......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... ..
T Consensus 84 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~ 162 (293)
T cd07843 84 VMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL-KP 162 (293)
T ss_pred EehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc-cc
Confidence 99999986655554444569999999999999999999999999999999999999999999999999998665432 22
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccC-CCCccc
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK-LPHATL 367 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~-~~~~~~ 367 (704)
.....+++.|+|||++.+...++.++|||||||++|+|++|.+||...+..+.+.+++..++.++...|.... ++....
T Consensus 163 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (293)
T cd07843 163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK 242 (293)
T ss_pred cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcc
Confidence 3345678899999998765667899999999999999999999999999999999999999999888887543 221111
Q ss_pred CCCCCCCCchhhhhccC--CCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 368 FKPQQPYDSSLRETFKD--LPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 368 ~~~~~~~~~~l~~~~~~--~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
..........+...++. +++.+.+||.+||..||++|||+.|+|.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 243 KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 11111112233444554 48999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=373.45 Aligned_cols=288 Identities=45% Similarity=0.823 Sum_probs=236.5
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC------
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL------ 202 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~------ 202 (704)
.++|+++++||.|+||.||+|++..+++.||||++............+.+|+++|+.++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 56899999999999999999999999999999998765433222345678999999999999999998875432
Q ss_pred CCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccC
Q 005289 203 SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (704)
Q Consensus 203 ~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~ 282 (704)
...+|+||||+.+++...+......+++..++.++.||+.||.|||++||+|+||||+|||+++++.+||+|||++....
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 166 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD 166 (311)
T ss_pred CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence 23579999999988777766666679999999999999999999999999999999999999999999999999997654
Q ss_pred CCCC----------CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Q 005289 283 TGHR----------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 352 (704)
Q Consensus 283 ~~~~----------~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~ 352 (704)
.... ...+...+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..+...++.+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T cd07866 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTP 246 (311)
T ss_pred CCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 3211 112334568899999998765678999999999999999999999999999999999999999988
Q ss_pred CchhhhccCCCCc-ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 353 PDDYWKKSKLPHA-TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 353 p~~~w~~~~~~~~-~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
++..|..+..... ............+...+..++..+.+||.+||..||.+|||+.++|.||||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 247 TEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred ChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 8776665432211 111111223334555667788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=371.31 Aligned_cols=283 Identities=41% Similarity=0.710 Sum_probs=230.3
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 210 (704)
+|++++.||.|+||.||+|++..+++.||||++..+.........+.+|+++|++++||||+++++++.+ ...+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc--CCcEEEEe
Confidence 4899999999999999999999999999999997655444444567889999999999999999999876 56899999
Q ss_pred ecccccccccccC-CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCc
Q 005289 211 EYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (704)
Q Consensus 211 Ey~~g~ll~~~~~-~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~ 289 (704)
||+.+++...+.. ....+++..++.++.||+.||+|||+++|+|+||+|+||+++.++.+||+|||++....... ...
T Consensus 79 e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-~~~ 157 (284)
T cd07860 79 EFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTY 157 (284)
T ss_pred eccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc-ccc
Confidence 9998765554432 34568999999999999999999999999999999999999999999999999987654322 223
Q ss_pred ccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCC
Q 005289 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (704)
Q Consensus 290 ~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~ 369 (704)
....+++.|+|||++.+...++.++|||||||++|+|++|+.||.+.++.+.+.++++..+.++...|............
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence 33456889999999877566788999999999999999999999999999999999998888877766532211000000
Q ss_pred CCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 370 ~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
........+....+.++.++++||.+||..||.+|||+.++|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 00011122334456788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=367.66 Aligned_cols=263 Identities=26% Similarity=0.400 Sum_probs=231.5
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCe
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (704)
+.+++|..++.||+|.||.|-+|+.+.++++||||+++++.+ ..+.+.....|-.+|+..+||++..|-..|+. ...
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt--~dr 242 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT--QDR 242 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc--Cce
Confidence 457889999999999999999999999999999999988764 35556677789999999999999999777776 578
Q ss_pred EEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
+|+||||..|+.|...+.....|+|..++.|-.+|+.||.|||+++||+||||.+|+|||.+|+|||+||||++..-...
T Consensus 243 lCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g 322 (516)
T KOG0690|consen 243 LCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG 322 (516)
T ss_pred EEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccccc
Confidence 99999999999888888888899999999999999999999999999999999999999999999999999998543322
Q ss_pred CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
....+.||||.|+|||+|.. ..|+.++|+|.+||++|||+||+.||...+....+..|.-.--.+
T Consensus 323 -~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kF------------- 387 (516)
T KOG0690|consen 323 -DTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKF------------- 387 (516)
T ss_pred -ceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccC-------------
Confidence 34577899999999999976 789999999999999999999999999988777776664321111
Q ss_pred ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcC-----HHHHHhccccCCCCCC
Q 005289 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPYA 422 (704)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpT-----a~e~L~hpwf~~~~~~ 422 (704)
...++++++.||..+|..||.+|.. |.++.+|+||....|.
T Consensus 388 ----------------Pr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~ 433 (516)
T KOG0690|consen 388 ----------------PRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWE 433 (516)
T ss_pred ----------------CccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHH
Confidence 1468999999999999999999964 8999999999987774
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-44 Score=381.85 Aligned_cols=253 Identities=25% Similarity=0.415 Sum_probs=212.5
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCCeEEEEEecc
Q 005289 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYM 213 (704)
Q Consensus 136 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~LV~Ey~ 213 (704)
+.||+|+||+||+|++..+++.||||++..... .......+..|+.++..+ +||||+++++++.. ...+||||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~--~~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT--PDRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc--CCEEEEEEcCC
Confidence 369999999999999999999999999976432 233455667899998877 79999999999977 57899999999
Q ss_pred cccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCccccc
Q 005289 214 EHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 293 (704)
Q Consensus 214 ~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~~~ 293 (704)
+++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+
T Consensus 79 ~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~~~ 157 (320)
T cd05590 79 NGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTSTFC 157 (320)
T ss_pred CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Ccccccc
Confidence 987666555555679999999999999999999999999999999999999999999999999987543221 2234457
Q ss_pred ccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCC
Q 005289 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 373 (704)
Q Consensus 294 gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~ 373 (704)
||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..|......
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~---------------------- 214 (320)
T cd05590 158 GTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV---------------------- 214 (320)
T ss_pred cCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC----------------------
Confidence 8999999999876 56899999999999999999999999999888877777541100
Q ss_pred CCchhhhhccCCCHHHHHHHHHhhccCCCCCcCH------HHHHhccccCCCCC
Q 005289 374 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA------SAALASEYFSTKPY 421 (704)
Q Consensus 374 ~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa------~e~L~hpwf~~~~~ 421 (704)
....++.++.+||.+||..||.+||++ ++++.||||+...|
T Consensus 215 -------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~ 261 (320)
T cd05590 215 -------YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDW 261 (320)
T ss_pred -------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence 012478899999999999999999998 99999999986543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=381.79 Aligned_cols=287 Identities=30% Similarity=0.533 Sum_probs=230.2
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC----CC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL----SC 204 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----~~ 204 (704)
.++|++++.||+|+||+||+|.+..+++.||||++............+.+|+.+++.++||||++++++|.... ..
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 35799999999999999999999999999999998755444445566778999999999999999999886432 24
Q ss_pred eEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
.+||||||+.+.+...+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 95 ~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 171 (353)
T cd07850 95 DVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 171 (353)
T ss_pred cEEEEEeccCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCC
Confidence 5799999999876665532 2899999999999999999999999999999999999999999999999999865433
Q ss_pred CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+.++...++.++.+++.......
T Consensus 172 ~--~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (353)
T cd07850 172 F--MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTV 248 (353)
T ss_pred C--CCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhh
Confidence 2 2334567899999999876 568999999999999999999999999999999999999999998877655422110
Q ss_pred cccCCCC-----CC---------CCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCC
Q 005289 365 ATLFKPQ-----QP---------YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (704)
Q Consensus 365 ~~~~~~~-----~~---------~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~ 421 (704)
....... .+ +...........+..+.+||.+||..||.+|||+.++|.||||+.+-.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~ 319 (353)
T cd07850 249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD 319 (353)
T ss_pred hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence 0000000 00 000001112345778999999999999999999999999999986544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=381.12 Aligned_cols=266 Identities=25% Similarity=0.356 Sum_probs=216.2
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN-FEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
++|++++.||+|+||+||++++..+++.||||++.+.. ........+.+|+.++..++|+||++++++|.+ ..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD--ENNLYL 78 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec--CCeEEE
Confidence 36999999999999999999999999999999997532 223345567889999999999999999999987 578999
Q ss_pred EEeccccccccccc-CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCC
Q 005289 209 VFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (704)
Q Consensus 209 V~Ey~~g~ll~~~~-~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~ 287 (704)
||||+.++.+..+. .....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.........
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred EEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 99999886555443 33557999999999999999999999999999999999999999999999999998765443322
Q ss_pred CcccccccccccCcccccC----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCC
Q 005289 288 PLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 288 ~~~~~~gT~~Y~APEvl~~----~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
.....++|+.|+|||++.. ...++.++|||||||+||+|++|+.||.+....+.+..+........
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~---------- 228 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQ---------- 228 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCccc----------
Confidence 2233568999999999863 34578899999999999999999999998887777776643211100
Q ss_pred CcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCC--CcCHHHHHhccccCCCCC
Q 005289 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK--RATASAALASEYFSTKPY 421 (704)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~k--RpTa~e~L~hpwf~~~~~ 421 (704)
+......++..+++||++||..++.+ |+++.++|+||||....|
T Consensus 229 --------------~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~ 274 (331)
T cd05597 229 --------------FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDW 274 (331)
T ss_pred --------------CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCH
Confidence 01112358899999999999765554 789999999999986544
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=375.31 Aligned_cols=308 Identities=24% Similarity=0.383 Sum_probs=251.2
Q ss_pred hhhhhhhhhhhcCccccccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCCh-HHHHHHHHHHHHHHhcCCC
Q 005289 111 AWLSAVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP-ESVRFMAREILILRRLDHP 189 (704)
Q Consensus 111 ~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~iL~~L~Hp 189 (704)
.++....++.+-++.|+..+.|...+.||+|+||.||-|+...||+.||+|.+.+..+.. .......+|-.||.+++.+
T Consensus 166 ~yf~rFlQWK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~ 245 (591)
T KOG0986|consen 166 DYFTRFLQWKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSP 245 (591)
T ss_pred HHHHHHHHHHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccC
Confidence 344555666777778999999999999999999999999999999999999987665432 2234456899999999999
Q ss_pred CceeEeEEEeecCCCeEEEEEecccccccccccCCCc--cccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccC
Q 005289 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI--KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE 267 (704)
Q Consensus 190 nIv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~~~--~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~ 267 (704)
+||.|-..|+. ...+||||..|.|+.+...+..-+ .|+|..+..|+.+|+.||++||+.+||+|||||+|||||+.
T Consensus 246 FiVslaYAfeT--kd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~ 323 (591)
T KOG0986|consen 246 FIVSLAYAFET--KDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDH 323 (591)
T ss_pred cEEEEeeeecC--CCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccC
Confidence 99999877776 578999999999988887765544 79999999999999999999999999999999999999999
Q ss_pred CceEEeccccccccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 005289 268 GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 347 (704)
Q Consensus 268 g~iKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~ 347 (704)
|+++|+|+|||..+..+ ++...++||.+|||||++.+.. |+...|+|||||+||||+.|+.||....+...-+.+-.
T Consensus 324 GhvRISDLGLAvei~~g--~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdr 400 (591)
T KOG0986|consen 324 GHVRISDLGLAVEIPEG--KPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDR 400 (591)
T ss_pred CCeEeeccceEEecCCC--CccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHH
Confidence 99999999999988765 4567789999999999998844 99999999999999999999999987654333323322
Q ss_pred HcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCc-----CHHHHHhccccCCCCCC
Q 005289 348 LCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPYA 422 (704)
Q Consensus 348 ~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRp-----Ta~e~L~hpwf~~~~~~ 422 (704)
..-..+. +....+++++++|++.+|..||.+|. .++++-+||||+..+|.
T Consensus 401 r~~~~~~-------------------------ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~ 455 (591)
T KOG0986|consen 401 RTLEDPE-------------------------EYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWR 455 (591)
T ss_pred HHhcchh-------------------------hcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHh
Confidence 2111111 11257899999999999999999995 57799999999998775
Q ss_pred C---CCCCCCCCCCChhHHhHhHHHHHhh
Q 005289 423 C---DLSSLPIYPPSKEIDAKHREDARRK 448 (704)
Q Consensus 423 ~---~~~~~p~~~~~~~~~~~~~~~~~~~ 448 (704)
. .....|..|+...+-++..-+....
T Consensus 456 rleagml~PPfiPdp~aVyakDv~DIeqF 484 (591)
T KOG0986|consen 456 RLEAGMLEPPFIPDPGAVYAKDVLDIEQF 484 (591)
T ss_pred HHhccCCCCCCCCCccccchhhhhhhhhc
Confidence 3 2334566677777766665554443
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=383.25 Aligned_cols=277 Identities=22% Similarity=0.334 Sum_probs=213.3
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
...|++++.||+|+||+||+|++..+++.||+|+..... ...|+.+|++++||||+++++++.. ....|+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~--------~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 134 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT--------TLIEAMLLQNVNHPSVIRMKDTLVS--GAITCM 134 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc--------cHHHHHHHHhCCCCCCcChhheEEe--CCeeEE
Confidence 347999999999999999999999999999999864322 2469999999999999999999987 467899
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
||||+.+++...+......+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||++...... ..
T Consensus 135 v~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~ 212 (357)
T PHA03209 135 VLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PA 212 (357)
T ss_pred EEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC--cc
Confidence 9999998887777666667999999999999999999999999999999999999999999999999999754322 12
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhC-CCCCCCCC---------HHHHHHHHHHHcCCCCchhhh
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG-KPILQGRT---------EVEQLHKIFKLCGSPPDDYWK 358 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG-~~pF~~~~---------~~e~l~~I~~~~g~~p~~~w~ 358 (704)
.....+|+.|+|||++.+ ..|+.++|||||||+||||+++ .++|.... ....+.++...++..+..+..
T Consensus 213 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 291 (357)
T PHA03209 213 FLGLAGTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR 291 (357)
T ss_pred cccccccccccCCeecCC-CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence 234578999999999876 5689999999999999999985 45554321 234455555656655543321
Q ss_pred ccCCCCc-cc----CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 359 KSKLPHA-TL----FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 359 ~~~~~~~-~~----~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
....... .+ .....++..........++.++.+||.+||++||.+|||+.|+|+||||++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 1000000 00 000011111001112367888999999999999999999999999999985
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=365.94 Aligned_cols=281 Identities=37% Similarity=0.625 Sum_probs=228.4
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeEEEeecCCCeEEEEE
Q 005289 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNIIKLEGLITSRLSCSIYLVF 210 (704)
Q Consensus 132 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~~~LV~ 210 (704)
|+++++||+|+||.||+|.+..+++.||+|++......... ....+|+.+|.++. |+||+++++++.+.....+|+||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 78899999999999999999999999999998764332222 23457999999984 99999999999875447899999
Q ss_pred ecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCcc
Q 005289 211 EYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 290 (704)
Q Consensus 211 Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~ 290 (704)
||++++++..+......+++..++.++.||+.||.|||++||+||||+|+||+++. +.+||+|||++...... ....
T Consensus 80 e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~--~~~~ 156 (282)
T cd07831 80 ELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK--PPYT 156 (282)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC--CCcC
Confidence 99998887776655567899999999999999999999999999999999999999 99999999999766432 2223
Q ss_pred cccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCC
Q 005289 291 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 370 (704)
Q Consensus 291 ~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~ 370 (704)
...+++.|+|||++.....++.++|||||||++|+|++|.+||.+.+..+.+..+...++.++..++..........+..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence 45678999999987655667899999999999999999999999999999999999988888775543222111111111
Q ss_pred CCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 371 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 371 ~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
.......+......++.++.+||.+||.+||++|||+.++|.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1111222334446789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=370.86 Aligned_cols=288 Identities=49% Similarity=0.876 Sum_probs=237.6
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC------
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL------ 202 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~------ 202 (704)
.++|++.+.||.|+||+||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 56899999999999999999999999999999999765433333455678999999999999999999886632
Q ss_pred --CCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccc
Q 005289 203 --SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 280 (704)
Q Consensus 203 --~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~ 280 (704)
...+||||||++++++..+......+++..+..++.||+.||.|||++||+|+||||+||++++++.+||+|||++..
T Consensus 86 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~ 165 (302)
T cd07864 86 KDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL 165 (302)
T ss_pred ccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccccc
Confidence 237899999999977776665555799999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhcc
Q 005289 281 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (704)
Q Consensus 281 ~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~ 360 (704)
.............++..|+|||++.+...++.++|||||||++|+|++|++||...+..+.+..+...++.++...|...
T Consensus 166 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (302)
T cd07864 166 YNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDV 245 (302)
T ss_pred ccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccc
Confidence 65443233333456888999998876556789999999999999999999999999999999999999998887776543
Q ss_pred CC-CCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 361 KL-PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 361 ~~-~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
.. +..............+...+..++..+.+||.+||..||.+|||+.++|.||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 246 IKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 21 111111112222234455667789999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=386.74 Aligned_cols=267 Identities=27% Similarity=0.370 Sum_probs=219.4
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCe
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (704)
+..++|++++.||+|+||+||+|++..+++.||+|++.+... .......+.+|+.+++.++||||+++++++.+ ...
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--~~~ 117 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD--DRY 117 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc--CCE
Confidence 345789999999999999999999999999999999975322 22334557789999999999999999999877 578
Q ss_pred EEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
+|||||||+++.+..+... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~ 196 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 196 (371)
T ss_pred EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC
Confidence 9999999998766655433 358999999999999999999999999999999999999999999999999998665433
Q ss_pred CCCcccccccccccCcccccCC---CCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCC
Q 005289 286 RQPLTSRVVTLWYRPPELLLGA---TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~---~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~ 362 (704)
.......+||+.|+|||++... ..|+.++|||||||+||+|++|.+||.+.+....+.+|.......+
T Consensus 197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~--------- 267 (371)
T cd05622 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT--------- 267 (371)
T ss_pred cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCccc---------
Confidence 2233456789999999998653 2488999999999999999999999999888877777754221110
Q ss_pred CCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCC--CcCHHHHHhccccCCCCC
Q 005289 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK--RATASAALASEYFSTKPY 421 (704)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~k--RpTa~e~L~hpwf~~~~~ 421 (704)
......++..+++||..||..++.+ |+++.++++|+||+..++
T Consensus 268 ----------------~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~ 312 (371)
T cd05622 268 ----------------FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 312 (371)
T ss_pred ----------------CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence 0012368899999999999844443 789999999999987554
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=382.74 Aligned_cols=253 Identities=24% Similarity=0.391 Sum_probs=211.7
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEeccc
Q 005289 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME 214 (704)
Q Consensus 136 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~ 214 (704)
+.||+|+||+||+|++..+++.||+|++..... .......+.+|+++++.++||||+++++++.. ...+||||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~--~~~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRLCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc--CCEEEEEEeCCC
Confidence 368999999999999999999999999976432 23345566789999999999999999998877 578999999999
Q ss_pred ccccccccCCCccccHHHHHHHHHHhhhhHHHHHh-cCcccccCCCccEEEccCCceEEeccccccccCCCCCCCccccc
Q 005289 215 HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 293 (704)
Q Consensus 215 g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~-~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~~~ 293 (704)
++.+..+......+++..++.++.||+.||.|||+ +||+||||||+||||+.++.+||+|||++....... ......+
T Consensus 79 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~ 157 (325)
T cd05594 79 GGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMKTFC 157 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-ccccccc
Confidence 87776665556679999999999999999999997 799999999999999999999999999987543221 2234457
Q ss_pred ccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCC
Q 005289 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 373 (704)
Q Consensus 294 gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~ 373 (704)
+|+.|+|||++.+ ..++.++|||||||+||+|++|..||.+.+..+.+..+......
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~---------------------- 214 (325)
T cd05594 158 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR---------------------- 214 (325)
T ss_pred CCcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCC----------------------
Confidence 8999999999876 56899999999999999999999999988776666655321100
Q ss_pred CCchhhhhccCCCHHHHHHHHHhhccCCCCCc-----CHHHHHhccccCCCCC
Q 005289 374 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 421 (704)
Q Consensus 374 ~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRp-----Ta~e~L~hpwf~~~~~ 421 (704)
....+++++.+||.+||..||++|+ ++.++|+||||....|
T Consensus 215 -------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 260 (325)
T cd05594 215 -------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVW 260 (325)
T ss_pred -------CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCH
Confidence 0135788999999999999999997 9999999999986433
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=378.64 Aligned_cols=258 Identities=25% Similarity=0.373 Sum_probs=216.5
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCCeEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~L 208 (704)
+|++++.||+|+||+||+|++..+++.||||++.+... .......+..|+.++..+ +|++|+++++++.. ...+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT--MDRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec--CCEEEE
Confidence 48999999999999999999999999999999986532 223345566788888887 68999999998877 568999
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
||||+.++.+.........+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ..
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-~~ 157 (323)
T cd05616 79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-VT 157 (323)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-Cc
Confidence 99999987666555555679999999999999999999999999999999999999999999999999997543221 22
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccC
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~ 368 (704)
....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..|......+
T Consensus 158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~---------------- 220 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY---------------- 220 (323)
T ss_pred cccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC----------------
Confidence 345678999999999876 568999999999999999999999999988888877775421111
Q ss_pred CCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcC-----HHHHHhccccCCCCC
Q 005289 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPY 421 (704)
Q Consensus 369 ~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpT-----a~e~L~hpwf~~~~~ 421 (704)
...++.++.+||.+||..||.+|++ ..++++||||....|
T Consensus 221 -------------p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~ 265 (323)
T cd05616 221 -------------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 265 (323)
T ss_pred -------------CCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCH
Confidence 1357889999999999999999998 489999999986544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=375.44 Aligned_cols=260 Identities=28% Similarity=0.403 Sum_probs=208.2
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|+++++||.|+||+||+|++..+++.||||++.... .......+.+|+++|+.++|+||+++++++.. ...+|+
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 149 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDH--NGEIQV 149 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEecc--CCeEEE
Confidence 356899999999999999999999999999999996543 33445678899999999999999999999977 578999
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
|||||.++.+... ..+.+..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ..
T Consensus 150 v~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 224 (353)
T PLN00034 150 LLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-DP 224 (353)
T ss_pred EEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc-cc
Confidence 9999998765432 245678889999999999999999999999999999999999999999999998664321 22
Q ss_pred cccccccccccCcccccC----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC
Q 005289 289 LTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~----~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
....++|..|+|||++.. ...++.++|||||||+||+|++|+.||......+....+.......+
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~----------- 293 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP----------- 293 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCC-----------
Confidence 345678999999998743 13345689999999999999999999974332222222211110000
Q ss_pred cccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCC
Q 005289 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (704)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~ 421 (704)
......++.++++||.+||..||++|||+.|+|+||||.....
T Consensus 294 --------------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~ 336 (353)
T PLN00034 294 --------------PEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQP 336 (353)
T ss_pred --------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCc
Confidence 0112367889999999999999999999999999999987543
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=379.57 Aligned_cols=253 Identities=26% Similarity=0.395 Sum_probs=212.4
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCCeEEEEEecc
Q 005289 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYM 213 (704)
Q Consensus 136 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~LV~Ey~ 213 (704)
+.||+|+||+||+|++..+++.||||++..... .......+..|+.+|..+ +||||+++++++.. ...+||||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~--~~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT--KDRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCeEEEEEeCC
Confidence 368999999999999999999999999976532 233455667899999876 89999999999987 56899999999
Q ss_pred cccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCccccc
Q 005289 214 EHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 293 (704)
Q Consensus 214 ~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~~~ 293 (704)
+++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~ 157 (321)
T cd05591 79 NGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTTTFC 157 (321)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC-ccccccc
Confidence 987666555555679999999999999999999999999999999999999999999999999987543222 2234457
Q ss_pred ccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCC
Q 005289 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 373 (704)
Q Consensus 294 gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~ 373 (704)
+|+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+....-.+
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~--------------------- 215 (321)
T cd05591 158 GTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLY--------------------- 215 (321)
T ss_pred cCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC---------------------
Confidence 8999999999875 568999999999999999999999999999888887775421000
Q ss_pred CCchhhhhccCCCHHHHHHHHHhhccCCCCCc-------CHHHHHhccccCCCCC
Q 005289 374 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-------TASAALASEYFSTKPY 421 (704)
Q Consensus 374 ~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRp-------Ta~e~L~hpwf~~~~~ 421 (704)
...++.++.+||.+||..||++|+ ++.++++||||....|
T Consensus 216 --------p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~ 262 (321)
T cd05591 216 --------PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDW 262 (321)
T ss_pred --------CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCH
Confidence 124678999999999999999999 9999999999976443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=363.91 Aligned_cols=283 Identities=36% Similarity=0.655 Sum_probs=228.1
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
++|++++.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.+++.++||||+++++++.. ...+|+|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR--KRKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee--CCEEEEE
Confidence 46999999999999999999999999999999987543333334556789999999999999999999987 5789999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCc
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~ 289 (704)
|||++++++..+......+++..++.++.||+.+|.|||++||+|+||||+|||++.++.+||+|||++........ ..
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~ 157 (286)
T cd07847 79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DY 157 (286)
T ss_pred EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-cc
Confidence 99999988887665556799999999999999999999999999999999999999999999999999986654321 22
Q ss_pred ccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCch---hhhccCCCCcc
Q 005289 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD---YWKKSKLPHAT 366 (704)
Q Consensus 290 ~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~---~w~~~~~~~~~ 366 (704)
....++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++..... .|....+...
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 236 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG- 236 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc-
Confidence 334578899999998765678899999999999999999999999988888777777665554322 1111111000
Q ss_pred cCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
...+.......+...+..++..+.+||.+||..||++|||+.++|.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 00111111122344567789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=366.48 Aligned_cols=284 Identities=37% Similarity=0.671 Sum_probs=228.7
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|++.+.||.|+||+||+|.+..+++.||||.+....... ....+.+|+.+++.++||||+++++++.+ ....|+
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 80 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHDIIHT--KKTLTL 80 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC-CchhHHHHHHHHhhCCCcceeeEEEEEec--CCeEEE
Confidence 468999999999999999999999999999999987543221 22345679999999999999999999986 578999
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
||||+.+++...+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~~ 159 (291)
T cd07844 81 VFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-KT 159 (291)
T ss_pred EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC-cc
Confidence 99999987666555545578999999999999999999999999999999999999999999999999987543221 11
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHcCCCCchhhhccCCCCccc
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT-EVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~-~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~ 367 (704)
.....++..|+|||++.+...++.++|||||||++|+|++|++||.+.. ..+.+..+.+.++.+..+.|..........
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 2233568899999998765668899999999999999999999998766 667888888888988887776543211111
Q ss_pred CC-CCCCCCchhhhhccCCC--HHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 368 FK-PQQPYDSSLRETFKDLP--TTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 368 ~~-~~~~~~~~l~~~~~~~s--~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
.. ........+...+..++ .++.+||.+||..||.+|||+.++|.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00 00111122334444555 889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=377.80 Aligned_cols=253 Identities=28% Similarity=0.458 Sum_probs=210.6
Q ss_pred EEEeeccCceEEEEEEEC---CCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 135 LEKIGQGTYSSVFRARDL---DTGKIVALKKVRFDNF--EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 135 ~~~LG~G~fg~Vy~a~~~---~~g~~vAvK~i~~~~~--~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
++.||+|+||.||+|++. .+++.||||++..... .......+.+|+.+|+.++||||++++++|.. ...+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~~lv 78 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT--GGKLYLI 78 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec--CCeEEEE
Confidence 368999999999999864 5789999999976432 12234456789999999999999999999987 5689999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCc
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~ 289 (704)
|||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...... ...
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 157 (323)
T cd05584 79 LEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TVT 157 (323)
T ss_pred EeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-Ccc
Confidence 9999987666655556678999999999999999999999999999999999999999999999999987543222 223
Q ss_pred ccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCC
Q 005289 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (704)
Q Consensus 290 ~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~ 369 (704)
...++|+.|+|||++.+ ..++.++|||||||+||+|++|++||.+.+....+..+.... .
T Consensus 158 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~--~----------------- 217 (323)
T cd05584 158 HTFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK--L----------------- 217 (323)
T ss_pred cccCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--C-----------------
Confidence 34578999999999876 568899999999999999999999999988777776664311 0
Q ss_pred CCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCc-----CHHHHHhccccCCCC
Q 005289 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKP 420 (704)
Q Consensus 370 ~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRp-----Ta~e~L~hpwf~~~~ 420 (704)
.....+++.+.+||.+||..||++|| ++.+++.||||....
T Consensus 218 ----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~ 263 (323)
T cd05584 218 ----------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVN 263 (323)
T ss_pred ----------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCC
Confidence 01135788999999999999999999 899999999998643
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=367.87 Aligned_cols=288 Identities=43% Similarity=0.714 Sum_probs=228.8
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC------
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL------ 202 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~------ 202 (704)
.++|+++++||.|+||+||+|.+..+++.||||++............+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 45799999999999999999999999999999998755433333344567999999999999999999886532
Q ss_pred CCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccC
Q 005289 203 SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (704)
Q Consensus 203 ~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~ 282 (704)
...+||||||+.+++...+......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....
T Consensus 91 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 170 (310)
T cd07865 91 KGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFS 170 (310)
T ss_pred CceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccccc
Confidence 24579999999987777666555578999999999999999999999999999999999999999999999999997654
Q ss_pred CCCC---CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhc
Q 005289 283 TGHR---QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359 (704)
Q Consensus 283 ~~~~---~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~ 359 (704)
.... .......++..|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..+...+|..+.+.|..
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (310)
T cd07865 171 LSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPG 250 (310)
T ss_pred CCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 3221 1223345688999999987756678999999999999999999999999998888889999999888777654
Q ss_pred cCCCCc-ccCCCCCCCCchhhhh--ccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 360 SKLPHA-TLFKPQQPYDSSLRET--FKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 360 ~~~~~~-~~~~~~~~~~~~l~~~--~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
...... ............+... ....+..+.+||.+||..||.+|||++++|+||||
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 251 VDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred ccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 321110 0000000000011111 11246788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=363.40 Aligned_cols=285 Identities=56% Similarity=1.009 Sum_probs=238.4
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEe
Q 005289 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFE 211 (704)
Q Consensus 132 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~E 211 (704)
|+++++||.|+||.||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++.......+|||||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 78899999999999999999999999999999876433344456778999999999999999999998743368999999
Q ss_pred cccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCccc
Q 005289 212 YMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 291 (704)
Q Consensus 212 y~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~ 291 (704)
|+++++...+......+++..++.++.||+.||+|||+.|++|+||+|+|||+++++.+||+|||++...........+.
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (287)
T cd07840 81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTN 160 (287)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccc
Confidence 99987766665555679999999999999999999999999999999999999999999999999998765443223344
Q ss_pred ccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCC-CCcccCCC
Q 005289 292 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL-PHATLFKP 370 (704)
Q Consensus 292 ~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~-~~~~~~~~ 370 (704)
..++..|+|||.+.+...++.++|||||||++|+|++|++||...+....+..+...++.++...|..... .....+..
T Consensus 161 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (287)
T cd07840 161 RVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKP 240 (287)
T ss_pred cccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccc
Confidence 56788999999887656789999999999999999999999999999999999999999888777765322 11122223
Q ss_pred CCCCCchhhhhccCC-CHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 371 QQPYDSSLRETFKDL-PTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 371 ~~~~~~~l~~~~~~~-s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
.......+.+.+... +..+.++|.+||..||.+|||+.++|.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 241 KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 333344455555565 9999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=382.97 Aligned_cols=282 Identities=23% Similarity=0.291 Sum_probs=219.4
Q ss_pred cCCeeEEEEeeccCceEEEEEEEC--CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDL--DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
..+|+++++||.|+||+||+|... .+++.||||.+.... ...+|+.+|+.|+|||||++++++.. ...+
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~ 161 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRW--KSTV 161 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEee--CCEE
Confidence 347999999999999999999754 456789999886432 24579999999999999999999877 5689
Q ss_pred EEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC
Q 005289 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~ 286 (704)
|+|||++.++++..+ .....+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||++........
T Consensus 162 ~lv~e~~~~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 162 CMVMPKYKCDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred EEEehhcCCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 999999998777665 4456799999999999999999999999999999999999999999999999999976543322
Q ss_pred C-CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHcCCCCchhhhccCC
Q 005289 287 Q-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT---EVEQLHKIFKLCGSPPDDYWKKSKL 362 (704)
Q Consensus 287 ~-~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~---~~e~l~~I~~~~g~~p~~~w~~~~~ 362 (704)
. .....++|+.|+|||++.+ ..|+.++|||||||+||+|++|+.||.+.. ....+..|.+.++..+.++......
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred cccccccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 1 2234578999999999876 568999999999999999999999997753 4567777887777665443221100
Q ss_pred CC-----cccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCC
Q 005289 363 PH-----ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (704)
Q Consensus 363 ~~-----~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~ 421 (704)
.. ........++...-......++.++.+||.+||.+||++|||+.++|.||||++.|+
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~ 383 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI 383 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence 00 000000011110000011246788999999999999999999999999999998665
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=376.66 Aligned_cols=253 Identities=26% Similarity=0.427 Sum_probs=209.1
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCCeEEEEEecc
Q 005289 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYM 213 (704)
Q Consensus 136 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~LV~Ey~ 213 (704)
+.||+|+||+||+|++..+++.||||++..... .....+.+..|..++..+ +||||+++++++.. ...+||||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT--KEHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 369999999999999999999999999976432 223344556677777754 89999999999877 56899999999
Q ss_pred cccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCccccc
Q 005289 214 EHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 293 (704)
Q Consensus 214 ~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~~~ 293 (704)
+++.+..+......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+
T Consensus 79 ~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~ 157 (316)
T cd05592 79 NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccccc
Confidence 987776655555679999999999999999999999999999999999999999999999999997543322 2334567
Q ss_pred ccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCC
Q 005289 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 373 (704)
Q Consensus 294 gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~ 373 (704)
||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~---------------------- 214 (316)
T cd05592 158 GTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPH---------------------- 214 (316)
T ss_pred CCccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC----------------------
Confidence 8999999999876 56899999999999999999999999998887777766431100
Q ss_pred CCchhhhhccCCCHHHHHHHHHhhccCCCCCcCH-HHHHhccccCCCCC
Q 005289 374 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA-SAALASEYFSTKPY 421 (704)
Q Consensus 374 ~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa-~e~L~hpwf~~~~~ 421 (704)
....++.++.+||.+||..||.+||++ .++++||||....|
T Consensus 215 -------~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05592 215 -------FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDW 256 (316)
T ss_pred -------CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCH
Confidence 012478889999999999999999986 58889999986443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=376.12 Aligned_cols=252 Identities=24% Similarity=0.398 Sum_probs=208.7
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCCeEEEEEecc
Q 005289 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYM 213 (704)
Q Consensus 136 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~LV~Ey~ 213 (704)
+.||+|+||.||+|++..+++.||||++...... ......+..|+.+|..+ +||||+++++++.+ ...+||||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT--KEHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe--CCEEEEEECCC
Confidence 4699999999999999999999999999764321 22345566788888765 89999999999987 57899999999
Q ss_pred cccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCccccc
Q 005289 214 EHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 293 (704)
Q Consensus 214 ~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~~~ 293 (704)
.++.+..+......+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++....... ......+
T Consensus 79 ~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 157 (316)
T cd05620 79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRASTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-CceeccC
Confidence 987666555555679999999999999999999999999999999999999999999999999987432221 2334567
Q ss_pred ccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCC
Q 005289 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 373 (704)
Q Consensus 294 gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~ 373 (704)
||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+..+.+..+... .+.
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~--~~~-------------------- 214 (316)
T cd05620 158 GTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD--TPH-------------------- 214 (316)
T ss_pred CCcCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCC--------------------
Confidence 8999999999876 56899999999999999999999999988887776666431 110
Q ss_pred CCchhhhhccCCCHHHHHHHHHhhccCCCCCcCH-HHHHhccccCCCC
Q 005289 374 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA-SAALASEYFSTKP 420 (704)
Q Consensus 374 ~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa-~e~L~hpwf~~~~ 420 (704)
....++.++.+||.+||..||.+|+++ +++++||||....
T Consensus 215 -------~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~ 255 (316)
T cd05620 215 -------YPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTIN 255 (316)
T ss_pred -------CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCC
Confidence 012468889999999999999999998 5888999998643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=368.33 Aligned_cols=262 Identities=24% Similarity=0.378 Sum_probs=214.5
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCCh-HHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP-ESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
+|++++.||+|+||+||++.+..+++.||||++....... .....+.+|+.+|+.++||||+++++.+.. ...+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET--KDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC--CCeEEEE
Confidence 4899999999999999999999999999999997644322 223456789999999999999999999877 4689999
Q ss_pred Eeccccccccccc-C-CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCC
Q 005289 210 FEYMEHDITGLLS-C-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (704)
Q Consensus 210 ~Ey~~g~ll~~~~-~-~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~ 287 (704)
|||+.++.+..+. . ....+++..+..++.||+.||.|||+.||+||||||+|||+++++.++|+|||++.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-- 156 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC--
Confidence 9999986665433 2 23468999999999999999999999999999999999999999999999999997654322
Q ss_pred CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCccc
Q 005289 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (704)
Q Consensus 288 ~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~ 367 (704)
.....++++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+...+...+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------- 221 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ-------------- 221 (285)
T ss_pred ccccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc--------------
Confidence 2234578999999999876 5689999999999999999999999998766544444433211110
Q ss_pred CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCc-----CHHHHHhccccCCCCCC
Q 005289 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPYA 422 (704)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRp-----Ta~e~L~hpwf~~~~~~ 422 (704)
......++..+.+||.+||..||.+|| ++.++++||||....|.
T Consensus 222 -----------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05605 222 -----------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFK 270 (285)
T ss_pred -----------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHH
Confidence 011235788999999999999999999 99999999999875553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=378.99 Aligned_cols=253 Identities=28% Similarity=0.433 Sum_probs=211.9
Q ss_pred EEEeeccCceEEEEEEE---CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEe
Q 005289 135 LEKIGQGTYSSVFRARD---LDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFE 211 (704)
Q Consensus 135 ~~~LG~G~fg~Vy~a~~---~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~E 211 (704)
++.||+|+||+||++++ ..+|+.||+|++............+.+|+++|++++||||+++++++.+ ...+|||||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e 78 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT--EGKLYLILD 78 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCEEEEEEc
Confidence 36799999999999986 3578999999998654433344556789999999999999999999987 578999999
Q ss_pred cccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCccc
Q 005289 212 YMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 291 (704)
Q Consensus 212 y~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~ 291 (704)
|++++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... .....
T Consensus 79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 157 (318)
T cd05582 79 FLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYS 157 (318)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cceec
Confidence 99986665555555679999999999999999999999999999999999999999999999999997654332 22344
Q ss_pred ccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCC
Q 005289 292 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 371 (704)
Q Consensus 292 ~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~ 371 (704)
.++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 158 ~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~-------------------- 216 (318)
T cd05582 158 FCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLG-------------------- 216 (318)
T ss_pred ccCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCC--------------------
Confidence 678999999999876 56789999999999999999999999998887777766442111
Q ss_pred CCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcC-----HHHHHhccccCCCC
Q 005289 372 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKP 420 (704)
Q Consensus 372 ~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpT-----a~e~L~hpwf~~~~ 420 (704)
....++..+.+||++||..||.+||| +.+++.||||....
T Consensus 217 ---------~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~ 261 (318)
T cd05582 217 ---------MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTID 261 (318)
T ss_pred ---------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence 11357889999999999999999999 78899999998643
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=365.69 Aligned_cols=286 Identities=41% Similarity=0.743 Sum_probs=232.8
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
++|++.+.||.|+||+||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.+ ...+|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS--EKRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec--CCeEEEE
Confidence 57999999999999999999999999999999987654433444567789999999999999999999987 5789999
Q ss_pred EecccccccccccC-CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEcc-CCceEEeccccccccCCCCCC
Q 005289 210 FEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-EGVLKLADFGLANFSNTGHRQ 287 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~-~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~-~g~iKL~DFGla~~~~~~~~~ 287 (704)
|||+++++...+.. ....+++..++.++.||+.||.|||++||+|+||+|+|||++. ++.+||+|||++....... .
T Consensus 80 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~-~ 158 (294)
T PLN00009 80 FEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-R 158 (294)
T ss_pred EecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc-c
Confidence 99998876665533 2334688999999999999999999999999999999999985 4579999999997654321 2
Q ss_pred CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCC-CCcc
Q 005289 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL-PHAT 366 (704)
Q Consensus 288 ~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~-~~~~ 366 (704)
......+++.|+|||++.+...++.++|||||||++|+|++|.+||...+..+.+.+++...+.+....|..... +...
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK 238 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence 223446688999999987656788999999999999999999999999999899999999999998888864321 1111
Q ss_pred cCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
...+. .....+....+.+++.+.+||.+||..||++||++.++|.||||...
T Consensus 239 ~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 239 SAFPK-WPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhccc-CCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 11111 01122333446789999999999999999999999999999999864
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=381.12 Aligned_cols=256 Identities=28% Similarity=0.444 Sum_probs=222.2
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
..|+.+.+||.|.||.||+|.+..+++.||+|++..+... ..++.+.+|+.+|..++++||.++|+.|.. +..++++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~-deIediqqei~~Ls~~~~~~it~yygsyl~--g~~Lwii 89 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE-DEIEDIQQEISVLSQCDSPNITEYYGSYLK--GTKLWII 89 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcc-hhhHHHHHHHHHHHhcCcchHHhhhhheee--cccHHHH
Confidence 4699999999999999999999999999999999877644 447788999999999999999999998877 5789999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCc
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~ 289 (704)
||||.|+.+..++..+..+.|..+..++++++.||.|||.++.+|||||+.||||..+|.+||+|||.+..........
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr- 168 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR- 168 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcc-
Confidence 9999998888888888778999999999999999999999999999999999999999999999999998776544333
Q ss_pred ccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCC
Q 005289 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (704)
Q Consensus 290 ~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~ 369 (704)
.+.+|||.||||||+.. ..|+.++||||||++.|||++|.||+........+..|-+
T Consensus 169 ~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk---------------------- 225 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK---------------------- 225 (467)
T ss_pred ccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC----------------------
Confidence 67899999999999984 6799999999999999999999999987665222222211
Q ss_pred CCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 370 ~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
...+.|. ..+++.+++||..||.+||+.||+|.++|+|+|++.
T Consensus 226 ---~~PP~L~---~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 226 ---SAPPRLD---GDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred ---CCCCccc---cccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 1111111 278899999999999999999999999999999986
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=375.99 Aligned_cols=252 Identities=25% Similarity=0.389 Sum_probs=208.5
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHH-HHHhcCCCCceeEeEEEeecCCCeEEEEEecc
Q 005289 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREIL-ILRRLDHPNIIKLEGLITSRLSCSIYLVFEYM 213 (704)
Q Consensus 136 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~-iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~ 213 (704)
+.||+|+||+||+|++..+++.||||++...... ......+..|.. +++.++||||+++++++.. ...+||||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~--~~~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--ADKLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe--CCEEEEEEcCC
Confidence 3699999999999999999999999999764321 222334445554 5678999999999999877 57899999999
Q ss_pred cccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCccccc
Q 005289 214 EHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 293 (704)
Q Consensus 214 ~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~~~ 293 (704)
.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 157 (323)
T cd05575 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTSTFC 157 (323)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Ccccccc
Confidence 997776655556689999999999999999999999999999999999999999999999999987543221 2234457
Q ss_pred ccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCC
Q 005289 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 373 (704)
Q Consensus 294 gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~ 373 (704)
+|+.|+|||++.+ ..++.++|||||||+||+|++|.+||.+.+..+.+..+.... .
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~--------------------- 213 (323)
T cd05575 158 GTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP--L--------------------- 213 (323)
T ss_pred CChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC--C---------------------
Confidence 8999999999876 568999999999999999999999999988777777664311 0
Q ss_pred CCchhhhhccCCCHHHHHHHHHhhccCCCCCcCH----HHHHhccccCCCC
Q 005289 374 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA----SAALASEYFSTKP 420 (704)
Q Consensus 374 ~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa----~e~L~hpwf~~~~ 420 (704)
.....++..+.+||.+||..||.+||++ .++|.||||....
T Consensus 214 ------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~ 258 (323)
T cd05575 214 ------RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSIN 258 (323)
T ss_pred ------CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 1123578999999999999999999998 6999999998643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=362.27 Aligned_cols=284 Identities=36% Similarity=0.647 Sum_probs=234.3
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 210 (704)
+|++.+.||.|+||+||+|.+..+++.||||++............+.+|+++|+.++|+||+++++++.. ...+|+||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv~ 79 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR--KGRLYLVF 79 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE--CCEEEEEE
Confidence 6999999999999999999999999999999987654444455678899999999999999999999987 57899999
Q ss_pred ecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCcc
Q 005289 211 EYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 290 (704)
Q Consensus 211 Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~ 290 (704)
||++++++..+......+++..+..++.||+.||.|||+++|+|+||+|+||++++++.+||+|||++............
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT 159 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence 99999888776655567999999999999999999999999999999999999999999999999999876654332445
Q ss_pred cccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc--ccC
Q 005289 291 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA--TLF 368 (704)
Q Consensus 291 ~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~--~~~ 368 (704)
..+++.+|+|||++.+...++.++|||||||++|+|++|++||.+....+.+..+...++..+...+........ ...
T Consensus 160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07833 160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA 239 (288)
T ss_pred CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccc
Confidence 567789999999998754789999999999999999999999999988888888888888777654433221100 000
Q ss_pred CCCCCCCchhhhhccC-CCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 369 KPQQPYDSSLRETFKD-LPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 369 ~~~~~~~~~l~~~~~~-~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
.+.......+...++. ++.++.+||++||..||++|||++++|.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0011111122333333 48999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=366.33 Aligned_cols=256 Identities=23% Similarity=0.338 Sum_probs=206.4
Q ss_pred eeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEeccccc
Q 005289 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD 216 (704)
Q Consensus 138 LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~ 216 (704)
||+|+||+||++.+..+++.||+|++...... ....+.+..|+.+|+.++||||+++++++.. ...+||||||++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT--KTDLCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC--CCeEEEEEeCCCCC
Confidence 79999999999999999999999999765432 2234556789999999999999999998877 46799999999987
Q ss_pred cccccc----CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCcccc
Q 005289 217 ITGLLS----CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 292 (704)
Q Consensus 217 ll~~~~----~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~~ 292 (704)
.+..+. .....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......
T Consensus 79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~ 157 (280)
T cd05608 79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ-SKTKGY 157 (280)
T ss_pred CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC-cccccc
Confidence 665332 234568999999999999999999999999999999999999999999999999997654432 223345
Q ss_pred cccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCC
Q 005289 293 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQ 372 (704)
Q Consensus 293 ~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~ 372 (704)
.+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+....-..+
T Consensus 158 ~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------------------- 217 (280)
T cd05608 158 AGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDS------------------- 217 (280)
T ss_pred CCCcCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccC-------------------
Confidence 78999999999876 5689999999999999999999999987543322222221110000
Q ss_pred CCCchhhhhccCCCHHHHHHHHHhhccCCCCCc-----CHHHHHhccccCCCCCC
Q 005289 373 PYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPYA 422 (704)
Q Consensus 373 ~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRp-----Ta~e~L~hpwf~~~~~~ 422 (704)
......++..+.+||.+||+.||++|| |++++|+||||+...|.
T Consensus 218 ------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~ 266 (280)
T cd05608 218 ------VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWR 266 (280)
T ss_pred ------CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHh
Confidence 011235889999999999999999999 89999999999875554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=362.40 Aligned_cols=282 Identities=37% Similarity=0.699 Sum_probs=231.3
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 210 (704)
+|+++++||.|++|+||+|++..+++.||||++...... .....+.+|+.+++.++||||+++++++.+ ....||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHT--ENKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEee--CCcEEEEE
Confidence 489999999999999999999999999999999765432 224456789999999999999999999987 46789999
Q ss_pred ecccccccccccCCC--ccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 211 EYMEHDITGLLSCPD--IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 211 Ey~~g~ll~~~~~~~--~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
||+++++...+.... ..+++..+..++.||+.||.|||+.||+|+||||+||++++++.++|+|||++....... ..
T Consensus 78 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-~~ 156 (284)
T cd07836 78 EYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-NT 156 (284)
T ss_pred ecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-cc
Confidence 999987666554322 468999999999999999999999999999999999999999999999999997654322 12
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccC
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~ 368 (704)
.....+++.|++||++.+...++.++|||||||++|+|++|++||.+.+..+.+.++......+....|...........
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 23446688999999987756688999999999999999999999999999999999999888888777765442111110
Q ss_pred CCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 369 ~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
.........+...++.++..+.++|.+||+.||.+|||+.++|+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 001111122334445678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=373.53 Aligned_cols=258 Identities=27% Similarity=0.399 Sum_probs=215.5
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcC-CCCceeEeEEEeecCCCeEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLD-HPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~~~L 208 (704)
+|++.+.||+|+||+||+|++..+++.||||++..... .....+.+..|+.++..+. |++|+++++++.. ...+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT--VDRLYF 78 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec--CCEEEE
Confidence 48899999999999999999999999999999986532 2334456778999999885 5778889888877 468999
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
||||++++.+..+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-~~ 157 (323)
T cd05615 79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-VT 157 (323)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-cc
Confidence 99999987766665555679999999999999999999999999999999999999999999999999987543221 12
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccC
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~ 368 (704)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+....+..|.......
T Consensus 158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~---------------- 220 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSY---------------- 220 (323)
T ss_pred ccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC----------------
Confidence 234568999999999876 568999999999999999999999999988887777775421111
Q ss_pred CCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcC-----HHHHHhccccCCCCC
Q 005289 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPY 421 (704)
Q Consensus 369 ~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpT-----a~e~L~hpwf~~~~~ 421 (704)
...++.++.+||.+||..||.+|++ ..++++||||....|
T Consensus 221 -------------p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~ 265 (323)
T cd05615 221 -------------PKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDW 265 (323)
T ss_pred -------------CccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence 1357889999999999999999997 579999999987544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=375.73 Aligned_cols=253 Identities=23% Similarity=0.405 Sum_probs=205.3
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCCeEEEEEecc
Q 005289 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYM 213 (704)
Q Consensus 136 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~LV~Ey~ 213 (704)
+.||+|+||+||+|++..+++.||||++...... ......+.+|+.++..+ +||||++++++|.. ...+|||||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~--~~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT--ESRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc--CCEEEEEEeCC
Confidence 3689999999999999999999999999865432 33456678899999998 79999999999987 57899999999
Q ss_pred cccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCccccc
Q 005289 214 EHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 293 (704)
Q Consensus 214 ~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~~~ 293 (704)
+++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...... ......+
T Consensus 79 ~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~ 157 (329)
T cd05588 79 SGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTSTFC 157 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCC-Ccccccc
Confidence 987666555555679999999999999999999999999999999999999999999999999987432211 2234567
Q ss_pred ccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCH--------HH-HHHHHHHHcCCCCchhhhccCCCC
Q 005289 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE--------VE-QLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 294 gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~--------~e-~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
||+.|+|||++.+ ..++.++|||||||++|+|++|++||..... .+ ..+.+... .
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---~------------ 221 (329)
T cd05588 158 GTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK---Q------------ 221 (329)
T ss_pred CCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC---C------------
Confidence 8999999999876 5689999999999999999999999963211 11 11111110 0
Q ss_pred cccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcC------HHHHHhccccCCCCC
Q 005289 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT------ASAALASEYFSTKPY 421 (704)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpT------a~e~L~hpwf~~~~~ 421 (704)
......++..+.+||.+||..||.+|+| +.++++||||....|
T Consensus 222 --------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~ 270 (329)
T cd05588 222 --------------IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW 270 (329)
T ss_pred --------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 0011357889999999999999999987 789999999976444
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=375.47 Aligned_cols=266 Identities=23% Similarity=0.335 Sum_probs=216.0
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
++|+++++||+|+||+||++++..+++.||+|++.+... .......+.+|+.++..++|+||+++++++.+ ...+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD--ENNLYL 78 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec--CCEEEE
Confidence 369999999999999999999999999999999965322 22334457789999999999999999999887 578999
Q ss_pred EEeccccccccccc-CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCC
Q 005289 209 VFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (704)
Q Consensus 209 V~Ey~~g~ll~~~~-~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~ 287 (704)
||||+.++.+..+. .....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.........
T Consensus 79 v~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred EEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 99999886555444 33457899999999999999999999999999999999999999999999999998765433222
Q ss_pred CcccccccccccCcccccC----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCC
Q 005289 288 PLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 288 ~~~~~~gT~~Y~APEvl~~----~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
.....+||+.|+|||++.. ...|+.++|||||||+||+|++|++||...+..+.+.+|.......+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~---------- 228 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ---------- 228 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCcccc----------
Confidence 2334578999999999862 34688999999999999999999999999888777777654211100
Q ss_pred CcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCC--CcCHHHHHhccccCCCCC
Q 005289 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK--RATASAALASEYFSTKPY 421 (704)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~k--RpTa~e~L~hpwf~~~~~ 421 (704)
+...+..++.++++||.+||..+|.+ |+++.++++||||+...|
T Consensus 229 --------------~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~ 274 (332)
T cd05623 229 --------------FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDW 274 (332)
T ss_pred --------------CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCH
Confidence 00112467899999999999776555 689999999999986544
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=412.64 Aligned_cols=276 Identities=29% Similarity=0.399 Sum_probs=236.7
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCe
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (704)
+..++|+|++.||.|+||.|.+++++.|++.||+|++++..+ .......|..|..||..-+.+-|+.|+..|++ ..+
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD--~~~ 149 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD--ERY 149 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC--ccc
Confidence 456789999999999999999999999999999999987432 34556778899999999999999999999988 689
Q ss_pred EEEEEecccccc-cccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 206 IYLVFEYMEHDI-TGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 206 ~~LV~Ey~~g~l-l~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
+|||||||.||. +.++.... +++|..+++|+..|+.||.-||+.|+|||||||+|||||..|+|||+|||.|..+..+
T Consensus 150 LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred eEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 999999999854 44544444 8999999999999999999999999999999999999999999999999999888766
Q ss_pred CCCCcccccccccccCcccccC----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH--cCCCCchhhh
Q 005289 285 HRQPLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL--CGSPPDDYWK 358 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~----~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~--~g~~p~~~w~ 358 (704)
..-.....+|||.|++||+|.. ...|+..||+|||||++|||+.|..||+.++-++.+-+|+.. .-.+|++
T Consensus 229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~--- 305 (1317)
T KOG0612|consen 229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDE--- 305 (1317)
T ss_pred CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcc---
Confidence 5555667799999999999842 257999999999999999999999999999999999999875 2222211
Q ss_pred ccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcC---HHHHHhccccCCCCCCCCCCCCCCCCC
Q 005289 359 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT---ASAALASEYFSTKPYACDLSSLPIYPP 433 (704)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpT---a~e~L~hpwf~~~~~~~~~~~~p~~~~ 433 (704)
..+|+++++||+++| .+|+.|.. ++++-.||||...+|..--...|.+.|
T Consensus 306 ------------------------~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vP 358 (1317)
T KOG0612|consen 306 ------------------------TDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVP 358 (1317)
T ss_pred ------------------------cccCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCC
Confidence 259999999999999 56999988 999999999999998544444455544
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=374.13 Aligned_cols=253 Identities=25% Similarity=0.428 Sum_probs=212.0
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCCeEEEEEecc
Q 005289 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYM 213 (704)
Q Consensus 136 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~LV~Ey~ 213 (704)
+.||+|+||+||+|++..+++.||||++.+... .......+.+|+.++..+ +||||+++++++.. ...+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~--~~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT--KDRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 369999999999999999999999999986532 233455667899999888 79999999999887 56899999999
Q ss_pred cccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCccccc
Q 005289 214 EHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 293 (704)
Q Consensus 214 ~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~~~ 293 (704)
.++.+.........+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 157 (318)
T cd05570 79 NGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTSTFC 157 (318)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cccccee
Confidence 987776655556679999999999999999999999999999999999999999999999999986532221 2233457
Q ss_pred ccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCC
Q 005289 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 373 (704)
Q Consensus 294 gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~ 373 (704)
+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 158 g~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~---------------------- 214 (318)
T cd05570 158 GTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVR---------------------- 214 (318)
T ss_pred cCccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC----------------------
Confidence 8999999999876 56899999999999999999999999988877766665431100
Q ss_pred CCchhhhhccCCCHHHHHHHHHhhccCCCCCcCH-----HHHHhccccCCCCC
Q 005289 374 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA-----SAALASEYFSTKPY 421 (704)
Q Consensus 374 ~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa-----~e~L~hpwf~~~~~ 421 (704)
....++..+.+||.+||..||.+|||+ .+++.||||+...|
T Consensus 215 -------~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~ 260 (318)
T cd05570 215 -------YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDW 260 (318)
T ss_pred -------CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 013578899999999999999999999 99999999987443
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=375.38 Aligned_cols=266 Identities=24% Similarity=0.337 Sum_probs=216.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
++|++++.||+|+||+||++++..+++.||||++..... .......+.+|+.++..++|+||+++++++.+ ...+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~--~~~~~l 78 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD--ENYLYL 78 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEEE
Confidence 479999999999999999999999999999999975321 23334557789999999999999999999987 578999
Q ss_pred EEecccccccccccC-CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCC
Q 005289 209 VFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~-~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~ 287 (704)
||||+.++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.........
T Consensus 79 v~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred EEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 999999866654443 3457899999999999999999999999999999999999999999999999999766543322
Q ss_pred CcccccccccccCcccccCC----CCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCC
Q 005289 288 PLTSRVVTLWYRPPELLLGA----TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 288 ~~~~~~gT~~Y~APEvl~~~----~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
.....+||+.|+|||++.+. ..++.++|||||||+||+|++|++||...+..+.+.+|......++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~---------- 228 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ---------- 228 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCccc----------
Confidence 22345789999999988642 3578899999999999999999999998887777776654211110
Q ss_pred CcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCC--CcCHHHHHhccccCCCCC
Q 005289 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK--RATASAALASEYFSTKPY 421 (704)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~k--RpTa~e~L~hpwf~~~~~ 421 (704)
+...+..++.++++||.+||..++.+ |++++++++||||+...|
T Consensus 229 --------------~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~ 274 (331)
T cd05624 229 --------------FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDW 274 (331)
T ss_pred --------------CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCH
Confidence 01112467899999999999976655 579999999999986444
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=382.76 Aligned_cols=258 Identities=28% Similarity=0.433 Sum_probs=231.8
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.+.|..++.||.|+||.+++++++..++.|++|+|..........+....|+.+++++.|||||.+.+.|... +..+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~-~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEED-GQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcC-CceEEE
Confidence 5689999999999999999999999999999999999887766677888999999999999999999999874 455999
Q ss_pred EEeccccccccccc-C-CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC
Q 005289 209 VFEYMEHDITGLLS-C-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 209 V~Ey~~g~ll~~~~-~-~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~ 286 (704)
||+||+|+.+...+ . .+..|+|+.+..|+.||+.||.|||++.|+|||||+.||+++.++.|||.|||+|+...+..
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~- 160 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED- 160 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch-
Confidence 99999997766543 2 34679999999999999999999999999999999999999999999999999999887654
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcc
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~ 366 (704)
....+.+|||.||.||++.+ .+|+.++|||||||++|||++-+++|.+.+-...+.+|+..+..|-
T Consensus 161 ~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Pl------------- 226 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPL------------- 226 (426)
T ss_pred hhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCC-------------
Confidence 34567899999999998886 7899999999999999999999999999999999999988664432
Q ss_pred cCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccC
Q 005289 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417 (704)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~ 417 (704)
...++.+++.||+.||..+|..||++.++|.+|.+.
T Consensus 227 ---------------p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 227 ---------------PSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred ---------------CccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 135788999999999999999999999999998776
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=363.18 Aligned_cols=284 Identities=34% Similarity=0.629 Sum_probs=229.9
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
++|+++++||.|+||.||+|.+..+++.||+|++..........+.+.+|+++|+.++||||+++++++.. ...+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR--KKRLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc--CCeEEEE
Confidence 36999999999999999999999999999999986544333345567789999999999999999999976 5789999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCc
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~ 289 (704)
|||+.++++..+......+++..+..++.||+.+|.|||+.||+|+||+|+||++++++.++|+|||++....... ...
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~ 157 (286)
T cd07846 79 FEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVY 157 (286)
T ss_pred EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-ccc
Confidence 9999998777665555568999999999999999999999999999999999999999999999999997654432 233
Q ss_pred ccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCC-C-Cccc
Q 005289 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL-P-HATL 367 (704)
Q Consensus 290 ~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~-~-~~~~ 367 (704)
....++..|+|||++.+...++.++|||||||++|+|++|++||......+.+..+....+......-..... + ....
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 4456789999999987656688899999999999999999999999888888888877666544321110000 0 0000
Q ss_pred CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
..+.......+...++.++..+.+||.+||..||++|||+.++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 1111122233445567899999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=363.53 Aligned_cols=286 Identities=42% Similarity=0.721 Sum_probs=228.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecC---CCe
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRL---SCS 205 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~---~~~ 205 (704)
++|++.+.||.|+||+||+|.+..+++.||||++............+.+|+.+++.+ +||||+++++++.... ...
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 369999999999999999999999999999999876543333345677899999999 4699999999887532 123
Q ss_pred EEEEEecccccccccccCC----CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEcc-CCceEEeccccccc
Q 005289 206 IYLVFEYMEHDITGLLSCP----DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-EGVLKLADFGLANF 280 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~~----~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~-~g~iKL~DFGla~~ 280 (704)
+|+||||+++++...+... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 7999999998766654322 345899999999999999999999999999999999999998 88999999999876
Q ss_pred cCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhcc
Q 005289 281 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (704)
Q Consensus 281 ~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~ 360 (704)
..... .......+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.++.+.+.+++..++.++...|...
T Consensus 161 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 161 FSIPV-KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred cCCCc-cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 54321 12233456889999999876567899999999999999999999999999999999999988888877766432
Q ss_pred CCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccC
Q 005289 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417 (704)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~ 417 (704)
.........+ +.....+....+.++..+.+||.+||.+||.+|||+.++|.||||+
T Consensus 240 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 240 SKLRDWHEFP-QWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhccchhhcC-cccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 2111100000 0011123344467899999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=360.19 Aligned_cols=284 Identities=37% Similarity=0.616 Sum_probs=224.1
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.+.|.+++.||+|+||.||+|.+..+++.||||++...... .....+.+|+.+|+.++|+||+++++++.. ....|+
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~l 80 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHT--KETLTF 80 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEec--CCeEEE
Confidence 35799999999999999999999999999999998754322 222345689999999999999999999876 568999
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
||||+.++++..+......+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||+++...... ..
T Consensus 81 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~ 159 (291)
T cd07870 81 VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-QT 159 (291)
T ss_pred EEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC-CC
Confidence 99999888777665555568889999999999999999999999999999999999999999999999987543322 12
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHcCCCCchhhhccCCCCccc
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT-EVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~-~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~ 367 (704)
.....+++.|+|||++.+...++.++|||||||+||+|++|.+||.+.. ..+.+.++...++.|....|..........
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK 239 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence 2344568999999998765668889999999999999999999997654 457777888888887766654432111100
Q ss_pred CCC-CCCCCchhhhhcc--CCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 368 FKP-QQPYDSSLRETFK--DLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 368 ~~~-~~~~~~~l~~~~~--~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
... .......+...+. ..+..+.+||.+||..||.+|||+.++|.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 000 0001111222222 236789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=360.19 Aligned_cols=256 Identities=25% Similarity=0.317 Sum_probs=213.0
Q ss_pred CCeeEE-EEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeec--CCCe
Q 005289 130 DAFEKL-EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSR--LSCS 205 (704)
Q Consensus 130 ~~y~~~-~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~--~~~~ 205 (704)
++|.+- ++||-|-.|.|..|.++.|++.+|+|++.. .....+|+++.-.. .|||||.++++|+.. +...
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-------SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-------CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 457765 579999999999999999999999999852 23456899987776 799999999999643 3457
Q ss_pred EEEEEecccccccccccCC--CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccC---CceEEeccccccc
Q 005289 206 IYLVFEYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE---GVLKLADFGLANF 280 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~~--~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~---g~iKL~DFGla~~ 280 (704)
+.||||+|+|+.|...+.. ...|+|.++..|++||..||.|||+.+|.||||||+|+|+... ..+||+|||+|+.
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~ 213 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE 213 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccc
Confidence 8899999999765544333 3459999999999999999999999999999999999999754 4699999999987
Q ss_pred cCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHcCCCCchh
Q 005289 281 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE----VEQLHKIFKLCGSPPDDY 356 (704)
Q Consensus 281 ~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~----~e~l~~I~~~~g~~p~~~ 356 (704)
.... ..+.+.|.||+|.|||++-. ..|+..+|+||+|||+|.||||.|||....- ...-.+|......+|.+.
T Consensus 214 t~~~--~~L~TPc~TPyYvaPevlg~-eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pE 290 (400)
T KOG0604|consen 214 TQEP--GDLMTPCFTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPE 290 (400)
T ss_pred cCCC--ccccCCcccccccCHHHhCc-hhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChh
Confidence 6542 45677889999999998865 6699999999999999999999999987653 344555655444455444
Q ss_pred hhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCC
Q 005289 357 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (704)
Q Consensus 357 w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~ 420 (704)
|..+|++++|||+.||..+|.+|+|+.+++.|||++..+
T Consensus 291 -------------------------Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 291 -------------------------WSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred -------------------------HhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 468999999999999999999999999999999998643
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=361.15 Aligned_cols=282 Identities=41% Similarity=0.738 Sum_probs=229.1
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEe
Q 005289 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFE 211 (704)
Q Consensus 132 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~E 211 (704)
|++++.||.|++|+||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++.+ ....|+|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~--~~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS--ENKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc--CCeEEEEEe
Confidence 678899999999999999999999999999998665443344567789999999999999999999876 578999999
Q ss_pred cccccccccccCCC-ccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCcc
Q 005289 212 YMEHDITGLLSCPD-IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 290 (704)
Q Consensus 212 y~~g~ll~~~~~~~-~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~ 290 (704)
|+++.+...+.... ..+++..+..++.||+.||.|||+++++|+||+|+|||++.++.++|+|||++....... ....
T Consensus 79 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~ 157 (283)
T cd07835 79 FLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-RTYT 157 (283)
T ss_pred ccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-cccC
Confidence 99876555443322 368999999999999999999999999999999999999999999999999997554322 1223
Q ss_pred cccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCC
Q 005289 291 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 370 (704)
Q Consensus 291 ~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~ 370 (704)
...+++.|+|||++.+...++.++|||||||++|+|++|.+||...+....+.++++..+.+....|.............
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF 237 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence 34568899999998765667899999999999999999999999999988888899888888877775532211100000
Q ss_pred CCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 371 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 371 ~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
.......+......++..+.+||.+||+.||.+|||+.++|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 238 PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred ccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0011112334456788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=371.80 Aligned_cols=253 Identities=27% Similarity=0.431 Sum_probs=208.9
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCCeEEEEEecc
Q 005289 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYM 213 (704)
Q Consensus 136 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~LV~Ey~ 213 (704)
+.||+|+||+||+|++..+++.||||++..... ..........|+.++..+ +||||+++++++.+ ...+||||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT--KENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe--CCEEEEEEeCC
Confidence 469999999999999999999999999976432 122344556788888764 99999999999987 56899999999
Q ss_pred cccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCccccc
Q 005289 214 EHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 293 (704)
Q Consensus 214 ~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~~~ 293 (704)
+++.+..+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 157 (316)
T cd05619 79 NGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cceeeec
Confidence 987666555555678999999999999999999999999999999999999999999999999987533221 2234557
Q ss_pred ccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCC
Q 005289 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 373 (704)
Q Consensus 294 gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~ 373 (704)
+|+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..+... .+.
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~~-------------------- 214 (316)
T cd05619 158 GTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--NPC-------------------- 214 (316)
T ss_pred CCccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCC--------------------
Confidence 8999999999876 56899999999999999999999999988877766665321 110
Q ss_pred CCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHH-HHHhccccCCCCC
Q 005289 374 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS-AALASEYFSTKPY 421 (704)
Q Consensus 374 ~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~-e~L~hpwf~~~~~ 421 (704)
....++.++.+||.+||..||++||++. +++.||||....|
T Consensus 215 -------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05619 215 -------YPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDW 256 (316)
T ss_pred -------CCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCH
Confidence 0124678899999999999999999996 8999999987554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=373.41 Aligned_cols=253 Identities=24% Similarity=0.422 Sum_probs=204.9
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCCeEEEEEecc
Q 005289 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYM 213 (704)
Q Consensus 136 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~LV~Ey~ 213 (704)
+.||+|+||+||+|++..+++.||+|++.+... .......+.+|+.++.++ +||||+++++++.. ...+||||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe--CCEEEEEEeCC
Confidence 469999999999999999999999999986533 234455677899998877 89999999999987 57899999999
Q ss_pred cccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCccccc
Q 005289 214 EHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 293 (704)
Q Consensus 214 ~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~~~ 293 (704)
.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...... ......+
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~~~~ 157 (329)
T cd05618 79 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTSTFC 157 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Ccccccc
Confidence 987766555555679999999999999999999999999999999999999999999999999987543221 2234467
Q ss_pred ccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC---------HHHHHHHHHHHcCCCCchhhhccCCCC
Q 005289 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT---------EVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 294 gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~---------~~e~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.... .......+....
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--------------- 221 (329)
T cd05618 158 GTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--------------- 221 (329)
T ss_pred CCccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC---------------
Confidence 8999999999876 568999999999999999999999995311 111111121100
Q ss_pred cccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcC------HHHHHhccccCCCCC
Q 005289 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT------ASAALASEYFSTKPY 421 (704)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpT------a~e~L~hpwf~~~~~ 421 (704)
......++..+.+||.+||..||.+||| +.++++||||+...|
T Consensus 222 --------------~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~ 270 (329)
T cd05618 222 --------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 270 (329)
T ss_pred --------------CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 0112357888999999999999999998 589999999986544
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=374.44 Aligned_cols=253 Identities=30% Similarity=0.441 Sum_probs=212.9
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcE-EEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKI-VALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~-vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 207 (704)
.+...+.+.||.|+||+||++.+. |+. ||||++..........+.+.+|+.+|.+|+|||||++++++.... ..++
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~-~~~~ 116 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP-GSLC 116 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-CceE
Confidence 345666677999999999999885 445 999999877666555778999999999999999999999998842 2689
Q ss_pred EEEecccccccccccCC--CccccHHHHHHHHHHhhhhHHHHHhcC-cccccCCCccEEEccCC-ceEEeccccccccCC
Q 005289 208 LVFEYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRG-VLHRDIKGSNLLVNNEG-VLKLADFGLANFSNT 283 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~--~~~l~e~~~~~i~~QIl~aL~yLH~~g-IvHrDLKp~NILl~~~g-~iKL~DFGla~~~~~ 283 (704)
|||||++++.+..++.. ...++...+..++.||+.||+|||+++ ||||||||+||||+.++ ++||+|||+++....
T Consensus 117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 99999999888876654 678999999999999999999999999 99999999999999998 999999999987654
Q ss_pred CCCCCcccccccccccCcccccC-CCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCC
Q 005289 284 GHRQPLTSRVVTLWYRPPELLLG-ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (704)
Q Consensus 284 ~~~~~~~~~~gT~~Y~APEvl~~-~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~ 362 (704)
.. ...+...||+.|||||++.+ ...|+.++||||||++||||+||..||.+.........+....-.|+
T Consensus 197 ~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~--------- 266 (362)
T KOG0192|consen 197 SK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP--------- 266 (362)
T ss_pred cc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC---------
Confidence 22 33455788999999999985 36799999999999999999999999999988666555543221111
Q ss_pred CCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
....+++.+..||..|+..||.+||+..+++.
T Consensus 267 ------------------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 267 ------------------IPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred ------------------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 11248899999999999999999999999873
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=358.87 Aligned_cols=258 Identities=26% Similarity=0.378 Sum_probs=219.7
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCCeEEEEEeccc
Q 005289 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYME 214 (704)
Q Consensus 136 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~LV~Ey~~ 214 (704)
+.||+|+|+.|--|....+|..||||+|.+. .......+.+|++++... .|+||++|+++|++ ...+|||||-|.
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd--d~~FYLVfEKm~ 159 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFED--DTRFYLVFEKMR 159 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc--cceEEEEEeccc
Confidence 5689999999999999999999999999765 456677889999999998 79999999999998 578999999999
Q ss_pred ccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCC---ceEEeccccccccC------CCC
Q 005289 215 HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSN------TGH 285 (704)
Q Consensus 215 g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g---~iKL~DFGla~~~~------~~~ 285 (704)
|+.+...+.....|+|.++..+++.|+.||.|||.+||.||||||+|||..+.. .||||||.|..-.. +..
T Consensus 160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas 239 (463)
T KOG0607|consen 160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS 239 (463)
T ss_pred CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence 977666666777899999999999999999999999999999999999997665 48999999875332 222
Q ss_pred CCCcccccccccccCccccc----CCCCCCCccchhhHHHHHHHHHhCCCCCCCCC---------------HHHHHHHHH
Q 005289 286 RQPLTSRVVTLWYRPPELLL----GATDYGPSVDLWSVGCVFAELLIGKPILQGRT---------------EVEQLHKIF 346 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~----~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~---------------~~e~l~~I~ 346 (704)
...+.+.+|+..|||||+.. ....|+.++|+||||||||.||+|.+||.|.. ....++.|.
T Consensus 240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQ 319 (463)
T KOG0607|consen 240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQ 319 (463)
T ss_pred CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHh
Confidence 33456678899999999863 34679999999999999999999999998753 345567776
Q ss_pred HHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCCC
Q 005289 347 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422 (704)
Q Consensus 347 ~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~~ 422 (704)
+....+|+..| ..++.+++|||..+|..|+..|.++.++|+|||++.....
T Consensus 320 EGkYeFPdkdW-------------------------ahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 320 EGKYEFPDKDW-------------------------AHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred ccCCcCChhhh-------------------------HHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 66556665544 6899999999999999999999999999999999864443
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=373.11 Aligned_cols=292 Identities=32% Similarity=0.562 Sum_probs=235.9
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeec--CCCeEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR--LSCSIY 207 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~--~~~~~~ 207 (704)
++|++.+.||.|+||.||+|.+..+++.||+|++............+.+|+.+|+.++||||+++++++... ....+|
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 579999999999999999999999999999999976543334456677899999999999999999987642 245789
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC-
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR- 286 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~- 286 (704)
+||||+.+++...+. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 85 lv~e~~~~~l~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 163 (334)
T cd07855 85 VVMDLMESDLHHIIH-SDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163 (334)
T ss_pred EEEehhhhhHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcC
Confidence 999999886655554 345699999999999999999999999999999999999999999999999999976543221
Q ss_pred --CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC
Q 005289 287 --QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 287 --~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
......+++.+|+|||++.....++.++|||||||++|+|++|++||.+.+...++..+...+|.++...+....-..
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~ 243 (334)
T cd07855 164 HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR 243 (334)
T ss_pred CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhh
Confidence 112345779999999998765668999999999999999999999999999999999999999999877654322110
Q ss_pred cc--cCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCCC
Q 005289 365 AT--LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422 (704)
Q Consensus 365 ~~--~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~~ 422 (704)
.. ...........+...++.++.++.+||.+||+.||.+|||+.++|.||||...+.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~ 303 (334)
T cd07855 244 VRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP 303 (334)
T ss_pred HHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCC
Confidence 00 00000011112334456789999999999999999999999999999999875544
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=357.58 Aligned_cols=260 Identities=30% Similarity=0.474 Sum_probs=213.5
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEe
Q 005289 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFE 211 (704)
Q Consensus 132 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~E 211 (704)
|++.+.||+|+||+||++++..+++.||+|++..............+|+.+++.++||||+++++++.. ...+|+|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD--DNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE--SSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc--ccccccccc
Confidence 889999999999999999999999999999998765444444445569999999999999999999988 578999999
Q ss_pred cccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCccc
Q 005289 212 YMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 291 (704)
Q Consensus 212 y~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~ 291 (704)
|+.++.+..+......+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||.+.... ........
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~~~~ 157 (260)
T PF00069_consen 79 YCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNENFNP 157 (260)
T ss_dssp EETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSEBSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccccc
Confidence 99996555444455678999999999999999999999999999999999999999999999999997542 12234455
Q ss_pred ccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCC
Q 005289 292 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 371 (704)
Q Consensus 292 ~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~ 371 (704)
..+|+.|+|||++.....++.++|||||||++|+|++|..||......+....+...........+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------------- 223 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS-------------- 223 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT--------------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc--------------
Confidence 678999999999873467899999999999999999999999988544444444433322111100
Q ss_pred CCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 372 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 372 ~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
......+..+.+||.+||+.||++|||+.++|+||||
T Consensus 224 --------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 224 --------QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp --------TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred --------cccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 0001224789999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=376.77 Aligned_cols=252 Identities=27% Similarity=0.395 Sum_probs=207.1
Q ss_pred eeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhc---CCCCceeEeEEEeecCCCeEEEEEecc
Q 005289 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRL---DHPNIIKLEGLITSRLSCSIYLVFEYM 213 (704)
Q Consensus 138 LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L---~HpnIv~l~~~~~~~~~~~~~LV~Ey~ 213 (704)
||+|+||+||+|++..+++.||||++...... ......+..|..++..+ +||||+++++++.. ...+||||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~--~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT--DSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec--CCeEEEEEcCC
Confidence 79999999999999999999999999754321 22334455677777765 79999999999877 57899999999
Q ss_pred cccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCccccc
Q 005289 214 EHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 293 (704)
Q Consensus 214 ~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~~~ 293 (704)
.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~ 157 (330)
T cd05586 79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNTFC 157 (330)
T ss_pred CCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCccCcc
Confidence 987665555556679999999999999999999999999999999999999999999999999987543322 2234567
Q ss_pred ccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCC
Q 005289 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 373 (704)
Q Consensus 294 gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~ 373 (704)
||+.|+|||++.+...++.++|||||||+||+|++|..||.+.+..+.+..+... ... +
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~--------~----------- 216 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG--KVR--------F----------- 216 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC--CCC--------C-----------
Confidence 8999999999976566899999999999999999999999988877766665331 100 0
Q ss_pred CCchhhhhccCCCHHHHHHHHHhhccCCCCCc----CHHHHHhccccCCCC
Q 005289 374 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRA----TASAALASEYFSTKP 420 (704)
Q Consensus 374 ~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRp----Ta~e~L~hpwf~~~~ 420 (704)
....++.++.+||.+||..||.+|| ++.++|+||||....
T Consensus 217 -------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 217 -------PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred -------CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence 0024688999999999999999998 799999999998643
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=372.82 Aligned_cols=252 Identities=25% Similarity=0.377 Sum_probs=207.9
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHH-HHHHhcCCCCceeEeEEEeecCCCeEEEEEecc
Q 005289 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREI-LILRRLDHPNIIKLEGLITSRLSCSIYLVFEYM 213 (704)
Q Consensus 136 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei-~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~ 213 (704)
+.||+|+||+||+|++..+++.||+|++...... ......+..|. .+++.++||||+++++++.. ...+||||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~--~~~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADKLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc--CCeEEEEEeCC
Confidence 3699999999999999999999999999754321 12223334444 45788999999999999877 57899999999
Q ss_pred cccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCccccc
Q 005289 214 EHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 293 (704)
Q Consensus 214 ~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~~~ 293 (704)
.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+
T Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~~~~ 157 (325)
T cd05602 79 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTSTFC 157 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCccccc
Confidence 997776666556678999999999999999999999999999999999999999999999999987543221 2234567
Q ss_pred ccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCC
Q 005289 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 373 (704)
Q Consensus 294 gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~ 373 (704)
||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.....
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~----------------------- 213 (325)
T cd05602 158 GTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL----------------------- 213 (325)
T ss_pred CCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc-----------------------
Confidence 8999999999876 5689999999999999999999999999888887777654110
Q ss_pred CCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHH----HHHhccccCCCC
Q 005289 374 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS----AALASEYFSTKP 420 (704)
Q Consensus 374 ~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~----e~L~hpwf~~~~ 420 (704)
...+.++..+.+||.+||..||.+|+++. ++++|+||....
T Consensus 214 ------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~ 258 (325)
T cd05602 214 ------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPIN 258 (325)
T ss_pred ------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCC
Confidence 01146789999999999999999999876 899999997543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=382.87 Aligned_cols=279 Identities=25% Similarity=0.348 Sum_probs=210.4
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
...|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|+.+|++|+|+|||++++++.. ....||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~--~~~~~l 237 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVV--GGLTCL 237 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEE--CCEEEE
Confidence 4579999999999999999999999999999997432 224679999999999999999999877 568899
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCC-
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ- 287 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~- 287 (704)
|||++.++++..+......+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++........
T Consensus 238 v~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 238 VLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred EEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 9999988877776655557999999999999999999999999999999999999999999999999999765432211
Q ss_pred CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCC-CCCC------HHHHHHHHHHHcCCCCchhhhc-
Q 005289 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL-QGRT------EVEQLHKIFKLCGSPPDDYWKK- 359 (704)
Q Consensus 288 ~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF-~~~~------~~e~l~~I~~~~g~~p~~~w~~- 359 (704)
.....+||+.|+|||++.+ ..++.++||||||||||||++|..++ .... ...++.+++...+....++-..
T Consensus 318 ~~~~~~GT~~Y~APE~~~~-~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred cccccCCCcCCcCHHHHcC-CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 1223568999999999976 56899999999999999999987544 3221 1234444544433321111000
Q ss_pred -cCC----CCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 360 -SKL----PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 360 -~~~----~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
.++ ...........+.......+..++.++.+||.+||++||.+|||+.|+|+||||+.
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 000 00000000000111111223356788999999999999999999999999999975
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=372.35 Aligned_cols=252 Identities=23% Similarity=0.359 Sum_probs=207.8
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHH-HHHhcCCCCceeEeEEEeecCCCeEEEEEecc
Q 005289 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREIL-ILRRLDHPNIIKLEGLITSRLSCSIYLVFEYM 213 (704)
Q Consensus 136 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~-iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~ 213 (704)
+.||+|+||+||+|++..+|+.||||++..... .......+..|.. +++.++||||+++++++.. ...+||||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~--~~~~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--TEKLYFVLDFV 78 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec--CCEEEEEEcCC
Confidence 368999999999999999999999999975432 2223344455554 5778999999999999877 57899999999
Q ss_pred cccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCccccc
Q 005289 214 EHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 293 (704)
Q Consensus 214 ~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~~~ 293 (704)
.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~ 157 (325)
T cd05604 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTTTFC 157 (325)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCccccc
Confidence 997776655566689999999999999999999999999999999999999999999999999987543221 2234567
Q ss_pred ccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCC
Q 005289 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 373 (704)
Q Consensus 294 gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~ 373 (704)
+|+.|+|||++.+ ..|+.++|||||||+||+|++|.+||...+..+.+.++.... .
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~--~--------------------- 213 (325)
T cd05604 158 GTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP--L--------------------- 213 (325)
T ss_pred CChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC--c---------------------
Confidence 8999999999876 568999999999999999999999999988777776664310 0
Q ss_pred CCchhhhhccCCCHHHHHHHHHhhccCCCCCcCH----HHHHhccccCCCC
Q 005289 374 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA----SAALASEYFSTKP 420 (704)
Q Consensus 374 ~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa----~e~L~hpwf~~~~ 420 (704)
...+.++..+.+||.+||..||.+||++ .+++.||||....
T Consensus 214 ------~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~ 258 (325)
T cd05604 214 ------VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLS 258 (325)
T ss_pred ------cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCC
Confidence 0113578889999999999999999987 5999999998643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=367.98 Aligned_cols=295 Identities=40% Similarity=0.725 Sum_probs=237.5
Q ss_pred CCeeEE-EEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHH------------HHHHHHHHHHHHhcCCCCceeEeE
Q 005289 130 DAFEKL-EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPES------------VRFMAREILILRRLDHPNIIKLEG 196 (704)
Q Consensus 130 ~~y~~~-~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~------------~~~~~~Ei~iL~~L~HpnIv~l~~ 196 (704)
++|..+ +.||.|+||+||+|.+..+++.||||++......... ...+.+|+.+|+.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 467654 6799999999999999999999999998754322100 123668999999999999999999
Q ss_pred EEeecCCCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccc
Q 005289 197 LITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFG 276 (704)
Q Consensus 197 ~~~~~~~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFG 276 (704)
++.. ...+|+||||+.+++...+. ....+++..+..++.||+.||.|||+.||+|+||+|+|||++.++.+||+|||
T Consensus 88 ~~~~--~~~~~lv~e~~~~~l~~~l~-~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 88 VYVE--GDFINLVMDIMASDLKKVVD-RKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred EEec--CCcEEEEEeccccCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence 9977 56899999999986655543 44568999999999999999999999999999999999999999999999999
Q ss_pred cccccCCC-------------CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHH
Q 005289 277 LANFSNTG-------------HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLH 343 (704)
Q Consensus 277 la~~~~~~-------------~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~ 343 (704)
++...... .........+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~ 244 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99765411 11122334568899999998876668999999999999999999999999999999999
Q ss_pred HHHHHcCCCCchhhhccCC-CCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCCC
Q 005289 344 KIFKLCGSPPDDYWKKSKL-PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422 (704)
Q Consensus 344 ~I~~~~g~~p~~~w~~~~~-~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~~ 422 (704)
.++..++.++...|..... +....+ .......+...+...+..+.+||.+||..||++|||++++|.||||+..+..
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~ 322 (335)
T PTZ00024 245 RIFELLGTPNEDNWPQAKKLPLYTEF--TPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP 322 (335)
T ss_pred HHHHHhCCCchhhCcchhhccccccc--CcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence 9999999988776654321 111111 1111223344556788999999999999999999999999999999998887
Q ss_pred CCCCCCC
Q 005289 423 CDLSSLP 429 (704)
Q Consensus 423 ~~~~~~p 429 (704)
+++..+|
T Consensus 323 ~~~~~~~ 329 (335)
T PTZ00024 323 CDPSQLP 329 (335)
T ss_pred CCcccCC
Confidence 7655544
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=363.98 Aligned_cols=286 Identities=38% Similarity=0.663 Sum_probs=225.2
Q ss_pred CeeEEEEeeccCceEEEEEEECC--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLD--TGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~--~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 207 (704)
+|+++++||+|+||.||+|.+.. +++.||||.+..... .......+.+|+.++..++||||+++++++.+.....+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48999999999999999999988 899999999976331 122234567899999999999999999999886557899
Q ss_pred EEEecccccccccccC----CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEcc----CCceEEecccccc
Q 005289 208 LVFEYMEHDITGLLSC----PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN----EGVLKLADFGLAN 279 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~----~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~----~g~iKL~DFGla~ 279 (704)
|||||++++++..+.. ....+++..++.++.||+.||.|||+.+|+||||||+|||++. ++.+||+|||++.
T Consensus 81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~ 160 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160 (316)
T ss_pred EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence 9999999876654422 2236899999999999999999999999999999999999999 8999999999998
Q ss_pred ccCCCCC--CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCH---------HHHHHHHHHH
Q 005289 280 FSNTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE---------VEQLHKIFKL 348 (704)
Q Consensus 280 ~~~~~~~--~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~---------~e~l~~I~~~ 348 (704)
....... ......++|+.|+|||++.+...++.++|||||||+||+|++|++||.+... ...+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (316)
T cd07842 161 LFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240 (316)
T ss_pred ccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHH
Confidence 6543321 1123346789999999987766789999999999999999999999987653 3467788888
Q ss_pred cCCCCchhhhccC-CCCccc---CCCCCCCC-chhh---hhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 349 CGSPPDDYWKKSK-LPHATL---FKPQQPYD-SSLR---ETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 349 ~g~~p~~~w~~~~-~~~~~~---~~~~~~~~-~~l~---~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
++.+....|.... ++.... ......+. ..+. +.+...+..+.+||.+||..||++|||+.+++.||||
T Consensus 241 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 241 LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred hCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 8887776664321 111100 00011111 1111 2223678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=366.97 Aligned_cols=288 Identities=34% Similarity=0.559 Sum_probs=229.9
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC---CCeE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL---SCSI 206 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~---~~~~ 206 (704)
++|++.++||+|+||+||+|.+..+++.||||++..... ......+.+|+.+|+.++||||+++++++.... ...+
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH-QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 579999999999999999999999999999999864322 233455678999999999999999998876431 2468
Q ss_pred EEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC
Q 005289 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~ 286 (704)
|+||||+.+++...+. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 84 ~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 161 (336)
T cd07849 84 YIVQELMETDLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD 161 (336)
T ss_pred EEEehhcccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccccc
Confidence 9999999987665553 34689999999999999999999999999999999999999999999999999976543221
Q ss_pred --CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC
Q 005289 287 --QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 287 --~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
......++|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..+...++.++.+.|.......
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (336)
T cd07849 162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLR 241 (336)
T ss_pred ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchh
Confidence 112335679999999988765678999999999999999999999999998888888898888888766554322111
Q ss_pred cccCC--CCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCC
Q 005289 365 ATLFK--PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (704)
Q Consensus 365 ~~~~~--~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~ 420 (704)
...+. ........+....+.++.++.+||.+||..||++|||+.++|+||||....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 242 ARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 10000 000111122334456789999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=369.59 Aligned_cols=251 Identities=24% Similarity=0.378 Sum_probs=205.6
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHH-HHHHhcCCCCceeEeEEEeecCCCeEEEEEecc
Q 005289 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREI-LILRRLDHPNIIKLEGLITSRLSCSIYLVFEYM 213 (704)
Q Consensus 136 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei-~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~ 213 (704)
+.||+|+||+||+|++..+++.||||++.+.... ......+..|+ .+++.++||||+++++++.+ ...+|||||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~--~~~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT--AEKLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 3699999999999999999999999999754321 22233444555 46788999999999998877 57899999999
Q ss_pred cccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCccccc
Q 005289 214 EHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 293 (704)
Q Consensus 214 ~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~~~ 293 (704)
+++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 157 (321)
T cd05603 79 NGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTSTFC 157 (321)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccccccc
Confidence 987766555556678999999999999999999999999999999999999999999999999987543221 2234457
Q ss_pred ccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCC
Q 005289 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 373 (704)
Q Consensus 294 gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~ 373 (704)
+|+.|+|||++.+ ..++.++|||||||+||+|++|.+||.+.+....+..+... +.
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~~-------------------- 213 (321)
T cd05603 158 GTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK---PL-------------------- 213 (321)
T ss_pred CCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC---CC--------------------
Confidence 8999999999876 56899999999999999999999999998877666665431 00
Q ss_pred CCchhhhhccCCCHHHHHHHHHhhccCCCCCcCH----HHHHhccccCCC
Q 005289 374 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA----SAALASEYFSTK 419 (704)
Q Consensus 374 ~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa----~e~L~hpwf~~~ 419 (704)
......+..+.+||.+||..||.+|+++ .++++|+||...
T Consensus 214 ------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~ 257 (321)
T cd05603 214 ------QLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPI 257 (321)
T ss_pred ------CCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCC
Confidence 0113567889999999999999999876 599999999853
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=368.39 Aligned_cols=290 Identities=36% Similarity=0.588 Sum_probs=233.2
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC---CCeE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL---SCSI 206 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~---~~~~ 206 (704)
.+|.+++.||.|+||+||+|++..+++.||||.+............+.+|+.+|+.++||||+++++++.... ...+
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 4799999999999999999999999999999998754333334456678999999999999999999886532 1458
Q ss_pred EEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC
Q 005289 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~ 286 (704)
||||||+.+++...+. ....+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~lv~e~~~~~L~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~- 162 (337)
T cd07858 85 YIVYELMDTDLHQIIR-SSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG- 162 (337)
T ss_pred EEEEeCCCCCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc-
Confidence 9999999877665554 34579999999999999999999999999999999999999999999999999997664322
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcc
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~ 366 (704)
.......++..|+|||++.....++.++|||||||++|+|++|++||.+.+....+..+....+.++.+.|.........
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (337)
T cd07858 163 DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKAR 242 (337)
T ss_pred ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhh
Confidence 22344567899999999876556899999999999999999999999999888889999999988877665322211110
Q ss_pred cCCCCCC--CCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCC
Q 005289 367 LFKPQQP--YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (704)
Q Consensus 367 ~~~~~~~--~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~ 421 (704)
.+....+ -...+...++.++.++.+||.+||..||++|||+.++|+||||.....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 243 RYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred HHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 0000000 011223445678999999999999999999999999999999986433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=401.62 Aligned_cols=262 Identities=27% Similarity=0.427 Sum_probs=215.3
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEE
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 207 (704)
..++|+++++||.|+||+||+|++..++..||+|++............+..|+.+|+.|+|||||+++++|.+.....+|
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 45689999999999999999999999999999999987666666677788999999999999999999998766567899
Q ss_pred EEEecccccccccccC----CCccccHHHHHHHHHHhhhhHHHHHhc-------CcccccCCCccEEEcc----------
Q 005289 208 LVFEYMEHDITGLLSC----PDIKFSEAQIKCYMNQLLHGLEHCHSR-------GVLHRDIKGSNLLVNN---------- 266 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~----~~~~l~e~~~~~i~~QIl~aL~yLH~~-------gIvHrDLKp~NILl~~---------- 266 (704)
||||||.++.|..++. ....|++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 9999999865544332 235699999999999999999999985 4999999999999964
Q ss_pred -------CCceEEeccccccccCCCCCCCcccccccccccCcccccC-CCCCCCccchhhHHHHHHHHHhCCCCCCCCCH
Q 005289 267 -------EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG-ATDYGPSVDLWSVGCVFAELLIGKPILQGRTE 338 (704)
Q Consensus 267 -------~g~iKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APEvl~~-~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~ 338 (704)
.+.+||+|||++....... .....++|+.|+|||++.+ ...++.++||||||||||+|++|.+||.....
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~ 248 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN 248 (1021)
T ss_pred cccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 2358999999997664332 2345578999999999864 24588999999999999999999999987665
Q ss_pred HHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 339 VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 339 ~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
...+..++... +. .....++.++.+||..||.++|.+|||+.++|.||||+.
T Consensus 249 ~~qli~~lk~~--p~--------------------------lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~ 300 (1021)
T PTZ00266 249 FSQLISELKRG--PD--------------------------LPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN 300 (1021)
T ss_pred HHHHHHHHhcC--CC--------------------------CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhh
Confidence 54443332211 00 001346888999999999999999999999999999986
Q ss_pred C
Q 005289 419 K 419 (704)
Q Consensus 419 ~ 419 (704)
.
T Consensus 301 i 301 (1021)
T PTZ00266 301 V 301 (1021)
T ss_pred c
Confidence 4
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=367.62 Aligned_cols=254 Identities=24% Similarity=0.420 Sum_probs=206.2
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCCeEEEEEecc
Q 005289 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYM 213 (704)
Q Consensus 136 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~LV~Ey~ 213 (704)
+.||+|+||+||+|++..+++.||||++...... ......+.+|+.++.++ +||||+++++++.. ...+||||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT--TSRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe--CCEEEEEEeCC
Confidence 4699999999999999999999999999865432 34456678899999988 69999999999877 56899999999
Q ss_pred cccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCccccc
Q 005289 214 EHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 293 (704)
Q Consensus 214 ~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~~~ 293 (704)
.++.+..+......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++...... ......+
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 157 (327)
T cd05617 79 NGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTSTFC 157 (327)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cceeccc
Confidence 987766555555679999999999999999999999999999999999999999999999999987532211 2234567
Q ss_pred ccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHHcCCCCchhhhccCCCCccc
Q 005289 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT------EVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (704)
Q Consensus 294 gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~------~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~ 367 (704)
||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.... ..+.+.++.. ..+
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~--------------- 219 (327)
T cd05617 158 GTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL--EKP--------------- 219 (327)
T ss_pred CCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH--hCC---------------
Confidence 8999999999876 578999999999999999999999996422 1122222211 000
Q ss_pred CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcC------HHHHHhccccCCCCC
Q 005289 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT------ASAALASEYFSTKPY 421 (704)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpT------a~e~L~hpwf~~~~~ 421 (704)
......++..+.+||.+||..||.+|++ ..+++.||||+...|
T Consensus 220 -----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~ 268 (327)
T cd05617 220 -----------IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDW 268 (327)
T ss_pred -----------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCH
Confidence 0011357888999999999999999998 479999999987554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=358.80 Aligned_cols=260 Identities=23% Similarity=0.391 Sum_probs=209.5
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
.|++.+.||+|+||+||++.+..+++.||||.+...... ......+.+|+.+|+.++|+||+.+++.+.+ ...+|+|
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv 78 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET--KDALCLV 78 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec--CCEEEEE
Confidence 488999999999999999999999999999998765433 2234456789999999999999999999877 4689999
Q ss_pred Eeccccccccccc--CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCC
Q 005289 210 FEYMEHDITGLLS--CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (704)
Q Consensus 210 ~Ey~~g~ll~~~~--~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~ 287 (704)
|||+.++.+..+. .....+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05630 79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156 (285)
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence 9999986655443 223458999999999999999999999999999999999999999999999999987654322
Q ss_pred CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCccc
Q 005289 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (704)
Q Consensus 288 ~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~ 367 (704)
.....++|+.|+|||++.+ ..++.++|||||||++|+|++|++||...........+...+...+
T Consensus 157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~-------------- 221 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ-------------- 221 (285)
T ss_pred cccCCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh--------------
Confidence 2234578999999999876 5689999999999999999999999987543221111111110000
Q ss_pred CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcC-----HHHHHhccccCCCC
Q 005289 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKP 420 (704)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpT-----a~e~L~hpwf~~~~ 420 (704)
......++.++.+||.+||+.||++||| +.++++||||+...
T Consensus 222 -----------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05630 222 -----------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN 268 (285)
T ss_pred -----------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccC
Confidence 0112357888999999999999999999 99999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=366.72 Aligned_cols=285 Identities=25% Similarity=0.362 Sum_probs=214.9
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEE
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 207 (704)
..++|+++++||.|+||+||++.+..++..+|+|++.... .......+.+|+++|+.++||||++++++|.+ ...+|
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 79 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEIS 79 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEE--CCEEE
Confidence 3568999999999999999999999999999999987643 34455678899999999999999999999987 56899
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhc-CcccccCCCccEEEccCCceEEeccccccccCCCCC
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~-gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~ 286 (704)
|||||+.++.+..+......+++..+..++.||+.||.|||+. +|+|+||||+|||++.++.+||+|||++......
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-- 157 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (333)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence 9999999877666555556789999999999999999999975 7999999999999999999999999998755332
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-HcCCCCchhhhccCCCCc
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK-LCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~-~~g~~p~~~w~~~~~~~~ 365 (704)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+.. ..+.+.............
T Consensus 158 -~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 158 -MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred -ccccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence 1234568999999999876 5689999999999999999999999987655433222110 011111000000000000
Q ss_pred cc---CCCC-CCCCc--hh-----hh-----hccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 366 TL---FKPQ-QPYDS--SL-----RE-----TFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 366 ~~---~~~~-~~~~~--~l-----~~-----~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
.. +.+. .+... .+ .. ....++.++++||.+||.+||++|||+.++|.||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 00 0000 00000 00 00 012367889999999999999999999999999999853
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=365.40 Aligned_cols=285 Identities=36% Similarity=0.615 Sum_probs=229.9
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC----C
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS----C 204 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~----~ 204 (704)
.++|++++.||.|+||+||++.+..+++.||||++............+.+|+.+|+.++||||+++++++..... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 467999999999999999999999999999999986543333445567789999999999999999999865321 2
Q ss_pred eEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
.+||||||+++.+...+. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 94 ~~~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 171 (343)
T cd07880 94 DFYLVMPFMGTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE 171 (343)
T ss_pred eEEEEEecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC
Confidence 569999999665544433 246899999999999999999999999999999999999999999999999999765432
Q ss_pred CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
.....+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+....+.+++...+.++.+++.......
T Consensus 172 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07880 172 ----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSED 247 (343)
T ss_pred ----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchh
Confidence 2334668999999998764568899999999999999999999999998888888888888877776665433211
Q ss_pred cccCCC--CCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 365 ATLFKP--QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 365 ~~~~~~--~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
...+.. .......+...++.++..+.+||.+||..||.+|||+.++|.||||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 248 AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred HHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 110000 0011122334456789999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=365.57 Aligned_cols=289 Identities=37% Similarity=0.591 Sum_probs=237.3
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC---CCeEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL---SCSIY 207 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~---~~~~~ 207 (704)
+|++.+.||.|+||.||+|++..+++.||||++..........+.+.+|+.+|+.++||||+++++++.... ...+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 589999999999999999999999999999999764433445567888999999999999999999887632 23689
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC-
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR- 286 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~- 286 (704)
+||||+++++...+.. ...+++..++.++.||+.||.|||++||+|+||||+||||+.++.++|+|||++........
T Consensus 81 lv~e~~~~~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~ 159 (330)
T cd07834 81 IVTELMETDLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159 (330)
T ss_pred EEecchhhhHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence 9999999866555543 34899999999999999999999999999999999999999999999999999987654321
Q ss_pred -CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 287 -QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 287 -~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
.......+|++|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.++.+.|........
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (330)
T cd07834 160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239 (330)
T ss_pred cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence 1234456799999999998754789999999999999999999999999999999999999999988776653222111
Q ss_pred ccCC--CCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCC
Q 005289 366 TLFK--PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (704)
Q Consensus 366 ~~~~--~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~ 420 (704)
..+. ........+...+..++..+.+||.+||.+||.+|||+.++|.||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 1110 111112234455667899999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=349.41 Aligned_cols=257 Identities=28% Similarity=0.437 Sum_probs=211.9
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC---hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE---PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~---~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
+.|++.+.||.|+||.||+|.+..+++.||||.+...... ......+.+|+.++++++||||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 79 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD--DETL 79 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc--CCeE
Confidence 4699999999999999999999999999999998765432 2234567889999999999999999999987 4689
Q ss_pred EEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC
Q 005289 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~ 286 (704)
|+||||++++.+..+......+++..+..++.||+.||.|||+.||+|+||+|+|||+++++.++|+|||++........
T Consensus 80 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 80 SIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 99999999876665554455689999999999999999999999999999999999999999999999999876543221
Q ss_pred CCc--ccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC
Q 005289 287 QPL--TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 287 ~~~--~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
... ....++..|+|||++.+ ..++.++|||||||++|+|++|++||...+..+.+.++......
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~------------- 225 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN------------- 225 (263)
T ss_pred ccccccCCCcCccccCcceecc-CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCC-------------
Confidence 111 23457889999999886 45889999999999999999999999876655554443221000
Q ss_pred cccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
......++..+.+||.+||..+|.+|||+.++|+|+||
T Consensus 226 --------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 226 --------------PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred --------------CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 01123578899999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=366.40 Aligned_cols=289 Identities=39% Similarity=0.638 Sum_probs=232.6
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCCeEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~ 207 (704)
.++|++.+.||.|+||.||+|.+..+++.||||++............+.+|+.+++++ +||||+++++++.......+|
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 4579999999999999999999999999999999865433334445677899999999 999999999998765456789
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC-
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR- 286 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~- 286 (704)
|||||+.+++...+.. . .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 86 lv~e~~~~~L~~~~~~-~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~ 163 (337)
T cd07852 86 LVFEYMETDLHAVIRA-N-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163 (337)
T ss_pred EEecccccCHHHHHhc-C-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccccc
Confidence 9999999766554433 2 788999999999999999999999999999999999999999999999999976543321
Q ss_pred ---CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCC
Q 005289 287 ---QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 287 ---~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
.......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+....+.+.++....+.++...|.....+
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (337)
T cd07852 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSP 243 (337)
T ss_pred ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhh
Confidence 12334567999999999876667889999999999999999999999999888889999888888776655432211
Q ss_pred Ccc-cCC-CCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 364 HAT-LFK-PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 364 ~~~-~~~-~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
... +.. ........+...++.++.++.+||.+||..||++|||+.++|+||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 244 FAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred hHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 000 000 00011112334456689999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=385.10 Aligned_cols=261 Identities=23% Similarity=0.325 Sum_probs=218.7
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC-----
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS----- 203 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~----- 203 (704)
.++|++.+.||+|+||+||+|++..+++.||||++............+.+|+.+|..++|+||+++++.+.....
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~ 110 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN 110 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence 468999999999999999999999999999999998776666667778899999999999999999887753211
Q ss_pred -CeEEEEEecccccccccccC----CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccc
Q 005289 204 -CSIYLVFEYMEHDITGLLSC----PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278 (704)
Q Consensus 204 -~~~~LV~Ey~~g~ll~~~~~----~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla 278 (704)
..++|||||+.++.+..++. ....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++
T Consensus 111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls 190 (496)
T PTZ00283 111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFS 190 (496)
T ss_pred ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccC
Confidence 24789999999865554332 2346899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCC-CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhh
Q 005289 279 NFSNTGH-RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 357 (704)
Q Consensus 279 ~~~~~~~-~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w 357 (704)
+...... .......+||+.|+|||++.+ ..|+.++|||||||+||+|++|+.||.+.+..+.+.++... ..+
T Consensus 191 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~--~~~---- 263 (496)
T PTZ00283 191 KMYAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG--RYD---- 263 (496)
T ss_pred eeccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC--CCC----
Confidence 7654321 122344678999999999876 56899999999999999999999999988877777666431 110
Q ss_pred hccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 358 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
.....+++++.+||.+||..||.+|||+.++|+|||++.
T Consensus 264 ----------------------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 264 ----------------------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred ----------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 012467899999999999999999999999999999874
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=355.20 Aligned_cols=261 Identities=23% Similarity=0.392 Sum_probs=214.5
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
.|++.+.||.|+||+||++.+..+++.||+|++...... ......+.+|+.+|+.++|+||+.+++.+.. ...+|+|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv 78 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET--KDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec--CCEEEEE
Confidence 388899999999999999999999999999999765433 2234456789999999999999999998877 5689999
Q ss_pred EecccccccccccC--CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCC
Q 005289 210 FEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~--~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~ 287 (704)
|||+.++.+..+.. ....+++..+..++.||+.||.|||+.||+||||||+|||+++++.+||+|||++...... .
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~--~ 156 (285)
T cd05632 79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--E 156 (285)
T ss_pred EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC--C
Confidence 99999865553332 2346999999999999999999999999999999999999999999999999998765432 2
Q ss_pred CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCccc
Q 005289 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (704)
Q Consensus 288 ~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~ 367 (704)
......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.........+.........
T Consensus 157 ~~~~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~------------- 222 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEE------------- 222 (285)
T ss_pred cccCCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccc-------------
Confidence 2244578999999999876 56899999999999999999999999987766555555432211110
Q ss_pred CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcC-----HHHHHhccccCCCCC
Q 005289 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPY 421 (704)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpT-----a~e~L~hpwf~~~~~ 421 (704)
.....++.++.+||.+||..||++||| +.+++.|+||+..++
T Consensus 223 ------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05632 223 ------------VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNF 269 (285)
T ss_pred ------------ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCH
Confidence 012357888999999999999999999 899999999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=352.80 Aligned_cols=282 Identities=44% Similarity=0.753 Sum_probs=233.8
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEe
Q 005289 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFE 211 (704)
Q Consensus 132 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~E 211 (704)
|++.+.||.|+||.||+|++..+++.||+|++............+..|+.+++.++|+||+++++++.+ ...+|+|||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT--ERKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc--CCceEEEec
Confidence 678899999999999999999999999999998654333444567789999999999999999999887 478999999
Q ss_pred cccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCccc
Q 005289 212 YMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 291 (704)
Q Consensus 212 y~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~ 291 (704)
|+++++...+......+++..+..++.||+.||.|||++||+|+||+|+||++++++.++|+|||++....... .....
T Consensus 79 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~-~~~~~ 157 (282)
T cd07829 79 YCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL-RTYTH 157 (282)
T ss_pred CcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc-cccCc
Confidence 99987666555443579999999999999999999999999999999999999999999999999997664432 12334
Q ss_pred ccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCC
Q 005289 292 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 371 (704)
Q Consensus 292 ~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~ 371 (704)
...+..|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+.++...++.+.+..|..............
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP 237 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence 45678899999987655789999999999999999999999999999999999999999998888865432210000011
Q ss_pred CCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 372 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 372 ~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
......+...++.++..+.++|.+||..||++|||+.++|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 111222345566779999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=366.59 Aligned_cols=289 Identities=36% Similarity=0.619 Sum_probs=235.0
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC----C
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS----C 204 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~----~ 204 (704)
.++|++.+.||.|+||+||+|++..+++.||||++............+.+|+.+++.++||||+++++++..... .
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 457999999999999999999999999999999987543334445667789999999999999999987765321 3
Q ss_pred eEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
.+|+|+||+.+++...+.. ..+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++......
T Consensus 94 ~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (343)
T cd07851 94 DVYLVTHLMGADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE 171 (343)
T ss_pred cEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc
Confidence 4899999997766554432 46899999999999999999999999999999999999999999999999999765432
Q ss_pred CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
.....+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.+++.+|.......
T Consensus 172 ----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07851 172 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSES 247 (343)
T ss_pred ----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchh
Confidence 3445678999999998765568899999999999999999999999999999999999999888887776544322
Q ss_pred cccCCCC--CCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCCCC
Q 005289 365 ATLFKPQ--QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 423 (704)
Q Consensus 365 ~~~~~~~--~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~~~ 423 (704)
...+... ......+...+..++..+.+||.+||..||++|||+.++|.||||.+...+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~ 308 (343)
T cd07851 248 ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPE 308 (343)
T ss_pred HHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCc
Confidence 1111100 0111223344556799999999999999999999999999999999755443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=361.60 Aligned_cols=280 Identities=26% Similarity=0.447 Sum_probs=222.0
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-C-C----CceeEeEEEeecC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-H-P----NIIKLEGLITSRL 202 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-H-p----nIv~l~~~~~~~~ 202 (704)
..+|++++.||+|+||.|..+.+..++..||||+|+.- ....+...-||++|+++. + | -+|++.++|.-
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy-- 162 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY-- 162 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc--
Confidence 35899999999999999999999999999999999743 233444567999999993 2 2 36777777876
Q ss_pred CCeEEEEEecccccccccccC-CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEcc---------------
Q 005289 203 SCSIYLVFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN--------------- 266 (704)
Q Consensus 203 ~~~~~LV~Ey~~g~ll~~~~~-~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~--------------- 266 (704)
.+++|||+|.++-++.+.+.. .-.+|+...++.+..||+.+|+|||+.+++|.||||+|||+.+
T Consensus 163 rghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 163 RGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred cCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccce
Confidence 578999999999877777655 3457999999999999999999999999999999999999842
Q ss_pred -----CCceEEeccccccccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHH
Q 005289 267 -----EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ 341 (704)
Q Consensus 267 -----~g~iKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~ 341 (704)
+..|+|+|||.|+.....+ .+.+.|..|+|||++++ ..++++|||||+||||+||++|..+|++.++.+.
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLg-LGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH 317 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILG-LGWSQPCDVWSIGCILVELYTGETLFQTHENLEH 317 (415)
T ss_pred eccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheec-cCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence 2358999999998766443 56677999999999998 6799999999999999999999999999999999
Q ss_pred HHHHHHHcCCCCchhhhcc-----------CCCCcccCCC---CCCCCchhhhhccC---CCHHHHHHHHHhhccCCCCC
Q 005289 342 LHKIFKLCGSPPDDYWKKS-----------KLPHATLFKP---QQPYDSSLRETFKD---LPTTAVNLIETLLSVEPYKR 404 (704)
Q Consensus 342 l~~I~~~~g~~p~~~w~~~-----------~~~~~~~~~~---~~~~~~~l~~~~~~---~s~~~~dLI~~mL~~dP~kR 404 (704)
+..|...+|++|.....+. +|+....... .......|...... .-..+.|||++||.+||.+|
T Consensus 318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R 397 (415)
T KOG0671|consen 318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR 397 (415)
T ss_pred HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence 9999999998886544332 1111100000 00000111221111 22358899999999999999
Q ss_pred cCHHHHHhccccCC
Q 005289 405 ATASAALASEYFST 418 (704)
Q Consensus 405 pTa~e~L~hpwf~~ 418 (704)
+|+.|+|.||||+.
T Consensus 398 iTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 398 ITLREALSHPFFAR 411 (415)
T ss_pred ccHHHHhcCHHhhc
Confidence 99999999999985
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=353.54 Aligned_cols=281 Identities=46% Similarity=0.779 Sum_probs=234.3
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEe
Q 005289 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFE 211 (704)
Q Consensus 132 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~E 211 (704)
|++.+.||.|++|.||+|.+..+++.+|+|++............+.+|+.+|+.++|+||+++++++.. ...+|+|||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH--KGDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc--CCCEEEEEe
Confidence 678899999999999999999999999999997665444455677889999999999999999999877 478999999
Q ss_pred cccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCccc
Q 005289 212 YMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 291 (704)
Q Consensus 212 y~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~ 291 (704)
|+++++...+......+++..+..++.||+.||.|||+++|+|+||||+||+++.++.++|+|||.+....... .....
T Consensus 79 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~~ 157 (283)
T cd05118 79 FMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTH 157 (283)
T ss_pred ccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccccC
Confidence 99987777766655689999999999999999999999999999999999999999999999999997765443 22334
Q ss_pred ccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCC--CcccCC
Q 005289 292 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP--HATLFK 369 (704)
Q Consensus 292 ~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~--~~~~~~ 369 (704)
..++..|+|||.+.+...++.++|||||||++|+|++|++||...+..+.+.++...++.+....|...... ......
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence 567889999999877557899999999999999999999999999999999999988888877766553320 000000
Q ss_pred CCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 370 ~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
+ ......+....+.++.++.+||.+||.+||.+||++.++|.||||
T Consensus 238 ~-~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 238 P-KKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred c-cccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 1 111112234456789999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=362.89 Aligned_cols=284 Identities=35% Similarity=0.597 Sum_probs=229.4
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC----CCe
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL----SCS 205 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----~~~ 205 (704)
++|.+.+.||.|+||+||+|++..+++.||||++............+.+|+.+|+.++||||+++++++.... ...
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 5799999999999999999999999999999998764333333455778999999999999999999886532 235
Q ss_pred EEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
+|+||||+...+.... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 95 ~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~- 170 (342)
T cd07879 95 FYLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE- 170 (342)
T ss_pred EEEEecccccCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC-
Confidence 7999999986443332 235899999999999999999999999999999999999999999999999998765322
Q ss_pred CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
.....+++.|+|||++.+...++.++|||||||++|+|++|+.||.+.+....+..+....+.+...++........
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (342)
T cd07879 171 ---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAA 247 (342)
T ss_pred ---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccch
Confidence 23446788999999987655688999999999999999999999999988888999999888887776655432211
Q ss_pred ccCCC--CCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCC
Q 005289 366 TLFKP--QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (704)
Q Consensus 366 ~~~~~--~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~ 420 (704)
..+.. .......+...++.++..+.+||.+||+.||.+|||+.++|.||||....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 248 KSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 11100 00111223344567889999999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=357.77 Aligned_cols=264 Identities=29% Similarity=0.400 Sum_probs=218.6
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCCh-HHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP-ESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
+|++.+.||+|+||+||+|.+..+++.||||.+....... .....+.+|+++|+.++||||+++++++.+ ...+|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv 79 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT--ETYLCLV 79 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec--CCEEEEE
Confidence 6999999999999999999999999999999998765432 345668889999999999999999999877 5789999
Q ss_pred EecccccccccccC--CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC-
Q 005289 210 FEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR- 286 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~--~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~- 286 (704)
|||+.++.+..+.. ....+++..++.++.||+.||.|||++||+|+||||+||||+.++.++|+|||++........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence 99998865554433 335799999999999999999999999999999999999999999999999999865432211
Q ss_pred ---------------------------CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHH
Q 005289 287 ---------------------------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV 339 (704)
Q Consensus 287 ---------------------------~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~ 339 (704)
......++|..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-CCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 01123467889999999876 56789999999999999999999999988877
Q ss_pred HHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcC----HHHHHhccc
Q 005289 340 EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT----ASAALASEY 415 (704)
Q Consensus 340 e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpT----a~e~L~hpw 415 (704)
..+.++...-...+ ....++..+.+||.+||..||++||| +.++|.|||
T Consensus 239 ~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~ 291 (316)
T cd05574 239 ETFSNILKKEVTFP---------------------------GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPF 291 (316)
T ss_pred HHHHHHhcCCccCC---------------------------CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCch
Confidence 76666542110000 01237899999999999999999999 999999999
Q ss_pred cCCCCCCCC
Q 005289 416 FSTKPYACD 424 (704)
Q Consensus 416 f~~~~~~~~ 424 (704)
|+...|+.-
T Consensus 292 ~~~~~~~~~ 300 (316)
T cd05574 292 FRGVNWALI 300 (316)
T ss_pred hhcCChhhc
Confidence 998776543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=343.97 Aligned_cols=255 Identities=24% Similarity=0.388 Sum_probs=212.4
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 210 (704)
.|++++.||.|+||.||++.+..+++.||||++..........+.+.+|++++++++|+||+++++.+... ...+|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE-DGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC-CCEEEEEe
Confidence 49999999999999999999999999999999987655555566788999999999999999999887543 35689999
Q ss_pred eccccccccccc-C-CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 211 EYMEHDITGLLS-C-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 211 Ey~~g~ll~~~~-~-~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
||++++.+.... . ....+++.++..++.||+.+|.|||++||+|+||||+|||++.++.++|+|||++....... ..
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-~~ 158 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-DM 158 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC-Cc
Confidence 999876554333 2 23468999999999999999999999999999999999999999999999999997664322 22
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccC
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~ 368 (704)
.....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+... ..+
T Consensus 159 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~--~~~--------------- 220 (257)
T cd08223 159 ASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEG--KLP--------------- 220 (257)
T ss_pred cccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--CCC---------------
Confidence 334567899999999876 56889999999999999999999999887766655554331 110
Q ss_pred CCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 369 ~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
.....++..+.+||.+||..||.+|||+.++|+||||
T Consensus 221 -----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 221 -----------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred -----------CCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0113578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=379.68 Aligned_cols=256 Identities=23% Similarity=0.340 Sum_probs=214.4
Q ss_pred CCeeEEEEeeccCceEEEEEEECCC-CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDT-GKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~-g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
..|.+.+.||.|+||.||+|.+..+ +..||+|.+.... ......+.+|+.+|+.++|||||+++++|.. ...+||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~--~~~~~l 142 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--ERQAAYARSELHCLAACDHFGIVKHFDDFKS--DDKLLL 142 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE--CCEEEE
Confidence 4599999999999999999998877 7889999875432 3444567789999999999999999999987 578999
Q ss_pred EEeccccccccccc----CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 209 VFEYMEHDITGLLS----CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 209 V~Ey~~g~ll~~~~----~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
||||+.++.|...+ .....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 99999986654322 23456899999999999999999999999999999999999999999999999999866432
Q ss_pred CC-CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCC
Q 005289 285 HR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 285 ~~-~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
.. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+++..+... ..+
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~--~~~---------- 289 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG--KYD---------- 289 (478)
T ss_pred cccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCC----------
Confidence 21 12345578999999999876 56899999999999999999999999988887777776541 110
Q ss_pred CcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
.....++.++.+||.+||..||++|||+.++|.|+|++.
T Consensus 290 ----------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 290 ----------------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred ----------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 001257789999999999999999999999999999963
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=353.92 Aligned_cols=255 Identities=23% Similarity=0.367 Sum_probs=201.4
Q ss_pred eeccCceEEEEEEECCCCcEEEEEEeecCCCCh-HHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEeccccc
Q 005289 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP-ESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD 216 (704)
Q Consensus 138 LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~ 216 (704)
||+|+||+||++++..+|+.||+|++....... .....+..|+++|+.++||||+++++++.. ...+||||||+.++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES--KTHLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec--CCeEEEEEecCCCC
Confidence 799999999999999999999999997543322 223345579999999999999999999876 57899999999986
Q ss_pred cccccc--CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCcccccc
Q 005289 217 ITGLLS--CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 294 (704)
Q Consensus 217 ll~~~~--~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~~~g 294 (704)
.+..+. .....+++..+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||++....... ......+
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~ 156 (277)
T cd05607 79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRAG 156 (277)
T ss_pred CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccCC
Confidence 654332 223358899999999999999999999999999999999999999999999999997664332 2234568
Q ss_pred cccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCC
Q 005289 295 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY 374 (704)
Q Consensus 295 T~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~ 374 (704)
|+.|+|||++.+ ..++.++|||||||++|+|++|++||...........+....-..
T Consensus 157 ~~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------------------- 213 (277)
T cd05607 157 TNGYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED---------------------- 213 (277)
T ss_pred CCCccCHHHHcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcc----------------------
Confidence 999999999876 458999999999999999999999997654321111111110000
Q ss_pred CchhhhhccCCCHHHHHHHHHhhccCCCCCcCH----HHHHhccccCCCCC
Q 005289 375 DSSLRETFKDLPTTAVNLIETLLSVEPYKRATA----SAALASEYFSTKPY 421 (704)
Q Consensus 375 ~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa----~e~L~hpwf~~~~~ 421 (704)
.+......++.++.+||.+||..||++|||+ ++++.||||+...+
T Consensus 214 --~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~ 262 (277)
T cd05607 214 --EVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINF 262 (277)
T ss_pred --ccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCH
Confidence 0000113578899999999999999999999 77889999987554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=372.90 Aligned_cols=259 Identities=25% Similarity=0.406 Sum_probs=220.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
+.+.|+..||.|+||.||+|.++.++-..|.|+|... ..+.++.+.-||+||..++||+||+|++.|.. .+.++|+
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~--enkLwil 107 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYF--ENKLWIL 107 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhc--cCceEEE
Confidence 4588999999999999999999999999999998643 35667888889999999999999999987766 4689999
Q ss_pred Eecccccccccc-cCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 210 FEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 210 ~Ey~~g~ll~~~-~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
.|||.|+-.+.+ +.-+..|++.++..+++|+|.||.|||+++|||||||..|||++-+|.|+|+|||.+..... ..+.
T Consensus 108 iEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qk 186 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQK 186 (1187)
T ss_pred EeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh-HHhh
Confidence 999999866643 45566799999999999999999999999999999999999999999999999999854332 2344
Q ss_pred cccccccccccCccccc----CCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC
Q 005289 289 LTSRVVTLWYRPPELLL----GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~----~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
..+++|||+|||||+.+ ...+|++++||||||++|.||..+.||-..-+....+-+|.+. .|| ..
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS--ePP-TL-------- 255 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--EPP-TL-------- 255 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc--CCC-cc--------
Confidence 56789999999999974 3568999999999999999999999999888888777777552 121 11
Q ss_pred cccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
-.....+..+.|||.+||.+||..||++.++|+||||+..
T Consensus 256 ---------------lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 256 ---------------LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred ---------------cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 0113567889999999999999999999999999999853
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=350.27 Aligned_cols=289 Identities=34% Similarity=0.559 Sum_probs=239.6
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC---CeEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS---CSIY 207 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~---~~~~ 207 (704)
+.+-.+.||.|+||.||.+.|..+|+.||+|++..-.-.-...+.+.+|+++|.-++|.|++.++++.+.... ..+|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 4666789999999999999999999999999986544344556778899999999999999999998765432 2368
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCC
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~ 287 (704)
+|+|+|..++...+..+ ..++...++.+++||+.||.|||+.+|+||||||.|+|++.+..+||||||+++........
T Consensus 134 V~TELmQSDLHKIIVSP-Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~ 212 (449)
T KOG0664|consen 134 VLTELMQSDLHKIIVSP-QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL 212 (449)
T ss_pred HHHHHHHhhhhheeccC-CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhh
Confidence 99999998877666554 47999999999999999999999999999999999999999999999999999998888888
Q ss_pred CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCC-CCcc
Q 005289 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL-PHAT 366 (704)
Q Consensus 288 ~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~-~~~~ 366 (704)
.++..+.|.+|+|||++++...|+.++||||+|||+.||+..+-+|+.....++++.|.+++|.|..+.++...- ....
T Consensus 213 hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H 292 (449)
T KOG0664|consen 213 NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNH 292 (449)
T ss_pred hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHH
Confidence 888899999999999999999999999999999999999999999999999999999999999998776544221 1111
Q ss_pred cCC--CCCCCCchhhhhc--cCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCC
Q 005289 367 LFK--PQQPYDSSLRETF--KDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (704)
Q Consensus 367 ~~~--~~~~~~~~l~~~~--~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~ 420 (704)
+.. +..+-...|...- ..-..++.+++..||.+||.+|++..++|.|+|..+..
T Consensus 293 ~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 293 VLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR 350 (449)
T ss_pred hhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence 111 1111111111111 23345689999999999999999999999999987543
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=368.55 Aligned_cols=266 Identities=27% Similarity=0.465 Sum_probs=214.1
Q ss_pred CccccccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeec
Q 005289 123 GWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSR 201 (704)
Q Consensus 123 ~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~ 201 (704)
..+.++...|+++++||.||.+.||++.. ...+.||+|++.....+...+.-+.+||.+|.+| .|.+||+|++|-..
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~- 431 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT- 431 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc-
Confidence 34455667899999999999999999985 3456788888877767778888899999999999 69999999998766
Q ss_pred CCCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEecccccccc
Q 005289 202 LSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (704)
Q Consensus 202 ~~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~ 281 (704)
+.++||||||-+.+|-..+......++.-.++.|.+|||.++.++|++||||.||||.|+|+.. |.+||+|||+|..+
T Consensus 432 -d~~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 432 -DGYLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAI 509 (677)
T ss_pred -CceEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhccc
Confidence 6899999999999988888776666666699999999999999999999999999999999975 89999999999988
Q ss_pred CCCCCCCc-ccccccccccCcccccCCC----------CCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Q 005289 282 NTGHRQPL-TSRVVTLWYRPPELLLGAT----------DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 350 (704)
Q Consensus 282 ~~~~~~~~-~~~~gT~~Y~APEvl~~~~----------~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g 350 (704)
..+..... .+.+||+.||+||.+.... ..+.++||||||||||+|+.|++||..-. ..+.++..+.
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~aI~- 586 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHAIT- 586 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHhhc-
Confidence 76543322 3568999999999986311 25678999999999999999999996432 1233332221
Q ss_pred CCCchhhhccCCCCcccCCCCCCCCchhhhhccCCC--HHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 351 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLP--TTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 351 ~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s--~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
.|. . ...|+.++ .+++++++.||..||.+|||+.++|+|||.+-.
T Consensus 587 ~P~-----------~-------------~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 587 DPN-----------H-------------EIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ 633 (677)
T ss_pred CCC-----------c-------------cccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence 110 0 11223332 238999999999999999999999999999843
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=362.16 Aligned_cols=255 Identities=22% Similarity=0.348 Sum_probs=199.6
Q ss_pred ccCCeeEEEEeeccCceEEEEEEEC-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeec
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDL-----DTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSR 201 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~ 201 (704)
..++|++.++||.|+||+||+|.+. .+++.||||++.... .......+.+|+.+|..+ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 3568999999999999999999752 345789999987432 334456688999999999 899999999988754
Q ss_pred CCCeEEEEEecccccccccccCC---------------------------------------------------------
Q 005289 202 LSCSIYLVFEYMEHDITGLLSCP--------------------------------------------------------- 224 (704)
Q Consensus 202 ~~~~~~LV~Ey~~g~ll~~~~~~--------------------------------------------------------- 224 (704)
...+|+||||++++.+..+...
T Consensus 84 -~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 84 -NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 3568999999998655433211
Q ss_pred -----CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCC-Ccccccccccc
Q 005289 225 -----DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWY 298 (704)
Q Consensus 225 -----~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~-~~~~~~gT~~Y 298 (704)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........ ......+++.|
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 124788899999999999999999999999999999999999999999999999765332211 11223456789
Q ss_pred cCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCch
Q 005289 299 RPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSS 377 (704)
Q Consensus 299 ~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~ 377 (704)
+|||++.+ ..|+.++|||||||+||||++ |.+||.+....+.+...... +..+
T Consensus 243 ~aPE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~~------------------------ 296 (338)
T cd05102 243 MAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD-GTRM------------------------ 296 (338)
T ss_pred cCcHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc-CCCC------------------------
Confidence 99999876 568999999999999999997 99999876544333332221 1100
Q ss_pred hhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 378 LRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 378 l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
.....+++++.+||.+||..||.+|||+.++++
T Consensus 297 --~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 297 --RAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred --CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 001356888999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=350.93 Aligned_cols=257 Identities=28% Similarity=0.444 Sum_probs=217.2
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
++|++++.||.|+||.||++.+..+++.||+|++..... .......+.+|+++|++++||||+++++++.+ ...+|+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 78 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD--DSNLYL 78 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCeEEE
Confidence 369999999999999999999999999999999975432 23445668899999999999999999999877 578999
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
||||+.++.+..+......+++..+..++.||+.||.|||++||+|+||+|.||||+.++.+||+|||++......
T Consensus 79 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---- 154 (290)
T cd05580 79 VMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---- 154 (290)
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence 9999987666655555567999999999999999999999999999999999999999999999999999766543
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccC
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~ 368 (704)
....++++.|+|||.+.+ ..++.++|||||||++|+|++|.+||...+..+...++.. +.++
T Consensus 155 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~--------------- 216 (290)
T cd05580 155 TYTLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE--GKVR--------------- 216 (290)
T ss_pred CCCCCCCccccChhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCcc---------------
Confidence 233467899999998875 4678899999999999999999999988776665655542 1110
Q ss_pred CCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCc-----CHHHHHhccccCCCCCC
Q 005289 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPYA 422 (704)
Q Consensus 369 ~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRp-----Ta~e~L~hpwf~~~~~~ 422 (704)
....++..+.+||.+||..||.+|+ +++++++||||....|.
T Consensus 217 ------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 263 (290)
T cd05580 217 ------------FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWI 263 (290)
T ss_pred ------------CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHH
Confidence 0124678899999999999999999 99999999999876553
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=373.37 Aligned_cols=258 Identities=28% Similarity=0.484 Sum_probs=228.9
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
...|.+++.||+|.|++|.++++..++..||||+|.+..++......+.+|+++|..|+|||||+|+.++.. ...+|+
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t--~~~lyl 132 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET--EATLYL 132 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee--cceeEE
Confidence 447999999999999999999999999999999999988887777778999999999999999999999987 478999
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
||||+.++.+..++.....+.+..++.++.|++.|++|||+++|||||||++||||+.+-++||+|||++.++... ..
T Consensus 133 V~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~--~~ 210 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG--LM 210 (596)
T ss_pred EEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc--cc
Confidence 9999999888877777778888999999999999999999999999999999999999999999999999988754 46
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccC
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~ 368 (704)
+.+.||++.|.|||++.+....++.+|+||+|++||.|++|..||.+.+-.+.-...+. |.
T Consensus 211 lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~--gk----------------- 271 (596)
T KOG0586|consen 211 LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR--GK----------------- 271 (596)
T ss_pred ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee--ee-----------------
Confidence 78899999999999999988788999999999999999999999998775443332211 11
Q ss_pred CCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 369 ~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
....--++.++.+||++||.++|.+|++++++..|.|+...
T Consensus 272 ----------~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 272 ----------YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred ----------ecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchh
Confidence 01112478889999999999999999999999999999864
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=358.78 Aligned_cols=281 Identities=23% Similarity=0.343 Sum_probs=207.6
Q ss_pred EEEEeecc--CceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEe
Q 005289 134 KLEKIGQG--TYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFE 211 (704)
Q Consensus 134 ~~~~LG~G--~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~E 211 (704)
++++||+| +|++||++++..+|+.||||++............+.+|+.+++.++||||++++++|.. ...+|+|||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--DNELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE--CCEEEEEEe
Confidence 56789999 78999999999999999999998765555556678889999999999999999999987 468999999
Q ss_pred cccccccccccCC--CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC-C-
Q 005289 212 YMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-Q- 287 (704)
Q Consensus 212 y~~g~ll~~~~~~--~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~-~- 287 (704)
|++++.+..+... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+||+.+........ .
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 9998766654422 34589999999999999999999999999999999999999999999999987543221100 0
Q ss_pred ----CcccccccccccCcccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCc--------
Q 005289 288 ----PLTSRVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD-------- 354 (704)
Q Consensus 288 ----~~~~~~gT~~Y~APEvl~~~-~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~-------- 354 (704)
......++..|+|||++.+. ..|+.++|||||||++|+|++|.+||........+..... +..+.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 237 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN--GTVPCLLDTTTIP 237 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc--CCccccccccchh
Confidence 01123457789999998753 4589999999999999999999999987655443333222 22111
Q ss_pred -hhhh-cc-C------CCCccc-CCCCC-CCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 355 -DYWK-KS-K------LPHATL-FKPQQ-PYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 355 -~~w~-~~-~------~~~~~~-~~~~~-~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
+.+. .. . +..... ..... ............+++.+.+||.+||++||++|||++++|+||||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 0000 00 0 000000 00000 0000111122456789999999999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=359.89 Aligned_cols=287 Identities=36% Similarity=0.590 Sum_probs=221.4
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC------
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS------ 203 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~------ 203 (704)
.+|++.+.||.|+||+||+|.+..+++.||+|++..... ...+.+.+|+.+|+.++||||+++++++.....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 579999999999999999999999999999999876543 345667889999999999999999987765321
Q ss_pred ------CeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEcc-CCceEEeccc
Q 005289 204 ------CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-EGVLKLADFG 276 (704)
Q Consensus 204 ------~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~-~g~iKL~DFG 276 (704)
..+|+||||+++++...+. ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~~~~~~~~lv~e~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 83 GSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred ccccccceEEEEeecccccHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcc
Confidence 3579999999976554442 236899999999999999999999999999999999999974 5578999999
Q ss_pred cccccCCCCC--CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCc
Q 005289 277 LANFSNTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 354 (704)
Q Consensus 277 la~~~~~~~~--~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~ 354 (704)
++........ .......++..|+|||++.....++.++|||||||++|+|++|++||.+.+..+.+..+.........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 9976532211 11123356889999998866567889999999999999999999999998888877777665433332
Q ss_pred hhhhccCCC-CcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCC
Q 005289 355 DYWKKSKLP-HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (704)
Q Consensus 355 ~~w~~~~~~-~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~ 420 (704)
..+...... ..............+....+.++.++.+||.+||..||.+|||+.++|.||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~ 307 (342)
T cd07854 241 EDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYS 307 (342)
T ss_pred HHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccccc
Confidence 222111000 000000111122233445567899999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=379.26 Aligned_cols=286 Identities=23% Similarity=0.305 Sum_probs=206.4
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCC-CcEEEEEEe--------------ec-CCCChHHHHHHHHHHHHHHhcCCCCce
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDT-GKIVALKKV--------------RF-DNFEPESVRFMAREILILRRLDHPNII 192 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~-g~~vAvK~i--------------~~-~~~~~~~~~~~~~Ei~iL~~L~HpnIv 192 (704)
.++|+++++||+|+||+||+|..+.. +..+++|.+ .+ ..........+.+|+.+|+.|+|||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 35799999999999999999876432 222222211 10 011123345678899999999999999
Q ss_pred eEeEEEeecCCCeEEEEEecccccccccccCC----CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCC
Q 005289 193 KLEGLITSRLSCSIYLVFEYMEHDITGLLSCP----DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG 268 (704)
Q Consensus 193 ~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~----~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g 268 (704)
++++++.. ....|+|++++.++++..+... ........++.|+.||+.||.|||++|||||||||+||||+.++
T Consensus 227 ~l~~~~~~--~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 227 KIEEILRS--EANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred cEeEEEEE--CCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 99999987 4678999999988776654322 22344677889999999999999999999999999999999999
Q ss_pred ceEEeccccccccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCC-CCC--CCHHHHHHHH
Q 005289 269 VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI-LQG--RTEVEQLHKI 345 (704)
Q Consensus 269 ~iKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~p-F~~--~~~~e~l~~I 345 (704)
.+||+|||++..+...........+||+.|+|||++.+ ..|+.++|||||||+||||++|..+ |.. .....++.++
T Consensus 305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~ 383 (501)
T PHA03210 305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383 (501)
T ss_pred CEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence 99999999998765443333345678999999999876 5689999999999999999998754 432 3445666666
Q ss_pred HHHcCCCCchhhhc----cCCC-CcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 346 FKLCGSPPDDYWKK----SKLP-HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 346 ~~~~g~~p~~~w~~----~~~~-~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
+..++.+..++... ..+. ...+..........+. ...++.++.+||.+||.+||.+|||+.|+|.||||...
T Consensus 384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIR--NLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHH--hcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 66555443322110 0000 0000000001111111 12478889999999999999999999999999999864
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=359.00 Aligned_cols=287 Identities=34% Similarity=0.564 Sum_probs=227.3
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC----CC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL----SC 204 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----~~ 204 (704)
.++|++++.||+|+||.||++.+..+++.||||++..........+.+.+|+.++++++||||+++++++.... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 46899999999999999999999999999999999764433334556778999999999999999999886421 24
Q ss_pred eEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
.+|+|++++.+.+...+. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 96 ~~~lv~~~~~~~L~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~- 172 (345)
T cd07877 96 DVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD- 172 (345)
T ss_pred cEEEEehhcccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc-
Confidence 578999998765544432 23589999999999999999999999999999999999999999999999999876532
Q ss_pred CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
......+++.|+|||++.+...++.++|||||||++|+|++|++||...+....+..+....+.++...+.......
T Consensus 173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (345)
T cd07877 173 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 249 (345)
T ss_pred ---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHh
Confidence 22345678999999998765678899999999999999999999999988888888888888877766554322110
Q ss_pred cccCCC--CCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCC
Q 005289 365 ATLFKP--QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (704)
Q Consensus 365 ~~~~~~--~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~ 421 (704)
...+.. .......+...+...+..+.+||.+||..||.+|||+.++|.||||++...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~ 308 (345)
T cd07877 250 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308 (345)
T ss_pred HHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence 000000 000011122223457889999999999999999999999999999997443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=353.43 Aligned_cols=280 Identities=24% Similarity=0.305 Sum_probs=213.2
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
++|+++++||+|+||.||++.+..++..||+|.+.... .......+.+|+++|++++||||++++++|.. ...+|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 77 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYS--DGEISIC 77 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCEEEEE
Confidence 36999999999999999999999999999999987542 34445667889999999999999999999987 5789999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHh-cCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~-~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
|||++++.+..+......+++..+..++.||+.||.|||+ ++|+|+||||+|||++.++.+||+|||++...... .
T Consensus 78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~ 154 (308)
T cd06615 78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M 154 (308)
T ss_pred eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc---c
Confidence 9999987776665555678999999999999999999997 59999999999999999999999999998755332 1
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccC
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~ 368 (704)
....++++.|+|||++.+ ..++.++|||||||++|+|++|++||...+..... .+........ ........+.. ..
T Consensus 155 ~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~-~~ 230 (308)
T cd06615 155 ANSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE-AMFGRPVSEG-EAKESHRPVSG-HP 230 (308)
T ss_pred cccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH-HhhcCccccc-cccCCcccccC-CC
Confidence 234577899999998865 56889999999999999999999999876643332 2221110000 00000000000 00
Q ss_pred CCCCC-C--Cchh---------hhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 369 KPQQP-Y--DSSL---------RETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 369 ~~~~~-~--~~~l---------~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
..... . ...+ ......++.++.+||.+||..||++|||+.++|+||||...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 00000 0 0000 00112367889999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=340.25 Aligned_cols=254 Identities=26% Similarity=0.379 Sum_probs=214.5
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 210 (704)
+|++.+.||+|+||.||+|.+..+++.|++|.+............+.+|+.+|+.++||||+++++++.. ...+|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD--KGKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc--CCEEEEEE
Confidence 4889999999999999999999999999999998766666667778899999999999999999999877 47899999
Q ss_pred ecccccccccccCC--CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 211 EYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 211 Ey~~g~ll~~~~~~--~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
||+.++.+..+... ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... ..
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~-~~ 157 (256)
T cd08529 79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT-NF 157 (256)
T ss_pred EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc-ch
Confidence 99988655544322 4578999999999999999999999999999999999999999999999999988665432 22
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccC
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~ 368 (704)
.....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+...++... ..+
T Consensus 158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~--------------- 219 (256)
T cd08529 158 ANTIVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRG--VFP--------------- 219 (256)
T ss_pred hhccccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCC---------------
Confidence 234467899999999876 55889999999999999999999999888876666655431 111
Q ss_pred CCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 369 ~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
.....++..+.++|.+||..+|++||++.++|+|||+
T Consensus 220 -----------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 220 -----------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred -----------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 0012567889999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=354.89 Aligned_cols=289 Identities=33% Similarity=0.542 Sum_probs=230.0
Q ss_pred CeeEEEEeeccCceEEEEEEECCC--CcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEee--cCCCe
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDT--GKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITS--RLSCS 205 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~--g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~--~~~~~ 205 (704)
+|++.+.||.|+||.||++++..+ +..||||++............+.+|+.+++++ +||||+++++++.. .....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 489999999999999999999888 89999999875432333345677899999999 69999999986542 22356
Q ss_pred EEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
+|+++||+++++...+. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~e~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 81 LYLYEELMEADLHQIIR-SGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred EEEEEecccCCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 89999999887665553 34578999999999999999999999999999999999999999999999999997654322
Q ss_pred C---CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCC
Q 005289 286 R---QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (704)
Q Consensus 286 ~---~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~ 362 (704)
. ......++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..++..+|.++.+.+.....
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS 239 (332)
T ss_pred ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhh
Confidence 1 1123346799999999887656789999999999999999999999999999999999999999888766554332
Q ss_pred CCcccCC-C-CCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCC
Q 005289 363 PHATLFK-P-QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (704)
Q Consensus 363 ~~~~~~~-~-~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~ 420 (704)
+....+. . .......+...++.++..+.+||.+||..||.+|||+.++|.||||.++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 240 PKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred hhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence 2110000 0 00001122334456789999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=355.19 Aligned_cols=285 Identities=36% Similarity=0.600 Sum_probs=231.2
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|++++.||.|+||.||+|.+..+++.||||++.+........+.+.+|+.+|+.++||||++++++|... ....|+
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~~l 87 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP-LEDIYF 87 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC-CCcEEE
Confidence 4689999999999999999999999999999999875443334456677899999999999999999988653 357899
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
||||+.+.+...+. ...+++..+..++.||+.||.|||++||+|+||+|.|||++.++.+||+|||++..... .
T Consensus 88 v~e~~~~~L~~~~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~----~ 161 (328)
T cd07856 88 VTELLGTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP----Q 161 (328)
T ss_pred EeehhccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC----C
Confidence 99999876544443 23588899999999999999999999999999999999999999999999999875432 2
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccC
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~ 368 (704)
.....+++.|+|||++.+...++.++|||||||++|+|++|++||.+......+..+.+.+|.++++++..........+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd07856 162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF 241 (328)
T ss_pred cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHH
Confidence 23446688999999886656789999999999999999999999999988888888889999998877654322111000
Q ss_pred C--CCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCC
Q 005289 369 K--PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (704)
Q Consensus 369 ~--~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~ 420 (704)
. ..........+.++.++..+.+||.+||..+|++|||+.++|.||||....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~ 295 (328)
T cd07856 242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH 295 (328)
T ss_pred HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence 0 000011122344567889999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=348.80 Aligned_cols=259 Identities=27% Similarity=0.426 Sum_probs=213.1
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
+.|+++++||.|+||.||+|++..+++.||+|++... .......+.+|+.+++.++||||+++++++.. ...+|+|
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 87 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYW--DGKLWIM 87 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe--CCeEEEE
Confidence 5799999999999999999999999999999998754 34456677889999999999999999999877 4689999
Q ss_pred Eecccccccccc-cCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 210 FEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 210 ~Ey~~g~ll~~~-~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
|||++++.+..+ ......+++..+..++.||+.+|.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~ 166 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QR 166 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccc-cc
Confidence 999998766543 3334568999999999999999999999999999999999999999999999999986543221 22
Q ss_pred cccccccccccCcccccC----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC
Q 005289 289 LTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~----~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
.....+++.|+|||++.+ ...++.++|||||||++|+|++|.+||...+....+.++... .++.
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~~~---------- 234 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--EPPT---------- 234 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC--CCcc----------
Confidence 234567889999999852 345788999999999999999999999887765555444321 1100
Q ss_pred cccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
......++.++.+||.+||..||++|||+.++|+||||...
T Consensus 235 --------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 275 (292)
T cd06644 235 --------------LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSV 275 (292)
T ss_pred --------------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 00113567889999999999999999999999999999753
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=345.68 Aligned_cols=255 Identities=25% Similarity=0.366 Sum_probs=206.9
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 210 (704)
+|++++.||.|+||+||+|.+..+++.||||++..+. .......+.+|+.+|++++||||+++++++.. ....+|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 78 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFV--ENRISICT 78 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE--CCEEEEEE
Confidence 6899999999999999999999999999999997653 33445668889999999999999999999987 46789999
Q ss_pred ecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCcc
Q 005289 211 EYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 290 (704)
Q Consensus 211 Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~ 290 (704)
||++++.+..+ ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++...... ...
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~~~ 151 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAK 151 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---ccc
Confidence 99999776544 25788999999999999999999999999999999999999999999999999765432 223
Q ss_pred cccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCCchhhhccCCCCccc
Q 005289 291 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ---LHKIFKLCGSPPDDYWKKSKLPHATL 367 (704)
Q Consensus 291 ~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~---l~~I~~~~g~~p~~~w~~~~~~~~~~ 367 (704)
..++|..|+|||++.+ ..++.++|||||||++|+|++|..||......+. ...+........
T Consensus 152 ~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------------- 216 (279)
T cd06619 152 TYVGTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-------------- 216 (279)
T ss_pred CCCCChhhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC--------------
Confidence 4578999999999876 5689999999999999999999999965321110 001111100000
Q ss_pred CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
.+ ......++.++.+||.+||..||++||++.++|+||||...
T Consensus 217 ----~~-----~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 217 ----PP-----VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred ----CC-----CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 00 00113467889999999999999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=350.52 Aligned_cols=263 Identities=26% Similarity=0.382 Sum_probs=216.0
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
+|++++.||.|+||.||++.+..+++.||||.+...... ......+.+|+.+++.++||||+++++.+.. ...+|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv 79 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET--KRHLCMV 79 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec--CCEEEEE
Confidence 699999999999999999999999999999998765432 2345567789999999999999999999876 5689999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC---
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR--- 286 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~--- 286 (704)
|||++++.+..+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (305)
T cd05609 80 MEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159 (305)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence 99999877766655556789999999999999999999999999999999999999999999999999864211100
Q ss_pred -----------CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCch
Q 005289 287 -----------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 355 (704)
Q Consensus 287 -----------~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~ 355 (704)
.......++..|+|||.+.. ..++.++|||||||++|+|++|..||.+.+..+.+..+.......+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~- 237 (305)
T cd05609 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE- 237 (305)
T ss_pred cccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC-
Confidence 01112356888999999876 56899999999999999999999999988777766665442111110
Q ss_pred hhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcC---HHHHHhccccCCCCCC
Q 005289 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT---ASAALASEYFSTKPYA 422 (704)
Q Consensus 356 ~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpT---a~e~L~hpwf~~~~~~ 422 (704)
....++.++.+||.+||..||++||| +.++|+||||...++.
T Consensus 238 -------------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~ 282 (305)
T cd05609 238 -------------------------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWN 282 (305)
T ss_pred -------------------------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHH
Confidence 00257889999999999999999998 8999999999876554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=341.22 Aligned_cols=261 Identities=27% Similarity=0.424 Sum_probs=214.7
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
++|++.+.||.|+||+||+|....++..||+|++....... ....+.+|+.+|+.++|+||+++++.+.. ...+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv 77 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVV--GDELWLV 77 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEee--CCEEEEE
Confidence 36999999999999999999998899999999997654433 56778899999999999999999998877 5789999
Q ss_pred EecccccccccccCC---CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC
Q 005289 210 FEYMEHDITGLLSCP---DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~---~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~ 286 (704)
|||+.++.+..+... ...+++..++.++.||+.||.|||++||+|+||+|+||++++++.++|+|||++........
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999998666554432 24689999999999999999999999999999999999999999999999999876654322
Q ss_pred C---CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCC
Q 005289 287 Q---PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 287 ~---~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
. .....+++..|+|||++.....++.++|||||||++|+|++|..||...+....+.++... .+..+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~------- 227 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPPSL------- 227 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CCCCc-------
Confidence 2 1233467899999999876557899999999999999999999999877665555544331 11000
Q ss_pred CcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
. . ...+..++..+.+||.+||..||++|||+.++|.||||
T Consensus 228 -----~----~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 228 -----E----T----GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred -----C----C----ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 0 0 00134678999999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=348.42 Aligned_cols=259 Identities=26% Similarity=0.437 Sum_probs=214.2
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|+++++||.|+||+||++.+..++..||+|++... .....+.+.+|+++|++++||||+++++++.. ...+||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 79 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFY--ENKLWI 79 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEec--CCeEEE
Confidence 35799999999999999999999889999999998754 24455678889999999999999999999987 568999
Q ss_pred EEeccccccccccc-CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCC
Q 005289 209 VFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (704)
Q Consensus 209 V~Ey~~g~ll~~~~-~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~ 287 (704)
||||++++.+..+. .....+++..++.++.||+.+|.|||++||+|+||||+||+++.++.++|+|||++....... .
T Consensus 80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~ 158 (280)
T cd06611 80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-Q 158 (280)
T ss_pred EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc-c
Confidence 99999997666554 334579999999999999999999999999999999999999999999999999987554322 1
Q ss_pred CcccccccccccCcccccC----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCC
Q 005289 288 PLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 288 ~~~~~~gT~~Y~APEvl~~----~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
......+|+.|+|||++.. ...++.++|||||||++|+|++|++||...+....+.++... .++.
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~--------- 227 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS--EPPT--------- 227 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcC--CCCC---------
Confidence 2234567999999999752 345788999999999999999999999887766655555321 1100
Q ss_pred CcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
......++.++.+||.+||..||.+|||+.++|+||||..
T Consensus 228 ---------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 267 (280)
T cd06611 228 ---------------LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSD 267 (280)
T ss_pred ---------------cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcc
Confidence 0011356788999999999999999999999999999985
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=348.32 Aligned_cols=260 Identities=23% Similarity=0.403 Sum_probs=212.4
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
++|++++.||.|+||+||+|++..+++.||+|.+... ........+.+|+.+|++++||||+++++.+.. ...+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv 77 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFI--EGAVYMC 77 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec--CCeEEEE
Confidence 3699999999999999999999999999999998754 234445678899999999999999999998877 5789999
Q ss_pred EecccccccccccCC---CccccHHHHHHHHHHhhhhHHHHHh-cCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 210 FEYMEHDITGLLSCP---DIKFSEAQIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~---~~~l~e~~~~~i~~QIl~aL~yLH~-~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
|||++++.+..+... ...+++..+..++.||+.||.|||+ .||+|+||||+|||++.++.+||+|||++......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 999998766655433 2378999999999999999999996 59999999999999999999999999998765332
Q ss_pred CCCcccccccccccCcccccCC-----CCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhcc
Q 005289 286 RQPLTSRVVTLWYRPPELLLGA-----TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~-----~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~ 360 (704)
......+++.|+|||++.+. ..++.++|||||||++|+|++|..||...........+.......+.
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------ 228 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPP------ 228 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCC------
Confidence 12334678899999988542 23688999999999999999999999876554444443332221110
Q ss_pred CCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCC
Q 005289 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (704)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~ 420 (704)
.....++.++.+||.+||..+|.+||++.+++.||||....
T Consensus 229 -------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 229 -------------------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred -------------------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 11235789999999999999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=342.30 Aligned_cols=258 Identities=28% Similarity=0.465 Sum_probs=208.1
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC---hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE---PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~---~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 207 (704)
+|++.+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.+|+.++||||+++++++.......+|
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 589999999999999999999999999999998754322 23456678899999999999999999998765557889
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC--
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-- 285 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~-- 285 (704)
+||||+.++.+.........+++..++.++.||+.||.|||+++|+|+||||+||+++.++.+||+|||++.......
T Consensus 83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS 162 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccccc
Confidence 999999986665554444568999999999999999999999999999999999999999999999999987553211
Q ss_pred CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
........++..|+|||++.+ ..++.++|||||||++|+|++|++||........+.++.. .+..
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~---~~~~----------- 227 (266)
T cd06651 163 GTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT---QPTN----------- 227 (266)
T ss_pred CCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc---CCCC-----------
Confidence 111223457889999999876 5688999999999999999999999987655444433321 1100
Q ss_pred ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccC
Q 005289 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417 (704)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~ 417 (704)
......+++.+.+|| .||..||++|||+.++|.||||+
T Consensus 228 -------------~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 228 -------------PQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred -------------CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 000124677889999 57778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=346.54 Aligned_cols=257 Identities=25% Similarity=0.389 Sum_probs=212.8
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 210 (704)
-|++++.||.|+||.||++.+..++..+|+|.+.... ......+.+|+++++.++||||+++++++.. ....|+||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~~v~ 81 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWILI 81 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCCCCCeeeEEEEEee--CCEEEEEE
Confidence 3788999999999999999999999999999986432 3445667889999999999999999999877 46899999
Q ss_pred eccccccccccc-CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCc
Q 005289 211 EYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (704)
Q Consensus 211 Ey~~g~ll~~~~-~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~ 289 (704)
||+.++.+..+. .....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....... ...
T Consensus 82 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~ 160 (282)
T cd06643 82 EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRR 160 (282)
T ss_pred EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc-ccc
Confidence 999987766543 334578999999999999999999999999999999999999999999999999987543221 222
Q ss_pred ccccccccccCccccc----CCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 290 TSRVVTLWYRPPELLL----GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 290 ~~~~gT~~Y~APEvl~----~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
....+|+.|+|||++. ....++.++|||||||++|+|++|.+||...+..+.+.++.... ++.
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~--~~~----------- 227 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE--PPT----------- 227 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcC--CCC-----------
Confidence 3456789999999974 23457889999999999999999999999877766665554321 100
Q ss_pred ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
......++.++.+||.+||..||.+|||+.++|+||||+.
T Consensus 228 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 267 (282)
T cd06643 228 -------------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTV 267 (282)
T ss_pred -------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEec
Confidence 0011357889999999999999999999999999999985
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=334.34 Aligned_cols=280 Identities=32% Similarity=0.591 Sum_probs=230.0
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeEEEeecCCCeEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~~~ 207 (704)
.++|++++++|.|-|+.||.|.+..+++.++||+++. -..+.+.+|+.||..|. ||||++|+++..++......
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 5689999999999999999999999999999999864 33567889999999995 99999999999998888889
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccC-CceEEeccccccccCCCCC
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~-g~iKL~DFGla~~~~~~~~ 286 (704)
||+||+.+..+..+- ..|+.-.++.|+.|||.||.|||++||+|||+||.|++||.. -.++|+|+|||.++.++
T Consensus 112 LiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~-- 186 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-- 186 (338)
T ss_pred hHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC--
Confidence 999999986554442 257888999999999999999999999999999999999976 46999999999988776
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCC-CCCCCCCHHHHHHHHHHHcCCCCc-hhhhccCCCC
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSPPD-DYWKKSKLPH 364 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~-~pF~~~~~~e~l~~I~~~~g~~p~-~~w~~~~~~~ 364 (704)
....-++.+..|--||+|..-..|+.+.|+|||||+|..|+..+ |.|.|.++.+|+.+|.+.+|...- .|..+..+.-
T Consensus 187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L 266 (338)
T KOG0668|consen 187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL 266 (338)
T ss_pred ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence 34566788999999999988888999999999999999999976 556789999999999999998542 2333333221
Q ss_pred cccCCC------CCCCCchhhhhc-cCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 365 ATLFKP------QQPYDSSLRETF-KDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 365 ~~~~~~------~~~~~~~l~~~~-~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
..-+.. ..++...+.... ...++++.|||.++|.+|-++|+||.|++.||||..
T Consensus 267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 267 DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 111111 112222222111 234699999999999999999999999999999973
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=345.64 Aligned_cols=257 Identities=28% Similarity=0.452 Sum_probs=208.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
++|++.+.||.|+||.||+|++..+++.||+|++.... ......+.+|+.+++.++||||+++++++.. ...+|+|
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~--~~~~~lv 84 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR--RDKLWIC 84 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--CCEEEEE
Confidence 47999999999999999999999999999999987553 2334557789999999999999999999877 5789999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCc
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~ 289 (704)
|||++++.+..+......+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... ...
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~~ 163 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AKR 163 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-ccc
Confidence 9999987666655555679999999999999999999999999999999999999999999999999987554321 222
Q ss_pred ccccccccccCccccc--CCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCccc
Q 005289 290 TSRVVTLWYRPPELLL--GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (704)
Q Consensus 290 ~~~~gT~~Y~APEvl~--~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~ 367 (704)
....+++.|+|||++. ....++.++|||||||++|+|++|.+||........+..+......++ .
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~--~----------- 230 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP--K----------- 230 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCC--c-----------
Confidence 3457899999999874 234588899999999999999999999876554433333221100000 0
Q ss_pred CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccc
Q 005289 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415 (704)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpw 415 (704)
+ .....++..+.+||.+||..||++|||+.++|+|||
T Consensus 231 ----------~-~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 231 ----------L-KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred ----------c-cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 0 001246788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=342.82 Aligned_cols=280 Identities=40% Similarity=0.705 Sum_probs=221.6
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc---CCCCceeEeEEEeecCC---Ce
Q 005289 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL---DHPNIIKLEGLITSRLS---CS 205 (704)
Q Consensus 132 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIv~l~~~~~~~~~---~~ 205 (704)
|++.+.||.|+||.||+|++..+++.||||++............+.+|+.+++++ +||||+++++++..... ..
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 7889999999999999999998899999999975443333334556788877766 69999999999876321 24
Q ss_pred EEEEEecccccccccccC-CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 206 IYLVFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~-~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
+|+||||+.+.+...+.. ....+++..++.++.||+.||.|||+++|+|+||+|+|||++.++.+||+|||++......
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~ 160 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence 899999998866554433 2236899999999999999999999999999999999999999999999999999766433
Q ss_pred CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
. ......++..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+.++....+.+....|.......
T Consensus 161 ~--~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07838 161 M--ALTSVVVTLWYRAPEVLLQ-SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP 237 (287)
T ss_pred c--ccccccccccccChHHhcc-CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccc
Confidence 2 2233457889999999876 568899999999999999999999999999999999998877766554443322111
Q ss_pred cccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
...+. ...........+.++..+.+||.+||..||.+|||+.++|.||||
T Consensus 238 ~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 238 RSSFP--SYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hhhcc--cccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 11111 111112234445678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=343.99 Aligned_cols=258 Identities=24% Similarity=0.417 Sum_probs=204.6
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHH-HHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILI-LRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~i-L~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
++|++++.||+|+||.||++.+..+|+.||||++......... ..+..|+.+ ++.++||||+++++++.. ...+|+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~--~~~~~l 77 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDCPYTVTFYGALFR--EGDVWI 77 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHH-HHHHHHHHHHHHHcCCCCeeeeeEEEec--CCcEEE
Confidence 3699999999999999999999999999999999765433333 344456664 666799999999999876 467999
Q ss_pred EEecccccccccc---cCCCccccHHHHHHHHHHhhhhHHHHHhc-CcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 209 VFEYMEHDITGLL---SCPDIKFSEAQIKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 209 V~Ey~~g~ll~~~---~~~~~~l~e~~~~~i~~QIl~aL~yLH~~-gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
||||+++.+...+ ......+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||++......
T Consensus 78 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 78 CMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred EhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999998654433 22345799999999999999999999997 9999999999999999999999999998765432
Q ss_pred CCCCcccccccccccCcccccCC---CCCCCccchhhHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHcCCCCchhhhcc
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGA---TDYGPSVDLWSVGCVFAELLIGKPILQGR-TEVEQLHKIFKLCGSPPDDYWKKS 360 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~---~~y~~~~DIWSlG~iLyeLltG~~pF~~~-~~~e~l~~I~~~~g~~p~~~w~~~ 360 (704)
. ..+...++..|+|||++.+. ..++.++|||||||++|+|++|+.||... ...+.+..+.. +..+ .
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~-~----- 227 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE--EPSP-Q----- 227 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh--cCCC-C-----
Confidence 1 12334678899999988542 34788999999999999999999999653 33333333322 1100 0
Q ss_pred CCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
.....+|.++.+||.+||..+|.+|||+.++|.||||...
T Consensus 228 -------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 228 -------------------LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred -------------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 0012478899999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=343.56 Aligned_cols=256 Identities=27% Similarity=0.414 Sum_probs=206.1
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecC----CC
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRL----SC 204 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~----~~ 204 (704)
+.|++.+.||.|+||+||+|.+..+++.||+|++..... ....+.+|+.+|.++ +||||+++++++.... ..
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 469999999999999999999999999999999975432 234567899999998 7999999999987532 24
Q ss_pred eEEEEEecccccccccccC--CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccC
Q 005289 205 SIYLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~~--~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~ 282 (704)
.+|+||||+.++.+..+.. ....+++..+..++.||+.||.|||+++|+|+||||+|||+++++.+||+|||++....
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~ 162 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 162 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence 6899999999865554433 23468999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCCCcccccccccccCcccccC----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhh
Q 005289 283 TGHRQPLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 358 (704)
Q Consensus 283 ~~~~~~~~~~~gT~~Y~APEvl~~----~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~ 358 (704)
... .......+++.|+|||++.. ...|+.++|||||||++|+|++|.+||...........+... +.
T Consensus 163 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~---~~----- 233 (272)
T cd06637 163 RTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---PA----- 233 (272)
T ss_pred ccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC---CC-----
Confidence 322 22344578999999999853 235888999999999999999999999765544333322110 00
Q ss_pred ccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 359 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
. ......++.++.+||.+||..||.+|||+.++|.||||
T Consensus 234 ----------------~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 234 ----------------P---RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred ----------------C---CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 0 00113567899999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=343.61 Aligned_cols=258 Identities=29% Similarity=0.448 Sum_probs=207.0
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|++.+.||.|+||.||+|++..+++.||+|++..... .....+.+|+.+|+.++||||+++++++.. ...+|+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~--~~~~~i 83 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLS--REKLWI 83 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEe--CCEEEE
Confidence 3579999999999999999999999999999999975432 234567789999999999999999999877 468999
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
||||++++.+..+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~~ 162 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-AK 162 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc-cc
Confidence 99999987666555455678999999999999999999999999999999999999999999999999997654321 11
Q ss_pred cccccccccccCcccccC--CCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcc
Q 005289 289 LTSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~--~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~ 366 (704)
.....+++.|+|||.+.. ...++.++|||||||++|+|++|.+||......+....+......+
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 228 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQP-------------- 228 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCC--------------
Confidence 233467889999998742 3457889999999999999999999986554333222221100000
Q ss_pred cCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccc
Q 005289 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415 (704)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpw 415 (704)
+. + .....++..+.+||.+||..||++|||++++|+|+|
T Consensus 229 ---~~------~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 229 ---PK------L-KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred ---CC------C-ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 00 0 001356889999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=343.76 Aligned_cols=280 Identities=39% Similarity=0.675 Sum_probs=227.5
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeEEEeecCCCeEEEEE
Q 005289 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNIIKLEGLITSRLSCSIYLVF 210 (704)
Q Consensus 132 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~~~LV~ 210 (704)
|++.+.||.|+||+||+|....+++.||||.+....... ......+|+..++++. ||||+++++++.+ ....|+||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv~ 77 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFVF 77 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch-hHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEEEE
Confidence 778899999999999999999999999999986543222 2233457999999998 9999999999877 57899999
Q ss_pred ecccccccccccCCC-ccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCc
Q 005289 211 EYMEHDITGLLSCPD-IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (704)
Q Consensus 211 Ey~~g~ll~~~~~~~-~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~ 289 (704)
||+.+.+...+.... ..+++..+..++.||+.+|.|||++||+|+||+|.||+++.++.++|+|||++...... ...
T Consensus 78 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~--~~~ 155 (283)
T cd07830 78 EYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR--PPY 155 (283)
T ss_pred ecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC--CCc
Confidence 999777666554433 46899999999999999999999999999999999999999999999999999765432 223
Q ss_pred ccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCC
Q 005289 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (704)
Q Consensus 290 ~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~ 369 (704)
....++..|+|||++.....++.++|||||||++|+|++|++||...+..+.+.++...++.+....|............
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence 44567899999999876566899999999999999999999999999999999999999999887766543221111100
Q ss_pred C-CCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 370 P-QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 370 ~-~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
. .......+...+...+..+.+||++||..||++|||+.|++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0 0011112334445568899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=340.13 Aligned_cols=255 Identities=29% Similarity=0.531 Sum_probs=209.5
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-------hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-------PESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-------~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 203 (704)
+|.+...||.|+||.||+|.+..+++.||+|.+...... ....+.+.+|+.+|++++||||+++++++.. .
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 78 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--A 78 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--C
Confidence 367788999999999999999999999999998654322 1233567789999999999999999999877 5
Q ss_pred CeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCC
Q 005289 204 CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~ 283 (704)
...|+||||+++..+..+......+++..+..++.||+.||.|||++||+||||+|+|||+++++.++|+|||++.....
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 79 DHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred CccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 68899999999876665555556789999999999999999999999999999999999999999999999999876642
Q ss_pred CCC-----CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhh
Q 005289 284 GHR-----QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 358 (704)
Q Consensus 284 ~~~-----~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~ 358 (704)
... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+....+.++.... .+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~----- 230 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA--SP----- 230 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC--CC-----
Confidence 211 11122357889999999876 567889999999999999999999998876655544443210 00
Q ss_pred ccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 359 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
.....++..+.+||.+||..||.+|||+.++|+||||
T Consensus 231 ---------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 231 ---------------------EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred ---------------------cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 1113578899999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=343.15 Aligned_cols=256 Identities=29% Similarity=0.478 Sum_probs=213.4
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
++|++++.||.|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++|+||+++++++.+ ...+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v 77 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA-EDEIEDIQQEIQFLSQCRSPYITKYYGSFLK--GSKLWII 77 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc-chHHHHHHHHHHHHHHcCCCCeeeeeEEEEE--CCeEEEE
Confidence 368999999999999999999999999999999976542 3345567889999999999999999999887 4789999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCc
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~ 289 (704)
+||+.++.+..+.... .+++..++.++.||+.||.|||+++|+|+||+|+||++++++.++|+|||++....... ...
T Consensus 78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~ 155 (274)
T cd06609 78 MEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SKR 155 (274)
T ss_pred EEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc-ccc
Confidence 9999986666554433 78999999999999999999999999999999999999999999999999997765432 222
Q ss_pred ccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCC
Q 005289 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (704)
Q Consensus 290 ~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~ 369 (704)
....+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+....+..+... .++.
T Consensus 156 ~~~~~~~~y~~PE~~~~-~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~--~~~~--------------- 217 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN--NPPS--------------- 217 (274)
T ss_pred ccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc--CCCC---------------
Confidence 34567889999999876 45899999999999999999999999877665555444321 1100
Q ss_pred CCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 370 ~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
+. ...++.++.++|.+||..||++|||+.++|.||||+.
T Consensus 218 --------~~--~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~ 256 (274)
T cd06609 218 --------LE--GNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKK 256 (274)
T ss_pred --------Cc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcC
Confidence 00 0127888999999999999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=354.61 Aligned_cols=263 Identities=27% Similarity=0.408 Sum_probs=232.0
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCC
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSC 204 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~ 204 (704)
++..+|.++..||+|+||.|.++..+.+.+.||||+++++.+ +.+.++....|-++|... +-|++++|+..|+. ..
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT--mD 423 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT--MD 423 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh--hh
Confidence 445689999999999999999999999999999999988764 445566777899999887 56899999998887 57
Q ss_pred eEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
.+|+||||+.|+.|-..++.-++|.|..+..|+.+|+-||-|||++|||+||||..||||+.+|+|||+|||+++.--.+
T Consensus 424 RLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred heeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccC
Confidence 89999999999888877777889999999999999999999999999999999999999999999999999999754332
Q ss_pred CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
. ....+.||||.|+|||++.- .+|+.++|+||+||+|||||.|++||.|.++.+.++.|.+..-.+|
T Consensus 504 ~-~TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyP----------- 570 (683)
T KOG0696|consen 504 G-VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYP----------- 570 (683)
T ss_pred C-cceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCc-----------
Confidence 2 34567899999999999875 6899999999999999999999999999999999999987543333
Q ss_pred cccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCH-----HHHHhccccCCCCCC
Q 005289 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA-----SAALASEYFSTKPYA 422 (704)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa-----~e~L~hpwf~~~~~~ 422 (704)
+.++.++.++++.+|.+.|.+|..+ .++-.||||+...|.
T Consensus 571 ------------------KslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWe 615 (683)
T KOG0696|consen 571 ------------------KSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWE 615 (683)
T ss_pred ------------------ccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHH
Confidence 5789999999999999999999764 688999999987775
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=337.20 Aligned_cols=256 Identities=30% Similarity=0.490 Sum_probs=214.9
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 210 (704)
+|++++.||.|+||+||+|.+..+++.||+|++..........+.+..|+.+|+.++||||+++++++.......+|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 48999999999999999999999999999999987666666677788999999999999999999988765567889999
Q ss_pred ecccccccccccC----CCccccHHHHHHHHHHhhhhHHHHH-----hcCcccccCCCccEEEccCCceEEecccccccc
Q 005289 211 EYMEHDITGLLSC----PDIKFSEAQIKCYMNQLLHGLEHCH-----SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (704)
Q Consensus 211 Ey~~g~ll~~~~~----~~~~l~e~~~~~i~~QIl~aL~yLH-----~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~ 281 (704)
||++++.+..+.. ....+++..++.++.||+.||.||| +.+|+|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 9999865543322 2457899999999999999999999 899999999999999999999999999999876
Q ss_pred CCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccC
Q 005289 282 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (704)
Q Consensus 282 ~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~ 361 (704)
..... ......+++.|+|||++.. ..++.++|||||||++|+|++|..||...+..+....+.. +.++
T Consensus 161 ~~~~~-~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~-------- 228 (265)
T cd08217 161 GHDSS-FAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKE--GKFR-------- 228 (265)
T ss_pred cCCcc-cccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhc--CCCC--------
Confidence 54321 1234567999999999876 4588999999999999999999999998775555544432 1110
Q ss_pred CCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
.....++..+.+||.+||..+|.+|||+.++|+|||+
T Consensus 229 ------------------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 229 ------------------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ------------------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 0113567899999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=346.86 Aligned_cols=256 Identities=27% Similarity=0.486 Sum_probs=211.9
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
.+|++++.||.|+||.||++.+..+++.||+|.+...... ....+.+|+.+++.++||||+++++.+.. ...+|+|
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~--~~~~~lv 95 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVV 95 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEe--CCEEEEe
Confidence 4799999999999999999999999999999999765432 34567889999999999999999999887 5689999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCc
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~ 289 (704)
|||+.++.+..+.. ...+++.++..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++....... ...
T Consensus 96 ~e~~~~~~L~~~~~-~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~-~~~ 173 (296)
T cd06654 96 MEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKR 173 (296)
T ss_pred ecccCCCCHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc-ccc
Confidence 99999876665543 2358899999999999999999999999999999999999999999999999987654322 122
Q ss_pred ccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCC
Q 005289 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (704)
Q Consensus 290 ~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~ 369 (704)
....+++.|+|||.+.+ ..++.++|||||||++|+|++|++||...+....+..+.. .+.++
T Consensus 174 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~---------------- 235 (296)
T cd06654 174 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPE---------------- 235 (296)
T ss_pred CcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc-CCCCC----------------
Confidence 34567899999998875 5578999999999999999999999988776544433321 01110
Q ss_pred CCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 370 ~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
......++..+.+||.+||..||++|||+.++|.||||..
T Consensus 236 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 275 (296)
T cd06654 236 ---------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (296)
T ss_pred ---------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhc
Confidence 0011357788999999999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=362.91 Aligned_cols=251 Identities=26% Similarity=0.432 Sum_probs=219.0
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEecccc
Q 005289 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH 215 (704)
Q Consensus 136 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g 215 (704)
+.||.|.||+||-++++.+|+.||||+|.+..+.......+.+|+.||+.++||.||.|.-.|+. .+.+++|||-+.|
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET--~ervFVVMEKl~G 647 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET--PERVFVVMEKLHG 647 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC--CceEEEEehhhcc
Confidence 67999999999999999999999999999888877777889999999999999999999888877 5789999999999
Q ss_pred ccccccc-CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCC---ceEEeccccccccCCCCCCCccc
Q 005289 216 DITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTS 291 (704)
Q Consensus 216 ~ll~~~~-~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g---~iKL~DFGla~~~~~~~~~~~~~ 291 (704)
+.|..++ ...++|++...+.++.|||.||.|||-++|+|+||||+||||.+.. .+||||||+|+.+.... ...+
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--FRrs 725 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--FRRS 725 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh--hhhh
Confidence 9888665 4677899999999999999999999999999999999999997653 69999999999987653 3467
Q ss_pred ccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCC
Q 005289 292 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 371 (704)
Q Consensus 292 ~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~ 371 (704)
.+|||.|+|||+|.. +.|+...|+||+|||+|--|+|..||..+.+ +-.+|.+...-+|..
T Consensus 726 VVGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNAaFMyPp~---------------- 786 (888)
T KOG4236|consen 726 VVGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNAAFMYPPN---------------- 786 (888)
T ss_pred hcCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCCccc--hhHHhhccccccCCC----------------
Confidence 899999999999987 6799999999999999999999999976543 333343322222222
Q ss_pred CCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 372 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 372 ~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
.|..++.+++|||..+|++.-.+|.|.++.|.|||++.
T Consensus 787 ---------PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~ 824 (888)
T KOG4236|consen 787 ---------PWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQD 824 (888)
T ss_pred ---------chhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhc
Confidence 24689999999999999999999999999999999985
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=345.84 Aligned_cols=256 Identities=28% Similarity=0.488 Sum_probs=214.6
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
.+|++++.||.|+||+||++.+..+++.||||.+..... ...+.+.+|+.+++.++||||+++++++.. ...+|+|
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 94 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLV--GDELFVV 94 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEec--CceEEEE
Confidence 469999999999999999999999999999999976443 234567889999999999999999999977 5789999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCc
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~ 289 (704)
|||+.++.+..+... ..+++.++..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++........ ..
T Consensus 95 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~ 172 (296)
T cd06655 95 MEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KR 172 (296)
T ss_pred EEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-cC
Confidence 999998777665543 3689999999999999999999999999999999999999999999999999876544321 22
Q ss_pred ccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCC
Q 005289 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (704)
Q Consensus 290 ~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~ 369 (704)
....+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||.+.+....+..+... +.++
T Consensus 173 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~---------------- 234 (296)
T cd06655 173 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE---------------- 234 (296)
T ss_pred CCcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCcc----------------
Confidence 33467899999998875 55789999999999999999999999988776655544321 1110
Q ss_pred CCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 370 ~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
......++..+.+||.+||..||.+|||+.++|.||||+.
T Consensus 235 ---------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 235 ---------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKL 274 (296)
T ss_pred ---------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhh
Confidence 0112357889999999999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=334.40 Aligned_cols=254 Identities=26% Similarity=0.445 Sum_probs=216.4
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 210 (704)
+|++++.||.|+||.||.+++..+++.+++|.+............+.+|+.+|++++|+||+++++++.+ ...+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD--DNTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec--CCeEEEEE
Confidence 5999999999999999999999999999999998766666666778899999999999999999999987 57899999
Q ss_pred ecccccccccccCC--CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 211 EYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 211 Ey~~g~ll~~~~~~--~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
||+.++.+..+... ...+++..+..++.||+.+|.|||+.||+|+||+|+||+++.++.+||+|||++....... ..
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~-~~ 157 (256)
T cd08221 79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY-SM 157 (256)
T ss_pred EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc-cc
Confidence 99998655544322 3568999999999999999999999999999999999999999999999999997664432 12
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccC
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~ 368 (704)
.....+++.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+.. +.++.
T Consensus 158 ~~~~~~~~~y~ape~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~~~~~-------------- 220 (256)
T cd08221 158 AETVVGTPYYMSPELCQG-VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ--GNYTP-------------- 220 (256)
T ss_pred ccccCCCccccCHhhcCC-CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc--CCCCC--------------
Confidence 344567999999999876 4578899999999999999999999998887777766643 21110
Q ss_pred CCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 369 ~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
....++.++.++|.+||..||.+|||+.++|+|+|+
T Consensus 221 ------------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 221 ------------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred ------------CccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 013578899999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=336.13 Aligned_cols=254 Identities=26% Similarity=0.495 Sum_probs=212.7
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 210 (704)
+|++++.||.|+||+||++++..+++.||||.+............+.+|+.++++++||||+++++++.. ....||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE--NGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC--CCeEEEEE
Confidence 4999999999999999999999999999999997655545556678899999999999999999999877 56899999
Q ss_pred eccccccccccc-C-CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 211 EYMEHDITGLLS-C-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 211 Ey~~g~ll~~~~-~-~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
||+.++.+.... . ....+++..+..++.||+.||.|||++||+|+||+|+|||++.++.++|+|||++....... ..
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~ 157 (256)
T cd08218 79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV-EL 157 (256)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch-hh
Confidence 999875444332 2 23357899999999999999999999999999999999999999999999999997654322 11
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccC
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~ 368 (704)
.....+++.|+|||++.+ ..++.++|||||||++|+|++|..||......+++.++.. +..+.
T Consensus 158 ~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~~~~~-------------- 220 (256)
T cd08218 158 ARTCIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR--GSYPP-------------- 220 (256)
T ss_pred hhhccCCccccCHHHhCC-CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc--CCCCC--------------
Confidence 223457889999999876 4578899999999999999999999988777776666643 22110
Q ss_pred CCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 369 ~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
....++.++.+||.+||..+|.+||++.++|+||||
T Consensus 221 ------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 221 ------------VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred ------------CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 113578889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=337.51 Aligned_cols=259 Identities=27% Similarity=0.434 Sum_probs=210.1
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC---ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF---EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~---~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
.+|++.+.||+|+||.||++.+..+++.||||++..... .......+.+|+.+|++++||||+++++++.+.....+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 369999999999999999999999999999999865432 23445678889999999999999999998876545678
Q ss_pred EEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC-
Q 005289 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH- 285 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~- 285 (704)
|+||||++++.+..+......+++..+..++.||+.+|.|||+++|+|+||||+|||++.++.++|+|||++.......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 9999999986666554444568899999999999999999999999999999999999999999999999987543211
Q ss_pred -CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC
Q 005289 286 -RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 286 -~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
........++..|+|||++.+ ..++.++|||||||++|+|++|++||........+.++.. .+..
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~~---------- 227 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QPTN---------- 227 (265)
T ss_pred cccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---CCCC----------
Confidence 112233467889999999876 5688999999999999999999999987655554443321 1100
Q ss_pred cccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccC
Q 005289 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417 (704)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~ 417 (704)
......++..+.++|.+|| .+|++|||++++|+|||+.
T Consensus 228 --------------~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 228 --------------PVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLRHTFVH 265 (265)
T ss_pred --------------CCCchhhCHHHHHHHHHHh-cChhhCCCHHHHhcCcccC
Confidence 0011356788999999999 5999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=338.23 Aligned_cols=256 Identities=26% Similarity=0.451 Sum_probs=209.4
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC----hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE----PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
+|++.+.||.|+||+||+|.+ .+++.+|||++...... ......+.+|+++|+.++|+||+++++++.+ ...+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 77 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD--DNTI 77 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec--CCeE
Confidence 478889999999999999986 47889999998754321 2334567889999999999999999999987 4789
Q ss_pred EEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC--
Q 005289 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG-- 284 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~-- 284 (704)
|+||||+.++.+..+......+++..+..++.||+.||+|||+.+|+|+||+|+|||+++++.++|+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 78 SIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 999999998777766555567899999999999999999999999999999999999999999999999998754211
Q ss_pred ---CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccC
Q 005289 285 ---HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (704)
Q Consensus 285 ---~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~ 361 (704)
.........++..|+|||++.+ ..++.++|||||||++|+|++|.+||...+.......+....+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 228 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMP-------- 228 (265)
T ss_pred cccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCC--------
Confidence 1112233467899999999876 5688999999999999999999999987665554444332211111
Q ss_pred CCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
.....++.++.+||.+||..||.+|||+.++|.||||
T Consensus 229 ------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 229 ------------------RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred ------------------CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 1123578899999999999999999999999999998
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=336.24 Aligned_cols=257 Identities=29% Similarity=0.465 Sum_probs=211.4
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
++|++.+.||.|+||.||+|.+..+++.+|+|++..... .....+.+|+.+|+.++||||+++++++.. ...+|||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~l~ 78 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLR--RDKLWIV 78 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEe--CCEEEEE
Confidence 579999999999999999999999999999999976542 345678899999999999999999999877 5789999
Q ss_pred EecccccccccccCC-CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 210 FEYMEHDITGLLSCP-DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~-~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
|||++++.+..+... ...+++..+..++.||+.||.|||++||+|+||+|+||++++++.+||+|||++....... ..
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~ 157 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-AK 157 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh-hc
Confidence 999998776655433 3679999999999999999999999999999999999999999999999999987654321 12
Q ss_pred cccccccccccCcccccCC--CCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcc
Q 005289 289 LTSRVVTLWYRPPELLLGA--TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~--~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~ 366 (704)
.....++..|+|||++.+. ..++.++|||||||++|+|++|.+||...+.......+......++
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~------------- 224 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPP------------- 224 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCc-------------
Confidence 2345678899999998653 2678899999999999999999999988776555444432100000
Q ss_pred cCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccc
Q 005289 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415 (704)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpw 415 (704)
.+ .....++.++.+||++||..||..|||+.++|.|+|
T Consensus 225 ----------~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 225 ----------KL-KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred ----------cc-cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 00 011245778999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=364.21 Aligned_cols=254 Identities=31% Similarity=0.504 Sum_probs=220.1
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
.|.-++.||.|+||.||-|++..+...||||++...... .+.+..+..|+.+|++|.|||+|.+-++|.- ....|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr--e~TaWLV 104 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR--EHTAWLV 104 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec--cchHHHH
Confidence 478889999999999999999999999999999876543 4567778899999999999999999999876 4678999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCc
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~ 289 (704)
||||-|.-.+++....+++.|.+++.|+.+.|.||.|||+.+.||||||..||||++.|.|||+|||.|....+ .
T Consensus 105 MEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-----A 179 (948)
T KOG0577|consen 105 MEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-----A 179 (948)
T ss_pred HHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc-----h
Confidence 99999976666655667899999999999999999999999999999999999999999999999999976654 4
Q ss_pred ccccccccccCccccc--CCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCccc
Q 005289 290 TSRVVTLWYRPPELLL--GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (704)
Q Consensus 290 ~~~~gT~~Y~APEvl~--~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~ 367 (704)
.+++|||+|||||||+ ..+.|+-++||||||++..||.-.+||+...+....+--|... .+|.
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN-esPt-------------- 244 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-ESPT-------------- 244 (948)
T ss_pred hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhc-CCCC--------------
Confidence 6789999999999985 3467999999999999999999999999888877666666431 1110
Q ss_pred CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
|. -...+..+.+||..||.+-|.+|||++++|.|+|...
T Consensus 245 ----------Lq--s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 245 ----------LQ--SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred ----------CC--CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 10 1356788999999999999999999999999999975
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=337.82 Aligned_cols=258 Identities=28% Similarity=0.431 Sum_probs=209.4
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecC----C
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRL----S 203 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~----~ 203 (704)
.++|++.+.||.|+||+||+|.+..+++.||+|++.... .....+.+|+.+++++ +|+||+++++++.... .
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 468999999999999999999999999999999987543 2345678999999999 7999999999987632 4
Q ss_pred CeEEEEEecccccccccccC----CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEecccccc
Q 005289 204 CSIYLVFEYMEHDITGLLSC----PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN 279 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~~~~----~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~ 279 (704)
..+||||||++++.+..+.. ....+++..++.++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccce
Confidence 56899999999865554432 24578999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCCcccccccccccCcccccC----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCch
Q 005289 280 FSNTGHRQPLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 355 (704)
Q Consensus 280 ~~~~~~~~~~~~~~gT~~Y~APEvl~~----~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~ 355 (704)
...... .......+++.|+|||++.. ...++.++|||||||+||+|++|.+||........+.++... .++ .
T Consensus 162 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~-~ 237 (275)
T cd06608 162 QLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN--PPP-T 237 (275)
T ss_pred ecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc--CCC-C
Confidence 654322 22234567899999998753 235788999999999999999999999876655555444321 110 0
Q ss_pred hhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 356 ~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
......++.++.+||.+||..||++|||+.++|+|||+
T Consensus 238 -----------------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 238 -----------------------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred -----------------------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 00012367889999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=332.70 Aligned_cols=253 Identities=26% Similarity=0.409 Sum_probs=211.9
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 210 (704)
+|++.+.||.|+||.||+|.+..+++.||||.+............+.+|+.+|+.++||||+++++.+.. ...+|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE--DKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec--CCEEEEEE
Confidence 4899999999999999999999999999999998766655667788899999999999999999998876 57899999
Q ss_pred ecccccccccccCC--CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCC-ceEEeccccccccCCCCCC
Q 005289 211 EYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQ 287 (704)
Q Consensus 211 Ey~~g~ll~~~~~~--~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g-~iKL~DFGla~~~~~~~~~ 287 (704)
||++++.+..+... ...+++..+..++.||+.+|.|||++||+|+||+|+||+++.++ .+||+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-- 156 (256)
T cd08220 79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-- 156 (256)
T ss_pred ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc--
Confidence 99998655544332 34589999999999999999999999999999999999998654 68999999998665332
Q ss_pred CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCccc
Q 005289 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (704)
Q Consensus 288 ~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~ 367 (704)
......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+.......+......
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~---------------- 219 (256)
T cd08220 157 KAYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA---------------- 219 (256)
T ss_pred cccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC----------------
Confidence 2233567889999999876 56788999999999999999999999887766665555331100
Q ss_pred CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
.....++..+.+||..||..||.+|||+.++|.||||
T Consensus 220 ------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 220 ------------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred ------------CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 0112478889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=338.76 Aligned_cols=260 Identities=32% Similarity=0.519 Sum_probs=208.9
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC----hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE----PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
+|++.+.||+|+||.||++.+..+++.||||++...... ......+.+|+.+|+.++|+||+++++++.+ ...+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 78 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE--DSHF 78 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc--CCeE
Confidence 488889999999999999999999999999999754321 2245678899999999999999999999977 5689
Q ss_pred EEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCC-ceEEeccccccccCCCC
Q 005289 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGH 285 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g-~iKL~DFGla~~~~~~~ 285 (704)
++||||+.++.+..+......+++..+..++.||+.||.|||++||+|+||+|+||+++.++ .+||+|||++.......
T Consensus 79 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 79 NLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 99999999877766555556789999999999999999999999999999999999998776 59999999987664321
Q ss_pred C---CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCC
Q 005289 286 R---QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (704)
Q Consensus 286 ~---~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~ 362 (704)
. .......+|..|+|||++.+ ..++.++|||||||++|+|++|.+||...........+....-...
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------- 228 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT--------- 228 (268)
T ss_pred ccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCC---------
Confidence 1 11123457889999999875 5688999999999999999999999975543333332222110000
Q ss_pred CCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccC
Q 005289 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417 (704)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~ 417 (704)
.......++.++.++|.+||..||++|||+.++|+||||+
T Consensus 229 ---------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 229 ---------------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred ---------------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 0011135788999999999999999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=338.91 Aligned_cols=253 Identities=30% Similarity=0.428 Sum_probs=211.3
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
+|++.+.||.|+||.||+|.+..+++.||+|++...... ....+.+.+|++++++++||||+++++++.+ ...+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD--EENMYLV 78 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC--CCeEEEE
Confidence 489999999999999999999999999999999865432 2456778899999999999999999998876 5789999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCc
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~ 289 (704)
|||+.++.+.........+++..+..++.||+.+|.|||++||+|+||+|+||++++++.++|+|||++....... ..
T Consensus 79 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~ 156 (258)
T cd05578 79 VDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LT 156 (258)
T ss_pred EeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--cc
Confidence 9999997776665555689999999999999999999999999999999999999999999999999987665432 22
Q ss_pred ccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCCchhhhccCCCCccc
Q 005289 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE--VEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (704)
Q Consensus 290 ~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~--~e~l~~I~~~~g~~p~~~w~~~~~~~~~~ 367 (704)
....++..|+|||++.. ..++.++|||||||++|+|++|..||...+. .+.+.+.... ..
T Consensus 157 ~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~-------------- 218 (258)
T cd05578 157 TSTSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET---AD-------------- 218 (258)
T ss_pred cccCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc---cc--------------
Confidence 34567889999999876 4589999999999999999999999987664 2222222110 00
Q ss_pred CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCH--HHHHhcccc
Q 005289 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA--SAALASEYF 416 (704)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa--~e~L~hpwf 416 (704)
......++..+.++|.+||..||.+||++ .++++||||
T Consensus 219 -----------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 219 -----------VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred -----------ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 01113567899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=346.29 Aligned_cols=256 Identities=27% Similarity=0.475 Sum_probs=210.9
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
.+|++++.||.|+||.||++.+..+++.||||.+...... ..+.+.+|+.+++.++||||+++++++.. ...+|+|
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv 94 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVV 94 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCEEEEe
Confidence 5799999999999999999999999999999999764432 34567889999999999999999999977 5789999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCc
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~ 289 (704)
|||++++.+..+... ..+++..+..++.||+.+|.|||+.||+||||||+|||++.++.++|+|||++....... ...
T Consensus 95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~ 172 (297)
T cd06656 95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKR 172 (297)
T ss_pred ecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc-cCc
Confidence 999998766655432 357899999999999999999999999999999999999999999999999987654332 122
Q ss_pred ccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCC
Q 005289 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (704)
Q Consensus 290 ~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~ 369 (704)
....+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||.+.+....+..+.. .+.++
T Consensus 173 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~~---------------- 234 (297)
T cd06656 173 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE---------------- 234 (297)
T ss_pred CcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCCC----------------
Confidence 34567899999999876 5678999999999999999999999987655433222211 11110
Q ss_pred CCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 370 ~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
......++..+.+||.+||..||++|||+.++|+||||..
T Consensus 235 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 274 (297)
T cd06656 235 ---------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKL 274 (297)
T ss_pred ---------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcc
Confidence 0012357788999999999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=340.84 Aligned_cols=256 Identities=26% Similarity=0.428 Sum_probs=206.6
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeec----CCC
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSR----LSC 204 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~----~~~ 204 (704)
+.|++.+.||.|+||+||+|++..+++.||+|++.... .....+..|+.+++++ +||||+++++++... ...
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 92 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD 92 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCC
Confidence 47999999999999999999999999999999986542 3345677899999998 799999999988532 245
Q ss_pred eEEEEEecccccccccccC--CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccC
Q 005289 205 SIYLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~~--~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~ 282 (704)
.+||||||+.++.+..+.. ....+++..+..++.||+.||.|||++||+|+||||+||+|++++.++|+|||++....
T Consensus 93 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~ 172 (282)
T cd06636 93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 172 (282)
T ss_pred EEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhh
Confidence 7899999999865554432 23458899999999999999999999999999999999999999999999999987554
Q ss_pred CCCCCCcccccccccccCcccccC----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhh
Q 005289 283 TGHRQPLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 358 (704)
Q Consensus 283 ~~~~~~~~~~~gT~~Y~APEvl~~----~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~ 358 (704)
... ......++++.|+|||++.. ...++.++|||||||++|+|++|.+||........+..+.... ++
T Consensus 173 ~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~--~~----- 244 (282)
T cd06636 173 RTV-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--PP----- 244 (282)
T ss_pred ccc-cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCC--CC-----
Confidence 221 12234567899999998753 2457889999999999999999999998766544443332110 00
Q ss_pred ccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 359 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
......++.++.+||.+||..||.+|||+.++|+||||
T Consensus 245 --------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 245 --------------------KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred --------------------CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 00113578899999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=339.69 Aligned_cols=259 Identities=27% Similarity=0.431 Sum_probs=208.3
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecC---CC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRL---SC 204 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~---~~ 204 (704)
.++|++...||.|+||.||+|.+..+++.||+|++.... .....+.+|+.+++++ +||||+++++++.... ..
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 97 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG 97 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence 468999999999999999999999999999999986432 2234567899999999 8999999999986532 24
Q ss_pred eEEEEEeccccccccccc----CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccc
Q 005289 205 SIYLVFEYMEHDITGLLS----CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 280 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~----~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~ 280 (704)
.+|+||||++++.+..+. .....+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..
T Consensus 98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~ 177 (291)
T cd06639 98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177 (291)
T ss_pred eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence 689999999986655433 2345789999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCcccccccccccCcccccCCC----CCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchh
Q 005289 281 SNTGHRQPLTSRVVTLWYRPPELLLGAT----DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 356 (704)
Q Consensus 281 ~~~~~~~~~~~~~gT~~Y~APEvl~~~~----~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~ 356 (704)
...... ......++..|+|||++.... .++.++|||||||++|+|++|++||........+..+... .++ ..
T Consensus 178 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~--~~~-~~ 253 (291)
T cd06639 178 LTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN--PPP-TL 253 (291)
T ss_pred cccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC--CCC-CC
Confidence 543221 122346788999999875422 3688999999999999999999999887665555444321 110 00
Q ss_pred hhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccC
Q 005289 357 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417 (704)
Q Consensus 357 w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~ 417 (704)
.....++..+.+||.+||..||++||++.++|+||||+
T Consensus 254 -----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 254 -----------------------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred -----------------------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 00124567899999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=337.38 Aligned_cols=261 Identities=29% Similarity=0.514 Sum_probs=209.2
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC--------hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE--------PESVRFMAREILILRRLDHPNIIKLEGLITSRL 202 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~--------~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 202 (704)
+|.+.+.||.|+||.||+|.+..+++.||||.+...... ....+.+.+|+.+|+.++||||+++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-- 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--
Confidence 488899999999999999999999999999998643211 1123457789999999999999999999877
Q ss_pred CCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccC
Q 005289 203 SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (704)
Q Consensus 203 ~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~ 282 (704)
...+++||||+.++.+..+......+++..++.++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 80 EEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred CCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 56899999999987666555555679999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCC-CcccccccccccCcccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhcc
Q 005289 283 TGHRQ-PLTSRVVTLWYRPPELLLGAT-DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (704)
Q Consensus 283 ~~~~~-~~~~~~gT~~Y~APEvl~~~~-~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~ 360 (704)
..... ......++..|+|||++.... .++.++|||||||++|+|++|..||......+.+..+......++
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------- 232 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPP------- 232 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCc-------
Confidence 22111 123345788999999987533 478999999999999999999999976555444433321110000
Q ss_pred CCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
+ .......++..+.+||.+||.+||.+|||+.++|+||||
T Consensus 233 -------------~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 233 -------------I---PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred -------------C---CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 0 011234678999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=341.82 Aligned_cols=245 Identities=20% Similarity=0.193 Sum_probs=204.4
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeEEEee--cCCCeEEEEEec
Q 005289 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITS--RLSCSIYLVFEY 212 (704)
Q Consensus 136 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~--~~~~~~~LV~Ey 212 (704)
..||+|+++.||+|.. +|+.||||++...... ....+.+.+|+.+|.+++|||||++++++.+ .....+||||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6799999999999987 7899999999765432 2335667899999999999999999999876 434678999999
Q ss_pred ccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhc-CcccccCCCccEEEccCCceEEeccccccccCCCCCCCccc
Q 005289 213 MEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 291 (704)
Q Consensus 213 ~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~-gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~ 291 (704)
+.++.+..+......+++.....++.||+.||.|||+. +++||||||+|||+++++.+||+|||++...... ...
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~----~~~ 179 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP----PFK 179 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc----ccc
Confidence 99987776666666789999999999999999999984 9999999999999999999999999999765432 123
Q ss_pred ccccccccCcccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCC
Q 005289 292 RVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 370 (704)
Q Consensus 292 ~~gT~~Y~APEvl~~~-~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~ 370 (704)
.++|+.|+|||++.+. ..|+.++|||||||++|||++|..||.+.+..+.+..+......++
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~----------------- 242 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK----------------- 242 (283)
T ss_pred ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC-----------------
Confidence 5678999999998642 4689999999999999999999999998887777766654221111
Q ss_pred CCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 371 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 371 ~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
....++..+.+||.+||+.||++|||+.++|+.
T Consensus 243 ----------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~ 275 (283)
T PHA02988 243 ----------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYN 275 (283)
T ss_pred ----------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 012568899999999999999999999999853
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=331.87 Aligned_cols=259 Identities=31% Similarity=0.508 Sum_probs=212.1
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 210 (704)
+|.+.+.||.|+||.||++.+..+++.||||.+..........+.+.+|+.+++.++|+||+++++++.. ...+++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH--REKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec--CCEEEEEE
Confidence 5899999999999999999999899999999998766555567788999999999999999999998876 57899999
Q ss_pred ecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCc-
Q 005289 211 EYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL- 289 (704)
Q Consensus 211 Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~- 289 (704)
||+.++.+..+......+++..+..++.||+.||.|||++||+|+||+|+||++++++.+||+|||++...........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence 9999877776665556689999999999999999999999999999999999999999999999999977654322111
Q ss_pred --ccccccccccCcccccCCC--CCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 290 --TSRVVTLWYRPPELLLGAT--DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 290 --~~~~gT~~Y~APEvl~~~~--~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
....+++.|+|||++.+.. .++.++|||||||++|+|++|.+||............... +..+.
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~----------- 226 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPP----------- 226 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCCC-----------
Confidence 1345688999999987532 3788999999999999999999999765432222221111 11110
Q ss_pred ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
...+..++..+.+||.+||..||.+|||+.+++.|||+
T Consensus 227 -------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 227 -------------IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred -------------CCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00123468889999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=345.91 Aligned_cols=258 Identities=25% Similarity=0.428 Sum_probs=213.0
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 210 (704)
.|.....||.|+||.||++.+..++..||||.+.... ....+.+.+|+.+++.++||||+++++.+.. ....|+||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~lv~ 98 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLV--GDELWVVM 98 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheec--CCeEEEEE
Confidence 4666788999999999999999999999999986533 3345667899999999999999999999876 57899999
Q ss_pred ecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCcc
Q 005289 211 EYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 290 (704)
Q Consensus 211 Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~ 290 (704)
||++++.+..+... ..+++..+..++.||+.||.|||++||+||||||+|||+++++.++|+|||++....... ....
T Consensus 99 e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~ 176 (292)
T cd06658 99 EFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKRK 176 (292)
T ss_pred eCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-ccCc
Confidence 99998776655433 368999999999999999999999999999999999999999999999999987554322 2233
Q ss_pred cccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCC
Q 005289 291 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 370 (704)
Q Consensus 291 ~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~ 370 (704)
...+++.|+|||++.+ ..++.++|||||||++|+|++|..||...+....+..+.......
T Consensus 177 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~------------------ 237 (292)
T cd06658 177 SLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPR------------------ 237 (292)
T ss_pred eeecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCc------------------
Confidence 4567999999998865 568899999999999999999999999877766655543321100
Q ss_pred CCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCC
Q 005289 371 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (704)
Q Consensus 371 ~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~ 421 (704)
......++..+.+||.+||..||.+|||+.++|+||||...+.
T Consensus 238 --------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~ 280 (292)
T cd06658 238 --------VKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGP 280 (292)
T ss_pred --------cccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCC
Confidence 0011246788999999999999999999999999999996544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=343.30 Aligned_cols=256 Identities=30% Similarity=0.494 Sum_probs=212.9
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
..|.+++.||.|+||+||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++.+ ....||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~--~~~~~l 92 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR--EHTAWL 92 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe--CCeEEE
Confidence 469999999999999999999999999999999875432 34445668899999999999999999999987 467899
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
||||+.+.+...+......+++..+..++.||+.||.|||++||+|+||+|+||++++++.+||+|||++......
T Consensus 93 v~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---- 168 (307)
T cd06607 93 VMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---- 168 (307)
T ss_pred EHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC----
Confidence 9999998776666544557899999999999999999999999999999999999999999999999998765432
Q ss_pred cccccccccccCcccccC--CCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcc
Q 005289 289 LTSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~--~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~ 366 (704)
....+++.|+|||++.. ...++.++|||||||++|+|++|.+||...+....+..+.. ..++.
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~--~~~~~------------ 233 (307)
T cd06607 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--NDSPT------------ 233 (307)
T ss_pred -CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc--CCCCC------------
Confidence 33467889999998752 35688899999999999999999999988766554444321 01100
Q ss_pred cCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
.....++..+.+||.+||..||.+|||+.+++.||||...
T Consensus 234 -------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 234 -------------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred -------------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 0012367789999999999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=337.51 Aligned_cols=252 Identities=20% Similarity=0.275 Sum_probs=204.8
Q ss_pred cCCeeEEEEeeccCceEEEEEEEC---CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCe
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDL---DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (704)
..+|++.+.||+|+||.||+|.+. ..+..||+|++.... .......+.+|+.+|.+++||||+++++++.. ...
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~ 80 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITR--GNT 80 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec--CCC
Confidence 457999999999999999999765 456789999997543 23445668889999999999999999999876 568
Q ss_pred EEEEEeccccccccccc-CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 206 IYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~-~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
+||||||++++.+..+. .....+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||.+......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999997776544 33457899999999999999999999999999999999999999999999999987654322
Q ss_pred CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCC
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
.........++..|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+.+..+......+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~----------- 228 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLP----------- 228 (266)
T ss_pred chhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC-----------
Confidence 1111112234678999998876 678999999999999999775 999999888877766664321100
Q ss_pred CcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
....++..+.+||.+||..+|.+|||+.++++
T Consensus 229 -----------------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 229 -----------------APRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred -----------------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 11357889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=357.20 Aligned_cols=281 Identities=30% Similarity=0.517 Sum_probs=228.7
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC------CCCceeEeEEEeecC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD------HPNIIKLEGLITSRL 202 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~------HpnIv~l~~~~~~~~ 202 (704)
..+|.+.-..|+|-|++|..|.+...|..||||+|+.... ..+.=+.|++||++|. --|+++|+..|..
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~---M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h-- 505 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV---MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH-- 505 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH---HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh--
Confidence 4589999999999999999999999999999999986532 2333457999999994 3488999888876
Q ss_pred CCeEEEEEecccccccccccC--CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccC-CceEEecccccc
Q 005289 203 SCSIYLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLAN 279 (704)
Q Consensus 203 ~~~~~LV~Ey~~g~ll~~~~~--~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~-g~iKL~DFGla~ 279 (704)
.+++|||||-+.-+|...+.. .+..|....++.|++||+.||..|-.+||+|.||||.||||++. ..+||||||.|.
T Consensus 506 knHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~ 585 (752)
T KOG0670|consen 506 KNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSAS 585 (752)
T ss_pred cceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccc
Confidence 579999999998877766643 33458889999999999999999999999999999999999876 468999999998
Q ss_pred ccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhc
Q 005289 280 FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359 (704)
Q Consensus 280 ~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~ 359 (704)
..... ..+.+..+..|+|||++++ ..|+...|+||+||+||||.||+-+|+|.++..++.-++.+-|.+|.....+
T Consensus 586 ~~~en---eitPYLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRK 661 (752)
T KOG0670|consen 586 FASEN---EITPYLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRK 661 (752)
T ss_pred ccccc---cccHHHHHHhccCcceeec-CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhh
Confidence 77654 3567788999999999998 7799999999999999999999999999999999999999999999876665
Q ss_pred cCCCCcccC----------------------CCCCC---CCchhhhh------ccCCCHHHHHHHHHhhccCCCCCcCHH
Q 005289 360 SKLPHATLF----------------------KPQQP---YDSSLRET------FKDLPTTAVNLIETLLSVEPYKRATAS 408 (704)
Q Consensus 360 ~~~~~~~~~----------------------~~~~~---~~~~l~~~------~~~~s~~~~dLI~~mL~~dP~kRpTa~ 408 (704)
..+....+. ....| +...|... -..+-..+.+||.+||.+||++|+|+.
T Consensus 662 gqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~n 741 (752)
T KOG0670|consen 662 GQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVN 741 (752)
T ss_pred cchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHH
Confidence 443221110 01111 11111110 011224589999999999999999999
Q ss_pred HHHhccccCC
Q 005289 409 AALASEYFST 418 (704)
Q Consensus 409 e~L~hpwf~~ 418 (704)
++|+||||+.
T Consensus 742 qAL~HpFi~~ 751 (752)
T KOG0670|consen 742 QALKHPFITE 751 (752)
T ss_pred HHhcCCcccC
Confidence 9999999985
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=341.76 Aligned_cols=283 Identities=32% Similarity=0.558 Sum_probs=234.6
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC----CCe
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL----SCS 205 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----~~~ 205 (704)
.+|.-++.+|.|.- .|..|.|..+++.||+|++..........+...+|..++..+.|+||++++.+|+... ...
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 47999999999998 8999999999999999998766544556677889999999999999999999997532 235
Q ss_pred EEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
+|+|||||..++...+. ..+.-..+..|+.|++.|+.|||+.||+||||||+||++..++.+||.|||+|+.....
T Consensus 96 ~y~v~e~m~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~- 171 (369)
T KOG0665|consen 96 VYLVMELMDANLCQVIL---MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD- 171 (369)
T ss_pred HHHHHHhhhhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc-
Confidence 79999999998776654 34677889999999999999999999999999999999999999999999999866554
Q ss_pred CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
-.++.++.|..|+|||++.+.+ |.+.+||||+|||+.||++|+-+|.|.+-.+++.+|.+.+|.|.+.+..+..-..+
T Consensus 172 -~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r 249 (369)
T KOG0665|consen 172 -FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR 249 (369)
T ss_pred -cccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence 3568889999999999999855 99999999999999999999999999999999999999999999888765332222
Q ss_pred ccCCCCCCCC-chhhhhc------------cCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 366 TLFKPQQPYD-SSLRETF------------KDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 366 ~~~~~~~~~~-~~l~~~~------------~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
.+......|. ..+.+.| +.-+..+.||+.+||..||++|++++++|+||||+-|
T Consensus 250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw 316 (369)
T KOG0665|consen 250 NYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVW 316 (369)
T ss_pred HHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeee
Confidence 2211111111 1111111 1224568999999999999999999999999999844
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=337.80 Aligned_cols=259 Identities=29% Similarity=0.446 Sum_probs=206.4
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEee---cCC
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITS---RLS 203 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~---~~~ 203 (704)
..++|++++.||.|+||+||+|.+..+++.||+|++.... .....+.+|+.+++.+ +||||+++++++.. ...
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 92 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG 92 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence 3568999999999999999999999999999999986432 1234567899999999 79999999998753 234
Q ss_pred CeEEEEEeccccccccccc----CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEecccccc
Q 005289 204 CSIYLVFEYMEHDITGLLS----CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN 279 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~~~----~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~ 279 (704)
..+||||||++++.+..+. .....+++..++.++.||+.||.|||+++|+||||||+||+++.++.+||+|||++.
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~ 172 (286)
T cd06638 93 DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA 172 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCcee
Confidence 6789999999986655432 234568999999999999999999999999999999999999999999999999997
Q ss_pred ccCCCCCCCcccccccccccCcccccC----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCch
Q 005289 280 FSNTGHRQPLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 355 (704)
Q Consensus 280 ~~~~~~~~~~~~~~gT~~Y~APEvl~~----~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~ 355 (704)
...... .......+++.|+|||++.. ...|+.++|||||||++|+|++|.+||........+.++... .++
T Consensus 173 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~--~~~-- 247 (286)
T cd06638 173 QLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN--PPP-- 247 (286)
T ss_pred ecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc--CCC--
Confidence 654322 22234468999999998753 245788999999999999999999999876654443332110 000
Q ss_pred hhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 356 ~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
.. .....++..+.+||.+||..||++|||+.++|+|+||
T Consensus 248 ----------~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 248 ----------TL------------HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred ----------cc------------cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 00 0012357789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=342.24 Aligned_cols=259 Identities=22% Similarity=0.280 Sum_probs=200.7
Q ss_pred cCCeeEEEEeeccCceEEEEEEECC----------------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCce
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLD----------------TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~----------------~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 192 (704)
.++|++.++||+|+||.||+|.+.. ++..||||++.... .......+.+|+.+|.+++||||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCee
Confidence 4579999999999999999998532 34579999987543 344456788999999999999999
Q ss_pred eEeEEEeecCCCeEEEEEecccccccccccCC-------------------CccccHHHHHHHHHHhhhhHHHHHhcCcc
Q 005289 193 KLEGLITSRLSCSIYLVFEYMEHDITGLLSCP-------------------DIKFSEAQIKCYMNQLLHGLEHCHSRGVL 253 (704)
Q Consensus 193 ~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~-------------------~~~l~e~~~~~i~~QIl~aL~yLH~~gIv 253 (704)
++++++.+ ...+||||||+.++.+..+... ...+++..+..++.||+.||.|||++||+
T Consensus 83 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 83 RLLGVCVD--EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred EEEEEEec--CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 99999987 4678999999988655433211 12467888999999999999999999999
Q ss_pred cccCCCccEEEccCCceEEeccccccccCCCCCC-CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh--CC
Q 005289 254 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI--GK 330 (704)
Q Consensus 254 HrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~-~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt--G~ 330 (704)
||||||+||||+.++.+||+|||++......... ......++..|+|||++.. ..++.++|||||||++|+|++ +.
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHHHHHccCC
Confidence 9999999999999999999999999765433211 1122345788999999875 568999999999999999986 56
Q ss_pred CCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHH
Q 005289 331 PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 410 (704)
Q Consensus 331 ~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~ 410 (704)
.||...+..+.+..+...+-..... .+ ......++..+.+||.+||..||.+|||+.++
T Consensus 240 ~p~~~~~~~~~~~~~~~~~~~~~~~-----------~~----------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i 298 (304)
T cd05096 240 QPYGELTDEQVIENAGEFFRDQGRQ-----------VY----------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDI 298 (304)
T ss_pred CCCCcCCHHHHHHHHHHHhhhcccc-----------cc----------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHH
Confidence 7888777666665554321110000 00 00113578899999999999999999999999
Q ss_pred Hh
Q 005289 411 LA 412 (704)
Q Consensus 411 L~ 412 (704)
.+
T Consensus 299 ~~ 300 (304)
T cd05096 299 HA 300 (304)
T ss_pred HH
Confidence 53
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=331.15 Aligned_cols=255 Identities=32% Similarity=0.492 Sum_probs=211.4
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC---ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF---EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~---~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 207 (704)
+|+..+.||.|+||+||+|.+..+++.||+|.+..... ..+..+.+.+|+.+|+.++|+||+++++++.. ...+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~ 78 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE--EDNLY 78 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec--CCeEE
Confidence 47788999999999999999988999999999876432 23456678899999999999999999998876 56899
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCC
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~ 287 (704)
+||||+++..+..+......+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-- 156 (258)
T cd06632 79 IFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-- 156 (258)
T ss_pred EEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence 999999987666555555568999999999999999999999999999999999999999999999999987654332
Q ss_pred CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCccc
Q 005289 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (704)
Q Consensus 288 ~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~ 367 (704)
......+++.|+|||.+.....++.++|+|||||++|+|++|.+||......+...++.... ..
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~--------------- 220 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK-EL--------------- 220 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc-cC---------------
Confidence 22445678999999998653348899999999999999999999998766555444432211 00
Q ss_pred CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
......++..+.+||.+||..||.+|||+.++|.||||
T Consensus 221 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 221 -----------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred -----------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 01123578899999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=342.12 Aligned_cols=261 Identities=20% Similarity=0.329 Sum_probs=206.8
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeEEEeecCCCeEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~~~L 208 (704)
++|+.+..||+|+||.||++.+..+++.||||++...... .....+.+|+.+|.++. ||||+++++++.. ....++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~--~~~~~~ 80 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFR--EGDCWI 80 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEec--CCcEEE
Confidence 4688889999999999999999999999999999765433 44556788999999995 9999999998876 467899
Q ss_pred EEecccccccccc----cCCCccccHHHHHHHHHHhhhhHHHHHhc-CcccccCCCccEEEccCCceEEeccccccccCC
Q 005289 209 VFEYMEHDITGLL----SCPDIKFSEAQIKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (704)
Q Consensus 209 V~Ey~~g~ll~~~----~~~~~~l~e~~~~~i~~QIl~aL~yLH~~-gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~ 283 (704)
+|||+...+.... ......+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 81 CMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred EEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 9999986433221 12335789999999999999999999975 999999999999999999999999999975543
Q ss_pred CCCCCcccccccccccCcccccCC--CCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccC
Q 005289 284 GHRQPLTSRVVTLWYRPPELLLGA--TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (704)
Q Consensus 284 ~~~~~~~~~~gT~~Y~APEvl~~~--~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~ 361 (704)
.. ......+++.|+|||++.+. ..++.++|||||||++|+|++|++||.... .....+.+.....+...
T Consensus 161 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~----- 231 (288)
T cd06616 161 SI--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDPPIL----- 231 (288)
T ss_pred CC--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCCCCcC-----
Confidence 21 12334678899999998764 368999999999999999999999997654 22233322221111000
Q ss_pred CCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
. ......++.++.+||.+||..||++|||+.+++.||||+.
T Consensus 232 -----------~-----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 232 -----------S-----NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred -----------C-----CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 0 0111357889999999999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=333.42 Aligned_cols=252 Identities=27% Similarity=0.389 Sum_probs=208.6
Q ss_pred eeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEeccccc
Q 005289 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD 216 (704)
Q Consensus 138 LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~ 216 (704)
||.|+||.||+|++..+++.||+|++...... ....+.+.+|+.+++.++||||+++++++.+ ...+|+||||+.++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD--KKYIYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc--CCccEEEEecCCCC
Confidence 69999999999999999999999999765432 3445678899999999999999999999876 57899999999987
Q ss_pred ccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCcccccccc
Q 005289 217 ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 296 (704)
Q Consensus 217 ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~~~gT~ 296 (704)
.+..+......+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... ......+++
T Consensus 79 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~ 156 (262)
T cd05572 79 ELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGTP 156 (262)
T ss_pred cHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCCc
Confidence 766665555678999999999999999999999999999999999999999999999999997665432 123346789
Q ss_pred cccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCC
Q 005289 297 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT--EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY 374 (704)
Q Consensus 297 ~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~--~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~ 374 (704)
.|++||.+.. ..++.++|||||||++|+|++|.+||.... ..+.+.++......++
T Consensus 157 ~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------- 214 (262)
T cd05572 157 EYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLE--------------------- 214 (262)
T ss_pred CccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCC---------------------
Confidence 9999998865 568899999999999999999999998776 4455555432111100
Q ss_pred CchhhhhccCCCHHHHHHHHHhhccCCCCCcC-----HHHHHhccccCCCCC
Q 005289 375 DSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPY 421 (704)
Q Consensus 375 ~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpT-----a~e~L~hpwf~~~~~ 421 (704)
....++.++.+||.+||..||.+||| +.|+++||||+...|
T Consensus 215 ------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 260 (262)
T cd05572 215 ------FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW 260 (262)
T ss_pred ------CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCC
Confidence 01234788999999999999999999 999999999986443
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=339.76 Aligned_cols=252 Identities=25% Similarity=0.388 Sum_probs=199.3
Q ss_pred EeeccCceEEEEEEECCCCcEEEEEEeecCCCChH-HHHHHHHHHHHHH---hcCCCCceeEeEEEeecCCCeEEEEEec
Q 005289 137 KIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPE-SVRFMAREILILR---RLDHPNIIKLEGLITSRLSCSIYLVFEY 212 (704)
Q Consensus 137 ~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~-~~~~~~~Ei~iL~---~L~HpnIv~l~~~~~~~~~~~~~LV~Ey 212 (704)
.||+|+||.||++.+..+++.||||.+........ ......+|..+++ ..+||||+.+++++.. ...+|+||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT--PDKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec--CCeEEEEEec
Confidence 48999999999999999999999999976543322 1223344544444 3479999999998877 4689999999
Q ss_pred ccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCcccc
Q 005289 213 MEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 292 (704)
Q Consensus 213 ~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~~ 292 (704)
+.++.+..+......+++..+..++.||+.||.|||+++|+||||||+|||++.++.++|+|||++....... ....
T Consensus 79 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~ 155 (279)
T cd05633 79 MNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHAS 155 (279)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---ccCc
Confidence 9987776665555679999999999999999999999999999999999999999999999999987554321 2334
Q ss_pred cccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCCCCchhhhccCCCCcccCCC
Q 005289 293 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV--EQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 370 (704)
Q Consensus 293 ~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~--e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~ 370 (704)
.+|+.|+|||++.....++.++|||||||++|+|++|..||...... ..+..+.. ..+
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~---~~~----------------- 215 (279)
T cd05633 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---TVN----------------- 215 (279)
T ss_pred CCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh---cCC-----------------
Confidence 68999999999865456889999999999999999999999764321 11211110 000
Q ss_pred CCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCc-----CHHHHHhccccCCCCC
Q 005289 371 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 421 (704)
Q Consensus 371 ~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRp-----Ta~e~L~hpwf~~~~~ 421 (704)
......++.++.+||.+||..||.+|+ |+.++++||||+...+
T Consensus 216 --------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~ 263 (279)
T cd05633 216 --------VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDW 263 (279)
T ss_pred --------cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCH
Confidence 011245788999999999999999999 6999999999987544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=333.75 Aligned_cols=253 Identities=29% Similarity=0.489 Sum_probs=209.0
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
++|++.+.||.|+||.||+|.+..+++.||+|.+.... ....+.+|+.+++.++||||+++++++.+ ...+|+|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l~ 76 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFK--NTDLWIV 76 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCcEEEE
Confidence 57999999999999999999999889999999986532 25678899999999999999999999987 4789999
Q ss_pred Eeccccccccccc-CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 210 FEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 210 ~Ey~~g~ll~~~~-~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
+||+.+..+..+. .....+++..++.++.||+.||.|||+.+|+|+||+|+||+++.++.++|+|||++........ .
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-K 155 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-c
Confidence 9999986665443 3355789999999999999999999999999999999999999999999999999986654321 2
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccC
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~ 368 (704)
.....++..|+|||++.+ ..++.++|||||||++|+|++|++||...........+.. ..+. .
T Consensus 156 ~~~~~~~~~y~~PE~~~~-~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~-~------------ 218 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN---KPPP-T------------ 218 (256)
T ss_pred cccccCCccccCHHHHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc---CCCC-C------------
Confidence 233457889999999876 5688999999999999999999999987655443332211 0000 0
Q ss_pred CCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 369 ~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
......++..+.+||.+||..||.+|||+.++|.||||
T Consensus 219 ----------~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 219 ----------LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred ----------CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 00113467889999999999999999999999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=337.70 Aligned_cols=251 Identities=25% Similarity=0.371 Sum_probs=200.3
Q ss_pred EeeccCceEEEEEEECCCCcEEEEEEeecCCCChH-HHHHHHHHH---HHHHhcCCCCceeEeEEEeecCCCeEEEEEec
Q 005289 137 KIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPE-SVRFMAREI---LILRRLDHPNIIKLEGLITSRLSCSIYLVFEY 212 (704)
Q Consensus 137 ~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~-~~~~~~~Ei---~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey 212 (704)
.||+|+||+||+|++..+++.||+|++........ .......|. .+++.+.||||+++++++.+ ...+|+||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PDKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCEEEEEEec
Confidence 38999999999999999999999999976543311 112223343 44555689999999999887 4689999999
Q ss_pred ccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCcccc
Q 005289 213 MEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 292 (704)
Q Consensus 213 ~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~~ 292 (704)
+.++.+..+......+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++...... .....
T Consensus 79 ~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~---~~~~~ 155 (278)
T cd05606 79 MNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHAS 155 (278)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc---CCcCc
Confidence 998777666655667999999999999999999999999999999999999999999999999998755432 12345
Q ss_pred cccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCCchhhhccCCCCcccCC
Q 005289 293 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV---EQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (704)
Q Consensus 293 ~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~---e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~ 369 (704)
+++..|+|||++.+...++.++|||||||++|+|++|++||...... .....+.. ..
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~----------------- 215 (278)
T cd05606 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT---MA----------------- 215 (278)
T ss_pred CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc---cC-----------------
Confidence 78999999999876556899999999999999999999999876322 21111110 00
Q ss_pred CCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCc-----CHHHHHhccccCCCCC
Q 005289 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 421 (704)
Q Consensus 370 ~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRp-----Ta~e~L~hpwf~~~~~ 421 (704)
......++..+.+||.+||..||.+|| ++.++|+||||+...|
T Consensus 216 ---------~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~ 263 (278)
T cd05606 216 ---------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDW 263 (278)
T ss_pred ---------CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCc
Confidence 011134688999999999999999999 9999999999987554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=339.28 Aligned_cols=258 Identities=25% Similarity=0.380 Sum_probs=211.1
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEE
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 207 (704)
+.++|++++.||+|+||+||++.+..+++.||+|++.... .....+.+.+|+++++.++||||+++++++.. ...+|
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~ 79 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLN--ENNIC 79 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEec--CCEEE
Confidence 3467999999999999999999999999999999987543 23445678899999999999999999999987 47899
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHh-cCcccccCCCccEEEccCCceEEeccccccccCCCCC
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~-~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~ 286 (704)
|||||++++.+..+......+++..+..++.||+.+|.|||+ .+|+|+||||+|||+++++.++|+|||++.......
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 80 MCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred EEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 999999997777665555678999999999999999999997 699999999999999999999999999986543221
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHH-----------HHHHHHHHHcCCCCch
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV-----------EQLHKIFKLCGSPPDD 355 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~-----------e~l~~I~~~~g~~p~~ 355 (704)
....+++..|+|||++.+ ..++.++|||||||++|+|++|.+||...... +.+..+.. ..+.
T Consensus 159 --~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~- 231 (284)
T cd06620 159 --ADTFVGTSTYMSPERIQG-GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ---EPPP- 231 (284)
T ss_pred --cCccccCcccCCHHHHcc-CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh---ccCC-
Confidence 123467999999999876 46889999999999999999999999865442 11111111 0000
Q ss_pred hhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 356 ~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
. .....++..+.+||.+||..||.+|||+.++++|+||.+.
T Consensus 232 -----------------~------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 232 -----------------R------LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred -----------------C------CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 0 0012367889999999999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=336.40 Aligned_cols=262 Identities=27% Similarity=0.398 Sum_probs=208.0
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
++|++.++||.|++|.||+|.+..+++.||+|.+..... ......+.+|+++|+.++||||++++++|.......+|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 369999999999999999999999999999999975432 2445668889999999999999999999876556689999
Q ss_pred Eecccccccccc----cCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 210 FEYMEHDITGLL----SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 210 ~Ey~~g~ll~~~----~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
|||++++.+..+ ......+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 999998655433 2234568999999999999999999999999999999999999999999999999987554321
Q ss_pred CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHcCCCCchhhhcc
Q 005289 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT-----EVEQLHKIFKLCGSPPDDYWKKS 360 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~-----~~e~l~~I~~~~g~~p~~~w~~~ 360 (704)
.....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.... ..+....+.. .....
T Consensus 160 ---~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~----- 227 (287)
T cd06621 160 ---AGTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN---MPNPE----- 227 (287)
T ss_pred ---cccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc---CCchh-----
Confidence 123456889999998875 568999999999999999999999998652 2222222211 00000
Q ss_pred CCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
+ ...+ ..-..+++.+.+||.+||..||.+|||+.|++.||||+.
T Consensus 228 -~-------~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 271 (287)
T cd06621 228 -L-------KDEP------GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA 271 (287)
T ss_pred -h-------ccCC------CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccc
Confidence 0 0000 000134678999999999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=337.82 Aligned_cols=255 Identities=26% Similarity=0.387 Sum_probs=203.6
Q ss_pred eeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEeccccc
Q 005289 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD 216 (704)
Q Consensus 138 LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~ 216 (704)
||.|+||+||+|.+..+++.||+|++...... ......+.+|+++|+.++||||+++++++.. ...+||||||++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET--KDDLCLVMTLMNGG 78 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec--CCeEEEEEecCCCC
Confidence 68999999999999999999999999764332 2234456689999999999999999999877 46899999999986
Q ss_pred ccccccCCC--ccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCcccccc
Q 005289 217 ITGLLSCPD--IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 294 (704)
Q Consensus 217 ll~~~~~~~--~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~~~g 294 (704)
.+..+.... ..+++..+..++.||+.||.|||++||+|+||+|+|||+++++.+||+|||++...... .......+
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~ 156 (277)
T cd05577 79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGRAG 156 (277)
T ss_pred cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC--CccccccC
Confidence 665443322 36899999999999999999999999999999999999999999999999998765432 22234567
Q ss_pred cccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCC
Q 005289 295 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY 374 (704)
Q Consensus 295 T~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~ 374 (704)
+..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+....-..+
T Consensus 157 ~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------------- 214 (277)
T cd05577 157 TPGYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMA--------------------- 214 (277)
T ss_pred CCCcCCHHHhcC-CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccccc---------------------
Confidence 889999999876 4488999999999999999999999977554222222211100000
Q ss_pred CchhhhhccCCCHHHHHHHHHhhccCCCCCc-----CHHHHHhccccCCCCCC
Q 005289 375 DSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPYA 422 (704)
Q Consensus 375 ~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRp-----Ta~e~L~hpwf~~~~~~ 422 (704)
......+++.+.+||.+||..||.+|| ++.++|.||||....|.
T Consensus 215 ----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~ 263 (277)
T cd05577 215 ----VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWR 263 (277)
T ss_pred ----ccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChh
Confidence 011235689999999999999999999 99999999999876553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=337.00 Aligned_cols=253 Identities=23% Similarity=0.352 Sum_probs=206.4
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCC-----cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTG-----KIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g-----~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 203 (704)
.++|++++.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+|..++||||+++++++.. .
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--~ 80 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK--E 80 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC--C
Confidence 457999999999999999999876555 689999986443 34445668899999999999999999999876 4
Q ss_pred CeEEEEEecccccccccccCCC----------------ccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccC
Q 005289 204 CSIYLVFEYMEHDITGLLSCPD----------------IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE 267 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~~~~~~----------------~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~ 267 (704)
...|++|||++++.+..+.... ..+++..+..++.||+.||.|||++||+|+||||+|||++++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 6789999999876554332211 458889999999999999999999999999999999999999
Q ss_pred CceEEeccccccccCCCCC-CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 005289 268 GVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKI 345 (704)
Q Consensus 268 g~iKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I 345 (704)
+.+||+|||++........ .......+++.|+|||.+.+ ..++.++|||||||+||||++ |..||.+....+....|
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999976543221 12233456889999998875 568999999999999999998 99999988877766665
Q ss_pred HHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 346 FKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 346 ~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
... ..+ .....++.++.+||.+||+.||.+|||+.+++++
T Consensus 240 ~~~--~~~--------------------------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 240 RSR--QLL--------------------------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HcC--CcC--------------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 431 110 0113678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=336.37 Aligned_cols=254 Identities=27% Similarity=0.407 Sum_probs=208.3
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 210 (704)
+|++.+.||.|+||.||+|.+..+++.||+|.+..... ......+.+|+++++.++||||+++++++.. ...+||||
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ 78 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYN--NGDISICM 78 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeec--CCEEEEEE
Confidence 68889999999999999999999999999999976543 3445667889999999999999999999877 47899999
Q ss_pred ecccccccccccCC-CccccHHHHHHHHHHhhhhHHHHHh-cCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 211 EYMEHDITGLLSCP-DIKFSEAQIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 211 Ey~~g~ll~~~~~~-~~~l~e~~~~~i~~QIl~aL~yLH~-~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
||+.+..+..+... ...+++..+..++.||+.+|.|||+ .||+|+||||+||++++++.++|+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 156 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-- 156 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--
Confidence 99997655544433 3678999999999999999999999 9999999999999999999999999999876543211
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHcCCCCchhhhccCCC
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT-----EVEQLHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~-----~~e~l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.... ..+.+..+.. ..+..
T Consensus 157 -~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~-------- 223 (265)
T cd06605 157 -KTFVGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN---EPPPR-------- 223 (265)
T ss_pred -hcccCChhccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc---CCCCC--------
Confidence 12567889999999876 578999999999999999999999997542 2233333221 11000
Q ss_pred CcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
+. ...++.++.+||.+||..||.+|||+.++|.||||+.
T Consensus 224 --------------~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 224 --------------LP--SGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred --------------CC--hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 00 0127888999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=342.48 Aligned_cols=258 Identities=26% Similarity=0.464 Sum_probs=213.0
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 210 (704)
.|....+||.|+||.||++.+..+++.||||++..... ...+.+.+|+.+|+.++||||+++++++.. ...+|+||
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~iv~ 97 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLV--GEELWVLM 97 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheee--CCeEEEEE
Confidence 46666789999999999999999999999999875432 234557789999999999999999999877 57899999
Q ss_pred ecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCcc
Q 005289 211 EYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 290 (704)
Q Consensus 211 Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~ 290 (704)
||++++.+..+... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... ....
T Consensus 98 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~ 175 (297)
T cd06659 98 EFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRK 175 (297)
T ss_pred ecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-cccc
Confidence 99998766655433 468999999999999999999999999999999999999999999999999987554322 2223
Q ss_pred cccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCC
Q 005289 291 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 370 (704)
Q Consensus 291 ~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~ 370 (704)
..++++.|+|||++.+ ..++.++|||||||++|+|++|++||...+..+.+..+.. .++ ..
T Consensus 176 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~-~~-------------- 236 (297)
T cd06659 176 SLVGTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD---SPP-PK-------------- 236 (297)
T ss_pred ceecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---cCC-CC--------------
Confidence 4567999999999876 5689999999999999999999999988777666655432 110 00
Q ss_pred CCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCC
Q 005289 371 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (704)
Q Consensus 371 ~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~ 421 (704)
......++..+.++|.+||..||.+|||+.++++||||.+...
T Consensus 237 --------~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 237 --------LKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGL 279 (297)
T ss_pred --------ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence 0112357888999999999999999999999999999987544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=329.72 Aligned_cols=254 Identities=27% Similarity=0.470 Sum_probs=209.4
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 210 (704)
+|++.+.||.|+||.||++.+..++..||+|.+..........+.+.+|+.+++.++|+||+++++.+.. ...+|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE--NGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc--CCeEEEEE
Confidence 4899999999999999999999999999999997765444455677899999999999999999998876 57899999
Q ss_pred ecccccccccccC--CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCC-ceEEeccccccccCCCCCC
Q 005289 211 EYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQ 287 (704)
Q Consensus 211 Ey~~g~ll~~~~~--~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g-~iKL~DFGla~~~~~~~~~ 287 (704)
||+.+..+..+.. ....+++..+..++.||+.||.|||+++|+|+||||+|||+++++ .+||+|||.+....... .
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~ 157 (257)
T cd08225 79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM-E 157 (257)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc-c
Confidence 9998855544332 233579999999999999999999999999999999999999886 46999999997665332 2
Q ss_pred CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCccc
Q 005289 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (704)
Q Consensus 288 ~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~ 367 (704)
......+++.|+|||++.. ..++.++|||||||++|+|++|.+||...+..+.+..+... ..
T Consensus 158 ~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~--------------- 219 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQG--YF--------------- 219 (257)
T ss_pred cccccCCCccccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc--cC---------------
Confidence 2233467889999998865 45889999999999999999999999877765555444321 00
Q ss_pred CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
....+.++.++.++|.+||..+|++|||+.++|+||||
T Consensus 220 -----------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 220 -----------APISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred -----------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 01113577899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=369.67 Aligned_cols=254 Identities=23% Similarity=0.402 Sum_probs=204.7
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeE-EEeec---C-
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNIIKLEG-LITSR---L- 202 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~-~~~~~---~- 202 (704)
..+++|.+.|.+|||+.||+|++...|..||+|++... +....+.+.+||++|++|. |+|||.+++ ..... +
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 34689999999999999999999988899999998755 5777888999999999995 999999999 33221 2
Q ss_pred CCeEEEEEecccc-cccccccC-CCccccHHHHHHHHHHhhhhHHHHHhcC--cccccCCCccEEEccCCceEEeccccc
Q 005289 203 SCSIYLVFEYMEH-DITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRG--VLHRDIKGSNLLVNNEGVLKLADFGLA 278 (704)
Q Consensus 203 ~~~~~LV~Ey~~g-~ll~~~~~-~~~~l~e~~~~~i~~QIl~aL~yLH~~g--IvHrDLKp~NILl~~~g~iKL~DFGla 278 (704)
...++|.||||.| ++++.+.. ....|+|.++.+|+.|+++||.+||... |||||||-|||||+.+|++||||||.|
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 2457899999995 77776642 2335999999999999999999999997 999999999999999999999999998
Q ss_pred cccCCCCCCC--------cccccccccccCcccc--cCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 005289 279 NFSNTGHRQP--------LTSRVVTLWYRPPELL--LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 348 (704)
Q Consensus 279 ~~~~~~~~~~--------~~~~~gT~~Y~APEvl--~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~ 348 (704)
+..-...... -.....|+.|+|||++ ......++++|||+|||+||-||....||.......++.--
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~--- 270 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGN--- 270 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEecc---
Confidence 6432221110 0112459999999996 34567899999999999999999999999876554433211
Q ss_pred cCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccc
Q 005289 349 CGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415 (704)
Q Consensus 349 ~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpw 415 (704)
..+| .++.++..+++||+.||..||.+||++-|++.+-+
T Consensus 271 -Y~~P---------------------------~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 271 -YSFP---------------------------PFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred -ccCC---------------------------CCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 1111 12467889999999999999999999999997643
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=329.31 Aligned_cols=255 Identities=31% Similarity=0.475 Sum_probs=212.7
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 210 (704)
+|++.+.||.|+||.||+|.+..+++.||||++...... .....+.+|+.++.+++|+||+++++++.. ...+|+||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~ 78 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYK--EGEISIVL 78 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcc--CCeEEEEE
Confidence 699999999999999999999999999999999765432 445678899999999999999999999877 47899999
Q ss_pred ecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHh-cCcccccCCCccEEEccCCceEEeccccccccCCCCCCCc
Q 005289 211 EYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (704)
Q Consensus 211 Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~-~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~ 289 (704)
||++++.+..+......+++..+..++.||+.+|.|||+ .|++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~-~~ 157 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD-QC 157 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC-cc
Confidence 999987666665555679999999999999999999999 9999999999999999999999999999986654322 22
Q ss_pred ccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHcCCCCchhhhccCCCCcc
Q 005289 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT---EVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (704)
Q Consensus 290 ~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~---~~e~l~~I~~~~g~~p~~~w~~~~~~~~~ 366 (704)
....++..|+|||.+.. ..++.++|||||||++|+|++|.+||.... ..+....+.. ...
T Consensus 158 ~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~~------------- 220 (264)
T cd06623 158 NTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD---GPP------------- 220 (264)
T ss_pred cceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc---CCC-------------
Confidence 24467889999998876 578899999999999999999999998764 3333333321 110
Q ss_pred cCCCCCCCCchhhhhccC-CCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 367 LFKPQQPYDSSLRETFKD-LPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~-~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
...... ++..+.+||.+||..+|++|||+.++|+||||+.
T Consensus 221 ------------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 221 ------------PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred ------------CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 000123 7889999999999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=331.18 Aligned_cols=253 Identities=30% Similarity=0.435 Sum_probs=204.2
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHH-HhcCCCCceeEeEEEeecCCCeEEEEEecc
Q 005289 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILIL-RRLDHPNIIKLEGLITSRLSCSIYLVFEYM 213 (704)
Q Consensus 136 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL-~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~ 213 (704)
+.||.|+||.||+|.+..+++.||||++...... ......+..|..++ ..++|+||+++++++.. ...+|+||||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS--KDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc--CCeEEEEEecc
Confidence 5789999999999999999999999998754332 22233344555544 45589999999999976 57899999999
Q ss_pred cccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCccccc
Q 005289 214 EHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 293 (704)
Q Consensus 214 ~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~~~ 293 (704)
.++.+..+......+++..+..++.||+.||.|||+.+|+|+||+|+|||++.++.+||+|||++..... .....
T Consensus 80 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~~ 154 (260)
T cd05611 80 NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKFV 154 (260)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----cccCC
Confidence 9977776665556789999999999999999999999999999999999999999999999999875432 12345
Q ss_pred ccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCC
Q 005289 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 373 (704)
Q Consensus 294 gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~ 373 (704)
+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||...+....+..+.......+
T Consensus 155 ~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------- 213 (260)
T cd05611 155 GTPDYLAPETILG-VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWP-------------------- 213 (260)
T ss_pred CCcCccChhhhcC-CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCC--------------------
Confidence 7889999999876 4489999999999999999999999998877766665543111100
Q ss_pred CCchhhhhccCCCHHHHHHHHHhhccCCCCCcC---HHHHHhccccCCCCC
Q 005289 374 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT---ASAALASEYFSTKPY 421 (704)
Q Consensus 374 ~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpT---a~e~L~hpwf~~~~~ 421 (704)
......++..+.+||.+||..||++||| +.|+|.||||+...|
T Consensus 214 -----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 214 -----EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred -----CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence 0111357899999999999999999995 579999999986443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=334.57 Aligned_cols=254 Identities=32% Similarity=0.503 Sum_probs=212.7
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcC-CCCceeEeEEEeecCCCeEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLD-HPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~~~L 208 (704)
+|.+.+.||.|+||.||+|.+..+++.||+|++..... .......+.+|+.+++++. ||||+++++++.+ ...+|+
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~l 79 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD--EENLYF 79 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC--CceEEE
Confidence 69999999999999999999999999999999976433 2344566788999999998 9999999998876 578999
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC--
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-- 286 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~-- 286 (704)
||||+.++.+..+......+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 80 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~ 159 (280)
T cd05581 80 VLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE 159 (280)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence 999997766555554555799999999999999999999999999999999999999999999999999876543321
Q ss_pred -----------------CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Q 005289 287 -----------------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 349 (704)
Q Consensus 287 -----------------~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~ 349 (704)
.......++..|+|||++.. ..++.++|||||||++|+|++|++||...+....+..+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 238 (280)
T cd05581 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE 238 (280)
T ss_pred cCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcC
Confidence 11223456889999998876 458889999999999999999999999887666665554321
Q ss_pred CCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCH----HHHHhcccc
Q 005289 350 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA----SAALASEYF 416 (704)
Q Consensus 350 g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa----~e~L~hpwf 416 (704)
.. ....+++.+.+||.+||..||.+|||+ .++|+||||
T Consensus 239 ~~-----------------------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 239 YS-----------------------------FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CC-----------------------------CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 11 113568889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=334.47 Aligned_cols=258 Identities=30% Similarity=0.506 Sum_probs=211.1
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC---CCCceeEeEEEeecCCCeEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD---HPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~---HpnIv~l~~~~~~~~~~~~~ 207 (704)
.|++++.||.|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.+. ||||+++++++.. ...+|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~--~~~~~ 78 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK--GPRLW 78 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee--CCEEE
Confidence 4888999999999999999999999999999987543 2334566788999999996 9999999999876 56899
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCC
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~ 287 (704)
|||||+.++.+..+... ..+++..+..++.||+.+|.|||+.||+|+||+|+||+++.++.++|+|||++....... .
T Consensus 79 lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~ 156 (277)
T cd06917 79 IIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-S 156 (277)
T ss_pred EEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-c
Confidence 99999998766655443 378999999999999999999999999999999999999999999999999997765433 2
Q ss_pred CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCccc
Q 005289 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (704)
Q Consensus 288 ~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~ 367 (704)
......++..|+|||.+.+...++.++|||||||++|+|++|.+||.+.+.......+... .++
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~~-------------- 220 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KPP-------------- 220 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC--CCC--------------
Confidence 2334467899999999876566789999999999999999999999876554333222110 000
Q ss_pred CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCC
Q 005289 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (704)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~ 420 (704)
.+ ....++.++.+||.+||..||++|||+.+++.|+||++..
T Consensus 221 ---------~~--~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 221 ---------RL--EDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred ---------CC--CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 00 0013678899999999999999999999999999998643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=361.10 Aligned_cols=247 Identities=27% Similarity=0.423 Sum_probs=208.0
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCCeEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~ 207 (704)
.+.|++...||.|+|+.|-.+.+..+++.+++|++.... ....+|+.++... +||||+++.+++.+ ..++|
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~~~--~~~~~ 392 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVYED--GKEIY 392 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeecceecC--Cceee
Confidence 567999999999999999999999999999999997652 1234578776666 89999999999988 68899
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEE-ccCCceEEeccccccccCCCCC
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV-NNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl-~~~g~iKL~DFGla~~~~~~~~ 286 (704)
+|||++.++.+...+.....+. .++..|+.||+.||.|||++|||||||||+|||+ ++.++|+|+|||.++.....
T Consensus 393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 9999999976665544444444 8888999999999999999999999999999999 58899999999999877653
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV-EQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~-e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
+.+.+-|..|.|||++.. ..|+++|||||||++||+||+|+.||...... +++.+| +.++..
T Consensus 470 --~~tp~~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i----~~~~~s---------- 532 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI----QMPKFS---------- 532 (612)
T ss_pred --hcccchhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh----cCCccc----------
Confidence 445577999999999984 78999999999999999999999999876655 333333 333211
Q ss_pred ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCC
Q 005289 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (704)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~ 420 (704)
..+|..++|||+.||++||.+|+++.+++.||||..++
T Consensus 533 -----------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~~~ 570 (612)
T KOG0603|consen 533 -----------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFLSHP 570 (612)
T ss_pred -----------------cccCHHHHHHHHHhccCChhhCcChhhhccCcchhcCC
Confidence 47899999999999999999999999999999994433
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=352.54 Aligned_cols=248 Identities=23% Similarity=0.381 Sum_probs=207.7
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.+.+++++.||+|.||.||+|.... ...||+|.+....+.. +.+.+|++||++|+|+|||+|+++|... ..+||
T Consensus 205 r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~~--~piyI 278 (468)
T KOG0197|consen 205 REELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTKQ--EPIYI 278 (468)
T ss_pred HHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEecC--CceEE
Confidence 3456778999999999999999854 3469999998655443 4466999999999999999999999873 57999
Q ss_pred EEecccccccccccC--CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC
Q 005289 209 VFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~--~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~ 286 (704)
|||||..+.|..++. .+..+...+...++.||++|++||+++++|||||-..||||+++..+||+|||||+....+..
T Consensus 279 VtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y 358 (468)
T KOG0197|consen 279 VTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY 358 (468)
T ss_pred EEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence 999999865554443 466799999999999999999999999999999999999999999999999999996655443
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
......-....|.|||.+.. ..++.++|||||||+||||+| |+.||.+.+..+.+..+.+..--|
T Consensus 359 ~~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp------------- 424 (468)
T KOG0197|consen 359 TASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLP------------- 424 (468)
T ss_pred eecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCC-------------
Confidence 33333344778999999976 568999999999999999998 899999999999999886521111
Q ss_pred ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHH
Q 005289 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411 (704)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L 411 (704)
....+|+++.+|+..|+..+|++|||.+.+.
T Consensus 425 ---------------~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 425 ---------------RPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred ---------------CCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 1247899999999999999999999998654
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=334.34 Aligned_cols=257 Identities=26% Similarity=0.482 Sum_probs=212.5
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 210 (704)
.|...+.||.|++|.||++.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.. ....|+|+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~--~~~~~~v~ 95 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLV--GDELWVVM 95 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEc--CCeEEEEE
Confidence 5777789999999999999999999999999986433 2334557889999999999999999998876 57889999
Q ss_pred ecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCcc
Q 005289 211 EYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 290 (704)
Q Consensus 211 Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~ 290 (704)
||+.+..+..+... ..+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++....... ....
T Consensus 96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-~~~~ 173 (285)
T cd06648 96 EFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-PRRK 173 (285)
T ss_pred eccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC-cccc
Confidence 99998666655444 468999999999999999999999999999999999999999999999999887554322 1223
Q ss_pred cccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCC
Q 005289 291 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 370 (704)
Q Consensus 291 ~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~ 370 (704)
...+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+....+.++... .++.
T Consensus 174 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~--~~~~---------------- 234 (285)
T cd06648 174 SLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN--LPPK---------------- 234 (285)
T ss_pred cccCCccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc--CCCC----------------
Confidence 3567999999999876 56899999999999999999999999887776666655432 1100
Q ss_pred CCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCC
Q 005289 371 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (704)
Q Consensus 371 ~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~ 420 (704)
......++..+.+||.+||..||++|||+.++|+||||+...
T Consensus 235 --------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 235 --------LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred --------CcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 001124778999999999999999999999999999998743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=373.41 Aligned_cols=149 Identities=29% Similarity=0.445 Sum_probs=132.3
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 207 (704)
.++|.++++||+|+||+||+|++..+++.||||++..... .......+.+|+.++..++||||+++++++.. ...+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~~ 80 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS--ANNVY 80 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE--CCEEE
Confidence 4689999999999999999999999999999999976443 34445678899999999999999999988876 57899
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEecccccc
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN 279 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~ 279 (704)
|||||+.++.+..++.....+++..++.|+.||+.||.|||.+|||||||||+||||+.++.+||+|||+++
T Consensus 81 lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999886666555545578999999999999999999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=338.09 Aligned_cols=255 Identities=29% Similarity=0.470 Sum_probs=213.3
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
.|..+++||+|+||+||+|++..+++.||+|++..... .......+.+|+.+++.++||||+++++++.+ ....|||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 99 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK--EHTAWLV 99 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe--CCEEEEE
Confidence 47888999999999999999999999999999976543 23445567889999999999999999999987 4788999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCc
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~ 289 (704)
|||+.+.++..+......+++..+..++.||+.+|.|||++||+|+||+|+||+++.++.+||+|||++..... .
T Consensus 100 ~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----~ 174 (313)
T cd06633 100 MEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----A 174 (313)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----C
Confidence 99999877776665566789999999999999999999999999999999999999999999999999864322 2
Q ss_pred ccccccccccCcccccC--CCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCccc
Q 005289 290 TSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (704)
Q Consensus 290 ~~~~gT~~Y~APEvl~~--~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~ 367 (704)
....++..|+|||++.. ...++.++|||||||++|+|++|.+||...+....+.++... ..+
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~--~~~-------------- 238 (313)
T cd06633 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DSP-------------- 238 (313)
T ss_pred CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--CCC--------------
Confidence 34567889999999742 345888999999999999999999999887766666555331 111
Q ss_pred CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
......++..+.+||.+||..+|.+|||+.++|.||||...
T Consensus 239 -----------~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 239 -----------TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred -----------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 00113467789999999999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=334.92 Aligned_cols=256 Identities=29% Similarity=0.474 Sum_probs=212.3
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 210 (704)
.|+.+++||.|+||.||+|.+..++..||||++..... ......+.+|+.+++.++||||+++++++.+ ...+||||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 81 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--GTKLWIIM 81 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCEEEEEE
Confidence 58899999999999999999999999999999875432 3445678889999999999999999999987 57899999
Q ss_pred ecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCcc
Q 005289 211 EYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 290 (704)
Q Consensus 211 Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~ 290 (704)
||++++.+..+... ..+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~ 159 (277)
T cd06640 82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRN 159 (277)
T ss_pred ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc-cccc
Confidence 99998766655443 468999999999999999999999999999999999999999999999999997654322 1223
Q ss_pred cccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCC
Q 005289 291 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 370 (704)
Q Consensus 291 ~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~ 370 (704)
...++..|+|||++.+ ..++.++|||||||++|+|++|.+||...+.......+.. +.++
T Consensus 160 ~~~~~~~y~apE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~--~~~~----------------- 219 (277)
T cd06640 160 TFVGTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK--NNPP----------------- 219 (277)
T ss_pred cccCcccccCHhHhcc-CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc--CCCC-----------------
Confidence 3467889999999875 5678999999999999999999999987765544433311 1010
Q ss_pred CCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCC
Q 005289 371 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (704)
Q Consensus 371 ~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~ 420 (704)
.....++..+.+||.+||..+|++|||+.++|.|+||....
T Consensus 220 ---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06640 220 ---------TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNA 260 (277)
T ss_pred ---------CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence 11234678899999999999999999999999999998644
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=324.88 Aligned_cols=254 Identities=30% Similarity=0.481 Sum_probs=213.8
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 210 (704)
+|++.+.||.|+||.||++.+..+++.||+|++............+.+|+++++.++|||++++++.+.. ...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~--~~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE--KGKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec--CCEEEEEE
Confidence 4899999999999999999999999999999998766555667778899999999999999999999877 47899999
Q ss_pred eccccccccccc-CC---CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC
Q 005289 211 EYMEHDITGLLS-CP---DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 211 Ey~~g~ll~~~~-~~---~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~ 286 (704)
||+++..+..+. .. ...+++..+..++.||+.||.|||++||+|+||+|+|||++.++.++|+|||++.......
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 157 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV- 157 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc-
Confidence 999985554433 22 3679999999999999999999999999999999999999999999999999997665432
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcc
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~ 366 (704)
.......+++.|+|||.+.. ..++.++||||||+++|+|++|..||...+..+....+.... .+
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--~~------------- 221 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ--YP------------- 221 (258)
T ss_pred ceecceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC--CC-------------
Confidence 12234567889999998875 558899999999999999999999998877655555543211 00
Q ss_pred cCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
.....++..+.++|.+||..+|++|||+.++|.||||
T Consensus 222 -------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 222 -------------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred -------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 0112577899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=329.53 Aligned_cols=256 Identities=30% Similarity=0.428 Sum_probs=201.8
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.+.+.....||+|+||+||+|++..++..||+|.+.... ....+.+.+|+.+++.++|+||+++++++.. ...+|+
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 82 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSE--NGFFKI 82 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeecc--CCEEEE
Confidence 345556678999999999999999999999999987543 3345678899999999999999999999877 578999
Q ss_pred EEecccccccccccC-CCccc--cHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEcc-CCceEEeccccccccCCC
Q 005289 209 VFEYMEHDITGLLSC-PDIKF--SEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-EGVLKLADFGLANFSNTG 284 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~-~~~~l--~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~-~g~iKL~DFGla~~~~~~ 284 (704)
||||+.++.+..+.. ....+ ++..+..++.||+.||.|||++||+||||||+||||+. .+.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 999999866554432 22345 88889999999999999999999999999999999976 679999999998765432
Q ss_pred CCCCcccccccccccCcccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCCchhhhccCC
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE-QLHKIFKLCGSPPDDYWKKSKL 362 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~-~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e-~l~~I~~~~g~~p~~~w~~~~~ 362 (704)
. .......+++.|+|||++.+. ..++.++|||||||++|+|++|++||....... ....+ ......
T Consensus 163 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~---------- 230 (268)
T cd06624 163 N-PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV-GMFKIH---------- 230 (268)
T ss_pred C-CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhh-hhhccC----------
Confidence 2 122334578899999998542 347889999999999999999999997543221 11111 000000
Q ss_pred CCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
......+++++.+||.+||..+|.+|||+.+++.||||
T Consensus 231 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 231 ----------------PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred ----------------CCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 01123578889999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=356.05 Aligned_cols=264 Identities=28% Similarity=0.425 Sum_probs=217.3
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN-FEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 207 (704)
..-|..++.||-|+||.|.+++..+|...||+|.+++.. +....+..+..|..||..-+.+-||+||..|++ ...+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD--kdnLY 705 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD--KDNLY 705 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc--CCceE
Confidence 446999999999999999999999999999999997654 345666777889999999999999999988888 57899
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEecccccccc------
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS------ 281 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~------ 281 (704)
+||+|+.|+.+-.++-..+-|.|..++.|+.+|.+||++.|..|+|||||||+|||||.+|+|||+|||||.-+
T Consensus 706 FVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred EEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccc
Confidence 99999998665544445667999999999999999999999999999999999999999999999999998532
Q ss_pred ---CCCCC--------------------------------CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHH
Q 005289 282 ---NTGHR--------------------------------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 326 (704)
Q Consensus 282 ---~~~~~--------------------------------~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeL 326 (704)
..+.. -.....+||+.|+|||+|.. ..|+..||+||.|||||||
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHhhHHHHHH
Confidence 11100 01145688999999999987 5699999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcC
Q 005289 327 LIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 406 (704)
Q Consensus 327 ltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpT 406 (704)
+.|++||-..+..+...+|++ |...- - .....+++.++.+||.+|. .+++.|+-
T Consensus 865 ~~g~~pf~~~tp~~tq~kv~n---------w~~~l-----~-----------~~~~~~ls~e~~~li~kLc-~sad~RLG 918 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQYKVIN---------WRNFL-----H-----------IPYQGNLSKEALDLIQKLC-CSADSRLG 918 (1034)
T ss_pred hhCCCCccCCCCCcceeeeee---------hhhcc-----c-----------cccccccCHHHHHHHHHHh-cChhhhhc
Confidence 999999998887666555533 22100 0 0112478999999999865 67888865
Q ss_pred ---HHHHHhccccCCCCC
Q 005289 407 ---ASAALASEYFSTKPY 421 (704)
Q Consensus 407 ---a~e~L~hpwf~~~~~ 421 (704)
++++-.||||+...|
T Consensus 919 kng~d~vKaHpfFkgIDf 936 (1034)
T KOG0608|consen 919 KNGADQVKAHPFFKGIDF 936 (1034)
T ss_pred ccchhhhhcCccccccch
Confidence 678999999997655
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=351.94 Aligned_cols=254 Identities=21% Similarity=0.293 Sum_probs=199.4
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCC-----CcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDT-----GKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRL 202 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~-----g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~ 202 (704)
.++|++.+.||+|+||.||+|++..+ +..||||++..... ......+.+|+.+|+.+ +|+|||++++++..
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~-- 113 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGACTH-- 113 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeEecC--
Confidence 45799999999999999999986544 35799999975432 34456688999999999 89999999999877
Q ss_pred CCeEEEEEecccccccccccC-----------------------------------------------------------
Q 005289 203 SCSIYLVFEYMEHDITGLLSC----------------------------------------------------------- 223 (704)
Q Consensus 203 ~~~~~LV~Ey~~g~ll~~~~~----------------------------------------------------------- 223 (704)
...+|||||||.++.+..+..
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 468999999998755443211
Q ss_pred -----------CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCc-cc
Q 005289 224 -----------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL-TS 291 (704)
Q Consensus 224 -----------~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~-~~ 291 (704)
....+++..+..|+.||+.||.|||++||+||||||+|||+++++.+||+|||+++.......... ..
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 113478899999999999999999999999999999999999999999999999976543321111 12
Q ss_pred ccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCC
Q 005289 292 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 370 (704)
Q Consensus 292 ~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~ 370 (704)
..+++.|+|||++.+ ..|+.++|||||||+||+|++ |++||........+.++......++
T Consensus 274 ~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~----------------- 335 (374)
T cd05106 274 ARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMS----------------- 335 (374)
T ss_pred CCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCcc-----------------
Confidence 234567999999875 568999999999999999997 9999987655444434332110000
Q ss_pred CCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 371 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 371 ~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
....++.++.+||.+||..||.+|||+.++++.
T Consensus 336 ----------~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~ 368 (374)
T cd05106 336 ----------RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQL 368 (374)
T ss_pred ----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 012467899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=338.46 Aligned_cols=254 Identities=30% Similarity=0.481 Sum_probs=212.9
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
.|..++.||+|+||+||++++..++..||||++..... .......+.+|+.+|+.++||||+++++++.+ ....|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 103 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR--EHTAWLV 103 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--CCeEEEE
Confidence 48899999999999999999999999999999976533 23445668889999999999999999999987 4678999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCc
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~ 289 (704)
|||+.+.++..+......+++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++......
T Consensus 104 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~----- 178 (317)
T cd06635 104 MEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA----- 178 (317)
T ss_pred EeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc-----
Confidence 999998776666555567899999999999999999999999999999999999999999999999998754432
Q ss_pred ccccccccccCcccccC--CCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCccc
Q 005289 290 TSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (704)
Q Consensus 290 ~~~~gT~~Y~APEvl~~--~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~ 367 (704)
....+++.|+|||++.. ...++.++|||||||++|+|++|.+||........+..+......+
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------------- 243 (317)
T cd06635 179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT--------------- 243 (317)
T ss_pred ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC---------------
Confidence 33467889999998742 3458889999999999999999999998877666665554321110
Q ss_pred CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
.....++..+.+||.+||..+|.+|||+.++++|+|+..
T Consensus 244 ------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 244 ------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred ------------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 001246778999999999999999999999999999965
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=329.50 Aligned_cols=250 Identities=20% Similarity=0.301 Sum_probs=204.4
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
..|.+.++||.|+||.||+|.+..+++.||+|++..+. .....+.+|+.+|+.++||||+++++++.. ...+|+|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 80 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFYII 80 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcC--CCCcEEE
Confidence 46999999999999999999999999999999987543 234567889999999999999999999876 4678999
Q ss_pred EecccccccccccC--CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCC
Q 005289 210 FEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~--~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~ 287 (704)
|||++++.+..+.. ....+++..+..++.||+.+|.|||++||+||||||+|||+++++.+||+|||++.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 99998765554432 2345899999999999999999999999999999999999999999999999999766543222
Q ss_pred CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcc
Q 005289 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (704)
Q Consensus 288 ~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~ 366 (704)
.......+..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.... .+
T Consensus 161 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~--~~------------- 224 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY--RM------------- 224 (263)
T ss_pred ccCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC--CC-------------
Confidence 1122233667999998865 568899999999999999998 999999877766655553210 00
Q ss_pred cCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.....++.++.+||.+||..||++|||+.++++.
T Consensus 225 -------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 225 -------------ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred -------------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 0113578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=327.67 Aligned_cols=257 Identities=27% Similarity=0.432 Sum_probs=209.7
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCC---CChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN---FEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~---~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 207 (704)
+|++.+.||+|+||.||+|++..+++.||+|++.... ........+.+|+.+++.++||||+++++++.+.....++
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence 6999999999999999999999999999999986432 1234556788999999999999999999998765556789
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC--
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-- 285 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~-- 285 (704)
+||||+.++.+..+......+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 162 (264)
T cd06653 83 IFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMS 162 (264)
T ss_pred EEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccccc
Confidence 999999886665544444568999999999999999999999999999999999999999999999999997653211
Q ss_pred CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
........++..|+|||++.+ ..++.++|||||||++|+|++|++||......+.+.++. ..+..
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~----------- 227 (264)
T cd06653 163 GTGIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA---TQPTK----------- 227 (264)
T ss_pred CccccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH---cCCCC-----------
Confidence 111233467899999999876 457899999999999999999999998776555544432 11110
Q ss_pred ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
......+++.+.++|.+||. +|.+|||+.++|.|||.
T Consensus 228 -------------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 228 -------------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred -------------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 01124678899999999998 57999999999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=323.46 Aligned_cols=259 Identities=24% Similarity=0.400 Sum_probs=215.1
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCCeEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~ 207 (704)
.++.+++..||.|+.|+||+++.+.+|...|||.++... +.+..++++..+.++... +.|+||+++++|.. +..++
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~--n~dV~ 167 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT--NTDVF 167 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee--CchHH
Confidence 456788899999999999999999999999999998765 345566777788776655 69999999999987 45678
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhc-CcccccCCCccEEEccCCceEEeccccccccCCCCC
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~-gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~ 286 (704)
|.||.|.--.-.++.....+++|..+-++...++.||.||.++ ||||||+||+|||||+.|+|||||||++-.+-..
T Consensus 168 IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS-- 245 (391)
T KOG0983|consen 168 ICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS-- 245 (391)
T ss_pred HHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc--
Confidence 8999987654445555566799999999999999999999965 8999999999999999999999999999665432
Q ss_pred CCcccccccccccCcccccC--CCCCCCccchhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHHcCCCCchhhhccCCC
Q 005289 287 QPLTSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQG-RTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~--~~~y~~~~DIWSlG~iLyeLltG~~pF~~-~~~~e~l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
...+...|.+.|||||.+.- ...|+..+||||||+.|+||.||..||.+ +++.+.+.+|.+. .||.
T Consensus 246 kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~--ePP~--------- 314 (391)
T KOG0983|consen 246 KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE--EPPL--------- 314 (391)
T ss_pred cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc--CCCC---------
Confidence 22344578899999999853 35699999999999999999999999998 5788888888762 2220
Q ss_pred CcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
|.. -..+++.+.+|+..||..|+.+||...++|+|||+..
T Consensus 315 --------------L~~-~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ 354 (391)
T KOG0983|consen 315 --------------LPG-HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKR 354 (391)
T ss_pred --------------CCc-ccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceee
Confidence 111 1248999999999999999999999999999999974
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=325.88 Aligned_cols=250 Identities=26% Similarity=0.456 Sum_probs=206.4
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 210 (704)
+|++.+.||.|+||.||++.+..+++.||+|.+..... ....+.+.+|+.+++.++||||+++++.+.+ ...+|+||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEA--DGHLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEE--CCEEEEEE
Confidence 48999999999999999999999999999999875432 3345677889999999999999999999987 57899999
Q ss_pred ecccccccc-cccC-CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 211 EYMEHDITG-LLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 211 Ey~~g~ll~-~~~~-~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
||++++.+. .+.. ....+++..+..++.||+.||.|||++||+|+||||+|||+++++.++|+|||++....... ..
T Consensus 78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~ 156 (255)
T cd08219 78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-AY 156 (255)
T ss_pred eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc-cc
Confidence 999875443 3322 34468999999999999999999999999999999999999999999999999997654322 12
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccC
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~ 368 (704)
.....+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+....+..+.. +..+
T Consensus 157 ~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~--------------- 218 (255)
T cd08219 157 ACTYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ--GSYK--------------- 218 (255)
T ss_pred cccccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhc--CCCC---------------
Confidence 234567899999999876 5689999999999999999999999998776665555432 1110
Q ss_pred CCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 369 ~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.....++..+.+||.+||..||++|||+.++|.-
T Consensus 219 -----------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 -----------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -----------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0113467889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=344.09 Aligned_cols=278 Identities=25% Similarity=0.363 Sum_probs=203.8
Q ss_pred EEeecc--CceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEecc
Q 005289 136 EKIGQG--TYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYM 213 (704)
Q Consensus 136 ~~LG~G--~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~ 213 (704)
..||.| +||+||+|++..+++.||||++..........+.+.+|+.+++.++||||++++++|.. ...+|+||||+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~~~~~v~e~~ 81 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT--GSWLWVISPFM 81 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec--CCceEEEEecc
Confidence 346666 99999999999999999999998765555666788899999999999999999999987 56889999999
Q ss_pred cccccccccCC--CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC-CC--
Q 005289 214 EHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QP-- 288 (704)
Q Consensus 214 ~g~ll~~~~~~--~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~-~~-- 288 (704)
.++.+..+... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+||+.+........ ..
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 98555544332 23589999999999999999999999999999999999999999999999986543221110 00
Q ss_pred ---cccccccccccCcccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC
Q 005289 289 ---LTSRVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 289 ---~~~~~gT~~Y~APEvl~~~-~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
.....++..|+|||++.+. ..++.++|||||||++|+|++|.+||........+..+... ++...|.....+.
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 238 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKG---PPYSPLDITTFPC 238 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcC---CCCCCccccccch
Confidence 0111235679999998753 34789999999999999999999999887665554444331 1111111110000
Q ss_pred c--ccC---------------CCC---CCCCchh-hhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 365 A--TLF---------------KPQ---QPYDSSL-RETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 365 ~--~~~---------------~~~---~~~~~~l-~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
. ... ... ......+ ......++..+++||.+||.+||++|||+.++|+||||..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~ 313 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ 313 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence 0 000 000 0000000 0112346788999999999999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=322.22 Aligned_cols=254 Identities=31% Similarity=0.546 Sum_probs=214.8
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 210 (704)
+|++.+.||.|++|.||++.+..+++.||+|.+............+.+|++++++++||||+++++++.+ ...+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET--SDSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe--CCEEEEEE
Confidence 4899999999999999999999999999999998776555567788899999999999999999999877 47899999
Q ss_pred ecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCcc
Q 005289 211 EYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 290 (704)
Q Consensus 211 Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~ 290 (704)
||+++..+..+......+++..+..++.||+.+|.|||++||+|+||+|+||+++.++.++|+|||++........ ...
T Consensus 79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~ 157 (254)
T cd06627 79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK-DDA 157 (254)
T ss_pred ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc-ccc
Confidence 9999876666555556799999999999999999999999999999999999999999999999999987654332 123
Q ss_pred cccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCC
Q 005289 291 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 370 (704)
Q Consensus 291 ~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~ 370 (704)
...++..|+|||.+.+ ..++.++|||+||+++|+|++|.+||...+....+.++.. ...+
T Consensus 158 ~~~~~~~y~~pe~~~~-~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~~~----------------- 217 (254)
T cd06627 158 SVVGTPYWMAPEVIEM-SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ--DDHP----------------- 217 (254)
T ss_pred ccccchhhcCHhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc--cCCC-----------------
Confidence 4467889999998876 4488999999999999999999999987665554444321 0000
Q ss_pred CCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 371 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 371 ~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
.....++..+.++|.+||..+|++|||+.++|.||||
T Consensus 218 ---------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 218 ---------PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred ---------CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 0113568899999999999999999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=329.13 Aligned_cols=253 Identities=31% Similarity=0.507 Sum_probs=208.0
Q ss_pred eeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEeccccc
Q 005289 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD 216 (704)
Q Consensus 138 LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~ 216 (704)
||.|+||.||++++..+++.||+|++..... .......+.+|++++++++||||+++++.+.. ...+|+||||+.++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG--KKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec--CcEEEEEEecCCCC
Confidence 6899999999999999999999999976543 23445668889999999999999999988876 57899999999886
Q ss_pred ccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC-------CCc
Q 005289 217 ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-------QPL 289 (704)
Q Consensus 217 ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~-------~~~ 289 (704)
.+..+......+++..+..++.||+.||.|||++||+|+||+|+|||++.++.++|+|||++........ ...
T Consensus 79 ~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 158 (265)
T cd05579 79 DLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158 (265)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccc
Confidence 6655544444789999999999999999999999999999999999999999999999999875543211 122
Q ss_pred ccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCC
Q 005289 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (704)
Q Consensus 290 ~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~ 369 (704)
....++..|+|||++.. ..++.++|||||||++|+|++|.+||......+.+..+.. +..+ |
T Consensus 159 ~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~---~------------ 220 (265)
T cd05579 159 KRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN--GKIE---W------------ 220 (265)
T ss_pred cCcccCccccCHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCcC---C------------
Confidence 33456889999999876 4488899999999999999999999998887776666543 1110 0
Q ss_pred CCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCH---HHHHhccccCCCC
Q 005289 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA---SAALASEYFSTKP 420 (704)
Q Consensus 370 ~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa---~e~L~hpwf~~~~ 420 (704)
. ....++..+.+||.+||+.+|.+|||+ .++|+||||+...
T Consensus 221 -----~-----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~ 264 (265)
T cd05579 221 -----P-----EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264 (265)
T ss_pred -----C-----ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence 0 001258899999999999999999999 9999999998643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=332.81 Aligned_cols=252 Identities=23% Similarity=0.362 Sum_probs=204.7
Q ss_pred cCCeeEEEEeeccCceEEEEEEECC-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLD-----TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 203 (704)
.++|.+++.||.|+||.||+|.+.. +++.||||++.... ..+....+.+|+++|+.++||||+++++++.. .
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTE--G 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEec--C
Confidence 4579999999999999999998743 46789999987543 23345678899999999999999999999987 4
Q ss_pred CeEEEEEecccccccccccC--------------CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCc
Q 005289 204 CSIYLVFEYMEHDITGLLSC--------------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV 269 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~~~~--------------~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~ 269 (704)
...|+||||+.++.+..+.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 78999999999866554432 1235889999999999999999999999999999999999999999
Q ss_pred eEEeccccccccCCCCC-CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Q 005289 270 LKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFK 347 (704)
Q Consensus 270 iKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~ 347 (704)
+||+|||++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+.+..+..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ 239 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 99999999975432211 11223345788999999876 568999999999999999998 9999988777766666542
Q ss_pred HcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 348 LCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 348 ~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
+..+ .....++..+.+||.+||..||++|||+.++|+
T Consensus 240 --~~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 240 --GRLL--------------------------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred --CCcC--------------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 1110 011357889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=325.85 Aligned_cols=248 Identities=21% Similarity=0.335 Sum_probs=201.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
++|++++.||.|+||.||++.... +..+|+|.+...... ...+.+|+.+|++++||||+++++++.. ...+|+|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQ--QKPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEcc--CCCEEEE
Confidence 569999999999999999998754 567999998654332 3456789999999999999999999877 4679999
Q ss_pred Eeccccccccccc-CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 210 FEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 210 ~Ey~~g~ll~~~~-~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
|||++++.+..+. .....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 9999876555443 334568999999999999999999999999999999999999999999999999987654322221
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCccc
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~ 367 (704)
.....++..|+|||++.+ ..++.++|||||||++|+|++ |++||...+..+.+..+......+
T Consensus 158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~--------------- 221 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLY--------------- 221 (256)
T ss_pred cCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCC---------------
Confidence 222234567999999875 568999999999999999999 999999888877777764411000
Q ss_pred CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
.....+..+.+||.+||..||.+|||+.++++
T Consensus 222 -------------~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 222 -------------RPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred -------------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 01235678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=331.01 Aligned_cols=247 Identities=26% Similarity=0.375 Sum_probs=196.0
Q ss_pred CCeeEEEEe--eccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCCeE
Q 005289 130 DAFEKLEKI--GQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 130 ~~y~~~~~L--G~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~ 206 (704)
+.|++.+.+ |.|+||+||++.+..++..+|+|++....... .|+.++..+ +||||+++++.|.. ...+
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~--~~~~ 84 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTT--LKGH 84 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEec--CCee
Confidence 456776666 99999999999999999999999987543221 133333323 79999999999987 4689
Q ss_pred EEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCC-ceEEeccccccccCCCC
Q 005289 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGH 285 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g-~iKL~DFGla~~~~~~~ 285 (704)
|+||||++++.+..+......+++..++.++.||+.||.|||+.||+||||||+|||++.++ .++|+|||++......
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~- 163 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP- 163 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-
Confidence 99999998866655544445899999999999999999999999999999999999999998 9999999998765432
Q ss_pred CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCCchhhhccCCCC
Q 005289 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ-LHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~-l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
....++..|+|||++.+ ..++.++|||||||++|+|++|..||......+. ...+.... ..+
T Consensus 164 ----~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~----------- 226 (267)
T PHA03390 164 ----SCYDGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKK----------- 226 (267)
T ss_pred ----ccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-ccc-----------
Confidence 23457889999999876 5689999999999999999999999986543321 11221111 000
Q ss_pred cccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcC-HHHHHhccccC
Q 005289 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-ASAALASEYFS 417 (704)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpT-a~e~L~hpwf~ 417 (704)
...++.+++.+.+||.+||+.||.+||+ .+++|+||||+
T Consensus 227 --------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 227 --------------LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred --------------CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 0112368899999999999999999997 59999999996
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=326.62 Aligned_cols=253 Identities=29% Similarity=0.448 Sum_probs=204.3
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN-FEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
++|++.+.||.|+||.||+|++..+++.||||.+.... ........+.+|+.+|+.++||||+++++++.+ ...+|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 79 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE--DNELNI 79 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE--CCeEEE
Confidence 47999999999999999999999999999999886533 334555667889999999999999999999887 468899
Q ss_pred EEeccccccccccc----CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 209 VFEYMEHDITGLLS----CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 209 V~Ey~~g~ll~~~~----~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
||||++++.+..+. .....+++..+..++.||+.||.|||++||+|+||||+||||+.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 99999986554332 23345899999999999999999999999999999999999999999999999998766432
Q ss_pred CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCCchhhhccCC
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE--VEQLHKIFKLCGSPPDDYWKKSKL 362 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~--~e~l~~I~~~~g~~p~~~w~~~~~ 362 (704)
. .......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||..... .+....+ ...+.++.
T Consensus 160 ~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~-------- 228 (267)
T cd08228 160 T-TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI-EQCDYPPL-------- 228 (267)
T ss_pred h-HHHhcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHH-hcCCCCCC--------
Confidence 2 11233467889999999876 4578999999999999999999999865432 2333332 21121110
Q ss_pred CCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
....++..+.+||.+||..+|++|||+.++|+.
T Consensus 229 ------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 229 ------------------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred ------------------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 012467889999999999999999999999964
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=340.12 Aligned_cols=256 Identities=26% Similarity=0.480 Sum_probs=213.1
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 210 (704)
-|.++.+||+|+||.||+|.++++|+.+|||.+..+. ....+..||.||++++.|++|++|+.|.. ...+||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s----DLQEIIKEISIMQQC~S~yVVKYYGSYFK--~sDLWIVM 107 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT----DLQEIIKEISIMQQCKSKYVVKYYGSYFK--HSDLWIVM 107 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc----hHHHHHHHHHHHHHcCCchhhhhhhhhcc--CCceEeeh
Confidence 4889999999999999999999999999999997543 35667789999999999999999987755 46799999
Q ss_pred ecccccccc-cccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCc
Q 005289 211 EYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (704)
Q Consensus 211 Ey~~g~ll~-~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~ 289 (704)
|||+.+... .+..+++.|+|.++..+++..|.||+|||...-||||||..||||+.+|+.||+|||.|..+.. .....
T Consensus 108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD-TMAKR 186 (502)
T KOG0574|consen 108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD-TMAKR 186 (502)
T ss_pred hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhh-hHHhh
Confidence 999976555 4455777899999999999999999999999999999999999999999999999999975543 22334
Q ss_pred ccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCC
Q 005289 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (704)
Q Consensus 290 ~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~ 369 (704)
.+.+|||.|||||++.. -.|+..+||||||++..||..|+|||..-... ..|+-.--.||+.+
T Consensus 187 NTVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM---RAIFMIPT~PPPTF------------- 249 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIHPM---RAIFMIPTKPPPTF------------- 249 (502)
T ss_pred CccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCccccccc---ceeEeccCCCCCCC-------------
Confidence 66789999999999975 56999999999999999999999999764443 22222222222211
Q ss_pred CCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCC
Q 005289 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (704)
Q Consensus 370 ~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~ 420 (704)
......+.++.|||++||.++|++|.||.++++|||++..+
T Consensus 250 ----------~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 250 ----------KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred ----------CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 11234678899999999999999999999999999998643
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=333.13 Aligned_cols=264 Identities=25% Similarity=0.435 Sum_probs=208.8
Q ss_pred CeeEEEEeeccCceEEEEEEEC---CCCcEEEEEEeecCCCC--hHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCC
Q 005289 131 AFEKLEKIGQGTYSSVFRARDL---DTGKIVALKKVRFDNFE--PESVRFMAREILILRRL-DHPNIIKLEGLITSRLSC 204 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAvK~i~~~~~~--~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~ 204 (704)
.|++.+.||.|+||.||+|++. .+|+.||+|++...... ....+.+.+|+.+|+.+ +|+||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--DT 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec--CC
Confidence 4899999999999999999875 47899999998754321 22345567899999999 69999999998876 46
Q ss_pred eEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
.+||||||+.++.+..+......+++..+..++.||+.||.|||+.||+||||+|+|||++.++.+||+|||++......
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred eEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 88999999998666655545567899999999999999999999999999999999999999999999999999766543
Q ss_pred CCCCcccccccccccCcccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCC
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~-~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
.........++..|+|||.+... ..++.++|||||||++|+|++|.+||...........+...+-..
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~----------- 227 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS----------- 227 (290)
T ss_pred cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc-----------
Confidence 32333345678999999998642 347789999999999999999999997543322222222211000
Q ss_pred CcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCc-----CHHHHHhccccCCCCC
Q 005289 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 421 (704)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRp-----Ta~e~L~hpwf~~~~~ 421 (704)
..++ ...++..+.+||.+||..||++|| ++.+++.||||+...|
T Consensus 228 -------~~~~-------~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 276 (290)
T cd05613 228 -------EPPY-------PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW 276 (290)
T ss_pred -------CCCC-------CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence 0000 134778899999999999999997 8999999999987554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=326.59 Aligned_cols=250 Identities=20% Similarity=0.321 Sum_probs=203.2
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEE
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 207 (704)
..++|+++++||+|+||+||+|.+. ++..||+|.+.... ...+.+.+|+.+++.++|+||+++++++.. ....|
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 77 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTK--EEPIY 77 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcC--CCCcE
Confidence 3568999999999999999999864 56779999986543 234567889999999999999999998876 46789
Q ss_pred EEEeccccccccccc--CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 208 LVFEYMEHDITGLLS--CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~--~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
|||||+.++.+..+. .....+++..+..++.||+.||.|||+++++||||||+|||++.++.+||+|||++.......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 999999875544333 234568899999999999999999999999999999999999999999999999998665432
Q ss_pred CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC
Q 005289 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
........++..|+|||++.. ..++.++|||||||++|+|++ |.+||.+.+..+....+......
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~------------- 223 (261)
T cd05072 158 YTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM------------- 223 (261)
T ss_pred eeccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence 222223345678999998865 568899999999999999998 99999988777766665432100
Q ss_pred cccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
.....++.++.+||.+||..||++|||++++++
T Consensus 224 ---------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 224 ---------------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred ---------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 011357889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=348.66 Aligned_cols=254 Identities=20% Similarity=0.304 Sum_probs=198.3
Q ss_pred cCCeeEEEEeeccCceEEEEEEE-----CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARD-----LDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRL 202 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~-----~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~ 202 (704)
.++|++.++||+|+||+||+|++ ..++..||||++..... ....+.+.+|+.+|..+ +||||+++++++..
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~-- 110 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTV-- 110 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeecc--
Confidence 45799999999999999999974 35677899999875432 23456678899999999 89999999999977
Q ss_pred CCeEEEEEecccccccccccC-----------------------------------------------------------
Q 005289 203 SCSIYLVFEYMEHDITGLLSC----------------------------------------------------------- 223 (704)
Q Consensus 203 ~~~~~LV~Ey~~g~ll~~~~~----------------------------------------------------------- 223 (704)
....|||||||+++.+..+..
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 467899999998754432221
Q ss_pred ----------------CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCC
Q 005289 224 ----------------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (704)
Q Consensus 224 ----------------~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~ 287 (704)
....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 1124788899999999999999999999999999999999999999999999999765433211
Q ss_pred C-cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 288 P-LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 288 ~-~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
. .....++..|+|||++.+ ..++.++|||||||+||+|++ |.+||........+.++... +..+
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~------------ 336 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKE-GYRM------------ 336 (375)
T ss_pred cccCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHh-CccC------------
Confidence 1 112234667999999876 568999999999999999998 89999876544433333221 0000
Q ss_pred ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
......+.++.+||.+||..||++|||+.++++.
T Consensus 337 --------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 337 --------------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred --------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 0012457889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=336.19 Aligned_cols=257 Identities=28% Similarity=0.484 Sum_probs=210.6
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|++++.||.|+||+||++.+..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~l 93 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLV--GDELWV 93 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehhheeee--CCcEEE
Confidence 358999999999999999999998899999999986543 2234567889999999999999999999977 468999
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
||||++++.+..+... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++........ .
T Consensus 94 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~ 171 (293)
T cd06647 94 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 171 (293)
T ss_pred EEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-c
Confidence 9999998766655433 3578999999999999999999999999999999999999999999999999876543322 2
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccC
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~ 368 (704)
.....+++.|+|||.+.. ..++.++|||||||++|+|++|.+||...+..+.+..+.. .+.+.
T Consensus 172 ~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~~--------------- 234 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE--------------- 234 (293)
T ss_pred cccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCCCC---------------
Confidence 233467889999999876 5688999999999999999999999987765544333211 00000
Q ss_pred CCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 369 ~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
......++..+.+||++||..+|++||++.++|.|+||+.
T Consensus 235 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~ 274 (293)
T cd06647 235 ----------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKI 274 (293)
T ss_pred ----------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 0012356788999999999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=326.70 Aligned_cols=253 Identities=19% Similarity=0.263 Sum_probs=202.7
Q ss_pred eeEEEEeeccCceEEEEEEECC---CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC----CC
Q 005289 132 FEKLEKIGQGTYSSVFRARDLD---TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL----SC 204 (704)
Q Consensus 132 y~~~~~LG~G~fg~Vy~a~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----~~ 204 (704)
|++.+.||+|+||.||+|.... ++..||||++..+.........+.+|+.+|+.++||||+++++++.... ..
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 6788999999999999998765 3478999999876555555677889999999999999999999875522 13
Q ss_pred eEEEEEeccccccccccc------CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccc
Q 005289 205 SIYLVFEYMEHDITGLLS------CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~------~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla 278 (704)
..++||||+.++.+..+. .....+++..+..++.||+.||.|||+++|+||||||+|||+++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 479999999986554332 12346899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCC-cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchh
Q 005289 279 NFSNTGHRQP-LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDY 356 (704)
Q Consensus 279 ~~~~~~~~~~-~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~ 356 (704)
+......... ......+..|+|||++.+ ..++.++|||||||++|||++ |.+||.+....+.+..+... ..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~--~~~--- 234 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG--NRL--- 234 (273)
T ss_pred eeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--CCC---
Confidence 8654332111 112234678999998865 568999999999999999999 99999888777666555331 100
Q ss_pred hhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 357 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 357 w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.....++..+.+||.+||..||.+|||+.+++++
T Consensus 235 -----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 235 -----------------------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred -----------------------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0113578899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=335.38 Aligned_cols=254 Identities=28% Similarity=0.463 Sum_probs=208.5
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 210 (704)
.|++++.||.|+||.||+|.+..+++.||||.+..... ......+.+|+.+++.++||||+++++++.. ...+|+||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 81 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLK--GTKLWIIM 81 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhccccc--CCceEEEE
Confidence 58888999999999999999999999999999875432 2345678899999999999999999999876 56899999
Q ss_pred ecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCcc
Q 005289 211 EYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 290 (704)
Q Consensus 211 Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~ 290 (704)
||++++.+..+... ..+++..++.++.||+.||.|||++||+|+||+|+||++++++.++|+|||++....... ....
T Consensus 82 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~ 159 (277)
T cd06642 82 EYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRN 159 (277)
T ss_pred EccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc-hhhh
Confidence 99998666555433 468999999999999999999999999999999999999999999999999997654322 1222
Q ss_pred cccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCC
Q 005289 291 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 370 (704)
Q Consensus 291 ~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~ 370 (704)
...++..|+|||++.+ ..++.++|||||||++|+|++|.+||...........+.. +.++
T Consensus 160 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~--~~~~----------------- 219 (277)
T cd06642 160 TFVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPK--NSPP----------------- 219 (277)
T ss_pred cccCcccccCHHHhCc-CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhc--CCCC-----------------
Confidence 3457889999999876 5688999999999999999999999976554443332211 0000
Q ss_pred CCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 371 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 371 ~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
.....++.++.+||.+||..+|.+|||+.++|+||||..
T Consensus 220 ---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 220 ---------TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred ---------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence 011246788999999999999999999999999999975
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=319.75 Aligned_cols=259 Identities=33% Similarity=0.530 Sum_probs=211.8
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 210 (704)
+|.+.+.||.|++|.||+|.+..+++.|++|++............+.+|+.++++++||||+++++.+.......+++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 48889999999999999999999999999999987655455677888999999999999999999998774337899999
Q ss_pred ecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCC-Cc
Q 005289 211 EYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PL 289 (704)
Q Consensus 211 Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~-~~ 289 (704)
||+.+..+..+......+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+......... ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT 160 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccc
Confidence 99987666655544448999999999999999999999999999999999999999999999999999876544210 12
Q ss_pred ccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCC
Q 005289 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (704)
Q Consensus 290 ~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~ 369 (704)
....++..|+|||.+.. ..++.++|||||||++|+|++|..||..... ....+.......
T Consensus 161 ~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~----------------- 220 (260)
T cd06606 161 GSVRGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELGN--PMAALYKIGSSG----------------- 220 (260)
T ss_pred cCCCCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHhccccC-----------------
Confidence 33567889999998876 4488999999999999999999999987662 112221111000
Q ss_pred CCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 370 ~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
........++..+.+||.+||..||.+|||+.++|.||||
T Consensus 221 -------~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 221 -------EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred -------CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 0011123558899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=328.58 Aligned_cols=255 Identities=30% Similarity=0.474 Sum_probs=211.0
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 210 (704)
-|++++.||.|+||.||+|.+..++..||||++..... ......+.+|+.++..++||||+++++++.. ...+|+||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 81 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--DTKLWIIM 81 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe--CCeEEEEE
Confidence 48899999999999999999999999999999865432 2345667889999999999999999999987 57899999
Q ss_pred ecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCcc
Q 005289 211 EYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 290 (704)
Q Consensus 211 Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~ 290 (704)
||+.++.+..+... ..+++..+..++.||+.+|.|||++||+|+||+|+||+++.++.++|+|||++....... ....
T Consensus 82 e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~ 159 (277)
T cd06641 82 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRN 159 (277)
T ss_pred EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch-hhhc
Confidence 99998766655433 468999999999999999999999999999999999999999999999999987654321 1223
Q ss_pred cccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCC
Q 005289 291 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 370 (704)
Q Consensus 291 ~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~ 370 (704)
...++..|+|||.+.+ ..++.++|||||||++|+|++|.+||...........+.. +.++
T Consensus 160 ~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~~~----------------- 219 (277)
T cd06641 160 TFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK--NNPP----------------- 219 (277)
T ss_pred cccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhc--CCCC-----------------
Confidence 3467889999998865 5678899999999999999999999987666555544322 1110
Q ss_pred CCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 371 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 371 ~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
.....++.++.++|.+||..+|.+||++.++|+||||...
T Consensus 220 ---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 220 ---------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred ---------CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 0113578889999999999999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=336.91 Aligned_cols=272 Identities=24% Similarity=0.326 Sum_probs=200.8
Q ss_pred CceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEecccccccccc
Q 005289 142 TYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL 221 (704)
Q Consensus 142 ~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~ 221 (704)
+++.||++++..+++.||||++............+.+|+.+|+.++||||+++++++.. ....|++|||+.++.+..+
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~--~~~~~~~~e~~~~~~l~~~ 89 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV--DSELYVVSPLMAYGSCEDL 89 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec--CCeEEEEEeccCCCCHHHH
Confidence 55667777777799999999998765556667789999999999999999999999877 5678999999998766654
Q ss_pred cCC--CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC------CCccccc
Q 005289 222 SCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR------QPLTSRV 293 (704)
Q Consensus 222 ~~~--~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~------~~~~~~~ 293 (704)
... ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||.+........ .......
T Consensus 90 l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (314)
T cd08216 90 LKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSV 169 (314)
T ss_pred HHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccccccc
Confidence 432 34689999999999999999999999999999999999999999999999998865432111 1112335
Q ss_pred ccccccCcccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCC--
Q 005289 294 VTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP-- 370 (704)
Q Consensus 294 gT~~Y~APEvl~~~-~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~-- 370 (704)
++..|+|||++... ..|+.++|||||||++|+|++|.+||........+.... .+..+. .+.....+.......
T Consensus 170 ~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~ 246 (314)
T cd08216 170 KNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKV--RGTVPC-LLDKSTYPLYEDSMSQS 246 (314)
T ss_pred ccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hccCcc-ccccCchhhhcCCcCcc
Confidence 67889999998653 358899999999999999999999998766554432222 222211 111111110000000
Q ss_pred ------CCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 371 ------QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 371 ------~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
..............++.++.+||.+||.+||++|||+.++|+||||+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~ 300 (314)
T cd08216 247 RSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQ 300 (314)
T ss_pred cccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhh
Confidence 000000001111245678999999999999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=335.55 Aligned_cols=255 Identities=29% Similarity=0.480 Sum_probs=210.9
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
..|+.++.||+|+||+||+|++..++..||||.+..... .......+.+|+.+|+.++|+||+++++++.. ....|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 92 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAWL 92 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCeeEE
Confidence 358889999999999999999999999999999875432 23445567789999999999999999999887 467899
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
||||+.+.+...+......+++..+..++.||+.||.|||+++|+|+||+|+|||++.++.+||+|||++......
T Consensus 93 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---- 168 (308)
T cd06634 93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 168 (308)
T ss_pred EEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc----
Confidence 9999998776665545556899999999999999999999999999999999999999999999999998765432
Q ss_pred cccccccccccCcccccC--CCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcc
Q 005289 289 LTSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~--~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~ 366 (704)
....+++.|+|||++.+ ...++.++|||||||++|+|++|.+||...+..+.+..+... ..+
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~~------------- 232 (308)
T cd06634 169 -NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--ESP------------- 232 (308)
T ss_pred -ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhc--CCC-------------
Confidence 23467889999999752 245788999999999999999999999876655544444321 100
Q ss_pred cCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
......++..+.+||.+||..+|.+|||+.+++.||||..
T Consensus 233 ------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 233 ------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred ------------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 0001356788999999999999999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=326.37 Aligned_cols=253 Identities=19% Similarity=0.273 Sum_probs=200.9
Q ss_pred eeEEEEeeccCceEEEEEEECCCCc--EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeec----CCCe
Q 005289 132 FEKLEKIGQGTYSSVFRARDLDTGK--IVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR----LSCS 205 (704)
Q Consensus 132 y~~~~~LG~G~fg~Vy~a~~~~~g~--~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~----~~~~ 205 (704)
|.+.+.||+|+||.||+|++..++. .||+|.+..........+.+.+|+.+|+.++||||+++++++... ....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999999877765 699999876554556677788999999999999999999977432 1235
Q ss_pred EEEEEeccccccccccc------CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEecccccc
Q 005289 206 IYLVFEYMEHDITGLLS------CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN 279 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~------~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~ 279 (704)
.++||||+.++.+..+. .....+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++.
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 78999999976544322 123458999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCC-cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhh
Q 005289 280 FSNTGHRQP-LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYW 357 (704)
Q Consensus 280 ~~~~~~~~~-~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w 357 (704)
......... .....+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+....+.. +..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~--~~~~---- 233 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ--GNRL---- 233 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc--CCCC----
Confidence 764332111 112234678999998876 568999999999999999999 8999988777666555532 1100
Q ss_pred hccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 358 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.....++..+.+||.+||..||++|||+.+++++
T Consensus 234 ----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 234 ----------------------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred ----------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0113567889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=329.32 Aligned_cols=254 Identities=20% Similarity=0.351 Sum_probs=203.7
Q ss_pred ccCCeeEEEEeeccCceEEEEEEE----CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARD----LDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~----~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 203 (704)
..++|++.+.||+|+||+||+|.. ..++..||+|.+.... .......+.+|+.+|+.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~ 79 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ--E 79 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec--C
Confidence 346799999999999999999985 3456789999987543 23445678889999999999999999999877 4
Q ss_pred CeEEEEEecccccccccccC-----------------CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEcc
Q 005289 204 CSIYLVFEYMEHDITGLLSC-----------------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN 266 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~~~~-----------------~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~ 266 (704)
...|+||||+.++.+..+.. ....+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~ 159 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE 159 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence 67899999998755443321 1224788999999999999999999999999999999999999
Q ss_pred CCceEEeccccccccCCCCC-CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 005289 267 EGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHK 344 (704)
Q Consensus 267 ~g~iKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~ 344 (704)
++.+||+|||+++....... .......++..|+|||++.+ ..++.++|||||||+||+|++ |.+||.+....+++..
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCcEEeccccccccccCCcceecccCCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999999976543221 11223345678999999875 568999999999999999998 9999988777666555
Q ss_pred HHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 345 IFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 345 I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
+.... .+ .....++..+.+||.+||..||++||++.+++++
T Consensus 239 ~~~~~-~~---------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 239 VRKRQ-LL---------------------------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHcCC-cC---------------------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 53211 00 0123578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=329.83 Aligned_cols=260 Identities=18% Similarity=0.276 Sum_probs=204.2
Q ss_pred cCCeeEEEEeeccCceEEEEEEECC-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLD-----TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 203 (704)
.++|+++++||.|+||.||+|..+. .+..||+|.+..... ......+.+|+.+++.++||||+++++++.. .
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 81 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS-LRERIEFLNEASVMKGFTCHHVVRLLGVVSK--G 81 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC--C
Confidence 4689999999999999999997542 355899999864432 2333456789999999999999999999876 4
Q ss_pred CeEEEEEecccccccccccCC----------CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEe
Q 005289 204 CSIYLVFEYMEHDITGLLSCP----------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLA 273 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~~~~~----------~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~ 273 (704)
...|+||||+.++.+..+... ...++...+..++.||+.||.|||+++|+||||||+|||++.++.+||+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEEC
Confidence 578999999987655544321 1235667889999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCC-CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCC
Q 005289 274 DFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGS 351 (704)
Q Consensus 274 DFGla~~~~~~~~~-~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~ 351 (704)
|||+++........ ......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+.. +.
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~--~~ 238 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD--GG 238 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc--CC
Confidence 99998755432211 1122344678999999875 568999999999999999998 7899988777666655432 11
Q ss_pred CCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh------ccccCCCC
Q 005289 352 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA------SEYFSTKP 420 (704)
Q Consensus 352 ~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~------hpwf~~~~ 420 (704)
.+ .....++..+.+||.+||+.||.+|||+.++++ ||||....
T Consensus 239 ~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 287 (288)
T cd05061 239 YL--------------------------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 287 (288)
T ss_pred CC--------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence 00 001245788999999999999999999999987 89987543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=335.95 Aligned_cols=253 Identities=19% Similarity=0.332 Sum_probs=201.0
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCCcE----EEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKI----VALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~----vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 203 (704)
...+|++++.||+|+||+||+|++..++.. ||||++.... .......+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~--- 80 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLT--- 80 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC---
Confidence 356799999999999999999998766654 8999986432 33445667889999999999999999999876
Q ss_pred CeEEEEEecccccccc-cccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccC
Q 005289 204 CSIYLVFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~-~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~ 282 (704)
...++|+||+.++.+. .+......+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 81 ~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 81 STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred CCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence 3467999999876544 444444568899999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCC-cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhcc
Q 005289 283 TGHRQP-LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (704)
Q Consensus 283 ~~~~~~-~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~ 360 (704)
...... ......+..|+|||++.+ ..++.++|||||||+||||++ |.+||.+....+... +......++
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~------- 231 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLP------- 231 (316)
T ss_pred CCCcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHhCCCCCC-------
Confidence 432211 122234678999999876 568999999999999999997 999998876555433 322111110
Q ss_pred CCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
....++.++.+||.+||..||.+|||+.+++.+
T Consensus 232 --------------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 232 --------------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred --------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 012456789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=322.86 Aligned_cols=245 Identities=24% Similarity=0.358 Sum_probs=196.2
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEecccc
Q 005289 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH 215 (704)
Q Consensus 136 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g 215 (704)
+.||+|+||+||+|++..+++.||+|.+... ...+....+.+|+++|+.++||||+++++++.. ...+||||||+.+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCCeEEEEeeccC
Confidence 3689999999999999999999999998643 334555678899999999999999999999877 4679999999988
Q ss_pred ccccccc-CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCc-cccc
Q 005289 216 DITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL-TSRV 293 (704)
Q Consensus 216 ~ll~~~~-~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~-~~~~ 293 (704)
+.+..+. .....+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++........... ....
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 6555443 3445689999999999999999999999999999999999999999999999999875443211110 1112
Q ss_pred ccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCC
Q 005289 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQ 372 (704)
Q Consensus 294 gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~ 372 (704)
.+..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+.......+.... .+
T Consensus 158 ~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~-~~-------------------- 215 (252)
T cd05084 158 IPVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV-RL-------------------- 215 (252)
T ss_pred CceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCC-CC--------------------
Confidence 2456999998876 568999999999999999997 899998776655444443210 00
Q ss_pred CCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 373 PYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 373 ~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
.....++..+.+||.+||..||++|||+.++++
T Consensus 216 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 216 -------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred -------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 001246788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=342.09 Aligned_cols=255 Identities=21% Similarity=0.327 Sum_probs=199.9
Q ss_pred cCCeeEEEEeeccCceEEEEEEECC-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLD-----TGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRL 202 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~ 202 (704)
.++|++++.||.|+||.||+|.+.. +++.||+|++.... .......+.+|+.++.++ +|+||+++++++...
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~- 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKP- 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-
Confidence 3579999999999999999997543 45789999987543 234456677899999999 899999999988654
Q ss_pred CCeEEEEEecccccccccccCC----------------------------------------------------------
Q 005289 203 SCSIYLVFEYMEHDITGLLSCP---------------------------------------------------------- 224 (704)
Q Consensus 203 ~~~~~LV~Ey~~g~ll~~~~~~---------------------------------------------------------- 224 (704)
...+|+||||+.++.+..++..
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 4678999999998655433211
Q ss_pred ---CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCC-CcccccccccccC
Q 005289 225 ---DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRP 300 (704)
Q Consensus 225 ---~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~-~~~~~~gT~~Y~A 300 (704)
...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++......... ......++..|+|
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 125789999999999999999999999999999999999999999999999999865432211 1223345678999
Q ss_pred cccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhh
Q 005289 301 PELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLR 379 (704)
Q Consensus 301 PEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~ 379 (704)
||++.+ ..++.++|||||||+||+|++ |.+||.+....+.+...... +..+
T Consensus 244 PE~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~-------------------------- 295 (337)
T cd05054 244 PESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKE-GTRM-------------------------- 295 (337)
T ss_pred cHHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhc-cCCC--------------------------
Confidence 999876 568999999999999999998 99999875544433333221 0000
Q ss_pred hhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 380 ETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 380 ~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.....+++++.+|+.+||+.+|++|||+.++++|
T Consensus 296 ~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 296 RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0012467889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=333.05 Aligned_cols=256 Identities=27% Similarity=0.482 Sum_probs=210.8
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEe
Q 005289 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFE 211 (704)
Q Consensus 132 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~E 211 (704)
|....+||+|+||.||++....+++.||||++.... ......+.+|+.+++.++|+||+++++++.. ....|+|||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e 97 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVVME 97 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEe--CCEEEEEEe
Confidence 444567999999999999999999999999986432 3345668889999999999999999999987 578999999
Q ss_pred cccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCccc
Q 005289 212 YMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 291 (704)
Q Consensus 212 y~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~ 291 (704)
|++++.+..+.. ...+++..+..++.||+.+|.|||++||+|+||+|+||+++.++.++|+|||++....... .....
T Consensus 98 ~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~ 175 (292)
T cd06657 98 FLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKS 175 (292)
T ss_pred cCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccc
Confidence 999876665543 3368999999999999999999999999999999999999999999999999987554322 12234
Q ss_pred ccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCC
Q 005289 292 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 371 (704)
Q Consensus 292 ~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~ 371 (704)
..+++.|+|||.+.. ..++.++|||||||++|+|++|.+||.+....+.+..+.... ++ .
T Consensus 176 ~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~--~~-~---------------- 235 (292)
T cd06657 176 LVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL--PP-K---------------- 235 (292)
T ss_pred cccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC--Cc-c----------------
Confidence 567899999998765 567899999999999999999999999877766655543311 00 0
Q ss_pred CCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCC
Q 005289 372 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (704)
Q Consensus 372 ~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~ 420 (704)
......++..+.+||.+||..||.+|||+.++|.||||....
T Consensus 236 -------~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 236 -------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred -------cCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 001235788899999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=330.52 Aligned_cols=251 Identities=22% Similarity=0.343 Sum_probs=203.0
Q ss_pred cCCeeEEEEeeccCceEEEEEEE-----CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARD-----LDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~-----~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 203 (704)
.++|.+.+.||.|+||+||++.+ ..++..||+|.+.... ......+.+|+.+|++++||||+++++++.. .
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 79 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVE--G 79 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec--C
Confidence 45799999999999999999985 3356679999986432 3445678899999999999999999999876 5
Q ss_pred CeEEEEEecccccccccccC-------------CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCce
Q 005289 204 CSIYLVFEYMEHDITGLLSC-------------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVL 270 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~~~~-------------~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~i 270 (704)
..+|+||||+.++.+..+.. ....+++..+..++.||+.||+|||++||+||||||+|||+++++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 78999999999765544332 11248999999999999999999999999999999999999999999
Q ss_pred EEeccccccccCCCCC-CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHH
Q 005289 271 KLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKL 348 (704)
Q Consensus 271 KL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~ 348 (704)
||+|||++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||......+.+..+..
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~- 237 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ- 237 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-
Confidence 9999999976543221 11122344778999998876 568999999999999999998 9999988887777666643
Q ss_pred cCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 349 CGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 349 ~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
+..+ .....++.++.+||.+||..||.+|||+.+++.
T Consensus 238 -~~~~--------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 238 -GRVL--------------------------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred -CCcC--------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 1110 011256788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=331.60 Aligned_cols=262 Identities=24% Similarity=0.391 Sum_probs=207.4
Q ss_pred ccccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCC
Q 005289 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSC 204 (704)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~ 204 (704)
.+..++|++.+.||.|+||+||+|.+..+++.||||++...... .....+.+|+.++.++ +||||+++++++.+ ..
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~ 87 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFIT--DS 87 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeec--CC
Confidence 34567899999999999999999999989999999999765432 2344556677767666 59999999999987 56
Q ss_pred eEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHh-cCcccccCCCccEEEccCCceEEeccccccccCC
Q 005289 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~-~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~ 283 (704)
.+|+||||+.+.+...+......+++..+..++.||+.||.|||+ .||+||||+|+|||+++++.+||+|||++.....
T Consensus 88 ~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 88 DVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 899999999875555544444578999999999999999999997 5999999999999999999999999999876543
Q ss_pred CCCCCcccccccccccCcccccCC---CCCCCccchhhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHcCCCCchhhhc
Q 005289 284 GHRQPLTSRVVTLWYRPPELLLGA---TDYGPSVDLWSVGCVFAELLIGKPILQGRT-EVEQLHKIFKLCGSPPDDYWKK 359 (704)
Q Consensus 284 ~~~~~~~~~~gT~~Y~APEvl~~~---~~y~~~~DIWSlG~iLyeLltG~~pF~~~~-~~e~l~~I~~~~g~~p~~~w~~ 359 (704)
.. ......+++.|+|||.+.+. ..++.++|||||||++|+|++|++||.... ..+.+..+.... .+.
T Consensus 168 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~----- 238 (296)
T cd06618 168 SK--AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE--PPS----- 238 (296)
T ss_pred CC--cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC--CCC-----
Confidence 22 12233567889999998653 247889999999999999999999997633 233444432210 000
Q ss_pred cCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
. .....++.++.+||.+||..||.+|||+.++|.||||..
T Consensus 239 --------------~-----~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 278 (296)
T cd06618 239 --------------L-----PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278 (296)
T ss_pred --------------C-----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence 0 001246788999999999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=323.73 Aligned_cols=253 Identities=24% Similarity=0.348 Sum_probs=204.6
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCC---CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCe
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDT---GKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (704)
.++|++.+.||+|+||+||+|.+..+ ...||||++.... .......+.+|+.+|+.++||||+++++++.. ...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 79 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK--SRP 79 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEec--CCc
Confidence 35799999999999999999988644 4579999987543 33445667889999999999999999999876 467
Q ss_pred EEEEEecccccccccc-cCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 206 IYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~-~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
+|+||||+.++.+..+ ......+++..+..++.||+.||.|||+++|+|+||||+||||+.++.++|+|||++......
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 8999999998655544 334457899999999999999999999999999999999999999999999999999876522
Q ss_pred CCC-CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCC
Q 005289 285 HRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (704)
Q Consensus 285 ~~~-~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~ 362 (704)
... ......+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+......+
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---------- 228 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLP---------- 228 (266)
T ss_pred ccceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC----------
Confidence 111 1111233678999998875 568999999999999999998 999998877766666554311000
Q ss_pred CCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
....++..+.+||.+||..||++||++.+++++
T Consensus 229 ------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 229 ------------------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred ------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 012568889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=316.82 Aligned_cols=252 Identities=33% Similarity=0.521 Sum_probs=208.9
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 210 (704)
.|++.+.||.|+||.||++.+..+++.|++|++..... .....+.+|+.+++.++|+||+++++++.. ....|+|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l~~ 76 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLK--KDELWIVM 76 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CCeEEEEE
Confidence 38899999999999999999998999999999976543 345678899999999999999999999877 46789999
Q ss_pred ecccccccccccCC-CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCc
Q 005289 211 EYMEHDITGLLSCP-DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (704)
Q Consensus 211 Ey~~g~ll~~~~~~-~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~ 289 (704)
||+++..+..+... ...+++..+..++.||+.+|.|||.+|++|+||+|+||++++++.++|+|||++........ .
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence 99997655544333 35789999999999999999999999999999999999999999999999999977654321 2
Q ss_pred ccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCC
Q 005289 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (704)
Q Consensus 290 ~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~ 369 (704)
....++..|+|||.+.. ..++.++|||||||++|+|++|.+||...+....+..+.. ...+..
T Consensus 155 ~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~-------------- 217 (253)
T cd05122 155 NTMVGTPYWMAPEVING-KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT--NGPPGL-------------- 217 (253)
T ss_pred cceecCCcccCHHHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh--cCCCCc--------------
Confidence 34567889999999876 4488999999999999999999999988765555544432 111000
Q ss_pred CCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccc
Q 005289 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415 (704)
Q Consensus 370 ~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpw 415 (704)
+ ....++..+.+||.+||..||++|||+.++|.|||
T Consensus 218 ---~-------~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 218 ---R-------NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred ---C-------cccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 0 00124788999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=324.72 Aligned_cols=250 Identities=21% Similarity=0.319 Sum_probs=201.2
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|++++.||+|+||+||++.+.. +..||||.+...... ...+.+|+.++++++||||+++++++.. ...+|+
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 76 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTK--QRPIYI 76 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEcc--CCCcEE
Confidence 3469999999999999999998754 456999998754432 3457889999999999999999999876 457899
Q ss_pred EEeccccccccccc-CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCC
Q 005289 209 VFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (704)
Q Consensus 209 V~Ey~~g~ll~~~~-~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~ 287 (704)
||||+.++.+..+. .....+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++.........
T Consensus 77 v~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 77 VTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred EEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 99999886555443 33346899999999999999999999999999999999999999999999999998765433211
Q ss_pred CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcc
Q 005289 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (704)
Q Consensus 288 ~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~ 366 (704)
......++..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+......+
T Consensus 157 ~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 221 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLY-SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLY-------------- 221 (256)
T ss_pred ecCCCccChhhCCHHHHhc-CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCC--------------
Confidence 1122234677999999875 458899999999999999998 999998877766666654321100
Q ss_pred cCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.....+..+.+||.+||..||.+|||+.++|.+
T Consensus 222 --------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 222 --------------RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred --------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 012357889999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=322.37 Aligned_cols=249 Identities=22% Similarity=0.321 Sum_probs=200.8
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|++.+.||.|+||.||+|.+. .++.||||.+...... .+.+.+|+.+|++++||||+++++++.. ....|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 78 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTL--EEPIYI 78 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEec--CCCeee
Confidence 457999999999999999999875 4578999998755432 3457789999999999999999998876 467899
Q ss_pred EEecccccccccccCC--CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC
Q 005289 209 VFEYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~--~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~ 286 (704)
||||+.++.+..+... ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++........
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 9999976554444322 34689999999999999999999999999999999999999999999999999987653221
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
........+..|+|||++.+ ..++.++|||||||++|+|++ |++||.+.+....+..+.... .++
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~------------ 224 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGY-RMP------------ 224 (261)
T ss_pred cccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCC------------
Confidence 11111222457999998875 568999999999999999999 999999888777666654311 000
Q ss_pred ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
....++..+.+||.+||..||.+|||+.+++.
T Consensus 225 ---------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 225 ---------------CPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred ---------------CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 01256788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=327.40 Aligned_cols=253 Identities=16% Similarity=0.244 Sum_probs=200.6
Q ss_pred cCCeeEEEEeeccCceEEEEEEECC-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLD-----TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 203 (704)
.++|++.+.||+|+||+||+|.+.. ++..||||++..... ......+.+|+.+++.++||||+++++++.. .
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--~ 81 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--G 81 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC--C
Confidence 4579999999999999999998642 456799999864332 2334557789999999999999999999876 4
Q ss_pred CeEEEEEecccccccccccCC----------CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEe
Q 005289 204 CSIYLVFEYMEHDITGLLSCP----------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLA 273 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~~~~~----------~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~ 273 (704)
..+|+||||+.++.+..+... ...++...+..++.||+.||.|||++||+|+||||+|||+++++.++|+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence 678999999998655544321 1235778899999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCC-CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCC
Q 005289 274 DFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGS 351 (704)
Q Consensus 274 DFGla~~~~~~~~~-~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~ 351 (704)
|||++......... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+... .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~--~ 238 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG--G 238 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC--C
Confidence 99998755432211 1122345778999999875 568999999999999999998 78999888776666554331 1
Q ss_pred CCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 352 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 352 ~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.+ .....++..+.+||.+||..||++|||+.++|++
T Consensus 239 ~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 239 LL--------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred cC--------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 10 0113567889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=324.84 Aligned_cols=248 Identities=23% Similarity=0.318 Sum_probs=199.9
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|+++++||+|+||+||+|++..+ ..||||++...... .+.+.+|+.+++.++||||+++++++.. ...|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~l 77 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYI 77 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEECC---CCcEE
Confidence 35799999999999999999998665 45999999764432 3457889999999999999999988754 45799
Q ss_pred EEecccccccccccC--CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC
Q 005289 209 VFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~--~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~ 286 (704)
||||+.++.+..+.. ....+++..+..++.||+.||.|||+++|+|+||||+|||+++++.+||+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 999999855544432 234578999999999999999999999999999999999999999999999999976654322
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
.......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+.+..+.... .+
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~-~~------------- 222 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-RM------------- 222 (262)
T ss_pred ccccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCC-CC-------------
Confidence 22223345678999998865 568999999999999999999 899998887776666553311 00
Q ss_pred ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
.....++..+.+||.+||..||++|||+.++++
T Consensus 223 --------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 223 --------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred --------------CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 001357888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=321.67 Aligned_cols=252 Identities=27% Similarity=0.457 Sum_probs=211.3
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 210 (704)
+|++.++||.|+||.||++.+..+++.||+|.+............+.+|+.+++.++|+||+++++++.+ ....|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD--GNKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc--CCEEEEEe
Confidence 4899999999999999999999999999999998765555556677889999999999999999999877 47899999
Q ss_pred ecccccccccccCC----CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC
Q 005289 211 EYMEHDITGLLSCP----DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 211 Ey~~g~ll~~~~~~----~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~ 286 (704)
||+.+..+..+... ...+++..++.++.||+.||.|||+.||+|+||+|+||++++++.+||+|||++......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-- 156 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-- 156 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence 99988655543322 356899999999999999999999999999999999999999999999999999776543
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcc
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~ 366 (704)
......+++.|+|||.+.+ ..++.++|+|||||++|+|++|++||...+..+....+.. +..+
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~------------- 219 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR--GKYP------------- 219 (256)
T ss_pred -CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCCC-------------
Confidence 2233467889999999876 5688899999999999999999999998876655544432 1110
Q ss_pred cCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
.....++.+++++|.+||..+|.+|||+.++|+||++
T Consensus 220 -------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 220 -------------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred -------------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 0112567889999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=323.68 Aligned_cols=249 Identities=22% Similarity=0.327 Sum_probs=200.7
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
.+|++.+.||.|+||.||++.+. ++..+|+|++...... ...+.+|+.+++.++||||+++++++.. ....|+|
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv 77 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTK--QRPIFIV 77 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcC--CCceEEE
Confidence 36999999999999999999875 4668999998654432 2346779999999999999999999876 4678999
Q ss_pred Eeccccccccc-ccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 210 FEYMEHDITGL-LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 210 ~Ey~~g~ll~~-~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
|||++++.+.. +......+++..+..++.||+.||.|||++||+||||||+|||+++++.+||+|||+++.........
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 99998865544 33334478999999999999999999999999999999999999999999999999987654322111
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCccc
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~ 367 (704)
.....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+......
T Consensus 158 ~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 220 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL---------------- 220 (256)
T ss_pred cCCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcC----------------
Confidence 111223457999998876 568999999999999999998 89999888777766655331100
Q ss_pred CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.....++..+.+||.+||..+|++|||+.++|+.
T Consensus 221 ------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 221 ------------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred ------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 0113478899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=323.74 Aligned_cols=248 Identities=21% Similarity=0.329 Sum_probs=200.4
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|+++++||+|+||+||+|.+. .+..||+|.+...... ...+.+|+.+|++++|+||+++++++.. ..+|+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~l 77 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVSE---EPIYI 77 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEECC---CCcEE
Confidence 457999999999999999999865 5667999999765443 2457889999999999999999988754 45799
Q ss_pred EEecccccccccccC--CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC
Q 005289 209 VFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~--~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~ 286 (704)
||||+.++.+..+.. ....+++..+..++.||+.||.|||++||+||||||+|||+++++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 999998865554432 234589999999999999999999999999999999999999999999999999976543322
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
.......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+.... .+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~------------- 222 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY-RM------------- 222 (260)
T ss_pred ccccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CC-------------
Confidence 21222334667999998865 568899999999999999999 899999887777666654311 00
Q ss_pred ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
......+..+.+||.+||..||++|||+.+++.
T Consensus 223 --------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 223 --------------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred --------------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 011356888999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=323.53 Aligned_cols=244 Identities=21% Similarity=0.290 Sum_probs=199.0
Q ss_pred EeeccCceEEEEEEE--CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEeccc
Q 005289 137 KIGQGTYSSVFRARD--LDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME 214 (704)
Q Consensus 137 ~LG~G~fg~Vy~a~~--~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~ 214 (704)
+||+|+||+||+|.+ ..++..||||++..........+.+.+|+.+|+.++||||+++++++.. ...+|||||+.
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA---ESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCcEEEEecCC
Confidence 589999999999964 4678899999987665555566778899999999999999999998754 46799999999
Q ss_pred ccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCC--Ccccc
Q 005289 215 HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ--PLTSR 292 (704)
Q Consensus 215 g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~--~~~~~ 292 (704)
++.+..+......+++..+..++.||+.||.|||++||+||||||.|||++.++.+||+|||++......... .....
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05116 79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG 158 (257)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence 8766655555557899999999999999999999999999999999999999999999999999765433211 11122
Q ss_pred cccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCC
Q 005289 293 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 371 (704)
Q Consensus 293 ~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~ 371 (704)
.+++.|+|||.+.. ..++.++|||||||++|||++ |.+||......+....+.... .+
T Consensus 159 ~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~--~~------------------ 217 (257)
T cd05116 159 KWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE--RM------------------ 217 (257)
T ss_pred CCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC--CC------------------
Confidence 33578999998865 568889999999999999998 999999887777666654311 00
Q ss_pred CCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 372 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 372 ~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
.....++.++.+||.+||+.||++||+++++..
T Consensus 218 --------~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 218 --------ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred --------CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 011357899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=327.23 Aligned_cols=253 Identities=21% Similarity=0.311 Sum_probs=201.5
Q ss_pred cCCeeEEEEeeccCceEEEEEEECC-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLD-----TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 203 (704)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++|+||+++++++.+ .
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 81 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE--R 81 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc--C
Confidence 3579999999999999999999977 77899999886543 23334567889999999999999999998876 4
Q ss_pred CeEEEEEecccccccccccCC-------CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCC---ceEEe
Q 005289 204 CSIYLVFEYMEHDITGLLSCP-------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLA 273 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~~~~~-------~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g---~iKL~ 273 (704)
...|+||||+.++.+..+... ...+++..+..++.||+.||.|||+++|+|+||||+|||++.++ .+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 567999999987655544321 12589999999999999999999999999999999999998765 59999
Q ss_pred ccccccccCCCCCC-CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCC
Q 005289 274 DFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGS 351 (704)
Q Consensus 274 DFGla~~~~~~~~~-~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~ 351 (704)
|||+++........ .......+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+... ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~ 239 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG-GR 239 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-Cc
Confidence 99999865322111 1112233567999999876 568999999999999999997 99999988776655544321 00
Q ss_pred CCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 352 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 352 ~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
+ .....++..+.+||.+||..||++|||+.++|+|
T Consensus 240 ~---------------------------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 240 L---------------------------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred C---------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 0013568899999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=329.59 Aligned_cols=259 Identities=20% Similarity=0.273 Sum_probs=204.3
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCC----------------cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCce
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTG----------------KIVALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g----------------~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 192 (704)
..+|++++.||+|+||.||+|.+..++ ..||+|++.... .......+.+|+.+|++++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 457999999999999999999876544 568999987553 234566788999999999999999
Q ss_pred eEeEEEeecCCCeEEEEEecccccccccccCCC-----------ccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCcc
Q 005289 193 KLEGLITSRLSCSIYLVFEYMEHDITGLLSCPD-----------IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSN 261 (704)
Q Consensus 193 ~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~~-----------~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~N 261 (704)
++++++.. ...+++||||+.++.+..+.... ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 83 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 83 RLLGVCTV--DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EEEEEEec--CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 99999877 46889999999876555443222 268999999999999999999999999999999999
Q ss_pred EEEccCCceEEeccccccccCCCCC-CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh--CCCCCCCCCH
Q 005289 262 LLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI--GKPILQGRTE 338 (704)
Q Consensus 262 ILl~~~g~iKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt--G~~pF~~~~~ 338 (704)
||++.++.++|+|||++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ +..||...+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 9999999999999999876543221 11223345788999998875 468999999999999999998 7788987777
Q ss_pred HHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 339 VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 339 ~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
.+.+..+........ . .. .......++.++.+||.+||..||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~--------~---~~----------~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 240 QQVIENAGHFFRDDG--------R---QI----------YLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHHhcccccc--------c---cc----------cCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 666666543211100 0 00 00111356789999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=327.86 Aligned_cols=255 Identities=24% Similarity=0.367 Sum_probs=203.7
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCC-----CcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEee
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDT-----GKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITS 200 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~-----g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~ 200 (704)
+..++|++.+.||+|+||.||++..... ...||+|.+.... .......+.+|+.++.++ +||||+++++++..
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 3456899999999999999999987644 3789999987543 234456678899999999 89999999999876
Q ss_pred cCCCeEEEEEeccccccccccc----------------CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEE
Q 005289 201 RLSCSIYLVFEYMEHDITGLLS----------------CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV 264 (704)
Q Consensus 201 ~~~~~~~LV~Ey~~g~ll~~~~----------------~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl 264 (704)
...+|+||||+.++.+..+. .....+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 88 --~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 88 --EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV 165 (293)
T ss_pred --CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE
Confidence 46799999999886554333 234568999999999999999999999999999999999999
Q ss_pred ccCCceEEeccccccccCCCCCC-CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHH
Q 005289 265 NNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQL 342 (704)
Q Consensus 265 ~~~g~iKL~DFGla~~~~~~~~~-~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l 342 (704)
++++.+||+|||+++........ ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+..
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 244 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 244 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH
Confidence 99999999999999865432211 1122234567999998865 568999999999999999997 99999887766655
Q ss_pred HHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 343 HKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 343 ~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
..+.... .+ .....++..+.+||.+||..||++|||+.++|++
T Consensus 245 ~~~~~~~--~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 245 KLLKEGY--RM--------------------------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHcCC--cC--------------------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 5443210 00 0112467889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=329.88 Aligned_cols=253 Identities=21% Similarity=0.317 Sum_probs=203.8
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCC-----CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDT-----GKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~-----g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 203 (704)
.++|+++++||+|+||+||+|.+..+ ++.||||++.... .....+.+.+|+.++..++||||+++++++.. .
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~ 80 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK--E 80 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--C
Confidence 45689999999999999999987543 5789999997543 23345667889999999999999999999977 4
Q ss_pred CeEEEEEecccccccccccC----------------CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccC
Q 005289 204 CSIYLVFEYMEHDITGLLSC----------------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE 267 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~~~~----------------~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~ 267 (704)
..+++++||+.++.+..+.. ....+++..+..++.||+.||.|||++||+||||||+|||++++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 57899999998755443321 12357888999999999999999999999999999999999999
Q ss_pred CceEEeccccccccCCCCC-CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 005289 268 GVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKI 345 (704)
Q Consensus 268 g~iKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I 345 (704)
+.+||+|||+++....... .......+++.|+|||++.. ..++.++|||||||++|||++ |.+||.+....+.+..+
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999876543221 11223345788999999875 458999999999999999998 89999988877777666
Q ss_pred HHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 346 FKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 346 ~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
...... .....++..+.+||..||+.+|.+||++.+++..
T Consensus 240 ~~~~~~----------------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 240 RNRQVL----------------------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HcCCcC----------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 442110 0113678889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=324.96 Aligned_cols=252 Identities=18% Similarity=0.295 Sum_probs=201.0
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCCc----EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTGK----IVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~----~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 203 (704)
..++|+++++||.|+||+||+|++..++. .||||++.... .......+.+|+.++..++||||+++++++..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--- 80 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT--- 80 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC---
Confidence 35689999999999999999999877776 48999987543 34445668889999999999999999998865
Q ss_pred CeEEEEEecccccccc-cccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccC
Q 005289 204 CSIYLVFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~-~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~ 282 (704)
...+++|||++++.+. .+......+++..+..++.||+.||.|||+++|+||||||+|||+++++.+||+|||+++...
T Consensus 81 ~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 81 STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 3578999999875544 443445578999999999999999999999999999999999999999999999999998664
Q ss_pred CCCCC-CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhcc
Q 005289 283 TGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (704)
Q Consensus 283 ~~~~~-~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~ 360 (704)
..... ......+++.|+|||.+.+ ..++.++|||||||+||||++ |.+||...........+.. ...++
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~------- 231 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK-GERLP------- 231 (279)
T ss_pred cccceeecCCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCcCC-------
Confidence 32211 1112234678999999876 568999999999999999998 9999987665554443322 11110
Q ss_pred CCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
....++.++.+||.+||..||++|||+.+++.
T Consensus 232 --------------------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 232 --------------------QPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred --------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01346788999999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=350.64 Aligned_cols=252 Identities=29% Similarity=0.500 Sum_probs=205.0
Q ss_pred EeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEeccccc
Q 005289 137 KIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD 216 (704)
Q Consensus 137 ~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~ 216 (704)
.||+|+||+||-|+|..|...+|||.|.-.. .....-+..||.+.+.|.|.|||++++.+.. ++++-|.||-++|+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~se--nGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVSE--NGFFKIFMEQVPGG 657 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccCC--CCeEEEEeecCCCC
Confidence 5999999999999999999999999996432 3345567899999999999999999999866 57888999999998
Q ss_pred ccccccCC-Cccc--cHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEc-cCCceEEeccccccccCCCCCCCcccc
Q 005289 217 ITGLLSCP-DIKF--SEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTSR 292 (704)
Q Consensus 217 ll~~~~~~-~~~l--~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~-~~g~iKL~DFGla~~~~~~~~~~~~~~ 292 (704)
.+..++.. =+++ .|..+..|.+||++||.|||++.|||||||.+||||+ -.|.+||+|||.++....- .....+.
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~TETF 736 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCTETF 736 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccC-Ccccccc
Confidence 77766543 3455 7899999999999999999999999999999999996 4689999999999866432 2334556
Q ss_pred cccccccCccccc-CCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCC
Q 005289 293 VVTLWYRPPELLL-GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 371 (704)
Q Consensus 293 ~gT~~Y~APEvl~-~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~ 371 (704)
.||..|||||++. +...|+.++|||||||++.||.||+|||..-.... ..|+++ .+++..
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq--AAMFkV-----------------GmyKvH 797 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ--AAMFKV-----------------GMYKVH 797 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh--Hhhhhh-----------------cceecC
Confidence 7899999999995 45679999999999999999999999997533221 112221 111211
Q ss_pred CCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 372 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 372 ~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
.+. ...++.+++.||.+|+.+||.+||+|.++|.+||++..
T Consensus 798 P~i-------Peelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 798 PPI-------PEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred CCC-------cHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 111 13577889999999999999999999999999999865
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=323.01 Aligned_cols=255 Identities=18% Similarity=0.271 Sum_probs=203.6
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCC-----CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeec
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDT-----GKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR 201 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~-----g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 201 (704)
+..++|++.+.||.|+||.||++.+... +..||+|.+.... .......+.+|+.+|..++||||+++++++..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~- 80 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVST- 80 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC-
Confidence 3456899999999999999999987643 4789999986443 23334567789999999999999999999887
Q ss_pred CCCeEEEEEecccccccccccC----------CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceE
Q 005289 202 LSCSIYLVFEYMEHDITGLLSC----------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLK 271 (704)
Q Consensus 202 ~~~~~~LV~Ey~~g~ll~~~~~----------~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iK 271 (704)
....|+||||+.++.+..+.. ....+++..+..++.||+.||.|||+++|+||||||+|||++.++.+|
T Consensus 81 -~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 81 -GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred -CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence 467899999998755543321 122468889999999999999999999999999999999999999999
Q ss_pred EeccccccccCCCCC-CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHc
Q 005289 272 LADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLC 349 (704)
Q Consensus 272 L~DFGla~~~~~~~~-~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~ 349 (704)
|+|||+++....... .......++..|+|||.+.. ..++.++|||||||++|+|++ |.+||.+.+..+.+..+..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-- 236 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID-- 236 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc--
Confidence 999999876543221 12233456788999998865 558999999999999999998 9999988877666655531
Q ss_pred CCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 350 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 350 g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
+..+ .....++..+.+||.+||..+|++|||+.+++..
T Consensus 237 ~~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~ 274 (277)
T cd05032 237 GGHL--------------------------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSS 274 (277)
T ss_pred CCCC--------------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 1110 0012457889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=344.22 Aligned_cols=254 Identities=21% Similarity=0.349 Sum_probs=209.8
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.+.+.+...||.|.||+||+|++-.+ ||||++..+..+++..+.|.+|+.+|++-+|.||+-+.|+|..+ .+.|
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p---~~AI 464 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP---PLAI 464 (678)
T ss_pred HHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC---ceee
Confidence 45678889999999999999998654 99999999888889999999999999999999999999999873 3489
Q ss_pred EEecccccccc-cccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC-CC
Q 005289 209 VFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG-HR 286 (704)
Q Consensus 209 V~Ey~~g~ll~-~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~-~~ 286 (704)
|+.+|+|..|. .+.....+|.......|++||+.|+.|||.++|||||||..||+|.+++.|||+||||+.....- ..
T Consensus 465 iTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~ 544 (678)
T KOG0193|consen 465 ITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGE 544 (678)
T ss_pred eehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccc
Confidence 99999996655 44556678999999999999999999999999999999999999999999999999999654311 11
Q ss_pred CCcccccccccccCccccc--CCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC
Q 005289 287 QPLTSRVVTLWYRPPELLL--GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~--~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
..+....+...|||||++. ...+|++.+|||||||++|||++|..||.....+.++..+-...+.
T Consensus 545 ~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~------------- 611 (678)
T KOG0193|consen 545 QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLM------------- 611 (678)
T ss_pred cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccC-------------
Confidence 2233445678899999985 3467999999999999999999999999955555444333221111
Q ss_pred cccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
..+.....+.+.++++|+..|+.+++++||+..+||.
T Consensus 612 -----------pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 612 -----------PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred -----------ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 1122334578889999999999999999999999986
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=320.93 Aligned_cols=248 Identities=21% Similarity=0.354 Sum_probs=201.4
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.+.|+++++||.|+||+||+|... +++.||+|.+...... ...+.+|+.+|+.++||||+++++++.. ..+|+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~ 77 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVTQ---EPIYI 77 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEcc---CCcEE
Confidence 467999999999999999999864 5788999998765433 3457789999999999999999998754 46899
Q ss_pred EEeccccccccccc--CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC
Q 005289 209 VFEYMEHDITGLLS--CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 209 V~Ey~~g~ll~~~~--~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~ 286 (704)
||||+.++.+..+. .....+++..+..++.||+.||.|||+.||+|+||||+||++++++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 99999875544332 2345689999999999999999999999999999999999999999999999999976653222
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
.......++..|+|||++.. ..++.++|||||||++|+|++ |++||.+.+..+.+..+......
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 222 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM-------------- 222 (260)
T ss_pred ccccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC--------------
Confidence 22223345678999998865 568899999999999999999 99999988776666655331110
Q ss_pred ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
.....++.++.+||.+||..||++|||+++++.
T Consensus 223 --------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 223 --------------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred --------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 011356788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=370.20 Aligned_cols=261 Identities=30% Similarity=0.471 Sum_probs=207.2
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeec------
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR------ 201 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~------ 201 (704)
...+|+.+..||+||||.||+|+++-+|+.||||+|.... .......+.+|+.+|.+|+|||||+++..+.+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 4567999999999999999999999999999999998765 566677889999999999999999976432110
Q ss_pred ----------------------------------------------------------C---------------------
Q 005289 202 ----------------------------------------------------------L--------------------- 202 (704)
Q Consensus 202 ----------------------------------------------------------~--------------------- 202 (704)
.
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0
Q ss_pred ------------------------C--------CeEEEEEecccccccccccCCCccc-cHHHHHHHHHHhhhhHHHHHh
Q 005289 203 ------------------------S--------CSIYLVFEYMEHDITGLLSCPDIKF-SEAQIKCYMNQLLHGLEHCHS 249 (704)
Q Consensus 203 ------------------------~--------~~~~LV~Ey~~g~ll~~~~~~~~~l-~e~~~~~i~~QIl~aL~yLH~ 249 (704)
. ..+||-||||+..++..+...+..+ ....+|.+++||+.||.|+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence 0 1478999999999988887766555 578899999999999999999
Q ss_pred cCcccccCCCccEEEccCCceEEeccccccccC-----------------CCCCCCcccccccccccCcccccCCC--CC
Q 005289 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN-----------------TGHRQPLTSRVVTLWYRPPELLLGAT--DY 310 (704)
Q Consensus 250 ~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~-----------------~~~~~~~~~~~gT~~Y~APEvl~~~~--~y 310 (704)
+|||||||||.||+|+.++.|||+|||+|+... .......++.+||.-|+|||++.+.. .|
T Consensus 716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y 795 (1351)
T KOG1035|consen 716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY 795 (1351)
T ss_pred CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence 999999999999999999999999999998611 01122567889999999999997765 69
Q ss_pred CCccchhhHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHH
Q 005289 311 GPSVDLWSVGCVFAELLIGKPILQGR-TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTA 389 (704)
Q Consensus 311 ~~~~DIWSlG~iLyeLltG~~pF~~~-~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~ 389 (704)
+.++||||||+||+||+. ||... ....++.++.+ |..|.+ +. .+..--+.-
T Consensus 796 n~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~--g~iP~~---------~~--------------f~~~~~~~e 847 (1351)
T KOG1035|consen 796 NSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRK--GSIPEP---------AD--------------FFDPEHPEE 847 (1351)
T ss_pred cchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhccc--CCCCCC---------cc--------------cccccchHH
Confidence 999999999999999994 46543 23344444432 222211 00 011222345
Q ss_pred HHHHHHhhccCCCCCcCHHHHHhccccC
Q 005289 390 VNLIETLLSVEPYKRATASAALASEYFS 417 (704)
Q Consensus 390 ~dLI~~mL~~dP~kRpTa~e~L~hpwf~ 417 (704)
..+|++||+.||.+||||.|+|++.||-
T Consensus 848 ~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 848 ASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 6899999999999999999999999985
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=323.52 Aligned_cols=248 Identities=21% Similarity=0.303 Sum_probs=205.1
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
.+|+++++||.|+||+||+|.+.. ++.+|+|++.... ......+.+|+.+|+.++||||+++++++.+ ...+|+|
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv 80 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSV--GEPVYII 80 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEec--CCCeEEE
Confidence 469999999999999999999877 8899999987553 2234567889999999999999999999877 4678999
Q ss_pred EecccccccccccC--CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCC
Q 005289 210 FEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~--~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~ 287 (704)
|||++++.+..+.. ....+++..+..++.||+.||.|||++||+|+||||+||||++++.+||+|||++.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 99999865554432 3456899999999999999999999999999999999999999999999999999766432211
Q ss_pred CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcc
Q 005289 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (704)
Q Consensus 288 ~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~ 366 (704)
.....++..|+|||++.. ..++.++|||||||++|+|++ |+.||.+.+..+.+..+..... +
T Consensus 161 -~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~-------------- 223 (261)
T cd05148 161 -SSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYR-M-------------- 223 (261)
T ss_pred -ccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCc-C--------------
Confidence 223345678999998875 568899999999999999998 8999998887777776653110 0
Q ss_pred cCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
.....+++.+.++|.+||..||.+|||+.++++
T Consensus 224 -------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 224 -------------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred -------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 011367889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=319.25 Aligned_cols=251 Identities=22% Similarity=0.331 Sum_probs=204.0
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
+..++|++.++||.|+||+||+|.+. .++.||||.+...... ...+.+|+.+|+.++||||+++++++.. ...+
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 76 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSE--EEPI 76 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeec--CCce
Confidence 34578999999999999999999975 4578999998765433 3457889999999999999999999876 4678
Q ss_pred EEEEeccccccccccc-C-CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 207 YLVFEYMEHDITGLLS-C-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~-~-~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
|+||||++++.+..+. . ....+++..+..++.||+.||.|||++||+|+||||+||+|++++.+||+|||++......
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 9999999886554443 2 2246899999999999999999999999999999999999999999999999998766432
Q ss_pred CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCC
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
..........+..|+|||.+.+ ..++.++|||||||++|+|++ |++||.+.+....+.++......+
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~----------- 224 (261)
T cd05034 157 EYTAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMP----------- 224 (261)
T ss_pred hhhhhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-----------
Confidence 2111122234568999998875 568999999999999999998 999999888777777764421110
Q ss_pred CcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
.....+.++.++|.+||..||++|||+.+++.
T Consensus 225 -----------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 225 -----------------RPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred -----------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 01245788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=330.51 Aligned_cols=253 Identities=25% Similarity=0.341 Sum_probs=199.3
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcE--EEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCC
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKI--VALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLS 203 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~--vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 203 (704)
+..++|++.+.||+|+||+||+|.+..++.. +|+|.+... ........+.+|+.+|.++ +||||+++++++.. .
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~--~ 80 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--R 80 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC--C
Confidence 3456899999999999999999998877764 567766432 2344456778899999999 89999999999877 4
Q ss_pred CeEEEEEecccccccccccC----------------CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccC
Q 005289 204 CSIYLVFEYMEHDITGLLSC----------------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE 267 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~~~~----------------~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~ 267 (704)
..+|+||||++++.+..+.. ....+++..++.++.||+.||+|||++||+||||||+||||+.+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~ 160 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 160 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence 67999999998754443321 12358899999999999999999999999999999999999999
Q ss_pred CceEEeccccccccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 005289 268 GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIF 346 (704)
Q Consensus 268 g~iKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~ 346 (704)
+.+||+|||++........ ......+..|+|||++.+ ..++.++|||||||+||+|++ |.+||.+.+..+....+.
T Consensus 161 ~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 237 (303)
T cd05088 161 YVAKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 237 (303)
T ss_pred CcEEeCccccCcccchhhh--cccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh
Confidence 9999999999864321111 111223567999998865 568899999999999999998 999998877766555442
Q ss_pred HHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 347 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 347 ~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.. ... .....++.++.+||.+||..||++|||+.++|.+
T Consensus 238 ~~--~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 238 QG--YRL--------------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred cC--CcC--------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 10 000 0112467889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=318.30 Aligned_cols=252 Identities=31% Similarity=0.462 Sum_probs=202.8
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
++|++.+.||.|+||.||+|.+..+++.||+|.++.... .......+.+|+++|++++|+||+++++++.. ....++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~--~~~~~l 79 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE--NNELNI 79 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeEEE
Confidence 479999999999999999999999999999999875332 33446678899999999999999999999987 468899
Q ss_pred EEeccccccccccc----CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 209 VFEYMEHDITGLLS----CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 209 V~Ey~~g~ll~~~~----~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
||||++++.+..+. .....+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 99999985554332 23456899999999999999999999999999999999999999999999999998765432
Q ss_pred CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCCchhhhccCC
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE--VEQLHKIFKLCGSPPDDYWKKSKL 362 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~--~e~l~~I~~~~g~~p~~~w~~~~~ 362 (704)
. .......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||..... .+....+.. +..+
T Consensus 160 ~-~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~--------- 226 (267)
T cd08224 160 T-TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK--CDYP--------- 226 (267)
T ss_pred C-cccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhc--CCCC---------
Confidence 2 12233467889999998875 5688999999999999999999999965432 122222211 0000
Q ss_pred CCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
+ .....++..+.++|.+||..+|++|||+.++|+
T Consensus 227 -------~---------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 227 -------P---------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred -------C---------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0 001256788999999999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=326.54 Aligned_cols=257 Identities=32% Similarity=0.542 Sum_probs=212.2
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.+.|++...||.|+||.||++.+..++..||+|++..... ....+.+|+++|+.++|+||+++++++.. ...+|+
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l 92 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLV--GDELWV 92 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEE--CCEEEE
Confidence 4569999999999999999999998899999999976542 45667889999999999999999999987 478999
Q ss_pred EEecccccccccccCCCc-cccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCC
Q 005289 209 VFEYMEHDITGLLSCPDI-KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~-~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~ 287 (704)
||||+++..+..+..... .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....... .
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-~ 171 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK-S 171 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch-h
Confidence 999999765555544333 79999999999999999999999999999999999999999999999999986554322 1
Q ss_pred CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCccc
Q 005289 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (704)
Q Consensus 288 ~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~ 367 (704)
......+++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+... +.++
T Consensus 172 ~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~-------------- 235 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIPP-------------- 235 (286)
T ss_pred hhccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCC--------------
Confidence 2233456889999998876 56899999999999999999999999877766555444321 1100
Q ss_pred CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
......++..+.+||.+||+.+|.+|||+.++|.|+||+.
T Consensus 236 -----------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 236 -----------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred -----------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 0011247889999999999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=317.78 Aligned_cols=246 Identities=25% Similarity=0.389 Sum_probs=203.8
Q ss_pred EEeeccCceEEEEEEECCC---CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEec
Q 005289 136 EKIGQGTYSSVFRARDLDT---GKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEY 212 (704)
Q Consensus 136 ~~LG~G~fg~Vy~a~~~~~---g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey 212 (704)
+.||+|+||.||+|.+... +..||+|++....... ....+.+|+.+++.++|+||+++++++.. ...++|||||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEEEEEe
Confidence 4689999999999999866 8999999997654333 46778899999999999999999999887 5789999999
Q ss_pred ccccccccccCC---------CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCC
Q 005289 213 MEHDITGLLSCP---------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (704)
Q Consensus 213 ~~g~ll~~~~~~---------~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~ 283 (704)
+.++.+..+... ...+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||.+.....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 977555544433 36799999999999999999999999999999999999999999999999999987654
Q ss_pred CCC-CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccC
Q 005289 284 GHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (704)
Q Consensus 284 ~~~-~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~ 361 (704)
... .......+++.|+|||.+.. ..++.++|||||||++|+|++ |.+||...+..+....+.. +..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~--~~~--------- 225 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKD-GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK--GYR--------- 225 (262)
T ss_pred ccccccccCCCcCccccCHHHhcc-CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc--CCC---------
Confidence 321 11233456889999998876 468999999999999999999 6999998877776666643 110
Q ss_pred CCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
......++.++.++|.+||..||.+|||+.+++++
T Consensus 226 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 226 -----------------LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred -----------------CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 01113568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=327.87 Aligned_cols=250 Identities=23% Similarity=0.292 Sum_probs=198.3
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCc--EEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCCeE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGK--IVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~--~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~ 206 (704)
++|++.+.||+|+||.||+|.+..++. .+++|.+... ......+.+.+|+.++.++ +||||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~ 78 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACEN--RGYL 78 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc--CCcc
Confidence 479999999999999999999877765 4688887632 2234456678899999999 79999999999876 4678
Q ss_pred EEEEecccccccccccCC----------------CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCce
Q 005289 207 YLVFEYMEHDITGLLSCP----------------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVL 270 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~~----------------~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~i 270 (704)
|+||||++++.+..+... ...+++..+..++.||+.||+|||++||+||||||+||||+.++.+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeE
Confidence 999999987554433221 1358899999999999999999999999999999999999999999
Q ss_pred EEeccccccccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHc
Q 005289 271 KLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLC 349 (704)
Q Consensus 271 KL~DFGla~~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~ 349 (704)
||+|||++....... .......+..|+|||++.. ..++.++|||||||++|+|++ |.+||...+..+.+.++....
T Consensus 159 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 159 KIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred EECCcCCCcccccee--ccCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 999999986432211 1111122557999998875 568999999999999999997 999999887776665543211
Q ss_pred CCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 350 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 350 g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.. .....++..+.+||.+||..||.+|||++++++.
T Consensus 236 ~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 RM----------------------------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CC----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 0113578899999999999999999999999755
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=350.55 Aligned_cols=253 Identities=25% Similarity=0.389 Sum_probs=217.7
Q ss_pred EEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEe
Q 005289 134 KLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF--EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFE 211 (704)
Q Consensus 134 ~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~E 211 (704)
....||+|+|-+||+|.|..+|-.||--.++...+ .+...+.+..|+.+|+.|+|||||++++.+.+.....+.+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 34679999999999999999999998655544433 3556788999999999999999999999998877788999999
Q ss_pred cccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhc--CcccccCCCccEEEccC-CceEEeccccccccCCCCCCC
Q 005289 212 YMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR--GVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 212 y~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~--gIvHrDLKp~NILl~~~-g~iKL~DFGla~~~~~~~~~~ 288 (704)
++..+.|..+...-..+....++.|++|||.||.|||++ -|||||||.+||+|+.+ |.|||+|+|||...... .
T Consensus 124 L~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s---~ 200 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS---H 200 (632)
T ss_pred cccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc---c
Confidence 999999998888778899999999999999999999998 49999999999999865 89999999999987653 3
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHcCCCCchhhhccCCCCccc
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR-TEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~-~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~ 367 (704)
....+|||.|||||++. ..|+..+||||||+++.||+|+..||... +...+++++.. |..|..+.
T Consensus 201 aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S--GiKP~sl~---------- 266 (632)
T KOG0584|consen 201 AKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS--GIKPAALS---------- 266 (632)
T ss_pred cceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc--CCCHHHhh----------
Confidence 45589999999999987 48999999999999999999999999764 55666777654 55543221
Q ss_pred CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
+--.+++++||.+||.. ...|+||.|+|.||||...
T Consensus 267 ---------------kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 267 ---------------KVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred ---------------ccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 12367899999999999 9999999999999999875
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=325.77 Aligned_cols=260 Identities=27% Similarity=0.437 Sum_probs=205.2
Q ss_pred CeeEEEEeeccCceEEEEEEEC---CCCcEEEEEEeecCCCC--hHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCC
Q 005289 131 AFEKLEKIGQGTYSSVFRARDL---DTGKIVALKKVRFDNFE--PESVRFMAREILILRRL-DHPNIIKLEGLITSRLSC 204 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAvK~i~~~~~~--~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~ 204 (704)
+|++.+.||+|+||+||++++. .+++.||||++...... ......+.+|+.+|.++ +||||+++++.+.. ..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~--~~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT--DT 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec--CC
Confidence 4899999999999999999864 46789999998754321 22345577899999999 69999999998876 56
Q ss_pred eEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
.+||||||+.++.+.........+++..++.++.||+.+|.|||+.|++|+||||.|||++.++.++|+|||++......
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 89999999998666555444557899999999999999999999999999999999999999999999999998765433
Q ss_pred CCCCcccccccccccCcccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHcCCCCchhhhc
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGAT-DYGPSVDLWSVGCVFAELLIGKPILQGRTEV----EQLHKIFKLCGSPPDDYWKK 359 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~~-~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~----e~l~~I~~~~g~~p~~~w~~ 359 (704)
.........+++.|+|||.+.+.. .++.++|||||||++|+|++|..||...... +..+.+.... +
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~------- 229 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK--P------- 229 (288)
T ss_pred cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccC--C-------
Confidence 222222345789999999986532 3678999999999999999999999654322 2222221110 0
Q ss_pred cCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcC---HHHHHhccccCCCCC
Q 005289 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT---ASAALASEYFSTKPY 421 (704)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpT---a~e~L~hpwf~~~~~ 421 (704)
.....++..+.+||.+||+.||++||| +.++|+||||+...|
T Consensus 230 --------------------~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~ 274 (288)
T cd05583 230 --------------------PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW 274 (288)
T ss_pred --------------------CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence 011346788999999999999999999 567799999987554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=364.38 Aligned_cols=255 Identities=25% Similarity=0.344 Sum_probs=202.1
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
++|+++++||+|+||+||+|++..+++.||||++..+... ....+.+.+|+.+++.++||||+++++++.+ ....|+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d--~~~lyL 79 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD--GDPVYY 79 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee--CCEEEE
Confidence 5799999999999999999999999999999999764332 3345668899999999999999999999877 578999
Q ss_pred EEecccccccccccCC-----------CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEecccc
Q 005289 209 VFEYMEHDITGLLSCP-----------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL 277 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~-----------~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGl 277 (704)
||||++++.+..+... ...++...+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCc
Confidence 9999998665543211 12356677889999999999999999999999999999999999999999999
Q ss_pred ccccCCCC-----------------CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHH
Q 005289 278 ANFSNTGH-----------------RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE 340 (704)
Q Consensus 278 a~~~~~~~-----------------~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e 340 (704)
+....... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.......
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 97652110 011123468999999999876 568999999999999999999999998755433
Q ss_pred HHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 341 QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 341 ~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.... .....+. . ...+..+|+.+.+++.+||..||++|++..+.|.+
T Consensus 239 i~~~--~~i~~P~-~-----------------------~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 239 ISYR--DVILSPI-E-----------------------VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhh--hhccChh-h-----------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2221 1111110 0 01124688999999999999999999988777765
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=346.01 Aligned_cols=268 Identities=23% Similarity=0.343 Sum_probs=236.3
Q ss_pred CccccccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeec
Q 005289 123 GWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSR 201 (704)
Q Consensus 123 ~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 201 (704)
....+...+++++..||-|+||.|=++........+|+|++++..+ +..+.+.+..|-.||..++.|+||+||..|.+
T Consensus 413 e~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd- 491 (732)
T KOG0614|consen 413 EFAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD- 491 (732)
T ss_pred hhcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc-
Confidence 4445667789999999999999999999877666799999987554 45567778899999999999999999998877
Q ss_pred CCCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEecccccccc
Q 005289 202 LSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (704)
Q Consensus 202 ~~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~ 281 (704)
..++||+||-|-|+.+..++...+.|.+..++.|+..+++|++|||++|||+|||||+|+||+.+|-+||.|||+|+..
T Consensus 492 -~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki 570 (732)
T KOG0614|consen 492 -SKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKI 570 (732)
T ss_pred -chhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHh
Confidence 6899999999999988888888889999999999999999999999999999999999999999999999999999988
Q ss_pred CCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccC
Q 005289 282 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (704)
Q Consensus 282 ~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~ 361 (704)
..+. ..-+.||||.|.|||++++ +..+.++|.|+||+++||||+|.|||.+.+...++..|.+.+..
T Consensus 571 ~~g~--KTwTFcGTpEYVAPEIILn-KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~---------- 637 (732)
T KOG0614|consen 571 GSGR--KTWTFCGTPEYVAPEIILN-KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK---------- 637 (732)
T ss_pred ccCC--ceeeecCCcccccchhhhc-cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh----------
Confidence 7764 3467899999999999987 56799999999999999999999999999999999999874421
Q ss_pred CCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcC-----HHHHHhccccCCCCCC
Q 005289 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPYA 422 (704)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpT-----a~e~L~hpwf~~~~~~ 422 (704)
.+....++..+.+||+++...+|.+|.- +.++-+|-||..-.|.
T Consensus 638 -----------------i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwe 686 (732)
T KOG0614|consen 638 -----------------IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWE 686 (732)
T ss_pred -----------------hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChh
Confidence 1122468889999999999999999976 8999999999876654
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=322.01 Aligned_cols=252 Identities=30% Similarity=0.459 Sum_probs=202.7
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
++|++.+.||.|+||.||++++..+++.||||.+..... .......+.+|+.+|+.++||||+++++++.. ...+|+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~ 79 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--DNELNI 79 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe--CCeEEE
Confidence 469999999999999999999999999999998865332 33445667889999999999999999999887 468999
Q ss_pred EEecccccccccccC----CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 209 VFEYMEHDITGLLSC----PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~----~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
||||+.++.+..+.. ....+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 999999865554322 3456899999999999999999999999999999999999999999999999998766433
Q ss_pred CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCCCCchhhhccCC
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV--EQLHKIFKLCGSPPDDYWKKSKL 362 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~--e~l~~I~~~~g~~p~~~w~~~~~ 362 (704)
. .......++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.... +....+.. ...++
T Consensus 160 ~-~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--------- 227 (267)
T cd08229 160 T-TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-CDYPP--------- 227 (267)
T ss_pred C-cccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhc-CCCCC---------
Confidence 2 22234567899999999876 56888999999999999999999999765432 22222211 00000
Q ss_pred CCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
.....++..+.+||.+||..||++|||+.++++
T Consensus 228 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 228 -----------------LPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred -----------------CCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 011357889999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=345.47 Aligned_cols=242 Identities=24% Similarity=0.369 Sum_probs=204.1
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.+...-++-||.|+.|.||+++. .++.||||+++- .-..+|+-|++|+||||+.+.++|+. ...+||
T Consensus 123 Fe~IsELeWlGSGaQGAVF~Grl--~netVAVKKV~e---------lkETdIKHLRkLkH~NII~FkGVCtq--sPcyCI 189 (904)
T KOG4721|consen 123 FEEISELEWLGSGAQGAVFLGRL--HNETVAVKKVRE---------LKETDIKHLRKLKHPNIITFKGVCTQ--SPCYCI 189 (904)
T ss_pred HHHhhhhhhhccCcccceeeeec--cCceehhHHHhh---------hhhhhHHHHHhccCcceeeEeeeecC--CceeEE
Confidence 34455678899999999999985 678999999752 12358999999999999999999987 578999
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
|||||..+-|..++.....++......|.++|+.|+.|||.+.|||||||.-||||..+..|||+|||.++..... ..
T Consensus 190 iMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--ST 267 (904)
T KOG4721|consen 190 IMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--ST 267 (904)
T ss_pred eeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh--hh
Confidence 9999999888888888889999999999999999999999999999999999999999999999999999877654 34
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccC
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~ 368 (704)
..+++||..|||||+|.+ .+.+.++|||||||+|||||||..||..-+...++ .- .|.-. ..
T Consensus 268 kMSFaGTVaWMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII---wG-VGsNs------L~------- 329 (904)
T KOG4721|consen 268 KMSFAGTVAWMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII---WG-VGSNS------LH------- 329 (904)
T ss_pred hhhhhhhHhhhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCccccchheeE---Ee-ccCCc------cc-------
Confidence 567899999999999987 77999999999999999999999999754433222 11 11110 00
Q ss_pred CCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 369 ~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
......+|+.++-||+.||.-.|..||+..++|.|
T Consensus 330 ----------LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 330 ----------LPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred ----------ccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 11224688999999999999999999999999998
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=326.19 Aligned_cols=252 Identities=21% Similarity=0.328 Sum_probs=201.8
Q ss_pred cCCeeEEEEeeccCceEEEEEEEC-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDL-----DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 203 (704)
..+|.+.+.||+|+||.||+|.+. .++..+++|.+.... ......+.+|+.++++++||||+++++++.. .
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 79 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGD--G 79 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEcc--C
Confidence 346999999999999999999853 345679999986433 3344567899999999999999999999876 5
Q ss_pred CeEEEEEecccccccccccC----------------CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccC
Q 005289 204 CSIYLVFEYMEHDITGLLSC----------------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE 267 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~~~~----------------~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~ 267 (704)
...++||||+.++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 67899999998765554332 12358899999999999999999999999999999999999999
Q ss_pred CceEEeccccccccCCCCC-CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 005289 268 GVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKI 345 (704)
Q Consensus 268 g~iKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I 345 (704)
+.++|+|||++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+.+..+
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 238 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 238 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999999976543221 11223455788999998876 568899999999999999998 99999887776665554
Q ss_pred HHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 346 FKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 346 ~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.. +..+ .....++..+.+||.+||..||.+|||+.++++.
T Consensus 239 ~~--~~~~--------------------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~ 278 (291)
T cd05094 239 TQ--GRVL--------------------------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKI 278 (291)
T ss_pred hC--CCCC--------------------------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 32 1110 0113468889999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=311.60 Aligned_cols=261 Identities=26% Similarity=0.407 Sum_probs=202.1
Q ss_pred ccccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeec---C
Q 005289 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR---L 202 (704)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~---~ 202 (704)
-+...+|+|.+.||+|||+-||+++...+++.||+|++.... .+..+...+|++..++++||||++++++.... .
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 345679999999999999999999999999999999997665 46678889999999999999999998875321 2
Q ss_pred CCeEEEEEeccccc-ccccc---cCCCccccHHHHHHHHHHhhhhHHHHHhcC--cccccCCCccEEEccCCceEEeccc
Q 005289 203 SCSIYLVFEYMEHD-ITGLL---SCPDIKFSEAQIKCYMNQLLHGLEHCHSRG--VLHRDIKGSNLLVNNEGVLKLADFG 276 (704)
Q Consensus 203 ~~~~~LV~Ey~~g~-ll~~~---~~~~~~l~e~~~~~i~~QIl~aL~yLH~~g--IvHrDLKp~NILl~~~g~iKL~DFG 276 (704)
....||+++|...+ +++.+ ...+..++|.++..|+.+|++||++||+.. ++||||||.|||+.+.+.++|+|||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEecc
Confidence 45689999999876 44433 234557999999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCC--------CCcccccccccccCcccccC--CCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 005289 277 LANFSNTGHR--------QPLTSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 346 (704)
Q Consensus 277 la~~~~~~~~--------~~~~~~~gT~~Y~APEvl~~--~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~ 346 (704)
.++...-.-. +.......|..|+|||++.- ....+.++|||||||+||+|+.|..||.- +.
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~---------~~ 245 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER---------IY 245 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH---------Hh
Confidence 9875432110 11122345889999998742 13468899999999999999999999952 22
Q ss_pred HHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 347 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 347 ~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
..-|+..-.. ....+..|+. ..+|+.+.+||+.||+.||.+|||+.++|.+
T Consensus 246 ~~GgSlaLAv------~n~q~s~P~~----------~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 246 QQGGSLALAV------QNAQISIPNS----------SRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred hcCCeEEEee------eccccccCCC----------CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 2111111000 0000000110 2488999999999999999999999999965
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=322.36 Aligned_cols=265 Identities=23% Similarity=0.317 Sum_probs=197.8
Q ss_pred Ce-eEEEEeeccCceEEEEEE----ECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCe
Q 005289 131 AF-EKLEKIGQGTYSSVFRAR----DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (704)
Q Consensus 131 ~y-~~~~~LG~G~fg~Vy~a~----~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (704)
+| ++++.||+|+||+||++. ...++..||+|++..... ......+.+|+.+|+.++||||+++++++.......
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 45 999999999999998865 345788999999875532 334566778999999999999999999887655567
Q ss_pred EEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
+|+||||+.++.+..+... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 161 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 161 (283)
T ss_pred EEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence 8999999998766655433 358999999999999999999999999999999999999999999999999998665322
Q ss_pred CC--CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH-cCCCCchhhhccCC
Q 005289 286 RQ--PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL-CGSPPDDYWKKSKL 362 (704)
Q Consensus 286 ~~--~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~-~g~~p~~~w~~~~~ 362 (704)
.. ......++..|+|||++.+ ..++.++|||||||++|+|++|..||...... +..+... .+......+.. .
T Consensus 162 ~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~--~ 236 (283)
T cd05080 162 EYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVRLIE--L 236 (283)
T ss_pred hhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccchhhhhh--h
Confidence 11 1112234667999998875 56899999999999999999999998654321 1111110 00000000000 0
Q ss_pred CCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
...... ......++..+.+||.+||..||++|||+++++.
T Consensus 237 -----~~~~~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 237 -----LERGMR-----LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred -----hhcCCC-----CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 000000 0012357889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=326.88 Aligned_cols=259 Identities=22% Similarity=0.296 Sum_probs=201.5
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCC--------------cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTG--------------KIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g--------------~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 194 (704)
.++|++.+.||+|+||.||+|++..++ ..||||+++... .......+.+|+++|++++||||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 357999999999999999999875432 358999987543 34455678899999999999999999
Q ss_pred eEEEeecCCCeEEEEEecccccccccccCCC------------ccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccE
Q 005289 195 EGLITSRLSCSIYLVFEYMEHDITGLLSCPD------------IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNL 262 (704)
Q Consensus 195 ~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~~------------~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NI 262 (704)
++++.. ...+|+||||+.++.+..+.... ..+++..+..++.||+.||.|||++||+|+||||+||
T Consensus 83 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 83 LGVCVS--DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred EEEEcC--CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 999976 46789999999986554433211 2368889999999999999999999999999999999
Q ss_pred EEccCCceEEeccccccccCCCCC-CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh--CCCCCCCCCHH
Q 005289 263 LVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI--GKPILQGRTEV 339 (704)
Q Consensus 263 Ll~~~g~iKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt--G~~pF~~~~~~ 339 (704)
||++++.+||+|||++........ .......++..|+|||++.+ ..++.++|||||||++|+|++ +..||...+..
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 999999999999999976543221 11122344678999999876 568999999999999999988 67899887776
Q ss_pred HHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 340 EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 340 e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
+.+..+......... ..+ ....+.+++.+.+||.+||..||.+|||++++++
T Consensus 240 ~~~~~~~~~~~~~~~-----------~~~----------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 240 QVIENTGEFFRNQGR-----------QIY----------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHHhhhhccc-----------ccc----------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 666655432111000 000 0112357889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=323.55 Aligned_cols=251 Identities=22% Similarity=0.319 Sum_probs=201.2
Q ss_pred cCCeeEEEEeeccCceEEEEEEE-----CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARD-----LDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~-----~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 203 (704)
..+|.+.++||+|+||+||++.. ..++..+|+|.+... .......+.+|+++++.++|+||+++++++.+ .
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 79 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTE--G 79 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEec--C
Confidence 35799999999999999999974 235678999988643 24445678899999999999999999998877 4
Q ss_pred CeEEEEEecccccccccccCC---------------CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCC
Q 005289 204 CSIYLVFEYMEHDITGLLSCP---------------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG 268 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~~~~~---------------~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g 268 (704)
..+|+||||+.++.+..+... ...+++..+..++.||+.||.|||++||+||||||+|||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 678999999988655543321 13588999999999999999999999999999999999999999
Q ss_pred ceEEeccccccccCCCCCC-CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 005289 269 VLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIF 346 (704)
Q Consensus 269 ~iKL~DFGla~~~~~~~~~-~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~ 346 (704)
.+||+|||++......... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||......+.+..+.
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 9999999999755432211 1122234678999998876 568999999999999999998 999998877776665553
Q ss_pred HHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 347 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 347 ~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
.. .++ .....++..+.+||.+||..||.+||++.+++.
T Consensus 239 ~~--~~~--------------------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 239 QG--REL--------------------------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred cC--ccC--------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 31 110 011357888999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=317.93 Aligned_cols=244 Identities=20% Similarity=0.282 Sum_probs=196.1
Q ss_pred EEeeccCceEEEEEEECCCC---cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEec
Q 005289 136 EKIGQGTYSSVFRARDLDTG---KIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEY 212 (704)
Q Consensus 136 ~~LG~G~fg~Vy~a~~~~~g---~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey 212 (704)
++||+|+||.||+|....++ ..||+|.+...... ...+.+.+|+.+|+.++||||+++++++.. ..+++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG---EPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC---CceEEEEEe
Confidence 46999999999999876555 78999999765543 345667889999999999999999998764 468999999
Q ss_pred ccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCccc-
Q 005289 213 MEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS- 291 (704)
Q Consensus 213 ~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~- 291 (704)
+.++.+..+......+++..+..++.||+.+|.|||.++|+|+||||+|||++.++.+||+|||+++............
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence 9876555554444578999999999999999999999999999999999999999999999999998664432211111
Q ss_pred -ccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCC
Q 005289 292 -RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (704)
Q Consensus 292 -~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~ 369 (704)
..++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+... .+
T Consensus 157 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~--~~----------------- 216 (257)
T cd05060 157 AGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG--ER----------------- 216 (257)
T ss_pred CccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC--Cc-----------------
Confidence 112457999998865 568999999999999999998 99999887766655554321 00
Q ss_pred CCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 370 ~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
......++..+.+||.+||..||.+|||+.++++
T Consensus 217 ---------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 217 ---------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred ---------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0011356788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=318.95 Aligned_cols=253 Identities=23% Similarity=0.339 Sum_probs=204.7
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCc---EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCe
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGK---IVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~---~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (704)
.++|+..+.||+|+||.||+|.+..++. .+|||.+.... .......+..|+++++.++||||+++++++.. ...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 80 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK--FKP 80 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc--CCC
Confidence 4579999999999999999999876654 79999986543 23345667889999999999999999999976 467
Q ss_pred EEEEEeccccccccccc-CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 206 IYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~-~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
+||||||++++.+..+. .....+++..+..++.|++.||.|||+.||+|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 89999999987666544 33457899999999999999999999999999999999999999999999999999765432
Q ss_pred CCCCccc--ccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccC
Q 005289 285 HRQPLTS--RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (704)
Q Consensus 285 ~~~~~~~--~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~ 361 (704)
....... ...++.|+|||++.. ..++.++|||||||++|+|++ |+.||...+..+....|.... ..+
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~-~~~-------- 230 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF-RLP-------- 230 (268)
T ss_pred cccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC-CCC--------
Confidence 2211111 122457999998875 568899999999999999997 999998877777666664321 111
Q ss_pred CCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
....++.++.+||.+||..||++||++.++++.
T Consensus 231 -------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~ 263 (268)
T cd05063 231 -------------------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNL 263 (268)
T ss_pred -------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 012567889999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=318.65 Aligned_cols=248 Identities=22% Similarity=0.330 Sum_probs=199.1
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|.+..+||.|+||+||+|.+..+ ..+|+|++...... .+.+.+|+.+|+.++||||+++++++.. ...|+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~ 77 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMM---PEAFLQEAQIMKKLRHDKLVPLYAVVSE---EPIYI 77 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCcc---HHHHHHHHHHHHhCCCCCeeeEEEEEcC---CCcEE
Confidence 35799999999999999999987655 45999998654322 3456789999999999999999988754 45799
Q ss_pred EEecccccccc-cccC-CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC
Q 005289 209 VFEYMEHDITG-LLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 209 V~Ey~~g~ll~-~~~~-~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~ 286 (704)
||||+.++.+. .+.. ....+++..+..++.||+.||.|||+.||+|+||||+|||+++++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 99999975444 4332 233578999999999999999999999999999999999999999999999999976643322
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
.......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+.... .+
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~------------- 222 (260)
T cd05069 158 TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY-RM------------- 222 (260)
T ss_pred cccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CC-------------
Confidence 22222345678999998865 568899999999999999999 999999888777666653311 00
Q ss_pred ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
.....++..+.+||.+||..||++|||++++++
T Consensus 223 --------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 223 --------------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred --------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 011357889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=320.73 Aligned_cols=254 Identities=20% Similarity=0.358 Sum_probs=203.0
Q ss_pred cCCeeEEEEeeccCceEEEEEEECC-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLD-----TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 203 (704)
.++|++++.||.|+||+||+|+.+. +.+.||+|.+.... .......+.+|+.+|++++||||+++++++.+ .
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 80 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCRE--A 80 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECC--C
Confidence 3579999999999999999999653 35679999886433 22345668899999999999999999999876 4
Q ss_pred CeEEEEEecccccccccccCCCc---------cccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEec
Q 005289 204 CSIYLVFEYMEHDITGLLSCPDI---------KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLAD 274 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~~~~~~~---------~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~D 274 (704)
...|+||||++++.+..+..... .+++..+..++.||+.||.|||+++|+||||||+|||++.++.++|+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcc
Confidence 67899999999766554433222 689999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCC
Q 005289 275 FGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPP 353 (704)
Q Consensus 275 FGla~~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p 353 (704)
||++...............++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||........+..+... ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~--~~~ 237 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG--KLE 237 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC--CcC
Confidence 99987543322223334456788999998875 457889999999999999998 88999876666555554321 100
Q ss_pred chhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 354 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 354 ~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
| .....++..+.++|.+||..||.+|||+.++|..
T Consensus 238 ---~----------------------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 238 ---L----------------------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred ---C----------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 0 0113578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=353.59 Aligned_cols=280 Identities=22% Similarity=0.312 Sum_probs=189.1
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCC----CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEe---
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDT----GKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLIT--- 199 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~----g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~--- 199 (704)
...++|++.++||+|+||+||+|++..+ +..||||++..... .+....| .++...+.+++.++..+.
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence 4578899999999999999999999988 99999999754221 1111111 122222333332222211
Q ss_pred -ecCCCeEEEEEecccccccccccCCC--------------------ccccHHHHHHHHHHhhhhHHHHHhcCcccccCC
Q 005289 200 -SRLSCSIYLVFEYMEHDITGLLSCPD--------------------IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIK 258 (704)
Q Consensus 200 -~~~~~~~~LV~Ey~~g~ll~~~~~~~--------------------~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLK 258 (704)
......+||||||+.++.+..+.... ....+..+..++.||+.||.|||+++|+|||||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK 282 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK 282 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence 12356789999999986554332211 112345577899999999999999999999999
Q ss_pred CccEEEcc-CCceEEeccccccccCCCCCCCcccccccccccCcccccCC---------------------CCCCCccch
Q 005289 259 GSNLLVNN-EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA---------------------TDYGPSVDL 316 (704)
Q Consensus 259 p~NILl~~-~g~iKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APEvl~~~---------------------~~y~~~~DI 316 (704)
|+||||+. ++.+||+|||+|+.............++|+.|+|||++... ..++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 57999999999986654433344566889999999976421 124556799
Q ss_pred hhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHh
Q 005289 317 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 396 (704)
Q Consensus 317 WSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~m 396 (704)
||||||||||+++. |........+.+++..++.... .|.....+. ..+. .....+.+......+.+||.+|
T Consensus 363 wSlGviL~el~~~~--~~~~~~~~~~~~~l~~~~~~~~-~~~~~~~~~---~~~~---~~~~~~~~d~~~~~~~dLi~~m 433 (566)
T PLN03225 363 YSAGLIFLQMAFPN--LRSDSNLIQFNRQLKRNDYDLV-AWRKLVEPR---ASPD---LRRGFEVLDLDGGAGWELLKSM 433 (566)
T ss_pred HHHHHHHHHHHhCc--CCCchHHHHHHHHHHhcCCcHH-HHHHhhccc---cchh---hhhhhhhccccchHHHHHHHHH
Confidence 99999999999854 4455556666666665544322 232211100 0000 0001122233455678999999
Q ss_pred hccCCCCCcCHHHHHhccccCCCCC
Q 005289 397 LSVEPYKRATASAALASEYFSTKPY 421 (704)
Q Consensus 397 L~~dP~kRpTa~e~L~hpwf~~~~~ 421 (704)
|++||.+|||+.++|+||||+....
T Consensus 434 L~~dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 434 MRFKGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred ccCCcccCCCHHHHhCCcCcCCCCc
Confidence 9999999999999999999987544
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=316.22 Aligned_cols=246 Identities=33% Similarity=0.499 Sum_probs=205.0
Q ss_pred eeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEeccccc
Q 005289 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD 216 (704)
Q Consensus 138 LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~ 216 (704)
||.|+||.||++.+..+++.||+|++...... ......+.+|+.+++.++||||+++++.+.. ...+|+||||+.++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT--EEKLYLVLEYAPGG 78 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec--CCeeEEEEecCCCC
Confidence 68999999999999989999999999765432 2345677889999999999999999998876 57899999999776
Q ss_pred ccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCcccccccc
Q 005289 217 ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 296 (704)
Q Consensus 217 ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~~~gT~ 296 (704)
.+..+......+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++....... .......++.
T Consensus 79 ~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~ 157 (250)
T cd05123 79 ELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGTP 157 (250)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCCc
Confidence 555555445578999999999999999999999999999999999999999999999999997654332 1223456788
Q ss_pred cccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCc
Q 005289 297 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDS 376 (704)
Q Consensus 297 ~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~ 376 (704)
.|++||.+.+ ..++.++|+|||||++|+|++|..||...+.......+.. +.++
T Consensus 158 ~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~----------------------- 211 (250)
T cd05123 158 EYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLR----------------------- 211 (250)
T ss_pred cccChHHhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCC-----------------------
Confidence 9999998876 4578899999999999999999999988776555555533 1110
Q ss_pred hhhhhccCCCHHHHHHHHHhhccCCCCCcCH---HHHHhcccc
Q 005289 377 SLRETFKDLPTTAVNLIETLLSVEPYKRATA---SAALASEYF 416 (704)
Q Consensus 377 ~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa---~e~L~hpwf 416 (704)
....++..+.+||.+||..||++|||+ .+++.||||
T Consensus 212 ----~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 212 ----FPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred ----CCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 112458889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=341.00 Aligned_cols=256 Identities=20% Similarity=0.262 Sum_probs=198.7
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCC-----CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeEEEee
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDT-----GKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNIIKLEGLITS 200 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~-----g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~ 200 (704)
...++|+++++||.|+||+||+|.+... +..||||++.... .....+.+.+|+.+|.++. |||||++++++..
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 3456899999999999999999987433 3479999996543 3344567889999999996 9999999999977
Q ss_pred cCCCeEEEEEecccccccccccC---------------------------------------------------------
Q 005289 201 RLSCSIYLVFEYMEHDITGLLSC--------------------------------------------------------- 223 (704)
Q Consensus 201 ~~~~~~~LV~Ey~~g~ll~~~~~--------------------------------------------------------- 223 (704)
...+|||||||.++.+..++.
T Consensus 113 --~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 113 --SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred --CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 568999999998754432211
Q ss_pred ---------------------------------------CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEE
Q 005289 224 ---------------------------------------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV 264 (704)
Q Consensus 224 ---------------------------------------~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl 264 (704)
....+++..+..++.||+.||.|||+++|+||||||+|||+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill 270 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE
Confidence 01247888899999999999999999999999999999999
Q ss_pred ccCCceEEeccccccccCCCCCC-CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHH
Q 005289 265 NNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQL 342 (704)
Q Consensus 265 ~~~g~iKL~DFGla~~~~~~~~~-~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l 342 (704)
+.++.+||+|||++......... ......+++.|+|||++.+ ..++.++|||||||+||+|++ |..||........+
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~ 349 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF 349 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH
Confidence 99999999999999765432211 1223345788999999876 568999999999999999997 99999876544333
Q ss_pred HHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 343 HKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 343 ~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.........+ .....++.++.+||.+||..||++|||+.++.+.
T Consensus 350 ~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~ 393 (400)
T cd05105 350 YNKIKSGYRM---------------------------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDI 393 (400)
T ss_pred HHHHhcCCCC---------------------------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHH
Confidence 2222210000 0113578899999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=326.11 Aligned_cols=256 Identities=21% Similarity=0.303 Sum_probs=202.0
Q ss_pred cccCCeeEEEEeeccCceEEEEEEE-----CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEee
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARD-----LDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITS 200 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~-----~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~ 200 (704)
+..++|.+.+.||+|+||.||++.+ ..++..||||++.... .....+.+.+|+.+|+++ +||||+++++++..
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 3456899999999999999999975 3355689999987543 234456788999999999 89999999999877
Q ss_pred cCCCeEEEEEecccccccccccC--CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccc
Q 005289 201 RLSCSIYLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278 (704)
Q Consensus 201 ~~~~~~~LV~Ey~~g~ll~~~~~--~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla 278 (704)
...+||||||+.++.+..+.. ....+++.++..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++
T Consensus 111 --~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 111 --GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred --CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccc
Confidence 467899999999765554432 2234899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCC-CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchh
Q 005289 279 NFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDY 356 (704)
Q Consensus 279 ~~~~~~~~~-~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~ 356 (704)
......... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||......+.+.++... +..+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~--- 263 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE-GYRM--- 263 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhcc-CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHc-CCcC---
Confidence 765432211 1122345778999998876 458899999999999999998 99999887665544443321 0000
Q ss_pred hhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 357 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 357 w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.....++..+.+||.+||..+|++|||+.++|..
T Consensus 264 -----------------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~ 297 (302)
T cd05055 264 -----------------------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQL 297 (302)
T ss_pred -----------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 0112467889999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=318.74 Aligned_cols=252 Identities=25% Similarity=0.372 Sum_probs=203.0
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCC---cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCe
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTG---KIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g---~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (704)
..+|++.+.||.|+||.||+|.+..++ ..+|+|.+.... .....+.+.+|+.+|+.++||||+++++++.. ...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 79 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK--SKP 79 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCc
Confidence 357999999999999999999886544 379999986543 33445678899999999999999999999876 467
Q ss_pred EEEEEecccccccccc-cCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 206 IYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~-~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
+||||||++++.+..+ ......+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 8999999998655544 333456899999999999999999999999999999999999999999999999999866543
Q ss_pred CCCCccc--ccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccC
Q 005289 285 HRQPLTS--RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (704)
Q Consensus 285 ~~~~~~~--~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~ 361 (704)
.....+. ...+..|+|||++.+ ..++.++|||||||++|+|++ |..||......+.+..+...... +
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~-~-------- 229 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRL-P-------- 229 (267)
T ss_pred cceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcC-C--------
Confidence 2211111 122567999999875 568999999999999999886 99999887766666655432100 0
Q ss_pred CCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
....++..+.+||.+||..+|.+|||+.++++
T Consensus 230 -------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 230 -------------------APMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred -------------------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 01356889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=325.95 Aligned_cols=254 Identities=22% Similarity=0.315 Sum_probs=200.3
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECC-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEe
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLD-------TGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLIT 199 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~-------~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~ 199 (704)
..++|.+.+.||+|+||.||+|++.. +...||+|++..+. .......+.+|+.+++.+ +||||+++++++.
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 34689999999999999999998643 23579999997543 233456677899999999 8999999999997
Q ss_pred ecCCCeEEEEEecccccccccccCC----------------CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEE
Q 005289 200 SRLSCSIYLVFEYMEHDITGLLSCP----------------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLL 263 (704)
Q Consensus 200 ~~~~~~~~LV~Ey~~g~ll~~~~~~----------------~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NIL 263 (704)
. ...+|+||||+.++.+..+... ...+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 95 ~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 172 (307)
T cd05098 95 Q--DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 172 (307)
T ss_pred c--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheE
Confidence 7 4678999999987554433221 235888999999999999999999999999999999999
Q ss_pred EccCCceEEeccccccccCCCCCCC-cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHH
Q 005289 264 VNNEGVLKLADFGLANFSNTGHRQP-LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQ 341 (704)
Q Consensus 264 l~~~g~iKL~DFGla~~~~~~~~~~-~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~ 341 (704)
++.++.+||+|||++.......... .....+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~ 251 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence 9999999999999987654321111 111223568999999876 568999999999999999998 8999987776555
Q ss_pred HHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 342 LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 342 l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
...+... .. ......++.++.+||.+||..+|.+|||+.+++++
T Consensus 252 ~~~~~~~--~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 252 FKLLKEG--HR--------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHcC--CC--------------------------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 5544221 00 01113578899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=314.36 Aligned_cols=249 Identities=24% Similarity=0.376 Sum_probs=202.0
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
.+|++.+.||.|+||.||++.+. .+..+|+|++...... ...+.+|+++|+.++||||+++++++.. ...+|+|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v 77 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTE--RSPICLV 77 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEcc--CCceEEE
Confidence 47999999999999999999875 4678999998755433 2356789999999999999999999876 4678999
Q ss_pred Eeccccccccccc-CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 210 FEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 210 ~Ey~~g~ll~~~~-~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
|||+.++.+..+. .....+++..++.++.||+.+|.|||+++|+|+||||+||+++.++.+||+|||++..........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 9999987665443 334568999999999999999999999999999999999999999999999999987554322111
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCccc
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~ 367 (704)
.....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||......+.+..+.+....+
T Consensus 158 ~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~--------------- 221 (256)
T cd05112 158 STGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLY--------------- 221 (256)
T ss_pred cCCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCC---------------
Confidence 222334678999998875 568899999999999999998 999998887777666653311000
Q ss_pred CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.....+..+.+|+.+||..+|++|||+.++|+.
T Consensus 222 -------------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 222 -------------KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred -------------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 012357889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=317.68 Aligned_cols=252 Identities=23% Similarity=0.349 Sum_probs=202.2
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCC---CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCe
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDT---GKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (704)
.++|.+.+.||+|+||.||+|.+... ...||||.+.... .....+.+.+|+.+++.++||||+++++++.+ ..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~---~~ 80 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE---NP 80 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC---CC
Confidence 45799999999999999999987544 4568999886443 24455678899999999999999999998875 45
Q ss_pred EEEEEecccccccccccC-CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 206 IYLVFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~-~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
.|+||||+.++.+..+.. ....+++..+..++.||+.||.|||++|++|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 789999998765554433 3446899999999999999999999999999999999999999999999999999765433
Q ss_pred CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCC
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
.....+...++..|+|||.+.. ..++.++|||||||++|+|++ |.+||.+.+..+.+..+... ...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~--~~~---------- 227 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENG--ERL---------- 227 (270)
T ss_pred cceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC--CcC----------
Confidence 2111222233567999998865 568999999999999999986 99999988877666555321 100
Q ss_pred CcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.....++..+.+||.+||..+|.+|||+.+++..
T Consensus 228 ----------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 228 ----------------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred ----------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0123578899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=320.71 Aligned_cols=253 Identities=18% Similarity=0.282 Sum_probs=198.8
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCCcE----EEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKI----VALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~----vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 203 (704)
..++|++++.||.|+||+||+|.+..++.. |++|.+.... .......+..|+.++..++||||+++++++..
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~--- 80 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG--- 80 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc-chHHHHHHHHHHHHHhcCCCCCcceEEEEECC---
Confidence 346799999999999999999998877764 6777764322 23334567788999999999999999998754
Q ss_pred CeEEEEEecccccccc-cccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccC
Q 005289 204 CSIYLVFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~-~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~ 282 (704)
...++|+||+.++.+. .+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 4578999999875554 443445578999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCC-cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhcc
Q 005289 283 TGHRQP-LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (704)
Q Consensus 283 ~~~~~~-~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~ 360 (704)
...... .....++..|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.........+.. +..+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~--~~~~~------ 231 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEK--GERLA------ 231 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC--CCcCC------
Confidence 332211 223345778999999875 568999999999999999998 9999988766554333321 11100
Q ss_pred CCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.....+.++.++|.+||..||++|||+.++++.
T Consensus 232 --------------------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~ 264 (279)
T cd05111 232 --------------------QPQICTIDVYMVMVKCWMIDENVRPTFKELANE 264 (279)
T ss_pred --------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 012356788999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=317.56 Aligned_cols=252 Identities=26% Similarity=0.406 Sum_probs=203.4
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCc---EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGK---IVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~---~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
..|++.+.||.|+||.||+|.+..+++ .||||++.... .......+..|+.+++.++||||+++++++.. ...+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~ 80 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK--SRPV 80 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECC--CCce
Confidence 469999999999999999999877665 59999986542 34456678899999999999999999999876 5678
Q ss_pred EEEEeccccccccccc-CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 207 YLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~-~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
|+||||++++.+..+. .....+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999986665443 344568999999999999999999999999999999999999999999999999987654322
Q ss_pred CCC-ccccc---ccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhcc
Q 005289 286 RQP-LTSRV---VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (704)
Q Consensus 286 ~~~-~~~~~---gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~ 360 (704)
... ..... .+..|+|||.+.+ ..++.++|||||||++|||++ |.+||......+....+......+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~-------- 231 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLP-------- 231 (269)
T ss_pred cccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCC--------
Confidence 111 11111 1457999999875 568999999999999999886 999998877776666653211000
Q ss_pred CCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
....++..+.+||.+||..+|.+|||+.+++..
T Consensus 232 --------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 264 (269)
T cd05065 232 --------------------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVST 264 (269)
T ss_pred --------------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 013567889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=315.27 Aligned_cols=245 Identities=19% Similarity=0.333 Sum_probs=197.8
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEE
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 207 (704)
..++|++.+.||+|+||.||++.. .+..||+|.+..+. ..+.+.+|+.+++.++|+||+++++++... ...+|
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~ 76 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLY 76 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcC-CCceE
Confidence 356899999999999999999976 47889999986432 245678899999999999999999876543 45789
Q ss_pred EEEecccccccccc-cCC-CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 208 LVFEYMEHDITGLL-SCP-DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 208 LV~Ey~~g~ll~~~-~~~-~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
+||||++++.+..+ ... ...+++..+..++.||+.||.|||++||+||||||+|||+++++.+||+|||++.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 99999997554433 322 2348899999999999999999999999999999999999999999999999987554321
Q ss_pred CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC
Q 005289 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
.....+..|+|||++.+ ..++.++|||||||++|+|++ |++||...+..+....+... ..+
T Consensus 157 ----~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~--~~~----------- 218 (256)
T cd05082 157 ----DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG--YKM----------- 218 (256)
T ss_pred ----CCCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC--CCC-----------
Confidence 22334668999998865 568899999999999999997 99999877766655554321 000
Q ss_pred cccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
.....++..+.+||.+||..||++|||+.++++
T Consensus 219 ---------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 219 ---------------DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred ---------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 011357889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=314.25 Aligned_cols=245 Identities=23% Similarity=0.354 Sum_probs=200.5
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|++.+.||.|+||.||+|.. .++.||||.+..... ....+.+|+.+++.++|+||+++++++.+ ....|+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~ 77 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQ--GNPLYI 77 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcC--CCCeEE
Confidence 45799999999999999999986 478999999975532 45667889999999999999999999887 577899
Q ss_pred EEecccccccccccCCC--ccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC
Q 005289 209 VFEYMEHDITGLLSCPD--IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~--~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~ 286 (704)
||||++++.+..+.... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~- 156 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ- 156 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc-
Confidence 99999975555443322 268999999999999999999999999999999999999999999999999997663221
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
.....+..|+|||.+.. ..++.++|||||||++|+|++ |..||...+..+....+... ..+
T Consensus 157 ---~~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~--~~~------------ 218 (256)
T cd05039 157 ---DSGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG--YRM------------ 218 (256)
T ss_pred ---ccCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC--CCC------------
Confidence 12334667999998875 568889999999999999997 99999887766655444321 000
Q ss_pred ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.....+++.+.+||.+||..+|++|||+.++++.
T Consensus 219 --------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 252 (256)
T cd05039 219 --------------EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQ 252 (256)
T ss_pred --------------CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 0113568899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=319.19 Aligned_cols=269 Identities=23% Similarity=0.338 Sum_probs=197.8
Q ss_pred CCeeEEEEeeccCceEEEEEE----ECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCe
Q 005289 130 DAFEKLEKIGQGTYSSVFRAR----DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~----~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (704)
.+|++++.||+|+||+||++. +..++..||||++.... ....+.+.+|+++|+.++||||+++++++.......
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 479999999999999999997 44678899999986543 444567889999999999999999999876554567
Q ss_pred EEEEEeccccccccccc-CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 206 IYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~-~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
+||||||+.++.+..+. .....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 89999999876555443 33456899999999999999999999999999999999999999999999999999866433
Q ss_pred CCCCc--ccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCC
Q 005289 285 HRQPL--TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (704)
Q Consensus 285 ~~~~~--~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~ 362 (704)
..... .....+..|+|||++.+ ..++.++|||||||++|||++|..++..... ..+..+...... +...+...+.
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~ 238 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSCSPPA-EFMRMMGNDKQG-QMIVYHLIEL 238 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCCCcch-hhhhhccccccc-ccchHHHHHH
Confidence 21111 11123456999999875 5689999999999999999998776644321 111111000000 0000000000
Q ss_pred CCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
...... ......++.++.+||.+||..+|++|||+.++++.
T Consensus 239 -----~~~~~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 239 -----LKNNGR-----LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred -----HhcCCc-----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 000000 01124678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=313.41 Aligned_cols=249 Identities=26% Similarity=0.368 Sum_probs=202.9
Q ss_pred eeEEEEeeccCceEEEEEEECCCC----cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEE
Q 005289 132 FEKLEKIGQGTYSSVFRARDLDTG----KIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 132 y~~~~~LG~G~fg~Vy~a~~~~~g----~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 207 (704)
|++.+.||.|+||.||++.+...+ ..||+|++..... ......+..|+.+|..++|+||+++++++.+ ....|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTE--EEPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcC--CCeeE
Confidence 457789999999999999998766 8999999965532 2256678899999999999999999999887 46899
Q ss_pred EEEecccccccccccCC-Ccc-ccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 208 LVFEYMEHDITGLLSCP-DIK-FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~-~~~-l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
+||||+.++.+..+... ... +++..+..++.||+.||.|||+.||+|+||||+||++++++.++|+|||++.......
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 99999988655544432 223 8999999999999999999999999999999999999999999999999997665432
Q ss_pred CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC
Q 005289 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
........+++.|+|||.+.. ..++.++|||||||++|+|++ |.+||...+..+.+..+.... .+
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~--~~----------- 223 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY--RL----------- 223 (258)
T ss_pred ccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC--CC-----------
Confidence 211111235788999998854 668999999999999999998 899998877777666654311 00
Q ss_pred cccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
.....++..+.++|.+||..||++|||+.++|+
T Consensus 224 ---------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 224 ---------------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred ---------------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 001237889999999999999999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=333.06 Aligned_cols=255 Identities=22% Similarity=0.327 Sum_probs=196.8
Q ss_pred cCCeeEEEEeeccCceEEEEEEE-----CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARD-----LDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRL 202 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~-----~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~ 202 (704)
.++|++.+.||.|+||+||+|++ ..+++.||||+++.... ......+.+|+.+|.++ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhcceeecC-
Confidence 45899999999999999999984 35678999999975432 33456678899999999 789999999988654
Q ss_pred CCeEEEEEecccccccccccCC----------------------------------------------------------
Q 005289 203 SCSIYLVFEYMEHDITGLLSCP---------------------------------------------------------- 224 (704)
Q Consensus 203 ~~~~~LV~Ey~~g~ll~~~~~~---------------------------------------------------------- 224 (704)
...+|||||||+++.+..+...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 4578999999998655433211
Q ss_pred ---------CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC-CCcccccc
Q 005289 225 ---------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVV 294 (704)
Q Consensus 225 ---------~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~-~~~~~~~g 294 (704)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .......+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 12367888899999999999999999999999999999999999999999999976532211 11122234
Q ss_pred cccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCC
Q 005289 295 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 373 (704)
Q Consensus 295 T~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~ 373 (704)
++.|+|||++.+ ..++.++|||||||++|+|++ |.+||........+...... +..+
T Consensus 244 ~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~-------------------- 301 (343)
T cd05103 244 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE-GTRM-------------------- 301 (343)
T ss_pred CcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhc-cCCC--------------------
Confidence 677999999876 568999999999999999997 99999775433322222110 1000
Q ss_pred CCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 374 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 374 ~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.....+++++.++|..||..||++|||+.++|+|
T Consensus 302 ------~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 302 ------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred ------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0012356789999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=321.67 Aligned_cols=250 Identities=20% Similarity=0.304 Sum_probs=197.9
Q ss_pred CeeEEEEeeccCceEEEEEEECC-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCe
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLD-----TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (704)
+|++.+.||+|+||+||+|.+.. ....+|+|.+.... .......+.+|+.+|+.++||||+++++.+.. ...
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ--DGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec--CCC
Confidence 47889999999999999998753 23578999886543 23445678899999999999999999999876 467
Q ss_pred EEEEEecccccccccccC------------------------CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCcc
Q 005289 206 IYLVFEYMEHDITGLLSC------------------------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSN 261 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~------------------------~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~N 261 (704)
.|+||||+.++.+..+.. ....+++..+..++.||+.||.|||+++|+||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 899999999765554321 12357899999999999999999999999999999999
Q ss_pred EEEccCCceEEeccccccccCCCCCC-CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHH
Q 005289 262 LLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEV 339 (704)
Q Consensus 262 ILl~~~g~iKL~DFGla~~~~~~~~~-~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~ 339 (704)
|||++++.+||+|||++......... ......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999999765332211 1122344678999998865 568999999999999999998 99999887766
Q ss_pred HHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 340 EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 340 e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
+....+...... .....++.++.+||..||..||.+||++.++++
T Consensus 237 ~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 237 RLFNLLKTGYRM----------------------------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHhCCCCC----------------------------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 554443221000 011357789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=315.72 Aligned_cols=263 Identities=24% Similarity=0.416 Sum_probs=220.6
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCC
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRL-DHPNIIKLEGLITSRLSC 204 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~ 204 (704)
+...+|.+++.||.|+|..|.+++.+.|.+.||+|+++++-++ .+.+..+..|-.+.... +||++|-|+..|+. +.
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt--es 324 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT--ES 324 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc--cc
Confidence 4567899999999999999999999999999999999887653 45667778888888776 89999999999987 57
Q ss_pred eEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
.+++|.||+.|+.+-...+...+++|+.++.|..+|+.||.|||++|||+||||..|+|||..|+|||+|+|+++..-.+
T Consensus 325 rlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred eEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence 89999999999877777777789999999999999999999999999999999999999999999999999999864332
Q ss_pred CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHHHcCCCCchh
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG--------RTEVEQLHKIFKLCGSPPDDY 356 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~--------~~~~e~l~~I~~~~g~~p~~~ 356 (704)
. ....+.||||.|+|||++.+ ..|+..+|+|+|||+++||+.|+.||.- .+++-.++-|.+..-
T Consensus 405 g-d~tstfcgtpnyiapeilrg-eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi------ 476 (593)
T KOG0695|consen 405 G-DTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI------ 476 (593)
T ss_pred C-cccccccCCCcccchhhhcc-cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc------
Confidence 2 34567899999999999987 6799999999999999999999999952 122222333322110
Q ss_pred hhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcC------HHHHHhccccCCCCCC
Q 005289 357 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT------ASAALASEYFSTKPYA 422 (704)
Q Consensus 357 w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpT------a~e~L~hpwf~~~~~~ 422 (704)
.....++-.+..+|+..|++||.+|.. ..++-.|+||....|.
T Consensus 477 -----------------------riprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd 525 (593)
T KOG0695|consen 477 -----------------------RIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWD 525 (593)
T ss_pred -----------------------cccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHH
Confidence 112356777889999999999999954 5799999999977664
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=373.06 Aligned_cols=260 Identities=29% Similarity=0.479 Sum_probs=218.8
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 210 (704)
++....+||.|.||.||-|.+..+|...|+|.|............+.+|+.+|..|.|||||+.+++-.+ .+.+||.|
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH--Rekv~IFM 1313 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH--REKVYIFM 1313 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec--HHHHHHHH
Confidence 4666789999999999999999999999999998766555666778899999999999999999998776 46789999
Q ss_pred ecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC---CC
Q 005289 211 EYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH---RQ 287 (704)
Q Consensus 211 Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~---~~ 287 (704)
|||+++.+..+...+.-.+|...+.|..|++.||.|||++|||||||||+||||+.+|.||++|||.|....... ..
T Consensus 1314 EyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred HHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCH
Confidence 999999999988888888999999999999999999999999999999999999999999999999998765432 12
Q ss_pred CcccccccccccCcccccCCC--CCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 288 PLTSRVVTLWYRPPELLLGAT--DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 288 ~~~~~~gT~~Y~APEvl~~~~--~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
.+...+||+.|||||++.+.. ...-+.|||||||++.||+||+.||...+..-++.-.+.. |..|
T Consensus 1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~-gh~P------------ 1460 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA-GHKP------------ 1460 (1509)
T ss_pred HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc-cCCC------------
Confidence 345678999999999997643 4566899999999999999999999765544332222221 2221
Q ss_pred ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
+. ...++.+..|||..||..||++|+|+.|+|+|.|-+..
T Consensus 1461 -----q~---------P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1461 -----QI---------PERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred -----CC---------chhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 11 13489999999999999999999999999999987653
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=323.68 Aligned_cols=255 Identities=23% Similarity=0.334 Sum_probs=203.5
Q ss_pred cccCCeeEEEEeeccCceEEEEEEEC-------CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEE
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDL-------DTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLI 198 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~-------~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~ 198 (704)
+..++|.+.+.||+|+||.||+|++. .++..||+|.+.... .......+.+|+.+++.+ +||||+++++++
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 34568999999999999999999753 234579999986442 334456788999999999 899999999999
Q ss_pred eecCCCeEEEEEecccccccccccC----------------CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccE
Q 005289 199 TSRLSCSIYLVFEYMEHDITGLLSC----------------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNL 262 (704)
Q Consensus 199 ~~~~~~~~~LV~Ey~~g~ll~~~~~----------------~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NI 262 (704)
.. ...+||||||+.++.+..+.. ....++...+..++.||+.||.|||++||+||||||+||
T Consensus 91 ~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 168 (304)
T cd05101 91 TQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV 168 (304)
T ss_pred ec--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence 87 467899999998865543322 123578889999999999999999999999999999999
Q ss_pred EEccCCceEEeccccccccCCCCCCC-cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHH
Q 005289 263 LVNNEGVLKLADFGLANFSNTGHRQP-LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVE 340 (704)
Q Consensus 263 Ll~~~g~iKL~DFGla~~~~~~~~~~-~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e 340 (704)
|++.++.+||+|||+++......... .....+++.|+|||++.+ ..|+.++|||||||+||+|++ |.+||.+.+..+
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 247 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 99999999999999998664322111 122344678999999876 568999999999999999998 889998887777
Q ss_pred HHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 341 QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 341 ~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
....+... ... .....++..+.+||.+||..+|.+|||+.++|+.
T Consensus 248 ~~~~~~~~--~~~--------------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 248 LFKLLKEG--HRM--------------------------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHcC--CcC--------------------------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 66655321 000 0113578899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=311.58 Aligned_cols=245 Identities=24% Similarity=0.335 Sum_probs=196.1
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEecccc
Q 005289 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH 215 (704)
Q Consensus 136 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g 215 (704)
+.||+|+||.||++... +++.||+|++.... .......+.+|+.+++.++||||+++++++.. ...+|+||||+++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQ--RQPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec--CCccEEEEECCCC
Confidence 36899999999999864 68899999987543 33444567889999999999999999999877 4678999999987
Q ss_pred cccccc-cCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCcccccc
Q 005289 216 DITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 294 (704)
Q Consensus 216 ~ll~~~-~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~~~g 294 (704)
+.+..+ ......+++..+..++.||+.+|.|||++|++|+||||+||+++.++.+||+|||++...............+
T Consensus 77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 655543 3334568899999999999999999999999999999999999999999999999987544322111122234
Q ss_pred cccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCC
Q 005289 295 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 373 (704)
Q Consensus 295 T~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~ 373 (704)
++.|+|||++.. ..++.++|||||||++|+|++ |..||.+.........+.... .
T Consensus 157 ~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~--~--------------------- 212 (250)
T cd05085 157 PIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY--R--------------------- 212 (250)
T ss_pred cccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC--C---------------------
Confidence 667999998865 568899999999999999998 999998887766555543210 0
Q ss_pred CCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 374 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 374 ~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
......++..+.+||.+||..+|++|||+.++++.
T Consensus 213 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 213 -----MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKE 247 (250)
T ss_pred -----CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 00113578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=324.05 Aligned_cols=252 Identities=23% Similarity=0.336 Sum_probs=200.5
Q ss_pred cCCeeEEEEeeccCceEEEEEEECC-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEee
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLD-------TGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITS 200 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~-------~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~ 200 (704)
.++|.+.++||+|+||.||+|++.. ....||+|++.... .......+.+|+.+|+.+ +||||+++++++.+
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 4579999999999999999998632 34579999987543 344456678899999999 69999999999876
Q ss_pred cCCCeEEEEEecccccccccccC----------------CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEE
Q 005289 201 RLSCSIYLVFEYMEHDITGLLSC----------------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV 264 (704)
Q Consensus 201 ~~~~~~~LV~Ey~~g~ll~~~~~----------------~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl 264 (704)
...+|+||||+.++.+..+.. ....+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 90 --~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 167 (314)
T cd05099 90 --EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV 167 (314)
T ss_pred --CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence 467899999998865543332 12358889999999999999999999999999999999999
Q ss_pred ccCCceEEeccccccccCCCCCCC-cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHH
Q 005289 265 NNEGVLKLADFGLANFSNTGHRQP-LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQL 342 (704)
Q Consensus 265 ~~~g~iKL~DFGla~~~~~~~~~~-~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l 342 (704)
+.++.+||+|||+++......... .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 246 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 999999999999997654321111 111223567999999876 568999999999999999999 89999888776666
Q ss_pred HHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 343 HKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 343 ~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
..+... ... .....++.++.+||.+||..||++|||+.++++
T Consensus 247 ~~~~~~--~~~--------------------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 247 KLLREG--HRM--------------------------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHcC--CCC--------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 655321 000 011356788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=312.41 Aligned_cols=245 Identities=24% Similarity=0.343 Sum_probs=196.6
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEecccc
Q 005289 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH 215 (704)
Q Consensus 136 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g 215 (704)
++||.|+||.||+|.+.. ++.||+|++...... .....+.+|+++++.++||||+++++++.+ ....|+||||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQ--KQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEec--CCCeEEEEEcCCC
Confidence 368999999999999877 999999998765433 445678899999999999999999999877 4678999999987
Q ss_pred cccc-cccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCc-cccc
Q 005289 216 DITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL-TSRV 293 (704)
Q Consensus 216 ~ll~-~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~-~~~~ 293 (704)
+.+. .+......+++..+..++.|++.+|.|||+++|+||||||+||||+.++.+||+|||++........... ....
T Consensus 77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 6544 3333445688999999999999999999999999999999999999999999999999976542211111 1122
Q ss_pred ccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCC
Q 005289 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQ 372 (704)
Q Consensus 294 gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~ 372 (704)
.+..|+|||++.+ ..++.++|||||||++|+|++ |.+||...........+......
T Consensus 157 ~~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~--------------------- 214 (251)
T cd05041 157 IPIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRM--------------------- 214 (251)
T ss_pred ceeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCC---------------------
Confidence 3567999998875 568999999999999999999 89999887765555444221000
Q ss_pred CCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 373 PYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 373 ~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.....++..+.+||.+||..+|.+|||+.++|+.
T Consensus 215 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~ 248 (251)
T cd05041 215 -------PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNE 248 (251)
T ss_pred -------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 0013567899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.26 Aligned_cols=268 Identities=23% Similarity=0.333 Sum_probs=199.7
Q ss_pred CeeEEEEeeccCceEEEEEEE----CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 131 AFEKLEKIGQGTYSSVFRARD----LDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~----~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
.|++++.||+|+||.||+|+. ..++..||+|.+.... .......+.+|+.+|+.+.||||+++++++.......+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 589999999999999999974 4578899999986543 23445678899999999999999999999877545678
Q ss_pred EEEEeccccccccccc-CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 207 YLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~-~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
||||||++++.+..+. .....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence 9999999887666544 333468999999999999999999999999999999999999999999999999998664322
Q ss_pred CC--CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCC
Q 005289 286 RQ--PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 286 ~~--~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
.. ......++..|+|||++.+ ..++.++|||||||++|+|+++..|+..... .+.+..+....+.......
T Consensus 164 ~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~- 236 (284)
T cd05079 164 EYYTVKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSESSPMT-----LFLKMIGPTHGQMTVTRLV- 236 (284)
T ss_pred cceeecCCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCCccccc-----hhhhhcccccccccHHHHH-
Confidence 11 1123345778999999876 4688999999999999999998776543211 1111111111110000000
Q ss_pred CcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
........ ......++..+.+||.+||..||.+|||+.++|+.
T Consensus 237 --~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 237 --RVLEEGKR-----LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred --HHHHcCcc-----CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 00000000 01124578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=317.91 Aligned_cols=254 Identities=19% Similarity=0.260 Sum_probs=202.8
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECC----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLD----TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~----~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 203 (704)
..++|++.+.||+|+||.||+|.+.. ++..||+|++... ........+.+|+.+|+.++||||+++++++... .
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~ 81 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED-G 81 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-C
Confidence 45689999999999999999999876 3578999988633 3455567788999999999999999999987654 4
Q ss_pred CeEEEEEecccccccccccCC--------CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEecc
Q 005289 204 CSIYLVFEYMEHDITGLLSCP--------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADF 275 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~~~~~--------~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DF 275 (704)
...++++||+.++.+..+... ...+++..+..++.||+.||.|||+++|+|+||||+|||+++++.+||+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCC
Confidence 578999999987555544321 145899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCC-cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCC
Q 005289 276 GLANFSNTGHRQP-LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPP 353 (704)
Q Consensus 276 Gla~~~~~~~~~~-~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p 353 (704)
|+++.+....... .....++..|+|||++.+ ..++.++|||||||++|+|++ |++||...+..+....+.... .+
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~- 238 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY-RL- 238 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC-CC-
Confidence 9998654332211 112234677999999876 568999999999999999998 999998877665544433210 00
Q ss_pred chhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 354 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 354 ~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
.....+++++.++|.+||..||++|||+.++++
T Consensus 239 --------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 239 --------------------------AQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred --------------------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 001246788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.48 Aligned_cols=252 Identities=25% Similarity=0.380 Sum_probs=200.7
Q ss_pred cCCeeEEEEeeccCceEEEEEEECC-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLD-----TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 203 (704)
.++|++++.||.|+||.||+|.+.. ++..||+|++.... .......+.+|+.+++.++||||+++++++.+ .
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~--~ 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAV--G 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcC--C
Confidence 4579999999999999999998743 67899999987543 33445668889999999999999999999876 4
Q ss_pred CeEEEEEecccccccccccC----------------------CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCcc
Q 005289 204 CSIYLVFEYMEHDITGLLSC----------------------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSN 261 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~~~~----------------------~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~N 261 (704)
..+|+||||+.++.+..+.. ....+++..+..++.||+.||.|||+++|+||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 67899999999754443321 11247888999999999999999999999999999999
Q ss_pred EEEccCCceEEeccccccccCCCCC-CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHH
Q 005289 262 LLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEV 339 (704)
Q Consensus 262 ILl~~~g~iKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~ 339 (704)
||++.++.++|+|||++........ ........+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999875432211 11122234667999998875 568999999999999999997 88899887776
Q ss_pred HHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 340 EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 340 e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
+.+..+... ... .....++.++.+||.+||..||++|||+.|+++
T Consensus 240 ~~~~~~~~~--~~~--------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 240 EVIYYVRDG--NVL--------------------------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHhcC--CCC--------------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 666555321 100 011356788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=316.60 Aligned_cols=253 Identities=24% Similarity=0.432 Sum_probs=203.4
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCC---CChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN---FEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~---~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 207 (704)
+|.+.++||.|+||+||++.+..++..+++|++.... ........+.+|+.+++.++||||+++++++.+ ....|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 78 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE--RDAFC 78 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc--CCceE
Confidence 5899999999999999999998877777777765322 222333456679999999999999999998876 46789
Q ss_pred EEEeccccccccccc----CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCC
Q 005289 208 LVFEYMEHDITGLLS----CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~----~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~ 283 (704)
+||||+.+..+..+. .....+++..++.++.||+.||.|||++||+|+||+|+||++++ +.+||+|||++.....
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 79 IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCC
Confidence 999999986655432 23457899999999999999999999999999999999999975 6799999999876543
Q ss_pred CCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCC
Q 005289 284 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 284 ~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
.. .......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||...........+.. +.++
T Consensus 158 ~~-~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~--~~~~---------- 223 (260)
T cd08222 158 SC-DLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE--GPTP---------- 223 (260)
T ss_pred Cc-ccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc--CCCC----------
Confidence 22 12223456889999998865 5678899999999999999999999987776665555432 1111
Q ss_pred CcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
.....++.++.+||.+||..||++||++.++|+||||
T Consensus 224 ----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 224 ----------------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred ----------------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 0113567899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=314.01 Aligned_cols=244 Identities=20% Similarity=0.272 Sum_probs=194.5
Q ss_pred EeeccCceEEEEEEEC--CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEeccc
Q 005289 137 KIGQGTYSSVFRARDL--DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME 214 (704)
Q Consensus 137 ~LG~G~fg~Vy~a~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~ 214 (704)
.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+|++++||||+++++++.. ..+|+||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~---~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA---EALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC---CCeEEEEEeCC
Confidence 4899999999999764 445679999986543 34445668899999999999999999998754 46899999999
Q ss_pred cccccccc-CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCc--cc
Q 005289 215 HDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL--TS 291 (704)
Q Consensus 215 g~ll~~~~-~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~--~~ 291 (704)
++.+..+. .....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........... ..
T Consensus 78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 86655443 3455789999999999999999999999999999999999999999999999999976543322111 11
Q ss_pred ccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCC
Q 005289 292 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 370 (704)
Q Consensus 292 ~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~ 370 (704)
..+++.|+|||++.. ..++.++|||||||++|+|++ |.+||......+.+..+.. +..+
T Consensus 158 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~--~~~~----------------- 217 (257)
T cd05115 158 GKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ--GKRL----------------- 217 (257)
T ss_pred CCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC--CCCC-----------------
Confidence 123578999998875 568899999999999999996 9999998877666555432 1110
Q ss_pred CCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 371 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 371 ~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
......++++.+||.+||..||++||++.++++.
T Consensus 218 ---------~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~ 251 (257)
T cd05115 218 ---------DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEER 251 (257)
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0113568899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=312.15 Aligned_cols=248 Identities=22% Similarity=0.347 Sum_probs=199.1
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|++.++||+|+||.||++.+. .+..||+|.+.... .....+.+|+.+|+.++|+||+++++++.. ...|+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~ 77 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYI 77 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC---CCeEE
Confidence 568999999999999999999864 45679999886432 234567889999999999999999998866 56899
Q ss_pred EEecccccccc-cccC-CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC
Q 005289 209 VFEYMEHDITG-LLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 209 V~Ey~~g~ll~-~~~~-~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~ 286 (704)
||||+.++.+. .+.. ....+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 99999875444 3332 234578889999999999999999999999999999999999999999999999976543322
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
.......++..|+|||++.. ..++.++|||||||++|+|++ |++||.+.+..+....+......
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-------------- 222 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM-------------- 222 (260)
T ss_pred ccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC--------------
Confidence 22222344677999999875 568899999999999999998 99999987776665554321100
Q ss_pred ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
.....++.++.++|.+||..||++||++.+++.
T Consensus 223 --------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 223 --------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred --------------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 011357889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=316.43 Aligned_cols=239 Identities=19% Similarity=0.256 Sum_probs=187.5
Q ss_pred EEeeccCceEEEEEEECC------------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC
Q 005289 136 EKIGQGTYSSVFRARDLD------------TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (704)
Q Consensus 136 ~~LG~G~fg~Vy~a~~~~------------~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 203 (704)
+.||+|+||+||+++... ....||+|++.... ......+.+|+.+|..++||||+++++++.. .
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~--~ 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVR--D 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEec--C
Confidence 368999999999998532 22358888875432 3334567789999999999999999999876 4
Q ss_pred CeEEEEEecccccccccccC-CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCc-------eEEecc
Q 005289 204 CSIYLVFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV-------LKLADF 275 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~~~~-~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~-------iKL~DF 275 (704)
...+|||||++++.+..+.. ....+++..+..++.||+.||.|||++||+||||||+||||+.++. +||+||
T Consensus 77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 56799999999877665543 3456899999999999999999999999999999999999987664 899999
Q ss_pred ccccccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHHcCCCCc
Q 005289 276 GLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPD 354 (704)
Q Consensus 276 Gla~~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLl-tG~~pF~~~~~~e~l~~I~~~~g~~p~ 354 (704)
|++...... ....++..|+|||++.....++.++|||||||+||+|+ +|.+||......+.. .+.. +..
T Consensus 157 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~--~~~-- 226 (262)
T cd05077 157 GIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYE--GQC-- 226 (262)
T ss_pred CCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHh--cCc--
Confidence 998655322 23456888999998875567899999999999999998 588888765543322 1111 000
Q ss_pred hhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 355 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 355 ~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
......+.++.+||.+||..||.+|||..++|++
T Consensus 227 -------------------------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 227 -------------------------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred -------------------------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 0012345778999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=311.79 Aligned_cols=245 Identities=24% Similarity=0.327 Sum_probs=198.0
Q ss_pred EEeeccCceEEEEEEECC-CC--cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEec
Q 005289 136 EKIGQGTYSSVFRARDLD-TG--KIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEY 212 (704)
Q Consensus 136 ~~LG~G~fg~Vy~a~~~~-~g--~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey 212 (704)
+.||.|+||+||+|.+.. .+ ..||||.+...... ...+.+.+|+.+|++++||||+++++++.. ..+++||||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEEEe
Confidence 368999999999998765 33 36999999876543 556778899999999999999999999876 678999999
Q ss_pred ccccccc-cccCCC-ccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCC--C
Q 005289 213 MEHDITG-LLSCPD-IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ--P 288 (704)
Q Consensus 213 ~~g~ll~-~~~~~~-~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~--~ 288 (704)
++++.+. .+.... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++......... .
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 9875444 333322 46899999999999999999999999999999999999999999999999999866442211 1
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCccc
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~ 367 (704)
.....++..|+|||.+.. ..++.++|||||||++|+|++ |.+||...+..+.+..+.......
T Consensus 157 ~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~--------------- 220 (257)
T cd05040 157 EEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERL--------------- 220 (257)
T ss_pred ccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcC---------------
Confidence 112345778999998865 568999999999999999998 999998888777766664311000
Q ss_pred CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
.....+|..+.+||.+||..+|++|||+.++++
T Consensus 221 ------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 221 ------------ERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred ------------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 001246788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=317.44 Aligned_cols=248 Identities=28% Similarity=0.409 Sum_probs=195.6
Q ss_pred eEEEEeeccCceEEEEEEEC----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 133 EKLEKIGQGTYSSVFRARDL----DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 133 ~~~~~LG~G~fg~Vy~a~~~----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.+.+.||.|.||.||+|... ..+..|+||++.. .......+.+.+|+++|++++||||+++++++.. ...++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~--~~~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE--NEPLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES--SSSEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeecccccccccccccccccccccc--cccccc
Confidence 46789999999999999987 4567899999954 3345557788999999999999999999999985 456999
Q ss_pred EEecccccccccc-cCC-CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC
Q 005289 209 VFEYMEHDITGLL-SCP-DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 209 V~Ey~~g~ll~~~-~~~-~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~ 286 (704)
|||||.++.+..+ ... ...+++..+..|+.||+.||.|||+++|+|+||++.||||+.++.+||+|||++........
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999997655543 333 46799999999999999999999999999999999999999999999999999976632211
Q ss_pred -CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC
Q 005289 287 -QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 287 -~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
...........|+|||++.. ..++.++||||||+++|||++ |+.||...+..+.+.++.+.. .+
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~-~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~-~~------------ 224 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKD-GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQ-RL------------ 224 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHH-SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTE-ET------------
T ss_pred ccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccc-cc------------
Confidence 11222345778999999875 448999999999999999999 789999888888777774321 00
Q ss_pred cccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
.....++..+.+||..||..||.+|||+.++++
T Consensus 225 ---------------~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 225 ---------------PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp ---------------TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ---------------eeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 011357899999999999999999999999985
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=326.09 Aligned_cols=255 Identities=22% Similarity=0.317 Sum_probs=201.8
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCC-------CcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEE
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDT-------GKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLI 198 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~-------g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~ 198 (704)
+...+|++.+.||+|+||.||+|++... ...||+|++... ........+.+|+.+++++ +||||+++++++
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 3345799999999999999999986432 236899988643 2344566788999999999 899999999998
Q ss_pred eecCCCeEEEEEecccccccccccC----------------CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccE
Q 005289 199 TSRLSCSIYLVFEYMEHDITGLLSC----------------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNL 262 (704)
Q Consensus 199 ~~~~~~~~~LV~Ey~~g~ll~~~~~----------------~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NI 262 (704)
.. ...+|+||||+.++.+..+.. ....++...+..++.||+.||.|||++||+||||||+||
T Consensus 88 ~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 165 (334)
T cd05100 88 TQ--DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV 165 (334)
T ss_pred cc--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence 77 467899999998865543322 123477888999999999999999999999999999999
Q ss_pred EEccCCceEEeccccccccCCCCCC-CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHH
Q 005289 263 LVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVE 340 (704)
Q Consensus 263 Ll~~~g~iKL~DFGla~~~~~~~~~-~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e 340 (704)
||+.++.+||+|||+++........ ......++..|+|||++.+ ..++.++|||||||+||+|++ |.+||.+.+..+
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 244 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999765432211 1112233567999999876 568899999999999999998 899999887777
Q ss_pred HHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 341 QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 341 ~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.+..+.... .+ .....++..+.+||.+||..+|.+|||+.++|.+
T Consensus 245 ~~~~~~~~~--~~--------------------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 245 LFKLLKEGH--RM--------------------------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHcCC--CC--------------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 665553210 00 0113567889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=317.92 Aligned_cols=238 Identities=21% Similarity=0.248 Sum_probs=186.7
Q ss_pred EeeccCceEEEEEEECC------------------------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCce
Q 005289 137 KIGQGTYSSVFRARDLD------------------------TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192 (704)
Q Consensus 137 ~LG~G~fg~Vy~a~~~~------------------------~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 192 (704)
.||+|+||.||++.... ....||+|++.... ......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 58999999999997432 12458899886432 23345577899999999999999
Q ss_pred eEeEEEeecCCCeEEEEEeccccccccccc-CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCC---
Q 005289 193 KLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG--- 268 (704)
Q Consensus 193 ~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~-~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g--- 268 (704)
++++++.+ ....||||||++++.+..+. .....+++..+..++.||+.||+|||++||+||||||+||||+..+
T Consensus 80 ~~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 80 FVHGVCVR--GSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eEEEEEEe--CCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 99999987 46789999999998776554 3456789999999999999999999999999999999999998654
Q ss_pred ----ceEEeccccccccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHH-hCCCCCCCCCHHHHHH
Q 005289 269 ----VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLH 343 (704)
Q Consensus 269 ----~iKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLl-tG~~pF~~~~~~e~l~ 343 (704)
.+||+|||++...... ....++..|+|||.+.+...++.++|||||||++|||+ +|.+||......+...
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 3899999988644321 22356788999999876567899999999999999995 6999998766544322
Q ss_pred HHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 344 KIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 344 ~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.+.. .... ....+..+.+||.+||..+|++|||+.++|++
T Consensus 233 ~~~~-~~~~-----------------------------~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 233 FYEK-KHRL-----------------------------PEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHh-ccCC-----------------------------CCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 2111 0000 01245678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=331.85 Aligned_cols=263 Identities=26% Similarity=0.370 Sum_probs=195.3
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
+++|..-+.||+|+||+||+|.-. ++..||||++....... ...|.+|+.+|.+++|||||+|+|||.+... ..+|
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~-~~~L 149 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGE-HRLL 149 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCc-eEEE
Confidence 468999999999999999999864 45899999887654332 3448999999999999999999999987422 5899
Q ss_pred EEecccccccccccC-CCc-cccHHHHHHHHHHhhhhHHHHHhcC---cccccCCCccEEEccCCceEEeccccccccCC
Q 005289 209 VFEYMEHDITGLLSC-PDI-KFSEAQIKCYMNQLLHGLEHCHSRG---VLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~-~~~-~l~e~~~~~i~~QIl~aL~yLH~~g---IvHrDLKp~NILl~~~g~iKL~DFGla~~~~~ 283 (704)
|||||.++.|...+. ... .+++.....|+.+++.||+|||+.. |||||||++|||||.+++.||+|||+|+....
T Consensus 150 VYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~ 229 (361)
T KOG1187|consen 150 VYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPE 229 (361)
T ss_pred EEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCc
Confidence 999999876665443 333 8999999999999999999999853 99999999999999999999999999976654
Q ss_pred CCCCCcccc-cccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHcCCCCchhhhc
Q 005289 284 GHRQPLTSR-VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT---EVEQLHKIFKLCGSPPDDYWKK 359 (704)
Q Consensus 284 ~~~~~~~~~-~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~---~~e~l~~I~~~~g~~p~~~w~~ 359 (704)
. ....... .||.+|+|||.+.. ...+.++|||||||+|.||++|+.+..... ......-.... |..
T Consensus 230 ~-~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~--------~~~ 299 (361)
T KOG1187|consen 230 G-DTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL--------LEE 299 (361)
T ss_pred c-ccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH--------HHC
Confidence 1 1222222 78999999998875 678999999999999999999998876432 11111100111 111
Q ss_pred cCCCCcccCCCCCCCCchhh-hhcc--CCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 360 SKLPHATLFKPQQPYDSSLR-ETFK--DLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~l~-~~~~--~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.++ ..+..+ .+. ..+. ..-..+..+..+|+..+|.+||+..++++.
T Consensus 300 ~~~--~eiiD~------~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~ 348 (361)
T KOG1187|consen 300 GKL--REIVDP------RLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKE 348 (361)
T ss_pred cch--hheeCC------CccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHH
Confidence 100 001111 111 0111 111236788889999999999999998643
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=317.18 Aligned_cols=238 Identities=19% Similarity=0.235 Sum_probs=187.9
Q ss_pred EeeccCceEEEEEEECCCCcE-------EEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 137 KIGQGTYSSVFRARDLDTGKI-------VALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 137 ~LG~G~fg~Vy~a~~~~~g~~-------vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
.||.|+||+||+|.+..++.. ||+|.+.... ....+.+..|+.+|+.++||||+++++++.. ....++|
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~~lv 77 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVC--GDESIMV 77 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEe--CCCcEEE
Confidence 689999999999998665443 8888875432 3334567789999999999999999999987 4678999
Q ss_pred Eeccccccccccc-CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCc--------eEEeccccccc
Q 005289 210 FEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV--------LKLADFGLANF 280 (704)
Q Consensus 210 ~Ey~~g~ll~~~~-~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~--------iKL~DFGla~~ 280 (704)
|||+.++.+..+. .....+++..+..++.||+.||.|||++||+||||||+|||++.++. ++|+|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999987665544 34446899999999999999999999999999999999999987764 69999999865
Q ss_pred cCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHcCCCCchhhhc
Q 005289 281 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG-KPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359 (704)
Q Consensus 281 ~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG-~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~ 359 (704)
.... ....+++.|+|||++.+...++.++|||||||++|+|++| .+||...+........ .....
T Consensus 158 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~-~~~~~-------- 223 (258)
T cd05078 158 VLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY-EDRHQ-------- 223 (258)
T ss_pred cCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-Hcccc--------
Confidence 5422 2345688899999997656689999999999999999998 4666655544332221 10000
Q ss_pred cCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.....+.++.+||.+||+.||++|||++++|+.
T Consensus 224 ---------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 224 ---------------------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred ---------------------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 012345678999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=319.18 Aligned_cols=258 Identities=21% Similarity=0.289 Sum_probs=198.2
Q ss_pred CCeeEEEEeeccCceEEEEEEECC----------------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCcee
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLD----------------TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIK 193 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~----------------~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 193 (704)
++|++.++||+|+||+||++.+.. +...||+|++.... .......+.+|+.+|+.++|+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcce
Confidence 469999999999999999986432 34579999987542 3344567889999999999999999
Q ss_pred EeEEEeecCCCeEEEEEecccccccccccCC-----------CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccE
Q 005289 194 LEGLITSRLSCSIYLVFEYMEHDITGLLSCP-----------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNL 262 (704)
Q Consensus 194 l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~-----------~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NI 262 (704)
+++++.. ...+|+||||+.++.+..+... ...+++..+..++.||+.||+|||++||+|+||||+||
T Consensus 84 ~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 84 LLAVCIT--SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred EEEEEec--CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 9999877 4678999999987554433221 12477889999999999999999999999999999999
Q ss_pred EEccCCceEEeccccccccCCCCCCC-cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh--CCCCCCCCCHH
Q 005289 263 LVNNEGVLKLADFGLANFSNTGHRQP-LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI--GKPILQGRTEV 339 (704)
Q Consensus 263 Ll~~~g~iKL~DFGla~~~~~~~~~~-~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt--G~~pF~~~~~~ 339 (704)
|++.++.++|+|||++.......... .....+++.|+|||++.+ ..++.++|||||||++|||++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 99999999999999997654322111 122334678999998765 468999999999999999998 77999877766
Q ss_pred HHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 340 EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 340 e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
+.+......... ... ... ......++..+.+||.+||..||.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~--------~~~---~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 241 QVIENTGEFFRD--------QGR---QVY----------LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHHhh--------ccc---ccc----------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 655544221100 000 000 0111346788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=314.01 Aligned_cols=251 Identities=21% Similarity=0.326 Sum_probs=201.8
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCc----EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGK----IVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~----~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 204 (704)
..+|++++.||+|+||+||+|.++.++. .||+|.+..... ......+.+|+.+|..++||||+++++++.. .
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~ 81 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS---S 81 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec---C
Confidence 4579999999999999999999877665 589998875543 4445667889999999999999999998876 5
Q ss_pred eEEEEEeccccccccc-ccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCC
Q 005289 205 SIYLVFEYMEHDITGL-LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~-~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~ 283 (704)
..++||||+.++.+.. +......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 7899999998755544 444445689999999999999999999999999999999999999999999999999986653
Q ss_pred CCCCC-cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccC
Q 005289 284 GHRQP-LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (704)
Q Consensus 284 ~~~~~-~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~ 361 (704)
..... .....++..|+|||.+.. ..++.++|||||||++|+|++ |.+||.+....+....+... ...+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~-------- 231 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG-ERLP-------- 231 (279)
T ss_pred cccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC-CCCC--------
Confidence 32111 111223567999998864 568899999999999999998 99999988776655555321 0000
Q ss_pred CCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
.....+.++.++|.+||..||.+|||+.++++
T Consensus 232 -------------------~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 232 -------------------QPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred -------------------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 01245678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=313.75 Aligned_cols=243 Identities=26% Similarity=0.346 Sum_probs=190.8
Q ss_pred EeeccCceEEEEEEECCCCc--EEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCCeEEEEEecc
Q 005289 137 KIGQGTYSSVFRARDLDTGK--IVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYM 213 (704)
Q Consensus 137 ~LG~G~fg~Vy~a~~~~~g~--~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~LV~Ey~ 213 (704)
.||+|+||.||+|++..++. .+|+|.+... ........+.+|+.++.++ +||||+++++++.. ...+|+||||+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e~~ 78 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLYLAIEYA 78 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec--CCCceEEEEeC
Confidence 58999999999999988776 4688887632 2344456778899999999 89999999999977 46789999999
Q ss_pred cccccccccCC----------------CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEecccc
Q 005289 214 EHDITGLLSCP----------------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL 277 (704)
Q Consensus 214 ~g~ll~~~~~~----------------~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGl 277 (704)
.++.+..+... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 87544433211 12478999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchh
Q 005289 278 ANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDY 356 (704)
Q Consensus 278 a~~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~ 356 (704)
+....... .......+..|+|||++.. ..++.++|||||||++|+|++ |.+||.+.+..+.+..+.... .
T Consensus 159 ~~~~~~~~--~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~--~---- 229 (270)
T cd05047 159 SRGQEVYV--KKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY--R---- 229 (270)
T ss_pred ccccchhh--hccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC--C----
Confidence 86332111 1111223567999998865 568999999999999999997 999998877666555442200 0
Q ss_pred hhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 357 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 357 w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
......++.++.+||.+||..||.+|||+.++|..
T Consensus 230 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 264 (270)
T cd05047 230 ----------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 264 (270)
T ss_pred ----------------------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 00112467889999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=311.53 Aligned_cols=251 Identities=24% Similarity=0.430 Sum_probs=203.4
Q ss_pred CeeEEEEeeccCceEEEEEEECC-CCcEEEEEEeecCC--------CChHHHHHHHHHHHHHHh-cCCCCceeEeEEEee
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLD-TGKIVALKKVRFDN--------FEPESVRFMAREILILRR-LDHPNIIKLEGLITS 200 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~-~g~~vAvK~i~~~~--------~~~~~~~~~~~Ei~iL~~-L~HpnIv~l~~~~~~ 200 (704)
.|++.+.||+|+||+||++.+.. +++.+|+|.+.... ........+.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 38889999999999999999887 78899999986432 123345557789998875 699999999999877
Q ss_pred cCCCeEEEEEecccccccccc----cCCCccccHHHHHHHHHHhhhhHHHHHh-cCcccccCCCccEEEccCCceEEecc
Q 005289 201 RLSCSIYLVFEYMEHDITGLL----SCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADF 275 (704)
Q Consensus 201 ~~~~~~~LV~Ey~~g~ll~~~----~~~~~~l~e~~~~~i~~QIl~aL~yLH~-~gIvHrDLKp~NILl~~~g~iKL~DF 275 (704)
...+||||||+++..+..+ ......+++..++.++.||+.+|.|||+ .+|+|+||+|.|||++.++.+||+||
T Consensus 81 --~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 --NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred --CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecc
Confidence 5789999999998554433 2344568999999999999999999996 78999999999999999999999999
Q ss_pred ccccccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCch
Q 005289 276 GLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 355 (704)
Q Consensus 276 Gla~~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~ 355 (704)
|++....... ......++..|+|||++.+ ..++.++|||||||++|+|++|.+||...........+......+.
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 233 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL-- 233 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC--
Confidence 9997655432 3345567899999999876 5589999999999999999999999987776665555543211110
Q ss_pred hhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 356 ~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
....++..+.+||.+||..||++|||+.++..+
T Consensus 234 -------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 234 -------------------------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred -------------------------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 012467889999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=312.74 Aligned_cols=251 Identities=19% Similarity=0.269 Sum_probs=190.4
Q ss_pred EEeeccCceEEEEEEECC--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEecc
Q 005289 136 EKIGQGTYSSVFRARDLD--TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYM 213 (704)
Q Consensus 136 ~~LG~G~fg~Vy~a~~~~--~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~ 213 (704)
+.||+|+||+||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++.+.. ...+||||||+
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~--~~~~~lv~e~~ 77 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE--SIPYLLVLEFC 77 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECC--CCceEEEEEeC
Confidence 368999999999996432 44578888876433 33445567789999999999999999999876 46789999999
Q ss_pred cccccccccCC-----CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC-C
Q 005289 214 EHDITGLLSCP-----DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-Q 287 (704)
Q Consensus 214 ~g~ll~~~~~~-----~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~-~ 287 (704)
.++.+..+... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 98666544322 12356788899999999999999999999999999999999999999999999865432211 1
Q ss_pred CcccccccccccCcccccC------CCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhcc
Q 005289 288 PLTSRVVTLWYRPPELLLG------ATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (704)
Q Consensus 288 ~~~~~~gT~~Y~APEvl~~------~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~ 360 (704)
......+++.|+|||++.. ...++.++|||||||++|+|++ |.+||....+.+.+.++.......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~-------- 229 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIK-------- 229 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCcc--------
Confidence 1122345678999998742 2357889999999999999999 789998877776666654421111
Q ss_pred CCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
++. ......++..+.+++..|+ .||++|||++++++-
T Consensus 230 -~~~--------------~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~ 266 (269)
T cd05042 230 -LPK--------------PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHEL 266 (269)
T ss_pred -CCC--------------CcccccCCHHHHHHHHHHh-cCcccccCHHHHHHH
Confidence 000 0112357788899999998 699999999999853
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=333.16 Aligned_cols=255 Identities=21% Similarity=0.267 Sum_probs=199.6
Q ss_pred ccCCeeEEEEeeccCceEEEEEEEC-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeEEEeec
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDL-----DTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNIIKLEGLITSR 201 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~ 201 (704)
..++|.+.++||+|+||.||+|++. .+++.||||++..... ......+.+|+.+|.++. |||||++++++..
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~- 112 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLGACTK- 112 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc-
Confidence 3457999999999999999999853 3557899999975432 333456788999999997 9999999999977
Q ss_pred CCCeEEEEEecccccccccccCC---------------------------------------------------------
Q 005289 202 LSCSIYLVFEYMEHDITGLLSCP--------------------------------------------------------- 224 (704)
Q Consensus 202 ~~~~~~LV~Ey~~g~ll~~~~~~--------------------------------------------------------- 224 (704)
...+|||||||.++.|..++..
T Consensus 113 -~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 113 -GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred -CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 4679999999997554432211
Q ss_pred -----------------------------------------CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEE
Q 005289 225 -----------------------------------------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLL 263 (704)
Q Consensus 225 -----------------------------------------~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NIL 263 (704)
...+++..+..|+.||+.||.|||+.+|+||||||+|||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiL 271 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVL 271 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEE
Confidence 123677788999999999999999999999999999999
Q ss_pred EccCCceEEeccccccccCCCCC-CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHH
Q 005289 264 VNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQ 341 (704)
Q Consensus 264 l~~~g~iKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~ 341 (704)
+++++.+||+|||+++....... ......++++.|+|||++.+ ..++.++|||||||+||||++ |..||......+.
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~ 350 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence 99999999999999976532211 11223456788999999876 568899999999999999998 8999987665554
Q ss_pred HHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 342 LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 342 l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
+...+.. +..+ .....++.++.+||.+||..+|.+||++.++|+.
T Consensus 351 ~~~~~~~-~~~~--------------------------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 351 FYNAIKR-GYRM--------------------------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHHc-CCCC--------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4333221 1000 0113568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=312.25 Aligned_cols=229 Identities=24% Similarity=0.331 Sum_probs=184.2
Q ss_pred cCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEeccccccccc
Q 005289 141 GTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGL 220 (704)
Q Consensus 141 G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~ 220 (704)
|.|+.||+|++..+++.||+|++.... ...+|...+....||||+++++++.+ ...+||||||+.++.+..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVS--EDSVFLVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheec--CCeEEEEEecCCCCCHHH
Confidence 899999999999999999999997542 12345555566689999999999877 578999999999866655
Q ss_pred ccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCcccccccccccC
Q 005289 221 LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP 300 (704)
Q Consensus 221 ~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~~~gT~~Y~A 300 (704)
+......+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++...... .....++..|+|
T Consensus 75 ~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~a 150 (237)
T cd05576 75 HISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCA 150 (237)
T ss_pred HHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccC
Confidence 4444456899999999999999999999999999999999999999999999999988655432 223345778999
Q ss_pred cccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhh
Q 005289 301 PELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRE 380 (704)
Q Consensus 301 PEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~ 380 (704)
||.+.. ..++.++|||||||++|+|++|++||...... +.. ... ..
T Consensus 151 PE~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~~----------------~~~------------~~ 196 (237)
T cd05576 151 PEVGGI-SEETEACDWWSLGAILFELLTGKTLVECHPSG-----INT----------------HTT------------LN 196 (237)
T ss_pred CcccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----ccc----------------ccc------------cC
Confidence 998865 56789999999999999999999887532110 000 000 00
Q ss_pred hccCCCHHHHHHHHHhhccCCCCCcCH-----HHHHhcccc
Q 005289 381 TFKDLPTTAVNLIETLLSVEPYKRATA-----SAALASEYF 416 (704)
Q Consensus 381 ~~~~~s~~~~dLI~~mL~~dP~kRpTa-----~e~L~hpwf 416 (704)
....++..+.+||.+||+.||++|||+ +++++||||
T Consensus 197 ~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 197 IPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred CcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 113578899999999999999999996 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=310.75 Aligned_cols=253 Identities=22% Similarity=0.300 Sum_probs=199.0
Q ss_pred eeEEEEeeccCceEEEEEEEC---CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC----C
Q 005289 132 FEKLEKIGQGTYSSVFRARDL---DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS----C 204 (704)
Q Consensus 132 y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~----~ 204 (704)
|++.+.||+|+||+||+|... .+++.||||++..+.......+.+.+|+.+|+.++||||+++++++..... .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 677889999999999999864 357899999997665555566778899999999999999999998865321 1
Q ss_pred eEEEEEeccccccccccc------CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccc
Q 005289 205 SIYLVFEYMEHDITGLLS------CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~------~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla 278 (704)
..++++||+.++.+..+. .....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 347899999876544321 12235789999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCC-CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchh
Q 005289 279 NFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDY 356 (704)
Q Consensus 279 ~~~~~~~~~-~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~ 356 (704)
+........ ......+++.|++||.+.. ..++.++|||||||++|+|++ |.+||.+.+..+....+... ..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~---- 234 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG-NRL---- 234 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC-CcC----
Confidence 865432211 1122334678999998875 567889999999999999999 89999887766655544321 000
Q ss_pred hhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 357 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 357 w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.....++..+.+|+.+||..+|.+|||+.+++..
T Consensus 235 -----------------------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 235 -----------------------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred -----------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0012467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=308.22 Aligned_cols=247 Identities=21% Similarity=0.309 Sum_probs=190.4
Q ss_pred EEeeccCceEEEEEEECC---CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEec
Q 005289 136 EKIGQGTYSSVFRARDLD---TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEY 212 (704)
Q Consensus 136 ~~LG~G~fg~Vy~a~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey 212 (704)
+.||+|+||+||+|.+.. ....||||.+.... .......+.+|+.+++.++||||+++++++... +...|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS-EGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecC-CCCcEEEEec
Confidence 368999999999998653 34679999985322 234456778899999999999999999977543 3467899999
Q ss_pred cccccccccc-CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC---CC
Q 005289 213 MEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR---QP 288 (704)
Q Consensus 213 ~~g~ll~~~~-~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~---~~ 288 (704)
+.++.+..+. .....+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 9976555443 3334567788889999999999999999999999999999999999999999999975432211 11
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCccc
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~ 367 (704)
.....++..|+|||++.+ ..++.++|||||||++|||++ |.+||...+..+....+.. +.++
T Consensus 159 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~--~~~~-------------- 221 (262)
T cd05058 159 HTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ--GRRL-------------- 221 (262)
T ss_pred cccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc--CCCC--------------
Confidence 112344678999998875 568999999999999999999 5778877666555444322 1110
Q ss_pred CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.....++..+.+||.+||..+|++|||+.++|..
T Consensus 222 ------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 222 ------------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred ------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 0012467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=316.95 Aligned_cols=253 Identities=20% Similarity=0.300 Sum_probs=198.7
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCCc----EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTGK----IVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~----~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 203 (704)
..++|++++.||.|+||.||+|.+..++. .||+|.+..... ......+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--- 80 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG-PKANVEFMDEALIMASMDHPHLVRLLGVCLS--- 80 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEcC---
Confidence 35679999999999999999999887776 478888865432 3334457789999999999999999998865
Q ss_pred CeEEEEEecccccccc-cccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccC
Q 005289 204 CSIYLVFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~-~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~ 282 (704)
...++|+||+.++.+. .+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 81 PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred CCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence 3467999999975444 444444468999999999999999999999999999999999999999999999999998664
Q ss_pred CCCCC-CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhcc
Q 005289 283 TGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (704)
Q Consensus 283 ~~~~~-~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~ 360 (704)
..... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+ .....++
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~------- 231 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL-EKGERLP------- 231 (303)
T ss_pred CcccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HCCCCCC-------
Confidence 33211 1222345778999999875 568999999999999999997 89999876544433322 2111110
Q ss_pred CCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.....+..+.++|..||..||++||++.++++.
T Consensus 232 --------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 232 --------------------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred --------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 012456789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=324.93 Aligned_cols=265 Identities=25% Similarity=0.409 Sum_probs=213.6
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCC-CC----hHHHHHHHHHHHHHHhcCCCCceeEeEEEeec
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN-FE----PESVRFMAREILILRRLDHPNIIKLEGLITSR 201 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~-~~----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 201 (704)
.-.++|-+++.||.|||+.||+|.+....++||||+-.... +. ....+...+|..|.+.|+||.||++|++|.-.
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 44578999999999999999999999999999999865432 11 22334467899999999999999999999754
Q ss_pred CCCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhc--CcccccCCCccEEEccC---CceEEeccc
Q 005289 202 LSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR--GVLHRDIKGSNLLVNNE---GVLKLADFG 276 (704)
Q Consensus 202 ~~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~--gIvHrDLKp~NILl~~~---g~iKL~DFG 276 (704)
...+|-|+|||+|+.|+.++.....++|.+++.|+.||+.||.||.+. .|||-||||.||||.+. |.|||+|||
T Consensus 540 -tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 540 -TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred -cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 468999999999999999888888899999999999999999999987 59999999999999654 679999999
Q ss_pred cccccCCCCCC------CcccccccccccCcccccC---CCCCCCccchhhHHHHHHHHHhCCCCCCCCCH-HHHHHH--
Q 005289 277 LANFSNTGHRQ------PLTSRVVTLWYRPPELLLG---ATDYGPSVDLWSVGCVFAELLIGKPILQGRTE-VEQLHK-- 344 (704)
Q Consensus 277 la~~~~~~~~~------~~~~~~gT~~Y~APEvl~~---~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~-~e~l~~-- 344 (704)
|++.+..+... ......||.||++||.+.- ....+.++||||+|||+|.++.|+.||..... .++++.
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT 698 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT 698 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence 99987654322 1233468999999999753 24578899999999999999999999965432 222221
Q ss_pred HHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 345 IFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 345 I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
|++. ..+..|. -+.++.++++||++||.+.-++|+...++..||||.-
T Consensus 699 IlkA----------------tEVqFP~----------KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 699 ILKA----------------TEVQFPP----------KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred hhcc----------------eeccCCC----------CCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 1110 0011111 1468899999999999999999999999999999973
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=307.98 Aligned_cols=243 Identities=25% Similarity=0.392 Sum_probs=196.2
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|++.+.||+|+||.||++. .+++.||+|++..+. ....+.+|+.+|+.++||||+++++++.. ...|+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~~~ 75 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILH---NGLYI 75 (254)
T ss_pred HHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcC---CCcEE
Confidence 3579999999999999999986 478899999986532 23457789999999999999999998865 34799
Q ss_pred EEeccccccccccc-C-CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC
Q 005289 209 VFEYMEHDITGLLS-C-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 209 V~Ey~~g~ll~~~~-~-~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~ 286 (704)
||||+.++.+..+. . ....+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 99999875544333 2 2335889999999999999999999999999999999999999999999999998754322
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
......+..|+|||.+.+ ..++.++|||||||++|+|++ |++||...+..+....+... ..+
T Consensus 154 --~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--~~~------------ 216 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG--YRM------------ 216 (254)
T ss_pred --CCCCCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCC--CCC------------
Confidence 122233567999998865 568899999999999999997 99999888776655544321 000
Q ss_pred ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.....++..+.+||.+||..+|.+|||+++++..
T Consensus 217 --------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 250 (254)
T cd05083 217 --------------EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREK 250 (254)
T ss_pred --------------CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0113578899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=311.12 Aligned_cols=258 Identities=23% Similarity=0.344 Sum_probs=199.1
Q ss_pred CCeeEEEEeeccCceEEEEEEEC----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCe
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDL----DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (704)
..|++++.||+|+||+||+|... .+++.||||++...... .....+.+|+.+++.+.||||+++++++.......
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 46899999999999999999864 34889999999765432 34667889999999999999999999987755678
Q ss_pred EEEEEeccccccccccc-CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 206 IYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~-~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
.|+||||++++.+..+. .....+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence 99999999875554443 33346899999999999999999999999999999999999999999999999999876532
Q ss_pred CCCC--cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHH-----------HHHHHHHcCC
Q 005289 285 HRQP--LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ-----------LHKIFKLCGS 351 (704)
Q Consensus 285 ~~~~--~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~-----------l~~I~~~~g~ 351 (704)
.... ......+..|+|||.+.+ ..++.++|||||||++|+|++|..||........ ...+...+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05038 163 KDYYYVKEPGESPIFWYAPECLRT-SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241 (284)
T ss_pred CcceeccCCCCCcccccCcHHHcc-CCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence 2111 112233567999998865 4688999999999999999999998865432110 1111111000
Q ss_pred CCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 352 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 352 ~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
. .. ......++.++.+||.+||..||++|||+.++++.
T Consensus 242 ~-------------------~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05038 242 G-------------------ER-----LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILI 279 (284)
T ss_pred C-------------------Cc-----CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 0 00 00113467889999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=308.18 Aligned_cols=250 Identities=21% Similarity=0.252 Sum_probs=188.0
Q ss_pred EEeeccCceEEEEEEEC--CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEecc
Q 005289 136 EKIGQGTYSSVFRARDL--DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYM 213 (704)
Q Consensus 136 ~~LG~G~fg~Vy~a~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~ 213 (704)
+.||+|+||.||+|... .++..+|+|.+..... ......+.+|+.+++.++||||+++++++.+ ...+|+||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~ 77 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE--VTPYLLVMEFC 77 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CCCcEEEEECC
Confidence 36899999999999754 3557899999875542 2334567789999999999999999999876 45789999999
Q ss_pred cccccccccC-----CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCC-
Q 005289 214 EHDITGLLSC-----PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ- 287 (704)
Q Consensus 214 ~g~ll~~~~~-----~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~- 287 (704)
+++.+..+.. ....+++..+..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++.........
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9765554332 1224567788899999999999999999999999999999999999999999998754322211
Q ss_pred CcccccccccccCcccccCC------CCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhcc
Q 005289 288 PLTSRVVTLWYRPPELLLGA------TDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (704)
Q Consensus 288 ~~~~~~gT~~Y~APEvl~~~------~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~ 360 (704)
......+++.|+|||++.+. ..++.++|||||||++|+|++ |.+||......+.+.........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--------- 228 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL--------- 228 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccC---------
Confidence 11234567889999998532 135789999999999999996 99999877665544332211000
Q ss_pred CCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
..+ . + ......+..+.+||..|+ .+|++|||+++++.
T Consensus 229 ~~~-----~---~------~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 229 KLP-----K---P------RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CCC-----C---C------ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 000 0 0 001246778999999998 68999999999984
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=309.86 Aligned_cols=245 Identities=22% Similarity=0.318 Sum_probs=194.0
Q ss_pred EEeeccCceEEEEEEECCCC------cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 136 EKIGQGTYSSVFRARDLDTG------KIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 136 ~~LG~G~fg~Vy~a~~~~~g------~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
+.||.|+||.||+|++.... +.||||.+.... .......+.+|+.+|+.++||||+++++++.. ....|+|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL--NEPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecC--CCCeEEE
Confidence 36899999999999976544 789999886532 23345667889999999999999999999876 4678999
Q ss_pred EecccccccccccC-------CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCC-----ceEEecccc
Q 005289 210 FEYMEHDITGLLSC-------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-----VLKLADFGL 277 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~-------~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g-----~iKL~DFGl 277 (704)
|||+.++.+..+.. ....+++..+..++.||+.||.|||+.+|+|+||||+|||++.++ .++|+|||+
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99998755443321 223478899999999999999999999999999999999999887 899999999
Q ss_pred ccccCCCCC-CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCch
Q 005289 278 ANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDD 355 (704)
Q Consensus 278 a~~~~~~~~-~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~ 355 (704)
+........ ........+..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~--~~--- 231 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG--GR--- 231 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC--Cc---
Confidence 875533211 11122345778999999876 568999999999999999998 99999887776665554221 00
Q ss_pred hhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 356 ~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
......+|..+.+||.+||..+|.+|||+.++++
T Consensus 232 -----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 232 -----------------------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred -----------------------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0112357889999999999999999999999975
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=307.29 Aligned_cols=236 Identities=22% Similarity=0.269 Sum_probs=186.4
Q ss_pred EEeeccCceEEEEEEECCCC----------cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCe
Q 005289 136 EKIGQGTYSSVFRARDLDTG----------KIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (704)
Q Consensus 136 ~~LG~G~fg~Vy~a~~~~~g----------~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (704)
+.||+|+||.||+|.+..++ ..|++|++.... .....+.+|+.+|+.++||||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR---DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec---CC
Confidence 36899999999999998776 357888775432 115667889999999999999999998876 35
Q ss_pred EEEEEecccccccccccCCCc-cccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCC-------ceEEecccc
Q 005289 206 IYLVFEYMEHDITGLLSCPDI-KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-------VLKLADFGL 277 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~~~~-~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g-------~iKL~DFGl 277 (704)
.||||||+.++.+..+..... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 689999999877765554333 789999999999999999999999999999999999999888 799999999
Q ss_pred ccccCCCCCCCcccccccccccCcccccCC-CCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCch
Q 005289 278 ANFSNTGHRQPLTSRVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDD 355 (704)
Q Consensus 278 a~~~~~~~~~~~~~~~gT~~Y~APEvl~~~-~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~ 355 (704)
+...... ....++..|+|||++.+. ..++.++|||||||++|+|++ |.+||...+..+....... ...
T Consensus 155 a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~-~~~---- 224 (259)
T cd05037 155 PITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD-QHR---- 224 (259)
T ss_pred ccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc-CCC----
Confidence 8765431 233556789999998764 368999999999999999999 5788876553332222110 000
Q ss_pred hhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 356 ~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
. .......+.+||.+||..||.+|||+.++|+
T Consensus 225 ------~-------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 225 ------L-------------------PMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred ------C-------------------CCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0 0011267899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=342.45 Aligned_cols=252 Identities=26% Similarity=0.394 Sum_probs=212.6
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECC-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeec
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLD-----TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR 201 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 201 (704)
+...+.+..+.||+|+||.||+|+-.. ....||||.++... .......|.||+++|..|+|||||+|+|+|..
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~- 560 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGVCRE- 560 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc-
Confidence 445567888999999999999997532 34679999997543 44567889999999999999999999999988
Q ss_pred CCCeEEEEEecccccccccccC----------C----CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccC
Q 005289 202 LSCSIYLVFEYMEHDITGLLSC----------P----DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE 267 (704)
Q Consensus 202 ~~~~~~LV~Ey~~g~ll~~~~~----------~----~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~ 267 (704)
++.+|||+|||.++.|..++. . ..+|+..+...|+.||+.|+.||-++.+|||||-..|+||.++
T Consensus 561 -~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 561 -GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGEN 639 (774)
T ss_pred -CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccc
Confidence 678999999999876665431 1 2238899999999999999999999999999999999999999
Q ss_pred CceEEeccccccccCCCCCCCcc-cccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 005289 268 GVLKLADFGLANFSNTGHRQPLT-SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKI 345 (704)
Q Consensus 268 g~iKL~DFGla~~~~~~~~~~~~-~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I 345 (704)
..|||+||||++.....+..... .......|||||.|+- ..|+.++||||+||+|||+++ |..|+.+.++.+.++.|
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i 718 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI 718 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence 99999999999876544433333 3345788999999986 679999999999999999997 99999999999999988
Q ss_pred HHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHH
Q 005289 346 FKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 410 (704)
Q Consensus 346 ~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~ 410 (704)
.+. . +.....+.|.++.+|+..|++.+|++||+..||
T Consensus 719 ~~g--~--------------------------lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 719 RAG--Q--------------------------LLSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred HcC--C--------------------------cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 651 1 123346899999999999999999999999987
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=310.01 Aligned_cols=260 Identities=18% Similarity=0.167 Sum_probs=188.3
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCC---CcEEEEEEeecCCCCh--HH-------HHHHHHHHHHHHhcCCCCceeEeE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDT---GKIVALKKVRFDNFEP--ES-------VRFMAREILILRRLDHPNIIKLEG 196 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAvK~i~~~~~~~--~~-------~~~~~~Ei~iL~~L~HpnIv~l~~ 196 (704)
..+|++.+.||+|+||+||+|.+..+ +..+|+|+........ +. ......++..+..++|+||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 45899999999999999999998877 6778888754433211 10 011123344566779999999998
Q ss_pred EEeecCC--CeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEec
Q 005289 197 LITSRLS--CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLAD 274 (704)
Q Consensus 197 ~~~~~~~--~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~D 274 (704)
.+..... ...|++++++...+...+. ....+++..++.++.||+.||.|||+++|+||||||+|||++.++.++|+|
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~D 169 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVENTKEIFK-RIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIID 169 (294)
T ss_pred eeeEecCCceEEEEEEehhccCHHHHHH-hhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEE
Confidence 7654321 2447888887654433332 223467888999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCC------CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHH
Q 005289 275 FGLANFSNTGHR------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE-VEQLHKIFK 347 (704)
Q Consensus 275 FGla~~~~~~~~------~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~-~e~l~~I~~ 347 (704)
||+|+.+..... .......+|+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+... ...+.....
T Consensus 170 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~ 248 (294)
T PHA02882 170 YGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC 248 (294)
T ss_pred cCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH
Confidence 999976542211 11223468999999998876 5689999999999999999999999987743 222221111
Q ss_pred HcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 348 LCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 348 ~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
+++..... -...+...+..+.++++.|+..+|++||+..++++
T Consensus 249 -------~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 249 -------DFIKRLHE---------------GKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred -------HHHHHhhh---------------hhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 00000000 00112456888999999999999999999999975
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=328.95 Aligned_cols=254 Identities=23% Similarity=0.347 Sum_probs=209.9
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCCc---E-EEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTGK---I-VALKKVRFDN-FEPESVRFMAREILILRRLDHPNIIKLEGLITSRL 202 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~---~-vAvK~i~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 202 (704)
..++..+.++||+|+||.||+|+....+. . ||||.+..+. ...+....+.+|+++|+.|+|||||+++|++..
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~-- 232 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL-- 232 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC--
Confidence 34566677999999999999998765422 3 8999998633 567888889999999999999999999999988
Q ss_pred CCeEEEEEecccccccccccCCCc-cccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEecccccccc
Q 005289 203 SCSIYLVFEYMEHDITGLLSCPDI-KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (704)
Q Consensus 203 ~~~~~LV~Ey~~g~ll~~~~~~~~-~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~ 281 (704)
...+|||||+|.|+.|..++.... .++..+...++.+.+.||+|||++++|||||-..|+|++.++.+||+|||+++..
T Consensus 233 ~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 233 EEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred CCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence 578999999999977766555443 6999999999999999999999999999999999999999999999999999765
Q ss_pred CCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhcc
Q 005289 282 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (704)
Q Consensus 282 ~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~ 360 (704)
...... ....-....|+|||.+.. ..|++++|||||||++||+++ |..||.+....+...+|.......+
T Consensus 313 ~~~~~~-~~~~klPirWLAPEtl~~-~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~------- 383 (474)
T KOG0194|consen 313 SQYVMK-KFLKKLPIRWLAPETLNT-GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMP------- 383 (474)
T ss_pred cceeec-cccccCcceecChhhhcc-CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCC-------
Confidence 421111 111234678999999986 489999999999999999998 8899999999999888854221111
Q ss_pred CCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
.....|.++..++.+|+..||++|||..++.+
T Consensus 384 --------------------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 384 --------------------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred --------------------CCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 11256788999999999999999999998864
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=305.11 Aligned_cols=249 Identities=20% Similarity=0.276 Sum_probs=187.9
Q ss_pred EeeccCceEEEEEEECCC--CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEeccc
Q 005289 137 KIGQGTYSSVFRARDLDT--GKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME 214 (704)
Q Consensus 137 ~LG~G~fg~Vy~a~~~~~--g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~ 214 (704)
.||+|+||+||++..... ...+++|.+..... ....+.+.+|+.+++.++||||+++++.+.+ ...+||||||+.
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~ 78 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS-SKEQNEFLQQGDPYRILQHPNILQCLGQCVE--AIPYLLVFEYCE 78 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC-hHHHHHHHHHHHHHhccCCcchhheEEEecC--CCccEEEEecCC
Confidence 689999999999975432 34567777654432 3345678899999999999999999999987 467899999999
Q ss_pred ccccccccCC----CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC-CCCc
Q 005289 215 HDITGLLSCP----DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-RQPL 289 (704)
Q Consensus 215 g~ll~~~~~~----~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~-~~~~ 289 (704)
++.+..+... ...+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++....... ....
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 8655543321 2346777889999999999999999999999999999999999999999999986432211 1112
Q ss_pred ccccccccccCcccccC------CCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCC
Q 005289 290 TSRVVTLWYRPPELLLG------ATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (704)
Q Consensus 290 ~~~~gT~~Y~APEvl~~------~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~ 362 (704)
...+++..|+|||++.. ...++.++|||||||++|||++ |.+||...++.+.+..+.......
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~---------- 228 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK---------- 228 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc----------
Confidence 34567889999998743 1245789999999999999997 578998877777776654321100
Q ss_pred CCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
.+.+ .....+++.+.+||..|+ .+|.+|||+.++++
T Consensus 229 ----~~~~---------~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 229 ----LFKP---------QLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred ----cCCC---------ccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 0000 001246788999999999 78999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=334.53 Aligned_cols=265 Identities=27% Similarity=0.426 Sum_probs=219.5
Q ss_pred cccccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEee---
Q 005289 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITS--- 200 (704)
Q Consensus 125 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~--- 200 (704)
.|...+.|+|...||.|.||.||+++++.+++.+|||++..+.- ..+.+..|.+||+.+ +|||++.++++|.-
T Consensus 14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d---~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED---EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc---ccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 45567899999999999999999999999999999999976542 234466799999988 79999999998853
Q ss_pred cCCCeEEEEEecccccccccccC--CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccc
Q 005289 201 RLSCSIYLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278 (704)
Q Consensus 201 ~~~~~~~LV~Ey~~g~ll~~~~~--~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla 278 (704)
.+++.+|||||||.++...++.. .+..+.|..+.+|++.++.||.+||.+.|||||||-.||||+.++.|||+|||++
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvS 170 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVS 170 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeee
Confidence 24578999999999976655532 2667999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccccccCcccccCC----CCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCc
Q 005289 279 NFSNTGHRQPLTSRVVTLWYRPPELLLGA----TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 354 (704)
Q Consensus 279 ~~~~~~~~~~~~~~~gT~~Y~APEvl~~~----~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~ 354 (704)
...... .....+.+|||+|||||++... ..|+..+|+||||++..||.-|.||+........+-+|- -.||+
T Consensus 171 aQldsT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~Ip---RNPPP 246 (953)
T KOG0587|consen 171 AQLDST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP---RNPPP 246 (953)
T ss_pred eeeecc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCC---CCCCc
Confidence 766542 2344667899999999998542 347889999999999999999999998877655444431 12221
Q ss_pred hhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 355 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 355 ~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
. ...+...++++.+||..||.+|-.+||+..++|+|||+++.
T Consensus 247 k-----------------------Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 247 K-----------------------LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred c-----------------------ccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 1 12245678899999999999999999999999999999853
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=335.20 Aligned_cols=203 Identities=31% Similarity=0.478 Sum_probs=174.2
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC----CCeE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL----SCSI 206 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----~~~~ 206 (704)
.+...+.||+|+||.||+++++.+|+.||||.++.... ....+...+|+++|++|+|||||+++++-++.. ....
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~-~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS-LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcc-cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 35566889999999999999999999999999986542 334566778999999999999999998866544 4556
Q ss_pred EEEEecccccccccccC---CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEcc--CC--ceEEecccccc
Q 005289 207 YLVFEYMEHDITGLLSC---PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN--EG--VLKLADFGLAN 279 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~---~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~--~g--~iKL~DFGla~ 279 (704)
.||||||.++.+..... ....|+|.++..++..+..||.|||++|||||||||.||++-. +| ..||+|||.|+
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 89999999977665543 2345999999999999999999999999999999999999843 23 47999999999
Q ss_pred ccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 005289 280 FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 336 (704)
Q Consensus 280 ~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~ 336 (704)
....+ ..+++.+||+.|++||++.....|+..+|.|||||++|+++||..||...
T Consensus 173 el~d~--s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 173 ELDDN--SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred cCCCC--CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 88765 47889999999999999986678999999999999999999999999653
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=301.34 Aligned_cols=262 Identities=23% Similarity=0.370 Sum_probs=210.5
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCCeEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~ 207 (704)
.++.+-+..||.|+||+|++..++.+|+..|||.|+..+...+ ..+++.|.+...+- +.||||++++.+-. ++..|
T Consensus 63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~ke-q~rll~e~d~~mks~~cp~IVkfyGa~F~--EGdcW 139 (361)
T KOG1006|consen 63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKE-QKRLLMEHDTVMKSSNCPNIVKFYGALFS--EGDCW 139 (361)
T ss_pred cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHH-HHHHHHHHHHHHhhcCCcHHHHHhhhhhc--CCcee
Confidence 4566777889999999999999999999999999998775443 55667788765555 89999999998766 35679
Q ss_pred EEEeccccccccccc----CCCccccHHHHHHHHHHhhhhHHHHHhc-CcccccCCCccEEEccCCceEEeccccccccC
Q 005289 208 LVFEYMEHDITGLLS----CPDIKFSEAQIKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~----~~~~~l~e~~~~~i~~QIl~aL~yLH~~-gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~ 282 (704)
|.||+|.-.+-.++. ..+..++|..+-.|...++.||+||-.. .|||||+||+||||+..|.+||||||.+-...
T Consensus 140 iCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 140 ICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred eeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 999999875544332 2455799999999999999999999965 89999999999999999999999999986554
Q ss_pred CCCCCCcccccccccccCcccccCCCC-CCCccchhhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCCchhhhcc
Q 005289 283 TGHRQPLTSRVVTLWYRPPELLLGATD-YGPSVDLWSVGCVFAELLIGKPILQGRTE-VEQLHKIFKLCGSPPDDYWKKS 360 (704)
Q Consensus 283 ~~~~~~~~~~~gT~~Y~APEvl~~~~~-y~~~~DIWSlG~iLyeLltG~~pF~~~~~-~e~l~~I~~~~g~~p~~~w~~~ 360 (704)
.. -..+...|...|||||-+..... |+.++||||||++|||+.||+.|+.+.+. .+++.+++. |.||.-..
T Consensus 220 ~S--iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~--gdpp~l~~--- 292 (361)
T KOG1006|consen 220 DS--IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI--GDPPILLF--- 292 (361)
T ss_pred HH--HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc--CCCCeecC---
Confidence 32 22344577889999999975444 99999999999999999999999988554 456655543 55542110
Q ss_pred CCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
....-.++..+..+|..||.+|-.+||...+++++||+..
T Consensus 293 ------------------~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~ 332 (361)
T KOG1006|consen 293 ------------------DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRM 332 (361)
T ss_pred ------------------cccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhh
Confidence 0111357889999999999999999999999999999974
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=337.08 Aligned_cols=254 Identities=23% Similarity=0.363 Sum_probs=210.4
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCC-----cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeec
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTG-----KIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR 201 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g-----~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 201 (704)
+..+..++++.||+|+||.||.|...... ..||||.+.+.. +.+....|.+|..+|+.++|||||+|++++.+
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~- 766 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD- 766 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-
Confidence 34567888999999999999999865432 249999987654 45667888999999999999999999999988
Q ss_pred CCCeEEEEEecccccccc-cccCC------CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEec
Q 005289 202 LSCSIYLVFEYMEHDITG-LLSCP------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLAD 274 (704)
Q Consensus 202 ~~~~~~LV~Ey~~g~ll~-~~~~~------~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~D 274 (704)
....+||+|||+++.|. .+... ...++..+...++.||+.|+.||+++++|||||-..|+||+....+||+|
T Consensus 767 -~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 767 -SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred -CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcc
Confidence 56789999999985544 55444 45689999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCcccc-cccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCC
Q 005289 275 FGLANFSNTGHRQPLTSR-VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSP 352 (704)
Q Consensus 275 FGla~~~~~~~~~~~~~~-~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~ 352 (704)
||+|+.+........... .....|||||.+.. ..++.++|||||||+|||+++ |..||...++.+++.-..+. |..
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~g-gRL 923 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEG-GRL 923 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhC-Ccc
Confidence 999995543332222222 23568999999986 679999999999999999998 89999999998888765542 111
Q ss_pred CchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 353 PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 353 p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
+....+|+.+.+||..|+.-+|++||+...+++
T Consensus 924 ---------------------------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 924 ---------------------------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred ---------------------------CCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 112468999999999999999999999999996
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=320.87 Aligned_cols=276 Identities=25% Similarity=0.332 Sum_probs=188.8
Q ss_pred cccCCeeEEEEeeccCceEEEEEEEC----------------CCCcEEEEEEeecCCCCh------------HHHHHHHH
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDL----------------DTGKIVALKKVRFDNFEP------------ESVRFMAR 178 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~----------------~~g~~vAvK~i~~~~~~~------------~~~~~~~~ 178 (704)
...++|++.++||+|+||+||+|... ..++.||||.+....... ...+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 35779999999999999999999752 245679999986542110 01112334
Q ss_pred HHHHHHhcCCCCc-----eeEeEEEeec------CCCeEEEEEecccccccccccCC-----------------------
Q 005289 179 EILILRRLDHPNI-----IKLEGLITSR------LSCSIYLVFEYMEHDITGLLSCP----------------------- 224 (704)
Q Consensus 179 Ei~iL~~L~HpnI-----v~l~~~~~~~------~~~~~~LV~Ey~~g~ll~~~~~~----------------------- 224 (704)
|+.++.++.|.++ ++++++|... .....||||||++++.+..+...
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7788888876654 6677776531 12468999999998655433211
Q ss_pred -CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCcccccccccccCccc
Q 005289 225 -DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPEL 303 (704)
Q Consensus 225 -~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APEv 303 (704)
...+++..++.++.||+.+|.|||+++|+||||||+|||++.++.+||+|||++...............+|+.|+|||+
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE 381 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence 1234567889999999999999999999999999999999999999999999997654332211122234889999999
Q ss_pred ccCCCC-------------------CC--CccchhhHHHHHHHHHhCCC-CCCCCCHHHHHHHHHHHcCCCCchhhhccC
Q 005289 304 LLGATD-------------------YG--PSVDLWSVGCVFAELLIGKP-ILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (704)
Q Consensus 304 l~~~~~-------------------y~--~~~DIWSlG~iLyeLltG~~-pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~ 361 (704)
+..... |+ ...||||+|||||+|+++.. ||........ ..... ......|...+
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~---~~~~~-~~~~~~~r~~~ 457 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT---ELRQY-DNDLNRWRMYK 457 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh---HHhhc-cchHHHHHhhc
Confidence 854211 22 24799999999999999874 6654221111 00000 00011232211
Q ss_pred CCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCC---CCCcCHHHHHhccccCC
Q 005289 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEP---YKRATASAALASEYFST 418 (704)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP---~kRpTa~e~L~hpwf~~ 418 (704)
.. .+. ...+..+++.++|||.+||..+| .+|+|+.|+|+||||..
T Consensus 458 ~~---------~~~---~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 458 GQ---------KYD---FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred cc---------CCC---cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 10 000 11345788999999999999876 68999999999999963
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=286.54 Aligned_cols=243 Identities=39% Similarity=0.584 Sum_probs=197.4
Q ss_pred CceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEecccccccccc
Q 005289 142 TYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL 221 (704)
Q Consensus 142 ~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~ 221 (704)
+||.||+|.+..+++.||+|++........ ...+.+|++++++++|+||+++++++.. ....++||||+.++.+..+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFED--EDKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheee--CCEEEEEEeCCCCCCHHHH
Confidence 589999999998999999999976543221 5678899999999999999999999876 4688999999999555544
Q ss_pred cCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCcccccccccccCc
Q 005289 222 SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPP 301 (704)
Q Consensus 222 ~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~~~gT~~Y~AP 301 (704)
......+++..+..++.+|+.+|.|||+.+|+|+||+|.||++++++.++|+|||++....... ......++..|++|
T Consensus 78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~p 155 (244)
T smart00220 78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAP 155 (244)
T ss_pred HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCCH
Confidence 4333348999999999999999999999999999999999999999999999999998765432 23445678899999
Q ss_pred ccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhh
Q 005289 302 ELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG-RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRE 380 (704)
Q Consensus 302 Evl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~-~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~ 380 (704)
|.+.. ..++.++|||+||+++|+|++|.+||.. ......+..+......+ ..
T Consensus 156 E~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~--------------------------~~ 208 (244)
T smart00220 156 EVLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF--------------------------PP 208 (244)
T ss_pred HHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC--------------------------cc
Confidence 98875 5678899999999999999999999987 33333333332211100 00
Q ss_pred hccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 381 TFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 381 ~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
....++.++.++|.+||..||++||++.++++||||
T Consensus 209 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 209 PEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred ccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 011278899999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=306.94 Aligned_cols=281 Identities=32% Similarity=0.522 Sum_probs=215.2
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECC---CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCC
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLD---TGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLS 203 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 203 (704)
-...|.++++||.|+|++||++.+.. ..++||+|.+..... ...+.+|+++|..+ .+.||+++.+.+.. +
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~~~rn--n 107 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNGCFRN--N 107 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchhhhcc--C
Confidence 34579999999999999999999887 788999999976542 34578999999999 69999999988865 6
Q ss_pred CeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccC-CceEEeccccccccC
Q 005289 204 CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSN 282 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~-g~iKL~DFGla~~~~ 282 (704)
..+++||||+++.....+.. .++..+++.|++.++.||.++|.+|||||||||+|||.+.. +.-.|+|||||....
T Consensus 108 d~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD 184 (418)
T ss_pred CeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHH
Confidence 78999999999966555533 46788999999999999999999999999999999999865 678999999986211
Q ss_pred CCC-------------------------------------------CCCcccccccccccCcccccCCCCCCCccchhhH
Q 005289 283 TGH-------------------------------------------RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSV 319 (704)
Q Consensus 283 ~~~-------------------------------------------~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSl 319 (704)
... ....-.+.||++|+|||+++....-++++||||.
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~ 264 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence 000 0001234689999999999988888899999999
Q ss_pred HHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCCCC--------ch--hhhccCCCCc--------cc----CCC-CCCCC
Q 005289 320 GCVFAELLIGKPIL-QGRTEVEQLHKIFKLCGSPP--------DD--YWKKSKLPHA--------TL----FKP-QQPYD 375 (704)
Q Consensus 320 G~iLyeLltG~~pF-~~~~~~e~l~~I~~~~g~~p--------~~--~w~~~~~~~~--------~~----~~~-~~~~~ 375 (704)
|||+.-+++++.|| ...++.+.+..|..++|.-. .. +|.+.+.+.. .+ ... .++ .
T Consensus 265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~-n 343 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP-N 343 (418)
T ss_pred cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc-c
Confidence 99999999998776 55667777777776666533 22 4543221110 00 000 000 0
Q ss_pred chhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 376 SSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 376 ~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
.........++..+.|||.+||..||.+|+||+++|+||||..
T Consensus 344 ~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 344 TEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred eeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 1112222445678999999999999999999999999999984
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=308.81 Aligned_cols=246 Identities=25% Similarity=0.380 Sum_probs=202.7
Q ss_pred eeEEEEeeccCceEEEEEEECCC--C--cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEE
Q 005289 132 FEKLEKIGQGTYSSVFRARDLDT--G--KIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 132 y~~~~~LG~G~fg~Vy~a~~~~~--g--~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 207 (704)
.+.-++||.|.||.||.|..... | --||||.++.++. ++..+.|..|.-+|+.++|||||+|+|+|.+ ..+|
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t-~d~tekflqEa~iMrnfdHphIikLIGv~~e---~P~W 466 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT-PDDTEKFLQEASIMRNFDHPHIIKLIGVCVE---QPMW 466 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC-hhhHHHHHHHHHHHHhCCCcchhheeeeeec---ccee
Confidence 44456799999999999976433 3 3589999987664 4557888999999999999999999999987 5789
Q ss_pred EEEeccccccccc-ccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC
Q 005289 208 LVFEYMEHDITGL-LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 208 LV~Ey~~g~ll~~-~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~ 286 (704)
||||++..+.+.. +......++......|+.||+.||.|||+..+|||||-..|||+.....+||+||||++.......
T Consensus 467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y 546 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY 546 (974)
T ss_pred EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccch
Confidence 9999999766654 445666799999999999999999999999999999999999999999999999999998876654
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
...+......-|||||.+.- ..++.++|||-|||++||++. |..||.+-.+.+.+-.|.+ |.-
T Consensus 547 YkaS~~kLPIKWmaPESINf-RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEn--GeR------------- 610 (974)
T KOG4257|consen 547 YKASRGKLPIKWMAPESINF-RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIEN--GER------------- 610 (974)
T ss_pred hhccccccceeecCccccch-hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecC--CCC-------------
Confidence 44333334778999999864 578999999999999999875 9999998776666554433 110
Q ss_pred ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHH
Q 005289 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 410 (704)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~ 410 (704)
....+++|+.+..|+.+|+.+||.+||+..++
T Consensus 611 -------------lP~P~nCPp~LYslmskcWayeP~kRPrftei 642 (974)
T KOG4257|consen 611 -------------LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEI 642 (974)
T ss_pred -------------CCCCCCCChHHHHHHHHHhccCcccCCcHHHH
Confidence 01235899999999999999999999997765
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=315.20 Aligned_cols=255 Identities=24% Similarity=0.389 Sum_probs=223.4
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCC---cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTG---KIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g---~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 203 (704)
+......|.+.||.|-||.|++++.+..| ..||||.++.. ..+.+...|+.|+.||-+++||||++|.++.+. .
T Consensus 626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk--s 702 (996)
T KOG0196|consen 626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK--S 702 (996)
T ss_pred cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec--C
Confidence 44566889999999999999999987766 46999999754 456677889999999999999999999999987 5
Q ss_pred CeEEEEEecccccccc-cccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccC
Q 005289 204 CSIYLVFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~-~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~ 282 (704)
..+.||+|||+++.|+ .+...++.|+..++.-+++.|+.|+.||-+.|+|||||-..||||+.+..+||+||||+++..
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecc
Confidence 7889999999997777 445677889999999999999999999999999999999999999999999999999999887
Q ss_pred CCCCCCcccccc--cccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhc
Q 005289 283 TGHRQPLTSRVV--TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359 (704)
Q Consensus 283 ~~~~~~~~~~~g--T~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~ 359 (704)
.+.....++.-| ...|.|||.|.- ..++.++||||+|++|||.++ |..||...++.+.++.|.+....||+
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP----- 856 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP----- 856 (996)
T ss_pred cCCCccccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC-----
Confidence 665444555444 678999999975 568999999999999999775 99999999999999999886655542
Q ss_pred cCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.++|..+..|+..|+++|-..||+..|++.+
T Consensus 857 -----------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 857 -----------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred -----------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 4799999999999999999999999999865
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=299.51 Aligned_cols=259 Identities=22% Similarity=0.281 Sum_probs=209.2
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.+...+.++||+|-||.|.+|.- ..+..||||+++.+. .......|..||++|.+|+|||||.|+++|.. .+.+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~--DePicm 612 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQ--DDPLCM 612 (807)
T ss_pred hhheehhhhhcCcccceeEEEEe-cCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeec--CCchHH
Confidence 45688899999999999999985 346899999998654 34446778999999999999999999999987 578999
Q ss_pred EEecccccccccccCCC-c-cccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC
Q 005289 209 VFEYMEHDITGLLSCPD-I-KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~-~-~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~ 286 (704)
|+|||+++.+..++... . .+.-.....|+.||+.||+||.+.++|||||.+.|+|++.++++||+|||+++....+..
T Consensus 613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCc
Confidence 99999987666443322 1 134455667999999999999999999999999999999999999999999996665544
Q ss_pred CCccc-ccccccccCcccccCCCCCCCccchhhHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCC
Q 005289 287 QPLTS-RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL--IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 287 ~~~~~-~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLl--tG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
..... .+....|||||.+.. ..++.++|+|+||++|||++ |...||...++.+..++...++...+...
T Consensus 693 y~vqgr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~------- 764 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQV------- 764 (807)
T ss_pred eeeecceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcce-------
Confidence 43333 344788999999875 57999999999999999985 57899999888888877765543332111
Q ss_pred CcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
......-+|..+.+||.+|+..|-++|||.+++-.+
T Consensus 765 --------------~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~ 800 (807)
T KOG1094|consen 765 --------------VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLF 800 (807)
T ss_pred --------------eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHH
Confidence 112234688999999999999999999999998543
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=302.59 Aligned_cols=252 Identities=22% Similarity=0.299 Sum_probs=208.3
Q ss_pred CeeEEEEeeccCceEEEEEEECCC-C--cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDT-G--KIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~-g--~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 207 (704)
...+.++||+|.||.||++.+... | -.||||.++.+.... ....|.+|+.+|.+|+|||+|+||++..+ ..+.
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~---qp~m 186 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD---QPAM 186 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc---chhh
Confidence 466678899999999999987643 3 358999998776654 56778999999999999999999999976 4578
Q ss_pred EEEecccccc-cccccC-CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 208 LVFEYMEHDI-TGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 208 LV~Ey~~g~l-l~~~~~-~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
||||+++++. ++.+.. ....|....+..|+.||+.||.||..+++|||||-..||||-....|||+||||.+.+..+.
T Consensus 187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 9999999754 444443 45678899999999999999999999999999999999999999999999999999876543
Q ss_pred CCC--cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCC
Q 005289 286 RQP--LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (704)
Q Consensus 286 ~~~--~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~ 362 (704)
... .........|+|||.|.. ..++.++|||++||+||||++ |..||.|....+++++|-+. .
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~--e----------- 332 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG--E----------- 332 (1039)
T ss_pred cceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc--c-----------
Confidence 221 112234677999999976 668999999999999999997 78999999999999988531 1
Q ss_pred CCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccc
Q 005289 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415 (704)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpw 415 (704)
.....+.+++++.+++..|+..+|++|||...|.+.-+
T Consensus 333 ---------------rLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 333 ---------------RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred ---------------cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 01123578999999999999999999999998864433
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-33 Score=306.03 Aligned_cols=261 Identities=30% Similarity=0.432 Sum_probs=220.0
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|+.+.++|.|+||.||+++++.+++..|+|+++.+. .....-+..||-+++..+|||||.+++-|.. ...++|
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep--~dd~~~iqqei~~~~dc~h~nivay~gsylr--~dklwi 89 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP--GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR--RDKLWI 89 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccC--CccccccccceeeeecCCCcChHHHHhhhhh--hcCcEE
Confidence 468999999999999999999999999999999998754 2345567789999999999999999998876 467899
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
.||||+++.++.+..--+.++|.++....++.+.||+|||+.|=+|||||-.|||+++.|.+|+.|||.+..+...- ..
T Consensus 90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati-~K 168 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI-AK 168 (829)
T ss_pred EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhh-hh
Confidence 99999999998887778899999999999999999999999999999999999999999999999999987665321 23
Q ss_pred cccccccccccCcccc--cCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcc
Q 005289 289 LTSRVVTLWYRPPELL--LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl--~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~ 366 (704)
..+.+||++|||||+- .....|...||||++|+...||---+||.........+..+-+....||.
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~------------ 236 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPT------------ 236 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCc------------
Confidence 4677999999999985 23457999999999999999998888887666665555555443333321
Q ss_pred cCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
.+.-...++.+-+|++.+|..+|++|||++.+|.|||...
T Consensus 237 ------------lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 237 ------------LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred ------------ccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 0111245677899999999999999999999999999974
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=292.65 Aligned_cols=247 Identities=20% Similarity=0.331 Sum_probs=202.8
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 210 (704)
+..+-++||.|.||.||.+.++.....||||.++-+.+ .++.|+.|+.+|+.+.|||+|+|+++|+. +..+|||+
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM---eveEFLkEAAvMKeikHpNLVqLLGVCT~--EpPFYIiT 342 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTH--EPPFYIIT 342 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcch---hHHHHHHHHHHHHhhcCccHHHHhhhhcc--CCCeEEEE
Confidence 46677899999999999999999999999999976543 36678889999999999999999999987 46789999
Q ss_pred ecccc-cccccccC-CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 211 EYMEH-DITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 211 Ey~~g-~ll~~~~~-~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
|||.. +||+++.. ....++...+.+++.||..|++||..+++|||||-..|+||.++..+||+||||++++..+..+.
T Consensus 343 EfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA 422 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA 422 (1157)
T ss_pred ecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceec
Confidence 99986 56665543 34456777788888999999999999999999999999999999999999999999887654333
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCccc
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~ 367 (704)
........-|.|||-|.- ..++.++|||+|||+||||.| |-.||.|-+....+..+.+.. .
T Consensus 423 HAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy----------------R- 484 (1157)
T KOG4278|consen 423 HAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY----------------R- 484 (1157)
T ss_pred ccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc----------------c-
Confidence 222333778999998864 468889999999999999987 889999877655544432210 0
Q ss_pred CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHH
Q 005289 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411 (704)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L 411 (704)
.+....+|+...+|++.|+.+.|.+||+..++-
T Consensus 485 -----------M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 485 -----------MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred -----------ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 112247899999999999999999999998873
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=308.23 Aligned_cols=248 Identities=28% Similarity=0.431 Sum_probs=188.2
Q ss_pred eeEEEEeeccCceE-EEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCCeEEEE
Q 005289 132 FEKLEKIGQGTYSS-VFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 132 y~~~~~LG~G~fg~-Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
|.--+.+|.|+-|+ ||+|.. .|+.||||.+-. +......+||..|+.- +|||||++++ .+....+.||.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc--~E~d~qF~YIa 581 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYC--SEQDRQFLYIA 581 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEe--eccCCceEEEE
Confidence 44446689998886 699975 688999999853 4456778999999998 6999999954 44447899999
Q ss_pred EecccccccccccCC--CccccH-HHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEcc---C--CceEEecccccccc
Q 005289 210 FEYMEHDITGLLSCP--DIKFSE-AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---E--GVLKLADFGLANFS 281 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~--~~~l~e-~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~---~--g~iKL~DFGla~~~ 281 (704)
.|+|...|.+.+... ...... ...+.++.|++.||++||+.+||||||||.||||+. + ..++|+|||+++..
T Consensus 582 lELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 582 LELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred ehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 999999877766542 111111 456888999999999999999999999999999976 3 46899999999987
Q ss_pred CCCCC--CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHcCCCCchhhh
Q 005289 282 NTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG-KPILQGRTEVEQLHKIFKLCGSPPDDYWK 358 (704)
Q Consensus 282 ~~~~~--~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG-~~pF~~~~~~e~l~~I~~~~g~~p~~~w~ 358 (704)
..+.. ....+..||-+|+|||++.... -+.++||+||||++|..++| ..||...- +.-.+|.. |.+.
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~--~R~~NIl~--~~~~----- 731 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSL--ERQANILT--GNYT----- 731 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchH--Hhhhhhhc--Cccc-----
Confidence 65432 2344567899999999997643 46699999999999999986 89996432 22233432 1110
Q ss_pred ccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccC
Q 005289 359 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417 (704)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~ 417 (704)
+...-.....++.|||.+||.+||..||||.++|.||+|=
T Consensus 732 -------------------L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW 771 (903)
T KOG1027|consen 732 -------------------LVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW 771 (903)
T ss_pred -------------------eeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence 0000011112899999999999999999999999999994
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=326.90 Aligned_cols=252 Identities=21% Similarity=0.301 Sum_probs=185.0
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 210 (704)
.|...+.||+|+||.||+|++..++..||||++...... ...|+++|++++|||||++++++.+ ....||||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~--~~~~~lv~ 762 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRS--EKGAYLIH 762 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEc--CCCCEEEE
Confidence 466778999999999999999999999999998643211 1346899999999999999999987 46789999
Q ss_pred ecccccccccccCCCccccHHHHHHHHHHhhhhHHHHH---hcCcccccCCCccEEEccCCceEEeccccccccCCCCCC
Q 005289 211 EYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH---SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (704)
Q Consensus 211 Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH---~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~ 287 (704)
||++++.+..+.. .+++..+..|+.||+.||+||| +.+|+||||||+|||++.++..++. ||.......
T Consensus 763 Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---- 834 (968)
T PLN00113 763 EYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---- 834 (968)
T ss_pred eCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----
Confidence 9999876665553 3788999999999999999999 6699999999999999998888776 665543321
Q ss_pred CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCC-CCchhhhccCCCCc
Q 005289 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE-VEQLHKIFKLCGS-PPDDYWKKSKLPHA 365 (704)
Q Consensus 288 ~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~-~e~l~~I~~~~g~-~p~~~w~~~~~~~~ 365 (704)
.....+|+.|+|||++.+ ..|+.++|||||||++|||++|+.||..... ...+......... .....|
T Consensus 835 -~~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 904 (968)
T PLN00113 835 -DTKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMW-------- 904 (968)
T ss_pred -CCCccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhhe--------
Confidence 123367899999999876 6699999999999999999999999854211 0111111111000 000000
Q ss_pred ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
..+...... ........++.+|+.+||..||++|||+.++++.
T Consensus 905 --~~~~~~~~~---~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 905 --IDPSIRGDV---SVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred --eCccccCCC---CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 000000000 0001122457899999999999999999999865
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=292.13 Aligned_cols=214 Identities=27% Similarity=0.420 Sum_probs=180.9
Q ss_pred hhhhhhcCcc--ccccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHH------HHHHHHHHHHHHhcC
Q 005289 116 VAGEAIQGWV--PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPES------VRFMAREILILRRLD 187 (704)
Q Consensus 116 ~~~~~~~~~~--~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~------~~~~~~Ei~iL~~L~ 187 (704)
+..+..-+|. +.+...|..++.||.|+||.||+|.++.+...|+||.|.++.+-.+. .-.+-.||.||..|+
T Consensus 545 ~e~e~~~~~e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~ 624 (772)
T KOG1152|consen 545 VEPEGNIGCEKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLN 624 (772)
T ss_pred cCccccccceeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhh
Confidence 3334444443 33456799999999999999999999999999999999876532111 122446999999997
Q ss_pred ---CCCceeEeEEEeecCCCeEEEEEeccccc-ccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEE
Q 005289 188 ---HPNIIKLEGLITSRLSCSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLL 263 (704)
Q Consensus 188 ---HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~-ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NIL 263 (704)
|+||++++++|++ .+++||+||.-..+ .|..++.....++|.+++.|++||+.|+++||+.||||||||-+|+.
T Consensus 625 ~~sH~NIlKlLdfFEd--dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvi 702 (772)
T KOG1152|consen 625 KHSHENILKLLDFFED--DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVI 702 (772)
T ss_pred hcCccchhhhhheeec--CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEE
Confidence 9999999999998 68999999987653 34455566678999999999999999999999999999999999999
Q ss_pred EccCCceEEeccccccccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 005289 264 VNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 334 (704)
Q Consensus 264 l~~~g~iKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~ 334 (704)
++.+|.+||+|||.|.....+ +....+||..|.|||+|.+....+..-|||+||++||.++....||.
T Consensus 703 vd~~g~~klidfgsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 703 VDSNGFVKLIDFGSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred EecCCeEEEeeccchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999999999999999877654 56778999999999999988888999999999999999999888875
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=258.05 Aligned_cols=215 Identities=25% Similarity=0.440 Sum_probs=179.7
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCCeE
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~ 206 (704)
..+....+..||.|+||.|=+.++..+|+..|+|.+...- +....+.+.+|+.+..+. .+|++|.+++.+.. ...+
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r--egdv 120 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR--EGDV 120 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc--cccE
Confidence 3456777788999999999999999999999999997543 345566778899887766 89999999997766 4679
Q ss_pred EEEEecccccccccc---cCCCccccHHHHHHHHHHhhhhHHHHHhc-CcccccCCCccEEEccCCceEEeccccccccC
Q 005289 207 YLVFEYMEHDITGLL---SCPDIKFSEAQIKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~---~~~~~~l~e~~~~~i~~QIl~aL~yLH~~-gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~ 282 (704)
+|.||.|.-.+...+ ...+..++|..+-+|+..++.||.|||++ .|||||+||+||||+.+|++||||||.+-.+.
T Consensus 121 wIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 121 WICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred EEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 999999987554433 45677899999999999999999999987 89999999999999999999999999997654
Q ss_pred CCCCCCcccccccccccCcccccC---CCCCCCccchhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHH
Q 005289 283 TGHRQPLTSRVVTLWYRPPELLLG---ATDYGPSVDLWSVGCVFAELLIGKPILQG-RTEVEQLHKIFK 347 (704)
Q Consensus 283 ~~~~~~~~~~~gT~~Y~APEvl~~---~~~y~~~~DIWSlG~iLyeLltG~~pF~~-~~~~e~l~~I~~ 347 (704)
..- ..+-..|...|||||.+.. ...|+.++||||||++++||.+++.||.. .++.+++.++++
T Consensus 201 dSi--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 201 DSI--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred hhh--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 321 1222456788999999853 34799999999999999999999999975 688899998876
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=242.44 Aligned_cols=213 Identities=38% Similarity=0.613 Sum_probs=179.5
Q ss_pred eeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEecccccc
Q 005289 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDI 217 (704)
Q Consensus 138 LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~l 217 (704)
||.|.+|.||++.+..+++.++||++....... ....+.+|+.+++.+.|++|+++++++.. ....++||||+.+..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFED--ENHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeec--CCeEEEEEecCCCCc
Confidence 689999999999998889999999997654322 34668899999999999999999999877 468899999999655
Q ss_pred cccccCCC-ccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEcc-CCceEEeccccccccCCCCCCCccccccc
Q 005289 218 TGLLSCPD-IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-EGVLKLADFGLANFSNTGHRQPLTSRVVT 295 (704)
Q Consensus 218 l~~~~~~~-~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~-~g~iKL~DFGla~~~~~~~~~~~~~~~gT 295 (704)
+..+.... ..+++..+..++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~ 156 (215)
T cd00180 78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT 156 (215)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence 55443322 46899999999999999999999999999999999999999 89999999999976654321 12334568
Q ss_pred ccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCC
Q 005289 296 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYD 375 (704)
Q Consensus 296 ~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~ 375 (704)
..|++||.+.....++.+.|+|+||+++++|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------- 187 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------- 187 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------------
Confidence 8899999887643778999999999999998
Q ss_pred chhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcc
Q 005289 376 SSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 414 (704)
Q Consensus 376 ~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hp 414 (704)
..+.++|..||..||.+|||+.++++|+
T Consensus 188 -----------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -----------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -----------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2356799999999999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-29 Score=287.77 Aligned_cols=251 Identities=24% Similarity=0.375 Sum_probs=198.1
Q ss_pred CCeeEEEEeeccCceEEEEEEEC----C---CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeec
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDL----D---TGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSR 201 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~----~---~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~ 201 (704)
++..+.+.||.|.||.||++.-. . ....||||.+...... ...+.+..|+++|+.+ .|+||+.+++.+..
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~- 373 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQ- 373 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeecc-
Confidence 34466679999999999999632 1 1457999998765444 6678889999999999 69999999999988
Q ss_pred CCCeEEEEEecccccccc-cccCCC---------------ccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEc
Q 005289 202 LSCSIYLVFEYMEHDITG-LLSCPD---------------IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN 265 (704)
Q Consensus 202 ~~~~~~LV~Ey~~g~ll~-~~~~~~---------------~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~ 265 (704)
...+++|+||+..+.+. .+.... ..++..+...++.||+.|++||++..+|||||-..||||.
T Consensus 374 -~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 374 -DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT 452 (609)
T ss_pred -CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec
Confidence 67899999999975544 333322 2388999999999999999999999999999999999999
Q ss_pred cCCceEEeccccccccCCCCCCCccccc--ccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-HHHH
Q 005289 266 NEGVLKLADFGLANFSNTGHRQPLTSRV--VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRT-EVEQ 341 (704)
Q Consensus 266 ~~g~iKL~DFGla~~~~~~~~~~~~~~~--gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~-~~e~ 341 (704)
.+..+||+|||+|+.............. ....|||||.+.. ..|+.++||||||++||||++ |..||.+-. ..+.
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l 531 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEEL 531 (609)
T ss_pred CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHH
Confidence 9999999999999865443322212112 2445999999987 789999999999999999998 789998744 4444
Q ss_pred HHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 342 LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 342 l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
++.+.. |.- .+....+++++.+|++.|+..+|++||+..++.+
T Consensus 532 ~~~l~~--G~r--------------------------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 532 LEFLKE--GNR--------------------------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHhc--CCC--------------------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 443322 110 1122456899999999999999999999999874
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=244.80 Aligned_cols=213 Identities=37% Similarity=0.576 Sum_probs=175.9
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEe
Q 005289 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFE 211 (704)
Q Consensus 132 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~E 211 (704)
|.+.+.||.|++|+||++.+..+++.+|||.+...... .....+.+|+..+++++|+||+++++++.. ....++|+|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFED--PEPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeec--CCceEEEEe
Confidence 67789999999999999999988999999999765433 246678899999999999999999998876 467899999
Q ss_pred cccccccccccCCCcc-ccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCcc
Q 005289 212 YMEHDITGLLSCPDIK-FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 290 (704)
Q Consensus 212 y~~g~ll~~~~~~~~~-l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~ 290 (704)
|+.+..+..+...... +++..+..++.|++.+|.|||+++++|+||+|.||+++.++.++|+|||++............
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 9998555544433333 899999999999999999999999999999999999999999999999999876543211223
Q ss_pred cccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC-CCHH-HHHHHHHH
Q 005289 291 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG-RTEV-EQLHKIFK 347 (704)
Q Consensus 291 ~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~-~~~~-e~l~~I~~ 347 (704)
...++..|++||.+.....++.++|||+|||++|+|++|++||.. .... .+.+.|..
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~ 216 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSF 216 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhc
Confidence 456788999999874446678899999999999999999999977 3444 55555543
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=269.67 Aligned_cols=264 Identities=24% Similarity=0.305 Sum_probs=186.6
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc--CCCCceeEeEEEeec--CCC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL--DHPNIIKLEGLITSR--LSC 204 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L--~HpnIv~l~~~~~~~--~~~ 204 (704)
.+..+++..||+|.||.||+|.. +++.||||++. .+....+.+|-+|.... .|+||+++++.-... ...
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFP-----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc--cCceeEEEecC-----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence 55678889999999999999975 66999999986 34566677788777754 899999997754321 134
Q ss_pred eEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhc---------CcccccCCCccEEEccCCceEEecc
Q 005289 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR---------GVLHRDIKGSNLLVNNEGVLKLADF 275 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~---------gIvHrDLKp~NILl~~~g~iKL~DF 275 (704)
.++||++|.+.+.|..++... .+++.....++..|+.||+|||+- .|+|||||..||||.++++..|+||
T Consensus 282 eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 789999999987777666433 689999999999999999999963 5999999999999999999999999
Q ss_pred ccccccCCCCC-CCcccccccccccCcccccCCCCCC-----CccchhhHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHH
Q 005289 276 GLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYG-----PSVDLWSVGCVFAELLIGKPILQ-GRTEVEQLHKIFKL 348 (704)
Q Consensus 276 Gla~~~~~~~~-~~~~~~~gT~~Y~APEvl~~~~~y~-----~~~DIWSlG~iLyeLltG~~pF~-~~~~~e~l~~I~~~ 348 (704)
|||..+.++.. ......+||..|||||+|.+...+. .+.||||+|.+||||++.-..+. +.... ...-....
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~-Yqlpfe~e 439 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPE-YQLPFEAE 439 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCc-ccCchhHH
Confidence 99987765432 2344578999999999998766555 36899999999999998643332 11100 00000001
Q ss_pred cCCCC--chhhhccCCCCcccCCCCCCCCchhhhhcc--CCCHHHHHHHHHhhccCCCCCcCHHHH
Q 005289 349 CGSPP--DDYWKKSKLPHATLFKPQQPYDSSLRETFK--DLPTTAVNLIETLLSVEPYKRATASAA 410 (704)
Q Consensus 349 ~g~~p--~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~--~~s~~~~dLI~~mL~~dP~kRpTa~e~ 410 (704)
+|.-| ++.|.- .+.+...| .+...|. ....-+++.|+-|+..||+.|+||.=+
T Consensus 440 vG~hPt~e~mq~~------VV~kK~RP---~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 440 VGNHPTLEEMQEL------VVRKKQRP---KIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred hcCCCCHHHHHHH------HHhhccCC---CChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 11111 000000 00000000 1111221 233558899999999999999998643
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=304.76 Aligned_cols=203 Identities=18% Similarity=0.212 Sum_probs=147.2
Q ss_pred hcCC-CCceeEeEEEeec-----CCCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCC
Q 005289 185 RLDH-PNIIKLEGLITSR-----LSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIK 258 (704)
Q Consensus 185 ~L~H-pnIv~l~~~~~~~-----~~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLK 258 (704)
.+.| +||+.+++.|... ....++++|||++++|...+......+++.+++.|+.||+.||.|||++||||||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 4455 5787888876211 124678899999888777776555679999999999999999999999999999999
Q ss_pred CccEEEccC-------------------CceEEeccccccccCCCC---------------CCCcccccccccccCcccc
Q 005289 259 GSNLLVNNE-------------------GVLKLADFGLANFSNTGH---------------RQPLTSRVVTLWYRPPELL 304 (704)
Q Consensus 259 p~NILl~~~-------------------g~iKL~DFGla~~~~~~~---------------~~~~~~~~gT~~Y~APEvl 304 (704)
|+||||+.. +.+||+|||+++...... .......++|++|||||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 999999654 455666666665321100 0001124679999999998
Q ss_pred cCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccC
Q 005289 305 LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKD 384 (704)
Q Consensus 305 ~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~ 384 (704)
.+ ..|+.++|||||||+||||++|.+||.... ..+..+.... .+.. +..
T Consensus 188 ~~-~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~--~~~~--------------------------~~~ 236 (793)
T PLN00181 188 NG-SSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV--LPPQ--------------------------ILL 236 (793)
T ss_pred cc-CCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh--cChh--------------------------hhh
Confidence 76 568999999999999999999998875322 1222221110 0100 001
Q ss_pred CCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 385 LPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 385 ~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
....+.+++.+||.+||.+|||+.++|+||||..
T Consensus 237 ~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~ 270 (793)
T PLN00181 237 NWPKEASFCLWLLHPEPSCRPSMSELLQSEFINE 270 (793)
T ss_pred cCHHHHHHHHHhCCCChhhCcChHHHhhchhhhh
Confidence 1344678999999999999999999999999975
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=277.66 Aligned_cols=249 Identities=20% Similarity=0.281 Sum_probs=201.0
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCc----EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGK----IVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~----~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
..+..++||.|+||+||++.+...|+ +||||++..... ......+..|+-+|.+|+||||++|++++... .+
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~-~~~s~e~LdeAl~masldHpnl~RLLgvc~~s---~~ 772 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS-PKASIELLDEALRMASLDHPNLLRLLGVCMLS---TL 772 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC-chhhHHHHHHHHHHhcCCCchHHHHhhhcccc---hH
Confidence 45667889999999999998866554 589998875543 34456678899999999999999999999873 47
Q ss_pred EEEEeccccc-ccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 207 YLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 207 ~LV~Ey~~g~-ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
.||++|++++ |++.+...+..+-......|..||++||.|||.+++|||||-..||||....++||.|||+++....+.
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 8999999975 555566667788899999999999999999999999999999999999999999999999999887654
Q ss_pred CCCccc-ccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCC
Q 005289 286 RQPLTS-RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 286 ~~~~~~-~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
.+.... -...+.|||-|.+.. ..|+.++|||||||++|||+| |..|+.+....++-..+.+. ..
T Consensus 853 ~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~g-eR------------ 918 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKG-ER------------ 918 (1177)
T ss_pred ccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcc-cc------------
Confidence 332221 122677899998875 679999999999999999987 89999988776654333220 00
Q ss_pred CcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
....+..+-++.-++-+||..|+..||+++++..
T Consensus 919 ---------------LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 919 ---------------LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred ---------------CCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 0112467888999999999999999999998764
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-28 Score=255.11 Aligned_cols=251 Identities=25% Similarity=0.312 Sum_probs=183.1
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHh--cCCCCceeEeEEEeecC--CCe
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRR--LDHPNIIKLEGLITSRL--SCS 205 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~--L~HpnIv~l~~~~~~~~--~~~ 205 (704)
.+..+++.||+|-||.||+|.+ .|..||||++.... .+.+.+|.+|.+. |+|+||+.++..-.... -..
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred heeEEEEEecCccccceeeccc--cCCceEEEEecccc-----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 3688999999999999999988 57899999986321 2345567777664 59999999876543211 246
Q ss_pred EEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhc--------CcccccCCCccEEEccCCceEEecccc
Q 005289 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR--------GVLHRDIKGSNLLVNNEGVLKLADFGL 277 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~--------gIvHrDLKp~NILl~~~g~iKL~DFGl 277 (704)
+|||++|.+.+.|.+++.. ..++.....+++..++.||+|||.. .|.|||||..||||.+++.+-|+|+||
T Consensus 284 LwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred EEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 8999999999888877766 5789999999999999999999954 499999999999999999999999999
Q ss_pred ccccCCCC---CCCcccccccccccCcccccCCCCC-----CCccchhhHHHHHHHHHhC----------CCCCCCC---
Q 005289 278 ANFSNTGH---RQPLTSRVVTLWYRPPELLLGATDY-----GPSVDLWSVGCVFAELLIG----------KPILQGR--- 336 (704)
Q Consensus 278 a~~~~~~~---~~~~~~~~gT~~Y~APEvl~~~~~y-----~~~~DIWSlG~iLyeLltG----------~~pF~~~--- 336 (704)
|....... .-..+.++||..|||||+|...... -..+||||||.|+||++.. .+||.+-
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~ 442 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS 442 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence 97655432 1245678999999999999653221 1258999999999999742 3666542
Q ss_pred -CHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCC--HHHHHHHHHhhccCCCCCcCHHHHH
Q 005289 337 -TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLP--TTAVNLIETLLSVEPYKRATASAAL 411 (704)
Q Consensus 337 -~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s--~~~~dLI~~mL~~dP~kRpTa~e~L 411 (704)
...+.+.+++-. +.+.+.+...|...+ ..+-.|++-|+..||.-|.||--+-
T Consensus 443 DPs~eeMrkVVCv-----------------------~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 443 DPSFEEMRKVVCV-----------------------QKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred CCCHHHHhcceee-----------------------cccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 222333322110 011111111222222 2356789999999999999986654
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=245.67 Aligned_cols=246 Identities=24% Similarity=0.320 Sum_probs=186.8
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCCeEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~ 207 (704)
.|.|.|.+.||+|-||.+.+|+++.+++.+++|.+.... ...+.+.+|...--.| .|.||+.-|++.-.. .+.++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt-~d~Yv 98 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQT-SDAYV 98 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhc-CceEE
Confidence 457999999999999999999999999999999997653 3456778888776666 689999988754332 46889
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEc--cCCceEEeccccccccCCCC
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN--NEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~--~~g~iKL~DFGla~~~~~~~ 285 (704)
+++||++.+.|..-... ..+-|...+.++.|+++||.|+|+.++||||||.+||||- +...|||||||+.+..+..
T Consensus 99 F~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t- 176 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT- 176 (378)
T ss_pred EeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce-
Confidence 99999997655543333 3578999999999999999999999999999999999984 3347999999998755431
Q ss_pred CCCcccccccccccCcccccC----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccC
Q 005289 286 RQPLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~----~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~ 361 (704)
..-.--+..|.+||++.. .-...+..|||.||+|+|.+|+|.+||+.....+ ..||+-..
T Consensus 177 ---V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d-------------~~Y~~~~~ 240 (378)
T KOG1345|consen 177 ---VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD-------------KPYWEWEQ 240 (378)
T ss_pred ---ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC-------------chHHHHHH
Confidence 111222667999998642 2235678999999999999999999997422111 12332222
Q ss_pred CCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCC
Q 005289 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 404 (704)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kR 404 (704)
+. +.....+...|..+++.+..+.++-|..+|++|
T Consensus 241 w~--------~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 241 WL--------KRKNPALPKKFNPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred Hh--------cccCccCchhhcccCHHHHHHHHHhcCCccccc
Confidence 11 111223456678899999999999999999999
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-28 Score=279.03 Aligned_cols=264 Identities=26% Similarity=0.329 Sum_probs=202.1
Q ss_pred eEEEEeeccCceEEEEEEECCCCcEEEEEEeec----CCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 133 EKLEKIGQGTYSSVFRARDLDTGKIVALKKVRF----DNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 133 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~----~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.....+|.|+||.|+.+......+.++.|..+. ..........+..|+.+-..|.||||+..+.++.+. ..++-
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~--~~~~~ 398 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI--DGILQ 398 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc--ccchh
Confidence 456789999999999998887777777776542 222222333367788899999999998887777653 33444
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC--
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-- 286 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~-- 286 (704)
+||||++ .+..+......++..++.++++||+.||+|||..||.||||||+|+|++.+|.+||+|||.+..+..+..
T Consensus 399 ~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 399 SMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred hhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 5999999 4444444446799999999999999999999999999999999999999999999999999987764433
Q ss_pred -CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHcCCCCchhhhccCCCC
Q 005289 287 -QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLH-KIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 287 -~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~-~I~~~~g~~p~~~w~~~~~~~ 364 (704)
......+|+..|+|||++.+...-...+||||+|++++.|++|+.||......+... .+.. ..|
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~-------~~~------- 543 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY-------SDQ------- 543 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc-------ccc-------
Confidence 345667889999999999875544557999999999999999999997543322211 1000 000
Q ss_pred cccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCC
Q 005289 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (704)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~ 420 (704)
..........+..++...+.+|.+||++||.+|+|+++||+.+||+...
T Consensus 544 -------~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 544 -------RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred -------cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 0011122445568899999999999999999999999999999999754
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9e-25 Score=226.68 Aligned_cols=264 Identities=34% Similarity=0.520 Sum_probs=206.2
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChH-HHHHHHHHHHHHHhcCCC-CceeEeEEEeecCCCeEEEE
Q 005289 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPE-SVRFMAREILILRRLDHP-NIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 132 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~-~~~~~~~Ei~iL~~L~Hp-nIv~l~~~~~~~~~~~~~LV 209 (704)
|.+...||.|+|+.||++.+. ..+++|.+........ ....+.+|+.++..+.|+ +|+++++++.. ....+++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~~~ 76 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD--EGSLYLV 76 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec--CCEEEEE
Confidence 788999999999999999987 7899999976554332 567788999999999988 79999999955 4558999
Q ss_pred EecccccccccccCCCc---cccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCC-ceEEeccccccccCCCC
Q 005289 210 FEYMEHDITGLLSCPDI---KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGH 285 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~---~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g-~iKL~DFGla~~~~~~~ 285 (704)
++|+.+..+..+..... .+++..+..++.|++.+|.|+|+.+++||||||+|||++..+ .++++|||++.......
T Consensus 77 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred EecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999866664444333 789999999999999999999999999999999999999988 79999999997554332
Q ss_pred CC-----CcccccccccccCcccccCC--CCCCCccchhhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHcCCCCch
Q 005289 286 RQ-----PLTSRVVTLWYRPPELLLGA--TDYGPSVDLWSVGCVFAELLIGKPILQGRTE---VEQLHKIFKLCGSPPDD 355 (704)
Q Consensus 286 ~~-----~~~~~~gT~~Y~APEvl~~~--~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~---~e~l~~I~~~~g~~p~~ 355 (704)
.. .....++|..|+|||++.+. ..+....|+|++|++++++++|..||..... ......++.....+...
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence 21 24667889999999998764 4788899999999999999999999887764 33333333322221000
Q ss_pred hhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 356 ~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
....... . ......+.+++..|+..+|..|.+..+...++|+...
T Consensus 237 -------------~~~~~~~---~---~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 237 -------------SPLSPSN---P---ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred -------------cccCccc---c---chhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 0000000 0 1234678999999999999999999999999777643
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-26 Score=222.34 Aligned_cols=161 Identities=23% Similarity=0.321 Sum_probs=123.8
Q ss_pred cccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCccccccccccc
Q 005289 220 LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYR 299 (704)
Q Consensus 220 ~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~~~gT~~Y~ 299 (704)
.+...+..+++..++.|+.||+.||.|||+++ ||+|||++.++.+|+ ||++...... ...+|+.|+
T Consensus 6 ~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------~~~g~~~y~ 71 (176)
T smart00750 6 ILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE------QSRVDPYFM 71 (176)
T ss_pred HHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc------cCCCccccc
Confidence 33333556999999999999999999999999 999999999999999 9999766432 226789999
Q ss_pred CcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchh
Q 005289 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV-EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSL 378 (704)
Q Consensus 300 APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~-e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l 378 (704)
|||++.+ ..|+.++|||||||++|||++|++||...... ..+..+....... . +..
T Consensus 72 aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~----------------~~~--- 128 (176)
T smart00750 72 APEVIQG-QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPAD---D----------------PRD--- 128 (176)
T ss_pred ChHHhcC-CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccC---C----------------ccc---
Confidence 9999976 56899999999999999999999999765432 3333333211100 0 000
Q ss_pred hhhccCCCH--HHHHHHHHhhccCCCCCcCHHHHHhccccC
Q 005289 379 RETFKDLPT--TAVNLIETLLSVEPYKRATASAALASEYFS 417 (704)
Q Consensus 379 ~~~~~~~s~--~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~ 417 (704)
......++. .+.+||.+||..||.+|||+.++++|+|+.
T Consensus 129 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 129 RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 000112333 699999999999999999999999999985
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=232.77 Aligned_cols=254 Identities=20% Similarity=0.290 Sum_probs=201.9
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCC-----cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTG-----KIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL 202 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g-----~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 202 (704)
..++++....+-+|.||.||.|.+.+.. +.|-+|.+. +...+-+...+..|..+|..+.|||+..+.+++.+.
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk-~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~- 359 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVK-QHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED- 359 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHH-hcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec-
Confidence 3457888889999999999999766543 345566664 233456677888999999999999999999988764
Q ss_pred CCeEEEEEecccccccccccC--------CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEec
Q 005289 203 SCSIYLVFEYMEHDITGLLSC--------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLAD 274 (704)
Q Consensus 203 ~~~~~LV~Ey~~g~ll~~~~~--------~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~D 274 (704)
....++++.+++-+.+..++. ....++..++..++.||..|++|||++||||.||-..|++|++...+||+|
T Consensus 360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltD 439 (563)
T KOG1024|consen 360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTD 439 (563)
T ss_pred cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEecc
Confidence 456778888887544443321 123477888899999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCccccc-ccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCC
Q 005289 275 FGLANFSNTGHRQPLTSRV-VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSP 352 (704)
Q Consensus 275 FGla~~~~~~~~~~~~~~~-gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~ 352 (704)
=.+++..-+.+...+...- -...||+||.+.+ ..|+.++|+|||||+||||+| |+.|+..-++.+...-+.+.
T Consensus 440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG---- 514 (563)
T KOG1024|consen 440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG---- 514 (563)
T ss_pred chhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc----
Confidence 9999877665544333322 2667999999987 679999999999999999998 89999988888877766541
Q ss_pred CchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 353 PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 353 p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
++..+| -++|+++..++.-|+..+|++||+.+|+..
T Consensus 515 ---------------yRlaQP---------~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 515 ---------------YRLAQP---------FNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ---------------ceecCC---------CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 111222 368999999999999999999999999864
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.6e-25 Score=237.21 Aligned_cols=166 Identities=20% Similarity=0.206 Sum_probs=129.7
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECC-CCcEEEEEEeecCCC---ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLD-TGKIVALKKVRFDNF---EPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~-~g~~vAvK~i~~~~~---~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 203 (704)
..+.|.+.+.||+|+||+||+|++.. +++.||||++..... .......+.+|+++|+.|.|+||+..+..+
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----- 90 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----- 90 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-----
Confidence 35689999999999999999999876 678889998753311 233456688999999999999998533221
Q ss_pred CeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccC-CCccEEEccCCceEEeccccccccC
Q 005289 204 CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDI-KGSNLLVNNEGVLKLADFGLANFSN 282 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDL-Kp~NILl~~~g~iKL~DFGla~~~~ 282 (704)
...|||||||+|..+.... .. . ...++.||+.+|.|||++||+|||| ||+|||++.++.+||+|||+|+.+.
T Consensus 91 ~~~~LVmE~~~G~~L~~~~-~~---~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLAR-PH---G---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred CCcEEEEEccCCCCHHHhC-cc---c---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 3479999999987665321 11 1 1467889999999999999999999 9999999999999999999998664
Q ss_pred CCCC-------CCcccccccccccCccccc
Q 005289 283 TGHR-------QPLTSRVVTLWYRPPELLL 305 (704)
Q Consensus 283 ~~~~-------~~~~~~~gT~~Y~APEvl~ 305 (704)
.... ...+..++++.|+|||.+.
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 3221 1124556788899999885
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-26 Score=252.99 Aligned_cols=242 Identities=28% Similarity=0.457 Sum_probs=202.6
Q ss_pred eeccCceEEEEEEE---CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeEEEeecCCCeEEEEEecc
Q 005289 138 IGQGTYSSVFRARD---LDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNIIKLEGLITSRLSCSIYLVFEYM 213 (704)
Q Consensus 138 LG~G~fg~Vy~a~~---~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~~~LV~Ey~ 213 (704)
+|.|.||.|++++. ...+..||+|++.+.............|..++..++ ||++|+++..|+. ...+|++++|.
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt--~~kl~l~ld~~ 79 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT--DGKLYLILDFL 79 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc--ccchhHhhhhc
Confidence 79999999999863 356788999998776543222224456889999996 9999999988877 56789999999
Q ss_pred cccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCccccc
Q 005289 214 EHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 293 (704)
Q Consensus 214 ~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~~~ 293 (704)
.++.+.........+.+...+.+...++.+++++|+.+|+|||+|++||+++.+|++++.|||+++..-.... .|
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-----~c 154 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-----AC 154 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh-----cc
Confidence 9987777777777899999999999999999999999999999999999999999999999999987654322 29
Q ss_pred ccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCC
Q 005289 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 373 (704)
Q Consensus 294 gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~ 373 (704)
||..|||||++.+ +..++|+||||+++++|++|..||.+ +++..|.+..-..|
T Consensus 155 gt~eymApEI~~g---h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p-------------------- 207 (612)
T KOG0603|consen 155 GTYEYRAPEIING---HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMP-------------------- 207 (612)
T ss_pred cchhhhhhHhhhc---cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCc--------------------
Confidence 9999999999873 67899999999999999999999998 67777766332222
Q ss_pred CCchhhhhccCCCHHHHHHHHHhhccCCCCCcCH-----HHHHhccccCCCCCC
Q 005289 374 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA-----SAALASEYFSTKPYA 422 (704)
Q Consensus 374 ~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa-----~e~L~hpwf~~~~~~ 422 (704)
..++..+.+++..|+..+|.+|.-+ .++++|+||+...|.
T Consensus 208 ---------~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 208 ---------RELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred ---------hhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence 3466789999999999999999764 799999999987664
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-24 Score=249.28 Aligned_cols=225 Identities=29% Similarity=0.451 Sum_probs=171.3
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
++|..++.|-.|+||.||+++++.+.+.+|+ +|++.++ +.+- ||.....|++|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~l-------ilRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNL-------ILRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhh-cccccch-------hhhc--cccccCCccee-----------------
Confidence 4699999999999999999999999999999 5544331 1111 23322333333
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC---
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR--- 286 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~--- 286 (704)
|+....+. .-+.++. +++.+++|||+.||+|||+||+|+||+.-|++|+.|||+++.......
T Consensus 136 -----gDc~tllk-~~g~lPv--------dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl 201 (1205)
T KOG0606|consen 136 -----GDCATLLK-NIGPLPV--------DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL 201 (1205)
T ss_pred -----chhhhhcc-cCCCCcc--------hhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence 22222222 2223332 337899999999999999999999999999999999999864321100
Q ss_pred ----------C-CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCch
Q 005289 287 ----------Q-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 355 (704)
Q Consensus 287 ----------~-~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~ 355 (704)
+ .-...|+||.|+||||+.. ..|+..+|||++|+|+||.+.|..||.+++..+.+..++......|+.
T Consensus 202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~ 280 (1205)
T KOG0606|consen 202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE 280 (1205)
T ss_pred hhcchHHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc
Confidence 0 1134589999999999986 569999999999999999999999999999999998887754443332
Q ss_pred hhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCC---cCHHHHHhccccCCCCCC
Q 005289 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR---ATASAALASEYFSTKPYA 422 (704)
Q Consensus 356 ~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kR---pTa~e~L~hpwf~~~~~~ 422 (704)
. ..+++++++||..||..+|..| ..+-++.+|+||+...|.
T Consensus 281 d--------------------------ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 281 D--------------------------EALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred C--------------------------cCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 2 3578999999999999999999 457788899999977765
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-22 Score=219.10 Aligned_cols=255 Identities=24% Similarity=0.221 Sum_probs=190.9
Q ss_pred CeeEEEEeeccCceEEEEEEECCCC-cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC----CCceeEeEEEeecCCCe
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTG-KIVALKKVRFDNFEPESVRFMAREILILRRLDH----PNIIKLEGLITSRLSCS 205 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g-~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~H----pnIv~l~~~~~~~~~~~ 205 (704)
+|.+.++||+|+||.||+|.+..++ ..+|+|.......... ..+..|+.+|..+.. .++..+++... ....+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCce
Confidence 7999999999999999999988775 6789998765432211 146679999998863 68888888774 22567
Q ss_pred EEEEEecccccccccccC-CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccC-----CceEEecccccc
Q 005289 206 IYLVFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-----GVLKLADFGLAN 279 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~-~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~-----g~iKL~DFGla~ 279 (704)
-||||+.++.+|..+... ....|+...+..++.|++.+|++||+.|+|||||||+|+++... ..+.|+|||+++
T Consensus 96 ~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 96 NFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred eEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 899999999888776633 34789999999999999999999999999999999999999765 369999999998
Q ss_pred --ccCCCCC----CC---cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Q 005289 280 --FSNTGHR----QP---LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 350 (704)
Q Consensus 280 --~~~~~~~----~~---~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g 350 (704)
.+..... .. .....||..|.++.+..+ ...+...|+||++.++.+|+.|..|+.+........++.....
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 3211111 11 123458999999998876 5678999999999999999999999977654333333322111
Q ss_pred CCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 351 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 351 ~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
... . .......+..+..++..+-..+...+|....+...
T Consensus 255 ~~~--------------~----------~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 255 KLL--------------T----------DRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhc--------------c----------ccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 100 0 00123456777778877777888888887766543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=200.67 Aligned_cols=210 Identities=23% Similarity=0.298 Sum_probs=171.4
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCCeEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
.|++.++||+|.||.++++.+..++++||||.-.... ....+..|....+.| ..+.|..++.+-.+ +.+-.||
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS----~APQLrdEYr~YKlL~g~~GIP~vYYFGqe--G~~NiLV 102 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQE--GKYNILV 102 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC----CcchHHHHHHHHHHHcCCCCCCceeeeccc--cchhhhh
Confidence 6999999999999999999999999999999864332 234466788888888 57899988644333 5667899
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccC-----CceEEeccccccccCCC
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-----GVLKLADFGLANFSNTG 284 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~-----g~iKL~DFGla~~~~~~ 284 (704)
||+++..|-+++.--+..|+...+..++.||+.-|+|+|++.+|+|||||+|+||... ..|.|+|||+|+.+...
T Consensus 103 idLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 103 IDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred hhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 9999987777666566789999999999999999999999999999999999999644 35999999999987644
Q ss_pred CCC------CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC---CCHHHHHHHHHH
Q 005289 285 HRQ------PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG---RTEVEQLHKIFK 347 (704)
Q Consensus 285 ~~~------~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~---~~~~e~l~~I~~ 347 (704)
... ...+..||..||+=-..++ ..-+...|+=|||.+++..|-|..||+| .+..+.+++|-+
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe 253 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGE 253 (449)
T ss_pred cccccCccccccccccceeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcc
Confidence 322 2245578999999777666 4457789999999999999999999987 456667777643
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.2e-22 Score=199.30 Aligned_cols=141 Identities=21% Similarity=0.229 Sum_probs=109.5
Q ss_pred EEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHH------------------------HHHHHHHHHHHHhcCCCC
Q 005289 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPES------------------------VRFMAREILILRRLDHPN 190 (704)
Q Consensus 135 ~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~------------------------~~~~~~Ei~iL~~L~Hpn 190 (704)
...||+|+||+||+|.+. +|+.||||+++........ .....+|+.+|.+|.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 357999999999999986 8999999999765321111 122345999999998887
Q ss_pred ceeEeEEEeecCCCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHH-HhcCcccccCCCccEEEccCCc
Q 005289 191 IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC-HSRGVLHRDIKGSNLLVNNEGV 269 (704)
Q Consensus 191 Iv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yL-H~~gIvHrDLKp~NILl~~~g~ 269 (704)
|.....+... ..+|||||++++.+.........+++..+..++.||+.+|.|| |+.||+||||||+|||++ ++.
T Consensus 81 v~~p~~~~~~----~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 81 IPCPEPILLK----SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCCcEEEec----CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCc
Confidence 7443322222 2389999999865543322345789999999999999999999 699999999999999998 478
Q ss_pred eEEecccccccc
Q 005289 270 LKLADFGLANFS 281 (704)
Q Consensus 270 iKL~DFGla~~~ 281 (704)
++|+|||+|...
T Consensus 156 v~LiDFG~a~~~ 167 (190)
T cd05147 156 LYIIDVSQSVEH 167 (190)
T ss_pred EEEEEccccccC
Confidence 999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.86 E-value=5e-22 Score=207.56 Aligned_cols=237 Identities=22% Similarity=0.326 Sum_probs=152.1
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCC----------CCceeEeEEEe
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDH----------PNIIKLEGLIT 199 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~H----------pnIv~l~~~~~ 199 (704)
.+.....||.|+++.||.+++..|++.+|||+....... ....+.+.+|......+.+ -.++..+++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 467788999999999999999999999999998765432 3456677777766555432 22333333322
Q ss_pred ec---------C-CC-----eEEEEEeccccccccccc------CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCC
Q 005289 200 SR---------L-SC-----SIYLVFEYMEHDITGLLS------CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIK 258 (704)
Q Consensus 200 ~~---------~-~~-----~~~LV~Ey~~g~ll~~~~------~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLK 258 (704)
-. . .. ..+++|+-+.+++...+. .....+.......+..|++..+++||..||||+||+
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 11 0 01 236788888876654432 111122223334555899999999999999999999
Q ss_pred CccEEEccCCceEEeccccccccCCCCCCCcccccccccccCcccccCC-------CCCCCccchhhHHHHHHHHHhCCC
Q 005289 259 GSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA-------TDYGPSVDLWSVGCVFAELLIGKP 331 (704)
Q Consensus 259 p~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APEvl~~~-------~~y~~~~DIWSlG~iLyeLltG~~ 331 (704)
|+|||++.+|.++|+||+.....+.. ......+..|.+||+.... ..++.+.|.|+||++||.|+|+..
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTR----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEE----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred eeeEEEcCCCCEEEcChHHHeecCce----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 99999999999999999987655432 1113446789999976331 347889999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCC
Q 005289 332 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 404 (704)
Q Consensus 332 pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kR 404 (704)
||...+..... .| .+. .+.++|+.+++||..||..||.+|
T Consensus 249 Pf~~~~~~~~~-------------~~-------------------~f~-~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADP-------------EW-------------------DFS-RCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTS-------------GG-------------------GGT-TSS---HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCccccc-------------cc-------------------cch-hcCCcCHHHHHHHHHHccCCcccC
Confidence 99754331100 00 112 223789999999999999999988
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-21 Score=192.58 Aligned_cols=248 Identities=21% Similarity=0.243 Sum_probs=189.0
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC-CCceeEeEEEeecCCCeE
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH-PNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~H-pnIv~l~~~~~~~~~~~~ 206 (704)
....|.++++||.|+||.+|++....+|..||||+-+..... ..+..|..+.+.|++ ..|..+..+..+ ..+-
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e--~~yn 86 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTE--KDYN 86 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhccc--cccc
Confidence 356899999999999999999999999999999987543322 235679999999965 667777766665 4677
Q ss_pred EEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccC---CceEEeccccccccCC
Q 005289 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE---GVLKLADFGLANFSNT 283 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~---g~iKL~DFGla~~~~~ 283 (704)
.|||++++..+-+++.--...|+...+.-++-|++.-|+|+|.+++|||||||+|+|+.-+ ..+.|+|||+|+.+..
T Consensus 87 vlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 87 VLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred eeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 8999999987776665555679999999999999999999999999999999999998543 4699999999987654
Q ss_pred CCCC------CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCCc
Q 005289 284 GHRQ------PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV---EQLHKIFKLCGSPPD 354 (704)
Q Consensus 284 ~~~~------~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~---e~l~~I~~~~g~~p~ 354 (704)
.... .-....||..|.+--...+ ..-+...|+=|+|.+|..+.-|..||++-... ..+++|.+.--
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g-~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~---- 241 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLG-IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKM---- 241 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhh-hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhc----
Confidence 3211 1234467888888665554 23466789999999999999999999986543 44555544221
Q ss_pred hhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcC
Q 005289 355 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 406 (704)
Q Consensus 355 ~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpT 406 (704)
...+...++.+|.++.-.|.-|-..--++-|.
T Consensus 242 --------------------s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pd 273 (341)
T KOG1163|consen 242 --------------------STPIEVLCKGFPAEFAMYLNYCRGLGFEEKPD 273 (341)
T ss_pred --------------------CCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCc
Confidence 22345667888999988888875554444443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-21 Score=198.87 Aligned_cols=174 Identities=14% Similarity=0.144 Sum_probs=132.2
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChH-HHHH------HHHHHHHHHhcCCCCceeEeEEEeec
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPE-SVRF------MAREILILRRLDHPNIIKLEGLITSR 201 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~-~~~~------~~~Ei~iL~~L~HpnIv~l~~~~~~~ 201 (704)
..+|++++.||.|+||.||++.+ ++..+|||+++......+ .... +.+|+..+.+|.||+|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 35899999999999999999765 467899999975543222 2222 57899999999999999999887643
Q ss_pred C------CCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEecc
Q 005289 202 L------SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADF 275 (704)
Q Consensus 202 ~------~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DF 275 (704)
. ....+|||||++|..+..+. .+++ ..+.+|+.+|..||+.||+||||||+|||++.+| ++|+||
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 2 23579999999996555442 2333 2456999999999999999999999999999988 999999
Q ss_pred ccccccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHH
Q 005289 276 GLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 327 (704)
Q Consensus 276 Gla~~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLl 327 (704)
|.......... -+.+.-...|+.++|||+||++|..+.
T Consensus 179 g~~~~~~e~~a--------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQRKA--------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccchhh--------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 98865432110 011222246778999999999988765
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-21 Score=192.67 Aligned_cols=142 Identities=20% Similarity=0.257 Sum_probs=111.8
Q ss_pred EEEeeccCceEEEEEEECCCCcEEEEEEeecCCCCh------------------------HHHHHHHHHHHHHHhcCCCC
Q 005289 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP------------------------ESVRFMAREILILRRLDHPN 190 (704)
Q Consensus 135 ~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~------------------------~~~~~~~~Ei~iL~~L~Hpn 190 (704)
+..||+|+||+||+|.+. +|+.||||+++...... .....+.+|+..+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 568999999999999987 89999999998653110 01223457999999999998
Q ss_pred ceeEeEEEeecCCCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHh-cCcccccCCCccEEEccCCc
Q 005289 191 IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGV 269 (704)
Q Consensus 191 Iv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~-~gIvHrDLKp~NILl~~~g~ 269 (704)
|.....+... ..||||||+++..+.........+++..+..++.||+.+|.+||+ +||+||||||+|||++ ++.
T Consensus 81 i~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~ 155 (190)
T cd05145 81 VPVPEPILLK----KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCCceEEEec----CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC
Confidence 8554444332 238999999986332221233467889999999999999999999 9999999999999998 789
Q ss_pred eEEeccccccccC
Q 005289 270 LKLADFGLANFSN 282 (704)
Q Consensus 270 iKL~DFGla~~~~ 282 (704)
++|+|||++....
T Consensus 156 ~~liDFG~a~~~~ 168 (190)
T cd05145 156 PYIIDVSQAVELD 168 (190)
T ss_pred EEEEEcccceecC
Confidence 9999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.7e-21 Score=190.61 Aligned_cols=192 Identities=19% Similarity=0.145 Sum_probs=140.8
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHHhcC-CCCceeEeEEEeecCCCeEEE
Q 005289 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF--EPESVRFMAREILILRRLD-HPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 132 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~~~L 208 (704)
+.+...|+.|+||+||++.. .+..++.+.+..... ..-....+.+|+++|++|. |++|++++++ ...|+
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~l 75 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW------DGRHL 75 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEEE
Confidence 45678899999999998875 677788777765433 1112235778999999995 5889999875 23589
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccC-CCccEEEccCCceEEeccccccccCCCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDI-KGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDL-Kp~NILl~~~g~iKL~DFGla~~~~~~~~~ 287 (704)
+|||+.|..+..... .. ...++.|++.+|.+||++||+|||| ||+|||++.++.++|+|||+|.........
T Consensus 76 vmeyI~G~~L~~~~~------~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 76 DRSYLAGAAMYQRPP------RG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred EEeeecCccHHhhhh------hh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 999999976643221 11 2357889999999999999999999 799999999999999999999865432210
Q ss_pred ----C--------cccccccccccCcccccCCCCCC-CccchhhHHHHHHHHHhCCCCCCCCCH
Q 005289 288 ----P--------LTSRVVTLWYRPPELLLGATDYG-PSVDLWSVGCVFAELLIGKPILQGRTE 338 (704)
Q Consensus 288 ----~--------~~~~~gT~~Y~APEvl~~~~~y~-~~~DIWSlG~iLyeLltG~~pF~~~~~ 338 (704)
. ..-...++.|+.|+.-.-....+ ...++++.|+.+|.++|+..++.++++
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 0 00112377888887642211222 467899999999999999988876553
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-21 Score=224.50 Aligned_cols=248 Identities=27% Similarity=0.424 Sum_probs=179.4
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCC--CChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN--FEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~--~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
+|...+.||.+.|=.|.+|++.+ | .|+||++-+.. +.-....+...|++ ...++|||++.+.-+... ....||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t--~kAAyl 98 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVT--DKAAYL 98 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHh--hHHHHH
Confidence 58889999999999999998743 4 49999985433 33344455556777 666799999998655433 456789
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccC--CCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN--TGHR 286 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~--~~~~ 286 (704)
|-+|+.++|.+.+. ....+.+.+.+.|+.||+.||.-||..||+|+|||.+||||+.=.=+.|+||..-+... .++.
T Consensus 99 vRqyvkhnLyDRlS-TRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 99 VRQYVKHNLYDRLS-TRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHHHHhhhhhhhhc-cchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 99999998877664 34468888999999999999999999999999999999999988889999998654322 2222
Q ss_pred CCccccc----ccccccCcccccCCC----------CCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHH-cC
Q 005289 287 QPLTSRV----VTLWYRPPELLLGAT----------DYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKL-CG 350 (704)
Q Consensus 287 ~~~~~~~----gT~~Y~APEvl~~~~----------~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~-~g 350 (704)
..++-.. --.+|+|||-+.... ..+++.||||+||+++||++ |+|||. +.++++. -|
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~-------LSQL~aYr~~ 250 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT-------LSQLLAYRSG 250 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc-------HHHHHhHhcc
Confidence 2222111 135799999875421 26788999999999999987 799995 2222220 00
Q ss_pred CCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 351 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 351 ~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
. ......+.+.. -+..+++||..|++.||++|.+|++.|+-
T Consensus 251 ~--------------------~~~~e~~Le~I--ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 251 N--------------------ADDPEQLLEKI--EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred C--------------------ccCHHHHHHhC--cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0 00000111111 13468999999999999999999999976
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4e-20 Score=193.75 Aligned_cols=258 Identities=24% Similarity=0.339 Sum_probs=172.2
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCC-----------------------------------cEEEEEEeec---CCC
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTG-----------------------------------KIVALKKVRF---DNF 168 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g-----------------------------------~~vAvK~i~~---~~~ 168 (704)
.+.++|+|...||+|....||.|+-..+| -+.|||.+-. +..
T Consensus 154 FtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~ 233 (598)
T KOG4158|consen 154 FTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSG 233 (598)
T ss_pred cchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCc
Confidence 34678999999999999999998744311 1245665421 111
Q ss_pred ChHHHHHHHHHH------HH--------HHhc--------CCCCceeEeEEEeec-------------------------
Q 005289 169 EPESVRFMAREI------LI--------LRRL--------DHPNIIKLEGLITSR------------------------- 201 (704)
Q Consensus 169 ~~~~~~~~~~Ei------~i--------L~~L--------~HpnIv~l~~~~~~~------------------------- 201 (704)
.....+.+-+|. .+ .+.+ .|||||++..+|.+.
T Consensus 234 ~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g 313 (598)
T KOG4158|consen 234 DAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAG 313 (598)
T ss_pred hHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccC
Confidence 122223333332 11 1112 599999998887652
Q ss_pred CCCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEc--cCC--ceEEecccc
Q 005289 202 LSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN--NEG--VLKLADFGL 277 (704)
Q Consensus 202 ~~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~--~~g--~iKL~DFGl 277 (704)
.+..+||||.-+.+.+..++... ..+....+-++.|+++|+.|||.+||.|||||.+||||. +++ .+.|+|||.
T Consensus 314 ~~~tlylvMkrY~~tLr~yl~~~--~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGC 391 (598)
T KOG4158|consen 314 EPKTLYLVMKRYRQTLREYLWTR--HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGC 391 (598)
T ss_pred CCceEEEehhcchhhHHHHHhcC--CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccce
Confidence 12468999999888777666433 356777888999999999999999999999999999984 343 489999998
Q ss_pred ccccCCC-----CCCCcccccccccccCcccccCCCC-----CCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 005289 278 ANFSNTG-----HRQPLTSRVVTLWYRPPELLLGATD-----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 347 (704)
Q Consensus 278 a~~~~~~-----~~~~~~~~~gT~~Y~APEvl~~~~~-----y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~ 347 (704)
+-..... ........-|.-..||||+...... .-.++|.|++|.+.||+++...||.+..+...-..
T Consensus 392 cLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r--- 468 (598)
T KOG4158|consen 392 CLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR--- 468 (598)
T ss_pred eeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechh---
Confidence 7432210 0111223345677899998753111 12378999999999999999999987443211000
Q ss_pred HcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCH---HHHHhc
Q 005289 348 LCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA---SAALAS 413 (704)
Q Consensus 348 ~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa---~e~L~h 413 (704)
.+.... |-.....+|+.+++|+..+|..||.||+++ ..+|+-
T Consensus 469 --------~Yqe~q----------------LPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~L 513 (598)
T KOG4158|consen 469 --------TYQESQ----------------LPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNL 513 (598)
T ss_pred --------hhhhhh----------------CCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHHH
Confidence 011111 122235688999999999999999999985 445543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.4e-19 Score=184.81 Aligned_cols=147 Identities=20% Similarity=0.190 Sum_probs=113.5
Q ss_pred CeeEEEEeeccCceEEEEEE-ECCCCcEEEEEEeecCCCCh----------------------HHHHHHHHHHHHHHhcC
Q 005289 131 AFEKLEKIGQGTYSSVFRAR-DLDTGKIVALKKVRFDNFEP----------------------ESVRFMAREILILRRLD 187 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~-~~~~g~~vAvK~i~~~~~~~----------------------~~~~~~~~Ei~iL~~L~ 187 (704)
-|.+.+.||+|+||.||+|. +..+|+.||||+++...... .....+.+|+.+|.+|.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999999 67789999999997543210 01123568999999997
Q ss_pred CCCceeEeEEEeecCCCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcC-cccccCCCccEEEcc
Q 005289 188 HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG-VLHRDIKGSNLLVNN 266 (704)
Q Consensus 188 HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~g-IvHrDLKp~NILl~~ 266 (704)
+.. +.+..++.. ...||||||+++..+.........+.+..+..++.||+.+|.+||.+| |+||||||+|||++
T Consensus 109 ~~~-i~~p~~~~~---~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAG-VPVPKPIAW---RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcC-CCCCeeeEe---cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 532 222223322 124899999999765544333445677778899999999999999999 99999999999999
Q ss_pred CCceEEeccccccccC
Q 005289 267 EGVLKLADFGLANFSN 282 (704)
Q Consensus 267 ~g~iKL~DFGla~~~~ 282 (704)
++.++|+|||++....
T Consensus 184 ~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 184 DGKVVIIDVSQSVELD 199 (237)
T ss_pred CCCEEEEEChhhhccC
Confidence 8899999999986543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=9e-19 Score=176.89 Aligned_cols=138 Identities=14% Similarity=0.181 Sum_probs=104.7
Q ss_pred eEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-----CCCCceeEeEEEeecCC-CeE
Q 005289 133 EKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-----DHPNIIKLEGLITSRLS-CSI 206 (704)
Q Consensus 133 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-----~HpnIv~l~~~~~~~~~-~~~ 206 (704)
.-...||+|+|+.||. ++.++.. +||++..... ...+.+.+|+.+|+.| +||||+++++++++..+ ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 3357899999999995 6777665 6999876432 2345688999999999 67999999999987532 343
Q ss_pred E-EEEeccc--ccccccccCCCccccHHHHHHHHHHhhhhH-HHHHhcCcccccCCCccEEEccC----CceEEeccccc
Q 005289 207 Y-LVFEYME--HDITGLLSCPDIKFSEAQIKCYMNQLLHGL-EHCHSRGVLHRDIKGSNLLVNNE----GVLKLADFGLA 278 (704)
Q Consensus 207 ~-LV~Ey~~--g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL-~yLH~~gIvHrDLKp~NILl~~~----g~iKL~DFGla 278 (704)
+ +||||++ ++.+..+.... .+++. ..++.|++.++ +|||+++||||||||+|||++.. +.++|+||+.+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 4 7899944 55555544333 46666 35688888888 99999999999999999999743 37999995443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.2e-20 Score=212.88 Aligned_cols=263 Identities=29% Similarity=0.407 Sum_probs=209.2
Q ss_pred CCeeEEEEeeccCceEEEEEEEC-CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeEEEeecCCCeEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDL-DTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~~~ 207 (704)
..|.+.+.||+|+|+.|-++... .....+|+|.+..........+.+..|..+-..+. |.|++.+++.... ....+
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~--~~~~~ 97 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS--PRSYL 97 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC--Ccccc
Confidence 36888999999999999998764 34456788877655433444555667888888886 9999999988876 57889
Q ss_pred EEEeccccccccccc-CCCc-cccHHHHHHHHHHhhhhHHHHH-hcCcccccCCCccEEEccCC-ceEEeccccccccCC
Q 005289 208 LVFEYMEHDITGLLS-CPDI-KFSEAQIKCYMNQLLHGLEHCH-SRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNT 283 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~-~~~~-~l~e~~~~~i~~QIl~aL~yLH-~~gIvHrDLKp~NILl~~~g-~iKL~DFGla~~~~~ 283 (704)
++++|..++.+.... .... ..+...+..++.|+..+|.|+| ..++.||||||+|.+++..+ .+++.|||+|..+..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999998887666655 4544 6788899999999999999999 99999999999999999999 999999999987665
Q ss_pred --CCCCCcccccc-cccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhcc
Q 005289 284 --GHRQPLTSRVV-TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (704)
Q Consensus 284 --~~~~~~~~~~g-T~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~ 360 (704)
+........+| ++.|+|||.+.+.....+..|+||+|+++.-|++|..|+......+.. ...|...
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-----------~~~~~~~ 246 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-----------YSSWKSN 246 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-----------ceeeccc
Confidence 44445566788 999999999987667788999999999999999999887654332200 0011111
Q ss_pred CCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
+ ...-...|..++..+.+++.++|..+|..|.+..++-.++|+..
T Consensus 247 ~-------------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 247 K-------------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred c-------------cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 0 00112345788999999999999999999999999999999987
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.8e-19 Score=192.98 Aligned_cols=178 Identities=27% Similarity=0.453 Sum_probs=133.2
Q ss_pred CeEEEEEecccccccccccC---CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccc
Q 005289 204 CSIYLVFEYMEHDITGLLSC---PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 280 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~~~~---~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~ 280 (704)
.++||.|++|.-..+..++. .....+......++.||..+++| +|.+|||+||.||++..+..+||.|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 36899999999876665543 23346677889999999999999 9999999999999999999999999999876
Q ss_pred cCCCC-----CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCc
Q 005289 281 SNTGH-----RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPD 354 (704)
Q Consensus 281 ~~~~~-----~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~ 354 (704)
..... ....+..++|++||+||.|.+ ..|+.++|||+||+||+||+. -...|. ....+..|.. |..|+
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~~f~T~~e---r~~t~~d~r~--g~ip~ 479 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLIQFSTQFE---RIATLTDIRD--GIIPP 479 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHHHhccHHH---HHHhhhhhhc--CCCCh
Confidence 55433 234567789999999999987 679999999999999999996 121111 1111112211 22332
Q ss_pred hhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 355 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 355 ~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
.+|. +. +.-.+||.+||...|.+||++.+.--|+|.
T Consensus 480 ~~~~-------------------------d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 480 EFLQ-------------------------DY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred HHhh-------------------------cC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 2221 12 235689999999999999988887777764
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1e-17 Score=168.67 Aligned_cols=137 Identities=21% Similarity=0.273 Sum_probs=109.1
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEeecCCCChH------HHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPE------SVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 136 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
+.||+|++|.||+|.+ .+..|+||+......... ....+.+|+.++..+.|++|+....++.+ ....+||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv 77 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD--PENFIIV 77 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe--CCCCEEE
Confidence 5799999999999987 677899998754332211 12346789999999999988776666554 3467899
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEecccccccc
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~ 281 (704)
|||++|..+..+.... .+ ....++.+|+.+|.+||+.||+|+||+|.|||++ ++.++|+|||++...
T Consensus 78 ~e~~~G~~L~~~~~~~---~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 78 MEYIEGEPLKDLINSN---GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred EEEeCCcCHHHHHHhc---cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 9999986665544322 12 7788999999999999999999999999999999 789999999998754
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.1e-18 Score=200.64 Aligned_cols=195 Identities=25% Similarity=0.318 Sum_probs=150.6
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC---CCCceeEeEEEeecCC
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD---HPNIIKLEGLITSRLS 203 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~---HpnIv~l~~~~~~~~~ 203 (704)
+..+.|.|-+.||+|+||+||+|.+.. |+.||||+-...+. ++ +.--.+++.+|+ -+-|+.+...+.. .
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~----WE-fYI~~q~~~RLk~~~~~~~~~~~~a~~~--~ 766 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP----WE-FYICLQVMERLKPQMLPSIMHISSAHVF--Q 766 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc----ee-eeehHHHHHhhchhhhcchHHHHHHHcc--C
Confidence 345679999999999999999999876 99999999755431 00 111123334443 2333343333333 2
Q ss_pred CeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEcc-------CCceEEeccc
Q 005289 204 CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-------EGVLKLADFG 276 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~-------~g~iKL~DFG 276 (704)
+..+||+||.+.+.+..+......+++..+..+..|||..|+.||..+|||+||||+|+||.. .--|+|||||
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecc
Confidence 345899999998777777778888999999999999999999999999999999999999942 2359999999
Q ss_pred cccccCC-CCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCC
Q 005289 277 LANFSNT-GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 330 (704)
Q Consensus 277 la~~~~~-~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~ 330 (704)
-+..+.. .....+...+.|-.+-.+|+..| ..+++.+|.|.|..++|.||.|+
T Consensus 847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred cceeeeEcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHH
Confidence 9864431 12246677788999999998887 78999999999999999999996
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.4e-17 Score=164.95 Aligned_cols=140 Identities=21% Similarity=0.209 Sum_probs=108.5
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCCh--------------------HHHHHHHHHHHHHHhcCCCC
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP--------------------ESVRFMAREILILRRLDHPN 190 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~--------------------~~~~~~~~Ei~iL~~L~Hpn 190 (704)
.|.+.+.||.|+||.||++... +|+.||||+++...... .......+|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3888899999999999999874 79999999987543110 01123567999999998874
Q ss_pred --ceeEeEEEeecCCCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCC
Q 005289 191 --IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG 268 (704)
Q Consensus 191 --Iv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g 268 (704)
++.+++ . ...|+||||+++..+..+.. ......++.+|+.+|.++|+.||+|+||||+||||+.++
T Consensus 95 i~v~~~~~---~---~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 95 FPVPKPID---W---NRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCCCceee---c---CCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC
Confidence 444432 1 34589999999976554432 134567888999999999999999999999999999999
Q ss_pred ceEEeccccccccCC
Q 005289 269 VLKLADFGLANFSNT 283 (704)
Q Consensus 269 ~iKL~DFGla~~~~~ 283 (704)
.++|+|||++.....
T Consensus 163 ~~~liDfg~~~~~~~ 177 (198)
T cd05144 163 KIYIIDWPQMVSTDH 177 (198)
T ss_pred cEEEEECCccccCCC
Confidence 999999999965543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.5e-18 Score=171.44 Aligned_cols=248 Identities=16% Similarity=0.208 Sum_probs=186.4
Q ss_pred cccccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCC
Q 005289 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (704)
Q Consensus 125 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 204 (704)
..+......++-+|.+...|..|++++. |.-+++|++..........+.|..|.-.|+-+.||||+.+++.|..+ .
T Consensus 185 ~gid~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp--p 260 (448)
T KOG0195|consen 185 TGIDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP--P 260 (448)
T ss_pred cCcchhhhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC--C
Confidence 3444556667788999999999999985 44577788876555555566788899999999999999999999874 6
Q ss_pred eEEEEEecccccccccccC--CCccccHHHHHHHHHHhhhhHHHHHhcC--cccccCCCccEEEccCCceEEe--ccccc
Q 005289 205 SIYLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRG--VLHRDIKGSNLLVNNEGVLKLA--DFGLA 278 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~~--~~~~l~e~~~~~i~~QIl~aL~yLH~~g--IvHrDLKp~NILl~~~g~iKL~--DFGla 278 (704)
.+.+|..||+.+.+..++. ...-.+..++..++..|+.|++|||+.. |.---|....++||++.+.+|. |--++
T Consensus 261 nlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfs 340 (448)
T KOG0195|consen 261 NLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFS 340 (448)
T ss_pred CceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceee
Confidence 7889999999876665443 3334677899999999999999999874 4444688889999999876653 43322
Q ss_pred cccCCCCCCCcccccccccccCcccccCCCCC--CCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchh
Q 005289 279 NFSNTGHRQPLTSRVVTLWYRPPELLLGATDY--GPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 356 (704)
Q Consensus 279 ~~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y--~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~ 356 (704)
.. ...+.-.|.||+||.+...... -.++|+|||.++||||.|...||..-...+.-.+|.- -|.-
T Consensus 341 fq--------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial-eglr---- 407 (448)
T KOG0195|consen 341 FQ--------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL-EGLR---- 407 (448)
T ss_pred ee--------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh-cccc----
Confidence 11 1123347889999998753322 2479999999999999999999998877776555521 1111
Q ss_pred hhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHH
Q 005289 357 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411 (704)
Q Consensus 357 w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L 411 (704)
....+.++..+..|+.-|+..||.+||..+.++
T Consensus 408 ----------------------v~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 408 ----------------------VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred ----------------------ccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 112357788899999999999999999876654
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.1e-16 Score=159.69 Aligned_cols=133 Identities=19% Similarity=0.227 Sum_probs=101.5
Q ss_pred EeeccCceEEEEEEECCCCcEEEEEEeecCCCCh------HHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEE
Q 005289 137 KIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP------ESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (704)
Q Consensus 137 ~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 210 (704)
.||+|+||+||++.. ++..|++|+........ .....+.+|++++..+.|++|....-++.. ....+|||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv~ 76 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD--PDNKTIVM 76 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE--CCCCEEEE
Confidence 379999999999984 67889999865433211 123556789999999988865444333333 34568999
Q ss_pred ecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEecccccccc
Q 005289 211 EYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (704)
Q Consensus 211 Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~ 281 (704)
||++|..+..+...... .++.||+.+|.+||+.||+|+||+|.|||++ ++.++|+|||++...
T Consensus 77 e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 77 EYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred EEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99998665544322111 7889999999999999999999999999999 789999999998653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.7e-16 Score=156.72 Aligned_cols=138 Identities=23% Similarity=0.224 Sum_probs=99.4
Q ss_pred EEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHH----------------------HHHHHHHHHhcCCCC--
Q 005289 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRF----------------------MAREILILRRLDHPN-- 190 (704)
Q Consensus 135 ~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~----------------------~~~Ei~iL~~L~Hpn-- 190 (704)
.+.||+|+||+||+|.+. +++.||||++............ ...|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999976 7999999998764322111111 135667777764433
Q ss_pred ceeEeEEEeecCCCeEEEEEeccccccccc-ccCCCccccHHHHHHHHHHhhhhHHHHHh-cCcccccCCCccEEEccCC
Q 005289 191 IIKLEGLITSRLSCSIYLVFEYMEHDITGL-LSCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEG 268 (704)
Q Consensus 191 Iv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~-~~~~~~~l~e~~~~~i~~QIl~aL~yLH~-~gIvHrDLKp~NILl~~~g 268 (704)
+.+++.+ ...+|||||++++.+.. ..... .. ...+..++.+++.++.+||. .||+|+||||+|||++ ++
T Consensus 81 ~~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~-~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 81 VPKPIDL------NRHVLVMEFIGGDGIPAPRLKDV-RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CCceEec------CCCEEEEEEeCCCCccChhhhhh-hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC
Confidence 4444332 13589999999843211 11110 11 16788999999999999999 9999999999999999 89
Q ss_pred ceEEeccccccccC
Q 005289 269 VLKLADFGLANFSN 282 (704)
Q Consensus 269 ~iKL~DFGla~~~~ 282 (704)
.++|+|||.+....
T Consensus 152 ~~~liDfg~a~~~~ 165 (187)
T cd05119 152 KVYIIDVPQAVEID 165 (187)
T ss_pred cEEEEECccccccc
Confidence 99999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.8e-16 Score=179.64 Aligned_cols=138 Identities=17% Similarity=0.177 Sum_probs=106.3
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC------hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCC
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE------PESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~------~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 204 (704)
.|...+.||+|+||+||++.... ..+++|+....... ....+.+.+|+++|..+.|++|+....++.+ ..
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~ 409 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD--PE 409 (535)
T ss_pred ccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe--CC
Confidence 45667899999999999998644 34455543221111 1123457789999999999999887666655 34
Q ss_pred eEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEecccccccc
Q 005289 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~ 281 (704)
..+|||||+++..+..+.. ....++.||+.+|.|||+.||+||||||+|||+ .++.++|+|||+++..
T Consensus 410 ~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 5689999999866654432 457789999999999999999999999999999 6789999999998754
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.8e-16 Score=174.24 Aligned_cols=205 Identities=27% Similarity=0.386 Sum_probs=153.3
Q ss_pred HHhcCCCCceeEeEEEeecCCCeEEEEEeccccccccccc-CCCccccHHHHHHHHHHhhhhHHHHHhcCc-ccccCCCc
Q 005289 183 LRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGV-LHRDIKGS 260 (704)
Q Consensus 183 L~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~-~~~~~l~e~~~~~i~~QIl~aL~yLH~~gI-vHrDLKp~ 260 (704)
|+.+.|.|+.++++.+.+. ..+++|.+||..+.+..+. .....++.--...+++.|+.||.|||.-.| .|+.|+..
T Consensus 1 l~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 4678999999999999884 7889999999986666554 446678888899999999999999998866 99999999
Q ss_pred cEEEccCCceEEeccccccccCCC-CCCCcccccccccccCcccccCCCC------CCCccchhhHHHHHHHHHhCCCCC
Q 005289 261 NLLVNNEGVLKLADFGLANFSNTG-HRQPLTSRVVTLWYRPPELLLGATD------YGPSVDLWSVGCVFAELLIGKPIL 333 (704)
Q Consensus 261 NILl~~~g~iKL~DFGla~~~~~~-~~~~~~~~~gT~~Y~APEvl~~~~~------y~~~~DIWSlG~iLyeLltG~~pF 333 (704)
|++++....+||+|||+....... .........-..-|.|||++..... .+.+.||||||+|++|+++...||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999998766421 0011111122456999999865311 466799999999999999999999
Q ss_pred CCCC----HHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHH
Q 005289 334 QGRT----EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 409 (704)
Q Consensus 334 ~~~~----~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e 409 (704)
.... ..+++..+.+ .+..+ +.+.+... ..+++++..++..|+..+|.+||++++
T Consensus 159 ~~~~~~~~~~eii~~~~~-~~~~~--------------------~rP~i~~~-~e~~~~l~~l~~~cw~e~P~~rPs~~~ 216 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKK-GGSNP--------------------FRPSIELL-NELPPELLLLVARCWEEIPEKRPSIEQ 216 (484)
T ss_pred ccccccCChHHHHHHHHh-cCCCC--------------------cCcchhhh-hhcchHHHHHHHHhcccChhhCccHHH
Confidence 7632 2345544433 11111 11111111 156668999999999999999999998
Q ss_pred HH
Q 005289 410 AL 411 (704)
Q Consensus 410 ~L 411 (704)
+-
T Consensus 217 i~ 218 (484)
T KOG1023|consen 217 IR 218 (484)
T ss_pred HH
Confidence 74
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.9e-15 Score=141.57 Aligned_cols=133 Identities=23% Similarity=0.240 Sum_probs=109.5
Q ss_pred EEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC--CCceeEeEEEeecCCCeEEEEEe
Q 005289 134 KLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH--PNIIKLEGLITSRLSCSIYLVFE 211 (704)
Q Consensus 134 ~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~H--pnIv~l~~~~~~~~~~~~~LV~E 211 (704)
+++.||.|.++.||++.... ..++||.+..... ...+.+|+.+++.+.| .++++++.++.. ....|++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~--~~~~~~v~e 73 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGES--DGWSYLLME 73 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC--CCccEEEEE
Confidence 46789999999999999743 7899999865432 3457789999999976 588998887765 357899999
Q ss_pred cccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhc---CcccccCCCccEEEccCCceEEecccccccc
Q 005289 212 YMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR---GVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (704)
Q Consensus 212 y~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~---gIvHrDLKp~NILl~~~g~iKL~DFGla~~~ 281 (704)
|+.+..+..+ +......++.+++.+|.+||.. +++|+||+|.|||+++.+.++|+|||++...
T Consensus 74 ~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 74 WIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 9998655443 4566677888999999999985 7999999999999999899999999998643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.62 E-value=3e-15 Score=154.59 Aligned_cols=138 Identities=18% Similarity=0.201 Sum_probs=102.3
Q ss_pred EEee-ccCceEEEEEEECCCCcEEEEEEeecCCC-----------ChHHHHHHHHHHHHHHhcCCCCc--eeEeEEEeec
Q 005289 136 EKIG-QGTYSSVFRARDLDTGKIVALKKVRFDNF-----------EPESVRFMAREILILRRLDHPNI--IKLEGLITSR 201 (704)
Q Consensus 136 ~~LG-~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-----------~~~~~~~~~~Ei~iL~~L~HpnI--v~l~~~~~~~ 201 (704)
..|| .|+.|+||.+.. .+..++||.+....+ .......+.+|+.++..|.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 899999999986 377899998854221 11233557789999999998875 6676664433
Q ss_pred CCC--eEEEEEecccc-cccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccc
Q 005289 202 LSC--SIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278 (704)
Q Consensus 202 ~~~--~~~LV~Ey~~g-~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla 278 (704)
... ..+|||||+++ ..+..+... ..+++.. +.||+.+|.+||++||+||||||+|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 222 23599999997 444444332 2455543 568999999999999999999999999999899999999988
Q ss_pred cc
Q 005289 279 NF 280 (704)
Q Consensus 279 ~~ 280 (704)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 64
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.3e-14 Score=161.32 Aligned_cols=257 Identities=22% Similarity=0.298 Sum_probs=196.6
Q ss_pred CCeeEEEEeec--cCceEEEEEEE--CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCC
Q 005289 130 DAFEKLEKIGQ--GTYSSVFRARD--LDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSC 204 (704)
Q Consensus 130 ~~y~~~~~LG~--G~fg~Vy~a~~--~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~ 204 (704)
..|.+...+|. |.+|.||.+.. ..++..+|+|.-......+.....-.+|+...+++ .|+|.++.+..++. ..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~--~~ 191 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG--SG 191 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc--CC
Confidence 45788899999 99999999998 88999999998433222222222334688877877 59999997777766 57
Q ss_pred eEEEEEecccccccccccCCCccccHHHHHHHHHHhhh----hHHHHHhcCcccccCCCccEEEccC-CceEEecccccc
Q 005289 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLH----GLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLAN 279 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~----aL~yLH~~gIvHrDLKp~NILl~~~-g~iKL~DFGla~ 279 (704)
..||-+|+|...+..........+++..++.++.+... ||.++|..+|+|-|+||.||++..+ ..++++|||+..
T Consensus 192 ~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 192 ILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred cceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence 88999999998877777777777999999999999999 9999999999999999999999999 889999999998
Q ss_pred ccCCCCCCCc----ccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCch
Q 005289 280 FSNTGHRQPL----TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 355 (704)
Q Consensus 280 ~~~~~~~~~~----~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~ 355 (704)
.+........ ....+..-|++||++.+ .++...|||+||.++.+-.++..++...-. .
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~----------------~ 333 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKN----------------S 333 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCC----------------C
Confidence 7776542211 11145667999999876 689999999999999998888655543200 0
Q ss_pred hhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 356 ~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
-|.. ..+.| .-.+.+...+.++..++..||..+|-.|++++.+++|+++..
T Consensus 334 ~W~~----------~r~~~--ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 334 SWSQ----------LRQGY--IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred Cccc----------ccccc--CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 1110 00011 001223456666777999999999999999999999999874
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.7e-15 Score=175.64 Aligned_cols=266 Identities=24% Similarity=0.291 Sum_probs=200.0
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 207 (704)
.+.+.+.+-+-.|.++.++.+.-..+|...++|+...... .....+.+.++-.++-...+|.++...--+.. ....+
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~--rsP~~ 880 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPC--RSPLP 880 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCC--CCCcc
Confidence 4678888999999999999999888888888887654321 22223334445555554556666655333222 45689
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC---
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG--- 284 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~--- 284 (704)
||++|+.++.+...+......+++-++.++..+..+++|||...++|||++|.|+|+..+++.++.|||+......-
T Consensus 881 L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred hhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 99999988655555445556788888999999999999999999999999999999999999999999843211100
Q ss_pred ------------------CC---------CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 005289 285 ------------------HR---------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT 337 (704)
Q Consensus 285 ------------------~~---------~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~ 337 (704)
.. ..-...++|+.|.+||.+.+ ...+..+|+|++|++++|.++|.+||...+
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg-~~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG-RRHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc-ccCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence 00 01123467999999999987 456889999999999999999999999999
Q ss_pred HHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHH---HHHhcc
Q 005289 338 EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS---AALASE 414 (704)
Q Consensus 338 ~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~---e~L~hp 414 (704)
...++++|...- .+ |. .-....+.++.+++..+|..+|.+|..+. ++-.|+
T Consensus 1040 pq~~f~ni~~~~--~~---~p---------------------~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~ 1093 (1205)
T KOG0606|consen 1040 PQQIFENILNRD--IP---WP---------------------EGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHP 1093 (1205)
T ss_pred hhhhhhccccCC--CC---CC---------------------CCccccChhhhhhhhhhhccCchhccCcccccccccCC
Confidence 888887775421 11 11 11135788899999999999999999988 889999
Q ss_pred ccCCCCCCC
Q 005289 415 YFSTKPYAC 423 (704)
Q Consensus 415 wf~~~~~~~ 423 (704)
||+..+|..
T Consensus 1094 ~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1094 FFQDVDWEN 1102 (1205)
T ss_pred ccCCCCccc
Confidence 999877754
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.6e-13 Score=153.00 Aligned_cols=145 Identities=20% Similarity=0.301 Sum_probs=99.1
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC---------------------------Ch-----HHHHHHH
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF---------------------------EP-----ESVRFMA 177 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~---------------------------~~-----~~~~~~~ 177 (704)
..|+. +.||.|++|+||+|+.+.+|+.||||+++..-. .. +..+.+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35776 789999999999999988899999999975410 00 1122233
Q ss_pred H------HHHHHHhc----CCCCceeEeEEEeecCCCeEEEEEecccccccccc---cCCC---ccccHHHHHHHHHHhh
Q 005289 178 R------EILILRRL----DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL---SCPD---IKFSEAQIKCYMNQLL 241 (704)
Q Consensus 178 ~------Ei~iL~~L----~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~---~~~~---~~l~e~~~~~i~~QIl 241 (704)
+ |+..+.++ .+.+.+.+-.+|.+- ....+|||||+.|..+..+ ...+ ..+.+..+..++.||+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 3 33333333 234444444444332 2446899999999655432 1111 1466666777777775
Q ss_pred hhHHHHHhcCcccccCCCccEEEccCC----ceEEeccccccccCC
Q 005289 242 HGLEHCHSRGVLHRDIKGSNLLVNNEG----VLKLADFGLANFSNT 283 (704)
Q Consensus 242 ~aL~yLH~~gIvHrDLKp~NILl~~~g----~iKL~DFGla~~~~~ 283 (704)
..|++|+|+||.||+|+.++ .++++|||++.....
T Consensus 278 -------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 -------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 48999999999999999988 999999999876654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.36 E-value=4.1e-12 Score=126.70 Aligned_cols=140 Identities=18% Similarity=0.199 Sum_probs=100.2
Q ss_pred EEeeccCceEEEEEEECC------CCcEEEEEEeecCCC-----------C---------hHHHHH----HHHHHHHHHh
Q 005289 136 EKIGQGTYSSVFRARDLD------TGKIVALKKVRFDNF-----------E---------PESVRF----MAREILILRR 185 (704)
Q Consensus 136 ~~LG~G~fg~Vy~a~~~~------~g~~vAvK~i~~~~~-----------~---------~~~~~~----~~~Ei~iL~~ 185 (704)
..||.|--+.||.|.... .+..+|||+.+.... + ...... ..+|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998643 357899998753210 0 011122 2379999999
Q ss_pred cCC--CCceeEeEEEeecCCCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHH-HhcCcccccCCCccE
Q 005289 186 LDH--PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC-HSRGVLHRDIKGSNL 262 (704)
Q Consensus 186 L~H--pnIv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yL-H~~gIvHrDLKp~NI 262 (704)
|.. -++++++.+. .-+|||||++++.+....-....+++..+..++.|++.+|..| |..||||+||++.||
T Consensus 83 l~~~Gv~vP~pi~~~------~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 83 MQKAGIPCPEVVVLK------KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHcCCCCCeEEEec------CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 943 5666666542 2379999998753221111223456667788889999999999 899999999999999
Q ss_pred EEccCCceEEeccccccccC
Q 005289 263 LVNNEGVLKLADFGLANFSN 282 (704)
Q Consensus 263 Ll~~~g~iKL~DFGla~~~~ 282 (704)
|+. ++.+.|+|||.+....
T Consensus 157 L~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 157 LWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EEE-CCcEEEEECCCceeCC
Confidence 997 4789999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.35 E-value=3.9e-13 Score=149.61 Aligned_cols=258 Identities=21% Similarity=0.230 Sum_probs=189.8
Q ss_pred cCccccccCCeeEEEEeeccCceEEEEEEEC-CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEe
Q 005289 122 QGWVPLRADAFEKLEKIGQGTYSSVFRARDL-DTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLIT 199 (704)
Q Consensus 122 ~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~ 199 (704)
..|..+...+|..+..||.|.|+.|+.+... .++..|++|.+............-..|+.+...+ .|.+++..+..+.
T Consensus 257 ~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~ 336 (524)
T KOG0601|consen 257 SDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS 336 (524)
T ss_pred cccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcc
Confidence 3445566778999999999999999998755 7788999998865544443334445688888877 6888888766665
Q ss_pred ecCCCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccC-CceEEeccccc
Q 005289 200 SRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLA 278 (704)
Q Consensus 200 ~~~~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~-g~iKL~DFGla 278 (704)
. ....||=.|||++....+.......+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||.+
T Consensus 337 ~--~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 337 Q--LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred c--cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccc
Confidence 4 35567999999987666555555568889999999999999999999999999999999999886 78899999988
Q ss_pred cccCCCCCCCccccccccccc-CcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhh
Q 005289 279 NFSNTGHRQPLTSRVVTLWYR-PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 357 (704)
Q Consensus 279 ~~~~~~~~~~~~~~~gT~~Y~-APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w 357 (704)
..+... ......+-++. .+|++.....+..+.|++|||..+++.+++.++-...... ..|+.
T Consensus 415 t~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---~~i~~---------- 477 (524)
T KOG0601|consen 415 TRLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---LTIRS---------- 477 (524)
T ss_pred ccccee----cccccccccccccchhhccccccccccccccccccccccccCcccCcccccc---eeeec----------
Confidence 642211 11122244455 3677776678899999999999999999987653322111 01100
Q ss_pred hccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccC
Q 005289 358 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417 (704)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~ 417 (704)
......+.....+..+.+.|+..++..|+.+.++..|.=|.
T Consensus 478 -------------------~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 478 -------------------GDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred -------------------ccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 00111133447788999999999999999999998886554
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.7e-12 Score=123.35 Aligned_cols=127 Identities=17% Similarity=0.119 Sum_probs=94.1
Q ss_pred EEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCc-eeEeEEEeecCCCeEEEEEecc
Q 005289 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI-IKLEGLITSRLSCSIYLVFEYM 213 (704)
Q Consensus 135 ~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-v~l~~~~~~~~~~~~~LV~Ey~ 213 (704)
++.|+.|.++.||+++.. +..|+||+...... ....+..|+.+|+.+.+.++ ++++.+.. ...++||||+
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~----~~~~lv~e~i 73 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP----ETGVLITEFI 73 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC----CCCeEEEEec
Confidence 467899999999999863 77899999754321 12235679999999865554 44544432 2347999999
Q ss_pred cccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCc-----ccccCCCccEEEccCCceEEecccccc
Q 005289 214 EHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGV-----LHRDIKGSNLLVNNEGVLKLADFGLAN 279 (704)
Q Consensus 214 ~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gI-----vHrDLKp~NILl~~~g~iKL~DFGla~ 279 (704)
+|..+... ......++.+|+.+|..||..++ +|+|++|.|||++ ++.++|+||+.+.
T Consensus 74 ~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 74 EGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 99654432 01123456799999999999985 9999999999999 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.32 E-value=5e-12 Score=141.65 Aligned_cols=142 Identities=20% Similarity=0.239 Sum_probs=93.6
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEeecCCCCh--------------------------------HHHH------HHH
Q 005289 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP--------------------------------ESVR------FMA 177 (704)
Q Consensus 136 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~--------------------------------~~~~------~~~ 177 (704)
+.||.|++|.||+|+. .+|+.||||+.+...... +... .+.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 6799999999999986 479999999986532100 0000 123
Q ss_pred HHHHHHHhc----CCCCceeEeEEEeecCCCeEEEEEecccccccccccCC-CccccHHHHHHHHHHhhh-hHHHHHhcC
Q 005289 178 REILILRRL----DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP-DIKFSEAQIKCYMNQLLH-GLEHCHSRG 251 (704)
Q Consensus 178 ~Ei~iL~~L----~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~-~~~l~e~~~~~i~~QIl~-aL~yLH~~g 251 (704)
+|+..+.++ .|.+-+.+-.+|.+. ....+|||||++|..+..+... ...+. ...++.+++. .+..+|..|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~-~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDR-TSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhh-cCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence 355545544 233334444444322 2346899999999665544221 11111 2334455554 467889999
Q ss_pred cccccCCCccEEEccCCceEEeccccccccC
Q 005289 252 VLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (704)
Q Consensus 252 IvHrDLKp~NILl~~~g~iKL~DFGla~~~~ 282 (704)
++|+|+||.||+++.++.++|+|||++....
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.7e-11 Score=137.78 Aligned_cols=183 Identities=21% Similarity=0.306 Sum_probs=133.3
Q ss_pred eeEEEEeeccCceEEE-EEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEE
Q 005289 132 FEKLEKIGQGTYSSVF-RARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (704)
Q Consensus 132 y~~~~~LG~G~fg~Vy-~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 210 (704)
|.+ ....-+..+ || .+..+.++.+|.|..+...+. +....+.+-++-|+.|+||||+++++.++. ...+|||+
T Consensus 15 Y~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~--~~~~ylvT 88 (690)
T KOG1243|consen 15 YDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEE--EGTLYLVT 88 (690)
T ss_pred ccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcc--cCceEEEe
Confidence 444 333333333 44 456677899999999876553 445566788899999999999999998877 46899999
Q ss_pred ecccccccccccCCCccccHHHHHHHHHHhhhhHHHHH-hcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCc
Q 005289 211 EYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH-SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (704)
Q Consensus 211 Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH-~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~ 289 (704)
|-+..- ..+.. .+....+...+.||+.||.||| ..+++|++|.-..|+|+..|..||.+|.++........ +.
T Consensus 89 ErV~Pl--~~~lk---~l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~ 162 (690)
T KOG1243|consen 89 ERVRPL--ETVLK---ELGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PA 162 (690)
T ss_pred eccccH--HHHHH---HhHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-cc
Confidence 988651 11111 2346778888999999999998 66899999999999999999999999998865432211 11
Q ss_pred ccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhC
Q 005289 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG 329 (704)
Q Consensus 290 ~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG 329 (704)
.....-..|..|+.+.. -.-..|.|-|||++++++.|
T Consensus 163 ~~~~~~~s~~~P~~~~~---s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 163 KSLYLIESFDDPEEIDP---SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ccchhhhcccChhhcCc---cccchhhhhHHHHHHHHhCc
Confidence 22222334777775543 12457999999999999999
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.16 E-value=6e-10 Score=121.95 Aligned_cols=233 Identities=18% Similarity=0.259 Sum_probs=164.1
Q ss_pred cccccCCeeEEEEeec--cCc-eEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeec
Q 005289 125 VPLRADAFEKLEKIGQ--GTY-SSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR 201 (704)
Q Consensus 125 ~~~~~~~y~~~~~LG~--G~f-g~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 201 (704)
.|.....|.-+..|-. +-| .+.|+|....+|..|++|.++.+... .......-+++++++.|+|||++.++|...
T Consensus 268 ~p~lv~~~~~L~pl~~~~~~~~~Ttyk~~s~~DG~~YvLkRlhg~r~~--~~nk~t~lve~wkkl~h~NvV~frevf~t~ 345 (655)
T KOG3741|consen 268 IPSLVESFVNLYPLELLNDLFSITTYKATSNVDGNAYVLKRLHGDRDQ--STNKDTSLVEAWKKLCHTNVVPFREVFLTY 345 (655)
T ss_pred CCcchhhhhceeecccccccccceeEeeeeccCCceeeeeeecccccc--CcccchHHHHHHHHhccCceeehhhhhhhh
Confidence 3444455655554432 224 57899999999999999999544321 111123467899999999999999988632
Q ss_pred --CCCeEEEEEecccc--cccccccC--------------CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEE
Q 005289 202 --LSCSIYLVFEYMEH--DITGLLSC--------------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLL 263 (704)
Q Consensus 202 --~~~~~~LV~Ey~~g--~ll~~~~~--------------~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NIL 263 (704)
....++|||+|.++ .|.+.+.. .+...+|..+|.|+.||..||.++|+.|+.-+-|.|.+||
T Consensus 346 tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIl 425 (655)
T KOG3741|consen 346 TFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKIL 425 (655)
T ss_pred ccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeE
Confidence 24678999999987 33333321 2335789999999999999999999999999999999999
Q ss_pred EccCCceEEeccccccccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHH
Q 005289 264 VNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLH 343 (704)
Q Consensus 264 l~~~g~iKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~ 343 (704)
++.+-+|+|...|.......+.. |.+.. -.+-|.=-||.+|+.|.||..-=...+.....
T Consensus 426 v~G~~RIriS~C~i~Dvl~~d~~---------------~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s- 485 (655)
T KOG3741|consen 426 VTGKMRIRISGCGIMDVLQEDPT---------------EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSS- 485 (655)
T ss_pred eeCcceEEEecccceeeecCCCC---------------cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHH-
Confidence 99988899988777665544321 11222 23569999999999999995321111111100
Q ss_pred HHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 344 KIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 344 ~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.+......++.++.++|.-+...++.. -++.++|.+
T Consensus 486 ---------------------------------~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 486 ---------------------------------HLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred ---------------------------------HHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 012223567889999999999999987 677888755
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=5.5e-12 Score=130.57 Aligned_cols=241 Identities=18% Similarity=0.191 Sum_probs=152.6
Q ss_pred EEEEEEECCCCcEEEEEEeecCCC-C-hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC---CCeEEEEEecccccccc
Q 005289 145 SVFRARDLDTGKIVALKKVRFDNF-E-PESVRFMAREILILRRLDHPNIIKLEGLITSRL---SCSIYLVFEYMEHDITG 219 (704)
Q Consensus 145 ~Vy~a~~~~~g~~vAvK~i~~~~~-~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~---~~~~~LV~Ey~~g~ll~ 219 (704)
.||++-+...|..|.--.++.... + ....+.+..-..-|-.+.|-|||+++.|+.+.. ...+.++.|||.-+.+.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 577777777776665433322110 0 011111112233455568999999999987632 23578899999976554
Q ss_pred ccc----CCCccccHHHHHHHHHHhhhhHHHHHhc--CcccccCCCccEEEccCCceEEeccccccccCCCC--CC-Ccc
Q 005289 220 LLS----CPDIKFSEAQIKCYMNQLLHGLEHCHSR--GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH--RQ-PLT 290 (704)
Q Consensus 220 ~~~----~~~~~l~e~~~~~i~~QIl~aL~yLH~~--gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~--~~-~~~ 290 (704)
.++ .....+.....++|+-||+.||.|||+. -|+|+++...-|++..+|-|||.---....-.... .+ ...
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~ 240 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKS 240 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhh
Confidence 433 3445688899999999999999999998 49999999999999999988875322111100000 00 001
Q ss_pred cccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCC
Q 005289 291 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI-LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (704)
Q Consensus 291 ~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~p-F~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~ 369 (704)
...+-++|.+||.=.. ...+.++|||+||....+|..+.-- -.+....+.-..|......
T Consensus 241 ~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~------------------ 301 (458)
T KOG1266|consen 241 VNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIG------------------ 301 (458)
T ss_pred ccccCCccccCCcCcc-cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheee------------------
Confidence 1234678999996432 4567789999999999999876422 2222222222222211100
Q ss_pred CCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 370 ~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
.-..--.++|.+||.-.|..||++.++|.||..-+
T Consensus 302 --------------len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 302 --------------LENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred --------------ccCccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 00111246899999999999999999999987643
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.12 E-value=4.9e-10 Score=112.89 Aligned_cols=144 Identities=19% Similarity=0.238 Sum_probs=105.3
Q ss_pred EEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC--CCceeEeEEEeecC-CCeEEEEEe
Q 005289 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH--PNIIKLEGLITSRL-SCSIYLVFE 211 (704)
Q Consensus 135 ~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~H--pnIv~l~~~~~~~~-~~~~~LV~E 211 (704)
++.|+.|.++.||++.... |+.++||+....... .....+.+|+.+++.+.+ .++++++.+..... ....|+|||
T Consensus 3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred ceecCCCccceEEEEEecC-CcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 3678999999999998643 678999997654321 124457889999999965 44577766654321 135689999
Q ss_pred cccccccccccCCCccccHHHHHHHHHHhhhhHHHHHh------------------------------------------
Q 005289 212 YMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS------------------------------------------ 249 (704)
Q Consensus 212 y~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~------------------------------------------ 249 (704)
|++|..+...... ..+++.+...++.+|+..|..||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9999765544321 346777777778888888888873
Q ss_pred --------------cCcccccCCCccEEEcc--CCceEEecccccccc
Q 005289 250 --------------RGVLHRDIKGSNLLVNN--EGVLKLADFGLANFS 281 (704)
Q Consensus 250 --------------~gIvHrDLKp~NILl~~--~g~iKL~DFGla~~~ 281 (704)
..++|+|++|.|||++. ++.+.|+||+.+...
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 23699999999999998 667899999987643
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.2e-09 Score=106.15 Aligned_cols=132 Identities=20% Similarity=0.277 Sum_probs=92.2
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChH-----HHHHHHHHHHHHHhcCCC--CceeEeEEEeecCCCeEE
Q 005289 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPE-----SVRFMAREILILRRLDHP--NIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 136 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~-----~~~~~~~Ei~iL~~L~Hp--nIv~l~~~~~~~~~~~~~ 207 (704)
..|.+|+-+.+|.+.. -|..+.+|.=..... .++ ..+...+|+.+|.++.-- +.+.++++.. ....
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~----~~~~ 75 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDP----DNGL 75 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcC----CCCE
Confidence 3578899999999965 344566664322222 122 233456799999998543 3344444332 3457
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEecccccccc
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~ 281 (704)
|+|||++|.++....... ...++..+=.-+.-||.+||||+||.++||++...+ +.++||||+.+.
T Consensus 76 I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 76 IVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred EEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 999999998877554332 245666777778899999999999999999998754 999999998644
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.99 E-value=3.5e-09 Score=105.23 Aligned_cols=128 Identities=26% Similarity=0.311 Sum_probs=83.5
Q ss_pred EEEEEEECCCCcEEEEEEeecCC--C----------------------ChHHHHHHHHHHHHHHhcCCC--CceeEeEEE
Q 005289 145 SVFRARDLDTGKIVALKKVRFDN--F----------------------EPESVRFMAREILILRRLDHP--NIIKLEGLI 198 (704)
Q Consensus 145 ~Vy~a~~~~~g~~vAvK~i~~~~--~----------------------~~~~~~~~~~Ei~iL~~L~Hp--nIv~l~~~~ 198 (704)
.||.|.. ..|..+|||+.+... + .........+|.++|.++..- ++++++.+.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 4899986 457899999975421 0 011123456799999999755 566776442
Q ss_pred eecCCCeEEEEEeccc--ccccccccCCCccccHHHHHHHHHHhhhhHHH-HHhcCcccccCCCccEEEccCCceEEecc
Q 005289 199 TSRLSCSIYLVFEYME--HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEH-CHSRGVLHRDIKGSNLLVNNEGVLKLADF 275 (704)
Q Consensus 199 ~~~~~~~~~LV~Ey~~--g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~y-LH~~gIvHrDLKp~NILl~~~g~iKL~DF 275 (704)
. -+|||||++ |..+..+... .++......++.+++..+.. +|..||||+||.+.|||++++ .+.|+||
T Consensus 80 ~------~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 R------NVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp T------TEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--G
T ss_pred C------CEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEec
Confidence 1 269999999 6555444322 22345667777888885555 579999999999999999887 9999999
Q ss_pred ccccccC
Q 005289 276 GLANFSN 282 (704)
Q Consensus 276 Gla~~~~ 282 (704)
|.+....
T Consensus 151 ~qav~~~ 157 (188)
T PF01163_consen 151 GQAVDSS 157 (188)
T ss_dssp TTEEETT
T ss_pred CcceecC
Confidence 9886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=2.2e-10 Score=129.37 Aligned_cols=155 Identities=25% Similarity=0.348 Sum_probs=116.5
Q ss_pred HhhhhHHHHHhc-CcccccCCCccEEEccCCceEEeccccccccCCCCCCCc-------cc-ccccccccCcccccCCCC
Q 005289 239 QLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL-------TS-RVVTLWYRPPELLLGATD 309 (704)
Q Consensus 239 QIl~aL~yLH~~-gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~-------~~-~~gT~~Y~APEvl~~~~~ 309 (704)
++..||.|+|.. ++||++|.|++|.++..+.+||+.|+++.....+...+. .. ..-...|.|||++.. ..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-TT 185 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-cc
Confidence 445899999966 899999999999999999999999999865443221111 11 112567999999987 66
Q ss_pred CCCccchhhHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHH
Q 005289 310 YGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTT 388 (704)
Q Consensus 310 y~~~~DIWSlG~iLyeLl-tG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~ 388 (704)
.+.++|++||||++|.+. .|++.|...........-....+.. ....-..+|.+
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~-------------------------~~~~s~~~p~e 240 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAG-------------------------AFGYSNNLPSE 240 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccc-------------------------cccccccCcHH
Confidence 789999999999999999 6788877665443333222211110 01111579999
Q ss_pred HHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 389 AVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 389 ~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
+++=|.++|..++..||++.+++..|||+..
T Consensus 241 l~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~ 271 (700)
T KOG2137|consen 241 LRESLKKLLNGDSAVRPTLDLLLSIPFFSDP 271 (700)
T ss_pred HHHHHHHHhcCCcccCcchhhhhcccccCCc
Confidence 9999999999999999999999999999864
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.97 E-value=4.2e-09 Score=102.03 Aligned_cols=144 Identities=18% Similarity=0.250 Sum_probs=98.9
Q ss_pred EEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC------hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEE
Q 005289 134 KLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE------PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 134 ~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~------~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 207 (704)
.+..|-+|+-+.|+++.. .|+.+.||.=....+. .-......+|+++|.++.--.|.--.=+|.+. ..-+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~--~~~~ 86 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDT--YGGQ 86 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEec--CCCe
Confidence 678889999999999975 6788778753222221 12234567899999998543432222244443 2336
Q ss_pred EEEecccc--cccccccCCCcc-ccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCc---eEEecccccccc
Q 005289 208 LVFEYMEH--DITGLLSCPDIK-FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV---LKLADFGLANFS 281 (704)
Q Consensus 208 LV~Ey~~g--~ll~~~~~~~~~-l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~---iKL~DFGla~~~ 281 (704)
|+|||++| .+...+...... ........++++|-..|.-||.++|||+||..+||||..++. +.|+|||++...
T Consensus 87 i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 87 IYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 89999998 333333322222 223334788889999999999999999999999999987653 589999998543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.80 E-value=4.9e-08 Score=102.46 Aligned_cols=132 Identities=16% Similarity=0.116 Sum_probs=88.5
Q ss_pred EEEEEECCCCcEEEEEEeecCCCCh---------HHHHHHHHHHHHHHhcCCCCc--eeEeEEEeecC---CCeEEEEEe
Q 005289 146 VFRARDLDTGKIVALKKVRFDNFEP---------ESVRFMAREILILRRLDHPNI--IKLEGLITSRL---SCSIYLVFE 211 (704)
Q Consensus 146 Vy~a~~~~~g~~vAvK~i~~~~~~~---------~~~~~~~~Ei~iL~~L~HpnI--v~l~~~~~~~~---~~~~~LV~E 211 (704)
|+++.. .|+.|.||......... .....+.+|...+.+|..-+| +.++.+.+... ...-+||||
T Consensus 38 vvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 38 TLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred EEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 445543 56788888664322110 001136689988888843333 33344443321 234689999
Q ss_pred ccccc-ccccccC--CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEcc-------CCceEEecccccc
Q 005289 212 YMEHD-ITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-------EGVLKLADFGLAN 279 (704)
Q Consensus 212 y~~g~-ll~~~~~--~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~-------~g~iKL~DFGla~ 279 (704)
++++. .+..+.. .....++.....++.+|+..+.-||.+||+|+||++.||||+. +..+.||||+.+.
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 99984 3433322 1234566778899999999999999999999999999999985 4679999999875
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=5.3e-08 Score=100.11 Aligned_cols=137 Identities=26% Similarity=0.255 Sum_probs=100.5
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCC------------------CC--hHHHHHHHHHHHHHHhcCCC--
Q 005289 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN------------------FE--PESVRFMAREILILRRLDHP-- 189 (704)
Q Consensus 132 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~------------------~~--~~~~~~~~~Ei~iL~~L~Hp-- 189 (704)
+.+..+||-|--+.||.|.+. .|..+|||.=+... .. .-......+|.++|.+|.-.
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 556789999999999999975 68999999743211 00 11234456899999999544
Q ss_pred CceeEeEEEeecCCCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCc
Q 005289 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV 269 (704)
Q Consensus 190 nIv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~ 269 (704)
.|++.+++ +.-.+||||++|-.+..+. ++...+..++..|+.-+.-+-..||||+||.+-|||++++|.
T Consensus 172 ~VP~P~~~------nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 172 KVPKPIAW------NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCCcccc------ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC
Confidence 66666543 3457999999996555443 234455556666666666666899999999999999999999
Q ss_pred eEEeccccccc
Q 005289 270 LKLADFGLANF 280 (704)
Q Consensus 270 iKL~DFGla~~ 280 (704)
+.|+||-.+..
T Consensus 241 ~~vIDwPQ~v~ 251 (304)
T COG0478 241 IVVIDWPQAVP 251 (304)
T ss_pred EEEEeCccccc
Confidence 99999976643
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.63 E-value=7.2e-07 Score=95.99 Aligned_cols=251 Identities=16% Similarity=0.154 Sum_probs=152.2
Q ss_pred EEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeE----E-EeecCCCeEEE
Q 005289 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEG----L-ITSRLSCSIYL 208 (704)
Q Consensus 135 ~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~----~-~~~~~~~~~~L 208 (704)
.+.||+|+-+.+|-.-.. +. .+.|++....- ... ..-+..|... .||-+-.-+. . +-......+-+
T Consensus 16 gr~LgqGgea~ly~l~e~--~d-~VAKIYh~Ppp--a~~---aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV--RD-QVAKIYHAPPP--AAQ---AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CccccCCccceeeecchh--hc-hhheeecCCCc--hHH---HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 477999999999976432 22 34577765431 111 1233444444 6664432111 1 11112334778
Q ss_pred EEeccccc--cccccc-----CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEecccccccc
Q 005289 209 VFEYMEHD--ITGLLS-----CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (704)
Q Consensus 209 V~Ey~~g~--ll~~~~-----~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~ 281 (704)
+|..+.+. ....+. .....+.+..+....+.|+.+.+.||+.|.+-+|+.++|||+.+++.+.|+|=..-...
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeec
Confidence 88888873 212221 11223667788899999999999999999999999999999999999999975432221
Q ss_pred CCCCCCCcccccccccccCccccc-C---CCCCCCccchhhHHHHHHHHHhC-CCCCCCCCHH----HHHH-HHHHHcCC
Q 005289 282 NTGHRQPLTSRVVTLWYRPPELLL-G---ATDYGPSVDLWSVGCVFAELLIG-KPILQGRTEV----EQLH-KIFKLCGS 351 (704)
Q Consensus 282 ~~~~~~~~~~~~gT~~Y~APEvl~-~---~~~y~~~~DIWSlG~iLyeLltG-~~pF~~~~~~----e~l~-~I~~~~g~ 351 (704)
. +.......++...|.+||... + .-.-+...|.|.||++|++||.| +.||.|-... .-++ .|.. |.
T Consensus 168 -~-ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~--g~ 243 (637)
T COG4248 168 -A-NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH--GR 243 (637)
T ss_pred -c-CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc--ce
Confidence 1 112334457899999999753 1 12346678999999999999987 9999773210 0000 1111 11
Q ss_pred CCchhhhccCCCCcccCCCCCCC-CchhhhhccCCCHHHHHHHHHhhcc--CCCCCcCHHH
Q 005289 352 PPDDYWKKSKLPHATLFKPQQPY-DSSLRETFKDLPTTAVNLIETLLSV--EPYKRATASA 409 (704)
Q Consensus 352 ~p~~~w~~~~~~~~~~~~~~~~~-~~~l~~~~~~~s~~~~dLI~~mL~~--dP~kRpTa~e 409 (704)
+. .. ...+..+ .......|.-+++++..|..+|+.. +|.-|||++.
T Consensus 244 f~----------ya--~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 244 FA----------YA--SDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred ee----------ec--hhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 00 00 0000111 1122334567899999999999874 3668999864
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.9e-07 Score=94.39 Aligned_cols=108 Identities=21% Similarity=0.202 Sum_probs=79.7
Q ss_pred HHHHHHHHHHHhcCCC--CceeEeEEEeecC--CCeEEEEEeccccc-ccccccCCCccccHHHHHHHHHHhhhhHHHHH
Q 005289 174 RFMAREILILRRLDHP--NIIKLEGLITSRL--SCSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248 (704)
Q Consensus 174 ~~~~~Ei~iL~~L~Hp--nIv~l~~~~~~~~--~~~~~LV~Ey~~g~-ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH 248 (704)
....+|...+..|..- .+++.+.+.+... ....+||+|++++. .+..+......++......++.+|...+.-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 3466788888877432 2344555554422 13458999999983 34444333223667788899999999999999
Q ss_pred hcCcccccCCCccEEEccCC---ceEEecccccccc
Q 005289 249 SRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFS 281 (704)
Q Consensus 249 ~~gIvHrDLKp~NILl~~~g---~iKL~DFGla~~~ 281 (704)
.+||+|+||++.||||+.++ .+.|+||+.+...
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999999999999999887 8999999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=2.5e-08 Score=111.85 Aligned_cols=245 Identities=16% Similarity=0.133 Sum_probs=169.3
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCC-ceeEeEEEeecCCCeEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPN-IIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hpn-Iv~l~~~~~~~~~~~~~LV 209 (704)
-|...+.+++|+++.+++.+...+...+ .+.+... ....-++++|.+++||| .+..++-++ .+.+.+++
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~--~E~~~~i~ 312 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYD--GEDYLWIP 312 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccccCC--cccccchh
Confidence 4667788999999999999987665555 6665422 22345899999999999 444433333 35678999
Q ss_pred Eeccccc--ccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCC
Q 005289 210 FEYMEHD--ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (704)
Q Consensus 210 ~Ey~~g~--ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~ 287 (704)
|+++..+ ...........|-+-+...+.+.-+++|+|||+--=+|+| |||..+ +..|..||+....+....
T Consensus 313 ~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-- 385 (829)
T KOG0576|consen 313 MRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-- 385 (829)
T ss_pred hhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc--
Confidence 9999875 3333333344566667777888889999999998888999 887765 789999999887665432
Q ss_pred CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCccc
Q 005289 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (704)
Q Consensus 288 ~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~ 367 (704)
...+..+|+.++|||+... ..|....|+|++++--.+|.-|-+|-..... ... ..|..+
T Consensus 386 ~~~t~~~~~~~~~pev~~~-~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~~----~~g~~p-------------- 444 (829)
T KOG0576|consen 386 KPRTAIGTPEPLAPEVIQE-NTIDGCPDSGSLAVSAIQMAPGLPPRSSPPA--VLP----MIGNGP-------------- 444 (829)
T ss_pred ccccCCCCCCCCCchhhcc-cccccCCCccCCCcchhhcCCCCCCCCCCcc--ccC----CCCCCC--------------
Confidence 2355678999999998876 5688899999999887778777777543100 000 001110
Q ss_pred CCCCCCCCchhh--hhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCC
Q 005289 368 FKPQQPYDSSLR--ETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (704)
Q Consensus 368 ~~~~~~~~~~l~--~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~ 421 (704)
....|. ..|.... -.++...||...|..|++...++.|.+|+.-|.
T Consensus 445 ------~s~~L~~~~aw~~~~--~~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl 492 (829)
T KOG0576|consen 445 ------NSPMLTDKSAWSPVF--HRDFPAPCLNGLPPTPKVHMGACFSKVFNGCPL 492 (829)
T ss_pred ------CccccchhhhcCccc--ccCCcccccCCCCCCCcchhhHHHHHHhccCcc
Confidence 000011 1111111 115778999999999999999999999986443
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.4e-06 Score=89.00 Aligned_cols=138 Identities=20% Similarity=0.253 Sum_probs=97.1
Q ss_pred EeeccCceEEEEEEECCCCcEEEEEEeecCCCC--------------------hHH--HHHHHHHHHHHHhcC--CCCce
Q 005289 137 KIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE--------------------PES--VRFMAREILILRRLD--HPNII 192 (704)
Q Consensus 137 ~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~--------------------~~~--~~~~~~Ei~iL~~L~--HpnIv 192 (704)
.|..|--+.||+|.. .++..||||+++..... ... ......|+.-|+++. +-.+.
T Consensus 55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 677888889999984 56889999998653211 111 112345788888873 44555
Q ss_pred eEeEEEeecCCCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHh-cCcccccCCCccEEEccCCceE
Q 005289 193 KLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLK 271 (704)
Q Consensus 193 ~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~-~gIvHrDLKp~NILl~~~g~iK 271 (704)
+-+.+... .|||||++....-.-.-....+.+.++..+..+++..+.-|-. .++||+||..-|||+. ++.+.
T Consensus 134 ~Pi~~~~n------VLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~ 206 (268)
T COG1718 134 EPIAFRNN------VLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPY 206 (268)
T ss_pred CceeecCC------eEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEE
Confidence 55554422 6999999875222111122334455788888899999988887 8999999999999999 78999
Q ss_pred EeccccccccC
Q 005289 272 LADFGLANFSN 282 (704)
Q Consensus 272 L~DFGla~~~~ 282 (704)
||||+.|....
T Consensus 207 iID~~QaV~~~ 217 (268)
T COG1718 207 IIDVSQAVTID 217 (268)
T ss_pred EEECccccccC
Confidence 99999986544
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.41 E-value=4.7e-06 Score=84.22 Aligned_cols=140 Identities=19% Similarity=0.225 Sum_probs=89.5
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChH-HHHH------HHHHHHHHHhcC---CCCceeEeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPE-SVRF------MAREILILRRLD---HPNIIKLEGLI 198 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~-~~~~------~~~Ei~iL~~L~---HpnIv~l~~~~ 198 (704)
..+|.+++.+-......|.+..- +|+.+.+|..+......+ .... ..+++..+.++. -..+..++-+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 34799999999888888888764 678899998764332111 1111 123444444442 22222322222
Q ss_pred ee---cCCCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEecc
Q 005289 199 TS---RLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADF 275 (704)
Q Consensus 199 ~~---~~~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DF 275 (704)
+- ......+|||||++|..+..+.. +++. +...|..+|.-||..|++|+|++|.|++++++ .++++||
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~ 178 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED----IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDT 178 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh----cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEEC
Confidence 21 11234568999999965544321 2332 33466778899999999999999999999865 5999999
Q ss_pred cccc
Q 005289 276 GLAN 279 (704)
Q Consensus 276 Gla~ 279 (704)
+..+
T Consensus 179 ~~k~ 182 (229)
T PF06176_consen 179 QGKR 182 (229)
T ss_pred cccc
Confidence 8654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.38 E-value=5.1e-06 Score=83.90 Aligned_cols=139 Identities=22% Similarity=0.313 Sum_probs=81.4
Q ss_pred EEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCC--CceeEeEEEeec-CCCeEEEEEe
Q 005289 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP--NIIKLEGLITSR-LSCSIYLVFE 211 (704)
Q Consensus 135 ~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hp--nIv~l~~~~~~~-~~~~~~LV~E 211 (704)
++.|+.|..+.||++.... ..++||..... .....+.+|+.+++.|... .+.+++.+.... .....+++|+
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~ 75 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME 75 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence 5789999999999998754 48999997532 3456677899999988433 355666544322 2345799999
Q ss_pred cccccccccc--------------------cC---CCccccH------HHHHHH---------------HHHhhh-hHHH
Q 005289 212 YMEHDITGLL--------------------SC---PDIKFSE------AQIKCY---------------MNQLLH-GLEH 246 (704)
Q Consensus 212 y~~g~ll~~~--------------------~~---~~~~l~e------~~~~~i---------------~~QIl~-aL~y 246 (704)
++++..+... .. ....+.. .....+ +..+.. .+..
T Consensus 76 ~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (239)
T PF01636_consen 76 YIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQE 155 (239)
T ss_dssp EESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred EeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHH
Confidence 9998644440 00 0000000 000000 111222 2333
Q ss_pred HH-------hcCcccccCCCccEEEc-cCCceEEecccccc
Q 005289 247 CH-------SRGVLHRDIKGSNLLVN-NEGVLKLADFGLAN 279 (704)
Q Consensus 247 LH-------~~gIvHrDLKp~NILl~-~~g~iKL~DFGla~ 279 (704)
++ ...++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 156 LEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 33 24699999999999999 66677899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.31 E-value=6.4e-06 Score=82.90 Aligned_cols=138 Identities=17% Similarity=0.195 Sum_probs=95.4
Q ss_pred eccCceEEEEEEECCCCcEEEEEEeecC---CCC-hHHHHHHHHHHHHHHhcCCC--CceeEeEEEe-e--cCCCeEEEE
Q 005289 139 GQGTYSSVFRARDLDTGKIVALKKVRFD---NFE-PESVRFMAREILILRRLDHP--NIIKLEGLIT-S--RLSCSIYLV 209 (704)
Q Consensus 139 G~G~fg~Vy~a~~~~~g~~vAvK~i~~~---~~~-~~~~~~~~~Ei~iL~~L~Hp--nIv~l~~~~~-~--~~~~~~~LV 209 (704)
|.||-+-|+.... .|+.+-||.-... .+. +-....+.+|+..|..|..- .++++. ++. . ...-.-+||
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 5588888998764 3446788875311 011 22345688999999998432 245544 332 1 112235799
Q ss_pred Eecccc--cccccccC-CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCc--eEEecccccc
Q 005289 210 FEYMEH--DITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV--LKLADFGLAN 279 (704)
Q Consensus 210 ~Ey~~g--~ll~~~~~-~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~--iKL~DFGla~ 279 (704)
+|-+++ ++...+.. .-.+.++.....++.+|...|.-||..||.|+|+-+.|||++.++. ++++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 998885 33333322 1224577777899999999999999999999999999999987777 9999998664
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.23 E-value=8.6e-06 Score=83.57 Aligned_cols=133 Identities=15% Similarity=0.151 Sum_probs=80.3
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCC--ceeEeEEEeecCCCeEEEEEecc
Q 005289 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPN--IIKLEGLITSRLSCSIYLVFEYM 213 (704)
Q Consensus 136 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hpn--Iv~l~~~~~~~~~~~~~LV~Ey~ 213 (704)
..||.|..+.||+. .+..+++|...... ....+.+|.++|+.+..-. +.+++++..+ .....+|||++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~--~~~~glv~e~i 76 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVED--GGRLGLIYELI 76 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEec--CCeeeeeeeec
Confidence 56899999999984 24467889876422 1234678999999985433 4566666554 45578999999
Q ss_pred cccc-cc-ccc---------------------C---CCccccHHHHHHHHHHh----------hh-hHHHHH----hcCc
Q 005289 214 EHDI-TG-LLS---------------------C---PDIKFSEAQIKCYMNQL----------LH-GLEHCH----SRGV 252 (704)
Q Consensus 214 ~g~l-l~-~~~---------------------~---~~~~l~e~~~~~i~~QI----------l~-aL~yLH----~~gI 252 (704)
+|.. +. .+. . ....++.. ...+..+| .. ...+|. ...+
T Consensus 77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~ 155 (226)
T TIGR02172 77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTC 155 (226)
T ss_pred CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCce
Confidence 9952 11 010 0 00011100 01110000 00 112222 1247
Q ss_pred ccccCCCccEEEccCCceEEeccccccc
Q 005289 253 LHRDIKGSNLLVNNEGVLKLADFGLANF 280 (704)
Q Consensus 253 vHrDLKp~NILl~~~g~iKL~DFGla~~ 280 (704)
+|+|+.|.||++++++ +.|+||+.+..
T Consensus 156 ~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 156 LHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred EecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 8999999999999888 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.22 E-value=4.6e-06 Score=94.87 Aligned_cols=139 Identities=22% Similarity=0.286 Sum_probs=86.7
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEeecCC---------------------------CCh-----HHHHH------HH
Q 005289 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDN---------------------------FEP-----ESVRF------MA 177 (704)
Q Consensus 136 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~---------------------------~~~-----~~~~~------~~ 177 (704)
..|+.++-|.||+|+.. +|+.||||+.+..- +.. +..+. +.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 67899999999999965 49999999976531 110 00111 22
Q ss_pred HHHHHHHhcC----CCCceeEeEEEeecCCCeEEEEEeccccccccccc-CCCcccc-----HHHHHHHHHHhhhhHHHH
Q 005289 178 REILILRRLD----HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS-CPDIKFS-----EAQIKCYMNQLLHGLEHC 247 (704)
Q Consensus 178 ~Ei~iL~~L~----HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~-~~~~~l~-----e~~~~~i~~QIl~aL~yL 247 (704)
+|..-+.++. ...-+.+-.+|.+- ...-.|+|||++|--+..+. -....++ +.-+..++.|++
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~-t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~------ 282 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEY-TTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLL------ 282 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhc-cCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHH------
Confidence 3444444441 22223333344321 23457999999994444331 1112233 333344444443
Q ss_pred HhcCcccccCCCccEEEccCCceEEeccccccccCC
Q 005289 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (704)
Q Consensus 248 H~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~ 283 (704)
..|++|.|.+|.||+++.+|.+-+.|||+.....+
T Consensus 283 -~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 283 -RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred -hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 47999999999999999999999999999876554
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.06 E-value=4.1e-05 Score=92.93 Aligned_cols=148 Identities=24% Similarity=0.375 Sum_probs=91.9
Q ss_pred EEEEeeccCceEEEEEEECCCC--cEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCc--eeEeEEEeecC-CCeEE
Q 005289 134 KLEKIGQGTYSSVFRARDLDTG--KIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNI--IKLEGLITSRL-SCSIY 207 (704)
Q Consensus 134 ~~~~LG~G~fg~Vy~a~~~~~g--~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnI--v~l~~~~~~~~-~~~~~ 207 (704)
.+..|+.|.+..+|+......+ ..+++|+....... .....+.+|+.+|+.|. |.+| ++++.++.+.. ....|
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 4678899999999998764432 46778876543221 12345779999999995 6665 77777776531 24578
Q ss_pred EEEecccccccccc------------------------cCCC----------c--cccHHHHHHHHHH------------
Q 005289 208 LVFEYMEHDITGLL------------------------SCPD----------I--KFSEAQIKCYMNQ------------ 239 (704)
Q Consensus 208 LV~Ey~~g~ll~~~------------------------~~~~----------~--~l~e~~~~~i~~Q------------ 239 (704)
+||||++|..+... .... . .+...++..|..|
T Consensus 121 lVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 200 (822)
T PLN02876 121 YIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPR 200 (822)
T ss_pred EEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCC
Confidence 99999998542210 0000 0 0111233222221
Q ss_pred ---hhhhHHHHHh-----------cCcccccCCCccEEEccC-C-ceEEeccccccccC
Q 005289 240 ---LLHGLEHCHS-----------RGVLHRDIKGSNLLVNNE-G-VLKLADFGLANFSN 282 (704)
Q Consensus 240 ---Il~aL~yLH~-----------~gIvHrDLKp~NILl~~~-g-~iKL~DFGla~~~~ 282 (704)
+...+.+|.. ..+||+|+++.|||++.+ + .+-|+||+++....
T Consensus 201 ~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 201 NPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN 259 (822)
T ss_pred ChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence 2223556632 249999999999999853 3 36799999987654
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.05 E-value=1e-05 Score=96.73 Aligned_cols=206 Identities=18% Similarity=0.168 Sum_probs=139.3
Q ss_pred HHHHHHHHHHHHhcCCCCceeEeEEEeecCCCe--EEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhc
Q 005289 173 VRFMAREILILRRLDHPNIIKLEGLITSRLSCS--IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250 (704)
Q Consensus 173 ~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~--~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~ 250 (704)
......|+..+.++.|+|++.++.|--.+.... +.+..++|....+..+...-..++...++.+..++++||.|+|+.
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 344456788888899999999987754432222 234456677655555556666789999999999999999999999
Q ss_pred CcccccCCCc---cEEEccCCceEEe--ccccccccCCCCCCCcccccccccccCcccccCCCCCCCc--cchhhHHHHH
Q 005289 251 GVLHRDIKGS---NLLVNNEGVLKLA--DFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS--VDLWSVGCVF 323 (704)
Q Consensus 251 gIvHrDLKp~---NILl~~~g~iKL~--DFGla~~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~--~DIWSlG~iL 323 (704)
...|.-|... +..++..+.+.+. ||+.+........ ......+..+.+||.+.. ..+..+ .|+|++|..+
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~--~~~~~~~~~~~~~e~~~~-~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK--SFSDLLAEIRNADEDLKE-NTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCccc--chhhcCcccccccccccc-ccchhhhhhHHHHHHHHH
Confidence 6666555554 4444556667766 8988876654322 223344667888887754 333333 6999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCC
Q 005289 324 AELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK 403 (704)
Q Consensus 324 yeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~k 403 (704)
..+..|..+-.- ...+..++ . ........+++.+|+.-++++
T Consensus 383 ~~~~~~~~i~~~------~~~~~~~l-----------------------------~---~~~~~~~~d~~~~~~~~~~~~ 424 (1351)
T KOG1035|consen 383 LQLSQGEDISEK------SAVPVSLL-----------------------------D---VLSTSELLDALPKCLDEDSEE 424 (1351)
T ss_pred hhhhhcCccccc------ccchhhhh-----------------------------c---cccchhhhhhhhhhcchhhhh
Confidence 999887544210 00000000 0 011126788999999999999
Q ss_pred CcCHHHHHhccccCCC
Q 005289 404 RATASAALASEYFSTK 419 (704)
Q Consensus 404 RpTa~e~L~hpwf~~~ 419 (704)
|+.+.++|.|+|.+..
T Consensus 425 Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 425 RLSALELLTHPFLRFP 440 (1351)
T ss_pred ccchhhhhhchhcccc
Confidence 9999999999999743
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.03 E-value=2.9e-05 Score=80.14 Aligned_cols=74 Identities=15% Similarity=0.108 Sum_probs=49.4
Q ss_pred EeeccCc-eEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeEEEeecCCCeEEEEEeccc
Q 005289 137 KIGQGTY-SSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNIIKLEGLITSRLSCSIYLVFEYME 214 (704)
Q Consensus 137 ~LG~G~f-g~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~~~LV~Ey~~ 214 (704)
.|-.|.+ ..||++... +..+.||+..... ...+.+|+.+|+.|. +--+.+++++... ....+||||+++
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~lv~e~i~ 75 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSD--DGRAWLLTSAVP 75 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEec--CCccEEEEEeeC
Confidence 3445555 789999753 4678888875432 234567999999883 4446667666654 345789999999
Q ss_pred ccccc
Q 005289 215 HDITG 219 (704)
Q Consensus 215 g~ll~ 219 (704)
|..+.
T Consensus 76 G~~l~ 80 (244)
T cd05150 76 GVPAA 80 (244)
T ss_pred CccHh
Confidence 85443
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.85 E-value=4e-05 Score=87.12 Aligned_cols=144 Identities=20% Similarity=0.198 Sum_probs=85.4
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEeecCC-----------------------------CChHHHHHHHHHHHHHH--
Q 005289 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDN-----------------------------FEPESVRFMAREILILR-- 184 (704)
Q Consensus 136 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~-----------------------------~~~~~~~~~~~Ei~iL~-- 184 (704)
+.||.-+.+.||+|+-+. |+.||||+-+..- +-.+..+.+..|+..++
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 579999999999999765 9999999864421 00111222333333222
Q ss_pred --------hcCCCC---ceeEeEEEeecCCCeEEEEEecccccccccccC-CCccccHHHHHHHHHHhhhhHHHHHhcCc
Q 005289 185 --------RLDHPN---IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGV 252 (704)
Q Consensus 185 --------~L~Hpn---Iv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~-~~~~l~e~~~~~i~~QIl~aL~yLH~~gI 252 (704)
.+.|-+ -|.+-.+|.+- ...-.|+||||+|.-+..+.. ....++...+...+.++..-+ |=..|+
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~-st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~q--If~~Gf 322 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL-STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQ--IFKTGF 322 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc-CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHH--HHhcCC
Confidence 223444 12233333332 234579999999943332211 122345554444333332211 224589
Q ss_pred ccccCCCccEEEcc----CCceEEeccccccccCC
Q 005289 253 LHRDIKGSNLLVNN----EGVLKLADFGLANFSNT 283 (704)
Q Consensus 253 vHrDLKp~NILl~~----~g~iKL~DFGla~~~~~ 283 (704)
+|+|-+|.|||+.. ++.+.|.|||+......
T Consensus 323 fHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 323 FHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred ccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 99999999999984 56899999999876654
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.84 E-value=6.1e-05 Score=73.30 Aligned_cols=131 Identities=21% Similarity=0.243 Sum_probs=89.3
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCcee-EeEEEeecCCCeEEEEE
Q 005289 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIK-LEGLITSRLSCSIYLVF 210 (704)
Q Consensus 132 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~-l~~~~~~~~~~~~~LV~ 210 (704)
....+.|++|++|.||++.+ .|..+|+|+-+.+. ....+..|+++|..+.-.++-. ++.|- ..++.|
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds----~r~~l~kEakiLeil~g~~~~p~vy~yg------~~~i~m 91 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDS----PRRNLEKEAKILEILAGEGVTPEVYFYG------EDFIRM 91 (201)
T ss_pred hhhhhhhhcccccEEEEeec--cCceEEEEEecCCc----chhhHHHHHHHHHHhhhcCCCceEEEec------hhhhhh
Confidence 44567899999999999987 56689999976543 3566788999999997666544 43322 224679
Q ss_pred ecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCC-CccEEEccCCceEEecccccccc
Q 005289 211 EYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIK-GSNLLVNNEGVLKLADFGLANFS 281 (704)
Q Consensus 211 Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLK-p~NILl~~~g~iKL~DFGla~~~ 281 (704)
||+.|-.+....... + +.-+..+++.---|-..||-|..|. |.-++|.+++.+.|+||.-|++.
T Consensus 92 e~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 92 EYIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 999995444432211 1 2223345555445667799999986 44444555569999999988743
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00031 Score=70.33 Aligned_cols=129 Identities=28% Similarity=0.358 Sum_probs=89.8
Q ss_pred CCeeEEEEeeccCc-eEEEEEEECCCCcEEEEEEeecC---C-------CCh---------HHHHHHHHHHHHHHhc---
Q 005289 130 DAFEKLEKIGQGTY-SSVFRARDLDTGKIVALKKVRFD---N-------FEP---------ESVRFMAREILILRRL--- 186 (704)
Q Consensus 130 ~~y~~~~~LG~G~f-g~Vy~a~~~~~g~~vAvK~i~~~---~-------~~~---------~~~~~~~~Ei~iL~~L--- 186 (704)
..++.++.||.|.- |.||+++. .|+.||||+...- . +.. ....-+..|.+...+|
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 57999999999999 99999985 6789999994321 1 000 1123356677776666
Q ss_pred CCCCc--eeEeEEEeec----------------CCCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHH
Q 005289 187 DHPNI--IKLEGLITSR----------------LSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248 (704)
Q Consensus 187 ~HpnI--v~l~~~~~~~----------------~~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH 248 (704)
.+.++ |++++++.-. .....-||.||+.... .++... +.+|++-|..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~----~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD----IPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----HHHHHHHHHHHH
Confidence 45566 9999987311 0112356777766533 223333 347778888999
Q ss_pred hcCcccccCCCccEEEccCCceEEeccccc
Q 005289 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278 (704)
Q Consensus 249 ~~gIvHrDLKp~NILl~~~g~iKL~DFGla 278 (704)
..||+-+|+++.|.. .=||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999985 4589999864
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00013 Score=75.07 Aligned_cols=74 Identities=15% Similarity=0.123 Sum_probs=44.0
Q ss_pred EEeeccCce-EEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCC---CceeEeEEEeecC-CCeEEEEE
Q 005289 136 EKIGQGTYS-SVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP---NIIKLEGLITSRL-SCSIYLVF 210 (704)
Q Consensus 136 ~~LG~G~fg-~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hp---nIv~l~~~~~~~~-~~~~~LV~ 210 (704)
..|+.|+.. .||+.. ..+++|+.... .....+.+|+++|..|... -+.+++....... ....|+||
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~ 73 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSAA----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVY 73 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCcc----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEE
Confidence 567777776 499862 24677875431 1234678899999888532 3444443332211 12458899
Q ss_pred eccccccc
Q 005289 211 EYMEHDIT 218 (704)
Q Consensus 211 Ey~~g~ll 218 (704)
++++|..+
T Consensus 74 ~~i~G~~l 81 (235)
T cd05155 74 RWLEGETA 81 (235)
T ss_pred EeecCCCC
Confidence 99998443
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.62 E-value=2.8e-06 Score=102.94 Aligned_cols=256 Identities=14% Similarity=0.015 Sum_probs=164.3
Q ss_pred cCCeeEEEEeeccCceEE-EEEEECCCCcEEEEEEee---cCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCC
Q 005289 129 ADAFEKLEKIGQGTYSSV-FRARDLDTGKIVALKKVR---FDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V-y~a~~~~~g~~vAvK~i~---~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 204 (704)
...|++.--++-+.++.- |+.. +. ..+.+|+.. ..++.+...+.+..|..-++...|+++.....-.......
T Consensus 1228 ~e~~EV~l~i~~~~~~R~k~Lr~-ki--d~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ 1304 (2724)
T KOG1826|consen 1228 MEHSEVNLGISNHFHFRNKWLRS-KI--DWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSEST 1304 (2724)
T ss_pred hhhhheeeecccceeeccchHhh-hh--ceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCCh
Confidence 445666655665555432 2221 11 124455543 2333344455566677778888999988876666555556
Q ss_pred eEEEEEecccccccc-cccC---CCccccHHHHHHHHHHhhhhHHHHHhc-----CcccccCCCccEEEccCCceEEecc
Q 005289 205 SIYLVFEYMEHDITG-LLSC---PDIKFSEAQIKCYMNQLLHGLEHCHSR-----GVLHRDIKGSNLLVNNEGVLKLADF 275 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~-~~~~---~~~~l~e~~~~~i~~QIl~aL~yLH~~-----gIvHrDLKp~NILl~~~g~iKL~DF 275 (704)
..|.+++|+.++.+. .+.. ....+.+.-+....++.+.+..-+|+. -.+|++||+-|.+|..+.++|+.++
T Consensus 1305 ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~ 1384 (2724)
T KOG1826|consen 1305 EEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKG 1384 (2724)
T ss_pred HHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccccccc
Confidence 678999999875544 3332 233455556666666768888888865 2799999999999999999999999
Q ss_pred ccccccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCch
Q 005289 276 GLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 355 (704)
Q Consensus 276 Gla~~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~ 355 (704)
|+.+...+ ........++++.|+.|++... ..++.++|+|..+|.+|++.-|.++|- ..++.+.+ |..
T Consensus 1385 gLdKIknp-~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s~~ly~rs~~n~~fi-----~flq~~Lk--gii--- 1452 (2724)
T KOG1826|consen 1385 GLDKIKNP-VLSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRSLSLYLRSDGNAYFI-----FFLQPALK--GII--- 1452 (2724)
T ss_pred ccccccCc-hHhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHHHHHHHHhcccHHHH-----HHHHHHHc--Ccc---
Confidence 99983332 2233455677899999997654 567888999999999999999887763 22222222 111
Q ss_pred hhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccC
Q 005289 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417 (704)
Q Consensus 356 ~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~ 417 (704)
.+.+.+. .-.-.|.++-.+...+|-+.-..||.-...+.-+.|-
T Consensus 1453 -------dn~tf~s-----------Ie~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1453 -------DNHTFFS-----------IEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred -------ccccccc-----------ccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 0111111 1112344455556666667777888888888777664
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00055 Score=70.06 Aligned_cols=74 Identities=15% Similarity=0.200 Sum_probs=46.9
Q ss_pred EEEeeccCceEEEEEEECC-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC-CCceeEeEEEeecCCCeEEEEEec
Q 005289 135 LEKIGQGTYSSVFRARDLD-TGKIVALKKVRFDNFEPESVRFMAREILILRRLDH-PNIIKLEGLITSRLSCSIYLVFEY 212 (704)
Q Consensus 135 ~~~LG~G~fg~Vy~a~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~H-pnIv~l~~~~~~~~~~~~~LV~Ey 212 (704)
++.|..|-...||++.... .++.|++|+..... ...-...+|+.+++.+.. .-.++++..+.. .+||||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~---~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~------~~l~e~ 73 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT---ELIIDRERELRIHKLLSKHGLAPKLYATFQN------GLIYEF 73 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCc---cceecHHHHHHHHHHHHhCCCCCeEEEEeCC------cEEEEe
Confidence 4677888888999997543 35678899765321 111123479999998843 334455443321 379999
Q ss_pred ccccc
Q 005289 213 MEHDI 217 (704)
Q Consensus 213 ~~g~l 217 (704)
++|..
T Consensus 74 i~G~~ 78 (235)
T cd05157 74 IPGRT 78 (235)
T ss_pred eCCCc
Confidence 98843
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00023 Score=70.95 Aligned_cols=98 Identities=26% Similarity=0.194 Sum_probs=77.2
Q ss_pred HHHHHHHhcCC-CCceeEeEEEeecCCCeEEEEEecccccccc-cc--cCCCccccHHHHHHHHHHhhhhHHHHHh---c
Q 005289 178 REILILRRLDH-PNIIKLEGLITSRLSCSIYLVFEYMEHDITG-LL--SCPDIKFSEAQIKCYMNQLLHGLEHCHS---R 250 (704)
Q Consensus 178 ~Ei~iL~~L~H-pnIv~l~~~~~~~~~~~~~LV~Ey~~g~ll~-~~--~~~~~~l~e~~~~~i~~QIl~aL~yLH~---~ 250 (704)
.|.-+|+.|.+ +++++++|+|-. ++|.||.....+. .. ...-...++.....|+.+++..+.+|+. .
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~------~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR------FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC------EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 58889999966 699999998833 5788999864222 10 0111235789999999999999999997 3
Q ss_pred CcccccCCCccEEEccCCceEEecccccccc
Q 005289 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (704)
Q Consensus 251 gIvHrDLKp~NILl~~~g~iKL~DFGla~~~ 281 (704)
.+.-.|++++||-|++++++|++|...+...
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 5788999999999999999999999987544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00039 Score=72.44 Aligned_cols=132 Identities=23% Similarity=0.219 Sum_probs=75.3
Q ss_pred eeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCc-eeEeEEEeecCCCeEEEEEeccccc
Q 005289 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI-IKLEGLITSRLSCSIYLVFEYMEHD 216 (704)
Q Consensus 138 LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-v~l~~~~~~~~~~~~~LV~Ey~~g~ 216 (704)
|..|-...+|+.. .+++.+++|+........ . -...+|..+|+.+..-.+ .+++.+.. -++||||++|.
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~-~-~~r~~E~~~l~~l~~~g~~P~~i~~~~------~~~v~e~i~G~ 73 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL-G-VDRQREYQILQALSALGLAPKPILVNE------HWLLVEWLEGE 73 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccccc-c-CcHHHHHHHHHHHHhcCCCCceEEEeC------CEEEEEeccCc
Confidence 4567778899887 356678888754321110 0 124679999998854333 34443321 26899999985
Q ss_pred ccccc------------------cC---CCccccH-HHHHHHHHHhh---------hhHHHHHh--------cCcccccC
Q 005289 217 ITGLL------------------SC---PDIKFSE-AQIKCYMNQLL---------HGLEHCHS--------RGVLHRDI 257 (704)
Q Consensus 217 ll~~~------------------~~---~~~~l~e-~~~~~i~~QIl---------~aL~yLH~--------~gIvHrDL 257 (704)
.+... .. ....++. ..+..+..++. ..+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 43321 00 0111111 12223322221 11111211 25899999
Q ss_pred CCccEEEccCCceEEeccccccc
Q 005289 258 KGSNLLVNNEGVLKLADFGLANF 280 (704)
Q Consensus 258 Kp~NILl~~~g~iKL~DFGla~~ 280 (704)
.|.|||+++++ +.|+||..+..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999999877 78999998754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.51 E-value=7.9e-05 Score=78.67 Aligned_cols=135 Identities=17% Similarity=0.218 Sum_probs=93.0
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC---------------hH-----HHHHHHHHHHHHHhc-CCC
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE---------------PE-----SVRFMAREILILRRL-DHP 189 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~---------------~~-----~~~~~~~Ei~iL~~L-~Hp 189 (704)
-+.+.++||-|--+.||.+-+ ..|++.++|+-+..... .. +.-...+|...|+.| .|-
T Consensus 93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 377889999999999999986 45888999964321110 00 011234699999988 343
Q ss_pred C-ceeEeEEEeecCCCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCC
Q 005289 190 N-IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG 268 (704)
Q Consensus 190 n-Iv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g 268 (704)
+ +++.+++ +..|+|||++.+-.+..+..- ..+..+...|+.-|--|-.+|+||+|+.--||+|++++
T Consensus 172 fpVPkpiD~------~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~ 239 (465)
T KOG2268|consen 172 FPVPKPIDH------NRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDD 239 (465)
T ss_pred CCCCCcccc------cceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCC
Confidence 3 3344433 345899999998554443311 12233444555566778899999999999999999999
Q ss_pred ceEEeccccc
Q 005289 269 VLKLADFGLA 278 (704)
Q Consensus 269 ~iKL~DFGla 278 (704)
.+++|||-.+
T Consensus 240 ~i~vIDFPQm 249 (465)
T KOG2268|consen 240 KIVVIDFPQM 249 (465)
T ss_pred CEEEeechHh
Confidence 9999999654
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0017 Score=71.99 Aligned_cols=78 Identities=23% Similarity=0.190 Sum_probs=53.4
Q ss_pred EEEEeeccCceEEEEEEECCCCcEEEEEEeecCC-C--C--hHHHHHHHHHHHHHHhcC---CCCceeEeEEEeecCCCe
Q 005289 134 KLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN-F--E--PESVRFMAREILILRRLD---HPNIIKLEGLITSRLSCS 205 (704)
Q Consensus 134 ~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~-~--~--~~~~~~~~~Ei~iL~~L~---HpnIv~l~~~~~~~~~~~ 205 (704)
..+.||.|.+..||++.....++.|+||.-.... . . +-..+....|.++|+.+. -.++++++.+.. ..
T Consensus 30 ~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~----~~ 105 (401)
T PRK09550 30 TAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE----EL 105 (401)
T ss_pred eeeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC----CC
Confidence 3578999999999999986443589999853110 0 0 123455677888888872 346777766532 34
Q ss_pred EEEEEecccc
Q 005289 206 IYLVFEYMEH 215 (704)
Q Consensus 206 ~~LV~Ey~~g 215 (704)
.+|||||+++
T Consensus 106 ~~lVME~L~~ 115 (401)
T PRK09550 106 AVTVMEDLSD 115 (401)
T ss_pred CEEEEecCCC
Confidence 6899999875
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0014 Score=65.75 Aligned_cols=129 Identities=19% Similarity=0.228 Sum_probs=86.8
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEeecCC--------------CChHHHHHHHHHHHHHHhcC------CCCceeEe
Q 005289 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDN--------------FEPESVRFMAREILILRRLD------HPNIIKLE 195 (704)
Q Consensus 136 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~--------------~~~~~~~~~~~Ei~iL~~L~------HpnIv~l~ 195 (704)
..||.|+.=.||.-- .....+||++.... ......+...+|+.....+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 578999999898753 34557899987665 11122344566776666665 78999999
Q ss_pred EEEeecCCCeEEEEEeccccc------ccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCC-
Q 005289 196 GLITSRLSCSIYLVFEYMEHD------ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG- 268 (704)
Q Consensus 196 ~~~~~~~~~~~~LV~Ey~~g~------ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g- 268 (704)
|+.+. +..+-+|+|.+... .+..+.. ...+++ .+.. .|-.-..||-+++|+.+||+|.||++....
T Consensus 84 G~veT--~~G~Glv~e~I~d~dG~~s~TL~~~l~-~~~~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 84 GFVET--NLGLGLVVELIRDADGNISPTLEDYLK-EGGLTE-ELRQ---ALDEFKRYLLDHHIVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred EEEec--CCceEEEEEEEECCCCCcCccHHHHHH-cCCccH-HHHH---HHHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence 99987 45567888887641 1222222 223444 3333 344456788899999999999999996543
Q ss_pred ---ceEEec
Q 005289 269 ---VLKLAD 274 (704)
Q Consensus 269 ---~iKL~D 274 (704)
.+.|+|
T Consensus 157 ~~~~lvlID 165 (199)
T PF10707_consen 157 GEFRLVLID 165 (199)
T ss_pred CceEEEEEe
Confidence 578887
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0014 Score=69.51 Aligned_cols=140 Identities=16% Similarity=0.129 Sum_probs=82.3
Q ss_pred eEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCC--CceeEeEEEe----ecCCCeE
Q 005289 133 EKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP--NIIKLEGLIT----SRLSCSI 206 (704)
Q Consensus 133 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hp--nIv~l~~~~~----~~~~~~~ 206 (704)
.-++.|..|....+|++.. .+..++||+.... ....+..|+.++..|.+- .+++++.... ....+..
T Consensus 17 ~~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~-----~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~ 89 (296)
T cd05153 17 LSFEGISAGIENTNYFVTT--DSGRYVLTLFEKV-----SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP 89 (296)
T ss_pred hheecccCccccceEEEEe--CCCcEEEEEcCCC-----ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence 3467788888889999864 3446889987531 134466788888888432 2444433110 0113456
Q ss_pred EEEEeccccccccccc---------------C--CC--c-----c-cc--HHHHH--------HHHHHhhhhHHHHHh--
Q 005289 207 YLVFEYMEHDITGLLS---------------C--PD--I-----K-FS--EAQIK--------CYMNQLLHGLEHCHS-- 249 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~---------------~--~~--~-----~-l~--e~~~~--------~i~~QIl~aL~yLH~-- 249 (704)
++||+|++|..+.... . .. . . .. ..... .....+..++.++..
T Consensus 90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~ 169 (296)
T cd05153 90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD 169 (296)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence 8999999985433210 0 00 0 0 00 00000 011112233444443
Q ss_pred -----cCcccccCCCccEEEccCCceEEecccccc
Q 005289 250 -----RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 279 (704)
Q Consensus 250 -----~gIvHrDLKp~NILl~~~g~iKL~DFGla~ 279 (704)
.++||+|+.|.|||+++++.+.|+||+.+.
T Consensus 170 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 170 PSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 379999999999999998778999999764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0015 Score=69.63 Aligned_cols=74 Identities=23% Similarity=0.268 Sum_probs=46.9
Q ss_pred EEEeeccCceEEEEEEECC------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCC-ceeEeEEEeecCCCeEE
Q 005289 135 LEKIGQGTYSSVFRARDLD------TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPN-IIKLEGLITSRLSCSIY 207 (704)
Q Consensus 135 ~~~LG~G~fg~Vy~a~~~~------~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hpn-Iv~l~~~~~~~~~~~~~ 207 (704)
++.|..|-...||++.... +++.|++|+..... .......+|+.++..+.... ..+++.++.. .
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~------~ 73 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIFPN------G 73 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEeCC------C
Confidence 4566667777999987543 25789999965432 12234567998998884332 3455555432 2
Q ss_pred EEEecccccc
Q 005289 208 LVFEYMEHDI 217 (704)
Q Consensus 208 LV~Ey~~g~l 217 (704)
+|+||++|..
T Consensus 74 ~v~e~i~G~~ 83 (302)
T cd05156 74 RIEEFIPSRT 83 (302)
T ss_pred chhheeCCCc
Confidence 5899988743
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0043 Score=66.39 Aligned_cols=79 Identities=16% Similarity=0.168 Sum_probs=54.9
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC---CCceeEeEEEeec-CCCeEE
Q 005289 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH---PNIIKLEGLITSR-LSCSIY 207 (704)
Q Consensus 132 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~H---pnIv~l~~~~~~~-~~~~~~ 207 (704)
..-.+.||.|..+.||..... ++ .+.+|..+ ... ....+..|...|+.|.- -.++++++++... ..+..+
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~-~~~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~ 89 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDS-QG-NPMPLMAR-SFS---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV 89 (297)
T ss_pred hheeeecCCccceeEEEEEcC-CC-CEEEEEec-ccc---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence 455678999999999999642 23 46677743 211 12467789999998843 4678888777542 234579
Q ss_pred EEEeccccc
Q 005289 208 LVFEYMEHD 216 (704)
Q Consensus 208 LV~Ey~~g~ 216 (704)
||||++++.
T Consensus 90 LVmE~i~G~ 98 (297)
T PRK10593 90 LLLERLRGV 98 (297)
T ss_pred EEEeccCCE
Confidence 999999874
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0033 Score=67.53 Aligned_cols=139 Identities=17% Similarity=0.185 Sum_probs=74.5
Q ss_pred EEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCC--ceeEeEE----EeecCCCeEE
Q 005289 134 KLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPN--IIKLEGL----ITSRLSCSIY 207 (704)
Q Consensus 134 ~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hpn--Iv~l~~~----~~~~~~~~~~ 207 (704)
-++.|..|...++|++... .| .++||++. .... ..+..|+.++..|.... +.+++.. ......+..+
T Consensus 26 ~~~~l~~G~~n~~y~v~t~-~g-~~vLK~~~--~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~ 98 (319)
T PRK05231 26 SLKGIAEGIENSNFFLTTT-QG-EYVLTLFE--RLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA 98 (319)
T ss_pred ccchhccccccceEEEEeC-CC-cEEEEEec--cCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence 3566778888899998742 33 68899875 2222 23344666666663211 3333221 0011134578
Q ss_pred EEEecccccccccc---------------cCCCccc--------c--H-HH-H-----------HHHHHHhh-hhHHHHH
Q 005289 208 LVFEYMEHDITGLL---------------SCPDIKF--------S--E-AQ-I-----------KCYMNQLL-HGLEHCH 248 (704)
Q Consensus 208 LV~Ey~~g~ll~~~---------------~~~~~~l--------~--e-~~-~-----------~~i~~QIl-~aL~yLH 248 (704)
++|+|++|...... ......+ . . .. + ...+.+.+ ..+..+.
T Consensus 99 ~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 178 (319)
T PRK05231 99 AIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLA 178 (319)
T ss_pred EEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhh
Confidence 99999998532110 0000000 0 0 00 0 01111111 1122222
Q ss_pred -------hcCcccccCCCccEEEccCCceEEecccccc
Q 005289 249 -------SRGVLHRDIKGSNLLVNNEGVLKLADFGLAN 279 (704)
Q Consensus 249 -------~~gIvHrDLKp~NILl~~~g~iKL~DFGla~ 279 (704)
..++||+|++|.|||++.+...-|+||+.+.
T Consensus 179 ~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 179 SAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 2389999999999999976666899999874
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0024 Score=68.85 Aligned_cols=141 Identities=21% Similarity=0.278 Sum_probs=96.8
Q ss_pred EEEEeeccCceEEEEEEECCCCcEEEEEEeecCC----------------------CCh-HHHH-HHHHHHHHHHhcCCC
Q 005289 134 KLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN----------------------FEP-ESVR-FMAREILILRRLDHP 189 (704)
Q Consensus 134 ~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~----------------------~~~-~~~~-~~~~Ei~iL~~L~Hp 189 (704)
+-.+|..|--+.||.|.. .+|..+|||+++..- .++ ..++ ....|+.-|.+|...
T Consensus 148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 345678899999999984 568889999864321 011 1111 233588888888655
Q ss_pred CceeEeEEEeecCCCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHH-hcCcccccCCCccEEEccCC
Q 005289 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH-SRGVLHRDIKGSNLLVNNEG 268 (704)
Q Consensus 190 nIv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH-~~gIvHrDLKp~NILl~~~g 268 (704)
.|.----+.. ..-.|||+|++.+-.-.-.-....++...+..+-.|++.-+.-|- .+++||.||.--|+|+- +|
T Consensus 227 GIP~PePIlL----k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG 301 (520)
T KOG2270|consen 227 GIPCPEPILL----KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DG 301 (520)
T ss_pred CCCCCCceee----ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CC
Confidence 5432211111 223699999986433322334556888889888888888887775 56999999999999986 48
Q ss_pred ceEEeccccccc
Q 005289 269 VLKLADFGLANF 280 (704)
Q Consensus 269 ~iKL~DFGla~~ 280 (704)
.+.|||.+.+..
T Consensus 302 ~lyiIDVSQSVE 313 (520)
T KOG2270|consen 302 KLYIIDVSQSVE 313 (520)
T ss_pred EEEEEEcccccc
Confidence 999999987753
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.002 Score=69.02 Aligned_cols=143 Identities=19% Similarity=0.180 Sum_probs=81.9
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCC--ceeEeEEEe----ecCCC
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPN--IIKLEGLIT----SRLSC 204 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hpn--Iv~l~~~~~----~~~~~ 204 (704)
....++.|+.|....||++.. .++ .+++|+..... . ...+..|++++..|.... +++++.... ....+
T Consensus 23 ~~~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~-~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g 96 (307)
T TIGR00938 23 ELLSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV-K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAG 96 (307)
T ss_pred CceeccccCCccccceEEEEe-CCC-cEEEEEecCCC-C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCC
Confidence 345577788888889999864 334 57789875421 1 233456778887774222 344433211 11135
Q ss_pred eEEEEEecccccccccc---------------cC--CCc--------cccH-HH--HH----------HHHHHhhhhHHH
Q 005289 205 SIYLVFEYMEHDITGLL---------------SC--PDI--------KFSE-AQ--IK----------CYMNQLLHGLEH 246 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~---------------~~--~~~--------~l~e-~~--~~----------~i~~QIl~aL~y 246 (704)
..++||+|++|...... .. ... .+.. .. .. .....+...+++
T Consensus 97 ~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 176 (307)
T TIGR00938 97 KPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDY 176 (307)
T ss_pred eEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHH
Confidence 67899999987432210 00 000 0000 00 00 001112234555
Q ss_pred HHh-------cCcccccCCCccEEEccCCceEEecccccc
Q 005289 247 CHS-------RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 279 (704)
Q Consensus 247 LH~-------~gIvHrDLKp~NILl~~~g~iKL~DFGla~ 279 (704)
+.. .++||+|+++.||+++.++.+.|+||+.+.
T Consensus 177 l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 177 LDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 532 589999999999999988877899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0067 Score=65.22 Aligned_cols=150 Identities=19% Similarity=0.231 Sum_probs=86.0
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC--CCceeEeEEEeecCCCeEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH--PNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~H--pnIv~l~~~~~~~~~~~~~L 208 (704)
...++..+-.|.--.+|...+ +++.++|. ...............+|..+|+.+.- .-+...+++|.+..-...|.
T Consensus 26 ~~~~v~~~~~G~sn~t~~~~~--~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~ 102 (321)
T COG3173 26 GLLIVEEISGGWSNDTFRLGD--TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFY 102 (321)
T ss_pred CCceeeeccCCcccceEEEec--CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceE
Confidence 345556664454444555554 37788888 43222223445667789999988843 22334455565432245689
Q ss_pred EEecccccccccccCCCc--------------------------------cccHHHHHHHHHHh--------------hh
Q 005289 209 VFEYMEHDITGLLSCPDI--------------------------------KFSEAQIKCYMNQL--------------LH 242 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~--------------------------------~l~e~~~~~i~~QI--------------l~ 242 (704)
||+|++|........... .+...++..+..+. ..
T Consensus 103 v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~ 182 (321)
T COG3173 103 VMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADR 182 (321)
T ss_pred EEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHH
Confidence 999999842221110000 00111111111111 12
Q ss_pred hHHHHHhc--------CcccccCCCccEEEccCCceEEeccccccccCC
Q 005289 243 GLEHCHSR--------GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (704)
Q Consensus 243 aL~yLH~~--------gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~ 283 (704)
-..||+.+ .++|+|+++.||||++.+.+=|+||+++....+
T Consensus 183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred HHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 23444433 489999999999999999999999999976543
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.0027 Score=70.91 Aligned_cols=171 Identities=21% Similarity=0.332 Sum_probs=110.1
Q ss_pred HHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccc
Q 005289 176 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHR 255 (704)
Q Consensus 176 ~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHr 255 (704)
+.--..+|+.+.|+|+...+++-.... ....+|||+++-++-+.+.... +- +. +++ .+++.|-
T Consensus 29 ilgr~~~lktl~~~~l~~yl~~~r~~~-~r~IVV~e~~~~Sled~~~~~~--l~---~~----s~~-------~~~~~~~ 91 (725)
T KOG1093|consen 29 ILGRFQYLKSLQHDNLCQYLDFSRGKH-ERVIVVMEHYTMSLEDILKTGN--LK---DE----SLL-------AHGVLHL 91 (725)
T ss_pred HhhhhHHHHhhcCccceeeEeeecCcc-ceEEEEehhhccchHHHHHhcc--cc---hh----hhc-------cccccee
Confidence 444678899999999999988876653 4588999999876555443221 00 00 111 2222221
Q ss_pred cCCCccEEEccCCceEEeccccccccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 005289 256 DIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 335 (704)
Q Consensus 256 DLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~ 335 (704)
+.++++| -++ +. | |- ..++++||||+|.|+.++.-|...+..
T Consensus 92 ------------~~~~~td-~~~------------t~-----~--~~------~~~pKsdVwsl~~i~~el~L~~~l~~~ 133 (725)
T KOG1093|consen 92 ------------NIIYITD-HFL------------TK-----Y--PS------PIGPKSDVWSLGFIILELYLGISLEAE 133 (725)
T ss_pred ------------hhhhccc-ccc------------cc-----C--CC------CCCcchhhhhHHHHHHHHHHhhHHHHH
Confidence 1233333 000 00 1 11 122599999999999999999999999
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccc
Q 005289 336 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415 (704)
Q Consensus 336 ~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpw 415 (704)
.++.+++..|.+....+-... ....-......++....+++.+|+...|..||...++++++-
T Consensus 134 ~~~s~~l~~i~k~~~~d~~~~-----------------~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i 196 (725)
T KOG1093|consen 134 LTESEYLEILLKYYTDDQELL-----------------STAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCS 196 (725)
T ss_pred HHHHHHHHHHHHhccCchhHH-----------------HHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCcc
Confidence 888888888877532221100 000011222456778899999999999999999999999988
Q ss_pred cCC
Q 005289 416 FST 418 (704)
Q Consensus 416 f~~ 418 (704)
|.+
T Consensus 197 ~~e 199 (725)
T KOG1093|consen 197 FTE 199 (725)
T ss_pred HHH
Confidence 875
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.018 Score=61.00 Aligned_cols=31 Identities=19% Similarity=0.394 Sum_probs=26.0
Q ss_pred CcccccCCCccEEEccCCc-eEEecccccccc
Q 005289 251 GVLHRDIKGSNLLVNNEGV-LKLADFGLANFS 281 (704)
Q Consensus 251 gIvHrDLKp~NILl~~~g~-iKL~DFGla~~~ 281 (704)
.++|+|++|.|||+++++. .-|+||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 4899999999999997555 569999988644
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.023 Score=61.70 Aligned_cols=147 Identities=18% Similarity=0.229 Sum_probs=81.1
Q ss_pred CccccccCCeeEEEEeeccCceEEEEEEECCC---CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCc-eeEeEEE
Q 005289 123 GWVPLRADAFEKLEKIGQGTYSSVFRARDLDT---GKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI-IKLEGLI 198 (704)
Q Consensus 123 ~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-v~l~~~~ 198 (704)
+|..+..+..++.. |..|-...+|++..... +..|++|+..... . ..-...+|+.+++.+..-+| +++++++
T Consensus 8 ~w~~~~~~~i~i~~-l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t--~-~~IdR~~E~~il~~l~~~gl~P~~l~~~ 83 (330)
T PLN02421 8 GWSDLDDSDFSVER-ISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT--D-YVIDRERELQAIKYLSAAGFGAKLLGVF 83 (330)
T ss_pred ccccCCcCceEEEE-eCCcccceEEEEEecCCCCCCceEEEEEecCCc--C-eEechHHHHHHHHHHHhcCCCCceeEEe
Confidence 34433344455544 44477788999875432 2378899875422 1 11123469999998855444 4555555
Q ss_pred eecCCCeEEEEEecccccccccc------------------cCCC---c-cc-cHHHHHHHHHHhh--------------
Q 005289 199 TSRLSCSIYLVFEYMEHDITGLL------------------SCPD---I-KF-SEAQIKCYMNQLL-------------- 241 (704)
Q Consensus 199 ~~~~~~~~~LV~Ey~~g~ll~~~------------------~~~~---~-~l-~e~~~~~i~~QIl-------------- 241 (704)
.. . +|.+|+++..+... .... . .+ ....+..++.++-
T Consensus 84 ~~---G---~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~ 157 (330)
T PLN02421 84 GN---G---MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYE 157 (330)
T ss_pred CC---c---EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhc
Confidence 22 2 58889877433210 0000 0 01 1222333332221
Q ss_pred --------hhHHH----HHhc----CcccccCCCccEEEcc-CCceEEecccccc
Q 005289 242 --------HGLEH----CHSR----GVLHRDIKGSNLLVNN-EGVLKLADFGLAN 279 (704)
Q Consensus 242 --------~aL~y----LH~~----gIvHrDLKp~NILl~~-~g~iKL~DFGla~ 279 (704)
.-+.. +... -++|.||.+.|||+++ ++.++|+||..|.
T Consensus 158 ~~~~~~l~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 158 TISFEELRDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred ccCHHHHHHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 11111 1111 2799999999999975 4789999999774
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.021 Score=60.86 Aligned_cols=29 Identities=28% Similarity=0.509 Sum_probs=25.6
Q ss_pred cCcccccCCCccEEEccCCceEEecccccc
Q 005289 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 279 (704)
Q Consensus 250 ~gIvHrDLKp~NILl~~~g~iKL~DFGla~ 279 (704)
.++||+|+.+.|||++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47999999999999987 678999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.029 Score=61.29 Aligned_cols=140 Identities=12% Similarity=0.168 Sum_probs=80.2
Q ss_pred eeEEEEeeccCceEEEEEEECC----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCc-eeEeEEEeecCCCeE
Q 005289 132 FEKLEKIGQGTYSSVFRARDLD----TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI-IKLEGLITSRLSCSI 206 (704)
Q Consensus 132 y~~~~~LG~G~fg~Vy~a~~~~----~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-v~l~~~~~~~~~~~~ 206 (704)
..-+..|-.|-.-.+|++.... .++.|++|+..... .. .-...+|+.+++.+..-+| .++++.+.. +
T Consensus 38 ~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~-~idR~~E~~~~~~l~~~gl~P~~~~~~~~--g--- 109 (344)
T PLN02236 38 ALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--EL-FFDRDDEIRTFECMSRHGQGPRLLGRFPN--G--- 109 (344)
T ss_pred cEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--Ce-eechHHHHHHHHHHHHcCCCCceEEEECC--c---
Confidence 4444566668888999987432 24678999875432 11 1123569999998854333 455555532 2
Q ss_pred EEEEecccccccccc--c----------------C---CCc--cccHHHHHHHHHHhh-----------------hhHHH
Q 005289 207 YLVFEYMEHDITGLL--S----------------C---PDI--KFSEAQIKCYMNQLL-----------------HGLEH 246 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~--~----------------~---~~~--~l~e~~~~~i~~QIl-----------------~aL~y 246 (704)
.|++|+++..+... . . +.. ......+..++.++. ..+..
T Consensus 110 -~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~ 188 (344)
T PLN02236 110 -RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINL 188 (344)
T ss_pred -eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHH
Confidence 57899877433211 0 0 000 111223333332221 11111
Q ss_pred H----H----hcCcccccCCCccEEEcc-CCceEEeccccccc
Q 005289 247 C----H----SRGVLHRDIKGSNLLVNN-EGVLKLADFGLANF 280 (704)
Q Consensus 247 L----H----~~gIvHrDLKp~NILl~~-~g~iKL~DFGla~~ 280 (704)
| . ...++|+||++.|||+++ ++.+.|+||..+..
T Consensus 189 L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 189 LEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1 1 236899999999999986 46899999988753
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.36 E-value=0.014 Score=63.69 Aligned_cols=74 Identities=19% Similarity=0.252 Sum_probs=47.6
Q ss_pred EeeccCceEEEEEEECCCCcEEEEEEeec------CCCChHHHHHHHHHHHHHHhcC--CC-CceeEeEEEeecCCCeEE
Q 005289 137 KIGQGTYSSVFRARDLDTGKIVALKKVRF------DNFEPESVRFMAREILILRRLD--HP-NIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 137 ~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~------~~~~~~~~~~~~~Ei~iL~~L~--Hp-nIv~l~~~~~~~~~~~~~ 207 (704)
.||.|....||++.+...++.|+||.-.. ..+ +-...+...|..+|+.+. -| .+++++.+- .....
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~w-pl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D----~e~~~ 76 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESW-PLTLDRARIESSALIRQGEHVPHLVPRIFHFD----TEMAV 76 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCC-CCCccHHHHHHHHHHHhhccCccccCeEEEEc----cccce
Confidence 57999999999999754446899997421 111 222344556888887763 34 455664432 23456
Q ss_pred EEEecccc
Q 005289 208 LVFEYMEH 215 (704)
Q Consensus 208 LV~Ey~~g 215 (704)
+|||+++.
T Consensus 77 ~vMEdL~~ 84 (370)
T TIGR01767 77 TVMEDLSH 84 (370)
T ss_pred ehHhhCcc
Confidence 99999864
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.055 Score=60.17 Aligned_cols=76 Identities=13% Similarity=0.093 Sum_probs=51.2
Q ss_pred EEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-Ch----HHHHHHHHHHHHHHhcC---CCCceeEeEEEeecCCCe
Q 005289 134 KLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EP----ESVRFMAREILILRRLD---HPNIIKLEGLITSRLSCS 205 (704)
Q Consensus 134 ~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~----~~~~~~~~Ei~iL~~L~---HpnIv~l~~~~~~~~~~~ 205 (704)
..+.||.|....||++.+. +..|+||.-..... .. ........|+..|+.+. ..++++++.++.+ .
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded----~ 109 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT----M 109 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC----C
Confidence 4788999999999999863 45688997541110 00 12344455777777663 3578888877754 3
Q ss_pred EEEEEecccc
Q 005289 206 IYLVFEYMEH 215 (704)
Q Consensus 206 ~~LV~Ey~~g 215 (704)
.+||||++++
T Consensus 110 ~vlvME~L~~ 119 (418)
T PLN02756 110 ALIGMRYLEP 119 (418)
T ss_pred CEEEEeecCC
Confidence 5789999976
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.03 E-value=0.023 Score=62.83 Aligned_cols=76 Identities=25% Similarity=0.253 Sum_probs=50.3
Q ss_pred EEEeeccCceEEEEEEECCCCcEEEEEEeec-----CCCChHHHHHHHHHHHHHHhcC--CC-CceeEeEEEeecCCCeE
Q 005289 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRF-----DNFEPESVRFMAREILILRRLD--HP-NIIKLEGLITSRLSCSI 206 (704)
Q Consensus 135 ~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~-----~~~~~~~~~~~~~Ei~iL~~L~--Hp-nIv~l~~~~~~~~~~~~ 206 (704)
++.||.|.-..||++.+...++.|+||.-.. ..+ +-..++...|.++|+.+. -| ++++++.+ + ....
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~sw-pL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D--~e~~ 108 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEF-KLSTNRIRIESDVLQLEEELAPGLVPKVYLF--D--SVMN 108 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCC-CCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--C--cHHh
Confidence 7889999999999999743356799997421 111 223455566888888773 34 56666443 2 2345
Q ss_pred EEEEecccc
Q 005289 207 YLVFEYMEH 215 (704)
Q Consensus 207 ~LV~Ey~~g 215 (704)
.+|||+++.
T Consensus 109 ~~vMEdL~~ 117 (409)
T PRK12396 109 CCVMEDLSD 117 (409)
T ss_pred hHHHHhCcc
Confidence 689998863
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.81 E-value=0.043 Score=55.32 Aligned_cols=29 Identities=38% Similarity=0.647 Sum_probs=20.9
Q ss_pred CcccccCCCccEEE-ccCCceEEecccccc
Q 005289 251 GVLHRDIKGSNLLV-NNEGVLKLADFGLAN 279 (704)
Q Consensus 251 gIvHrDLKp~NILl-~~~g~iKL~DFGla~ 279 (704)
-++|.||.|.|||+ +.++.++|+||..|.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 58999999999999 888999999998774
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.42 E-value=0.12 Score=54.92 Aligned_cols=76 Identities=16% Similarity=0.194 Sum_probs=45.8
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC---CCCceeEeEEEeecCCCeEEE
Q 005289 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD---HPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 132 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~---HpnIv~l~~~~~~~~~~~~~L 208 (704)
.+-.+.|+.|....+|+.. .+++.+.||+-... ....+..|..-|+.|. --.+++++.+.... ..-||
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~-----~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~--~~~fL 89 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSES-----GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD--DDAFL 89 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG-----GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S--SCCEE
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecChh-----hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec--CCceE
Confidence 4566789999999999987 57788999997632 2345667888888773 34567777766543 34489
Q ss_pred EEeccccc
Q 005289 209 VFEYMEHD 216 (704)
Q Consensus 209 V~Ey~~g~ 216 (704)
||||++.+
T Consensus 90 lle~l~~~ 97 (288)
T PF03881_consen 90 LLEFLEMG 97 (288)
T ss_dssp EEE-----
T ss_pred EEEeecCC
Confidence 99998754
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.38 E-value=0.08 Score=58.70 Aligned_cols=87 Identities=21% Similarity=0.280 Sum_probs=48.4
Q ss_pred cCccccccCCeeEEEEeeccCceEEEEEEECCC-CcE-----EEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCc-eeE
Q 005289 122 QGWVPLRADAFEKLEKIGQGTYSSVFRARDLDT-GKI-----VALKKVRFDNFEPESVRFMAREILILRRLDHPNI-IKL 194 (704)
Q Consensus 122 ~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~-g~~-----vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-v~l 194 (704)
..|..+..+..++ +.|..|-...+|++..... +.. |.+++.. . . .+..-.-.+|+.+++.|...++ .++
T Consensus 43 p~w~~~~~~~i~i-~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g-~-~-~~l~IdR~~E~~i~~~Ls~~glgP~l 118 (383)
T PTZ00384 43 PFWNNVNPEFIEI-KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS-T-Y-NSLVIDNDLQYNIAKLLGDNNFGPKI 118 (383)
T ss_pred CccccCCcccEEE-EEeCCcccceEEEEEecCCCCCccccceEEEEecc-C-C-CceEeccHHHHHHHHHHHhCCCCCeE
Confidence 3444333344444 4565588889999975432 122 3333321 1 1 1111122469999999965444 556
Q ss_pred eEEEeecCCCeEEEEEeccccccc
Q 005289 195 EGLITSRLSCSIYLVFEYMEHDIT 218 (704)
Q Consensus 195 ~~~~~~~~~~~~~LV~Ey~~g~ll 218 (704)
++.+.. ++|.||++|..+
T Consensus 119 ~~~f~~------g~l~efIeGr~l 136 (383)
T PTZ00384 119 IGRFGD------FTIQEWVEGNTM 136 (383)
T ss_pred EEecCC------EEEEEEeccccC
Confidence 665532 589999998543
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.19 E-value=0.19 Score=56.85 Aligned_cols=92 Identities=14% Similarity=0.199 Sum_probs=56.2
Q ss_pred hhhhhhhcCccccccCCeeEEEEeeccCceEEEEEEECC--------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc
Q 005289 115 AVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLD--------TGKIVALKKVRFDNFEPESVRFMAREILILRRL 186 (704)
Q Consensus 115 ~~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~--------~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L 186 (704)
....+...+|..+..+.. -++.|..|-.-.+|++.... .++.|.+++.-... +..-...+|..+++.+
T Consensus 91 ~i~~~~vp~W~~~~~~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t---e~lIdR~~E~~v~~~l 166 (442)
T PTZ00296 91 KICLEKVPEWRRFTEDDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV---DELYNPISEFEVYKTM 166 (442)
T ss_pred HHHHHHCCccccCCcccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc---cceeCHHHHHHHHHHH
Confidence 334444556765555666 66777778888999997542 25678888874321 1111234688888888
Q ss_pred CCCCc-eeEeEEEeecCCCeEEEEEeccccc
Q 005289 187 DHPNI-IKLEGLITSRLSCSIYLVFEYMEHD 216 (704)
Q Consensus 187 ~HpnI-v~l~~~~~~~~~~~~~LV~Ey~~g~ 216 (704)
..-+| .++++.+.. +.|.||++|.
T Consensus 167 s~~gi~P~l~~~f~g------g~I~efi~g~ 191 (442)
T PTZ00296 167 SKYRIAPQLLNTFSG------GRIEEWLYGD 191 (442)
T ss_pred HHCCCCCceEEEeCC------CEEEEeeCCc
Confidence 54444 345555432 3678998874
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.08 E-value=0.088 Score=56.49 Aligned_cols=31 Identities=19% Similarity=0.256 Sum_probs=28.2
Q ss_pred CcccccCCCccEEEccCCceEEecccccccc
Q 005289 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (704)
Q Consensus 251 gIvHrDLKp~NILl~~~g~iKL~DFGla~~~ 281 (704)
++||+|+.+.|||++.++.+.|+||..+...
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~d 227 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASFA 227 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcccC
Confidence 7999999999999999999999999987643
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.96 E-value=0.15 Score=55.33 Aligned_cols=137 Identities=22% Similarity=0.319 Sum_probs=79.8
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-C--CC---ceeEeEEEeecCC--CeEE
Q 005289 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-H--PN---IIKLEGLITSRLS--CSIY 207 (704)
Q Consensus 136 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-H--pn---Iv~l~~~~~~~~~--~~~~ 207 (704)
..|.+ .-..||++.. .+|++ +||+.+.. .. ...+..|+.+|..|. + += |..+-+-...... ...+
T Consensus 32 ~~l~s-~eN~~f~~~~-~~g~~-iLki~~~~-~~---~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a 104 (331)
T COG2334 32 RGLNS-EENSNFRVQT-EDGRY-ILKIYRPG-WT---RAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPA 104 (331)
T ss_pred ccccc-ccCceEEEEe-cCCCe-EEEEecCC-CC---HHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeE
Confidence 44555 5567899975 33444 99998765 33 344566888888883 2 11 3333232222222 3778
Q ss_pred EEEeccccccccc-ccC-----------------CCc---------cccHH----HH---------HHHHHHhhhhHHHH
Q 005289 208 LVFEYMEHDITGL-LSC-----------------PDI---------KFSEA----QI---------KCYMNQLLHGLEHC 247 (704)
Q Consensus 208 LV~Ey~~g~ll~~-~~~-----------------~~~---------~l~e~----~~---------~~i~~QIl~aL~yL 247 (704)
-|++|++|..+.. ... .+. ...+. .. .....++...+..+
T Consensus 105 ~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~ 184 (331)
T COG2334 105 ALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRL 184 (331)
T ss_pred EEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHH
Confidence 8999999866552 110 000 00110 00 11222344445555
Q ss_pred Hhc--------C--cccccCCCccEEEccCCc-eEEecccccc
Q 005289 248 HSR--------G--VLHRDIKGSNLLVNNEGV-LKLADFGLAN 279 (704)
Q Consensus 248 H~~--------g--IvHrDLKp~NILl~~~g~-iKL~DFGla~ 279 (704)
.+. + |||+|+.|.|||++.+.. +.++||+-+.
T Consensus 185 ~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 185 LARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred HhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 432 4 999999999999999875 8999999764
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.70 E-value=0.26 Score=61.56 Aligned_cols=31 Identities=35% Similarity=0.549 Sum_probs=26.3
Q ss_pred cCcccccCCCccEEEccCC--ceE-Eeccccccc
Q 005289 250 RGVLHRDIKGSNLLVNNEG--VLK-LADFGLANF 280 (704)
Q Consensus 250 ~gIvHrDLKp~NILl~~~g--~iK-L~DFGla~~ 280 (704)
.+|||.|+.+.|||++.++ .+. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999999875 555 999998753
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.39 E-value=0.15 Score=55.45 Aligned_cols=73 Identities=22% Similarity=0.320 Sum_probs=54.5
Q ss_pred CCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhc-CcccccCCCccEEEccCCceEEecccccccc
Q 005289 203 SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (704)
Q Consensus 203 ~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~-gIvHrDLKp~NILl~~~g~iKL~DFGla~~~ 281 (704)
..+.|++|++-...+...- .-..+++..|+.+.+.-+.-+..+ .+-||||...||||+ +|+|-|+||-+++.-
T Consensus 298 ~~y~yl~~kdhgt~is~ik-----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~ 371 (488)
T COG5072 298 TLYLYLHFKDHGTPISIIK-----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS 371 (488)
T ss_pred ceEEEEEEecCCceeeeee-----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence 4567888887665443221 123567777888877766666654 689999999999999 899999999999843
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.65 E-value=1 Score=48.76 Aligned_cols=73 Identities=15% Similarity=0.176 Sum_probs=42.3
Q ss_pred EeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCC--ceeE---eE--EEeecCCCeEEEE
Q 005289 137 KIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPN--IIKL---EG--LITSRLSCSIYLV 209 (704)
Q Consensus 137 ~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hpn--Iv~l---~~--~~~~~~~~~~~LV 209 (704)
.|+ +.-..||++.. .++..+++|+.+..... ...+..|+.++..|.... ++.. -+ +.. .++..+.|
T Consensus 33 ~l~-s~eN~vy~v~~-~~~~~~vlKv~r~~~~~---~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~--~~g~~~~l 105 (325)
T PRK11768 33 ALN-SYENRVYQFGD-EDGRRVVAKFYRPERWS---DAQILEEHAFALELAEAEIPVVAPLAFNGQTLHE--HQGFRFAL 105 (325)
T ss_pred eec-cccceEEEEec-CCCCEEEEEEcCcccCC---HHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEE--ECCEEEEE
Confidence 344 34457999874 44677999987644322 344566888887773211 2221 11 111 13567889
Q ss_pred Eeccccc
Q 005289 210 FEYMEHD 216 (704)
Q Consensus 210 ~Ey~~g~ 216 (704)
+++++|.
T Consensus 106 ~~~~~G~ 112 (325)
T PRK11768 106 FPRRGGR 112 (325)
T ss_pred EeeeCCC
Confidence 9998874
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=92.83 E-value=0.35 Score=49.24 Aligned_cols=115 Identities=19% Similarity=0.194 Sum_probs=70.6
Q ss_pred cCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEeccccccccc
Q 005289 141 GTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGL 220 (704)
Q Consensus 141 G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~ 220 (704)
++-+|.-.+.-.- ....+|+++.-...- ....+..+..++.++. .|++|. .+ +.-.+-+|.|+|-.-
T Consensus 73 ~gNsTl~~~kt~i--G~L~lKKi~slp~~~-~~~~y~nky~v~Armh--GilrL~---ND-n~~~yGvIlE~Cy~~---- 139 (308)
T PF07387_consen 73 NGNSTLLIGKTKI--GPLFLKKIRSLPCCI-NDALYFNKYRVFARMH--GILRLK---ND-NNYKYGVILERCYKI---- 139 (308)
T ss_pred CCceEEEEecccc--chhhhhhccCCCccc-chhhhhhhhhHHHHhh--heeEee---cC-CCceeEEEEeeccCc----
Confidence 4555555544322 345566665332221 2334567888888774 466665 22 345567888988531
Q ss_pred ccCCCccccHHHHHHHHHHhhhhHHHHHh--cCcccccCCCccEEEccCCceEEecccc
Q 005289 221 LSCPDIKFSEAQIKCYMNQLLHGLEHCHS--RGVLHRDIKGSNLLVNNEGVLKLADFGL 277 (704)
Q Consensus 221 ~~~~~~~l~e~~~~~i~~QIl~aL~yLH~--~gIvHrDLKp~NILl~~~g~iKL~DFGl 277 (704)
.. .+ ..++.-=+..|.-.|+ .+.+|+|..|+||+-|..|.+||.|=+.
T Consensus 140 ----~i-~~----~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 140 ----KI-NF----SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred ----cc-ch----hHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 00 00 1112122567788884 3799999999999999999999999653
|
The function of this family is unknown. |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.71 E-value=0.18 Score=50.24 Aligned_cols=30 Identities=33% Similarity=0.527 Sum_probs=25.9
Q ss_pred CcccccCCCccEEEccCCceEEecccccccc
Q 005289 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (704)
Q Consensus 251 gIvHrDLKp~NILl~~~g~iKL~DFGla~~~ 281 (704)
-.+|+|+.|.||++++++ ++|+||+.+...
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~g 107 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGDG 107 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccCC
Confidence 479999999999998877 999999987543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 704 | ||||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-61 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-61 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-61 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-61 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-56 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-56 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-56 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-56 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-56 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-56 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-56 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-56 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-56 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-56 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-56 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-56 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-56 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-56 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-56 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-56 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-56 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-56 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-56 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 8e-56 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 8e-56 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-56 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 9e-56 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 9e-56 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 9e-56 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-56 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-56 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 9e-56 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 9e-56 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-55 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-55 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-55 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-55 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-55 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-55 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-55 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-55 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-55 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-55 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-54 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-54 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-54 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-53 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-50 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-49 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-49 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-49 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-49 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-48 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-48 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-48 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-48 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-46 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-46 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-42 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-42 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-41 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-41 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-41 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-41 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-41 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-41 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-41 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-41 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-41 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-41 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-41 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-41 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-41 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-41 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-41 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-41 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-41 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-41 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-41 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-41 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-41 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-41 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-41 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-40 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-40 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-40 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-40 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-40 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-40 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-40 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-40 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-40 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-40 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-40 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-40 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-40 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-40 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-40 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-40 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-40 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-40 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-40 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-40 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-40 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-40 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-40 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-40 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-40 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-40 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-40 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-40 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-40 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-40 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-40 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-40 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-40 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-40 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-40 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-40 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-40 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-40 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-40 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-40 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-40 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-40 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-40 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-40 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 8e-40 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-40 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 9e-40 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-39 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-39 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-39 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-39 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-39 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-39 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-39 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-39 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-39 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-39 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-39 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-39 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-39 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-39 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-39 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-39 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-39 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-39 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-39 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-39 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-39 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-39 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-39 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-39 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-39 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-39 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-39 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-39 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-39 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-39 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-39 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-39 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-39 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-39 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-38 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-38 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-38 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-38 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-38 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-38 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-38 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-38 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-38 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-38 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-38 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-36 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 9e-36 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-35 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-35 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-34 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-33 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-33 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-33 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-32 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-32 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-32 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-32 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-32 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-32 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-32 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-32 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-32 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-32 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-32 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-32 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-32 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-32 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-32 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-32 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-32 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-32 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-32 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-32 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-32 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-32 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-32 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-32 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-32 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-32 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-32 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-32 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-31 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-31 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-31 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-31 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-30 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-27 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-27 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-27 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-27 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-27 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-27 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-27 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-27 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-27 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-27 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-27 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-27 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-27 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-27 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-27 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-27 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-27 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-27 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-27 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-27 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-27 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-27 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-27 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-27 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 9e-27 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-26 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-26 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-26 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-26 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-26 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-26 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-26 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-26 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-26 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-26 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-26 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-26 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-26 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-26 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-26 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-26 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-26 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 3e-26 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 9e-26 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-25 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-25 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-25 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-25 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-25 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-25 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-25 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-25 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-25 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-25 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-25 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-25 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-25 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 4e-25 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-25 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 5e-25 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 5e-25 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-24 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-24 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-24 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-24 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-24 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-24 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-24 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-24 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-24 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-24 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-24 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-23 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-23 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-23 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-23 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-23 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-23 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-23 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-23 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-23 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-23 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-23 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-22 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-22 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-22 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-22 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-22 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-22 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-22 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-22 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-22 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-22 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-22 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-22 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-22 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-22 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-22 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-21 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-21 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-21 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-21 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-21 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-21 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-21 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-21 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-21 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-21 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-21 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-21 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-21 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-21 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-21 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-21 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-21 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-21 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-21 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-21 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-21 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-21 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-21 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-21 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-21 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-21 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-21 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 9e-21 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 9e-21 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 9e-21 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-20 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-20 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-20 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-20 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-20 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-20 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-20 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-20 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-20 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-20 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-20 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-20 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-20 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-20 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-20 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-20 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-20 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-19 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-19 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-19 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-19 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-19 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-19 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-19 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-19 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-19 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-19 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-19 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-19 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-19 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-19 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-19 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-19 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-19 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-19 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-19 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-19 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-19 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-19 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-19 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-19 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-19 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-19 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-19 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-19 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-19 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-19 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-19 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-19 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-18 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-18 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-18 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-18 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-18 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-18 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-18 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-18 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-18 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-18 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-18 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-18 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-18 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-18 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-18 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-18 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-18 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-18 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-18 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-18 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-18 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-18 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-18 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-18 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-17 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-17 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-17 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-17 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-17 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-17 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-17 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-17 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-17 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-17 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-17 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-17 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-17 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-17 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-17 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-17 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-17 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-17 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-17 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-17 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-17 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-17 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-17 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-17 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-17 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-17 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-17 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-16 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-16 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-16 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-16 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-16 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-16 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-16 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-16 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-16 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-16 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-16 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-16 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-16 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-16 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-16 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-16 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-16 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-16 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-16 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-16 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-16 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-16 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-16 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-16 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-16 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-16 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-16 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-16 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 7e-16 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-16 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-16 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-15 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-15 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-15 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-15 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-15 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-15 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-15 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-15 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-15 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-15 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-15 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-15 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-15 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-15 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-15 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-15 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-15 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-15 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-15 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-15 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-15 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-15 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-15 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-15 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-15 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-15 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-15 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-15 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-15 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-15 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-15 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-15 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-15 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-15 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-15 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 9e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-14 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-14 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-14 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-14 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-14 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-14 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-14 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-14 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-14 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-14 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-14 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-14 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-14 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-14 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-14 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-14 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-14 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-14 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-14 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-14 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-14 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-14 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-14 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-14 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-14 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-14 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-14 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-14 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-14 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-14 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-14 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-14 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 8e-14 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-14 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-14 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 8e-14 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 9e-14 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 9e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 9e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-13 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-13 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-13 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-13 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-13 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-13 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-13 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-13 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-13 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-13 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-13 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-13 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-13 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-13 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-13 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-13 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 9e-13 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-12 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-12 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-12 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-12 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-12 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-12 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 3e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-12 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 3e-12 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-12 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-12 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-12 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-12 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 4e-12 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-12 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-12 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-12 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-12 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-12 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-12 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 7e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-12 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-12 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 9e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-11 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-11 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-11 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-11 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-11 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-11 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-11 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-11 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-11 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-11 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-11 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-11 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-11 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-11 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-11 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-11 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-11 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-11 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-11 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-11 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-11 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-11 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-11 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-11 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-11 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-11 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-11 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-11 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-11 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-11 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-11 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 4e-11 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-11 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-11 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-11 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-11 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-11 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-11 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 4e-11 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-11 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-11 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-11 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-11 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-11 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-11 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-11 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-11 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-11 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-11 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-11 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-11 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-11 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-11 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-11 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-11 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-11 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-11 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-11 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 7e-11 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-11 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-11 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 8e-11 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 8e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-11 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 9e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 9e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 9e-11 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-10 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-10 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-10 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-10 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-10 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-10 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 8e-10 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 9e-10 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 9e-10 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-09 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-09 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-09 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-09 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-08 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 5e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-08 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 6e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 8e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 8e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 9e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-08 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-07 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-07 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 1e-07 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-07 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 1e-07 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 1e-07 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-07 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-07 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-07 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-07 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-07 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-07 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-07 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-07 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-07 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-07 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-07 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-07 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-07 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-07 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 6e-07 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-07 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 7e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 7e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 8e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-06 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-06 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-06 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 1e-06 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 1e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-06 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-06 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-06 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-06 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-06 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-06 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-06 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-06 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-06 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-06 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-06 |
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 523 bits (1350), Expect = 0.0
Identities = 134/344 (38%), Positives = 190/344 (55%), Gaps = 16/344 (4%)
Query: 119 EAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA- 177
++++ +EKL KIGQGT+ VF+AR TG+ VALKKV +N E E A
Sbjct: 6 DSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITAL 64
Query: 178 REILILRRLDHPNIIKLEGLITSRLS------CSIYLVFEYMEHDITGLLSCPDIKFSEA 231
REI IL+ L H N++ L + ++ S SIYLVF++ EHD+ GLLS +KF+ +
Sbjct: 65 REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS 124
Query: 232 QIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF---SNTGHRQP 288
+IK M LL+GL + H +LHRD+K +N+L+ +GVLKLADFGLA +
Sbjct: 125 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 348
T+RVVTLWYRPPELLLG DYGP +DLW GC+ AE+ PI+QG TE QL I +L
Sbjct: 185 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 244
Query: 349 CGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDL--PTTAVNLIETLLSVEPYKRA 405
CGS + W + + +++ K A++LI+ LL ++P +R
Sbjct: 245 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 304
Query: 406 TASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKK 449
+ AL ++F + P DL + + + RRK
Sbjct: 305 DSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAP--PRRKH 346
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 476 bits (1228), Expect = e-165
Identities = 127/344 (36%), Positives = 189/344 (54%), Gaps = 12/344 (3%)
Query: 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE--PESVRFMA-REIL 181
V RA +EKL+ +G+G +++V++ARD +T +IVA+KK++ + + + A REI
Sbjct: 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 182 ILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLL 241
+L+ L HPNII L + +I LVF++ME D+ ++ + + + IK YM L
Sbjct: 65 LLQELSHPNIIGLLDAFGHK--SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTL 122
Query: 242 HGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPP 301
GLE+ H +LHRD+K +NLL++ GVLKLADFGLA + +R T +VVT WYR P
Sbjct: 123 QGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AYTHQVVTRWYRAP 181
Query: 302 ELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-S 360
ELL GA YG VD+W+VGC+ AELL+ P L G ++++QL +IF+ G+P ++ W
Sbjct: 182 ELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 241
Query: 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420
LP FK L F ++LI+ L P R TA+ AL +YFS +P
Sbjct: 242 SLPDYVTFKSFPGIP--LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299
Query: 421 YACDLSSLPIYPPSKEIDAKHRE---DARRKKVGGRVRGAETRK 461
LP E + +RK+ +G +K
Sbjct: 300 GPTPGCQLPRPNCPVETLKEQSNPALAIKRKRTEALEQGGLPKK 343
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 408 bits (1051), Expect = e-138
Identities = 112/324 (34%), Positives = 173/324 (53%), Gaps = 12/324 (3%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ + KL+K+G+GTY++V++ + T +VALK++R ++ E + RE+ +L+ L H
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHA 60
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
NI+ L +I + S+ LVFEY++ D+ L + +K ++ QLL GL +CH
Sbjct: 61 NIVTLHDIIHTE--KSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR 118
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
+ VLHRD+K NLL+N G LKLADFGLA S + + VVTLWYRPP++LLG+T
Sbjct: 119 QKVLHRDLKPQNLLINERGELKLADFGLARAKSI--PTKTYDNEVVTLWYRPPDILLGST 176
Query: 309 DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHATL 367
DY +D+W VGC+F E+ G+P+ G T EQLH IF++ G+P ++ W
Sbjct: 177 DYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236
Query: 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSS 427
+ + +L L + +L+ LL E R +A A+ +F +
Sbjct: 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIH--K 294
Query: 428 LPIYP---PSKEIDAKHREDARRK 448
LP KEI + R
Sbjct: 295 LPDTTSIFALKEIQLQKEASLRSA 318
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 407 bits (1049), Expect = e-138
Identities = 112/311 (36%), Positives = 165/311 (53%), Gaps = 20/311 (6%)
Query: 123 GWVPLRA-DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRF---MAR 178
G + A +E + +IG G Y +V++ARD +G VALK VR N R
Sbjct: 1 GPLGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR 60
Query: 179 EILILRRL---DHPNIIKLEGLITSR---LSCSIYLVFEYMEHDITGLL-SCPDIKFSEA 231
E+ +LRRL +HPN+++L + + + LVFE+++ D+ L P
Sbjct: 61 EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE 120
Query: 232 QIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLT 290
IK M Q L GL+ H+ ++HRD+K N+LV + G +KLADFGLA + ++ LT
Sbjct: 121 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALT 177
Query: 291 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 350
VVTLWYR PE+LL +T Y VD+WSVGC+FAE+ KP+ G +E +QL KIF L G
Sbjct: 178 PVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 236
Query: 351 SPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 409
PP+D W + LP P + ++ ++ + L+ +L+ P+KR +A
Sbjct: 237 LPPEDDWPRDVSLPRGAF--PPRGP-RPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFR 293
Query: 410 ALASEYFSTKP 420
AL Y
Sbjct: 294 ALQHSYLHKDE 304
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 403 bits (1039), Expect = e-137
Identities = 110/322 (34%), Positives = 170/322 (52%), Gaps = 20/322 (6%)
Query: 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRL 186
+ F++LEK+G GTY++V++ + TG VALK+V+ D+ E E A REI +++ L
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-E-EGTPSTAIREISLMKEL 60
Query: 187 DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIK-----FSEAQIKCYMNQLL 241
H NI++L +I + + LVFE+M++D+ + + +K + QLL
Sbjct: 61 KHENIVRLYDVIHTE--NKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 242 HGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYRP 300
GL CH +LHRD+K NLL+N G LKL DFGLA F +S VVTLWYR
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI--PVNTFSSEVVTLWYRA 176
Query: 301 PELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK- 359
P++L+G+ Y S+D+WS GC+ AE++ GKP+ G + EQL IF + G+P + W
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV 236
Query: 360 SKLPHATLFKPQQPYDSSLRETFKD-----LPTTAVNLIETLLSVEPYKRATASAALASE 414
+KLP Q+P LR+ + L ++ + LL + P R +A AL
Sbjct: 237 TKLPKYNPNIQQRPP-RDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP 295
Query: 415 YFSTKPYACDLSSLPIYPPSKE 436
+F+ + + +
Sbjct: 296 WFAEYYHHASMGGSRSHHHHHH 317
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 402 bits (1036), Expect = e-136
Identities = 124/295 (42%), Positives = 176/295 (59%), Gaps = 10/295 (3%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDH 188
+EKLEKIG+GTY +VF+A++ +T +IVALK+VR D+ + E V A REI +L+ L H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKH 60
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
NI++L ++ S + LVFE+ + D+ + +K ++ QLL GL CH
Sbjct: 61 KNIVRLHDVLHSD--KKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
SR VLHRD+K NLL+N G LKLA+FGLA F + ++ VVTLWYRPP++L GA
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRCYSAEVVTLWYRPPDVLFGA 176
Query: 308 TDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHA 365
Y S+D+WS GC+FAEL G+P+ G +QL +IF+L G+P ++ W +KLP
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420
+ P P +SL L T +L++ LL P +R +A AL YFS
Sbjct: 237 KPY-PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 401 bits (1033), Expect = e-136
Identities = 120/300 (40%), Positives = 174/300 (58%), Gaps = 9/300 (3%)
Query: 124 WVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILI 182
+ + ++KLEK+G+GTY V++A+D G+IVALK++R D E E + A REI +
Sbjct: 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDA-EDEGIPSTAIREISL 72
Query: 183 LRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLH 242
L+ L HPNI+ L +I S + LVFE+ME D+ +L ++QIK Y+ QLL
Sbjct: 73 LKELHHPNIVSLIDVIHSE--RCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLR 130
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYRPP 301
G+ HCH +LHRD+K NLL+N++G LKLADFGLA F + T VVTLWYR P
Sbjct: 131 GVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI--PVRSYTHEVVTLWYRAP 188
Query: 302 ELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-S 360
++L+G+ Y SVD+WS+GC+FAE++ GKP+ G T+ +QL KIF + G+P W +
Sbjct: 189 DVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ 248
Query: 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420
+LP Q ++L+ +L +P KR +A A+ YF
Sbjct: 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 398 bits (1025), Expect = e-135
Identities = 111/291 (38%), Positives = 171/291 (58%), Gaps = 10/291 (3%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDH 188
+ + LEKIG+GTY V++A++ + G+ ALKK+R + E E + REI IL+ L H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEK-EDEGIPSTTIREISILKELKH 59
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
NI+KL +I ++ + LVFE+++ D+ LL + K ++ QLL+G+ +CH
Sbjct: 60 SNIVKLYDVIHTK--KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
R VLHRD+K NLL+N EG LK+ADFGLA F + T +VTLWYR P++L+G+
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRKYTHEIVTLWYRAPDVLMGS 175
Query: 308 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHAT 366
Y ++D+WSVGC+FAE++ G P+ G +E +QL +IF++ G+P W ++LP
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417
K L + ++L+ +L ++P +R TA AL YF
Sbjct: 236 PNFTVYEP-LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 399 bits (1027), Expect = e-135
Identities = 118/323 (36%), Positives = 176/323 (54%), Gaps = 21/323 (6%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDL-DTGKIVALKKVRFDNFEPESVRFMA-REILILRRL- 186
+E + +IG+G Y VF+ARDL + G+ VALK+VR E + RE+ +LR L
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-GEEGMPLSTIREVAVLRHLE 69
Query: 187 --DHPNIIKLEGLITSRLS---CSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQL 240
+HPN+++L + T + + LVFE+++ D+T L P+ IK M QL
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 129
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYR 299
L GL+ HS V+HRD+K N+LV + G +KLADFGLA + + LTS VVTLWYR
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYR 186
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359
PE+LL ++ Y VDLWSVGC+FAE+ KP+ +G ++V+QL KI + G P ++ W +
Sbjct: 187 APEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 245
Query: 360 -SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418
LP + + D+ +L+ L+ P KR +A +AL+ YF
Sbjct: 246 DVALPRQAFHSKSA---QPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 302
Query: 419 KPYACD--LSSLPIYPPSKEIDA 439
+ S LP + E++
Sbjct: 303 LERCKENLDSHLPPSQNTSELNT 325
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 401 bits (1032), Expect = e-134
Identities = 111/397 (27%), Positives = 184/397 (46%), Gaps = 46/397 (11%)
Query: 122 QGWVPLRADAFEKL-EKIGQGTYSSVFRARDLD--TGKIVALKKVRFDNFEPESVRFMAR 178
D FE K+G+GTY V++A+ D K ALK++ + R
Sbjct: 12 SSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR---- 67
Query: 179 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL--------SCPDIKFSE 230
EI +LR L HPN+I L+ + S ++L+F+Y EHD+ ++ + ++
Sbjct: 68 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 127
Query: 231 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFSNTGHR 286
+K + Q+L G+ + H+ VLHRD+K +N+LV G +K+AD G A N+ +
Sbjct: 128 GMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 187
Query: 287 Q--PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV----- 339
L VVT WYR PELLLGA Y ++D+W++GC+FAELL +PI R E
Sbjct: 188 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 247
Query: 340 ----EQLHKIFKLCGSPPDDYWKK-SKLPHATLFKP---QQPYDSS-----LRETFKDLP 386
+QL +IF + G P D W+ K+P + + Y + + +
Sbjct: 248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPD 307
Query: 387 TTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLP---IYPPSKEIDAKHRE 443
+ A +L++ LL+++P KR T+ A+ YF P YP + + + +
Sbjct: 308 SKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQIPYPKREFLTEEEPD 367
Query: 444 DA----RRKKVGGRVRGAETRKTTRKSHGMSKLAPVE 476
D +++ G T + ++ P++
Sbjct: 368 DKGDKKNQQQQQGNNHTNGTGHPGNQDSSHTQGPPLK 404
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 395 bits (1018), Expect = e-134
Identities = 106/311 (34%), Positives = 161/311 (51%), Gaps = 9/311 (2%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDH 188
+ +EK+ KIG+G+Y VF+ R+ DTG+IVA+KK + ++ +A REI +L++L H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKH 61
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
PN++ L + + ++LVFEY +H + L E +K Q L + CH
Sbjct: 62 PNLVNLLEVFRRK--RRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
+HRD+K N+L+ V+KL DFG A + G V T WYR PELL+G
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFARLLT--GPSDYYDDEVATRWYRSPELLVGD 177
Query: 308 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHAT 366
T YGP VD+W++GCVFAELL G P+ G+++V+QL+ I K G + + S + +
Sbjct: 178 TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237
Query: 367 LFK-PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDL 425
K P L F ++ A+ L++ L ++P +R T L YF DL
Sbjct: 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDL 297
Query: 426 SSLPIYPPSKE 436
+ P
Sbjct: 298 AKEHDKPAENL 308
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 394 bits (1015), Expect = e-133
Identities = 99/320 (30%), Positives = 172/320 (53%), Gaps = 17/320 (5%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDH 188
+ +E L +G+G+Y V + R+ DTG+IVA+KK + + + V+ +A REI +L++L H
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRH 83
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
N++ L + + YLVFE+++H I L ++ Y+ Q+++G+ CH
Sbjct: 84 ENLVNLLEVCKKK--KRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH 141
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
S ++HRDIK N+LV+ GV+KL DFG A + G + V T WYR PELL+G
Sbjct: 142 SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVYDDEVATRWYRAPELLVGD 199
Query: 308 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHAT 366
YG +VD+W++GC+ E+ +G+P+ G ++++QL+ I G+ + + +K P
Sbjct: 200 VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA 259
Query: 367 LFK-PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDL 425
+ P+ L + L ++L + L ++P KR + L ++F +A
Sbjct: 260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAER- 318
Query: 426 SSLPIYPPSKEIDAKHREDA 445
S+E+ K ++DA
Sbjct: 319 -------FSQELQLKVQKDA 331
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 394 bits (1014), Expect = e-133
Identities = 113/301 (37%), Positives = 175/301 (58%), Gaps = 16/301 (5%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDH 188
D + ++ K+G+GTY V++A D T + VA+K++R ++ E E V A RE+ +L+ L H
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH-EEEGVPGTAIREVSLLKELQH 92
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHC 247
NII+L+ +I ++L+FEY E+D+ + PD S IK ++ QL++G+ C
Sbjct: 93 RNIIELKSVIHHN--HRLHLIFEYAENDLKKYMDKNPD--VSMRVIKSFLYQLINGVNFC 148
Query: 248 HSRGVLHRDIKGSNLLVN-----NEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYRPP 301
HSR LHRD+K NLL++ VLK+ DFGLA F + T ++TLWYRPP
Sbjct: 149 HSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI--PIRQFTHEIITLWYRPP 206
Query: 302 ELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-S 360
E+LLG+ Y SVD+WS+ C++AE+L+ P+ G +E++QL KIF++ G P D W +
Sbjct: 207 EILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVT 266
Query: 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420
LP P+ + R L ++L+ +L ++P KR +A AL YFS
Sbjct: 267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326
Query: 421 Y 421
+
Sbjct: 327 F 327
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 333 bits (857), Expect = e-108
Identities = 116/349 (33%), Positives = 173/349 (49%), Gaps = 19/349 (5%)
Query: 79 SGRASSNSESLSFRLGNLHKYIEGEQVAAGWPA-WLSAVAGEAIQGWVPLRADAFEKLEK 137
SGR + S + S + +V+ ++ V QG + ++ +
Sbjct: 2 SGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKV 61
Query: 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGL 197
IG G++ V++A+ D+G++VA+KKV D RF RE+ I+R+LDH NI++L
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYF 115
Query: 198 ITSRLS----CSIYLVFEYMEHDITGLL---SCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
S + LV +Y+ + + S +K YM QL L + HS
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 175
Query: 251 GVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD 309
G+ HRDIK NLL++ + VLKL DFG A G +P S + + +YR PEL+ GATD
Sbjct: 176 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRYYRAPELIFGATD 233
Query: 310 YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369
Y S+D+WS GCV AELL+G+PI G + V+QL +I K+ G+P + ++ P+ T FK
Sbjct: 234 YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN-PNYTEFK 292
Query: 370 -PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417
PQ + P A+ L LL P R T A A +F
Sbjct: 293 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 341
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 315 bits (809), Expect = e-101
Identities = 103/295 (34%), Positives = 153/295 (51%), Gaps = 19/295 (6%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+ + IG G++ VF+A+ +++ + VA+KKV D RF RE+ I+R + HPN+
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK------RFKNRELQIMRIVKHPNV 94
Query: 192 IKLEGLITSRLSCS----IYLVFEYMEHDITGLL---SCPDIKFSEAQIKCYMNQLLHGL 244
+ L+ S + LV EY+ + + IK YM QLL L
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSL 154
Query: 245 EHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPEL 303
+ HS G+ HRDIK NLL++ GVLKL DFG A G +P S + + +YR PEL
Sbjct: 155 AYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG--EPNVSYICSRYYRAPEL 212
Query: 304 LLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363
+ GAT+Y ++D+WS GCV AEL+ G+P+ G + ++QL +I K+ G+P + K+ P
Sbjct: 213 IFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI-KTMNP 271
Query: 364 HATLFKPQQPYDSSLRETF-KDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417
+ K Q + F P A++LI LL P R TA AL +F
Sbjct: 272 NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFD 326
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 298 bits (765), Expect = 2e-95
Identities = 100/337 (29%), Positives = 150/337 (44%), Gaps = 27/337 (8%)
Query: 114 SAVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESV 173
S A A D F+ GQGT+ +V ++ TG VA+KKV D
Sbjct: 7 SLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD------P 60
Query: 174 RFMAREILILRRL---DHPNIIKLEGLITSRLSCS-----IYLVFEYME---HDITGLLS 222
RF RE+ I++ L HPNI++L+ + + +V EY+ H
Sbjct: 61 RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYY 120
Query: 223 CPDIKFSEAQIKCYMNQLLHGLE--HCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLAN 279
+ IK ++ QL+ + H S V HRDIK N+LVN G LKL DFG A
Sbjct: 121 RRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK 180
Query: 280 FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV 339
+ +P + + + +YR PEL+ G Y +VD+WSVGC+FAE+++G+PI +G
Sbjct: 181 KLSPS--EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA 238
Query: 340 EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ---QPYDSSLRETFKDLPTTAVNLIETL 396
QLH+I ++ G P + +K H + P+ + + A +L+ L
Sbjct: 239 GQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSAL 298
Query: 397 LSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPP 433
L P +R AL YF + LP
Sbjct: 299 LQYLPEERMKPYEALCHPYFD--ELHDPATKLPNNKD 333
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 293 bits (753), Expect = 3e-93
Identities = 100/334 (29%), Positives = 153/334 (45%), Gaps = 52/334 (15%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRR 185
+ + + +G G++ V D+++GK ALKKV D R+ RE+ I++
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP------RYKNRELDIMKV 56
Query: 186 LDHPNIIKLEGLITSRLSCS------------------------------------IYLV 209
LDH NIIKL + + ++
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 210 FEYME---HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN- 265
EY+ H + I Y+ QL + HS G+ HRDIK NLLVN
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176
Query: 266 NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAE 325
+ LKL DFG A +P + + + +YR PEL+LGAT+Y PS+DLWS+GCVF E
Sbjct: 177 KDNTLKLCDFGSAKKLIPS--EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234
Query: 326 LLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK-PQQPYDSSLRETF-K 383
L++GKP+ G T ++QL +I ++ G+P + + PH T + P R+ +
Sbjct: 235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMN-PHYTEVRFPTLK-AKDWRKILPE 292
Query: 384 DLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417
P+ A++L+E +L EP R A+A +F
Sbjct: 293 GTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFD 326
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 288 bits (738), Expect = 8e-92
Identities = 93/301 (30%), Positives = 152/301 (50%), Gaps = 23/301 (7%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DH 188
D ++ + K+G+G YS VF A ++ + V +K ++ P + + REI IL L
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-----PVKKKKIKREIKILENLRGG 90
Query: 189 PNIIKLEGLITSRLSCSIYLVFEY-MEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
PNII L ++ +S + LVFE+ D L ++ I+ YM ++L L++C
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYC 146
Query: 248 HSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG 306
HS G++HRD+K N+++++E L+L D+GLA F + G Q RV + +++ PELL+
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG--QEYNVRVASRYFKGPELLVD 204
Query: 307 ATDYGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSPP-DDYWKKSKLPH 364
Y S+D+WS+GC+ A ++ K P G +QL +I K+ G+ DY K +
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264
Query: 365 ATLFKPQQPYDSSLR-------ETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417
F S R E + A++ ++ LL + R TA A+ YF
Sbjct: 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 324
Query: 418 T 418
T
Sbjct: 325 T 325
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 276 bits (707), Expect = 2e-87
Identities = 107/303 (35%), Positives = 161/303 (53%), Gaps = 22/303 (7%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+ L+ +G G VF A D D K VA+KK+ + P+SV+ REI I+RRLDH NI
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALREIKIIRRLDHDNI 70
Query: 192 IKLEGLITSRLSCS------------IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQ 239
+K+ ++ S +Y+V EYME D+ +L + E + +M Q
Sbjct: 71 VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPL--LEEHARLFMYQ 128
Query: 240 LLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLA--NFSNTGHRQPLTSRVVTL 296
LL GL++ HS VLHRD+K +NL +N E VLK+ DFGLA + H+ L+ +VT
Sbjct: 129 LLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 297 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 356
WYR P LLL +Y ++D+W+ GC+FAE+L GK + G E+EQ+ I + ++
Sbjct: 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEED 248
Query: 357 WKK--SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 414
++ S +P +P L + + AV+ +E +L+ P R TA AL+
Sbjct: 249 RQELLSVIPVYIRNDMTEP-HKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHP 307
Query: 415 YFS 417
Y S
Sbjct: 308 YMS 310
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 276 bits (709), Expect = 5e-87
Identities = 107/315 (33%), Positives = 158/315 (50%), Gaps = 15/315 (4%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR-FDNFEPESVRFMAREILILRRLDHPN 190
+ L IG+G Y V A D VA+KK+ F++ + REI IL R H N
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--QTYCQRTLREIKILLRFRHEN 86
Query: 191 IIKLEGLITSRLSCS---IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
II + +I + +Y+V + ME D+ LL + S I ++ Q+L GL++
Sbjct: 87 IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHL--SNDHICYFLYQILRGLKYI 144
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLA--NFSNTGHRQPLTSRVVTLWYRPPELLL 305
HS VLHRD+K SNLL+N LK+ DFGLA + H LT V T WYR PE++L
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365
+ Y S+D+WSVGC+ AE+L +PI G+ ++QL+ I + GSP + A
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 366 TLFKPQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 423
+ P+ + F + + A++L++ +L+ P+KR ALA Y Y
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE--QYY- 321
Query: 424 DLSSLPIYPPSKEID 438
D S PI + D
Sbjct: 322 DPSDEPIAEAPFKFD 336
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 278 bits (712), Expect = 3e-86
Identities = 103/377 (27%), Positives = 162/377 (42%), Gaps = 78/377 (20%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESV--RFMAREILILRRLDHP 189
+E IG G+Y V A D ++VA+KK+ FE R + REI IL RL+H
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI-LRVFEDLIDCKR-ILREIAILNRLNHD 112
Query: 190 NIIKLEGLITSRLSCS---IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEH 246
+++K+ ++ + +Y+V E + D L P + +E IK + LL G+++
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKY 171
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA--------------------------NF 280
HS G+LHRD+K +N LVN + +K+ DFGLA
Sbjct: 172 VHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFP 231
Query: 281 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-----------IG 329
++ LT VVT WYR PEL+L +Y ++D+WS+GC+FAELL
Sbjct: 232 HTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADR 291
Query: 330 KPILQG--------------------RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369
P+ G R +QL+ IF + G+P ++ + + A +
Sbjct: 292 GPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYI 351
Query: 370 PQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSS 427
P L E F A++L++ +L P KR T + LA +F
Sbjct: 352 RIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFK---------- 401
Query: 428 LPIYPPSKEIDAKHRED 444
+ E +A +
Sbjct: 402 -EVRIAEVETNATEKVR 417
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 273 bits (701), Expect = 5e-86
Identities = 98/302 (32%), Positives = 151/302 (50%), Gaps = 20/302 (6%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR-FDNFEPESVRFMAREILILRRLDHPN 190
F+ +G+G Y V A TG+IVA+KK+ FD P REI IL+ H N
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK--PLFALRTLREIKILKHFKHEN 70
Query: 191 IIKLEGLITSRLSCS---IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
II + + + +Y++ E M+ D+ ++S + S+ I+ ++ Q L ++
Sbjct: 71 IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQML--SDDHIQYFIYQTLRAVKVL 128
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLA---------NFSNTGHRQPLTSRVVTLWY 298
H V+HRD+K SNLL+N+ LK+ DFGLA N TG + + V T WY
Sbjct: 129 HGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWY 188
Query: 299 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 358
R PE++L + Y ++D+WS GC+ AEL + +PI GR QL IF + G+P D
Sbjct: 189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDL 248
Query: 359 KS-KLPHATLFKPQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415
+ + P A + P L + F + ++L++ +L +P KR TA AL Y
Sbjct: 249 RCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY 308
Query: 416 FS 417
Sbjct: 309 LQ 310
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 273 bits (700), Expect = 6e-86
Identities = 105/321 (32%), Positives = 165/321 (51%), Gaps = 28/321 (8%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR--FDNFEPESVRFMAREILILRRLDHP 189
+ +G G Y SV A D +G+ VA+KK+ F + + RE+L+L+ + H
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS--EIFAKRAYRELLLLKHMQHE 83
Query: 190 NIIKLEGLITSRLSCS----IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
N+I L + T S YLV +M+ D+ ++ FSE +I+ + Q+L GL+
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK---FSEEKIQYLVYQMLKGLK 140
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
+ HS GV+HRD+K NL VN + LK+ DFGLA ++ +T VVT WYR PE++L
Sbjct: 141 YIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA----EMTGYVVTRWYRAPEVIL 196
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365
Y +VD+WSVGC+ AE+L GK + +G+ ++QL +I K+ G P ++ +K A
Sbjct: 197 SWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA 256
Query: 366 TLFKPQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 423
+ P + F A +L+E +L ++ KR TA+ AL +F
Sbjct: 257 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE------ 310
Query: 424 DLSSLPIYPPSKEIDAKHRED 444
P P +E +A+ D
Sbjct: 311 -----PFRDPEEETEAQQPFD 326
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 272 bits (697), Expect = 3e-85
Identities = 100/310 (32%), Positives = 159/310 (51%), Gaps = 19/310 (6%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR--FDNFEPESVRFMAREILILRRLDHP 189
+ L+ +G G Y +V A D TG VA+KK+ F + + RE+ +L+ + H
Sbjct: 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS--ELFAKRAYRELRLLKHMRHE 84
Query: 190 NIIKLEGLITSRLSCS----IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
N+I L + T + YLV +M D+ L+ K E +I+ + Q+L GL
Sbjct: 85 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE--KLGEDRIQFLVYQMLKGLR 142
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
+ H+ G++HRD+K NL VN + LK+ DFGLA +++ +T VVT WYR PE++L
Sbjct: 143 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVIL 198
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365
Y +VD+WSVGC+ AE++ GK + +G ++QL +I K+ G+PP ++ ++ + A
Sbjct: 199 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 258
Query: 366 TLFKPQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 423
+ P + AVNL+E +L ++ +R TA ALA YF
Sbjct: 259 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE--SLH- 315
Query: 424 DLSSLPIYPP 433
D P
Sbjct: 316 DTEDEPQVQK 325
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 271 bits (695), Expect = 5e-85
Identities = 84/302 (27%), Positives = 128/302 (42%), Gaps = 20/302 (6%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVR-FMA--------REILI 182
+ I G+Y +V D G VA+K+V + +V REI +
Sbjct: 24 YTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 183 LRRLDHPNIIKLEGLITSRLSCS---IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQ 239
L HPNI+ L + + +YLV E M D+ ++ I S I+ +M
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYH 142
Query: 240 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYR 299
+L GL H GV+HRD+ N+L+ + + + DF LA T V WYR
Sbjct: 143 ILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD--ANKTHYVTHRWYR 200
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359
PEL++ + VD+WS GCV AE+ K + +G T QL+KI ++ G+P +
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVM 260
Query: 360 SKLPHATLF----KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415
P A + P + A++LI +L P +R + AL Y
Sbjct: 261 FSSPSARDYLRNSLSNVP-ARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPY 319
Query: 416 FS 417
F
Sbjct: 320 FE 321
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 269 bits (690), Expect = 4e-84
Identities = 103/310 (33%), Positives = 158/310 (50%), Gaps = 19/310 (6%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR--FDNFEPESVRFMAREILILRRLDHP 189
++ L +G G Y SV A D TG VA+KK+ F + + RE+ +L+ + H
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHE 88
Query: 190 NIIKLEGLITSRLSCS----IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
N+I L + T S +YLV M D+ ++ C + ++ ++ + Q+L GL+
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQILRGLK 146
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
+ HS ++HRD+K SNL VN + LK+ DFGLA + +T V T WYR PE++L
Sbjct: 147 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA----DEMTGYVATRWYRAPEIML 202
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365
Y +VD+WSVGC+ AELL G+ + G ++QL I +L G+P + KK A
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 262
Query: 366 TLFKPQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 423
+ + F AV+L+E +L ++ KR TA+ ALA YF+ Y
Sbjct: 263 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA--QYH- 319
Query: 424 DLSSLPIYPP 433
D P+ P
Sbjct: 320 DPDDEPVADP 329
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 262 bits (672), Expect = 3e-81
Identities = 98/326 (30%), Positives = 165/326 (50%), Gaps = 43/326 (13%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRL-DHP 189
+E ++K+G+G Y V+++ D TG++VA+KK+ FD F+ + REI+IL L H
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKI-FDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
NI+ L ++ + +YLVF+YME D+ ++ + + + QL+ +++ HS
Sbjct: 70 NIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANIL--EPVHKQYVVYQLIKVIKYLHS 127
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLA--------------------NFSNTGHRQPL 289
G+LHRD+K SN+L+N E +K+ADFGL+ + + L
Sbjct: 128 GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPIL 187
Query: 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 349
T V T WYR PE+LLG+T Y +D+WS+GC+ E+L GKPI G + + QL +I +
Sbjct: 188 TDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVI 247
Query: 350 GSPPDDYW----------------KKSKLPHATLFKPQQPYDSSLRETFKDLPTT--AVN 391
P ++ +K ++ + + + L + A++
Sbjct: 248 DFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALD 307
Query: 392 LIETLLSVEPYKRATASAALASEYFS 417
L++ LL P KR +A+ AL + S
Sbjct: 308 LLDKLLQFNPNKRISANDALKHPFVS 333
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 258 bits (662), Expect = 5e-80
Identities = 90/330 (27%), Positives = 158/330 (47%), Gaps = 38/330 (11%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR--FDNFEPESVRFMAREILILRRLDHP 189
++ L+ IG G V A D + VA+KK+ F N + RE+++++ ++H
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN--QTHAKRAYRELVLMKCVNHK 84
Query: 190 NIIKLEGLITSRLSCS----IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
NII L + T + S +Y+V E M+ ++ ++ ++ + Q+L G++
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQMLCGIK 141
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
H HS G++HRD+K SN++V ++ LK+ DFGLA + T +T VVT +YR PE++L
Sbjct: 142 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVIL 199
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK------ 359
G Y +VD+WSVGC+ E++ G + G ++Q +K+ + G+P ++ KK
Sbjct: 200 G-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 258
Query: 360 ---SKLPHATLFKPQQPYDS--------SLRETFKDLPTTAVNLIETLLSVEPYKRATAS 408
P ++ + E K + A +L+ +L ++ KR +
Sbjct: 259 TYVENRPK----YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 314
Query: 409 AALASEYFSTKPYACDLSSLPIYPPSKEID 438
AL Y + + D S PP
Sbjct: 315 EALQHPYIN--VWY-DPSEAEAPPPKIPDK 341
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 258 bits (661), Expect = 3e-79
Identities = 107/368 (29%), Positives = 159/368 (43%), Gaps = 68/368 (18%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPN 190
+ IG+G+Y V+ A D +T K VA+KKV FE + + REI IL RL
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV-NRMFEDLIDCKRILREITILNRLKSDY 86
Query: 191 IIKLEGLITSRLSCS---IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
II+L LI +Y+V E + D+ L P I +E IK + LL G
Sbjct: 87 IIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTP-IFLTEEHIKTILYNLLLGENFI 145
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLA---------------------NFSNTGHR 286
H G++HRD+K +N L+N + +K+ DFGLA N +
Sbjct: 146 HESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLK 205
Query: 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG-----------KPILQG 335
+ LTS VVT WYR PEL+L +Y S+D+WS GC+FAELL P+ G
Sbjct: 206 KQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPG 265
Query: 336 -----------------RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDS-- 376
++ +QL+ IF + G+P +D K P + P+
Sbjct: 266 SSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPI 325
Query: 377 SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKE 436
+L++ + + +NL+E++L P KR T AL Y + E
Sbjct: 326 NLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLK-----------DVRKKKLE 374
Query: 437 IDAKHRED 444
+ +
Sbjct: 375 NFSTKKII 382
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 256 bits (655), Expect = 5e-78
Identities = 91/327 (27%), Positives = 160/327 (48%), Gaps = 38/327 (11%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR--FDNFEPESVRFMAREILILRRLDHP 189
++ L+ IG G V A D + VA+KK+ F N + RE+++++ ++H
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN--QTHAKRAYRELVLMKCVNHK 121
Query: 190 NIIKLEGLITSRLSCS----IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
NII L + T + + +YLV E M+ ++ ++ ++ + Q+L G++
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQMLCGIK 178
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
H HS G++HRD+K SN++V ++ LK+ DFGLA + T +T VVT +YR PE++L
Sbjct: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVIL 236
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK------ 359
G Y +VD+WSVGC+ E++ K + GR ++Q +K+ + G+P ++ KK
Sbjct: 237 G-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 295
Query: 360 ---SKLPHATLFKPQQPYDS--------SLRETFKDLPTTAVNLIETLLSVEPYKRATAS 408
P + + E K + A +L+ +L ++P KR +
Sbjct: 296 NYVENRPK----YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 351
Query: 409 AALASEYFSTKPYACDLSSLPIYPPSK 435
AL Y + + D + + PP
Sbjct: 352 DALQHPYIN--VWY-DPAEVEAPPPQI 375
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 2e-63
Identities = 68/313 (21%), Positives = 129/313 (41%), Gaps = 55/313 (17%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
FE++ +GQG + V +AR+ + A+KK+R + ++ E+++L L+H +
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL---SEVMLLASLNHQYV 64
Query: 192 IKL-----------EGLITSRLSCSIYLVFEYME-HDITGLLSCPDIKFSEAQIKCYMNQ 239
++ + + + ++++ EY E + L+ ++ + Q
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ 124
Query: 240 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------------NFSNTGHR 286
+L L + HS+G++HRD+K N+ ++ +K+ DFGLA + + G
Sbjct: 125 ILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 346
LTS + T Y E+L G Y +D++S+G +F E++ P G V L K+
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILKKLR 242
Query: 347 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 406
+ P D+ + +I L+ +P KR
Sbjct: 243 SVSIEFPPDFD-------------------------DNKMKVEKKIIRLLIDHDPNKRPG 277
Query: 407 ASAALASEYFSTK 419
A L S + K
Sbjct: 278 ARTLLNSGWLPVK 290
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 3e-63
Identities = 68/303 (22%), Positives = 119/303 (39%), Gaps = 46/303 (15%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPN- 190
+ L++IG G S VF+ + + +I A+K V + + +++ EI L +L +
Sbjct: 30 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 191 -IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
II+L + IY+V E D+ L + K Y +L + H
Sbjct: 89 KIIRLYDYEIT--DQYIYMVMECGNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVVTLWYRPPELLLGA- 307
G++H D+K +N L+ + G+LKL DFG+AN S+V T+ Y PPE +
Sbjct: 146 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 308 ---------TDYGPSVDLWSVGCVFAELLIGKPILQGRTE-VEQLHKIFKLCGSPPDDYW 357
+ P D+WS+GC+ + GK Q + +LH I + ++
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID--PNHEIEFP 262
Query: 358 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417
++++ L +P +R + LA Y
Sbjct: 263 -------------------------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297
Query: 418 TKP 420
+
Sbjct: 298 IQT 300
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 2e-62
Identities = 72/354 (20%), Positives = 132/354 (37%), Gaps = 46/354 (12%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPN- 190
+ L++IG G S VF+ + + +I A+K V + + +++ EI L +L +
Sbjct: 11 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 191 -IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
II+L + IY+V E D+ L + K Y +L + H
Sbjct: 70 KIIRLYDYEIT--DQYIYMVMECGNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVVTLWYRPPELLLG-- 306
G++H D+K +N L+ + G+LKL DFG+AN S+V T+ Y PPE +
Sbjct: 127 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 307 --------ATDYGPSVDLWSVGCVFAELLIGKPILQGRTE-VEQLHKIFKLCGSPPDDYW 357
+ P D+WS+GC+ + GK Q + +LH I + ++
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID--PNHEIEFP 243
Query: 358 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417
++++ L +P +R + LA Y
Sbjct: 244 DI-------------------------PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278
Query: 418 TKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSK 471
+ + + + K + + + + + +SH S
Sbjct: 279 IQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSS 332
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 4e-61
Identities = 72/354 (20%), Positives = 129/354 (36%), Gaps = 46/354 (12%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPN- 190
+ L++IG G S VF+ + + +I A+K V + + +++ EI L +L +
Sbjct: 58 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 191 -IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
II+L + IY+V E D+ L + K Y +L + H
Sbjct: 117 KIIRLYDYEIT--DQYIYMVMECGNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
G++H D+K +N L+ + G+LKL DFG+AN S+V + Y PPE + +
Sbjct: 174 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 309 D----------YGPSVDLWSVGCVFAELLIGKPILQGRTE-VEQLHKIFKLCGSPPDDYW 357
P D+WS+GC+ + GK Q + +LH I
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE---- 288
Query: 358 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417
P ++++ L +P +R + LA Y
Sbjct: 289 ----FP-------------------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325
Query: 418 TKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSK 471
+ + + + K + + + + + +SH S
Sbjct: 326 IQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSS 379
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 3e-60
Identities = 79/300 (26%), Positives = 129/300 (43%), Gaps = 39/300 (13%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRR 185
P RA+ +E L IG G+Y + R GKI+ K++ + + + + E+ +LR
Sbjct: 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 186 LDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLL---SCPDIKFSEAQIKCYMNQLL 241
L HPNI++ I R + ++Y+V EY E D+ ++ + E + M QL
Sbjct: 62 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 242 HGLEHCHSRG-----VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 296
L+ CH R VLHRD+K +N+ ++ + +KL DFGLA N + V T
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKTFVGTP 180
Query: 297 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 356
+Y PE + Y D+WS+GC+ EL P ++ E KI + G
Sbjct: 181 YYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE--GKFR--- 234
Query: 357 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
++P Y L +I +L+++ Y R + L +
Sbjct: 235 ----RIP--------YRYSDELN-----------EIITRMLNLKDYHRPSVEEILENPLI 271
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 4e-60
Identities = 70/301 (23%), Positives = 118/301 (39%), Gaps = 25/301 (8%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ + +GQG ++VFR R TG + A+K +F M RE +L++L+H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHK 67
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCP--DIKFSEAQIKCYMNQLLHGLEH 246
NI+KL + + L+ E+ + +L P E++ + ++ G+ H
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 247 CHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPE 302
G++HR+IK N++ + + V KL DFG A + S T Y P+
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQFVSLYGTEEYLHPD 185
Query: 303 LLLGATD-------YGPSVDLWSVGCVFAELLIGKP----ILQGRTEVEQLHKIFKLCGS 351
+ A YG +VDLWS+G F G R E ++KI S
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 352 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411
+K++ + P SL + L ++ +L + K
Sbjct: 246 GAISGVQKAE-NGPIDWSGDMPVSCSLSRGLQVL---LTPVLANILEADQEKCWGFDQFF 301
Query: 412 A 412
A
Sbjct: 302 A 302
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 3e-58
Identities = 70/293 (23%), Positives = 118/293 (40%), Gaps = 40/293 (13%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DH 188
+F++L ++G G+Y VF+ R + G++ A+K+ P+ E+ ++ H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
P ++LE +YL E + EAQ+ Y+ L L H H
Sbjct: 117 PCCVRLEQAWEEG--GILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH 174
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
S+G++H D+K +N+ + G KL DFGL G + + Y PELL G
Sbjct: 175 SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE---VQEGDPRYMAPELLQG- 230
Query: 308 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367
YG + D++S+G E+ + E ++ + G P ++
Sbjct: 231 -SYGTAADVFSLGLTILEVACNMELP---HGGEGWQQLRQ--GYLPPEFTAG-------- 276
Query: 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420
S LR +++ +L +P RATA A LA +P
Sbjct: 277 ------LSSELR-----------SVLVMMLEPDPKLRATAEALLALPVL-RQP 311
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 6e-58
Identities = 71/305 (23%), Positives = 123/305 (40%), Gaps = 60/305 (19%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
F+++E IG G + VF+A+ GK +K+V+++N E RE+ L +LDH NI
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAE---REVKALAKLDHVNI 66
Query: 192 IKL--------------EGLITSRLSCSIYLVFEYMEH-DITGLLS-CPDIKFSEAQIKC 235
+ + + +++ E+ + + + K +
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 236 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVV 294
Q+ G+++ HS+ +++RD+K SN+ + + +K+ DFGL + N G R T
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR---TRSKG 183
Query: 295 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 354
TL Y PE + DYG VDL+++G + AELL T E L
Sbjct: 184 TLRYMSPEQISS-QDYGKEVDLYALGLILAELLHV-----CDTAFETSKFFTDL------ 231
Query: 355 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 414
+ + +D + L++ LLS +P R S L +
Sbjct: 232 ---RDGIIS--------DIFDKKEK-----------TLLQKLLSKKPEDRPNTSEILRTL 269
Query: 415 YFSTK 419
K
Sbjct: 270 TVWKK 274
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 8e-58
Identities = 75/357 (21%), Positives = 142/357 (39%), Gaps = 39/357 (10%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ + +L+KIG+G++ + + G+ +K++ + RE+ +L + HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHC 247
NI++ S+Y+V +Y E D+ ++ + F E QI + Q+ L+H
Sbjct: 84 NIVQYRESFEEN--GSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYRPPELLLG 306
H R +LHRDIK N+ + +G ++L DFG+A ++T + + T +Y PE+
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL--ARACIGTPYYLSPEICEN 199
Query: 307 ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366
Y D+W++GCV EL K + + + KI GS P +
Sbjct: 200 -KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS--GSFP-------PVS--- 246
Query: 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLS 426
Y LR +L+ L P R + ++ L + + +
Sbjct: 247 -----LHYSYDLR-----------SLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSP 290
Query: 427 SLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVEDVAVRTQ 483
L + +K K R + + + ++K A + + +
Sbjct: 291 QLIAEEFCLKTFSKFGSQPIPAK---RPASGQNSISVMPAQKITKPAAKYGIPLAYK 344
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 200 bits (509), Expect = 1e-57
Identities = 68/303 (22%), Positives = 116/303 (38%), Gaps = 29/303 (9%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ + +GQG ++VFR R TG + A+K +F M RE +L++L+H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHK 67
Query: 190 NIIKLEGLITSRLSCSIYLVFEYME-----HDITGLLSCPDIKFSEAQIKCYMNQLLHGL 244
NI+KL + + L+ E+ + + E++ + ++ G+
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY--GLPESEFLIVLRDVVGGM 125
Query: 245 EHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP 300
H G++HR+IK N++ + + V KL DFG A + S T Y
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQFVSLYGTEEYLH 183
Query: 301 PELLLGATD-------YGPSVDLWSVGCVFAELLIGKP----ILQGRTEVEQLHKIFKLC 349
P++ A YG +VDLWS+G F G R E ++KI
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243
Query: 350 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 409
S +K++ + P SL + L ++ +L + K
Sbjct: 244 PSGAISGVQKAE-NGPIDWSGDMPVSCSLSRGLQVL---LTPVLANILEADQEKCWGFDQ 299
Query: 410 ALA 412
A
Sbjct: 300 FFA 302
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 1e-55
Identities = 81/290 (27%), Positives = 118/290 (40%), Gaps = 40/290 (13%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA-REILILRRLDH 188
F +KIG+G +S V+RA L G VALKKV+ + R +EI +L++L+H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYME----HDITGLLSCPDIKFSEAQIKCYMNQLLHGL 244
PN+IK + +V E + + E + Y QL L
Sbjct: 92 PNVIKYYASFIED--NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYRPPEL 303
EH HSR V+HRDIK +N+ + GV+KL D GL FS+ S V T +Y PE
Sbjct: 150 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYMSPER 207
Query: 304 LLGATDYGPSVDLWSVGCVFAELLIGKPILQGR-TEVEQL-HKIFKLCGSPPDDYWKKSK 361
+ Y D+WS+GC+ E+ + G + L KI + P
Sbjct: 208 IHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ--CDYPP------- 257
Query: 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411
P Y LR L+ ++ +P KR +
Sbjct: 258 -------LPSDHYSEELR-----------QLVNMCINPDPEKRPDVTYVY 289
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 8e-54
Identities = 83/340 (24%), Positives = 138/340 (40%), Gaps = 59/340 (17%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRF-MAREILILR 184
P + + +G+G ++ F D DT ++ A K V R M+ EI I R
Sbjct: 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 96
Query: 185 RLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP-----DI-----KFSEAQIK 234
L H +++ G +++V E C ++ +E + +
Sbjct: 97 SLAHQHVVGFHGFFEDNDF--VFVVLEL----------CRRRSLLELHKRRKALTEPEAR 144
Query: 235 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT-GHRQPLTSRV 293
Y+ Q++ G ++ H V+HRD+K NL +N + +K+ DFGLA G R
Sbjct: 145 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLC 202
Query: 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 353
T Y PE+L + VD+WS+GC+ LL+GKP + E +I K
Sbjct: 203 GTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN----- 256
Query: 354 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413
+Y +P K + A +LI+ +L +P R T + L
Sbjct: 257 -EY----SIP-------------------KHINPVAASLIQKMLQTDPTARPTINELLND 292
Query: 414 EYFST--KPYACDLSSLPIYPPSKEIDAKHREDARRKKVG 451
E+F++ P ++ L I PP I + + RK +
Sbjct: 293 EFFTSGYIPARLPITCLTI-PPRFSIAPSSLDPSNRKPLT 331
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 2e-53
Identities = 68/312 (21%), Positives = 125/312 (40%), Gaps = 58/312 (18%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
FE ++ +G+G + VF A++ A+K++R N E + M RE+ L +L+HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVM-REVKALAKLEHP 63
Query: 190 NIIK----------LEGLITSRLSCSIYLVFEYMEH-DITGLLS--CPDIKFSEAQIKCY 236
I++ E L S +Y+ + ++ ++ C + +
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 237 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-----------NFSNTGH 285
Q+ +E HS+G++HRD+K SN+ + V+K+ DFGL +
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 345
T +V T Y PE + G Y VD++S+G + ELL P T++E++ +
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY--PF---STQMERVRTL 237
Query: 346 FKLC-GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 404
+ P + +K +++ +LS P +R
Sbjct: 238 TDVRNLKFPPLFTQKYP--------------------------CEYVMVQDMLSPSPMER 271
Query: 405 ATASAALASEYF 416
A + + F
Sbjct: 272 PEAINIIENAVF 283
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 2e-53
Identities = 70/287 (24%), Positives = 111/287 (38%), Gaps = 51/287 (17%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
++G+G++ V R +D TG A+KKVR + F E E++ L P I
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRI 112
Query: 192 IKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI-----KFSEAQIKCYMNQLLHGLEH 246
+ L G + +I++ E +E G S + E + Y+ Q L GLE+
Sbjct: 113 VPLYGAVREGPWVNIFM--ELLE---GG--SLGQLIKQMGCLPEDRALYYLGQALEGLEY 165
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVL-KLADFG----LANFSNTGHRQPLTSRVVTLWYRPP 301
H+R +LH D+K N+L++++G L DFG L T + P
Sbjct: 166 LHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225
Query: 302 ELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361
E+++G VD+WS C+ +L G T+ + K+ PP
Sbjct: 226 EVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPW---TQYFRGPLCLKIASEPP-------- 273
Query: 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 408
P + S I+ L EP RA+A
Sbjct: 274 --------PIREIPPSCAPLTAQ-------AIQEGLRKEPVHRASAM 305
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 194 bits (493), Expect = 4e-53
Identities = 72/311 (23%), Positives = 119/311 (38%), Gaps = 19/311 (6%)
Query: 118 GEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA 177
G +E E++G G + V R DTG+ VA+K+ R + P++
Sbjct: 2 GGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELS-PKNRERWC 60
Query: 178 REILILRRLDHPNIIKL----EGLITSRLSCSIYLVFEYMEH-DITGLLSCPD--IKFSE 230
EI I+++L+HPN++ +GL + L EY E D+ L+ + E
Sbjct: 61 LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE 120
Query: 231 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLANFSNTGHRQ 287
I+ ++ + L + H ++HRD+K N+++ + K+ D G A + G +
Sbjct: 121 GPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--E 178
Query: 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 347
T V TL Y PELL Y +VD WS G + E + G + Q H +
Sbjct: 179 LCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR 237
Query: 348 LCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 407
+ L A F P + L ++ +L +R T
Sbjct: 238 --EKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGK---LERWLQCMLMWHQRQRGTD 292
Query: 408 SAALASEYFST 418
F
Sbjct: 293 PQNPNVGCFQA 303
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 5e-53
Identities = 79/291 (27%), Positives = 131/291 (45%), Gaps = 46/291 (15%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ +++++K+G G Y V RD T A+K +R + S + E+ +L+ LDHP
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITG--LLSCPDI----KFSEAQIKCYMNQLLHG 243
NI+KL + + YLV E G L +I KF+E + Q+L G
Sbjct: 97 NIMKLYDFFEDKR--NYYLVMECY----KGGELFD--EIIHRMKFNEVDAAVIIKQVLSG 148
Query: 244 LEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP 300
+ + H ++HRD+K NLL+ + + ++K+ DFGL+ + + R+ T +Y
Sbjct: 149 VTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ--KKMKERLGTAYYIA 206
Query: 301 PELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360
PE+L Y D+WS+G + LL G P G+T+ E L K+ K + WK
Sbjct: 207 PEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKN- 263
Query: 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411
+ A +LI+ +L + +R +A AL
Sbjct: 264 ------------------------VSEGAKDLIKQMLQFDSQRRISAQQAL 290
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 6e-53
Identities = 79/322 (24%), Positives = 131/322 (40%), Gaps = 58/322 (18%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRF-MAREILILR 184
P + + +G+G ++ F D DT ++ A K V R M+ EI I R
Sbjct: 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 70
Query: 185 RLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCP-----DI-----KFSEAQIK 234
L H +++ G +++V E C ++ +E + +
Sbjct: 71 SLAHQHVVGFHGFFEDNDF--VFVVLEL----------CRRRSLLELHKRRKALTEPEAR 118
Query: 235 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT-GHRQPLTSRV 293
Y+ Q++ G ++ H V+HRD+K NL +N + +K+ DFGLA G R
Sbjct: 119 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLC 176
Query: 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 353
T Y PE+L + VD+WS+GC+ LL+GKP + E +I K
Sbjct: 177 GTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN----- 230
Query: 354 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413
+Y +P K + A +LI+ +L +P R T + L
Sbjct: 231 -EY----SIP-------------------KHINPVAASLIQKMLQTDPTARPTINELLND 266
Query: 414 EYFST--KPYACDLSSLPIYPP 433
E+F++ P ++ L I P
Sbjct: 267 EFFTSGYIPARLPITCLTIPPR 288
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 9e-53
Identities = 62/293 (21%), Positives = 114/293 (38%), Gaps = 44/293 (15%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+ ++K+G+G +S V L G ALK++ + RE + R +HPNI
Sbjct: 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE--QQDREEAQREADMHRLFNHPNI 88
Query: 192 IKLEG--LITSRLSCSIYLVFEYME----HDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
++L L +L+ + + + L +E QI + + GLE
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR--------QPLTSRVVTLW 297
H++G HRD+K +N+L+ +EG L D G N + Q ++ T+
Sbjct: 149 AIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208
Query: 298 YRPPELLLGA--TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 355
YR PEL D+WS+GCV ++ G+ + + +
Sbjct: 209 YRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL-AVQN----- 262
Query: 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 408
+ +P + S+L L+ ++++V+P++R
Sbjct: 263 ---QLSIP------QSPRHSSALW-----------QLLNSMMTVDPHQRPHIP 295
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 1e-52
Identities = 72/291 (24%), Positives = 129/291 (44%), Gaps = 46/291 (15%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ + + +G+G++ V + +D T + A+K + + + + + RE+ +L++LDHP
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITG--LLSCPDI----KFSEAQIKCYMNQLLHG 243
NI+KL ++ S Y+V E TG L +I +FSE + Q+ G
Sbjct: 82 NIMKLFEILEDSS--SFYIVGELY----TGGELFD--EIIKRKRFSEHDAARIIKQVFSG 133
Query: 244 LEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP 300
+ + H ++HRD+K N+L+ + + +K+ DFGL+ + R+ T +Y
Sbjct: 134 ITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRIGTAYYIA 191
Query: 301 PELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360
PE+L G Y D+WS G + LL G P G+ E + L ++ + W+
Sbjct: 192 PEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRT- 248
Query: 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411
+ A +LI +L+ P R TA+ L
Sbjct: 249 ------------------------ISDDAKDLIRKMLTFHPSLRITATQCL 275
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 4e-52
Identities = 82/296 (27%), Positives = 124/296 (41%), Gaps = 53/296 (17%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
D ++ E++G+G +S V R TG A K + + + RE I R+L HP
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 190 NIIKLEGLITSRLSCSIYLVFEYME-----HDIT--GLLSCPDIKFSEAQIKCYMNQLLH 242
NI++L I YLVF+ + DI +SEA + Q+L
Sbjct: 66 NIVRLHDSIQEE--SFHYLVFDLVTGGELFEDIVARE-------FYSEADASHCIQQILE 116
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRVVTLWYR 299
+ +CHS G++HR++K NLL+ ++ +KLADFGLA N + T Y
Sbjct: 117 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAGTPGYL 174
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP--PDDYW 357
PE+L Y VD+W+ G + LL+G P + +I G+ P W
Sbjct: 175 SPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEW 231
Query: 358 KK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
+ A +LI+++L+V P KR TA AL
Sbjct: 232 DTVTP--------------------------EAKSLIDSMLTVNPKKRITADQALK 261
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 4e-52
Identities = 80/311 (25%), Positives = 133/311 (42%), Gaps = 47/311 (15%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDH 188
D ++ +G+G++ V +D TG+ A+K + + + RE+ +L++LDH
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITG--LLSCPDI----KFSEAQIKCYMNQLLH 242
PNI+KL + YLV E G L +I +FSE + Q+L
Sbjct: 86 PNIMKLYEFFEDKGY--FYLVGEVYT----GGELFD--EIISRKRFSEVDAARIIRQVLS 137
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYR 299
G+ + H ++HRD+K NLL+ + + +++ DFGL+ + + ++ T +Y
Sbjct: 138 GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS--KKMKDKIGTAYYI 195
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359
PE+L G Y D+WS G + LL G P G E + L K+ K + WKK
Sbjct: 196 APEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKK 253
Query: 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419
+ +A +LI +L+ P R +A AL E+ T
Sbjct: 254 -------------------------VSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288
Query: 420 PYACDLSSLPI 430
+P
Sbjct: 289 TKEQISVDVPS 299
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 6e-52
Identities = 71/296 (23%), Positives = 126/296 (42%), Gaps = 54/296 (18%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ + + +G+G++ V + +D T + A+K + + + + + RE+ +L++LDHP
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 190 NIIKLEGLITSRLSCSIYLVFEYME-----HDIT--GLLSCPDIKFSEAQIKCYMNQLLH 242
NI+KL ++ S Y+V E +I +FSE + Q+
Sbjct: 82 NIMKLFEILEDSS--SFYIVGELYTGGELFDEIIKRK-------RFSEHDAARIIKQVFS 132
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRVVTLWYR 299
G+ + H ++HRD+K N+L+ ++ +K+ DFGL+ + R+ T +Y
Sbjct: 133 GITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRIGTAYYI 190
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP--PDDYW 357
PE+L G Y D+WS G + LL G P G+ E + L ++ G W
Sbjct: 191 APEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV--ETGKYAFDLPQW 246
Query: 358 KK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
+ S A +LI +L+ P R TA+ L
Sbjct: 247 RTISD--------------------------DAKDLIRKMLTFHPSLRITATQCLE 276
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 2e-51
Identities = 82/299 (27%), Positives = 137/299 (45%), Gaps = 35/299 (11%)
Query: 120 AIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRF-MAR 178
++ + + + F+ +G+G+++ V+RA + TG VA+K + + +
Sbjct: 1 SLATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQN 60
Query: 179 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYM 237
E+ I +L HP+I++L S +YLV E + ++ L FSE + + +M
Sbjct: 61 EVKIHCQLKHPSILELYNYFED--SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFM 118
Query: 238 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 297
+Q++ G+ + HS G+LHRD+ SNLL+ +K+ADFGLA H + T T
Sbjct: 119 HQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL-CGTPN 177
Query: 298 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 357
Y PE+ + +G D+WS+GC+F LLIG+P T L+K+ DY
Sbjct: 178 YISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA------DY- 229
Query: 358 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
++P L A +LI LL P R + S+ L +
Sbjct: 230 ---EMP-------------------SFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFM 266
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 3e-51
Identities = 64/338 (18%), Positives = 123/338 (36%), Gaps = 49/338 (14%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALK---KVRFDNFEPESVRFMA----------- 177
+ + + QG ++ + K ALK K + +
Sbjct: 33 YRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 178 -REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME--------HDITGLLSCPDIKF 228
E+ I+ + + + EG+IT+ +Y+++EYME L
Sbjct: 91 KNELQIITDIKNEYCLTCEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 229 SEAQIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287
IKC + +L+ + H+ + + HRD+K SN+L++ G +KL+DFG + + +
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK 208
Query: 288 PLTSRVVTLWYRPPELLLGATDY-GPSVDLWSVGCVFAELLIGKPILQGRTEVEQLH-KI 345
S T + PPE + Y G VD+WS+G + + + +L I
Sbjct: 209 --GS-RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI 265
Query: 346 FKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 405
+ + P + + L ++ ++ L P +R
Sbjct: 266 RT------KNI----EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI 315
Query: 406 TASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHRE 443
T+ AL E+ + + SKE+ K ++
Sbjct: 316 TSEDALKHEWLADTNIE------DLREFSKELYKKRKK 347
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 3e-51
Identities = 55/348 (15%), Positives = 92/348 (26%), Gaps = 66/348 (18%)
Query: 110 PAWLSAVAGEAIQGWVPLRADA--------FEKLEKIGQGTYSSVFRARDLDTGKIVALK 161
A + AV D+ + +E + G S VF RD++ + ALK
Sbjct: 34 AAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALK 93
Query: 162 KVRFDNFEPES-VRFMAREILILRRLDHPN------------------------IIKLEG 196
S + + RL + +L
Sbjct: 94 VFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSP 153
Query: 197 LITSRLSCSIYLVFEYMEHDITGLLSCPDI------KFSEAQIKCYMNQLLHGLEHCHSR 250
+ L+ D+ L S D + QL+ + S+
Sbjct: 154 GQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK 213
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG-ATD 309
G++H NL + +G L L D T + V + Y P E L
Sbjct: 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTAT 269
Query: 310 YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP-DDYWKKSKLPHATLF 368
+ +++ W +G + C P K
Sbjct: 270 FTHALNAWQLGLSIYRV---------------------WCLFLPFGLVTPGIKGSWKRPS 308
Query: 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
DS + LP LI L+ + +R A+ + F
Sbjct: 309 LRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF 356
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 4e-51
Identities = 82/323 (25%), Positives = 131/323 (40%), Gaps = 57/323 (17%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR-----------FDNFEPESVRFMAR 178
+++ K+ K+G G Y V ++ + A+K ++ + + +
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 179 EILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG--LLSCPDI----KFSEAQ 232
EI +L+ LDHPNIIKL + + YLV E+ G L I KF E
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKKY--FYLVTEFY----EGGELFE--QIINRHKFDECD 147
Query: 233 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHRQPL 289
M Q+L G+ + H ++HRDIK N+L+ N +K+ DFGL++F + L
Sbjct: 148 AANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD--YKL 205
Query: 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 349
R+ T +Y PE+L Y D+WS G + LL G P G+ + + + K+ K
Sbjct: 206 RDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGK 263
Query: 350 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 409
+ WK + A LI+ +L+ + KR TA
Sbjct: 264 YYFDFNDWKN-------------------------ISDEAKELIKLMLTYDYNKRCTAEE 298
Query: 410 ALASEYFSTKPYACDLSSLPIYP 432
AL S + + S
Sbjct: 299 ALNSRWIKKYANNINKSDQKTLC 321
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 5e-51
Identities = 62/296 (20%), Positives = 108/296 (36%), Gaps = 45/296 (15%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPN 190
F + +G G ++ R + + VA+K++ PE F RE+ +LR D HPN
Sbjct: 26 FCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRI-----LPECFSFADREVQLLRESDEHPN 79
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
+I+ R Y+ E + + D + + Q GL H HS
Sbjct: 80 VIRYFCTEKDRQF--QYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL 137
Query: 251 GVLHRDIKGSNLLVNNEG-----VLKLADFGLANFSNTGHR--QPLTSRVVTLWYRPPEL 303
++HRD+K N+L++ ++DFGL G + T + PE+
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197
Query: 304 LLGATD--YGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360
L +VD++S GCVF ++ G + + + +
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHED 257
Query: 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
+ A LIE +++++P KR +A L +F
Sbjct: 258 VI--------------------------ARELIEKMIAMDPQKRPSAKHVLKHPFF 287
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 8e-51
Identities = 57/308 (18%), Positives = 109/308 (35%), Gaps = 62/308 (20%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPN 190
F +LEKIG G + SVF+ G I A+K+ + + RE+ L H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIK---FSEAQIKCYMNQLLHGLEH 246
+++ + + EY + +S F EA++K + Q+ GL +
Sbjct: 73 VVRYFSAWAED--DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVL-------------------KLADFGLANFSNTGHRQ 287
HS ++H DIK SN+ ++ + K+ D G
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV-----TRIS 185
Query: 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 347
+ E+L + P D++++ +P+ + +Q H+I +
Sbjct: 186 SPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR---NGDQWHEIRQ 242
Query: 348 LCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 407
G P +P L + F + L++ ++ +P +R +A
Sbjct: 243 --GRLPR-------IP------------QVLSQEFTE-------LLKVMIHPDPERRPSA 274
Query: 408 SAALASEY 415
A +
Sbjct: 275 MALVKHSV 282
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 8e-51
Identities = 85/293 (29%), Positives = 132/293 (45%), Gaps = 50/293 (17%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALK-----KVRFDNFEPESVRFMAREILILRRL 186
FE +G+G + +V+ AR+ + I+ALK ++ E +R RE+ I L
Sbjct: 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLR---REVEIQSHL 66
Query: 187 DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS---CPDIKFSEAQIKCYMNQLLHG 243
HPNI++L G + +YL+ EY G + KF E + Y+ +L +
Sbjct: 67 RHPNILRLYGYFHD--ATRVYLILEYAPL---GTVYRELQKLSKFDEQRTATYITELANA 121
Query: 244 LEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPEL 303
L +CHS+ V+HRDIK NLL+ + G LK+ADFG + + + R L TL Y PPE+
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCG---TLDYLPPEM 178
Query: 304 LLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363
+ G + VDLWS+G + E L+GKP + T E +I ++ ++ P
Sbjct: 179 IEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------EF----TFP 227
Query: 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
+ A +LI LL P +R L +
Sbjct: 228 -------------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 1e-50
Identities = 82/296 (27%), Positives = 124/296 (41%), Gaps = 53/296 (17%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
D ++ E++G+G +S V R TG A K + + + RE I R+L HP
Sbjct: 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 88
Query: 190 NIIKLEGLITSRLSCSIYLVFEYME-----HDIT--GLLSCPDIKFSEAQIKCYMNQLLH 242
NI++L I YLVF+ + DI +SEA + Q+L
Sbjct: 89 NIVRLHDSIQEE--SFHYLVFDLVTGGELFEDIVARE-------FYSEADASHCIQQILE 139
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRVVTLWYR 299
+ +CHS G++HR++K NLL+ ++ +KLADFGLA N + T Y
Sbjct: 140 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAGTPGYL 197
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP--PDDYW 357
PE+L Y VD+W+ G + LL+G P + +I G+ P W
Sbjct: 198 SPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEW 254
Query: 358 KK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
+ A +LI+++L+V P KR TA AL
Sbjct: 255 DTVTP--------------------------EAKSLIDSMLTVNPKKRITADQALK 284
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 1e-50
Identities = 76/333 (22%), Positives = 117/333 (35%), Gaps = 80/333 (24%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALK---KVRFDNFEPESVRFMAREILILRRL 186
+ IGQG+Y V A + T I A+K K + P+ V + E+ ++++L
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 187 DHPNIIKLEGLITSRLSCSIYLVFEYME-------------------------------- 214
HPNI +L + I LV E
Sbjct: 86 HHPNIARLYEVYEDEQY--ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 215 --------HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV-- 264
I G D E I M Q+ L + H++G+ HRDIK N L
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFST 203
Query: 265 NNEGVLKLADFGLANF---SNTGHRQPLTSRVVTLWYRPPELLLGATD-YGPSVDLWSVG 320
N +KL DFGL+ N G +T++ T ++ PE+L + YGP D WS G
Sbjct: 204 NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263
Query: 321 CVFAELLIGKPILQGRTEVEQLHKIFKLCGSP--PDDYWKKSKLPHATLFKPQQPYDSSL 378
+ LL+G G + + + ++ + +
Sbjct: 264 VLLHLLLMGAVPFPGVNDADTISQVLN--KKLCFENPNY--------------------- 300
Query: 379 RETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411
L A +L+ LL+ +R A AL
Sbjct: 301 ----NVLSPLARDLLSNLLNRNVDERFDAMRAL 329
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 2e-50
Identities = 75/317 (23%), Positives = 130/317 (41%), Gaps = 52/317 (16%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKV------RFDNFEPESVRFMAREILIL 183
D + + +G G V A + T K VA+K + E + + EI IL
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 184 RRLDHPNIIKLEGLITSRLSCSIYLVFEYME-----HDITGLLSCPDIKFSEAQIKCYMN 238
++L+HP IIK++ + Y+V E ME + G + + EA K Y
Sbjct: 70 KKLNHPCIIKIKNFFDAE---DYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFY 121
Query: 239 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRVVT 295
Q+L +++ H G++HRD+K N+L++++ ++K+ DFG + + + T
Sbjct: 122 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLCGT 179
Query: 296 LWYRPPELLLGATD--YGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSP 352
Y PE+L+ Y +VD WS+G + L G P + RT+V +I +
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 239
Query: 353 PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
+ W ++ A++L++ LL V+P R T AL
Sbjct: 240 IPEVW-------------------------AEVSEKALDLVKKLLVVDPKARFTTEEALR 274
Query: 413 SEYFSTKPYACDLSSLP 429
+ + L
Sbjct: 275 HPWLQDEDMKRKFQDLL 291
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 4e-50
Identities = 78/287 (27%), Positives = 123/287 (42%), Gaps = 50/287 (17%)
Query: 134 KLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIK 193
+G+GTY V+ RDL +A+K++ + + + EI + + L H NI++
Sbjct: 26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQ 83
Query: 194 LEGLITSRLSCSIYLVFEYMEHD-ITGLL--SCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
G + I++ E + ++ LL +K +E I Y Q+L GL++ H
Sbjct: 84 YLGSFSENGFIKIFM--EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN 141
Query: 251 GVLHRDIKGSNLLVNN-EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD 309
++HRDIKG N+L+N GVLK++DFG + G + TL Y PE++
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRL-AGINPCTETFTGTLQYMAPEIIDKGPR 200
Query: 310 -YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368
YG + D+WS+GC E+ GKP P + + P A +F
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKP--------------------P----FYELGEPQAAMF 236
Query: 369 K-------PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 408
K P+ P S K I +P KRA A+
Sbjct: 237 KVGMFKVHPEIPESMS--AEAKA-------FILKCFEPDPDKRACAN 274
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 1e-49
Identities = 70/293 (23%), Positives = 116/293 (39%), Gaps = 46/293 (15%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKV--RFDNFEPESVRFMAREILILRRLD 187
D F K+G G + V + +G +K + E + EI +L+ LD
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIE---AEIEVLKSLD 78
Query: 188 HPNIIKLEGLITSRLSCSIYLVFEYME-----HDITGLLSCPDIKFSEAQIKCYMNQLLH 242
HPNIIK+ + + +Y+V E E I + SE + M Q+++
Sbjct: 79 HPNIIKIFEVFEDYHN--MYIVMETCEGGELLERIVSAQARGK-ALSEGYVAELMKQMMN 135
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYR 299
L + HS+ V+H+D+K N+L + +K+ DFGLA + + T+ T Y
Sbjct: 136 ALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD--EHSTNAAGTALYM 193
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359
PE+ D D+WS G V LL G G + E K
Sbjct: 194 APEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA------------TY 239
Query: 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
+ + + L AV+L++ +L+ +P +R +A+ L
Sbjct: 240 KEP--------------NYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 1e-49
Identities = 82/305 (26%), Positives = 128/305 (41%), Gaps = 60/305 (19%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALK---KVRFDNFEPESVR----FMAREILI 182
+ +E E +G+G S V R T K A+K +F E V+ +E+ I
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 183 LRRLD-HPNIIKLEGLITSRLSCSIYLVFEYME-----HDIT--GLLSCPDIKFSEAQIK 234
LR++ HPNII+L+ + +LVF+ M+ +T SE + +
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTF--FFLVFDLMKKGELFDYLTEKV-------TLSEKETR 127
Query: 235 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 294
M LL + H ++HRD+K N+L++++ +KL DFG + + G + L
Sbjct: 128 KIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCG 185
Query: 295 TLWYRPPELLLGATD-----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 349
T Y PE++ + + YG VD+WS G + LL G P R ++ L I +
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI--MS 243
Query: 350 GSP--PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 407
G+ W +T KD L+ L V+P KR TA
Sbjct: 244 GNYQFGSPEWD------------------DYSDTVKD-------LVSRFLVVQPQKRYTA 278
Query: 408 SAALA 412
ALA
Sbjct: 279 EEALA 283
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 1e-49
Identities = 81/297 (27%), Positives = 125/297 (42%), Gaps = 54/297 (18%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALK---KVRFDNFEPESVRFMAREILILRRL 186
+ ++ E++G+G +S V R + G+ A + + + + RE I R L
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE---REARICRLL 67
Query: 187 DHPNIIKLEGLITSRLSCSIYLVFEYME-----HDITGLLSCPDIKFSEAQIKCYMNQLL 241
HPNI++L I+ YL+F+ + DI +SEA + Q+L
Sbjct: 68 KHPNIVRLHDSISEEG--HHYLIFDLVTGGELFEDI-----VAREYYSEADASHCIQQIL 120
Query: 242 HGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRVVTLWY 298
+ HCH GV+HR++K NLL+ ++ +KLADFGLA G +Q T Y
Sbjct: 121 EAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWFGFAGTPGY 179
Query: 299 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP--PDDY 356
PE+L YG VDLW+ G + LL+G P + +I G+ P
Sbjct: 180 LSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI--KAGAYDFPSPE 236
Query: 357 WKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
W + A +LI +L++ P KR TA+ AL
Sbjct: 237 WDTVTP--------------------------EAKDLINKMLTINPSKRITAAEALK 267
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 2e-49
Identities = 74/301 (24%), Positives = 127/301 (42%), Gaps = 56/301 (18%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKV------RFDNFEPESVRFMAREILIL 183
D + + +G G V A + T K VA++ + E + + EI IL
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 184 RRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG--LLSCPDI----KFSEAQIKCYM 237
++L+HP IIK++ + Y+V E M G L + + EA K Y
Sbjct: 195 KKLNHPCIIKIKNFFDAE---DYYIVLELM----EGGELFD--KVVGNKRLKEATCKLYF 245
Query: 238 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRVV 294
Q+L +++ H G++HRD+K N+L++++ ++K+ DFG + + +
Sbjct: 246 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLCG 303
Query: 295 TLWYRPPELLLGATD--YGPSVDLWSVGCVFAELLIG-KPILQGRTEVEQLHKIFKLCGS 351
T Y PE+L+ Y +VD WS+G + L G P + RT+V +I +
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 363
Query: 352 PPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 410
+ W + S+ A++L++ LL V+P R T A
Sbjct: 364 FIPEVWAEVSE--------------------------KALDLVKKLLVVDPKARFTTEEA 397
Query: 411 L 411
L
Sbjct: 398 L 398
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 177 bits (449), Expect = 2e-49
Identities = 78/373 (20%), Positives = 134/373 (35%), Gaps = 59/373 (15%)
Query: 129 ADAFEKLEKIGQG--TYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL 186
+E L IG+G +V AR TG+ V ++++ + E V F+ E+ + +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 187 DHPNIIKLEG--LITSRLSCSIYLVFEYMEHDITGLLSCPDI-------KFSEAQIKCYM 237
+HPNI+ + + L ++V +M + G S D+ +E I +
Sbjct: 84 NHPNIVPYRATFIADNEL----WVVTSFMAY---G--SAKDLICTHFMDGMNELAIAYIL 134
Query: 238 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFG-LANFSNTGHRQ-----PLTS 291
+L L++ H G +HR +K S++L++ +G + L+ + + G RQ
Sbjct: 135 QGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKY 194
Query: 292 RVVTLWYRPPELLL-GATDYGPSVDLWSVGCVFAELLIGKP-------------ILQGRT 337
V L + PE+L Y D++SVG EL G L G
Sbjct: 195 SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV 254
Query: 338 -----------EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLP 386
E + + S D S + P PY + F
Sbjct: 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHH-- 312
Query: 387 TTAVNLIETLLSVEPYKRATASAALASEYF-STKPYACDLSSLPIYPPSKEIDAKHREDA 445
+E L P R +AS L +F K A + + P + + + +
Sbjct: 313 -----FVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQ 367
Query: 446 RRKKVGGRVRGAE 458
+ G V E
Sbjct: 368 DHSGIFGLVTNLE 380
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-49
Identities = 86/307 (28%), Positives = 123/307 (40%), Gaps = 58/307 (18%)
Query: 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKL 194
IG+G++ V A T A KK+ E + + +EI I++ LDHPNII+L
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK---QEIEIMKSLDHPNIIRL 71
Query: 195 EGLITSRLSCSIYLVFEYME-----HDIT--GLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
IYLV E + F E+ M +L + +C
Sbjct: 72 YETFEDNTD--IYLVMELCTGGELFERVVHKR-------VFRESDAARIMKDVLSAVAYC 122
Query: 248 HSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELL 304
H V HRD+K N L + LKL DFGLA G + + ++V T +Y P++L
Sbjct: 123 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--KMMRTKVGTPYYVSPQVL 180
Query: 305 LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP--PDDYWKK-SK 361
G YGP D WS G + LL G P T+ E + KI G+ P+ W S
Sbjct: 181 EG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI--REGTFTFPEKDWLNVSP 236
Query: 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421
A +LI LL+ P +R T+ AL E+F +
Sbjct: 237 --------------------------QAESLIRRLLTKSPKQRITSLQALEHEWFEKQLS 270
Query: 422 ACDLSSL 428
+ + L
Sbjct: 271 SSPRNLL 277
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 3e-49
Identities = 76/297 (25%), Positives = 121/297 (40%), Gaps = 58/297 (19%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDH 188
F +E +G G +S VF + TGK+ ALK ++ S+ EI +L+++ H
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVLKKIKH 65
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYME-----HDIT--GLLSCPDIKFSEAQIKCYMNQLL 241
NI+ LE + S YLV + + I G ++E + Q+L
Sbjct: 66 ENIVTLEDIYESTTH--YYLVMQLVSGGELFDRILERG-------VYTEKDASLVIQQVL 116
Query: 242 HGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRVVTLWY 298
+++ H G++HRD+K NLL + + DFGL+ G +++ T Y
Sbjct: 117 SAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---IMSTACGTPGY 173
Query: 299 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP--PDDY 356
PE+L Y +VD WS+G + LL G P TE + KI + G +
Sbjct: 174 VAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKE--GYYEFESPF 230
Query: 357 WKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
W S+ +A + I LL +P +R T AL+
Sbjct: 231 WDDISE--------------------------SAKDFICHLLEKDPNERYTCEKALS 261
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 3e-49
Identities = 55/283 (19%), Positives = 106/283 (37%), Gaps = 46/283 (16%)
Query: 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLE 195
+IG+G++ +V++ D +T VA +++ + E +L+ L HPNI++
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 196 G--LITSRLSCSIYLVFEYMEHDITGLLSCPDI-----KFSEAQIKCYMNQLLHGLEHCH 248
T + I LV E M +G + ++ + Q+L GL+ H
Sbjct: 92 DSWESTVKGKKCIVLVTELMT---SG--TLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 146
Query: 249 SRG--VLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
+R ++HRD+K N+ + G +K+ D GLA + + + T + PE +
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPE--M 201
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365
Y SVD+++ G E+ + Q+++
Sbjct: 202 YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR-------------------V 242
Query: 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 408
T +D K+ +IE + +R +
Sbjct: 243 TSGVKPASFDKVAIPEVKE-------IIEGCIRQNKDERYSIK 278
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 4e-49
Identities = 84/319 (26%), Positives = 134/319 (42%), Gaps = 54/319 (16%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALK-----KVRFDNFEPESVRFMAREI 180
D F+ +G+G + +V+ AR+ I+ALK ++ + E +R REI
Sbjct: 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVE-HQLR---REI 65
Query: 181 LILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQ 239
I L HPNI+++ R IYL+ E+ ++ L +F E + +M +
Sbjct: 66 EIQSHLRHPNILRMYNYFHDR--KRIYLMLEFAPRGELYKELQ-KHGRFDEQRSATFMEE 122
Query: 240 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYR 299
L L +CH R V+HRDIK NLL+ +G LK+ADFG + + + R+ + TL Y
Sbjct: 123 LADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCG---TLDYL 179
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359
PPE++ G + VDLW G + E L+G P + E +I + D
Sbjct: 180 PPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV------DL--- 229
Query: 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF--S 417
K P L + +LI LL P +R + + +
Sbjct: 230 -KFP-------------------PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269
Query: 418 TKPYACDLSSLPIYPPSKE 436
++ LP S +
Sbjct: 270 SRRV------LPPVYQSTQ 282
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 3e-48
Identities = 73/319 (22%), Positives = 128/319 (40%), Gaps = 45/319 (14%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRR 185
+ D +E E IG G + V A + VA+K++ + + + + +EI + +
Sbjct: 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS-MDELLKEIQAMSQ 69
Query: 186 LDHPNIIKLEG--LITSRLSCSIYLVFEYME----HDI----TGLLSCPDIKFSEAQIKC 235
HPNI+ ++ L +LV + + DI E+ I
Sbjct: 70 CHHPNIVSYYTSFVVKDEL----WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT 125
Query: 236 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-SNTGHRQPLTSR-- 292
+ ++L GLE+ H G +HRD+K N+L+ +G +++ADFG++ F + G R
Sbjct: 126 ILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185
Query: 293 -VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 351
V T + PE++ Y D+WS G EL G ++ L +
Sbjct: 186 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ--ND 243
Query: 352 PPDDYWKKSKLPHATLFKPQQPYDSSLR--ETFKDLPTTAVNLIETLLSVEPYKRATASA 409
PP +L Q + + ++F+ +I L +P KR TA+
Sbjct: 244 PP------------SLETGVQDKEMLKKYGKSFRK-------MISLCLQKDPEKRPTAAE 284
Query: 410 ALASEYFSTKPYACDLSSL 428
L ++F A + L
Sbjct: 285 LLRHKFFQK---AKNKEFL 300
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 6e-48
Identities = 73/297 (24%), Positives = 126/297 (42%), Gaps = 50/297 (16%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALK---KVRFDNFE-PESVRFMAREILILRR 185
D +E E++G G ++ V + R TGK A K K R + S + RE+ ILR
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 186 LDHPNIIKLEGLITSRLSCSIYLVFEYME-----HDITGLLSCPDIKFSEAQIKCYMNQL 240
+ HPNII L + ++ + L+ E + + +E + ++ Q+
Sbjct: 65 IRHPNIITLHDIFENKTD--VVLILELVSGGELFDFLA-----EKESLTEDEATQFLKQI 117
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNEGV----LKLADFGLANFSNTGHRQPLTSRVVTL 296
L G+ + HS+ + H D+K N+++ ++ V +KL DFG+A+ G + T
Sbjct: 118 LDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG--NEFKNIFGTP 175
Query: 297 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 356
+ PE++ G D+WS+G + LL G G T+ E L I + ++Y
Sbjct: 176 EFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEY 234
Query: 357 WKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
+ S+L A + I LL +P +R T + +L
Sbjct: 235 FSNTSEL--------------------------AKDFIRRLLVKDPKRRMTIAQSLE 265
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 8e-48
Identities = 80/299 (26%), Positives = 127/299 (42%), Gaps = 54/299 (18%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALK---KVRFDNFEPESVRFMAREILILRRL 186
D +E E IG+G +S V R + +TG+ A+K +F + S + RE I L
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 187 DHPNIIKLEGLITSRLSCSIYLVFEYME-----HDITGLLSCPDIKFSEAQIKCYMNQLL 241
HP+I++L +S +Y+VFE+M+ +I +SEA YM Q+L
Sbjct: 84 KHPHIVELLETYSSDGM--LYMVFEFMDGADLCFEIVKRAD-AGFVYSEAVASHYMRQIL 140
Query: 242 HGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLW 297
L +CH ++HRD+K +L+ N +KL FG+A +G RV T
Sbjct: 141 EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG--LVAGGRVGTPH 198
Query: 298 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK--LCGSP--P 353
+ PE++ YG VD+W G + LL G G E ++F+ + G
Sbjct: 199 FMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKMN 252
Query: 354 DDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411
W S+ +A +L+ +L ++P +R T AL
Sbjct: 253 PRQWSHISE--------------------------SAKDLVRRMLMLDPAERITVYEAL 285
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 9e-48
Identities = 73/320 (22%), Positives = 121/320 (37%), Gaps = 62/320 (19%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-H 188
+ + +G G+ +V + G+ VA+K++ D + EI +L D H
Sbjct: 15 NLVVSEKILGYGSSGTV-VFQGSFQGRPVAVKRMLIDFCD-----IALMEIKLLTESDDH 68
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYME---HDI---TGLLSCPDIKFSEAQIKCYMNQLLH 242
PN+I+ T+ +Y+ E D+ + E + Q+
Sbjct: 69 PNVIRYYCSETTDRF--LYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNNEGV-------------LKLADFGLANFSNTGH---R 286
G+ H HS ++HRD+K N+LV+ + ++DFGL ++G R
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 287 QPLTSRVVTLWYRPPELLLGATD------YGPSVDLWSVGCVFAELL-IGKPILQGRTEV 339
L + T +R PELL + + S+D++S+GCVF +L GK +
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246
Query: 340 EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSV 399
E I + L + +D SL D LI ++
Sbjct: 247 ES--NIIR----------GIFSLDE-----MKCLHDRSLIAEATD-------LISQMIDH 282
Query: 400 EPYKRATASAALASEYFSTK 419
+P KR TA L F K
Sbjct: 283 DPLKRPTAMKVLRHPLFWPK 302
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 9e-48
Identities = 84/304 (27%), Positives = 121/304 (39%), Gaps = 59/304 (19%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALK-----KVRFDNFEPESVRFM-AREILIL 183
++ + IG+G S V R TG A+K R + E VR RE IL
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 184 RRL-DHPNIIKLEGLITSRLSCSIYLVFEYME-----HDIT--GLLSCPDIKFSEAQIKC 235
R++ HP+II L S ++LVF+ M +T SE + +
Sbjct: 154 RQVAGHPHIITLIDSYESSSF--MFLVFDLMRKGELFDYLTEKV-------ALSEKETRS 204
Query: 236 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 295
M LL + H+ ++HRD+K N+L+++ ++L+DFG + G + L T
Sbjct: 205 IMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG--EKLRELCGT 262
Query: 296 LWYRPPELLLGATD-----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 350
Y PE+L + D YG VDLW+ G + LL G P R ++ L I + G
Sbjct: 263 PGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI--MEG 320
Query: 351 SP--PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 408
W T KD LI LL V+P R TA
Sbjct: 321 QYQFSSPEW------------------DDRSSTVKD-------LISRLLQVDPEARLTAE 355
Query: 409 AALA 412
AL
Sbjct: 356 QALQ 359
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 1e-47
Identities = 71/310 (22%), Positives = 120/310 (38%), Gaps = 60/310 (19%)
Query: 123 GWVPLRADAFEKL----EKIGQGTYSSVFRARDLDTGKIVALK-------KVRFDNFEPE 171
G P + E E++G G ++ V + R+ TG A K + E
Sbjct: 1 GMEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSRE 60
Query: 172 SVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME-----HDITGLLSCPDI 226
+ RE+ ILR++ H N+I L + +R + L+ E + +
Sbjct: 61 EIE---REVSILRQVLHHNVITLHDVYENRTD--VVLILELVSGGELFDFLA-----QKE 110
Query: 227 KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFSN 282
SE + ++ Q+L G+ + H++ + H D+K N+++ +KL DFGLA+
Sbjct: 111 SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 283 TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQL 342
G + T + PE++ G D+WS+G + LL G G T+ E L
Sbjct: 171 DG--VEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 227
Query: 343 HKIFKLCGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEP 401
I + ++++ S+L A + I LL E
Sbjct: 228 ANITSVSYDFDEEFFSHTSEL--------------------------AKDFIRKLLVKET 261
Query: 402 YKRATASAAL 411
KR T AL
Sbjct: 262 RKRLTIQEAL 271
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 1e-47
Identities = 67/296 (22%), Positives = 123/296 (41%), Gaps = 50/296 (16%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR----FDNFEPESVRFMAREILILRR 185
D ++ E++G G ++ V + R+ TG A K ++ + S + RE+ IL+
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 186 LDHPNIIKLEGLITSRLSCSIYLVFEYME-----HDITGLLSCPDIKFSEAQIKCYMNQL 240
+ HPN+I L + ++ + L+ E + + +E + ++ Q+
Sbjct: 71 IQHPNVITLHEVYENKTD--VILILELVAGGELFDFLA-----EKESLTEEEATEFLKQI 123
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNE----GVLKLADFGLANFSNTGHRQPLTSRVVTL 296
L+G+ + HS + H D+K N+++ + +K+ DFGLA+ + G + T
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIFGTP 181
Query: 297 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 356
+ PE++ G D+WS+G + LL G G T+ E L + + D+Y
Sbjct: 182 EFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 357 WKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411
+ S L A + I LL +P KR T +L
Sbjct: 241 FSNTSAL--------------------------AKDFIRRLLVKDPKKRMTIQDSL 270
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 1e-47
Identities = 69/360 (19%), Positives = 124/360 (34%), Gaps = 57/360 (15%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ + E +G+G + V R + + K K V+ + V+ +EI IL H
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHR 61
Query: 190 NIIKLEGLITSRLSCSIYLVFEYME-----HDITGLLSCPDIKFSEAQIKCYMNQLLHGL 244
NI+ L S + ++FE++ I + +E +I Y++Q+ L
Sbjct: 62 NILHLHESFESM--EELVMIFEFISGLDIFERINTS----AFELNEREIVSYVHQVCEAL 115
Query: 245 EHCHSRGVLHRDIKGSNLLVNNE--GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPE 302
+ HS + H DI+ N++ +K+ +FG A G Y PE
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFRLLFTAPEYYAPE 173
Query: 303 LLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362
+ + D+WS+G + LL G T + + I + ++ +
Sbjct: 174 VHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF----- 227
Query: 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422
K++ A++ ++ LL E R TAS AL + K
Sbjct: 228 --------------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIER 267
Query: 423 CDLSSLPIYPPSKEIDAKHREDARRKKVGGRVR-------GAETRKTTRKSHGMSKLAPV 475
+ + + + KK V G R S K+A +
Sbjct: 268 VSTKVI------RTLKHRRYYHTLIKKDLNMVVSAARISCGGAIRSQKGVSVAKVKVASI 321
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-47
Identities = 82/337 (24%), Positives = 142/337 (42%), Gaps = 67/337 (19%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAR----EILILRRL- 186
+E L+ IG+G++ V +A D + VALK VR + + R EI IL L
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR-------NEKRFHRQAAEEIRILEHLR 151
Query: 187 -----DHPNIIKLEGLITSRLSCSIY-----LVFEYMEHDITGLLSCPDIK-FSEAQIKC 235
+ N+I + L + + FE + ++ L+ + FS ++
Sbjct: 152 KQDKDNTMNVIHM-------LENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRK 204
Query: 236 YMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG--VLKLADFGLANFSNTGHRQPLTSRV 293
+ + +L L+ H ++H D+K N+L+ +G +K+ DFG + + + Q + + +
Sbjct: 205 FAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH----QRVYTYI 260
Query: 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 353
+ +YR PE++LGA YG +D+WS+GC+ AELL G P+L G E +QL + +L G P
Sbjct: 261 QSRFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPS 319
Query: 354 DDYWKKSK----------LPHATLFKPQQ------PYDSSLRETFKDLPTTA-------- 389
SK P S R + P +
Sbjct: 320 QKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKG 379
Query: 390 ------VNLIETLLSVEPYKRATASAALASEYFSTKP 420
++ ++ L +P R T AL + +
Sbjct: 380 CDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRL 416
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 7e-47
Identities = 72/292 (24%), Positives = 120/292 (41%), Gaps = 47/292 (16%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDH 188
D ++ LE++G G + V R + TG++ K + +V+ EI I+ +L H
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK---NEISIMNQLHH 107
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITG-----LLSCPDIKFSEAQIKCYMNQLLHG 243
P +I L + + L+ E+ ++G ++ D K SEA++ YM Q G
Sbjct: 108 PKLINLHDAFEDKYE--MVLILEF----LSGGELFDRIAAEDYKMSEAEVINYMRQACEG 161
Query: 244 LEHCHSRGVLHRDIKGSNLLVNN--EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPP 301
L+H H ++H DIK N++ +K+ DFGLA N + + T + P
Sbjct: 162 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAP 219
Query: 302 ELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-S 360
E++ G D+W++G + LL G G ++E L + + +D + S
Sbjct: 220 EIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVS 278
Query: 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
A + I+ LL EP KR T AL
Sbjct: 279 PE--------------------------AKDFIKNLLQKEPRKRLTVHDALE 304
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 2e-46
Identities = 67/293 (22%), Positives = 107/293 (36%), Gaps = 56/293 (19%)
Query: 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKL 194
+ +G G V TG+ ALK + + R +E+ + P+I+ +
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLLY----DSPKAR---QEVDHHWQASGGPHIVCI 87
Query: 195 EGLI--TSRLSCSIYLVFEYME-----HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
+ + ++ E ME I D F+E + M + ++
Sbjct: 88 LDVYENMHHGKRCLLIIMECMEGGELFSRI---QERGDQAFTEREAAEIMRDIGTAIQFL 144
Query: 248 HSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELL 304
HS + HRD+K NLL ++ VLKL DFG A + L + T +Y PE +
Sbjct: 145 HSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN---ALQTPCYTPYYVAPE-V 200
Query: 305 LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK--LCGSP--PDDYWKK- 359
LG Y S D+WS+G + LL G P T + + G P+ W +
Sbjct: 201 LGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEV 260
Query: 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
S+ A LI LL +P +R T + +
Sbjct: 261 SE--------------------------DAKQLIRLLLKTDPTERLTITQFMN 287
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 2e-46
Identities = 76/330 (23%), Positives = 137/330 (41%), Gaps = 51/330 (15%)
Query: 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP-ESVRFMAREILILRRLD 187
F L +IG G++ +V+ ARD+ ++VA+KK+ + + E + + +E+ L++L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 188 HPNIIKLEG--LITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
HPN I+ G L +LV EY + LL E +I + L GL
Sbjct: 113 HPNTIQYRGCYLREHTA----WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLA 168
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR---VVTLWYRPPE 302
+ HS ++HRD+K N+L++ G++KL DFG ++ + V T ++ PE
Sbjct: 169 YLHSHNMIHRDVKAGNILLSEPGLVKLGDFG---SASI-----MAPANSFVGTPYWMAPE 220
Query: 303 LLLGATD--YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360
++L + Y VD+WS+G EL KP L + + ++ + +
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAERKPPL---FNMNAMSALYHIAQNES------- 270
Query: 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420
P L E F++ +++ L P R T+ L +
Sbjct: 271 --P--ALQSGH------WSEYFRN-------FVDSCLQKIPQDRPTSEVLLKHRFVLR-- 311
Query: 421 YACDLSSL-PIYPPSKEIDAKHREDARRKK 449
+ + + +K+ + RK
Sbjct: 312 -ERPPTVIMDLIQRTKDAVRELDNLQYRKM 340
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 4e-46
Identities = 70/296 (23%), Positives = 122/296 (41%), Gaps = 50/296 (16%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR----FDNFEPESVRFMAREILILRR 185
D ++ E++G G ++ V + R+ TG A K ++ + + RE+ ILR+
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 186 LDHPNIIKLEGLITSRLSCSIYLVFEYME-----HDITGLLSCPDIKFSEAQIKCYMNQL 240
+ HPNII L + +R + L+ E + + SE + ++ Q+
Sbjct: 72 VLHPNIITLHDVYENRTD--VVLILELVSGGELFDFLA-----QKESLSEEEATSFIKQI 124
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 296
L G+ + H++ + H D+K N+++ +KL DFGLA+ G + T
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFKNIFGTP 182
Query: 297 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 356
+ PE++ G D+WS+G + LL G G T+ E L I + +++
Sbjct: 183 EFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEF 241
Query: 357 WKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411
+ + S+L A + I LL E KR T AL
Sbjct: 242 FSQTSEL--------------------------AKDFIRKLLVKETRKRLTIQEAL 271
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 4e-46
Identities = 50/342 (14%), Positives = 99/342 (28%), Gaps = 81/342 (23%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP-ESVRFMAREILILRRL---- 186
+ +GQ + A D +TG+ + F P +++ M E+L LR L
Sbjct: 75 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 134
Query: 187 ---------------------DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLL---- 221
+I++ S + ++ M+ ++
Sbjct: 135 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 194
Query: 222 --SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN 279
S Q++ L H G++H ++ +++++ G + L F
Sbjct: 195 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 254
Query: 280 FSNTGHRQPLTSRVVTLWYRPPELL----------LGATDYGPSVDLWSVGCVFAELLIG 329
V+ + PPEL T S D W++G V +
Sbjct: 255 RDGA-----RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
Query: 330 KPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTA 389
+ + IF+ C K++P
Sbjct: 310 DLPITKDAALGGSEWIFRSC---------------------------------KNIPQPV 336
Query: 390 VNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIY 431
L+E L R A+ + + + ++LP+Y
Sbjct: 337 RALLEGFLRYPKEDRLLPLQAMETPEY-EQLRTELSAALPLY 377
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 5e-46
Identities = 76/385 (19%), Positives = 127/385 (32%), Gaps = 54/385 (14%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
D ++ E++G G + V R + TG A K V + + +EI + L HP
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHP 214
Query: 190 NIIKLEGLITSRLSCSIYLVFEYME-----HDITGLLSCPDIKFSEAQIKCYMNQLLHGL 244
++ L + +++E+M + K SE + YM Q+ GL
Sbjct: 215 TLVNLHDAFEDDNE--MVMIYEFMSGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGL 268
Query: 245 EHCHSRGVLHRDIKGSNLLVNN--EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPE 302
H H +H D+K N++ LKL DFGL + Q + T + PE
Sbjct: 269 CHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QSVKVTTGTAEFAAPE 326
Query: 303 LLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SK 361
+ G G D+WSVG + LL G G + E L + + D + S+
Sbjct: 327 VAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 385
Query: 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421
+ I LL +P R T AL + +
Sbjct: 386 D--------------------------GKDFIRKLLLADPNTRMTIHQALEHPWLTP--- 416
Query: 422 ACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTR-KSHGMSKLAPVEDVAV 480
+ K R+ + K R ++ + ++ ++
Sbjct: 417 --GNAPGRDSQIPSSRYTKIRDSIKTKY---DAWPEPLPPLGRISNYSSLRKHRPQEYSI 471
Query: 481 RTQFAKKINGHSLHILKDDELSGRE 505
R F + I+K E
Sbjct: 472 RDAFWDRSEAQPRFIVKPYGTEVGE 496
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 5e-46
Identities = 74/304 (24%), Positives = 115/304 (37%), Gaps = 45/304 (14%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
K E +G G + V + + TG +A K ++ + + EI ++ +LDH N+
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANL 148
Query: 192 IKLEGLITSRLSCSIYLVFEYME-----HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEH 246
I+L S+ I LV EY++ I +E +M Q+ G+ H
Sbjct: 149 IQLYDAFESKND--IVLVMEYVDGGELFDRII----DESYNLTELDTILFMKQICEGIRH 202
Query: 247 CHSRGVLHRDIKGSNLLVNN--EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELL 304
H +LH D+K N+L N +K+ DFGLA + L T + PE++
Sbjct: 203 MHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR--EKLKVNFGTPEFLAPEVV 260
Query: 305 LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLP 363
D+WSVG + LL G G + E L+ I D+ ++ S+
Sbjct: 261 NY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEE- 318
Query: 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 423
A I LL E R +AS AL + S
Sbjct: 319 -------------------------AKEFISKLLIKEKSWRISASEALKHPWLSDHKLHS 353
Query: 424 DLSS 427
LS+
Sbjct: 354 RLSA 357
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-45
Identities = 79/312 (25%), Positives = 130/312 (41%), Gaps = 37/312 (11%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALK---KVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
+G+G+Y V D +T A+K K + P + +EI +LRRL H N+I+L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRR-IPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 195 EGLITSRLSCSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 253
++ + +Y+V EY + +L S P+ +F Q Y QL+ GLE+ HS+G++
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIV 131
Query: 254 HRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDY-G 311
H+DIK NLL+ G LK++ G+A + + + ++PPE+ G + G
Sbjct: 132 HKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSG 191
Query: 312 PSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 371
VD+WS G + G +G + I K Y +P
Sbjct: 192 FKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK------GSY----AIP-------- 233
Query: 372 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIY 431
D +L++ +L EP KR + +F K + + +PI
Sbjct: 234 -----------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF-RKKHPPAEAPVPIP 281
Query: 432 PPSKEIDAKHRE 443
P D
Sbjct: 282 PSPDTKDRWRSM 293
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-45
Identities = 83/304 (27%), Positives = 138/304 (45%), Gaps = 50/304 (16%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+ + EKIGQG +V+ A D+ TG+ VA++++ + + EIL++R +PNI
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNPNI 79
Query: 192 IKLEG--LITSRLSCSIYLVFEYMEHDITGLLSCPDI----KFSEAQIKCYMNQLLHGLE 245
+ L+ L ++V EY+ G S D+ E QI + L LE
Sbjct: 80 VNYLDSYLVGDEL----WVVMEYLA---GG--SLTDVVTETCMDEGQIAAVCRECLQALE 130
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLWYRPPELL 304
HS V+HRDIK N+L+ +G +KL DFG A + ++ ++ V T ++ PE++
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVV 188
Query: 305 LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364
YGP VD+WS+G + E++ G+P L ++ + + P
Sbjct: 189 TR-KAYGPKVDIWSLGIMAIEMIEGEPPY---LNENPLRALYLIATNGT---------P- 234
Query: 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACD 424
L P++ L F+D + L ++ KR +A L ++ A
Sbjct: 235 -ELQNPEK-----LSAIFRD-------FLNRCLEMDVEKRGSAKELLQHQFLKI---AKP 278
Query: 425 LSSL 428
LSSL
Sbjct: 279 LSSL 282
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-45
Identities = 79/295 (26%), Positives = 120/295 (40%), Gaps = 59/295 (20%)
Query: 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNIIKL 194
+ +G+G++S + + + A+K + + + +EI L+ + HPNI+KL
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKII--SKRMEANTQ---KEITALKLCEGHPNIVKL 71
Query: 195 EGLITSRLSCSIYLVFEYMEHDITG--LLSCPDI----KFSEAQIKCYMNQLLHGLEHCH 248
+ +L +LV E + G L I FSE + M +L+ + H H
Sbjct: 72 HEVFHDQLH--TFLVMELL----NGGELFE--RIKKKKHFSETEASYIMRKLVSAVSHMH 123
Query: 249 SRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
GV+HRD+K NLL +E +K+ DFG A QPL + TL Y PE LL
Sbjct: 124 DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK-PPDNQPLKTPCFTLHYAAPE-LL 181
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTE---VEQLHKIFK--LCGSP--PDDYWK 358
Y S DLWS+G + +L G+ Q +I K G + WK
Sbjct: 182 NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWK 241
Query: 359 K-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
S+ A +LI+ LL+V+P KR S
Sbjct: 242 NVSQ--------------------------EAKDLIQGLLTVDPNKRLKMSGLRY 270
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 2e-45
Identities = 74/359 (20%), Positives = 133/359 (37%), Gaps = 64/359 (17%)
Query: 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKL 194
+ +G G V + + T + ALK ++ + R RE+ + R P+I+++
Sbjct: 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQ----DCPKAR---REVELHWRASQCPHIVRI 120
Query: 195 EGLI--TSRLSCSIYLVFEYME-----HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
+ + +V E ++ I D F+E + M + +++
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFSRI---QDRGDQAFTEREASEIMKSIGEAIQYL 177
Query: 248 HSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELL 304
HS + HRD+K NLL ++ +LKL DFG A + + LT+ T +Y PE +
Sbjct: 178 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTTPCYTPYYVAPE-V 234
Query: 305 LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK--LCGSP--PDDYWKK- 359
LG Y S D+WS+G + LL G P + + G P+ W +
Sbjct: 235 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 294
Query: 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419
S+ LI LL EP +R T + + +
Sbjct: 295 SE--------------------------EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328
Query: 420 PYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVEDV 478
P++ + K R + ++++ + T R + K+ +ED
Sbjct: 329 TKV---PQTPLHTSRVLKEDKERWEDVKEEMTSALA------TMRVDYEQIKIKKIEDA 378
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 2e-45
Identities = 83/357 (23%), Positives = 145/357 (40%), Gaps = 50/357 (14%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-------- 186
+ K+G G +S+V+ A+D+ VA+K VR D E+ EI +L+R+
Sbjct: 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED---EIKLLQRVNDADNTKE 80
Query: 187 ---DHPNIIKLEG--LITSRLSCSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQL 240
+I+KL + +VFE + ++ L+ +K QL
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 140
Query: 241 LHGLEHCHSR-GVLHRDIKGSNLLVNNE------GVLKLADFGLANFSNTGHRQPLTSRV 293
L GL++ H R G++H DIK N+L+ +K+AD G A + + + T+ +
Sbjct: 141 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD----EHYTNSI 196
Query: 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT------EVEQLHKIFK 347
T YR PE+LLGA +G D+WS C+ EL+ G + + + + + +I +
Sbjct: 197 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255
Query: 348 LCGSPP----------DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTA---VNLIE 394
L G P ++ L P + L E +K A + +
Sbjct: 256 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 315
Query: 395 TLLSVEPYKRATASAALASEYFSTKPYACDLS--SLPIYPPSKEIDAKHREDARRKK 449
+L ++P KRA A + + ++ +Y +I E K+
Sbjct: 316 PMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWFEEVRDHKR 372
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 6e-45
Identities = 61/288 (21%), Positives = 111/288 (38%), Gaps = 46/288 (15%)
Query: 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH-PNIIKL 194
+++G+G ++ V + TG+ A K ++ + + EI +L P +I L
Sbjct: 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94
Query: 195 EGLITSRLSCSIYLVFEYMEHDITG------LLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
+ + I L+ EY G L SE + + Q+L G+ + H
Sbjct: 95 HEVYENTSE--IILILEYA----AGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH 148
Query: 249 SRGVLHRDIKGSNLLVNNE---GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
++H D+K N+L+++ G +K+ DFG++ L + T Y PE+L
Sbjct: 149 QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA--CELREIMGTPEYLAPEILN 206
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPH 364
+ D+W++G + LL G E I ++ ++ + S+L
Sbjct: 207 Y-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQL-- 263
Query: 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
A + I++LL P KR TA L+
Sbjct: 264 ------------------------ATDFIQSLLVKNPEKRPTAEICLS 287
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 7e-45
Identities = 70/322 (21%), Positives = 117/322 (36%), Gaps = 69/322 (21%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALK-----KVRFDNFEPESVRFMAREILILRRL 186
+ +G+G + +VF L VA+K +V + +SV E+ +L ++
Sbjct: 33 YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVT-CPLEVALLWKV 91
Query: 187 D----HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI--------KFSEAQIK 234
HP +I+L ++ LV E D+ E +
Sbjct: 92 GAGGGHPGVIRLLDWFETQEG--FMLVLERPL-------PAQDLFDYITEKGPLGEGPSR 142
Query: 235 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQPLTSRV 293
C+ Q++ ++HCHSRGV+HRDIK N+L++ G KL DFG H +P T
Sbjct: 143 CFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYTDFD 199
Query: 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 353
T Y PPE + + +WS+G + L+ + +CG P
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGIL-------------------LYDM--VCGDIP 238
Query: 354 -DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
+ ++ A L P + LI L+ +P R + L
Sbjct: 239 FERD---QEILEAELHFPAH------------VSPDCCALIRRCLAPKPSSRPSLEEILL 283
Query: 413 SEYFSTKPYACDLSSLPIYPPS 434
+ P + P+
Sbjct: 284 DPWM-QTPAEDVPLNPSKGGPA 304
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 7e-45
Identities = 89/324 (27%), Positives = 152/324 (46%), Gaps = 51/324 (15%)
Query: 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH 188
+ F KLEKIG+G++ VF+ D T K+VA+K + + E E + + +EI +L + D
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDS 79
Query: 189 PNIIKLEG--LITSRLSCSIYLVFEYMEHDITGLLSCPDI----KFSEAQIKCYMNQLLH 242
P + K G L ++L +++ EY+ G S D+ E QI + ++L
Sbjct: 80 PYVTKYYGSYLKDTKL----WIIMEYLG---GG--SALDLLEPGPLDETQIATILREILK 130
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLWYRPP 301
GL++ HS +HRDIK +N+L++ G +KLADFG+ ++T ++ + V T ++ P
Sbjct: 131 GLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAP 188
Query: 302 ELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361
E++ + Y D+WS+G EL G+P +E+ + +F + + P
Sbjct: 189 EVIKQS-AYDSKADIWSLGITAIELARGEPPH---SELHPMKVLFLIPKNNP-------- 236
Query: 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421
P TL + + + K+ +E L+ EP R TA L ++
Sbjct: 237 -P--TL-------EGNYSKPLKE-------FVEACLNKEPSFRPTAKELLKHKFI--LRN 277
Query: 422 ACDLSSL-PIYPPSKEIDAKHRED 444
A S L + K A+ D
Sbjct: 278 AKKTSYLTELIDRYKRWKAEQSHD 301
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 8e-45
Identities = 69/301 (22%), Positives = 117/301 (38%), Gaps = 63/301 (20%)
Query: 136 EKIGQGTYSSVFRARDLDTGKIVALK--------KVRFDNFEPESVRFMA---------- 177
++IG+G+Y V A + + A+K + P
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 178 ------REILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH----DITGLLSCPDIK 227
+EI IL++LDHPN++KL ++ +Y+VFE + ++
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKP 133
Query: 228 FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287
SE Q + Y L+ G+E+ H + ++HRDIK SNLLV +G +K+ADFG++N
Sbjct: 134 LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193
Query: 288 PLTSRVVTLWYRPPELLLGAT-DY-GPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 345
L++ V T + PE L + G ++D+W++G + G+ + KI
Sbjct: 194 -LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKI 252
Query: 346 FKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 405
+ P D+ +LI +L P R
Sbjct: 253 KS------QAL----EFPD-----------------QPDIAEDLKDLITRMLDKNPESRI 285
Query: 406 T 406
Sbjct: 286 V 286
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 9e-45
Identities = 77/307 (25%), Positives = 136/307 (44%), Gaps = 43/307 (14%)
Query: 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH 188
+ +E + ++G G + V++A++ +TG + A K + + E + EI IL DH
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELEDYIVEIEILATCDH 75
Query: 189 PNIIKLEG--LITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
P I+KL G +L +++ E+ + ++ D +E QI+ Q+L L
Sbjct: 76 PYIVKLLGAYYHDGKL----WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALN 131
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
HS+ ++HRD+K N+L+ EG ++LADFG++ N Q S + T ++ PE+++
Sbjct: 132 FLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSA-KNLKTLQKRDSFIGTPYWMAPEVVM 190
Query: 306 GAT----DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361
T Y D+WS+G E+ +P E+ + + K+ S P
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEPPH---HELNPMRVLLKIAKSDP-------- 239
Query: 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421
P TL P S F+D ++ L P R +A+ L + S+
Sbjct: 240 -P--TLLTP-----SKWSVEFRD-------FLKIALDKNPETRPSAAQLLEHPFVSS--- 281
Query: 422 ACDLSSL 428
+L
Sbjct: 282 ITSNKAL 288
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-44
Identities = 75/304 (24%), Positives = 138/304 (45%), Gaps = 50/304 (16%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+ KIG+G+ V AR+ +G+ VA+K + D + + + E++I+R H N+
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM--DLRKQQRRELLFNEVVIMRDYQHFNV 104
Query: 192 IKLEG--LITSRLSCSIYLVFEYMEHDITGLLSCPDI----KFSEAQIKCYMNQLLHGLE 245
+++ L+ L +++ E+++ G + DI + +E QI +L L
Sbjct: 105 VEMYKSYLVGEEL----WVLMEFLQ---GG--ALTDIVSQVRLNEEQIATVCEAVLQALA 155
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLWYRPPELL 304
+ H++GV+HRDIK ++L+ +G +KL+DFG A S ++ S V T ++ PE++
Sbjct: 156 YLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR--KSLVGTPYWMAPEVI 213
Query: 305 LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364
+ Y VD+WS+G + E++ G+P + + +L SPP P
Sbjct: 214 SR-SLYATEVDIWSLGIMVIEMVDGEPPY---FSDSPVQAMKRLRDSPP---------P- 259
Query: 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACD 424
L + + +D +E +L +P +RATA L +
Sbjct: 260 -KLKNSHK-----VSPVLRDF-------LERMLVRDPQERATAQELLDHPFLLQ---TGL 303
Query: 425 LSSL 428
L
Sbjct: 304 PECL 307
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-44
Identities = 92/363 (25%), Positives = 134/363 (36%), Gaps = 74/363 (20%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DH 188
D +E E IG G+YS R T A+K + + EI IL R H
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII---DKSKRDPT---EEIEILLRYGQH 75
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITG--LLSCPDI----KFSEAQIKCYMNQLLH 242
PNII L+ + +Y+V E M G LL I FSE + + +
Sbjct: 76 PNIITLKDVYDDGKY--VYVVTELM----KGGELLD--KILRQKFFSEREASAVLFTITK 127
Query: 243 GLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 298
+E+ H++GV+HRD+K SN+L N +++ DFG A L + T +
Sbjct: 128 TVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR-AENGLLMTPCYTANF 186
Query: 299 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKP---ILQGRTEVEQLHKIFKLCGSPPDD 355
PE+L Y + D+WS+G + +L G T E L +I S
Sbjct: 187 VAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGG 245
Query: 356 YWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 414
YW S TA +L+ +L V+P++R TA+ L
Sbjct: 246 YWNSVSD--------------------------TAKDLVSKMLHVDPHQRLTAALVLRH- 278
Query: 415 YFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSH----GMS 470
P+ LP Y +R+DA G + G S
Sbjct: 279 -----PWIVHWDQLPQYQL-------NRQDAPHLVKGAMAATYSALNRNQSPVLEPVGRS 326
Query: 471 KLA 473
LA
Sbjct: 327 TLA 329
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 5e-44
Identities = 75/346 (21%), Positives = 132/346 (38%), Gaps = 84/346 (24%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAR----EILILRRL- 186
F + K+G GT+ V + +D K A+K VR +++ R E IL+++
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVR-------NIKKYTRSAKIEADILKKIQ 89
Query: 187 ----DHPNIIKLEG---------LITSRLSCSIYLVFEYM-EHDITGLLSCPDIKFSEAQ 232
++ NI+K G LI L S+Y E + ++ G F
Sbjct: 90 NDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLY---EIITRNNYNG--------FHIED 138
Query: 233 IKCYMNQLLHGLEHCHSRGVLHRDIKGSN-LLVNNEGV---------------------- 269
IK Y ++L L + + H D+K N LL +
Sbjct: 139 IKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKS 198
Query: 270 --LKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 327
+KL DFG A F + S + T YR PE++L + S D+WS GCV AEL
Sbjct: 199 TGIKLIDFGCATFKS----DYHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELY 253
Query: 328 IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF------KPQQPYDSSLRET 381
G + + +E L + + P + ++ + + + K P ++S +
Sbjct: 254 TGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINS 313
Query: 382 FKDLPTTA-----------VNLIETLLSVEPYKRATASAALASEYF 416
K + + + ++L ++P R + + L ++
Sbjct: 314 IKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 6e-44
Identities = 88/324 (27%), Positives = 158/324 (48%), Gaps = 43/324 (13%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ F+ LEK+G+G+Y SV++A +TG+IVA+K+V ++ + + + +EI I+++ D P
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEII---KEISIMQQCDSP 84
Query: 190 NIIKLEG--LITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEH 246
+++K G + L ++V EY ++ ++ + +E +I + L GLE+
Sbjct: 85 HVVKYYGSYFKNTDL----WIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEY 140
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG 306
H +HRDIK N+L+N EG KLADFG+A T + + T ++ PE++
Sbjct: 141 LHFMRKIHRDIKAGNILLNTEGHAKLADFGVAG-QLTDTMAKRNTVIGTPFWMAPEVIQE 199
Query: 307 ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366
Y D+WS+G E+ GKP ++ + IF + +PP P T
Sbjct: 200 I-GYNCVADIWSLGITAIEMAEGKPPY---ADIHPMRAIFMIPTNPP---------P--T 244
Query: 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLS 426
KP+ + F D ++ L P +RATA+ L + + A +S
Sbjct: 245 FRKPEL-----WSDNFTD-------FVKQCLVKSPEQRATATQLLQHPFVRS---AKGVS 289
Query: 427 SL-PIYPPSKEIDAKHREDARRKK 449
L + + ++ K +E +R++
Sbjct: 290 ILRDLINEAMDVKLKRQESQQREE 313
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-43
Identities = 67/309 (21%), Positives = 114/309 (36%), Gaps = 64/309 (20%)
Query: 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKL 194
+ +G+G ++ V +L T + A+K + S + RE+ +L + H N+++L
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSR--VFREVEMLYQCQGHRNVLEL 76
Query: 195 EGLITSRLSCSIYLVFEYMEHDITG--LLSCPDI----KFSEAQIKCYMNQLLHGLEHCH 248
YLVFE M G +LS I F+E + + + L+ H
Sbjct: 77 IEFFEEEDR--FYLVFEKM----RGGSILS--HIHKRRHFNELEASVVVQDVASALDFLH 128
Query: 249 SRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHR------QPLTSRVVTLWYR 299
++G+ HRD+K N+L + +K+ DF L + L + + Y
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188
Query: 300 PPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP-- 353
PE++ A+ Y DLWS+G + IL L G PP
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVILY-------IL--------------LSGYPPFV 227
Query: 354 --DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPT--------TAVNLIETLLSVEPYK 403
A ++S + + P A +LI LL + +
Sbjct: 228 GRCGSDCGWDRGEACPACQNMLFESIQEGKY-EFPDKDWAHISCAAKDLISKLLVRDAKQ 286
Query: 404 RATASAALA 412
R +A+ L
Sbjct: 287 RLSAAQVLQ 295
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 3e-43
Identities = 61/301 (20%), Positives = 117/301 (38%), Gaps = 57/301 (18%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPN 190
+ +G ++ V+ A+D+ +G+ ALK++ + E R + +E+ +++L HPN
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSGHPN 87
Query: 191 IIKLEGLITSRLSCSIYLVFEY---MEHDITGLLSC-----PDIKFSEAQIKCYMNQLLH 242
I++ + S E+ E L+ S + Q
Sbjct: 88 IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCR 147
Query: 243 GLEHCHSRG--VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS--------- 291
++H H + ++HRD+K NLL++N+G +KL DFG A + ++
Sbjct: 148 AVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 292 --RVVTLWYRPPEL--LLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 347
R T YR PE+ L G D+W++GC+ L + + ++ ++ +
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYS 267
Query: 348 LCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 407
+ PP D + +LI +L V P +R +
Sbjct: 268 I---PPHD-----------------TQYTVFH-----------SLIRAMLQVNPEERLSI 296
Query: 408 S 408
+
Sbjct: 297 A 297
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 4e-43
Identities = 72/344 (20%), Positives = 135/344 (39%), Gaps = 74/344 (21%)
Query: 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAR----EILILR 184
D +E IG+G++ V +A D + VA+K ++ + + E+ +L
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK-------NKKAFLNQAQIEVRLLE 105
Query: 185 RL------DHPNIIKLEGLITSRLSCSIY-----LVFEYMEHDITGLLSCPDIK-FSEAQ 232
+ I+ L ++ LVFE + +++ LL + + S
Sbjct: 106 LMNKHDTEMKYYIVHL-------KRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNL 158
Query: 233 IKCYMNQLLHGLEHCHSR--GVLHRDIKGSNLLVNNEG--VLKLADFGLANFSNTGHRQP 288
+ + Q+ L + ++H D+K N+L+ N +K+ DFG + Q
Sbjct: 159 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG----QR 214
Query: 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 348
+ + + +YR PE+LLG Y ++D+WS+GC+ E+ G+P+ G EV+Q++KI ++
Sbjct: 215 IYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV 273
Query: 349 CGSPPDDYWKKS---------------------------------KLPHATLFKPQQPYD 375
G PP ++ KL + + P
Sbjct: 274 LGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGG 333
Query: 376 SSLRETFKDLPTTA--VNLIETLLSVEPYKRATASAALASEYFS 417
E+ + +LI +L +P R AL +F
Sbjct: 334 RRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFK 377
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 4e-43
Identities = 86/297 (28%), Positives = 124/297 (41%), Gaps = 58/297 (19%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
D FE ++G+G S V+R + T K ALK ++ + + VR EI +L RL HP
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK-KIVR---TEIGVLLRLSHP 108
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITG--LLSCPDI----KFSEAQIKCYMNQLLHG 243
NIIKL+ + + I LV E + TG L I +SE + Q+L
Sbjct: 109 NIIKLKEIFETPTE--ISLVLELV----TGGELFD--RIVEKGYYSERDAADAVKQILEA 160
Query: 244 LEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRVVTLWYRP 300
+ + H G++HRD+K NLL LK+ADFGL+ + + T Y
Sbjct: 161 VAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ--VLMKTVCGTPGYCA 218
Query: 301 PELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK--LCGSP--PDDY 356
PE+L G YGP VD+WSVG + LL G +F+ L +
Sbjct: 219 PEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERG---DQFMFRRILNCEYYFISPW 274
Query: 357 WKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
W + S A +L+ L+ ++P KR T AL
Sbjct: 275 WDEVSL--------------------------NAKDLVRKLIVLDPKKRLTTFQALQ 305
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 6e-43
Identities = 69/324 (21%), Positives = 120/324 (37%), Gaps = 68/324 (20%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALK---KVRFDNF-EPESVRFMAREILILRRLD 187
++ +G G + SV+ + VA+K K R ++ E + + E+++L+++
Sbjct: 45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104
Query: 188 H--PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI--------KFSEAQIKCYM 237
+I+L S L+ E E D+ E + +
Sbjct: 105 SGFSGVIRLLDWFERPDS--FVLILERPE-------PVQDLFDFITERGALQEELARSFF 155
Query: 238 NQLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTSRVVTL 296
Q+L + HCH+ GVLHRDIK N+L++ N G LKL DFG T T
Sbjct: 156 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTR 212
Query: 297 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP-DD 355
Y PPE + +G S +WS+G + ++ +CG P +
Sbjct: 213 VYSPPEWIRYHRYHGRSAAVWSLGILLYDM---------------------VCGDIPFEH 251
Query: 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415
++ +F Q+ + + +LI L++ P R T +
Sbjct: 252 ---DEEIIRGQVFFRQR------------VSSECQHLIRWCLALRPSDRPTFEEIQNHPW 296
Query: 416 F---STKPYACDLSSLPIYP-PSK 435
++ + P PSK
Sbjct: 297 MQDVLLPQETAEIHLHSLSPGPSK 320
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 7e-43
Identities = 75/277 (27%), Positives = 119/277 (42%), Gaps = 44/277 (15%)
Query: 138 IGQGTYSSVFRARDLDTGKIVALK---KVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
+G+G Y V A + T + VA+K R + PE+++ +EI I + L+H N++K
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC-PENIK---KEICINKMLNHENVVKF 70
Query: 195 EGLITSRLSCSIYLVFEYMEHDITGLL---SCPDIKFSEAQIKCYMNQLLHGLEHCHSRG 251
G YL EY G L PDI E + + +QL+ G+ + H G
Sbjct: 71 YGHRREG--NIQYLFLEYCSG---GELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 252 VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-TLWYRPPELLLGATDY 310
+ HRDIK NLL++ LK++DFGLA +R+ L +++ TL Y PELL +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 311 GPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369
VD+WS G V +L G+ P Q ++ + +
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-----------------KKTYL 228
Query: 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 406
+K + + + L+ +L P R T
Sbjct: 229 NP----------WKKIDSAPLALLHKILVENPSARIT 255
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 9e-43
Identities = 80/322 (24%), Positives = 140/322 (43%), Gaps = 57/322 (17%)
Query: 134 KLEK-IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192
+L K IG+G ++ V AR + TG+ VA+K + P S++ + RE+ I++ L+HPNI+
Sbjct: 18 RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIV 77
Query: 193 KL-EGLITSRLSCSIYLVFEY----------MEHDITGLLSCPDIKFSEAQIKCYMNQLL 241
KL E + T + ++YL+ EY + H + E + + Q++
Sbjct: 78 KLFEVIETEK---TLYLIMEYASGGEVFDYLVAHG----------RMKEKEARSKFRQIV 124
Query: 242 HGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPP 301
+++CH + ++HRD+K NLL++ + +K+ADFG +N G L + Y P
Sbjct: 125 SAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GKLDAFCGAPPYAAP 182
Query: 302 ELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361
EL G GP VD+WS+G + L+ G G+ E ++ + G ++
Sbjct: 183 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR--GKYRIPFY---- 236
Query: 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421
+ T NL++ L + P KR T + + +
Sbjct: 237 -----------------------MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWI-NAGH 272
Query: 422 ACDLSSLPIYPPSKEIDAKHRE 443
D + P D K +
Sbjct: 273 EEDELKPFVEPELDISDQKRID 294
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 2e-42
Identities = 68/323 (21%), Positives = 124/323 (38%), Gaps = 63/323 (19%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALK-----KVRFDNF-EPESVRFMAREILILRR 185
+ + +G G + V+ A D + K V +K KV D + E + + EI IL R
Sbjct: 26 YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 186 LDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI--------KFSEAQIKCYM 237
++H NIIK+ + ++ LV ME +GL D+ + E
Sbjct: 86 VEHANIIKVLDIFENQGF--FQLV---MEKHGSGL----DLFAFIDRHPRLDEPLASYIF 136
Query: 238 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 297
QL+ + + + ++HRDIK N+++ + +KL DFG A + G + T+
Sbjct: 137 RQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK--LFYTFCGTIE 194
Query: 298 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP-DDY 356
Y PE+L+G GP +++WS+G L + P +
Sbjct: 195 YCAPEVLMGNPYRGPELEMWSLGVTLYTL---------------------VFEENPFCEL 233
Query: 357 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
+ + A + P + ++L+ LL P +R T + +
Sbjct: 234 EETVE---AAIHPP------------YLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWV 278
Query: 417 STKPYACDLSSLPIYPPSKEIDA 439
T+P + + ++
Sbjct: 279 -TQPVNLADYTWEEVFRVNKPES 300
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-42
Identities = 69/346 (19%), Positives = 123/346 (35%), Gaps = 82/346 (23%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTG-KIVALKKVRFDNFEPESVRFMAR----EILILRRL 186
+E ++ +G+G + V D G + VA+K V+ +V EI +L L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVK-------NVDRYCEAARSEIQVLEHL 68
Query: 187 ------DHPNIIKLEG---------LITSRLSCSIYLVFEYM-EHDITGLLSCPDIKFSE 230
+++ ++ L S Y +++ E+ F
Sbjct: 69 NTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTY---DFIKENGFLP--------FRL 117
Query: 231 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSN-LLVNNEGV------------------LK 271
I+ Q+ + HS + H D+K N L V ++ +K
Sbjct: 118 DHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIK 177
Query: 272 LADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 331
+ DFG A + + + ++ V T YR PE++L + D+WS+GC+ E +G
Sbjct: 178 VVDFGSATYDD----EHHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFT 232
Query: 332 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF---KPQQPYDSSLRETF----KD 384
+ E L + ++ G P +K++ F + SS K
Sbjct: 233 VFPTHDSKEHLAMMERILGPLPKHMIQKTRKRK--YFHHDRLDWDEHSSAGRYVSRACKP 290
Query: 385 LPT----------TAVNLIETLLSVEPYKRATASAALASEYFSTKP 420
L +LI+ +L +P KR T AL +F
Sbjct: 291 LKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLK 336
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-42
Identities = 78/314 (24%), Positives = 123/314 (39%), Gaps = 46/314 (14%)
Query: 134 KLEK-IGQGTYSSVFRARDLDTGKIVALK---KVRFDNFEPESVRFMAREILILRRLDHP 189
L + +G+G Y V A + T + VA+K R + PE+++ +EI I + L+H
Sbjct: 10 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC-PENIK---KEICINKMLNHE 65
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITGLL---SCPDIKFSEAQIKCYMNQLLHGLEH 246
N++K G YL EY G L PDI E + + +QL+ G+ +
Sbjct: 66 NVVKFYGHRREG--NIQYLFLEYCSG---GELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLL 305
H G+ HRDIK NLL++ LK++DFGLA +R + L TL Y PELL
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 306 GATDYGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364
+ VD+WS G V +L G+ P Q ++ +
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE----------------- 223
Query: 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACD 424
+ +K + + + L+ +L P R T ++ KP
Sbjct: 224 KKTYLNP----------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWY-NKPLKKG 272
Query: 425 LSSLPIYPPSKEID 438
+
Sbjct: 273 AKRPRVTSGGVSES 286
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 6e-42
Identities = 71/345 (20%), Positives = 130/345 (37%), Gaps = 80/345 (23%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGK-IVALKKVRFDNFEPESVRFMAR----EILILRRL 186
+E + +G+GT+ V D GK VALK +R +V EI +L+++
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIR-------NVGKYREAARLEINVLKKI 73
Query: 187 ------DHPNIIKLEG---------LITSRLSCSIYLVFEYM-EHDITGLLSCPDIKFSE 230
+ + + + L + + E++ E++ +
Sbjct: 74 KEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTF---EFLKENNFQP--------YPL 122
Query: 231 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSN-LLVNNEGV------------------LK 271
++ QL H L H + H D+K N L VN+E ++
Sbjct: 123 PHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIR 182
Query: 272 LADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 331
+ADFG A F + + T+ V T YRPPE++L + D+WS+GC+ E G
Sbjct: 183 VADFGSATFDH----EHHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFT 237
Query: 332 ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH----------------ATLFKPQQPYD 375
+ Q E L + K+ G P +++ + + +P
Sbjct: 238 LFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLK 297
Query: 376 SSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420
S + + + +L+ +L +P +R T + AL +F+
Sbjct: 298 SYMLQDSLEHVQL-FDLMRRMLEFDPAQRITLAEALLHPFFAGLT 341
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-41
Identities = 59/292 (20%), Positives = 100/292 (34%), Gaps = 76/292 (26%)
Query: 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKL 194
+ +G G V + + T + ALK ++ + R RE+ + R P+I+++
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQ----DCPKAR---REVELHWRASQCPHIVRI 76
Query: 195 EGLI--TSRLSCSIYLVFEYME-----HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
+ + +V E ++ I D F+E + M + +++
Sbjct: 77 VDVYENLYAGRKCLLIVMECLDGGELFSRI---QDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 248 HSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELL 304
HS + HRD+K NLL ++ +LKL DFG A E
Sbjct: 134 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA----------------------KETT 171
Query: 305 LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK--LCGSP--PDDYWKK- 359
Y S D+WS+G + LL G P + + G P+ W +
Sbjct: 172 --GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 229
Query: 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411
S+ LI LL EP +R T + +
Sbjct: 230 SE--------------------------EVKMLIRNLLKTEPTQRMTITEFM 255
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-41
Identities = 41/321 (12%), Positives = 86/321 (26%), Gaps = 69/321 (21%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPES-VRFMAREILILRRL---- 186
+ +GQ + A D +TG+ + F P + ++ M E+L LR L
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 187 ---------------------DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLS--- 222
+I++ S + ++ M+ ++
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 223 ---CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN 279
Q++ L H G++H ++ +++++ G + L F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 280 FSNTGHRQPLTSRVVTLWYRPPELLLGA----TDYGPSVDLWSVGCVFAELLIGKPILQG 335
P+ +L T + D W++G +
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD 319
Query: 336 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 395
+ IF+ C K++P L+E
Sbjct: 320 DAALGGSEWIFRSC---------------------------------KNIPQPVRALLEG 346
Query: 396 LLSVEPYKRATASAALASEYF 416
L R A+ + +
Sbjct: 347 FLRYPKEDRLLPLQAMETPEY 367
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 9e-41
Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 21/217 (9%)
Query: 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-D 187
A FE +E +G GTY V++ R + TG++ A+K + + + + +EI +L++
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLKKYSH 79
Query: 188 HPNIIKLEG----LITSRLSCSIYLVFEYME----HDITGLLSCPDIKFSEAQIKCYMNQ 239
H NI G + ++LV E+ D+ + + E I +
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL--IKNTKGNTLKEEWIAYICRE 137
Query: 240 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLWY 298
+L GL H H V+HRDIKG N+L+ +KL DFG+ A T R+ + + T ++
Sbjct: 138 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR--NTFIGTPYW 195
Query: 299 RPPELLLGATD----YGPSVDLWSVGCVFAELLIGKP 331
PE++ + Y DLWS+G E+ G P
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-39
Identities = 67/272 (24%), Positives = 114/272 (41%), Gaps = 22/272 (8%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL 186
L+ D FEK+ ++G G VF+ +G ++A K + + +P + RE+ +L
Sbjct: 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHEC 88
Query: 187 DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDI-----KFSEAQIKCYMNQLL 241
+ P I+ G S I + E+M+ G S + + E + ++
Sbjct: 89 NSPYIVGFYGAFYS--DGEISICMEHMD---GG--SLDQVLKKAGRIPEQILGKVSIAVI 141
Query: 242 HGLEHCHSRG-VLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLWYR 299
GL + + ++HRD+K SN+LVN+ G +KL DFG++ ++ S V T Y
Sbjct: 142 KGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYM 197
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359
PE L G T Y D+WS+G E+ +G+ + E + +
Sbjct: 198 SPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 256
Query: 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 391
+ P L + DS +L VN
Sbjct: 257 PRTPGRPL--NKFGMDSRPPMAIFELLDYIVN 286
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-39
Identities = 79/323 (24%), Positives = 127/323 (39%), Gaps = 49/323 (15%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
++ ++ IG G + RD T ++VA+K + E+V+ REI+ R L HPNI
Sbjct: 22 YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ---REIINHRSLRHPNI 78
Query: 192 IKL-EGLITSRLSCSIYLVFEYMEHDITGLLS---CPDIKFSEAQIKCYMNQLLHGLEHC 247
++ E ++T + ++ EY G L C +FSE + + + QLL G+ +C
Sbjct: 79 VRFKEVILTPT---HLAIIMEYASG---GELYERICNAGRFSEDEARFFFQQLLSGVSYC 132
Query: 248 HSRGVLHRDIKGSNLLV--NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
HS + HRD+K N L+ + LK+ DFG + S + S V T Y PE+LL
Sbjct: 133 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLL 190
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK--LCG--SPPDDYWKKSK 361
G D+WS G +L+G + E K + L S PDD
Sbjct: 191 RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR---- 246
Query: 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421
+ +LI + +P R + +F K
Sbjct: 247 -----------------------ISPECCHLISRIFVADPATRISIPEIKTHSWF-LKNL 282
Query: 422 ACDLSSLPIYPPSKEIDAKHRED 444
DL + + + +
Sbjct: 283 PADLMNESNTGSQFQEPEQPMQS 305
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 5e-39
Identities = 66/297 (22%), Positives = 112/297 (37%), Gaps = 41/297 (13%)
Query: 121 IQGWV-PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMARE 179
I G + E L ++G GT V++ R TG ++A+K++R E + + +
Sbjct: 15 IGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG-NKEENKRILMD 73
Query: 180 ILILRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMN 238
+ ++ + D P I++ G + I E M L E +
Sbjct: 74 LDVVLKSHDCPYIVQCFGTFITNTDVFI--AMELMGTCAEKLKKRMQGPIPERILGKMTV 131
Query: 239 QLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTL 296
++ L + GV+HRD+K SN+L++ G +KL DFG+ + +
Sbjct: 132 AIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DRSAGCA 188
Query: 297 WYRPPE----LLLGATDYGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGS 351
Y PE DY D+WS+G EL G+ P +T+ E L K+ +
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--EE 246
Query: 352 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 408
PP LP F F+ ++ L+ + KR +
Sbjct: 247 PP-------LLPGHMGFSGD----------FQS-------FVKDCLTKDHRKRPKYN 279
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-38
Identities = 49/288 (17%), Positives = 95/288 (32%), Gaps = 35/288 (12%)
Query: 125 VPLRADAFEKLEKIGQGTYSSVFRAR-----DLDTGKIVALKKVRFDNFEPESVRFMARE 179
L + +G+G ++ V+ A D + LK + N P +
Sbjct: 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--PWEFYIGTQL 117
Query: 180 ILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD-----ITGLLSCPDIKFSEAQIK 234
+ L+ +K + LV E + I + P+ + +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGS--VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 235 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-----------EGVLKLADFGLANFSNT 283
+ ++L+ +E H ++H DIK N ++ N L L D G +
Sbjct: 176 SFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 284 -GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI-LQGRTEVEQ 341
T++ T ++ E+L + +D + V +L G + ++ +
Sbjct: 236 FPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK 294
Query: 342 LHKIFKLCGSPPDDYWKKSKLPHATLFKPQ---QPYDSSLRETFKDLP 386
+F+ P D W + H L P P LR+ K +
Sbjct: 295 PEGLFR--RLPHLDMWN--EFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-38
Identities = 66/294 (22%), Positives = 121/294 (41%), Gaps = 41/294 (13%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRR 185
A+ + L +IG+G Y SV + +G+I+A+K++R + + + + ++ ++ R
Sbjct: 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMR 76
Query: 186 L-DHPNIIKLEGLITSRLSCSIYLVFEYM----EHDITGLLSCPDIKFSEAQIKCYMNQL 240
D P I++ G + C I E M + + S D E +
Sbjct: 77 SSDCPYIVQFYGALFREGDCWI--CMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLAT 134
Query: 241 LHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLWY 298
+ L H ++HRDIK SN+L++ G +KL DFG+ ++ + T Y
Sbjct: 135 VKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK---TRDAGCRPY 191
Query: 299 RPPELLLGATD---YGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSPPD 354
PE + + Y D+WS+G EL G+ P + + +QL ++ K G PP
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK--GDPP- 248
Query: 355 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 408
+L + ++ + S F + + L+ + KR
Sbjct: 249 ------QLSN----SEEREFSPS----FIN-------FVNLCLTKDESKRPKYK 281
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-38
Identities = 75/278 (26%), Positives = 116/278 (41%), Gaps = 41/278 (14%)
Query: 134 KLEK-IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRF-MAREILILRRLDHPNI 191
L +G GT+ V TG VA+K + V + REI L+ HP+I
Sbjct: 14 VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHI 73
Query: 192 IKLEGLITSRLSCSIYLVFEYMEHDITGLLS---CPDIKFSEAQIKCYMNQLLHGLEHCH 248
IKL +I++ ++V EY+ G L C + E + + Q+L +++CH
Sbjct: 74 IKLYQVISTP--TDFFMVMEYVSG---GELFDYICKHGRVEEMEARRLFQQILSAVDYCH 128
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
V+HRD+K N+L++ K+ADFGL+N + G L + + Y PE++ G
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRTSCGSPNYAAPEVISGRL 186
Query: 309 DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368
GP VD+WS G + LL G KI + +P
Sbjct: 187 YAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRG------GVF----YIP----- 231
Query: 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 406
+ L + L+ +L V+P KRAT
Sbjct: 232 --------------EYLNRSVATLLMHMLQVDPLKRAT 255
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-38
Identities = 73/281 (25%), Positives = 129/281 (45%), Gaps = 36/281 (12%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPES-VRFMAREILILRR 185
R + F+ + +G+G++S+V AR+L T + A+K + + E+ V ++ RE ++ R
Sbjct: 27 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 86
Query: 186 LDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGL 244
LDHP +KL T + +Y Y ++ ++ + F E + Y +++ L
Sbjct: 87 LDHPFFVKLYF--TFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSAL 143
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-TLWYRPPEL 303
E+ H +G++HRD+K N+L+N + +++ DFG A + +Q + V T Y PEL
Sbjct: 144 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 203
Query: 304 LLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363
L S DLW++GC+ +L+ G P + E KI K + P
Sbjct: 204 LTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK----------LEYDFP 252
Query: 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 404
+ A +L+E LL ++ KR
Sbjct: 253 -------------------EKFFPKARDLVEKLLVLDATKR 274
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-38
Identities = 73/287 (25%), Positives = 122/287 (42%), Gaps = 60/287 (20%)
Query: 134 KLEK-IGQGTYSSVFRARDLDTGKIVALK---KVRFDNFE-PESVRFMAREILILRRLDH 188
+ + +G+G++ V A T + VALK + + V REI L+ L H
Sbjct: 12 IIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE---REISYLKLLRH 68
Query: 189 PNIIKLEGLITSRLSCSIYLVFEY---------MEHDITGLLSCPDIKFSEAQIKCYMNQ 239
P+IIKL +IT+ I +V EY +E + +E + + + Q
Sbjct: 69 PHIIKLYDVITTP--TDIVMVIEYAGGELFDYIVEKK----------RMTEDEGRRFFQQ 116
Query: 240 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYR 299
++ +E+CH ++HRD+K NLL+++ +K+ADFGL+N G+ L + + Y
Sbjct: 117 IICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN--FLKTSCGSPNYA 174
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359
PE++ G GP VD+WS G V +L+G+ K+ Y
Sbjct: 175 APEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNS------CVY--- 225
Query: 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 406
+P L A +LI ++ +P +R T
Sbjct: 226 -VMP-------------------DFLSPGAQSLIRRMIVADPMQRIT 252
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-37
Identities = 58/248 (23%), Positives = 105/248 (42%), Gaps = 21/248 (8%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILI-LR 184
++AD E + ++G+G Y V + R + +G+I+A+K++R + + + ++ I +R
Sbjct: 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV-NSQEQKRLLMDLDISMR 61
Query: 185 RLDHPNIIKLEGLITSRLSCSIYLVFEYME---HDITGLLSCPDIKFSEAQIKCYMNQLL 241
+D P + G + I E M+ + E + ++
Sbjct: 62 TVDCPFTVTFYGALFREGDVWI--CMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119
Query: 242 HGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLWYR 299
LEH HS V+HRD+K SN+L+N G +K+ DFG+ + + Y
Sbjct: 120 KALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK---DIDAGCKPYM 176
Query: 300 PPELLLGATD---YGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSPP-- 353
PE + + Y D+WS+G EL I + P T +QL ++ + P
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV--VEEPSPQL 234
Query: 354 -DDYWKKS 360
D +
Sbjct: 235 PADKFSAE 242
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-36
Identities = 81/317 (25%), Positives = 128/317 (40%), Gaps = 56/317 (17%)
Query: 134 KLEK-IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRF-MAREILILRRLDHPNI 191
L +G GT+ V + TG VA+K + V + REI L+ HP+I
Sbjct: 19 ILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHI 78
Query: 192 IKLEGLITSRLSCSIYLVFEY----------MEHDITGLLSCPDIKFSEAQIKCYMNQLL 241
IKL +I++ I++V EY ++ + E + + Q+L
Sbjct: 79 IKLYQVISTP--SDIFMVMEYVSGGELFDYICKNG----------RLDEKESRRLFQQIL 126
Query: 242 HGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPP 301
G+++CH V+HRD+K N+L++ K+ADFGL+N + G L + + Y P
Sbjct: 127 SGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRTSCGSPNYAAP 184
Query: 302 ELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361
E++ G GP VD+WS G + LL G KI G +
Sbjct: 185 EVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICD--G----IF----Y 234
Query: 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421
P + L + ++L++ +L V+P KRAT E+F +
Sbjct: 235 TP-------------------QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWF-KQDL 274
Query: 422 ACDLSSLPIYPPSKEID 438
L S ID
Sbjct: 275 PKYLFPEDPSYSSTMID 291
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-36
Identities = 50/215 (23%), Positives = 100/215 (46%), Gaps = 19/215 (8%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL 186
R E +G+G + + +TG+++ +K+ F+ E+ R +E+ ++R L
Sbjct: 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKE--LIRFDEETQRTFLKEVKVMRCL 64
Query: 187 DHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
+HPN++K G++ + + EY++ + G++ D ++ +Q + + G+
Sbjct: 65 EHPNVLKFIGVLYK--DKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMA 122
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------------NFSNTGHRQPLTSR 292
+ HS ++HRD+ N LV + +ADFGLA R+ +
Sbjct: 123 YLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV 182
Query: 293 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 327
V ++ PE++ G Y VD++S G V E++
Sbjct: 183 VGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEII 216
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-36
Identities = 60/353 (16%), Positives = 111/353 (31%), Gaps = 99/353 (28%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVA----------------------LKKVRFDNFE 169
FE ++ +G+G + VF A++ A L K+
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 170 PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS------------------------ 205
++ + +K E S S
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 206 --------IYLVFEYMEH-DITGLLS--CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 254
+Y+ + ++ ++ C Q+ +E HS+G++H
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMH 187
Query: 255 RDIKGSNLLVNNEGVLKLADFGLA-----------NFSNTGHRQPLTSRVVTLWYRPPEL 303
RD+K SN+ + V+K+ DFGL + T +V T Y PE
Sbjct: 188 RDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQ 247
Query: 304 LLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363
+ G +Y VD++S+G + ELL T++E++ I + + K P
Sbjct: 248 IHG-NNYSHKVDIFSLGLILFELLYSFS-----TQMERVRIITDV---------RNLKFP 292
Query: 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
F +++ +LS P +R A+ + + F
Sbjct: 293 ----------------LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIF 329
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 6e-35
Identities = 48/213 (22%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPES-----VRFMAREILILRRL 186
E ++IG+G + V + R + +VA+K + + E E+ + RE+ I+ L
Sbjct: 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 187 DHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
+HPNI+KL GL+ + +V E++ D+ L + M + G+E
Sbjct: 81 NHPNIVKLYGLMHNPP----RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136
Query: 246 HCHSRG--VLHRDIKGSNLLVNNEG-----VLKLADFGLANFSNTGHRQPLTSRVVTLWY 298
+ ++ ++HRD++ N+ + + K+ADFGL+ S ++ + +
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS----VSGLLGNFQW 192
Query: 299 RPPELLLGATD-YGPSVDLWSVGCVFAELLIGK 330
PE + + Y D +S + +L G+
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGE 225
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-34
Identities = 72/293 (24%), Positives = 112/293 (38%), Gaps = 47/293 (16%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN-FEPESVRFMAREILILR 184
L+ D FE L+ IG+G +S V + TG++ A+K + + + V E +L
Sbjct: 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLV 116
Query: 185 RLDHPNIIKLEGLITSRLSCS------IYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYM 237
D I +L + +YLV EY D+ LLS + + Y+
Sbjct: 117 NGDRRWITQLH--------FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYL 168
Query: 238 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 297
+++ ++ H G +HRDIK N+L++ G ++LADFG V T
Sbjct: 169 AEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPD 228
Query: 298 YRPPELLLG------ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 351
Y PE+L YGP D W++G E+ G+ + E KI
Sbjct: 229 YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH---- 284
Query: 352 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 404
K L P + +P A + I+ LL P R
Sbjct: 285 ------YKEHLSL-----PLVD---------EGVPEEARDFIQRLLC-PPETR 316
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 135 bits (340), Expect = 2e-34
Identities = 76/369 (20%), Positives = 139/369 (37%), Gaps = 98/369 (26%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-----DHP 189
+ K+G G +S+V+ + D+ K VA+K V+ E+ EI +L+ + + P
Sbjct: 42 IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETAL---DEIRLLKSVRNSDPNDP 98
Query: 190 N---IIKLEG--LITSRLSCSIYLVFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHG 243
N +++L I+ I +VFE + H + + +K + Q+L G
Sbjct: 99 NREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQG 158
Query: 244 LEHCHSR-GVLHRDIKGSNLLVNNE----------------------------------- 267
L++ H++ ++H DIK N+L++
Sbjct: 159 LDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 268 --------------GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 313
+K+AD G A + + + + +R YR E+L+G+ Y
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ----YRSLEVLIGS-GYNTP 273
Query: 314 VDLWSVGCVFAELLIGKPILQGRT------EVEQLHKIFKLCGSPPDDYWKKSK------ 361
D+WS C+ EL G + + + + + + I +L G P K
Sbjct: 274 ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFF 333
Query: 362 -----LPHATLFKPQ-------QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 409
L H T KP + Y+ S E + + +L + P KRATA+
Sbjct: 334 TKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFT-----DFLLPMLELIPEKRATAAE 388
Query: 410 ALASEYFST 418
L + ++
Sbjct: 389 CLRHPWLNS 397
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-34
Identities = 44/206 (21%), Positives = 94/206 (45%), Gaps = 22/206 (10%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
++IG G++ +V++ + VA+K + P+ ++ E+ +LR+ H NI+
Sbjct: 29 GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85
Query: 195 EGLITSRLSCS---IYLVFEYMEHDITG----LLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
G + + +V ++ E L + KF ++ Q G+++
Sbjct: 86 MG------YSTAPQLAIVTQWCEG---SSLYHHLHASETKFEMKKLIDIARQTARGMDYL 136
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-SNTGHRQPLTSRVVTLWYRPPELLLG 306
H++ ++HRD+K +N+ ++ + +K+ DFGLA S ++ + PE++
Sbjct: 137 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 307 ATD--YGPSVDLWSVGCVFAELLIGK 330
Y D+++ G V EL+ G+
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQ 222
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-32
Identities = 64/245 (26%), Positives = 102/245 (41%), Gaps = 14/245 (5%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR-FDNFEPESVRFMAREILILRR 185
L + FE L+ IG+G + V + + K+ A+K + ++ + E +L
Sbjct: 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN 130
Query: 186 LDHPNIIKLEGLI--TSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLH 242
D I L + L YLV +Y D+ LLS + + E + Y+ +++
Sbjct: 131 GDSKWITTLHYAFQDDNNL----YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVI 186
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPE 302
++ H +HRDIK N+L++ G ++LADFG + V T Y PE
Sbjct: 187 AIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 246
Query: 303 LLLGATD----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI--FKLCGSPPDDY 356
+L YGP D WS+G E+L G+ + VE KI K P
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQV 306
Query: 357 WKKSK 361
S+
Sbjct: 307 TDVSE 311
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 30/204 (14%), Positives = 76/204 (37%), Gaps = 18/204 (8%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
L K+ + +++ R G + +K ++ ++ R E LR HPN++ +
Sbjct: 15 LTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72
Query: 195 EGLITSRLSCSIYLVFEYME----HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
G S + L+ +M +++ L + ++Q + + G+ H+
Sbjct: 73 LGACQSPPAPHPTLITHWMPYGSLYNV--LHEGTNFVVDQSQAVKFALDMARGMAFLHTL 130
Query: 251 G--VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG-- 306
+ + +++++ + +++ + + R+ + PE L
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS------PGRMYAPAWVAPEALQKKP 184
Query: 307 ATDYGPSVDLWSVGCVFAELLIGK 330
S D+WS + EL+ +
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTRE 208
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 26/208 (12%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
E E +G+G + V +A+ K VA+K++ ++ F+ E+ L R++HPNI
Sbjct: 10 IEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKA---FI-VELRQLSRVNHPNI 63
Query: 192 IKLEGLITSRLSCSIYLVFEYME----HDITGLLSC-PDIKFSEAQIKCYMNQLLHGLEH 246
+KL G + + LV EY E +++ L P ++ A + Q G+ +
Sbjct: 64 VKLYGACLNPV----CLVMEYAEGGSLYNV--LHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 247 CHSR---GVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPE 302
HS ++HRD+K NLL+ G VLK+ DFG A T +T+ + + PE
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MTNNKGSAAWMAPE 173
Query: 303 LLLGATDYGPSVDLWSVGCVFAELLIGK 330
+ G ++Y D++S G + E++ +
Sbjct: 174 VFEG-SNYSEKCDVFSWGIILWEVITRR 200
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-32
Identities = 77/285 (27%), Positives = 118/285 (41%), Gaps = 39/285 (13%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR-FDNFEPESVRFMAREILILRR 185
++A+ +E ++ IG+G + V R T K+ A+K + F+ + F E I+
Sbjct: 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 125
Query: 186 LDHPNIIKLEGLI--TSRLSCSIYLVFEYME-HDITGLLSCPDIKFSEAQIKCYMNQLLH 242
+ P +++L L Y+V EYM D+ L+S + E + Y +++
Sbjct: 126 ANSPWVVQLFYAFQDDRYL----YMVMEYMPGGDLVNLMS--NYDVPEKWARFYTAEVVL 179
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPE 302
L+ HS G +HRD+K N+L++ G LKLADFG N + V T Y PE
Sbjct: 180 ALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE 239
Query: 303 LLL---GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359
+L G YG D WSVG E+L+G + V KI K
Sbjct: 240 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN----------HK 289
Query: 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 404
+ L P D+ A NLI L+ + R
Sbjct: 290 NSLTF-----PDDN----------DISKEAKNLICAFLT-DREVR 318
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-32
Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 132 FEKL---EKIGQGTYSSVFRA--RDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL 186
+ L EKIG G++ +V RA G VA+K + +F E V RE+ I++RL
Sbjct: 36 WCDLNIKEKIGAGSFGTVHRAEWH----GSDVAVKILMEQDFHAERVNEFLREVAIMKRL 91
Query: 187 DHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIK--FSEAQIKCYMNQLLHG 243
HPNI+ G +T + SI V EY+ + LL + E + + G
Sbjct: 92 RHPNIVLFMGAVTQPPNLSI--VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 149
Query: 244 LEHCHSRG--VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPP 301
+ + H+R ++HR++K NLLV+ + +K+ DFGL+ + S T + P
Sbjct: 150 MNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS-SKSAAGTPEWMAP 208
Query: 302 ELLLGATDYGPSVDLWSVGCVFAELLIGK 330
E+L D++S G + EL +
Sbjct: 209 EVLRD-EPSNEKSDVYSFGVILWELATLQ 236
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 6e-32
Identities = 60/291 (20%), Positives = 115/291 (39%), Gaps = 51/291 (17%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILR 184
P+ + F + +G+G + V + TGK+ A KK+ + + E IL
Sbjct: 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILE 239
Query: 185 RLDHPNIIKLEGLITSRLSC-----SIYLVFEYME------HDITGLLSCPDIKFSEAQI 233
+++ ++ L ++ LV M H + F EA+
Sbjct: 240 KVNSRFVVSLA-------YAYETKDALCLVLTLMNGGDLKFH----IYHMGQAGFPEARA 288
Query: 234 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 293
Y ++ GLE H +++RD+K N+L+++ G ++++D GLA + Q + RV
Sbjct: 289 VFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRV 346
Query: 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 353
T+ Y PE++ Y S D W++GC+ E++ G+ Q R + + ++
Sbjct: 347 GTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE------- 398
Query: 354 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 404
+ + + A +L LL +P +R
Sbjct: 399 -----RLVKEVPEEYSER-------------FSPQARSLCSQLLCKDPAER 431
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 42/215 (19%), Positives = 93/215 (43%), Gaps = 22/215 (10%)
Query: 132 FEKL---EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH 188
FE+L E IG+G + V+ R VA++ + + + ++ RE++ R+ H
Sbjct: 32 FEQLEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRH 88
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
N++ G S +I + + + ++ I + + +++ G+ +
Sbjct: 89 ENVVLFMGACMSPPHLAI--ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL 146
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLA----NFSNTGHRQPLTSRVVTLWYRPPEL 303
H++G+LH+D+K N+ +N G + + DFGL L + L + PE+
Sbjct: 147 HAKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 304 LLGATD--------YGPSVDLWSVGCVFAELLIGK 330
+ + + D++++G ++ EL +
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-31
Identities = 65/289 (22%), Positives = 118/289 (40%), Gaps = 55/289 (19%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN-FEPESVRFMAREILILRRLDH 188
D FE L IG+G++ V + DT K+ A+K + E VR + +E+ I++ L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 189 PNIIKLEGLI--TSRLSCSIYLVFEYME------HDITGLLSCPDIKFSEAQIKCYMNQL 240
P ++ L + ++V + + H L ++ F E +K ++ +L
Sbjct: 75 PFLVNLWYSFQDEEDM----FMVVDLLLGGDLRYH-----LQ-QNVHFKEETVKLFICEL 124
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP 300
+ L++ ++ ++HRD+K N+L++ G + + DF +A + +T+ T Y
Sbjct: 125 VMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIA--AMLPRETQITTMAGTKPYMA 182
Query: 301 PELLL--GATDYGPSVDLWSVGCVFAELLIGKP---ILQGRTEVEQLHKIFKLCGSPPDD 355
PE+ Y +VD WS+G ELL G+ I + E +H
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET-------- 234
Query: 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 404
P V+L++ LL P +R
Sbjct: 235 --TVVTYP-------------------SAWSQEMVSLLKKLLEPNPDQR 262
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-31
Identities = 67/292 (22%), Positives = 117/292 (40%), Gaps = 50/292 (17%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN-FEPESVRFMAREILILR 184
P+ D F +G+G + VF + TGK+ A KK+ + + + E IL
Sbjct: 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 185 RLDHPNIIKLEGLITSRLSC-----SIYLVFEYME------HDITGLLSCPDIKFSEAQI 233
++ I+ L + LV M H I + F E +
Sbjct: 241 KVHSRFIVSLA-------YAFETKTDLCLVMTIMNGGDIRYH-IYNVDEDNP-GFQEPRA 291
Query: 234 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 293
Y Q++ GLEH H R +++RD+K N+L++++G ++++D GLA G +
Sbjct: 292 IFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG-YA 350
Query: 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 353
T + PELLLG +Y SVD +++G E++ + + R E + ++ +
Sbjct: 351 GTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ------ 403
Query: 354 DDYWKKSKLPHATLFKPQQPYDSSLRETF-KDLPTTAVNLIETLLSVEPYKR 404
L + T+ + + E LL +P KR
Sbjct: 404 -----------RVLEQA---------VTYPDKFSPASKDFCEALLQKDPEKR 435
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 62/218 (28%), Positives = 95/218 (43%), Gaps = 31/218 (14%)
Query: 132 FEKL---EKIGQGTYSSVFRA--RDLDTGKIVALKKVRFDNFEPESVRFM--AREILILR 184
F +L E IG G + V+RA G VA+K R D E S +E +
Sbjct: 6 FAELTLEEIIGIGGFGKVYRAFWI----GDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 185 RLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHG 243
L HPNII L G+ ++ LV E+ + +LS I + + Q+ G
Sbjct: 62 MLKHPNIIALRGVCLKEP--NLCLVMEFARGGPLNRVLSGKRIPPD--ILVNWAVQIARG 117
Query: 244 LEHCHSRG---VLHRDIKGSNLLVNNEG--------VLKLADFGLANFSNTGHRQPLTSR 292
+ + H ++HRD+K SN+L+ + +LK+ DFGLA HR S
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW---HRTTKMSA 174
Query: 293 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 330
+ PE++ + + D+WS G + ELL G+
Sbjct: 175 AGAYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGE 211
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 8e-29
Identities = 75/294 (25%), Positives = 124/294 (42%), Gaps = 62/294 (21%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRAR---DLDTGKIVALKKVRFDN-FEPESVRFMAREILI 182
FE L+ +GQG++ VF + D ++ A+K ++ + VR E I
Sbjct: 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDI 79
Query: 183 LRRLDHPNIIKLEGLITSRLSCS------IYLVFEY------MEHDITGLLSCPDIKFSE 230
L ++HP I+KL + +YL+ ++ LS ++ F+E
Sbjct: 80 LVEVNHPFIVKLH--------YAFQTEGKLYLILDFLRGGDLFTR-----LS-KEVMFTE 125
Query: 231 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 290
+K Y+ +L L+H HS G+++RD+K N+L++ EG +KL DFGL+ + H +
Sbjct: 126 EDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAY 184
Query: 291 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 350
S T+ Y PE++ + S D WS G + E+L G QG+ E + I K
Sbjct: 185 SFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK--- 240
Query: 351 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 404
K +P + L A +L+ L P R
Sbjct: 241 -------AKLGMP-------------------QFLSPEAQSLLRMLFKRNPANR 268
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 3e-28
Identities = 63/288 (21%), Positives = 114/288 (39%), Gaps = 55/288 (19%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN-FEPESVRFMAREILILRR 185
F+ L +G G++ V R G+ A+K ++ + + V E L+L
Sbjct: 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62
Query: 186 LDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-----LLSCPDIKFSEAQIKCYMNQL 240
+ HP II++ G T + + I+++ +Y+E G LL +F K Y ++
Sbjct: 63 VTHPFIIRMWG--TFQDAQQIFMIMDYIE----GGELFSLLRK-SQRFPNPVAKFYAAEV 115
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW--- 297
LE+ HS+ +++RD+K N+L++ G +K+ DFG A + TL
Sbjct: 116 CLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--------VTYTLCGTP 167
Query: 298 -YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 356
Y PE++ Y S+D WS G + E+L G ++ KI
Sbjct: 168 DYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN--------- 217
Query: 357 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 404
+ + P +L+ L++ + +R
Sbjct: 218 -AELRFP-------------------PFFNEDVKDLLSRLITRDLSQR 245
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 71/299 (23%), Positives = 120/299 (40%), Gaps = 74/299 (24%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRR 185
+ + F+ L+ +G+GT+ V R+ TG+ A+K +R + + V E +L+
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 186 LDHPNIIKLEGLITSRLSC-----SIYLVFEY------MEHDITGLLSCPDIKFSEAQIK 234
HP + L+ + V EY H LS + F+E + +
Sbjct: 62 TRHPFLTALK-------YAFQTHDRLCFVMEYANGGELFFH-----LS-RERVFTEERAR 108
Query: 235 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------NFSNT--GH 285
Y +++ LE+ HSR V++RDIK NL+++ +G +K+ DFGL T G
Sbjct: 109 FYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG- 167
Query: 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 345
T Y PE+L DYG +VD W +G V E++ G+ + I
Sbjct: 168 ---------TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217
Query: 346 FKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 404
++ + P + L A +L+ LL +P +R
Sbjct: 218 LM----------EEIRFP-------------------RTLSPEAKSLLAGLLKKDPKQR 247
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-28
Identities = 66/292 (22%), Positives = 121/292 (41%), Gaps = 57/292 (19%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILR 184
+ + FE L+ +G+GT+ V ++ TG+ A+K ++ + + V E +L+
Sbjct: 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 203
Query: 185 RLDHPNIIKLEGLITSRLSC-----SIYLVFEY------MEHDITGLLSCPDIKFSEAQI 233
HP + L+ + V EY H LS + FSE +
Sbjct: 204 NSRHPFLTALK-------YSFQTHDRLCFVMEYANGGELFFH-----LS-RERVFSEDRA 250
Query: 234 KCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 292
+ Y +++ L++ HS + V++RD+K NL+++ +G +K+ DFGL + +
Sbjct: 251 RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTF 309
Query: 293 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 352
T Y PE+L DYG +VD W +G V E++ G+ + + I
Sbjct: 310 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM----- 363
Query: 353 PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 404
++ + P + L A +L+ LL +P +R
Sbjct: 364 -----EEIRFP-------------------RTLGPEAKSLLSGLLKKDPKQR 391
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 52/214 (24%), Positives = 87/214 (40%), Gaps = 26/214 (12%)
Query: 133 EKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192
+ +++IG+G Y V+ + G+ VA+K E+ F EI + H NI+
Sbjct: 40 QMVKQIGKGRYGEVWMGK-WR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENIL 94
Query: 193 KLEG--LITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
+ + +YL+ +Y E+ + L + Y + GL H H+
Sbjct: 95 GFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAY--SSVSGLCHLHT 152
Query: 250 R--------GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ---PLTSRVVTLWY 298
+ HRD+K N+LV G +AD GLA + + P +RV T Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 299 RPPELLLGAT-----DYGPSVDLWSVGCVFAELL 327
PPE+L + D++S G + E+
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-28
Identities = 63/285 (22%), Positives = 124/285 (43%), Gaps = 47/285 (16%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN-FEPESVRFMAREILILR 184
+ D F++++ +G G++ V + ++G A+K + + + + E IL+
Sbjct: 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 185 RLDHPNIIKLEGLITSRLSCSIYLVFEYME-HDITGLLSCPDIKFSEAQIKCYMNQLLHG 243
++ P ++KLE + + + ++Y+V EY+ ++ L +FSE + Y Q++
Sbjct: 97 AVNFPFLVKLEF--SFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLT 153
Query: 244 LEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL----WYR 299
E+ HS +++RD+K NLL++ +G +++ DFG A + + R TL
Sbjct: 154 FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA--------KRVKGRTWTLCGTPEAL 205
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359
PE++L Y +VD W++G + E+ G P ++ KI K
Sbjct: 206 APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----------GK 254
Query: 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 404
+ P + +L+ LL V+ KR
Sbjct: 255 VRFP-------------------SHFSSDLKDLLRNLLQVDLTKR 280
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 114 bits (285), Expect = 7e-28
Identities = 51/340 (15%), Positives = 99/340 (29%), Gaps = 78/340 (22%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE------PESVRFMAREILIL 183
+ ++ EKIG+G + VF+ VA+K + + + ++ + EI+I
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTI--ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 184 RRL---------DHPNIIKLEGLITSRLSCS----------------------------I 206
+ L I L + + S +
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVN 265
++V E+ L S A K ++QL L + HRD+ N+L+
Sbjct: 138 FIVLEFEFGG-IDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK 196
Query: 266 NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAE 325
+ KL S P V++ DY S VF +
Sbjct: 197 KTSLKKLHYTLNGKSSTI----PSCGLQVSII-----------DYTLSRLERDGIVVFCD 241
Query: 326 LLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH---------ATLFKPQQPYDS 376
+ + + + G + + I++L ++ W + + K
Sbjct: 242 VSMDEDLFTG--DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTK 299
Query: 377 SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
K + T+L+ +A+ L
Sbjct: 300 CNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 8e-28
Identities = 75/303 (24%), Positives = 122/303 (40%), Gaps = 78/303 (25%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDL---DTGKIVALKKVRFDNF--EPESVRFMAREIL 181
+R + FE L +G+G Y VF+ R + +TGKI A+K ++ + E
Sbjct: 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERN 73
Query: 182 ILRRLDHPNIIKLEGLITSRLSC-----SIYLVFEY------MEHDITGLLSCPDIKFSE 230
IL + HP I+ L +YL+ EY L + F E
Sbjct: 74 ILEEVKHPFIVDLI-------YAFQTGGKLYLILEYLSGGELFMQ-----LE-REGIFME 120
Query: 231 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------NFSNT 283
Y+ ++ L H H +G+++RD+K N+++N++G +KL DFGL ++T
Sbjct: 121 DTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT 180
Query: 284 --GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ 341
G T+ Y PE+L+ + + +VD WS+G + ++L G P G +
Sbjct: 181 FCG----------TIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT 229
Query: 342 LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEP 401
+ KI K K LP L A +L++ LL
Sbjct: 230 IDKILK----------CKLNLP-------------------PYLTQEARDLLKKLLKRNA 260
Query: 402 YKR 404
R
Sbjct: 261 ASR 263
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 53/214 (24%), Positives = 79/214 (36%), Gaps = 26/214 (12%)
Query: 133 EKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192
LE +G+G Y V+R G+ VA+K + + F E+ L H NI+
Sbjct: 11 TLLECVGKGRYGEVWRGS-WQ-GENVAVKIFSSRDEKSW---FRETELYNTVMLRHENIL 65
Query: 193 KLEG--LITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
+ + S ++L+ Y E + L + + GL H H
Sbjct: 66 GFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVL--SIASGLAHLHI 123
Query: 250 R--------GVLHRDIKGSNLLVNNEGVLKLADFGLA---NFSNTGHRQPLTSRVVTLWY 298
+ HRD+K N+LV G +AD GLA + S RV T Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 299 RPPELLLGATDYGPS-----VDLWSVGCVFAELL 327
PE+L VD+W+ G V E+
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-27
Identities = 47/218 (21%), Positives = 85/218 (38%), Gaps = 25/218 (11%)
Query: 129 ADAFEKLEKIGQGTYSSVFRARDLD-TGKIVALKKVRFDNFEPESVRFMAREILILRRLD 187
A +E I G ++ A D + G+ V LK + M E L +
Sbjct: 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAM-AERQFLAEVV 137
Query: 188 HPNIIKL------EGLITSRLSCSIYLVFEYME-HDITGLLSCPDIKFSEAQIKCYMNQL 240
HP+I+++ + Y+V EY+ + A+ Y+ ++
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVG---YIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEI 191
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-TLWYR 299
L L + HS G+++ D+K N+++ E + KL D G R + T ++
Sbjct: 192 LPALSYLHSIGLVYNDLKPENIMLTEEQL-KLIDLGAV------SRINSFGYLYGTPGFQ 244
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT 337
PE++ + D+++VG A L + P GR
Sbjct: 245 APEIVRTGPT--VATDIYTVGRTLAALTLDLPTRNGRY 280
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 57/235 (24%), Positives = 98/235 (41%), Gaps = 27/235 (11%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL 186
++ + LE +G + V++A+ + VA+K F + +S + E+ L +
Sbjct: 21 FQSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKI--FPIQDKQSWQN-EYEVYSLPGM 75
Query: 187 DHPNIIKLEG--LITSRLSCSIYLVFEYMEH------------DITGLLSCPDIKFSEAQ 232
H NI++ G + + ++L+ + E L I + A+
Sbjct: 76 KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCH---IAETMAR 132
Query: 233 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 292
Y+++ + GL+ H + HRDIK N+L+ N +ADFGLA G T
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHG 192
Query: 293 VV-TLWYRPPELLLGA----TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQL 342
V T Y PE+L GA D +D++++G V EL G + L
Sbjct: 193 QVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 63/211 (29%), Positives = 105/211 (49%), Gaps = 24/211 (11%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFD-NFEPESV-RFMAREILILRRLDHP 189
++ ++K+G G S+V+ A D VA+K + + E++ RF RE+ +L H
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRF-EREVHNSSQLSHQ 71
Query: 190 NIIKL------EGLITSRLSCSIYLVFEYME-HDITGLLSCPDIKFSEAQIKCYMNQLLH 242
NI+ + + YLV EY+E ++ + S + NQ+L
Sbjct: 72 NIVSMIDVDEEDDCY--------YLVMEYIEGPTLSEYIE-SHGPLSVDTAINFTNQILD 122
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVV-TLWYRP 300
G++H H ++HRDIK N+L+++ LK+ DFG+A S T Q T+ V+ T+ Y
Sbjct: 123 GIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ--TNHVLGTVQYFS 180
Query: 301 PELLLGATDYGPSVDLWSVGCVFAELLIGKP 331
PE G D++S+G V E+L+G+P
Sbjct: 181 PEQAKGEA-TDECTDIYSIGIVLYEMLVGEP 210
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-27
Identities = 69/286 (24%), Positives = 122/286 (42%), Gaps = 41/286 (14%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA---REIL- 181
L + F IG+G + V+ R DTGK+ A+K + + + +A R +L
Sbjct: 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 244
Query: 182 ILRRLDHPNIIKLEGLI--TSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMN 238
++ D P I+ + +L + + M D+ LS FSEA ++ Y
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKL----SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAA 299
Query: 239 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 298
+++ GLEH H+R V++RD+K +N+L++ G ++++D GLA + + V T Y
Sbjct: 300 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGY 356
Query: 299 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 358
PE+L Y S D +S+GC+ +LL G + ++ H+I +
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDR----------- 404
Query: 359 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 404
+ P +L+E LL + +R
Sbjct: 405 --MTLTMAVELPDS------------FSPELRSLLEGLLQRDVNRR 436
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 14/203 (6%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFD-NFEPESVRFMAREILILRRLDHPNIIK 193
+G+G V+ A D +IVALK + + +P M RE RL P+++
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 194 L--EGLITSRLSCSIYLVFEYME-HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
+ G I +L Y+ + D+ +L + + + Q+ L+ H+
Sbjct: 99 IHDFGEIDGQL----YVDMRLINGVDLAAMLR-RQGPLAPPRAVAIVRQIGSALDAAHAA 153
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVV-TLWYRPPELLLGAT 308
G HRD+K N+LV+ + L DFG+A+ ++ Q V TL+Y PE +
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ--LGNTVGTLYYMAPERFSESH 211
Query: 309 DYGPSVDLWSVGCVFAELLIGKP 331
D++++ CV E L G P
Sbjct: 212 -ATYRADIYALTCVLYECLTGSP 233
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 59/207 (28%), Positives = 102/207 (49%), Gaps = 10/207 (4%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFD-NFEPESV-RFMAREILILRRLDHP 189
+E E +G G S V ARDL + VA+K +R D +P RF RE L+HP
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRF-RREAQNAAALNHP 72
Query: 190 NIIKL--EGLITSRLSCSIYLVFEYME-HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEH 246
I+ + G + Y+V EY++ + ++ + + + + L
Sbjct: 73 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQALNF 131
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVV-TLWYRPPELL 304
H G++HRD+K +N++++ +K+ DFG+A +++G+ T+ V+ T Y PE
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 305 LGATDYGPSVDLWSVGCVFAELLIGKP 331
G + D++S+GCV E+L G+P
Sbjct: 192 RGDS-VDARSDVYSLGCVLYEVLTGEP 217
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-27
Identities = 69/302 (22%), Positives = 114/302 (37%), Gaps = 79/302 (26%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALK----KVRFDNFEPESVRFMAREILI 182
+ F L+ IG+G++ V AR A+K K E + + R +L
Sbjct: 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIM-SERNVL- 92
Query: 183 LRRLDHPNIIKLEGLITSRLSC-----SIYLVFEY------MEHDITGLLSCPDIKFSEA 231
L+ + HP ++ L +Y V +Y H L + F E
Sbjct: 93 LKNVKHPFLVGLH-------FSFQTADKLYFVLDYINGGELFYH-----LQ-RERCFLEP 139
Query: 232 QIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------NFSNT- 283
+ + Y ++ L + HS +++RD+K N+L++++G + L DFGL + ++T
Sbjct: 140 RARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTF 199
Query: 284 -GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQL 342
G T Y PE+L Y +VD W +G V E+L G P R E
Sbjct: 200 CG----------TPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY 248
Query: 343 HKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPY 402
I K +L ++ +A +L+E LL +
Sbjct: 249 DNILN----------KPLQLK-------------------PNITNSARHLLEGLLQKDRT 279
Query: 403 KR 404
KR
Sbjct: 280 KR 281
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 44/154 (28%), Positives = 76/154 (49%), Gaps = 6/154 (3%)
Query: 130 DAFEKLEKIGQGTYSSVFRAR----DLDTGKIVALKKVRFDNFEPESVRFMAREILILRR 185
+++ +G+G + V R +TG+ VA+K ++ ++ +EI ILR
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK-KEIEILRN 79
Query: 186 LDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGL 244
L H NI+K +G+ T I L+ E++ + L K + Q Y Q+ G+
Sbjct: 80 LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGM 139
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
++ SR +HRD+ N+LV +E +K+ DFGL
Sbjct: 140 DYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 55/214 (25%), Positives = 84/214 (39%), Gaps = 26/214 (12%)
Query: 133 EKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192
E IG+G + V+R + G+ VA+K F + E S F EI L H NI+
Sbjct: 45 VLQESIGKGRFGEVWRGK-WR-GEEVAVKI--FSSREERSW-FREAEIYQTVMLRHENIL 99
Query: 193 KLEG--LITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
+ ++LV +Y EH + L+ + GL H H
Sbjct: 100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLAL--STASGLAHLHM 157
Query: 250 R--------GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ---PLTSRVVTLWY 298
+ HRD+K N+LV G +AD GLA ++ RV T Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 299 RPPELLLGAT-----DYGPSVDLWSVGCVFAELL 327
PE+L + + D++++G VF E+
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 70/303 (23%), Positives = 122/303 (40%), Gaps = 79/303 (26%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR----FDNFEPESVRFMAREIL 181
L D FE + +G+G++ V AR +TG + A+K ++ + + E + IL
Sbjct: 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTM-TEKRIL 77
Query: 182 ILRRLDHPNIIKLEGLITSRLSC-----SIYLVFEY------MEHDITGLLSCPDIKFSE 230
L R +HP + +L C ++ V E+ M H + +F E
Sbjct: 78 SLAR-NHPFLTQL-------FCCFQTPDRLFFVMEFVNGGDLMFH-----IQ-KSRRFDE 123
Query: 231 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------NFSNT 283
A+ + Y +++ L H +G+++RD+K N+L+++EG KLADFG+ + T
Sbjct: 124 ARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT 183
Query: 284 --GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ 341
G T Y PE+L YGP+VD W++G + E+L G + E +
Sbjct: 184 FCG----------TPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL 232
Query: 342 LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEP 401
I + P L A ++++ ++ P
Sbjct: 233 FEAILN----------DEVVYP-------------------TWLHEDATGILKSFMTKNP 263
Query: 402 YKR 404
R
Sbjct: 264 TMR 266
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 3e-26
Identities = 53/227 (23%), Positives = 94/227 (41%), Gaps = 37/227 (16%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMARE--ILILRRLDHP 189
+ LE IG+G Y +V++ LD + VA+K F + + E I + ++H
Sbjct: 15 LKLLELIGRGRYGAVYKGS-LD-ERPVAVKV-----FSFANRQNFINEKNIYRVPLMEHD 67
Query: 190 NIIKLEG---LITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
NI + +T+ LV EY + + LS + + + + GL
Sbjct: 68 NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAH--SVTRGLA 125
Query: 246 HCHS---------RGVLHRDIKGSNLLVNNEGVLKLADFGLA-------NFSNTGHRQPL 289
+ H+ + HRD+ N+LV N+G ++DFGL+
Sbjct: 126 YLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAA 185
Query: 290 TSRVVTLWYRPPELLLGATD------YGPSVDLWSVGCVFAELLIGK 330
S V T+ Y PE+L GA + VD++++G ++ E+ +
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 6e-26
Identities = 71/294 (24%), Positives = 121/294 (41%), Gaps = 61/294 (20%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR----FDNFEPESVRFMAREIL 181
L+ + F + +G+G++ VF A T + A+K ++ + + E + + +L
Sbjct: 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTM-VEKRVL 71
Query: 182 ILRRLDHPNIIKLEGLITSRLSC-----SIYLVFEY------MEHDITGLLSCPDIKFSE 230
+HP + + +++ V EY M H + KF
Sbjct: 72 -SLAWEHPFLTHM-------FCTFQTKENLFFVMEYLNGGDLMYH-----IQSCH-KFDL 117
Query: 231 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 290
++ Y +++ GL+ HS+G+++RD+K N+L++ +G +K+ADFG+ N
Sbjct: 118 SRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK-ENMLGDAKTN 176
Query: 291 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 350
+ T Y PE+LLG Y SVD WS G + E+LIG+ G+ E E H I
Sbjct: 177 TFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--- 232
Query: 351 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 404
P + L A +L+ L EP KR
Sbjct: 233 -------DNPFYP-------------------RWLEKEAKDLLVKLFVREPEKR 260
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 6e-26
Identities = 66/288 (22%), Positives = 118/288 (40%), Gaps = 51/288 (17%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF----EPESVRFMAREILI 182
++ F L +G+G++ V + T ++ A+K ++ D + E + + +L
Sbjct: 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTM-VEKRVLA 396
Query: 183 LRRLDHPNIIKLEGLITSRLSC-----SIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCY 236
L P + +L SC +Y V EY+ D+ + +F E Y
Sbjct: 397 LPG-KPPFLTQL-------HSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFY 447
Query: 237 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 296
++ GL S+G+++RD+K N+++++EG +K+ADFG+ N + T
Sbjct: 448 AAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTP 506
Query: 297 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 356
Y PE++ YG SVD W+ G + E+L G+ +G E E I +
Sbjct: 507 DYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--------- 556
Query: 357 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 404
P K + AV + + L++ P KR
Sbjct: 557 -HNVAYP-------------------KSMSKEAVAICKGLMTKHPGKR 584
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 47/154 (30%), Positives = 84/154 (54%), Gaps = 7/154 (4%)
Query: 130 DAFEKLEKIGQGTYSSVFRAR----DLDTGKIVALKKVRFDNFEPESVRFMAREILILRR 185
+ L+++G+G + SV R +TG++VA+KK++ E +R REI IL+
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKS 98
Query: 186 LDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGL 244
L H NI+K +G+ S ++ L+ EY+ + + L + ++ Y +Q+ G+
Sbjct: 99 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 158
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
E+ ++ +HRD+ N+LV NE +K+ DFGL
Sbjct: 159 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 47/154 (30%), Positives = 84/154 (54%), Gaps = 7/154 (4%)
Query: 130 DAFEKLEKIGQGTYSSVFRAR----DLDTGKIVALKKVRFDNFEPESVRFMAREILILRR 185
+ L+++G+G + SV R +TG++VA+KK++ E +R REI IL+
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKS 67
Query: 186 LDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGL 244
L H NI+K +G+ S ++ L+ EY+ + + L + ++ Y +Q+ G+
Sbjct: 68 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
E+ ++ +HRD+ N+LV NE +K+ DFGL
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 67/303 (22%), Positives = 118/303 (38%), Gaps = 79/303 (26%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR----FDNFEPESVRFMAREIL 181
++ F L +G+G++ V + T ++ A+K ++ + + E + + +L
Sbjct: 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTM-VEKRVL 74
Query: 182 ILRRLDHPNIIKLEGLITSRLSC-----SIYLVFEY------MEHDITGLLSCPDIKFSE 230
L P + +L SC +Y V EY M H + +F E
Sbjct: 75 ALPG-KPPFLTQL-------HSCFQTMDRLYFVMEYVNGGDLMYH-----IQQVG-RFKE 120
Query: 231 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------NFSNT 283
Y ++ GL S+G+++RD+K N+++++EG +K+ADFG+ + T
Sbjct: 121 PHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT 180
Query: 284 --GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ 341
G T Y PE++ YG SVD W+ G + E+L G+ +G E E
Sbjct: 181 FCG----------TPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 229
Query: 342 LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEP 401
I + P K + AV + + L++ P
Sbjct: 230 FQSIME----------HNVAYP-------------------KSMSKEAVAICKGLMTKHP 260
Query: 402 YKR 404
KR
Sbjct: 261 GKR 263
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 72/311 (23%), Positives = 127/311 (40%), Gaps = 86/311 (27%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR----FDNFEPESVRFMAREIL 181
PL F+ L IG+G+Y+ V R T +I A+K V+ D+ + + V+ + +
Sbjct: 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQ-TEKHVF 63
Query: 182 ILRRLDHPNIIKLEGLI--TSRLSCSIYLVFEY------MEHDITGLLSCPDIKFSEAQI 233
+HP ++ L SRL + V EY M H + K E
Sbjct: 64 EQAS-NHPFLVGLHSCFQTESRL----FFVIEYVNGGDLMFH-----MQ-RQRKLPEEHA 112
Query: 234 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------NFSNT--G 284
+ Y ++ L + H RG+++RD+K N+L+++EG +KL D+G+ + ++T G
Sbjct: 113 RFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG 172
Query: 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHK 344
T Y PE+L G DYG SVD W++G + E++ G+
Sbjct: 173 ----------TPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRS------------- 208
Query: 345 IFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF-----------KDLPTTAVNLI 393
P + P ++ F + L A +++
Sbjct: 209 ------------------PFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVL 250
Query: 394 ETLLSVEPYKR 404
++ L+ +P +R
Sbjct: 251 KSFLNKDPKER 261
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 46/155 (29%), Positives = 80/155 (51%), Gaps = 10/155 (6%)
Query: 130 DAFEKLEKIGQGTYSSVFRAR----DLDTGKIVALKKVRFDNFEPESVRFMAREILILRR 185
+K+ +G+G + V + TG++VA+K ++ D + +EI ILR
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWK-QEIDILRT 89
Query: 186 LDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-LLSC-PDIKFSEAQIKCYMNQLLHG 243
L H +IIK +G + S+ LV EY+ G L P AQ+ + Q+ G
Sbjct: 90 LYHEHIIKYKGCCEDAGAASLQLVMEYVPL---GSLRDYLPRHSIGLAQLLLFAQQICEG 146
Query: 244 LEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
+ + H++ +HRD+ N+L++N+ ++K+ DFGLA
Sbjct: 147 MAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA 181
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-25
Identities = 71/294 (24%), Positives = 128/294 (43%), Gaps = 52/294 (17%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDL---DTGKIVALKKVRFDNF--EPESVRFMAREIL 181
+ + FE L+ +G G Y VF R + DTGK+ A+K ++ + ++ E
Sbjct: 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 110
Query: 182 ILRRLDH-PNIIKLEGLI--TSRLSCSIYLVFEY------MEHDITGLLSCPDIKFSEAQ 232
+L + P ++ L ++L +L+ +Y H LS +F+E +
Sbjct: 111 VLEHIRQSPFLVTLHYAFQTETKL----HLILDYINGGELFTH-----LSQ-RERFTEHE 160
Query: 233 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 292
++ Y+ +++ LEH H G+++RDIK N+L+++ G + L DFGL+ +
Sbjct: 161 VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF 220
Query: 293 VVTLWYRPPELLLGATD-YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF-KLCG 350
T+ Y P+++ G + +VD WS+G + ELL G E +I ++
Sbjct: 221 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK 280
Query: 351 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 404
S P P +++ A +LI+ LL +P KR
Sbjct: 281 SEP-------PYP-------------------QEMSALAKDLIQRLLMKDPKKR 308
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 47/154 (30%), Positives = 80/154 (51%), Gaps = 7/154 (4%)
Query: 130 DAFEKLEKIGQGTYSSVFRAR----DLDTGKIVALKKVRFDNFEPESVRFMAREILILRR 185
+ + ++G+G + SV R +TG +VA+K+++ P+ R REI IL+
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQREIQILKA 80
Query: 186 LDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGL 244
L I+K G+ S+ LV EY+ + L + +++ Y +Q+ G+
Sbjct: 81 LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGM 140
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
E+ SR +HRD+ N+LV +E +K+ADFGLA
Sbjct: 141 EYLGSRRCVHRDLAARNILVESEAHVKIADFGLA 174
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-24
Identities = 69/314 (21%), Positives = 126/314 (40%), Gaps = 92/314 (29%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR----FDNFEPESVRFMAREIL 181
L F+ L IG+G+Y+ V R T +I A++ V+ D+ + + V+ + +
Sbjct: 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQ-TEKHVF 106
Query: 182 ILRRLDHPNIIKLEGLITSRLSC-----SIYLVFEY------MEHDITGLLSCPDIKFSE 230
+HP ++ L SC ++ V EY M H + K E
Sbjct: 107 EQAS-NHPFLVGL-------HSCFQTESRLFFVIEYVNGGDLMFH-----MQ-RQRKLPE 152
Query: 231 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------NFSNT 283
+ Y ++ L + H RG+++RD+K N+L+++EG +KL D+G+ + ++T
Sbjct: 153 EHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST 212
Query: 284 --GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ 341
G T Y PE+L G DYG SVD W++G + E++ G+
Sbjct: 213 FCG----------TPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRS---------- 251
Query: 342 LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF-----------KDLPTTAV 390
P + P ++ F + L A
Sbjct: 252 ---------------------PFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAA 290
Query: 391 NLIETLLSVEPYKR 404
+++++ L+ +P +R
Sbjct: 291 SVLKSFLNKDPKER 304
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 37/222 (16%), Positives = 65/222 (29%), Gaps = 38/222 (17%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESV--RFMAREILILRRLDHPNII 192
L G ++A D + VAL V P+ V + L L R+D P +
Sbjct: 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETL-SRTLRLSRIDKPGVA 94
Query: 193 KLEGLITSRLSCSIYLVFEYME-HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG 251
++ ++ +R +V E++ + + + M L + H G
Sbjct: 95 RVLDVVHTRAGG--LVVAEWIRGGSLQEVADTSPSPVGAIRA---MQSLAAAADAAHRAG 149
Query: 252 VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYG 311
V S + V+ +G + LA P
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPA---------------------TMPDA--------N 180
Query: 312 PSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 353
P D+ +G LL+ + L L + P
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQP 222
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 46/148 (31%), Positives = 76/148 (51%), Gaps = 7/148 (4%)
Query: 135 LEKIGQGTYSSVFRARDLDTGK---IVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+ IG G V R G+ VA+K ++ E + F+ E I+ + DHPNI
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFL-SEASIMGQFDHPNI 112
Query: 192 IKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
I+LEG++T +V EYME+ + L D +F+ Q+ + + G+ +
Sbjct: 113 IRLEGVVT--RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL 170
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLA 278
G +HRD+ N+LV++ V K++DFGL+
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLS 198
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 39/159 (24%), Positives = 74/159 (46%), Gaps = 6/159 (3%)
Query: 124 WVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKI---VALKKVRFDNFEPESVRFMAREI 180
+ + E IG+G + V+ LD A+K + E +F+ E
Sbjct: 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL-TEG 77
Query: 181 LILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQ 239
+I++ HPN++ L G+ R S +V YM+H D+ + + + + Q
Sbjct: 78 IIMKDFSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 136
Query: 240 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
+ G+++ S+ +HRD+ N +++ + +K+ADFGLA
Sbjct: 137 VAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 175
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 7e-24
Identities = 46/158 (29%), Positives = 77/158 (48%), Gaps = 5/158 (3%)
Query: 122 QGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREIL 181
WV L + E+IG+G + VF R +VA+K R +F+ +E
Sbjct: 107 DKWV-LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFL-QEAR 164
Query: 182 ILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQL 240
IL++ HPNI++L G+ T + IY+V E ++ D L + + +
Sbjct: 165 ILKQYSHPNIVRLIGVCTQKQP--IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDA 222
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
G+E+ S+ +HRD+ N LV + VLK++DFG++
Sbjct: 223 AAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMS 260
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 37/160 (23%), Positives = 77/160 (48%), Gaps = 15/160 (9%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRAR---DLDTGKI-VALKKVRFDNFEPESVRFMAREILI 182
L+ F+K++ +G G + +V++ + + KI VA+K++R + + E +
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYV 70
Query: 183 LRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-LLSC---PDIKFSEAQIKCYMN 238
+ +D+P++ +L G+ + ++ L+ + M G LL + +
Sbjct: 71 MASVDNPHVCRLLGICLTS---TVQLITQLMPF---GCLLDYVREHKDNIGSQYLLNWCV 124
Query: 239 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
Q+ G+ + R ++HRD+ N+LV +K+ DFGLA
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 52/232 (22%), Positives = 99/232 (42%), Gaps = 7/232 (3%)
Query: 52 RGSSNRKKGSKGEFGVAVSCGGSELGESGRASSNSESLSFRLGNLHKYIEGEQVAAGWPA 111
+ ++ + G+ V G L S SL + G+ + Y +G +
Sbjct: 10 HHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLS 69
Query: 112 WLSAVAGEAIQGWVPLRADAFEKLEK-IGQGTYSSVFRARDLDTGKI---VALKKVRFDN 167
L+ +A+Q V + + IG+G + V+ LD A+K +
Sbjct: 70 ALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT 129
Query: 168 FEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDI 226
E +F+ E +I++ HPN++ L G+ R S +V YM+H D+ +
Sbjct: 130 DIGEVSQFL-TEGIIMKDFSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETH 187
Query: 227 KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
+ + + Q+ G++ S+ +HRD+ N +++ + +K+ADFGLA
Sbjct: 188 NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 239
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 30/209 (14%)
Query: 135 LEKIGQGTYSSVFRARDLDTGK---IVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+ +G G + V R K VA+K ++ E + F+ E I+ + DHPNI
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPNI 108
Query: 192 IKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
I+LEG++T S + +V EYME+ + L D +F+ Q+ + + G+++
Sbjct: 109 IRLEGVVT--KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLA---------NFSNTGHRQPLTSRVVTLWYRPP 301
G +HRD+ N+L+N+ V K++DFGL ++ G + P+ W P
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPI------RWT-SP 219
Query: 302 ELLLGATDYG---PSVDLWSVGCVFAELL 327
E A Y + D+WS G V E++
Sbjct: 220 E----AIAYRKFTSASDVWSYGIVLWEVM 244
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 5e-23
Identities = 43/168 (25%), Positives = 79/168 (47%), Gaps = 9/168 (5%)
Query: 115 AVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKI---VALKKVRFDNFEPE 171
G + + + ++ + E IG+G + V + + VA+K + +
Sbjct: 1 GAMGSSTRDYE-IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV 59
Query: 172 SVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSE 230
+F+ +E L +R+ DHP+I+KL G+IT ++++ E ++ L
Sbjct: 60 REKFL-QEALTMRQFDHPHIVKLIGVITEN---PVWIIMELCTLGELRSFLQVRKYSLDL 115
Query: 231 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
A + Y QL L + S+ +HRDI N+LV++ +KL DFGL+
Sbjct: 116 ASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 163
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 7e-23
Identities = 40/149 (26%), Positives = 71/149 (47%), Gaps = 13/149 (8%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
K+G G Y V+ VA+K ++ D E E F+ +E +++ + HPN+++L
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FL-KEAAVMKEIKHPNLVQL 74
Query: 195 EGLITSRLSCSIYLVFEYMEHDITG-----LLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
G+ T Y++ E+M + G L C + S + Q+ +E+
Sbjct: 75 LGVCT--REPPFYIITEFMTY---GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
+ +HRD+ N LV ++K+ADFGL+
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLS 158
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 9e-23
Identities = 44/169 (26%), Positives = 74/169 (43%), Gaps = 23/169 (13%)
Query: 126 PLRADAFE-------KLEKIGQGTYSSVFRA--RDLDTGKI-VALKKVRFDNFEPESVR- 174
PL++ LEK+G G++ V R + VA+K ++ D
Sbjct: 7 PLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD 66
Query: 175 -FMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-LLSC---PDIKFS 229
F+ RE+ + LDH N+I+L G++ + + +V E G LL F
Sbjct: 67 DFI-REVNAMHSLDHRNLIRLYGVVLTP---PMKMVTELAPL---GSLLDRLRKHQGHFL 119
Query: 230 EAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
+ Y Q+ G+ + S+ +HRD+ NLL+ ++K+ DFGL
Sbjct: 120 LGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM 168
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 35/145 (24%), Positives = 74/145 (51%), Gaps = 7/145 (4%)
Query: 137 KIGQGTYSSVFRAR-DLDTGKI-VALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
++G G + SV + + +I VA+K ++ + ++ M RE I+ +LD+P I++L
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM-REAQIMHQLDNPYIVRL 75
Query: 195 EGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 253
G+ + ++ LV E + L + + + ++Q+ G+++ + +
Sbjct: 76 IGVCQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 132
Query: 254 HRDIKGSNLLVNNEGVLKLADFGLA 278
HRD+ N+L+ N K++DFGL+
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLS 157
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 45/157 (28%), Positives = 82/157 (52%), Gaps = 8/157 (5%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRAR-DLDTGKI---VALKKVRFDNFEPESVRFMAREILI 182
+ + + IG G + V++ +GK VA+K ++ E + V F+ E I
Sbjct: 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL-GEAGI 99
Query: 183 LRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLL 241
+ + H NII+LEG+I+ + ++ EYME+ + L D +FS Q+ + +
Sbjct: 100 MGQFSHHNIIRLEGVISK--YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 157
Query: 242 HGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
G+++ + +HRD+ N+LVN+ V K++DFGL+
Sbjct: 158 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS 194
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 8/148 (5%)
Query: 135 LEKIGQGTYSSVFRA--RDLDTGKI-VALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+G+G + V+ + KI VA+K + D +FM E +I++ LDHP+I
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFM-SEAVIMKNLDHPHI 75
Query: 192 IKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
+KL G+I +++ E + ++ L + Y Q+ + + S
Sbjct: 76 VKLIGIIEEE---PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI 132
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLA 278
+HRDI N+LV + +KL DFGL+
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLS 160
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 46/199 (23%), Positives = 85/199 (42%), Gaps = 16/199 (8%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
K+G G Y V+ VA+K ++ D E E F+ E +++ + HPN+++L
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLK-EAAVMKEIKHPNLVQL 281
Query: 195 EGLITSRLSCSIYLVFEYMEHDITG-----LLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
G+ T Y++ E+M + G L C + S + Q+ +E+
Sbjct: 282 LGVCTR--EPPFYIITEFMTY---GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG-HRQPLTSRVVTLWYRPPELLLGAT 308
+ +HR++ N LV ++K+ADFGL+ + ++ W P L
Sbjct: 337 KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK- 395
Query: 309 DYGPSVDLWSVGCVFAELL 327
+ D+W+ G + E+
Sbjct: 396 -FSIKSDVWAFGVLLWEIA 413
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 34/157 (21%), Positives = 76/157 (48%), Gaps = 9/157 (5%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRAR---DLDTGKI-VALKKVRFDNFEPESVRFMAREILI 182
L+ F+K++ +G G + +V++ + + KI VA+K++R + + E +
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYV 70
Query: 183 LRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLL 241
+ +D+P++ +L G+ + ++ L+ + M + + + + Q+
Sbjct: 71 MASVDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 242 HGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
G+ + R ++HRD+ N+LV +K+ DFGLA
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 4e-22
Identities = 40/145 (27%), Positives = 69/145 (47%), Gaps = 7/145 (4%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
+++IG G + V L+ K VA+K +R E F+ E ++ +L HP +++L
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEED--FI-EEAEVMMKLSHPKLVQL 68
Query: 195 EGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 253
G+ I LV E+MEH ++ L F+ + + G+ + V+
Sbjct: 69 YGVCL--EQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 126
Query: 254 HRDIKGSNLLVNNEGVLKLADFGLA 278
HRD+ N LV V+K++DFG+
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMT 151
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 5e-22
Identities = 33/164 (20%), Positives = 74/164 (45%), Gaps = 15/164 (9%)
Query: 126 PLRADAFE--------KLEKIGQGTYSSVFRAR-DLDTGKI-VALKKVRFDNFEPESVRF 175
+R + +++G G + +V + + VA+K ++ + +P
Sbjct: 5 EIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE 64
Query: 176 MAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIK 234
+ E ++++LD+P I+++ G+ + S LV E E + L + I
Sbjct: 65 LLAEANVMQQLDNPYIVRMIGICEAE---SWMLVMEMAELGPLNKYLQQNR-HVKDKNII 120
Query: 235 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
++Q+ G+++ +HRD+ N+L+ + K++DFGL+
Sbjct: 121 ELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS 164
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 8e-22
Identities = 49/204 (24%), Positives = 88/204 (43%), Gaps = 23/204 (11%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKI---VALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
IG+G + V + + VA+K + + +F+ +E L +R+ DHP+I
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFL-QEALTMRQFDHPHI 453
Query: 192 IKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
+KL G+IT ++++ E ++ L A + Y QL L + S+
Sbjct: 454 VKLIGVITEN---PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK 510
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANF-------SNTGHRQPLTSRVVTLWYRPPEL 303
+HRDI N+LV++ +KL DFGL+ + + + P+ W P +
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI------KWMAPESI 564
Query: 304 LLGATDYGPSVDLWSVGCVFAELL 327
+ + D+W G E+L
Sbjct: 565 NFRR--FTSASDVWMFGVCMWEIL 586
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 38/159 (23%), Positives = 74/159 (46%), Gaps = 6/159 (3%)
Query: 124 WVPLRADAFEKLEKIGQGTYSSVFRARDLDTGK---IVALKKVRFDNFEPESVRFMAREI 180
+P IG+G + V+ +D + A+K + + F+ RE
Sbjct: 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFL-REG 73
Query: 181 LILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQ 239
L++R L+HPN++ L G++ +++ YM H D+ + P + + + Q
Sbjct: 74 LLMRGLNHPNVLALIGIMLPP-EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQ 132
Query: 240 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
+ G+E+ + +HRD+ N +++ +K+ADFGLA
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLA 171
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 98.1 bits (244), Expect = 2e-21
Identities = 37/185 (20%), Positives = 82/185 (44%), Gaps = 7/185 (3%)
Query: 97 HKYIEGEQVAAGWPAWLSAVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRAR-DLDTG 155
K + + + S + R + ++G G + SV + +
Sbjct: 303 DKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKK 362
Query: 156 KI-VALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYME 214
+I VA+K ++ + ++ M RE I+ +LD+P I++L G+ + ++ LV E
Sbjct: 363 QIDVAIKVLKQGTEKADTEEMM-REAQIMHQLDNPYIVRLIGVCQAE---ALMLVMEMAG 418
Query: 215 H-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLA 273
+ L + + + ++Q+ G+++ + +HR++ N+L+ N K++
Sbjct: 419 GGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKIS 478
Query: 274 DFGLA 278
DFGL+
Sbjct: 479 DFGLS 483
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 33/157 (21%), Positives = 71/157 (45%), Gaps = 9/157 (5%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRAR---DLDTGKI-VALKKVRFDNFEPESVRFMAREILI 182
+ KL+ +G G + +V + + ++ KI V +K + + +L
Sbjct: 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVT-DHMLA 68
Query: 183 LRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLL 241
+ LDH +I++L GL S+ LV +Y+ + + + + Q+
Sbjct: 69 IGSLDHAHIVRLLGLCPGS---SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA 125
Query: 242 HGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
G+ + G++HR++ N+L+ + +++ADFG+A
Sbjct: 126 KGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVA 162
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 42/154 (27%), Positives = 82/154 (53%), Gaps = 15/154 (9%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ + +E++G G + V+ K VA+K ++ + P++ F+A E ++++L H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDA--FLA-EANLMKQLQHQ 68
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITG-----LLSCPDIKFSEAQIKCYMNQLLHGL 244
+++L ++T IY++ EYME+ G L + IK + ++ Q+ G+
Sbjct: 69 RLVRLYAVVTQE---PIYIITEYMEN---GSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
R +HRD++ +N+LV++ K+ADFGLA
Sbjct: 123 AFIEERNYIHRDLRAANILVSDTLSCKIADFGLA 156
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 35/156 (22%), Positives = 71/156 (45%), Gaps = 12/156 (7%)
Query: 135 LEKIGQGTYSSVFRA--RDLDTGKI-VALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+ +G+G + SV + D + VA+K ++ DN + E ++ HPN+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 192 IKLEGLIT---SRLSCSIYLVFEYMEH-DITGLL-----SCPDIKFSEAQIKCYMNQLLH 242
I+L G+ S+ ++ +M++ D+ L + +M +
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
G+E+ +R LHRD+ N ++ ++ + +ADFGL+
Sbjct: 159 GMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLS 194
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 3e-21
Identities = 51/204 (25%), Positives = 87/204 (42%), Gaps = 18/204 (8%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
++ K+GQG + V+ T + VA+K ++ PE F+ +E ++++L H
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPE--AFL-QEAQVMKKLRHE 239
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITG-----LLSCPDIKFSEAQIKCYMNQLLHGL 244
+++L +++ IY+V EYM G L Q+ Q+ G+
Sbjct: 240 KLVQLYAVVSEE---PIYIVTEYMSK---GSLLDFLKGETGKYLRLPQLVDMAAQIASGM 293
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL-WYRPPEL 303
+ +HRD++ +N+LV V K+ADFGLA + W P
Sbjct: 294 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 353
Query: 304 LLGATDYGPSVDLWSVGCVFAELL 327
L G + D+WS G + EL
Sbjct: 354 LYGR--FTIKSDVWSFGILLTELT 375
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 4e-21
Identities = 38/145 (26%), Positives = 73/145 (50%), Gaps = 7/145 (4%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
L+++G G + V + VA+K ++ + + F+ E ++ L H +++L
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDE--FI-EEAKVMMNLSHEKLVQL 84
Query: 195 EGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 253
G+ T I+++ EYM + + L +F Q+ + +E+ S+ L
Sbjct: 85 YGVCTK--QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 142
Query: 254 HRDIKGSNLLVNNEGVLKLADFGLA 278
HRD+ N LVN++GV+K++DFGL+
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLS 167
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 37/160 (23%), Positives = 69/160 (43%), Gaps = 19/160 (11%)
Query: 135 LEKIGQGTYSSVFRA--RDLDTGKI-VALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+G+G + SV A + D + VA+K ++ D + RE ++ DHP++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 192 IKLEGLIT----SRLSCSIYLVFEYMEHDITG-----LLSC----PDIKFSEAQIKCYMN 238
KL G+ ++ +M+H G LL+ + +M
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKH---GDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 239 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
+ G+E+ SR +HRD+ N ++ + + +ADFGL+
Sbjct: 145 DIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS 184
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 4e-21
Identities = 33/145 (22%), Positives = 66/145 (45%), Gaps = 7/145 (4%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
L+++G G + V + VA+K ++ + + F +E + +L HP ++K
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSED--EFF-QEAQTMMKLSHPKLVKF 68
Query: 195 EGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 253
G+ + IY+V EY+ + + L +Q+ + G+ S +
Sbjct: 69 YGVCS--KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFI 126
Query: 254 HRDIKGSNLLVNNEGVLKLADFGLA 278
HRD+ N LV+ + +K++DFG+
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMT 151
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 6e-21
Identities = 43/171 (25%), Positives = 74/171 (43%), Gaps = 16/171 (9%)
Query: 113 LSAVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPES 172
++A GW L + L+ IG+G + V G VA+K ++ D
Sbjct: 5 VAAQDEFYRSGWA-LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQA- 60
Query: 173 VRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-----LLSCPDIK 227
F+ E ++ +L H N+++L G+I +Y+V EYM G L S
Sbjct: 61 --FL-AEASVMTQLRHSNLVQLLGVIVEEKG-GLYIVTEYMAK---GSLVDYLRSRGRSV 113
Query: 228 FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
+ + + +E+ +HRD+ N+LV+ + V K++DFGL
Sbjct: 114 LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 164
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 1e-20
Identities = 51/204 (25%), Positives = 87/204 (42%), Gaps = 18/204 (8%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
++ K+GQG + V+ T + VA+K ++ PE F+ +E ++++L H
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPE--AFL-QEAQVMKKLRHE 322
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITG-----LLSCPDIKFSEAQIKCYMNQLLHGL 244
+++L +++ IY+V EYM G L Q+ Q+ G+
Sbjct: 323 KLVQLYAVVSEE---PIYIVTEYMSK---GSLLDFLKGETGKYLRLPQLVDMAAQIASGM 376
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL-WYRPPEL 303
+ +HRD++ +N+LV V K+ADFGLA + W P
Sbjct: 377 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 436
Query: 304 LLGATDYGPSVDLWSVGCVFAELL 327
L G + D+WS G + EL
Sbjct: 437 LYGR--FTIKSDVWSFGILLTELT 458
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 29/159 (18%), Positives = 72/159 (45%), Gaps = 18/159 (11%)
Query: 135 LEKIGQGTYSSVFR--ARDLDTGK---IVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
++GQG++ V+ A+ + + VA+K V E + F+ E +++ +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNCH 88
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH-DITGLL--SCPDIKFSEAQIKCYMNQLLH---- 242
++++L G+++ ++ E M D+ L P + + +++++
Sbjct: 89 HVVRLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 146
Query: 243 ---GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
G+ + ++ +HRD+ N +V + +K+ DFG+
Sbjct: 147 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT 185
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 7e-20
Identities = 36/165 (21%), Positives = 69/165 (41%), Gaps = 24/165 (14%)
Query: 135 LEKIGQGTYSSVFR--ARDLDTGK---IVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+E++G+ + V++ G+ VA+K ++ P F E ++ RL HP
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR-HEAMLRARLQHP 72
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH----------------DITGLLSCPDIKFSEAQI 233
N++ L G++T + ++F Y H T
Sbjct: 73 NVVCLLGVVT--KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDF 130
Query: 234 KCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
+ Q+ G+E+ S V+H+D+ N+LV ++ +K++D GL
Sbjct: 131 VHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-19
Identities = 43/170 (25%), Positives = 73/170 (42%), Gaps = 16/170 (9%)
Query: 114 SAVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESV 173
+A GW L + L+ IG+G + V G VA+K ++ D
Sbjct: 178 AAQDEFYRSGWA-LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQA-- 232
Query: 174 RFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITG-----LLSCPDIKF 228
F+ E ++ +L H N+++L G+I +Y+V EYM G L S
Sbjct: 233 -FL-AEASVMTQLRHSNLVQLLGVIVEE-KGGLYIVTEYMAK---GSLVDYLRSRGRSVL 286
Query: 229 SEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
+ + + +E+ +HRD+ N+LV+ + V K++DFGL
Sbjct: 287 GGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 336
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 41/238 (17%), Positives = 82/238 (34%), Gaps = 30/238 (12%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKI-------VALKKVRFDNFEPESVRFMARE 179
+R + E +GQGT++ +F+ + G V LK + + F
Sbjct: 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE-SFF-EA 62
Query: 180 ILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMN 238
++ +L H +++ G+ LV E+++ + L +
Sbjct: 63 ASMMSKLSHKHLVLNYGVCV--CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK 120
Query: 239 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEG--------VLKLADFGLANF--SNTGHRQP 288
QL + ++H ++ N+L+ E +KL+D G++ ++
Sbjct: 121 QLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQER 180
Query: 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKI 345
+ W PPE + + + D WS G E+ G L +L
Sbjct: 181 IP------WV-PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 1e-19
Identities = 42/154 (27%), Positives = 77/154 (50%), Gaps = 15/154 (9%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
++ + +K+G G + V+ A K VA+K ++ + E+ F+ E +++ L H
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEA--FL-AEANVMKTLQHD 243
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITG-----LLSCPDIKFSEAQIKCYMNQLLHGL 244
++KL ++T IY++ E+M G L S K ++ + Q+ G+
Sbjct: 244 KLVKLHAVVTKE---PIYIITEFMAK---GSLLDFLKSDEGSKQPLPKLIDFSAQIAEGM 297
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
R +HRD++ +N+LV+ V K+ADFGLA
Sbjct: 298 AFIEQRNYIHRDLRAANILVSASLVCKIADFGLA 331
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 43/227 (18%), Positives = 83/227 (36%), Gaps = 44/227 (19%)
Query: 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLE 195
+KIG G + ++ A + + A V+ E + + E+ +R+ + IK
Sbjct: 43 KKIGSGGFGLIYLAFPTNKPEKDARHVVKV---EYQENGPLFSELKFYQRVAKKDCIKKW 99
Query: 196 GLITSRLSCSI-----------------YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMN 238
I ++V E + D+ + + F ++ +
Sbjct: 100 IERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQ-NGTFKKSTVLQLGI 158
Query: 239 QLLHGLEHCHSRGVLHRDIKGSNLLV--NNEGVLKLADFGLA-NFSNTGHRQPLTSRVVT 295
++L LE+ H +H DIK +NLL+ N + LAD+GL+ + G+ +
Sbjct: 159 RMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQ----- 213
Query: 296 LWYRPPELLLGATDYGPSV------------DLWSVGCVFAELLIGK 330
P + G ++ S+ D+ +G L GK
Sbjct: 214 --ENPRKGHNGTIEF-TSLDAHKGVALSRRSDVEILGYCMLRWLCGK 257
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 40/166 (24%), Positives = 69/166 (41%), Gaps = 28/166 (16%)
Query: 135 LEKIGQGTYSSVFR--ARDLDTGK---IVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
++G+G + VF +L + +VA+K ++ + E F RE +L L H
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQ-REAELLTMLQHQ 103
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH----------DITGLLSCPDIKFSEAQIKCYMNQ 239
+I++ G+ T + +VFEYM H L + + + Q
Sbjct: 104 HIVRFFGVCT--EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG--LGQ 159
Query: 240 LLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
LL G+ + +HRD+ N LV V+K+ DFG++
Sbjct: 160 LLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 40/162 (24%), Positives = 68/162 (41%), Gaps = 22/162 (13%)
Query: 136 EKIGQGTYSSVFRAR--DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNII 192
+ IG+G + V +AR A+K+++ + + F E+ +L +L HPNII
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA-GELEVLCKLGHHPNII 89
Query: 193 KLEGLITSRLSCSIYLVFEYMEH----------------DITGLLSCPDIKFSEAQIKCY 236
L G +YL EY H + + S Q+ +
Sbjct: 90 NLLGACE--HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147
Query: 237 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
+ G+++ + +HRD+ N+LV V K+ADFGL+
Sbjct: 148 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 189
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 5e-18
Identities = 61/269 (22%), Positives = 97/269 (36%), Gaps = 64/269 (23%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRF--MAREILILRRLDH- 188
F +KIG G + + ++L T + VA+K EP R + E ++L
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIK------LEPMKSRAPQLHLEYRFYKQLGSG 64
Query: 189 PNIIKL-----EGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHG 243
I ++ G +V E + + L D FS + QL+
Sbjct: 65 DGIPQVYYFGPCGKYN-------AMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISR 117
Query: 244 LEHCHSRGVLHRDIKGSNLLV-----NNEGVLKLADFGLANF---SNTGHRQPLTSRVVT 295
+E+ HS+ +++RD+K N L+ + V+ + DF LA T P
Sbjct: 118 MEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIP------- 170
Query: 296 LWYRPPELLLGATDYGPSV------------DLWSVGCVFAELLIGK-P--ILQGRTEVE 340
YR + L G Y S+ DL ++G +F L G P L+ T E
Sbjct: 171 --YREHKSLTGTARYM-SINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKE 227
Query: 341 QLHKIFKLCGSPPDDYWKKSKLPHATLFK 369
+ KI K P L +
Sbjct: 228 RYQKIGD----------TKRATPIEVLCE 246
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 6e-18
Identities = 44/173 (25%), Positives = 71/173 (41%), Gaps = 32/173 (18%)
Query: 135 LEKIGQGTYSSVFR--ARDLDTGK---IVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ IG+G + VF+ A L + +VA+K ++ + F RE ++ D+P
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-REAALMAEFDNP 110
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH-----------------DITGLLSCPDIKFSEAQ 232
NI+KL G+ + + L+FEYM + LS S
Sbjct: 111 NIVKLLGVCA--VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 168
Query: 233 IKCYMNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
+ L G+ + R +HRD+ N LV V+K+ADFGL+
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 221
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 6e-18
Identities = 38/164 (23%), Positives = 65/164 (39%), Gaps = 28/164 (17%)
Query: 135 LEKIGQGTYSSVFR--ARDLDTGK---IVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ +G G + V+ + VA+K + E + + F+ E LI+ + +H
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL-MEALIISKFNHQ 93
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITG-----LLSCPDIKFSEAQIKCYMNQLLH-- 242
NI++ G+ S +++ E M G L + + M LLH
Sbjct: 94 NIVRCIGVSL--QSLPRFILMELMAG---GDLKSFLRETRPRPSQPSSLA--MLDLLHVA 146
Query: 243 -----GLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLA 278
G ++ +HRDI N L+ G V K+ DFG+A
Sbjct: 147 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 6e-18
Identities = 44/165 (26%), Positives = 78/165 (47%), Gaps = 25/165 (15%)
Query: 135 LEKIGQGTYSSVFR--ARDLDTGK---IVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
++G+G + VF +L K +VA+K ++ D F RE +L L H
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK-DPTLAARKDFQ-REAELLTNLQHE 77
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH-DITGLL--------SCPDIKFSEAQIKCYMNQL 240
+I+K G+ + +VFEYM+H D+ L D + +A+ + ++Q+
Sbjct: 78 HIVKFYGVCG--DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135
Query: 241 LH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
LH G+ + S+ +HRD+ N LV ++K+ DFG++
Sbjct: 136 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 58/263 (22%), Positives = 98/263 (37%), Gaps = 62/263 (23%)
Query: 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRF--MAREILILRRLDH-PNII 192
KIG G++ ++ D+ G+ VA+K E + + E I + + I
Sbjct: 15 RKIGSGSFGDIYLGTDIAAGEEVAIK------LECVKTKHPQLHIESKIYKMMQGGVGIP 68
Query: 193 KL-----EGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
+ EG +V E + + L + KFS + +Q++ +E+
Sbjct: 69 TIRWCGAEGDYN-------VMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 121
Query: 248 HSRGVLHRDIKGSNLLV---NNEGVLKLADFGLANF---SNTGHRQPLTSRVVTLWYRPP 301
HS+ +HRD+K N L+ ++ + DFGLA + T P YR
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP---------YREN 172
Query: 302 ELLLGATDYGPSV------------DLWSVGCVFAELLIGK---PILQGRTEVEQLHKIF 346
+ L G Y S+ DL S+G V +G L+ T+ ++ +I
Sbjct: 173 KNLTGTARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 231
Query: 347 KLCGSPPDDYWKKSKLPHATLFK 369
+ KK P L K
Sbjct: 232 E----------KKMSTPIEVLCK 244
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 58/235 (24%), Positives = 106/235 (45%), Gaps = 43/235 (18%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
D F +G+G + V++ R L G +VA+K+++ + + ++F E+ ++ H
Sbjct: 30 DNFSNKNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQT-EVEMISMAVHR 87
Query: 190 NIIKLEGL-ITS--RLSCSIYLVFEYME--------HDITGLLSCPD------IKFSEAQ 232
N+++L G +T RL LV+ YM + D I A+
Sbjct: 88 NLLRLRGFCMTPTERL-----LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR 142
Query: 233 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG--HRQPLT 290
Y LH +HC + ++HRD+K +N+L++ E + DFGLA + H +T
Sbjct: 143 GLAY----LH--DHCDPK-IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH---VT 192
Query: 291 SRVV-TLWYRPPE-LLLG-ATDYGPSVDLWSVGCVFAELLIG-KPILQGRTEVEQ 341
+ V T+ + PE L G +++ D++ G + EL+ G + R +
Sbjct: 193 TAVRGTIGHIAPEYLSTGKSSE---KTDVFGYGVMLLELITGQRAFDLARLANDD 244
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 38/164 (23%), Positives = 65/164 (39%), Gaps = 28/164 (17%)
Query: 135 LEKIGQGTYSSVFR--ARDLDTGK---IVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ +G G + V+ + VA+K + E + + F+ E LI+ + +H
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL-MEALIISKFNHQ 134
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITG-----LLSCPDIKFSEAQIKCYMNQLLH-- 242
NI++ G+ S +++ E M G L + + M LLH
Sbjct: 135 NIVRCIGVSL--QSLPRFILLELMAG---GDLKSFLRETRPRPSQPSSLA--MLDLLHVA 187
Query: 243 -----GLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLA 278
G ++ +HRDI N L+ G V K+ DFG+A
Sbjct: 188 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 38/166 (22%), Positives = 68/166 (40%), Gaps = 24/166 (14%)
Query: 135 LEKIGQGTYSSVFRA--RDLDTGK---IVALKKVRFDNFEPESVRFMAREILILRRLD-H 188
+ +G+G + V A +D VA+K ++ E M E+ IL + H
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM-SELKILIHIGHH 90
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEH----------------DITGLLSCPDIKFSEAQ 232
N++ L G T + + ++ E+ + +
Sbjct: 91 LNVVNLLGACT-KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 233 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
+ CY Q+ G+E SR +HRD+ N+L++ + V+K+ DFGLA
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 195
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 5e-17
Identities = 33/173 (19%), Positives = 73/173 (42%), Gaps = 32/173 (18%)
Query: 135 LEKIGQGTYSSVFRARDLDTGK-----IVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ +G+G + V +A VA+K ++ + E + E +L++++HP
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLL-SEFNVLKQVNHP 86
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH------------------------DITGLLSCPD 225
++IKL G + + L+ EY ++ + + L +
Sbjct: 87 HVIKLYGACS--QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 226 IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
+ + + Q+ G+++ ++HRD+ N+LV +K++DFGL+
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS 197
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 6e-17
Identities = 63/284 (22%), Positives = 102/284 (35%), Gaps = 63/284 (22%)
Query: 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRF--MAREILILRRLDH-PNII 192
+IG+G++ +F +L + VA+K FEP + E + L I
Sbjct: 16 RRIGEGSFGVIFEGTNLLNNQQVAIK------FEPRRSDAPQLRDEYRTYKLLAGCTGIP 69
Query: 193 KLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGV 252
+ L LV + + + LL KFS + Q+L ++ H + +
Sbjct: 70 NVYYFGQEGLHN--VLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSL 127
Query: 253 LHRDIKGSNLLV-----NNEGVLKLADFGLANF---SNTGHRQPLTSRVVTLWYRPPELL 304
++RDIK N L+ N ++ + DFG+ F T P YR + L
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP---------YREKKNL 178
Query: 305 LGATDYGPSV------------DLWSVGCVFAELLIGK---PILQGRTEVEQLHKIFKLC 349
G Y S+ DL ++G VF L G L+ T ++ +I +
Sbjct: 179 SGTARYM-SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE-- 235
Query: 350 GSPPDDYWKKSKLPHATLFK--PQQ-----PYDSSLRETFKDLP 386
KK P L P++ Y +L F P
Sbjct: 236 --------KKQSTPLRELCAGFPEEFYKYMHYARNLA--FDATP 269
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 7e-17
Identities = 56/219 (25%), Positives = 91/219 (41%), Gaps = 48/219 (21%)
Query: 137 KIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVR----FMAREILILRRLDHPNII 192
K+G+G + V++ ++ VA+KK+ + + F EI ++ + H N++
Sbjct: 38 KMGEGGFGVVYKGY-VN-NTTVAVKKLA-AMVDITTEELKQQFDQ-EIKVMAKCQHENLV 93
Query: 193 KL-----EGLITSRLSCSIYLVFEYME--------HDITGLLSCP-----DIKFSEAQIK 234
+L +G LV+ YM + G I A
Sbjct: 94 ELLGFSSDG--DDLC-----LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN-- 144
Query: 235 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV 294
G+ H +HRDIK +N+L++ K++DFGLA S + +TSR+V
Sbjct: 145 --------GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIV 196
Query: 295 -TLWYRPPELLLG-ATDYGPSVDLWSVGCVFAELLIGKP 331
T Y PE L G T D++S G V E++ G P
Sbjct: 197 GTTAYMAPEALRGEITP---KSDIYSFGVVLLEIITGLP 232
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 61/240 (25%), Positives = 97/240 (40%), Gaps = 57/240 (23%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVR----FMAREILILRRLD 187
F+ IG G + V++ L G VALK+ PES + F EI L
Sbjct: 41 FDHKFLIGHGVFGKVYKGV-LRDGAKVALKR-----RTPESSQGIEEFET-EIETLSFCR 93
Query: 188 HPNIIKLEGLITSRLSCSIY--------LVFEYMEHDITGLLSCPDIKFSEAQIKCYM-- 237
HP+++ L G + L+++YME+ G L + M
Sbjct: 94 HPHLVSLIG----------FCDERNEMILIYKYMEN---GNLK--RHLYGSDLPTMSMSW 138
Query: 238 NQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 290
Q L GL + H+R ++HRD+K N+L++ V K+ DFG++ + L+
Sbjct: 139 EQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS 198
Query: 291 SRVV-TLWYRPPELLLGATDYGPS------VDLWSVGCVFAELLIGKPILQGRTEVEQLH 343
+ V TL Y PE Y D++S G V E+L + + E ++
Sbjct: 199 TVVKGTLGYIDPE-------YFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN 251
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 41/168 (24%), Positives = 72/168 (42%), Gaps = 27/168 (16%)
Query: 135 LEKIGQGTYSSVFRARDLDTGK-------IVALKKVRFDNFEPESVRFMAREILILRRL- 186
+ +G+G + V A + K VA+K ++ D E + + E+ +++ +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV-SEMEMMKMIG 98
Query: 187 DHPNIIKLEGLITSRLSCSIYLVFEYMEH----------------DITGLLSCPDIKFSE 230
H NII L G T +Y++ EY + P+ + +
Sbjct: 99 KHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 231 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
+ QL G+E+ S+ +HRD+ N+LV V+K+ADFGLA
Sbjct: 157 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 9e-16
Identities = 42/168 (25%), Positives = 73/168 (43%), Gaps = 27/168 (16%)
Query: 135 LEKIGQGTYSSVFRAR--DLDTGK-----IVALKKVRFDNFEPESVRFMAREILILRRL- 186
+ +G+G + V A +D K VA+K ++ D E + + E+ +++ +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV-SEMEMMKMIG 144
Query: 187 DHPNIIKLEGLITSRLSCSIYLVFEYMEH----------------DITGLLSCPDIKFSE 230
H NII L G T +Y++ EY + P+ + +
Sbjct: 145 KHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 202
Query: 231 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
+ QL G+E+ S+ +HRD+ N+LV V+K+ADFGLA
Sbjct: 203 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 250
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 39/168 (23%), Positives = 67/168 (39%), Gaps = 31/168 (18%)
Query: 135 LEKIGQGTYSSVFRARDLDTGK-----IVALKKVRFDNFEPESVRFMAREILILRRLD-H 188
+ +G G + V A GK VA+K ++ E M E+ I+ L H
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM-SELKIMSHLGQH 109
Query: 189 PNIIKLEGLITSRLSCS----IYLVFEYMEH--------------DITGLLSCPDIKFSE 230
NI+ L G C+ + ++ EY + + + + S
Sbjct: 110 ENIVNLLGA------CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAST 163
Query: 231 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
+ + +Q+ G+ S+ +HRD+ N+L+ N V K+ DFGLA
Sbjct: 164 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 37/168 (22%), Positives = 63/168 (37%), Gaps = 27/168 (16%)
Query: 135 LEKIGQGTYSSVFRARDLDTGK-----IVALKKVRFDNFEPESVRFMAREILILRRL-DH 188
+ +G G + V A K VA+K ++ E M E+ +L L +H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM-SELKVLSYLGNH 86
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEH-----------DITGLLSCPDIKFSEAQIKCYM 237
NI+ L G T ++ EY + D + ++ +
Sbjct: 87 MNIVNLLGACTIGGP--TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 238 NQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
LL G+ S+ +HRD+ N+L+ + + K+ DFGLA
Sbjct: 145 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 41/168 (24%), Positives = 72/168 (42%), Gaps = 27/168 (16%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKI-------VALKKVRFDNFEPESVRFMAREILILRRL- 186
+ +G+G + V A + K VA+K ++ D E + + E+ +++ +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI-SEMEMMKMIG 132
Query: 187 DHPNIIKLEGLITSRLSCSIYLVFEYMEH----------------DITGLLSCPDIKFSE 230
H NII L G T +Y++ EY P+ + S
Sbjct: 133 KHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190
Query: 231 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
+ Q+ G+E+ S+ +HRD+ N+LV + V+K+ADFGLA
Sbjct: 191 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 238
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 46/245 (18%), Positives = 81/245 (33%), Gaps = 44/245 (17%)
Query: 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLE 195
IGQG + ++ A ++ + V EP + E+ +R P I+
Sbjct: 41 LPIGQGGFGCIYLADM-NSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKW 99
Query: 196 GLITSRLSCSI-----------------YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMN 238
+ +++ + D+ + +FS +
Sbjct: 100 IRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSL 159
Query: 239 QLLHGLEHCHSRGVLHRDIKGSNLLVN--NEGVLKLADFGLA-NFSNTGHRQPLTSRVVT 295
++L LE+ H +H DIK SNLL+N N + L D+GLA + G +
Sbjct: 160 RILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYA----- 214
Query: 296 LWYRPPELLLGATDYGPSV------------DLWSVGCVFAELLIGK-P--ILQGRTEVE 340
P G ++ S+ DL +G + L G P +
Sbjct: 215 --ADPKRCHDGTIEFT-SIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV 271
Query: 341 QLHKI 345
+ KI
Sbjct: 272 RDSKI 276
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 5e-15
Identities = 43/173 (24%), Positives = 67/173 (38%), Gaps = 32/173 (18%)
Query: 135 LEKIGQGTYSSVFRARDLDTGK-----IVALKKVRFDNFEPESVRFMAREILILRRL-DH 188
+ +G G + V A K VA+K ++ E M E+ ++ +L H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALM-SELKMMTQLGSH 108
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEH----------------DITGLLSCPDIKFSEAQ 232
NI+ L G T IYL+FEY + D + ++ E
Sbjct: 109 ENIVNLLGACTLSGP--IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 233 IKCYMNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
LL G+E + +HRD+ N+LV + V+K+ DFGLA
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 219
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 76.6 bits (188), Expect = 7e-15
Identities = 59/256 (23%), Positives = 94/256 (36%), Gaps = 48/256 (18%)
Query: 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKL 194
KIG G++ ++ ++ T + VA+K P+ + E I R L I +
Sbjct: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LLYESKIYRILQGGTGIPNV 68
Query: 195 EGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 254
LV + + + L + K S + +Q+++ +E HS+ LH
Sbjct: 69 RWFGVEGDYN--VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 126
Query: 255 RDIKGSNLLV---NNEGVLKLADFGLANF---SNTGHRQPLTSRVVTLWYRPPELLLGAT 308
RDIK N L+ + + DFGLA ++T P YR + L G
Sbjct: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP---------YRENKNLTGTA 177
Query: 309 DYGPSV------------DLWSVGCVFAELLIGK---PILQGRTEVEQLHKIFKLCGSPP 353
Y SV DL S+G V L G L+ T+ ++ KI +
Sbjct: 178 RY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE------ 230
Query: 354 DDYWKKSKLPHATLFK 369
KK L +
Sbjct: 231 ----KKVATSIEALCR 242
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 9e-15
Identities = 38/235 (16%), Positives = 69/235 (29%), Gaps = 57/235 (24%)
Query: 136 EKIGQGTYSSVFRARDLDTGKI--------VALKKVRFDNFEPESVRFMAREILILRRLD 187
+ ++ A T +LK + + R + E +R
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK------LDAKDGR-LFNEQNFFQRAA 100
Query: 188 HPNIIKLEGLITSRLSCSI--------------YLVFEYMEHDITGLL-SCPDIKFSEAQ 232
P + + S +I +LV + + L P SE
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERS 160
Query: 233 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV--NNEGVLKLADFGLA-NFSNTGHRQPL 289
+ +LL LE H +H ++ N+ V ++ + LA +G A + +G
Sbjct: 161 VLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVA- 219
Query: 290 TSRVVTLWYR--PPELLLGATDYGPSV------------DLWSVGCVFAELLIGK 330
Y G ++ S+ DL S+G + L G
Sbjct: 220 --------YVEGSRSPHEGDLEFI-SMDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.5 bits (125), Expect = 4e-07
Identities = 68/513 (13%), Positives = 130/513 (25%), Gaps = 183/513 (35%)
Query: 330 KPILQGRTEVEQLHKIF-KLCGSPP------------DDY-WKKSKLPHATLFKPQQP-- 373
I+ + V ++F L +Y + S + + +QP
Sbjct: 52 DHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKT----EQRQPSM 107
Query: 374 ----YDSSLRETFKDLPTTA---VN-------LIETLLSVEPY------------KRATA 407
Y + D A V+ L + LL + P K A
Sbjct: 108 MTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVA 167
Query: 408 SAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSH 467
S K I+ + + + + + + + + T+R H
Sbjct: 168 LDVCLSYKVQCKM------DFKIFWLN--LKNCNSPETVLEMLQKLLYQIDPNWTSRSDH 219
Query: 468 GMSKLAPVEDV--AVRTQFAKKINGHSLHILKD--------------------------D 499
+ + + +R K + L +L + D
Sbjct: 220 SSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTD 279
Query: 500 ELSGREVQKPLVDNREEA----------SHVKNASHGDIPFS----GPLQVSTSSGFA-- 543
LS +D+ + D+P P ++S A
Sbjct: 280 FLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSI---IAES 336
Query: 544 -------WAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNY-------------- 582
W + + + +S +N LEP+ R +
Sbjct: 337 IRDGLATWDNWKHVNCDKLTTIIESS----LNVLEPA---EYRKMFDRLSVFPPSAHIPT 389
Query: 583 --------DSRKHENGDIINGSRTDS-----------RGHDSLEAVKIAMLNQWSQLER- 622
D K + ++N S +K+ + N+ L R
Sbjct: 390 ILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENE-YALHRS 448
Query: 623 -------PDSFDASD--------------GYHSQELSLALYQREEMATKRN---NLGFQD 658
P +FD+ D G+H + + E M R + F +
Sbjct: 449 IVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHP----ERMTLFRMVFLDFRFLE 504
Query: 659 QGEKVEFSGPLLSQSHRIDELL---ERHERQIR 688
Q K+ + S I L + ++ I
Sbjct: 505 Q--KIRHDSTAWNASGSILNTLQQLKFYKPYIC 535
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.2 bits (124), Expect = 6e-07
Identities = 67/458 (14%), Positives = 133/458 (29%), Gaps = 143/458 (31%)
Query: 102 GEQVAAGWPAWLSAVAGEAIQG-------WVPL-RADAFEKLEKIGQGTYSSV---FRAR 150
G+ A L +Q W+ L ++ E + ++ Q + + +R
Sbjct: 162 GKTWVA-----LDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSR 216
Query: 151 DLDTGKIVALKKVRFDNFEPESVRFMARE-----ILILRRLDHPNIIK-LEG----LITS 200
+ I K+R + + E R + + +L+L + + L+T+
Sbjct: 217 SDHSSNI----KLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTT 272
Query: 201 R-------LSCSIYLVFEYMEHDITG---------LLSCPDIKFSE--AQIKCYMNQLLH 242
R LS + ++H LL D + + ++ N
Sbjct: 273 RFKQVTDFLSAATTTHIS-LDHHSMTLTPDEVKSLLLKYLDCRPQDLPREV-LTTNPRRL 330
Query: 243 GL-------EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-------- 287
+ H VN + + + + L +R+
Sbjct: 331 SIIAESIRDGLATWDNWKH---------VNCDKLTTIIESSLNVLEPAEYRKMFDRLSVF 381
Query: 288 ----PLTSRV-VTLW----YRPPELLLGATDYGPS-VDLWSVGCVFAELLIGKPILQGRT 337
+ + + +W +++ + S V+ E I P +
Sbjct: 382 PPSAHIPTILLSLIWFDVIKSDVMVVV-NKLHKYSLVEKQP-----KESTISIPSIYLEL 435
Query: 338 EVE-----QLHKIF--------KLCG---SPP--DDYWKKSKLP-HATLFKPQQP-YDSS 377
+V+ LH+ PP D Y+ S + H L + P +
Sbjct: 436 KVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYF-YSHIGHH--LKNIEHPERMTL 492
Query: 378 LRETFKDL---------PTTAVN----LIETLLSVEPYKR-----ATASAALASEY--FS 417
R F D +TA N ++ TL ++ YK L + F
Sbjct: 493 FRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFL 552
Query: 418 TK--------PYACDLSSLPIYPPSKEI-DAKHREDAR 446
K Y DL + + + I + H++ R
Sbjct: 553 PKIEENLICSKY-TDLLRIALMAEDEAIFEEAHKQVQR 589
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 9e-06
Identities = 19/44 (43%), Positives = 29/44 (65%)
Query: 235 CYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278
CY Q+ G+E SR +HRD+ N+L++ + V+K+ DFGLA
Sbjct: 197 CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 240
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 34/197 (17%), Positives = 67/197 (34%), Gaps = 19/197 (9%)
Query: 126 PLRADAFE------KLEK-IGQGTYSSVFRARDLDTGK-----IVALKKVRFDNFEPESV 173
P A +E KL K +G+G + V A K VA+K ++ E
Sbjct: 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR 70
Query: 174 RFMAREILILRRLD-HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQ 232
M E+ IL + H N++ L G T + + ++ E+ + G LS ++ +
Sbjct: 71 ALM-SELKILIHIGHHLNVVNLLGACT-KPGGPLMVIVEFCKF---GNLSTY-LRSKRNE 124
Query: 233 IKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 292
Y + + G + D+K + + + F + +
Sbjct: 125 FVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPED 184
Query: 293 VVTLWYRPPELLLGATD 309
+ + L+ +
Sbjct: 185 LYKDFLTLEHLICYSFQ 201
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 704 | |||
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.71 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.18 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.09 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.95 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.69 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.49 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.43 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.39 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.24 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.13 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.11 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.97 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.62 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.46 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.44 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.38 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.32 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.28 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.28 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.2 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.98 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.92 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.82 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.78 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.76 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.42 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.22 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.53 | |
| 3k21_A | 191 | PFCDPK3, calcium-dependent protein kinase 3; calci | 89.89 | |
| 1ij5_A | 323 | Plasmodial specific LAV1-2 protein; fourty kDa cal | 88.46 | |
| 3pm8_A | 197 | PFCDPK2, calcium-dependent protein kinase 2; malar | 82.81 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 82.6 |
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-60 Score=521.22 Aligned_cols=293 Identities=32% Similarity=0.522 Sum_probs=247.3
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeec----CCCe
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR----LSCS 205 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~----~~~~ 205 (704)
++|++++.||+|+||+||+|+++.+|+.||||+|..........+.+.+|+.+|+.|+|||||++++++... ....
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 579999999999999999999999999999999987665666677888999999999999999999998643 2367
Q ss_pred EEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC-
Q 005289 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG- 284 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~- 284 (704)
+|||||||+|+++..+. ....|++.+++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.+...
T Consensus 134 ~~ivmE~~~g~L~~~i~-~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~ 212 (398)
T 4b99_A 134 VYVVLDLMESDLHQIIH-SSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSP 212 (398)
T ss_dssp EEEEEECCSEEHHHHHT-SSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC----
T ss_pred EEEEEeCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCc
Confidence 99999999988666654 4568999999999999999999999999999999999999999999999999999865432
Q ss_pred --CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCC
Q 005289 285 --HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (704)
Q Consensus 285 --~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~ 362 (704)
.....++.+||++|||||++.+...|+.++||||||||||||++|++||.+.+..+++..|+...|.|+...|.....
T Consensus 213 ~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~ 292 (398)
T 4b99_A 213 AEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGA 292 (398)
T ss_dssp ---CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC----
T ss_pred cccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhh
Confidence 223456789999999999998877889999999999999999999999999999999999999999999887765332
Q ss_pred CCccc--CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCCCC
Q 005289 363 PHATL--FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 423 (704)
Q Consensus 363 ~~~~~--~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~~~ 423 (704)
..... ..........+...++.++++++|||.+||.+||.+||||.|+|+||||++.+.+.
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~ 355 (398)
T 4b99_A 293 ERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPD 355 (398)
T ss_dssp -CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGG
T ss_pred hhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCc
Confidence 11110 00111122345667788999999999999999999999999999999999866543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-60 Score=504.76 Aligned_cols=262 Identities=27% Similarity=0.423 Sum_probs=229.4
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 207 (704)
.++|++++.||+|+||+||+|+++.+++.||||++.+... .....+.+.+|+++|+.|+|||||+++++|++ ...+|
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~y 108 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD--DEKLY 108 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEE
Confidence 4679999999999999999999999999999999976432 12335678899999999999999999999988 57899
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC-C
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-R 286 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~-~ 286 (704)
||||||+|+.|..++.....|+|.+++.|+.||+.||+|||++|||||||||+||||+.++++||+|||+|+...... .
T Consensus 109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 999999997776666566789999999999999999999999999999999999999999999999999998765432 2
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcc
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~ 366 (704)
....+.+||+.|||||++.+ ..|+.++||||||||||+|++|++||.+.+..+++.+|.+.-..+
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~-------------- 253 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDF-------------- 253 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC--------------
T ss_pred ccccCcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC--------------
Confidence 34567799999999999986 679999999999999999999999999999999999987632111
Q ss_pred cCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHH------HHhccccCCCCCC
Q 005289 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA------ALASEYFSTKPYA 422 (704)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e------~L~hpwf~~~~~~ 422 (704)
...+++++++||.+||.+||++|||++| +++||||+...|.
T Consensus 254 ---------------p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~ 300 (311)
T 4aw0_A 254 ---------------PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE 300 (311)
T ss_dssp ---------------CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred ---------------CcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHH
Confidence 1357899999999999999999999987 5899999887664
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-60 Score=508.66 Aligned_cols=258 Identities=26% Similarity=0.448 Sum_probs=225.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
+.|+++++||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.+|+.|+|||||+++++|.+ ...+|||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~--~~~~~iv 149 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVV 149 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEE
Confidence 4699999999999999999999999999999999765432 23457899999999999999999999988 5789999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCc
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~ 289 (704)
||||+++.|..+... ..+++.+++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+...... ...
T Consensus 150 mEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~ 227 (346)
T 4fih_A 150 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRR 227 (346)
T ss_dssp ECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCB
T ss_pred EeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC-Ccc
Confidence 999999777666543 469999999999999999999999999999999999999999999999999998765432 345
Q ss_pred ccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCC
Q 005289 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (704)
Q Consensus 290 ~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~ 369 (704)
++.+||++|||||++.+ ..|+.++||||||||||||++|++||.+.+..+++..|...... .
T Consensus 228 ~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~-~---------------- 289 (346)
T 4fih_A 228 KSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-R---------------- 289 (346)
T ss_dssp CCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCC-C----------------
T ss_pred cccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-C----------------
Confidence 67899999999999876 67999999999999999999999999999999998888652211 0
Q ss_pred CCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCC
Q 005289 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (704)
Q Consensus 370 ~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~ 420 (704)
...+..+++++++||.+||.+||++|||+.|+|+||||++..
T Consensus 290 ---------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 290 ---------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp ---------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred ---------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 012346899999999999999999999999999999998643
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-60 Score=509.11 Aligned_cols=258 Identities=25% Similarity=0.454 Sum_probs=222.5
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
+++|+++++||+|+||+||+|+++.+|+.||||++.+........+.+.+|+.+|++|+|||||+++++|++ ...+||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~--~~~~yi 100 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE--NGSLYI 100 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE--CCEEEE
Confidence 578999999999999999999999999999999999887777778889999999999999999999999988 578999
Q ss_pred EEeccccccccccc--CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC
Q 005289 209 VFEYMEHDITGLLS--CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 209 V~Ey~~g~ll~~~~--~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~ 286 (704)
|||||+|+.|..++ .....++|.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+......
T Consensus 101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 179 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV- 179 (350)
T ss_dssp EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence 99999986555443 344568999999999999999999999999999999999999999999999999998765321
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcc
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~ 366 (704)
...++.+||+.|||||++.+ ..|+.++||||||||||||++|++||.+.+..+++.+|... .++.
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~~~------------ 244 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG--SFPP------------ 244 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT--CCCC------------
T ss_pred ccccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC--CCCC------------
Confidence 22355789999999999986 67999999999999999999999999999999999888762 2210
Q ss_pred cCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
....+|+++++||.+||.+||++|||+.|+|+||||++
T Consensus 245 --------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 245 --------------VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp --------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred --------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 12368999999999999999999999999999999975
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-59 Score=491.39 Aligned_cols=256 Identities=29% Similarity=0.464 Sum_probs=209.6
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 207 (704)
.++|++++.||+|+||+||+|++..+|+.||||++.+.... ......+.+|+.+|+.|+|||||+++++|.+ ...+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~ 89 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS--KDEII 89 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEEE
Confidence 46899999999999999999999999999999999876543 3345678899999999999999999999987 57899
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCC
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~ 287 (704)
||||||+|+++..+.. ...+++.+++.|+.||+.||+|||++|||||||||+||||+.++++||+|||+|+..... .
T Consensus 90 ivmEy~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--~ 166 (275)
T 3hyh_A 90 MVIEYAGNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG--N 166 (275)
T ss_dssp EEEECCCEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred EEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC--C
Confidence 9999998877776643 457999999999999999999999999999999999999999999999999999876543 2
Q ss_pred CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCccc
Q 005289 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (704)
Q Consensus 288 ~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~ 367 (704)
...+.+||+.|||||++.+...++.++|||||||+||+|++|++||.+.+..+.+.+|......+
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~--------------- 231 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTL--------------- 231 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC---------------
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC---------------
Confidence 34567999999999999875556789999999999999999999999999888888886521111
Q ss_pred CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
...+++++++||.+||++||++|||++|+|+||||+.
T Consensus 232 --------------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 232 --------------PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp --------------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred --------------CCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 1357899999999999999999999999999999974
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-58 Score=509.35 Aligned_cols=257 Identities=26% Similarity=0.463 Sum_probs=225.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
+.|+++++||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.+|+.|+|||||+++++|.+ ...+|||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~--~~~~~iV 226 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVV 226 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCCCceEEEEEE--CCEEEEE
Confidence 4699999999999999999999999999999999865432 23557899999999999999999999988 5789999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCc
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~ 289 (704)
||||+|+.|..+.. ...|++.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+...... ...
T Consensus 227 mEy~~gG~L~~~i~-~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~ 304 (423)
T 4fie_A 227 MEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRR 304 (423)
T ss_dssp EECCTTEEHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-CCB
T ss_pred EeCCCCCcHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC-ccc
Confidence 99999977776654 3469999999999999999999999999999999999999999999999999998765432 345
Q ss_pred ccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCC
Q 005289 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (704)
Q Consensus 290 ~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~ 369 (704)
.+.+||++|||||++.+ ..|+.++||||||||||||++|++||.+.+..+++..|..... +.
T Consensus 305 ~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~---------------- 366 (423)
T 4fie_A 305 KSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PR---------------- 366 (423)
T ss_dssp CCCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CC----------------
T ss_pred cccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CC----------------
Confidence 67899999999999876 6799999999999999999999999999999999888865321 10
Q ss_pred CCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 370 ~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
...+..+++++++||.+||.+||++|||+.|+|+||||++.
T Consensus 367 ---------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 367 ---------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp ---------CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ---------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 01234789999999999999999999999999999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-58 Score=482.51 Aligned_cols=256 Identities=22% Similarity=0.315 Sum_probs=218.3
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeec--CCCeEEEE
Q 005289 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR--LSCSIYLV 209 (704)
Q Consensus 132 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~--~~~~~~LV 209 (704)
|++.++||+|+||+||+|++..++..||||++..........+.+.+|+.+|++|+|||||+++++|.+. ....+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 4777889999999999999999999999999987777777778899999999999999999999998753 24578999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcC--cccccCCCccEEEcc-CCceEEeccccccccCCCCC
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG--VLHRDIKGSNLLVNN-EGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~g--IvHrDLKp~NILl~~-~g~iKL~DFGla~~~~~~~~ 286 (704)
||||+++.|..++.....+++..++.|+.||+.||.|||++| ||||||||+||||+. ++.+||+|||+|+....
T Consensus 108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~--- 184 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--- 184 (290)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT---
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC---
Confidence 999999877776666678999999999999999999999998 999999999999985 78999999999986543
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcc
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~ 366 (704)
....+.+||+.|||||++.+ .|+.++|||||||+||||+||++||.+.+....+.+.+.. +..|..
T Consensus 185 ~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~-~~~~~~----------- 250 (290)
T 3fpq_A 185 SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKPAS----------- 250 (290)
T ss_dssp TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCCGG-----------
T ss_pred CccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHc-CCCCCC-----------
Confidence 34466799999999999865 5999999999999999999999999876655444333221 111111
Q ss_pred cCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
....+++++++||.+||..||++|||+.|+|+||||++
T Consensus 251 --------------~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 251 --------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp --------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred --------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 12457889999999999999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-59 Score=494.01 Aligned_cols=260 Identities=28% Similarity=0.428 Sum_probs=218.8
Q ss_pred cCCeeEEEEeeccCceEEEEEEEC---CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCe
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDL---DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (704)
.++|++++.||+|+||+||+|++. .+++.||||++.+..........+.+|+.+|++|+|||||+++++|++ ...
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~ 100 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT--EGK 100 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE--TTE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCE
Confidence 357999999999999999999974 468899999997654433333457789999999999999999999988 578
Q ss_pred EEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
+|||||||+|+.|..++.....+++.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+......
T Consensus 101 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 101 LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp EEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 99999999997777666666689999999999999999999999999999999999999999999999999998654332
Q ss_pred CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
....+.+||+.|||||++.+ ..|+.++|||||||+||||++|++||.+.+..+++.+|.+..-.+
T Consensus 181 -~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~------------- 245 (304)
T 3ubd_A 181 -KKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM------------- 245 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-------------
T ss_pred -ccccccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC-------------
Confidence 33456799999999999976 679999999999999999999999999999999999887621111
Q ss_pred ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcC-----HHHHHhccccCCCCC
Q 005289 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPY 421 (704)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpT-----a~e~L~hpwf~~~~~ 421 (704)
...+|+++++||.+||++||++||| ++|+|+||||+...|
T Consensus 246 ----------------p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw 290 (304)
T 3ubd_A 246 ----------------PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDW 290 (304)
T ss_dssp ----------------CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred ----------------CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCH
Confidence 1358899999999999999999998 589999999997654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-57 Score=483.76 Aligned_cols=255 Identities=27% Similarity=0.370 Sum_probs=217.2
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.+.|++.++||+|+||+||+|+++.+|+.||||+++.+... .+|+.+|+.|+|||||+++++|.+ ...+||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~--~~~~~i 127 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVRE--GPWVNI 127 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEE--CCEEEE
Confidence 45699999999999999999999999999999999875432 369999999999999999999987 578999
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCC-ceEEeccccccccCCCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQ 287 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g-~iKL~DFGla~~~~~~~~~ 287 (704)
|||||+|+.|..++.....|++.+++.|+.||+.||.|||++|||||||||+||||+.+| .+||+|||+|+........
T Consensus 128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 999999977776666666899999999999999999999999999999999999999988 6999999999876543211
Q ss_pred ----CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCC
Q 005289 288 ----PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 288 ----~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
.....+||+.|||||++.+ ..|+.++||||||||||||++|++||.+.+..+++.+|... .++
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~---------- 274 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE--PPP---------- 274 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS--CCG----------
T ss_pred cceecCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC--CCC----------
Confidence 1234589999999999987 67999999999999999999999999998877777777651 111
Q ss_pred CcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHH-------------HhccccCCC
Q 005289 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA-------------LASEYFSTK 419 (704)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~-------------L~hpwf~~~ 419 (704)
+.+.++.+++++.+||.+||.+||.+|||+.|+ |+|||+.+.
T Consensus 275 --------------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 275 --------------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp --------------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred --------------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 123346789999999999999999999999998 468888753
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-56 Score=483.10 Aligned_cols=283 Identities=27% Similarity=0.423 Sum_probs=222.5
Q ss_pred ccCCeeEEEEeeccCceEEEEEEEC---CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCC
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDL---DTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLS 203 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 203 (704)
-.++|+++++||+|+||+||+|+++ .+++.||||++.... ....+.+|+++|+.+ +|||||+++++|.+ .
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~--~ 92 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRK--N 92 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE--T
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEE--C
Confidence 3568999999999999999999874 467899999986543 234577899999998 79999999999988 5
Q ss_pred CeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccC-CceEEeccccccccC
Q 005289 204 CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSN 282 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~-g~iKL~DFGla~~~~ 282 (704)
.++|||||||+++.+..+.. .+++.+++.|+.||+.||+|||++|||||||||+||||+.+ +.+||+|||+|+...
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH 169 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred CEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence 78999999999866555542 58999999999999999999999999999999999999877 799999999997554
Q ss_pred CCC---------------------------CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCC-C
Q 005289 283 TGH---------------------------RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL-Q 334 (704)
Q Consensus 283 ~~~---------------------------~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF-~ 334 (704)
... ....++.+||++|||||++.+...|+.++||||||||||||++|++|| .
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 321 122455689999999999988777999999999999999999999887 5
Q ss_pred CCCHHHHHHHHHHHcCCCCchhhhccC---------CCCcc------------cCCC----CCCCCchhhhhccCCCHHH
Q 005289 335 GRTEVEQLHKIFKLCGSPPDDYWKKSK---------LPHAT------------LFKP----QQPYDSSLRETFKDLPTTA 389 (704)
Q Consensus 335 ~~~~~e~l~~I~~~~g~~p~~~w~~~~---------~~~~~------------~~~~----~~~~~~~l~~~~~~~s~~~ 389 (704)
+.++.+++.+|+..+|.++...|.... .+... ...+ .........+.|..+++++
T Consensus 250 ~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a 329 (361)
T 4f9c_A 250 ASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEA 329 (361)
T ss_dssp CSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHH
T ss_pred CCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHH
Confidence 677889999999999876543322110 00000 0000 0000011223467899999
Q ss_pred HHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 390 VNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 390 ~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
+|||.+||.+||++||||+|+|+||||++.
T Consensus 330 ~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 330 YDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999999999864
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=460.76 Aligned_cols=260 Identities=23% Similarity=0.391 Sum_probs=199.0
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC------
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS------ 203 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~------ 203 (704)
++|++++.||+|+||+||+|+++.+|+.||||++.... .....+.+.+|+.+|++|+|||||+++++|.+...
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 36999999999999999999999999999999998654 34455678899999999999999999999875432
Q ss_pred ----CeEEEEEecccccccccccCCCcc---ccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccc
Q 005289 204 ----CSIYLVFEYMEHDITGLLSCPDIK---FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFG 276 (704)
Q Consensus 204 ----~~~~LV~Ey~~g~ll~~~~~~~~~---l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFG 276 (704)
.++|||||||.++.+..+...... .++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence 257999999998766655443333 4556789999999999999999999999999999999999999999999
Q ss_pred cccccCCCCC-----------CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 005289 277 LANFSNTGHR-----------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 345 (704)
Q Consensus 277 la~~~~~~~~-----------~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I 345 (704)
+|+....... ...++.+||+.|||||++.+ ..|+.++||||||||||||++ ||.+. .+....+
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~~ 237 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQ--MERVRTL 237 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHHH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHHH
Confidence 9987654321 12345689999999999986 679999999999999999996 77543 2333333
Q ss_pred HHHcC-CCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCCC
Q 005289 346 FKLCG-SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422 (704)
Q Consensus 346 ~~~~g-~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~~ 422 (704)
..... .+| ..+...++.+.+||.+||+.||++|||+.|+|+||||+...|+
T Consensus 238 ~~~~~~~~p--------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p 289 (299)
T 4g31_A 238 TDVRNLKFP--------------------------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFP 289 (299)
T ss_dssp HHHHTTCCC--------------------------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC---
T ss_pred HHHhcCCCC--------------------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCC
Confidence 22211 111 1123456778999999999999999999999999999875553
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-54 Score=495.94 Aligned_cols=265 Identities=25% Similarity=0.383 Sum_probs=232.8
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|++++.||+|+||+||+|+++.+|+.||||++.... ....+.+.+|+.+|+.|+|||||+|+++|.+ ...+||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~i 231 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFED--DNEMVM 231 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC--SSEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEE
Confidence 468999999999999999999999999999999997653 3445678899999999999999999999987 578999
Q ss_pred EEeccccccc-ccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccC--CceEEeccccccccCCCC
Q 005289 209 VFEYMEHDIT-GLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE--GVLKLADFGLANFSNTGH 285 (704)
Q Consensus 209 V~Ey~~g~ll-~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~--g~iKL~DFGla~~~~~~~ 285 (704)
|||||+|+.| ..+......|++.+++.|+.||+.||.|||++||+||||||+||||+.+ +.+||+|||+|+.....
T Consensus 232 v~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~- 310 (573)
T 3uto_A 232 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 310 (573)
T ss_dssp EEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-
T ss_pred EEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC-
Confidence 9999998555 4454556689999999999999999999999999999999999999865 89999999999887644
Q ss_pred CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
......+||+.|||||++.+ ..|+.++||||||||||+|++|.+||.+.+..+++.+|......++..
T Consensus 311 -~~~~~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~---------- 378 (573)
T 3uto_A 311 -QSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS---------- 378 (573)
T ss_dssp -SEEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSG----------
T ss_pred -CceeeeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcc----------
Confidence 34566799999999999987 679999999999999999999999999999999999987754443322
Q ss_pred ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCCCCCC
Q 005289 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDL 425 (704)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~~~~~ 425 (704)
.+..+++++++||.+||.+||.+|||+.|+|+||||+...++...
T Consensus 379 ---------------~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~~~ 423 (573)
T 3uto_A 379 ---------------AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRD 423 (573)
T ss_dssp ---------------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTTTT
T ss_pred ---------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCCch
Confidence 335789999999999999999999999999999999987765443
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-53 Score=489.20 Aligned_cols=264 Identities=24% Similarity=0.361 Sum_probs=221.4
Q ss_pred cccccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC----ChHHHHHHHHHHHHHHhcCCCCceeEeEEEee
Q 005289 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF----EPESVRFMAREILILRRLDHPNIIKLEGLITS 200 (704)
Q Consensus 125 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~----~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 200 (704)
.++..++|++++.||+|+||+||+|+++.+|+.||||+|.+..+ ..........++.+++.++|||||+++++|++
T Consensus 184 ~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~ 263 (689)
T 3v5w_A 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 263 (689)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred CCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence 36678899999999999999999999999999999999976432 12222223345677788899999999999988
Q ss_pred cCCCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccc
Q 005289 201 RLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 280 (704)
Q Consensus 201 ~~~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~ 280 (704)
...+|||||||.|+.|..++.....|+|..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.
T Consensus 264 --~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 264 --PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp --SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred --CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeee
Confidence 578999999999977776666667899999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHcCCCCchhh
Q 005289 281 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT---EVEQLHKIFKLCGSPPDDYW 357 (704)
Q Consensus 281 ~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~---~~e~l~~I~~~~g~~p~~~w 357 (704)
.... ...+.|||+.|||||++.+...|+.++||||||||||||++|++||.+.+ ..++...+... .+
T Consensus 342 ~~~~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~--~~----- 411 (689)
T 3v5w_A 342 FSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--AV----- 411 (689)
T ss_dssp CSSC---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC--CC-----
T ss_pred cCCC---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC--CC-----
Confidence 6543 23567999999999999765679999999999999999999999998643 23334444331 10
Q ss_pred hccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcC-----HHHHHhccccCCCCCC
Q 005289 358 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPYA 422 (704)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpT-----a~e~L~hpwf~~~~~~ 422 (704)
..+..+++++++||.+||..||.+|++ ++||++||||+...|.
T Consensus 412 ----------------------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~ 459 (689)
T 3v5w_A 412 ----------------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ 459 (689)
T ss_dssp ----------------------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHH
T ss_pred ----------------------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHH
Confidence 012468999999999999999999998 7999999999987664
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-53 Score=450.02 Aligned_cols=259 Identities=22% Similarity=0.341 Sum_probs=210.7
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
+..++|++.++||+|+||+||+|+... .||||+++......+..+.+.+|+.+|++|+|||||++++++.. ..+
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~---~~~ 106 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK---DNL 106 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSC
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC---CeE
Confidence 345689999999999999999998643 59999998766667778889999999999999999999998865 458
Q ss_pred EEEEecccccccccc-cCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 207 YLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~-~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
|||||||+++.|..+ ......+++.++..|+.||+.||.|||+++||||||||+||||++++++||+|||+|+......
T Consensus 107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 999999998666544 4455679999999999999999999999999999999999999999999999999998765322
Q ss_pred -CCCcccccccccccCcccccCC--CCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCC
Q 005289 286 -RQPLTSRVVTLWYRPPELLLGA--TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (704)
Q Consensus 286 -~~~~~~~~gT~~Y~APEvl~~~--~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~ 362 (704)
.......+||+.|||||++.+. ..|+.++|||||||+||||+||++||.+.+....+..+......+|
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p--------- 257 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASP--------- 257 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCC---------
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC---------
Confidence 2334567899999999998642 4689999999999999999999999998777666655544221111
Q ss_pred CCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcc
Q 005289 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 414 (704)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hp 414 (704)
.+...+..+|+++.+||.+||+.||++|||+.+++++-
T Consensus 258 --------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L 295 (307)
T 3omv_A 258 --------------DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSI 295 (307)
T ss_dssp --------------CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHH
T ss_pred --------------CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 01223357899999999999999999999999887653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=433.95 Aligned_cols=287 Identities=40% Similarity=0.701 Sum_probs=245.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
++|+++++||+|+||+||+|++..+++.||||++............+.+|+.+|+.++||||+++++++.+ ...+|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 79 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe--CCEEEEE
Confidence 57999999999999999999999999999999998776655666778899999999999999999999987 5789999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCc
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~ 289 (704)
||||+++++..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ...
T Consensus 80 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 158 (292)
T 3o0g_A 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCY 158 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-SCC
T ss_pred EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-ccc
Confidence 9999998888777666789999999999999999999999999999999999999999999999999998765332 334
Q ss_pred ccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCC-CCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccC
Q 005289 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (704)
Q Consensus 290 ~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~-~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~ 368 (704)
...++|+.|+|||++.+...|+.++|||||||++|+|++|. |+|.+.+..+++..+...++.++...|...........
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccc
Confidence 55678999999999987666899999999999999999765 55788889999999999999999888765332111111
Q ss_pred CCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 369 ~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
.+..+....+....+.++.++++||.+||.+||++|||+.|+|+||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 122222333445557899999999999999999999999999999999863
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-52 Score=441.54 Aligned_cols=256 Identities=22% Similarity=0.354 Sum_probs=213.2
Q ss_pred cccCCeeEEEEeeccCceEEEEEEEC-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeec
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDL-----DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR 201 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 201 (704)
+..++|.+.++||+|+||+||+|++. .++..||||+++.. .....+.+.+|+++|++|+|||||+++++|.+
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~- 86 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE- 86 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee-
Confidence 44568999999999999999999865 36889999999753 35566778999999999999999999999987
Q ss_pred CCCeEEEEEecccccccccccC-------------CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCC
Q 005289 202 LSCSIYLVFEYMEHDITGLLSC-------------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG 268 (704)
Q Consensus 202 ~~~~~~LV~Ey~~g~ll~~~~~-------------~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g 268 (704)
...+|||||||+++.|..++. ....|++.++..|+.||+.||.|||+++||||||||+||||+.++
T Consensus 87 -~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 87 -GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 165 (299)
T ss_dssp -SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred -CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence 567999999999876665432 234699999999999999999999999999999999999999999
Q ss_pred ceEEeccccccccCCCCCC-CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 005289 269 VLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIF 346 (704)
Q Consensus 269 ~iKL~DFGla~~~~~~~~~-~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~ 346 (704)
.+||+|||+|+........ .....+||+.|||||++.+ ..|+.++|||||||+||||+| |++||.+.+..+++..|.
T Consensus 166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 244 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 244 (299)
T ss_dssp CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred cEEECCcccceecCCCCceeecCceecChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999865433222 2233468999999999976 579999999999999999998 899999999988888886
Q ss_pred HHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccC
Q 005289 347 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417 (704)
Q Consensus 347 ~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~ 417 (704)
. |..+ .....+|+++.+||.+||+.||++|||+.+++ +|++
T Consensus 245 ~--~~~~--------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~ 285 (299)
T 4asz_A 245 Q--GRVL--------------------------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQ 285 (299)
T ss_dssp H--TCCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHH
T ss_pred c--CCCC--------------------------CCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHH
Confidence 5 2211 01136889999999999999999999999994 5664
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=435.46 Aligned_cols=287 Identities=40% Similarity=0.714 Sum_probs=239.0
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|+++++||+|+||+||+|++. +++.||||++............+.+|+.+|+.++||||+++++++.+ ...+||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 96 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS--ERCLTL 96 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC--SSCEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc--CCEEEE
Confidence 468999999999999999999985 58999999997665444455678899999999999999999999987 578999
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
|||||+++++..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ..
T Consensus 97 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~ 175 (311)
T 3niz_A 97 VFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV-RS 175 (311)
T ss_dssp EEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-C-
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc-cc
Confidence 99999998888877777779999999999999999999999999999999999999999999999999998765332 23
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccC
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~ 368 (704)
....++|+.|+|||++.+...|+.++|||||||++|+|++|++||.+.+..+.+.++...++.++...|...........
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 255 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255 (311)
T ss_dssp --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHS
T ss_pred ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhh
Confidence 44567899999999998767799999999999999999999999999999999999999999998877765332110000
Q ss_pred -CCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 369 -KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 369 -~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
.........+....+.+++++++||.+||.+||.+|||+.|+|+||||+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp CCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred cccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 001111223445567889999999999999999999999999999999864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=442.27 Aligned_cols=253 Identities=22% Similarity=0.316 Sum_probs=206.5
Q ss_pred ccCCeeEEEEeeccCceEEEEEEEC-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDL-----DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL 202 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 202 (704)
..++|.+.++||+|+||+||+|+.. .+++.||||+++.. .....+.+.+|+.+|++|+|||||+++++|.+
T Consensus 39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-- 114 (329)
T 4aoj_A 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTE-- 114 (329)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--
T ss_pred CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--
Confidence 3457999999999999999999864 46889999999753 35566789999999999999999999999987
Q ss_pred CCeEEEEEecccccccccccCC---------------CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccC
Q 005289 203 SCSIYLVFEYMEHDITGLLSCP---------------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE 267 (704)
Q Consensus 203 ~~~~~LV~Ey~~g~ll~~~~~~---------------~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~ 267 (704)
...+|||||||+++.|..++.. ...+++.++..|+.||+.||.|||+++||||||||+||||+.+
T Consensus 115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG 194 (329)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCC
Confidence 5679999999998766654321 2469999999999999999999999999999999999999999
Q ss_pred CceEEeccccccccCCCCC-CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 005289 268 GVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKI 345 (704)
Q Consensus 268 g~iKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I 345 (704)
+.+||+|||+|+....... ...+..+||+.|||||++.+ ..|+.++|||||||+||||+| |++||.+.+..+.+..|
T Consensus 195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 273 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI 273 (329)
T ss_dssp TEEEECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH
T ss_pred CcEEEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999987644322 22345678999999999886 679999999999999999998 89999999998888887
Q ss_pred HHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 346 FKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 346 ~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
... ..+ .....+|+++.+||.+||+.||++|||+.|++++
T Consensus 274 ~~g--~~~--------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 274 TQG--REL--------------------------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHT--CCC--------------------------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HcC--CCC--------------------------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 652 111 0113688999999999999999999999999865
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=467.40 Aligned_cols=329 Identities=28% Similarity=0.394 Sum_probs=263.7
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCCh-----------HHHHHHHHHHHHHHhcCCCCceeEeEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP-----------ESVRFMAREILILRRLDHPNIIKLEGLI 198 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~-----------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~ 198 (704)
++|+++++||+|+||+||+|++..+++.||||++....... ...+.+.+|+.+|+.|+|||||+++++|
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 57999999999999999999999999999999997654321 2346688999999999999999999999
Q ss_pred eecCCCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCC---ceEEecc
Q 005289 199 TSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADF 275 (704)
Q Consensus 199 ~~~~~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g---~iKL~DF 275 (704)
.+ ...+|||||||+++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+||
T Consensus 116 ~~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 116 ED--KKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp EC--SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred Ec--CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 87 578999999999866554444456799999999999999999999999999999999999999876 6999999
Q ss_pred ccccccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCch
Q 005289 276 GLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 355 (704)
Q Consensus 276 Gla~~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~ 355 (704)
|++...... ......++|+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+++..+......++.
T Consensus 194 g~a~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~- 268 (504)
T 3q5i_A 194 GLSSFFSKD--YKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDF- 268 (504)
T ss_dssp TTCEECCTT--SCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH-
T ss_pred CCCEEcCCC--CccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc-
Confidence 999876543 23456789999999999864 6899999999999999999999999999999999888763322222
Q ss_pred hhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCCCCCCCCCCCCCCCh
Q 005289 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSK 435 (704)
Q Consensus 356 ~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~~~~~~~~p~~~~~~ 435 (704)
..|..+++++++||.+||.+||.+|||+.++|+||||+...... .
T Consensus 269 ------------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~--------~--- 313 (504)
T 3q5i_A 269 ------------------------NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNI--------N--- 313 (504)
T ss_dssp ------------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCC--------C---
T ss_pred ------------------------cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcc--------c---
Confidence 23467899999999999999999999999999999998643211 0
Q ss_pred hHHhHhHHHHHhhhhCCCccccccccccccccCCCCCCChHHHHHHHHHhHhhcCCCCCcccccccC
Q 005289 436 EIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVEDVAVRTQFAKKINGHSLHILKDDELS 502 (704)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~~~~~f~~~d~~~~~~~~~~e~~ 502 (704)
..+.+......... .++......+......++.++.+.+++..+.+.|+.+|.|++|.|+.+|+.
T Consensus 314 ~~~~~~~~~~~~~~--~~~~~~~kl~~a~l~~i~~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~ 378 (504)
T 3q5i_A 314 KSDQKTLCGALSNM--RKFEGSQKLAQAAILFIGSKLTTLEERKELTDIFKKLDKNGDGQLDKKELI 378 (504)
T ss_dssp GGGHHHHHHHHHHH--HHCCCCSHHHHHHHHHHHHHTSCHHHHHHHHHHHHHHCTTCSSEECHHHHH
T ss_pred ccchhhHHHHHHHH--HHHHHHHHHHHHHHHHhhccCCcHHHHHHHHHHHHeeCCCCCCeEcHHHHH
Confidence 01111111111111 123344455555666777777799999999999999999999999999974
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-52 Score=467.41 Aligned_cols=329 Identities=24% Similarity=0.382 Sum_probs=261.9
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
++|+++++||+|+||+||+|++..+++.||||++............+.+|+.+|+.|+||||+++++++.+ ...+|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv 99 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED--SSSFYIV 99 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc--CCEEEEE
Confidence 47999999999999999999999999999999997543222335668899999999999999999999987 5789999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEc---cCCceEEeccccccccCCCCC
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN---NEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~---~~g~iKL~DFGla~~~~~~~~ 286 (704)
||||.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||++......
T Consensus 100 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-- 177 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-- 177 (486)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC--
Confidence 99999866654444455799999999999999999999999999999999999995 4567999999999876543
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcc
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~ 366 (704)
......++|+.|+|||++.+ .|+.++||||||||+|+|++|.+||.+.+..+++..+......++.
T Consensus 178 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~------------ 243 (486)
T 3mwu_A 178 TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL------------ 243 (486)
T ss_dssp ----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCS------------
T ss_pred CccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC------------
Confidence 23456689999999999876 5899999999999999999999999999999998888764322221
Q ss_pred cCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCCCCCCCCCCCCCCChhHHhHhHHHHH
Q 005289 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDAR 446 (704)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 446 (704)
..+..+++++++||.+||.+||.+|||+.++|+||||+...... |.. ...+.........+
T Consensus 244 -------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~-----~~~-~~~~~~~~~~~~~~ 304 (486)
T 3mwu_A 244 -------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSET-----PTI-SDLPSLESAMTNIR 304 (486)
T ss_dssp -------------GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCCC-----CCG-GGHHHHHHHHHHHH
T ss_pred -------------cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcccC-----ccc-cccccHHHHHHHHH
Confidence 22357899999999999999999999999999999998643211 110 01111111111122
Q ss_pred hhhhCCCccccccccccccccCCCCCCChHHHHHHHHHhHhhcCCCCCccccccc
Q 005289 447 RKKVGGRVRGAETRKTTRKSHGMSKLAPVEDVAVRTQFAKKINGHSLHILKDDEL 501 (704)
Q Consensus 447 ~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~~~~~f~~~d~~~~~~~~~~e~ 501 (704)
+.. .....+......++.++.+.+++..+.+.|+.+|.|++|.|+.+|+
T Consensus 305 ~~~------~~~~~~~~~l~~ia~~l~~~~~~~~l~~~F~~~D~d~dG~I~~~El 353 (486)
T 3mwu_A 305 QFQ------AEKKLAQAALLYMASKLTTLDETKQLTEIFRKLDTNNDGMLDRDEL 353 (486)
T ss_dssp HHH------HSCHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCTTCSSSBCHHHH
T ss_pred HHH------HHHHHHHHHHHHHHHHhccHHHHHHHHHHHHHhCCCCCceeeHHHH
Confidence 211 2233444555666667778999999999999999999999999997
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-51 Score=426.59 Aligned_cols=284 Identities=38% Similarity=0.696 Sum_probs=234.3
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
++|++++.||+|+||+||+|++ .+++.||||++............+.+|+.+|+.++||||+++++++.. ...+|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT--KKRLVLV 78 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--SSCEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc--CCeEEEE
Confidence 5799999999999999999998 679999999997654333334567789999999999999999999987 5689999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCc
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~ 289 (704)
|||+++++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ...
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 157 (288)
T 1ob3_A 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKY 157 (288)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc-ccc
Confidence 9999998777776656679999999999999999999999999999999999999999999999999998664322 233
Q ss_pred ccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCC-CCcccC
Q 005289 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL-PHATLF 368 (704)
Q Consensus 290 ~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~-~~~~~~ 368 (704)
...++|+.|+|||++.+...|+.++|||||||++|+|++|.+||.+.+..+.+..++..++.++...|..... +....
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 236 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP- 236 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT-
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccc-
Confidence 4557899999999998766789999999999999999999999999999999999999999988777754221 11000
Q ss_pred CCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 369 ~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
.........+...+..+++++.+||.+||..||++|||+.++|+||||++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 00000112234445678999999999999999999999999999999985
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-51 Score=455.30 Aligned_cols=294 Identities=33% Similarity=0.553 Sum_probs=230.3
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC---CCe
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL---SCS 205 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~---~~~ 205 (704)
.++|++++.||+|+||+||+|++..+++.||||++..........+.+.+|+.+|+.|+|||||++++++.... ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 35799999999999999999999999999999999766555666778899999999999999999999985432 357
Q ss_pred EEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
+||||||+++++...+.. ...+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++......
T Consensus 132 ~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 210 (458)
T 3rp9_A 132 LYVVLEIADSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210 (458)
T ss_dssp EEEEECCCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCT
T ss_pred EEEEEeccccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCcc
Confidence 999999999877666543 4579999999999999999999999999999999999999999999999999998764321
Q ss_pred C--------------------------CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-----------
Q 005289 286 R--------------------------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI----------- 328 (704)
Q Consensus 286 ~--------------------------~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt----------- 328 (704)
. ...+..++|++|+|||++.....|+.++||||||||||||++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~ 290 (458)
T 3rp9_A 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290 (458)
T ss_dssp TCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGG
T ss_pred ccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccccc
Confidence 1 134566889999999987666789999999999999999998
Q ss_pred CCCCCCCCC--------------------HHHHHHHHHHHcCCCCchhhhccCCCCcccC--CCCCCCCchhhhhccCCC
Q 005289 329 GKPILQGRT--------------------EVEQLHKIFKLCGSPPDDYWKKSKLPHATLF--KPQQPYDSSLRETFKDLP 386 (704)
Q Consensus 329 G~~pF~~~~--------------------~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~--~~~~~~~~~l~~~~~~~s 386 (704)
|+++|.+.+ ..+++..|++.+|.++.+.|..........+ .........+.+.++.++
T Consensus 291 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 370 (458)
T 3rp9_A 291 RGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASS 370 (458)
T ss_dssp CCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSC
T ss_pred ccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCC
Confidence 888888765 3688999999999999887765433211100 011112234566778899
Q ss_pred HHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCCCC
Q 005289 387 TTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 423 (704)
Q Consensus 387 ~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~~~ 423 (704)
+++++||.+||.+||.+|||++|+|+||||+...++.
T Consensus 371 ~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~ 407 (458)
T 3rp9_A 371 ADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE 407 (458)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGG
T ss_pred HHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCc
Confidence 9999999999999999999999999999999876543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=437.28 Aligned_cols=255 Identities=20% Similarity=0.318 Sum_probs=212.5
Q ss_pred cccCCeeEEEEeeccCceEEEEEEEC-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeec
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDL-----DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR 201 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 201 (704)
+..++++++++||+|+||+||+|+.. .+++.||||+++... .....+.+.+|+.+|++|+|||||+++++|.+
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~- 100 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK- 100 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE-
Confidence 44567999999999999999999853 467899999997543 33445678899999999999999999999987
Q ss_pred CCCeEEEEEecccccccccccCC----------------CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEc
Q 005289 202 LSCSIYLVFEYMEHDITGLLSCP----------------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN 265 (704)
Q Consensus 202 ~~~~~~LV~Ey~~g~ll~~~~~~----------------~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~ 265 (704)
...+|||||||+++.|..++.. ...+++.++..|+.||+.||.|||+++||||||||+||||+
T Consensus 101 -~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 101 -DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY 179 (308)
T ss_dssp -SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred -CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence 4678999999998766544311 23589999999999999999999999999999999999999
Q ss_pred cCCceEEeccccccccCCCC-CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 005289 266 NEGVLKLADFGLANFSNTGH-RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLH 343 (704)
Q Consensus 266 ~~g~iKL~DFGla~~~~~~~-~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~ 343 (704)
+++++||+|||+|+...... ....+..+||+.|||||++.+ ..|+.++|||||||+||||+| |.+||.+.+..+++.
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~ 258 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999999998664332 223455688999999999876 579999999999999999998 899999999988888
Q ss_pred HHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 344 KIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 344 ~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.|... ..+ .....+|+++.+||.+||..||++|||+.+++++
T Consensus 259 ~i~~~--~~~--------------------------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 259 MIRNR--QVL--------------------------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHTT--CCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcC--CCC--------------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 77542 110 0124688999999999999999999999999876
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=463.62 Aligned_cols=329 Identities=26% Similarity=0.373 Sum_probs=263.2
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 207 (704)
.++|++++.||+|+||+||+|++..+++.||||++...... ......+.+|+.+|+.|+||||+++++++.+ ...+|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~ 102 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED--KGYFY 102 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCEEE
Confidence 35799999999999999999999999999999999766543 3345678899999999999999999999987 57899
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEE---ccCCceEEeccccccccCCC
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl---~~~g~iKL~DFGla~~~~~~ 284 (704)
||||||.++.+.........+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++......
T Consensus 103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 999999986665554455679999999999999999999999999999999999999 56789999999999876543
Q ss_pred CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
......++|+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+++.++......++.
T Consensus 183 --~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~---------- 248 (484)
T 3nyv_A 183 --KKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFEL---------- 248 (484)
T ss_dssp --CSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS----------
T ss_pred --cccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC----------
Confidence 23456789999999999876 6899999999999999999999999999999999888764333221
Q ss_pred cccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCCCCCCCCCCCCCCChhHHhHhHHH
Q 005289 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHRED 444 (704)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 444 (704)
..+..+++++++||.+||.+||.+|||+.++|+||||+........... +.....-..
T Consensus 249 ---------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~~~~~~---~~~~~~~~~---- 306 (484)
T 3nyv_A 249 ---------------PQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDV---PSLDNAILN---- 306 (484)
T ss_dssp ---------------GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-----CC---CBCHHHHHH----
T ss_pred ---------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccccccccccc---cchHHHHHH----
Confidence 2235789999999999999999999999999999999854332111111 111111111
Q ss_pred HHhhhhCCCccccccccccccccCCCCCCChHHHHHHHHHhHhhcCCCCCccccccc
Q 005289 445 ARRKKVGGRVRGAETRKTTRKSHGMSKLAPVEDVAVRTQFAKKINGHSLHILKDDEL 501 (704)
Q Consensus 445 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~~~~~f~~~d~~~~~~~~~~e~ 501 (704)
.++. ......++.....++.++.+.+++..+.+.|+.+|.|++|.|+.+|+
T Consensus 307 ~~~~------~~~~kl~qa~l~~i~~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El 357 (484)
T 3nyv_A 307 IRQF------QGTQKLAQAALLYMGSKLTSQDETKELTAIFHKMDKNGDGQLDRAEL 357 (484)
T ss_dssp HHHH------HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSEEEHHHH
T ss_pred HHHH------hhhhHHHHHHHHHHHhccCcHHHHHHHHHHHHHhCcCCCceEeHHHH
Confidence 1111 11122333334455555557889999999999999999999999997
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=465.08 Aligned_cols=331 Identities=27% Similarity=0.400 Sum_probs=260.0
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
++|+++++||+|+||+||+|++..++..||||++............+.+|+.+|+.|+|||||+++++|.+ ...+|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv 114 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED--KRNYYLV 114 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEEEE
Confidence 46999999999999999999999999999999998765444445678899999999999999999999987 5789999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccC---CceEEeccccccccCCCCC
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE---GVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~---g~iKL~DFGla~~~~~~~~ 286 (704)
||||.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.. +.+||+|||++......
T Consensus 115 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~-- 192 (494)
T 3lij_A 115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-- 192 (494)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT--
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC--
Confidence 9999986665444445679999999999999999999999999999999999999764 45999999999876543
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcc
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~ 366 (704)
......++|+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+++.++......++..
T Consensus 193 ~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~----------- 259 (494)
T 3lij_A 193 KKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSP----------- 259 (494)
T ss_dssp BCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSG-----------
T ss_pred ccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCch-----------
Confidence 33456789999999999864 69999999999999999999999999999999998887744333322
Q ss_pred cCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCCCCC-CCCCCCCCCChhHHhHhHHHH
Q 005289 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACD-LSSLPIYPPSKEIDAKHREDA 445 (704)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~~~~-~~~~p~~~~~~~~~~~~~~~~ 445 (704)
.|..+++.+++||.+||.+||.+|||+.++|+||||+....... ...+|.. .. ..+..
T Consensus 260 --------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~---~~----~~~~~ 318 (494)
T 3lij_A 260 --------------EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSL---AN----AIENM 318 (494)
T ss_dssp --------------GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHHHHHC---CCCC---SS----HHHHH
T ss_pred --------------hcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCccccccccccccc---HH----HHHHH
Confidence 23578999999999999999999999999999999975311100 0011111 11 11111
Q ss_pred HhhhhCCCccccccccccccccCCCCCCChHHHHHHHHHhHhhcCCCCCcccccccCcc
Q 005289 446 RRKKVGGRVRGAETRKTTRKSHGMSKLAPVEDVAVRTQFAKKINGHSLHILKDDELSGR 504 (704)
Q Consensus 446 ~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~~~~~f~~~d~~~~~~~~~~e~~~~ 504 (704)
++ +......++.....++.++.+.+++..+.+.|+.+|.|++|.|+.+|+...
T Consensus 319 ~~------~~~~~~l~qa~l~~ia~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~ 371 (494)
T 3lij_A 319 RK------FQNSQKLAQAALLYMASKLTSQEETKELTDIFRHIDKNGDGQLDRQELIDG 371 (494)
T ss_dssp HT------TTTCCHHHHHHHHHHHHHSCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHT
T ss_pred HH------HHHhHHHHHHHHHHHHHhcccHHHHHHHHHHHHHhCcCCCCeEcHHHHHHH
Confidence 11 222333444455566666778999999999999999999999999998433
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-51 Score=457.56 Aligned_cols=286 Identities=30% Similarity=0.530 Sum_probs=232.0
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC----CC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL----SC 204 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----~~ 204 (704)
.++|+++++||+|+||+||+|++..+++.||||++..........+.+.+|+.+|+.++|||||+++++|.... ..
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 46899999999999999999999999999999999876555666778889999999999999999999996532 25
Q ss_pred eEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
.+|||||||+++++..+.. .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 141 ~~~lv~E~~~~~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 217 (464)
T 3ttj_A 141 DVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 217 (464)
T ss_dssp EEEEEEECCSEEHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----C
T ss_pred eEEEEEeCCCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC
Confidence 7899999999987776643 4899999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
...+..++|++|+|||++.+ ..|+.++||||||||||+|++|++||.+.+..+++.+|++.+|.|+.++|.......
T Consensus 218 --~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~ 294 (464)
T 3ttj_A 218 --FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294 (464)
T ss_dssp --CCC----CCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred --cccCCCcccccccCHHHHcC-CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence 33466789999999999987 579999999999999999999999999999999999999999999988876532110
Q ss_pred cccCCCCCCCC-chhhhhcc------------CCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCC
Q 005289 365 ATLFKPQQPYD-SSLRETFK------------DLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (704)
Q Consensus 365 ~~~~~~~~~~~-~~l~~~~~------------~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~ 420 (704)
.........+. ..+...++ ..++++++||.+||.+||++|||++|+|+||||+...
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~ 363 (464)
T 3ttj_A 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 363 (464)
T ss_dssp HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhcc
Confidence 00000000000 01111111 1267799999999999999999999999999998643
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-51 Score=444.94 Aligned_cols=290 Identities=33% Similarity=0.566 Sum_probs=229.4
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeEEEeecCCCeEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~~~ 207 (704)
.++|++++.||+|+||+||+|.+..+++.||||++............+.+|+.+|+.+. ||||+++++++.......+|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 45899999999999999999999999999999999766555666777889999999997 99999999999876566899
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC---
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG--- 284 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~--- 284 (704)
||||||++++...+.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 88 lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 165 (388)
T 3oz6_A 88 LVFDYMETDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165 (388)
T ss_dssp EEEECCSEEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCC
T ss_pred EEecccCcCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccc
Confidence 9999999876665543 46899999999999999999999999999999999999999999999999999765321
Q ss_pred -----------------CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 005289 285 -----------------HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 347 (704)
Q Consensus 285 -----------------~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~ 347 (704)
.....+..++|++|+|||++.+...|+.++||||||||||+|++|++||.+.+..+++..|+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 245 (388)
T 3oz6_A 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245 (388)
T ss_dssp CCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 112345568999999999998767899999999999999999999999999999999999999
Q ss_pred HcCCCCchhhhccCCCCcccCC---------CCCCCCc---hhh------hhccCCCHHHHHHHHHhhccCCCCCcCHHH
Q 005289 348 LCGSPPDDYWKKSKLPHATLFK---------PQQPYDS---SLR------ETFKDLPTTAVNLIETLLSVEPYKRATASA 409 (704)
Q Consensus 348 ~~g~~p~~~w~~~~~~~~~~~~---------~~~~~~~---~l~------~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e 409 (704)
.++.|+.+.+.....+....+. ....+.. .+. .....+++++.+||.+||.+||.+|||+.|
T Consensus 246 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e 325 (388)
T 3oz6_A 246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAND 325 (388)
T ss_dssp HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred hcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHH
Confidence 9999988776543322110000 0000000 000 011378999999999999999999999999
Q ss_pred HHhccccCCCC
Q 005289 410 ALASEYFSTKP 420 (704)
Q Consensus 410 ~L~hpwf~~~~ 420 (704)
+|+||||+...
T Consensus 326 ~l~Hp~~~~~~ 336 (388)
T 3oz6_A 326 ALKHPFVSIFH 336 (388)
T ss_dssp HTTSTTTTTTC
T ss_pred HhCCHHHHHhc
Confidence 99999998643
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-50 Score=430.00 Aligned_cols=260 Identities=28% Similarity=0.465 Sum_probs=228.2
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|++++.||+|+||+||+|++..+|+.||||++..........+.+.+|+.+|+.++||||+++++++.. ...+||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~l 91 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET--EKTLYL 91 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCEEEE
Confidence 568999999999999999999999999999999998877677777888999999999999999999999987 578999
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... ..
T Consensus 92 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--~~ 169 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GK 169 (328)
T ss_dssp EECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS--CG
T ss_pred EEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC--Cc
Confidence 9999988666655544567999999999999999999999999999999999999999999999999999876543 23
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccC
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~ 368 (704)
....++|++|+|||++.+...++.++|||||||+||+|++|++||.+.+..+...++.......
T Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~---------------- 233 (328)
T 3fe3_A 170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI---------------- 233 (328)
T ss_dssp GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC----------------
T ss_pred cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC----------------
Confidence 4667899999999999875555689999999999999999999999999888888776521111
Q ss_pred CCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCC
Q 005289 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (704)
Q Consensus 369 ~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~ 421 (704)
...+++++.+||.+||.+||.+|||+.|+|+||||+....
T Consensus 234 -------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 234 -------------PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHE 273 (328)
T ss_dssp -------------CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred -------------CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence 1247889999999999999999999999999999986543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-50 Score=445.26 Aligned_cols=294 Identities=35% Similarity=0.551 Sum_probs=241.2
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC---Ce
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS---CS 205 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~---~~ 205 (704)
.++|++++.||+|+||+||+|++..+++.||||++..........+.+.+|+.+|+.|+||||+++++++..... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999999999999999998665556667788999999999999999999999876421 57
Q ss_pred EEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
+||||||+++++...+. ....+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 105 ~~lv~e~~~~~L~~~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 183 (432)
T 3n9x_A 105 LYIVLEIADSDLKKLFK-TPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183 (432)
T ss_dssp EEEEEECCSEEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC----
T ss_pred EEEEEecCCcCHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccc
Confidence 99999999987666554 44579999999999999999999999999999999999999999999999999998765332
Q ss_pred C---------------------CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-----------CCCCC
Q 005289 286 R---------------------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-----------GKPIL 333 (704)
Q Consensus 286 ~---------------------~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-----------G~~pF 333 (704)
. ...+..++|++|+|||++.....|+.++||||||||||||++ |.|+|
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f 263 (432)
T 3n9x_A 184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLF 263 (432)
T ss_dssp ---------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSC
T ss_pred cccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccC
Confidence 1 124677899999999997666789999999999999999998 67777
Q ss_pred CCCC-----------------HHHHHHHHHHHcCCCCchhhhccCCCCccc--CCCCCCCCchhhhhccCCCHHHHHHHH
Q 005289 334 QGRT-----------------EVEQLHKIFKLCGSPPDDYWKKSKLPHATL--FKPQQPYDSSLRETFKDLPTTAVNLIE 394 (704)
Q Consensus 334 ~~~~-----------------~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~--~~~~~~~~~~l~~~~~~~s~~~~dLI~ 394 (704)
.+.+ ..+++..|+..+|.|+.+.|.......... ..........+...++.+++++++||.
T Consensus 264 ~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~ 343 (432)
T 3n9x_A 264 PGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLE 343 (432)
T ss_dssp CCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHH
T ss_pred CCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHH
Confidence 7754 478999999999999988776543321110 001112223456677889999999999
Q ss_pred HhhccCCCCCcCHHHHHhccccCCCCCCC
Q 005289 395 TLLSVEPYKRATASAALASEYFSTKPYAC 423 (704)
Q Consensus 395 ~mL~~dP~kRpTa~e~L~hpwf~~~~~~~ 423 (704)
+||.+||.+|||+.|+|+||||+...++.
T Consensus 344 ~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~ 372 (432)
T 3n9x_A 344 SMLKFNPNKRITIDQALDHPYLKDVRKKK 372 (432)
T ss_dssp HHSCSSTTTSCCHHHHHTCGGGTTTCCTT
T ss_pred HHhcCCcccCCCHHHHhcChhhhhccCcc
Confidence 99999999999999999999999865543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=429.50 Aligned_cols=289 Identities=36% Similarity=0.646 Sum_probs=224.0
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|+++++||+|+||+||+|++..+++.||||++..... ......+.+|+.+|+.++||||+++++++.. ...+||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 80 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHT--ENKLTL 80 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECC--TTEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEE--CCeEEE
Confidence 3579999999999999999999999999999999976542 2233567789999999999999999999987 578999
Q ss_pred EEecccccccccccC-----CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCC
Q 005289 209 VFEYMEHDITGLLSC-----PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~-----~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~ 283 (704)
||||+++++...+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 81 v~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 81 VFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 999999876655432 223589999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCC
Q 005289 284 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 284 ~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
.. ......++|+.|+|||++.+...|+.++|||||||++|+|++|++||.+.+..+++..|+..++.++...|......
T Consensus 161 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (317)
T 2pmi_A 161 PV-NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239 (317)
T ss_dssp CC-CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred Cc-ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhh
Confidence 32 23345678999999999987667999999999999999999999999999999999999999999998888763321
Q ss_pred CcccCCCCCCCCchhhh-----hccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCC
Q 005289 364 HATLFKPQQPYDSSLRE-----TFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (704)
Q Consensus 364 ~~~~~~~~~~~~~~l~~-----~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~ 421 (704)
..............+.. ....++.++.+||.+||..||.+|||+.|+|+||||++...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 11000000111111111 22468999999999999999999999999999999987444
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-50 Score=430.44 Aligned_cols=295 Identities=42% Similarity=0.697 Sum_probs=242.5
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC------
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL------ 202 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~------ 202 (704)
.++|+++++||+|+||+||+|++..+++.||||++............+.+|+.+|+.++||||+++++++....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 46899999999999999999999999999999999766544444456778999999999999999999987642
Q ss_pred CCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccC
Q 005289 203 SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (704)
Q Consensus 203 ~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~ 282 (704)
...+|||||||+++++..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 96 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 175 (351)
T 3mi9_A 96 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 175 (351)
T ss_dssp -CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccccc
Confidence 35789999999998888877766789999999999999999999999999999999999999999999999999997654
Q ss_pred CC---CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhc
Q 005289 283 TG---HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359 (704)
Q Consensus 283 ~~---~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~ 359 (704)
.. ........++|+.|+|||++.+...|+.++|||||||++|+|++|.+||.+.+..+++..+...++.++...|..
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 255 (351)
T 3mi9_A 176 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 255 (351)
T ss_dssp CCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred ccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccc
Confidence 22 122335567899999999998767789999999999999999999999999999999999999999998887765
Q ss_pred cCCCCc-ccCCCCCCCCchhhhhc--cCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCCCC
Q 005289 360 SKLPHA-TLFKPQQPYDSSLRETF--KDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 423 (704)
Q Consensus 360 ~~~~~~-~~~~~~~~~~~~l~~~~--~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~~~ 423 (704)
...... ............+...+ ...++.+.+||.+||.+||.+|||+.|+|+||||+..+.+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 322 (351)
T 3mi9_A 256 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 322 (351)
T ss_dssp GGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCC
T ss_pred cccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcc
Confidence 332110 00000001111111111 12478899999999999999999999999999999866653
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-50 Score=435.79 Aligned_cols=288 Identities=33% Similarity=0.581 Sum_probs=235.0
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC----C
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS----C 204 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~----~ 204 (704)
.++|++++.||+|+||+||+|++..+|+.||||++..........+.+.+|+.+|+.++||||+++++++..... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 357999999999999999999999999999999997655555666778899999999999999999999976421 4
Q ss_pred eEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
.+||||||+++++...+.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 104 ~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~- 180 (367)
T 1cm8_A 104 DFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS- 180 (367)
T ss_dssp CCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS-
T ss_pred eEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc-
Confidence 5799999996655544432 4689999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
..+..++|++|+|||++.+...|+.++||||||||+|+|++|++||.+.+..+++..|++.+|.++.+++.......
T Consensus 181 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~ 257 (367)
T 1cm8_A 181 ---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 257 (367)
T ss_dssp ---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred ---ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHH
Confidence 23556889999999999876779999999999999999999999999999999999999999999988876543211
Q ss_pred cccCC--CCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCCC
Q 005289 365 ATLFK--PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422 (704)
Q Consensus 365 ~~~~~--~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~~ 422 (704)
...+. ........+...+..+++.+.+||.+||.+||.+|||+.++|+||||+....+
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~ 317 (367)
T 1cm8_A 258 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 317 (367)
T ss_dssp HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred HHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCC
Confidence 10000 00011123455667889999999999999999999999999999999975544
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=430.79 Aligned_cols=288 Identities=36% Similarity=0.667 Sum_probs=234.2
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
++|+++++||+|+||+||+|++..+++.||||++...... .....+.+|+.+|+.++||||+++++++.. ...+|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHT--EKSLTLV 78 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEEC--SSCEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEee--CCEEEEE
Confidence 5799999999999999999999999999999999754321 111234579999999999999999999987 5789999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCc
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~ 289 (704)
|||+++++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ...
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~ 157 (324)
T 3mtl_A 79 FEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTY 157 (324)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred ecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc-ccc
Confidence 9999998887776666679999999999999999999999999999999999999999999999999997654332 233
Q ss_pred ccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc-ccC
Q 005289 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA-TLF 368 (704)
Q Consensus 290 ~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~-~~~ 368 (704)
...++|+.|+|||++.+...|+.++|||||||++|+|++|++||.+.+..+++..+...++.++...|........ ..+
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY 237 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence 4567899999999998767799999999999999999999999999999999999999999999887764321110 001
Q ss_pred CCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCC
Q 005289 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (704)
Q Consensus 369 ~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~ 421 (704)
.........+...+..+++++.+||.+||.+||.+|||+.|+|+||||+....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 11111222345566789999999999999999999999999999999986543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-50 Score=428.05 Aligned_cols=288 Identities=37% Similarity=0.692 Sum_probs=228.4
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|+++++||+|+||+||+|++..+++.||||++............+.+|+.+|+.++||||+++++++.+ ...+||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 110 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH--NHRLHL 110 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec--CCEEEE
Confidence 457999999999999999999999999999999998765544455667789999999999999999999987 578999
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEc-----cCCceEEeccccccccCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN-----NEGVLKLADFGLANFSNT 283 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~-----~~g~iKL~DFGla~~~~~ 283 (704)
||||+++++...+.. ...+++..++.++.||+.||.|||++||+||||||+||||+ ..+.+||+|||++.....
T Consensus 111 v~e~~~~~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~ 189 (329)
T 3gbz_A 111 IFEYAENDLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189 (329)
T ss_dssp EEECCSEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred EEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence 999999876665543 34699999999999999999999999999999999999994 455699999999986653
Q ss_pred CCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCC-
Q 005289 284 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL- 362 (704)
Q Consensus 284 ~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~- 362 (704)
.. ......++|+.|+|||++.+...|+.++|||||||+||+|++|.+||.+.+..+.+.+++..++.++...|.....
T Consensus 190 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (329)
T 3gbz_A 190 PI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL 268 (329)
T ss_dssp -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred cc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhh
Confidence 32 2344567899999999998766799999999999999999999999999999999999999999998877754321
Q ss_pred CCcccCCCCCCCCchhhhh-ccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCC
Q 005289 363 PHATLFKPQQPYDSSLRET-FKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (704)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~-~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~ 421 (704)
+......+.. ....+... ...+++++.+||.+||.+||.+|||+.|+|+||||+...|
T Consensus 269 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 269 PDWKQSFPKF-RGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp TTCCTTCCCC-CCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred hhhhhhhhhh-ccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence 1111111111 11122222 2348899999999999999999999999999999997655
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=427.07 Aligned_cols=295 Identities=40% Similarity=0.683 Sum_probs=242.0
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCCh---HHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCe
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP---ESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~---~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (704)
.++|++++.||+|+||+||+|++..+|+.||||++....... .....+.+|+.+|+.++||||+++++++.+ ...
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 86 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH--KSN 86 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC--TTC
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee--CCc
Confidence 568999999999999999999999999999999997543221 112457789999999999999999999977 567
Q ss_pred EEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
+||||||+++++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 87 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (346)
T 1ua2_A 87 ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166 (346)
T ss_dssp CEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred eEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence 89999999998777776666679999999999999999999999999999999999999999999999999998765332
Q ss_pred CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCC-CC
Q 005289 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL-PH 364 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~-~~ 364 (704)
......++|+.|+|||++.+...|+.++|||||||++|+|++|.+||.+.+..+++.+|+..++.++...|..... +.
T Consensus 167 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 245 (346)
T 1ua2_A 167 -RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245 (346)
T ss_dssp -CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred -ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcc
Confidence 2345568899999999997766789999999999999999999999999999999999999999998888765432 11
Q ss_pred cccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCCCCCCCCC
Q 005289 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSL 428 (704)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~~~~~~~~ 428 (704)
...+. ......+...+..++.++++||.+||..||.+|||+.|+|+||||+..+.+.....+
T Consensus 246 ~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~~~~~ 307 (346)
T 1ua2_A 246 YVTFK--SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQL 307 (346)
T ss_dssp CCCCC--CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSSSS
T ss_pred ccccc--ccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCCcccC
Confidence 11111 111123455667899999999999999999999999999999999988776554333
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=431.24 Aligned_cols=261 Identities=26% Similarity=0.390 Sum_probs=228.1
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCCh----HHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP----ESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 204 (704)
.+.|++++.||+|+||+||+|++..+|+.||||++....... ...+.+.+|+.+|+.|+||||++++++|.+ ..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~ 88 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN--RT 88 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SS
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe--CC
Confidence 357999999999999999999999999999999998754321 134668899999999999999999999987 57
Q ss_pred eEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCC----ceEEeccccccc
Q 005289 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG----VLKLADFGLANF 280 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g----~iKL~DFGla~~ 280 (704)
.+|||||||.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++..
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 8999999998876666666667899999999999999999999999999999999999998877 799999999987
Q ss_pred cCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhcc
Q 005289 281 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (704)
Q Consensus 281 ~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~ 360 (704)
.... ......+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+..+.+..|......++..+
T Consensus 169 ~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~---- 241 (361)
T 2yab_A 169 IEDG--VEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEF---- 241 (361)
T ss_dssp CCTT--CCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHH----
T ss_pred cCCC--CccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchh----
Confidence 6543 23456789999999999876 5789999999999999999999999999999999988876544443333
Q ss_pred CCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
+..+++.+++||.+||..||.+|||+.++|+||||+..
T Consensus 242 ---------------------~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 242 ---------------------FSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp ---------------------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred ---------------------ccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 35789999999999999999999999999999999853
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=418.92 Aligned_cols=286 Identities=37% Similarity=0.662 Sum_probs=234.4
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC---hHHHHHHHHHHHHHHhc---CCCCceeEeEEEeecC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE---PESVRFMAREILILRRL---DHPNIIKLEGLITSRL 202 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~---~~~~~~~~~Ei~iL~~L---~HpnIv~l~~~~~~~~ 202 (704)
.++|+++++||+|+||+||+|++..+++.||||++...... ......+.+|+.+++.+ +||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 46899999999999999999999999999999999754321 11123455677777766 4999999999997642
Q ss_pred C---CeEEEEEecccccccccccCCC-ccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccc
Q 005289 203 S---CSIYLVFEYMEHDITGLLSCPD-IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278 (704)
Q Consensus 203 ~---~~~~LV~Ey~~g~ll~~~~~~~-~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla 278 (704)
. ..+||||||+.+++...+.... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 167 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA 167 (308)
T ss_dssp SSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCT
T ss_pred CCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccc
Confidence 2 2589999999987766654433 34999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhh
Q 005289 279 NFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 358 (704)
Q Consensus 279 ~~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~ 358 (704)
...... ......++|+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+++.+++..++.++...|.
T Consensus 168 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (308)
T 3g33_A 168 RIYSYQ--MALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 244 (308)
T ss_dssp TTSTTC--CCSGGGGCCCSSCCHHHHHT-SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSC
T ss_pred cccCCC--cccCCccccccccCchHHcC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 876543 23456788999999999876 568999999999999999999999999999999999999999999988886
Q ss_pred ccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 359 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
.........+.+. ....+....+.+++.+.+||.+||.+||.+|||+.|+|+||||+..
T Consensus 245 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 245 RDVSLPRGAFPPR--GPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp SSCSSCGGGSCCC--CCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred chhhccccccCCC--CCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 5432222222222 2234556678899999999999999999999999999999999864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-50 Score=435.31 Aligned_cols=256 Identities=21% Similarity=0.311 Sum_probs=209.5
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCC-----CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC-CCceeEeEEEeec
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDT-----GKIVALKKVRFDNFEPESVRFMAREILILRRLDH-PNIIKLEGLITSR 201 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~-----g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~H-pnIv~l~~~~~~~ 201 (704)
..++|++.++||+|+||+||+|++..+ ++.||||++.... .....+.+.+|+.+|.+|.| ||||+++++|...
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 356899999999999999999987654 4689999997543 34456778899999999965 9999999998764
Q ss_pred CCCeEEEEEecccccccccccCC----------------CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEc
Q 005289 202 LSCSIYLVFEYMEHDITGLLSCP----------------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN 265 (704)
Q Consensus 202 ~~~~~~LV~Ey~~g~ll~~~~~~----------------~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~ 265 (704)
...+|||||||+++.|..++.. ...+++.++..|+.||+.||.|||+++||||||||+||||+
T Consensus 141 -~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~ 219 (353)
T 4ase_A 141 -GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 219 (353)
T ss_dssp -TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred -CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeC
Confidence 3568999999998766654321 23589999999999999999999999999999999999999
Q ss_pred cCCceEEeccccccccCCCCCC-CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 005289 266 NEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLH 343 (704)
Q Consensus 266 ~~g~iKL~DFGla~~~~~~~~~-~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~ 343 (704)
+++.+||+|||+|+........ ..+..+||+.|||||++.+ ..|+.++|||||||+||||+| |.+||.+....+.+.
T Consensus 220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~ 298 (353)
T 4ase_A 220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 298 (353)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH
T ss_pred CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999876543322 2345678999999999986 679999999999999999998 999999876544444
Q ss_pred HHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 344 KIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 344 ~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
+++..-..++ ....+++++.+||.+||..||++|||+.++++|
T Consensus 299 ~~i~~g~~~~---------------------------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 299 RRLKEGTRMR---------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCCC---------------------------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 4333211110 113578999999999999999999999999988
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-49 Score=414.67 Aligned_cols=290 Identities=34% Similarity=0.588 Sum_probs=236.9
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|+++++||+|+||+||+|++..+++.||||++..........+.+.+|+.+|+.++||||+++++++.. ...+||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 79 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR--KRRLHL 79 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec--CCeEEE
Confidence 357999999999999999999999999999999997766556666778899999999999999999999987 578999
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
||||++++++..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ..
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 158 (311)
T 4agu_A 80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS-DY 158 (311)
T ss_dssp EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-cc
Confidence 99999998888776666779999999999999999999999999999999999999999999999999998765332 23
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc--c
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA--T 366 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~--~ 366 (704)
....++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+.++......+........ .
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 34567899999999998767789999999999999999999999999999999999999888876544322111100 0
Q ss_pred cCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCC
Q 005289 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (704)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~ 421 (704)
...+.......+...++.++.++.+||.+||.+||.+|||+.++|+||||+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 293 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence 0011111222345566789999999999999999999999999999999997544
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=430.87 Aligned_cols=288 Identities=34% Similarity=0.571 Sum_probs=226.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeec----CCCe
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR----LSCS 205 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~----~~~~ 205 (704)
++|++++.||+|+||+||+|.+..+|+.||||++............+.+|+.+|+.|+||||+++++++... ....
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 589999999999999999999999999999999976555556677788999999999999999999998653 1256
Q ss_pred EEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
+||||||+++++...+.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 109 ~~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~-- 184 (367)
T 2fst_X 109 VYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-- 184 (367)
T ss_dssp CEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-----------
T ss_pred EEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc--
Confidence 899999997666555433 4699999999999999999999999999999999999999999999999999986543
Q ss_pred CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
..+..++|++|+|||++.+...|+.++||||||||||+|++|++||.+.+..+++..|++.+|.|+.+.|........
T Consensus 185 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~ 262 (367)
T 2fst_X 185 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 262 (367)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHH
T ss_pred --cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence 235568899999999998767899999999999999999999999999999999999999999999887765332111
Q ss_pred ccC--CCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCCCC
Q 005289 366 TLF--KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 423 (704)
Q Consensus 366 ~~~--~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~~~ 423 (704)
..+ .........+...+..+++.+.+||.+||.+||.+|||+.++|+||||+....+.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~ 322 (367)
T 2fst_X 263 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322 (367)
T ss_dssp HHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGG
T ss_pred HHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCC
Confidence 000 0001112234566678899999999999999999999999999999999765543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=434.27 Aligned_cols=283 Identities=36% Similarity=0.586 Sum_probs=230.9
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC----CCe
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL----SCS 205 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----~~~ 205 (704)
.+|++++.||+|+||+||+|++..+++ ||+|++..... ...+|+.+|+.++||||++++++|.... ...
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 479999999999999999999987766 88888764431 1236999999999999999999986532 234
Q ss_pred EEEEEeccccccccccc---CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEc-cCCceEEecccccccc
Q 005289 206 IYLVFEYMEHDITGLLS---CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANFS 281 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~---~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~-~~g~iKL~DFGla~~~ 281 (704)
+|||||||+++++..+. .....+++..++.|+.||+.||.|||++||+||||||+||||+ .++.+||+|||+++..
T Consensus 113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 88999999997665443 2345799999999999999999999999999999999999999 7899999999999876
Q ss_pred CCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccC
Q 005289 282 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (704)
Q Consensus 282 ~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~ 361 (704)
.... .....++|++|+|||++.+...|+.++|||||||+||+|++|++||.+.+..+++..|.+.+|.++.+.|....
T Consensus 193 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 270 (394)
T 4e7w_A 193 IAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN 270 (394)
T ss_dssp CTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred cCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 5432 33456789999999999876779999999999999999999999999999999999999999999987765432
Q ss_pred CCCcccCCCCCCCCchhhhhc-cCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCCC
Q 005289 362 LPHATLFKPQQPYDSSLRETF-KDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422 (704)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~-~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~~ 422 (704)
........+.. ....+...+ ..+++++.+||.+||.+||.+|||+.++|+||||+...+.
T Consensus 271 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 331 (394)
T 4e7w_A 271 PNYMEHKFPQI-RPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTG 331 (394)
T ss_dssp GGGSSSCCCCC-CCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSS
T ss_pred hhhhhhccccc-cCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccc
Confidence 11111111111 112223333 4589999999999999999999999999999999975543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-49 Score=422.93 Aligned_cols=261 Identities=26% Similarity=0.409 Sum_probs=224.4
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
..++|++++.||+|+||+||+|++..+++.||||++.+... .......+.+|+.+|+.++||||+++++++.. ...+
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--~~~~ 80 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRL 80 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC--SSEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe--CCEE
Confidence 35689999999999999999999999999999999976421 12235567889999999999999999999987 5789
Q ss_pred EEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC
Q 005289 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~ 286 (704)
||||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 81 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 159 (337)
T 1o6l_A 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG- 159 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC-
Confidence 9999999987766655555679999999999999999999999999999999999999999999999999998643322
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcc
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~ 366 (704)
......+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+.+..|....-.+
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-------------- 224 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF-------------- 224 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------------
T ss_pred CcccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC--------------
Confidence 23456789999999999876 578999999999999999999999999998888887776521110
Q ss_pred cCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCc-----CHHHHHhccccCCCCC
Q 005289 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 421 (704)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRp-----Ta~e~L~hpwf~~~~~ 421 (704)
...+++++.+||.+||..||.+|| ++.++++||||+...|
T Consensus 225 ---------------p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~ 269 (337)
T 1o6l_A 225 ---------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp ---------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred ---------------CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCH
Confidence 135789999999999999999999 9999999999987554
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=431.05 Aligned_cols=287 Identities=30% Similarity=0.530 Sum_probs=225.1
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC----CC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL----SC 204 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----~~ 204 (704)
.++|++++.||+|+||+||+|++..+++.||||++............+.+|+.+|+.++||||+++++++.... ..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 45899999999999999999999999999999999876555666777889999999999999999999997642 23
Q ss_pred eEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
.+|||||||++++...+. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 104 ~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 180 (371)
T 2xrw_A 104 DVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180 (371)
T ss_dssp EEEEEEECCSEEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-------
T ss_pred ceEEEEEcCCCCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccc
Confidence 789999999998776664 35899999999999999999999999999999999999999999999999999866432
Q ss_pred CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
......++|+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+++.++++.++.++.++|.......
T Consensus 181 --~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 257 (371)
T 2xrw_A 181 --FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257 (371)
T ss_dssp -----------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred --cccCCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 23345688999999999986 568999999999999999999999999999999999999999998887765432100
Q ss_pred cccCCCCCCCC-chhhhhc------------cCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCC
Q 005289 365 ATLFKPQQPYD-SSLRETF------------KDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (704)
Q Consensus 365 ~~~~~~~~~~~-~~l~~~~------------~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~ 421 (704)
.........+. ..+...+ ...+.++++||.+||.+||.+|||+.++|+||||+....
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 327 (371)
T 2xrw_A 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD 327 (371)
T ss_dssp HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred HHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcC
Confidence 00000000000 0011111 122678999999999999999999999999999986544
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=425.46 Aligned_cols=259 Identities=30% Similarity=0.458 Sum_probs=227.1
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
++|++++.||+|+||+||+|.+..+++.||||++..........+.+.+|+.+|+.|+||||+++++++.+ ...+|||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~lv 106 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHYLV 106 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEEEE
Confidence 46999999999999999999999999999999998877766777888999999999999999999999987 5789999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCC---ceEEeccccccccCCCCC
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHR 286 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g---~iKL~DFGla~~~~~~~~ 286 (704)
||||.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++......
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~-- 184 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-- 184 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC--
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC--
Confidence 99999866655555556799999999999999999999999999999999999998654 5999999999876543
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcc
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~ 366 (704)
......++|+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+..+.+..|......++..
T Consensus 185 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~----------- 252 (362)
T 2bdw_A 185 EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP----------- 252 (362)
T ss_dssp CSCCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT-----------
T ss_pred cccccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcc-----------
Confidence 23455689999999999876 568999999999999999999999999999888888887643333222
Q ss_pred cCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
.+..+++++++||.+||..||.+|||+.++|+||||+.
T Consensus 253 --------------~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 253 --------------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp --------------GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred --------------cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 23568999999999999999999999999999999975
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=430.29 Aligned_cols=261 Identities=26% Similarity=0.423 Sum_probs=220.4
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCCe
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCS 205 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~ 205 (704)
..++|++++.||+|+||+||+|+++.+++.||||++.+... .....+.+.+|+.+|..+ +||||++++++|.+ ...
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~ 98 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT--PDR 98 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe--CCE
Confidence 35689999999999999999999999999999999976432 123456677899999998 79999999999987 578
Q ss_pred EEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
+|||||||.++.+..+......+++..++.|+.||+.||.|||++||+||||||+||||+.++++||+|||+++......
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~ 178 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG 178 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence 99999999987776665555679999999999999999999999999999999999999999999999999998643322
Q ss_pred CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
......+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+++.+|......+|
T Consensus 179 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p------------ 244 (353)
T 3txo_A 179 -VTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP------------ 244 (353)
T ss_dssp --------CCGGGCCHHHHHH-HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC------------
T ss_pred -ccccccCCCcCeEChhhcCC-CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC------------
Confidence 23456789999999999876 5689999999999999999999999999999999988876321111
Q ss_pred ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCH------HHHHhccccCCCCC
Q 005289 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA------SAALASEYFSTKPY 421 (704)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa------~e~L~hpwf~~~~~ 421 (704)
..++.++.+||.+||..||.+||++ .++|+||||+...|
T Consensus 245 -----------------~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w 289 (353)
T 3txo_A 245 -----------------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDW 289 (353)
T ss_dssp -----------------TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCH
T ss_pred -----------------CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCH
Confidence 2478899999999999999999999 99999999997655
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=431.24 Aligned_cols=282 Identities=36% Similarity=0.593 Sum_probs=231.2
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeec----CCCe
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR----LSCS 205 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~----~~~~ 205 (704)
.+|++++.||+|+||+||+|++..+++.||||++..+.. ...+|+++|+.|+|||||+++++|... ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 469999999999999999999999999999999975431 234699999999999999999988542 1235
Q ss_pred EEEEEeccccccccccc---CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccC-CceEEecccccccc
Q 005289 206 IYLVFEYMEHDITGLLS---CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFS 281 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~---~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~-g~iKL~DFGla~~~ 281 (704)
++|||||+++++...+. .....+++..++.|+.||+.||.|||++||+||||||+||||+.+ +.+||+|||+++..
T Consensus 128 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 128 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 78999999987655443 345679999999999999999999999999999999999999965 67899999999876
Q ss_pred CCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccC
Q 005289 282 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (704)
Q Consensus 282 ~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~ 361 (704)
.... .....++|++|+|||++.+...|+.++||||||||||||++|++||.+.+..+++.+|++.+|.+..+.|....
T Consensus 208 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~ 285 (420)
T 1j1b_A 208 VRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 285 (420)
T ss_dssp CTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHC
T ss_pred ccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 5432 23456889999999999876679999999999999999999999999999999999999999999988776543
Q ss_pred CCCcccCCCCCCCCchhhhhc-cCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCC
Q 005289 362 LPHATLFKPQQPYDSSLRETF-KDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (704)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~-~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~ 420 (704)
-....+..+.. ....+...+ ..++.++++||.+||.+||.+|||+.|+|+||||+...
T Consensus 286 ~~~~~~~~p~~-~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 286 PNYTEFKFPQI-KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp SCCCCCCCCCC-CCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hhhhhhccCcc-CCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 21111111111 111222222 46799999999999999999999999999999998643
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=425.75 Aligned_cols=281 Identities=34% Similarity=0.587 Sum_probs=231.7
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeec-------
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR------- 201 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~------- 201 (704)
.++|++++.||+|+||+||+|++..+++.||||++..+... ..+|+.+|+.|+|||||+++++|...
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 46899999999999999999999999999999999754321 23699999999999999999998542
Q ss_pred -----------------------------CCCeEEEEEecccccccccc---cCCCccccHHHHHHHHHHhhhhHHHHHh
Q 005289 202 -----------------------------LSCSIYLVFEYMEHDITGLL---SCPDIKFSEAQIKCYMNQLLHGLEHCHS 249 (704)
Q Consensus 202 -----------------------------~~~~~~LV~Ey~~g~ll~~~---~~~~~~l~e~~~~~i~~QIl~aL~yLH~ 249 (704)
...++|||||||++++...+ ......+++..++.|+.||+.||.|||+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 159 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS 159 (383)
T ss_dssp ------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 23458999999998754443 3455679999999999999999999999
Q ss_pred cCcccccCCCccEEEc-cCCceEEeccccccccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh
Q 005289 250 RGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI 328 (704)
Q Consensus 250 ~gIvHrDLKp~NILl~-~~g~iKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt 328 (704)
+||+||||||+||||+ .++.+||+|||+++...... .....++|+.|+|||++.+...|+.++|||||||++|+|++
T Consensus 160 ~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 160 LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence 9999999999999998 68899999999998765432 33556789999999999876779999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhc-cCCCHHHHHHHHHhhccCCCCCcCH
Q 005289 329 GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF-KDLPTTAVNLIETLLSVEPYKRATA 407 (704)
Q Consensus 329 G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~-~~~s~~~~dLI~~mL~~dP~kRpTa 407 (704)
|++||.+.+..+++..|+..+|.++.+.|............+... ...+...+ ..++.++.+||.+||.+||.+|||+
T Consensus 238 g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 316 (383)
T 3eb0_A 238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLK-AKDWRKILPEGTPSLAIDLLEQILRYEPDLRINP 316 (383)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCC-CCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccC-cccHHhhCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence 999999999999999999999999988776543221111111111 11223323 4589999999999999999999999
Q ss_pred HHHHhccccCC
Q 005289 408 SAALASEYFST 418 (704)
Q Consensus 408 ~e~L~hpwf~~ 418 (704)
.|+|+||||+.
T Consensus 317 ~e~l~hp~f~~ 327 (383)
T 3eb0_A 317 YEAMAHPFFDH 327 (383)
T ss_dssp HHHHTSGGGHH
T ss_pred HHHhcCHHHHH
Confidence 99999999974
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=421.86 Aligned_cols=287 Identities=34% Similarity=0.551 Sum_probs=239.6
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC---CCeE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL---SCSI 206 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~---~~~~ 206 (704)
++|++++.||+|+||+||+|++..+++.||||++.... .......+.+|+.+|++++||||+++++++.... ...+
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 58999999999999999999999999999999997533 3445577889999999999999999999986532 2468
Q ss_pred EEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC
Q 005289 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~ 286 (704)
||||||+++++...+.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 106 ~iv~e~~~~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 183 (364)
T 3qyz_A 106 YIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183 (364)
T ss_dssp EEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEEEcccCcCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCC
Confidence 99999999877666543 3589999999999999999999999999999999999999999999999999986653221
Q ss_pred --CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC
Q 005289 287 --QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 287 --~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
......++|+.|+|||++.+...++.++|||||||+||+|++|++||.+.+..+.+..|...++.++.+.|.......
T Consensus 184 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 263 (364)
T 3qyz_A 184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 263 (364)
T ss_dssp BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence 123456889999999998776779999999999999999999999999999999999999999999987765432111
Q ss_pred ccc--CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 365 ATL--FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 365 ~~~--~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
... ..........+...+..++.++.+||.+||.+||.+|||+.++|+||||+..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 264 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 000 0001111223455667899999999999999999999999999999999975
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=436.24 Aligned_cols=260 Identities=30% Similarity=0.451 Sum_probs=225.9
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
++|++++.||+|+||+||+|.+..+|+.||+|++............+.+|+.+|+.|+|||||++++++.+ ...+|||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~lv 88 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE--EGHHYLI 88 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC--SSEEEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE--CCEEEEE
Confidence 47999999999999999999999999999999998776666667778899999999999999999999987 5789999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEc---cCCceEEeccccccccCCCCC
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN---NEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~---~~g~iKL~DFGla~~~~~~~~ 286 (704)
||||.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||++.......
T Consensus 89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~- 167 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ- 167 (444)
T ss_dssp ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC-
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC-
Confidence 99999866655444456799999999999999999999999999999999999998 45789999999998765432
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcc
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~ 366 (704)
......+||+.|+|||++.+ ..|+.++||||||||||+|++|.+||.+.+..+.+..+......++..
T Consensus 168 ~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~----------- 235 (444)
T 3soa_A 168 QAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSP----------- 235 (444)
T ss_dssp CBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTT-----------
T ss_pred ceeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcc-----------
Confidence 33455789999999999876 578999999999999999999999999999999988887744333322
Q ss_pred cCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
.+..+++++++||.+||..||.+|||+.|+|+||||+.
T Consensus 236 --------------~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 236 --------------EWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp --------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred --------------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 23578999999999999999999999999999999974
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=416.57 Aligned_cols=259 Identities=24% Similarity=0.356 Sum_probs=225.2
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|++++.||+|+||+||+|++..+++.||+|++... ......+.+|+.+|+.++||||+++++++.+ ...+||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~l 78 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFES--MEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEE--TTEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEec--CCEEEE
Confidence 35899999999999999999999999999999999743 3445668899999999999999999999987 578999
Q ss_pred EEecccccccc-cccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEcc--CCceEEeccccccccCCCC
Q 005289 209 VFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN--EGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 209 V~Ey~~g~ll~-~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~--~g~iKL~DFGla~~~~~~~ 285 (704)
|||||+++.+. .+......+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++......
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~- 157 (321)
T 1tki_A 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-
Confidence 99999985544 44444457999999999999999999999999999999999999987 789999999999876543
Q ss_pred CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
......++|+.|+|||++.+ ..++.++|||||||+||+|++|.+||.+.+..+.+..+......++
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~------------ 223 (321)
T 1tki_A 158 -DNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD------------ 223 (321)
T ss_dssp -CEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC------------
T ss_pred -CccccccCChhhcCcHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCC------------
Confidence 23455678999999999876 4589999999999999999999999999999998888877443333
Q ss_pred ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCC
Q 005289 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (704)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~ 420 (704)
...+..++.++.+||.+||..||.+|||+.|+|+||||++..
T Consensus 224 -------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 224 -------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp -------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred -------------hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence 233467899999999999999999999999999999998643
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=413.51 Aligned_cols=260 Identities=26% Similarity=0.392 Sum_probs=226.0
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCCh----HHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCe
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP----ESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (704)
+.|++.+.||+|+||+||+|++..+++.||||++....... ...+.+.+|+.+|+.|+||||+++++++.+ ...
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 88 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN--KTD 88 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCE
Confidence 46999999999999999999999999999999998654321 135678899999999999999999999987 578
Q ss_pred EEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCC----ceEEecccccccc
Q 005289 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG----VLKLADFGLANFS 281 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g----~iKL~DFGla~~~ 281 (704)
+|||||||+++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++...
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 999999999876666666667899999999999999999999999999999999999999887 7999999999876
Q ss_pred CCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccC
Q 005289 282 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (704)
Q Consensus 282 ~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~ 361 (704)
... ......++|+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+.+..+......++.
T Consensus 169 ~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~------- 238 (326)
T 2y0a_A 169 DFG--NEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED------- 238 (326)
T ss_dssp CTT--SCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCH-------
T ss_pred CCC--CccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCc-------
Confidence 543 23345678999999999875 56899999999999999999999999999988888888764333322
Q ss_pred CCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
..+..++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 239 ------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 239 ------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp ------------------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred ------------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 2345789999999999999999999999999999999853
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=407.41 Aligned_cols=260 Identities=26% Similarity=0.407 Sum_probs=215.7
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCCh------------------------HHHHHHHHHHHHHH
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP------------------------ESVRFMAREILILR 184 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~------------------------~~~~~~~~Ei~iL~ 184 (704)
.++|++.+.||+|+||+||+|++..+++.||||++....... ...+.+.+|+.+|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468999999999999999999999999999999997654211 12355788999999
Q ss_pred hcCCCCceeEeEEEeecCCCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEE
Q 005289 185 RLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV 264 (704)
Q Consensus 185 ~L~HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl 264 (704)
.|+||||+++++++.+.....+||||||++++.+..+.. ...+++..++.++.||+.||.|||++||+||||||+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~ 170 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV 170 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence 999999999999998765678999999999877666543 3479999999999999999999999999999999999999
Q ss_pred ccCCceEEeccccccccCCCCCCCcccccccccccCcccccCCCC--CCCccchhhHHHHHHHHHhCCCCCCCCCHHHHH
Q 005289 265 NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD--YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQL 342 (704)
Q Consensus 265 ~~~g~iKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~--y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l 342 (704)
+.++.+||+|||++....... ......++|+.|+|||++.+... ++.++|||||||+||+|++|.+||.+.......
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 249 (298)
T 2zv2_A 171 GEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLH 249 (298)
T ss_dssp CTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHH
Confidence 999999999999998765432 22345678999999999876332 477899999999999999999999988877766
Q ss_pred HHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccC
Q 005289 343 HKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417 (704)
Q Consensus 343 ~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~ 417 (704)
..+......++ ....+++++.+||.+||..||.+|||+.++|+||||+
T Consensus 250 ~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 250 SKIKSQALEFP---------------------------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHCCCCCC---------------------------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHhcccCCCC---------------------------CccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 66654211110 1146889999999999999999999999999999996
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=415.68 Aligned_cols=287 Identities=31% Similarity=0.586 Sum_probs=237.3
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|++++.||+|+||+||+|++..+++.||||++..........+.+.+|+.+|+.++||||+++++++.+ ...+||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 101 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK--KKRWYL 101 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec--CCEEEE
Confidence 568999999999999999999999999999999998766666666778899999999999999999999987 578999
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
||||++++++..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ..
T Consensus 102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 180 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EV 180 (331)
T ss_dssp EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc-cc
Confidence 99999998888776556679999999999999999999999999999999999999999999999999997654332 23
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC--cc
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH--AT 366 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~--~~ 366 (704)
....++|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.+++..+....... ..
T Consensus 181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
T 4aaa_A 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG 260 (331)
T ss_dssp ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTT
T ss_pred cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccc
Confidence 3456789999999999876678999999999999999999999999999999999999988887755432211000 00
Q ss_pred cCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
...+.......+...++.+++.+.+||.+||..||.+|||+.|+|+||||+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 0111111223345566789999999999999999999999999999999985
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=414.86 Aligned_cols=258 Identities=23% Similarity=0.371 Sum_probs=223.6
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
..++|++++.||+|+||+||+|++..+|+.||||++.+.... ....+.+.+|+.+|+.++||||+++++++.+ ...+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~ 81 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD--AQQI 81 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--SSEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe--CCEE
Confidence 356899999999999999999999999999999999754211 1234567789999999999999999999987 5789
Q ss_pred EEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC
Q 005289 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~ 286 (704)
||||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-- 159 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 159 (318)
T ss_dssp EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc--
Confidence 999999998766665555567999999999999999999999999999999999999999999999999999865432
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcc
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~ 366 (704)
....+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+.+.+|......+
T Consensus 160 --~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-------------- 222 (318)
T 1fot_A 160 --TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF-------------- 222 (318)
T ss_dssp --BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCC--------------
T ss_pred --cccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--------------
Confidence 345689999999999876 568999999999999999999999999999888888886621111
Q ss_pred cCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCc-----CHHHHHhccccCCCCC
Q 005289 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 421 (704)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRp-----Ta~e~L~hpwf~~~~~ 421 (704)
...++.++.+||.+||..||.+|| +++++++||||+...|
T Consensus 223 ---------------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~ 267 (318)
T 1fot_A 223 ---------------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 267 (318)
T ss_dssp ---------------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred ---------------CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCH
Confidence 135789999999999999999999 9999999999997655
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=418.51 Aligned_cols=285 Identities=35% Similarity=0.587 Sum_probs=236.4
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCC----e
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSC----S 205 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~----~ 205 (704)
++|.+.+.||+|+||+||+|++..+|+.||||++............+.+|+.+|+.++||||+++++++...... .
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 579999999999999999999999999999999987665566677788999999999999999999999764221 3
Q ss_pred EEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
+||||||+.+++...+. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 122 ~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~- 197 (371)
T 4exu_A 122 FYLVMPFMQTDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE- 197 (371)
T ss_dssp CEEEEECCCEEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-------
T ss_pred EEEEEccccccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC-
Confidence 49999999987665552 34899999999999999999999999999999999999999999999999999865432
Q ss_pred CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
....++|+.|+|||++.+...++.++|||||||+||+|++|++||.+.+..+.+..+....+.++.+++........
T Consensus 198 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 274 (371)
T 4exu_A 198 ---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA 274 (371)
T ss_dssp -----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHH
T ss_pred ---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhh
Confidence 34567899999999998767899999999999999999999999999999999999999999998887655332110
Q ss_pred cc--CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCC
Q 005289 366 TL--FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (704)
Q Consensus 366 ~~--~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~ 421 (704)
.. ..........+...+..+++.+.+||.+||.+||.+|||+.|+|+||||+....
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 332 (371)
T 4exu_A 275 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 332 (371)
T ss_dssp HHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCC
Confidence 00 000111122345566788999999999999999999999999999999986443
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-48 Score=415.87 Aligned_cols=262 Identities=25% Similarity=0.431 Sum_probs=220.0
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCC
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSC 204 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~ 204 (704)
+..++|++++.||+|+||+||+|+++.+++.||||++.+... .......+.+|+.+|.++ +||||++++++|.+ ..
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~ 83 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ES 83 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SS
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe--CC
Confidence 456789999999999999999999999999999999987654 345567788999999988 89999999999987 57
Q ss_pred eEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
.+||||||+.++.+..+......+++..++.|+.||+.||.|||++||+||||||+||||+.++++||+|||+++.....
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 89999999998766655555567999999999999999999999999999999999999999999999999999864322
Q ss_pred CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC---------CHHHHHHHHHHHcCCCCch
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR---------TEVEQLHKIFKLCGSPPDD 355 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~---------~~~e~l~~I~~~~g~~p~~ 355 (704)
. ......+||+.|+|||++.+ ..|+.++|||||||+||+|++|++||... ........|....-.
T Consensus 164 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~---- 237 (345)
T 3a8x_A 164 G-DTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR---- 237 (345)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC----
T ss_pred C-CcccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC----
Confidence 2 23456789999999999876 57899999999999999999999999752 223333344321000
Q ss_pred hhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCH------HHHHhccccCCCCC
Q 005289 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA------SAALASEYFSTKPY 421 (704)
Q Consensus 356 ~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa------~e~L~hpwf~~~~~ 421 (704)
....++.++.+||.+||..||.+||++ .++++||||+...|
T Consensus 238 -------------------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w 284 (345)
T 3a8x_A 238 -------------------------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 284 (345)
T ss_dssp -------------------------CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred -------------------------CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence 013578999999999999999999995 89999999987655
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=425.77 Aligned_cols=261 Identities=24% Similarity=0.423 Sum_probs=217.5
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCCe
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCS 205 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~ 205 (704)
..++|++++.||+|+||+||+|+++.+++.||||++.+.... ......+.+|+.+|.++ +|||||+++++|.+ ...
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~ 127 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESR 127 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE--CCE
Confidence 356899999999999999999999999999999999876443 33445577899999887 89999999999987 578
Q ss_pred EEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
+|||||||.++.+..+......+++..++.|+.||+.||.|||++||+||||||+||||+.++++||+|||+++......
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 207 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 207 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence 99999999997776665555679999999999999999999999999999999999999999999999999998633222
Q ss_pred CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC---------HHHHHHHHHHHcCCCCchh
Q 005289 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT---------EVEQLHKIFKLCGSPPDDY 356 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~---------~~e~l~~I~~~~g~~p~~~ 356 (704)
......+||+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.. .......|.... +
T Consensus 208 -~~~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--~---- 279 (396)
T 4dc2_A 208 -DTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--I---- 279 (396)
T ss_dssp -CCBCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC--C----
T ss_pred -CccccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc--c----
Confidence 33456789999999999986 678999999999999999999999996432 222333333311 0
Q ss_pred hhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCH------HHHHhccccCCCCC
Q 005289 357 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA------SAALASEYFSTKPY 421 (704)
Q Consensus 357 w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa------~e~L~hpwf~~~~~ 421 (704)
.....++.++++||.+||..||.+||++ .++++||||+...|
T Consensus 280 -----------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w 327 (396)
T 4dc2_A 280 -----------------------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 327 (396)
T ss_dssp -----------------------CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCH
T ss_pred -----------------------CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCH
Confidence 0113578999999999999999999995 89999999997665
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=422.96 Aligned_cols=258 Identities=27% Similarity=0.418 Sum_probs=202.5
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEE
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 207 (704)
..++|++++.||+|+||+||+|++..+++.||||++...... .+.+.+|+.+++.|+||||+++++++.. ...+|
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~ 92 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---DENVQREIINHRSLRHPNIVRFKEVILT--PTHLA 92 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS---CHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc---cHHHHHHHHHHHhCCCCCCCcEEEEEee--CCEEE
Confidence 357899999999999999999999999999999999765432 2456789999999999999999999987 57899
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCc--eEEeccccccccCCCC
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV--LKLADFGLANFSNTGH 285 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~--iKL~DFGla~~~~~~~ 285 (704)
||||||.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||+++.....
T Consensus 93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~- 171 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 171 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-
Confidence 99999988666655545567999999999999999999999999999999999999987765 999999999754322
Q ss_pred CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHcCCCCchhhhccC
Q 005289 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV----EQLHKIFKLCGSPPDDYWKKSK 361 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~----e~l~~I~~~~g~~p~~~w~~~~ 361 (704)
......++|+.|+|||++.+...++.++|||||||+||+|++|++||.+.... ..+..+.......+
T Consensus 172 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-------- 242 (361)
T 3uc3_A 172 -SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIP-------- 242 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCC--------
T ss_pred -CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCC--------
Confidence 22345678999999999987544445599999999999999999999875543 33333322111110
Q ss_pred CCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
....+++++.+||.+||..||.+|||+.++|+||||...
T Consensus 243 -------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 243 -------------------DDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp -------------------TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred -------------------CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 112578999999999999999999999999999999653
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=436.22 Aligned_cols=270 Identities=24% Similarity=0.335 Sum_probs=226.5
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCe
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (704)
+..++|+++++||+|+||+||+|++..+++.||||++.+.... ......+.+|+.+|..++||||++++++|.+ ...
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~--~~~ 148 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD--DNN 148 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC--SSE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--CCE
Confidence 4467899999999999999999999999999999999753211 1112336789999999999999999999987 578
Q ss_pred EEEEEeccccccccccc-CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 206 IYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~-~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
+|||||||.++.+..++ .....+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.....
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 228 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 228 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence 99999999886555444 43568999999999999999999999999999999999999999999999999999876554
Q ss_pred CCCCcccccccccccCccccc----CCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhcc
Q 005289 285 HRQPLTSRVVTLWYRPPELLL----GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~----~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~ 360 (704)
........+||+.|+|||++. +...|+.++|||||||+||||++|++||.+.+..+++.+|......++
T Consensus 229 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~------- 301 (437)
T 4aw2_A 229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ------- 301 (437)
T ss_dssp SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC-------
T ss_pred CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccccc-------
Confidence 433345568999999999986 235689999999999999999999999999999999988865321110
Q ss_pred CCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCC--CcCHHHHHhccccCCCCCC
Q 005289 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK--RATASAALASEYFSTKPYA 422 (704)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~k--RpTa~e~L~hpwf~~~~~~ 422 (704)
+ ...+..+++++++||++||..+|++ |++++++++||||+...|.
T Consensus 302 -~----------------p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~ 348 (437)
T 4aw2_A 302 -F----------------PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWD 348 (437)
T ss_dssp -C----------------CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTT
T ss_pred -C----------------CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHH
Confidence 0 0112468999999999999999988 9999999999999987775
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=420.86 Aligned_cols=263 Identities=27% Similarity=0.405 Sum_probs=223.6
Q ss_pred ccccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCC
Q 005289 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRL-DHPNIIKLEGLITSRLS 203 (704)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 203 (704)
.+..++|++++.||+|+||+||+|+++.+++.||||++.+... .......+.+|+.+|..+ +||||+++++++.+ .
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~--~ 90 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--K 90 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--S
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe--C
Confidence 3457799999999999999999999999999999999976421 112345577899999987 99999999999987 5
Q ss_pred CeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCC
Q 005289 204 CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~ 283 (704)
..+|||||||.++.+..+......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 91 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 91 ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 78999999999876666555556799999999999999999999999999999999999999999999999999986433
Q ss_pred CCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCC
Q 005289 284 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 284 ~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
.. ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+++.+|.......
T Consensus 171 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~----------- 237 (345)
T 1xjd_A 171 GD-AKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY----------- 237 (345)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-----------
T ss_pred CC-CcccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCC-----------
Confidence 22 23456789999999999876 568999999999999999999999999999988888876521110
Q ss_pred CcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHH-HHHhccccCCCCC
Q 005289 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS-AALASEYFSTKPY 421 (704)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~-e~L~hpwf~~~~~ 421 (704)
...++.++.+||.+||..||.+||++. ++++||||+...|
T Consensus 238 ------------------p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w 278 (345)
T 1xjd_A 238 ------------------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 278 (345)
T ss_dssp ------------------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred ------------------CcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCH
Confidence 124789999999999999999999998 9999999997655
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-48 Score=406.19 Aligned_cols=257 Identities=27% Similarity=0.461 Sum_probs=220.2
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|+++++||+|+||+||+|++..+++.||||++...... ..+.+.+|+.+|+.++||||+++++++.. ...+||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 94 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV--GDELWV 94 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--HHHHHHHHHHHHhcCCCCCCCeEeEEEEE--CCEEEE
Confidence 45799999999999999999999999999999999765432 24567889999999999999999999987 578999
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
|||||+++.+..+... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ..
T Consensus 95 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 172 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SK 172 (297)
T ss_dssp EEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CC
T ss_pred EEECCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc-cc
Confidence 9999988766655433 358999999999999999999999999999999999999999999999999998765433 23
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccC
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~ 368 (704)
....++|+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+....+..+..... +..
T Consensus 173 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-~~~-------------- 236 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PEL-------------- 236 (297)
T ss_dssp BCCCCSCGGGCCHHHHHC-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS-CCC--------------
T ss_pred cCCccCCcCccChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCC--------------
Confidence 445688999999999876 5689999999999999999999999999888877776654321 110
Q ss_pred CCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 369 ~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
.....++..+.+||.+||..||.+|||+.++|+||||+.
T Consensus 237 -----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~ 275 (297)
T 3fxz_A 237 -----------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKI 275 (297)
T ss_dssp -----------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred -----------CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcc
Confidence 012357899999999999999999999999999999985
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=405.84 Aligned_cols=252 Identities=27% Similarity=0.406 Sum_probs=209.2
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCCeEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
+|+++++||+|+||+||+|++..+++.||||++...............|+..+..+ .||||++++++|.+ ...+|||
T Consensus 58 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~--~~~~~lv 135 (311)
T 3p1a_A 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE--GGILYLQ 135 (311)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred heeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe--CCEEEEE
Confidence 69999999999999999999999999999999876655555555556677666665 99999999999987 5789999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCc
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~ 289 (704)
|||+.+++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... ...
T Consensus 136 ~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~--~~~ 213 (311)
T 3p1a_A 136 TELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA--GAG 213 (311)
T ss_dssp EECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-------
T ss_pred EeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC--CCC
Confidence 999988877776655667999999999999999999999999999999999999999999999999999876543 223
Q ss_pred ccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCC
Q 005289 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (704)
Q Consensus 290 ~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~ 369 (704)
....||+.|+|||++.+ .++.++|||||||+||+|++|..||.+.... ..+.. +..+
T Consensus 214 ~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~---~~~~~--~~~~---------------- 270 (311)
T 3p1a_A 214 EVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGW---QQLRQ--GYLP---------------- 270 (311)
T ss_dssp -CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH---HHHTT--TCCC----------------
T ss_pred cccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHhc--cCCC----------------
Confidence 45578999999999876 6899999999999999999998777654332 22211 1111
Q ss_pred CCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 370 ~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
......+++++.+||.+||..||++|||+.++|+||||++
T Consensus 271 ---------~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 271 ---------PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp ---------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred ---------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 1223578999999999999999999999999999999985
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=424.14 Aligned_cols=291 Identities=36% Similarity=0.667 Sum_probs=219.7
Q ss_pred CCeeEE-EEeeccCceEEEEEEEC--CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 130 DAFEKL-EKIGQGTYSSVFRARDL--DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 130 ~~y~~~-~~LG~G~fg~Vy~a~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
+.|++. ++||+|+||+||+|++. .+++.||||++...... ..+.+|+.+|+.|+|||||+++++|.......+
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 457774 57999999999999966 57899999999765433 346789999999999999999999977667889
Q ss_pred EEEEecccccccccccC--------CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEE----ccCCceEEec
Q 005289 207 YLVFEYMEHDITGLLSC--------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLAD 274 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~--------~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl----~~~g~iKL~D 274 (704)
||||||++++++..+.. ....+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|
T Consensus 96 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 96 WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp EEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred EEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 99999999987765532 22348999999999999999999999999999999999999 6778999999
Q ss_pred cccccccCCCCC--CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCH---------HHHHH
Q 005289 275 FGLANFSNTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE---------VEQLH 343 (704)
Q Consensus 275 FGla~~~~~~~~--~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~---------~e~l~ 343 (704)
||+++....... ......++|++|+|||++.+...|+.++||||||||||+|++|.+||.+... .+++.
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 999987653211 2334568899999999998766799999999999999999999999987665 48899
Q ss_pred HHHHHcCCCCchhhhccC-CCCccc----CC----CCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcc
Q 005289 344 KIFKLCGSPPDDYWKKSK-LPHATL----FK----PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 414 (704)
Q Consensus 344 ~I~~~~g~~p~~~w~~~~-~~~~~~----~~----~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hp 414 (704)
.|+..+|.++...|.... ++.... +. ........+.......+..+.+||.+||.+||.+|||+.|+|+||
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp 335 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 335 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 999999999988886542 111000 00 000000111122234578899999999999999999999999999
Q ss_pred ccCCCCCCCC
Q 005289 415 YFSTKPYACD 424 (704)
Q Consensus 415 wf~~~~~~~~ 424 (704)
||+..+++..
T Consensus 336 ~f~~~~~~~~ 345 (405)
T 3rgf_A 336 YFLEDPLPTS 345 (405)
T ss_dssp GGTSSSCCCS
T ss_pred hhccCCCCcc
Confidence 9998777643
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=430.96 Aligned_cols=268 Identities=27% Similarity=0.382 Sum_probs=224.9
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCe
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (704)
+..++|++++.||+|+||+||+|++..+++.||||++.+... .......+.+|+.+|+.++|||||+++++|.+ ...
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~ 143 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD--DRY 143 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCE
Confidence 456789999999999999999999999999999999975321 01112346789999999999999999999987 578
Q ss_pred EEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
+|||||||+++.+..+.. ...+++..++.|+.||+.||.|||++||+||||||+||||+.++++||+|||+++......
T Consensus 144 ~~lV~E~~~gg~L~~~l~-~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~ 222 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMS-NYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222 (410)
T ss_dssp EEEEECCCTTEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEEEeCCCCCcHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence 999999998866655543 2368999999999999999999999999999999999999999999999999998765443
Q ss_pred CCCcccccccccccCcccccCCC---CCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCC
Q 005289 286 RQPLTSRVVTLWYRPPELLLGAT---DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~---~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~ 362 (704)
.....+.+||+.|+|||++.+.. .|+.++|||||||+||+|++|++||.+.+..+++.+|......+. +
T Consensus 223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~--------~ 294 (410)
T 3v8s_A 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT--------F 294 (410)
T ss_dssp EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC--------C
T ss_pred cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccccc--------C
Confidence 33345678999999999987532 278999999999999999999999999999999888875321110 0
Q ss_pred CCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCC--CcCHHHHHhccccCCCCCC
Q 005289 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK--RATASAALASEYFSTKPYA 422 (704)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~k--RpTa~e~L~hpwf~~~~~~ 422 (704)
..+..++.++++||.+||..+|.+ |++++++++||||+...|.
T Consensus 295 -----------------p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~ 339 (410)
T 3v8s_A 295 -----------------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA 339 (410)
T ss_dssp -----------------CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCC
T ss_pred -----------------CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHH
Confidence 011368999999999999999998 9999999999999987664
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-48 Score=418.39 Aligned_cols=262 Identities=24% Similarity=0.363 Sum_probs=223.6
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCC
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSC 204 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~ 204 (704)
+..++|++++.||+|+||+||+|++..+++.||||++.+... .....+.+.+|+.+|..+ +||||+++++++.+ ..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~ 94 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MD 94 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC--SS
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc--CC
Confidence 446789999999999999999999999999999999976422 122345677899999988 89999999999987 57
Q ss_pred eEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
.+|||||||.++.+..+......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 89999999998766655555567999999999999999999999999999999999999999999999999999864322
Q ss_pred CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
. ......+||+.|+|||++.+ ..|+.++|||||||+||||++|++||.+.+..+++.+|....-.+
T Consensus 175 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~------------ 240 (353)
T 2i0e_A 175 G-VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY------------ 240 (353)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC------------
T ss_pred C-cccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCC------------
Confidence 2 23456789999999999876 568999999999999999999999999999988888887621111
Q ss_pred cccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCc-----CHHHHHhccccCCCCC
Q 005289 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 421 (704)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRp-----Ta~e~L~hpwf~~~~~ 421 (704)
...++.++.+||.+||..||.+|| ++.++++||||+...|
T Consensus 241 -----------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w 285 (353)
T 2i0e_A 241 -----------------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 285 (353)
T ss_dssp -----------------CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCH
T ss_pred -----------------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCH
Confidence 135789999999999999999999 4799999999987655
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-48 Score=420.50 Aligned_cols=301 Identities=24% Similarity=0.404 Sum_probs=237.6
Q ss_pred CCCcccccCCcccccchhhhhcccchhhhhhhhhhhcCccccccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeec
Q 005289 86 SESLSFRLGNLHKYIEGEQVAAGWPAWLSAVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRF 165 (704)
Q Consensus 86 ~~s~s~~~g~~~~~~~ge~~~~~~p~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~ 165 (704)
.....|..++++++..|+.+. ++|+++++||+|+||+||+|++..+++.||||++..
T Consensus 16 e~~~~~~~~~~~~~~~g~~~~-----------------------~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~ 72 (397)
T 1wak_A 16 EDPNDYCKGGYHLVKIGDLFN-----------------------GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS 72 (397)
T ss_dssp ------CC--CCSSCTTCEET-----------------------TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS
T ss_pred cccccCCCCCceEEehhhhcC-----------------------CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec
Confidence 345667778888888877654 379999999999999999999999999999999964
Q ss_pred CCCChHHHHHHHHHHHHHHhcC--------CCCceeEeEEEeec--CCCeEEEEEecccccccccccCC-CccccHHHHH
Q 005289 166 DNFEPESVRFMAREILILRRLD--------HPNIIKLEGLITSR--LSCSIYLVFEYMEHDITGLLSCP-DIKFSEAQIK 234 (704)
Q Consensus 166 ~~~~~~~~~~~~~Ei~iL~~L~--------HpnIv~l~~~~~~~--~~~~~~LV~Ey~~g~ll~~~~~~-~~~l~e~~~~ 234 (704)
. ....+.+.+|+.+|+.+. |+||++++++|... ....+||||||++++++..+... ...+++..++
T Consensus 73 ~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~ 149 (397)
T 1wak_A 73 A---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVK 149 (397)
T ss_dssp C---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHH
T ss_pred C---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHH
Confidence 3 445667889999999995 78899999998732 34689999999998888876543 3569999999
Q ss_pred HHHHHhhhhHHHHHhc-CcccccCCCccEEEccCC---------------------------------------------
Q 005289 235 CYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEG--------------------------------------------- 268 (704)
Q Consensus 235 ~i~~QIl~aL~yLH~~-gIvHrDLKp~NILl~~~g--------------------------------------------- 268 (704)
.|+.||+.||.|||++ ||+||||||+||||+.++
T Consensus 150 ~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (397)
T 1wak_A 150 KIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKN 229 (397)
T ss_dssp HHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGG
T ss_pred HHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCccccccccccccccc
Confidence 9999999999999998 999999999999998775
Q ss_pred ----ceEEeccccccccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC------H
Q 005289 269 ----VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT------E 338 (704)
Q Consensus 269 ----~iKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~------~ 338 (704)
.+||+|||++...... ....++|+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+ .
T Consensus 230 ~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 304 (397)
T 1wak_A 230 AEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIG-SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRD 304 (397)
T ss_dssp GGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHH
T ss_pred ccccceEecccccccccccc----CccCCCCCcccCChhhcC-CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCch
Confidence 7999999999876532 345678999999999987 568999999999999999999999998765 6
Q ss_pred HHHHHHHHHHcCCCCchhhhccCCCCcccCCC--------CCCCC--chhhhh---ccCCCHHHHHHHHHhhccCCCCCc
Q 005289 339 VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP--------QQPYD--SSLRET---FKDLPTTAVNLIETLLSVEPYKRA 405 (704)
Q Consensus 339 ~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~--------~~~~~--~~l~~~---~~~~s~~~~dLI~~mL~~dP~kRp 405 (704)
.+.+..+...+|.+|...|...+.....+... ..++. ..+... ...++..+.+||.+||.+||.+||
T Consensus 305 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 384 (397)
T 1wak_A 305 EDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRA 384 (397)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSC
T ss_pred HHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcC
Confidence 78889999999999887765544322111110 00000 001111 123356789999999999999999
Q ss_pred CHHHHHhccccC
Q 005289 406 TASAALASEYFS 417 (704)
Q Consensus 406 Ta~e~L~hpwf~ 417 (704)
|+.|+|+||||+
T Consensus 385 t~~e~l~hp~~~ 396 (397)
T 1wak_A 385 TAAECLRHPWLN 396 (397)
T ss_dssp CHHHHHTSGGGG
T ss_pred CHHHHhhCcccc
Confidence 999999999997
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-48 Score=415.30 Aligned_cols=291 Identities=31% Similarity=0.497 Sum_probs=226.9
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC-----
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL----- 202 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----- 202 (704)
..++|++++.||+|+||+||+|++..+++.||||++..+... .....+|+..|..++||||++++++|....
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 357899999999999999999999999999999998654322 223456888889999999999999986532
Q ss_pred CCeEEEEEecccccccccc---cCCCccccHHHHHHHHHHhhhhHHHHH--hcCcccccCCCccEEEcc-CCceEEeccc
Q 005289 203 SCSIYLVFEYMEHDITGLL---SCPDIKFSEAQIKCYMNQLLHGLEHCH--SRGVLHRDIKGSNLLVNN-EGVLKLADFG 276 (704)
Q Consensus 203 ~~~~~LV~Ey~~g~ll~~~---~~~~~~l~e~~~~~i~~QIl~aL~yLH--~~gIvHrDLKp~NILl~~-~g~iKL~DFG 276 (704)
...+||||||++++++..+ ......+++..++.++.||+.||.||| ++||+||||||+||||+. ++.+||+|||
T Consensus 98 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg 177 (360)
T 3e3p_A 98 DIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG 177 (360)
T ss_dssp CEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCT
T ss_pred ceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCC
Confidence 2248999999999765543 245667899999999999999999999 999999999999999997 8999999999
Q ss_pred cccccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchh
Q 005289 277 LANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 356 (704)
Q Consensus 277 la~~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~ 356 (704)
++....... .....++|+.|+|||++.+...++.++|||||||+||+|++|++||.+.+..+.+..+...++.++.+.
T Consensus 178 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (360)
T 3e3p_A 178 SAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREV 255 (360)
T ss_dssp TCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred CceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHH
Confidence 998765432 334567899999999997766799999999999999999999999999999999999999999999888
Q ss_pred hhccCCCCcccC---CCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCCCC
Q 005289 357 WKKSKLPHATLF---KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 423 (704)
Q Consensus 357 w~~~~~~~~~~~---~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~~~ 423 (704)
|........... ....++...+.......+.++.+||.+||++||.+|||+.|+|+||||+....+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 325 (360)
T 3e3p_A 256 LRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPA 325 (360)
T ss_dssp HHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTT
T ss_pred HHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCcc
Confidence 776443221111 1111111122222234678999999999999999999999999999999765543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=424.52 Aligned_cols=281 Identities=28% Similarity=0.487 Sum_probs=230.5
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc------CCCCceeEeEEEeecC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL------DHPNIIKLEGLITSRL 202 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L------~HpnIv~l~~~~~~~~ 202 (704)
..+|++++.||+|+||+||+|++..+++.||||++... ......+.+|+.+|+.+ .|+||+++++++..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~-- 170 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF-- 170 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE--
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc--
Confidence 34799999999999999999999999999999999743 34456677899998888 57799999999987
Q ss_pred CCeEEEEEecccccccccccCCC-ccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCc--eEEecccccc
Q 005289 203 SCSIYLVFEYMEHDITGLLSCPD-IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV--LKLADFGLAN 279 (704)
Q Consensus 203 ~~~~~LV~Ey~~g~ll~~~~~~~-~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~--iKL~DFGla~ 279 (704)
...+||||||+.+++...+.... ..+++..++.|+.||+.||.|||++|||||||||+||||+.++. +||+|||+++
T Consensus 171 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 171 RNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp TTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred CCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 57899999999987777665433 45899999999999999999999999999999999999999987 9999999997
Q ss_pred ccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhc
Q 005289 280 FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359 (704)
Q Consensus 280 ~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~ 359 (704)
.... .....++|+.|+|||++.+ ..|+.++||||||||||+|++|.+||.+.+..+++..|++.++.++..+|..
T Consensus 251 ~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~ 325 (429)
T 3kvw_A 251 YEHQ----RVYTYIQSRFYRAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA 325 (429)
T ss_dssp ETTC----CCCSSCSCGGGCCHHHHHT-BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred ecCC----cccccCCCCCccChHHHhC-CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHh
Confidence 6543 2345688999999999987 5689999999999999999999999999999999999999999999887654
Q ss_pred cCCCCcccCCC-----------------------------CCCCCchhhhhc-cCCCHHHHHHHHHhhccCCCCCcCHHH
Q 005289 360 SKLPHATLFKP-----------------------------QQPYDSSLRETF-KDLPTTAVNLIETLLSVEPYKRATASA 409 (704)
Q Consensus 360 ~~~~~~~~~~~-----------------------------~~~~~~~l~~~~-~~~s~~~~dLI~~mL~~dP~kRpTa~e 409 (704)
.......+... ..+....+...+ ...++.+.+||.+||.+||++|||+.|
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e 405 (429)
T 3kvw_A 326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ 405 (429)
T ss_dssp BTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred hhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHH
Confidence 32211000000 000111111112 345888999999999999999999999
Q ss_pred HHhccccCCC
Q 005289 410 ALASEYFSTK 419 (704)
Q Consensus 410 ~L~hpwf~~~ 419 (704)
+|+||||+..
T Consensus 406 ~L~Hpw~~~~ 415 (429)
T 3kvw_A 406 ALRHPWLRRR 415 (429)
T ss_dssp HHTSTTTC--
T ss_pred HhCChhhccC
Confidence 9999999863
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-48 Score=417.07 Aligned_cols=260 Identities=23% Similarity=0.378 Sum_probs=225.0
Q ss_pred ccccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCC
Q 005289 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (704)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 204 (704)
....++|++++.||+|+||+||+|++..+++.||||++.+... .....+.+.+|+.+|+.++||||+++++++.+ ..
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~ 114 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--NS 114 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SS
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc--CC
Confidence 3456789999999999999999999999999999999975432 11234567889999999999999999999987 57
Q ss_pred eEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
.+||||||++++.+..+......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC
Confidence 89999999988666655545557999999999999999999999999999999999999999999999999999876532
Q ss_pred CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
....+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+.+.+|......+
T Consensus 195 ----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~------------ 257 (350)
T 1rdq_E 195 ----TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF------------ 257 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC------------
T ss_pred ----cccccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCC------------
Confidence 245688999999999876 568999999999999999999999999999988888886621111
Q ss_pred cccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcC-----HHHHHhccccCCCCC
Q 005289 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPY 421 (704)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpT-----a~e~L~hpwf~~~~~ 421 (704)
...++.++.+||.+||..||.+||+ +.++++||||+...|
T Consensus 258 -----------------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w 302 (350)
T 1rdq_E 258 -----------------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp -----------------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred -----------------CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence 1357899999999999999999999 999999999987655
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=409.33 Aligned_cols=261 Identities=27% Similarity=0.384 Sum_probs=215.4
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|++++.||+|+||+||+|++..+++.||||++...... ...+.+.+|+.+|+.++||||+++++++.+ ...+||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~l 82 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYL 82 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCeEEEEEec--CCeEEE
Confidence 46899999999999999999999999999999999754322 233567889999999999999999999987 578999
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC-CC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-RQ 287 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~-~~ 287 (704)
|||||+++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ..
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 99999987777666667789999999999999999999999999999999999999999999999999997654222 12
Q ss_pred CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCccc
Q 005289 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (704)
Q Consensus 288 ~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~ 367 (704)
.....+||+.|+|||++.+...++.++|||||||+||+|++|++||.+.................
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------------- 227 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--------------- 227 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT---------------
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc---------------
Confidence 33456889999999999875556789999999999999999999998765532222221110000
Q ss_pred CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
...+..++..+.+||.+||..||.+|||+.|+|+||||+.
T Consensus 228 -----------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~ 267 (323)
T 3tki_A 228 -----------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267 (323)
T ss_dssp -----------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred -----------CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcc
Confidence 1123568899999999999999999999999999999985
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=419.62 Aligned_cols=262 Identities=24% Similarity=0.394 Sum_probs=221.5
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCe
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (704)
+..++|++++.||+|+||+||+|++..+++.||||++..... .......+.+|+.+|+.++|||||+++++|.+ ...
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~ 89 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD--EED 89 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCE
Confidence 446789999999999999999999999999999999975431 12335667899999999999999999999987 578
Q ss_pred EEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
+|||||||.++.+..+......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 168 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE- 168 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC-
Confidence 9999999998777766666678999999999999999999999999999999999999999999999999999876543
Q ss_pred CCCcccccccccccCcccccC--CCCCCCccchhhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHcCCCCchhhhcc
Q 005289 286 RQPLTSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQGRT---EVEQLHKIFKLCGSPPDDYWKKS 360 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~--~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~---~~e~l~~I~~~~g~~p~~~w~~~ 360 (704)
......+||+.|+|||++.. ...|+.++|||||||+||+|++|.+||.... ..+.+..+......
T Consensus 169 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--------- 238 (384)
T 4fr4_A 169 -TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVT--------- 238 (384)
T ss_dssp -CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCC---------
T ss_pred -CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccC---------
Confidence 33466789999999999864 2458999999999999999999999998543 33344443321111
Q ss_pred CCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcC-HHHHHhccccCCCCC
Q 005289 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-ASAALASEYFSTKPY 421 (704)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpT-a~e~L~hpwf~~~~~ 421 (704)
....++..+.+||.+||..||.+||+ ++++++||||+...|
T Consensus 239 --------------------~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w 280 (384)
T 4fr4_A 239 --------------------YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINW 280 (384)
T ss_dssp --------------------CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred --------------------CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence 11357899999999999999999999 999999999987655
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=428.81 Aligned_cols=271 Identities=25% Similarity=0.347 Sum_probs=224.7
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCe
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (704)
+..++|++++.||+|+||+||+|+++.+++.||||++.+... .......+.+|+.+|..++||||++++++|.+ ...
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~--~~~ 135 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD--ENY 135 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC--SSE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee--CCE
Confidence 456789999999999999999999999999999999975321 12223447789999999999999999999987 578
Q ss_pred EEEEEecccccccccccC-CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 206 IYLVFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~-~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
+|||||||.++.+..+.. ....+++..++.|+.||+.||.|||++|||||||||+||||+.++++||+|||+++.....
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~ 215 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence 999999998765554443 3347999999999999999999999999999999999999999999999999999876544
Q ss_pred CCCCcccccccccccCcccccC------CCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhh
Q 005289 285 HRQPLTSRVVTLWYRPPELLLG------ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 358 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~------~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~ 358 (704)
........+||+.|+|||++.. ...|+.++|||||||+||||++|++||.+.+..+++.+|.......
T Consensus 216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~------ 289 (412)
T 2vd5_A 216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL------ 289 (412)
T ss_dssp SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC------
T ss_pred CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCc------
Confidence 3323345689999999999862 3468999999999999999999999999999998888886521100
Q ss_pred ccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCC---cCHHHHHhccccCCCCCCCC
Q 005289 359 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR---ATASAALASEYFSTKPYACD 424 (704)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kR---pTa~e~L~hpwf~~~~~~~~ 424 (704)
.+ ......++.++++||++||. +|.+| ++++++++||||+...|..-
T Consensus 290 --~~----------------p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l 339 (412)
T 2vd5_A 290 --SL----------------PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGL 339 (412)
T ss_dssp --CC----------------C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred --CC----------------CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence 00 00114689999999999999 99998 59999999999998877644
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=411.37 Aligned_cols=279 Identities=25% Similarity=0.394 Sum_probs=226.7
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-----CCCceeEeEEEeecCC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-----HPNIIKLEGLITSRLS 203 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-----HpnIv~l~~~~~~~~~ 203 (704)
.++|+++++||+|+||+||+|++..+++.||||++... ......+..|+.+|+.+. ||||+++++++.. .
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~--~ 108 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY--Y 108 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE--T
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE--C
Confidence 45899999999999999999999999999999999642 344566778999999996 9999999999987 5
Q ss_pred CeEEEEEecccccccccccCC-CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEcc----------------
Q 005289 204 CSIYLVFEYMEHDITGLLSCP-DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---------------- 266 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~~~~~-~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~---------------- 266 (704)
..+||||||+.+++...+... ...+++..++.++.||+.||.|||++||+||||||+||||+.
T Consensus 109 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~ 188 (360)
T 3llt_A 109 DHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDG 188 (360)
T ss_dssp TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTC
T ss_pred CeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccc
Confidence 789999999966666655432 235999999999999999999999999999999999999975
Q ss_pred ---------CCceEEeccccccccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 005289 267 ---------EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT 337 (704)
Q Consensus 267 ---------~g~iKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~ 337 (704)
++.+||+|||++...... ....++|+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+
T Consensus 189 ~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 189 KKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp CEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcC-CCCCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence 788999999999865432 245678999999999986 569999999999999999999999999999
Q ss_pred HHHHHHHHHHHcCCCCchhhhccCCCCcccC---------CCCCCC-Cchh-------hhhccCCCHHHHHHHHHhhccC
Q 005289 338 EVEQLHKIFKLCGSPPDDYWKKSKLPHATLF---------KPQQPY-DSSL-------RETFKDLPTTAVNLIETLLSVE 400 (704)
Q Consensus 338 ~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~---------~~~~~~-~~~l-------~~~~~~~s~~~~dLI~~mL~~d 400 (704)
..+.+..+....+.+|...+..........+ .+.... ...+ .......++.+.+||.+||++|
T Consensus 264 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 343 (360)
T 3llt_A 264 HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQID 343 (360)
T ss_dssp HHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCC
Confidence 9999999999999988776544322111000 000000 0000 0011234578899999999999
Q ss_pred CCCCcCHHHHHhccccC
Q 005289 401 PYKRATASAALASEYFS 417 (704)
Q Consensus 401 P~kRpTa~e~L~hpwf~ 417 (704)
|++|||+.|+|+||||+
T Consensus 344 P~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 344 PTLRPSPAELLKHKFLE 360 (360)
T ss_dssp GGGSCCHHHHTTSGGGC
T ss_pred hhhCCCHHHHhcCcccC
Confidence 99999999999999996
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-47 Score=407.40 Aligned_cols=285 Identities=35% Similarity=0.591 Sum_probs=234.1
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC----Ce
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS----CS 205 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~----~~ 205 (704)
++|.+.+.||+|+||+||+|++..+|+.||||++............+.+|+.+|+.++||||+++++++..... ..
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 57999999999999999999999999999999998765556666778899999999999999999999976422 24
Q ss_pred EEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
+||||||+.+++...+. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 104 ~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~- 179 (353)
T 3coi_A 104 FYLVMPFMQTDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE- 179 (353)
T ss_dssp CEEEEECCSEEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-----
T ss_pred EEEEeccccCCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC-
Confidence 69999999986655543 35899999999999999999999999999999999999999999999999999765432
Q ss_pred CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
....++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+++..+.+.+|.++.+++........
T Consensus 180 ---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 256 (353)
T 3coi_A 180 ---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA 256 (353)
T ss_dssp -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHH
T ss_pred ---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHH
Confidence 34567899999999988767799999999999999999999999999999999999999999998877655332100
Q ss_pred cc--CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCC
Q 005289 366 TL--FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (704)
Q Consensus 366 ~~--~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~ 421 (704)
.. ..........+...+..++.++.+||.+||..||.+|||+.++|+||||+....
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~ 314 (353)
T 3coi_A 257 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 314 (353)
T ss_dssp HHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred HHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccC
Confidence 00 000000111223445678999999999999999999999999999999986443
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-48 Score=416.05 Aligned_cols=260 Identities=29% Similarity=0.441 Sum_probs=215.6
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC---ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF---EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~---~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
+.|++++.||+|+||+||+|++..+++.||||++..... .....+.+.+|+.+|+.|+||||+++++++.+ ...+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~ 101 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS--DGML 101 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCEE
Confidence 469999999999999999999999999999999965321 11135668899999999999999999999987 5789
Q ss_pred EEEEecccccccc-cccC---CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCc---eEEecccccc
Q 005289 207 YLVFEYMEHDITG-LLSC---PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV---LKLADFGLAN 279 (704)
Q Consensus 207 ~LV~Ey~~g~ll~-~~~~---~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~---iKL~DFGla~ 279 (704)
|||||||+++.+. .+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++.
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 9999999975554 3321 2335899999999999999999999999999999999999987655 9999999998
Q ss_pred ccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhc
Q 005289 280 FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359 (704)
Q Consensus 280 ~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~ 359 (704)
...... ......++|+.|+|||++.+ ..|+.++||||||||||+|++|.+||.+.. .+.+..+......++
T Consensus 182 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~------ 252 (351)
T 3c0i_A 182 QLGESG-LVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMN------ 252 (351)
T ss_dssp ECCTTS-CBCCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCC------
T ss_pred EecCCC-eeecCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCC------
Confidence 765432 22345689999999999876 568999999999999999999999998753 455555554222221
Q ss_pred cCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
...+..++.++++||.+||..||.+|||+.++|+||||+..
T Consensus 253 -------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 253 -------------------PRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp -------------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred -------------------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 12345789999999999999999999999999999999863
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=395.18 Aligned_cols=262 Identities=30% Similarity=0.455 Sum_probs=226.8
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|++++.||+|+||+||+|.+..+++.||+|++............+.+|+.+|++++||||+++++++.. ....|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 82 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHYL 82 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc--CCEEEE
Confidence 468999999999999999999999999999999998877677777888899999999999999999999977 578899
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCc---eEEeccccccccCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV---LKLADFGLANFSNTGH 285 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~---iKL~DFGla~~~~~~~ 285 (704)
||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++......
T Consensus 83 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~- 161 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS- 161 (284)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS-
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC-
Confidence 9999998665544444557999999999999999999999999999999999999987665 999999999766543
Q ss_pred CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+.......+.
T Consensus 162 -~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----------- 228 (284)
T 3kk8_A 162 -EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS----------- 228 (284)
T ss_dssp -CBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT-----------
T ss_pred -ccccCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCc-----------
Confidence 23345678999999999876 56899999999999999999999999999988888887664333221
Q ss_pred ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCC
Q 005289 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (704)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~ 420 (704)
..+..+++++.+||.+||..||.+|||+.++|+||||+...
T Consensus 229 --------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 229 --------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp --------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred --------------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 12346889999999999999999999999999999998643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=407.70 Aligned_cols=262 Identities=28% Similarity=0.452 Sum_probs=213.1
Q ss_pred cccCCeeEEEEeeccCceEEEEEEEC---CCCcEEEEEEeecCCCC--hHHHHHHHHHHHHHHhcCCCCceeEeEEEeec
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDL---DTGKIVALKKVRFDNFE--PESVRFMAREILILRRLDHPNIIKLEGLITSR 201 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAvK~i~~~~~~--~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 201 (704)
+..++|++++.||+|+||+||+|++. .+++.||||++...... ......+.+|+.+|+.++||||+++++++..
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 92 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT- 92 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC-
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc-
Confidence 34568999999999999999999985 68999999999765432 2334557789999999999999999999987
Q ss_pred CCCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEecccccccc
Q 005289 202 LSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (704)
Q Consensus 202 ~~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~ 281 (704)
...+|||||||.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...
T Consensus 93 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 93 -GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp -SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred -CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 5789999999998666655555557899999999999999999999999999999999999999999999999999754
Q ss_pred CCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccC
Q 005289 282 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (704)
Q Consensus 282 ~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~ 361 (704)
.... ......+||+.|+|||++.+ ..++.++|||||||+||+|++|.+||.+.+..+.+.+|.......
T Consensus 172 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~--------- 240 (327)
T 3a62_A 172 IHDG-TVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL--------- 240 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC---------
T ss_pred ccCC-ccccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC---------
Confidence 3322 22345678999999999876 568999999999999999999999999999888888886632111
Q ss_pred CCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCc-----CHHHHHhccccCCCCC
Q 005289 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 421 (704)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRp-----Ta~e~L~hpwf~~~~~ 421 (704)
...++.++.+||.+||..||.+|| ++.++|+||||+...|
T Consensus 241 --------------------p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~ 285 (327)
T 3a62_A 241 --------------------PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINW 285 (327)
T ss_dssp --------------------CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred --------------------CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCH
Confidence 135789999999999999999999 8999999999987544
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=408.79 Aligned_cols=289 Identities=28% Similarity=0.466 Sum_probs=231.2
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC---------hHHHHHHHHHHHHHHhcCCCCceeEeEEEe
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE---------PESVRFMAREILILRRLDHPNIIKLEGLIT 199 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~---------~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~ 199 (704)
.++|++++.||+|+||+||+|.+.. ++.||||++...... ....+.+.+|+.+|+.++||||+++++++.
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 4689999999999999999999865 999999998654321 233467889999999999999999999985
Q ss_pred e---cCCCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccc
Q 005289 200 S---RLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFG 276 (704)
Q Consensus 200 ~---~~~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFG 276 (704)
. .....+||||||++++++..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||
T Consensus 100 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 179 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN 179 (362)
T ss_dssp ECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTT
T ss_pred eccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecC
Confidence 4 2245789999999998888887777789999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchh
Q 005289 277 LANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 356 (704)
Q Consensus 277 la~~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~ 356 (704)
++...... ......++|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.++...
T Consensus 180 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 257 (362)
T 3pg1_A 180 LAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED 257 (362)
T ss_dssp C-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHH
Confidence 99755433 2234567899999999988767799999999999999999999999999999999999999999988665
Q ss_pred hhccCCCCcccC---CCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCC
Q 005289 357 WKKSKLPHATLF---KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (704)
Q Consensus 357 w~~~~~~~~~~~---~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~ 420 (704)
+.....+....+ .........+......+++.+.+||.+||.+||.+|||+.++|+||||+...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp HHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 433221110000 0001112234455678899999999999999999999999999999999753
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=413.86 Aligned_cols=260 Identities=27% Similarity=0.445 Sum_probs=222.6
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.+.|++++.||+|+||+||+|.+..+++.||+|++.... ......+.+|+.+|+.|+||||+++++++.+ ...+||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~l 125 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFED--KYEMVL 125 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC--SSEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe--CCEEEE
Confidence 467999999999999999999999999999999997543 3345568899999999999999999999987 578999
Q ss_pred EEecccccccc-cccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEcc--CCceEEeccccccccCCCC
Q 005289 209 VFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN--EGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 209 V~Ey~~g~ll~-~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~--~g~iKL~DFGla~~~~~~~ 285 (704)
|||||.++.+. .+......+++..++.++.||+.||.|||++||+||||||+||||+. .+.+||+|||++......
T Consensus 126 v~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~- 204 (387)
T 1kob_A 126 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 204 (387)
T ss_dssp EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred EEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC-
Confidence 99999886554 44444557999999999999999999999999999999999999974 467999999999876543
Q ss_pred CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
......++|+.|+|||++.+ ..++.++|||||||+||+|++|.+||.+.+..+.+..+......++
T Consensus 205 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~------------ 270 (387)
T 1kob_A 205 -EIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD------------ 270 (387)
T ss_dssp -SCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC------------
T ss_pred -cceeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC------------
Confidence 23345678999999999876 5689999999999999999999999999998888888765322211
Q ss_pred ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCC
Q 005289 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (704)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~ 420 (704)
...+..+++++.+||.+||..||.+|||+.++|+||||+...
T Consensus 271 -------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 271 -------------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp -------------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred -------------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 112357899999999999999999999999999999998643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=417.35 Aligned_cols=292 Identities=21% Similarity=0.315 Sum_probs=218.6
Q ss_pred ccCCeeEEEEeecc--CceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCe
Q 005289 128 RADAFEKLEKIGQG--TYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (704)
Q Consensus 128 ~~~~y~~~~~LG~G--~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (704)
..++|+++++||+| +||+||+|++..+++.||||++............+.+|+.+|+.++|||||+++++|.+ ...
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~ 100 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--DNE 100 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE--CCE
Confidence 35689999999999 99999999999999999999998876667777888899999999999999999999987 578
Q ss_pred EEEEEecccccccccccCC--CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCC
Q 005289 206 IYLVFEYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~~--~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~ 283 (704)
+|||||||+++.+..+... ...+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 9999999998666655432 35699999999999999999999999999999999999999999999999998864321
Q ss_pred CC------CCCcccccccccccCcccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC-----
Q 005289 284 GH------RQPLTSRVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS----- 351 (704)
Q Consensus 284 ~~------~~~~~~~~gT~~Y~APEvl~~~-~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~----- 351 (704)
.. .......++|+.|+|||++.+. ..|+.++||||||||||+|++|++||.+.+..+.+..+....-.
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 260 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence 11 1112334789999999998763 56899999999999999999999999987766555444321100
Q ss_pred ---CCchhhhccC-------CCCcccCCCCC--CCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 352 ---PPDDYWKKSK-------LPHATLFKPQQ--PYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 352 ---~p~~~w~~~~-------~~~~~~~~~~~--~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
+....+.... +.......... .........+..+++.+.+||.+||.+||.+|||+.|+|+||||+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~ 340 (389)
T 3gni_B 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 340 (389)
T ss_dssp ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence 0000000000 00000000000 00001122345689999999999999999999999999999999875
Q ss_pred CC
Q 005289 420 PY 421 (704)
Q Consensus 420 ~~ 421 (704)
.+
T Consensus 341 ~~ 342 (389)
T 3gni_B 341 KR 342 (389)
T ss_dssp --
T ss_pred hh
Confidence 44
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=416.72 Aligned_cols=261 Identities=24% Similarity=0.370 Sum_probs=216.3
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHH-HHhcCCCCceeEeEEEeecCCCe
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILI-LRRLDHPNIIKLEGLITSRLSCS 205 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~i-L~~L~HpnIv~l~~~~~~~~~~~ 205 (704)
..++|++++.||+|+||+||+|+++.+++.||||++.+.... ......+.+|..+ ++.++||||++++++|.+ ...
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~--~~~ 113 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADK 113 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC--SSE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe--CCE
Confidence 356899999999999999999999999999999999876532 2334556677776 567899999999999987 578
Q ss_pred EEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
+|||||||.++.+..+......+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++......
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~ 193 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 193 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence 99999999987666655555679999999999999999999999999999999999999999999999999998643322
Q ss_pred CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
......+||+.|+|||++.+ ..|+.++|||||||+||||++|.+||.+.+..+++.+|....-.
T Consensus 194 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~-------------- 257 (373)
T 2r5t_A 194 -STTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ-------------- 257 (373)
T ss_dssp -CCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCC--------------
T ss_pred -CccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccC--------------
Confidence 23456789999999999876 56899999999999999999999999999998888888652111
Q ss_pred ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCH----HHHHhccccCCCCC
Q 005289 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA----SAALASEYFSTKPY 421 (704)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa----~e~L~hpwf~~~~~ 421 (704)
....++.++.+||.+||..||.+||++ .++++||||+...|
T Consensus 258 ---------------~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w 302 (373)
T 2r5t_A 258 ---------------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINW 302 (373)
T ss_dssp ---------------CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCH
T ss_pred ---------------CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCH
Confidence 113678999999999999999999997 69999999997655
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=419.24 Aligned_cols=258 Identities=28% Similarity=0.457 Sum_probs=213.5
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
..++|.+++.||+|+||+||+|++..+++.||||++...... ......+.+|+.+|+.++||||+++++++.. ...+
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~ 84 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT--PTDI 84 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEE
Confidence 356899999999999999999999999999999999753211 1123467899999999999999999999987 5689
Q ss_pred EEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC
Q 005289 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~ 286 (704)
||||||++++++..+.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 85 ~lv~E~~~g~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~-- 161 (336)
T 3h4j_B 85 VMVIEYAGGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-- 161 (336)
T ss_dssp EEEECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS--
T ss_pred EEEEECCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC--
Confidence 99999998777766543 346999999999999999999999999999999999999999999999999999876543
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcc
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~ 366 (704)
......+||+.|+|||++.+...++.++|||||||+||+|++|.+||.+....+.+.++ .
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i---------------~----- 221 (336)
T 3h4j_B 162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV---------------N----- 221 (336)
T ss_dssp BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC---------------C-----
T ss_pred cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH---------------H-----
Confidence 23456689999999999987554578999999999999999999999764322111100 0
Q ss_pred cCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
.........+++++.+||.+||..||.+|||+.|+|+||||+..
T Consensus 222 ---------~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 222 ---------SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp ---------SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred ---------cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 00011124578999999999999999999999999999999863
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=413.87 Aligned_cols=255 Identities=28% Similarity=0.390 Sum_probs=214.3
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEEe
Q 005289 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFE 211 (704)
Q Consensus 132 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~E 211 (704)
|...+.||+|+||+||+|++..+|+.||||++.... ....+.+.+|+.+|++|+||||+++++++.+ ...+|||||
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~E 166 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFES--KNDIVLVME 166 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEEEE
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEEEEe
Confidence 344678999999999999999999999999998643 3445678899999999999999999999987 578999999
Q ss_pred ccccccc-ccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEE--ccCCceEEeccccccccCCCCCCC
Q 005289 212 YMEHDIT-GLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV--NNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 212 y~~g~ll-~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl--~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
||+++.+ ..+......+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++....... .
T Consensus 167 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~ 244 (373)
T 2x4f_A 167 YVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--K 244 (373)
T ss_dssp CCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--B
T ss_pred CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--c
Confidence 9987544 4454455679999999999999999999999999999999999999 556789999999998765432 3
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccC
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~ 368 (704)
....++|+.|+|||++.+ ..++.++|||||||+||+|++|.+||.+.+..+.+.+|......++
T Consensus 245 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~--------------- 308 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLE--------------- 308 (373)
T ss_dssp CCCCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSC---------------
T ss_pred cccccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC---------------
Confidence 345678999999999875 5689999999999999999999999999999999888876432222
Q ss_pred CCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 369 ~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
...+..+++++++||.+||.+||.+|||+.++|+||||+.
T Consensus 309 ----------~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 309 ----------DEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp ----------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred ----------hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 1234578999999999999999999999999999999985
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-48 Score=408.73 Aligned_cols=254 Identities=24% Similarity=0.282 Sum_probs=190.0
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC--CeEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS--CSIYL 208 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~--~~~~L 208 (704)
+|.+.++||+|+||+||+|++ +|+.||||++.... ........|+.++.+|+|||||++++++.+... ..+||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 599999999999999999987 68999999996532 222223456677778999999999999986532 36899
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhc--------CcccccCCCccEEEccCCceEEeccccccc
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR--------GVLHRDIKGSNLLVNNEGVLKLADFGLANF 280 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~--------gIvHrDLKp~NILl~~~g~iKL~DFGla~~ 280 (704)
|||||+++.|..++.. ..+++..+..++.||+.||.|||++ +||||||||+||||+.++++||+|||+|+.
T Consensus 79 V~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 9999998776655533 3689999999999999999999987 999999999999999999999999999987
Q ss_pred cCCCCCC---CcccccccccccCcccccCCC-----CCCCccchhhHHHHHHHHHhCCCCCCCCCH--------------
Q 005289 281 SNTGHRQ---PLTSRVVTLWYRPPELLLGAT-----DYGPSVDLWSVGCVFAELLIGKPILQGRTE-------------- 338 (704)
Q Consensus 281 ~~~~~~~---~~~~~~gT~~Y~APEvl~~~~-----~y~~~~DIWSlG~iLyeLltG~~pF~~~~~-------------- 338 (704)
....... .....+||+.|||||++.+.. .|+.++|||||||+||||+||.+||.....
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 6543221 223468999999999987532 367799999999999999999887753221
Q ss_pred HHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhc--cCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 339 VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF--KDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 339 ~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~--~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.+.+.+....-+. .+ .+...+ ...+..+.+||.+||..||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~-----------------rp------~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 238 VEEMRKVVCEQKL-----------------RP------NIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp HHHHHHHHTTSCC-----------------CC------CCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcccC-----------------CC------CCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1111111110000 00 000111 1234578899999999999999999999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=403.30 Aligned_cols=292 Identities=32% Similarity=0.534 Sum_probs=234.0
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeec---CCCe
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR---LSCS 205 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~---~~~~ 205 (704)
.++|++.+.||+|+||+||+|++..+++.||||++.... .......+.+|+.+|+.++||||+++++++... ....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 468999999999999999999999999999999996432 344556678999999999999999999987652 1367
Q ss_pred EEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
+||||||+.+++...+.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 89 ~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (353)
T 2b9h_A 89 VYIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166 (353)
T ss_dssp EEEEECCCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EEEEEeccCccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence 899999999876665543 368999999999999999999999999999999999999999999999999998664321
Q ss_pred CC---------CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchh
Q 005289 286 RQ---------PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 356 (704)
Q Consensus 286 ~~---------~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~ 356 (704)
.. .....++|+.|+|||++.+...++.++|||||||+||+|++|++||.+.+..+++..++..++.++...
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 246 (353)
T 2b9h_A 167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246 (353)
T ss_dssp -------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTT
T ss_pred ccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhc
Confidence 11 123457899999999987656789999999999999999999999999999999999999988876332
Q ss_pred hhc-cCCCCc-ccC-CCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCCCC
Q 005289 357 WKK-SKLPHA-TLF-KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 423 (704)
Q Consensus 357 w~~-~~~~~~-~~~-~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~~~ 423 (704)
... ...... ... .........+...++.+++++.+||.+||..||.+|||+.++|+||||+....+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 316 (353)
T 2b9h_A 247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN 316 (353)
T ss_dssp TTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred cccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcc
Confidence 111 000000 000 0000112234556678999999999999999999999999999999999766543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=425.55 Aligned_cols=261 Identities=25% Similarity=0.391 Sum_probs=215.1
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
..++|+++++||+|+||+||+|++..+++.||||++..... .......+.+|+.+|+.++||||++++++|.. ...+
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--~~~~ 223 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRL 223 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE--TTEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee--CCEE
Confidence 45689999999999999999999999999999999976422 23334567789999999999999999999987 5789
Q ss_pred EEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHh-cCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~-~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
|||||||+++.+..+......+++..++.++.||+.||.|||+ +|||||||||+||||+.++.+||+|||+++......
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence 9999999997776665555679999999999999999999998 999999999999999999999999999997643322
Q ss_pred CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
......+||+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+..+.+..|......+
T Consensus 304 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~------------- 368 (446)
T 4ejn_A 304 -ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF------------- 368 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-------------
T ss_pred -cccccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC-------------
Confidence 33456789999999999876 678999999999999999999999999999888888776522111
Q ss_pred ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCc-----CHHHHHhccccCCCCC
Q 005289 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 421 (704)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRp-----Ta~e~L~hpwf~~~~~ 421 (704)
...+++++.+||.+||.+||.+|| |+.++|+||||+...|
T Consensus 369 ----------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~ 413 (446)
T 4ejn_A 369 ----------------PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVW 413 (446)
T ss_dssp ----------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred ----------------CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCH
Confidence 135789999999999999999999 9999999999997544
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=400.92 Aligned_cols=260 Identities=26% Similarity=0.374 Sum_probs=224.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCCh----HHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCe
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP----ESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (704)
++|++.+.||+|+||+||+|++..+++.||||++....... ...+.+.+|+.+|+.+.||||+++++++.+ ...
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 89 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN--RTD 89 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec--CCE
Confidence 46999999999999999999999999999999997654321 135668899999999999999999999987 578
Q ss_pred EEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCC----ceEEecccccccc
Q 005289 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG----VLKLADFGLANFS 281 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g----~iKL~DFGla~~~ 281 (704)
+||||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++...
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 999999998866665555566799999999999999999999999999999999999999888 7999999999876
Q ss_pred CCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccC
Q 005289 282 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (704)
Q Consensus 282 ~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~ 361 (704)
.... ......+|+.|+|||++.+ ..++.++|||||||+||+|++|..||.+.+..+.+..+......++.
T Consensus 170 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~------- 239 (321)
T 2a2a_A 170 EDGV--EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDE------- 239 (321)
T ss_dssp CTTC--CCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH-------
T ss_pred Cccc--cccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccCh-------
Confidence 5432 2345678999999999876 56899999999999999999999999999988888887654332221
Q ss_pred CCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
..+..++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 240 ------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 240 ------------------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp ------------------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred ------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 2335789999999999999999999999999999999853
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=425.14 Aligned_cols=260 Identities=29% Similarity=0.455 Sum_probs=224.7
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCe
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (704)
+..++|.+++.||+|+||+||+|++..+|+.||||++...... ......+.+|+.+|+.++||||+++++++.. ...
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~~~ 90 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST--PSD 90 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSE
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCE
Confidence 3467899999999999999999999999999999999754321 1234568899999999999999999999987 578
Q ss_pred EEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
+|||||||+++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 91 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~- 169 (476)
T 2y94_A 91 IFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG- 169 (476)
T ss_dssp EEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT-
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc-
Confidence 9999999988776666666678999999999999999999999999999999999999999999999999999876543
Q ss_pred CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
......+||+.|+|||++.+...++.++|||||||+||+|++|.+||.+.+....+.+|.......
T Consensus 170 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~------------- 235 (476)
T 2y94_A 170 -EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYT------------- 235 (476)
T ss_dssp -CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCC-------------
T ss_pred -ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCC-------------
Confidence 234566899999999999875555789999999999999999999999988888887776522111
Q ss_pred ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
...+++++.+||.+||..||.+|||+.++|+||||+..
T Consensus 236 ----------------p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 236 ----------------PQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp ----------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred ----------------CccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 12578899999999999999999999999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=397.49 Aligned_cols=288 Identities=39% Similarity=0.667 Sum_probs=234.4
Q ss_pred cCCeeEEEEeeccCceEEEEEEEC-CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc---CCCCceeEeEEEee---c
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDL-DTGKIVALKKVRFDNFEPESVRFMAREILILRRL---DHPNIIKLEGLITS---R 201 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIv~l~~~~~~---~ 201 (704)
.++|++++.||+|+||+||+|++. .+++.||||++............+.+|+.+++.+ .||||+++++++.. .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 468999999999999999999995 6789999999976543322223455778777766 89999999999862 1
Q ss_pred CCCeEEEEEecccccccccccC-CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccc
Q 005289 202 LSCSIYLVFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 280 (704)
Q Consensus 202 ~~~~~~LV~Ey~~g~ll~~~~~-~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~ 280 (704)
....+||||||+++++...+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..
T Consensus 90 ~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 169 (326)
T 1blx_A 90 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 169 (326)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred CCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccccc
Confidence 2467899999999876665543 234589999999999999999999999999999999999999999999999999976
Q ss_pred cCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhcc
Q 005289 281 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (704)
Q Consensus 281 ~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~ 360 (704)
.... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+.++...++.++...|...
T Consensus 170 ~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (326)
T 1blx_A 170 YSFQ--MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 246 (326)
T ss_dssp CCGG--GGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred ccCC--CCccccccccceeCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccc
Confidence 5432 23345678999999999876 56899999999999999999999999999999999999999999888777643
Q ss_pred CCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCC
Q 005289 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (704)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~ 421 (704)
.......+... ....+...+..++..+.+||.+||..||.+|||+.++|+||||+....
T Consensus 247 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 247 VALPRQAFHSK--SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp CSSCGGGSCCC--CCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccchhhhccc--CcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 22111111111 112344556789999999999999999999999999999999987543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=404.35 Aligned_cols=258 Identities=30% Similarity=0.424 Sum_probs=202.6
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|++.+.||+|+||+||+|++..+++.||||++.... ..+.+.+|+.+|++|+||||+++++++.. ...+||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 125 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFET--PTEISL 125 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEec--CCeEEE
Confidence 357999999999999999999999999999999997542 23457789999999999999999999987 578999
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEcc---CCceEEeccccccccCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~---~g~iKL~DFGla~~~~~~~ 285 (704)
||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++......
T Consensus 126 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~- 204 (349)
T 2w4o_A 126 VLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ- 204 (349)
T ss_dssp EECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc-
Confidence 9999998666655555667999999999999999999999999999999999999975 789999999999866432
Q ss_pred CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCCchhhhccCCCC
Q 005289 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE-QLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e-~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
......++|+.|+|||++.+ ..|+.++|||||||+||+|++|..||......+ .+..+......++
T Consensus 205 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~----------- 271 (349)
T 2w4o_A 205 -VLMKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFI----------- 271 (349)
T ss_dssp ---------CGGGSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCC-----------
T ss_pred -cccccccCCCCccCHHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccC-----------
Confidence 22345678999999999876 568999999999999999999999998766544 4555544221111
Q ss_pred cccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCC
Q 005289 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (704)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~ 420 (704)
...+..++.++.+||.+||..||++|||+.++|+||||+...
T Consensus 272 --------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 272 --------------SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp --------------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred --------------CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 112357899999999999999999999999999999998643
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=398.36 Aligned_cols=290 Identities=35% Similarity=0.596 Sum_probs=227.4
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeec-------
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR------- 201 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~------- 201 (704)
.++|++++.||+|+||+||+|++..+++.||||++... .....+.+.+|+.+|+.++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 35799999999999999999999999999999999754 355667788999999999999999999988432
Q ss_pred -----CCCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEc-cCCceEEecc
Q 005289 202 -----LSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADF 275 (704)
Q Consensus 202 -----~~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~-~~g~iKL~DF 275 (704)
....+||||||+++++...+. ...+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+||
T Consensus 88 ~~~~~~~~~~~lv~e~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYMETDLANVLE--QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp ---CCSCSEEEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred cccccccCceeEEeeccCCCHHHHhh--cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccC
Confidence 236789999999986665553 34689999999999999999999999999999999999997 5679999999
Q ss_pred ccccccCCCC--CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Q 005289 276 GLANFSNTGH--RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 353 (704)
Q Consensus 276 Gla~~~~~~~--~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p 353 (704)
|++....... ........+|+.|+|||++.+...++.++|||||||+||+|++|++||.+.+..+.+..+......+.
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (320)
T 2i6l_A 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245 (320)
T ss_dssp TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCC
T ss_pred ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 9998664321 12234456799999999987666789999999999999999999999999999999999988777666
Q ss_pred chhhhccCCCCcc-cCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCCC
Q 005289 354 DDYWKKSKLPHAT-LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422 (704)
Q Consensus 354 ~~~w~~~~~~~~~-~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~~ 422 (704)
...|......... ...........+...++.++.++.+||.+||..||.+|||+.++|+||||+...++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p 315 (320)
T 2i6l_A 246 EEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP 315 (320)
T ss_dssp HHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred hhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence 5544331110000 00000001122345567899999999999999999999999999999999976664
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=391.41 Aligned_cols=256 Identities=32% Similarity=0.454 Sum_probs=222.4
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
++|++.+.||+|+||+||+|.+..++..||+|++...... ..+.+.+|+.+|+.++||||+++++++.+ ...+|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 84 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPNIIRLYETFED--NTDIYLV 84 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCeEEEE
Confidence 4699999999999999999999999999999999765432 34667899999999999999999999987 5789999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEE---ccCCceEEeccccccccCCCCC
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl---~~~g~iKL~DFGla~~~~~~~~ 286 (704)
|||++++.+..+......+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~-- 162 (277)
T 3f3z_A 85 MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-- 162 (277)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT--
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc--
Confidence 9999986665554445579999999999999999999999999999999999999 78889999999999876543
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcc
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~ 366 (704)
.......+|+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+.++......++..
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 229 (277)
T 3f3z_A 163 KMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEK----------- 229 (277)
T ss_dssp SCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH-----------
T ss_pred cchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCch-----------
Confidence 23345678999999999875 48999999999999999999999999999988888887644333322
Q ss_pred cCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
.+..+++.+.+||.+||..||.+|||+.++|+||||++
T Consensus 230 --------------~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 230 --------------DWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp --------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred --------------hhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 23578999999999999999999999999999999975
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=409.47 Aligned_cols=256 Identities=29% Similarity=0.381 Sum_probs=213.6
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCCeEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~ 207 (704)
.++|++++.||+|+||+||+|+++.+++.||||++...... ..+|+++|.++ +||||+++++++.+ ...+|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~ 92 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDD--GKYVY 92 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEc--CCEEE
Confidence 35799999999999999999999999999999999865432 34688889888 79999999999987 57899
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccC----CceEEeccccccccCC
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE----GVLKLADFGLANFSNT 283 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~----g~iKL~DFGla~~~~~ 283 (704)
||||||.++.+.........+++..++.++.||+.||.|||++||+||||||+||||.++ +.+||+|||++.....
T Consensus 93 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 93 VVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp EEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 999999986655554455679999999999999999999999999999999999998543 3599999999987654
Q ss_pred CCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC---CCHHHHHHHHHHHcCCCCchhhhcc
Q 005289 284 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG---RTEVEQLHKIFKLCGSPPDDYWKKS 360 (704)
Q Consensus 284 ~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~---~~~~e~l~~I~~~~g~~p~~~w~~~ 360 (704)
.. ......++|+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+ .+..+++..|......++.
T Consensus 173 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~------ 244 (342)
T 2qr7_A 173 EN-GLLMTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSG------ 244 (342)
T ss_dssp TT-CCBCCSSCCSSCCCHHHHHH-HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCS------
T ss_pred CC-CceeccCCCccccCHHHhcC-CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCc------
Confidence 32 23455688999999999875 4588999999999999999999999986 3555666666542211111
Q ss_pred CCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
..+..+++++++||.+||..||.+|||+.++|+||||..+
T Consensus 245 -------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 245 -------------------GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp -------------------TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred -------------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 1235789999999999999999999999999999999753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=399.07 Aligned_cols=263 Identities=23% Similarity=0.335 Sum_probs=221.8
Q ss_pred CeeEE-EEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCCeEEE
Q 005289 131 AFEKL-EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 131 ~y~~~-~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~L 208 (704)
+|.+. +.||+|+||+||+|++..+++.||||++............+.+|+.+|..+ .||||+++++++.. ...+||
T Consensus 29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~--~~~~~l 106 (327)
T 3lm5_A 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN--TSEIIL 106 (327)
T ss_dssp HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEE
T ss_pred EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe--CCeEEE
Confidence 68888 899999999999999999999999999987654444566788999999999 56999999999987 578999
Q ss_pred EEecccccccccccC--CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEcc---CCceEEeccccccccCC
Q 005289 209 VFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNT 283 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~--~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~---~g~iKL~DFGla~~~~~ 283 (704)
|||||.++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++.....
T Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 186 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186 (327)
T ss_dssp EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence 999999866655543 2467999999999999999999999999999999999999998 78999999999987654
Q ss_pred CCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCC
Q 005289 284 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 284 ~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
. ......++|+.|+|||++.+ ..++.++|||||||+||+|++|.+||.+.+..+.+..+......++.
T Consensus 187 ~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~--------- 254 (327)
T 3lm5_A 187 A--CELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE--------- 254 (327)
T ss_dssp ---------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT---------
T ss_pred c--cccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc---------
Confidence 3 22345678999999999876 56899999999999999999999999999998888888765433322
Q ss_pred CcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCCCC
Q 005289 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 423 (704)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~~~ 423 (704)
..+..++..+.+||.+||..||.+|||+.++|+||||+...+..
T Consensus 255 ----------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~ 298 (327)
T 3lm5_A 255 ----------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFEN 298 (327)
T ss_dssp ----------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTC
T ss_pred ----------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccccc
Confidence 22357889999999999999999999999999999999876653
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=403.03 Aligned_cols=265 Identities=27% Similarity=0.376 Sum_probs=217.1
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCC---CChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN---FEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~---~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
++|++++.||+|+||+||+|++..+++.||||++.... ......+.+.+|+.+|+.++||||+++++++.+ ...+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~ 103 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED--EQYI 103 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc--CCeE
Confidence 47999999999999999999999999999999997542 233456778899999999999999999999987 5789
Q ss_pred EEEEecccccccccccC----------------------------------------CCccccHHHHHHHHHHhhhhHHH
Q 005289 207 YLVFEYMEHDITGLLSC----------------------------------------PDIKFSEAQIKCYMNQLLHGLEH 246 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~----------------------------------------~~~~l~e~~~~~i~~QIl~aL~y 246 (704)
|||||||+++.+..+.. ....+++..++.++.||+.||.|
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 183 (345)
T 3hko_A 104 CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183 (345)
T ss_dssp EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence 99999998765543331 12346788999999999999999
Q ss_pred HHhcCcccccCCCccEEEccCC--ceEEeccccccccCCC---CCCCcccccccccccCcccccCC-CCCCCccchhhHH
Q 005289 247 CHSRGVLHRDIKGSNLLVNNEG--VLKLADFGLANFSNTG---HRQPLTSRVVTLWYRPPELLLGA-TDYGPSVDLWSVG 320 (704)
Q Consensus 247 LH~~gIvHrDLKp~NILl~~~g--~iKL~DFGla~~~~~~---~~~~~~~~~gT~~Y~APEvl~~~-~~y~~~~DIWSlG 320 (704)
||++||+||||||+||||+.++ .+||+|||++...... .........+|+.|+|||++.+. ..|+.++||||||
T Consensus 184 LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG 263 (345)
T 3hko_A 184 LHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263 (345)
T ss_dssp HHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHH
T ss_pred HHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHH
Confidence 9999999999999999998776 8999999999765322 11223556789999999998642 5789999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccC
Q 005289 321 CVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVE 400 (704)
Q Consensus 321 ~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~d 400 (704)
|+||+|++|.+||.+.+..+.+..+......++ ...+..+++.+.+||.+||..|
T Consensus 264 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~~ 318 (345)
T 3hko_A 264 VLLHLLLMGAVPFPGVNDADTISQVLNKKLCFE-------------------------NPNYNVLSPLARDLLSNLLNRN 318 (345)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTT-------------------------SGGGGGSCHHHHHHHHHHSCSC
T ss_pred HHHHHHHHCCCCCCCCChHHHHHHHHhcccccC-------------------------CcccccCCHHHHHHHHHHcCCC
Confidence 999999999999999999888888776322221 1123457899999999999999
Q ss_pred CCCCcCHHHHHhccccCCCCC
Q 005289 401 PYKRATASAALASEYFSTKPY 421 (704)
Q Consensus 401 P~kRpTa~e~L~hpwf~~~~~ 421 (704)
|.+|||+.++|+||||+...+
T Consensus 319 p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 319 VDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp TTTSCCHHHHHHSHHHHTTSS
T ss_pred hhHCCCHHHHhcChhhccChH
Confidence 999999999999999987544
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=398.58 Aligned_cols=281 Identities=30% Similarity=0.537 Sum_probs=223.8
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeEEEeecCCCeEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~~~ 207 (704)
.++|+++++||+|+||+||+|++..+++.||||++.... .+.+.+|+.+|+.|. ||||+++++++.+.....+|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 468999999999999999999999999999999997432 456789999999996 99999999999876667899
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCC-ceEEeccccccccCCCCC
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHR 286 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g-~iKL~DFGla~~~~~~~~ 286 (704)
|||||+.++.+..+.. .+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++.......
T Consensus 110 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~- 185 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ- 185 (330)
T ss_dssp EEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC-
T ss_pred EEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC-
Confidence 9999999876665542 589999999999999999999999999999999999999777 89999999998765432
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCCCCch-hhhccCCCC
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL-QGRTEVEQLHKIFKLCGSPPDD-YWKKSKLPH 364 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF-~~~~~~e~l~~I~~~~g~~p~~-~w~~~~~~~ 364 (704)
.....++|+.|+|||++.+...++.++|||||||+||+|++|..|| .+....+.+..+...++.+... ++.......
T Consensus 186 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 264 (330)
T 3nsz_A 186 -EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264 (330)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred -ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccc
Confidence 3355678999999999987677999999999999999999999888 4566777888877776654321 111111100
Q ss_pred ccc------CCCCCCCCchh-hhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 365 ATL------FKPQQPYDSSL-RETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 365 ~~~------~~~~~~~~~~l-~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
... ......+...+ ......+++++.+||.+||.+||.+|||+.|+|+||||+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 000 00000000000 11123479999999999999999999999999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=390.57 Aligned_cols=258 Identities=32% Similarity=0.492 Sum_probs=217.7
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
..++|++++.||+|+||+||+|++..+++.||||++...... ......+.+|+.+++.++||||+++++++.+ ...+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 84 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD--ATRV 84 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec--CCEE
Confidence 357899999999999999999999999999999999654321 1224557889999999999999999999987 5789
Q ss_pred EEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC
Q 005289 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~ 286 (704)
||||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-- 162 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-- 162 (279)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc--
Confidence 999999998666655544557999999999999999999999999999999999999999999999999998655432
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcc
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~ 366 (704)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+.+..+.......+
T Consensus 163 -~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------- 227 (279)
T 3fdn_A 163 -RRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP------------- 227 (279)
T ss_dssp ------CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC-------------
T ss_pred -cccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCC-------------
Confidence 2345578999999999876 5689999999999999999999999999998888877765322111
Q ss_pred cCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCC
Q 005289 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (704)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~ 420 (704)
..++..+.+||.+||..||.+|||+.++|+||||+..+
T Consensus 228 ----------------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 228 ----------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp ----------------TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred ----------------CcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 34788999999999999999999999999999998643
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=406.27 Aligned_cols=281 Identities=25% Similarity=0.434 Sum_probs=225.1
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CC-----CceeEeEEEeecC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HP-----NIIKLEGLITSRL 202 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-Hp-----nIv~l~~~~~~~~ 202 (704)
.++|++++.||+|+||+||+|++..+++.||||++... ......+.+|+.+|+.+. |+ +|+++++++..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~-- 127 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF-- 127 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE--
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc--
Confidence 45899999999999999999999999999999999743 344566778999999884 55 49999999987
Q ss_pred CCeEEEEEecccccccccccCCC-ccccHHHHHHHHHHhhhhHHHHH--hcCcccccCCCccEEEc--cCCceEEecccc
Q 005289 203 SCSIYLVFEYMEHDITGLLSCPD-IKFSEAQIKCYMNQLLHGLEHCH--SRGVLHRDIKGSNLLVN--NEGVLKLADFGL 277 (704)
Q Consensus 203 ~~~~~LV~Ey~~g~ll~~~~~~~-~~l~e~~~~~i~~QIl~aL~yLH--~~gIvHrDLKp~NILl~--~~g~iKL~DFGl 277 (704)
...+||||||+++++...+.... ..+++..++.++.||+.||.||| +.|||||||||+||||+ .++.+||+|||+
T Consensus 128 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 128 RNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred CCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 57899999999987777665432 46899999999999999999999 57999999999999995 477899999999
Q ss_pred ccccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhh
Q 005289 278 ANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 357 (704)
Q Consensus 278 a~~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w 357 (704)
++..... ....++|+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+..+++.+|...++.++...|
T Consensus 208 a~~~~~~----~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 282 (382)
T 2vx3_A 208 SCQLGQR----IYQYIQSRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL 282 (382)
T ss_dssp CEETTCC----CCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred ceecccc----cccccCCccccChHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9876532 345688999999999987 56999999999999999999999999999999999999999999987766
Q ss_pred hccCC--------CCccc---------CCCCCCCCchhhhhccC------------------CCHHHHHHHHHhhccCCC
Q 005289 358 KKSKL--------PHATL---------FKPQQPYDSSLRETFKD------------------LPTTAVNLIETLLSVEPY 402 (704)
Q Consensus 358 ~~~~~--------~~~~~---------~~~~~~~~~~l~~~~~~------------------~s~~~~dLI~~mL~~dP~ 402 (704)
..... +.... .....+....+...+.. ..+++++||.+||.+||+
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 362 (382)
T 2vx3_A 283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPK 362 (382)
T ss_dssp TTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTT
T ss_pred HhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChh
Confidence 43211 10000 00000111111111110 014789999999999999
Q ss_pred CCcCHHHHHhccccCCC
Q 005289 403 KRATASAALASEYFSTK 419 (704)
Q Consensus 403 kRpTa~e~L~hpwf~~~ 419 (704)
+|||+.|+|+||||+..
T Consensus 363 ~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 363 TRIQPYYALQHSFFKKT 379 (382)
T ss_dssp TSCCHHHHTTSGGGCC-
T ss_pred hCCCHHHHhcCcccccC
Confidence 99999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=403.15 Aligned_cols=255 Identities=31% Similarity=0.463 Sum_probs=194.6
Q ss_pred CeeEE---EEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeEEEeecCCCeE
Q 005289 131 AFEKL---EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 131 ~y~~~---~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~~ 206 (704)
+|++. +.||+|+||+||+|++..+++.||||++... ....+.+|+.+|+.+. ||||+++++++.+ ...+
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~--~~~~ 81 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHD--QLHT 81 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc--CCEE
Confidence 57775 7899999999999999999999999999743 3456778999999996 9999999999987 5789
Q ss_pred EEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCC---ceEEeccccccccCC
Q 005289 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNT 283 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g---~iKL~DFGla~~~~~ 283 (704)
|||||||+++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 161 (325)
T 3kn6_A 82 FLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP 161 (325)
T ss_dssp EEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred EEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence 99999999866665555556799999999999999999999999999999999999998766 899999999986654
Q ss_pred CCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHHHcCCCCchh
Q 005289 284 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE-------VEQLHKIFKLCGSPPDDY 356 (704)
Q Consensus 284 ~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~-------~e~l~~I~~~~g~~p~~~ 356 (704)
.. ......++|+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+. .+.+.++......++
T Consensus 162 ~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~--- 236 (325)
T 3kn6_A 162 DN-QPLKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE--- 236 (325)
T ss_dssp ------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC---
T ss_pred CC-CcccccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC---
Confidence 32 33456678999999999876 5689999999999999999999999987543 344444433221111
Q ss_pred hhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 357 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 357 w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
...+..+++++++||.+||..||.+|||+.++|+||||+..
T Consensus 237 ----------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 237 ----------------------GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp ----------------------SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred ----------------------cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 22345789999999999999999999999999999999864
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=401.62 Aligned_cols=256 Identities=29% Similarity=0.478 Sum_probs=220.6
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
+.|++++.||+|+||+||+|++..+++.||||++...... ....+.+.+|+.+|++++||||+++++++.. ...+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l 131 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAWL 131 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCeEEE
Confidence 3599999999999999999999999999999999865433 3445678899999999999999999999987 578999
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
||||+.+++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 132 v~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~----- 206 (348)
T 1u5q_A 132 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 206 (348)
T ss_dssp EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----
T ss_pred EEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-----
Confidence 999999887776655556799999999999999999999999999999999999999999999999999976643
Q ss_pred cccccccccccCcccccC--CCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcc
Q 005289 289 LTSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~--~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~ 366 (704)
....++|+.|+|||++.+ ...|+.++|||||||+||+|++|.+||.+.+..+.+..+.... .+.
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~--~~~------------ 272 (348)
T 1u5q_A 207 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE--SPA------------ 272 (348)
T ss_dssp BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--CCC------------
T ss_pred CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--CCC------------
Confidence 234578999999999852 3568999999999999999999999999988877776665421 110
Q ss_pred cCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
.....+++.+.+||.+||..||.+|||+.++|+||||...
T Consensus 273 -------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 273 -------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp -------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred -------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 0013578899999999999999999999999999999753
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=404.65 Aligned_cols=299 Identities=27% Similarity=0.465 Sum_probs=231.3
Q ss_pred cccCCcccccchhhhhcccchhhhhhhhhhhcCccccccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCCh
Q 005289 91 FRLGNLHKYIEGEQVAAGWPAWLSAVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP 170 (704)
Q Consensus 91 ~~~g~~~~~~~ge~~~~~~p~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~ 170 (704)
|+.|++++...|+.+.. ++|++++.||+|+||+||+|++..+++.||||++..+ .
T Consensus 2 y~~~~~~p~~~~~~~~~----------------------~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~ 56 (373)
T 1q8y_A 2 YRPGGYHPAFKGEPYKD----------------------ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---K 56 (373)
T ss_dssp -----CCCCCTTCEETT----------------------TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---H
T ss_pred CCCCCceeeecCCcccC----------------------CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---c
Confidence 67788888887765543 5899999999999999999999999999999999743 3
Q ss_pred HHHHHHHHHHHHHHhcC-----------CCCceeEeEEEeecC--CCeEEEEEecccccccccccC-CCccccHHHHHHH
Q 005289 171 ESVRFMAREILILRRLD-----------HPNIIKLEGLITSRL--SCSIYLVFEYMEHDITGLLSC-PDIKFSEAQIKCY 236 (704)
Q Consensus 171 ~~~~~~~~Ei~iL~~L~-----------HpnIv~l~~~~~~~~--~~~~~LV~Ey~~g~ll~~~~~-~~~~l~e~~~~~i 236 (704)
.....+.+|+.+|+++. ||||+++++++.... ...+||||||+.+++...+.. ....+++..++.+
T Consensus 57 ~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i 136 (373)
T 1q8y_A 57 VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 136 (373)
T ss_dssp HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHH
T ss_pred cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHH
Confidence 44566788999999886 899999999987632 337899999997676665543 3345999999999
Q ss_pred HHHhhhhHHHHHhc-CcccccCCCccEEEcc------CCceEEeccccccccCCCCCCCcccccccccccCcccccCCCC
Q 005289 237 MNQLLHGLEHCHSR-GVLHRDIKGSNLLVNN------EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD 309 (704)
Q Consensus 237 ~~QIl~aL~yLH~~-gIvHrDLKp~NILl~~------~g~iKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~ 309 (704)
+.||+.||.|||++ ||+||||||+||||+. .+.+||+|||++...... ....++|+.|+|||++.+ ..
T Consensus 137 ~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~-~~ 211 (373)
T 1q8y_A 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLG-AP 211 (373)
T ss_dssp HHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHT-CC
T ss_pred HHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhC-CC
Confidence 99999999999998 9999999999999954 347999999999866532 344578999999999986 56
Q ss_pred CCCccchhhHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHHcCCCCchhhhccCCCCccc-----CCCCCC-----
Q 005289 310 YGPSVDLWSVGCVFAELLIGKPILQGRT------EVEQLHKIFKLCGSPPDDYWKKSKLPHATL-----FKPQQP----- 373 (704)
Q Consensus 310 y~~~~DIWSlG~iLyeLltG~~pF~~~~------~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~-----~~~~~~----- 373 (704)
|+.++|||||||+||+|++|.+||.+.+ ..+.+..+...+|.+|...|...+.....+ ......
T Consensus 212 ~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (373)
T 1q8y_A 212 WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWP 291 (373)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCC
T ss_pred CCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccc
Confidence 8999999999999999999999998754 677888999999999987765544321100 000000
Q ss_pred CCchhhhhc---cCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 374 YDSSLRETF---KDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 374 ~~~~l~~~~---~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
....+...+ ..++.++.+||.+||..||.+|||+.++|+||||+..
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 340 (373)
T 1q8y_A 292 LEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 340 (373)
T ss_dssp HHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred hhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhcc
Confidence 000111111 2346788999999999999999999999999999974
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=389.19 Aligned_cols=257 Identities=28% Similarity=0.406 Sum_probs=210.4
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|.+.++||+|+||+||+|++..++..||+|++...... ...+.+.+|+.+|+.++||||+++++++.+ ...+||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 97 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHPNIIKIFEVFED--YHNMYI 97 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc-hhHHHHHHHHHHHHhCCCchHHhHHHheec--CCeEEE
Confidence 35799999999999999999999999999999999865432 235678899999999999999999999987 578999
Q ss_pred EEecccccccc-cccC---CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEE---ccCCceEEecccccccc
Q 005289 209 VFEYMEHDITG-LLSC---PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLANFS 281 (704)
Q Consensus 209 V~Ey~~g~ll~-~~~~---~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl---~~~g~iKL~DFGla~~~ 281 (704)
||||++++.+. .+.. ....+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++...
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999985444 3321 23569999999999999999999999999999999999999 45578999999999766
Q ss_pred CCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccC
Q 005289 282 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (704)
Q Consensus 282 ~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~ 361 (704)
... ......++|+.|+|||++.+ .++.++|||||||+||+|++|..||.+.+..+....+.......
T Consensus 178 ~~~--~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------- 244 (285)
T 3is5_A 178 KSD--EHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY--------- 244 (285)
T ss_dssp -----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC---------
T ss_pred CCc--ccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccc---------
Confidence 543 22345678999999998864 68999999999999999999999999988777766654421111
Q ss_pred CCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
......+++.+.+||.+||..||.+|||+.|+|+||||++
T Consensus 245 -----------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 245 -----------------AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp -----------------CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred -----------------ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 0112357899999999999999999999999999999985
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=394.28 Aligned_cols=257 Identities=24% Similarity=0.442 Sum_probs=219.5
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVF 210 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV~ 210 (704)
.|...++||+|+||+||+|++..+|+.||||++..... ...+.+.+|+.+|+.++||||+++++++.. ...+||||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 121 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHFNVVEMYKSYLV--GEELWVLM 121 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CSHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCcceEEEEEEE--CCEEEEEE
Confidence 48889999999999999999999999999999976542 234567899999999999999999999987 56899999
Q ss_pred ecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCcc
Q 005289 211 EYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 290 (704)
Q Consensus 211 Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~ 290 (704)
||++++.+..+... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ....
T Consensus 122 e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~ 199 (321)
T 2c30_A 122 EFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRK 199 (321)
T ss_dssp CCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCBC
T ss_pred ecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc-cccc
Confidence 99998777666543 469999999999999999999999999999999999999999999999999998665432 2234
Q ss_pred cccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCC
Q 005289 291 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 370 (704)
Q Consensus 291 ~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~ 370 (704)
..++|+.|+|||++.+ ..++.++|||||||+||+|++|++||.+.+..+.+..+.... ++.
T Consensus 200 ~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~--~~~---------------- 260 (321)
T 2c30_A 200 SLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP--PPK---------------- 260 (321)
T ss_dssp CCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS--CCC----------------
T ss_pred cccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CCC----------------
Confidence 5678999999999876 568999999999999999999999999988888777765421 110
Q ss_pred CCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCC
Q 005289 371 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (704)
Q Consensus 371 ~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~ 420 (704)
......+++.+.+||.+||..||++|||+.++|+||||++..
T Consensus 261 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 261 --------LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp --------CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred --------cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence 001235788999999999999999999999999999998643
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=412.58 Aligned_cols=260 Identities=27% Similarity=0.426 Sum_probs=206.7
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC------hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE------PESVRFMAREILILRRLDHPNIIKLEGLITSRL 202 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~------~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 202 (704)
.++|.+.+.||+|+||+||+|++..+++.||||++...... ......+.+|+.+|++|+||||+++++++..
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-- 211 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 211 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES--
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec--
Confidence 46899999999999999999999999999999999764321 1222347789999999999999999999865
Q ss_pred CCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCC---ceEEecccccc
Q 005289 203 SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLAN 279 (704)
Q Consensus 203 ~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g---~iKL~DFGla~ 279 (704)
..+|||||||.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+++
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred -CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 45899999999877766666667899999999999999999999999999999999999997554 59999999998
Q ss_pred ccCCCCCCCcccccccccccCcccccC--CCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHcCCCCchh
Q 005289 280 FSNTGHRQPLTSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQL-HKIFKLCGSPPDDY 356 (704)
Q Consensus 280 ~~~~~~~~~~~~~~gT~~Y~APEvl~~--~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l-~~I~~~~g~~p~~~ 356 (704)
..... ......+||+.|+|||++.+ ...|+.++|||||||+||+|++|.+||........+ ..+......+
T Consensus 291 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~---- 364 (419)
T 3i6u_A 291 ILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF---- 364 (419)
T ss_dssp SCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCC----
T ss_pred ecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCC----
Confidence 76543 23455688999999999853 356888999999999999999999999875443222 2332211111
Q ss_pred hhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 357 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 357 w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
+...+..+++.+.+||.+||.+||.+|||+.++|+||||+.
T Consensus 365 ---------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 365 ---------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp ---------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ---------------------CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 12345678999999999999999999999999999999985
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=385.05 Aligned_cols=260 Identities=22% Similarity=0.307 Sum_probs=217.9
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeec--CCCeE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR--LSCSI 206 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~--~~~~~ 206 (704)
...|++.+.||+|+||+||+|.+..++..||+|++............+.+|+.+|+.++||||+++++++... ....+
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 4469999999999999999999999999999999987776777778889999999999999999999998653 24678
Q ss_pred EEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcC--cccccCCCccEEEc-cCCceEEeccccccccCC
Q 005289 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG--VLHRDIKGSNLLVN-NEGVLKLADFGLANFSNT 283 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~g--IvHrDLKp~NILl~-~~g~iKL~DFGla~~~~~ 283 (704)
||||||++++.+..+......+++..++.++.||+.||.|||++| |+||||||+||||+ .++.+||+|||++.....
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 999999998766666555567999999999999999999999999 99999999999998 789999999999976543
Q ss_pred CCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCC
Q 005289 284 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 284 ~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
. ......+|+.|+|||++.+ .++.++|||||||++|+|++|+.||........+...... +..+
T Consensus 185 ~---~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~---------- 248 (290)
T 1t4h_A 185 S---FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKP---------- 248 (290)
T ss_dssp T---SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCC----------
T ss_pred c---ccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhc-cCCc----------
Confidence 2 2345678999999998875 5899999999999999999999999886554444333221 1111
Q ss_pred CcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
.......++++.+||.+||..||.+|||+.++|+||||++.
T Consensus 249 ---------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 249 ---------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp ---------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred ---------------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 11124567899999999999999999999999999999863
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=389.23 Aligned_cols=261 Identities=23% Similarity=0.402 Sum_probs=203.1
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
+..++|++++.||+|+||+||+|++..+++.||||++..........+.+.++..+++.++||||+++++++.+ ...+
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~--~~~~ 81 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR--EGDV 81 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSSE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec--cCCE
Confidence 34578999999999999999999999999999999997654444444555566667888999999999999987 5679
Q ss_pred EEEEeccccccccccc---CCCccccHHHHHHHHHHhhhhHHHHHhc-CcccccCCCccEEEccCCceEEeccccccccC
Q 005289 207 YLVFEYMEHDITGLLS---CPDIKFSEAQIKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~---~~~~~l~e~~~~~i~~QIl~aL~yLH~~-gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~ 282 (704)
||||||+++++...+. .....+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||++....
T Consensus 82 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 82 WICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred EEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9999999986644432 3456799999999999999999999998 99999999999999999999999999998665
Q ss_pred CCCCCCcccccccccccCcccc---cCCCCCCCccchhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHHcCCCCchhhh
Q 005289 283 TGHRQPLTSRVVTLWYRPPELL---LGATDYGPSVDLWSVGCVFAELLIGKPILQG-RTEVEQLHKIFKLCGSPPDDYWK 358 (704)
Q Consensus 283 ~~~~~~~~~~~gT~~Y~APEvl---~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~-~~~~e~l~~I~~~~g~~p~~~w~ 358 (704)
... ......+|+.|+|||++ .....++.++|||||||++|+|++|.+||.. ......+..+.......
T Consensus 162 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------ 233 (290)
T 3fme_A 162 DDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ------ 233 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCC------
T ss_pred ccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCC------
Confidence 432 22345789999999997 3446789999999999999999999999986 34444454444311000
Q ss_pred ccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 359 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
.....++.++.+||.+||..||.+|||+.++|+||||+.
T Consensus 234 ---------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 234 ---------------------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp ---------------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred ---------------------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 011357899999999999999999999999999999974
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=401.23 Aligned_cols=260 Identities=30% Similarity=0.457 Sum_probs=221.8
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC--Ch----HHHHHHHHHHHHHHhc-CCCCceeEeEEEeecC
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF--EP----ESVRFMAREILILRRL-DHPNIIKLEGLITSRL 202 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~--~~----~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~ 202 (704)
++|++.+.||.|+||+||+|++..+|+.||||++..... .. ...+.+.+|+.+|+++ +||||+++++++..
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 171 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES-- 171 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB--
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee--
Confidence 479999999999999999999999999999999976532 21 2245577899999999 89999999999977
Q ss_pred CCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccC
Q 005289 203 SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (704)
Q Consensus 203 ~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~ 282 (704)
...+||||||++++.+..+......+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||+|||++....
T Consensus 172 ~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 172 SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 57899999999986666555445579999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCCcccccccccccCcccccC-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhh
Q 005289 283 TGHRQPLTSRVVTLWYRPPELLLG-----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 357 (704)
Q Consensus 283 ~~~~~~~~~~~gT~~Y~APEvl~~-----~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w 357 (704)
... .....++|+.|+|||++.+ ...|+.++|||||||+||+|++|.+||.+.+....+..+......++
T Consensus 252 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~---- 325 (365)
T 2y7j_A 252 PGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFS---- 325 (365)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----
T ss_pred CCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC----
Confidence 432 3455688999999999853 23588999999999999999999999999888888877766332222
Q ss_pred hccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 358 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
...+..++..+.+||.+||..||.+|||+.++|+||||++
T Consensus 326 ---------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 326 ---------------------SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp ---------------------HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ---------------------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 1234578899999999999999999999999999999973
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=395.70 Aligned_cols=262 Identities=24% Similarity=0.331 Sum_probs=207.5
Q ss_pred cCCeeEE-EEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCCeE
Q 005289 129 ADAFEKL-EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 129 ~~~y~~~-~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~ 206 (704)
.+.|++. +.||+|+||+||+|++..+++.||||++..... .....+.+|+.+|.++ +||||+++++++.+ ...+
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~--~~~~ 86 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEFFEE--EDRF 86 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEee--CCEE
Confidence 4579996 789999999999999999999999999976532 2345678999999985 79999999999987 5789
Q ss_pred EEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCc---eEEeccccccccCC
Q 005289 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV---LKLADFGLANFSNT 283 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~---iKL~DFGla~~~~~ 283 (704)
||||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++.....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999997666555544557999999999999999999999999999999999999998776 99999999876532
Q ss_pred CC------CCCcccccccccccCcccccC----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCH---------------
Q 005289 284 GH------RQPLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTE--------------- 338 (704)
Q Consensus 284 ~~------~~~~~~~~gT~~Y~APEvl~~----~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~--------------- 338 (704)
.. .......++|+.|+|||++.+ ...|+.++|||||||++|+|++|++||.+...
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 21 112234568999999999863 13578999999999999999999999987642
Q ss_pred HHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 339 VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 339 ~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
...+..+......++ ...+..++.++++||.+||..||.+|||+.++|+||||+.
T Consensus 247 ~~~~~~i~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 301 (316)
T 2ac3_A 247 NMLFESIQEGKYEFP-------------------------DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG 301 (316)
T ss_dssp HHHHHHHHHCCCCCC-------------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-
T ss_pred HHHHHHHhccCcccC-------------------------chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcC
Confidence 223333333211111 1233578999999999999999999999999999999986
Q ss_pred C
Q 005289 419 K 419 (704)
Q Consensus 419 ~ 419 (704)
.
T Consensus 302 ~ 302 (316)
T 2ac3_A 302 C 302 (316)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=438.66 Aligned_cols=263 Identities=24% Similarity=0.362 Sum_probs=225.9
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCC
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSC 204 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~ 204 (704)
+..++|++++.||+|+||+||+|++..+++.||||++.+... .....+.+.+|+.+|..+ +||||++++++|++ ..
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~--~~ 415 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MD 415 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC--SS
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe--CC
Confidence 456789999999999999999999999999999999975421 122345677899999988 79999999999987 57
Q ss_pred eEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
.+||||||+.++.|..++.....|++..++.|+.||+.||.|||++|||||||||+||||+.++++||+|||+++.....
T Consensus 416 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 416 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred EEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 89999999998777666655567999999999999999999999999999999999999999999999999999864332
Q ss_pred CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
. ......+||+.|+|||++.+ ..|+.++||||||||||||++|.+||.+.+..+++.+|......+
T Consensus 496 ~-~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~------------ 561 (674)
T 3pfq_A 496 G-VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY------------ 561 (674)
T ss_dssp T-CCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCC------------
T ss_pred C-cccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCC------------
Confidence 2 23456789999999999876 679999999999999999999999999999999998886522111
Q ss_pred cccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCH-----HHHHhccccCCCCCC
Q 005289 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA-----SAALASEYFSTKPYA 422 (704)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa-----~e~L~hpwf~~~~~~ 422 (704)
...++.++++||.+||..||.+||++ .++++||||+...|.
T Consensus 562 -----------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~ 607 (674)
T 3pfq_A 562 -----------------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 607 (674)
T ss_dssp -----------------CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHH
T ss_pred -----------------CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHH
Confidence 13688999999999999999999997 999999999976653
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=390.04 Aligned_cols=257 Identities=28% Similarity=0.419 Sum_probs=217.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
++|.+++.||+|+||+||+|++..+++.||||++..... .....+.+|+.+|+.++||||+++++++.+ ...+|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 84 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYES--TTHYYLV 84 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhccc--CCEEEEE
Confidence 479999999999999999999999999999999986432 223567889999999999999999999987 5789999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEE---ccCCceEEeccccccccCCCCC
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl---~~~g~iKL~DFGla~~~~~~~~ 286 (704)
|||++++.+..+......+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-- 162 (304)
T 2jam_A 85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-- 162 (304)
T ss_dssp ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB--
T ss_pred EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC--
Confidence 9999876555444444578999999999999999999999999999999999999 77889999999999755432
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcc
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~ 366 (704)
.....++|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......++.
T Consensus 163 -~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~------------ 228 (304)
T 2jam_A 163 -IMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFES------------ 228 (304)
T ss_dssp -TTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCT------------
T ss_pred -ccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc------------
Confidence 2345578999999999876 56899999999999999999999999999988888887663322211
Q ss_pred cCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
..+..++.++.+||.+||..||.+|||+.++|+||||+..
T Consensus 229 -------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 229 -------------PFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp -------------TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred -------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 1234688999999999999999999999999999999863
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=430.88 Aligned_cols=262 Identities=25% Similarity=0.424 Sum_probs=218.7
Q ss_pred ccccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCC
Q 005289 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (704)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 204 (704)
++..++|++++.||+|+||+||+|++..+|+.||||++.+.... ......+.+|+.+|+.++|||||+++++|.+ ..
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~ 257 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET--KD 257 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SS
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee--CC
Confidence 46678899999999999999999999999999999999754321 1224557789999999999999999999987 57
Q ss_pred eEEEEEecccccccccccCC--CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccC
Q 005289 205 SIYLVFEYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~~~--~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~ 282 (704)
.+|||||||.++.+..+... ...+++..++.|+.||+.||.|||++|||||||||+||||+.++++||+|||++....
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 89999999988666544332 2349999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHcCCCCchhhh
Q 005289 283 TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE----VEQLHKIFKLCGSPPDDYWK 358 (704)
Q Consensus 283 ~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~----~e~l~~I~~~~g~~p~~~w~ 358 (704)
.. ......+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+... .++...+... +.
T Consensus 338 ~~--~~~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~----~~---- 406 (576)
T 2acx_A 338 EG--QTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV----PE---- 406 (576)
T ss_dssp TT--CCEECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC----CC----
T ss_pred cC--ccccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc----cc----
Confidence 43 23455689999999999876 5689999999999999999999999987642 3333333321 10
Q ss_pred ccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCc-----CHHHHHhccccCCCCC
Q 005289 359 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 421 (704)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRp-----Ta~e~L~hpwf~~~~~ 421 (704)
.....++.++++||.+||..||.+|| ++.++++||||+...|
T Consensus 407 ---------------------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w 453 (576)
T 2acx_A 407 ---------------------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNF 453 (576)
T ss_dssp ---------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCH
T ss_pred ---------------------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCH
Confidence 01136789999999999999999999 8999999999997655
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-46 Score=385.73 Aligned_cols=259 Identities=27% Similarity=0.415 Sum_probs=218.8
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCCh----HHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCe
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP----ESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (704)
++|++++.||+|+||+||+|++..+++.||||++....... ...+.+.+|+.+|+.++||||+++++++.+ ...
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~ 82 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN--KTD 82 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC--CCe
Confidence 47999999999999999999999999999999998654321 135678899999999999999999999987 578
Q ss_pred EEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCC----ceEEecccccccc
Q 005289 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG----VLKLADFGLANFS 281 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g----~iKL~DFGla~~~ 281 (704)
+||||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 999999998766665554455799999999999999999999999999999999999998877 7999999999876
Q ss_pred CCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccC
Q 005289 282 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (704)
Q Consensus 282 ~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~ 361 (704)
.... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......++
T Consensus 163 ~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 231 (283)
T 3bhy_A 163 EAGN--EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD-------- 231 (283)
T ss_dssp C----------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC--------
T ss_pred cCCC--cccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCc--------
Confidence 5432 2345578999999999875 5689999999999999999999999999988888777755322221
Q ss_pred CCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
...+..++..+.+||.+||..||.+|||+.++|+||||+.
T Consensus 232 -----------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 232 -----------------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp -----------------HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred -----------------chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 2334578999999999999999999999999999999974
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=380.70 Aligned_cols=259 Identities=26% Similarity=0.384 Sum_probs=216.2
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
++|++++.||+|+||+||+|++..+++.||||++...... ...+.+.+|+.+++.++||||+++++++.+ ...+|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 83 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYLF 83 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEc--CCEEEEE
Confidence 4799999999999999999999999999999999765432 345678899999999999999999999987 5789999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC-CCC
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-RQP 288 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~-~~~ 288 (704)
|||++++.+..+......+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++....... ...
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 163 (276)
T 2yex_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (276)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence 9999986666666666689999999999999999999999999999999999999999999999999997654321 122
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCCchhhhccCCCCccc
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE-QLHKIFKLCGSPPDDYWKKSKLPHATL 367 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e-~l~~I~~~~g~~p~~~w~~~~~~~~~~ 367 (704)
....++|+.|+|||++.+...++.++|||||||++|+|++|..||.+..... .+..+......
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------- 227 (276)
T 2yex_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY---------------- 227 (276)
T ss_dssp BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT----------------
T ss_pred ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc----------------
Confidence 3456789999999999875545789999999999999999999998765432 22222211000
Q ss_pred CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
...+..++..+.+||.+||..||.+|||+.++|+||||+.
T Consensus 228 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 267 (276)
T 2yex_A 228 -----------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267 (276)
T ss_dssp -----------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred -----------cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccC
Confidence 0113468899999999999999999999999999999986
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=407.34 Aligned_cols=256 Identities=24% Similarity=0.342 Sum_probs=200.8
Q ss_pred cCCeeEE-EEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHh-cCCCCceeEeEEEee--cCCC
Q 005289 129 ADAFEKL-EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRR-LDHPNIIKLEGLITS--RLSC 204 (704)
Q Consensus 129 ~~~y~~~-~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~-L~HpnIv~l~~~~~~--~~~~ 204 (704)
.++|.++ +.||.|+||+||+|++..+++.||||++... ..+.+|+.++.+ ++||||++++++|.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~ 132 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence 4578887 7899999999999999999999999999632 345679988754 489999999999864 2245
Q ss_pred eEEEEEeccccccccccc-CC-CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEcc---CCceEEecccccc
Q 005289 205 SIYLVFEYMEHDITGLLS-CP-DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLAN 279 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~-~~-~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~---~g~iKL~DFGla~ 279 (704)
.+|||||||.++.+..++ .. ...+++..++.|+.||+.||.|||++||+||||||+||||+. ++.+||+|||+++
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 789999999885554443 32 346999999999999999999999999999999999999998 7889999999998
Q ss_pred ccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHcCCCCch
Q 005289 280 FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE----QLHKIFKLCGSPPDD 355 (704)
Q Consensus 280 ~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e----~l~~I~~~~g~~p~~ 355 (704)
..... ......++|+.|+|||++.+ ..|+.++||||||||||+|++|.+||.+..... ....+......++
T Consensus 213 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~-- 287 (400)
T 1nxk_A 213 ETTSH--NSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP-- 287 (400)
T ss_dssp ECC-------------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCC--
T ss_pred ccCCC--CccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCC--
Confidence 66533 23456788999999999875 679999999999999999999999998765322 2233322111111
Q ss_pred hhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 356 ~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
...+..++.++++||.+||..||.+|||+.++|+||||...
T Consensus 288 -----------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 288 -----------------------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp -----------------------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred -----------------------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 11235789999999999999999999999999999999853
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-46 Score=386.37 Aligned_cols=259 Identities=29% Similarity=0.440 Sum_probs=219.5
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCe
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (704)
+..++|++.+.||+|+||+||+|++..+++.||||++...... ......+.+|+.+++.++||||+++++++.+ ...
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 88 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD--RKR 88 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc--CCE
Confidence 4467899999999999999999999999999999999754221 1123567889999999999999999999987 578
Q ss_pred EEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
+||||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~- 167 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL- 167 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence 9999999988655544444457999999999999999999999999999999999999999999999999998765432
Q ss_pred CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+....+......
T Consensus 168 --~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------------- 230 (284)
T 2vgo_A 168 --RRRTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLK-------------- 230 (284)
T ss_dssp --CBCCCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC--------------
T ss_pred --ccccccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccC--------------
Confidence 2244578999999999876 56899999999999999999999999998888777766542111
Q ss_pred ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCC
Q 005289 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (704)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~ 420 (704)
....++..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 231 ---------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 231 ---------------FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp ---------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred ---------------CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 0135788999999999999999999999999999998543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=393.75 Aligned_cols=264 Identities=24% Similarity=0.353 Sum_probs=216.5
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC--Ce
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLS--CS 205 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~--~~ 205 (704)
.++|++++.||+|+||+||+|++..+++.||||++..... .......+.+|+.+++.++||||+++++++..... ..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 4689999999999999999999999999999999987543 34556678899999999999999999999876432 25
Q ss_pred EEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
+||||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 170 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-------
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccc
Confidence 69999999987776665555679999999999999999999999999999999999999999999999999997654322
Q ss_pred C--CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCC
Q 005289 286 R--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 286 ~--~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
. ......++|+.|+|||++.+ ..++.++|||||||+||+|++|++||.+.+..+....+......++
T Consensus 171 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---------- 239 (311)
T 3ork_A 171 NSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP---------- 239 (311)
T ss_dssp -----------CCTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCH----------
T ss_pred cccccccccCcCcccCCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCc----------
Confidence 1 12234568999999999876 5689999999999999999999999999988887776655322111
Q ss_pred CcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
......++.++.+||.+||..||.+||++.++|.|+|++.
T Consensus 240 ---------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 240 ---------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp ---------------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ---------------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 2233578999999999999999999999999999999974
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=385.74 Aligned_cols=262 Identities=27% Similarity=0.403 Sum_probs=224.5
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
..++|.+.+.||+|+||+||+|++..+++.||+|++..... .....+.+.+|+.+|+.++||||+++++++.+ ...+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 90 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--NDFV 90 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc--CCEE
Confidence 35689999999999999999999999999999999976543 34556778899999999999999999999987 5789
Q ss_pred EEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC
Q 005289 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~ 286 (704)
||||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~- 169 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG- 169 (294)
T ss_dssp EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc-
Confidence 9999999987666655555679999999999999999999999999999999999999999999999999998765322
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcc
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~ 366 (704)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||......+.+..+......
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------- 233 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS--------------- 233 (294)
T ss_dssp CCBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC---------------
T ss_pred cccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCC---------------
Confidence 22344678999999999876 56899999999999999999999999998887776666431110
Q ss_pred cCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCCC
Q 005289 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422 (704)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~~ 422 (704)
....++..+.+||.+||..||.+|||+.++|+||||+....+
T Consensus 234 --------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~ 275 (294)
T 2rku_A 234 --------------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP 275 (294)
T ss_dssp --------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred --------------CccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcC
Confidence 113578899999999999999999999999999999876554
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=421.92 Aligned_cols=265 Identities=24% Similarity=0.387 Sum_probs=220.8
Q ss_pred cccccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC
Q 005289 125 VPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (704)
Q Consensus 125 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 203 (704)
.++..++|++++.||+|+||+||+|+++.+|+.||||++.+.... ......+.+|+.+|+.++||||++++++|.+ .
T Consensus 180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~ 257 (543)
T 3c4z_A 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET--K 257 (543)
T ss_dssp SCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--S
T ss_pred ccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee--C
Confidence 345678999999999999999999999999999999999754321 1234567889999999999999999999987 5
Q ss_pred CeEEEEEecccccccccccCC----CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEecccccc
Q 005289 204 CSIYLVFEYMEHDITGLLSCP----DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN 279 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~~~~~----~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~ 279 (704)
..+|||||||+++.+..+... ...+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++
T Consensus 258 ~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~ 337 (543)
T 3c4z_A 258 TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV 337 (543)
T ss_dssp SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceee
Confidence 789999999998666543322 3469999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHcCCCCch
Q 005289 280 FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT----EVEQLHKIFKLCGSPPDD 355 (704)
Q Consensus 280 ~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~----~~e~l~~I~~~~g~~p~~ 355 (704)
...... ......+||+.|+|||++.+ ..|+.++|||||||+||||++|++||.+.. ..++...+......
T Consensus 338 ~~~~~~-~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~---- 411 (543)
T 3c4z_A 338 ELKAGQ-TKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVT---- 411 (543)
T ss_dssp ECCTTC-CCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCC----
T ss_pred eccCCC-cccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccC----
Confidence 765432 22344689999999999986 679999999999999999999999998763 34455555431111
Q ss_pred hhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcC-----HHHHHhccccCCCCCC
Q 005289 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPYA 422 (704)
Q Consensus 356 ~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpT-----a~e~L~hpwf~~~~~~ 422 (704)
....++..+.+||.+||..||.+||+ +.++++||||+...|.
T Consensus 412 -------------------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~ 458 (543)
T 3c4z_A 412 -------------------------YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWR 458 (543)
T ss_dssp -------------------------CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHH
T ss_pred -------------------------CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHH
Confidence 01367899999999999999999996 5899999999976653
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=382.92 Aligned_cols=262 Identities=29% Similarity=0.421 Sum_probs=222.4
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC---C----hHHHHHHHHHHHHHHhcC-CCCceeEeEEEee
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF---E----PESVRFMAREILILRRLD-HPNIIKLEGLITS 200 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~---~----~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~ 200 (704)
.++|++++.||+|+||+||+|++..+++.||||++..... . ....+.+.+|+.+|+++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 4689999999999999999999999999999999976531 1 123456778999999995 9999999999977
Q ss_pred cCCCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccc
Q 005289 201 RLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 280 (704)
Q Consensus 201 ~~~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~ 280 (704)
...+||||||++++.+..+......+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++..
T Consensus 96 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 96 --NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred --CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 578999999999866665554456799999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCcccccccccccCccccc-----CCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCch
Q 005289 281 SNTGHRQPLTSRVVTLWYRPPELLL-----GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 355 (704)
Q Consensus 281 ~~~~~~~~~~~~~gT~~Y~APEvl~-----~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~ 355 (704)
..... .....++|+.|+|||++. ....++.++|||||||++|+|++|.+||...+..+.+..+......++.
T Consensus 174 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~- 250 (298)
T 1phk_A 174 LDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS- 250 (298)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT-
T ss_pred cCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc-
Confidence 65432 334567899999999985 2356889999999999999999999999998888887777653222211
Q ss_pred hhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 356 ~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
..+..++..+.+||.+||..||.+|||+.++|+||||++.
T Consensus 251 ------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (298)
T 1phk_A 251 ------------------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290 (298)
T ss_dssp ------------------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred ------------------------ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence 1234688999999999999999999999999999999864
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=393.75 Aligned_cols=260 Identities=27% Similarity=0.406 Sum_probs=223.9
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 207 (704)
.++|.+.+.||+|+||+||+|++..+++.||+|++..... .....+.+.+|+.+|+.++||||+++++++.+ ...+|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 117 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--NDFVF 117 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec--CCeEE
Confidence 4579999999999999999999999999999999976543 34566778899999999999999999999987 57899
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCC
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~ 287 (704)
|||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... .
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~ 196 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-E 196 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT-C
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc-c
Confidence 999999987666555555679999999999999999999999999999999999999999999999999998765332 2
Q ss_pred CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCccc
Q 005289 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (704)
Q Consensus 288 ~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~ 367 (704)
.....++|+.|+|||++.+ ..++.++|||||||+||+|++|..||......+.+..+......
T Consensus 197 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------------- 259 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS---------------- 259 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC----------------
T ss_pred cccccCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCC----------------
Confidence 2345678999999999876 56899999999999999999999999998887777766542111
Q ss_pred CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCC
Q 005289 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (704)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~ 421 (704)
....++..+.+||.+||..||.+|||+.++|+||||+....
T Consensus 260 -------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~ 300 (335)
T 2owb_A 260 -------------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 300 (335)
T ss_dssp -------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred -------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence 01357889999999999999999999999999999987544
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=382.73 Aligned_cols=259 Identities=28% Similarity=0.422 Sum_probs=211.0
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
..++|++++.||+|+||+||+|++..+++.||||++...... ......+.+|+.+|+.++||||+++++++.. ...+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 86 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST--PTDF 86 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec--CCeE
Confidence 356899999999999999999999999999999999753211 1234567899999999999999999999987 5789
Q ss_pred EEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC
Q 005289 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~ 286 (704)
||||||+.++.+..+......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~- 165 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE- 165 (276)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc-
Confidence 9999999886665554444578999999999999999999999999999999999999999999999999998765432
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcc
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~ 366 (704)
......+|+.|+|||++.+...++.++|||||||++|+|++|..||......+.+..+.......
T Consensus 166 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 230 (276)
T 2h6d_A 166 -FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYI-------------- 230 (276)
T ss_dssp ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------------
T ss_pred -ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccC--------------
Confidence 23445789999999999874445689999999999999999999999888877777665421110
Q ss_pred cCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
...++..+.+||.+||..||.+|||+.++|+||||++.
T Consensus 231 ---------------~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 231 ---------------PEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp ---------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred ---------------chhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 13468899999999999999999999999999999863
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=391.92 Aligned_cols=280 Identities=24% Similarity=0.416 Sum_probs=227.4
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCC-cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCC------ceeEeEEEeec
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTG-KIVALKKVRFDNFEPESVRFMAREILILRRLDHPN------IIKLEGLITSR 201 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g-~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hpn------Iv~l~~~~~~~ 201 (704)
.++|++++.||+|+||+||+|++..++ +.||||++... ......+.+|+.+|+.+.|++ |+.+++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~- 93 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF- 93 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE-
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee-
Confidence 358999999999999999999998877 68999999643 344566788999999997665 8999998887
Q ss_pred CCCeEEEEEecccccccccccCCC-ccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEE----------------
Q 005289 202 LSCSIYLVFEYMEHDITGLLSCPD-IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV---------------- 264 (704)
Q Consensus 202 ~~~~~~LV~Ey~~g~ll~~~~~~~-~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl---------------- 264 (704)
...+||||||++++++..+.... ..+++..++.++.||+.||.|||++||+||||||+||||
T Consensus 94 -~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 94 -HGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp -TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred -CCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccc
Confidence 56899999999888887665433 469999999999999999999999999999999999999
Q ss_pred ---ccCCceEEeccccccccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHH
Q 005289 265 ---NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ 341 (704)
Q Consensus 265 ---~~~g~iKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~ 341 (704)
+.++.+||+|||++...... ....++|+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+.
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeec-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 56789999999999865432 245678999999999876 5689999999999999999999999999999999
Q ss_pred HHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCc------hhhhh----------ccCCCHHHHHHHHHhhccCCCCCc
Q 005289 342 LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDS------SLRET----------FKDLPTTAVNLIETLLSVEPYKRA 405 (704)
Q Consensus 342 l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~------~l~~~----------~~~~s~~~~dLI~~mL~~dP~kRp 405 (704)
+..+...++.+|..++......... +.....+.. .+... ....+.++.+||.+||.+||.+||
T Consensus 248 ~~~~~~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 248 LVMMEKILGPIPSHMIHRTRKQKYF-YKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHCCCCHHHHHHCSCGGGE-ETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHcCCCcHHHhhhccchhhh-cccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 9999999999988776554321110 000000000 00000 012245789999999999999999
Q ss_pred CHHHHHhccccCCC
Q 005289 406 TASAALASEYFSTK 419 (704)
Q Consensus 406 Ta~e~L~hpwf~~~ 419 (704)
|+.++|+||||+..
T Consensus 327 t~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 327 TLAEALLHPFFAGL 340 (355)
T ss_dssp CHHHHTTSGGGGGC
T ss_pred CHHHHhcChhhcCC
Confidence 99999999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=383.84 Aligned_cols=262 Identities=26% Similarity=0.387 Sum_probs=215.3
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 207 (704)
.++|++++.||+|+||+||+|++..+++.||||++..... .....+.+.+|+.+++.++||||+++++++.. ...+|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~ 87 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE--DDCYY 87 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC--SSEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee--CCeEE
Confidence 4589999999999999999999999999999999976543 34556778899999999999999999999977 57899
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCC
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~ 287 (704)
|||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.........
T Consensus 88 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167 (294)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence 99999998766666555567999999999999999999999999999999999999999999999999999876544333
Q ss_pred CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCccc
Q 005289 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (704)
Q Consensus 288 ~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~ 367 (704)
.....++|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+...++... ..+
T Consensus 168 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~--~~~-------------- 230 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQD--SVP-------------- 230 (294)
T ss_dssp -------CCSSCCHHHHHT-CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSS--CCC--------------
T ss_pred ccCccccCccccCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc--cCC--------------
Confidence 3445678999999999886 56899999999999999999999999998887765554331 111
Q ss_pred CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccC
Q 005289 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417 (704)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~ 417 (704)
.........+|+.+.+||.+||..||.+||+..+.|.+.|..
T Consensus 231 --------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 231 --------NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp --------CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred --------CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 111233467899999999999999999999777778787765
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=395.20 Aligned_cols=263 Identities=26% Similarity=0.443 Sum_probs=209.2
Q ss_pred ccccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC--CCceeEeEEEeecCC
Q 005289 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH--PNIIKLEGLITSRLS 203 (704)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~H--pnIv~l~~~~~~~~~ 203 (704)
.+..++|++++.||+|+||+||+|.+ .+++.||||++..........+.+.+|+.+|..|.| |||+++++++.. .
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~--~ 81 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--D 81 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--S
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee--C
Confidence 34567899999999999999999997 468999999998777667777888999999999976 999999999987 5
Q ss_pred CeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCC
Q 005289 204 CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~ 283 (704)
..+|||||++.+++...+. ....+++..++.|+.||+.||.|||++||+||||||+||||+ ++.+||+|||++.....
T Consensus 82 ~~~~lv~e~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 82 QYIYMVMECGNIDLNSWLK-KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp SEEEEEECCCSEEHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred CEEEEEEeCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 7899999977666655554 345799999999999999999999999999999999999997 68899999999987654
Q ss_pred CCCC-CcccccccccccCcccccC----------CCCCCCccchhhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCC
Q 005289 284 GHRQ-PLTSRVVTLWYRPPELLLG----------ATDYGPSVDLWSVGCVFAELLIGKPILQGRTE-VEQLHKIFKLCGS 351 (704)
Q Consensus 284 ~~~~-~~~~~~gT~~Y~APEvl~~----------~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~-~e~l~~I~~~~g~ 351 (704)
.... .....+||+.|+|||++.+ ...|+.++|||||||+||+|++|++||..... ...+..+......
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 239 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 239 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcc
Confidence 3221 2345678999999999853 24688999999999999999999999987543 3333333221000
Q ss_pred CCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCC
Q 005289 352 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (704)
Q Consensus 352 ~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~ 420 (704)
. ......+.++.+||.+||..||.+|||+.++|+||||+...
T Consensus 240 ~---------------------------~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 240 I---------------------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp C---------------------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred c---------------------------CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 0 01124567899999999999999999999999999998643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=391.93 Aligned_cols=257 Identities=23% Similarity=0.370 Sum_probs=203.9
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC------
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS------ 203 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~------ 203 (704)
++|++++.||+|+||+||+|++..+++.||||++.... .....+.+.+|+.+|++|+||||++++++|.+...
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 47999999999999999999999999999999998654 23445678899999999999999999998865321
Q ss_pred -------------------------------------------------CeEEEEEecccccccccccCCC---ccccHH
Q 005289 204 -------------------------------------------------CSIYLVFEYMEHDITGLLSCPD---IKFSEA 231 (704)
Q Consensus 204 -------------------------------------------------~~~~LV~Ey~~g~ll~~~~~~~---~~l~e~ 231 (704)
..+|||||||+++.+..+.... ...++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 2489999999986666544322 335666
Q ss_pred HHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC-----------CCcccccccccccC
Q 005289 232 QIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-----------QPLTSRVVTLWYRP 300 (704)
Q Consensus 232 ~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~-----------~~~~~~~gT~~Y~A 300 (704)
.++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........ ......++|+.|+|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 7999999999999999999999999999999999999999999999987654321 12344578999999
Q ss_pred cccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhh
Q 005289 301 PELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRE 380 (704)
Q Consensus 301 PEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~ 380 (704)
||++.+ ..|+.++|||||||++|+|++|..|+.. ....+..+.. +..+ .
T Consensus 245 PE~~~~-~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~--~~~~--------------------------~ 293 (332)
T 3qd2_B 245 PEQIHG-NNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRN--LKFP--------------------------L 293 (332)
T ss_dssp HHHHHC-CCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHT--TCCC--------------------------H
T ss_pred hHHhcC-CCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhc--cCCC--------------------------c
Confidence 999876 5689999999999999999998766421 1112222211 1111 1
Q ss_pred hccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 381 TFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 381 ~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
.+...++++.+||.+||..||.+|||+.++|+||||+.
T Consensus 294 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 294 LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred ccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 22345678899999999999999999999999999985
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=389.52 Aligned_cols=279 Identities=23% Similarity=0.414 Sum_probs=225.7
Q ss_pred cCCeeEEEEeeccCceEEEEEEE-CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCC------CceeEeEEEeec
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARD-LDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP------NIIKLEGLITSR 201 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~-~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hp------nIv~l~~~~~~~ 201 (704)
.++|++++.||+|+||+||+|.+ ..+++.||||++... ....+.+.+|+.+|+.+.|+ +|+++++++..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~- 88 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH- 88 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE-
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc-
Confidence 35899999999999999999998 568899999999643 34456788899999999765 49999999987
Q ss_pred CCCeEEEEEecccccccccccCCC-ccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEcc--------------
Q 005289 202 LSCSIYLVFEYMEHDITGLLSCPD-IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-------------- 266 (704)
Q Consensus 202 ~~~~~~LV~Ey~~g~ll~~~~~~~-~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~-------------- 266 (704)
...+||||||+++++...+.... ..+++..++.++.||+.||.|||++||+||||||+||||+.
T Consensus 89 -~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 89 -HGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp -TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred -CCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 57899999999777776664332 36899999999999999999999999999999999999987
Q ss_pred -----CCceEEeccccccccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHH
Q 005289 267 -----EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ 341 (704)
Q Consensus 267 -----~g~iKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~ 341 (704)
++.+||+|||++...... ....++|+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+.
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred cccccCCCceEeeCcccccCccc----cccccCCccccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 668999999999865432 245678999999999876 5689999999999999999999999999999999
Q ss_pred HHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCc-------------hhh---hhccCCCHHHHHHHHHhhccCCCCCc
Q 005289 342 LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDS-------------SLR---ETFKDLPTTAVNLIETLLSVEPYKRA 405 (704)
Q Consensus 342 l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~-------------~l~---~~~~~~s~~~~dLI~~mL~~dP~kRp 405 (704)
+..+...++.+|...|........ +......+.. .+. ......++++.+||.+||..||.+||
T Consensus 243 ~~~~~~~~~~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 243 LAMMERILGPLPKHMIQKTRKRKY-FHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHCSCCHHHHHHCSCGGG-EETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHhCCCCHHHHhhccchhH-HhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 999999999998877665432110 0000000000 000 00122357799999999999999999
Q ss_pred CHHHHHhccccCC
Q 005289 406 TASAALASEYFST 418 (704)
Q Consensus 406 Ta~e~L~hpwf~~ 418 (704)
|+.|+|+||||+.
T Consensus 322 t~~ell~hp~f~~ 334 (339)
T 1z57_A 322 TLREALKHPFFDL 334 (339)
T ss_dssp CHHHHTTSGGGGG
T ss_pred CHHHHhcCHHHHH
Confidence 9999999999984
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=381.97 Aligned_cols=262 Identities=28% Similarity=0.449 Sum_probs=221.2
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
...++|++++.||+|+||+||+|++..+++.||+|++..........+.+.+|+.+|+.++||||+++++++.+.....+
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 44678999999999999999999999999999999998877677777888999999999999999999998876556789
Q ss_pred EEEEecccccccccccC----CCccccHHHHHHHHHHhhhhHHHHHhcC-----cccccCCCccEEEccCCceEEecccc
Q 005289 207 YLVFEYMEHDITGLLSC----PDIKFSEAQIKCYMNQLLHGLEHCHSRG-----VLHRDIKGSNLLVNNEGVLKLADFGL 277 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~----~~~~l~e~~~~~i~~QIl~aL~yLH~~g-----IvHrDLKp~NILl~~~g~iKL~DFGl 277 (704)
||||||++++.+..+.. ....+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 99999998855544432 2334899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhh
Q 005289 278 ANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 357 (704)
Q Consensus 278 a~~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w 357 (704)
+....... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+....+... ..+
T Consensus 163 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~--~~~---- 234 (279)
T 2w5a_A 163 ARILNHDT-SFAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG--KFR---- 234 (279)
T ss_dssp HHHC---C-HHHHHHHSCCTTCCHHHHHC-C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCC----
T ss_pred heeecccc-ccccccCCCccccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhc--ccc----
Confidence 97665322 12234578999999999876 56899999999999999999999999998887777776552 110
Q ss_pred hccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 358 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
.....++.++.+||.+||..||.+|||+.++|+|+|+..
T Consensus 235 ----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 235 ----------------------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp ----------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred ----------------------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 011357899999999999999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=386.87 Aligned_cols=265 Identities=27% Similarity=0.408 Sum_probs=218.8
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC--hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE--PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~--~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
.++|++.+.||+|+||+||+|.+..+++.||||++...... ......+.+|+.+|+.++||||+++++++.......+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 35799999999999999999999999999999999754321 2345678899999999999999999999865546789
Q ss_pred EEEEecccccccccccC-CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 207 YLVFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~-~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
||||||+.+++...+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 163 (305)
T 2wtk_C 84 YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163 (305)
T ss_dssp EEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred EEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence 99999999986554432 34579999999999999999999999999999999999999999999999999998664322
Q ss_pred -CCCcccccccccccCcccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCC
Q 005289 286 -RQPLTSRVVTLWYRPPELLLGAT-DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 286 -~~~~~~~~gT~~Y~APEvl~~~~-~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
........+|+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+..+.+..+....-.
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~------------ 231 (305)
T 2wtk_C 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYA------------ 231 (305)
T ss_dssp SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC------------
T ss_pred cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCC------------
Confidence 12234456899999999987532 3467999999999999999999999998888777776542100
Q ss_pred CcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCCC
Q 005289 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422 (704)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~~ 422 (704)
....++..+.+||.+||..||.+|||+.++|+||||+....+
T Consensus 232 -----------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 273 (305)
T 2wtk_C 232 -----------------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP 273 (305)
T ss_dssp -----------------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred -----------------CCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence 113578899999999999999999999999999999875443
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=402.31 Aligned_cols=260 Identities=26% Similarity=0.428 Sum_probs=208.6
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC--CCCceeEeEEEeecCCCeE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD--HPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~--HpnIv~l~~~~~~~~~~~~ 206 (704)
...|++++.||+|+||+||+|.+.. ++.||||++............+.+|+.+|+.|. ||||+++++++.. ...+
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~--~~~~ 131 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQYI 131 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec--CCEE
Confidence 3469999999999999999999865 899999999877666777788999999999996 5999999999887 5679
Q ss_pred EEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC
Q 005289 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~ 286 (704)
|||||++.+++...+.. ...+++..++.|+.||+.||.|||++||+||||||+||||+ ++.+||+|||+++.......
T Consensus 132 ~lv~E~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 132 YMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp EEEEECCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred EEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 99999766666555443 34789999999999999999999999999999999999995 58999999999987654322
Q ss_pred C-CcccccccccccCcccccC----------CCCCCCccchhhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCCc
Q 005289 287 Q-PLTSRVVTLWYRPPELLLG----------ATDYGPSVDLWSVGCVFAELLIGKPILQGRTE-VEQLHKIFKLCGSPPD 354 (704)
Q Consensus 287 ~-~~~~~~gT~~Y~APEvl~~----------~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~-~e~l~~I~~~~g~~p~ 354 (704)
. .....+||+.|+|||++.+ ...|+.++||||||||||+|++|++||..... ...+..+.......
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~-- 287 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI-- 287 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCC--
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccC--
Confidence 1 2345689999999999864 13688999999999999999999999987543 34444443211000
Q ss_pred hhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCC
Q 005289 355 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (704)
Q Consensus 355 ~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~ 420 (704)
......+.++.+||.+||..||.+|||+.++|+||||+...
T Consensus 288 -------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 288 -------------------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp -------------------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred -------------------------CCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 00123478899999999999999999999999999998643
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=400.27 Aligned_cols=250 Identities=22% Similarity=0.365 Sum_probs=209.9
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChH------HHHHHHHHHHHHHhcCCCCceeEeEEEeecCC
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPE------SVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 203 (704)
++|++++.||+|+||+||+|++..+++.||||++........ ....+.+|+.+|+.++||||++++++|.+ .
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--~ 101 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN--Q 101 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC--S
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee--C
Confidence 479999999999999999999999999999999987543211 23346679999999999999999999987 5
Q ss_pred CeEEEEEeccccc-ccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccC
Q 005289 204 CSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (704)
Q Consensus 204 ~~~~LV~Ey~~g~-ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~ 282 (704)
..+||||||+.++ .+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 7899999999764 555555555679999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCC
Q 005289 283 TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (704)
Q Consensus 283 ~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~ 362 (704)
.. ......++|+.|+|||++.+...++.++|||||||++|+|++|.+||..... +.. .
T Consensus 182 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~---~----------- 239 (335)
T 3dls_A 182 RG--KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVE---A----------- 239 (335)
T ss_dssp TT--CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTT---T-----------
T ss_pred CC--CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHh---h-----------
Confidence 43 2334567899999999998755458899999999999999999999965221 000 0
Q ss_pred CCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
. ......+++++.+||.+||..||.+|||+.++|+||||+.
T Consensus 240 ---~------------~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 240 ---A------------IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp ---C------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred ---c------------cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence 0 0011347899999999999999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=390.38 Aligned_cols=259 Identities=27% Similarity=0.425 Sum_probs=209.4
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC------hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE------PESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~------~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 203 (704)
++|++++.||+|+||+||+|++..+++.||||++...... ......+.+|+.+|+.++||||+++++++..
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--- 86 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA--- 86 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES---
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC---
Confidence 4799999999999999999999999999999999764321 1223457789999999999999999999876
Q ss_pred CeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCc---eEEeccccccc
Q 005289 204 CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV---LKLADFGLANF 280 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~---iKL~DFGla~~ 280 (704)
..+||||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++..
T Consensus 87 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 87 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp SSEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred CceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 348999999998666555555668999999999999999999999999999999999999987664 99999999987
Q ss_pred cCCCCCCCcccccccccccCccccc--CCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCCchhh
Q 005289 281 SNTGHRQPLTSRVVTLWYRPPELLL--GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV-EQLHKIFKLCGSPPDDYW 357 (704)
Q Consensus 281 ~~~~~~~~~~~~~gT~~Y~APEvl~--~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~-e~l~~I~~~~g~~p~~~w 357 (704)
.... ......++|+.|+|||++. +...|+.++|||||||+||+|++|.+||...... .....+......+
T Consensus 167 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----- 239 (322)
T 2ycf_A 167 LGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF----- 239 (322)
T ss_dssp CCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCC-----
T ss_pred cccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcccc-----
Confidence 6432 2234457899999999974 3457899999999999999999999999875433 2223332211111
Q ss_pred hccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 358 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
+...+..++..+.+||.+||..||.+|||+.++|+||||+.
T Consensus 240 --------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 240 --------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp --------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred --------------------CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 12334678999999999999999999999999999999985
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=382.75 Aligned_cols=252 Identities=21% Similarity=0.289 Sum_probs=207.9
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCCeEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~ 207 (704)
.++|++++.||+|+||+||+|++..+++.||||++............+.+|+.++..+ +||||+++++++.+ ...+|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~--~~~~~ 87 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE--DDHML 87 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE--TTEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeEE
Confidence 3579999999999999999999999999999999987655555567788999999999 99999999999987 57899
Q ss_pred EEEecccccccccccCCC----ccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccC----------------
Q 005289 208 LVFEYMEHDITGLLSCPD----IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE---------------- 267 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~----~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~---------------- 267 (704)
|||||++++.+..+.... ..+++..++.++.||+.||.|||++||+||||||+||||+.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 999999885555443322 458999999999999999999999999999999999999844
Q ss_pred ---CceEEeccccccccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 005289 268 ---GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHK 344 (704)
Q Consensus 268 ---g~iKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~ 344 (704)
..+||+|||++...... ....+|+.|+|||++.+...++.++|||||||++|+|++|.++|..... ...
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~ 239 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSP-----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHE 239 (289)
T ss_dssp --CCCEEECCCTTCEETTCS-----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHH
T ss_pred CCceEEEEcccccccccCCc-----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHH
Confidence 47999999999876543 2346899999999998755677899999999999999999988765432 222
Q ss_pred HHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 345 IFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 345 I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
+.. +..+ .....+++.+.+||.+||..||.+|||+.++|+||||+.
T Consensus 240 ~~~--~~~~--------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 285 (289)
T 1x8b_A 240 IRQ--GRLP--------------------------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285 (289)
T ss_dssp HHT--TCCC--------------------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred HHc--CCCC--------------------------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence 221 1110 112467899999999999999999999999999999985
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=384.12 Aligned_cols=259 Identities=31% Similarity=0.480 Sum_probs=191.6
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
..++|++.+.||+|+||+||+|++..+++.||||++...... ......+.+|+.+++.++||||+++++++.+ ...+
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 86 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED--SNYV 86 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC--SSEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc--CCeE
Confidence 356799999999999999999999999999999999753211 1224567899999999999999999999987 5789
Q ss_pred EEEEeccccccccc-ccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 207 YLVFEYMEHDITGL-LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~-~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
||||||++++.+.. +......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 99999998755554 44444679999999999999999999999999999999999999999999999999998665332
Q ss_pred CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|++||...+..+.+..+.. .
T Consensus 167 -~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---------------~-- 227 (278)
T 3cok_A 167 -EKHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL---------------A-- 227 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS---------------S--
T ss_pred -CcceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh---------------c--
Confidence 12234578999999999876 5689999999999999999999999987654433322210 0
Q ss_pred ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
. ......++.++.+||.+||..||.+|||+.++|+||||+..
T Consensus 228 -----~-------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 228 -----D-------YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp -----C-------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred -----c-------cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 0 00113578899999999999999999999999999999863
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=393.06 Aligned_cols=278 Identities=23% Similarity=0.330 Sum_probs=213.7
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|++.+.||+|+||+||+|++..+++.||||++..... ....+.+.+|+.+|++++||||+++++++.......+||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 4579999999999999999999999999999999975432 223456778999999999999999999998766668999
Q ss_pred EEecccccccccccCCCc---cccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEE----ccCCceEEecccccccc
Q 005289 209 VFEYMEHDITGLLSCPDI---KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFS 281 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~---~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl----~~~g~iKL~DFGla~~~ 281 (704)
||||++++.+..+..... .+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++..
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 999998766554443322 38999999999999999999999999999999999999 77788999999999876
Q ss_pred CCCCCCCcccccccccccCcccccC-------CCCCCCccchhhHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHcC
Q 005289 282 NTGHRQPLTSRVVTLWYRPPELLLG-------ATDYGPSVDLWSVGCVFAELLIGKPILQGRT----EVEQLHKIFKLCG 350 (704)
Q Consensus 282 ~~~~~~~~~~~~gT~~Y~APEvl~~-------~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~----~~e~l~~I~~~~g 350 (704)
.... .....++|+.|+|||++.. ...|+.++|||||||+||+|++|.+||.... ..+.+.++..
T Consensus 167 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~--- 241 (319)
T 4euu_A 167 EDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT--- 241 (319)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH---
T ss_pred CCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc---
Confidence 5432 3345678999999999852 3578999999999999999999999997533 3444444443
Q ss_pred CCCchhhhccCCCCcccCC--CCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccc
Q 005289 351 SPPDDYWKKSKLPHATLFK--PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415 (704)
Q Consensus 351 ~~p~~~w~~~~~~~~~~~~--~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpw 415 (704)
..|...|..........+. ...+.. ......++..+.+||.+||.+||++|||++|+|+||=
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVS---CSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTT---CSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred CCCcccchhhhcccCCccccCccCCcc---cccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 2333333221110000000 000000 0111345678899999999999999999999999973
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=382.07 Aligned_cols=260 Identities=27% Similarity=0.448 Sum_probs=220.0
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|++++.||+|+||+||+|++..+++.||||++............+.+|+.+|++++||||+++++++.. ...+|+
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 98 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED--SSSFYI 98 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC--CCeEEE
Confidence 357999999999999999999999999999999997655444456678899999999999999999999987 578999
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccC---CceEEeccccccccCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE---GVLKLADFGLANFSNTGH 285 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~---g~iKL~DFGla~~~~~~~ 285 (704)
||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.+ +.+||+|||++......
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~- 177 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN- 177 (287)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC-
T ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC-
Confidence 99999876554443334578999999999999999999999999999999999999764 46999999999866543
Q ss_pred CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
.......+|+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+......++
T Consensus 178 -~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------ 242 (287)
T 2wei_A 178 -TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD------------ 242 (287)
T ss_dssp -SSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC------------
T ss_pred -CccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC------------
Confidence 22344568999999999875 489999999999999999999999999988888777765221111
Q ss_pred ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
...+..++.++.+||.+||..||.+|||+.++|+||||++.
T Consensus 243 -------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 243 -------------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp -------------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred -------------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 11235789999999999999999999999999999999853
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=399.74 Aligned_cols=262 Identities=26% Similarity=0.453 Sum_probs=211.8
Q ss_pred cCCeeEEEEeeccCceEEEEEEEC---CCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDL---DTGKIVALKKVRFDNF--EPESVRFMAREILILRRL-DHPNIIKLEGLITSRL 202 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAvK~i~~~~~--~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~ 202 (704)
.++|++++.||+|+||+||+|++. .+++.||||++..... .....+.+.+|+.+|+.+ +||||+++++++..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 130 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-- 130 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee--
Confidence 468999999999999999999984 5899999999865321 111233456799999999 79999999999987
Q ss_pred CCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccC
Q 005289 203 SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (704)
Q Consensus 203 ~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~ 282 (704)
...+|||||||+++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 56899999999986666555455579999999999999999999999999999999999999999999999999998664
Q ss_pred CCCCCCcccccccccccCcccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHcCCCCchhh
Q 005289 283 TGHRQPLTSRVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIGKPILQGRT----EVEQLHKIFKLCGSPPDDYW 357 (704)
Q Consensus 283 ~~~~~~~~~~~gT~~Y~APEvl~~~-~~y~~~~DIWSlG~iLyeLltG~~pF~~~~----~~e~l~~I~~~~g~~p~~~w 357 (704)
..........++|+.|+|||++.+. ..++.++|||||||+||+|++|.+||.... ...+...+... .+
T Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--~~----- 283 (355)
T 1vzo_A 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS--EP----- 283 (355)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC--CC-----
T ss_pred cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc--CC-----
Confidence 4333334456889999999998752 457899999999999999999999997543 23333333221 10
Q ss_pred hccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCc-----CHHHHHhccccCCCCC
Q 005289 358 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 421 (704)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRp-----Ta~e~L~hpwf~~~~~ 421 (704)
.....++..+.+||.+||..||.+|| |+.++|+||||+...|
T Consensus 284 ----------------------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~ 330 (355)
T 1vzo_A 284 ----------------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 330 (355)
T ss_dssp ----------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred ----------------------CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCCh
Confidence 01136788999999999999999999 9999999999987543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=395.50 Aligned_cols=287 Identities=23% Similarity=0.318 Sum_probs=217.5
Q ss_pred ccccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCe
Q 005289 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (704)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (704)
.+..++|++++.||+|+||+||+|++..+++.||+|++.... .......+.+|+.+|+.++||||+++++++.. ...
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 105 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGE 105 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE--TTE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE--CCE
Confidence 345678999999999999999999999999999999998653 45556778899999999999999999999987 578
Q ss_pred EEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhc-CcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~-gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
+||||||++++.+..+......+++..++.++.||+.||.|||+. ||+||||||+||||+.++.+||+|||++......
T Consensus 106 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 999999999866666555555799999999999999999999996 9999999999999999999999999998654322
Q ss_pred CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC-CCCchhhhccCC-
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG-SPPDDYWKKSKL- 362 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g-~~p~~~w~~~~~- 362 (704)
.....++|+.|+|||++.+ ..|+.++|||||||++|+|++|+.||...+..+....+..... ......+.....
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp ---C----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred ---cccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 2244578999999999876 5689999999999999999999999998876665443321111 111111100000
Q ss_pred -CCcccCCCCCCCC---chh---------hhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 363 -PHATLFKPQQPYD---SSL---------RETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 363 -~~~~~~~~~~~~~---~~l---------~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
..........+.. ..+ ......++.++.+||.+||.+||.+|||+.++|+||||+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 0000000000000 000 00113478899999999999999999999999999999853
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=382.35 Aligned_cols=259 Identities=25% Similarity=0.363 Sum_probs=209.2
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
+..++|++.+.||+|+||+||+|++ +++.||||++..........+.+.+|+.+|++++||||+++++++.. ...+
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~ 109 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ--PPNL 109 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--TTCC
T ss_pred CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCce
Confidence 3456899999999999999999987 68899999998777677777888999999999999999999999977 4678
Q ss_pred EEEEecccccccccccCCCc---cccHHHHHHHHHHhhhhHHHHHhcC--cccccCCCccEEEccCCceEEecccccccc
Q 005289 207 YLVFEYMEHDITGLLSCPDI---KFSEAQIKCYMNQLLHGLEHCHSRG--VLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~~~~---~l~e~~~~~i~~QIl~aL~yLH~~g--IvHrDLKp~NILl~~~g~iKL~DFGla~~~ 281 (704)
||||||++++.+..+..... .+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++..
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 99999999866555443332 3999999999999999999999999 999999999999999999999999999765
Q ss_pred CCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccC
Q 005289 282 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (704)
Q Consensus 282 ~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~ 361 (704)
.... ......++|+.|+|||++.+ ..++.++|||||||+||+|++|..||.+.+..+.+..+......+
T Consensus 190 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~--------- 258 (309)
T 3p86_A 190 ASTF-LSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL--------- 258 (309)
T ss_dssp -------------CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC---------
T ss_pred cccc-cccccCCCCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC---------
Confidence 4322 22345678999999999876 568999999999999999999999999988887776664322111
Q ss_pred CCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh--ccccCC
Q 005289 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA--SEYFST 418 (704)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~--hpwf~~ 418 (704)
.....+++.+.+||.+||..||.+|||+.++++ .+|++.
T Consensus 259 ------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 259 ------------------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp ------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred ------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 112468899999999999999999999999997 577664
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=376.54 Aligned_cols=259 Identities=25% Similarity=0.445 Sum_probs=204.2
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeec--------
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR-------- 201 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~-------- 201 (704)
++|++++.||+|+||+||+|++..+++.||||++... ......+.+|+.+|+.++||||+++++++.+.
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 4699999999999999999999999999999999643 35567788999999999999999999988652
Q ss_pred ---CCCeEEEEEecccccccc-cccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEecccc
Q 005289 202 ---LSCSIYLVFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL 277 (704)
Q Consensus 202 ---~~~~~~LV~Ey~~g~ll~-~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGl 277 (704)
....+||||||++++.+. .+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 135789999999875444 4444556788999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCC-------------CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC-CCHHHHHH
Q 005289 278 ANFSNTGH-------------RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG-RTEVEQLH 343 (704)
Q Consensus 278 a~~~~~~~-------------~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~-~~~~e~l~ 343 (704)
+....... .......++|+.|+|||++.+...++.++|||||||++|+|++ ||.. .+..+.+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~ 239 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK 239 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHH
Confidence 97654221 1223455789999999999875679999999999999999998 4443 33334444
Q ss_pred HHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 344 KIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 344 ~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
.+.......+. ......+..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 240 ~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 240 KLRSVSIEFPP-------------------------DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHHSTTCCCCT-------------------------TCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred hccccccccCc-------------------------cccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 44332111110 1124567889999999999999999999999999999853
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=387.57 Aligned_cols=275 Identities=23% Similarity=0.388 Sum_probs=217.6
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCCh---------------HHHHHHHHHHHHHHhcCCCCcee
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP---------------ESVRFMAREILILRRLDHPNIIK 193 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~---------------~~~~~~~~Ei~iL~~L~HpnIv~ 193 (704)
.++|++++.||+|+||+||+|++ +++.||||++....... .....+.+|+.+|+.|+||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 56899999999999999999998 89999999997542211 11267889999999999999999
Q ss_pred EeEEEeecCCCeEEEEEecccccccccc------cCC--CccccHHHHHHHHHHhhhhHHHHHh-cCcccccCCCccEEE
Q 005289 194 LEGLITSRLSCSIYLVFEYMEHDITGLL------SCP--DIKFSEAQIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLV 264 (704)
Q Consensus 194 l~~~~~~~~~~~~~LV~Ey~~g~ll~~~------~~~--~~~l~e~~~~~i~~QIl~aL~yLH~-~gIvHrDLKp~NILl 264 (704)
+++++.+ ...+||||||++++.+..+ ... ...+++..++.++.||+.||.|||+ +||+||||||+||||
T Consensus 108 ~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 108 CEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM 185 (348)
T ss_dssp CSEEEES--SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE
T ss_pred EEEEEee--CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE
Confidence 9999987 5789999999998655554 333 5679999999999999999999999 999999999999999
Q ss_pred ccCCceEEeccccccccCCCCCCCcccccccccccCcccccCCCCCCC-ccchhhHHHHHHHHHhCCCCCCCCCH-HHHH
Q 005289 265 NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGP-SVDLWSVGCVFAELLIGKPILQGRTE-VEQL 342 (704)
Q Consensus 265 ~~~g~iKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~-~~DIWSlG~iLyeLltG~~pF~~~~~-~e~l 342 (704)
+.++.+||+|||++...... ......+|+.|+|||++.+...++. ++|||||||++|+|++|.+||.+.+. .+.+
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 262 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 99999999999999876443 3345678999999999987545666 99999999999999999999998776 6666
Q ss_pred HHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCC
Q 005289 343 HKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (704)
Q Consensus 343 ~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~ 420 (704)
..+.......+... ....... ...........++.++.+||.+||..||.+|||+.++|+||||+..+
T Consensus 263 ~~i~~~~~~~~~~~--------~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 263 NNIRTKNIEYPLDR--------NHFLYPL--TNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp HHHTSCCCCCCCSS--------SSSTTTT--CC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred HHHhccCcCCccch--------hhhhccc--cccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence 66644222211110 0000000 00111222357899999999999999999999999999999998644
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=381.10 Aligned_cols=261 Identities=26% Similarity=0.415 Sum_probs=209.8
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecC----C
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRL----S 203 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~----~ 203 (704)
.++|++++.||.|+||+||+|++..+++.||||++..... ....+.+|+.+|+++ +||||+++++++.... .
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 99 (326)
T 2x7f_A 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 99 (326)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc---cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence 4689999999999999999999999999999999976532 235677899999999 8999999999997642 4
Q ss_pred CeEEEEEecccccccccccC--CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEecccccccc
Q 005289 204 CSIYLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~~~~--~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~ 281 (704)
..+||||||++++.+..+.. ....+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++...
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 179 (326)
T 2x7f_A 100 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179 (326)
T ss_dssp CEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred ceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence 67899999999855554432 2356899999999999999999999999999999999999999999999999999765
Q ss_pred CCCCCCCcccccccccccCcccccC----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhh
Q 005289 282 NTGHRQPLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 357 (704)
Q Consensus 282 ~~~~~~~~~~~~gT~~Y~APEvl~~----~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w 357 (704)
.... ......++|+.|+|||++.. ...++.++|||||||+||+|++|.+||.+......+..+.... .+
T Consensus 180 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~---- 252 (326)
T 2x7f_A 180 DRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--AP---- 252 (326)
T ss_dssp ------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--CC----
T ss_pred CcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc--cc----
Confidence 4322 12344578999999999862 3568999999999999999999999999888777666554311 10
Q ss_pred hccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCC
Q 005289 358 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (704)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~ 420 (704)
......++..+.+||.+||..||.+|||+.++|+||||+..+
T Consensus 253 ---------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 253 ---------------------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp ---------------------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred ---------------------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 001246789999999999999999999999999999998643
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=396.73 Aligned_cols=265 Identities=19% Similarity=0.227 Sum_probs=193.7
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhc--CCCCceeEe-------EEEe
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRL--DHPNIIKLE-------GLIT 199 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L--~HpnIv~l~-------~~~~ 199 (704)
..|++++.||+|+||+||+|++..+++.||||++...... ....+.+.+|+.+++.| +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 3599999999999999999999999999999999876543 34556677885555555 699988855 4444
Q ss_pred ecCC---------------CeEEEEEecccccccccccCCCccccHHHH------HHHHHHhhhhHHHHHhcCcccccCC
Q 005289 200 SRLS---------------CSIYLVFEYMEHDITGLLSCPDIKFSEAQI------KCYMNQLLHGLEHCHSRGVLHRDIK 258 (704)
Q Consensus 200 ~~~~---------------~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~------~~i~~QIl~aL~yLH~~gIvHrDLK 258 (704)
.... ..+|||||||++++...+......+++... ..++.||+.||.|||++||+|||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik 221 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence 3221 458999999997766665443333444444 5666999999999999999999999
Q ss_pred CccEEEccCCceEEeccccccccCCCCCCCcccccccccccCcccccC-CCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 005289 259 GSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG-ATDYGPSVDLWSVGCVFAELLIGKPILQGRT 337 (704)
Q Consensus 259 p~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APEvl~~-~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~ 337 (704)
|+||||+.++.+||+|||+++..... .....+|+.|+|||++.+ ...|+.++|||||||+||+|++|++||.+..
T Consensus 222 p~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 297 (371)
T 3q60_A 222 PDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297 (371)
T ss_dssp GGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCC
T ss_pred HHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcC
Confidence 99999999999999999999866432 224566799999999864 2468999999999999999999999998764
Q ss_pred HHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccC
Q 005289 338 EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417 (704)
Q Consensus 338 ~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~ 417 (704)
... ...|........ .........+..+++.+.+||.+||.+||++|||+.++|+||||+
T Consensus 298 ~~~-------------~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 357 (371)
T 3q60_A 298 PGI-------------KGSWKRPSLRVP-------GTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357 (371)
T ss_dssp TTC-------------TTCCCBCCTTSC-------CCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHH
T ss_pred ccc-------------ccchhhhhhhhc-------cccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHH
Confidence 320 001111000000 000001122357899999999999999999999999999999997
Q ss_pred C
Q 005289 418 T 418 (704)
Q Consensus 418 ~ 418 (704)
.
T Consensus 358 ~ 358 (371)
T 3q60_A 358 Q 358 (371)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=380.37 Aligned_cols=260 Identities=27% Similarity=0.428 Sum_probs=211.9
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|++++.||.|+||+||+|++..+++.||+|++.... ......+.+|+.+|+.++||||+++++++.. ...+||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 93 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYH--DGKLWI 93 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--C-CEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeee--CCeEEE
Confidence 457999999999999999999999999999999987543 2335677889999999999999999999987 468999
Q ss_pred EEeccccccccccc-CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCC
Q 005289 209 VFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (704)
Q Consensus 209 V~Ey~~g~ll~~~~-~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~ 287 (704)
||||++++.+..+. .....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... .
T Consensus 94 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 172 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-Q 172 (302)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-H
T ss_pred EEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-c
Confidence 99999987666443 234569999999999999999999999999999999999999999999999999975332110 1
Q ss_pred CcccccccccccCccccc----CCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCC
Q 005289 288 PLTSRVVTLWYRPPELLL----GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 288 ~~~~~~gT~~Y~APEvl~----~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
......+|+.|+|||++. ....++.++|||||||++|+|++|.+||...+....+..+.... ++.
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~--------- 241 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD--PPT--------- 241 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--CCC---------
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccC--Ccc---------
Confidence 123457899999999984 34678999999999999999999999999988877776665421 110
Q ss_pred CcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
......++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 242 ---------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 242 ---------------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp ---------------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred ---------------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence 00113578899999999999999999999999999999863
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=382.96 Aligned_cols=271 Identities=25% Similarity=0.390 Sum_probs=195.3
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
+..++|++++.||+|+||+||+|++..+++.||||++..... ......+.+|+.+|+.++||||+++++++.. ...+
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 88 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVV--KDEL 88 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEES--SSCE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEee--cCCc
Confidence 345789999999999999999999999999999999875432 2335567889999999999999999999987 4679
Q ss_pred EEEEecccccccccccC--------CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccc
Q 005289 207 YLVFEYMEHDITGLLSC--------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 278 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~--------~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla 278 (704)
|+||||++++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 99999998765544332 3456899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCC----CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCc
Q 005289 279 NFSNTGHR----QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 354 (704)
Q Consensus 279 ~~~~~~~~----~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~ 354 (704)
........ .......+|+.|+|||++.+...++.++|||||||+||+|++|.+||........+..... ..++.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~ 246 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ--NDPPS 246 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHT--SSCCC
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhc--cCCCc
Confidence 76543211 1223457899999999986545689999999999999999999999998776655544332 11110
Q ss_pred hhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 355 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 355 ~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
.. ...........++.++.+||.+||..||.+|||+.++|+||||+..
T Consensus 247 -~~----------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 247 -LE----------------TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp -TT----------------C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred -cc----------------cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 00 0000112335788999999999999999999999999999999864
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=404.84 Aligned_cols=252 Identities=17% Similarity=0.238 Sum_probs=199.3
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHH---HHHHhcCCCCceeEe-------EE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREI---LILRRLDHPNIIKLE-------GL 197 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei---~iL~~L~HpnIv~l~-------~~ 197 (704)
.++|++.+.||+|+||+||+|++..+|+.||||++..... .....+.+.+|+ .+|+.++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 4679999999999999999999999999999999986533 344567788999 455555899999998 66
Q ss_pred EeecCC----------C-----eEEEEEecccccccccccCC------CccccHHHHHHHHHHhhhhHHHHHhcCccccc
Q 005289 198 ITSRLS----------C-----SIYLVFEYMEHDITGLLSCP------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRD 256 (704)
Q Consensus 198 ~~~~~~----------~-----~~~LV~Ey~~g~ll~~~~~~------~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrD 256 (704)
+..... . ..||||||+++++...+... ...+++..++.|+.||+.||.|||++||+|||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD 231 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 231 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 655311 0 37999999987665554321 23345588889999999999999999999999
Q ss_pred CCCccEEEccCCceEEeccccccccCCCCCCCcccccccccccCcccccCC----------CCCCCccchhhHHHHHHHH
Q 005289 257 IKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA----------TDYGPSVDLWSVGCVFAEL 326 (704)
Q Consensus 257 LKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APEvl~~~----------~~y~~~~DIWSlG~iLyeL 326 (704)
|||+||||+.++.+||+|||+++.... .....+| +.|+|||++.+. ..|+.++|||||||+||+|
T Consensus 232 ikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el 306 (377)
T 3byv_A 232 LRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306 (377)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred CCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence 999999999999999999999986432 3345677 999999998763 2689999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcC
Q 005289 327 LIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 406 (704)
Q Consensus 327 ltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpT 406 (704)
++|++||.+.+..+.+..+ ...+..+++++.+||.+||..||.+|||
T Consensus 307 ltg~~Pf~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt 353 (377)
T 3byv_A 307 WCADLPITKDAALGGSEWI---------------------------------FRSCKNIPQPVRALLEGFLRYPKEDRLL 353 (377)
T ss_dssp HHSSCCC------CCSGGG---------------------------------GSSCCCCCHHHHHHHHHHTCSSGGGCCC
T ss_pred HHCCCCCcccccccchhhh---------------------------------hhhccCCCHHHHHHHHHHcCCCchhCCC
Confidence 9999999765432211111 1122578999999999999999999999
Q ss_pred HHHHHhccccCC
Q 005289 407 ASAALASEYFST 418 (704)
Q Consensus 407 a~e~L~hpwf~~ 418 (704)
+.++|+||||+.
T Consensus 354 ~~e~l~hp~f~~ 365 (377)
T 3byv_A 354 PLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHTSHHHHH
T ss_pred HHHHhhChHHHH
Confidence 999999999973
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=373.32 Aligned_cols=256 Identities=30% Similarity=0.479 Sum_probs=218.9
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.+.|++++.||+|+||+||+|++..+++.||||++...... ...+.+.+|+.+|+.++||||+++++++.. ...+||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 97 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLK--DTKLWI 97 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CCeEEE
Confidence 35799999999999999999999999999999999865433 345678899999999999999999999987 568999
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
||||++++.+..+... ..+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++....... ..
T Consensus 98 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 175 (303)
T 3a7i_A 98 IMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IK 175 (303)
T ss_dssp EEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-CC
T ss_pred EEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc-cc
Confidence 9999998666655543 479999999999999999999999999999999999999999999999999997665432 22
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccC
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~ 368 (704)
.....+|+.|+|||++.+ ..++.++|||||||+||+|++|.+||........+..+... .++
T Consensus 176 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~--------------- 237 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN--NPP--------------- 237 (303)
T ss_dssp BCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--CCC---------------
T ss_pred cCccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC--CCC---------------
Confidence 345578999999999876 56899999999999999999999999988877766655431 111
Q ss_pred CCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 369 ~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
.....++..+.+||.+||..||.+|||+.++|+||||..
T Consensus 238 -----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 238 -----------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp -----------CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred -----------CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence 011367899999999999999999999999999999975
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=375.76 Aligned_cols=258 Identities=28% Similarity=0.456 Sum_probs=211.9
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|++++.||.|+||+||+|.+..+|+.||||++..... ...+.+|+.+|+.++||||+++++++.. ...+||
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 101 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFK--NTDLWI 101 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEe--CCEEEE
Confidence 4679999999999999999999999999999999976432 3457789999999999999999999987 578999
Q ss_pred EEecccccccccccC-CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCC
Q 005289 209 VFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~-~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~ 287 (704)
||||++++.+..+.. ....+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++....... .
T Consensus 102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~ 180 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM-A 180 (314)
T ss_dssp EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-S
T ss_pred EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-c
Confidence 999999865554432 45579999999999999999999999999999999999999999999999999997665332 2
Q ss_pred CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCccc
Q 005289 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (704)
Q Consensus 288 ~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~ 367 (704)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||........+..+.... ++ .
T Consensus 181 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~-~------------ 244 (314)
T 3com_A 181 KRNTVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP--PP-T------------ 244 (314)
T ss_dssp CBCCCCSCGGGCCHHHHSS-SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--CC-C------------
T ss_pred ccCccCCCCCccChhhcCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC--Cc-c------------
Confidence 2344578999999999876 568999999999999999999999999887766655543311 10 0
Q ss_pred CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCC
Q 005289 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (704)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~ 420 (704)
......++..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 245 -----------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 245 -----------FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp -----------CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred -----------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 001134688999999999999999999999999999998643
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=377.61 Aligned_cols=260 Identities=23% Similarity=0.380 Sum_probs=198.1
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|++++.||+|+||+||+|++..+++.||||++..........+.+..+..+++.++||||+++++++.. ...+||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~--~~~~~l 101 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT--NTDVFI 101 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec--CCcEEE
Confidence 568999999999999999999999999999999998765444444555556667888899999999999987 578999
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhc-CcccccCCCccEEEccCCceEEeccccccccCCCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~-gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~ 287 (704)
||||+++.+..........+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||++.......
T Consensus 102 v~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-- 179 (318)
T 2dyl_A 102 AMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK-- 179 (318)
T ss_dssp EECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred EEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc--
Confidence 999995544333333345789999999999999999999995 99999999999999999999999999997654432
Q ss_pred CcccccccccccCccccc----CCCCCCCccchhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHHcCCCCchhhhccCC
Q 005289 288 PLTSRVVTLWYRPPELLL----GATDYGPSVDLWSVGCVFAELLIGKPILQG-RTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (704)
Q Consensus 288 ~~~~~~gT~~Y~APEvl~----~~~~y~~~~DIWSlG~iLyeLltG~~pF~~-~~~~e~l~~I~~~~g~~p~~~w~~~~~ 362 (704)
......+|+.|+|||++. ....++.++|||||||+||+|++|..||.. ....+.+..+... .++.
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~-------- 249 (318)
T 2dyl_A 180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE--EPPL-------- 249 (318)
T ss_dssp -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHS--CCCC--------
T ss_pred cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhcc--CCCC--------
Confidence 234457899999999985 235688999999999999999999999987 4555666665442 1110
Q ss_pred CCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
......++.++.+||.+||..||.+|||+.++|+||||+.
T Consensus 250 ----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 250 ----------------LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp ----------------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred ----------------CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 0011357899999999999999999999999999999974
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=367.62 Aligned_cols=252 Identities=23% Similarity=0.341 Sum_probs=212.1
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
+..++|++++.||+|+||+||+|++. +++.||||++...... .+.+.+|+.+|++++||||+++++++.+ ...+
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~ 80 (269)
T 4hcu_A 7 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPI 80 (269)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECS--SSSE
T ss_pred eChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC---HHHHHHHHHHHHhCCCCCEeeEEEEEec--CCce
Confidence 34568999999999999999999986 4778999999865433 3457889999999999999999999977 4679
Q ss_pred EEEEecccccccccc-cCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 207 YLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~-~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
||||||++++.+..+ ......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred EEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 999999998655544 3455679999999999999999999999999999999999999999999999999998665433
Q ss_pred CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC
Q 005289 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
........+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+.......
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~------------ 227 (269)
T 4hcu_A 161 YTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY------------ 227 (269)
T ss_dssp HHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC------------
T ss_pred cccccCcccccccCCHHHhcC-CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCC------------
Confidence 223344456888999999875 568999999999999999999 999999999888877775421110
Q ss_pred cccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
....+++.+.+||.+||..||.+|||+.++|+|
T Consensus 228 ----------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 228 ----------------KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp ----------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 013468899999999999999999999999986
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=378.98 Aligned_cols=264 Identities=19% Similarity=0.281 Sum_probs=195.6
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCc---EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGK---IVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~---~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 203 (704)
+..++|++++.||+|+||+||+|++..++. .||||++..........+.+.+|+.+|+.++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 345689999999999999999999887765 89999998765555667788999999999999999999999876321
Q ss_pred C----eEEEEEecccccccccccC------CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEe
Q 005289 204 C----SIYLVFEYMEHDITGLLSC------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLA 273 (704)
Q Consensus 204 ~----~~~LV~Ey~~g~ll~~~~~------~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~ 273 (704)
. ..|+||||+.++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~ 179 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVA 179 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEEC
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEe
Confidence 1 2499999999865554432 12258999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCC-CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCC
Q 005289 274 DFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGS 351 (704)
Q Consensus 274 DFGla~~~~~~~~-~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~ 351 (704)
|||++........ .......+|+.|+|||++.+ ..|+.++|||||||++|+|++ |.+||.+.+..+.+..+......
T Consensus 180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~ 258 (323)
T 3qup_A 180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRL 258 (323)
T ss_dssp CCCC-----------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC
T ss_pred eccccccccccccccccccccCcccccCchhhcC-CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCC
Confidence 9999986644321 12223455788999999876 568999999999999999999 99999998887777766542110
Q ss_pred CCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcC-------HHHHHhccccCCC
Q 005289 352 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-------ASAALASEYFSTK 419 (704)
Q Consensus 352 ~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpT-------a~e~L~hpwf~~~ 419 (704)
.....+++++.+||.+||..||.+||| ++++|.|+|+...
T Consensus 259 ----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 259 ----------------------------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp ----------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred ----------------------------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 011467899999999999999999999 7889999999864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=381.67 Aligned_cols=257 Identities=22% Similarity=0.313 Sum_probs=208.7
Q ss_pred cccCCeeEEEEeeccCceEEEEEE-----ECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEee
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRAR-----DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITS 200 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~-----~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~ 200 (704)
+..++|++.+.||+|+||+||+|+ +..+++.||||++.... .....+.+.+|+.+|.++ +||||+++++++..
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 97 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTK 97 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence 345789999999999999999998 56677999999997543 344567788999999999 89999999999876
Q ss_pred cCCCeEEEEEecccccccccccCCC-------------------------------------------------------
Q 005289 201 RLSCSIYLVFEYMEHDITGLLSCPD------------------------------------------------------- 225 (704)
Q Consensus 201 ~~~~~~~LV~Ey~~g~ll~~~~~~~------------------------------------------------------- 225 (704)
. ...+|||||||.++.+..+....
T Consensus 98 ~-~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (359)
T 3vhe_A 98 P-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV 176 (359)
T ss_dssp T-TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred C-CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence 4 35689999999986555443221
Q ss_pred -----------ccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC-CCccccc
Q 005289 226 -----------IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRV 293 (704)
Q Consensus 226 -----------~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~-~~~~~~~ 293 (704)
..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........ .......
T Consensus 177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 256 (359)
T 3vhe_A 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256 (359)
T ss_dssp -------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CE
T ss_pred hhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccC
Confidence 1289999999999999999999999999999999999999999999999999986543221 2234456
Q ss_pred ccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCC
Q 005289 294 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQ 372 (704)
Q Consensus 294 gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~ 372 (704)
+|+.|+|||++.+ ..|+.++|||||||+||+|++ |.+||.+....+.+.........++
T Consensus 257 ~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~------------------- 316 (359)
T 3vhe_A 257 LPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR------------------- 316 (359)
T ss_dssp ECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC-------------------
T ss_pred CCceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCC-------------------
Confidence 7899999999875 568999999999999999998 9999998775555444433211110
Q ss_pred CCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 373 PYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 373 ~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
....+++++.+||.+||..||.+|||+.++|+|
T Consensus 317 --------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 317 --------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp --------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 113578899999999999999999999999987
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=376.37 Aligned_cols=255 Identities=24% Similarity=0.341 Sum_probs=210.7
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCc---EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGK---IVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~---~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 203 (704)
+..++|++.+.||+|+||+||+|++..+++ .||||++.... .....+.+.+|+.+|+.|+||||+++++++.+ .
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 122 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR--G 122 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG--G
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--C
Confidence 345689999999999999999999986555 59999997543 45556778899999999999999999999977 4
Q ss_pred CeEEEEEecccccccccc-cCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccC
Q 005289 204 CSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~~-~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~ 282 (704)
..+||||||++++.+..+ ......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 678999999988655544 3455679999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCC--cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhc
Q 005289 283 TGHRQP--LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359 (704)
Q Consensus 283 ~~~~~~--~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~ 359 (704)
...... .....+|+.|+|||++.+ ..|+.++|||||||+||+|++ |.+||.+.+..+.+..+......+
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~------- 274 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAF-RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP------- 274 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC-------
T ss_pred cCccceeeccCCCCcccccCHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC-------
Confidence 432221 222345778999999875 568999999999999999999 999999999888887775521111
Q ss_pred cCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
....++..+.+||.+||..||.+|||+.++++.
T Consensus 275 ---------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~ 307 (325)
T 3kul_A 275 ---------------------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSV 307 (325)
T ss_dssp ---------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 113678999999999999999999999999853
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=364.01 Aligned_cols=253 Identities=20% Similarity=0.283 Sum_probs=210.9
Q ss_pred ccccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCe
Q 005289 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (704)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (704)
.+..++|++++.||+|+||+||+|.+. ++..||||++...... ...+.+|+.+|+.++||||+++++++.. ...
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~ 77 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS---EDEFFQEAQTMMKLSHPKLVKFYGVCSK--EYP 77 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC---HHHHHHHHHHHHHCCCTTBCCEEEEECS--SSS
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc---HHHHHHHHHHHHhCCCCCEeeEEEEEcc--CCc
Confidence 345678999999999999999999875 5778999999765533 3457889999999999999999999976 567
Q ss_pred EEEEEecccccccccc-cCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 206 IYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~-~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
+||||||++++.+..+ ......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 78 IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred eEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 9999999987655544 333456999999999999999999999999999999999999999999999999999876544
Q ss_pred CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCC
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
.........+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+.+..+......+
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~----------- 225 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFHY-FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLY----------- 225 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHHH-SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC-----------
T ss_pred hhhcccCCCcCcccCCHHHHhc-cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCC-----------
Confidence 3333334455778999999875 568999999999999999999 999999988887777665421110
Q ss_pred CcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
....+++.+.+||.+||..||.+|||+.++|++
T Consensus 226 -----------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 226 -----------------RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp -----------------CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 012468899999999999999999999999987
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=372.04 Aligned_cols=249 Identities=22% Similarity=0.386 Sum_probs=205.3
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEE
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 207 (704)
..++|.+.+.||+|+||+||+|++..+++.||+|++.. ......+.+.+|+.+|+.|+||||+++++++.+ ...+|
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~ 83 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK--DKRLN 83 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec--CCeeE
Confidence 45689999999999999999999999999999999854 345667788999999999999999999999987 57899
Q ss_pred EEEeccccccccccc-CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC
Q 005289 208 LVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~-~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~ 286 (704)
|||||++++.+..+. .....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 999999986555443 3456799999999999999999999999999999999999999999999999999986643321
Q ss_pred CC-------------cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHHH
Q 005289 287 QP-------------LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ-----LHKIFKL 348 (704)
Q Consensus 287 ~~-------------~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~-----l~~I~~~ 348 (704)
.. ....+||+.|+|||++.+ ..++.++|||||||+||+|++|.+||........ ......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~- 241 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD- 241 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH-
T ss_pred cccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc-
Confidence 11 124578999999999876 6789999999999999999999999865321100 000000
Q ss_pred cCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 349 CGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 349 ~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
......+++.+.+||.+||..||++|||+.++++
T Consensus 242 ------------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 242 ------------------------------RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp ------------------------------HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------------ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1112467889999999999999999999999986
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=366.92 Aligned_cols=252 Identities=21% Similarity=0.311 Sum_probs=208.2
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
+..++|++++.||+|+||+||++.+. ++..||||++...... .+.+.+|+.+|+.++||||+++++++.+ ...+
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~ 94 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTK--QRPI 94 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECS--SSSE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC---HHHHHHHHHHHhcCCCCCEeeEEEEEec--CCCe
Confidence 34568999999999999999999876 5778999999865433 3457889999999999999999999976 5679
Q ss_pred EEEEecccccccccc-cCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 207 YLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~-~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
||||||+.++.+..+ ......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp EEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 999999987655544 3335679999999999999999999999999999999999999999999999999998665432
Q ss_pred CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC
Q 005289 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
........+|+.|+|||++.+ ..++.++|||||||++|+|++ |++||...+..+....+........
T Consensus 175 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~----------- 242 (283)
T 3gen_A 175 YTSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR----------- 242 (283)
T ss_dssp HHSTTSTTSCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC-----------
T ss_pred cccccCCccCcccCCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCC-----------
Confidence 222333456788999999875 468999999999999999998 9999999988888877755321110
Q ss_pred cccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
...+++.+.+||.+||..||.+|||+.++|+|
T Consensus 243 -----------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 243 -----------------PHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp -----------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 13468899999999999999999999999987
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=368.39 Aligned_cols=258 Identities=29% Similarity=0.448 Sum_probs=204.9
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
+.|.....||+|+||+||+|++..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.. ...+|||
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 97 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSE--NGFIKIF 97 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe--CCcEEEE
Confidence 45566668999999999999999999999999997653 3345668899999999999999999999987 5689999
Q ss_pred EecccccccccccC-C--CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEcc-CCceEEeccccccccCCCC
Q 005289 210 FEYMEHDITGLLSC-P--DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-EGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~-~--~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~-~g~iKL~DFGla~~~~~~~ 285 (704)
|||++++.+..+.. . ...+++..++.++.||+.||.|||++||+|+||||+||||+. ++.+||+|||++.......
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 99998765554432 2 235679999999999999999999999999999999999987 8999999999998664322
Q ss_pred CCCcccccccccccCcccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCCchhhhccCCC
Q 005289 286 RQPLTSRVVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ-LHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~-~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~-l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
.......+|+.|+|||++.+. ..++.++|||||||++|+|++|++||........ +..... ....+
T Consensus 178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~---------- 245 (295)
T 2clq_A 178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGM-FKVHP---------- 245 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHH-HCCCC----------
T ss_pred -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcc-ccccc----------
Confidence 123445789999999998642 2478899999999999999999999976543322 222111 11110
Q ss_pred CcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
.....++.++.+||.+||..||++|||+.++|+||||+..
T Consensus 246 ----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 246 ----------------EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp ----------------CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred ----------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 1124678999999999999999999999999999999853
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=383.42 Aligned_cols=254 Identities=22% Similarity=0.324 Sum_probs=209.3
Q ss_pred ccCCeeEEEEeeccCceEEEEEEEC-------CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEe
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDL-------DTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLIT 199 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~-------~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~ 199 (704)
..++|++.+.||+|+||+||+|++. .++..||||++.... .....+.+.+|+.+|+.+ +||||++++++|.
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 3568999999999999999999874 345689999997553 445567788999999999 8999999999997
Q ss_pred ecCCCeEEEEEecccccccccccCC----------------CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEE
Q 005289 200 SRLSCSIYLVFEYMEHDITGLLSCP----------------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLL 263 (704)
Q Consensus 200 ~~~~~~~~LV~Ey~~g~ll~~~~~~----------------~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NIL 263 (704)
. ...+||||||+.++.+..+... ...+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 158 ~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl 235 (370)
T 2psq_A 158 Q--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 235 (370)
T ss_dssp S--SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred c--CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEE
Confidence 7 4678999999998655543321 235899999999999999999999999999999999999
Q ss_pred EccCCceEEeccccccccCCCCC-CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHH
Q 005289 264 VNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQ 341 (704)
Q Consensus 264 l~~~g~iKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~ 341 (704)
|+.++.+||+|||+++....... .......+|+.|+|||++.+ ..|+.++|||||||+||||++ |.+||.+....+.
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~ 314 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 314 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 99999999999999986654322 22233456889999999876 568999999999999999999 9999998877766
Q ss_pred HHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 342 LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 342 l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
+..+.... .+ .....++.++.+||.+||..||.+|||+.+++++
T Consensus 315 ~~~~~~~~--~~--------------------------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 315 FKLLKEGH--RM--------------------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHHTTC--CC--------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCC--CC--------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 66554311 00 0113678899999999999999999999999975
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=385.32 Aligned_cols=259 Identities=18% Similarity=0.260 Sum_probs=211.0
Q ss_pred ccCCeeEEEEeeccCceEEEEEE-----ECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC
Q 005289 128 RADAFEKLEKIGQGTYSSVFRAR-----DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL 202 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~-----~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 202 (704)
..++|++++.||+|+||+||+|+ +..+++.||||++.... .......+.+|+.+|+.++|||||++++++..
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-- 145 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ-- 145 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec--
Confidence 35689999999999999999999 45678899999997543 34455668889999999999999999999977
Q ss_pred CCeEEEEEecccccccccccC-------CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCC---ceEE
Q 005289 203 SCSIYLVFEYMEHDITGLLSC-------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKL 272 (704)
Q Consensus 203 ~~~~~LV~Ey~~g~ll~~~~~-------~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g---~iKL 272 (704)
....|||||||.++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence 467799999998755544332 124589999999999999999999999999999999999999655 5999
Q ss_pred eccccccccCCC-CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcC
Q 005289 273 ADFGLANFSNTG-HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCG 350 (704)
Q Consensus 273 ~DFGla~~~~~~-~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g 350 (704)
+|||+++..... .........+|+.|+|||++.+ ..|+.++|||||||+||+|++ |.+||.+.+..+.+..+.....
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~ 304 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 304 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 999999754221 1122344567999999999876 568999999999999999998 9999999998888777754211
Q ss_pred CCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 351 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 351 ~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
.. ....++..+.+||.+||..||.+|||+.++|++.|+..
T Consensus 305 ~~----------------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 305 MD----------------------------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp CC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC----------------------------CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 10 11367889999999999999999999999999988753
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=365.59 Aligned_cols=254 Identities=22% Similarity=0.350 Sum_probs=198.9
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCC---CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDT---GKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 203 (704)
+..++|++.+.||+|+||+||+|++..+ +..||||++.... .....+.+.+|+.+|+.++||||+++++++.+
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--- 87 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE--- 87 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEcc---
Confidence 3456899999999999999999998654 4579999986542 34556778899999999999999999999854
Q ss_pred CeEEEEEecccccccccc-cCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccC
Q 005289 204 CSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~~-~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~ 282 (704)
..+||||||+.++.+..+ ......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccC
Confidence 468999999998555544 3344579999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccC
Q 005289 283 TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (704)
Q Consensus 283 ~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~ 361 (704)
...........+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+......
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~---------- 236 (281)
T 1mp8_A 168 DSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---------- 236 (281)
T ss_dssp -----------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC----------
T ss_pred cccccccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC----------
Confidence 433223334456789999999875 568999999999999999996 99999998877777666441100
Q ss_pred CCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.....+++.+.+||.+||..||.+|||+.+++++
T Consensus 237 ------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 237 ------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp ------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0124688999999999999999999999999865
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=369.68 Aligned_cols=264 Identities=26% Similarity=0.426 Sum_probs=207.2
Q ss_pred ccccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC--CCCceeEeEEEeecCC
Q 005289 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD--HPNIIKLEGLITSRLS 203 (704)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~--HpnIv~l~~~~~~~~~ 203 (704)
.+..++|++++.||+|+||+||+|.+. +++.||||++............+.+|+.+|.++. ||||+++++++.. .
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~--~ 100 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--D 100 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC--S
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec--C
Confidence 344568999999999999999999985 5899999999877666677788899999999997 5999999999987 5
Q ss_pred CeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCC
Q 005289 204 CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~ 283 (704)
..+|||||++.+++...+.. ...+++..++.++.||+.||.|||++||+||||||+||||++ +.+||+|||++.....
T Consensus 101 ~~~~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~ 178 (313)
T 3cek_A 101 QYIYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQP 178 (313)
T ss_dssp SEEEEEECCCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC---
T ss_pred CEEEEEEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccccC
Confidence 68999999766666555543 347899999999999999999999999999999999999964 8999999999986654
Q ss_pred CCCC-CcccccccccccCcccccCC----------CCCCCccchhhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCC
Q 005289 284 GHRQ-PLTSRVVTLWYRPPELLLGA----------TDYGPSVDLWSVGCVFAELLIGKPILQGRTE-VEQLHKIFKLCGS 351 (704)
Q Consensus 284 ~~~~-~~~~~~gT~~Y~APEvl~~~----------~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~-~e~l~~I~~~~g~ 351 (704)
.... .....++|+.|+|||++.+. ..++.++|||||||+||+|++|..||..... ...+..+......
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 258 (313)
T 3cek_A 179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 258 (313)
T ss_dssp -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC
T ss_pred ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccc
Confidence 3211 22345789999999998641 3688899999999999999999999987543 3333333221000
Q ss_pred CCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCC
Q 005289 352 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (704)
Q Consensus 352 ~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~ 421 (704)
. ......+.++.+||.+||..||.+|||+.++|+||||+....
T Consensus 259 ~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 301 (313)
T 3cek_A 259 I---------------------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 301 (313)
T ss_dssp C---------------------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC--
T ss_pred c---------------------------CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCC
Confidence 0 011245788999999999999999999999999999987544
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=373.16 Aligned_cols=252 Identities=21% Similarity=0.245 Sum_probs=205.7
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCCeEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~ 207 (704)
.++|++++.||+|+||+||+|++..+++.||||++...... ..+.+|+.+|+.| +||||+++++++.. ....|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~ 81 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPC--GKYNA 81 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEE--TTEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEec--CCccE
Confidence 35799999999999999999999999999999999755322 2467899999999 99999999999987 57899
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCc-----eEEeccccccccC
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV-----LKLADFGLANFSN 282 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~-----iKL~DFGla~~~~ 282 (704)
|||||+.+++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||+++...
T Consensus 82 lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 82 MVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred EEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99999955555555444567999999999999999999999999999999999999998887 9999999998654
Q ss_pred CCCCC------CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHcCCCC
Q 005289 283 TGHRQ------PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT---EVEQLHKIFKLCGSPP 353 (704)
Q Consensus 283 ~~~~~------~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~---~~e~l~~I~~~~g~~p 353 (704)
..... .....+||+.|+|||++.+ ..++.++|||||||+||+|++|.+||.+.+ ..+.+..+.......+
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP 240 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred cCCCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence 33211 1245688999999999886 668999999999999999999999998843 4444555533211111
Q ss_pred chhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 354 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 354 ~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
.......+| ++.+||..||..||.+||++.++++
T Consensus 241 ------------------------~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 241 ------------------------IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp ------------------------HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ------------------------HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 111223455 9999999999999999999998875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=368.65 Aligned_cols=255 Identities=22% Similarity=0.296 Sum_probs=200.0
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 207 (704)
.++|++++.||+|+||+||+|++..+++.||||++..... .....+.+.+|+.+|+.++||||+++++++.. ...+|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~ 110 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI--DGQLY 110 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee--CCeEE
Confidence 5689999999999999999999999999999999976533 24445778899999999999999999999987 57899
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCC
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~ 287 (704)
|||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.........
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 190 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT 190 (309)
T ss_dssp EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccc
Confidence 99999998666655545557999999999999999999999999999999999999999999999999999876554333
Q ss_pred CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCccc
Q 005289 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (704)
Q Consensus 288 ~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~ 367 (704)
......+|+.|+|||++.+ ..++.++|||||||+||+|++|++||.+.........+ ......
T Consensus 191 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~--------------- 253 (309)
T 2h34_A 191 QLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-NQAIPR--------------- 253 (309)
T ss_dssp ------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH-HSCCCC---------------
T ss_pred cccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh-ccCCCC---------------
Confidence 4455678999999999876 56899999999999999999999999887655333332 211110
Q ss_pred CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCc-CHHHHHh
Q 005289 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-TASAALA 412 (704)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRp-Ta~e~L~ 412 (704)
.......+|..+.+||.+||..||.+|| |++++++
T Consensus 254 ----------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 254 ----------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp ----------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred ----------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 1122357899999999999999999999 7777764
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=361.96 Aligned_cols=254 Identities=20% Similarity=0.236 Sum_probs=209.3
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCCeEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~ 207 (704)
.++|++++.||+|+||+||+|++..+++.||||++..... ...+.+|+.+++.+ +|+||+++++++.. ....|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~ 82 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNV 82 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc----cHHHHHHHHHHHHHhcCCCCCeEEeecCC--CceeE
Confidence 4679999999999999999999999999999999875432 23467899999999 89999999999876 57899
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCc-----eEEeccccccccC
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV-----LKLADFGLANFSN 282 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~-----iKL~DFGla~~~~ 282 (704)
|||||+.+++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++....
T Consensus 83 lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 83 LVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99999955665555544556999999999999999999999999999999999999987776 9999999998765
Q ss_pred CCCC------CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC---CHHHHHHHHHHHcCCCC
Q 005289 283 TGHR------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR---TEVEQLHKIFKLCGSPP 353 (704)
Q Consensus 283 ~~~~------~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~---~~~e~l~~I~~~~g~~p 353 (704)
.... .......+|+.|+|||++.+ ..++.++|||||||+||+|++|++||.+. ...+.+..+......++
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 241 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred cccccccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence 4322 12345678999999999876 56899999999999999999999999874 34455555443221111
Q ss_pred chhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 354 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 354 ~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
+......+++++.+||.+||..||.+|||+.++++.
T Consensus 242 ------------------------~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 242 ------------------------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp ------------------------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred ------------------------HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 123345789999999999999999999999998754
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=377.49 Aligned_cols=260 Identities=23% Similarity=0.325 Sum_probs=180.1
Q ss_pred cCCeeEEE-EeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeec--CCCe
Q 005289 129 ADAFEKLE-KIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR--LSCS 205 (704)
Q Consensus 129 ~~~y~~~~-~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~--~~~~ 205 (704)
.++|.+++ .||+|+||+||+|++..+++.||||++... .. ...+....++.+.||||+++++++... ....
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PK---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HH---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HH---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 35799976 599999999999999999999999999643 11 122233446677999999999998652 2346
Q ss_pred EEEEEeccccccccccc-CC-CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccC---CceEEeccccccc
Q 005289 206 IYLVFEYMEHDITGLLS-CP-DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE---GVLKLADFGLANF 280 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~-~~-~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~---g~iKL~DFGla~~ 280 (704)
+|||||||+++.+..+. .. ...+++..++.++.||+.||.|||++||+||||||+||||+.+ +.+||+|||++..
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 89999999985554443 32 2469999999999999999999999999999999999999864 4599999999986
Q ss_pred cCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhcc
Q 005289 281 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (704)
Q Consensus 281 ~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~ 360 (704)
.... .....++|+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.........+.......
T Consensus 181 ~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------- 248 (336)
T 3fhr_A 181 TTQN---ALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLG-------- 248 (336)
T ss_dssp C--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------------
T ss_pred cccc---ccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcc--------
Confidence 6532 2345678999999999865 568899999999999999999999998766544322221110000
Q ss_pred CCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
.. .+ ....+..++.++.+||.+||..||.+|||+.++|+||||+..
T Consensus 249 -----~~-----~~---~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 249 -----QY-----GF---PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp ------------CC---CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred -----cc-----cc---CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 00 00 012235789999999999999999999999999999999863
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=374.72 Aligned_cols=263 Identities=24% Similarity=0.391 Sum_probs=190.2
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHH-HHHhcCCCCceeEeEEEeecCCCe
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREIL-ILRRLDHPNIIKLEGLITSRLSCS 205 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~-iL~~L~HpnIv~l~~~~~~~~~~~ 205 (704)
+..++|++++.||+|+||+||+|.+..+++.||||++..... ......+..|+. +++.++||||+++++++.. ...
T Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~--~~~ 95 (327)
T 3aln_A 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR--EGD 95 (327)
T ss_dssp CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC--SSE
T ss_pred cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe--CCc
Confidence 345789999999999999999999999999999999986543 333445555665 7778899999999999987 568
Q ss_pred EEEEEeccccccccccc----CCCccccHHHHHHHHHHhhhhHHHHHhc-CcccccCCCccEEEccCCceEEeccccccc
Q 005289 206 IYLVFEYMEHDITGLLS----CPDIKFSEAQIKCYMNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANF 280 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~----~~~~~l~e~~~~~i~~QIl~aL~yLH~~-gIvHrDLKp~NILl~~~g~iKL~DFGla~~ 280 (704)
+||||||+.+++...+. .....+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||++..
T Consensus 96 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 96 CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp EEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred eEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 99999999987655443 1345789999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCCCCcccccccccccCccccc---CCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCCchh
Q 005289 281 SNTGHRQPLTSRVVTLWYRPPELLL---GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV-EQLHKIFKLCGSPPDDY 356 (704)
Q Consensus 281 ~~~~~~~~~~~~~gT~~Y~APEvl~---~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~-e~l~~I~~~~g~~p~~~ 356 (704)
..... ......+|+.|+|||++. ....++.++|||||||+||+|++|..||.+.... +.+..+.. +.++
T Consensus 176 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~--- 248 (327)
T 3aln_A 176 LVDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK--GDPP--- 248 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCC--SCCC---
T ss_pred ccccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhc--CCCC---
Confidence 65332 223447899999999984 2356899999999999999999999999865432 11111100 0000
Q ss_pred hhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 357 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 357 w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
.+ .......++..+.+||.+||..||.+|||+.++|+||||..
T Consensus 249 ----------------~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 249 ----------------QL---SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp ----------------CC---CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred ----------------CC---CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 00 01122468899999999999999999999999999999974
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=358.08 Aligned_cols=252 Identities=14% Similarity=0.201 Sum_probs=211.2
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
+..++|++++.||+|+||+||+|++. ++.||||++..........+.+.+|+.+|+.++||||+++++++.+.....+
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 7 IDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp CCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred CCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence 45678999999999999999999984 8899999998877677777889999999999999999999999987655788
Q ss_pred EEEEecccccccccccCCCc--cccHHHHHHHHHHhhhhHHHHHhcC--cccccCCCccEEEccCCceEEeccccccccC
Q 005289 207 YLVFEYMEHDITGLLSCPDI--KFSEAQIKCYMNQLLHGLEHCHSRG--VLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~~~~--~l~e~~~~~i~~QIl~aL~yLH~~g--IvHrDLKp~NILl~~~g~iKL~DFGla~~~~ 282 (704)
||||||++++.+..+..... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.++|+|||++....
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 99999999855554433322 5899999999999999999999999 9999999999999999999999999875433
Q ss_pred CCCCCCcccccccccccCcccccCCC--CCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhcc
Q 005289 283 TGHRQPLTSRVVTLWYRPPELLLGAT--DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (704)
Q Consensus 283 ~~~~~~~~~~~gT~~Y~APEvl~~~~--~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~ 360 (704)
. ....+|+.|+|||++.+.. .++.++|||||||++|+|++|.+||.+.+..+....+......+
T Consensus 165 ~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-------- 230 (271)
T 3kmu_A 165 S------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP-------- 230 (271)
T ss_dssp C------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC--------
T ss_pred c------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC--------
Confidence 2 3457799999999987632 22337999999999999999999999988887776665421111
Q ss_pred CCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.....++.++.+||.+||..||.+|||+.++++.
T Consensus 231 -------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 264 (271)
T 3kmu_A 231 -------------------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPI 264 (271)
T ss_dssp -------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0124688999999999999999999999999863
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=363.27 Aligned_cols=258 Identities=21% Similarity=0.356 Sum_probs=200.4
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
+..++|++.++||+|+||+||+|++.. .||||++..........+.+.+|+.+|+.++||||+++++++.. ..+
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~ 94 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---PQL 94 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSC
T ss_pred cCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC---Ccc
Confidence 446689999999999999999998643 59999998776667777889999999999999999999997644 468
Q ss_pred EEEEecccccccc-cccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC-
Q 005289 207 YLVFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG- 284 (704)
Q Consensus 207 ~LV~Ey~~g~ll~-~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~- 284 (704)
++||||+.++.+. .+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp EEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred EEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccc
Confidence 9999999976554 44445667999999999999999999999999999999999999999999999999999765432
Q ss_pred CCCCcccccccccccCccccc--CCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCC
Q 005289 285 HRQPLTSRVVTLWYRPPELLL--GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~--~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~ 362 (704)
.........+|+.|+|||++. ....++.++|||||||++|+|++|+.||.+....+.+..+.......+
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--------- 245 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP--------- 245 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC---------
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc---------
Confidence 122334557899999999986 235678899999999999999999999998776666555544221111
Q ss_pred CCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.+......+++.+.+||.+||..||.+|||+.++|+.
T Consensus 246 --------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 282 (289)
T 3og7_A 246 --------------DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE 282 (289)
T ss_dssp --------------CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 0112234688999999999999999999999999864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=366.84 Aligned_cols=248 Identities=19% Similarity=0.223 Sum_probs=202.7
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCC-------cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEe
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTG-------KIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLIT 199 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g-------~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~ 199 (704)
+..++|++.+.||+|+||+||+|++..++ ..||+|++.... ....+.+.+|+.+|+.++||||+++++++.
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCV 82 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence 45678999999999999999999998877 469999996543 344567889999999999999999999998
Q ss_pred ecCCCeEEEEEeccccccccc-ccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCc--------e
Q 005289 200 SRLSCSIYLVFEYMEHDITGL-LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV--------L 270 (704)
Q Consensus 200 ~~~~~~~~LV~Ey~~g~ll~~-~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~--------i 270 (704)
+ ....||||||+.++.+.. +......+++..++.++.||+.||.|||++||+||||||+||||+.++. +
T Consensus 83 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 83 C--GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp C--TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred e--CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 7 467899999999755554 4444445999999999999999999999999999999999999998887 9
Q ss_pred EEeccccccccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHc
Q 005289 271 KLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG-KPILQGRTEVEQLHKIFKLC 349 (704)
Q Consensus 271 KL~DFGla~~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG-~~pF~~~~~~e~l~~I~~~~ 349 (704)
||+|||++..... .....+|+.|+|||++.+...++.++|||||||++|+|++| .+||...........+ ...
T Consensus 161 kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~-~~~ 234 (289)
T 4fvq_A 161 KLSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY-EDR 234 (289)
T ss_dssp EECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-HTT
T ss_pred eeccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh-hcc
Confidence 9999999865532 23446789999999998756789999999999999999995 5666555554443332 211
Q ss_pred CCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 350 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 350 g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.. .....+.++.+||.+||..||.+|||+.++|++
T Consensus 235 ~~-----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 235 HQ-----------------------------LPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp CC-----------------------------CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CC-----------------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 11 012456778999999999999999999999987
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=366.53 Aligned_cols=271 Identities=23% Similarity=0.360 Sum_probs=202.4
Q ss_pred ccCCeeEEEEeeccCceEEEEEE----ECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC
Q 005289 128 RADAFEKLEKIGQGTYSSVFRAR----DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~----~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 203 (704)
..++|+++++||+|+||+||+|+ +..+++.||||++... .....+.+.+|+.+|+.++||||+++++++.....
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 85 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 85 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 35689999999999999999998 6678999999999754 35556778899999999999999999999876545
Q ss_pred CeEEEEEecccccccc-cccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccC
Q 005289 204 CSIYLVFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~-~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~ 282 (704)
..+||||||++++.+. .+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 6789999999875554 444445569999999999999999999999999999999999999999999999999998765
Q ss_pred CCCC--CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhcc
Q 005289 283 TGHR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (704)
Q Consensus 283 ~~~~--~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~ 360 (704)
.... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...... . ....+..+...+...
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~---~~~~~~~~~~~~~~~ 239 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--F---MRMIGNDKQGQMIVF 239 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--H---HHHHCTTCCTHHHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcC-CCCChHHHHHHHHHHHHHHHhcccccCCChHH--H---HhhhcCccccchhHH
Confidence 3321 11223456788999999876 56899999999999999999999998653221 1 111111111000000
Q ss_pred CCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.... ....... ......+++++.+||.+||..||.+|||+.++++.
T Consensus 240 ~~~~--~~~~~~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~ 285 (295)
T 3ugc_A 240 HLIE--LLKNNGR-----LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285 (295)
T ss_dssp HHHH--HHHTTCC-----CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHH--HHhccCc-----CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 0000 0000000 01124688999999999999999999999999853
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=380.51 Aligned_cols=252 Identities=25% Similarity=0.369 Sum_probs=207.5
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCCh----HHHHHHHHHHHHHHhcC--CCCceeEeEEEeecC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP----ESVRFMAREILILRRLD--HPNIIKLEGLITSRL 202 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~----~~~~~~~~Ei~iL~~L~--HpnIv~l~~~~~~~~ 202 (704)
.++|++.+.||+|+||+||+|++..+++.||||++....... .....+.+|+.+|+++. ||||+++++++..
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~-- 119 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-- 119 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec--
Confidence 457999999999999999999999999999999997654321 11234567999999996 5999999999987
Q ss_pred CCeEEEEEecccc-cccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEc-cCCceEEeccccccc
Q 005289 203 SCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANF 280 (704)
Q Consensus 203 ~~~~~LV~Ey~~g-~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~-~~g~iKL~DFGla~~ 280 (704)
...+|+|||++.+ +.+..+......+++..++.++.||+.||.|||++||+||||||+||||+ +++.+||+|||++..
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~ 199 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 199 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccc
Confidence 5789999999974 44444433455789999999999999999999999999999999999999 789999999999987
Q ss_pred cCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhcc
Q 005289 281 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (704)
Q Consensus 281 ~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~ 360 (704)
.... ......+|+.|+|||++.+...++.++|||||||+||+|++|..||..... +.. +..
T Consensus 200 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~--~~~-------- 260 (320)
T 3a99_A 200 LKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR--GQV-------- 260 (320)
T ss_dssp CCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH--CCC--------
T ss_pred cccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhc--ccc--------
Confidence 6542 234567899999999987655557889999999999999999999975321 111 000
Q ss_pred CCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCC
Q 005289 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (704)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~ 420 (704)
.....+++++.+||.+||..||.+|||+.++|+||||+...
T Consensus 261 -------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 261 -------------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp -------------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred -------------------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 00136789999999999999999999999999999998643
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=372.49 Aligned_cols=252 Identities=24% Similarity=0.394 Sum_probs=200.7
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCCh----HHHHHHHHHHHHHHhc----CCCCceeEeEEEee
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP----ESVRFMAREILILRRL----DHPNIIKLEGLITS 200 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~----~~~~~~~~Ei~iL~~L----~HpnIv~l~~~~~~ 200 (704)
.++|++.+.||+|+||+||+|++..+++.||||++....... .....+.+|+.+|.++ +||||+++++++..
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 457999999999999999999999999999999997654322 1223355799999999 89999999999877
Q ss_pred cCCCeEEEEEec-ccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEc-cCCceEEeccccc
Q 005289 201 RLSCSIYLVFEY-MEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLA 278 (704)
Q Consensus 201 ~~~~~~~LV~Ey-~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~-~~g~iKL~DFGla 278 (704)
...+|+|||| +.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||++
T Consensus 110 --~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 110 --QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred --CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 4678999999 66655555544455799999999999999999999999999999999999999 8899999999999
Q ss_pred cccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhh
Q 005289 279 NFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 358 (704)
Q Consensus 279 ~~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~ 358 (704)
...... ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||..... +.... .
T Consensus 188 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~--~------ 250 (312)
T 2iwi_A 188 ALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAE--L------ 250 (312)
T ss_dssp EECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHTC--C------
T ss_pred hhcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhhhc--c------
Confidence 876543 234567899999999987644455689999999999999999999975321 11100 0
Q ss_pred ccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCC
Q 005289 359 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (704)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~ 420 (704)
.....++..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 251 ---------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 251 ---------------------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp ---------------------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred ---------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 01135788999999999999999999999999999998643
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=376.73 Aligned_cols=255 Identities=22% Similarity=0.326 Sum_probs=211.5
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCC-------CcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEE
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDT-------GKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLI 198 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~-------g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~ 198 (704)
+..++|.+.++||+|+||+||+|++..+ +..||||++.... .......+.+|+.+|+.+ +||||+++++++
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-CHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 3456899999999999999999997543 3579999997653 455567788999999999 999999999999
Q ss_pred eecCCCeEEEEEecccccccccccCC----------------CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccE
Q 005289 199 TSRLSCSIYLVFEYMEHDITGLLSCP----------------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNL 262 (704)
Q Consensus 199 ~~~~~~~~~LV~Ey~~g~ll~~~~~~----------------~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NI 262 (704)
.. ...+||||||++++.+..+... ...+++..++.|+.||+.||.|||++||+||||||+||
T Consensus 145 ~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 222 (382)
T 3tt0_A 145 TQ--DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 222 (382)
T ss_dssp CS--SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred cc--CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceE
Confidence 87 4678999999988555544321 23599999999999999999999999999999999999
Q ss_pred EEccCCceEEeccccccccCCCCC-CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHH
Q 005289 263 LVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVE 340 (704)
Q Consensus 263 Ll~~~g~iKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e 340 (704)
||+.++.+||+|||+++....... .......+|+.|+|||++.+ ..++.++|||||||+||+|++ |.+||.+.+..+
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~ 301 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999986654322 22334466889999999876 668999999999999999999 999999988877
Q ss_pred HHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 341 QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 341 ~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.+..+...... .....++.++.+||.+||..||.+|||+.+++++
T Consensus 302 ~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 302 LFKLLKEGHRM----------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHTTCCC----------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCC----------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 77666442100 0113678999999999999999999999999976
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=363.93 Aligned_cols=253 Identities=20% Similarity=0.304 Sum_probs=212.0
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
+..++|++.+.||+|+||+||+|.+..++..||||++..+. ...+.+.+|+.+|+.++||||+++++++.+ ...+
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~ 84 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPF 84 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcc--CCCE
Confidence 34568999999999999999999999999999999997543 345678899999999999999999999977 5679
Q ss_pred EEEEecccccccccccC--CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 207 YLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~--~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
|+||||++++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 99999999755544332 3456999999999999999999999999999999999999999999999999999876654
Q ss_pred CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCC
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
.........+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+.......+......
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~------------ 231 (288)
T 3kfa_A 165 TYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM------------ 231 (288)
T ss_dssp SSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC------------
T ss_pred ccccccCCccccCcCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCC------------
Confidence 3333344456889999999875 568999999999999999999 99999988776666555432100
Q ss_pred CcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.....+++.+.+||.+||..||.+|||+.++++.
T Consensus 232 ----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~ 265 (288)
T 3kfa_A 232 ----------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQA 265 (288)
T ss_dssp ----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHH
Confidence 0113678999999999999999999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=372.42 Aligned_cols=255 Identities=24% Similarity=0.358 Sum_probs=210.1
Q ss_pred cccCCeeEEEEeeccCceEEEEEEEC-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeec
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDL-----DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR 201 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 201 (704)
+..++|++++.||+|+||+||+|++. .+++.||||++.... .....+.+.+|+.+|+.++||||+++++++..
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 121 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAV- 121 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc-
Confidence 34578999999999999999999987 455899999997543 34556778899999999999999999999977
Q ss_pred CCCeEEEEEecccccccccccCC------------------------CccccHHHHHHHHHHhhhhHHHHHhcCcccccC
Q 005289 202 LSCSIYLVFEYMEHDITGLLSCP------------------------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDI 257 (704)
Q Consensus 202 ~~~~~~LV~Ey~~g~ll~~~~~~------------------------~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDL 257 (704)
...+||||||++++.+..+... ...+++.+++.++.||+.||.|||++||+||||
T Consensus 122 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 122 -GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred -CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 5678999999998555443321 156899999999999999999999999999999
Q ss_pred CCccEEEccCCceEEeccccccccCCCCC-CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCC
Q 005289 258 KGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQG 335 (704)
Q Consensus 258 Kp~NILl~~~g~iKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~ 335 (704)
||+||||+.++.+||+|||++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc-CCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 99999999999999999999976543211 12234567899999999875 568999999999999999999 9999999
Q ss_pred CCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 336 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 336 ~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.+..+.+..+... ..+ .....++..+.+||.+||..||.+|||+.+++++
T Consensus 280 ~~~~~~~~~~~~~--~~~--------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 280 MAHEEVIYYVRDG--NIL--------------------------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp SCHHHHHHHHHTT--CCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CChHHHHHHHhCC--CcC--------------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 8888777766541 110 0113678999999999999999999999999865
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=356.72 Aligned_cols=251 Identities=24% Similarity=0.357 Sum_probs=198.4
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC--hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCC
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE--PESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~--~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 204 (704)
+..++|++.+.||+|+||+||+|.+ +++.||||++...... ....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 79 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK--EP 79 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC--C-
T ss_pred cchhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec--CC
Confidence 4467899999999999999999997 4889999998764322 2335678899999999999999999999987 46
Q ss_pred eEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcC---cccccCCCccEEEcc--------CCceEEe
Q 005289 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG---VLHRDIKGSNLLVNN--------EGVLKLA 273 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~g---IvHrDLKp~NILl~~--------~g~iKL~ 273 (704)
.+||||||++++.+..+.. ...+++..++.++.||+.||.|||++| |+||||||+||||+. ++.+||+
T Consensus 80 ~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 80 NLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp -CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred ceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 7899999999877766654 347999999999999999999999999 999999999999986 6789999
Q ss_pred ccccccccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Q 005289 274 DFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 353 (704)
Q Consensus 274 DFGla~~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p 353 (704)
|||++....... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+......+
T Consensus 159 Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~- 233 (271)
T 3dtc_A 159 DFGLAREWHRTT---KMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL- 233 (271)
T ss_dssp CCCC----------------CCGGGSCHHHHHH-CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCC-
T ss_pred cCCccccccccc---ccCCCCccceeCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCC-
Confidence 999997655432 234578999999999875 568999999999999999999999999988777666554311100
Q ss_pred chhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 354 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 354 ~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.....+++.+.+||.+||..||.+|||+.++|++
T Consensus 234 --------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 234 --------------------------PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp --------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 0113678999999999999999999999999976
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=359.22 Aligned_cols=252 Identities=25% Similarity=0.370 Sum_probs=205.2
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHH-----HHHHHHHHHHHHhcCCCCceeEeEEEeec
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPES-----VRFMAREILILRRLDHPNIIKLEGLITSR 201 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 201 (704)
+..++|++.+.||+|+||+||+|++..+++.||||++......... .+.+.+|+.+|+.++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 3457899999999999999999999999999999999765432211 15678999999999999999999998663
Q ss_pred CCCeEEEEEecccc-cccccccCCCccccHHHHHHHHHHhhhhHHHHHhcC--cccccCCCccEEEccCCc-----eEEe
Q 005289 202 LSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG--VLHRDIKGSNLLVNNEGV-----LKLA 273 (704)
Q Consensus 202 ~~~~~~LV~Ey~~g-~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~g--IvHrDLKp~NILl~~~g~-----iKL~ 273 (704)
. +|||||+.+ ++...+......+++..++.++.||+.||.|||++| |+||||||+||||+.++. +||+
T Consensus 96 --~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 96 --P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp --T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred --C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 2 799999996 444556566668999999999999999999999999 999999999999988776 9999
Q ss_pred ccccccccCCCCCCCcccccccccccCcccccC-CCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHcC
Q 005289 274 DFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG-ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ--LHKIFKLCG 350 (704)
Q Consensus 274 DFGla~~~~~~~~~~~~~~~gT~~Y~APEvl~~-~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~--l~~I~~~~g 350 (704)
|||++..... ......+|+.|+|||++.. ...++.++|||||||++|+|++|++||........ ...+.. .+
T Consensus 172 Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~ 246 (287)
T 4f0f_A 172 DFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE-EG 246 (287)
T ss_dssp CCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH-SC
T ss_pred CCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc-cC
Confidence 9999975443 2345678999999999843 34578899999999999999999999987553322 333322 11
Q ss_pred CCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 351 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 351 ~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
..+ .....+++.+.+||.+||..||.+|||+.++++.
T Consensus 247 ~~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 283 (287)
T 4f0f_A 247 LRP--------------------------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283 (287)
T ss_dssp CCC--------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCC--------------------------CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 110 0124678999999999999999999999999863
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=366.61 Aligned_cols=254 Identities=19% Similarity=0.293 Sum_probs=208.9
Q ss_pred ccCCeeEEEEeeccCceEEEEEEEC-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDL-----DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL 202 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 202 (704)
..++|.+.+.||+|+||+||+|++. .+++.||||++.... .....+.+.+|+.+|+.|+||||+++++++.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 97 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ-- 97 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEec--
Confidence 3568999999999999999999973 456899999997543 45566778899999999999999999999977
Q ss_pred CCeEEEEEecccccccccccCC------------------------CccccHHHHHHHHHHhhhhHHHHHhcCcccccCC
Q 005289 203 SCSIYLVFEYMEHDITGLLSCP------------------------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIK 258 (704)
Q Consensus 203 ~~~~~LV~Ey~~g~ll~~~~~~------------------------~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLK 258 (704)
...+||||||+.++.+..+... ...+++..++.++.||+.||.|||++||+|||||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik 177 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA 177 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Confidence 4678999999997555544321 2348999999999999999999999999999999
Q ss_pred CccEEEccCCceEEeccccccccCCCCC-CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCC
Q 005289 259 GSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGR 336 (704)
Q Consensus 259 p~NILl~~~g~iKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~ 336 (704)
|+||||+.++.+||+|||++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999986643321 12233456889999999875 568999999999999999999 99999988
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 337 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 337 ~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
+.......+.... .+ .....+++.+.+||.+||..||.+|||+.+++++
T Consensus 257 ~~~~~~~~~~~~~--~~--------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 257 PPERLFNLLKTGH--RM--------------------------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp CGGGHHHHHHTTC--CC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHhhcCC--cC--------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 7766665553311 00 1124678999999999999999999999999976
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=377.21 Aligned_cols=273 Identities=22% Similarity=0.252 Sum_probs=202.1
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC--CC
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL--SC 204 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~--~~ 204 (704)
+..++|+++++||+|+||+||+|++. ++.||||++.... .......+|+.+|++++|||||++++++.... ..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDV 95 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred cchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCc
Confidence 44568999999999999999999874 7899999996542 33444567999999999999999999998643 34
Q ss_pred eEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhc----------CcccccCCCccEEEccCCceEEec
Q 005289 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR----------GVLHRDIKGSNLLVNNEGVLKLAD 274 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~----------gIvHrDLKp~NILl~~~g~iKL~D 274 (704)
.+|||||||+++.+..+... ..+++..++.++.||+.||.|||+. ||+||||||+||||+.++.+||+|
T Consensus 96 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 96 DLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred eEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 58999999998666555432 3589999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCC-CCcccccccccccCcccccCC----CCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Q 005289 275 FGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGA----TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 349 (704)
Q Consensus 275 FGla~~~~~~~~-~~~~~~~gT~~Y~APEvl~~~----~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~ 349 (704)
||+++....... ......++|+.|+|||++.+. ..++.++|||||||+||+|++|++||.+......+.......
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 999976654322 223446789999999998763 245567899999999999999999998754322111111111
Q ss_pred CCCCchhhhccCCCCcccCCCCCCCCchhhhhc--cCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 350 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF--KDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 350 g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~--~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
..+....+....... .....+...+ ...+.++.+||.+||..||++|||+.++++.
T Consensus 255 ~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 312 (322)
T 3soc_A 255 QHPSLEDMQEVVVHK--------KKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312 (322)
T ss_dssp SSCCHHHHHHHHTTS--------CCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCchhhhhhhhhcc--------cCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 111111111100000 0000011111 1234669999999999999999999999864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=388.21 Aligned_cols=276 Identities=24% Similarity=0.350 Sum_probs=210.9
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|++.+.||+|+||+||+|++..+++.||||++..... ....+.+.+|+++|++++||||+++++++.......+||
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 4579999999999999999999999999999999975432 223456778999999999999999999998765668899
Q ss_pred EEecccccccccccCCCc---cccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEE----ccCCceEEecccccccc
Q 005289 209 VFEYMEHDITGLLSCPDI---KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFS 281 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~---~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl----~~~g~iKL~DFGla~~~ 281 (704)
|||||.++.+..+..... .+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++..
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 999998866665544332 29999999999999999999999999999999999999 77778999999999876
Q ss_pred CCCCCCCcccccccccccCcccccCC-------CCCCCccchhhHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHHcC
Q 005289 282 NTGHRQPLTSRVVTLWYRPPELLLGA-------TDYGPSVDLWSVGCVFAELLIGKPILQGR----TEVEQLHKIFKLCG 350 (704)
Q Consensus 282 ~~~~~~~~~~~~gT~~Y~APEvl~~~-------~~y~~~~DIWSlG~iLyeLltG~~pF~~~----~~~e~l~~I~~~~g 350 (704)
... ......++|+.|+|||++.+. ..|+.++|||||||++|+|++|++||... ...+.+.++.. +
T Consensus 167 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~--~ 242 (396)
T 4eut_A 167 EDD--EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT--G 242 (396)
T ss_dssp CCG--GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH--S
T ss_pred cCC--CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc--C
Confidence 543 233456789999999997531 35778999999999999999999999753 33455555543 3
Q ss_pred CCCchhhhccCCCCccc--CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 351 SPPDDYWKKSKLPHATL--FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 351 ~~p~~~w~~~~~~~~~~--~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
. |...|.......... +....+.. ......++..+.+||.+||.+||++|||+.+++++
T Consensus 243 ~-p~~~~~~~~~~~~~~~~~~~~~~~~---~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 243 K-PSGAISGVQKAENGPIDWSGDMPVS---CSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp C-CTTCCEEEECSTTCCEEEESSCCTT---CSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred C-CcccchhheeccCCCcccCccCCcc---cccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 3 333322211100000 00000000 01113456778999999999999999999999764
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=359.92 Aligned_cols=254 Identities=20% Similarity=0.281 Sum_probs=205.5
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECC---CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLD---TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 203 (704)
+..++|++.+.||+|+||+||+|++.. ++..||||++.... .....+.+.+|+.+|+.++||||+++++++.+
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--- 84 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE--- 84 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS---
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC---
Confidence 445689999999999999999998653 34569999997653 34556778899999999999999999999865
Q ss_pred CeEEEEEeccccccccccc-CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccC
Q 005289 204 CSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~~~-~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~ 282 (704)
...|+||||+.++.+..+. .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 85 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 85 EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 3468999999976555443 334568999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccC
Q 005289 283 TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (704)
Q Consensus 283 ~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~ 361 (704)
...........+|+.|+|||++.+ ..++.++|||||||++|+|++ |++||......+....+......+
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~--------- 234 (281)
T 3cc6_A 165 DEDYYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP--------- 234 (281)
T ss_dssp --------CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCC---------
T ss_pred cccccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCC---------
Confidence 443333344456889999999865 568999999999999999998 999998877766666554421110
Q ss_pred CCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
....+++.+.+||.+||..||.+|||+.+++++
T Consensus 235 -------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 235 -------------------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp -------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 013578899999999999999999999999976
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=355.25 Aligned_cols=252 Identities=23% Similarity=0.334 Sum_probs=209.8
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
+..++|++++.||+|+||+||+|.+. +++.||||++...... .+.+.+|+.+|+.++||||+++++++.+ ...+
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 78 (267)
T 3t9t_A 5 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPI 78 (267)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECS--SSSC
T ss_pred EchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcc--CCCe
Confidence 34568999999999999999999986 5788999999865433 3567889999999999999999999977 4678
Q ss_pred EEEEeccccccccc-ccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 207 YLVFEYMEHDITGL-LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~-~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
|+||||++++.+.. +......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 79 CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp EEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred EEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence 99999998755544 43444568999999999999999999999999999999999999999999999999998664322
Q ss_pred CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC
Q 005289 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
........+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+.+..+.......
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~------------ 225 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY------------ 225 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC------------
T ss_pred ccccccccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCC------------
Confidence 222234456788999999875 568999999999999999999 899999988888777765421100
Q ss_pred cccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
....++..+.+||.+||..||.+|||+.+++++
T Consensus 226 ----------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 226 ----------------KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp ----------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 012468899999999999999999999999975
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=371.19 Aligned_cols=254 Identities=19% Similarity=0.263 Sum_probs=204.2
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcE----EEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKI----VALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL 202 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~----vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 202 (704)
+..++|++++.||+|+||+||+|++..+++. ||+|++..... ......+.+|+.+|+.++||||+++++++.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-- 86 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-- 86 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEECB--
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--
Confidence 3457899999999999999999999888876 67777643321 2223345689999999999999999999864
Q ss_pred CCeEEEEEecccccccc-cccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEecccccccc
Q 005289 203 SCSIYLVFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (704)
Q Consensus 203 ~~~~~LV~Ey~~g~ll~-~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~ 281 (704)
..+|+||||+.++.+. .+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..
T Consensus 87 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 87 -SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp -SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred -CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccccc
Confidence 5689999999975444 44444568999999999999999999999999999999999999999999999999999877
Q ss_pred CCCCCC-CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhc
Q 005289 282 NTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359 (704)
Q Consensus 282 ~~~~~~-~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~ 359 (704)
...... ......+|+.|+|||++.+ ..|+.++|||||||+||+|++ |.+||.+....+....+......+
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~------- 237 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHF-GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLA------- 237 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCC-------
T ss_pred CcccccccccCCCCcccccChHHhcc-CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCC-------
Confidence 544322 2344566889999999875 568999999999999999999 999999887766665554311000
Q ss_pred cCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
....++.++.+||.+||..||.+|||+.+++++
T Consensus 238 ---------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 238 ---------------------QPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp ---------------------CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred ---------------------CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 012356778999999999999999999999987
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=380.05 Aligned_cols=255 Identities=25% Similarity=0.367 Sum_probs=209.5
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
+..++|++.+.||+|+||+||+|++..+++.||||++... ........+.+|+.+|+.++||||+++++++.. ...+
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~ 187 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQPI 187 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS--SSSC
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec--CCCc
Confidence 4457899999999999999999999999999999998754 344555667899999999999999999999976 4678
Q ss_pred EEEEecccccccc-cccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 207 YLVFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 207 ~LV~Ey~~g~ll~-~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
|||||||+++.+. .+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 188 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 9999999875544 444344569999999999999999999999999999999999999999999999999997654321
Q ss_pred CCC-cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCC
Q 005289 286 RQP-LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 286 ~~~-~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
... .....+++.|+|||++.. ..|+.++|||||||+||||++ |.+||.+.+..+....+.... .++
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~---------- 335 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNY-GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG-RLP---------- 335 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC-CCC----------
T ss_pred eeecCCCCCCCcCcCCHhHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCC----------
Confidence 111 112234778999999875 468999999999999999998 999999988777666554311 110
Q ss_pred CcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
....+|+++.+||.+||..||.+|||+.++++.
T Consensus 336 -----------------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~ 368 (377)
T 3cbl_A 336 -----------------CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQE 368 (377)
T ss_dssp -----------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 113578899999999999999999999999853
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=363.90 Aligned_cols=256 Identities=22% Similarity=0.312 Sum_probs=207.0
Q ss_pred ccCCeeEEEEeeccCceEEEEEEE-----CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeec
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARD-----LDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSR 201 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~-----~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~ 201 (704)
..++|++.+.||+|+||+||+|++ ..+++.||||++.... .....+.+.+|+.+|..+ +||||+++++++...
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 356899999999999999999984 4577899999997653 344566788999999999 799999999998764
Q ss_pred CCCeEEEEEecccccccccccCCCc----------------cccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEc
Q 005289 202 LSCSIYLVFEYMEHDITGLLSCPDI----------------KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN 265 (704)
Q Consensus 202 ~~~~~~LV~Ey~~g~ll~~~~~~~~----------------~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~ 265 (704)
...+|+||||++++.+..+..... .+++..++.++.||+.||.|||++||+||||||+||||+
T Consensus 104 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~ 182 (316)
T 2xir_A 104 -GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 182 (316)
T ss_dssp -TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred -CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC
Confidence 356899999999855554432222 289999999999999999999999999999999999999
Q ss_pred cCCceEEeccccccccCCCCCC-CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 005289 266 NEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLH 343 (704)
Q Consensus 266 ~~g~iKL~DFGla~~~~~~~~~-~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~ 343 (704)
.++.+||+|||++......... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+.+.
T Consensus 183 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~ 261 (316)
T 2xir_A 183 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261 (316)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred CCCCEEECCCccccccccCccceeccCCCcceeecCchhhcc-ccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHH
Confidence 9999999999999866543221 2233466889999999875 568999999999999999998 999998876544443
Q ss_pred HHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 344 KIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 344 ~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
........++ ....+++.+.+||.+||..||.+|||+.++++|
T Consensus 262 ~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 262 RRLKEGTRMR---------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhccCccCC---------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3332211110 113578899999999999999999999999987
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=367.83 Aligned_cols=254 Identities=23% Similarity=0.374 Sum_probs=188.7
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeEEEee------c
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNIIKLEGLITS------R 201 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~------~ 201 (704)
..+|++.+.||+|+||+||+|++..+++.||||++.... ......+.+|+.+|.++. ||||+++++++.. .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc--hHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 347999999999999999999999999999999986543 455667889999999995 9999999999842 2
Q ss_pred CCCeEEEEEecccccccccccC--CCccccHHHHHHHHHHhhhhHHHHHhcC--cccccCCCccEEEccCCceEEecccc
Q 005289 202 LSCSIYLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRG--VLHRDIKGSNLLVNNEGVLKLADFGL 277 (704)
Q Consensus 202 ~~~~~~LV~Ey~~g~ll~~~~~--~~~~l~e~~~~~i~~QIl~aL~yLH~~g--IvHrDLKp~NILl~~~g~iKL~DFGl 277 (704)
....+||||||+.+++...+.. ....+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+
T Consensus 105 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 105 GQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp SSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred CCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 2456899999999877766543 3456999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCC-----------CcccccccccccCccccc--CCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 005289 278 ANFSNTGHRQ-----------PLTSRVVTLWYRPPELLL--GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHK 344 (704)
Q Consensus 278 a~~~~~~~~~-----------~~~~~~gT~~Y~APEvl~--~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~ 344 (704)
+......... .....++|+.|+|||++. ....++.++|||||||+||+|++|.+||........+..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 264 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG 264 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence 9876543211 112456899999999983 335688899999999999999999999976544332221
Q ss_pred HHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccc
Q 005289 345 IFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415 (704)
Q Consensus 345 I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpw 415 (704)
.. .. ......+..+.+||.+||..||.+|||+.++|++-+
T Consensus 265 ~~----~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 265 KY----SI---------------------------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp -C----CC---------------------------CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred cc----cC---------------------------CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 10 00 011345677899999999999999999999998843
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=363.34 Aligned_cols=258 Identities=19% Similarity=0.267 Sum_probs=203.3
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECC---CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLD---TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 203 (704)
+..++|.+.+.||+|+||+||+|++.. ++..||||++..........+.+.+|+.+|++++||||+++++++.....
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 445689999999999999999998765 56689999998776666777888999999999999999999999876432
Q ss_pred ---CeEEEEEeccccccccccc------CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEec
Q 005289 204 ---CSIYLVFEYMEHDITGLLS------CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLAD 274 (704)
Q Consensus 204 ---~~~~LV~Ey~~g~ll~~~~------~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~D 274 (704)
...|+||||++++.+..+. .....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~D 190 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVAD 190 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECS
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEee
Confidence 2469999999986555443 3445799999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCC-CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCC
Q 005289 275 FGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSP 352 (704)
Q Consensus 275 FGla~~~~~~~~-~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~ 352 (704)
||++........ .......+++.|+|||++.+ ..++.++|||||||+||+|++ |.+||.+....+....+.... .
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~--~ 267 (313)
T 3brb_A 191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH--R 267 (313)
T ss_dssp CSCC----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC--C
T ss_pred cCcceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC--C
Confidence 999976643321 11233456889999999876 568999999999999999999 999999888777766664421 1
Q ss_pred CchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 353 PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 353 p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
+ .....+++.+.+||.+||..||.+|||+.+++++
T Consensus 268 ~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 268 L--------------------------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp C--------------------------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred C--------------------------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 0124678999999999999999999999999976
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=370.11 Aligned_cols=254 Identities=20% Similarity=0.324 Sum_probs=200.0
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEE----EEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIV----ALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL 202 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~v----AvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 202 (704)
+..++|++++.||+|+||+||+|++..+++.+ |+|.+.... .....+.+.+|+.+|++++||||+++++++..
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 88 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLT-- 88 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEES--
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec--
Confidence 44678999999999999999999998887765 777765332 23345678899999999999999999999986
Q ss_pred CCeEEEEEecccccccc-cccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEecccccccc
Q 005289 203 SCSIYLVFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (704)
Q Consensus 203 ~~~~~LV~Ey~~g~ll~-~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~ 281 (704)
...++||||+.++.+. .+......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++..
T Consensus 89 -~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 89 -STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp -SSEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred -CCeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 3478899999875544 44444567999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCC-CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhc
Q 005289 282 NTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359 (704)
Q Consensus 282 ~~~~~~-~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~ 359 (704)
...... ......+|+.|+|||++.+ ..|+.++|||||||+||+|++ |.+||.+.+..+....+......+
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~------- 239 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP------- 239 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC-------
T ss_pred cCCcccccccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCC-------
Confidence 543222 2233455889999999876 578999999999999999999 999999887766655553311100
Q ss_pred cCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
....++.++.+||.+||..||.+|||+.++|++
T Consensus 240 ---------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 240 ---------------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp ---------------------CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred ---------------------CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 113578899999999999999999999999976
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=362.65 Aligned_cols=256 Identities=20% Similarity=0.287 Sum_probs=208.7
Q ss_pred cccCCeeEEEEeeccCceEEEEEEE-----CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEee
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARD-----LDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITS 200 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~-----~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~ 200 (704)
+..++|++.+.||+|+||+||+|++ ..+++.||||++.... .....+.+.+|+.+|++| +||||+++++++..
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 3356899999999999999999984 4678899999997553 344567788999999999 99999999999977
Q ss_pred cCCCeEEEEEeccccccccccc-CCC-----------------ccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccE
Q 005289 201 RLSCSIYLVFEYMEHDITGLLS-CPD-----------------IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNL 262 (704)
Q Consensus 201 ~~~~~~~LV~Ey~~g~ll~~~~-~~~-----------------~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NI 262 (704)
...+||||||++++.+..+. ... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 99 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 176 (313)
T 1t46_A 99 --GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176 (313)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred --CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence 46789999999885444332 221 2489999999999999999999999999999999999
Q ss_pred EEccCCceEEeccccccccCCCCCCC-cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHH
Q 005289 263 LVNNEGVLKLADFGLANFSNTGHRQP-LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVE 340 (704)
Q Consensus 263 Ll~~~g~iKL~DFGla~~~~~~~~~~-~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e 340 (704)
||+.++.+||+|||++.......... .....+|+.|+|||++.+ ..++.++|||||||+||+|++ |.+||.+.....
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 99999999999999998765443221 223456889999999875 568999999999999999998 999998877655
Q ss_pred HHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 341 QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 341 ~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.+..+......+. ....++..+.+||.+||..||.+|||+.+++++
T Consensus 256 ~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 256 KFYKMIKEGFRML---------------------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHHHTCCCC---------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhccCCCCC---------------------------CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 5555443211110 013578999999999999999999999999975
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=369.79 Aligned_cols=256 Identities=21% Similarity=0.283 Sum_probs=204.6
Q ss_pred ccCCeeEEEEeeccCceEEEEEEE-----CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeec
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARD-----LDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSR 201 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~-----~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~ 201 (704)
..++|++.+.||+|+||+||+|++ ..++..||||++.... .....+.+.+|+.+|.+| +||||+++++++..
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~- 120 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTL- 120 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee-
Confidence 356899999999999999999997 3467789999997543 233456788999999999 99999999999987
Q ss_pred CCCeEEEEEecccccccccc-cCCC----------------------ccccHHHHHHHHHHhhhhHHHHHhcCcccccCC
Q 005289 202 LSCSIYLVFEYMEHDITGLL-SCPD----------------------IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIK 258 (704)
Q Consensus 202 ~~~~~~LV~Ey~~g~ll~~~-~~~~----------------------~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLK 258 (704)
...+||||||++++.+..+ .... ..+++..++.++.||+.||.|||++||+|||||
T Consensus 121 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik 199 (344)
T 1rjb_A 121 -SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA 199 (344)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred -CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 4678999999987554433 3222 237999999999999999999999999999999
Q ss_pred CccEEEccCCceEEeccccccccCCCCCC-CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCC
Q 005289 259 GSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGR 336 (704)
Q Consensus 259 p~NILl~~~g~iKL~DFGla~~~~~~~~~-~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~ 336 (704)
|+||||+.++.+||+|||++......... ......+|+.|+|||++.+ ..++.++|||||||+||+|++ |.+||.+.
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-CCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999866543221 1233456889999999875 568999999999999999998 99999987
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcc
Q 005289 337 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 414 (704)
Q Consensus 337 ~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hp 414 (704)
.....+..+......+ .....+++++.+||.+||..||.+|||+.+++++-
T Consensus 279 ~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 279 PVDANFYKLIQNGFKM---------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp CCSHHHHHHHHTTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CcHHHHHHHHhcCCCC---------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 7655555544321111 01135789999999999999999999999999874
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=356.33 Aligned_cols=255 Identities=20% Similarity=0.244 Sum_probs=205.4
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|++.+.||+|+||+||+|++..+++.||||++...... ..+.+|+.+++.+.|++++..+.++... ...+||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEE-TTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCC-CCceEE
Confidence 46899999999999999999999999999999998765432 2467899999999998877777666443 578899
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEE---ccCCceEEeccccccccCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl---~~~g~iKL~DFGla~~~~~~~ 285 (704)
||||+.+++...+......+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++.......
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 99999666655555455679999999999999999999999999999999999999 488899999999998765432
Q ss_pred CC------CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHcCCCCchh
Q 005289 286 RQ------PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT---EVEQLHKIFKLCGSPPDDY 356 (704)
Q Consensus 286 ~~------~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~---~~e~l~~I~~~~g~~p~~~ 356 (704)
.. ......+|+.|+|||++.+ ..++.++|||||||+||+|++|++||.+.. ..+.+..+......++
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--- 238 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--- 238 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC---
T ss_pred cccccccccccccccccccCChhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc---
Confidence 21 1245578999999999876 568999999999999999999999998743 2233333332111111
Q ss_pred hhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 357 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 357 w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.......+|+++.+||.+||+.||.+|||+.++++.
T Consensus 239 ---------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 274 (296)
T 3uzp_A 239 ---------------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 274 (296)
T ss_dssp ---------------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred ---------------------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHH
Confidence 122235789999999999999999999999998753
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=358.51 Aligned_cols=253 Identities=19% Similarity=0.253 Sum_probs=206.5
Q ss_pred ccCCeeEEE-EeeccCceEEEEEE--ECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCC
Q 005289 128 RADAFEKLE-KIGQGTYSSVFRAR--DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (704)
Q Consensus 128 ~~~~y~~~~-~LG~G~fg~Vy~a~--~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 204 (704)
..++|++.+ .||+|+||+||+|. +..+++.||||++..........+.+.+|+.+|+.++||||+++++++.. .
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~ 90 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---E 90 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---S
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC---C
Confidence 356799998 99999999999994 45678899999998665445556778899999999999999999999843 5
Q ss_pred eEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
.+|+||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred CcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence 78999999998766655555557999999999999999999999999999999999999999999999999999876543
Q ss_pred CCC--CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccC
Q 005289 285 HRQ--PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (704)
Q Consensus 285 ~~~--~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~ 361 (704)
... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+... ..+
T Consensus 171 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~--~~~-------- 239 (291)
T 1xbb_A 171 ENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG--ERM-------- 239 (291)
T ss_dssp CSEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT--CCC--------
T ss_pred CCcccccccCCCCceeeChHHhcc-CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCC--------
Confidence 221 1122345788999999875 457889999999999999999 99999998887766665431 110
Q ss_pred CCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
.....++..+.+||.+||..||.+|||+.++++
T Consensus 240 ------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 240 ------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp ------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011367899999999999999999999999985
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=360.66 Aligned_cols=269 Identities=24% Similarity=0.344 Sum_probs=201.7
Q ss_pred cCCeeEEEEeeccCceEEEEEE----ECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRAR----DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~----~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 204 (704)
...|++++.||+|+||+||+|+ +..+++.||||++.... .......+.+|+.+|+.++||||+++++++......
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 3469999999999999999999 67789999999997543 223456788999999999999999999999876557
Q ss_pred eEEEEEeccccccccccc-CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCC
Q 005289 205 SIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~-~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~ 283 (704)
.+||||||++++.+..+. .....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 178 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred eEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccC
Confidence 799999999885555443 4445699999999999999999999999999999999999999999999999999987654
Q ss_pred CCC--CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccC
Q 005289 284 GHR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (704)
Q Consensus 284 ~~~--~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~ 361 (704)
... .......+|..|+|||++.+ ..++.++|||||||++|+|++|..|+.... ..+....+......... .
T Consensus 179 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~-~ 251 (302)
T 4e5w_A 179 DKEYYTVKDDRDSPVFWYAPECLMQ-SKFYIASDVWSFGVTLHELLTYCDSDSSPM-----ALFLKMIGPTHGQMTVT-R 251 (302)
T ss_dssp TCCEEECCCCTTCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHH-----HHHHHHHCSCCGGGHHH-H
T ss_pred CCcceeccCCCCCCccccCCeeecC-CCCCcchhHHHHHHHHHHHHHccCCCcchh-----hHHhhccCCcccccCHH-H
Confidence 332 12334567888999999876 467889999999999999999998864321 11111112211110000 0
Q ss_pred CCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
+.. ... ... .......+++.+.+||.+||..||.+|||+.++|+
T Consensus 252 ~~~-~~~-~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 252 LVN-TLK-EGK-----RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHH-HHH-TTC-----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHH-HHh-ccC-----CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 000 000 000 00112468899999999999999999999999985
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=354.95 Aligned_cols=256 Identities=20% Similarity=0.249 Sum_probs=211.0
Q ss_pred cccCCeeEEE-EeeccCceEEEEEEEC--CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC
Q 005289 127 LRADAFEKLE-KIGQGTYSSVFRARDL--DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (704)
Q Consensus 127 ~~~~~y~~~~-~LG~G~fg~Vy~a~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 203 (704)
+..++|.++. .||+|+||+||+|.+. .++..||||++.... .....+.+.+|+.+|+.++||||+++++++..
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--- 81 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--- 81 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEecC---
Confidence 3456788887 9999999999999864 467889999997653 45567778899999999999999999999954
Q ss_pred CeEEEEEecccccccccc-cCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccC
Q 005289 204 CSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~~-~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~ 282 (704)
..+||||||++++.+..+ ......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 568999999998655544 4455679999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCC--CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhc
Q 005289 283 TGHRQ--PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359 (704)
Q Consensus 283 ~~~~~--~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~ 359 (704)
..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |++||.+.+..+.+..+... ..+
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~--~~~------ 232 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG--KRM------ 232 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT--CCC------
T ss_pred cCcceeeccccccccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcC--CcC------
Confidence 43221 1223345889999999875 468899999999999999998 99999998887777666441 110
Q ss_pred cCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccc
Q 005289 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415 (704)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpw 415 (704)
.....+++.+.+||.+||..||.+|||+.+++++.+
T Consensus 233 --------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 233 --------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp --------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred --------------------CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 011368899999999999999999999999998743
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=366.13 Aligned_cols=269 Identities=24% Similarity=0.320 Sum_probs=207.3
Q ss_pred cccCCeeEEEEeeccCceEEEEEE----ECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRAR----DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL 202 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~----~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 202 (704)
+..++|++++.||+|+||+||+|+ +..+++.||||++... .....+.+.+|+.+|+.++||||+++++++....
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence 345689999999999999999999 5678999999999754 3555677889999999999999999999988665
Q ss_pred CCeEEEEEeccccccccccc-CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEecccccccc
Q 005289 203 SCSIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (704)
Q Consensus 203 ~~~~~LV~Ey~~g~ll~~~~-~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~ 281 (704)
...+||||||++++.+..+. .....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceec
Confidence 77899999999876555443 33456999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCC--CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCc--hhh
Q 005289 282 NTGHRQ--PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD--DYW 357 (704)
Q Consensus 282 ~~~~~~--~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~--~~w 357 (704)
...... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||......... .+ ......+. ...
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~-~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSD-NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR-MM-GCERDVPALSRLL 254 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HC-C----CCHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhcc-CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhh-hc-ccccccccHHHHH
Confidence 543211 2233457888999999876 56789999999999999999999998754332110 00 00000000 000
Q ss_pred hccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 358 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
..... ... ......+++.+.+||.+||..||.+|||+.+++++
T Consensus 255 ~~~~~--------~~~-----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 255 ELLEE--------GQR-----LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHT--------TCC-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhhc--------ccC-----CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00000 000 01124688999999999999999999999999644
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=356.54 Aligned_cols=254 Identities=20% Similarity=0.240 Sum_probs=201.7
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|++.+.||+|+||+||+|++..+++.||||++...... ..+.+|+.+++.+.|++++..+..+... ....||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~l 82 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVM 82 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEE-TTEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCC-CCceEE
Confidence 35799999999999999999999999999999997654322 2367899999999998888877766543 578899
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEE---ccCCceEEeccccccccCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl---~~~g~iKL~DFGla~~~~~~~ 285 (704)
||||+.+++...+......+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++.......
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 99999666665555455679999999999999999999999999999999999999 788999999999998765432
Q ss_pred C------CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCCchh
Q 005289 286 R------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV---EQLHKIFKLCGSPPDDY 356 (704)
Q Consensus 286 ~------~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~---e~l~~I~~~~g~~p~~~ 356 (704)
. .......+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.... ..+..+.......
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---- 237 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST---- 237 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS----
T ss_pred cCccCCCCcccccCCCccccchHHhcC-CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc----
Confidence 2 12235578999999999886 56899999999999999999999999874322 2222222211111
Q ss_pred hhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 357 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 357 w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
........+|+++.+||.+||..||++|||+.++++
T Consensus 238 --------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 238 --------------------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp --------------------CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred --------------------hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 112233578999999999999999999999999985
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=368.19 Aligned_cols=261 Identities=17% Similarity=0.127 Sum_probs=199.4
Q ss_pred cCCeeEEEEeeccCceEEEEEEECC---CCcEEEEEEeecCCCChH---------HHHHHHHHHHHHHhcCCCCceeEeE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLD---TGKIVALKKVRFDNFEPE---------SVRFMAREILILRRLDHPNIIKLEG 196 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~---~g~~vAvK~i~~~~~~~~---------~~~~~~~Ei~iL~~L~HpnIv~l~~ 196 (704)
.++|++.+.||+|+||+||+|++.. ++..||||++........ ....+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 4689999999999999999999987 788999999976542110 1123557889999999999999999
Q ss_pred EEeec--CCCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCC--ceEE
Q 005289 197 LITSR--LSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG--VLKL 272 (704)
Q Consensus 197 ~~~~~--~~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g--~iKL 272 (704)
++... ....+||||||| ++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL 194 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL 194 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence 98763 246899999999 555554444445899999999999999999999999999999999999999887 9999
Q ss_pred eccccccccCCCC------CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC--CHHHHHHH
Q 005289 273 ADFGLANFSNTGH------RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR--TEVEQLHK 344 (704)
Q Consensus 273 ~DFGla~~~~~~~------~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~--~~~e~l~~ 344 (704)
+|||+++...... ........+|+.|+|||++.+ ..++.++|||||||+||+|++|++||.+. ........
T Consensus 195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 273 (345)
T 2v62_A 195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA 273 (345)
T ss_dssp CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred EeCCCceecccccccccchhccccccCCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence 9999997654221 112245578999999999886 56899999999999999999999999653 33333333
Q ss_pred HHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhcc--CCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 345 IFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFK--DLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 345 I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~--~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
........+.. +..... .++.++.+||.+||..||.+|||+.++++.
T Consensus 274 ~~~~~~~~~~~----------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 274 KTNLLDELPQS----------------------VLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHTTTHH----------------------HHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHhhcccccHH----------------------HHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 22222222211 112222 789999999999999999999999999864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=353.57 Aligned_cols=249 Identities=21% Similarity=0.342 Sum_probs=207.5
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEE
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 207 (704)
..++|++++.||+|+||+||+|.+. ++..||||++...... .+.+.+|+.+|+.++||||+++++++.. ..+|
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~ 83 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIY 83 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcC---CCcE
Confidence 3468999999999999999999975 5678999999765433 4567889999999999999999999864 4589
Q ss_pred EEEecccccccccccCCC--ccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 208 LVFEYMEHDITGLLSCPD--IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~--~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
+||||+.++.+..+.... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 84 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred EEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 999999886666555433 268999999999999999999999999999999999999999999999999998765443
Q ss_pred CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC
Q 005289 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
........+|+.|+|||++.+ ..++.++|||||||++|+|++ |++||.+.+..+.+..+......
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~------------- 229 (279)
T 1qpc_A 164 YTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM------------- 229 (279)
T ss_dssp EECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-------------
T ss_pred cccccCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCC-------------
Confidence 223334456889999999875 468899999999999999999 99999998888777766442100
Q ss_pred cccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
.....++..+.+||.+||..||.+|||+.++++
T Consensus 230 ---------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 230 ---------------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp ---------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 011367899999999999999999999999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=367.45 Aligned_cols=254 Identities=20% Similarity=0.322 Sum_probs=200.6
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEE----EEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIV----ALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL 202 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~v----AvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 202 (704)
+..++|++++.||+|+||+||+|++..+++.| |+|.+.... .......+.+|+.+|+.++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~- 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-
Confidence 44678999999999999999999998888765 666654332 233456788999999999999999999999863
Q ss_pred CCeEEEEEecccccccc-cccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEecccccccc
Q 005289 203 SCSIYLVFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (704)
Q Consensus 203 ~~~~~LV~Ey~~g~ll~-~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~ 281 (704)
..++||||+.++.+. .+......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++...
T Consensus 90 --~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 90 --TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp --SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred --CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 478899999875444 44444567999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCC-CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhc
Q 005289 282 NTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359 (704)
Q Consensus 282 ~~~~~-~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~ 359 (704)
..... .......+|+.|+|||++.+ ..|+.++|||||||+||+|++ |.+||.+....+....+......+
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~------- 239 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP------- 239 (327)
T ss_dssp ------------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC-------
T ss_pred cCccccccccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC-------
Confidence 43321 12233455889999999876 568999999999999999999 999999888777665554321110
Q ss_pred cCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
....++.++.+||.+||..||.+|||+.++|+.
T Consensus 240 ---------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 240 ---------------------QPPICTIDVYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp ---------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 113578899999999999999999999999964
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=386.16 Aligned_cols=256 Identities=24% Similarity=0.359 Sum_probs=196.1
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCCeEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~ 207 (704)
..+|.+.+.||+|+||+||. ....+++.||||++..... ..+.+|+.+|+.+ +|||||++++++.+ ...+|
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~--~~~~~ 94 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKD--RQFQY 94 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEE--TTEEE
T ss_pred cEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEec--CCEEE
Confidence 34699999999999999764 3456799999999975432 2245799999999 89999999999887 57899
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEcc---C--CceEEeccccccccC
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---E--GVLKLADFGLANFSN 282 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~---~--g~iKL~DFGla~~~~ 282 (704)
||||||.+++...+......+++..+..++.||+.||.|||++||+||||||+||||+. + ..+||+|||+++...
T Consensus 95 lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 95 IAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp EEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred EEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 99999999887777666656777778899999999999999999999999999999953 2 357899999998765
Q ss_pred CCCC--CCcccccccccccCcccccC--CCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhh
Q 005289 283 TGHR--QPLTSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYW 357 (704)
Q Consensus 283 ~~~~--~~~~~~~gT~~Y~APEvl~~--~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w 357 (704)
.... ......+||+.|+|||++.+ ...++.++|||||||+||+|++ |.+||........ ..+ .+......+
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-~~~---~~~~~~~~~ 250 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-NIL---LGACSLDCL 250 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-HHH---TTCCCCTTS
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-HHH---hccCCcccc
Confidence 3321 22345678999999999874 3467889999999999999999 9999966544332 221 111110000
Q ss_pred hccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 358 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
......+..+.+||.+||..||.+|||+.++|+||||..
T Consensus 251 ----------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 251 ----------------------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp ----------------------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred ----------------------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 001123566899999999999999999999999999975
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=366.17 Aligned_cols=253 Identities=25% Similarity=0.343 Sum_probs=204.8
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEE--EEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCC
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIV--ALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLS 203 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~v--AvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 203 (704)
+..++|++.+.||+|+||+||+|++..++..+ |||.+.... .....+.+.+|+.+|+++ +||||+++++++.+ .
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~ 98 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--R 98 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--T
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeee--C
Confidence 45678999999999999999999998888865 999987432 234456688999999999 99999999999987 5
Q ss_pred CeEEEEEecccccccccccCCC----------------ccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccC
Q 005289 204 CSIYLVFEYMEHDITGLLSCPD----------------IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE 267 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~~~~~~----------------~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~ 267 (704)
..+||||||++++.+..+.... ..+++..++.++.||+.||.|||++||+||||||+||||+.+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~ 178 (327)
T 1fvr_A 99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 178 (327)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCC
Confidence 7899999999875544443222 368999999999999999999999999999999999999999
Q ss_pred CceEEeccccccccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 005289 268 GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIF 346 (704)
Q Consensus 268 g~iKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~ 346 (704)
+.+||+|||++...... .......+|+.|+|||++.+ ..++.++|||||||+||+|++ |.+||.+.+..+.+..+.
T Consensus 179 ~~~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~ 255 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255 (327)
T ss_dssp GCEEECCTTCEESSCEE--CCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred CeEEEcccCcCcccccc--ccccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh
Confidence 99999999999744322 11233456889999999875 568899999999999999998 999999988877666653
Q ss_pred HHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 347 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 347 ~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
..... .....+++.+.+||.+||..||.+|||+.++|++
T Consensus 256 ~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 256 QGYRL----------------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp GTCCC----------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCC----------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 31100 0113578999999999999999999999999976
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=374.82 Aligned_cols=255 Identities=24% Similarity=0.369 Sum_probs=199.6
Q ss_pred cccCCeeEEEEeeccCceEEEEEEEC---CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDL---DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 203 (704)
+..++|++.+.||+|+||+||+|++. .++..||||++.... .....+.+.+|+.+|++++||||+++++++.. .
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~ 118 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK--S 118 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--S
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--C
Confidence 34568999999999999999999876 467789999997543 45556778899999999999999999999977 4
Q ss_pred CeEEEEEeccccccccc-ccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccC
Q 005289 204 CSIYLVFEYMEHDITGL-LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~-~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~ 282 (704)
..+|||||||+++.+.. +......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 67899999998755554 44445579999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCCcc--cccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhc
Q 005289 283 TGHRQPLT--SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359 (704)
Q Consensus 283 ~~~~~~~~--~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~ 359 (704)
........ ...+|+.|+|||++.+ ..|+.++|||||||+||||++ |++||...+..+.+..+......+
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~------- 270 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP------- 270 (373)
T ss_dssp ---------------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECC-------
T ss_pred cCCccceeccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------
Confidence 43222212 2234778999999875 568999999999999999998 999999988887777664421111
Q ss_pred cCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
....++..+.+||.+||..||.+|||+.++++.
T Consensus 271 ---------------------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~ 303 (373)
T 2qol_A 271 ---------------------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303 (373)
T ss_dssp ---------------------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CCccccHHHHHHHHHHhCcChhhCcCHHHHHHH
Confidence 013578899999999999999999999999853
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=363.74 Aligned_cols=255 Identities=22% Similarity=0.324 Sum_probs=208.6
Q ss_pred cccCCeeEEEEeeccCceEEEEEEEC-------CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEE
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDL-------DTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLI 198 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~-------~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~ 198 (704)
+..++|++.+.||+|+||+||+|++. .++..||||++.... .......+.+|+.+|+.+ +||||+++++++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 34568999999999999999999975 467789999997543 445567788999999999 999999999999
Q ss_pred eecCCCeEEEEEecccccccccccCCC----------------ccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccE
Q 005289 199 TSRLSCSIYLVFEYMEHDITGLLSCPD----------------IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNL 262 (704)
Q Consensus 199 ~~~~~~~~~LV~Ey~~g~ll~~~~~~~----------------~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NI 262 (704)
.. ...+||||||++++.+..+.... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 111 ~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 188 (334)
T 2pvf_A 111 TQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188 (334)
T ss_dssp CS--SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred cc--CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceE
Confidence 77 46789999999885555443221 2489999999999999999999999999999999999
Q ss_pred EEccCCceEEeccccccccCCCCC-CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHH
Q 005289 263 LVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVE 340 (704)
Q Consensus 263 Ll~~~g~iKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e 340 (704)
||+.++.+||+|||++........ .......+|+.|+|||++.+ ..++.++|||||||+||+|++ |.+||.+.+..+
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 267 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcC-CCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence 999999999999999986654321 11233456889999999875 568999999999999999999 999999988877
Q ss_pred HHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 341 QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 341 ~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.+..+...... .....++..+.+||.+||..||.+|||+.+++++
T Consensus 268 ~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 268 LFKLLKEGHRM----------------------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHHTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCC----------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 77666542100 0113678899999999999999999999999976
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=372.88 Aligned_cols=263 Identities=19% Similarity=0.174 Sum_probs=198.6
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCC-----CcEEEEEEeecCCCCh-HH--------HHHHHHHHHHHHhcCCCCceeE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDT-----GKIVALKKVRFDNFEP-ES--------VRFMAREILILRRLDHPNIIKL 194 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~-----g~~vAvK~i~~~~~~~-~~--------~~~~~~Ei~iL~~L~HpnIv~l 194 (704)
.++|++++.||+|+||+||+|.+..+ ++.||||++....... .. ...+..|+..+..+.||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 45799999999999999999998765 5889999997653110 00 0123346667778889999999
Q ss_pred eEEEeecC--CCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEc--cCCce
Q 005289 195 EGLITSRL--SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN--NEGVL 270 (704)
Q Consensus 195 ~~~~~~~~--~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~--~~g~i 270 (704)
++++.... ...+|||||||.+++...+......+++..++.|+.||+.||.|||++||+||||||+||||+ .++.+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~ 193 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQV 193 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCE
T ss_pred EeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeE
Confidence 99987642 256899999995555555555556799999999999999999999999999999999999999 88999
Q ss_pred EEeccccccccCCCCC------CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 005289 271 KLADFGLANFSNTGHR------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHK 344 (704)
Q Consensus 271 KL~DFGla~~~~~~~~------~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~ 344 (704)
||+|||+++....... ......+||+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+......+..
T Consensus 194 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~ 272 (364)
T 3op5_A 194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG-VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVR 272 (364)
T ss_dssp EECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH
T ss_pred EEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHH
Confidence 9999999976543211 12234568999999999876 5689999999999999999999999986433222222
Q ss_pred HHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhc--cCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 345 IFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF--KDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 345 I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~--~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
.......... ...+...+ ..+|.++.+||..||..||.+|||+.++++
T Consensus 273 ~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 273 DSKIRYRENI--------------------ASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHCH--------------------HHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHhhhhH--------------------HHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 2111000000 00111111 578999999999999999999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=365.38 Aligned_cols=261 Identities=16% Similarity=0.251 Sum_probs=212.7
Q ss_pred cCCeeEEEEeeccCceEEEEEEEC-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDL-----DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 203 (704)
.++|++.+.||+|+||+||+|++. .+++.||||++.... .......+.+|+.+|+.++||||+++++++.+ .
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~ 100 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--G 100 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS--S
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc--C
Confidence 467999999999999999999876 467889999997543 34445668899999999999999999999977 4
Q ss_pred CeEEEEEecccccccccccCC----------CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEe
Q 005289 204 CSIYLVFEYMEHDITGLLSCP----------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLA 273 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~~~~~----------~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~ 273 (704)
..+||||||++++.+..+... ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~ 180 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 180 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEEC
Confidence 678999999998555544321 1356899999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCC-CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCC
Q 005289 274 DFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGS 351 (704)
Q Consensus 274 DFGla~~~~~~~~-~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~ 351 (704)
|||++........ .......+|+.|+|||++.+ ..++.++|||||||+||+|++ |.+||.+.+..+....+... .
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~--~ 257 (322)
T 1p4o_A 181 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG--G 257 (322)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT--C
T ss_pred cCccccccccccccccccCCCCCCCccChhhhcc-CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcC--C
Confidence 9999976543221 11223456889999999875 568999999999999999999 89999998887777666441 1
Q ss_pred CCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc------cccCCCCC
Q 005289 352 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS------EYFSTKPY 421 (704)
Q Consensus 352 ~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h------pwf~~~~~ 421 (704)
.+ .....++..+.+||.+||..||.+|||+.+++++ +||+...+
T Consensus 258 ~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~~ 307 (322)
T 1p4o_A 258 LL--------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSF 307 (322)
T ss_dssp CC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCS
T ss_pred cC--------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCccccc
Confidence 10 0123678999999999999999999999999987 66654433
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=365.46 Aligned_cols=259 Identities=18% Similarity=0.258 Sum_probs=205.8
Q ss_pred ccCCeeEEEEeeccCceEEEEEE-----ECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC
Q 005289 128 RADAFEKLEKIGQGTYSSVFRAR-----DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL 202 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~-----~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 202 (704)
..++|++++.||+|+||+||+|+ +..+++.||||++.... .......+.+|+.+|+.++||||+++++++..
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 104 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ-- 104 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC--
Confidence 34689999999999999999999 56678899999997443 34556678899999999999999999999987
Q ss_pred CCeEEEEEecccccccccccC-CC------ccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccC---CceEE
Q 005289 203 SCSIYLVFEYMEHDITGLLSC-PD------IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE---GVLKL 272 (704)
Q Consensus 203 ~~~~~LV~Ey~~g~ll~~~~~-~~------~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~---g~iKL 272 (704)
...+||||||++++.+..+.. .. ..+++..++.++.||+.||.|||++||+||||||+||||+.+ ..+||
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence 467899999997755544332 21 358999999999999999999999999999999999999844 46999
Q ss_pred eccccccccCCCCC-CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcC
Q 005289 273 ADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCG 350 (704)
Q Consensus 273 ~DFGla~~~~~~~~-~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g 350 (704)
+|||++........ .......+|+.|+|||++.+ ..++.++|||||||+||+|++ |.+||...+..+.+..+.....
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~ 263 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 263 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCC
Confidence 99999975432221 22234567899999999875 568999999999999999998 9999999888777766644210
Q ss_pred CCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 351 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 351 ~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
. .....++..+.+||.+||..||.+|||+.++|++.|+-.
T Consensus 264 ~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 264 M----------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp C----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C----------------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 0 011367889999999999999999999999999988753
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=356.75 Aligned_cols=254 Identities=30% Similarity=0.453 Sum_probs=195.9
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN-FEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 207 (704)
.++|++++.||+|+||+||+|.+..+++.||||++.... ........+.+|+.+|+.++||||+++++++.. ...+|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~ 108 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--DNELN 108 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCcEE
Confidence 457999999999999999999999999999999997643 345566778899999999999999999999987 56899
Q ss_pred EEEecccccccccccC----CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCC
Q 005289 208 LVFEYMEHDITGLLSC----PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~----~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~ 283 (704)
|||||++++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 9999999865554432 345689999999999999999999999999999999999999999999999999976653
Q ss_pred CCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHcCCCCchhhhccC
Q 005289 284 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT--EVEQLHKIFKLCGSPPDDYWKKSK 361 (704)
Q Consensus 284 ~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~--~~e~l~~I~~~~g~~p~~~w~~~~ 361 (704)
.. .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.. .......+.. ...++
T Consensus 189 ~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~-------- 257 (310)
T 2wqm_A 189 KT-TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-CDYPP-------- 257 (310)
T ss_dssp -----------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHT-TCSCC--------
T ss_pred CC-ccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhc-ccCCC--------
Confidence 32 22334578999999999876 568999999999999999999999997643 2233333322 11110
Q ss_pred CCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.....++.++.+||.+||..||.+|||+.+++++
T Consensus 258 ------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 258 ------------------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp ------------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 0013578999999999999999999999999864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=355.03 Aligned_cols=247 Identities=26% Similarity=0.399 Sum_probs=203.3
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEee---------
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITS--------- 200 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~--------- 200 (704)
.+|++++.||+|+||+||+|++..+++.||||++.... ..+.+|+.+|+.++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 36999999999999999999999999999999997643 235689999999999999999998854
Q ss_pred -----cCCCeEEEEEecccccccccccC--CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEe
Q 005289 201 -----RLSCSIYLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLA 273 (704)
Q Consensus 201 -----~~~~~~~LV~Ey~~g~ll~~~~~--~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~ 273 (704)
.....+||||||++++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEEC
Confidence 11346899999999855554432 23568999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Q 005289 274 DFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 353 (704)
Q Consensus 274 DFGla~~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p 353 (704)
|||++....... ......+|+.|+|||++.+ ..++.++|||||||+||+|++|..||... ......+.. +.
T Consensus 165 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~--~~-- 235 (284)
T 2a19_B 165 DFGLVTSLKNDG--KRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRD--GI-- 235 (284)
T ss_dssp CCTTCEESSCCS--CCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHT--TC--
T ss_pred cchhheeccccc--cccccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhc--cc--
Confidence 999998765432 2344578999999999876 56899999999999999999999887431 111222111 00
Q ss_pred chhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 354 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 354 ~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
....++..+.+||.+||..||.+|||+.+++++.|+-.
T Consensus 236 ---------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 236 ---------------------------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp ---------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred ---------------------------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 01357888999999999999999999999999987754
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=368.78 Aligned_cols=268 Identities=21% Similarity=0.278 Sum_probs=204.0
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|++.+.||+|+||+||+|++ .+++.||||++.... ....+.+.+|+.+|+.++||||+++++++.. ...+||
T Consensus 38 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 112 (321)
T 2qkw_B 38 TNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDE--RNEMIL 112 (321)
T ss_dssp CCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCC--TTCCEE
T ss_pred HhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CCeEEE
Confidence 56899999999999999999996 468999999987553 3345678899999999999999999999976 467899
Q ss_pred EEecccccccccccCC----CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 209 VFEYMEHDITGLLSCP----DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~----~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
||||++++.+..+... ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 192 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999998666554432 235899999999999999999999999999999999999999999999999999765432
Q ss_pred C-CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCC
Q 005289 285 H-RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 285 ~-~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
. ........+|+.|+|||++.+ ..++.++|||||||+||+|++|++||.+....+....+.... .......+.
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~ 266 (321)
T 2qkw_B 193 DQTHLSTVVKGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV-----ESHNNGQLE 266 (321)
T ss_dssp SCCCCBCCCEEETTTCCHHHHHH-CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTH-----HHHTTTCCC
T ss_pred cccccccccCCCccccCHHHhcC-CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhh-----hccccccHH
Confidence 2 122334568999999999875 468999999999999999999999997654322111110000 000000000
Q ss_pred CcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcc
Q 005289 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 414 (704)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hp 414 (704)
....+. . .......++..+.+||.+||..||++|||+.++|++-
T Consensus 267 --~~~~~~--~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 267 --QIVDPN--L---ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp --SSSSSS--C---TTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --HhcChh--h---ccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 000000 0 0011124567899999999999999999999999873
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=362.55 Aligned_cols=255 Identities=21% Similarity=0.293 Sum_probs=207.6
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCCc-----EEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeec
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTGK-----IVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSR 201 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~-----~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~ 201 (704)
..++|++.+.||+|+||+||+|.+..+++ .||||++.... .....+.+.+|+.+|+.| +||||+++++++..
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 121 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTH- 121 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec-
Confidence 35689999999999999999999977664 79999997543 345567788999999999 89999999999977
Q ss_pred CCCeEEEEEecccccccccccCC--------------CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccC
Q 005289 202 LSCSIYLVFEYMEHDITGLLSCP--------------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE 267 (704)
Q Consensus 202 ~~~~~~LV~Ey~~g~ll~~~~~~--------------~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~ 267 (704)
...+||||||++++.+..+... ...+++..++.++.||+.||.|||++||+||||||+||||+.+
T Consensus 122 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 122 -GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG 200 (333)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG
T ss_pred -CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC
Confidence 4678999999988555443321 2357999999999999999999999999999999999999999
Q ss_pred CceEEeccccccccCCCCCC-CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 005289 268 GVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKI 345 (704)
Q Consensus 268 g~iKL~DFGla~~~~~~~~~-~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I 345 (704)
+.+||+|||++......... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+......+..+
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 279 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL 279 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHH
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhcc-CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHH
Confidence 99999999999865433221 1233456889999999875 568999999999999999998 99999987665555555
Q ss_pred HHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 346 FKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 346 ~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
......++ ....++..+.+||.+||..||.+|||+.+++++
T Consensus 280 ~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 280 VKDGYQMA---------------------------QPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhcCCCCC---------------------------CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 44221110 013468899999999999999999999999964
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=380.76 Aligned_cols=250 Identities=22% Similarity=0.346 Sum_probs=207.8
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
+..++|++.+.||+|+||+||+|.+. ++..||||++..... ..+.+.+|+.+|+.|+|||||++++++.. ..+
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~l~~~~~~---~~~ 257 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPI 257 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB---CHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSC
T ss_pred echHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc---cHHHHHHHHHHHhhCCCCCEeeEEEEEeC---Ccc
Confidence 44578999999999999999999985 467899999976542 35678899999999999999999999863 568
Q ss_pred EEEEecccccccccccCC--CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 207 YLVFEYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~~--~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
|||||||.++.+..++.. ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 999999988655544432 236889999999999999999999999999999999999999999999999999876532
Q ss_pred CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCC
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
.........+|+.|+|||++.. ..|+.++|||||||+||||++ |++||.+.+..+.+..+......+
T Consensus 338 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~----------- 405 (454)
T 1qcf_A 338 EYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP----------- 405 (454)
T ss_dssp HHHTTCSSSSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC-----------
T ss_pred ceeccCCCcccccccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-----------
Confidence 2122233345788999999875 568999999999999999999 999999999888887775521110
Q ss_pred CcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
....+++++.+||.+||..||.+|||+.+++.
T Consensus 406 -----------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 406 -----------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp -----------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 01367899999999999999999999999975
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=360.45 Aligned_cols=255 Identities=22% Similarity=0.339 Sum_probs=203.8
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCC----cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTG----KIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL 202 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g----~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 202 (704)
+...+|++.+.||+|+||+||+|++..++ ..||||++.... .......+.+|+.+|+.++||||+++++++..
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 117 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-- 117 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec--
Confidence 44678999999999999999999876553 459999997543 44556678899999999999999999999976
Q ss_pred CCeEEEEEecccccccccc-cCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEecccccccc
Q 005289 203 SCSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (704)
Q Consensus 203 ~~~~~LV~Ey~~g~ll~~~-~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~ 281 (704)
...+||||||++++.+..+ ......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 5689999999998555544 344567999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCCC--cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhh
Q 005289 282 NTGHRQP--LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWK 358 (704)
Q Consensus 282 ~~~~~~~--~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~ 358 (704)
....... .....+|+.|+|||++.+ ..++.++|||||||+||+|++ |..||.+.+..+.+..+......+
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~------ 270 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP------ 270 (333)
T ss_dssp -------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC------
T ss_pred ccccccccccCCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCC------
Confidence 5432111 122345788999999875 568999999999999999998 999999988887777665421100
Q ss_pred ccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 359 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
....++..+.+||.+||..||.+|||+.+++++
T Consensus 271 ----------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 271 ----------------------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp ----------------------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ----------------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 013578999999999999999999999999865
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=351.36 Aligned_cols=255 Identities=22% Similarity=0.310 Sum_probs=205.1
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCCc---EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCC
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTGK---IVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~---~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 204 (704)
..-.|.+.++||+|+||+||+|++..++. .||+|++.... .....+.+.+|+.+|+.++||||+++++++.+. ..
T Consensus 19 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~ 96 (298)
T 3pls_A 19 ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP-EG 96 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS-SS
T ss_pred cceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC-CC
Confidence 34468888999999999999999765554 79999986532 345567788999999999999999999999764 34
Q ss_pred eEEEEEecccccccc-cccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCC
Q 005289 205 SIYLVFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~-~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~ 283 (704)
..|+||||+.++.+. .+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 97 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 97 LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp CCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred CcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 458999999775444 4445566799999999999999999999999999999999999999999999999999975543
Q ss_pred CC---CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhc
Q 005289 284 GH---RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359 (704)
Q Consensus 284 ~~---~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~ 359 (704)
.. ........+|+.|+|||++.+ ..++.++|||||||++|+|++ +.+||...+..+....+......+
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~------- 248 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLP------- 248 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCC-------
T ss_pred CcccccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCC-------
Confidence 21 122234467899999999876 568999999999999999999 567777766666655554321110
Q ss_pred cCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
....+++.+.+||.+||..||.+|||+.++|+.
T Consensus 249 ---------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 249 ---------------------QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp ---------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CCccchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 113578899999999999999999999999854
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=378.84 Aligned_cols=258 Identities=27% Similarity=0.380 Sum_probs=192.3
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCCeEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~ 207 (704)
.+.|.+.+.||+|+||+||.+. ..+|+.||||++..+. .+.+.+|+.+|+++ +|||||++++++.+ ...+|
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~~~ 85 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETT--DRFLY 85 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEE
T ss_pred hheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEec--CCeEE
Confidence 3457778899999999998764 4679999999987532 34567899999987 89999999999876 57899
Q ss_pred EEEecccccccccccCCCcc------ccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccC-------------C
Q 005289 208 LVFEYMEHDITGLLSCPDIK------FSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-------------G 268 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~------l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~-------------g 268 (704)
||||||++++...+...... .++..++.++.||+.||.|||++||+||||||+||||+.+ +
T Consensus 86 lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 86 IALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp EEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred EEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCce
Confidence 99999988665555432211 1334567899999999999999999999999999999754 4
Q ss_pred ceEEeccccccccCCCCCC---CcccccccccccCcccccC------CCCCCCccchhhHHHHHHHHHh-CCCCCCCCCH
Q 005289 269 VLKLADFGLANFSNTGHRQ---PLTSRVVTLWYRPPELLLG------ATDYGPSVDLWSVGCVFAELLI-GKPILQGRTE 338 (704)
Q Consensus 269 ~iKL~DFGla~~~~~~~~~---~~~~~~gT~~Y~APEvl~~------~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~ 338 (704)
.+||+|||++......... .....+||+.|+|||++.+ ...++.++|||||||+||+|++ |.+||.....
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 8999999999876543211 2234578999999999865 2568999999999999999999 9999976654
Q ss_pred HHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 339 VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 339 ~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
.+ ..+.......+. ... .....++.++.+||.+||..||.+|||+.++|+||||..
T Consensus 246 ~~--~~i~~~~~~~~~----------------~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 246 RE--SNIIRGIFSLDE----------------MKC------LHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp HH--HHHHHTCCCCCC----------------CTT------CCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred hH--HHHhcCCCCccc----------------ccc------cccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 33 233321111100 000 001235678999999999999999999999999999963
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=386.43 Aligned_cols=253 Identities=20% Similarity=0.310 Sum_probs=210.6
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
+..++|++.++||+|+||+||+|++..++..||||++...... .+.+.+|+.+|++|+|||||++++++.. ...+
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~ 291 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPF 291 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSC
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEec--CCcE
Confidence 3456799999999999999999999999999999999765432 4568899999999999999999999977 4678
Q ss_pred EEEEecccccccccccC--CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 207 YLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~--~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
|||||||.++.+..++. ....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 99999999755544432 3456899999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCC
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
.........+|+.|+|||++.. ..|+.++|||||||+||||++ |.+||.+.+..+.+..+......
T Consensus 372 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~------------ 438 (495)
T 1opk_A 372 TYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM------------ 438 (495)
T ss_dssp CEECCTTCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC------------
T ss_pred ceeecCCCcCCcceeCHhHHhc-CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC------------
Confidence 3222333455788999999875 568999999999999999999 99999988876666555331100
Q ss_pred CcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.....+++.+.+||.+||..||.+|||+.++++.
T Consensus 439 ----------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~ 472 (495)
T 1opk_A 439 ----------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQA 472 (495)
T ss_dssp ----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 0124678999999999999999999999999863
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=353.51 Aligned_cols=255 Identities=20% Similarity=0.259 Sum_probs=204.2
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCC---CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCC
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDT---GKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 204 (704)
...+|++.+.||+|+||+||+|++..+ ...||+|++.... .....+.+.+|+.+|++++||||+++++++... ..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~ 100 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EG 100 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS-SS
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC-CC
Confidence 345799999999999999999997543 3468999987532 345567788999999999999999999987543 45
Q ss_pred eEEEEEecccccccc-cccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCC
Q 005289 205 SIYLVFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~-~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~ 283 (704)
..|+||||++++.+. .+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 789999999985554 4444556789999999999999999999999999999999999999999999999999986543
Q ss_pred CCC---CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhc
Q 005289 284 GHR---QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359 (704)
Q Consensus 284 ~~~---~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~ 359 (704)
... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+......+
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 252 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL------- 252 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCC-------
T ss_pred cchhccccccCCCCCccccChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCC-------
Confidence 221 12234456889999999875 568999999999999999999 778888877666665554321110
Q ss_pred cCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
....++..+.+||.+||..||.+|||+.++++.
T Consensus 253 ---------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 285 (298)
T 3f66_A 253 ---------------------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 285 (298)
T ss_dssp ---------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 013578899999999999999999999999863
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=353.78 Aligned_cols=244 Identities=26% Similarity=0.402 Sum_probs=192.0
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
+..++|++.+.||+|+||+||+|++ .++.||||++... ...+.+.+|+.+|++++||||+++++++.+ .+
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~ 74 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN----PV 74 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT----TT
T ss_pred CCHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC----Cc
Confidence 3456899999999999999999987 4789999998643 345678899999999999999999998864 36
Q ss_pred EEEEecccccccccccCCC---ccccHHHHHHHHHHhhhhHHHHHh---cCcccccCCCccEEEccCCc-eEEecccccc
Q 005289 207 YLVFEYMEHDITGLLSCPD---IKFSEAQIKCYMNQLLHGLEHCHS---RGVLHRDIKGSNLLVNNEGV-LKLADFGLAN 279 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~~~---~~l~e~~~~~i~~QIl~aL~yLH~---~gIvHrDLKp~NILl~~~g~-iKL~DFGla~ 279 (704)
||||||++++.+..+.... ..+++..+..++.||+.||.|||+ +||+||||||+||||+.++. +||+|||++.
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~ 154 (307)
T 2eva_A 75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC 154 (307)
T ss_dssp EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence 8999999886555444322 247899999999999999999999 89999999999999998886 7999999997
Q ss_pred ccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCCchhh
Q 005289 280 FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE--VEQLHKIFKLCGSPPDDYW 357 (704)
Q Consensus 280 ~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~--~e~l~~I~~~~g~~p~~~w 357 (704)
..... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ......+.. +..+
T Consensus 155 ~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~---- 223 (307)
T 2eva_A 155 DIQTH----MTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN--GTRP---- 223 (307)
T ss_dssp --------------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT--TCCC----
T ss_pred ccccc----cccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc--CCCC----
Confidence 65432 234568999999999876 5789999999999999999999999986432 222222211 1111
Q ss_pred hccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 358 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.....++..+.+||.+||..||.+|||+.+++++
T Consensus 224 ----------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 224 ----------------------PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp ----------------------CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 1124688999999999999999999999999873
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=351.27 Aligned_cols=256 Identities=26% Similarity=0.304 Sum_probs=195.9
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHh--cCCCCceeEeEEEeec--CCC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRR--LDHPNIIKLEGLITSR--LSC 204 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~--L~HpnIv~l~~~~~~~--~~~ 204 (704)
.++|++++.||+|+||+||+|++ +++.||||++... ....+.+|.+++.. ++||||+++++++... ...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 45899999999999999999987 6899999998643 23445567777766 7999999999987542 235
Q ss_pred eEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHH--------hcCcccccCCCccEEEccCCceEEeccc
Q 005289 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH--------SRGVLHRDIKGSNLLVNNEGVLKLADFG 276 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH--------~~gIvHrDLKp~NILl~~~g~iKL~DFG 276 (704)
.+||||||++++.+..+.. ...+++..+..++.||+.||.||| ++||+||||||+||||+.++.+||+|||
T Consensus 80 ~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 158 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG 158 (301)
T ss_dssp EEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred eeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCC
Confidence 6899999999866665553 347999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCCC---CcccccccccccCcccccCCC-----CCCCccchhhHHHHHHHHHhC----------CCCCCCCC-
Q 005289 277 LANFSNTGHRQ---PLTSRVVTLWYRPPELLLGAT-----DYGPSVDLWSVGCVFAELLIG----------KPILQGRT- 337 (704)
Q Consensus 277 la~~~~~~~~~---~~~~~~gT~~Y~APEvl~~~~-----~y~~~~DIWSlG~iLyeLltG----------~~pF~~~~- 337 (704)
++......... .....++|+.|+|||++.+.. .++.++|||||||++|+|++| .+||....
T Consensus 159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~ 238 (301)
T 3q4u_A 159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238 (301)
T ss_dssp TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence 99765433221 123347899999999987643 244689999999999999999 88886532
Q ss_pred ---HHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 338 ---EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 338 ---~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
....+..+....+..+ .... ......++..+.+||.+||..||.+|||+.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~-------------------~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~ 296 (301)
T 3q4u_A 239 NDPSFEDMRKVVCVDQQRP-------------------NIPN--RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296 (301)
T ss_dssp SSCCHHHHHHHHTTSCCCC-------------------CCCG--GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred CCcchhhhhHHHhccCCCC-------------------CCCh--hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 2233333322111110 0000 00112356789999999999999999999999863
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=375.61 Aligned_cols=256 Identities=23% Similarity=0.340 Sum_probs=205.6
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
+..++|++.++||+|+||+||+|.+.. +..||||++...... .+.+.+|+.+|++|+||||+++++++.+ ..+
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~ 253 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPI 253 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC---Cce
Confidence 445689999999999999999999865 467999999865433 3567899999999999999999999865 468
Q ss_pred EEEEecccccccccccCC--CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 207 YLVFEYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~~--~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
|||||||.++.+..+... ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 254 ~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred EEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 999999998655554432 245899999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCC
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
.........+|+.|+|||++.. ..++.++|||||||+||||++ |.+||.+.+..+.+..+......+
T Consensus 334 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~----------- 401 (452)
T 1fmk_A 334 EYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP----------- 401 (452)
T ss_dssp ---------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-----------
T ss_pred ceecccCCcccccccCHhHHhc-CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-----------
Confidence 3222334456789999999875 568999999999999999999 999999998888877765421000
Q ss_pred CcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc--cccCC
Q 005289 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS--EYFST 418 (704)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h--pwf~~ 418 (704)
....+++.+.+||.+||..||++|||+.++++. .+|..
T Consensus 402 -----------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 402 -----------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp -----------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred -----------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 113678999999999999999999999999863 56653
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=357.46 Aligned_cols=255 Identities=23% Similarity=0.341 Sum_probs=200.2
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeec--CCCeE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR--LSCSI 206 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~--~~~~~ 206 (704)
.++|++++.||+|+||+||+|++..+++.||||++... .....+.+.+|+.+++.++||||+++++++... ....+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 45799999999999999999999999999999998754 345567788999999999999999999998642 23578
Q ss_pred EEEEecccccccccccC----CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccC
Q 005289 207 YLVFEYMEHDITGLLSC----PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~----~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~ 282 (704)
|+||||+.++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 99999999855543322 35679999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCC--------CcccccccccccCcccccCCC--CCCCccchhhHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcC
Q 005289 283 TGHRQ--------PLTSRVVTLWYRPPELLLGAT--DYGPSVDLWSVGCVFAELLIGKPILQGRTE--VEQLHKIFKLCG 350 (704)
Q Consensus 283 ~~~~~--------~~~~~~gT~~Y~APEvl~~~~--~y~~~~DIWSlG~iLyeLltG~~pF~~~~~--~e~l~~I~~~~g 350 (704)
..... ......+|+.|+|||++.+.. .++.++|||||||++|+|++|..||..... ......+.. ..
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~ 264 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN-QL 264 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC-C-
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc-cC
Confidence 21100 012345699999999987532 368899999999999999999999953110 011111110 00
Q ss_pred CCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 351 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 351 ~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.. .....++..+.+||.+||..||.+|||+.++|++
T Consensus 265 ~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 265 SI---------------------------PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp -C---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CC---------------------------CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 00 0113678999999999999999999999999987
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=365.75 Aligned_cols=256 Identities=15% Similarity=0.164 Sum_probs=199.6
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCC--------CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCcee-------
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDT--------GKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIK------- 193 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~--------g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~------- 193 (704)
.++|++.+.||+|+||+||+|++..+ ++.||||++... ..+.+|+.+|++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 46899999999999999999999874 889999999754 24678999999999999988
Q ss_pred --------EeEEEeecCCCeEEEEEecccccccccccCC-CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEE
Q 005289 194 --------LEGLITSRLSCSIYLVFEYMEHDITGLLSCP-DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV 264 (704)
Q Consensus 194 --------l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~-~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl 264 (704)
+++++... ...+||||||+.++|...+... ...+++..++.++.||+.||.|||++||+||||||+||||
T Consensus 114 ~~~~~i~~~~~~~~~~-~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQ-DKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192 (352)
T ss_dssp CTTCSCCCCCEEEEET-TTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred CCccCccchhhccccC-CcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence 55666542 4789999999954554444332 3679999999999999999999999999999999999999
Q ss_pred ccCC--ceEEeccccccccCCCCC------CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 005289 265 NNEG--VLKLADFGLANFSNTGHR------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR 336 (704)
Q Consensus 265 ~~~g--~iKL~DFGla~~~~~~~~------~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~ 336 (704)
+.++ .+||+|||+++....... .......+|+.|+|||++.+ ..++.++|||||||+||+|++|+.||.+.
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-CGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 9998 899999999976543211 12234578999999999876 56899999999999999999999999876
Q ss_pred C--HHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 337 T--EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 337 ~--~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
. .......+......++. +. .....+..++.++.+||.+||..||.+|||+.++++.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~-~~-------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVDKPGP-FV-------------------GPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp TTCHHHHHHHHHHHHHSCCC-EE-------------------CTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred CcCHHHHHHHHHhccCChhh-hh-------------------hhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 3 33333333222211110 00 0011234689999999999999999999999999754
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=358.34 Aligned_cols=254 Identities=25% Similarity=0.348 Sum_probs=200.5
Q ss_pred eeEEEEeeccCceEEEEEE----ECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEE
Q 005289 132 FEKLEKIGQGTYSSVFRAR----DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 132 y~~~~~LG~G~fg~Vy~a~----~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 207 (704)
|+++++||+|+||+||++. +..+++.||||++.... .......+.+|+.+|+.|+||||+++++++.+.....+|
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 5999999999999998875 34578999999997653 445567788999999999999999999999886667899
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC-
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR- 286 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~- 286 (704)
|||||++++.+..+.... .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 112 lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 190 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 190 (318)
T ss_dssp EEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSE
T ss_pred EEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccccccc
Confidence 999999986665554332 489999999999999999999999999999999999999999999999999987654322
Q ss_pred -CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHH-----------HHHHHHHHcCCCCc
Q 005289 287 -QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE-----------QLHKIFKLCGSPPD 354 (704)
Q Consensus 287 -~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e-----------~l~~I~~~~g~~p~ 354 (704)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||....... ....+...+...
T Consensus 191 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 267 (318)
T 3lxp_A 191 YRVREDGDSPVFWYAPECLKE-YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG-- 267 (318)
T ss_dssp EEC---CCCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT--
T ss_pred cccccCCCCCceeeChHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc--
Confidence 11233457888999999875 457889999999999999999999997543211 001111100000
Q ss_pred hhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 355 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 355 ~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
. .......++.++.+||.+||..||.+|||+.++++
T Consensus 268 ------~----------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 268 ------E----------------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp ------C----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------c----------------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0 00112467899999999999999999999999984
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=366.45 Aligned_cols=268 Identities=20% Similarity=0.271 Sum_probs=201.7
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|++.+.||+|+||+||+|++ .+++.||||++...... .....+.+|+.+|+.++||||+++++++.. ....||
T Consensus 29 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 104 (326)
T 3uim_A 29 SDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTERLL 104 (326)
T ss_dssp TTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECC--SSCCEE
T ss_pred hhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEec--CCceEE
Confidence 56899999999999999999985 46899999999764322 112357889999999999999999999987 467899
Q ss_pred EEecccccccccccC----CCccccHHHHHHHHHHhhhhHHHHHhc---CcccccCCCccEEEccCCceEEecccccccc
Q 005289 209 VFEYMEHDITGLLSC----PDIKFSEAQIKCYMNQLLHGLEHCHSR---GVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~----~~~~l~e~~~~~i~~QIl~aL~yLH~~---gIvHrDLKp~NILl~~~g~iKL~DFGla~~~ 281 (704)
||||+.++.+..+.. ....+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||++...
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 184 (326)
T 3uim_A 105 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 184 (326)
T ss_dssp EEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccccc
Confidence 999999865554432 233499999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHHHcCCCCchh
Q 005289 282 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR-----TEVEQLHKIFKLCGSPPDDY 356 (704)
Q Consensus 282 ~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~-----~~~e~l~~I~~~~g~~p~~~ 356 (704)
............+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||... ........+......
T Consensus 185 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----- 258 (326)
T 3uim_A 185 DYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE----- 258 (326)
T ss_dssp CSSSSCEECCCCSCGGGCCHHHHHH-SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSS-----
T ss_pred CcccccccccccCCcCccCHHHhcc-CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhc-----
Confidence 5544444455668999999999875 45899999999999999999999999621 111111111000000
Q ss_pred hhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 357 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 357 w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
..+. ....... ........+..+.+||.+||..||.+|||+.++|+|-+-
T Consensus 259 ---~~~~--~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 259 ---KKLE--ALVDVDL-----QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp ---CCST--TSSCTTC-----TTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred ---hhhh--hhcChhh-----ccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 0000 0000000 001112345779999999999999999999999998553
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=375.27 Aligned_cols=246 Identities=20% Similarity=0.330 Sum_probs=203.2
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
+..++|++++.||+|+||+||+|.+. ++.||||+++... ..+.+.+|+.+|++|+|||||++++++... ...+
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~ 262 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGL 262 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECT-TSCE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcC-CCce
Confidence 55678999999999999999999874 7899999997543 345678999999999999999999998764 3478
Q ss_pred EEEEecccccccccccCC--CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 207 YLVFEYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~~--~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
|||||||.++.+..+... ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 263 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp EEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 999999998555544332 223799999999999999999999999999999999999999999999999999855432
Q ss_pred CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCC
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
.....+|+.|+|||++.+ ..|+.++|||||||+||||++ |.+||.+.+..+.+..+.... .+
T Consensus 343 ----~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~--~~---------- 405 (450)
T 1k9a_A 343 ----QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--KM---------- 405 (450)
T ss_dssp --------CCCTTTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTC--CC----------
T ss_pred ----ccCCCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--CC----------
Confidence 123356889999999876 568999999999999999998 999999887777666654311 00
Q ss_pred CcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
.....+++.+.+||.+||..||.+|||+.++++
T Consensus 406 ----------------~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 406 ----------------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp ----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 011367899999999999999999999999975
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=353.29 Aligned_cols=255 Identities=26% Similarity=0.359 Sum_probs=198.8
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECC-CCc--EEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLD-TGK--IVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~-~g~--~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 203 (704)
..++|++++.||+|+||+||+|++.. +++ .||||++..... .....+.+.+|+.+|+.++||||+++++++...
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 93 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-- 93 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC--
Confidence 35689999999999999999998643 333 689999976543 235567788999999999999999999999763
Q ss_pred CeEEEEEecccccccc-cccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccC
Q 005289 204 CSIYLVFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~-~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~ 282 (704)
..++||||+.++.+. .+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 94 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 94 -PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred -CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 378999999875444 444444579999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCC--CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhc
Q 005289 283 TGHRQ--PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359 (704)
Q Consensus 283 ~~~~~--~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~ 359 (704)
..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+......++
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~------ 245 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP------ 245 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC------
T ss_pred ccccchhhhccCCCCceeeCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCC------
Confidence 43221 1223456888999999875 457899999999999999999 9999999988887777654211110
Q ss_pred cCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
....++.++.+||.+||..||.+|||+.+++++
T Consensus 246 ---------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 246 ---------------------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp ---------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 113678999999999999999999999999974
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=350.08 Aligned_cols=246 Identities=20% Similarity=0.325 Sum_probs=195.5
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
+..++|++++.||+|+||+||++.+ +++.||||++.... ..+.+.+|+.+|+.++||||+++++++... ...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~ 90 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGL 90 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC---CC
T ss_pred CChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CCce
Confidence 4456899999999999999999987 48899999997543 345678899999999999999999987653 3478
Q ss_pred EEEEecccccccccccCCCc--cccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 207 YLVFEYMEHDITGLLSCPDI--KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~~~~--~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
|+||||++++.+..+..... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 99999999855544433222 3889999999999999999999999999999999999999999999999999765432
Q ss_pred CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCC
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
.....+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+.... .
T Consensus 171 ----~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~--~----------- 232 (278)
T 1byg_A 171 ----QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--K----------- 232 (278)
T ss_dssp ---------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC--C-----------
T ss_pred ----ccCCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC--C-----------
Confidence 223456889999999875 568999999999999999998 999999877666655553210 0
Q ss_pred CcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
......+++.+.+||.+||..||.+|||+.++++
T Consensus 233 ---------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 233 ---------------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp ---------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 0112467899999999999999999999999985
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=389.91 Aligned_cols=250 Identities=19% Similarity=0.256 Sum_probs=205.2
Q ss_pred CeeEE-EEeeccCceEEEEEEE--CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEE
Q 005289 131 AFEKL-EKIGQGTYSSVFRARD--LDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 131 ~y~~~-~~LG~G~fg~Vy~a~~--~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 207 (704)
.+.+. ++||+|+||+||+|.+ ..+++.||||++..........+.+.+|+.+|++|+|||||++++++.. ..+|
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---~~~~ 445 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWM 445 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEE
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCEE
Confidence 34443 4899999999999954 4667899999998765555556788999999999999999999999865 4589
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC-
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR- 286 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~- 286 (704)
||||||.++.+..++.....+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.......
T Consensus 446 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 446 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred EEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 9999999877766655566799999999999999999999999999999999999999999999999999987654321
Q ss_pred -CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC
Q 005289 287 -QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 287 -~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
.......+|+.|+|||++.+ ..|+.++|||||||+||||++ |++||.+.+..+.+..+......
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~------------- 591 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM------------- 591 (635)
T ss_dssp ---------CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-------------
T ss_pred cccccCCCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence 12233355788999999875 568999999999999999998 99999999988877776542100
Q ss_pred cccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
.....++.++.+||..||..||++|||+.++++
T Consensus 592 ---------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 592 ---------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp ---------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 011368899999999999999999999999975
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=377.71 Aligned_cols=250 Identities=16% Similarity=0.193 Sum_probs=195.8
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCC-CCcee---------Ee---
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDH-PNIIK---------LE--- 195 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~H-pnIv~---------l~--- 195 (704)
..|.+.+.||+|+||+||+|++..+|+.||||++..... .....+.+.+|+.+++.|.| +|+.. .+
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 458899999999999999999999999999999874332 22335678899999999987 32111 11
Q ss_pred ---------EEEeecC---CCeEEEEEecccccccccc------cCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccC
Q 005289 196 ---------GLITSRL---SCSIYLVFEYMEHDITGLL------SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDI 257 (704)
Q Consensus 196 ---------~~~~~~~---~~~~~LV~Ey~~g~ll~~~------~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDL 257 (704)
.++.... ...+|++|+++.+++...+ ......+++..+..++.||+.||.|||++|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 1111111 2357899999888776655 334567889999999999999999999999999999
Q ss_pred CCccEEEccCCceEEeccccccccCCCCCCCcccccccccccCccccc---------CCCCCCCccchhhHHHHHHHHHh
Q 005289 258 KGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL---------GATDYGPSVDLWSVGCVFAELLI 328 (704)
Q Consensus 258 Kp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APEvl~---------~~~~y~~~~DIWSlG~iLyeLlt 328 (704)
||+||||+.++.+||+|||+++..... ....+| +.|+|||++. ....|+.++|||||||+||+|++
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt 312 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred ccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence 999999999999999999999765432 345577 9999999983 33568889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHH
Q 005289 329 GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 408 (704)
Q Consensus 329 G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~ 408 (704)
|+.||.+.+..+....+ ...+..+|+++.+||.+||..||.+|||+.
T Consensus 313 g~~Pf~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ 359 (413)
T 3dzo_A 313 ADLPNTDDAALGGSEWI---------------------------------FRSCKNIPQPVRALLEGFLRYPKEDRLLPL 359 (413)
T ss_dssp SSCCCCTTGGGSCSGGG---------------------------------GSSCCCCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCCCCcchhhhHHHH---------------------------------HhhcccCCHHHHHHHHHHccCChhhCcCHH
Confidence 99999865532211111 112246889999999999999999999999
Q ss_pred HHHhccccC
Q 005289 409 AALASEYFS 417 (704)
Q Consensus 409 e~L~hpwf~ 417 (704)
++|+||||+
T Consensus 360 ~~l~~~~~~ 368 (413)
T 3dzo_A 360 QAMETPEYE 368 (413)
T ss_dssp HHTTSHHHH
T ss_pred HHHhCHHHH
Confidence 999999997
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=352.29 Aligned_cols=239 Identities=23% Similarity=0.326 Sum_probs=186.7
Q ss_pred cCCeeEE-EEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHH-HhcCCCCceeEeEEEee--cCCC
Q 005289 129 ADAFEKL-EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILIL-RRLDHPNIIKLEGLITS--RLSC 204 (704)
Q Consensus 129 ~~~y~~~-~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL-~~L~HpnIv~l~~~~~~--~~~~ 204 (704)
.++|.++ +.||+|+||+||+|++..+++.||||++... ..+.+|+.++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 3578888 7799999999999999999999999999632 3456799888 55699999999999865 2246
Q ss_pred eEEEEEecccccccc-cccC-CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEcc---CCceEEecccccc
Q 005289 205 SIYLVFEYMEHDITG-LLSC-PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLAN 279 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~-~~~~-~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~---~g~iKL~DFGla~ 279 (704)
.+||||||++++.+. .+.. ....+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++.
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred eEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 789999999885444 3332 2346999999999999999999999999999999999999998 7889999999985
Q ss_pred ccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhc
Q 005289 280 FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359 (704)
Q Consensus 280 ~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~ 359 (704)
.... ..|+.++|||||||+||+|++|.+||.+.........+..
T Consensus 169 ~~~~------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~------------ 212 (299)
T 3m2w_A 169 ETTG------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT------------ 212 (299)
T ss_dssp ECTT------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC------------
T ss_pred cccc------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH------------
Confidence 4321 3467899999999999999999999987654332111100
Q ss_pred cCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
........ .....+..+++++.+||.+||..||.+|||+.++|+||||+..
T Consensus 213 ------~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 213 ------RIRMGQYE---FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp ------SSCTTCCS---SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred ------HHhhcccc---CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 00000000 1122346789999999999999999999999999999999864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=365.28 Aligned_cols=255 Identities=20% Similarity=0.262 Sum_probs=196.4
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCC---CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCC
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDT---GKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 204 (704)
....|++.+.||+|+||+||+|++..+ +..||||.+.... .....+.+.+|+.+|++++||||+++++++... ..
T Consensus 87 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~ 164 (373)
T 3c1x_A 87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EG 164 (373)
T ss_dssp TTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC-SS
T ss_pred hhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC-CC
Confidence 344689999999999999999987543 3468999986533 345567788999999999999999999987543 35
Q ss_pred eEEEEEecccccccc-cccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCC
Q 005289 205 SIYLVFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~-~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~ 283 (704)
..||||||++++.+. .+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 165 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred CeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccc
Confidence 679999999985554 4444556789999999999999999999999999999999999999999999999999986543
Q ss_pred CCCC---CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhc
Q 005289 284 GHRQ---PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359 (704)
Q Consensus 284 ~~~~---~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~ 359 (704)
.... ......+|+.|+|||++.+ ..|+.++|||||||+||+|++ |.+||.+.+..+....+... ..+
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~--~~~------ 315 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG--RRL------ 315 (373)
T ss_dssp -------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT--CCC------
T ss_pred cccccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC--CCC------
Confidence 2211 1233456889999999875 568999999999999999999 78999887665555554331 110
Q ss_pred cCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.....++..+.+||.+||..||.+|||+.+++++
T Consensus 316 --------------------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 316 --------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp --------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0013578899999999999999999999999865
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=361.58 Aligned_cols=250 Identities=18% Similarity=0.202 Sum_probs=194.8
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC------ChHHHHHHHHHHHHHHhcC---------CCCcee
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF------EPESVRFMAREILILRRLD---------HPNIIK 193 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~------~~~~~~~~~~Ei~iL~~L~---------HpnIv~ 193 (704)
.++|+++++||+|+||+||+|++ +|+.||||++..... .....+.+.+|+.+|+.|+ |||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 45799999999999999999998 789999999987642 2233466788999999886 777777
Q ss_pred EeEEEeec----------------------------CCCeEEEEEeccccc-ccccccCCCccccHHHHHHHHHHhhhhH
Q 005289 194 LEGLITSR----------------------------LSCSIYLVFEYMEHD-ITGLLSCPDIKFSEAQIKCYMNQLLHGL 244 (704)
Q Consensus 194 l~~~~~~~----------------------------~~~~~~LV~Ey~~g~-ll~~~~~~~~~l~e~~~~~i~~QIl~aL 244 (704)
+++++... ....+|||||||.++ ++..+.. ..+++..++.|+.||+.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence 77664311 146899999999875 5665543 4689999999999999999
Q ss_pred HHHH-hcCcccccCCCccEEEccCC--------------------ceEEeccccccccCCCCCCCcccccccccccCccc
Q 005289 245 EHCH-SRGVLHRDIKGSNLLVNNEG--------------------VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPEL 303 (704)
Q Consensus 245 ~yLH-~~gIvHrDLKp~NILl~~~g--------------------~iKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APEv 303 (704)
.||| ++|||||||||+||||+.++ .+||+|||+|+.... ...+||+.|+|||+
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------~~~~gt~~y~aPE~ 248 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------GIVVFCDVSMDEDL 248 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------TEEECCCCTTCSGG
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------CcEEEeecccChhh
Confidence 9999 99999999999999999987 899999999987653 23588999999999
Q ss_pred ccCCCCCCCccchhhHHHH-HHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhh
Q 005289 304 LLGATDYGPSVDLWSVGCV-FAELLIGKPILQGRTE-VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRET 381 (704)
Q Consensus 304 l~~~~~y~~~~DIWSlG~i-LyeLltG~~pF~~~~~-~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~ 381 (704)
+.+.. +.++|||||+++ ++++++|.+||..... ......+........ ......
T Consensus 249 ~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~ 304 (336)
T 2vuw_A 249 FTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKT----------------------KCNTPA 304 (336)
T ss_dssp GCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSS----------------------CCCSHH
T ss_pred hcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCc----------------------ccchhh
Confidence 98633 889999998777 7888999999854211 112233322110000 001123
Q ss_pred ccCCCHHHHHHHHHhhccCCCCCcCHHHHH-hccccC
Q 005289 382 FKDLPTTAVNLIETLLSVEPYKRATASAAL-ASEYFS 417 (704)
Q Consensus 382 ~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L-~hpwf~ 417 (704)
+..+++++++||++||.+| ||.|+| +||||+
T Consensus 305 ~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 305 MKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred hhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 3567899999999999987 999999 999995
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=361.38 Aligned_cols=247 Identities=16% Similarity=0.171 Sum_probs=194.2
Q ss_pred cccCCeeEEEEeeccCceEEEEE-----EECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC---CCCceeEeEEE
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRA-----RDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD---HPNIIKLEGLI 198 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a-----~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~---HpnIv~l~~~~ 198 (704)
+..++|.+.+.||+|+||+||+| .+..+++.||||++.... ...+.+|+.++..|. |+||+++++++
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 44678999999999999999999 467789999999997542 345667888888886 99999999999
Q ss_pred eecCCCeEEEEEecccccccccccC-----CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEcc-------
Q 005289 199 TSRLSCSIYLVFEYMEHDITGLLSC-----PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN------- 266 (704)
Q Consensus 199 ~~~~~~~~~LV~Ey~~g~ll~~~~~-----~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~------- 266 (704)
.. ....|||||||+++.+..+.. ....+++..++.|+.||+.||.|||++|||||||||+||||+.
T Consensus 137 ~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 137 LF--QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp EC--SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC--
T ss_pred ec--CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccc
Confidence 87 467899999999766554442 3557999999999999999999999999999999999999998
Q ss_pred ----CCceEEeccccccccCC-CCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHH
Q 005289 267 ----EGVLKLADFGLANFSNT-GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ 341 (704)
Q Consensus 267 ----~g~iKL~DFGla~~~~~-~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~ 341 (704)
++.+||+|||+|+.... .........+||+.|+|||++.+ ..|+.++|||||||+||+|++|++||......
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~-- 291 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG-- 291 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT--
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC-CCCCccccHHHHHHHHHHHHhCCCccccCCCC--
Confidence 89999999999975431 22234456789999999999987 55999999999999999999999998643220
Q ss_pred HHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcc
Q 005289 342 LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 414 (704)
Q Consensus 342 l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hp 414 (704)
.|... ..+. . ...++.+.+||..||..+|.+|++..+.|.+.
T Consensus 292 --------------~~~~~-----------~~~~----~--~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~ 333 (365)
T 3e7e_A 292 --------------ECKPE-----------GLFR----R--LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333 (365)
T ss_dssp --------------EEEEC-----------SCCT----T--CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred --------------ceeec-----------hhcc----c--cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence 01000 0000 0 02356788999999999999997766655543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=380.70 Aligned_cols=255 Identities=22% Similarity=0.329 Sum_probs=209.8
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
+..++|++.++||+|+||+||+|.+.. +..||||++...... .+.+.+|+.+|++|+|||||++++++.+ ..+
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~ 336 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPI 336 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSC
T ss_pred cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee---ccc
Confidence 445679999999999999999999865 467999999865433 3567899999999999999999999865 468
Q ss_pred EEEEecccccccccccCC--CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 207 YLVFEYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~~--~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
|||||||.++.|..++.. ...+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.....
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 999999998655544432 245899999999999999999999999999999999999999999999999999866432
Q ss_pred CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCC
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
.........+|..|+|||++.. ..|+.++|||||||+||||++ |+.||.+....+.+..+......
T Consensus 417 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~------------ 483 (535)
T 2h8h_A 417 EYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM------------ 483 (535)
T ss_dssp HHHTTCSTTSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC------------
T ss_pred ceecccCCcCcccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC------------
Confidence 2112223355788999999875 568999999999999999999 99999999888887776542100
Q ss_pred CcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc--cccC
Q 005289 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS--EYFS 417 (704)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h--pwf~ 417 (704)
.....++..+.+||.+||..||++|||+.++++. .+|.
T Consensus 484 ----------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 484 ----------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp ----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred ----------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 0113678999999999999999999999999864 5554
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=356.39 Aligned_cols=254 Identities=17% Similarity=0.281 Sum_probs=203.0
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
+..++|++.+.||+|+||+||+|++.. .||||++..........+.+.+|+.+|+.++||||+++++++.+ ...+
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 104 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS--PPHL 104 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC--SSCE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec--CCce
Confidence 345789999999999999999999754 49999997654443344556789999999999999999999987 4679
Q ss_pred EEEEeccccccccccc-CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC-
Q 005289 207 YLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG- 284 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~-~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~- 284 (704)
||||||+.++.+..+. .....+++..++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||++......
T Consensus 105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 9999999876555444 3444799999999999999999999999999999999999998 689999999998754321
Q ss_pred ---CCCCcccccccccccCcccccC--------CCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Q 005289 285 ---HRQPLTSRVVTLWYRPPELLLG--------ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 353 (704)
Q Consensus 285 ---~~~~~~~~~gT~~Y~APEvl~~--------~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p 353 (704)
.........+|+.|+|||++.. ...|+.++|||||||++|+|++|..||........+..+.... .+
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~ 261 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM--KP 261 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTC--CC
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCC--CC
Confidence 1122334568999999999864 2457889999999999999999999999988877776664421 11
Q ss_pred chhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 354 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 354 ~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
. .....++.++.+||.+||..||.+|||+.++++.
T Consensus 262 ~-------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 262 N-------------------------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp C-------------------------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred C-------------------------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 0 0012577889999999999999999999999964
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=374.87 Aligned_cols=253 Identities=22% Similarity=0.250 Sum_probs=203.4
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCce-eEeEEEeecCCCeEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNII-KLEGLITSRLSCSIY 207 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv-~l~~~~~~~~~~~~~ 207 (704)
.++|+++++||+|+||+||+|++..+++.||||++...... ..+.+|+++|+.|.|++++ .+..++.. ....|
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~--~~~~~ 79 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVE--GDYNV 79 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEE--TTEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEee--CCEEE
Confidence 46899999999999999999999999999999998765432 2367899999999875544 44444444 57889
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEE---ccCCceEEeccccccccCCC
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl---~~~g~iKL~DFGla~~~~~~ 284 (704)
|||||+.+.+...+......+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+++.....
T Consensus 80 lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 80 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 999999666666665455679999999999999999999999999999999999999 68899999999999876543
Q ss_pred CCC------CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHcCCCCch
Q 005289 285 HRQ------PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE---VEQLHKIFKLCGSPPDD 355 (704)
Q Consensus 285 ~~~------~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~---~e~l~~I~~~~g~~p~~ 355 (704)
... .....++|+.|+|||++.+ ..|+.++||||||||||+|++|++||.+... .+.+.++....-.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~---- 234 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA---- 234 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH----
T ss_pred ccccccccccccccCCCccccCHHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc----
Confidence 221 1235678999999999886 5689999999999999999999999987543 3444444332100
Q ss_pred hhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 356 ~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
..+......++.++.+||..||..||.+||++.++++
T Consensus 235 --------------------~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 235 --------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp --------------------SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred --------------------ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1123344678999999999999999999999998764
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=353.20 Aligned_cols=271 Identities=24% Similarity=0.364 Sum_probs=202.6
Q ss_pred cccCCeeEEEEeeccCceEEEEEE----ECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRAR----DLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL 202 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~----~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 202 (704)
+..++|++++.||+|+||+||+|+ +..+++.||||++... .....+.+.+|+.+|+.++||||+++++++....
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 115 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence 345679999999999999999998 4678999999999754 3455677889999999999999999999987654
Q ss_pred CCeEEEEEecccccccc-cccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEecccccccc
Q 005289 203 SCSIYLVFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (704)
Q Consensus 203 ~~~~~LV~Ey~~g~ll~-~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~ 281 (704)
...+||||||++++.+. .+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 55789999999885544 44444456999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCC--CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhc
Q 005289 282 NTGHRQ--PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359 (704)
Q Consensus 282 ~~~~~~--~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~ 359 (704)
...... ......+|..|+|||++.+ ..++.++|||||||+||+|++|..||..... + +....+......+..
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~~~~~~~~-~----~~~~~~~~~~~~~~~ 269 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPA-E----FMRMIGNDKQGQMIV 269 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH-H----HHHHHCTTCCTHHHH
T ss_pred cccccccccccCCCCceeEECchhhcC-CCCCchhhHHHHHHHHHHHHhcCCCCCCCHH-H----HHHhhccccchhhhH
Confidence 543211 1223456788999999875 4578999999999999999999998864311 1 111111111100000
Q ss_pred cCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
..+. ........ ......++.++.+||.+||..||.+|||+.++++
T Consensus 270 ~~~~--~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 270 FHLI--ELLKNNGR-----LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHH--HHHHTTCC-----CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHH--HHhhcCCC-----CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0000 00000000 0012467899999999999999999999999985
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=360.71 Aligned_cols=280 Identities=23% Similarity=0.266 Sum_probs=192.9
Q ss_pred ccccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHH--HHHHhcCCCCceeEeEEEee---
Q 005289 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREI--LILRRLDHPNIIKLEGLITS--- 200 (704)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei--~iL~~L~HpnIv~l~~~~~~--- 200 (704)
.+..++|++++.||+|+||+||+|++ +++.||||++.... ...+..|. ..+..++||||+++++.+..
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 81 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTA 81 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECT
T ss_pred CcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheeccccccc
Confidence 45678999999999999999999976 68999999997542 22333344 44556899999999976542
Q ss_pred cCCCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhc---------CcccccCCCccEEEccCCceE
Q 005289 201 RLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR---------GVLHRDIKGSNLLVNNEGVLK 271 (704)
Q Consensus 201 ~~~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~---------gIvHrDLKp~NILl~~~g~iK 271 (704)
.....+|||||||+++.+..+... ..+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+|
T Consensus 82 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 82 DGRMEYLLVMEYYPNGSLXKYLSL-HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp TSCEEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred CCCceEEEEEecCCCCcHHHHHhh-cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence 224468999999988655554432 2458899999999999999999999 999999999999999999999
Q ss_pred EeccccccccCCCC-------CCCcccccccccccCcccccCC------CCCCCccchhhHHHHHHHHHhCCCCC-CCCC
Q 005289 272 LADFGLANFSNTGH-------RQPLTSRVVTLWYRPPELLLGA------TDYGPSVDLWSVGCVFAELLIGKPIL-QGRT 337 (704)
Q Consensus 272 L~DFGla~~~~~~~-------~~~~~~~~gT~~Y~APEvl~~~------~~y~~~~DIWSlG~iLyeLltG~~pF-~~~~ 337 (704)
|+|||++....... .......++|+.|+|||++.+. ..++.++|||||||+||+|++|..|| .+..
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 99999997654321 1223345789999999998752 34567899999999999999996554 4332
Q ss_pred HHHHHHHHHHHcCCCCc-hhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHH------
Q 005289 338 EVEQLHKIFKLCGSPPD-DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA------ 410 (704)
Q Consensus 338 ~~e~l~~I~~~~g~~p~-~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~------ 410 (704)
..+....+....+..+. ..+...... ....+ .+... ......+++.+.+||.+||..||++|||+.++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~--~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ 315 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSR--EKQRP--KFPEA-WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTT--SCCCC--CCCTT-CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcc--cccCC--CCCcc-cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence 21111111111111111 110000000 00000 00000 00012245679999999999999999999999
Q ss_pred HhccccCC
Q 005289 411 LASEYFST 418 (704)
Q Consensus 411 L~hpwf~~ 418 (704)
|.++|-++
T Consensus 316 ll~~~~~~ 323 (336)
T 3g2f_A 316 LMMIWERN 323 (336)
T ss_dssp HHHCCCC-
T ss_pred HHHHHHhc
Confidence 55677664
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=380.98 Aligned_cols=257 Identities=20% Similarity=0.257 Sum_probs=206.2
Q ss_pred ccCCeeEEE-EeeccCceEEEEEEEC--CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCC
Q 005289 128 RADAFEKLE-KIGQGTYSSVFRARDL--DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (704)
Q Consensus 128 ~~~~y~~~~-~LG~G~fg~Vy~a~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 204 (704)
..++|.+.+ +||+|+||+||+|.+. .++..||||+++... .....+.+.+|+.+|+.|+|||||++++++.. .
T Consensus 333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---~ 408 (613)
T 2ozo_A 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---E 408 (613)
T ss_dssp CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES---S
T ss_pred cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc---C
Confidence 345677777 8999999999999875 356679999997653 23346678899999999999999999999975 4
Q ss_pred eEEEEEecccccccccc-cCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCC
Q 005289 205 SIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~-~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~ 283 (704)
.+|||||||.++.+..+ ......+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++....
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 58999999998666544 44556799999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCC--cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhcc
Q 005289 284 GHRQP--LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (704)
Q Consensus 284 ~~~~~--~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~ 360 (704)
..... .....+|+.|+|||++.+ ..|+.++|||||||+||||++ |++||.+.+..+.+..|... ...
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~--~~~------- 558 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG--KRM------- 558 (613)
T ss_dssp -------------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTT--CCC-------
T ss_pred CCceeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC--CCC-------
Confidence 32111 122234688999999875 578999999999999999998 99999998888877776541 110
Q ss_pred CCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHH---hccccC
Q 005289 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL---ASEYFS 417 (704)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L---~hpwf~ 417 (704)
.....+++++.+||.+||..||.+|||+.+++ ++.|+.
T Consensus 559 -------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 559 -------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp -------------------CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 01136889999999999999999999999974 555544
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=352.06 Aligned_cols=262 Identities=22% Similarity=0.263 Sum_probs=200.3
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCC--CChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDN--FEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 132 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~--~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
|...++||+|+||+||+|.+ +++.||||++.... ......+.+.+|+.+|+.++||||+++++++.. ...+|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 108 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD--GDDLCLV 108 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec--CCceEEE
Confidence 44558999999999999986 68899999997542 223456778899999999999999999999977 4678999
Q ss_pred EecccccccccccC---CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC
Q 005289 210 FEYMEHDITGLLSC---PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~---~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~ 286 (704)
|||++++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 188 (307)
T 2nru_A 109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188 (307)
T ss_dssp EECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSS
T ss_pred EEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccc
Confidence 99998755543332 234589999999999999999999999999999999999999999999999999976654322
Q ss_pred C-CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 287 Q-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 287 ~-~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
. ......+|+.|+|||++.+ .++.++|||||||++|+|++|.+||........+..+...+..........
T Consensus 189 ~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 260 (307)
T 2nru_A 189 TVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDY------ 260 (307)
T ss_dssp CEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHH------
T ss_pred cccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhh------
Confidence 1 1234578999999998875 588999999999999999999999987654433333322211111000000
Q ss_pred ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.. ..+.......+..+.+||.+||..||.+|||+.+++++
T Consensus 261 --~~------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 261 --ID------KKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp --SC------SSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred --cc------ccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00 00001112345778999999999999999999999975
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=395.51 Aligned_cols=281 Identities=24% Similarity=0.306 Sum_probs=208.1
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEee----cCCC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITS----RLSC 204 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~----~~~~ 204 (704)
.++|++.++||.|+||+||+|.+..+|+.||||++... ......+.+.+|+.+|+.++||||+++++++.. ....
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 35799999999999999999999999999999998754 345666778899999999999999999998754 1246
Q ss_pred eEEEEEecccccccccccCC---CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCc---eEEeccccc
Q 005289 205 SIYLVFEYMEHDITGLLSCP---DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV---LKLADFGLA 278 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~~~---~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~---iKL~DFGla 278 (704)
..|||||||+++.+..+... ...+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 78999999988655544322 236899999999999999999999999999999999999997765 999999999
Q ss_pred cccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhh
Q 005289 279 NFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 358 (704)
Q Consensus 279 ~~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~ 358 (704)
....... .....++|+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+......+.......+. ...+.
T Consensus 172 ~~~~~~~--~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~--~~~~~ 246 (676)
T 3qa8_A 172 KELDQGE--LCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSN--EHIVV 246 (676)
T ss_dssp CBTTSCC--CCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC--------CCS
T ss_pred ccccccc--ccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccc--hhhhh
Confidence 8765432 3345688999999999876 67899999999999999999999999876544322111100000 00000
Q ss_pred ccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 359 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
.........+....+. .......+++.+.+||.+||.+||.+|||+.++|+||||+.
T Consensus 247 ~~~l~g~~~~~~~lp~---p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPT---PNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp CCCCSSSCCCCSSSCC---SCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhhccccccccccCC---chhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 0000000001000011 11122457789999999999999999999999999999973
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=349.11 Aligned_cols=254 Identities=23% Similarity=0.293 Sum_probs=190.0
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc--CCCCceeEeEEEeecCC--Ce
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL--DHPNIIKLEGLITSRLS--CS 205 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L--~HpnIv~l~~~~~~~~~--~~ 205 (704)
++|++++.||+|+||+||+|++. ++.||||++.... .....+|.+++..+ +||||+++++++..... ..
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred cceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 47999999999999999999874 8999999986432 23344566666554 99999999999876422 67
Q ss_pred EEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhc--------CcccccCCCccEEEccCCceEEecccc
Q 005289 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR--------GVLHRDIKGSNLLVNNEGVLKLADFGL 277 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~--------gIvHrDLKp~NILl~~~g~iKL~DFGl 277 (704)
+||||||++++.+..+.. ...+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||+
T Consensus 110 ~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~ 188 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLK-STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 188 (337)
T ss_dssp EEEEECCCTTCBHHHHHH-HCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred eEEEEeccCCCcHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCC
Confidence 999999999865554443 23689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCC---CcccccccccccCcccccCCCCCCCc------cchhhHHHHHHHHHhC----------CCCCCCCC-
Q 005289 278 ANFSNTGHRQ---PLTSRVVTLWYRPPELLLGATDYGPS------VDLWSVGCVFAELLIG----------KPILQGRT- 337 (704)
Q Consensus 278 a~~~~~~~~~---~~~~~~gT~~Y~APEvl~~~~~y~~~------~DIWSlG~iLyeLltG----------~~pF~~~~- 337 (704)
+......... .....++|+.|+|||++.+. .+... +|||||||+||||++| ..||....
T Consensus 189 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~ 267 (337)
T 3mdy_A 189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES-LNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267 (337)
T ss_dssp CEECC---------CCSSCSCGGGCCHHHHTTC-CCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred ceeeccccccccCCCCCCccCcceeChhhcccc-cCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcC
Confidence 9765433211 12345789999999998763 34444 8999999999999999 66665421
Q ss_pred ---HHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 338 ---EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 338 ---~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
....+..+.......+ .+.. ......+++++.+||.+||..||.+|||+.+++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~-------------------~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 268 SDPSYEDMREIVCIKKLRP-------------------SFPN--RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp SSCCHHHHHHHHTTSCCCC-------------------CCCG--GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCchhhhHHHHhhhccCc-------------------cccc--cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 2222222221111000 0000 00112456789999999999999999999999976
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=378.78 Aligned_cols=253 Identities=23% Similarity=0.358 Sum_probs=206.9
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCC---CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCC
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDT---GKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 204 (704)
..++|++.+.||+|+||+||+|++..+ +..||||++.... .....+.+.+|+.+|+.++||||+++++++.+ .
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~ 463 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE---N 463 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---S
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec---C
Confidence 356899999999999999999998654 4679999986533 34556778899999999999999999999854 4
Q ss_pred eEEEEEeccccccccccc-CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCC
Q 005289 205 SIYLVFEYMEHDITGLLS-CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~-~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~ 283 (704)
.+||||||++++.+..+. .....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 689999999976555443 3445689999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCC
Q 005289 284 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (704)
Q Consensus 284 ~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~ 362 (704)
..........+|+.|+|||++.+ ..|+.++|||||||+||||++ |.+||.+....+.+..+......+
T Consensus 544 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~---------- 612 (656)
T 2j0j_A 544 STYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP---------- 612 (656)
T ss_dssp ----------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC----------
T ss_pred CcceeccCCCCCcceeCHHHhcC-CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC----------
Confidence 43333334456889999999875 578999999999999999997 999999999888887775521100
Q ss_pred CCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
....+++.+.+||.+||..||.+|||+.++++.
T Consensus 613 ------------------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 613 ------------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp ------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CCccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 113678999999999999999999999999864
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=344.48 Aligned_cols=255 Identities=23% Similarity=0.258 Sum_probs=195.2
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHh--cCCCCceeEeEEEeecCC--Ce
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRR--LDHPNIIKLEGLITSRLS--CS 205 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~--L~HpnIv~l~~~~~~~~~--~~ 205 (704)
++|++.+.||+|+||+||+|++ +++.||||++... ....+.+|++++.. ++||||+++++++..... ..
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 3799999999999999999997 5899999998643 24556789999887 799999999999877432 27
Q ss_pred EEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHH--------hcCcccccCCCccEEEccCCceEEecccc
Q 005289 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH--------SRGVLHRDIKGSNLLVNNEGVLKLADFGL 277 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH--------~~gIvHrDLKp~NILl~~~g~iKL~DFGl 277 (704)
+||||||++++.+..+.. ...+++..++.++.||+.||.||| ++||+||||||+||||+.++.+||+|||+
T Consensus 115 ~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 193 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 193 (342)
T ss_dssp EEEEECCCTTCBHHHHHH-HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred eEEEEeecCCCcHHHHHh-ccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCC
Confidence 899999999865554443 236899999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCC---CcccccccccccCcccccCCCC-----CCCccchhhHHHHHHHHHhC----------CCCCCCCC--
Q 005289 278 ANFSNTGHRQ---PLTSRVVTLWYRPPELLLGATD-----YGPSVDLWSVGCVFAELLIG----------KPILQGRT-- 337 (704)
Q Consensus 278 a~~~~~~~~~---~~~~~~gT~~Y~APEvl~~~~~-----y~~~~DIWSlG~iLyeLltG----------~~pF~~~~-- 337 (704)
+......... .....++|+.|+|||++.+... ++.++|||||||+||+|++| ..||....
T Consensus 194 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~ 273 (342)
T 1b6c_B 194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 273 (342)
T ss_dssp CEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred ceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcC
Confidence 9766543211 2344578999999999876322 23689999999999999999 67886542
Q ss_pred --HHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 338 --EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 338 --~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
..+.+..........+ .....+ ....++..+.+||.+||..||.+|||+.++++|
T Consensus 274 ~~~~~~~~~~~~~~~~~~-------------------~~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 274 DPSVEEMRKVVCEQKLRP-------------------NIPNRW--QSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp SCCHHHHHHHHTTSCCCC-------------------CCCGGG--GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cccHHHHHHHHHHHHhCC-------------------CCcccc--cchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 1222222211000000 000000 012345679999999999999999999999976
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=336.95 Aligned_cols=228 Identities=18% Similarity=0.140 Sum_probs=185.4
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
++|++++.||+|+||+||+|++..+++.||||++...... ....+.+.+|+.++..++||||+++++++.+ ...+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~l 108 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT--RAGGLV 108 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE--CCcEEE
Confidence 5799999999999999999999999999999999876543 4556778899999999999999999999987 578999
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
||||++++.+..+.... ..+.++..|+.||+.||.|||++||+||||||+||||+.++.+||++++
T Consensus 109 v~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------------ 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------------ 174 (286)
T ss_dssp EEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC------------
T ss_pred EEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc------------
Confidence 99999987666555433 3566788899999999999999999999999999999999999998543
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccC
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~ 368 (704)
|++ .++.++|||||||+||+|++|++||.+.+..+.+... .
T Consensus 175 ---------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~----------------------~ 215 (286)
T 3uqc_A 175 ---------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA----------------------E 215 (286)
T ss_dssp ---------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC----------------------C
T ss_pred ---------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH----------------------H
Confidence 333 3688999999999999999999999875532211000 0
Q ss_pred CCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 369 ~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
................+++++.+||.+||..||.+| |+.++++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 216 RDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp BCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred HHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 000000112234456899999999999999999999 99999864
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=381.82 Aligned_cols=242 Identities=23% Similarity=0.320 Sum_probs=198.9
Q ss_pred CCeeEEEEeeccCceEEEEEEECC-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC---Ce
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLD-TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS---CS 205 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~---~~ 205 (704)
++|++++.||+|+||+||+|++.. +++.||||++.... .......+.+|+.+|.+|+|||||++++++..... ..
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 589999999999999999999976 78999999986543 34556678899999999999999999999986432 12
Q ss_pred EEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
+|||||||+++.+..+... .+++..++.|+.||+.||.|||++|||||||||+||||+.+ .+||+|||+++.....
T Consensus 159 ~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~- 234 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF- 234 (681)
T ss_dssp EEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC-
T ss_pred eEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC-
Confidence 7999999998777665433 79999999999999999999999999999999999999885 9999999999876532
Q ss_pred CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
...+||+.|+|||++.+ .++.++||||||||||+|++|.+||.+.... . ++
T Consensus 235 ----~~~~gt~~y~aPE~~~~--~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~-----------~----------~~-- 285 (681)
T 2pzi_A 235 ----GYLYGTPGFQAPEIVRT--GPTVATDIYTVGRTLAALTLDLPTRNGRYVD-----------G----------LP-- 285 (681)
T ss_dssp ----SCCCCCTTTSCTTHHHH--CSCHHHHHHHHHHHHHHHHSCCCEETTEECS-----------S----------CC--
T ss_pred ----CccCCCccccCHHHHcC--CCCCceehhhhHHHHHHHHhCCCCCcccccc-----------c----------cc--
Confidence 45678999999999875 3588999999999999999999988642100 0 00
Q ss_pred ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccC
Q 005289 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417 (704)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~ 417 (704)
.. .....+++.+.+||.+||..||.+||++.++|.|+|+.
T Consensus 286 --------~~----~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 286 --------ED----DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp --------TT----CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred --------cc----ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 00 00112467899999999999999999999999999984
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-32 Score=316.81 Aligned_cols=186 Identities=17% Similarity=0.066 Sum_probs=134.3
Q ss_pred eeccCceEEEEEEECCCCcEEEEEEeecCCC----C----hHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCCeEEE
Q 005289 138 IGQGTYSSVFRARDLDTGKIVALKKVRFDNF----E----PESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 138 LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~----~----~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~L 208 (704)
++.|++|.+..++....|+.||+|++.++.. . ....+.+.+|+++|+++ .|+||+++++++++ ...+||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed--~~~~yL 319 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN--AQSGWL 319 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC--SSEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE--CCEEEE
Confidence 4567777777777777899999999976532 1 23345688999999999 79999999999988 578999
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
|||||+|+.|..++.....+++. .|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+...... ..
T Consensus 320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~-~~ 395 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC-SW 395 (569)
T ss_dssp EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC----CC
T ss_pred EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC-cc
Confidence 99999998888777777778765 478999999999999999999999999999999999999999998765433 34
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCC
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 331 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~ 331 (704)
..+.+||+.|||||++.+ .+..++|+|++||++|+|+++..
T Consensus 396 ~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 396 PTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp SHHHHHHHHHHHHHHC-------------------CCCCTTHH
T ss_pred ccCceechhhccHHHhCC--CCCCcccccccccchhhhccccc
Confidence 566789999999999976 46788999999999998876643
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-26 Score=264.55 Aligned_cols=188 Identities=16% Similarity=0.132 Sum_probs=139.4
Q ss_pred eEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChH------HHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 133 EKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPE------SVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 133 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
...+.||+|+||+||+|. ..++.+|+|++........ ..+.+.+|+++|++++||||+++..++.. ....
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--~~~~ 414 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD--LDNK 414 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE--TTTT
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe--CCcc
Confidence 345689999999999994 4678899998765433211 23457899999999999999954444444 3456
Q ss_pred EEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC
Q 005289 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~ 286 (704)
|||||||+++.+..+... +..|+.||+.||.|||++||+||||||+||||+. .+||+|||+++.......
T Consensus 415 ~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 415 RIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp EEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred EEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 999999997665555433 6689999999999999999999999999999998 999999999987754321
Q ss_pred CC------cccccccccccCcccccC-CCCCCCccchhhHHHHHHHHHhCCCCCC
Q 005289 287 QP------LTSRVVTLWYRPPELLLG-ATDYGPSVDLWSVGCVFAELLIGKPILQ 334 (704)
Q Consensus 287 ~~------~~~~~gT~~Y~APEvl~~-~~~y~~~~DIWSlG~iLyeLltG~~pF~ 334 (704)
.. ....+||+.|||||++.. ...|+..+|+|+..+-..+.+.++.+|.
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 11 235678999999999853 1347788999999988888887776653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=5.8e-24 Score=223.22 Aligned_cols=146 Identities=16% Similarity=0.142 Sum_probs=115.2
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCCh----------------HHHHHHHHHHHHHHhcCCCCceeE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP----------------ESVRFMAREILILRRLDHPNIIKL 194 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~----------------~~~~~~~~Ei~iL~~L~HpnIv~l 194 (704)
.|.+.+.||.|+||.||+|++ .+|+.||||+++...... .....+.+|+.+|++++ | +++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 355569999999999999999 889999999996532211 23556789999999999 4 566
Q ss_pred eEEEeecCCCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEec
Q 005289 195 EGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLAD 274 (704)
Q Consensus 195 ~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~D 274 (704)
.+++.. ...|||||||+++.+..+.. .....++.||+.||.|||++||+||||||+||||+ ++.+||+|
T Consensus 167 ~~~~~~---~~~~lvmE~~~g~~L~~l~~-------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 167 PKVYAW---EGNAVLMELIDAKELYRVRV-------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp CCEEEE---ETTEEEEECCCCEEGGGCCC-------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECC
T ss_pred CeEEec---cceEEEEEecCCCcHHHcch-------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEE
Confidence 665544 34599999999865555321 23457999999999999999999999999999999 99999999
Q ss_pred cccccccCCCCCCCcccccccccccCccccc
Q 005289 275 FGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305 (704)
Q Consensus 275 FGla~~~~~~~~~~~~~~~gT~~Y~APEvl~ 305 (704)
||+|+. +..|+|||++.
T Consensus 236 FG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 236 FPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp CTTCEE--------------TTSTTHHHHHH
T ss_pred CCCCeE--------------CCCCCHHHHHH
Confidence 999863 23478899874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=6.8e-21 Score=196.99 Aligned_cols=143 Identities=17% Similarity=0.205 Sum_probs=107.3
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcE--EEEEEeecCCCCh----------------------HHHHHHHHHHHHHHhc
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKI--VALKKVRFDNFEP----------------------ESVRFMAREILILRRL 186 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~--vAvK~i~~~~~~~----------------------~~~~~~~~Ei~iL~~L 186 (704)
-|++.+.||.|+||+||+|.+..+|+. ||||+++...... .....+.+|+.+|..|
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 388999999999999999998778999 9999976432110 1123577899999999
Q ss_pred CCCCc--eeEeEEEeecCCCeEEEEEecccc-c-ccccccCCCccccHHHHHHHHHHhhhhHHHHH-hcCcccccCCCcc
Q 005289 187 DHPNI--IKLEGLITSRLSCSIYLVFEYMEH-D-ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH-SRGVLHRDIKGSN 261 (704)
Q Consensus 187 ~HpnI--v~l~~~~~~~~~~~~~LV~Ey~~g-~-ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH-~~gIvHrDLKp~N 261 (704)
.|++| +.++.+ ...||||||+++ + +...+......+++..+..++.||+.+|.||| ++|||||||||+|
T Consensus 128 ~~~~i~~p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N 201 (258)
T 1zth_A 128 KEAGVSVPQPYTY------MKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN 201 (258)
T ss_dssp HHTTCCCCCEEEE------ETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred HhCCCCCCeEEEc------CCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence 88764 334332 235899999953 2 11111111112345678899999999999999 9999999999999
Q ss_pred EEEccCCceEEecccccccc
Q 005289 262 LLVNNEGVLKLADFGLANFS 281 (704)
Q Consensus 262 ILl~~~g~iKL~DFGla~~~ 281 (704)
|||+. .++|+|||+|...
T Consensus 202 ILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 202 IMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp EEESS--SEEECCCTTCEET
T ss_pred EEEcC--cEEEEECcccccC
Confidence 99998 9999999999654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.71 E-value=3.6e-17 Score=177.99 Aligned_cols=139 Identities=17% Similarity=0.182 Sum_probs=100.5
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC---------------ChHHH-----HHHHHHHHHHHhcCCCC
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF---------------EPESV-----RFMAREILILRRLDHPN 190 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~---------------~~~~~-----~~~~~Ei~iL~~L~Hpn 190 (704)
-|++..+||.|+||.||+|.+. +|+.||||+++.... ..... ....+|...|.+|.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 3999999999999999999974 699999999754210 00111 11235777888875544
Q ss_pred ceeEeEEEeecCCCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCC--
Q 005289 191 IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-- 268 (704)
Q Consensus 191 Iv~l~~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g-- 268 (704)
+.. ...+... ..+|||||++|..+..+... ..+..++.||+.+|.|||++|||||||||.||||++++
T Consensus 175 v~v-p~p~~~~---~~~LVME~i~G~~L~~l~~~------~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 175 FPV-PEPIAQS---RHTIVMSLVDALPMRQVSSV------PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CSC-CCEEEEE---TTEEEEECCSCEEGGGCCCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred CCC-Ceeeecc---CceEEEEecCCccHhhhccc------HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence 322 1122211 12799999998666554321 23467889999999999999999999999999999887
Q ss_pred --------ceEEeccccccc
Q 005289 269 --------VLKLADFGLANF 280 (704)
Q Consensus 269 --------~iKL~DFGla~~ 280 (704)
.+.||||+.+..
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEE
T ss_pred ccccccccceEEEEeCCccc
Confidence 389999997753
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=6.5e-12 Score=128.82 Aligned_cols=139 Identities=14% Similarity=0.092 Sum_probs=107.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeEEEeecCCCeEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~~~L 208 (704)
+.|++...++.|+++.||++.. .++.++||+....... ....+.+|+.+|+.|. +..++++++++.. ....|+
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~--~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~l 87 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNL 87 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEE
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCC--CHHHHHHHHHHHHHHhcCCCCCeEEEEEec--CCceEE
Confidence 4699999999999999999974 3678999998653111 1234778999999994 6778889888876 467899
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHh---------------------------------------
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS--------------------------------------- 249 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~--------------------------------------- 249 (704)
||||++|..+..... +......++.++..+|..||+
T Consensus 88 v~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp EEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred EEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 999999966554311 122334677899999999998
Q ss_pred --------------------cCcccccCCCccEEEccCCceEEecccccc
Q 005289 250 --------------------RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 279 (704)
Q Consensus 250 --------------------~gIvHrDLKp~NILl~~~g~iKL~DFGla~ 279 (704)
..++|+|++|.|||++++..+.|+||+.+.
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999876566799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.18 E-value=7.9e-11 Score=119.62 Aligned_cols=134 Identities=14% Similarity=0.105 Sum_probs=96.0
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCC--ceeEeEEEeecCCCeEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPN--IIKLEGLITSRLSCSIY 207 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hpn--Iv~l~~~~~~~~~~~~~ 207 (704)
..|.+....+.|..+.||++.. .+|..++||+..... ...+.+|+.+|+.|.+.+ +++++.+... ....|
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~--~~~~~ 91 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDW 91 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEE
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccC--CCCCE
Confidence 3566654445666799999964 567789999976431 234678999999985434 5568777665 45689
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcC------------------------------------
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG------------------------------------ 251 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~g------------------------------------ 251 (704)
+||||++|..+. .. . .. ...++.++...|..||+..
T Consensus 92 ~v~e~i~G~~l~-~~-~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 92 LLLGEVPGQDLL-SS-H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp EEEECCSSEETT-TS-C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EEEEecCCcccC-cC-c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 999999997664 21 1 11 1245667777777777643
Q ss_pred ----------------------cccccCCCccEEEccCCceEEecccccc
Q 005289 252 ----------------------VLHRDIKGSNLLVNNEGVLKLADFGLAN 279 (704)
Q Consensus 252 ----------------------IvHrDLKp~NILl~~~g~iKL~DFGla~ 279 (704)
++|+||+|.|||+++++.+.|+||+.+.
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877667799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.09 E-value=3.3e-10 Score=121.90 Aligned_cols=145 Identities=15% Similarity=0.217 Sum_probs=106.4
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEee--cCCCChHHHHHHHHHHHHHHhcC--CCCceeEeEEEeecC-CCeE
Q 005289 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR--FDNFEPESVRFMAREILILRRLD--HPNIIKLEGLITSRL-SCSI 206 (704)
Q Consensus 132 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~--~~~~~~~~~~~~~~Ei~iL~~L~--HpnIv~l~~~~~~~~-~~~~ 206 (704)
...++.|+.|.++.||++... +..++||+.. ..... .....+.+|+.+|+.|. +..+++++.++.+.. ....
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECS--SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred CceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence 445788999999999999853 4678888875 32211 12345778999999996 456788888776532 1457
Q ss_pred EEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHh-------------------------------------
Q 005289 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS------------------------------------- 249 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~------------------------------------- 249 (704)
|+||||++|..+.... -..+++.+...++.+++..|..||+
T Consensus 117 ~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 8999999996653321 1236788888999999999999997
Q ss_pred ---------------------cCcccccCCCccEEEccCCc--eEEecccccccc
Q 005289 250 ---------------------RGVLHRDIKGSNLLVNNEGV--LKLADFGLANFS 281 (704)
Q Consensus 250 ---------------------~gIvHrDLKp~NILl~~~g~--iKL~DFGla~~~ 281 (704)
..+||+|++|.|||++.++. +.|+||+.+...
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 36999999999999997753 699999998754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.95 E-value=1.9e-10 Score=120.96 Aligned_cols=183 Identities=15% Similarity=0.134 Sum_probs=118.8
Q ss_pred EEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCC--ceeEeEEEeecC-CCeEEEEE
Q 005289 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPN--IIKLEGLITSRL-SCSIYLVF 210 (704)
Q Consensus 135 ~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~Hpn--Iv~l~~~~~~~~-~~~~~LV~ 210 (704)
++.|+.|.+..||++. ..++||+... ......+.+|+.+|+.| .+.. +.+++....... ....|+||
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 3458999999999874 4588998642 23456788999999988 3332 344444332211 12348999
Q ss_pred ecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHh-----------------------------------------
Q 005289 211 EYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS----------------------------------------- 249 (704)
Q Consensus 211 Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~----------------------------------------- 249 (704)
++++|..+.... ...+++.+...++.|+...|..||+
T Consensus 96 ~~i~G~~l~~~~--~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 96 TKIKGVPLTPLL--LNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp ECCCCEECCHHH--HHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred cccCCeECCccc--cccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 999996654321 1246677777888888888888885
Q ss_pred -----------------cCcccccCCCccEEEcc--CCceEEeccccccccCCCCCCCcccccccccc---cCcccccC-
Q 005289 250 -----------------RGVLHRDIKGSNLLVNN--EGVLKLADFGLANFSNTGHRQPLTSRVVTLWY---RPPELLLG- 306 (704)
Q Consensus 250 -----------------~gIvHrDLKp~NILl~~--~g~iKL~DFGla~~~~~~~~~~~~~~~gT~~Y---~APEvl~~- 306 (704)
..++|+|++|.|||+++ ...+.|+||+.+....+. ........+ ..|+.+..
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-----~Dl~~~~~~~~~~~~~~~~~~ 248 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-----NDFISLMEDDEEYGMEFVSKI 248 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-----HHHHTTCCTTTSCCHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-----HHHHHHHhhccccCHHHHHHH
Confidence 13799999999999998 456899999998754321 111111111 22222100
Q ss_pred CCCCC------------CccchhhHHHHHHHHHhCCCCC
Q 005289 307 ATDYG------------PSVDLWSVGCVFAELLIGKPIL 333 (704)
Q Consensus 307 ~~~y~------------~~~DIWSlG~iLyeLltG~~pF 333 (704)
...|. .-.+.|+++.++|.+.+|.++|
T Consensus 249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 00111 1258999999999999998776
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.49 E-value=1.1e-06 Score=92.48 Aligned_cols=135 Identities=16% Similarity=0.171 Sum_probs=90.3
Q ss_pred EEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCC---CceeEeEEEeecCCCeEEEEEe
Q 005289 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP---NIIKLEGLITSRLSCSIYLVFE 211 (704)
Q Consensus 135 ~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hp---nIv~l~~~~~~~~~~~~~LV~E 211 (704)
+..|+.|....||++ +..++||+.. .......+.+|+.+|+.|.+. .|.+++.+.... ....|+|||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~-~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRS-DGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECT-TSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccC-CCceEEEEe
Confidence 456889999999998 4668889853 234456788999999999652 355666555422 456789999
Q ss_pred cccccccccccCCCccccHHHHHHHHHHhhhhHHHHHh------------------------------------------
Q 005289 212 YMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS------------------------------------------ 249 (704)
Q Consensus 212 y~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~------------------------------------------ 249 (704)
|++|..+....- ..+++.+...++.|+...|..||+
T Consensus 94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 999965543110 012334444444444444444442
Q ss_pred ------------------cCcccccCCCccEEEcc---CCc-eEEecccccccc
Q 005289 250 ------------------RGVLHRDIKGSNLLVNN---EGV-LKLADFGLANFS 281 (704)
Q Consensus 250 ------------------~gIvHrDLKp~NILl~~---~g~-iKL~DFGla~~~ 281 (704)
..++|+|++|.|||++. ++. +.|+||+.+...
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 14699999999999987 455 589999987654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=1.5e-06 Score=89.03 Aligned_cols=133 Identities=15% Similarity=0.131 Sum_probs=87.9
Q ss_pred EeeccCce-EEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeEEEeecCCCeEEEEEeccc
Q 005289 137 KIGQGTYS-SVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNIIKLEGLITSRLSCSIYLVFEYME 214 (704)
Q Consensus 137 ~LG~G~fg-~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~~~LV~Ey~~ 214 (704)
.+..|..+ .||+......+..+.||+-.. .....+.+|..+|+.|. +--+.+++.++.+ ....|||||+++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~--~~~~~lvme~l~ 103 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRT--PDDAWLLTTAIP 103 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEEEECCC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEE--CCeEEEEEEeeC
Confidence 34445444 799988777778899998753 33556788999999884 3346777777776 467899999999
Q ss_pred ccccccccCCCccccHHHHHHHHHHhhhhHHHHHh---------------------------------------------
Q 005289 215 HDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS--------------------------------------------- 249 (704)
Q Consensus 215 g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~--------------------------------------------- 249 (704)
|..+...... .......++.++...|.-||.
T Consensus 104 G~~~~~~~~~----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 104 GKTAFQVLEE----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp SEEHHHHHHH----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred CccccccccC----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 8543322100 011112233333333333332
Q ss_pred -------------cCcccccCCCccEEEccCCceEEeccccccc
Q 005289 250 -------------RGVLHRDIKGSNLLVNNEGVLKLADFGLANF 280 (704)
Q Consensus 250 -------------~gIvHrDLKp~NILl~~~g~iKL~DFGla~~ 280 (704)
..++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 1379999999999999877778999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=4.2e-06 Score=90.98 Aligned_cols=78 Identities=18% Similarity=0.155 Sum_probs=49.1
Q ss_pred EEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC--Ch---HHHHHHHHHHHHHHhcCC--C-CceeEeEEEeecCCCe
Q 005289 134 KLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF--EP---ESVRFMAREILILRRLDH--P-NIIKLEGLITSRLSCS 205 (704)
Q Consensus 134 ~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~--~~---~~~~~~~~Ei~iL~~L~H--p-nIv~l~~~~~~~~~~~ 205 (704)
.++.||.|.++.||++.....++.|+||....... .. .....+..|+++|+.+.. | .+.+++.+ +. ..
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~--~~ 109 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DT--EM 109 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ET--TT
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cC--Cc
Confidence 46789999999999997665678899998653210 00 112345679999988732 3 34456543 21 23
Q ss_pred EEEEEecccc
Q 005289 206 IYLVFEYMEH 215 (704)
Q Consensus 206 ~~LV~Ey~~g 215 (704)
.+|||||+++
T Consensus 110 ~~lvmE~l~g 119 (397)
T 2olc_A 110 AVTVMEDLSH 119 (397)
T ss_dssp TEEEECCCTT
T ss_pred cEEEEEeCCC
Confidence 5799999986
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.11 E-value=6.8e-06 Score=87.79 Aligned_cols=88 Identities=7% Similarity=0.038 Sum_probs=56.0
Q ss_pred eeEEEEe-eccCceEEEEEEEC--C----CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcC-C--CCceeEeEEEee
Q 005289 132 FEKLEKI-GQGTYSSVFRARDL--D----TGKIVALKKVRFDNF-EPESVRFMAREILILRRLD-H--PNIIKLEGLITS 200 (704)
Q Consensus 132 y~~~~~L-G~G~fg~Vy~a~~~--~----~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~-H--pnIv~l~~~~~~ 200 (704)
...++.| +.|....+|++... . ++..+++|+...... .......+.+|+.+|+.|. + -.+.+++.++.+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 4456788 88999999998753 0 156788998653220 0000134567899888883 3 356777776654
Q ss_pred cC-CCeEEEEEecccccccc
Q 005289 201 RL-SCSIYLVFEYMEHDITG 219 (704)
Q Consensus 201 ~~-~~~~~LV~Ey~~g~ll~ 219 (704)
.. ....|+||||++|..+.
T Consensus 102 ~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp STTTSSCEEEEECCCCBCCC
T ss_pred CCccCCceEEEEecCCCChh
Confidence 21 13468999999985443
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.97 E-value=2.7e-05 Score=81.99 Aligned_cols=30 Identities=17% Similarity=0.274 Sum_probs=27.1
Q ss_pred cCcccccCCCccEEEccCCceEEecccccc
Q 005289 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 279 (704)
Q Consensus 250 ~gIvHrDLKp~NILl~~~g~iKL~DFGla~ 279 (704)
..+||+|+++.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 479999999999999888899999999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00051 Score=72.48 Aligned_cols=76 Identities=18% Similarity=0.180 Sum_probs=58.3
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC---CCCceeEeEEEeecCCCeEEE
Q 005289 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD---HPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 132 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~---HpnIv~l~~~~~~~~~~~~~L 208 (704)
..-++.|+.|.+..+|++.. .+..++||+.... ....+..|+..|+.|. ...+++++.+... ....|+
T Consensus 38 i~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~--~g~~~l 108 (312)
T 3jr1_A 38 IKHKEKLYSGEMNEIWLIND--EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNS--QGHSFL 108 (312)
T ss_dssp CCEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC--SSEEEE
T ss_pred eeeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec--CCceEE
Confidence 34567899999999999974 4677889987642 2456788999999883 3567788777655 467899
Q ss_pred EEeccccc
Q 005289 209 VFEYMEHD 216 (704)
Q Consensus 209 V~Ey~~g~ 216 (704)
||||+++.
T Consensus 109 vme~l~G~ 116 (312)
T 3jr1_A 109 LLEALNKS 116 (312)
T ss_dssp EEECCCCC
T ss_pred EEEeccCC
Confidence 99999874
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00032 Score=73.07 Aligned_cols=70 Identities=17% Similarity=0.088 Sum_probs=43.7
Q ss_pred EEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCc-eeEeEEEeecCCCeEEEEEecc
Q 005289 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI-IKLEGLITSRLSCSIYLVFEYM 213 (704)
Q Consensus 135 ~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-v~l~~~~~~~~~~~~~LV~Ey~ 213 (704)
++.|+.|....+|++ ..+++|+..... .......+|+.+++.+..-.+ .+++.++.+ .-++|+||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~~~~~~~----~~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGT---EEYINRANEAVAAREAAKAGVSPEVLHVDPA----TGVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEECTT----TCCEEEECC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCc---cceeCHHHHHHHHHHHHHcCCCCceEEEECC----CCEEEEeec
Confidence 688999999999999 458889875421 111112468888887732222 466544322 236899999
Q ss_pred -cccc
Q 005289 214 -EHDI 217 (704)
Q Consensus 214 -~g~l 217 (704)
++..
T Consensus 90 ~~g~~ 94 (301)
T 3dxq_A 90 AGAQT 94 (301)
T ss_dssp TTCEE
T ss_pred CCCcc
Confidence 6643
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00034 Score=76.64 Aligned_cols=34 Identities=12% Similarity=0.391 Sum_probs=29.1
Q ss_pred HhcCcccccCCCccEEEccCCceEEeccccccccC
Q 005289 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (704)
Q Consensus 248 H~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~ 282 (704)
+...++|+||+|.|||++.++ +.|+||+.+....
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~ 263 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGP 263 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEEC
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCc
Confidence 456799999999999998876 9999999886543
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00045 Score=72.30 Aligned_cols=142 Identities=14% Similarity=0.074 Sum_probs=77.1
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCC--ceeEeEEEee----cCCCe
Q 005289 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPN--IIKLEGLITS----RLSCS 205 (704)
Q Consensus 132 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hpn--Iv~l~~~~~~----~~~~~ 205 (704)
..-++.|+.|....||++... .+ .+++|+..... ....+..|+.+++.|.... +.+++..... ...+.
T Consensus 24 ~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~ 97 (322)
T 2ppq_A 24 LTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR 97 (322)
T ss_dssp EEEEEEECC---EEEEEEEES-SC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred ceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCE
Confidence 455678888999999999753 33 68899986421 1223456888887773212 2333211000 01245
Q ss_pred EEEEEecccccccccc---------------c---C----CC-ccccHHHHHHHH---------------HHhhhhHHHH
Q 005289 206 IYLVFEYMEHDITGLL---------------S---C----PD-IKFSEAQIKCYM---------------NQLLHGLEHC 247 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~---------------~---~----~~-~~l~e~~~~~i~---------------~QIl~aL~yL 247 (704)
.++||+|++|..+... . . .. ...........+ ..+...+.+|
T Consensus 98 ~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l 177 (322)
T 2ppq_A 98 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL 177 (322)
T ss_dssp EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred EEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHH
Confidence 7899999998532210 0 0 00 000000000000 0122334444
Q ss_pred Hh-------cCcccccCCCccEEEccCCceEEecccccc
Q 005289 248 HS-------RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 279 (704)
Q Consensus 248 H~-------~gIvHrDLKp~NILl~~~g~iKL~DFGla~ 279 (704)
.. .++||+|+++.|||++.++.+.|+||+.+.
T Consensus 178 ~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 178 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 42 479999999999999887666899998764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00059 Score=70.53 Aligned_cols=76 Identities=16% Similarity=0.201 Sum_probs=53.5
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC---CCceeEeEEEeecCCCeEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH---PNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~H---pnIv~l~~~~~~~~~~~~~ 207 (704)
...-+..+|.|..+.||+++. .+|+.|.||+...... .....+.+|+..|+.|.- -.+++++.+ + .-+
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~----~~~ 86 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAP--ALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D----DRT 86 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCC--CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E----TTE
T ss_pred CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCc--chhhHHHHHHHHHHHHHhhCCCCcceEEec--c----Cce
Confidence 567789999999999999985 5789999998654332 112346789999998842 234455443 2 126
Q ss_pred EEEecccc
Q 005289 208 LVFEYMEH 215 (704)
Q Consensus 208 LV~Ey~~g 215 (704)
+||||+.+
T Consensus 87 lv~e~l~~ 94 (288)
T 3f7w_A 87 LAMEWVDE 94 (288)
T ss_dssp EEEECCCC
T ss_pred EEEEeecc
Confidence 89999875
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.28 E-value=0.001 Score=72.07 Aligned_cols=146 Identities=18% Similarity=0.203 Sum_probs=86.6
Q ss_pred ccccccCCeeEEEEeeccCceEEEEEEECC-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEe
Q 005289 124 WVPLRADAFEKLEKIGQGTYSSVFRARDLD-------TGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNIIKLE 195 (704)
Q Consensus 124 ~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~-------~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~ 195 (704)
|..+..+.++ ++.|..|-...+|++.... +++.|.||+.... ......+.+|..+|+.|. +.-..+++
T Consensus 45 W~~~~~~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll 120 (379)
T 3feg_A 45 WRRVQPEELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLY 120 (379)
T ss_dssp GGGCCGGGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEE
T ss_pred CCCCCcCceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEE
Confidence 4433334454 3567778888999998642 3578999985321 112345668999998883 33346676
Q ss_pred EEEeecCCCeEEEEEecccccccccc--c----------------CC----Cccc--cHHHHHHHHHHhhh---------
Q 005289 196 GLITSRLSCSIYLVFEYMEHDITGLL--S----------------CP----DIKF--SEAQIKCYMNQLLH--------- 242 (704)
Q Consensus 196 ~~~~~~~~~~~~LV~Ey~~g~ll~~~--~----------------~~----~~~l--~e~~~~~i~~QIl~--------- 242 (704)
+++.+ .+||||++|..+... . .. .... -..++..++.++..
T Consensus 121 ~~~~~------g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~ 194 (379)
T 3feg_A 121 GVFPE------GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEM 194 (379)
T ss_dssp EEETT------EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSC
T ss_pred EEcCC------ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchh
Confidence 66533 289999998443311 0 00 0111 24566666655422
Q ss_pred ----------hHHHHH----h----cCcccccCCCccEEEccC----CceEEecccccc
Q 005289 243 ----------GLEHCH----S----RGVLHRDIKGSNLLVNNE----GVLKLADFGLAN 279 (704)
Q Consensus 243 ----------aL~yLH----~----~gIvHrDLKp~NILl~~~----g~iKL~DFGla~ 279 (704)
.+..|. . ..++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 195 ~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 195 NLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp CHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred hhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 123332 1 259999999999999876 789999998775
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.28 E-value=0.0018 Score=71.22 Aligned_cols=73 Identities=19% Similarity=0.212 Sum_probs=49.9
Q ss_pred EEEEeeccCceEEEEEEECC-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCC-ceeEeEEEeecCCCe
Q 005289 134 KLEKIGQGTYSSVFRARDLD-------TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPN-IIKLEGLITSRLSCS 205 (704)
Q Consensus 134 ~~~~LG~G~fg~Vy~a~~~~-------~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hpn-Iv~l~~~~~~~~~~~ 205 (704)
.++.|+.|-...||++.... .+..|+||+..... . ...+.+|+.+|+.|...+ .+++++.+.+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT-----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC-----
Confidence 45778889999999998643 25789999874321 1 134457999999884333 3667665532
Q ss_pred EEEEEeccccc
Q 005289 206 IYLVFEYMEHD 216 (704)
Q Consensus 206 ~~LV~Ey~~g~ 216 (704)
.+||||++|.
T Consensus 148 -g~v~e~l~G~ 157 (429)
T 1nw1_A 148 -GRLEEYIPSR 157 (429)
T ss_dssp -EEEECCCCEE
T ss_pred -CEEEEEeCCc
Confidence 2899999873
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0013 Score=70.34 Aligned_cols=75 Identities=11% Similarity=0.076 Sum_probs=44.3
Q ss_pred EEEEeeccCceEEEEEEECC--------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCC-ceeEeEEEeecCCC
Q 005289 134 KLEKIGQGTYSSVFRARDLD--------TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPN-IIKLEGLITSRLSC 204 (704)
Q Consensus 134 ~~~~LG~G~fg~Vy~a~~~~--------~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hpn-Iv~l~~~~~~~~~~ 204 (704)
.+..|+.|....||++.... .+..+++|+..... ........|+.+|+.|...+ +.+++..+. .
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~ 109 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTFN----G 109 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEET----T
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEecC----C
Confidence 35678888889999998643 13678899865321 11112357888888884323 456665431 2
Q ss_pred eEEEEEecccccc
Q 005289 205 SIYLVFEYMEHDI 217 (704)
Q Consensus 205 ~~~LV~Ey~~g~l 217 (704)
++||||++|..
T Consensus 110 --~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 --GRIEEWLYGDP 120 (369)
T ss_dssp --EEEEECCCSEE
T ss_pred --cEEEEEecCCc
Confidence 68999998743
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0076 Score=62.96 Aligned_cols=76 Identities=11% Similarity=0.111 Sum_probs=47.4
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCC--CceeEeEEEee----cCCCeEEEE
Q 005289 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP--NIIKLEGLITS----RLSCSIYLV 209 (704)
Q Consensus 136 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hp--nIv~l~~~~~~----~~~~~~~LV 209 (704)
..|+ |....||++.. .+|+.+++|+....... ...+..|+.+++.|... .+++++.. .. ...+..++|
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~---~~~~~~E~~~~~~L~~~g~~vp~~~~~-~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAF-NGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCB-TTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCC---HHHHHHHHHHHHHHHHcCCeecceeec-CCcEEEEECCEEEEE
Confidence 4566 88889999864 34667999998643322 33456788888877321 23444332 11 013466899
Q ss_pred Eecccccc
Q 005289 210 FEYMEHDI 217 (704)
Q Consensus 210 ~Ey~~g~l 217 (704)
|++++|..
T Consensus 106 ~~~i~G~~ 113 (328)
T 1zyl_A 106 FPSVGGRQ 113 (328)
T ss_dssp EECCCCEE
T ss_pred EEecCCCC
Confidence 99999843
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0072 Score=67.07 Aligned_cols=76 Identities=18% Similarity=0.164 Sum_probs=48.9
Q ss_pred eEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCc-eeEeEEEeecCCCeEEEEEe
Q 005289 133 EKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI-IKLEGLITSRLSCSIYLVFE 211 (704)
Q Consensus 133 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-v~l~~~~~~~~~~~~~LV~E 211 (704)
-.++.|+.|-...+|++.....+..|+||+..... . . .-...+|+.+|+.|...+| +++++++.. .+|||
T Consensus 111 ~~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~-~-~idR~~E~~vl~~L~~~gl~P~ll~~~~~------G~v~e 181 (458)
T 2qg7_A 111 LEFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-D-E-IINREREKKISCILYNKNIAKKIYVFFTN------GRIEE 181 (458)
T ss_dssp EEEEEECC--CEEEEEEEETTTTEEEEEEEECC-C-C-S-CSCHHHHHHHHHHHTTSSSBCCEEEEETT------EEEEE
T ss_pred eEEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-h-h-hcCHHHHHHHHHHHHhcCCCCCEEEEeCC------eEEEE
Confidence 34678888999999999875445788999874321 0 0 1112479999999964444 567766621 25999
Q ss_pred cccccc
Q 005289 212 YMEHDI 217 (704)
Q Consensus 212 y~~g~l 217 (704)
|++|..
T Consensus 182 ~I~G~~ 187 (458)
T 2qg7_A 182 FMDGYA 187 (458)
T ss_dssp CCCSEE
T ss_pred eeCCcc
Confidence 998743
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0057 Score=64.89 Aligned_cols=32 Identities=28% Similarity=0.415 Sum_probs=28.0
Q ss_pred cCcccccCCCccEEEccCCceEEecccccccc
Q 005289 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (704)
Q Consensus 250 ~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~ 281 (704)
..++|+|+.+.|||++.++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 36999999999999998888999999877643
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0055 Score=60.88 Aligned_cols=95 Identities=17% Similarity=0.090 Sum_probs=61.2
Q ss_pred ccccccCCCccccHHHHHHHHHHhhhhHHHHH-hcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCccccccc
Q 005289 217 ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH-SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 295 (704)
Q Consensus 217 ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH-~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~~~~~gT 295 (704)
|...+...+.+|+|+++|.++.|.+..|.-+- ...-..+=+.|..|+|..+|.|-+.+ ..+. ...
T Consensus 35 L~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------~~~ 100 (229)
T 2yle_A 35 LEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------AGE 100 (229)
T ss_dssp HHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-------------------
T ss_pred HHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-------------ccc
Confidence 33444556778999999999999998877662 11222344567899999999988764 2110 012
Q ss_pred ccccCcccccCCCCCCCccchhhHHHHHHHHH
Q 005289 296 LWYRPPELLLGATDYGPSVDLWSVGCVFAELL 327 (704)
Q Consensus 296 ~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLl 327 (704)
..+.|||.+. ...+.+.=|||||++||.-+
T Consensus 101 ~~~~~pe~~~--~~~te~~~IysLG~tLY~AL 130 (229)
T 2yle_A 101 PPPVAGKLGY--SQCMETEVIESLGIIIYKAL 130 (229)
T ss_dssp ------CCSS--SSSCHHHHHHHHHHHHHHHH
T ss_pred cCCCChhhcc--ccchHHHHHHHHHHHHHHHh
Confidence 2367888763 24467788999999999987
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.76 E-value=0.002 Score=67.80 Aligned_cols=34 Identities=29% Similarity=0.371 Sum_probs=28.4
Q ss_pred hcCcccccCCCccEEEccC----CceEEeccccccccC
Q 005289 249 SRGVLHRDIKGSNLLVNNE----GVLKLADFGLANFSN 282 (704)
Q Consensus 249 ~~gIvHrDLKp~NILl~~~----g~iKL~DFGla~~~~ 282 (704)
...+||+|+.+.|||++.+ +.+.|+||+.+....
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 3479999999999999874 679999999886543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.22 E-value=0.0095 Score=65.40 Aligned_cols=75 Identities=9% Similarity=0.024 Sum_probs=48.3
Q ss_pred EEEEeeccCceEEEEEEECCC-------CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeEEEeecCCCe
Q 005289 134 KLEKIGQGTYSSVFRARDLDT-------GKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNIIKLEGLITSRLSCS 205 (704)
Q Consensus 134 ~~~~LG~G~fg~Vy~a~~~~~-------g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~ 205 (704)
.++.|..|-...+|++..... ++.|+|++..... +..-...+|..+|+.|. +.-..++++.+. .
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~- 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADFP----E- 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----T-
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----C-
Confidence 456777788889999986521 5789999864321 11112357888888884 333456665432 1
Q ss_pred EEEEEecccccc
Q 005289 206 IYLVFEYMEHDI 217 (704)
Q Consensus 206 ~~LV~Ey~~g~l 217 (704)
++||||++|..
T Consensus 146 -~~I~efI~G~~ 156 (424)
T 3mes_A 146 -GRIEEFIDGEP 156 (424)
T ss_dssp -EEEEECCCSEE
T ss_pred -CEEEEEeCCcc
Confidence 68999999854
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.53 E-value=0.13 Score=55.71 Aligned_cols=30 Identities=27% Similarity=0.476 Sum_probs=24.9
Q ss_pred CcccccCCCccEEE------ccCCceEEeccccccc
Q 005289 251 GVLHRDIKGSNLLV------NNEGVLKLADFGLANF 280 (704)
Q Consensus 251 gIvHrDLKp~NILl------~~~g~iKL~DFGla~~ 280 (704)
.++|+|+.+.|||+ +++..+.|+||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36899999999999 3456799999998753
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A | Back alignment and structure |
|---|
Probab=89.89 E-value=0.069 Score=51.21 Aligned_cols=69 Identities=6% Similarity=-0.193 Sum_probs=45.0
Q ss_pred CCCCChhHHhHhHHHHHhhhhCCCccccccccccccccCCCCCCChHHHHHHHHHhHhhcCCCCCcccccccCccc
Q 005289 430 IYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVEDVAVRTQFAKKINGHSLHILKDDELSGRE 505 (704)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~~~~~f~~~d~~~~~~~~~~e~~~~~ 505 (704)
..++..+++.......++.. ..+..++.....+...+ +.+++..+.+.|..+|.|++|.|+.+|+....
T Consensus 10 ~~~~~~~l~~~~~~~l~~~~------~~~~l~~~~l~~~~~~l-~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l 78 (191)
T 3k21_A 10 GRENLYFQGIHVLENFKNYG------LLLKFQKLAMTIIAQQS-NDYDVEKLKSTFLVLDEDGKGYITKEQLKKGL 78 (191)
T ss_dssp ----CHHHHHHHHHHHHHHH------HHHHHHHHHHHHHHHHC-CCHHHHHHHHHHHHHCTTCSSEECHHHHHHHH
T ss_pred CccccccccHHHHHHHHHHH------hhHHHHHHHHHHHHHHC-CHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHH
Confidence 34455566666655554433 22334444444554455 88999999999999999999999999974443
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A | Back alignment and structure |
|---|
Probab=88.46 E-value=0.047 Score=57.51 Aligned_cols=112 Identities=17% Similarity=0.130 Sum_probs=63.1
Q ss_pred ccCCCHHHHHHHHHhh---ccCCCCCcCHHHHHhc------cccCCCCCCCCCCCCCCCCCChhHHhHhHHHHHhhhhCC
Q 005289 382 FKDLPTTAVNLIETLL---SVEPYKRATASAALAS------EYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGG 452 (704)
Q Consensus 382 ~~~~s~~~~dLI~~mL---~~dP~kRpTa~e~L~h------pwf~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 452 (704)
++.+..++.+|.++++ ..+|+.|.+.++.+.| +|+...+.. ...+.+++.|....+....+
T Consensus 14 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~r~~~~~~~a~g 83 (323)
T 1ij5_A 14 VKKVHENLEELQKKLDHTSFAHKEDRDRLEAQIAQKEQEQKAKLAEYDQK----------VQNEFDARERAEREREAARG 83 (323)
T ss_dssp HHHHHHHHHHHHHHHTTCCCC-----CCHHHHHHHHHHHHHHHHHHHHHH----------HHHHHHHHHHHHHHHHHTTS
T ss_pred HHHHHHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHHHHHHHH----------HcChhhhhHHHHHHHHhhcC
Confidence 4567788999999998 8999999999999998 777532110 01122333333332222111
Q ss_pred Cccc-----cccccc--------cccccCCCCCCChHHHHHHHHHhHhhcCCCCCcccccccCcc
Q 005289 453 RVRG-----AETRKT--------TRKSHGMSKLAPVEDVAVRTQFAKKINGHSLHILKDDELSGR 504 (704)
Q Consensus 453 ~~~~-----~~~~k~--------~~~~~~~~~~~~~~e~~~~~~~f~~~d~~~~~~~~~~e~~~~ 504 (704)
.... ....+. .....++ ...+.+++..+...|..+|.|++|.|+.+|+...
T Consensus 84 ~~~~e~q~~~~vl~~l~~~f~~~~~lkk~~-~~Ls~~e~~~l~~~F~~~D~d~dG~Is~~El~~~ 147 (323)
T 1ij5_A 84 DAAAEKQRLASLLKDLEDDASGYNRLRPSK-PMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQV 147 (323)
T ss_dssp CHHHHHHHHHHHHHHC-------------C-CCCCHHHHHHHHHHHTSSSSTTSSCCCHHHHHHH
T ss_pred CCCCcchhhHHHHHHHHHHHHHhhhHHHHH-HhCCHHHHHHHHHHHHHHhCCCCCCCcHHHHHHH
Confidence 1110 000000 0111122 2348899999999999999999999999997433
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} | Back alignment and structure |
|---|
Probab=82.81 E-value=0.25 Score=47.52 Aligned_cols=47 Identities=9% Similarity=-0.052 Sum_probs=35.9
Q ss_pred ccccccccccCCCCCCChHHHHHHHHHhHhhcCCCCCcccccccCccc
Q 005289 458 ETRKTTRKSHGMSKLAPVEDVAVRTQFAKKINGHSLHILKDDELSGRE 505 (704)
Q Consensus 458 ~~~k~~~~~~~~~~~~~~~e~~~~~~~f~~~d~~~~~~~~~~e~~~~~ 505 (704)
+..++.....++..+ +.+|+..+.+.|+.+|.|++|.|+.+|+....
T Consensus 37 ~~lk~~~l~~i~~~l-~~~e~~~l~~~F~~~D~d~~G~Is~~El~~~l 83 (197)
T 3pm8_A 37 NELKKIALTIIAKHL-CDVEINNLRNIFIALDVDNSGTLSSQEILDGL 83 (197)
T ss_dssp CHHHHHHHHHHHHHC-CHHHHHHHHHHHHHHCTTCSSEECHHHHHHHH
T ss_pred cHHHHHHHHHHHHHC-CHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHH
Confidence 344444444555555 88999999999999999999999999974433
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=82.60 E-value=0.067 Score=59.32 Aligned_cols=65 Identities=14% Similarity=0.187 Sum_probs=18.5
Q ss_pred eEEEEeeccCceEEEEEEECCCCcEEEE------EEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEee
Q 005289 133 EKLEKIGQGTYSSVFRARDLDTGKIVAL------KKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITS 200 (704)
Q Consensus 133 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAv------K~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 200 (704)
.+.++|| ||.||++........||+ |.+.......+....+.+|..+++.++||||++.+.+...
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 3445666 999999988665568888 7765444444555667889999999999999999877643
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 704 | ||||
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-83 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-83 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-76 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-75 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-75 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-74 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-74 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-74 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-73 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-71 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-70 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-68 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-68 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-68 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-68 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-68 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-67 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-67 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-66 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-66 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-66 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-66 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-65 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-63 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-63 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-62 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-61 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-57 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-56 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-56 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-55 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-54 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-54 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-53 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-53 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-52 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-52 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-51 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-50 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-50 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-50 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-50 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-49 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-49 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-48 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-48 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-48 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-48 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-48 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-47 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-46 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-46 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-45 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-44 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-43 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-42 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-42 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-41 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-41 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-41 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-40 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-27 |
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 264 bits (676), Expect = 1e-83
Identities = 119/302 (39%), Positives = 174/302 (57%), Gaps = 9/302 (2%)
Query: 133 EKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF---EPESVRFMAREILILRRLDHP 189
EKL+ +G+G +++V++ARD +T +IVA+KK++ + + R REI +L+ L HP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
NII L + +I LVF++ME D+ ++ + + + IK YM L GLE+ H
Sbjct: 61 NIIGLLDAFGHK--SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD 309
+LHRD+K +NLL++ GVLKLADFGLA + +R T +VVT WYR PELL GA
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-THQVVTRWYRAPELLFGARM 177
Query: 310 YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHATLF 368
YG VD+W+VGC+ AELL+ P L G ++++QL +IF+ G+P ++ W LP F
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSL 428
K L F ++LI+ L P R TA+ AL +YFS +P L
Sbjct: 238 KSFPGIP--LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQL 295
Query: 429 PI 430
P
Sbjct: 296 PR 297
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 263 bits (673), Expect = 5e-83
Identities = 130/306 (42%), Positives = 176/306 (57%), Gaps = 12/306 (3%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+EKL KIGQGT+ VF+AR TG+ VALKKV +N + REI IL+ L H N+
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 192 IKLEGLITSRLS------CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
+ L + ++ S SIYLVF++ EHD+ GLLS +KF+ ++IK M LL+GL
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLY 131
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF---SNTGHRQPLTSRVVTLWYRPPE 302
+ H +LHRD+K +N+L+ +GVLKLADFGLA + T+RVVTLWYRPPE
Sbjct: 132 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191
Query: 303 LLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW---KK 359
LLLG DYGP +DLW GC+ AE+ PI+QG TE QL I +LCGS + W
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251
Query: 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419
+L Q R A++LI+ LL ++P +R + AL ++F +
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311
Query: 420 PYACDL 425
P DL
Sbjct: 312 PMPSDL 317
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 247 bits (631), Expect = 2e-76
Identities = 108/327 (33%), Positives = 157/327 (48%), Gaps = 13/327 (3%)
Query: 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH 188
+ L IG+G Y V A D VA+KK+ + R + REI IL R H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRH 65
Query: 189 PNIIKLEGLI---TSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
NII + +I T +YLV M D+ LL S I ++ Q+L GL+
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLK 123
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQPLTSRVVTLWYRPPEL 303
+ HS VLHRD+K SNLL+N LK+ DFGLA + H LT V T WYR PE+
Sbjct: 124 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 304 LLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363
+L + Y S+D+WSVGC+ AE+L +PI G+ ++QL+ I + GSP +
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 364 HATLFKPQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421
A + P+ + F + + A++L++ +L+ P+KR ALA Y
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY- 302
Query: 422 ACDLSSLPIYPPSKEIDAKHREDARRK 448
D S PI + D + + + K
Sbjct: 303 --DPSDEPIAEAPFKFDMELDDLPKEK 327
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 245 bits (626), Expect = 1e-75
Identities = 101/325 (31%), Positives = 164/325 (50%), Gaps = 12/325 (3%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ L+ +G G Y +V A D TG VA+KK+ + RE+ +L+ + H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 190 NIIKLEGLITSR----LSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
N+I L + T YLV +M D+ L+ K E +I+ + Q+L GL
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE--KLGEDRIQFLVYQMLKGLR 135
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
+ H+ G++HRD+K NL VN + LK+ DFGLA ++ +T VVT WYR PE++L
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD----SEMTGYVVTRWYRAPEVIL 191
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365
Y +VD+WSVGC+ AE++ GK + +G ++QL +I K+ G+PP ++ ++ + A
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251
Query: 366 TLFKPQQPY--DSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 423
+ P + AVNL+E +L ++ +R TA ALA YF +
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 311
Query: 424 DLSSLPIYPPSKEIDAKHREDARRK 448
D + Y S + + ++ +R
Sbjct: 312 DEPQVQKYDDSFDDVDRTLDEWKRV 336
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 243 bits (621), Expect = 5e-75
Identities = 105/314 (33%), Positives = 156/314 (49%), Gaps = 18/314 (5%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+ + IG G++ V++A+ D+G++VA+KKV D RF RE+ I+R+LDH NI
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNI 75
Query: 192 IKLEGLITS----RLSCSIYLVFEYMEHDITGLL---SCPDIKFSEAQIKCYMNQLLHGL 244
++L S + + LV +Y+ + + S +K YM QL L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 245 EHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPEL 303
+ HS G+ HRDIK NLL++ + VLKL DFG A G +P S + + +YR PEL
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRYYRAPEL 193
Query: 304 LLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363
+ GATDY S+D+WS GCV AELL+G+PI G + V+QL +I K+ G+P + ++
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253
Query: 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 423
+ PQ + P A+ L LL P R T A A +F
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF--DELRD 311
Query: 424 DLSSLPIYPPSKEI 437
LP + +
Sbjct: 312 PNVKLPNGRDTPAL 325
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (616), Expect = 3e-74
Identities = 104/324 (32%), Positives = 161/324 (49%), Gaps = 12/324 (3%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ ++ L +G G Y SV A D TG VA+KK+ + RE+ +L+ + H
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 190 NIIKLEGLITSRLSC----SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
N+I L + T S +YLV M D+ ++ C K ++ ++ + Q+L GL+
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLK 135
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
+ HS ++HRD+K SNL VN + LK+ DFGLA ++ T V T WYR PE++L
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIML 191
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK--SKLP 363
Y +VD+WSVGC+ AELL G+ + G ++QL I +L G+P + KK S+
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251
Query: 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 423
+ Q + F AV+L+E +L ++ KR TA+ ALA YF+
Sbjct: 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311
Query: 424 DLSSLPIYPPSKEIDAKHREDARR 447
D Y S E ++ +
Sbjct: 312 DEPVADPYDQSFESRDLLIDEWKS 335
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 238 bits (609), Expect = 7e-74
Identities = 118/294 (40%), Positives = 168/294 (57%), Gaps = 6/294 (2%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ F+K+EKIG+GTY V++AR+ TG++VALKK+R D REI +L+ L+HP
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCH 248
NI+KL +I + +YLVFE++ D+ + + IK Y+ QLL GL CH
Sbjct: 62 NIVKLLDVIHTE--NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
S VLHRD+K NLL+N EG +KLADFGLA R T VVTLWYR PE+LLG
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEILLGCK 178
Query: 309 DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368
Y +VD+WS+GC+FAE++ + + G +E++QL +IF+ G+P + W
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS--TKP 420
+ + L +L+ +L +P KR +A AALA +F TKP
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 238 bits (607), Expect = 7e-74
Identities = 106/287 (36%), Positives = 164/287 (57%), Gaps = 4/287 (1%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ + LEKIG+GTY V++A++ + G+ ALKK+R + + REI IL+ L H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
NI+KL +I ++ + LVFE+++ D+ LL + K ++ QLL+G+ +CH
Sbjct: 61 NIVKLYDVIHTK--KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD 309
R VLHRD+K NLL+N EG LK+ADFGLA R+ +VTLWYR P++L+G+
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH-EIVTLWYRAPDVLMGSKK 177
Query: 310 YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369
Y ++D+WSVGC+FAE++ G P+ G +E +QL +IF++ G+P W
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
K L + ++L+ +L ++P +R TA AL YF
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (605), Expect = 2e-73
Identities = 117/287 (40%), Positives = 165/287 (57%), Gaps = 4/287 (1%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+EKLEKIG+GTY +VF+A++ +T +IVALK+VR D+ + REI +L+ L H NI
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 192 IKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG 251
++L ++ S + LVFE+ + D+ + +K ++ QLL GL CHSR
Sbjct: 64 VRLHDVLHSD--KKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 252 VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYG 311
VLHRD+K NLL+N G LKLA+FGLA R ++ VVTLWYRPP++L GA Y
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 312 PSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 370
S+D+WS GC+FAEL P+ G +QL +IF+L G+P ++ W P
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240
Query: 371 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417
P +SL L T +L++ LL P +R +A AL YFS
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (589), Expect = 3e-71
Identities = 74/293 (25%), Positives = 125/293 (42%), Gaps = 31/293 (10%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ ++ ++ +G+G Y V A + T + VA+K V + + +EI I + L+H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHE 63
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
N++K G R YL EY PDI E + + +QL+ G+ + H
Sbjct: 64 NVVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-TLWYRPPELLLGAT 308
G+ HRDIK NLL++ LK++DFGLA +R+ L +++ TL Y PELL
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 309 DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368
+ VD+WS G V +L G+ ++ Q + +K + +
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP------------- 228
Query: 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421
+K + + + L+ +L P R T ++ KP
Sbjct: 229 -------------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWY-NKPL 267
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (587), Expect = 3e-70
Identities = 66/306 (21%), Positives = 120/306 (39%), Gaps = 23/306 (7%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL 186
L+ D FEK+ ++G G VF+ +G ++A K + + + + RE+ +L
Sbjct: 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII-RELQVLHEC 61
Query: 187 DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEH 246
+ P I+ G S I + E+M+ + + E + ++ GL +
Sbjct: 62 NSPYIVGFYGAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 119
Query: 247 CHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
+ ++HRD+K SN+LVN+ G +KL DFG++ S V T Y PE L
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQ 176
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE-QLHKIFKLCGSPPDDYWK-----K 359
G T Y D+WS+G E+ +G+ + E +L ++ G + + +
Sbjct: 177 G-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235
Query: 360 SKLPHATLFKPQQPYDSSLRETFKDLPTT---------AVNLIETLLSVEPYKRATASAA 410
+ +P L + P + + L P +RA
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
Query: 411 LASEYF 416
+ +
Sbjct: 296 MVHAFI 301
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 226 bits (578), Expect = 1e-68
Identities = 71/340 (20%), Positives = 121/340 (35%), Gaps = 35/340 (10%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
D ++ E++G G + V R + TG A K V + + +EI + L HP
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHP 83
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
++ L + +++E+M ++ ++ K SE + YM Q+ GL H H
Sbjct: 84 TLVNLHDAFEDD--NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 141
Query: 249 SRGVLHRDIKGSNLLVNNE--GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG 306
+H D+K N++ + LKL DFGL + + T + PE+ G
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--VKVTTGTAEFAAPEVAEG 199
Query: 307 ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366
G D+WSVG + LL G G + E L + + D +
Sbjct: 200 -KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF--------- 249
Query: 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLS 426
+ + I LL +P R T AL + + S
Sbjct: 250 ----------------SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 293
Query: 427 SLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKS 466
+P +K D+ + + + + RK
Sbjct: 294 QIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKH 333
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 224 bits (572), Expect = 2e-68
Identities = 78/321 (24%), Positives = 133/321 (41%), Gaps = 39/321 (12%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPN 190
F L +IG G++ +V+ ARD+ ++VA+KK+ + + E + + +E+ L++L HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
I+ G + +LV EY + LL E +I + L GL + HS
Sbjct: 77 TIQYRGCYLRE--HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD- 309
++HRD+K N+L++ G++KL DFG A+ P S V T ++ PE++L +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASI-----MAPANSFVGTPYWMAPEVILAMDEG 189
Query: 310 -YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368
Y VD+WS+G EL KP L + L+ I + P
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--NESPALQS----------- 236
Query: 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSL 428
N +++ L P R T+ L + + + L
Sbjct: 237 --------------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDL 282
Query: 429 P--IYPPSKEIDAKHREDARR 447
+E+D ++
Sbjct: 283 IQRTKDAVRELDNLQYRKMKK 303
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 226 bits (576), Expect = 2e-68
Identities = 75/323 (23%), Positives = 129/323 (39%), Gaps = 40/323 (12%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
D ++ LE++G G + V R + TG++ K + P + EI I+ +L HP
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHP 86
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
+I L + + L+ E++ ++ ++ D K SEA++ YM Q GL+H H
Sbjct: 87 KLINLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 144
Query: 249 SRGVLHRDIKGSNLLV--NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG 306
++H DIK N++ +K+ DFGLA N + T + PE++
Sbjct: 145 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--VKVTTATAEFAAPEIVDR 202
Query: 307 ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366
G D+W++G + LL G G ++E L + + +D +
Sbjct: 203 -EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS------- 254
Query: 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLS 426
+ A + I+ LL EP KR T AL + D S
Sbjct: 255 ------------------VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG-----DHS 291
Query: 427 SLPIYPPSKEIDAKHREDARRKK 449
+L PS + ++ +
Sbjct: 292 NLTSRIPSSRYNKIRQKIKEKYA 314
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 7e-68
Identities = 84/289 (29%), Positives = 131/289 (45%), Gaps = 36/289 (12%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVR-FMAREILILRRLDH 188
+ FE +G+G + +V+ AR+ + I+ALK + E V + RE+ I L H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
PNI++L G + +YL+ EY KF E + Y+ +L + L +CH
Sbjct: 66 PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 123
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
S+ V+HRDIK NLL+ + G LK+ADFG + + + R + TL Y PPE++ G
Sbjct: 124 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEMIEGRM 180
Query: 309 DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368
+ VDLWS+G + E L+GKP + T E +I ++ + PD
Sbjct: 181 -HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD-------------- 225
Query: 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417
+ A +LI LL P +R L + +
Sbjct: 226 ---------------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 259
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (567), Expect = 7e-68
Identities = 81/308 (26%), Positives = 134/308 (43%), Gaps = 41/308 (13%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+ + EKIGQG +V+ A D+ TG+ VA++++ + EIL++R +PNI
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNI 79
Query: 192 IKLEGLITSRLSCSIYLVFEYMEHDITGLLS--CPDIKFSEAQIKCYMNQLLHGLEHCHS 249
+ +++V EY+ G L+ + E QI + L LE HS
Sbjct: 80 VNYLDSYLV--GDELWVVMEYLAG---GSLTDVVTETCMDEGQIAAVCRECLQALEFLHS 134
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD 309
V+HRDIK N+L+ +G +KL DFG + ++ V T ++ PE++
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTMVGTPYWMAPEVVTR-KA 192
Query: 310 YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369
YGP VD+WS+G + E++ G+P + L+ I G+P +K
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNPEK---------- 241
Query: 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSL- 428
L + + L ++ KR +A L ++ A LSSL
Sbjct: 242 ---------------LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI---AKPLSSLT 283
Query: 429 PIYPPSKE 436
P+ +KE
Sbjct: 284 PLIAAAKE 291
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (560), Expect = 7e-67
Identities = 74/296 (25%), Positives = 129/296 (43%), Gaps = 34/296 (11%)
Query: 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRL 186
R + F+ + +G+G++S+V AR+L T + A+K + + + V ++ RE ++ RL
Sbjct: 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 65
Query: 187 DHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEH 246
DHP +KL +Y Y ++ F E + Y +++ LE+
Sbjct: 66 DHPFFVKLYFTFQDD--EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-TLWYRPPELLL 305
H +G++HRD+K N+L+N + +++ DFG A + +Q + V T Y PELL
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365
+ S DLW++GC+ +L+ G P + E KI KL P+ ++ K
Sbjct: 184 EKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK------ 236
Query: 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421
A +L+E LL ++ KR P+
Sbjct: 237 -----------------------ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (560), Expect = 8e-67
Identities = 67/293 (22%), Positives = 122/293 (41%), Gaps = 36/293 (12%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
D +E + ++G G + V++A++ +T + A K + + E + EI IL DHP
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHP 69
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
NI+KL +++++ E+ + ++ + +E+QI+ Q L L + H
Sbjct: 70 NIVKLLDAFYYE--NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 127
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
++HRD+K N+L +G +KLADFG++ NT Q S + T ++ PE+++ T
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAK-NTRTIQRRDSFIGTPYWMAPEVVMCET 186
Query: 309 D----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364
Y D+WS+G E+ +P + L KI K P +
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK-SEPPTLAQPSR----- 240
Query: 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417
+ + ++ L R T S L + +
Sbjct: 241 --------------------WSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVT 273
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 1e-66
Identities = 112/293 (38%), Positives = 165/293 (56%), Gaps = 13/293 (4%)
Query: 132 FEKLEKIGQGTYSSVFRARDL-DTGKIVALKKVRFDNFEPESVRFMAREILILRRL---D 187
+E + +IG+G Y VF+ARDL + G+ VALK+VR E RE+ +LR L +
Sbjct: 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68
Query: 188 HPNIIKLEGLITSRLSCS---IYLVFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLLHG 243
HPN+++L + T + + LVFE+++ D+T L P+ IK M QLL G
Sbjct: 69 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 128
Query: 244 LEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPEL 303
L+ HS V+HRD+K N+LV + G +KLADFGLA + TS VVTLWYR PE+
Sbjct: 129 LDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLWYRAPEV 186
Query: 304 LLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363
LL ++ Y VDLWSVGC+FAE+ KP+ +G ++V+QL KI + G P ++ W +
Sbjct: 187 LLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245
Query: 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
F + + + D+ +L+ L+ P KR +A +AL+ YF
Sbjct: 246 PRQAFHSKSAQP--IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 220 bits (560), Expect = 2e-66
Identities = 90/300 (30%), Positives = 151/300 (50%), Gaps = 21/300 (7%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DH 188
D ++ + K+G+G YS VF A ++ + V +K ++ P + + REI IL L
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-----PVKKKKIKREIKILENLRGG 89
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
PNII L ++ +S + LVFE++ + ++ I+ YM ++L L++CH
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNN---TDFKQLYQTLTDYDIRFYMYEILKALDYCH 146
Query: 249 SRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
S G++HRD+K N+++++E L+L D+GLA F + G RV + +++ PELL+
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDY 204
Query: 308 TDYGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSP-PDDYWKKSKLPHA 365
Y S+D+WS+GC+ A ++ K P G +QL +I K+ G+ DY K +
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264
Query: 366 TLFKPQQPYDSSLR-------ETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418
F S R E + A++ ++ LL + R TA A+ YF T
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 3e-66
Identities = 75/297 (25%), Positives = 124/297 (41%), Gaps = 39/297 (13%)
Query: 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD 187
RA+ +E L IG G+Y + R GKI+ K++ + + + + E+ +LR L
Sbjct: 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK 61
Query: 188 HPNIIKLEGLITSRLSCSIYLVFEYME----HDITGLLSCPDIKFSEAQIKCYMNQLLHG 243
HPNI++ I R + ++Y+V EY E + + E + M QL
Sbjct: 62 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121
Query: 244 LEHCHSRG-----VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 298
L+ CH R VLHRD+K +N+ ++ + +KL DFGLA N + V T +Y
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPYY 180
Query: 299 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 358
PE + Y D+WS+GC+ EL P ++ E KI + K
Sbjct: 181 MSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE---------GK 230
Query: 359 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415
++P+ +I +L+++ Y R + L +
Sbjct: 231 FRRIPY-------------------RYSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (560), Expect = 4e-66
Identities = 91/337 (27%), Positives = 167/337 (49%), Gaps = 24/337 (7%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
++ L+ IG G V A D + VA+KK+ + RE+++++ ++H NI
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 192 IKLEGLITSRLSCS----IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
I L + T + + +YLV E M+ L ++ ++ + Q+L G++H
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMDA---NLCQVIQMELDHERMSYLLYQMLCGIKHL 135
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
HS G++HRD+K SN++V ++ LK+ DFGLA + T +T VVT +YR PE++LG
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVILG- 192
Query: 308 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367
Y +VD+WSVGC+ E++ K + GR ++Q +K+ + G+P ++ KK +
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252
Query: 368 FKPQQPYDS-------------SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 414
+ + Y + E K + A +L+ +L ++P KR + AL
Sbjct: 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 312
Query: 415 YFSTKPYACDLSSLPIYPPSKEID-AKHREDARRKKV 450
Y + ++ + P K++D +H + ++ +
Sbjct: 313 YINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELI 349
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 4e-65
Identities = 67/344 (19%), Positives = 124/344 (36%), Gaps = 39/344 (11%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ + E +G+G + V R + + K K V+ + V+ +EI IL H
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHR 61
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
NI+ L S + ++FE++ DI ++ + +E +I Y++Q+ L+ H
Sbjct: 62 NILHLHESFESM--EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 249 SRGVLHRDIKGSNLLVNN--EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG 306
S + H DI+ N++ +K+ +FG A G Y PE+
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLFTAPEYYAPEVHQH 177
Query: 307 ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366
+ D+WS+G + LL G T + + I + ++ +
Sbjct: 178 -DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF--------- 227
Query: 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLS 426
K++ A++ ++ LL E R TAS AL + K
Sbjct: 228 ----------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTK 271
Query: 427 SLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMS 470
+ + ++D R+ R G+S
Sbjct: 272 VIRTLKHRRYYHTLIKKDLNMVVSAARISCG---GAIRSQKGVS 312
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 211 bits (537), Expect = 3e-63
Identities = 74/317 (23%), Positives = 132/317 (41%), Gaps = 36/317 (11%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
D ++ + +G G +S V A D T K+VA+K + E + EI +L ++ HP
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSME-NEIAVLHKIKHP 67
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
NI+ L+ + S +YL+ + + ++ + ++E + Q+L +++ H
Sbjct: 68 NIVALDDIYESG--GHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLH 124
Query: 249 SRGVLHRDIKGSNLLV---NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
G++HRD+K NLL + + + ++DFGL+ + G L++ T Y PE+L
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV--LSTACGTPGYVAPEVLA 182
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365
Y +VD WS+G + LL G P + + +I K YW
Sbjct: 183 Q-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW-------- 233
Query: 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDL 425
D+ +A + I L+ +P KR T AL + +
Sbjct: 234 -----------------DDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKN 276
Query: 426 SSLPIYPPSKEIDAKHR 442
+ K+ AK +
Sbjct: 277 IHQSVSEQIKKNFAKSK 293
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 209 bits (533), Expect = 4e-63
Identities = 79/301 (26%), Positives = 126/301 (41%), Gaps = 44/301 (14%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPES-------VRFMAREILI 182
+ +E E +G+G S V R T K A+K + S +E+ I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 183 LRRL-DHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQL 240
LR++ HPNII+L+ + +LVF+ M+ ++ L+ + SE + + M L
Sbjct: 63 LRKVSGHPNIIQLKDTYETN--TFFFLVFDLMKKGELFDYLT-EKVTLSEKETRKIMRAL 119
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP 300
L + H ++HRD+K N+L++++ +KL DFG + + G + L T Y
Sbjct: 120 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSYLA 177
Query: 301 PELLLGATD-----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 355
PE++ + + YG VD+WS G + LL G P R ++ L I
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237
Query: 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 415
W D T +L+ L V+P KR TA ALA +
Sbjct: 238 EW-------------------------DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 272
Query: 416 F 416
F
Sbjct: 273 F 273
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 1e-62
Identities = 71/312 (22%), Positives = 130/312 (41%), Gaps = 38/312 (12%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR----FDNFEPESVRFMAREILILRR 185
D ++ E++G G ++ V + R+ TG A K ++ + S + RE+ IL+
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 186 LDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
+ HPN+I L + ++ + L+ E + +E + ++ Q+L+G+
Sbjct: 70 IQHPNVITLHEVYENK--TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 127
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGV----LKLADFGLANFSNTGHRQPLTSRVVTLWYRPP 301
+ HS + H D+K N+++ + V +K+ DFGLA+ + G+ + T + P
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAP 185
Query: 302 ELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361
E++ G D+WS+G + LL G G T+ E L + + D+Y+
Sbjct: 186 EIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF---- 240
Query: 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421
+ A + I LL +P KR T +L + K
Sbjct: 241 ---------------------SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 279
Query: 422 ACDLSSLPIYPP 433
LSS +P
Sbjct: 280 QQALSSAWSHPQ 291
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 6e-61
Identities = 55/288 (19%), Positives = 117/288 (40%), Gaps = 33/288 (11%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
++IG G++ +V++ + VA+K + P+ ++ E+ +LR+ H
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
NI+ G T+ + +V ++ E + L + KF ++ Q G+++ H
Sbjct: 65 NILLFMGYSTA---PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-TLWYRPPELLLGA 307
++ ++HRD+K +N+ ++ + +K+ DFGLA + ++ ++ + PE++
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 308 TD--YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365
Y D+++ G V EL+ G+ +Q+ + PD
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD----------- 230
Query: 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413
L + + P L+ L + +R LAS
Sbjct: 231 ------------LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 196 bits (499), Expect = 2e-58
Identities = 63/291 (21%), Positives = 114/291 (39%), Gaps = 31/291 (10%)
Query: 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLD 187
+D +E E +G G S V ARDL + VA+K +R D +P RE L+
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 188 HPNIIKLEGLITSR--LSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
HP I+ + + Y+V EY++ + + + + + L
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 125
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQPLTSRVVTLWYRPPEL 303
H G++HRD+K +N++++ +K+ DFG+A + + + T Y PE
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185
Query: 304 LLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363
G + D++S+GCV E+L G+P G + V ++ + PP
Sbjct: 186 ARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH------ 238
Query: 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 414
+ L ++ L+ P R +A + ++
Sbjct: 239 -------------------EGLSADLDAVVLKALAKNPENRYQTAAEMRAD 270
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 1e-57
Identities = 58/291 (19%), Positives = 107/291 (36%), Gaps = 37/291 (12%)
Query: 132 FEKLE-KIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPN 190
F K + +IG+G++ +V++ D +T VA +++ + E +L+ L HPN
Sbjct: 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 69
Query: 191 IIKLEGLI--TSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
I++ T + I LV E M ++ + Q+L GL+ H
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 249 SRG--VLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
+R ++HRD+K N+ + G +K+ D GLA + + T + PE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF---AKAVIGTPEFMAPEMYE 186
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365
Y SVD+++ G E+ + Q+++ G P +
Sbjct: 187 E--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT-SGVKPASFD-------- 235
Query: 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
K +IE + +R + L +F
Sbjct: 236 -----------------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 193 bits (492), Expect = 3e-56
Identities = 70/330 (21%), Positives = 133/330 (40%), Gaps = 45/330 (13%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMA----REILILRR 185
+ F IG+G + V+ R DTGK+ A+K + + + +A + ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 186 LDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
D P I+ + + + + + M FSEA ++ Y +++ GLE
Sbjct: 64 GDCPFIVCMSYAFHTP--DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
H H+R V++RD+K +N+L++ G ++++D GLA + ++ + V T Y PE+L
Sbjct: 122 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS---KKKPHASVGTHGYMAPEVLQ 178
Query: 306 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365
Y S D +S+GC+ +LL G + ++ H+I ++ + +
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVELP-------- 229
Query: 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE-----YFST-- 418
+L+E LL + +R A E +F +
Sbjct: 230 -----------------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272
Query: 419 --KPYACDLSSLPIYPPSKEIDAKHREDAR 446
+ P+ PP E++A D
Sbjct: 273 WQMVFLQKYPP-PLIPPRGEVNAADAFDIG 301
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 191 bits (485), Expect = 9e-56
Identities = 65/321 (20%), Positives = 120/321 (37%), Gaps = 43/321 (13%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPN 190
F+ L +G G++ V R G+ A+K ++ + + V E L+L + HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 191 IIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
II++ G I+++ +Y+E L +F K Y ++ LE+ HS+
Sbjct: 66 IIRMWGTFQDA--QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDY 310
+++RD+K N+L++ G +K+ DFG A + + T Y PE++ Y
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEVVSTKP-Y 178
Query: 311 GPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 370
S+D WS G + E+L G ++ KI P + +
Sbjct: 179 NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNED----------- 227
Query: 371 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR-----ATASAALASEYFSTKPYACDL 425
+L+ L++ + +R +F + L
Sbjct: 228 ------------------VKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE-KL 268
Query: 426 SSLPIYPPSKEIDAKHREDAR 446
S I P + + + D
Sbjct: 269 LSRNIETPYEPPIQQGQGDTS 289
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 6e-55
Identities = 68/284 (23%), Positives = 121/284 (42%), Gaps = 35/284 (12%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF--EPESVRFMAREILILRRLD 187
+ F + +G+G++ VF A T + A+K ++ D + + M + ++ +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 188 HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
HP + + ++ +++ V EY+ KF ++ Y +++ GL+
Sbjct: 62 HPFLTHMFCTFQTK--ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 119
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
HS+G+++RD+K N+L++ +G +K+ADFG+ + G + + T Y PE+LLG
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT-NTFCGTPDYIAPEILLGQ 178
Query: 308 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367
Y SVD WS G + E+LIG+ G+ E E H I P
Sbjct: 179 K-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR------------- 224
Query: 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411
L A +L+ L EP KR +
Sbjct: 225 ----------------WLEKEAKDLLVKLFVREPEKRLGVRGDI 252
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 1e-54
Identities = 70/357 (19%), Positives = 135/357 (37%), Gaps = 49/357 (13%)
Query: 130 DAFEKLEK-IGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-D 187
D ++ + +G G V + + T + ALK ++ RE+ + R
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQ 63
Query: 188 HPNIIKLEGLITSRLSC--SIYLVFEYMEH-DITGLL-SCPDIKFSEAQIKCYMNQLLHG 243
P+I+++ + + + + +V E ++ ++ + D F+E + M +
Sbjct: 64 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123
Query: 244 LEHCHSRGVLHRDIKGSNLLVN---NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP 300
+++ HS + HRD+K NLL +LKL DFG A + + + + T +Y
Sbjct: 124 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT--TPCYTPYYVA 181
Query: 301 PELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360
PE+L Y S D+WS+G + LL G P + +
Sbjct: 182 PEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ------- 233
Query: 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420
++ P S + E K LI LL EP +R T + + +
Sbjct: 234 -------YEFPNPEWSEVSEEVKM-------LIRNLLKTEPTQRMTITEFMNHPWIMQ-- 277
Query: 421 YACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVED 477
+ + P++ + K R + ++++ T R + K+ +ED
Sbjct: 278 -STKVPQTPLHTSRVLKEDKERWEDVKEEM------TSALATMRVDYEQIKIKKIED 327
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 5e-54
Identities = 64/299 (21%), Positives = 109/299 (36%), Gaps = 49/299 (16%)
Query: 126 PLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVR----FDNFEPESVRFMAREIL 181
PL ++ +G G + SV+ + VA+K V D E + + E++
Sbjct: 1 PL-ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 59
Query: 182 ILRRLD--HPNIIKLEGLITSRLSCSIYLVFEYMEHDITGL-LSCPDIKFSEAQIKCYMN 238
+L+++ +I+L S L+ E E E + +
Sbjct: 60 LLKKVSSGFSGVIRLLDWFERP--DSFVLILERPEPVQDLFDFITERGALQEELARSFFW 117
Query: 239 QLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 297
Q+L + HCH+ GVLHRDIK N+L++ N G LKL DFG T T
Sbjct: 118 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRV 174
Query: 298 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 357
Y PPE + +G S +WS+G + +++ G + E+ + F+
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR---------- 224
Query: 358 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416
+ + + +LI L++ P R T +
Sbjct: 225 -------------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 5e-53
Identities = 57/293 (19%), Positives = 119/293 (40%), Gaps = 41/293 (13%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+ + +E++G G + V+ + VA+K ++ + P++ E ++++L H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFL---AEANLMKQLQHQ 68
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHD--ITGLLSCPDIKFSEAQIKCYMNQLLHGLEHC 247
+++L ++T IY++ EYME+ + L + IK + ++ Q+ G+
Sbjct: 69 RLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
R +HRD++ +N+LV++ K+ADFGLA + + PE +
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 308 TDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366
T + D+WS G + E++ G+ G T E + + +
Sbjct: 186 T-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------------------- 225
Query: 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA--SEYFS 417
++ +P + P L+ P R T + ++F+
Sbjct: 226 GYRMVRP---------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 9e-53
Identities = 75/326 (23%), Positives = 137/326 (42%), Gaps = 45/326 (13%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDH 188
+ F+ L+ +G+GT+ V R+ TG+ A+K +R + + V E +L+ H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
P + L+ + + V EY + F+E + + Y +++ LE+ H
Sbjct: 65 PFLTALKYAFQTH--DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
SR V++RDIK NL+++ +G +K+ DFGL + + + T Y PE+L
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKTFCGTPEYLAPEVLED-N 180
Query: 309 DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368
DYG +VD W +G V E++ G+ + I
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--------------------E 220
Query: 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR-----ATASAALASEYFSTKPYAC 423
+ + P + L A +L+ LL +P +R + A + +F + +
Sbjct: 221 EIRFP---------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ- 270
Query: 424 DLSSLPIYPPSK-----EIDAKHRED 444
D+ + PP K E+D ++ +D
Sbjct: 271 DVVQKKLLPPFKPQVTSEVDTRYFDD 296
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 2e-52
Identities = 65/313 (20%), Positives = 116/313 (37%), Gaps = 49/313 (15%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
++ K+GQG + V+ T + VA+K ++ PE+ +E ++++L H
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFL---QEAQVMKKLRHE 72
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITGLL--SCPDIKFSEAQIKCYMNQLLHGLEHC 247
+++L +++ IY+V EYM Q+ Q+ G+ +
Sbjct: 73 KLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 129
Query: 248 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA 307
+HRD++ +N+LV V K+ADFGLA + + PE L
Sbjct: 130 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 189
Query: 308 TDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366
+ D+WS G + EL G+ G E L ++ + P
Sbjct: 190 R-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP----------- 237
Query: 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA--SEYFSTKPYACD 424
+ P + +L+ EP +R T A +YF+
Sbjct: 238 -----------------ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT------- 273
Query: 425 LSSLPIYPPSKEI 437
S+ P Y P + +
Sbjct: 274 -STEPQYQPGENL 285
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 181 bits (459), Expect = 8e-52
Identities = 62/316 (19%), Positives = 124/316 (39%), Gaps = 43/316 (13%)
Query: 124 WVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILI 182
+ D F++++ +G G++ V + ++G A+K + + + + E I
Sbjct: 35 QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 183 LRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLH 242
L+ ++ P ++KLE ++Y+V EY+ +FSE + Y Q++
Sbjct: 95 LQAVNFPFLVKLEFSFKDN--SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPE 302
E+ HS +++RD+K NLL++ +G +++ DFG A + + T PE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWTLCGTPEALAPE 208
Query: 303 LLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362
++L Y +VD W++G + E+ G P ++ KI P +
Sbjct: 209 IILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSD--- 264
Query: 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR-----ATASAALASEYFS 417
+L+ LL V+ KR + ++F+
Sbjct: 265 --------------------------LKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298
Query: 418 TKPYACDLSSLPIYPP 433
T + + + P
Sbjct: 299 TTDWI-AIYQRKVEAP 313
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 3e-51
Identities = 68/288 (23%), Positives = 109/288 (37%), Gaps = 39/288 (13%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDT---GKIVALKKVRFDNF-EPESVRFMAREILILRRLD 187
LEK+G G++ V R VA+K ++ D +PE++ RE+ + LD
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 188 HPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEH 246
H N+I+L G++ + + +V E + L F + Y Q+ G+ +
Sbjct: 70 HRNLIRLYGVVLT---PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 247 CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQPLTSRVVTLWYRPPELL 304
S+ +HRD+ NLL+ ++K+ DFGL N H R V + PE L
Sbjct: 127 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 305 LGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363
T + + D W G E+ G+ G + LHKI K P
Sbjct: 187 KTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP-------- 237
Query: 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411
+D P N++ + +P R T A
Sbjct: 238 -------------------EDCPQDIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 176 bits (447), Expect = 1e-50
Identities = 51/289 (17%), Positives = 98/289 (33%), Gaps = 36/289 (12%)
Query: 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH 188
+ + KIG G++ ++ D+ G+ VA+K P+ + E I + +
Sbjct: 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMMQG 61
Query: 189 PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
I + +V E + + L + KFS + +Q++ +E+ H
Sbjct: 62 GVGIPTIRWCGAE-GDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 249 SRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTG------HRQPLTSRVVTLWYR 299
S+ +HRD+K N L+ ++ + DFGLA + + T Y
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359
LG + DL S+G V +G QG + K ++
Sbjct: 181 SINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS---------- 229
Query: 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 408
++ + + K P+ + S+ + S
Sbjct: 230 -----------EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYS 267
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 1e-50
Identities = 71/318 (22%), Positives = 133/318 (41%), Gaps = 40/318 (12%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDL---DTGKIVALKKVRFDNF--EPESVRFMAREILILR 184
+ FE L+ +G G Y VF R + DTGK+ A+K ++ + ++ E +L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 185 RLDH-PNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHG 243
+ P ++ L + ++L+ +Y+ +F+E +++ Y+ +++
Sbjct: 84 HIRQSPFLVTLHYAFQTE--TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA 141
Query: 244 LEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPEL 303
LEH H G+++RDIK N+L+++ G + L DFGL+ + T+ Y P++
Sbjct: 142 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 201
Query: 304 LLGA-TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362
+ G + + +VD WS+G + ELL G E +I + Y
Sbjct: 202 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP----- 256
Query: 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR-----ATASAALASEYFS 417
+++ A +LI+ LL +P KR A +F
Sbjct: 257 --------------------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 296
Query: 418 TKPYACDLSSLPIYPPSK 435
+ DL++ + P K
Sbjct: 297 KINWD-DLAAKKVPAPFK 313
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 174 bits (443), Expect = 3e-50
Identities = 50/284 (17%), Positives = 93/284 (32%), Gaps = 38/284 (13%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
++ +IG+G++ +F +L + VA+K + P+ + E + L
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ----LRDEYRTYKLLAGCTG 62
Query: 192 IKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG 251
I LV + + + LL KFS + Q+L ++ H +
Sbjct: 63 IPNVYYFGQE-GLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 252 VLHRDIKGSNLLVNN-----EGVLKLADFGLANF------SNTGHRQPLTSRVVTLWYRP 300
+++RDIK N L+ ++ + DFG+ F + + T Y
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 301 PELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360
LG + DL ++G VF L G QG K ++
Sbjct: 182 INTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG----------- 229
Query: 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 404
++ + LRE P + ++
Sbjct: 230 ----------EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDAT 263
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 6e-50
Identities = 53/292 (18%), Positives = 107/292 (36%), Gaps = 44/292 (15%)
Query: 123 GWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILI 182
GW L + L+ IG+G + V G VA+K ++ + + E +
Sbjct: 1 GW-ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIK----NDATAQAFLAEASV 53
Query: 183 LRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD--ITGLLSCPDIKFSEAQIKCYMNQL 240
+ +L H N+++L G+I +Y+V EYM + L S + + +
Sbjct: 54 MTQLRHSNLVQLLGVIVEE-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 112
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP 300
+E+ +HRD+ N+LV+ + V K++DFGL +++ + + + +
Sbjct: 113 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTA 168
Query: 301 PELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359
PE L + D+WS G + E+ G+ + + ++ K
Sbjct: 169 PEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------ 215
Query: 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411
+K P P +++ ++ R +
Sbjct: 216 -------GYKMDAP---------DGCPPAVYEVMKNCWHLDAAMRPSFLQLR 251
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 1e-49
Identities = 62/284 (21%), Positives = 106/284 (37%), Gaps = 37/284 (13%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
+++IG G + V L+ VA+K +R E E ++ +L HP
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFI---EEAEVMMKLSHP 60
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCH 248
+++L G+ I LVFE+MEH ++ L F+ + + G+ +
Sbjct: 61 KLVQLYGVCLE--QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 249 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT 308
V+HRD+ N LV V+K++DFG+ F T + + PE+ +
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-S 177
Query: 309 DYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367
Y D+WS G + E+ GK + R+ E + I +T
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-------------------STG 218
Query: 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411
F+ +P + T ++ P R S L
Sbjct: 219 FRLYKP---------RLASTHVYQIMNHCWKERPEDRPAFSRLL 253
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 1e-49
Identities = 55/283 (19%), Positives = 110/283 (38%), Gaps = 37/283 (13%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
L+++G G + V + VA+K ++ + + E ++ L H +
Sbjct: 6 LTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFI---EEAKVMMNLSHEKL 61
Query: 192 IKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSR 250
++L G+ T I+++ EYM + + L +F Q+ + +E+ S+
Sbjct: 62 VQLYGVCTK--QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 251 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDY 310
LHRD+ N LVN++GV+K++DFGL+ + + + PPE+L+ + +
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKF 178
Query: 311 GPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369
D+W+ G + E+ +GK + T E I A +
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-------------------AQGLR 219
Query: 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
+P ++ + + +R T L+
Sbjct: 220 LYRP---------HLASEKVYTIMYSCWHEKADERPTFKILLS 253
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 170 bits (431), Expect = 1e-48
Identities = 49/282 (17%), Positives = 95/282 (33%), Gaps = 31/282 (10%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHP 189
K+G G Y V+ VA+K ++ D E E +E +++ + HP
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL---KEAAVMKEIKHP 73
Query: 190 NIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS 249
N+++L G+ T I F + + L C + S + Q+ +E+
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD 309
+ +HRD+ N LV ++K+ADFGL+ + + PE L
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NK 192
Query: 310 YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369
+ D+W+ G + E+ ++ Q++++ +
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP-------------- 238
Query: 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411
+ P L+ P R + +
Sbjct: 239 -------------EGCPEKVYELMRACWQWNPSDRPSFAEIH 267
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 2e-48
Identities = 60/288 (20%), Positives = 115/288 (39%), Gaps = 38/288 (13%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDT---GKIVALKKVRFDNFEPESVRFMAREILILRRL 186
+ E IG+G + V + + VA+K + + +F+ +E L +R+
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL-QEALTMRQF 65
Query: 187 DHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLE 245
DHP+I+KL G+IT ++++ E ++ L A + Y QL L
Sbjct: 66 DHPHIVKLIGVITE---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 122
Query: 246 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 305
+ S+ +HRDI N+LV++ +KL DFGL+ + + + + + PE +
Sbjct: 123 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182
Query: 306 GATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364
+ + D+W G E+L+ G QG + + +I ++ +P
Sbjct: 183 F-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN---------GERLPMP- 231
Query: 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
+ P T +L+ + +P +R + A
Sbjct: 232 ------------------PNCPPTLYSLMTKCWAYDPSRRPRFTELKA 261
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 172 bits (435), Expect = 3e-48
Identities = 75/352 (21%), Positives = 138/352 (39%), Gaps = 53/352 (15%)
Query: 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI 191
+ + K+G G +S+V+ A+D+ VA+K VR D E+ EI +L+R++ +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE---DEIKLLQRVNDADN 71
Query: 192 IKLEGLITSRL-----------SCSIYLVFEYMEHDITGL---LSCPDIKFSEAQIKCYM 237
K + + + + +++V + L +K
Sbjct: 72 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131
Query: 238 NQLLHGLEHC-HSRGVLHRDIKGSNLLVNNEGV------LKLADFGLANFSNTGHRQPLT 290
QLL GL++ G++H DIK N+L+ +K+AD G A + + + +
Sbjct: 132 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 291 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT------EVEQLHK 344
+R YR PE+LLGA +G D+WS C+ EL+ G + + + + + +
Sbjct: 192 TR----EYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246
Query: 345 IFKLCGSPPDDYWKKSKLPHATL-------------FKPQQPYDSSLRETFKDLPTTAVN 391
I +L G P + K F P + + + KD +
Sbjct: 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 306
Query: 392 LIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHRE 443
+ +L ++P KRA A + + L I P +E+ +
Sbjct: 307 FLSPMLQLDPRKRADAGGLVNHPWLKD-----TLGMEEIRVPDRELYGSGSD 353
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 3e-48
Identities = 50/290 (17%), Positives = 110/290 (37%), Gaps = 40/290 (13%)
Query: 137 KIGQGTYSSVFRA--RDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
++G G + +V + + K VA+K ++ + +P + E ++++LD+P I+++
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 195 EGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLH 254
G+ + S LV E E + + I ++Q+ G+++ +H
Sbjct: 74 IGICEAE---SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 255 RDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQPLTSRVVTLWYRPPELLLGATDYGP 312
RD+ N+L+ + K++DFGL+ ++ + + T + + PE + +
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFSS 189
Query: 313 SVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 371
D+WS G + E G+ +G E + K ++ P
Sbjct: 190 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK---------GERMGCP-------- 232
Query: 372 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS---AALASEYFST 418
P +L+ + + R + L + Y+
Sbjct: 233 -----------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 169 bits (428), Expect = 5e-48
Identities = 63/294 (21%), Positives = 117/294 (39%), Gaps = 41/294 (13%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGK---IVALKKVRFDNFEPESVRFMAREILIL 183
+ + + IG G + V GK VA+K ++ E + F+ E I+
Sbjct: 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFL-SEASIM 81
Query: 184 RRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLH 242
+ DHPN+I LEG++T S + ++ E+ME+ + L D +F+ Q+ + +
Sbjct: 82 GQFDHPNVIHLEGVVTK--STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAA 139
Query: 243 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV----TLWY 298
G+++ +HRD+ N+LVN+ V K++DFGL+ F P + + + +
Sbjct: 140 GMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW 199
Query: 299 RPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDDYW 357
PE + + + D+WS G V E++ G+ T + ++ I + PP
Sbjct: 200 TAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPM-- 256
Query: 358 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 411
D P+ L+ + R +
Sbjct: 257 --------------------------DCPSALHQLMLDCWQKDRNHRPKFGQIV 284
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 4e-47
Identities = 54/290 (18%), Positives = 112/290 (38%), Gaps = 42/290 (14%)
Query: 137 KIGQGTYSSVFRA--RDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
++G G + SV + R VA+K ++ + ++ M RE I+ +LD+P I++L
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM-REAQIMHQLDNPYIVRL 74
Query: 195 EGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVL 253
G+ + ++ LV E + L + + + ++Q+ G+++ + +
Sbjct: 75 IGVCQA---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 131
Query: 254 HRDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQPLTSRVVTLWYRPPELLLGATDYG 311
HRD+ N+L+ N K++DFGL+ ++ + ++ L + PE + +
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFS 190
Query: 312 PSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP 370
D+WS G E L G+ + E + I + K+ + P
Sbjct: 191 SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ---------GKRMECP------- 234
Query: 371 QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS---AALASEYFS 417
+ P L+ + R + + Y+S
Sbjct: 235 ------------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 2e-46
Identities = 67/310 (21%), Positives = 113/310 (36%), Gaps = 62/310 (20%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKI-----VALKKVRFDNFEPESVRFMAREILILR 184
+ E + +G G + V A K VA+K ++ E M E+ ++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALM-SELKMMT 95
Query: 185 RL-DHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSE------------ 230
+L H NI+ L G T S IYL+FEY + D+ L KFSE
Sbjct: 96 QLGSHENIVNLLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 231 ----------AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 280
+ C+ Q+ G+E + +HRD+ N+LV + V+K+ DFGLA
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 281 SNTGHRQPL-TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTE 338
+ + + + + + PE L Y D+WS G + E+ +G G
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272
Query: 339 VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLS 398
+K+ + FK QP ++++ +
Sbjct: 273 DANFYKLIQ------------------NGFKMDQP---------FYATEEIYIIMQSCWA 305
Query: 399 VEPYKRATAS 408
+ KR +
Sbjct: 306 FDSRKRPSFP 315
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 164 bits (415), Expect = 4e-46
Identities = 66/310 (21%), Positives = 115/310 (37%), Gaps = 63/310 (20%)
Query: 130 DAFEKLEKIGQGTYSSVFRAR-----DLDTGKIVALKKVRFDNFEPESVRFMAREILILR 184
+ E + IG+G + VF+AR + +VA+K ++ + F RE ++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-REAALMA 71
Query: 185 RLDHPNIIKLEGLITSRLSCSIYLVFEYMEH------------------------DITGL 220
D+PNI+KL G+ + L+FEYM + +
Sbjct: 72 EFDNPNIVKLLGVCAV--GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 129
Query: 221 LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-N 279
S S A+ C Q+ G+ + R +HRD+ N LV V+K+ADFGL+ N
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 280 FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTE 338
+ + + + + + + PPE + Y D+W+ G V E+ G G
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248
Query: 339 VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLS 398
E ++ + D ++ ++ P NL+ S
Sbjct: 249 EEVIYYVR----------------------------DGNILACPENCPLELYNLMRLCWS 280
Query: 399 VEPYKRATAS 408
P R +
Sbjct: 281 KLPADRPSFC 290
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 6e-45
Identities = 50/293 (17%), Positives = 106/293 (36%), Gaps = 40/293 (13%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALK---KVRFDNFEPESVRFMAREILIL 183
L+ F+K++ +G G + +V++ + G+ V + K + P++ + + E ++
Sbjct: 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 184 RRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIK---FSEAQIKCYMNQL 240
+D+P++ +L G+ + ++ L+ + M LL + + Q+
Sbjct: 66 ASVDNPHVCRLLGICLTS---TVQLITQLMPFG--CLLDYVREHKDNIGSQYLLNWCVQI 120
Query: 241 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-TLWYR 299
G+ + R ++HRD+ N+LV +K+ DFGLA ++ + +
Sbjct: 121 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359
E +L Y D+WS G EL+ GS P D
Sbjct: 181 ALESILHRI-YTHQSDVWSYGVTVWELM--------------------TFGSKPYDGIPA 219
Query: 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
S++ + P ++ ++ R +
Sbjct: 220 SEISSILEKGERLPQP-------PICTIDVYMIMVKCWMIDADSRPKFRELII 265
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (404), Expect = 1e-44
Identities = 66/293 (22%), Positives = 102/293 (34%), Gaps = 33/293 (11%)
Query: 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKL 194
E IG+G + V+R + G+ VA+K E F EI L H NI+
Sbjct: 8 QESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGF 62
Query: 195 EGLITSRLSC--SIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-- 249
++LV +Y EH + L+ + + GL H H
Sbjct: 63 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 250 ------RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ---PLTSRVVTLWYRP 300
+ HRD+K N+LV G +AD GLA ++ RV T Y
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 301 PELLLGA-----TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 355
PE+L + + D++++G VF E+ I G E QL + P +
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI-GGIHEDYQLPYYDLVPSDPSVE 239
Query: 356 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 408
+K +P P E + + ++ R TA
Sbjct: 240 EMRKVVCEQ--KLRPNIPNRWQSCEALRVM----AKIMRECWYANGAARLTAL 286
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 2e-43
Identities = 54/308 (17%), Positives = 100/308 (32%), Gaps = 57/308 (18%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDL-----DTGKIVALKKVRFDNFEPESVRFMAREILILR 184
+ + +G G + V A D VA+K ++ E M E+ +L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM-SELKVLS 81
Query: 185 RL-DHPNIIKLEGLITSRLSCSIYLVFEYMEH------------------DITGLLSCPD 225
L +H NI+ L G T ++ EY + ++ +
Sbjct: 82 YLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 226 IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285
+ + + Q+ G+ S+ +HRD+ N+L+ + + K+ DFGLA
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 286 RQPLTSRVV-TLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLH 343
+ + + PE + Y D+WS G EL +G G + +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 344 KIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK 403
K+ K + P ++++T +P K
Sbjct: 259 KMIKEGFRMLSP---------------------------EHAPAEMYDIMKTCWDADPLK 291
Query: 404 RATASAAL 411
R T +
Sbjct: 292 RPTFKQIV 299
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 2e-42
Identities = 57/293 (19%), Positives = 111/293 (37%), Gaps = 38/293 (12%)
Query: 127 LRADAFEKLEKIGQGTYSSVFRARDLDTG----KIVALKKVRFDNFEPESVRFMAREILI 182
+ + + IG G + V++ + VA+K ++ E + V F+ E I
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL-GEAGI 62
Query: 183 LRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSC-PDIKFSEAQIKCYMNQLL 241
+ + H NII+LEG+I+ + ++ EYME+ D +FS Q+ + +
Sbjct: 63 MGQFSHHNIIRLEGVISKY--KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120
Query: 242 HGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQPLTSRVVTLWYR 299
G+++ + +HRD+ N+LVN+ V K++DFGL+ + + + + +
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 300 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359
PE + + D+WS G V E++ ++ K P
Sbjct: 181 APEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP---- 235
Query: 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
D P+ L+ E +R + ++
Sbjct: 236 -----------------------MDCPSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 3e-42
Identities = 55/285 (19%), Positives = 105/285 (36%), Gaps = 39/285 (13%)
Query: 136 EKIGQGTYSSVFRARDLD---TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNII 192
E IG+G + V+ LD A+K + E +F+ E +I++ HPN++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL-TEGIIMKDFSHPNVL 91
Query: 193 KLEGLITSRLSCSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG 251
L G I R S +V YM+H D+ + + + + Q+ G++ S+
Sbjct: 92 SLLG-ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 150
Query: 252 VLHRDIKGSNLLVNNEGVLKLADFGLANF---SNTGHRQPLTSRVVTLWYRPPELLLGAT 308
+HRD+ N +++ + +K+ADFGLA T + + + E L
Sbjct: 151 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-Q 209
Query: 309 DYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367
+ D+WS G + EL+ G P + + + ++ P
Sbjct: 210 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ---------GRRLLQP---- 256
Query: 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412
+ P ++ + R + S ++
Sbjct: 257 ---------------EYCPDPLYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 1e-41
Identities = 63/304 (20%), Positives = 118/304 (38%), Gaps = 54/304 (17%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGKI--VALKKVRFDNFEPESVRFMAREILILRRL- 186
+ + + IG+G + V +AR G A+K+++ + + F E+ +L +L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA-GELEVLCKLG 68
Query: 187 DHPNIIKLEGLITSRLSCSIYLVFEYMEH----------------DITGLLSCPDIKFSE 230
HPNII L G R +YL EY H + + S
Sbjct: 69 HHPNIINLLGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126
Query: 231 AQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT 290
Q+ + + G+++ + +HRD+ N+LV V K+ADFGL+ ++ T
Sbjct: 127 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--T 184
Query: 291 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLC 349
+ + + E L + Y + D+WS G + E++ +G G T E K+ +
Sbjct: 185 MGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-- 241
Query: 350 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 409
++ ++P + +L+ +PY+R + +
Sbjct: 242 -----------------GYRLEKP---------LNCDDEVYDLMRQCWREKPYERPSFAQ 275
Query: 410 ALAS 413
L S
Sbjct: 276 ILVS 279
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 3e-41
Identities = 51/321 (15%), Positives = 113/321 (35%), Gaps = 50/321 (15%)
Query: 110 PAWLSAVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARD-----LDTGKIVALKKVR 164
P + SA W + + ++GQG++ V+ + VA+K V
Sbjct: 1 PEYFSAADVYVPDEW-EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN 59
Query: 165 FDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH-DITGLLSC 223
E + F+ E +++ + ++++L G+++ ++ E M D+ L
Sbjct: 60 EAASMRERIEFL-NEASVMKEFNCHHVVRLLGVVSQ--GQPTLVIMELMTRGDLKSYLRS 116
Query: 224 PD---------IKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLAD 274
S +++ ++ G+ + ++ +HRD+ N +V + +K+ D
Sbjct: 117 LRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 176
Query: 275 FGLAN-FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG-KPI 332
FG+ T + + ++ + + PE L + D+WS G V E+ +
Sbjct: 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP 235
Query: 333 LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 392
QG + + L + + L + + P L
Sbjct: 236 YQGLSNEQVLRFVM----------------------------EGGLLDKPDNCPDMLFEL 267
Query: 393 IETLLSVEPYKRATASAALAS 413
+ P R + ++S
Sbjct: 268 MRMCWQYNPKMRPSFLEIISS 288
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 8e-41
Identities = 59/306 (19%), Positives = 103/306 (33%), Gaps = 54/306 (17%)
Query: 130 DAFEKLEKIGQGTYSSVFRARDLDTGK-------IVALKKVRFDNFEPESVRFMAREILI 182
D + +G+G + V A + K VA+K ++ D E + ++ ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 183 LRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEH----------------DITGLLSCPDI 226
H NII L G T +Y++ EY P+
Sbjct: 73 KMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 227 KFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR 286
+ S + Q+ G+E+ S+ +HRD+ N+LV + V+K+ADFGLA +
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 287 QPLT-SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 345
T + + + + PE L Y D+WS G + E+ VE+L K+
Sbjct: 191 YKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249
Query: 346 FKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 405
K + ++ P +R
Sbjct: 250 LKEGHRMDKP---------------------------SNCTNELYMMMRDCWHAVPSQRP 282
Query: 406 TASAAL 411
T +
Sbjct: 283 TFKQLV 288
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 5e-40
Identities = 53/305 (17%), Positives = 95/305 (31%), Gaps = 52/305 (17%)
Query: 130 DAFEKLEKIGQGTYSSVFRARD-----LDTGKIVALKKVRFDNFEPESVRFMAREILILR 184
D + + +G+G + V A T + VA+K ++ E M+ +++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 185 RLDHPNIIKLEGLITSRLSCSIYLVFEYMEHD----------------ITGLLSCPDIKF 228
H N++ L G T + ++ E+ +
Sbjct: 73 IGHHLNVVNLLGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 229 SEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288
+ + CY Q+ G+E SR +HRD+ N+L++ + V+K+ DFGLA
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191
Query: 289 LTSRVV-TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG-KPILQGRTEVEQLHKIF 346
L + PE + Y D+WS G + E+ G E+ +
Sbjct: 192 RKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 250
Query: 347 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 406
K + EP +R T
Sbjct: 251 KEGTRMRAP---------------------------DYTTPEMYQTMLDCWHGEPSQRPT 283
Query: 407 ASAAL 411
S +
Sbjct: 284 FSELV 288
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 105 bits (263), Expect = 9e-27
Identities = 29/204 (14%), Positives = 67/204 (32%), Gaps = 42/204 (20%)
Query: 136 EKIGQGTYSSVFRARDLDTGKIVALKKVRFDN----------------FEPESVRFMARE 179
+ +G+G S+VF +K + + F ++R E
Sbjct: 6 KLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 180 ILILRRLDHPNIIKLEGLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQ 239
L++L + K+ + ++ E ++ + ++
Sbjct: 65 FRALQKLQGLAVPKVYAWEGN------AVLMELIDAKELY-------RVRVENPDEVLDM 111
Query: 240 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR---VVTL 296
+L + + RG++H D+ N+LV+ EG+ + DF + + + R +
Sbjct: 112 ILEEVAKFYHRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWREILERDVRNIIT 170
Query: 297 WYRPPELLLGATDYGPSVDLWSVG 320
++ Y D+ S
Sbjct: 171 YFS--------RTYRTEKDINSAI 186
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 704 | |||
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.3 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.01 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.8 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.25 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.15 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.04 | |
| d2opoa1 | 81 | Polcalcin Che a 3 {Pigweed (Chenopodium album) [Ta | 80.59 |
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-59 Score=491.38 Aligned_cols=294 Identities=39% Similarity=0.657 Sum_probs=247.6
Q ss_pred eEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCCh---HHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 133 EKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP---ESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 133 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~---~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
+.+++||+|+||+||+|+++.+|+.||||++....... ...+.+.+|+.+|+.++|||||+++++|.+ ...+|||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~--~~~~~iv 78 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH--KSNISLV 78 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC--TTCCEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc--CCceeeh
Confidence 35789999999999999999999999999997654321 123457899999999999999999999987 5679999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCc
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~ 289 (704)
||||.++++..+......+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...... ...
T Consensus 79 mE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~-~~~ 157 (299)
T d1ua2a_ 79 FDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAY 157 (299)
T ss_dssp EECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-CCC
T ss_pred hhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCc-ccc
Confidence 9999998888887777889999999999999999999999999999999999999999999999999998765433 234
Q ss_pred ccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCC
Q 005289 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (704)
Q Consensus 290 ~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~ 369 (704)
...++|+.|+|||++.....|+.++|||||||+||||++|.+||.+.++.+++.+|.+.+|.++.+.|............
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence 45689999999999987678999999999999999999999999999999999999999999988877653322111111
Q ss_pred CCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCCCCCCCCCCC
Q 005289 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPI 430 (704)
Q Consensus 370 ~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~~~~~~~~p~ 430 (704)
.......+...+..+++++++||.+||++||++||||.|+|+||||++.|.+++...+|.
T Consensus 238 -~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~~~~p~ 297 (299)
T d1ua2a_ 238 -KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPR 297 (299)
T ss_dssp -CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSSSSCC
T ss_pred -ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCCCCCCCC
Confidence 111123456667889999999999999999999999999999999999998887766653
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-58 Score=476.81 Aligned_cols=261 Identities=27% Similarity=0.384 Sum_probs=218.3
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|++++.||+|+||+||+|+++.+|+.||||++...... +..+.+.+|+.+|++|+|||||++++++.+ ...+||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~--~~~~~i 80 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYL 80 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhCCCCCEeeEeeeecc--CceeEE
Confidence 46799999999999999999999999999999999865432 334567899999999999999999999988 578999
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC-CC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-RQ 287 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~-~~ 287 (704)
|||||+++.|..+......+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+...... ..
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 99999987776666667789999999999999999999999999999999999999999999999999998765332 22
Q ss_pred CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCccc
Q 005289 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (704)
Q Consensus 288 ~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~ 367 (704)
..+..+||+.|||||++.+...++.++|||||||+||+|++|++||...........+.......
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~--------------- 225 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--------------- 225 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT---------------
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---------------
Confidence 34567899999999999875556788999999999999999999998766544333332211110
Q ss_pred CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
...+..+++++++||.+||+.||++|||++|+|+||||++
T Consensus 226 -----------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 226 -----------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp -----------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred -----------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 1123568999999999999999999999999999999985
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-57 Score=474.03 Aligned_cols=291 Identities=39% Similarity=0.681 Sum_probs=243.2
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
+|+|+++++||+|+||+||+|++..+|+.||||++............+.+|+++|++++|||||+++++|.+ ...+||
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~--~~~~~i 78 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYL 78 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc--ccceeE
Confidence 368999999999999999999999999999999997765444446678899999999999999999999988 578999
Q ss_pred EEecccccccccc-cCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCC
Q 005289 209 VFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (704)
Q Consensus 209 V~Ey~~g~ll~~~-~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~ 287 (704)
|||||.++++..+ ......+++..++.|+.||+.||.|||++|||||||||+|||++.++.+||+|||+|+...... .
T Consensus 79 v~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-~ 157 (298)
T d1gz8a_ 79 VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-R 157 (298)
T ss_dssp EEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-B
T ss_pred EEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc-c
Confidence 9999998876655 3445679999999999999999999999999999999999999999999999999998765432 3
Q ss_pred CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCccc
Q 005289 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (704)
Q Consensus 288 ~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~ 367 (704)
.....++|+.|+|||++.....++.++|||||||+||+|++|++||.+.+..+++.++....+.+.+..|..........
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence 44566899999999998876777899999999999999999999999999999999999999999887776533211111
Q ss_pred CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCCC
Q 005289 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422 (704)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~~ 422 (704)
..........+...+..++.++++||.+||.+||++|||++|+|+||||++.+.|
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 1111112223455667899999999999999999999999999999999876543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-57 Score=473.25 Aligned_cols=255 Identities=32% Similarity=0.483 Sum_probs=223.5
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 207 (704)
.++|++++.||+|+||+||+|+++.+++.||||++.+.... ......+.+|+.+|+.++|||||++++++.+ ...+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~ 82 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD--ATRVY 82 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE--CCEEE
Confidence 56899999999999999999999999999999999754322 2234567899999999999999999999987 57899
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCC
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~ 287 (704)
||||||+++.+..+......+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|......
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--- 159 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--- 159 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC---
T ss_pred EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC---
Confidence 99999998777666555667999999999999999999999999999999999999999999999999999866543
Q ss_pred CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCccc
Q 005289 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (704)
Q Consensus 288 ~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~ 367 (704)
.....+||+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+..+.+.+|.+.-...
T Consensus 160 ~~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~--------------- 223 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF--------------- 223 (263)
T ss_dssp CCEETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC---------------
T ss_pred cccccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC---------------
Confidence 3356689999999999987 668999999999999999999999999999988888876521111
Q ss_pred CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
...+|+++++||.+||..||++|||++|+|+||||+.
T Consensus 224 --------------p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 224 --------------PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp --------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred --------------CccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 1357899999999999999999999999999999974
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-57 Score=467.93 Aligned_cols=258 Identities=28% Similarity=0.455 Sum_probs=213.2
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|++++.||+|+||+||+|+++.+|+.||||++..........+.+.+|+++|++|+|||||++++++.+.....+||
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 46899999999999999999999999999999999888777777788899999999999999999999997765678999
Q ss_pred EEecccccccccccC----CCccccHHHHHHHHHHhhhhHHHHHhcC-----cccccCCCccEEEccCCceEEecccccc
Q 005289 209 VFEYMEHDITGLLSC----PDIKFSEAQIKCYMNQLLHGLEHCHSRG-----VLHRDIKGSNLLVNNEGVLKLADFGLAN 279 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~----~~~~l~e~~~~~i~~QIl~aL~yLH~~g-----IvHrDLKp~NILl~~~g~iKL~DFGla~ 279 (704)
|||||+++.|..+.. ....+++..++.++.||+.||.|||++| ||||||||+||||+.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 999999876665432 3456999999999999999999999976 9999999999999999999999999998
Q ss_pred ccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhc
Q 005289 280 FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359 (704)
Q Consensus 280 ~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~ 359 (704)
...... ......+||+.|+|||++.+ ..|+.++|||||||+||||++|++||.+.+..+++.+|... .++
T Consensus 163 ~~~~~~-~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~--~~~------ 232 (269)
T d2java1 163 ILNHDT-SFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG--KFR------ 232 (269)
T ss_dssp HC------------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT--CCC------
T ss_pred ecccCC-CccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC--CCC------
Confidence 765432 23456789999999999876 57999999999999999999999999999998888887652 111
Q ss_pred cCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhcccc
Q 005289 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 416 (704)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf 416 (704)
.....+|+++.+||.+||..||.+|||++|+|+|||+
T Consensus 233 --------------------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 233 --------------------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp --------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred --------------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 0113578999999999999999999999999999995
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.6e-56 Score=477.69 Aligned_cols=268 Identities=25% Similarity=0.378 Sum_probs=231.8
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|++++.||+|+||+||+|+++.+|+.||||++.... ....+.+.+|+.+|++|+|||||+++++|.+ ...+||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~i 100 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFED--DNEMVM 100 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE--TTEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEE
Confidence 468999999999999999999999999999999997543 4446678899999999999999999999988 578999
Q ss_pred EEecccccccc-cccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEcc--CCceEEeccccccccCCCC
Q 005289 209 VFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN--EGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 209 V~Ey~~g~ll~-~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~--~g~iKL~DFGla~~~~~~~ 285 (704)
|||||+++.|. .+......+++..++.|+.||+.||.|||++|||||||||+||||+. ++.+||+|||+|+.....
T Consensus 101 vmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~- 179 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 179 (350)
T ss_dssp EECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-
T ss_pred EEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc-
Confidence 99999986554 44455667999999999999999999999999999999999999964 578999999999877543
Q ss_pred CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
......+||+.|||||++.+ ..|+.++|||||||+||+|++|++||.+.+..+++.+|......++.
T Consensus 180 -~~~~~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~----------- 246 (350)
T d1koaa2 180 -QSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD----------- 246 (350)
T ss_dssp -SCEEEECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCC-----------
T ss_pred -cccceecCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc-----------
Confidence 33456789999999999986 66899999999999999999999999999999999998774433322
Q ss_pred ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCCCCCCCCC
Q 005289 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSL 428 (704)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~~~~~~~~ 428 (704)
..+..+++++++||.+||.+||.+|||++|+|+||||+...++.....+
T Consensus 247 --------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~~ 295 (350)
T d1koaa2 247 --------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQI 295 (350)
T ss_dssp --------------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCSCCCCB
T ss_pred --------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCCchhhC
Confidence 2235789999999999999999999999999999999987665544333
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.4e-56 Score=464.99 Aligned_cols=286 Identities=37% Similarity=0.665 Sum_probs=240.6
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
+++|+++++||+|+||+||+|+++ +|+.||||++..........+.+.+|+.+|++++|||||+++++|.+ ...+||
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~i 77 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT--KKRLVL 77 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--SSCEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc--CCceeE
Confidence 368999999999999999999985 78999999997765444445678899999999999999999999987 578999
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
||||+.++++..+......+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||++....... ..
T Consensus 78 ~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~~ 156 (286)
T d1ob3a_ 78 VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RK 156 (286)
T ss_dssp EEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc-cc
Confidence 99999999988888878889999999999999999999999999999999999999999999999999998765432 23
Q ss_pred cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccC
Q 005289 289 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~ 368 (704)
....++|+.|+|||++.+...++.++|||||||+||||++|++||.+.++.+++.++...++.++...|...........
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence 34557899999999998777889999999999999999999999999999999999999999998877754321111111
Q ss_pred CCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 369 ~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
.............+..+++++.|||++||.+||++|||+.|+|+||||++
T Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 11111122234556788999999999999999999999999999999974
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-56 Score=470.54 Aligned_cols=256 Identities=27% Similarity=0.467 Sum_probs=223.1
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
++|+++++||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.+|+.++|||||+++++|.+ ...+|||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~iv 95 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVV 95 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEE--CCEEEEE
Confidence 4799999999999999999999999999999999865432 24568899999999999999999999988 5789999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCc
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~ 289 (704)
||||+++.+..+... ..+++.+++.|+.||+.||.|||++|||||||||+||||+.++++||+|||+|+...... ...
T Consensus 96 mEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~ 173 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKR 173 (293)
T ss_dssp EECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CCB
T ss_pred EEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc-ccc
Confidence 999999777665433 469999999999999999999999999999999999999999999999999998765433 334
Q ss_pred ccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccCC
Q 005289 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 369 (704)
Q Consensus 290 ~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~ 369 (704)
...+||+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+..+.+..+.... .++.
T Consensus 174 ~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~-~~~~--------------- 236 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPEL--------------- 236 (293)
T ss_dssp CCCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-SCCC---------------
T ss_pred cccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-CCCC---------------
Confidence 56789999999999986 678999999999999999999999999999888887776532 1110
Q ss_pred CCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 370 PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 370 ~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
..+..+++++++||.+||..||.+|||+.|+|+||||+.
T Consensus 237 ----------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 237 ----------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp ----------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred ----------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 112468999999999999999999999999999999974
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-57 Score=472.45 Aligned_cols=262 Identities=27% Similarity=0.428 Sum_probs=223.1
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 207 (704)
.++|++++.||+|+||+||+|+++.+++.||||++.+... .....+.+.+|+++|++|+|||||+++++|.+ ...+|
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~ 84 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD--DEKLY 84 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC--SSEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE--CCEEE
Confidence 4679999999999999999999999999999999975432 12335668899999999999999999999987 57899
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC-C
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-R 286 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~-~ 286 (704)
||||||+++.+..+......+++..++.++.||+.||.|||++|||||||||+||||++++.+||+|||+|+...... .
T Consensus 85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 999999987766665566689999999999999999999999999999999999999999999999999998765332 2
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcc
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~ 366 (704)
......+||+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+..+++.+|...-..+
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~-------------- 229 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF-------------- 229 (288)
T ss_dssp -----CCCCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCC--------------
T ss_pred cccccccCCccccCceeecc-CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCC--------------
Confidence 33456789999999999986 578999999999999999999999999999999888886521111
Q ss_pred cCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHH------HHhccccCCCCCC
Q 005289 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA------ALASEYFSTKPYA 422 (704)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e------~L~hpwf~~~~~~ 422 (704)
...+++++++||.+||++||.+|||++| +++||||+...|.
T Consensus 230 ---------------p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~ 276 (288)
T d1uu3a_ 230 ---------------PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE 276 (288)
T ss_dssp ---------------CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred ---------------CccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHH
Confidence 1357899999999999999999999987 5889999876654
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-56 Score=476.52 Aligned_cols=262 Identities=26% Similarity=0.410 Sum_probs=229.4
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCe
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (704)
+.+++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+|+.++|||||+++++|++ ...
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~ 79 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDR 79 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC--SSE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc--ccc
Confidence 346789999999999999999999999999999999986432 12335667899999999999999999999988 578
Q ss_pred EEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
+|||||||+++.+..+......++|..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+......
T Consensus 80 ~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 80 LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred cccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 99999999998877777667789999999999999999999999999999999999999999999999999998665332
Q ss_pred CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
......+||+.|+|||++.+ ..|+.++|||||||+||||++|++||.+.+..+++.++....-.+
T Consensus 160 -~~~~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~------------- 224 (337)
T d1o6la_ 160 -ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF------------- 224 (337)
T ss_dssp -CCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-------------
T ss_pred -cccccceeCHHHhhhhhccC-CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCC-------------
Confidence 34556789999999999887 679999999999999999999999999999988888876522111
Q ss_pred ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCc-----CHHHHHhccccCCCCC
Q 005289 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 421 (704)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRp-----Ta~e~L~hpwf~~~~~ 421 (704)
+..+++++++||.+||++||.+|+ +++++|+||||+...|
T Consensus 225 ----------------p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~ 269 (337)
T d1o6la_ 225 ----------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp ----------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred ----------------CccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCH
Confidence 136899999999999999999999 5999999999987544
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-56 Score=466.63 Aligned_cols=262 Identities=25% Similarity=0.380 Sum_probs=227.2
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCCh----HHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCe
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP----ESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (704)
++|++++.||+|+||+||+|+++.+|+.||||++.+..... ...+.+.+|+.+|++|+|||||+++++|.+ ...
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~ 87 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN--KTD 87 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCE
Confidence 57999999999999999999999999999999998654422 235678899999999999999999999988 578
Q ss_pred EEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCC----ceEEecccccccc
Q 005289 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG----VLKLADFGLANFS 281 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g----~iKL~DFGla~~~ 281 (704)
+|||||||+++.+..++.....+++..++.++.||+.||.|||++|||||||||+||||+.++ .+||+|||+|...
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 999999999877766655556899999999999999999999999999999999999998876 4999999999877
Q ss_pred CCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccC
Q 005289 282 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (704)
Q Consensus 282 ~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~ 361 (704)
.... .....++|+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+..+.+.+|......++
T Consensus 168 ~~~~--~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~-------- 236 (293)
T d1jksa_ 168 DFGN--EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE-------- 236 (293)
T ss_dssp TTSC--BCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC--------
T ss_pred CCCc--cccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC--------
Confidence 5442 3456688999999999976 5789999999999999999999999999999999988876433322
Q ss_pred CCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCC
Q 005289 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (704)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~ 421 (704)
...+..+|.++++||.+||..||.+|||++|+|+||||+...+
T Consensus 237 -----------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 279 (293)
T d1jksa_ 237 -----------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 279 (293)
T ss_dssp -----------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC---
T ss_pred -----------------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCh
Confidence 2234578999999999999999999999999999999986544
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-56 Score=471.42 Aligned_cols=258 Identities=27% Similarity=0.440 Sum_probs=207.2
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
+.|++++.||+|+||+||+|+++.+++.||||++....... ....+.+|+.+|+.|+|||||+++++|.+ ...+|||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv 85 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYES--GGHLYLI 85 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEE
Confidence 56999999999999999999999999999999998765432 23557789999999999999999999987 5789999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEc---cCCceEEeccccccccCCCCC
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN---NEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~---~~g~iKL~DFGla~~~~~~~~ 286 (704)
||||+++.|..++.....+++.+++.|+.||+.||.|||++|||||||||+|||+. +++.+||+|||+|+.....
T Consensus 86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~-- 163 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-- 163 (307)
T ss_dssp ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC--
Confidence 99999866665555566899999999999999999999999999999999999995 5789999999999876543
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcc
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~ 366 (704)
....+.+||+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+..++..+|......++.
T Consensus 164 ~~~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~------------ 230 (307)
T d1a06a_ 164 SVLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS------------ 230 (307)
T ss_dssp ---------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCT------------
T ss_pred CeeeeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCC------------
Confidence 23456789999999999886 57999999999999999999999999999998888888663222211
Q ss_pred cCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
..++.+|+++++||.+||.+||++|||+.|+|+||||+.
T Consensus 231 -------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 231 -------------PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp -------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred -------------ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 123578999999999999999999999999999999985
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-55 Score=457.83 Aligned_cols=254 Identities=22% Similarity=0.323 Sum_probs=216.8
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeec--CCCeEEEE
Q 005289 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR--LSCSIYLV 209 (704)
Q Consensus 132 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~--~~~~~~LV 209 (704)
|++.++||+|+||+||+|++..+++.||||++..........+.+.+|+++|++|+|||||+++++|.+. ....+|||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 4777899999999999999999999999999987766667777889999999999999999999998753 34578999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcC--cccccCCCccEEEc-cCCceEEeccccccccCCCCC
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRG--VLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~g--IvHrDLKp~NILl~-~~g~iKL~DFGla~~~~~~~~ 286 (704)
||||+++.+..+......+++..++.|+.||+.||+|||+++ ||||||||+||||+ +++.+||+|||+|+....
T Consensus 91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~--- 167 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--- 167 (270)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT---
T ss_pred EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC---
Confidence 999999877766666668999999999999999999999998 99999999999997 478999999999986543
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCCchhhhccCCCCc
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ-LHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~-l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
....+.+||+.|+|||++.+ .|+.++|||||||+||||++|++||.+...... +.++.. +..+..
T Consensus 168 ~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~--~~~~~~---------- 233 (270)
T d1t4ha_ 168 SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS--GVKPAS---------- 233 (270)
T ss_dssp TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT--TCCCGG----------
T ss_pred CccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc--CCCCcc----------
Confidence 23456789999999999875 599999999999999999999999987655444 344422 222211
Q ss_pred ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccC
Q 005289 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417 (704)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~ 417 (704)
....+++++.+||.+||.+||++|||++|+|+||||+
T Consensus 234 ---------------~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 234 ---------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp ---------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred ---------------cCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 1246788999999999999999999999999999996
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-55 Score=468.71 Aligned_cols=254 Identities=29% Similarity=0.483 Sum_probs=223.5
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
.|+++++||+|+||+||+|++..+++.||||++...... ....+.+.+|+.+|++|+|||||+++++|.+ ...+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~iv 93 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAWLV 93 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE--CCEEEEE
Confidence 599999999999999999999999999999999876554 4455678899999999999999999999987 5789999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCc
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~ 289 (704)
||||.++++..+......+++.+++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|..... .
T Consensus 94 ~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-----~ 168 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----A 168 (309)
T ss_dssp EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----B
T ss_pred EEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC-----C
Confidence 99999988876665667899999999999999999999999999999999999999999999999999986543 2
Q ss_pred ccccccccccCcccccC--CCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCccc
Q 005289 290 TSRVVTLWYRPPELLLG--ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (704)
Q Consensus 290 ~~~~gT~~Y~APEvl~~--~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~ 367 (704)
...+||+.|+|||++.+ ...|+.++|||||||+||||++|.+||.+.+..+.+.++... ..+.
T Consensus 169 ~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~--~~~~------------- 233 (309)
T d1u5ra_ 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--ESPA------------- 233 (309)
T ss_dssp CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--CCCC-------------
T ss_pred CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC--CCCC-------------
Confidence 45689999999999864 246899999999999999999999999999988888877652 1110
Q ss_pred CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
.....+|+++++||.+||..||.+|||++|+|+||||+.
T Consensus 234 ------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 234 ------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp ------------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred ------------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 001357899999999999999999999999999999975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-56 Score=478.19 Aligned_cols=285 Identities=24% Similarity=0.339 Sum_probs=216.5
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
+..++|+++++||+|+||+||+|++..+|+.||||+++... .......+.+|+.+|+.|+|||||+++++|.+ ...+
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~ 79 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEI 79 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC--SSEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEE
Confidence 45678999999999999999999999999999999998654 33445678899999999999999999999987 5789
Q ss_pred EEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHh-cCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~-~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
|||||||+++.+..+......+++..++.++.||+.||.|||+ +|||||||||+||||+.++++||+|||+|+.....
T Consensus 80 ~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 158 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 158 (322)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence 9999999997777666556679999999999999999999997 59999999999999999999999999999866432
Q ss_pred CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCCchhhhccCC--
Q 005289 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE-QLHKIFKLCGSPPDDYWKKSKL-- 362 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e-~l~~I~~~~g~~p~~~w~~~~~-- 362 (704)
..++.+||++|+|||++.+ ..|+.++|||||||+||||++|++||.+.+..+ ++..+....+.+....+.....
T Consensus 159 --~~~~~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 159 --MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp --TC---CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred --ccccccCCccccCchHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 2356789999999999987 679999999999999999999999998765432 2222223333222111000000
Q ss_pred CCcccCCCCCCCC---chhhh---------hccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 363 PHATLFKPQQPYD---SSLRE---------TFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 363 ~~~~~~~~~~~~~---~~l~~---------~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
..........+.. ..+.. ....++.+++|||.+||.+||.+||||+|+|+||||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 0000000000000 00000 01236789999999999999999999999999999975
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-55 Score=466.23 Aligned_cols=296 Identities=42% Similarity=0.699 Sum_probs=240.9
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC------
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL------ 202 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~------ 202 (704)
.++|+++++||+|+||+||+|++..+|+.||||++............+.+|+++|++|+||||+++++++....
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 46899999999999999999999999999999999776655555667789999999999999999999885521
Q ss_pred CCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccC
Q 005289 203 SCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (704)
Q Consensus 203 ~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~ 282 (704)
...+|||||||.++++.........+++..++.+++||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~ 168 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 168 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence 34689999999999888877777889999999999999999999999999999999999999999999999999997665
Q ss_pred CCC---CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhc
Q 005289 283 TGH---RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359 (704)
Q Consensus 283 ~~~---~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~ 359 (704)
... .....+.++|++|+|||++.+...|+.++|||||||++|||++|++||.+.++.+.+..|...++.++.+.|..
T Consensus 169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 248 (318)
T d3blha1 169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248 (318)
T ss_dssp C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccc
Confidence 322 12334467899999999998777899999999999999999999999999999999999999999998877655
Q ss_pred cCCCCc-ccCCCCCCCCchhhhhc--cCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCCCCC
Q 005289 360 SKLPHA-TLFKPQQPYDSSLRETF--KDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACD 424 (704)
Q Consensus 360 ~~~~~~-~~~~~~~~~~~~l~~~~--~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~~~~ 424 (704)
...... ............+...+ ...+++++|||.+||.+||++||||.|+|+||||++.|.|++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p~~ 316 (318)
T d3blha1 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSD 316 (318)
T ss_dssp CCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCCCC
T ss_pred cchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCCCC
Confidence 332111 11111111111222222 235788999999999999999999999999999998776543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.8e-55 Score=475.13 Aligned_cols=259 Identities=27% Similarity=0.455 Sum_probs=227.6
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.+.|++++.||+|+||+||+|++..+|+.||||++.... ......+.+|+.+|++|+|||||+++++|.+ ...+||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~i 103 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFED--KYEMVL 103 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC--SSEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEE
Confidence 467999999999999999999999999999999997653 3445667899999999999999999999987 578999
Q ss_pred EEecccccccc-cccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEc--cCCceEEeccccccccCCCC
Q 005289 209 VFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVN--NEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 209 V~Ey~~g~ll~-~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~--~~g~iKL~DFGla~~~~~~~ 285 (704)
|||||+++.|. .+......|++.+++.|+.||+.||.|||++|||||||||+||||+ .++.+||+|||+|......
T Consensus 104 vmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~- 182 (352)
T d1koba_ 104 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 182 (352)
T ss_dssp EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred EEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC-
Confidence 99999986654 4555566799999999999999999999999999999999999998 5689999999999887654
Q ss_pred CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
......++|+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+..+++.+|......++..
T Consensus 183 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~---------- 250 (352)
T d1koba_ 183 -EIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDED---------- 250 (352)
T ss_dssp -SCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSS----------
T ss_pred -CceeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc----------
Confidence 33456788999999999876 679999999999999999999999999999999999987754333322
Q ss_pred ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
.+..+++++++||.+||++||.+|||+.|+|+||||+..
T Consensus 251 ---------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 251 ---------------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp ---------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred ---------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 235789999999999999999999999999999999863
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-56 Score=467.73 Aligned_cols=258 Identities=25% Similarity=0.388 Sum_probs=221.3
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
+.|+++++||+|+||+||+|+++.+++.||||++.... ....+.+.+|+++|++|+|||||++++++.+ ...+|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~lv 87 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWIL 87 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCeEEEE
Confidence 46999999999999999999999999999999997653 3345678899999999999999999999988 5789999
Q ss_pred Eecccccccccc-cCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCC
Q 005289 210 FEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP 288 (704)
Q Consensus 210 ~Ey~~g~ll~~~-~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~ 288 (704)
||||+++.+..+ ......+++.+++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+...... ..
T Consensus 88 mEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~ 166 (288)
T d2jfla1 88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 166 (288)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HH
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc-cc
Confidence 999998777655 3345579999999999999999999999999999999999999999999999999997553221 12
Q ss_pred cccccccccccCcccccC----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC
Q 005289 289 LTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 289 ~~~~~gT~~Y~APEvl~~----~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
..+.+||+.|+|||++.. ...|+.++|||||||+||+|++|++||.+.+..+++.++... .++.
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~--~~~~---------- 234 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS--EPPT---------- 234 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS--CCCC----------
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC--CCCC----------
Confidence 345689999999999842 356899999999999999999999999999988888887652 1110
Q ss_pred cccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 365 ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 365 ~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
......+++++++||.+||+.||.+|||+.|+|+||||+.
T Consensus 235 --------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 235 --------------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp --------------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred --------------CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 0112468899999999999999999999999999999984
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-55 Score=460.18 Aligned_cols=286 Identities=40% Similarity=0.679 Sum_probs=237.1
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCC-CcEEEEEEeecCCCChHHHHHHHHHHHHHHhc---CCCCceeEeEEEeec---
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDT-GKIVALKKVRFDNFEPESVRFMAREILILRRL---DHPNIIKLEGLITSR--- 201 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~-g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIv~l~~~~~~~--- 201 (704)
.++|+++++||+|+||+||+|++..+ ++.||||++............+.+|+.+|+.| +|||||+++++|...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 35899999999999999999999765 67899999976544333333456788887776 799999999998642
Q ss_pred CCCeEEEEEecccccccccc-cCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccc
Q 005289 202 LSCSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 280 (704)
Q Consensus 202 ~~~~~~LV~Ey~~g~ll~~~-~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~ 280 (704)
....+|||||||.++++... ......+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||++..
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 24578999999998766533 34556799999999999999999999999999999999999999999999999999976
Q ss_pred cCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhcc
Q 005289 281 SNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (704)
Q Consensus 281 ~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~ 360 (704)
.... ......+||+.|+|||++.+ ..|+.++|||||||+||||++|++||.+.+..+++.+|...++.++...|...
T Consensus 166 ~~~~--~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 242 (305)
T d1blxa_ 166 YSFQ--MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242 (305)
T ss_dssp CCGG--GGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred hccc--ccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccc
Confidence 5433 34456789999999999876 67999999999999999999999999999999999999999999988877654
Q ss_pred CCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
.......+.... ...+...+..+++.+++||.+||.+||++||||.|+|+||||++.
T Consensus 243 ~~~~~~~~~~~~--~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 243 VALPRQAFHSKS--AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp CSSCGGGSCCCC--CCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccchhhhhcccc--ccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 332222222111 122344567899999999999999999999999999999999864
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-55 Score=469.29 Aligned_cols=290 Identities=33% Similarity=0.576 Sum_probs=237.0
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC----CC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL----SC 204 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----~~ 204 (704)
.++|+++++||+|+||+||+|+++.+|+.||||++..........+.+.+|+++|+.|+|||||+++++|.... ..
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 35899999999999999999999999999999999876666667778899999999999999999999997642 23
Q ss_pred eEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
.+|||||||+..+..... ...|++..++.|+.||+.||.|||++|||||||||+|||++.++.+||+|||+|+....
T Consensus 97 ~~~lv~e~~~~~l~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~- 173 (346)
T d1cm8a_ 97 DFYLVMPFMGTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS- 173 (346)
T ss_dssp CCEEEEECCSEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS-
T ss_pred eEEEEEecccccHHHHHH--hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC-
Confidence 679999999665444432 34699999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
..+..++|+.|+|||++.+...++.++|||||||+||+|++|++||.+.+..+++..+....+.++.++|.......
T Consensus 174 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (346)
T d1cm8a_ 174 ---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250 (346)
T ss_dssp ---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred ---ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchh
Confidence 34567899999999999876778999999999999999999999999999999999999999999988876544321
Q ss_pred cccCC--CCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCCCCC
Q 005289 365 ATLFK--PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACD 424 (704)
Q Consensus 365 ~~~~~--~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~~~~ 424 (704)
..... ........+...+..+++++++||.+||.+||.+|||+.|+|+||||+....+.+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~ 312 (346)
T d1cm8a_ 251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED 312 (346)
T ss_dssp HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC----
T ss_pred hhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccc
Confidence 10000 0011122344556788999999999999999999999999999999997554433
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.2e-55 Score=466.52 Aligned_cols=257 Identities=23% Similarity=0.373 Sum_probs=226.6
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~ 207 (704)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.... ....+.+.+|+.+|+.++|||||++++++.+ ...+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~ 80 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD--AQQIF 80 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--SSEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee--CCeee
Confidence 45799999999999999999999999999999999754321 2335668899999999999999999999987 57899
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCC
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~ 287 (704)
||||||.++.+..+......+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.....
T Consensus 81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--- 157 (316)
T d1fota_ 81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 157 (316)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc---
Confidence 99999999887777777778999999999999999999999999999999999999999999999999999876532
Q ss_pred CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCccc
Q 005289 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (704)
Q Consensus 288 ~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~ 367 (704)
..+.+||+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+..+.+.+|.......
T Consensus 158 -~~~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~--------------- 220 (316)
T d1fota_ 158 -TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF--------------- 220 (316)
T ss_dssp -BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCC---------------
T ss_pred -cccccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC---------------
Confidence 345789999999999876 579999999999999999999999999999999988887621111
Q ss_pred CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCc-----CHHHHHhccccCCCCC
Q 005289 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 421 (704)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRp-----Ta~e~L~hpwf~~~~~ 421 (704)
...+++++++||.+||..||.+|+ |++++|+||||+...|
T Consensus 221 --------------p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~ 265 (316)
T d1fota_ 221 --------------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 265 (316)
T ss_dssp --------------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred --------------CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCH
Confidence 135789999999999999999996 9999999999987544
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-54 Score=466.04 Aligned_cols=281 Identities=36% Similarity=0.567 Sum_probs=235.1
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeec----CCCeE
Q 005289 131 AFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR----LSCSI 206 (704)
Q Consensus 131 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~----~~~~~ 206 (704)
+|+.+++||+|+||+||+|++..+|+.||||++..+... +.+|+.+|++|+|||||+++++|... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 599999999999999999999999999999999765421 24799999999999999999998542 34568
Q ss_pred EEEEeccccccccccc---CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCC-ceEEeccccccccC
Q 005289 207 YLVFEYMEHDITGLLS---CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSN 282 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~---~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g-~iKL~DFGla~~~~ 282 (704)
|||||||+++++..+. .....+++.+++.|+.||+.||+|||++|||||||||+||||+.++ .+||+|||+++...
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 9999999987655442 3556799999999999999999999999999999999999999775 89999999998765
Q ss_pred CCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCC
Q 005289 283 TGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (704)
Q Consensus 283 ~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~ 362 (704)
.. ....+.++|+.|+|||++.+...|+.++|||||||++|||++|++||.+.+..+++.+|++.+|.++.+.|.....
T Consensus 175 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 252 (350)
T d1q5ka_ 175 RG--EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252 (350)
T ss_dssp TT--SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC
T ss_pred CC--cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhcc
Confidence 43 2345678999999999988777899999999999999999999999999999999999999999999888876443
Q ss_pred CCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
.......+..............+++++.+||.+||.+||++||||.|+|+||||++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 222221121111122233346789999999999999999999999999999999853
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.9e-55 Score=470.76 Aligned_cols=259 Identities=23% Similarity=0.379 Sum_probs=227.1
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCe
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCS 205 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (704)
...++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+|+.++|||||+++++|.+ ...
T Consensus 38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~ 115 (350)
T d1rdqe_ 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSN 115 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSE
T ss_pred CCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc--ccc
Confidence 446899999999999999999999999999999999975432 12335667899999999999999999999987 578
Q ss_pred EEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
+|+||||+.++.+..+......+++..++.|+.||+.||.|||++|||||||||+||||+.++++||+|||+|+.....
T Consensus 116 ~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred cccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 9999999999777666655668999999999999999999999999999999999999999999999999999877532
Q ss_pred CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
....+||+.|||||++.+ ..|+.++|||||||+||+|++|++||.+.+...++.+|......+
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~------------- 257 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF------------- 257 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-------------
T ss_pred ---cccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCC-------------
Confidence 345689999999999986 678999999999999999999999999999999888886632111
Q ss_pred ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCc-----CHHHHHhccccCCCCC
Q 005289 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKPY 421 (704)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRp-----Ta~e~L~hpwf~~~~~ 421 (704)
...+++++.+||++||.+||.+|+ |++++|+||||+...|
T Consensus 258 ----------------p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~ 302 (350)
T d1rdqe_ 258 ----------------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp ----------------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred ----------------CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCH
Confidence 136889999999999999999995 9999999999987554
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-54 Score=448.11 Aligned_cols=286 Identities=40% Similarity=0.691 Sum_probs=245.0
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
++|+++++||+|+||+||+|++..+++.||||+++...........+.+|+.+|+.++|||||+++++|.+ ...++||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~~~~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc--ccceeEE
Confidence 68999999999999999999999999999999998776666667888999999999999999999999988 5789999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCCCc
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL 289 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~~~ 289 (704)
|+++.++.+..+......+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||.++...... ...
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~-~~~ 158 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCY 158 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC-SCC
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC-ccc
Confidence 9999998888777777889999999999999999999999999999999999999999999999999998765433 233
Q ss_pred ccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcccC
Q 005289 290 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI-LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 368 (704)
Q Consensus 290 ~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~p-F~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~ 368 (704)
....+++.|+|||++.....++.++|||||||++|||++|+.| |.+.+..+++.++....+.+....|...........
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccc
Confidence 4456789999999988766789999999999999999998866 677888899999999999988777755322111111
Q ss_pred CCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 369 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 369 ~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
.+.......+...+..+++.+.+||++||++||.+||||+|+|+||||++
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 12222233344556788999999999999999999999999999999985
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-54 Score=460.44 Aligned_cols=258 Identities=24% Similarity=0.366 Sum_probs=224.9
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|++++.||+|+||+||+|+++.+++.||||++.... .....+.+|+.+|+.++|||||+++++|.+ ...+||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~l 78 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFES--MEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE--TTEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEE
Confidence 368999999999999999999999999999999997653 334557799999999999999999999988 578999
Q ss_pred EEeccccccccc-ccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccC--CceEEeccccccccCCCC
Q 005289 209 VFEYMEHDITGL-LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE--GVLKLADFGLANFSNTGH 285 (704)
Q Consensus 209 V~Ey~~g~ll~~-~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~--g~iKL~DFGla~~~~~~~ 285 (704)
|||||+++.+.. +......+++.+++.|+.||+.||.|||++||+||||||+||||+.+ ..+||+|||+++.....
T Consensus 79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~- 157 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC-
Confidence 999999855554 44445579999999999999999999999999999999999999854 47999999999876543
Q ss_pred CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
......++|+.|+|||++.+ ..|+.++||||||||||+|++|.+||.+.+..+.+.+|......++.
T Consensus 158 -~~~~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~----------- 224 (321)
T d1tkia_ 158 -DNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE----------- 224 (321)
T ss_dssp -CEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCH-----------
T ss_pred -CcccccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCh-----------
Confidence 23455678999999998876 56899999999999999999999999999999999999875444433
Q ss_pred ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
..++.+++++++||.+||.+||.+|||++|+|+||||++.
T Consensus 225 --------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 225 --------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp --------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred --------------hhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 3346789999999999999999999999999999999864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.8e-54 Score=449.08 Aligned_cols=260 Identities=30% Similarity=0.424 Sum_probs=225.0
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC-------hHHHHHHHHHHHHHHhcC-CCCceeEeEEEeec
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE-------PESVRFMAREILILRRLD-HPNIIKLEGLITSR 201 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-------~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~ 201 (704)
++|++++.||+|+||+||+|++..+++.||||++.+.... ....+.+.+|+.+|++|+ |||||++++++.+
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~- 81 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET- 81 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc-
Confidence 5899999999999999999999999999999999876532 122345778999999996 9999999999987
Q ss_pred CCCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEecccccccc
Q 005289 202 LSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (704)
Q Consensus 202 ~~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~ 281 (704)
...+|||||||+++.|..++.....+++.+++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+++..
T Consensus 82 -~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 82 -NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp -SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred -CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence 6789999999998666655555668999999999999999999999999999999999999999999999999999877
Q ss_pred CCCCCCCcccccccccccCcccccC-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchh
Q 005289 282 NTGHRQPLTSRVVTLWYRPPELLLG-----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 356 (704)
Q Consensus 282 ~~~~~~~~~~~~gT~~Y~APEvl~~-----~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~ 356 (704)
.... ..+..+||+.|+|||++.+ ...|+.++|||||||+||+|++|++||.+.+..+.+..|....-.++
T Consensus 161 ~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~--- 235 (277)
T d1phka_ 161 DPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG--- 235 (277)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC---
T ss_pred cCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCC---
Confidence 6543 3455789999999999852 34578999999999999999999999999999988888876322111
Q ss_pred hhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCC
Q 005289 357 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 418 (704)
Q Consensus 357 w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~ 418 (704)
...+..+|+++++||.+||+.||.+|||++|+|+||||++
T Consensus 236 ----------------------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 236 ----------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp ----------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred ----------------------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 1123578999999999999999999999999999999985
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.5e-54 Score=467.10 Aligned_cols=263 Identities=24% Similarity=0.335 Sum_probs=217.3
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC----hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE----PESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 203 (704)
..++|++++.||+|+||+||+|++..+|+.||||++.+.... .........|+.+|+.++|||||+++++|.+ .
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~--~ 79 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--P 79 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC--S
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE--C
Confidence 467899999999999999999999999999999999754321 1112222345777888899999999999987 5
Q ss_pred CeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCC
Q 005289 204 CSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~ 283 (704)
..+|||||||+++.|..++.....+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+....
T Consensus 80 ~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 80 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred CEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 78999999999877776666667899999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCC
Q 005289 284 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 284 ~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
. .....+||+.|+|||++.....|+.++|||||||+||+|++|++||.+.+..+....+.. ....+.
T Consensus 160 ~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~-~~~~~~--------- 226 (364)
T d1omwa3 160 K---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TLTMAV--------- 226 (364)
T ss_dssp S---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH-SSSCCC---------
T ss_pred C---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-cccCCC---------
Confidence 3 234568999999999997667799999999999999999999999987654333322221 111110
Q ss_pred CcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcC-----HHHHHhccccCCCCC
Q 005289 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-----ASAALASEYFSTKPY 421 (704)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpT-----a~e~L~hpwf~~~~~ 421 (704)
..+..+++++++||.+||.+||.+||| |+++|+||||+...|
T Consensus 227 ----------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~ 273 (364)
T d1omwa3 227 ----------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 273 (364)
T ss_dssp ----------------CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred ----------------CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence 112468999999999999999999999 899999999997554
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-54 Score=464.58 Aligned_cols=287 Identities=30% Similarity=0.515 Sum_probs=229.3
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeec----CCCe
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR----LSCS 205 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~----~~~~ 205 (704)
++|+++++||+|+||+||+|+++.+|+.||||++............+.+|+.+|++++|||||+++++|... ...+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 579999999999999999999999999999999988776777777889999999999999999999999653 2478
Q ss_pred EEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
+|||||||.++++..+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 97 ~~iv~Ey~~~~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~- 172 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS- 172 (355)
T ss_dssp EEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred eEEEEeccchHHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc-
Confidence 99999999998887663 36899999999999999999999999999999999999999999999999998866543
Q ss_pred CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 286 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 286 ~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
...+..++|+.|+|||++.+ ..|++++||||+||++|+|++|++||.+.+...++.++...++.++.++|........
T Consensus 173 -~~~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 250 (355)
T d2b1pa1 173 -FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_dssp ---------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred -cccccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence 33456678999999999987 6799999999999999999999999999999999999999999998888865321100
Q ss_pred ccCCC-----CCCCC--------chhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCCC
Q 005289 366 TLFKP-----QQPYD--------SSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422 (704)
Q Consensus 366 ~~~~~-----~~~~~--------~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~~ 422 (704)
..... ..... .........+++++++||++||.+||++||||+|||+||||+...++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~ 320 (355)
T d2b1pa1 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP 320 (355)
T ss_dssp HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCH
T ss_pred HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCc
Confidence 00000 00000 00011122357789999999999999999999999999999975543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=455.54 Aligned_cols=259 Identities=27% Similarity=0.428 Sum_probs=223.3
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHH-hcCCCCceeEeEEEeecCCCeEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILR-RLDHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~-~L~HpnIv~l~~~~~~~~~~~~~ 207 (704)
++|++++.||+|+||+||+|+++.+++.||||++++... .....+.+.+|+.+|. .++|||||++++++.+ ...+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~--~~~~y 79 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KENLF 79 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc--CCcee
Confidence 689999999999999999999999999999999976432 1223455667777665 6899999999999988 57899
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCC
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~ 287 (704)
||||||+++.+..+......+++.+++.|+.||+.||.|||++|||||||||+|||++.++.+||+|||+++...... .
T Consensus 80 ivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~-~ 158 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-A 158 (320)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-C
T ss_pred EEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccc-c
Confidence 999999998777776667789999999999999999999999999999999999999999999999999998665432 3
Q ss_pred CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCccc
Q 005289 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 367 (704)
Q Consensus 288 ~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~ 367 (704)
..+..+||+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+..+++.+|.. +.+.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~--~~~~-------------- 221 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--DNPF-------------- 221 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCC--------------
T ss_pred cccccCCCCCcCCHHHHcC-CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCC--------------
Confidence 3455789999999999986 6799999999999999999999999999999998888865 2221
Q ss_pred CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHH-HHHhccccCCCCC
Q 005289 368 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS-AALASEYFSTKPY 421 (704)
Q Consensus 368 ~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~-e~L~hpwf~~~~~ 421 (704)
....+|+++++||.+||.+||.+|||+. ++++||||+...|
T Consensus 222 -------------~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~ 263 (320)
T d1xjda_ 222 -------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 263 (320)
T ss_dssp -------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred -------------CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCH
Confidence 0135799999999999999999999995 8999999986543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=450.87 Aligned_cols=287 Identities=33% Similarity=0.525 Sum_probs=233.1
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeec----CCC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR----LSC 204 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~----~~~ 204 (704)
.++|+++++||+|+||+||+|++..+|+.||||++.+........+.+.+|+.+|+.|+|||||+++++|... ...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 3689999999999999999999999999999999987766666677888999999999999999999998642 123
Q ss_pred eEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 205 SIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
.+||+++ +.++.|..+.. ...+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 97 ~~~i~~~-~~gg~L~~~~~-~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~- 173 (348)
T d2gfsa1 97 DVYLVTH-LMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD- 173 (348)
T ss_dssp CCEEEEE-CCSEEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG-
T ss_pred eEEEEEe-ecCCchhhhcc-cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc-
Confidence 4555555 45544444443 34699999999999999999999999999999999999999999999999999976542
Q ss_pred CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
...+..+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......|....+.++.+.+.......
T Consensus 174 ---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 250 (348)
T d2gfsa1 174 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250 (348)
T ss_dssp ---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred ---ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchh
Confidence 34556889999999998876778999999999999999999999999999999999999999998876654432211
Q ss_pred ccc--CCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCC
Q 005289 365 ATL--FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (704)
Q Consensus 365 ~~~--~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~ 421 (704)
... ..........+...+..++++++|||.+||.+||.+||||.|+|+||||++...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309 (348)
T ss_dssp HHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence 100 001111223345567789999999999999999999999999999999997544
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.4e-52 Score=443.55 Aligned_cols=283 Identities=30% Similarity=0.520 Sum_probs=228.4
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCCCeEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLSCSIY 207 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~~~ 207 (704)
.++|+++++||+|+||+||+|+++.+|+.||||++.... .+.+.+|+.+|+.| .||||++++++|.......+|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 468999999999999999999999999999999997532 45678899999999 499999999999876667899
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCC-ceEEeccccccccCCCCC
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHR 286 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g-~iKL~DFGla~~~~~~~~ 286 (704)
+|||||.++.+..+. ..|++..++.++.||+.||.|||++|||||||||+||||+.++ .+||+|||+|.......
T Consensus 109 ~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~- 184 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ- 184 (328)
T ss_dssp EEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC-
T ss_pred EEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC-
Confidence 999999997766553 3699999999999999999999999999999999999998665 69999999998766442
Q ss_pred CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHHcCCCCchhh-hccCCCC
Q 005289 287 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG-RTEVEQLHKIFKLCGSPPDDYW-KKSKLPH 364 (704)
Q Consensus 287 ~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~-~~~~e~l~~I~~~~g~~p~~~w-~~~~~~~ 364 (704)
.....++|+.|+|||++.+...|+.++|||||||++|+|++|+.||.. .+..++...+...+|.+....| .......
T Consensus 185 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 263 (328)
T d3bqca1 185 -EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263 (328)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred -cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence 345678899999999998877799999999999999999999999865 4567778888888876543322 2222211
Q ss_pred cccCC------CCCCCCc-hhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCC
Q 005289 365 ATLFK------PQQPYDS-SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 421 (704)
Q Consensus 365 ~~~~~------~~~~~~~-~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~ 421 (704)
...+. ....... ........++++++|||++||.+||.+|||++|||+||||++..|
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 11100 0000000 011223457899999999999999999999999999999997544
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-53 Score=452.46 Aligned_cols=260 Identities=23% Similarity=0.341 Sum_probs=208.1
Q ss_pred cCCeeEEE-EeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEee--cCCC
Q 005289 129 ADAFEKLE-KIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITS--RLSC 204 (704)
Q Consensus 129 ~~~y~~~~-~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~--~~~~ 204 (704)
.++|+++. .||+|+||+||+|++..+++.||||+++.. ..+.+|+.++.++ +|||||+++++|++ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 46899986 599999999999999999999999999642 3467899987655 89999999999975 2346
Q ss_pred eEEEEEecccccccc-cccCC-CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEcc---CCceEEecccccc
Q 005289 205 SIYLVFEYMEHDITG-LLSCP-DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLAN 279 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~-~~~~~-~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~---~g~iKL~DFGla~ 279 (704)
.+|||||||+|+.|. .+... ...|++.+++.|+.||+.||+|||++||+||||||+||||+. .+.+||+|||+|+
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceee
Confidence 789999999975554 44333 357999999999999999999999999999999999999986 4579999999998
Q ss_pred ccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhc
Q 005289 280 FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 359 (704)
Q Consensus 280 ~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~ 359 (704)
...... .....+||+.|+|||++.+ ..|+.++||||||||||+|+||++||.+.+..+....+........
T Consensus 163 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~------ 233 (335)
T d2ozaa1 163 ETTSHN--SLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ------ 233 (335)
T ss_dssp ECCCCC--CCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCS------
T ss_pred eccCCC--ccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCC------
Confidence 766543 3456789999999999876 5699999999999999999999999988776655554433211100
Q ss_pred cCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 360 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
..+. ...+..+++++++||.+||.+||++|||+.|+|+||||++.
T Consensus 234 ------------~~~~---~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 234 ------------YEFP---NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp ------------SSCC---TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred ------------CCCC---CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 0000 12234689999999999999999999999999999999753
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-52 Score=445.49 Aligned_cols=290 Identities=34% Similarity=0.540 Sum_probs=233.6
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC---CCeE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL---SCSI 206 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~---~~~~ 206 (704)
++|+++++||+|+||+||+|++..+|+.||||++.+.. .....+.+.+|+.+|+.|+||||+++++++.... ...+
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 57999999999999999999999999999999997654 3455667889999999999999999999986532 2457
Q ss_pred EEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC-
Q 005289 207 YLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH- 285 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~- 285 (704)
||||+++.++|...+.. ..+++..++.++.||+.||+|||++|||||||||+||||++++.+||+|||++.......
T Consensus 87 ~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp EEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 78877776666655532 369999999999999999999999999999999999999999999999999997654322
Q ss_pred -CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCC
Q 005289 286 -RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH 364 (704)
Q Consensus 286 -~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~ 364 (704)
.......++|+.|+|||++.....|+.++||||+||++|+|++|++||.+.+..++...+...++.+............
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence 1234556789999999999776788999999999999999999999999999999999999888888765433221110
Q ss_pred c--ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCCCC
Q 005289 365 A--TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 422 (704)
Q Consensus 365 ~--~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~~~ 422 (704)
. ............+...++.++.++++||.+||.+||.+|||+.|+|+||||+....+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~ 304 (345)
T d1pmea_ 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304 (345)
T ss_dssp HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence 0 001111112223456678899999999999999999999999999999999965443
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-53 Score=439.76 Aligned_cols=250 Identities=24% Similarity=0.364 Sum_probs=209.0
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCCh----HHHHHHHHHHHHHHhcC--CCCceeEeEEEeecCC
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEP----ESVRFMAREILILRRLD--HPNIIKLEGLITSRLS 203 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~----~~~~~~~~Ei~iL~~L~--HpnIv~l~~~~~~~~~ 203 (704)
++|++.+.||+|+||+||+|++..+|+.||||++.+..... .....+.+|+.+|++++ |||||+++++|.+ .
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~--~ 81 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER--P 81 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--S
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee--C
Confidence 47999999999999999999999999999999998654321 11233568999999996 8999999999987 5
Q ss_pred CeEEEEEecccc-cccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEcc-CCceEEecccccccc
Q 005289 204 CSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-EGVLKLADFGLANFS 281 (704)
Q Consensus 204 ~~~~LV~Ey~~g-~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~-~g~iKL~DFGla~~~ 281 (704)
..+|+||||+.+ +++..+......+++.+++.|+.||+.||.|||++|||||||||+||||+. ++.+||+|||+|+..
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 789999999976 455444445567999999999999999999999999999999999999985 479999999999865
Q ss_pred CCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccC
Q 005289 282 NTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK 361 (704)
Q Consensus 282 ~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~ 361 (704)
.. ...++.+||+.|+|||++.+...++.++|||||||+||+|++|++||.+.+ .+.. +..
T Consensus 162 ~~---~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~--~~~--------- 221 (273)
T d1xwsa_ 162 KD---TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR--GQV--------- 221 (273)
T ss_dssp CS---SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH--CCC---------
T ss_pred cc---ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhh--ccc---------
Confidence 43 234567899999999999765556788999999999999999999997632 2222 110
Q ss_pred CCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCC
Q 005289 362 LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 419 (704)
Q Consensus 362 ~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~ 419 (704)
.....+|+++++||.+||.+||++|||++|+|+||||++.
T Consensus 222 ------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 222 ------------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp ------------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred ------------------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 0113689999999999999999999999999999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.3e-52 Score=431.84 Aligned_cols=263 Identities=24% Similarity=0.349 Sum_probs=215.8
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC--CCe
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNF-EPESVRFMAREILILRRLDHPNIIKLEGLITSRL--SCS 205 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~--~~~ 205 (704)
.++|++++.||+|+||+||+|++..+|+.||||+++.... .......+.+|+.+|+.++|||||++++++.... ...
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 3679999999999999999999999999999999987654 3455667889999999999999999999987643 245
Q ss_pred EEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 206 IYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 206 ~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
+|||||||+++.+..+......+++.+++.|+.||+.||.|||++|||||||||+||||+.++.++|+|||++.......
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence 89999999998777666666689999999999999999999999999999999999999999999999999987554322
Q ss_pred --CCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCC
Q 005289 286 --RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 286 --~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
.......+||+.|+|||++.+ ..|+.++|||||||+||+|+||++||.+.+..+.+.++......++
T Consensus 166 ~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~---------- 234 (277)
T d1o6ya_ 166 NSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP---------- 234 (277)
T ss_dssp -------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCG----------
T ss_pred ccccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCC----------
Confidence 223455689999999999876 5789999999999999999999999999999888888766322221
Q ss_pred CcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccC
Q 005289 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 417 (704)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~ 417 (704)
...+..+|+++.+||.+||.+||.+||+..+.|.|+|++
T Consensus 235 ---------------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 235 ---------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp ---------------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ---------------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 123357899999999999999999999655556677764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=430.32 Aligned_cols=258 Identities=21% Similarity=0.332 Sum_probs=211.0
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
+..++|++.++||+|+||+||+|+.. ..||||+++.........+.+.+|+.+|++++|||||++++++.+ ..+
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~---~~~ 78 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---PQL 78 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSC
T ss_pred cccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec---cEE
Confidence 34578999999999999999999853 359999998776666777889999999999999999999998754 458
Q ss_pred EEEEeccccccccc-ccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCC
Q 005289 207 YLVFEYMEHDITGL-LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH 285 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~-~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~ 285 (704)
|||||||+++.|.. +......+++..+..|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|+......
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 99999999866554 44555679999999999999999999999999999999999999999999999999998765332
Q ss_pred -CCCcccccccccccCcccccCC--CCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCC
Q 005289 286 -RQPLTSRVVTLWYRPPELLLGA--TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (704)
Q Consensus 286 -~~~~~~~~gT~~Y~APEvl~~~--~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~ 362 (704)
........||+.|||||++.+. ..|+.++|||||||+||||+||+.||.+.+....+..+......+|
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p--------- 229 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP--------- 229 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCC---------
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC---------
Confidence 2334556789999999998642 3589999999999999999999999998877766655554322221
Q ss_pred CCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.+......+|+++.+||.+||..||.+|||+.+++++
T Consensus 230 --------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 230 --------------DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp --------------CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1123345789999999999999999999999999987
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-51 Score=423.78 Aligned_cols=255 Identities=21% Similarity=0.355 Sum_probs=214.2
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
+..++|+++++||+|+||+||+|++. +++.||||++...... .+.+.+|+.+|++++|||||++++++.+ ..+
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~---~~~ 82 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPI 82 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSC
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeecc---CCe
Confidence 34568999999999999999999975 5788999999765433 3568899999999999999999998865 457
Q ss_pred EEEEecccccccccccCC--CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 207 YLVFEYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~~--~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
|||||||+++.+..+... ...+++..+..|+.||+.||.|||+++|+||||||+||||++++.+||+|||+|+.....
T Consensus 83 ~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCC
Confidence 999999998777654332 235899999999999999999999999999999999999999999999999999877654
Q ss_pred CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCC
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
.........+|+.|+|||++.+ ..|+.++|||||||+||||+| |.+||...+..+.+..+... ..+
T Consensus 163 ~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~--~~~---------- 229 (272)
T d1qpca_ 163 EYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG--YRM---------- 229 (272)
T ss_dssp CEECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT--CCC----------
T ss_pred ccccccccCCcccccChHHHhC-CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc--CCC----------
Confidence 4344455678999999999875 568999999999999999999 57777888887777776542 110
Q ss_pred CcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh--ccccC
Q 005289 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA--SEYFS 417 (704)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~--hpwf~ 417 (704)
.....+++++.+||.+||+.||++|||++++++ |+||+
T Consensus 230 ----------------~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 230 ----------------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp ----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----------------CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 011368899999999999999999999999998 88886
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.7e-51 Score=426.01 Aligned_cols=252 Identities=20% Similarity=0.309 Sum_probs=209.4
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
+..++|++.++||+|+||+||+|++..+++.||||+++.+... .+.+.+|+.+|++|+|||||+++++|.+ ...+
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~ 88 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPF 88 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSC
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEee--CCee
Confidence 3456899999999999999999999999999999999765433 4568899999999999999999999987 5678
Q ss_pred EEEEeccccccccccc--CCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 207 YLVFEYMEHDITGLLS--CPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~--~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
|||||||+++.+..+. .....+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.....
T Consensus 89 ~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 9999999986655443 34567999999999999999999999999999999999999999999999999999877654
Q ss_pred CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCC-CCCCCCHHHHHHHHHHHcCCCCchhhhccCCC
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP-ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~-pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
.........+|+.|+|||++.+ ..|+.++|||||||+||||++|.. ||.+.+..++...+... ..+
T Consensus 169 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~-~~~----------- 235 (287)
T d1opja_ 169 TYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRM----------- 235 (287)
T ss_dssp SSEEETTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CCC-----------
T ss_pred CceeeccccccccccChHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC-CCC-----------
Confidence 4333444567999999999876 579999999999999999999654 55555555544444321 000
Q ss_pred CcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
.....+|+++.+||.+||..||++|||+.++++
T Consensus 236 ----------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 236 ----------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp ----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 012468899999999999999999999999976
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-50 Score=416.82 Aligned_cols=250 Identities=23% Similarity=0.346 Sum_probs=201.8
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|+++++||+|+||+||+|++. +++.||||+++.+... .+.+.+|+++|++++|||||++++++.+ ...+||
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~--~~~~~l 77 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPICL 77 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc---HHHHHHHHHHHHhcCCCCcccccceecc--CCceEE
Confidence 468999999999999999999976 5678999999865543 3467899999999999999999999987 467899
Q ss_pred EEeccccccccc-ccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCC
Q 005289 209 VFEYMEHDITGL-LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (704)
Q Consensus 209 V~Ey~~g~ll~~-~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~ 287 (704)
|||||+++.+.. +......+++..+..|+.||+.||.|||+++|+||||||+||||+.++.+||+|||+++........
T Consensus 78 v~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred EEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 999999876654 4455567899999999999999999999999999999999999999999999999999877654434
Q ss_pred CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcc
Q 005289 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (704)
Q Consensus 288 ~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~ 366 (704)
......+|+.|+|||++.+ ..|+.++|||||||+||||+| |.+||...+..+++..+......+
T Consensus 158 ~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~-------------- 222 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY-------------- 222 (263)
T ss_dssp -------CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCC--------------
T ss_pred eecceecCcccCChHHhcC-CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCC--------------
Confidence 4445678999999999876 569999999999999999999 688888888888887775521100
Q ss_pred cCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
....+++++.+||.+||..||++|||++++|+|
T Consensus 223 --------------~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 223 --------------KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp --------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------CccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 013568899999999999999999999999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.1e-50 Score=422.33 Aligned_cols=255 Identities=24% Similarity=0.379 Sum_probs=202.8
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCc---EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGK---IVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~---~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 203 (704)
+..++|++.+.||+|+||+||+|+++.+++ .||||++.... .....+.+.+|+.+|++|+|||||++++++.. .
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~ 99 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK--S 99 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--S
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEee--C
Confidence 345689999999999999999999987765 58899886543 34556778999999999999999999999977 4
Q ss_pred CeEEEEEeccccccccc-ccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccC
Q 005289 204 CSIYLVFEYMEHDITGL-LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~-~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~ 282 (704)
..+|||||||+++.+.. +......+++.++..|+.||+.||.|||++|||||||||+||||+.++++||+|||+++...
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEcc
Confidence 67899999999877665 44445679999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCC----cccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhh
Q 005289 283 TGHRQP----LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYW 357 (704)
Q Consensus 283 ~~~~~~----~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w 357 (704)
...... .....+|+.|+|||++.+ ..|+.++|||||||+||||+| |.+||.+.+..+++..+....-.+
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~----- 253 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP----- 253 (299)
T ss_dssp ----------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC-----
T ss_pred CCCCcceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-----
Confidence 432211 122356899999999876 579999999999999999998 899999999888887775421111
Q ss_pred hccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 358 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
....+++++.+||.+||+.||.+|||+.|++++
T Consensus 254 -----------------------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 254 -----------------------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp -----------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred -----------------------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 113678999999999999999999999999865
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-50 Score=414.12 Aligned_cols=250 Identities=21% Similarity=0.313 Sum_probs=216.1
Q ss_pred cCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
.++|+++++||+|+||+||+|+++ +++.||||+++...... +.+.+|+.+|++++|||||+++++|.+ ...+|+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~--~~~~~i 76 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTK--QRPIFI 76 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECC--SSSEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEee--CCceEE
Confidence 468999999999999999999984 78899999998765543 457899999999999999999999987 467999
Q ss_pred EEecccccccccc-cCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCC
Q 005289 209 VFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ 287 (704)
Q Consensus 209 V~Ey~~g~ll~~~-~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~ 287 (704)
||||++++.+..+ ......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++........
T Consensus 77 v~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp EEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred EEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 9999997655544 555667999999999999999999999999999999999999999999999999999876655444
Q ss_pred CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCcc
Q 005289 288 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT 366 (704)
Q Consensus 288 ~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~ 366 (704)
......+|+.|+|||++.+ ..|+.++|||||||++|||+| |+.||.+.+..+++.+|......+
T Consensus 157 ~~~~~~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~-------------- 221 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY-------------- 221 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC--------------
T ss_pred eecccCCCCCcCCcHHhcC-CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCC--------------
Confidence 4555678999999999876 568999999999999999998 899999999988888776521111
Q ss_pred cCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 367 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 367 ~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
....+++++.+||.+||+.||++|||++++|+|
T Consensus 222 --------------~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 222 --------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp --------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred --------------CcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 013578899999999999999999999999987
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=421.17 Aligned_cols=254 Identities=20% Similarity=0.292 Sum_probs=207.3
Q ss_pred eeEE-EEeeccCceEEEEEEEC--CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 132 FEKL-EKIGQGTYSSVFRARDL--DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 132 y~~~-~~LG~G~fg~Vy~a~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
+.+. ++||+|+||+||+|.+. .+++.||||+++.........+.+.+|+.+|++|+|||||++++++.. ..+||
T Consensus 8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~---~~~~l 84 (277)
T d1xbba_ 8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWML 84 (277)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---SSEEE
T ss_pred CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc---CCEEE
Confidence 3443 47999999999999754 456789999997665555666788999999999999999999999865 35789
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCCC-
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ- 287 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~~- 287 (704)
|||||+++.+..+......+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++........
T Consensus 85 vmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 85 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred EEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 9999999877766666667999999999999999999999999999999999999999999999999999876543222
Q ss_pred -CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCCCc
Q 005289 288 -PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA 365 (704)
Q Consensus 288 -~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~~~ 365 (704)
......||+.|+|||++.+ ..|+.++|||||||+||||++ |++||.+.+..++...|.+ |..+
T Consensus 165 ~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~--~~~~------------ 229 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK--GERM------------ 229 (277)
T ss_dssp EC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT--TCCC------------
T ss_pred ccccccCCCceecCchhhcC-CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHc--CCCC------------
Confidence 1233467999999999876 568999999999999999998 8999999988877776654 2111
Q ss_pred ccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHH---HhccccC
Q 005289 366 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA---LASEYFS 417 (704)
Q Consensus 366 ~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~---L~hpwf~ 417 (704)
.....+|+++.+||.+||..||++|||+.++ |+|+|+.
T Consensus 230 --------------~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 230 --------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp --------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred --------------CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 0113678999999999999999999999998 5676653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-50 Score=418.88 Aligned_cols=257 Identities=21% Similarity=0.283 Sum_probs=214.6
Q ss_pred ccCCeeEEE-EeeccCceEEEEEEECC--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCC
Q 005289 128 RADAFEKLE-KIGQGTYSSVFRARDLD--TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (704)
Q Consensus 128 ~~~~y~~~~-~LG~G~fg~Vy~a~~~~--~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 204 (704)
..++|.+.+ +||+|+||+||+|.++. ++..||||++.... .....+.+.+|+++|++|+|||||++++++.+ .
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---~ 81 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---E 81 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---S
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc---C
Confidence 346799988 49999999999998754 45579999997543 45567788999999999999999999999865 4
Q ss_pred eEEEEEecccccccccc-cCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCC
Q 005289 205 SIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~~-~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~ 283 (704)
.+|||||||+++.+..+ ......+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+....
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 58999999998766654 55566899999999999999999999999999999999999999999999999999987654
Q ss_pred CCC--CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhcc
Q 005289 284 GHR--QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (704)
Q Consensus 284 ~~~--~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~ 360 (704)
... .......+|+.|+|||++.. ..|+.++|||||||+||||+| |++||.+.+..+++..|.. |..+
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~--~~~~------- 231 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ--GKRM------- 231 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT--TCCC-------
T ss_pred cccccccccccccCccccChHHHhC-CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHc--CCCC-------
Confidence 322 12234567999999999875 568999999999999999998 9999999888887777654 2111
Q ss_pred CCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHH---HhccccC
Q 005289 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA---LASEYFS 417 (704)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~---L~hpwf~ 417 (704)
...+.+|+++.+||.+||..||++|||+.++ |+|+|+.
T Consensus 232 -------------------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 232 -------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp -------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------------------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 0124688999999999999999999999887 6788874
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-51 Score=432.99 Aligned_cols=266 Identities=25% Similarity=0.401 Sum_probs=218.3
Q ss_pred ccCCeeEEEEeeccCceEEEEEEE---CCCCcEEEEEEeecCCCC--hHHHHHHHHHHHHHHhcCC-CCceeEeEEEeec
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARD---LDTGKIVALKKVRFDNFE--PESVRFMAREILILRRLDH-PNIIKLEGLITSR 201 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~---~~~g~~vAvK~i~~~~~~--~~~~~~~~~Ei~iL~~L~H-pnIv~l~~~~~~~ 201 (704)
..++|+++++||+|+||+||+|++ ..+|+.||||++.+.... ....+.+.+|+++|++++| |||+++++++.+
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~- 100 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT- 100 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE-
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc-
Confidence 357899999999999999999987 447899999998654321 1223456789999999966 899999999988
Q ss_pred CCCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEecccccccc
Q 005289 202 LSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (704)
Q Consensus 202 ~~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~ 281 (704)
...+|+|||||.++.+..+......+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++..
T Consensus 101 -~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 101 -ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp -TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred -CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 5789999999999777766666667899999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCCCcccccccccccCcccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhcc
Q 005289 282 NTGHRQPLTSRVVTLWYRPPELLLGAT-DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (704)
Q Consensus 282 ~~~~~~~~~~~~gT~~Y~APEvl~~~~-~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~ 360 (704)
............+|+.|+|||++.+.. .++.++|||||||+||+|++|++||.+.+..+....+......+..
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~------ 253 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP------ 253 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC------
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCC------
Confidence 554444455678899999999987543 5788999999999999999999999887655555444432211100
Q ss_pred CCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCc-----CHHHHHhccccCCCC
Q 005289 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA-----TASAALASEYFSTKP 420 (704)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRp-----Ta~e~L~hpwf~~~~ 420 (704)
.....+++++.+||.+||.+||++|| |++|+|+||||+...
T Consensus 254 -------------------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 254 -------------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp -------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred -------------------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 01246899999999999999999999 599999999998654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-50 Score=426.40 Aligned_cols=255 Identities=22% Similarity=0.281 Sum_probs=207.0
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCCc-----EEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeec
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTGK-----IVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSR 201 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~-----~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~ 201 (704)
..++|++.++||+|+||+||+|++..+++ .||+|++.... .......+.+|+.+|.++ +|||||++++++.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~- 112 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTL- 112 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee-
Confidence 34689999999999999999999876543 69999986543 233445678899999998 89999999999987
Q ss_pred CCCeEEEEEecccccccccccC-C----------------------CccccHHHHHHHHHHhhhhHHHHHhcCcccccCC
Q 005289 202 LSCSIYLVFEYMEHDITGLLSC-P----------------------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIK 258 (704)
Q Consensus 202 ~~~~~~LV~Ey~~g~ll~~~~~-~----------------------~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLK 258 (704)
...+|||||||+++.+..++. . ...+++..++.|+.||+.||.|||++||||||||
T Consensus 113 -~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlK 191 (325)
T d1rjba_ 113 -SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA 191 (325)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred -CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCc
Confidence 467899999999866554432 1 1348999999999999999999999999999999
Q ss_pred CccEEEccCCceEEeccccccccCCCCCC-CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCC
Q 005289 259 GSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGR 336 (704)
Q Consensus 259 p~NILl~~~g~iKL~DFGla~~~~~~~~~-~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~ 336 (704)
|+|||++.++.+||+|||+|+........ .....++|+.|||||++.+ ..|+.++|||||||+||||++ |.+||.+.
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-CCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999876543322 2334567999999999875 579999999999999999997 89999987
Q ss_pred CHHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 337 TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 337 ~~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
+..+.+.+++..-..++ ....+|+++++||.+||+.||++|||++|+++|
T Consensus 271 ~~~~~~~~~~~~~~~~~---------------------------~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 271 PVDANFYKLIQNGFKMD---------------------------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CCSHHHHHHHHTTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHhcCCCCC---------------------------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 77666666655211111 113678999999999999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=412.83 Aligned_cols=253 Identities=23% Similarity=0.352 Sum_probs=201.4
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCC---cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCC
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTG---KIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g---~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 204 (704)
..++|++.+.||+|+||+||+|++..++ ..||||++.... .....+.+.+|+.+|++++|||||++++++.+ .
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~ 80 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE---N 80 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---S
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---C
Confidence 3468999999999999999999987543 468888885432 45556778899999999999999999999864 5
Q ss_pred eEEEEEeccccccccc-ccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCC
Q 005289 205 SIYLVFEYMEHDITGL-LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~~-~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~ 283 (704)
.+|||||||+++.+.. +......+++..++.++.||+.||.|||+++||||||||+|||++.++.+||+|||+|+....
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred eEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccC
Confidence 6899999999866554 344556799999999999999999999999999999999999999999999999999987665
Q ss_pred CCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCC
Q 005289 284 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 362 (704)
Q Consensus 284 ~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~ 362 (704)
......+...+|+.|+|||++.+ ..|+.++|||||||+||||++ |.+||.+.+..+.+.++... ..+
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~--~~~--------- 228 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG--ERL--------- 228 (273)
T ss_dssp ----------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT--CCC---------
T ss_pred CcceeccceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCC---------
Confidence 44344455677999999999875 578999999999999999998 89999999888888777542 111
Q ss_pred CCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 363 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 363 ~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
..++.+|+++.+||.+||..||.+|||+.++++|
T Consensus 229 -----------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 229 -----------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp -----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1124689999999999999999999999999976
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-49 Score=414.02 Aligned_cols=257 Identities=23% Similarity=0.350 Sum_probs=207.7
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
+..++|++.+.||+|+||+||+|++..+ +.||||++...... .+.+.+|+.+|++++|||||++++++.+ ..+
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~---~~~ 86 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPI 86 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSC
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEec---CCe
Confidence 3456899999999999999999998765 56999999765543 3568899999999999999999999865 457
Q ss_pred EEEEecccccccccccC--CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 207 YLVFEYMEHDITGLLSC--PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~--~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
|||||||+++.+..+.. ....+++.++..|+.||+.||+|||++||+||||||+||||+.++++||+|||+++.....
T Consensus 87 ~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred EEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 89999999876554433 2346899999999999999999999999999999999999999999999999999877554
Q ss_pred CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCC
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
.........+|+.|+|||++.. ..++.++|||||||+||||++ |.+||.+....+++..+......+
T Consensus 167 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~----------- 234 (285)
T d1fmka3 167 EYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP----------- 234 (285)
T ss_dssp ---------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-----------
T ss_pred CceeeccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-----------
Confidence 4444455678999999999875 568999999999999999999 567777778877877775422111
Q ss_pred CcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh--ccccCCC
Q 005289 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA--SEYFSTK 419 (704)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~--hpwf~~~ 419 (704)
....+++++++||.+||+.||++|||++++++ ++||+..
T Consensus 235 -----------------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 235 -----------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp -----------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred -----------------CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 12467899999999999999999999999988 8999753
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-48 Score=403.97 Aligned_cols=254 Identities=22% Similarity=0.319 Sum_probs=201.7
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCC----cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecC
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTG----KIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRL 202 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g----~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 202 (704)
+..+.|++.+.||+|+||+||+|.+..++ ..||||++.... .......+.+|+.+|++|+|||||++++++.+
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~-- 80 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-- 80 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--
T ss_pred CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec--
Confidence 34567999999999999999999877654 479999997543 44555678899999999999999999999977
Q ss_pred CCeEEEEEecccccccccc-cCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEecccccccc
Q 005289 203 SCSIYLVFEYMEHDITGLL-SCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 281 (704)
Q Consensus 203 ~~~~~LV~Ey~~g~ll~~~-~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~ 281 (704)
...+|+|||||.++++..+ ......+++.++..++.||+.||.|||+++||||||||+||||+.++.+||+|||+++..
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcc
Confidence 4678999999998766544 345567999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCC--CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHcCCCCchhhh
Q 005289 282 NTGHRQ--PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG-KPILQGRTEVEQLHKIFKLCGSPPDDYWK 358 (704)
Q Consensus 282 ~~~~~~--~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG-~~pF~~~~~~e~l~~I~~~~g~~p~~~w~ 358 (704)
...... ......||+.|+|||++.+ ..|+.++|||||||+||||+++ .+||...+..+.+..+.... .+
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~-~~------ 232 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF-RL------ 232 (283)
T ss_dssp -------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-CC------
T ss_pred cCCCccceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccC-CC------
Confidence 543221 2233467999999999876 6799999999999999999985 66677777777666664321 00
Q ss_pred ccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 359 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
.....++..+.+||.+||..||++|||+.++++
T Consensus 233 ---------------------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 233 ---------------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp ---------------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---------------------CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 011357899999999999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-48 Score=413.07 Aligned_cols=253 Identities=19% Similarity=0.327 Sum_probs=203.9
Q ss_pred ccCCeeEEEEeeccCceEEEEEEECCCCc----EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC
Q 005289 128 RADAFEKLEKIGQGTYSSVFRARDLDTGK----IVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (704)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~----~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 203 (704)
+.++|++++.||+|+||+||+|++..+|+ .||+|++.... .....+.+.+|+.+|++|+|||||+++++|.+
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--- 82 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLT--- 82 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES---
T ss_pred CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---
Confidence 34679999999999999999999988876 57888876432 23345678899999999999999999999976
Q ss_pred CeEEEEEecccc-cccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccC
Q 005289 204 CSIYLVFEYMEH-DITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 282 (704)
Q Consensus 204 ~~~~LV~Ey~~g-~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~ 282 (704)
...++||||+.+ +++..+......+++..+..|+.||+.||.|||++|||||||||+||||+.++++||+|||+|+...
T Consensus 83 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 83 STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred CCeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecc
Confidence 346677777775 5555566666789999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCC-CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhcc
Q 005289 283 TGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (704)
Q Consensus 283 ~~~~~-~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~ 360 (704)
..... ......+|+.|+|||++.+ ..|+.++|||||||+||||+| |.+||.+.+..++...+.... .++
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~-~~~------- 233 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-RLP------- 233 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC-CCC-------
T ss_pred cccccccccccccCccccChHHHhc-CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-CCC-------
Confidence 43322 2233467999999999876 579999999999999999998 899999888777766665421 110
Q ss_pred CCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
....+++++.+||.+||..||.+|||+.++|.|
T Consensus 234 --------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 234 --------------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp --------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 113678999999999999999999999999988
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=404.33 Aligned_cols=255 Identities=22% Similarity=0.314 Sum_probs=197.6
Q ss_pred cCCeeEEEEeeccCceEEEEEEECC-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLD-----TGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRL 202 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~ 202 (704)
.++|+++++||+|+||+||+|++.. +++.||||++.... .....+.+.+|+.++.++ +|+|||.+++++...
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~- 89 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 89 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC-
Confidence 4689999999999999999999754 45789999997544 344456677788888777 789999999887654
Q ss_pred CCeEEEEEecccccccccccC----------------CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEcc
Q 005289 203 SCSIYLVFEYMEHDITGLLSC----------------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN 266 (704)
Q Consensus 203 ~~~~~LV~Ey~~g~ll~~~~~----------------~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~ 266 (704)
...+|+|||||+++.+..+.. ....+++.++..|+.||+.||.|||++|||||||||+||||+.
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 169 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECC
Confidence 457899999999876655432 1235899999999999999999999999999999999999999
Q ss_pred CCceEEeccccccccCCCCC-CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhC-CCCCCCCCHHHHHHH
Q 005289 267 EGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG-KPILQGRTEVEQLHK 344 (704)
Q Consensus 267 ~g~iKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG-~~pF~~~~~~e~l~~ 344 (704)
++++||+|||+|+....... ......+||+.|+|||++.+ ..|+.++|||||||++|||++| .+||.+....+.+.+
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~ 248 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999986554322 23345678999999999976 6789999999999999999986 578887765555544
Q ss_pred HHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 345 IFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 345 I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
+... +..+ .....+++++++||.+||+.||++|||+.|+|+|
T Consensus 249 ~~~~-~~~~--------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 249 RLKE-GTRM--------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHH-TCCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhc-CCCC--------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4432 1111 0113578999999999999999999999999987
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.4e-47 Score=411.11 Aligned_cols=295 Identities=26% Similarity=0.413 Sum_probs=227.5
Q ss_pred cccccchhhhhcccchhhhhhhhhhhcCccccccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHH
Q 005289 96 LHKYIEGEQVAAGWPAWLSAVAGEAIQGWVPLRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRF 175 (704)
Q Consensus 96 ~~~~~~ge~~~~~~p~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~ 175 (704)
|||+..||.+.+ .+|+++++||+|+||+||+|+++.+|+.||||+++.+ ....+.
T Consensus 1 ~~p~~~g~~~~~----------------------~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~ 55 (362)
T d1q8ya_ 1 YHPAFKGEPYKD----------------------ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEA 55 (362)
T ss_dssp CCCCCTTCEETT----------------------TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHH
T ss_pred CCCCCCCCCccC----------------------CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHH
Confidence 567777776665 3799999999999999999999999999999999754 233456
Q ss_pred HHHHHHHHHhcC-----------CCCceeEeEEEeecCCCeEEEEEecccccc---cccccCCCccccHHHHHHHHHHhh
Q 005289 176 MAREILILRRLD-----------HPNIIKLEGLITSRLSCSIYLVFEYMEHDI---TGLLSCPDIKFSEAQIKCYMNQLL 241 (704)
Q Consensus 176 ~~~Ei~iL~~L~-----------HpnIv~l~~~~~~~~~~~~~LV~Ey~~g~l---l~~~~~~~~~l~e~~~~~i~~QIl 241 (704)
+.+|+.+|+.++ |+|||++++++........++||+++.... ..........+++..++.++.||+
T Consensus 56 ~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil 135 (362)
T d1q8ya_ 56 AEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135 (362)
T ss_dssp HHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHH
Confidence 778999998885 578999999987765667777777765422 222334556789999999999999
Q ss_pred hhHHHHHh-cCcccccCCCccEEEccCCc------eEEeccccccccCCCCCCCcccccccccccCcccccCCCCCCCcc
Q 005289 242 HGLEHCHS-RGVLHRDIKGSNLLVNNEGV------LKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSV 314 (704)
Q Consensus 242 ~aL~yLH~-~gIvHrDLKp~NILl~~~g~------iKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~ 314 (704)
.||.|||+ .||+||||||+||||+.++. +||+|||.+..... .....++|+.|+|||++.. ..|+.++
T Consensus 136 ~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~ 210 (362)
T d1q8ya_ 136 LGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLG-APWGCGA 210 (362)
T ss_dssp HHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHT-CCCCTHH
T ss_pred HHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeeccccccccc----ccccccccccccChhhccc-cCCCccc
Confidence 99999997 89999999999999987653 99999999976543 2345688999999999886 5689999
Q ss_pred chhhHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHHcCCCCchhhhccCCCCcccC-----CC--C---CCCCchh
Q 005289 315 DLWSVGCVFAELLIGKPILQGRT------EVEQLHKIFKLCGSPPDDYWKKSKLPHATLF-----KP--Q---QPYDSSL 378 (704)
Q Consensus 315 DIWSlG~iLyeLltG~~pF~~~~------~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~-----~~--~---~~~~~~l 378 (704)
|||||||+|++|++|++||.... ..+.+..++..+|.++...+........... .. . .+....+
T Consensus 211 DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (362)
T d1q8ya_ 211 DIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVL 290 (362)
T ss_dssp HHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHH
T ss_pred cccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhc
Confidence 99999999999999999997543 4577888889999988777655433211110 00 0 0111111
Q ss_pred hhh---ccCCCHHHHHHHHHhhccCCCCCcCHHHHHhccccCCCC
Q 005289 379 RET---FKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 420 (704)
Q Consensus 379 ~~~---~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~hpwf~~~~ 420 (704)
... ....+++++|||.+||.+||.+||||+|||+||||++.+
T Consensus 291 ~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 291 TEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp HHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred ccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCC
Confidence 111 123467899999999999999999999999999999643
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-48 Score=400.49 Aligned_cols=253 Identities=26% Similarity=0.356 Sum_probs=200.0
Q ss_pred cCCeeEEEEeeccCceEEEEEEECC-CC--cEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDLD-TG--KIVALKKVRFDNFE-PESVRFMAREILILRRLDHPNIIKLEGLITSRLSC 204 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~~-~g--~~vAvK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 204 (704)
.++|++++.||+|+||+||+|+... ++ ..||||++...... ....+.+.+|+.+|++|+|||||++++++.+ .
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~---~ 83 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---P 83 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---S
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee---c
Confidence 4579999999999999999998643 33 36899999765442 3456778899999999999999999999975 3
Q ss_pred eEEEEEecccccccc-cccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCC
Q 005289 205 SIYLVFEYMEHDITG-LLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 283 (704)
Q Consensus 205 ~~~LV~Ey~~g~ll~-~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~ 283 (704)
.+|||||||+++.+. .+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 578999999975544 4444456799999999999999999999999999999999999999999999999999987654
Q ss_pred CCCC--CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhcc
Q 005289 284 GHRQ--PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (704)
Q Consensus 284 ~~~~--~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~ 360 (704)
.... ......+|..|+|||++.+ ..|+.++|||||||+||||+| |.+||.+.+..+.+.+|.+....++
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~------- 235 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP------- 235 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC-------
T ss_pred CCCcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCC-------
Confidence 3221 1233456889999999986 678999999999999999998 8999999999998888765211111
Q ss_pred CCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
....+|+++.+||.+||..||++|||+.++++
T Consensus 236 --------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 236 --------------------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp --------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 12468899999999999999999999999873
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.5e-47 Score=400.37 Aligned_cols=252 Identities=24% Similarity=0.350 Sum_probs=209.0
Q ss_pred cCCeeEEEEeeccCceEEEEEEEC-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC
Q 005289 129 ADAFEKLEKIGQGTYSSVFRARDL-----DTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS 203 (704)
Q Consensus 129 ~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 203 (704)
.++|+++++||+|+||+||+|+.+ .+++.||||++.... .....+.+.+|+.+|++++||||+++++++.. .
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~ 88 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAV--G 88 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--S
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeeecc--C
Confidence 457999999999999999999875 356889999997543 45556778999999999999999999999987 4
Q ss_pred CeEEEEEecccccccccccC------------------------CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCC
Q 005289 204 CSIYLVFEYMEHDITGLLSC------------------------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKG 259 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~~~~------------------------~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp 259 (704)
..+++||||++++.+..++. ....+++..+..|+.||+.||+|||+++||||||||
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp 168 (301)
T d1lufa_ 89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 168 (301)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence 67899999999865554321 122488999999999999999999999999999999
Q ss_pred ccEEEccCCceEEeccccccccCCCCC-CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhC-CCCCCCCC
Q 005289 260 SNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG-KPILQGRT 337 (704)
Q Consensus 260 ~NILl~~~g~iKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG-~~pF~~~~ 337 (704)
+||||+.++++||+|||+|+....... ...++.++|+.|+|||++.+ ..|+.++|||||||+||||++| .+||.+.+
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 999999999999999999976543322 23345678999999999876 6799999999999999999998 58899999
Q ss_pred HHHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 338 EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 338 ~~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
..+++..+.+. ..+ .....+++++.+||.+||+.||++|||+.|+++
T Consensus 248 ~~e~~~~v~~~--~~~--------------------------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 248 HEEVIYYVRDG--NIL--------------------------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHHHTT--CCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcC--CCC--------------------------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99888887542 111 112468899999999999999999999999975
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-47 Score=393.34 Aligned_cols=247 Identities=19% Similarity=0.325 Sum_probs=200.1
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeE
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSI 206 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~ 206 (704)
+..++|+++++||+|+||+||+|++ +|+.||||+++.+. ..+.+.+|+++|++++|||||++++++.+. ...+
T Consensus 4 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~ 76 (262)
T d1byga_ 4 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGL 76 (262)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC---CC
T ss_pred cCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEec-CCcE
Confidence 4467899999999999999999997 47899999997543 345678999999999999999999988653 3568
Q ss_pred EEEEecccccccccccCC--CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCC
Q 005289 207 YLVFEYMEHDITGLLSCP--DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG 284 (704)
Q Consensus 207 ~LV~Ey~~g~ll~~~~~~--~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~ 284 (704)
||||||++++.+..++.. ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC
Confidence 999999998766655432 235899999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCCchhhhccCCC
Q 005289 285 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 285 ~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
.....+|+.|+|||++.+ ..|+.++|||||||++|||+| |++||...+..+++..|.+. ..+
T Consensus 157 ----~~~~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~--~~~---------- 219 (262)
T d1byga_ 157 ----QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG--YKM---------- 219 (262)
T ss_dssp ---------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT--CCC----------
T ss_pred ----CccccccccCCChHHHhC-CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC--CCC----------
Confidence 233467899999999876 578999999999999999998 79999988887777776431 110
Q ss_pred CcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
+....+++++.+||.+||..||.+|||+.+++++
T Consensus 220 ----------------~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 220 ----------------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp ----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1123678999999999999999999999999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=394.68 Aligned_cols=254 Identities=22% Similarity=0.346 Sum_probs=206.0
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCC-------cEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEE
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTG-------KIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLI 198 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g-------~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~ 198 (704)
+..++|++.+.||+|+||+||+|++..++ ..||||+++.+. .......+.+|+.++.++ +|||||+++++|
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~ 88 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGAC 88 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence 34578999999999999999999976554 479999997654 445566788899999888 899999999999
Q ss_pred eecCCCeEEEEEecccccccccccCC----------------CccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccE
Q 005289 199 TSRLSCSIYLVFEYMEHDITGLLSCP----------------DIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNL 262 (704)
Q Consensus 199 ~~~~~~~~~LV~Ey~~g~ll~~~~~~----------------~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NI 262 (704)
.+ ...+|+|||||+++.+..++.. ...+++..+..++.||+.||.|||+++||||||||+||
T Consensus 89 ~~--~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~Ni 166 (299)
T d1fgka_ 89 TQ--DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 166 (299)
T ss_dssp CS--SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred cc--CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccce
Confidence 87 4679999999998766654421 24589999999999999999999999999999999999
Q ss_pred EEccCCceEEeccccccccCCCCC-CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHH
Q 005289 263 LVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVE 340 (704)
Q Consensus 263 Ll~~~g~iKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e 340 (704)
|++.++.+||+|||+++....... ......++|+.|+|||++.+ ..|+.++|||||||+||||++ |.+||.+.+..+
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~ 245 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH
Confidence 999999999999999987654332 22344578999999999876 679999999999999999998 799999888877
Q ss_pred HHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 341 QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 341 ~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
.+..+.. +..+ .....+++++.+||.+||+.||.+|||+.|+|+
T Consensus 246 ~~~~i~~--~~~~--------------------------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 246 LFKLLKE--GHRM--------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHT--TCCC--------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHc--CCCC--------------------------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 7666543 1111 011367899999999999999999999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=398.16 Aligned_cols=253 Identities=25% Similarity=0.324 Sum_probs=206.9
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECCCCcE--EEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEeecCC
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLDTGKI--VALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITSRLS 203 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~--vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 203 (704)
+..++|++.++||+|+||+||+|+++.++.. ||||++.... .....+.+.+|+++|.++ +|||||+++++|.+ .
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~ 83 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--R 83 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--T
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec--C
Confidence 4567899999999999999999999888875 6677775432 233456788999999999 79999999999987 5
Q ss_pred CeEEEEEecccccccccccC----------------CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccC
Q 005289 204 CSIYLVFEYMEHDITGLLSC----------------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE 267 (704)
Q Consensus 204 ~~~~LV~Ey~~g~ll~~~~~----------------~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~ 267 (704)
..+|||||||+++.+..++. ....+++..+..++.||+.||.|||+++||||||||+|||++.+
T Consensus 84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~ 163 (309)
T d1fvra_ 84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 163 (309)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC
Confidence 78999999999866665542 23568999999999999999999999999999999999999999
Q ss_pred CceEEeccccccccCCCCCCCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhC-CCCCCCCCHHHHHHHHH
Q 005289 268 GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG-KPILQGRTEVEQLHKIF 346 (704)
Q Consensus 268 g~iKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG-~~pF~~~~~~e~l~~I~ 346 (704)
+.+||+|||+++...... ......+|+.|+|||.+.+ ..|+.++|||||||++|||++| .+||.+.+..+.+..+.
T Consensus 164 ~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~ 240 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 240 (309)
T ss_dssp GCEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred CceEEccccccccccccc--cccceecCCcccchHHhcc-CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 999999999997655332 1234467999999999976 5689999999999999999996 57899888888777764
Q ss_pred HHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 347 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 347 ~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.. ..+ .....+++++.+||.+||+.||++|||+.++|++
T Consensus 241 ~~--~~~--------------------------~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 241 QG--YRL--------------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp GT--CCC--------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hc--CCC--------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 31 111 0123678999999999999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-46 Score=393.21 Aligned_cols=262 Identities=19% Similarity=0.241 Sum_probs=206.3
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYLV 209 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~LV 209 (704)
++|++++.||+|+||+||+|++..+|+.||||++...... ..+.+|+++++.++|+|+|.++..+... ....|+|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~-~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEE-TTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEec-CCEEEEE
Confidence 5799999999999999999999999999999998765432 2367899999999887766655544333 5788999
Q ss_pred EecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEcc---CCceEEeccccccccCCCCC
Q 005289 210 FEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHR 286 (704)
Q Consensus 210 ~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~---~g~iKL~DFGla~~~~~~~~ 286 (704)
||||++++...+......+++..+..++.||+.||+|||++|||||||||+|||++. +..+||+|||+|+.......
T Consensus 82 me~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 82 MELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred EEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 999999887777667778999999999999999999999999999999999999864 45799999999987654321
Q ss_pred ------CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCchhhhcc
Q 005289 287 ------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 360 (704)
Q Consensus 287 ------~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~~~e~l~~I~~~~g~~p~~~w~~~ 360 (704)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||...........+.......
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~-------- 232 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK-------- 232 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH--------
T ss_pred ccceeccccCCcCCCccccCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhccc--------
Confidence 12345678999999999886 569999999999999999999999998866554443332211000
Q ss_pred CCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHH---HHHhccccCC
Q 005289 361 KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS---AALASEYFST 418 (704)
Q Consensus 361 ~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~---e~L~hpwf~~ 418 (704)
...........+|+++.+||..||..||++||++. ++|+|+|.+.
T Consensus 233 -------------~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 233 -------------MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp -------------HHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred -------------CCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 00011334467999999999999999999999986 5578887653
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=397.52 Aligned_cols=254 Identities=16% Similarity=0.232 Sum_probs=211.0
Q ss_pred cccCCeeEEEEeeccCceEEEEEEECC-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeec
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARDLD-----TGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSR 201 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 201 (704)
+..++|++.++||+|+||+||+|.+.. +++.||||+++... .......+.+|+.+|++++|||||++++++..
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~- 94 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ- 94 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS-
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec-
Confidence 345789999999999999999998752 45789999997543 44555678899999999999999999999976
Q ss_pred CCCeEEEEEecccccccccccC----------CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceE
Q 005289 202 LSCSIYLVFEYMEHDITGLLSC----------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLK 271 (704)
Q Consensus 202 ~~~~~~LV~Ey~~g~ll~~~~~----------~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iK 271 (704)
...++||||||.++.+..+.. ....+++..+..|+.||+.||.|||+++|+||||||+||||+.++++|
T Consensus 95 -~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~K 173 (308)
T d1p4oa_ 95 -GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 173 (308)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred -CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEE
Confidence 467899999999876655432 123468899999999999999999999999999999999999999999
Q ss_pred EeccccccccCCCCCC-CcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHc
Q 005289 272 LADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG-KPILQGRTEVEQLHKIFKLC 349 (704)
Q Consensus 272 L~DFGla~~~~~~~~~-~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG-~~pF~~~~~~e~l~~I~~~~ 349 (704)
|+|||+++........ .....++|+.|+|||.+.+ ..|+.++|||||||+||||+|| .+||.+.+..+.+..+.+.
T Consensus 174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~- 251 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG- 251 (308)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT-
T ss_pred EeecccceeccCCcceeeccceecccccCCHHHHcc-CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC-
Confidence 9999999866433222 2233467999999999876 5689999999999999999998 5899999988888877542
Q ss_pred CCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 350 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 350 g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
..+ .....+++.+.+||.+||+.||.+|||+.++|+
T Consensus 252 -~~~--------------------------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 252 -GLL--------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp -CCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CCC--------------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 111 011367899999999999999999999999998
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-46 Score=393.48 Aligned_cols=255 Identities=20% Similarity=0.295 Sum_probs=210.9
Q ss_pred cccCCeeEEEEeeccCceEEEEEEE-----CCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeEEEee
Q 005289 127 LRADAFEKLEKIGQGTYSSVFRARD-----LDTGKIVALKKVRFDNFEPESVRFMAREILILRRL-DHPNIIKLEGLITS 200 (704)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~Vy~a~~-----~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~ 200 (704)
+..++|++.++||+|+||.||+|++ ..+++.||||+++... .......+.+|+.+++++ +|||||++++++.+
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 3356899999999999999999985 3567899999998654 345566788999999999 79999999999987
Q ss_pred cCCCeEEEEEecccccccccccC------------------CCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccE
Q 005289 201 RLSCSIYLVFEYMEHDITGLLSC------------------PDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNL 262 (704)
Q Consensus 201 ~~~~~~~LV~Ey~~g~ll~~~~~------------------~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NI 262 (704)
...+|||||||+++.+..+.. ....+++..+..|+.||+.||.|||++|||||||||+||
T Consensus 99 --~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NI 176 (311)
T d1t46a_ 99 --GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176 (311)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred --CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccc
Confidence 467899999999876554432 223589999999999999999999999999999999999
Q ss_pred EEccCCceEEeccccccccCCCCC-CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCHHH
Q 005289 263 LVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVE 340 (704)
Q Consensus 263 Ll~~~g~iKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLlt-G~~pF~~~~~~e 340 (704)
||+.++.+||+|||+++....... ...+..++|+.|+|||++.. ..++.++|||||||+||||+| |.+||.+....+
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~ 255 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999987654332 22344577999999999875 578999999999999999998 788888877777
Q ss_pred HHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 341 QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 341 ~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
.+.+++..-..+. ....+++.+.+||.+||+.||.+|||+.++|+
T Consensus 256 ~~~~~i~~~~~~~---------------------------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 256 KFYKMIKEGFRML---------------------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHHHHTCCCC---------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhcCCCCC---------------------------CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 7766655311110 11357899999999999999999999999985
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=382.62 Aligned_cols=251 Identities=20% Similarity=0.249 Sum_probs=199.2
Q ss_pred eeEEEEeeccCceEEEEEEECCCC---cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCCCeEEE
Q 005289 132 FEKLEKIGQGTYSSVFRARDLDTG---KIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 132 y~~~~~LG~G~fg~Vy~a~~~~~g---~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~~~L 208 (704)
+.+-++||+|+||+||+|++..++ ..||||+++.. ......+.+.+|+++|++|+|||||++++++... ...+|+
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~l 106 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGSPLV 106 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET-TTEEEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec-CCceEE
Confidence 344678999999999999986643 36999999753 3456678899999999999999999999998653 457899
Q ss_pred EEeccccccccc-ccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEeccccccccCCCCC-
Q 005289 209 VFEYMEHDITGL-LSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR- 286 (704)
Q Consensus 209 V~Ey~~g~ll~~-~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DFGla~~~~~~~~- 286 (704)
|||||+++.+.. +......+++..+..++.||+.||.|||+.+|+||||||+||||++++.+||+|||+++.......
T Consensus 107 v~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 107 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred EEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 999999877664 444555688899999999999999999999999999999999999999999999999987654322
Q ss_pred --CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHHcCCCCchhhhccCCC
Q 005289 287 --QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG-RTEVEQLHKIFKLCGSPPDDYWKKSKLP 363 (704)
Q Consensus 287 --~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~-~~~~e~l~~I~~~~g~~p~~~w~~~~~~ 363 (704)
.......+|+.|+|||++.. ..|+.++|||||||+||||++|..||.. .+..+....+.. |..+
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~--g~~~---------- 253 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--GRRL---------- 253 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHT--TCCC----------
T ss_pred cceecccccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHc--CCCC----------
Confidence 22233567999999999875 5789999999999999999997666654 344444444432 1111
Q ss_pred CcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 364 HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 364 ~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.....+++++.+||.+||..||++|||+.|+++|
T Consensus 254 ----------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 254 ----------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp ----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 0013578899999999999999999999999987
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.7e-44 Score=375.81 Aligned_cols=252 Identities=20% Similarity=0.231 Sum_probs=207.0
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC-CCceeEeEEEeecCCCeEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH-PNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~H-pnIv~l~~~~~~~~~~~~~L 208 (704)
++|+++++||+|+||+||+|++..+|+.||||++...... ..+.+|+++++.|.| +||+.+++++.. ....|+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~~ 78 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVL 78 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeec--CCccEE
Confidence 5799999999999999999999999999999998754322 235679999999965 899999998877 578999
Q ss_pred EEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEcc-----CCceEEeccccccccCC
Q 005289 209 VFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-----EGVLKLADFGLANFSNT 283 (704)
Q Consensus 209 V~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~-----~g~iKL~DFGla~~~~~ 283 (704)
|||||++++...+......+++..+..++.||+.||.|||++|||||||||+||||+. ++.+||+|||+|+....
T Consensus 79 vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 79 VIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred EEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 9999988877777666678999999999999999999999999999999999999974 57899999999987643
Q ss_pred CCC------CCcccccccccccCcccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHcCCCCc
Q 005289 284 GHR------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT---EVEQLHKIFKLCGSPPD 354 (704)
Q Consensus 284 ~~~------~~~~~~~gT~~Y~APEvl~~~~~y~~~~DIWSlG~iLyeLltG~~pF~~~~---~~e~l~~I~~~~g~~p~ 354 (704)
... ......+||+.|||||++.+ ..|+.++|||||||++|||++|.+||.+.. ..+.+.++....-.+
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~-- 235 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST-- 235 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS--
T ss_pred CccccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC--
Confidence 221 12345679999999999986 679999999999999999999999998653 334444443321111
Q ss_pred hhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHh
Q 005289 355 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 412 (704)
Q Consensus 355 ~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~ 412 (704)
.+.+.++.+|+++.+||..|+..+|++||+.+.+.+
T Consensus 236 ----------------------~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 236 ----------------------PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp ----------------------CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ----------------------ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 123445688999999999999999999999776643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=374.68 Aligned_cols=257 Identities=24% Similarity=0.268 Sum_probs=189.2
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeEEEeecCC--CeEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNIIKLEGLITSRLS--CSIY 207 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~--~~~~ 207 (704)
.+|.+.++||+|+||+||+|+. +|+.||||++.... ........|+..+..++|||||++++++.+... ..+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 3699999999999999999986 68999999986432 212223345556667899999999999976432 3689
Q ss_pred EEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHh--------cCcccccCCCccEEEccCCceEEecccccc
Q 005289 208 LVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHS--------RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 279 (704)
Q Consensus 208 LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~--------~gIvHrDLKp~NILl~~~g~iKL~DFGla~ 279 (704)
||||||+++.+..++.. ..+++..+..++.|++.||.|||+ +|||||||||+||||+.++.+||+|||++.
T Consensus 78 lv~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999998776655543 368999999999999999999996 599999999999999999999999999998
Q ss_pred ccCCCCC---CCcccccccccccCcccccCCC-----CCCCccchhhHHHHHHHHHhCCCCCCCCCH-------------
Q 005289 280 FSNTGHR---QPLTSRVVTLWYRPPELLLGAT-----DYGPSVDLWSVGCVFAELLIGKPILQGRTE------------- 338 (704)
Q Consensus 280 ~~~~~~~---~~~~~~~gT~~Y~APEvl~~~~-----~y~~~~DIWSlG~iLyeLltG~~pF~~~~~------------- 338 (704)
....... ......+||+.|+|||++.+.. .++.++|||||||+||||+||.+||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 7654322 1234567899999999986532 256789999999999999999988754221
Q ss_pred -HHHHHHHHHHcCCCCchhhhccCCCCcccCCCCCCCCchhhhhccCCCHHHHHHHHHhhccCCCCCcCHHHHHhc
Q 005289 339 -VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 413 (704)
Q Consensus 339 -~e~l~~I~~~~g~~p~~~w~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~~~dLI~~mL~~dP~kRpTa~e~L~h 413 (704)
.+.+.......+ ..+. ... .......+..+.+||.+||..||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~-----------------~~p~--~~~--~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 237 SVEEMRKVVCEQK-----------------LRPN--IPN--RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CHHHHHHHHTTSC-----------------CCCC--CCG--GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHhccc-----------------cCCC--CCc--ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 111111110000 0000 000 00011234568999999999999999999999864
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=5.6e-25 Score=214.96 Aligned_cols=164 Identities=16% Similarity=0.110 Sum_probs=121.2
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCC----------------hHHHHHHHHHHHHHHhcCCCCceeEe
Q 005289 132 FEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFE----------------PESVRFMAREILILRRLDHPNIIKLE 195 (704)
Q Consensus 132 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~----------------~~~~~~~~~Ei~iL~~L~HpnIv~l~ 195 (704)
+.+.++||+|+||+||+|++. +|+.||||+++..... ........+|+.+|.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 567899999999999999984 6899999987642110 11123345689999999999999987
Q ss_pred EEEeecCCCeEEEEEecccccccccccCCCccccHHHHHHHHHHhhhhHHHHHhcCcccccCCCccEEEccCCceEEecc
Q 005289 196 GLITSRLSCSIYLVFEYMEHDITGLLSCPDIKFSEAQIKCYMNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADF 275 (704)
Q Consensus 196 ~~~~~~~~~~~~LV~Ey~~g~ll~~~~~~~~~l~e~~~~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~g~iKL~DF 275 (704)
++.. .+|||||+++..... +++..+..++.||+.+|.|||++||+||||||+||||+++ .++|+||
T Consensus 81 ~~~~------~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 81 AWEG------NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp EEET------TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred EecC------CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEEC
Confidence 6531 279999999865433 3445567899999999999999999999999999999865 5899999
Q ss_pred ccccccCCCCCCCcccccccccccC------cccccCCCCCCCccchhhHHH
Q 005289 276 GLANFSNTGHRQPLTSRVVTLWYRP------PELLLGATDYGPSVDLWSVGC 321 (704)
Q Consensus 276 Gla~~~~~~~~~~~~~~~gT~~Y~A------PEvl~~~~~y~~~~DIWSlG~ 321 (704)
|+|......... .|.. .+.+. +.|+..+||||+.-
T Consensus 147 G~a~~~~~~~~~---------~~l~rd~~~~~~~f~--r~y~~~~d~~s~~~ 187 (191)
T d1zara2 147 PQSVEVGEEGWR---------EILERDVRNIITYFS--RTYRTEKDINSAID 187 (191)
T ss_dssp TTCEETTSTTHH---------HHHHHHHHHHHHHHH--HHHCCCCCHHHHHH
T ss_pred CCcccCCCCCcH---------HHHHHHHHHHHHHHc--CCCCCcccHHHHHH
Confidence 999765432111 1111 11121 46889999999753
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.30 E-value=7.9e-07 Score=88.10 Aligned_cols=84 Identities=10% Similarity=0.033 Sum_probs=56.7
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeEEEeecCCCeEEE
Q 005289 130 DAFEKLEKIGQGTYSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNIIKLEGLITSRLSCSIYL 208 (704)
Q Consensus 130 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~~~L 208 (704)
..|+.++..+.++.+.||++. ..++.+.||+....... ....+.+|..+|..|. +--+.+++.+... ....||
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~--~~~~~l 87 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNL 87 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEEec--CCceEE
Confidence 467777766656667999986 35667888887543211 1223567888888773 4345677766665 467899
Q ss_pred EEecccccccc
Q 005289 209 VFEYMEHDITG 219 (704)
Q Consensus 209 V~Ey~~g~ll~ 219 (704)
||++++|..+.
T Consensus 88 v~~~l~G~~~~ 98 (263)
T d1j7la_ 88 LMSEADGVLCS 98 (263)
T ss_dssp EEECCSSEEHH
T ss_pred EEEeccccccc
Confidence 99999985543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.01 E-value=1.8e-05 Score=77.55 Aligned_cols=74 Identities=14% Similarity=0.090 Sum_probs=49.3
Q ss_pred EeeccC-ceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC--CCceeEeEEEeecCCCeEEEEEecc
Q 005289 137 KIGQGT-YSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDH--PNIIKLEGLITSRLSCSIYLVFEYM 213 (704)
Q Consensus 137 ~LG~G~-fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~H--pnIv~l~~~~~~~~~~~~~LV~Ey~ 213 (704)
.+..|. -+.||++.. ..+..+.||....... ..+.+|+.+|+.|.. -.+.+++.+..+ ....++||+++
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~--~~~~~~v~~~i 88 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDWLLLGEV 88 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEEEEEECC
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeeccc--ccceEEEEEee
Confidence 444454 368999974 4566788898654332 235678888887732 335667766655 46789999999
Q ss_pred ccccc
Q 005289 214 EHDIT 218 (704)
Q Consensus 214 ~g~ll 218 (704)
+|..+
T Consensus 89 ~G~~~ 93 (255)
T d1nd4a_ 89 PGQDL 93 (255)
T ss_dssp SSEET
T ss_pred ecccc
Confidence 87543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.80 E-value=1.3e-05 Score=84.79 Aligned_cols=76 Identities=21% Similarity=0.248 Sum_probs=48.2
Q ss_pred EEEeeccCceEEEEEEECCCCcEEEEEEeec------CCCChHHHHHHHHHHHHHHhc-CC--CCceeEeEEEeecCCCe
Q 005289 135 LEKIGQGTYSSVFRARDLDTGKIVALKKVRF------DNFEPESVRFMAREILILRRL-DH--PNIIKLEGLITSRLSCS 205 (704)
Q Consensus 135 ~~~LG~G~fg~Vy~a~~~~~g~~vAvK~i~~------~~~~~~~~~~~~~Ei~iL~~L-~H--pnIv~l~~~~~~~~~~~ 205 (704)
.+.||.|....||++.+..+++.|+||.-.. +.. +....+...|+.+|+.+ .+ ..+++++.+.. ..
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~-~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~----~~ 105 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESW-PLTIDRARIESSALIRQGEHVPHLVPRVFYSDT----EM 105 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCC-CCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET----TT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCC-CCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC----CC
Confidence 5679999999999999877788999997532 111 11233455688888877 23 34566654432 23
Q ss_pred EEEEEecccc
Q 005289 206 IYLVFEYMEH 215 (704)
Q Consensus 206 ~~LV~Ey~~g 215 (704)
.+||||++++
T Consensus 106 ~~lvmE~L~~ 115 (392)
T d2pula1 106 AVTVMEDLSH 115 (392)
T ss_dssp TEEEECCCTT
T ss_pred CEEEEeccCC
Confidence 4789999976
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.25 E-value=0.00037 Score=71.12 Aligned_cols=69 Identities=14% Similarity=0.228 Sum_probs=44.3
Q ss_pred ceEEEEEEECCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCc-----eeEeE--EEeecCCCeEEEEEecccc
Q 005289 143 YSSVFRARDLDTGKIVALKKVRFDNFEPESVRFMAREILILRRLDHPNI-----IKLEG--LITSRLSCSIYLVFEYMEH 215 (704)
Q Consensus 143 fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-----v~l~~--~~~~~~~~~~~LV~Ey~~g 215 (704)
--.||+++. .+|..|++|+.+..... .+.+..|+.+|..|....| +..-+ .+. .....+.|++++.|
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~--~~~~~~~l~~~~~G 108 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLN--HQGFYFAVFPSVGG 108 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEE--ETTEEEEEEECCCC
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCCC---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeee--eeeEEEEEEeecCC
Confidence 358999985 56888999998765433 3456678988888842222 11111 111 14567899999987
Q ss_pred cc
Q 005289 216 DI 217 (704)
Q Consensus 216 ~l 217 (704)
..
T Consensus 109 ~~ 110 (325)
T d1zyla1 109 RQ 110 (325)
T ss_dssp EE
T ss_pred cC
Confidence 43
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.15 E-value=0.0011 Score=69.35 Aligned_cols=83 Identities=18% Similarity=0.175 Sum_probs=55.0
Q ss_pred ccccccCCeeEEEEeeccCceEEEEEEECC-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEe
Q 005289 124 WVPLRADAFEKLEKIGQGTYSSVFRARDLD-------TGKIVALKKVRFDNFEPESVRFMAREILILRRLD-HPNIIKLE 195 (704)
Q Consensus 124 ~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~-------~g~~vAvK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~ 195 (704)
|..+..+.+++ +.|+.|-.-.+|++.... ..+.|.+++.-. ... .-...+|..+++.+. +.-..+++
T Consensus 37 W~~~~~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~---~idr~~E~~i~~~ls~~gl~Pkll 111 (395)
T d1nw1a_ 37 WKTVPLEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PET---ESHLVAESVIFTLLSERHLGPKLY 111 (395)
T ss_dssp HHHCCGGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCC---HHHHHHHHHHHHHHHHTTSSSCEE
T ss_pred ccCCCccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cch---hhHHHHHHHHHHHHHhCCCCCeEE
Confidence 44444555655 678888889999998653 235677777642 211 234567999999884 44456777
Q ss_pred EEEeecCCCeEEEEEecccccc
Q 005289 196 GLITSRLSCSIYLVFEYMEHDI 217 (704)
Q Consensus 196 ~~~~~~~~~~~~LV~Ey~~g~l 217 (704)
+++.+ .+||||++|..
T Consensus 112 ~~~~~------g~I~efi~g~~ 127 (395)
T d1nw1a_ 112 GIFSG------GRLEEYIPSRP 127 (395)
T ss_dssp EEETT------EEEECCCCEEE
T ss_pred EEcCC------ceEEEEecccc
Confidence 77643 58999999843
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.04 E-value=0.006 Score=61.08 Aligned_cols=30 Identities=30% Similarity=0.450 Sum_probs=26.9
Q ss_pred cCcccccCCCccEEEccCCceEEecccccc
Q 005289 250 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 279 (704)
Q Consensus 250 ~gIvHrDLKp~NILl~~~g~iKL~DFGla~ 279 (704)
.||||+|+.+.|||++.+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 479999999999999988777899999874
|
| >d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Polcalcin domain: Polcalcin Che a 3 species: Pigweed (Chenopodium album) [TaxId: 3559]
Probab=80.59 E-value=0.28 Score=38.39 Aligned_cols=32 Identities=19% Similarity=0.239 Sum_probs=27.9
Q ss_pred ChHHHHHHHHHhHhhcCCCCCcccccccCccc
Q 005289 474 PVEDVAVRTQFAKKINGHSLHILKDDELSGRE 505 (704)
Q Consensus 474 ~~~e~~~~~~~f~~~d~~~~~~~~~~e~~~~~ 505 (704)
+++++..+++.|+.+|.|++|.|+..|+....
T Consensus 1 T~ee~~e~~~~F~~~D~d~~G~I~~~El~~~l 32 (81)
T d2opoa1 1 TPQDIADRERIFKRFDTNGDGKISSSELGDAL 32 (81)
T ss_dssp CHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHH
Confidence 46889999999999999999999999984443
|